Citrus Sinensis ID: 046639

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-
Protein Sequence
KKPAHKDSNMLSMKQQFPMISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETFLGTRI
Secondary Structure (PSIPRED)
cccccccccccccccccccccHHHHHHHHccccccccEEcccccEEEEEEEcccccEEEEEEEEcccccccccHHHHHHHHHcccccccccEEEEcccccccccEEEEEEEcccccccHHHHccccccccccHHHHHHHHHHHHHHHHHHHccccccEEEccccccccccccccEEEEccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHccccccccccccccHHHHHHHHcccccccccccccccccccccHHHHHHHHHHHHHHHHHcccccccccccHHHHHHHHHHHHHHHHcccc
Secondary Structure Prediction (SSPRO)
ccccccccccccccccccEEcHHHHHHHHccccHHcccccccccEEEEEEcccccEEEEEEEEcccccccHHHHHHHHHHHHHHHcHcHHEEEEEEEcccccccccEEEEEEEcccccHHHHHcccccccccHHHHHHHHHHHHHHHHHHHHHccccEEEEccHHHHEEcccccccHHcHHcHHHHcccccccccccccEEEEEEEcccccccHHHHHcccccccHHHHHHHHHHHHHHcccccccccccccccHHHHHHHHHcccHHHHccHHHccccccccccccHHHHHHHHHHHHHHHcccHcccccHHHHHHHHHcHHcccccccc
Coil and Loop (DISEMBL)
kkpahkdsnmlsmkqqfpMISYAELSkatnnfspankigqggVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICssidfegfDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFhhhcqpsivhgdlkpsnilldqDIVAHVGDLGLAKflfgyepgtaaetasnsieIKGIvgyvapeygmgskasvsgdvYNFGILLLEMFtrrrptdamfnegLTLHEFVKmalpdkvmeivdpsllleVTANNYSWIEDCLVAVIGTgvtcsmespmerMEMRDVVAKLRHARETFLGTRI
Flexible Loop (DISEMBL)
kkpahkdsnmlsmkqQFPMISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTaaetasnsieiKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARetflgtri
Low Complexity Region (SEG)
KKPAHKDSNMLSMKQQFPMISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCsmespmermemrDVVAKLRHARETFLGTRI
Disordered region (IsUnstruct)
**********************************ANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCS*****************************
Disordered Region (DISOPRED)
******************MISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLF**************IEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETFLGTR*
Disordered Region (DISEMBL)
*********MLSMKQQFPMISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETFLGTRI
Disordered Region (DISPRO)
**************QQFPMISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRH*R********
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
KKPAHKDSNMLSMKQQFPMISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETFLGTRI
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	331	2.2.26 [Sep-21-2011]
Q9SD62	1025	Putative receptor-like pr	yes	no	0.966	0.312	0.466	8e-80
C0LGP4	1010	Probable LRR receptor-lik	no	no	0.921	0.301	0.452	3e-78
C0LGT6	1031	LRR receptor-like serine/	no	no	0.930	0.298	0.433	2e-70
Q9ZUI0	980	Putative leucine-rich rep	no	no	0.912	0.308	0.404	2e-54
Q9LYN8	1192	Leucine-rich repeat recep	no	no	0.885	0.245	0.333	5e-43
Q9FL28	1173	LRR receptor-like serine/	no	no	0.858	0.242	0.339	2e-41
C0LGQ5	1249	LRR receptor-like serine/	no	no	0.861	0.228	0.338	2e-40
Q9M0G7	1013	Leucine-rich repeat recep	no	no	0.803	0.262	0.317	3e-39
Q9ZVR7	1008	Phytosulfokine receptor 1	no	no	0.845	0.277	0.332	7e-39
Q9FFW5	681	Proline-rich receptor-lik	no	no	0.888	0.431	0.324	9e-39

>sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1

 Score =  297 bits (760), Expect = 8e-80,   Method: Compositional matrix adjust.
 Identities = 154/330 (46%), Positives = 212/330 (64%), Gaps = 10/330 (3%)

Query: 6    KDSNMLSMKQQFPMISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL 65
             D +   +K  +  ISY EL K T  FS +N IG G    V+KG L      VA+KV+NL
Sbjct: 693  NDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNL 752

Query: 66   KQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWL-- 123
             ++ A++SF AEC AL  IRHRNL+K++TICSS DFEG DF+A+V+E+M N NL+ WL  
Sbjct: 753  CKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHP 812

Query: 124  ---RQSNGQLRFLT--QRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHV 178
                ++    R L    R+NIAIDV+ A+ Y H +C   I H D+KPSNILLD+D+ AHV
Sbjct: 813  DEIEETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHV 872

Query: 179  GDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEM 238
             D GLA+ L  ++  T     S S  ++G +GY APEYGMG   S+ GDVY+FGI+LLE+
Sbjct: 873  SDFGLAQLLLKFDRDTFHIQFS-SAGVRGTIGYAAPEYGMGGHPSIMGDVYSFGIVLLEI 931

Query: 239  FTRRRPTDAMFNEGLTLHEFVKMALPDK-VMEIVDPSLLLEVTANNYSWIEDCLVAVIGT 297
            FT +RPT+ +F +GLTLH F K AL  +  ++I D ++L    A +++ +E CL  V   
Sbjct: 932  FTGKRPTNKLFVDGLTLHSFTKSALQKRQALDITDETILRGAYAQHFNMVE-CLTLVFRV 990

Query: 298  GVTCSMESPMERMEMRDVVAKLRHARETFL 327
            GV+CS ESP+ R+ M + ++KL   RE+F 
Sbjct: 991  GVSCSEESPVNRISMAEAISKLVSIRESFF 1020

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1

 Score =  291 bits (746), Expect = 3e-78,   Method: Compositional matrix adjust.
 Identities = 142/314 (45%), Positives = 205/314 (65%), Gaps = 9/314 (2%)

Query: 20   ISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECN 79
            ISY +L  ATN FS +N +G G    VYK +L   + +VAVKV+N++++ A +SF AEC 
Sbjct: 690  ISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRRGAMKSFMAECE 749

Query: 80   ALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSN-------GQLRF 132
            +L++IRHRNL+K++T CSSIDF+G +F+A+++E+M N +L+ WL            +   
Sbjct: 750  SLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLHPEEVEEIHRPSRTLT 809

Query: 133  LTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEP 192
            L +R+NIAIDV+  ++Y H HC   I H DLKPSN+LLD D+ AHV D GLA+ L  ++ 
Sbjct: 810  LLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTAHVSDFGLARLLLKFDE 869

Query: 193  GTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEG 252
             +     S S  ++G +GY APEYG+G + S++GDVY+FGILLLEMFT +RPT+ +F   
Sbjct: 870  ESFFNQLS-SAGVRGTIGYAAPEYGVGGQPSINGDVYSFGILLLEMFTGKRPTNELFGGN 928

Query: 253  LTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEM 312
             TL+ + K ALP+++++IVD S+L       +  +E CL  V   G+ C  ESPM R+  
Sbjct: 929  FTLNSYTKSALPERILDIVDESILHIGLRVGFPVVE-CLTMVFEVGLRCCEESPMNRLAT 987

Query: 313  RDVVAKLRHARETF 326
              VV +L   RE F
Sbjct: 988  SIVVKELISIRERF 1001

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1

 Score =  266 bits (680), Expect = 2e-70,   Method: Compositional matrix adjust.
 Identities = 144/332 (43%), Positives = 201/332 (60%), Gaps = 24/332 (7%)

Query: 7    DSNMLSMKQQFPMISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK 66
            DS  L M  +   +SY EL  AT+ FS  N IG G    V+KG+L     +VAVKV+NL 
Sbjct: 689  DSTTLGMFHE--KVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNLL 746

Query: 67   QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLR-- 124
            +  A++SF AEC   + IRHRNL+K+IT+CSS+D EG DF+A+V+E+M   +L+ WL+  
Sbjct: 747  KHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQLE 806

Query: 125  ---QSNGQLRFLT--QRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVG 179
               + N   R LT  +++NIAIDV+ A+EY H HC   + H D+KPSNILLD D+ AHV 
Sbjct: 807  DLERVNDHSRSLTPAEKLNIAIDVASALEYLHVHCHDPVAHCDIKPSNILLDDDLTAHVS 866

Query: 180  DLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMF 239
            D GLA+ L+ Y+  +     S S  ++G +GY APEYGMG + S+ GDVY+FGILLLEMF
Sbjct: 867  DFGLAQLLYKYDRESFLNQFS-SAGVRGTIGYAAPEYGMGGQPSIQGDVYSFGILLLEMF 925

Query: 240  TRRRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYS-WIEDCLVAVIGTG 298
            + ++PTD  F     LH + K             S+L   T++  S  I++ L  V+  G
Sbjct: 926  SGKKPTDESFAGDYNLHSYTK-------------SILSGCTSSGGSNAIDEGLRLVLQVG 972

Query: 299  VTCSMESPMERMEMRDVVAKLRHARETFLGTR 330
            + CS E P +RM   + V +L   R  F  ++
Sbjct: 973  IKCSEEYPRDRMRTDEAVRELISIRSKFFSSK 1004

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1

 Score =  213 bits (541), Expect = 2e-54,   Method: Compositional matrix adjust.
 Identities = 130/321 (40%), Positives = 184/321 (57%), Gaps = 19/321 (5%)

Query: 16  QFPMISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK-EASRSF 74
           ++P ISY +L  AT  F+ ++ IG G    VYKG+L  + + VAVKV++ K   E S SF
Sbjct: 645 KYPRISYQQLIAATGGFNASSLIGSGRFGHVYKGVL-RNNTKVAVKVLDPKTALEFSGSF 703

Query: 75  AAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWL---RQSNGQLR 131
             EC  L+  RHRNLI+IIT CS   F      A+V   M N +LE+ L     S+  L 
Sbjct: 704 KRECQILKRTRHRNLIRIITTCSKPGF-----NALVLPLMPNGSLERHLYPGEYSSKNLD 758

Query: 132 FLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYE 191
            L Q VNI  DV+  I Y HH+    +VH DLKPSNILLD ++ A V D G+++ + G E
Sbjct: 759 -LIQLVNICSDVAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVE 817

Query: 192 PGTAAETA----SNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDA 247
              + + +    S    + G VGY+APEYGMG +AS  GDVY+FG+LLLE+ + RRPTD 
Sbjct: 818 ETVSTDDSVSFGSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVSGRRPTDV 877

Query: 248 MFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIE----DCLVAVIGTGVTCSM 303
           + NEG +LHEF+K   PD +  I++ +L            E    + ++ +I  G+ C+ 
Sbjct: 878 LVNEGSSLHEFMKSHYPDSLEGIIEQALSRWKPQGKPEKCEKLWREVILEMIELGLVCTQ 937

Query: 304 ESPMERMEMRDVVAKLRHARE 324
            +P  R +M DV  ++   +E
Sbjct: 938 YNPSTRPDMLDVAHEMGRLKE 958

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1

 Score =  175 bits (443), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 106/318 (33%), Positives = 172/318 (54%), Gaps = 25/318 (7%)

Query: 9    NMLSMKQQFPMISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK 68
            N+   +Q    +   ++ +AT++FS  N IG GG   VYK  L   ++ VAVK ++  + 
Sbjct: 894  NIAMFEQPLLKVRLGDIVEATDHFSKKNIIGDGGFGTVYKACLPGEKT-VAVKKLSEAKT 952

Query: 69   EASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNG 128
            + +R F AE   L  ++H NL+ ++  CS   F   + K +V+EYM N +L+ WLR   G
Sbjct: 953  QGNREFMAEMETLGKVKHPNLVSLLGYCS---FS--EEKLLVYEYMVNGSLDHWLRNQTG 1007

Query: 129  QLRFL--TQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF 186
             L  L  ++R+ IA+  +  + + HH   P I+H D+K SNILLD D    V D GLA+ 
Sbjct: 1008 MLEVLDWSKRLKIAVGAARGLAFLHHGFIPHIIHRDIKASNILLDGDFEPKVADFGLARL 1067

Query: 187  LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTD 246
            +      +A E+  +++ I G  GY+ PEYG  ++A+  GDVY+FG++LLE+ T + PT 
Sbjct: 1068 I------SACESHVSTV-IAGTFGYIPPEYGQSARATTKGDVYSFGVILLELVTGKEPTG 1120

Query: 247  AMFNE---GLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSM 303
              F E   G  +   ++     K ++++DP LL+ V   N        + ++   + C  
Sbjct: 1121 PDFKESEGGNLVGWAIQKINQGKAVDVIDP-LLVSVALKNSQ------LRLLQIAMLCLA 1173

Query: 304  ESPMERMEMRDVVAKLRH 321
            E+P +R  M DV+  L+ 
Sbjct: 1174 ETPAKRPNMLDVLKALKE 1191

Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1

 Score =  169 bits (428), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 106/312 (33%), Positives = 174/312 (55%), Gaps = 28/312 (8%)

Query: 24   ELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ--KEASRSFAAECNAL 81
            EL +AT++F+ AN IG   +S VYKG L E  +++AVKV+NLK+   E+ + F  E   L
Sbjct: 862  ELEQATDSFNSANIIGSSSLSTVYKGQL-EDGTVIAVKVLNLKEFSAESDKWFYTEAKTL 920

Query: 82   RNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI 141
              ++HRNL+KI+       +E    KA+V  +M+N NLE  +  S   +  L +++++ +
Sbjct: 921  SQLKHRNLVKILGFA----WESGKTKALVLPFMENGNLEDTIHGSAAPIGSLLEKIDLCV 976

Query: 142  DVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASN 201
             ++  I+Y H      IVH DLKP+NILLD D VAHV D G A+ L   E G+   TAS 
Sbjct: 977  HIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARILGFREDGST--TAST 1034

Query: 202  SIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPT--DAMFNEGLTLHEFV 259
            S   +G +GY+APE+    K +   DV++FGI+++E+ T++RPT  +   ++ +TL + V
Sbjct: 1035 S-AFEGTIGYLAPEFAYMRKVTTKADVFSFGIIMMELMTKQRPTSLNDEDSQDMTLRQLV 1093

Query: 260  KMALPDKV--------MEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERME 311
            + ++ +          ME+ D  + L+       +++ CL         C+   P +R +
Sbjct: 1094 EKSIGNGRKGMVRVLDMELGDSIVSLKQEEAIEDFLKLCLF--------CTSSRPEDRPD 1145

Query: 312  MRDVVAKLRHAR 323
            M +++  L   R
Sbjct: 1146 MNEILTHLMKLR 1157

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1

 Score =  166 bits (420), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 107/316 (33%), Positives = 163/316 (51%), Gaps = 31/316 (9%)

Query: 20   ISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECN 79
            I + ++ +AT+N S    IG GG   VYK  L+   ++   K++      +++SF+ E  
Sbjct: 939  IRWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKILWKDDLMSNKSFSREVK 998

Query: 80   ALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSN------GQLRFL 133
             L  IRHR+L+K++  CSS   EG +   +++EYM+N ++  WL +         +L   
Sbjct: 999  TLGRIRHRHLVKLMGYCSS-KSEGLNL--LIYEYMKNGSIWDWLHEDKPVLEKKKKLLDW 1055

Query: 134  TQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPG 193
              R+ IA+ ++  +EY HH C P IVH D+K SN+LLD ++ AH+GD GLAK L      
Sbjct: 1056 EARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVL---TEN 1112

Query: 194  TAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGL 253
                T SN+       GY+APEY    KA+   DVY+ GI+L+E+ T + PTD++F   +
Sbjct: 1113 CDTNTDSNTW-FACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAEM 1171

Query: 254  TLHEFVKMALP------DKVMEIVDPSL--LLEVTANNYSWIEDCLVAVIGTGVTCSMES 305
             +  +V+  L       DK   ++DP L  LL          ED    V+   + C+  S
Sbjct: 1172 DMVRWVETHLEVAGSARDK---LIDPKLKPLLPFE-------EDAACQVLEIALQCTKTS 1221

Query: 306  PMERMEMRDVVAKLRH 321
            P ER   R     L H
Sbjct: 1222 PQERPSSRQACDSLLH 1237

Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M0G7|PXL2_ARATH Leucine-rich repeat receptor-like protein kinase PXL2 OS=Arabidopsis thaliana GN=PXL2 PE=2 SV=1

 Score =  162 bits (411), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 96/302 (31%), Positives = 158/302 (52%), Gaps = 36/302 (11%)

Query: 35  ANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKE----ASRSFAAECNALRNIRHRNLI 90
           +N IG G   IVYK  +  S +++AVK +     +     +  F  E N L  +RHRN++
Sbjct: 702 SNMIGMGATGIVYKAEMSRSSTVLAVKKLWRSAADIEDGTTGDFVGEVNLLGKLRHRNIV 761

Query: 91  KIITICSSIDFEGFDFK----AIVFEYMQNRNLEQWLRQSNGQLRFLT---QRVNIAIDV 143
           +++         GF +      IV+E+M N NL   +   N   R L     R NIA+ V
Sbjct: 762 RLL---------GFLYNDKNMMIVYEFMLNGNLGDAIHGKNAAGRLLVDWVSRYNIALGV 812

Query: 144 SFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSI 203
           +  + Y HH C P ++H D+K +NILLD ++ A + D GLA+ +         ET S   
Sbjct: 813 AHGLAYLHHDCHPPVIHRDIKSNNILLDANLDARIADFGLARMM-----ARKKETVS--- 864

Query: 204 EIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMAL 263
            + G  GY+APEYG   K     D+Y++G++LLE+ T RRP +  F E + + E+V+  +
Sbjct: 865 MVAGSYGYIAPEYGYTLKVDEKIDIYSYGVVLLELLTGRRPLEPEFGESVDIVEWVRRKI 924

Query: 264 PDKVM--EIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRH 321
            D +   E +DP++       N  ++++ ++ V+   + C+ + P +R  MRDV++ L  
Sbjct: 925 RDNISLEEALDPNV------GNCRYVQEEMLLVLQIALLCTTKLPKDRPSMRDVISMLGE 978

Query: 322 AR 323
           A+
Sbjct: 979 AK 980

Involved in the regulation of procambium maintenance and polarity during vascular-tissue development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZVR7|PSKR1_ARATH Phytosulfokine receptor 1 OS=Arabidopsis thaliana GN=PSKR1 PE=2 SV=4

 Score =  161 bits (407), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 101/304 (33%), Positives = 157/304 (51%), Gaps = 24/304 (7%)

Query: 20   ISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECN 79
            +SY +L  +TN+F  AN IG GG  +VYK  L + +  VA+K ++    +  R F AE  
Sbjct: 722  LSYDDLLDSTNSFDQANIIGCGGFGMVYKATLPDGKK-VAIKKLSGDCGQIEREFEAEVE 780

Query: 80   ALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLT--QRV 137
             L   +H NL+ +   C    F   D + +++ YM+N +L+ WL + N     L    R+
Sbjct: 781  TLSRAQHPNLVLLRGFC----FYKND-RLLIYSYMENGSLDYWLHERNDGPALLKWKTRL 835

Query: 138  NIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAE 197
             IA   +  + Y H  C P I+H D+K SNILLD++  +H+ D GLA+ +  YE      
Sbjct: 836  RIAQGAAKGLLYLHEGCDPHILHRDIKSSNILLDENFNSHLADFGLARLMSPYETHV--- 892

Query: 198  TASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLT--L 255
                S ++ G +GY+ PEYG  S A+  GDVY+FG++LLE+ T +RP D    +G    +
Sbjct: 893  ----STDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTDKRPVDMCKPKGCRDLI 948

Query: 256  HEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDV 315
               VKM    +  E+ DP  L+    N+       +  V+     C  E+P +R   + +
Sbjct: 949  SWVVKMKHESRASEVFDP--LIYSKENDKE-----MFRVLEIACLCLSENPKQRPTTQQL 1001

Query: 316  VAKL 319
            V+ L
Sbjct: 1002 VSWL 1005

Phytosulfokine receptor with a serine/threonine-protein kinase activity. Regulates, in response to phytosulfokine binding, a signaling cascade involved in plant cell differentiation, organogenesis, somatic embryogenesis, cellular proliferation and plant growth. Not involved in PSY perception.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FFW5|PERK8_ARATH Proline-rich receptor-like protein kinase PERK8 OS=Arabidopsis thaliana GN=PERK8 PE=1 SV=1

 Score =  160 bits (406), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 105/324 (32%), Positives = 156/324 (48%), Gaps = 30/324 (9%)

Query: 4   AHKDSNMLSMKQQFPMISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVV 63
           A  DS M+S ++ +   SY ELS+ T+ FS  N +G+GG   VYKG+L + R  VAVK +
Sbjct: 313 ASSDSGMVSNQRSW--FSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGRE-VAVKQL 369

Query: 64  NLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWL 123
            +   +  R F AE   +  + HR+L+ ++  C S        + +V++Y+ N  L   L
Sbjct: 370 KIGGSQGEREFKAEVEIISRVHHRHLVTLVGYCISEQH-----RLLVYDYVPNNTLHYHL 424

Query: 124 RQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGL 183
                 +     RV +A   +  I Y H  C P I+H D+K SNILLD    A V D GL
Sbjct: 425 HAPGRPVMTWETRVRVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGL 484

Query: 184 AKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRR 243
           AK     +  T   T      + G  GY+APEY    K S   DVY++G++LLE+ T R+
Sbjct: 485 AKIAQELDLNTHVST-----RVMGTFGYMAPEYATSGKLSEKADVYSYGVILLELITGRK 539

Query: 244 PTDAMFNEGLTLHEFVKMALP--------DKVMEIVDPSLLLEVTANNYSWIEDCLVAVI 295
           P D   ++ L     V+ A P        ++  E+VDP L         ++I   +  ++
Sbjct: 540 PVDT--SQPLGDESLVEWARPLLGQAIENEEFDELVDPRL-------GKNFIPGEMFRMV 590

Query: 296 GTGVTCSMESPMERMEMRDVVAKL 319
                C   S  +R +M  VV  L
Sbjct: 591 EAAAACVRHSAAKRPKMSQVVRAL 614

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	331
224141953	1026	predicted protein [Populus trichocarpa]	0.978	0.315	0.513	7e-94
224127492	1022	predicted protein [Populus trichocarpa]	0.969	0.314	0.5	3e-93
359482058	1040	PREDICTED: probable LRR receptor-like se	0.939	0.299	0.511	2e-92
147853780	1904	hypothetical protein VITISV_030954 [Viti	0.939	0.163	0.511	1e-91
359486510	965	PREDICTED: probable LRR receptor-like se	0.933	0.320	0.521	6e-91
255571897	1013	serine-threonine protein kinase, plant-t	0.945	0.308	0.523	2e-90
224119102	1007	predicted protein [Populus trichocarpa]	0.930	0.305	0.528	9e-90
224119106	919	predicted protein [Populus trichocarpa]	0.930	0.335	0.525	2e-89
224117950	1018	predicted protein [Populus trichocarpa]	0.942	0.306	0.506	4e-89
224119098	768	predicted protein [Populus trichocarpa]	0.930	0.401	0.525	4e-89

>gi|224141953|ref|XP_002324325.1| predicted protein [Populus trichocarpa] gi|222865759|gb|EEF02890.1| predicted protein [Populus trichocarpa]

 Score =  350 bits (897), Expect = 7e-94,   Method: Compositional matrix adjust.
 Identities = 174/339 (51%), Positives = 229/339 (67%), Gaps = 15/339 (4%)

Query: 1    KKPAHKDSNMLSMKQQFPMISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAV 60
            K+  H    +L  K+ FP ISY  L KAT+ FS  N IG G  S VYKG +DE  ++VA+
Sbjct: 676  KRKEHSSDTLL--KESFPQISYERLFKATDGFSTTNLIGVGSFSSVYKGRIDEDGTLVAI 733

Query: 61   KVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLE 120
            KV+NL+++ AS+SF  EC ALRNIRHRNL+KIIT CSSIDF+G +FKA+V+EYM   +LE
Sbjct: 734  KVLNLQRRGASKSFKDECEALRNIRHRNLVKIITSCSSIDFQGNNFKALVYEYMPKGSLE 793

Query: 121  QWLRQSNG----------QLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILL 170
            +WL  +            Q   L +R+NIAIDV+ A++Y HHHC   I+H D+KPSNILL
Sbjct: 794  KWLHPTQETHDDQQINQVQRPNLLERINIAIDVAAALDYLHHHCHSPIIHCDVKPSNILL 853

Query: 171  DQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYN 230
            D+D++ H+GD GLA+    ++  +     S+S  IKG  GY APEYG G + S+ GDVY+
Sbjct: 854  DKDMIGHLGDFGLARI---FQEFSEPSLESSSAGIKGTTGYAAPEYGQGREVSIDGDVYS 910

Query: 231  FGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDC 290
            +GILLLEM T +RP D  F +GL LH F KMALPD V+EI DP LL E    N + +E+C
Sbjct: 911  YGILLLEMMTGKRPIDDTFEKGLNLHMFAKMALPDHVIEITDPVLLSERHLENAASMEEC 970

Query: 291  LVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETFLGT 329
            L +++  GV CSM+SP +RM+M  VV +L   R+TF GT
Sbjct: 971  LTSLVKIGVACSMDSPRDRMDMSRVVRELLMVRDTFQGT 1009

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224127492|ref|XP_002329291.1| predicted protein [Populus trichocarpa] gi|222870745|gb|EEF07876.1| predicted protein [Populus trichocarpa]

 Score =  348 bits (892), Expect = 3e-93,   Method: Compositional matrix adjust.
 Identities = 174/348 (50%), Positives = 235/348 (67%), Gaps = 27/348 (7%)

Query: 2    KPAHKDSNMLSMKQQFPMISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVK 61
            KPA       S++  FP ++Y +L  AT+ FS AN IG+G    V+KGIL   + +VAVK
Sbjct: 682  KPAASQP---SLETSFPRVAYEDLLGATDGFSSANLIGEGSFGSVFKGILGPDKIVVAVK 738

Query: 62   VVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQ 121
            V+NL +K AS+SF AEC AL++IRHRNL+K++T CSSIDF+G DFKA+V+E+M N NLE+
Sbjct: 739  VLNLLRKGASKSFMAECEALKSIRHRNLVKLLTTCSSIDFQGNDFKALVYEFMVNGNLEE 798

Query: 122  WLR------QSNGQLRF-LTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDI 174
            WL       ++NG     L  R+NIAI ++ A+ Y HH CQ  I+H DLKPSNILLD ++
Sbjct: 799  WLHPVQTSDEANGPKALDLMHRLNIAIHMASALNYLHHDCQMPIIHCDLKPSNILLDTNM 858

Query: 175  VAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGIL 234
             AHVGD GLA+F       + A   ++S+ +KG +GY APEYG+G K S  GDVY++GIL
Sbjct: 859  TAHVGDFGLARF------HSEASNQTSSVGLKGTIGYAAPEYGIGGKVSTYGDVYSYGIL 912

Query: 235  LLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYS--------- 285
            LLEMFT +RP D MF +GL LH + KMALPD+++E+VDP L+ E+ + N S         
Sbjct: 913  LLEMFTGKRPVDGMFKDGLNLHSYAKMALPDRIVEVVDPLLVREIRSVNSSDEMGMYHIG 972

Query: 286  --WIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETFLGTRI 331
               I  CL+ +I  GV CS+E P ERM++ DVV +L   ++T LGTR+
Sbjct: 973  PHEISACLMTIIKMGVACSVELPRERMDIGDVVTELNRIKDTLLGTRM 1020

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359482058|ref|XP_002274540.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera]

 Score =  345 bits (884), Expect = 2e-92,   Method: Compositional matrix adjust.
 Identities = 171/334 (51%), Positives = 231/334 (69%), Gaps = 23/334 (6%)

Query: 20   ISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECN 79
            +SY  L KAT  FS AN IG GG   VYKGIL +  ++VAVKV+ L Q+ A +SF AEC 
Sbjct: 701  VSYDGLFKATGGFSSANLIGTGGFGSVYKGILGQDETVVAVKVIQLHQRGAVKSFKAECE 760

Query: 80   ALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLR------QSNGQLRFL 133
            ALRNIRHRNL+K++T CSS+D++G DFKA+V+E+M N +LE WL       + N  LR L
Sbjct: 761  ALRNIRHRNLVKVLTTCSSVDYQGNDFKALVYEFMPNGSLENWLHPVPTPDEINDVLRIL 820

Query: 134  T--QRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYE 191
            +  QR+NIAIDV+ A++Y HHHC   IVH DLKPSNILLD D+ AHVGD GLA+F+    
Sbjct: 821  SLPQRLNIAIDVASALDYLHHHCHKPIVHCDLKPSNILLDNDMTAHVGDFGLARFI-PEA 879

Query: 192  PGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNE 251
             G +  + S+SI +KG +GY APEYGMG+K S  GD Y++GILLLEMFT +RPT++MF++
Sbjct: 880  AGRSHPSQSSSIGLKGTIGYAAPEYGMGTKVSALGDTYSYGILLLEMFTGKRPTESMFSD 939

Query: 252  GLTLHEFVKMALPDKVMEIVDPSLLL------EVTANNYSWI--------EDCLVAVIGT 297
             L LH FVKMALP+++ +I+DP  L       E TA + S +         +CL++++  
Sbjct: 940  QLNLHNFVKMALPERIADIIDPFFLSSEAKEEETTAADSSNLAHMKREKMHECLISILRI 999

Query: 298  GVTCSMESPMERMEMRDVVAKLRHARETFLGTRI 331
            GV+CS+ESP ERM + + + +L+  R+  LG  +
Sbjct: 1000 GVSCSLESPRERMAITEAIKELQLIRKILLGNGV 1033

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147853780|emb|CAN83822.1| hypothetical protein VITISV_030954 [Vitis vinifera]

 Score =  342 bits (877), Expect = 1e-91,   Method: Compositional matrix adjust.
 Identities = 171/334 (51%), Positives = 230/334 (68%), Gaps = 23/334 (6%)

Query: 20   ISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECN 79
            +SY  L KAT  FS AN IG GG   VYKG L +  ++VAVKV+ L Q+ A +SF AEC 
Sbjct: 732  VSYDGLFKATGGFSSANLIGTGGFGSVYKGXLGQDETVVAVKVIQLHQRGAVKSFKAECE 791

Query: 80   ALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLR------QSNGQLRFL 133
            ALRNIRHRNL+K++T CSS+D++G DFKA+V+E+M N +LE WL       + N  LR L
Sbjct: 792  ALRNIRHRNLVKVLTTCSSVDYQGNDFKALVYEFMPNGSLENWLHPVPTPDEINDVLRIL 851

Query: 134  T--QRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYE 191
            +  QR+NIAIDV+ A++Y HHHC   IVH DLKPSNILLD D+ AHVGD GLA+F+    
Sbjct: 852  SLPQRLNIAIDVASALDYLHHHCHKPIVHCDLKPSNILLDNDMTAHVGDFGLARFI-PEA 910

Query: 192  PGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNE 251
             G +  + S+SI +KG +GY APEYGMG+K S  GD Y++GILLLEMFT +RPT++MF++
Sbjct: 911  AGRSHPSQSSSIGLKGTIGYAAPEYGMGTKVSALGDTYSYGILLLEMFTGKRPTESMFSD 970

Query: 252  GLTLHEFVKMALPDKVMEIVDPSLLL------EVTANNYSWI--------EDCLVAVIGT 297
             L LH FVKMALP+++ +I+DP  L       E TA + S +         +CL++++  
Sbjct: 971  QLNLHNFVKMALPERIADIIDPFFLSSEAKEEETTAADSSNLAHMKREKMHECLISILRI 1030

Query: 298  GVTCSMESPMERMEMRDVVAKLRHARETFLGTRI 331
            GV+CS+ESP ERM + + + +L+  R+  LG  I
Sbjct: 1031 GVSCSLESPRERMAITEAIKELQLIRKILLGNGI 1064

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359486510|ref|XP_002271317.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like, partial [Vitis vinifera]

 Score =  340 bits (872), Expect = 6e-91,   Method: Compositional matrix adjust.
 Identities = 173/332 (52%), Positives = 226/332 (68%), Gaps = 23/332 (6%)

Query: 20  ISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECN 79
           +SY  L +AT+ FS +N IG G    VYKGILD   + +AVKV+NL +K AS+SF AEC 
Sbjct: 626 VSYQSLLRATDGFSSSNLIGVGSFGSVYKGILDHDGTAIAVKVLNLLRKGASKSFIAECE 685

Query: 80  ALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNG---------QL 130
           ALRNIRHRNL+K++T CS +D++G DFKA+V+E+M N +LEQWL  +           +L
Sbjct: 686 ALRNIRHRNLVKVLTACSGVDYQGNDFKAVVYEFMVNGSLEQWLHPTPTTAEASAPPRKL 745

Query: 131 RFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGY 190
            FL QR+NIAIDV+ A++Y HH CQ  IVH DLKPSN+LLD ++  HVGD G+AKFL   
Sbjct: 746 NFL-QRLNIAIDVACALDYLHHQCQTPIVHCDLKPSNVLLDTEMTGHVGDFGIAKFL--P 802

Query: 191 EPGT-AAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMF 249
           E  T   E  S+SI I+G +GY APEYGMGS+ S SGDVY+FGILLLEMFT +RPT+ MF
Sbjct: 803 EAATRVPEIQSSSIGIRGTIGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKRPTEDMF 862

Query: 250 NEGLTLHEFVKMALPDKVMEIVDPSLLLE-VTANNYSW---------IEDCLVAVIGTGV 299
            + L +H FVK A+P++V EI DP LL E V  +N +           ++CL+++ G G+
Sbjct: 863 KDSLNIHNFVKTAVPERVAEIADPVLLQEGVEMDNTTSQRRMASSHDAQECLISIFGIGL 922

Query: 300 TCSMESPMERMEMRDVVAKLRHARETFLGTRI 331
            CS E P ER  + D  A+L   R+ FLGT +
Sbjct: 923 ACSAELPRERKNITDAAAELNSVRDIFLGTGL 954

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255571897|ref|XP_002526891.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223533790|gb|EEF35522.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  338 bits (866), Expect = 2e-90,   Method: Compositional matrix adjust.
 Identities = 169/323 (52%), Positives = 226/323 (69%), Gaps = 10/323 (3%)

Query: 11   LSMKQQFPMISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEA 70
            LS+K QF  ISY EL +AT+ FS AN IG G    VY+G L +S+S +AVKV NL+ + A
Sbjct: 686  LSLKDQFIKISYQELLQATDGFSDANLIGFGSYGSVYRGFLHQSQSFIAVKVFNLRHRGA 745

Query: 71   SRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLR-----Q 125
            S+SF +EC AL++IRHRNL+KI ++C+S+D++G DF+A+++E+M   +LE WL       
Sbjct: 746  SKSFISECKALKHIRHRNLLKISSVCASVDYQGNDFRAVIYEFMPRGSLESWLHPQEVAD 805

Query: 126  SNGQLRFLT--QRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGL 183
            +  +LR L   QR++IAI V+ A+EY H HCQP IVH DLKPSN+LLD+D+VAHVGD GL
Sbjct: 806  NEHELRNLNLEQRLSIAIGVASAVEYLHCHCQPPIVHSDLKPSNVLLDEDMVAHVGDFGL 865

Query: 184  AKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRR 243
            AK L       A E  S+S+ IKG VGYV PEYGMG   S  GD Y+FGILLLE+FT RR
Sbjct: 866  AKVLSKVS-DNAREDQSSSVIIKGSVGYVPPEYGMGEGLSTQGDAYSFGILLLEIFTARR 924

Query: 244  PTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSM 303
            PTD MF   L LH F +MALP++V +IVDP LL E   N    +++CL +V+  G++CS 
Sbjct: 925  PTDGMFQGELNLHNFCRMALPERVRDIVDPLLLPE--ENTGERVQNCLASVLRIGLSCST 982

Query: 304  ESPMERMEMRDVVAKLRHARETF 326
            E+P +RME+R+ V +L   +  +
Sbjct: 983  ETPRDRMEIRNAVRELHLVKNAY 1005

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224119102|ref|XP_002331325.1| predicted protein [Populus trichocarpa] gi|222873908|gb|EEF11039.1| predicted protein [Populus trichocarpa]

 Score =  336 bits (861), Expect = 9e-90,   Method: Compositional matrix adjust.
 Identities = 168/318 (52%), Positives = 222/318 (69%), Gaps = 10/318 (3%)

Query: 20   ISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECN 79
            +SY  L KATN FS  N IG G    VYKGILD + + VAVKV+NL+++ AS+SF AEC 
Sbjct: 692  VSYQSLLKATNGFSSINLIGTGSFGSVYKGILDHNGTAVAVKVLNLRRQGASKSFMAECE 751

Query: 80   ALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQ-----LRFLT 134
            AL N+RHRNL+K++T CS +D+ G DFKA+V+E+M N +LE WL  S        +  LT
Sbjct: 752  ALPNVRHRNLVKVVTACSGVDYHGNDFKALVYEFMVNGSLETWLHPSRATDEVRGILDLT 811

Query: 135  QRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGT 194
            QR++IAIDV+ A++YFHH C+  IVH DLKP N+LLD ++V HVGD GLAKFL   +   
Sbjct: 812  QRLSIAIDVAHALDYFHHQCEKQIVHCDLKPGNVLLDDEMVGHVGDFGLAKFLL-EDTLH 870

Query: 195  AAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLT 254
             +   S+SI I+G +GY  PEYG G++ S  GDVY++GILLLEMFT +RPTD +FN GL 
Sbjct: 871  HSTNPSSSIGIRGTIGYTPPEYGAGNEVSAYGDVYSYGILLLEMFTGKRPTDDLFN-GLN 929

Query: 255  LHEFVKMALPDKVMEIVDPSLL---LEVTANNYSWIEDCLVAVIGTGVTCSMESPMERME 311
            LH +VK  LP+KV++I DP+L     E  +   + +  CLV+V  TG++CS+ESP ERM 
Sbjct: 930  LHSYVKTFLPEKVLQIADPTLPQINFEGNSIEQNRVLQCLVSVFTTGISCSVESPQERMG 989

Query: 312  MRDVVAKLRHARETFLGT 329
            + DV+A+L  AR   LGT
Sbjct: 990  IADVIAQLFSARNELLGT 1007

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224119106|ref|XP_002331326.1| predicted protein [Populus trichocarpa] gi|222873909|gb|EEF11040.1| predicted protein [Populus trichocarpa]

 Score =  335 bits (858), Expect = 2e-89,   Method: Compositional matrix adjust.
 Identities = 167/318 (52%), Positives = 221/318 (69%), Gaps = 10/318 (3%)

Query: 20  ISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECN 79
           +SY  L KATN FS  N IG G    VYKGILD + + VAVKV+NL ++ AS+SF AEC 
Sbjct: 604 VSYQSLLKATNGFSSINLIGTGSFGSVYKGILDHNGTAVAVKVLNLTRQGASKSFMAECE 663

Query: 80  ALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQ-----LRFLT 134
           AL N+RHRNL+K++T CS +D+ G DFKA+V+E+M N +LE WL  S        +  LT
Sbjct: 664 ALPNVRHRNLVKVVTACSGVDYHGNDFKALVYEFMVNGSLETWLHPSRATDEVRGILDLT 723

Query: 135 QRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGT 194
           QR++IAIDV+ A++YFHH C+  IVH DLKP N+LLD ++V HVGD GLAKFL   +   
Sbjct: 724 QRLSIAIDVAHALDYFHHQCEKQIVHCDLKPGNVLLDDEMVGHVGDFGLAKFLL-EDTLH 782

Query: 195 AAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLT 254
            +   S+SI I+G +GY  PEYG G++ S  GDVY++GILLLEMFT +RPTD +FN GL 
Sbjct: 783 HSTNPSSSIGIRGTIGYAPPEYGAGNEVSAYGDVYSYGILLLEMFTGKRPTDDLFN-GLN 841

Query: 255 LHEFVKMALPDKVMEIVDPSLL---LEVTANNYSWIEDCLVAVIGTGVTCSMESPMERME 311
           LH +VK  LP+KV++I DP+L     E  +   + +  CLV++  TG++CS+ESP ERM 
Sbjct: 842 LHSYVKTFLPEKVLQIADPTLPQINFEGNSIEQNRVLQCLVSIFTTGISCSVESPQERMG 901

Query: 312 MRDVVAKLRHARETFLGT 329
           + DV+A+L  AR   LGT
Sbjct: 902 IADVIAQLFSARNELLGT 919

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224117950|ref|XP_002317696.1| predicted protein [Populus trichocarpa] gi|222858369|gb|EEE95916.1| predicted protein [Populus trichocarpa]

 Score =  334 bits (856), Expect = 4e-89,   Method: Compositional matrix adjust.
 Identities = 166/328 (50%), Positives = 226/328 (68%), Gaps = 16/328 (4%)

Query: 12   SMKQQFPMISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEAS 71
            +M+++F ++SY +L++AT+ FS AN IG GG   VYKGIL      VA+KV+  +Q+ A+
Sbjct: 687  TMEKKFQIVSYQDLARATDGFSSANMIGDGGYGSVYKGILGPDGQTVAIKVLKPEQRGAN 746

Query: 72   RSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQS----- 126
            R+F AEC  LR IRHRNL+KI+T CSSIDF+G DFKA+VF++M   +LE WL  S     
Sbjct: 747  RTFVAECETLRRIRHRNLVKIVTACSSIDFKGNDFKALVFDFMPGGSLESWLHPSAVESQ 806

Query: 127  NGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF 186
            N +   L QR+++ IDV+ A++Y H+HC   IVH DLKPSNILLD D+ AHVGD GLA+ 
Sbjct: 807  NSKRLSLLQRISMLIDVASALDYLHNHCDEQIVHCDLKPSNILLDNDLTAHVGDFGLARI 866

Query: 187  LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTD 246
            L     G    T+++S+ ++G VGYVAPEYGMG + S+SGDVY++GILLLEMFT +RPTD
Sbjct: 867  L-SAATGETPSTSTSSLGVRGTVGYVAPEYGMGGQVSISGDVYSYGILLLEMFTGKRPTD 925

Query: 247  AMFNEGLTLHEFVKMALPDKVMEIVDPSL------LLEVTANNYSW----IEDCLVAVIG 296
            +MF    +LH F K ALPD+V EI+DP L      L E + N  S     IE CL++++ 
Sbjct: 926  SMFTGNNSLHNFAKTALPDQVSEIIDPLLKIDTQQLAESSRNGPSSSRDKIEGCLISILQ 985

Query: 297  TGVTCSMESPMERMEMRDVVAKLRHARE 324
             GV CS+E P ERM + +V+++    R+
Sbjct: 986  IGVLCSVELPSERMVIAEVLSEFNKIRK 1013

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224119098|ref|XP_002331324.1| predicted protein [Populus trichocarpa] gi|222873907|gb|EEF11038.1| predicted protein [Populus trichocarpa]

 Score =  334 bits (856), Expect = 4e-89,   Method: Compositional matrix adjust.
 Identities = 167/318 (52%), Positives = 220/318 (69%), Gaps = 10/318 (3%)

Query: 20  ISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECN 79
           +SY  L KATN FS  N IG G    VYKG LD +   VAVKV+NL ++ AS+SF AEC 
Sbjct: 453 VSYQSLLKATNGFSSINLIGTGSFGSVYKGTLDHNGIAVAVKVLNLTRQGASKSFMAECE 512

Query: 80  ALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQ-----LRFLT 134
           ALRN+RHRNL+K++T CS +D+ G DFKA+V+E+M N +LE WL  S        +  L+
Sbjct: 513 ALRNVRHRNLVKVVTACSGVDYHGNDFKALVYEFMVNGSLETWLHPSPATDEVRGILDLS 572

Query: 135 QRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGT 194
           QR+NIAIDV+ A++Y HH C+  IVH DLKP N+LLD ++V HVGD GLAKFL   +   
Sbjct: 573 QRLNIAIDVAHALDYLHHQCEKQIVHCDLKPGNVLLDDEMVGHVGDFGLAKFLL-EDTLH 631

Query: 195 AAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLT 254
            +   S+SI I+G +GY  PEYG G++ S  GDVY++GILLLEMFT +RPTD +FN GL 
Sbjct: 632 HSTNPSSSIGIRGTIGYAPPEYGAGNEVSAYGDVYSYGILLLEMFTGKRPTDDLFN-GLN 690

Query: 255 LHEFVKMALPDKVMEIVDPSLL---LEVTANNYSWIEDCLVAVIGTGVTCSMESPMERME 311
           LH +VK  LP+KV++I DP+L     E  +   + + +CLV+V  TG++CS+ESP ERM 
Sbjct: 691 LHSYVKTFLPEKVLQIADPTLPQINFEGNSIEQNRVLECLVSVFTTGISCSVESPQERMG 750

Query: 312 MRDVVAKLRHARETFLGT 329
           + DV+A+L  AR   LGT
Sbjct: 751 IADVIAQLFSARNELLGT 768

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	331
TAIR|locus:2075661	1025	AT3G47110 [Arabidopsis thalian	0.960	0.310	0.448	2.1e-70
TAIR|locus:2079157	1011	AT3G47580 [Arabidopsis thalian	0.990	0.324	0.412	4.1e-69
TAIR|locus:2079142	1010	AT3G47570 [Arabidopsis thalian	0.921	0.301	0.442	5.2e-69
TAIR|locus:2075631	1009	AT3G47090 [Arabidopsis thalian	0.933	0.306	0.424	4.3e-68
UNIPROTKB|Q40640	1025	Xa21 "Receptor kinase-like pro	0.942	0.304	0.430	7.2e-65
TAIR|locus:2175703	502	AT5G39390 [Arabidopsis thalian	0.752	0.496	0.494	1.2e-63
TAIR|locus:2149922	1031	EFR "EF-TU receptor" [Arabidop	0.767	0.246	0.481	2.5e-61
TAIR|locus:2047525	980	AT2G24130 [Arabidopsis thalian	0.764	0.258	0.451	6.1e-49
TAIR|locus:2182870	1192	EMS1 "EXCESS MICROSPOROCYTES1"	0.788	0.218	0.35	7.7e-39
TAIR|locus:2170483	1173	FLS2 "FLAGELLIN-SENSITIVE 2" [	0.700	0.197	0.381	2.5e-38

TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)]

 Score = 715 (256.8 bits), Expect = 2.1e-70, P = 2.1e-70
 Identities = 147/328 (44%), Positives = 204/328 (62%)

Query:     7 DSNMLSMKQQFPMISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK 66
             D +   +K  +  ISY EL K T  FS +N IG G    V+KG L      VA+KV+NL 
Sbjct:   694 DRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLC 753

Query:    67 QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLR-- 124
             ++ A++SF AEC AL  IRHRNL+K++TICSS DFEG DF+A+V+E+M N NL+ WL   
Sbjct:   754 KRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHPD 813

Query:   125 ---QSNGQLRFLT--QRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVG 179
                ++    R L    R+NIAIDV+ A+ Y H +C   I H D+KPSNILLD+D+ AHV 
Sbjct:   814 EIEETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHVS 873

Query:   180 DLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMF 239
             D GLA+ L  ++  T      +S  ++G +GY APEYGMG   S+ GDVY+FGI+LLE+F
Sbjct:   874 DFGLAQLLLKFDRDTF-HIQFSSAGVRGTIGYAAPEYGMGGHPSIMGDVYSFGIVLLEIF 932

Query:   240 TRRRPTDAMFNEGLTLHEFVKMALPDK-VMEIVDPSLLLEVTANNYSWIEDCLVAVIGTG 298
             T +RPT+ +F +GLTLH F K AL  +  ++I D ++L    A +++ +E CL  V   G
Sbjct:   933 TGKRPTNKLFVDGLTLHSFTKSALQKRQALDITDETILRGAYAQHFNMVE-CLTLVFRVG 991

Query:   299 VTCXXXXXXXXXXXXDVVAKLRHARETF 326
             V+C            + ++KL   RE+F
Sbjct:   992 VSCSEESPVNRISMAEAISKLVSIRESF 1019

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)]

 Score = 703 (252.5 bits), Expect = 4.1e-69, P = 4.1e-69
 Identities = 140/339 (41%), Positives = 207/339 (61%)

Query:     1 KKPAHKDSNMLSMKQQF--PMISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIV 58
             ++   + +N++  K +     ISY +L  ATN FS +N +G G    V+K +L     IV
Sbjct:   670 RRKNQQTNNLVPSKLEIFHEKISYGDLRNATNGFSSSNMVGSGSFGTVFKALLPTESKIV 729

Query:    59 AVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRN 118
             AVKV+N++++ A +SF AEC +L++ RHRNL+K++T C+S DF+G +F+A+++EY+ N +
Sbjct:   730 AVKVLNMQRRGAMKSFMAECESLKDTRHRNLVKLLTACASTDFQGNEFRALIYEYLPNGS 789

Query:   119 LEQWLRQSNGQL-----RFLT--QRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLD 171
             ++ WL     +      R LT  +R+NI IDV+  ++Y H HC   I H DLKPSN+LL+
Sbjct:   790 VDMWLHPEEVEEIRRPPRTLTLLERLNIVIDVASVLDYLHVHCHEPIAHCDLKPSNVLLE 849

Query:   172 QDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNF 231
              D+ AHV D GLA+ L  ++  +     S S  ++G +GY APEYGMG + S+ GDVY+F
Sbjct:   850 DDLTAHVSDFGLARLLLKFDKESFLNQLS-SAGVRGTIGYAAPEYGMGGQPSIHGDVYSF 908

Query:   232 GILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCL 291
             G+LLLEMFT +RPTD +F   LTLH + K+ALP+KV EI D ++L       +   E CL
Sbjct:   909 GVLLLEMFTGKRPTDELFGGNLTLHSYTKLALPEKVFEIADKAILHIGLRVGFRTAE-CL 967

Query:   292 VAVIGTGVTCXXXXXXXXXXXXDVVAKLRHARETFLGTR 330
               V+  G+ C            +V  +L   RE F  TR
Sbjct:   968 TLVLEVGLRCCEEYPTNRLATSEVAKELISIRERFFKTR 1006

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)]

 Score = 702 (252.2 bits), Expect = 5.2e-69, P = 5.2e-69
 Identities = 139/314 (44%), Positives = 201/314 (64%)

Query:    20 ISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECN 79
             ISY +L  ATN FS +N +G G    VYK +L   + +VAVKV+N++++ A +SF AEC 
Sbjct:   690 ISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRRGAMKSFMAECE 749

Query:    80 ALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQ-----LRFLT 134
             +L++IRHRNL+K++T CSSIDF+G +F+A+++E+M N +L+ WL     +      R LT
Sbjct:   750 SLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLHPEEVEEIHRPSRTLT 809

Query:   135 --QRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEP 192
               +R+NIAIDV+  ++Y H HC   I H DLKPSN+LLD D+ AHV D GLA+ L  ++ 
Sbjct:   810 LLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTAHVSDFGLARLLLKFDE 869

Query:   193 GTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEG 252
              +     S S  ++G +GY APEYG+G + S++GDVY+FGILLLEMFT +RPT+ +F   
Sbjct:   870 ESFFNQLS-SAGVRGTIGYAAPEYGVGGQPSINGDVYSFGILLLEMFTGKRPTNELFGGN 928

Query:   253 LTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCXXXXXXXXXXX 312
              TL+ + K ALP+++++IVD S+L       +  +E CL  V   G+ C           
Sbjct:   929 FTLNSYTKSALPERILDIVDESILHIGLRVGFPVVE-CLTMVFEVGLRCCEESPMNRLAT 987

Query:   313 XDVVAKLRHARETF 326
               VV +L   RE F
Sbjct:   988 SIVVKELISIRERF 1001

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)]

 Score = 694 (249.4 bits), Expect = 4.3e-68, P = 4.3e-68
 Identities = 135/318 (42%), Positives = 201/318 (63%)

Query:    20 ISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECN 79
             +SY +L  AT+ FS +N +G G    V+K +L     IVAVKV+N++++ A +SF AEC 
Sbjct:   689 LSYGDLRNATDGFSSSNIVGSGSFGTVFKALLQTENKIVAVKVLNMQRRGAMKSFMAECE 748

Query:    80 ALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQ-----LRFLT 134
             +L++IRHRNL+K++T C+SIDF+G +F+A+++E+M N +L++WL     +      R LT
Sbjct:   749 SLKDIRHRNLVKLLTACASIDFQGNEFRALIYEFMPNGSLDKWLHPEEVEEIHRPSRTLT 808

Query:   135 --QRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEP 192
               +R+NIAIDV+  ++Y H HC   I H DLKPSNILLD D+ AHV D GLA+ L  ++ 
Sbjct:   809 LLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNILLDDDLTAHVSDFGLARLLLKFDQ 868

Query:   193 GTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEG 252
              +     S S  ++G +GY APEYGMG + S+ GDVY+FG+L+LEMFT +RPT+ +F   
Sbjct:   869 ESFFNQLS-SAGVRGTIGYAAPEYGMGGQPSIHGDVYSFGVLVLEMFTGKRPTNELFGGN 927

Query:   253 LTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCXXXXXXXXXXX 312
              TL+ + K ALP++V++I D S+L       +  +E CL  ++  G+ C           
Sbjct:   928 FTLNSYTKAALPERVLDIADKSILHSGLRVGFPVLE-CLKGILDVGLRCCEESPLNRLAT 986

Query:   313 XDVVAKLRHARETFLGTR 330
              +   +L   RE F  TR
Sbjct:   987 SEAAKELISIRERFFKTR 1004

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009507 "chloroplast" evidence=IDA

UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)]

 Score = 666 (239.5 bits), Expect = 7.2e-65, P = 7.2e-65
 Identities = 142/330 (43%), Positives = 212/330 (64%)

Query:    12 SMKQQFPMISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEAS 71
             SMK   P++SY++L KAT+ F+P N +G G    VYKG L+  +  VAVKV+ L+  +A 
Sbjct:   689 SMKGH-PLVSYSQLVKATDGFAPTNLLGSGSFGSVYKGKLN-IQDHVAVKVLKLENPKAL 746

Query:    72 RSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLR-QSNGQL 130
             +SF AEC ALRN+RHRNL+KI+TICSSID  G DFKAIV+++M N +LE W+  ++N Q 
Sbjct:   747 KSFTAECEALRNMRHRNLVKIVTICSSIDNRGNDFKAIVYDFMPNGSLEDWIHPETNDQA 806

Query:   131 --RFLT--QRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF 186
               R L   +RV I +DV+ A++Y H H    +VH D+K SN+LLD D+VAHVGD GLA+ 
Sbjct:   807 DQRHLNLHRRVTILLDVACALDYLHRHGPEPVVHCDIKSSNVLLDSDMVAHVGDFGLARI 866

Query:   187 LFGYEPGTAA-ETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPT 245
             L     GT+  + +++S+   G +GY APEYG+G  AS  GD+Y++GIL+LE+ T +RPT
Sbjct:   867 LVD---GTSLIQQSTSSMGFIGTIGYAAPEYGVGLIASTHGDIYSYGILVLEIVTGKRPT 923

Query:   246 DAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLE----VTANNYS---WIEDCLVAVIGTG 298
             D+ F   L L ++V++ L  +V ++VD  L+L+    + + N S    I +C+V ++  G
Sbjct:   924 DSTFRPDLGLRQYVELGLHGRVTDVVDTKLILDSENWLNSTNNSPCRRITECIVWLLRLG 983

Query:   299 VTCXXXXXXXXXXXXDVVAKLRHARETFLG 328
             ++C            D++ +L   ++   G
Sbjct:   984 LSCSQELPSSRTPTGDIIDELNAIKQNLSG 1013

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2175703 AT5G39390 [Arabidopsis thaliana (taxid:3702)]

 Score = 649 (233.5 bits), Expect = 1.2e-63, P = 1.2e-63
 Identities = 127/257 (49%), Positives = 174/257 (67%)

Query:    14 KQQFPMISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRS 73
             K++   ISY EL  AT+ FS +N IG G  S V+KG+L     +VAVKV+NL +  A++S
Sbjct:   191 KKKNDKISYEELYNATSGFSSSNLIGSGNFSDVFKGLLGLEEKLVAVKVLNLLKHGATKS 250

Query:    74 FAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLR-----QSNG 128
             F AEC + + IRHRNL K+IT+CSS+D +G DF+A+V+E+M   +L+ WL+      +N 
Sbjct:   251 FIAECESFKGIRHRNLAKLITVCSSLDSQGNDFRALVYEFMPKGSLDMWLQPEDLESANN 310

Query:   129 QLRFLT--QRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF 186
               R LT  ++VNIAIDV+ A+EY H +C   + H D+KPSN+LLD D+ AHV D GLA+ 
Sbjct:   311 HSRSLTFAEKVNIAIDVASALEYLHVYCHDPVAHCDIKPSNVLLDDDLTAHVSDFGLARL 370

Query:   187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTD 246
             L+ ++  T     S S  ++G +GY APEYGMGSK S+ GDVY+FG+LLLEMFT ++PTD
Sbjct:   371 LYNFDEKTFLNQFS-SAGVRGTIGYAAPEYGMGSKPSIQGDVYSFGVLLLEMFTGKKPTD 429

Query:   247 AMFNEGLTLHEFVKMAL 263
               F  G  LH + K  L
Sbjct:   430 NSFGGGYNLHGYTKSVL 446

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)]

 Score = 634 (228.2 bits), Expect = 2.5e-61, P = 2.5e-61
 Identities = 127/264 (48%), Positives = 172/264 (65%)

Query:     7 DSNMLSMKQQFPMISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK 66
             DS  L M  +   +SY EL  AT+ FS  N IG G    V+KG+L     +VAVKV+NL 
Sbjct:   689 DSTTLGMFHE--KVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNLL 746

Query:    67 QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLR-- 124
             +  A++SF AEC   + IRHRNL+K+IT+CSS+D EG DF+A+V+E+M   +L+ WL+  
Sbjct:   747 KHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQLE 806

Query:   125 ---QSNGQLRFLT--QRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVG 179
                + N   R LT  +++NIAIDV+ A+EY H HC   + H D+KPSNILLD D+ AHV 
Sbjct:   807 DLERVNDHSRSLTPAEKLNIAIDVASALEYLHVHCHDPVAHCDIKPSNILLDDDLTAHVS 866

Query:   180 DLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMF 239
             D GLA+ L+ Y+  +     S S  ++G +GY APEYGMG + S+ GDVY+FGILLLEMF
Sbjct:   867 DFGLAQLLYKYDRESFLNQFS-SAGVRGTIGYAAPEYGMGGQPSIQGDVYSFGILLLEMF 925

Query:   240 TRRRPTDAMFNEGLTLHEFVKMAL 263
             + ++PTD  F     LH + K  L
Sbjct:   926 SGKKPTDESFAGDYNLHSYTKSIL 949

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010204 "defense response signaling pathway, resistance gene-independent" evidence=IMP

GO:0016045 "detection of bacterium" evidence=RCA;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0002764 "immune response-regulating signaling pathway" evidence=IMP

GO:0009626 "plant-type hypersensitive response" evidence=IMP

GO:0019199 "transmembrane receptor protein kinase activity" evidence=TAS

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0050776 "regulation of immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)]

 Score = 519 (187.8 bits), Expect = 6.1e-49, P = 6.1e-49
 Identities = 121/268 (45%), Positives = 167/268 (62%)

Query:    16 QFPMISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK-EASRSF 74
             ++P ISY +L  AT  F+ ++ IG G    VYKG+L  + + VAVKV++ K   E S SF
Sbjct:   645 KYPRISYQQLIAATGGFNASSLIGSGRFGHVYKGVL-RNNTKVAVKVLDPKTALEFSGSF 703

Query:    75 AAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWL---RQSNGQLR 131
               EC  L+  RHRNLI+IIT CS     GF+  A+V   M N +LE+ L     S+  L 
Sbjct:   704 KRECQILKRTRHRNLIRIITTCSK---PGFN--ALVLPLMPNGSLERHLYPGEYSSKNLD 758

Query:   132 FLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYE 191
              L Q VNI  DV+  I Y HH+    +VH DLKPSNILLD ++ A V D G+++ + G E
Sbjct:   759 -LIQLVNICSDVAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVE 817

Query:   192 PGTAAETASN--SIE--IKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDA 247
                + + + +  S +  + G VGY+APEYGMG +AS  GDVY+FG+LLLE+ + RRPTD 
Sbjct:   818 ETVSTDDSVSFGSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVSGRRPTDV 877

Query:   248 MFNEGLTLHEFVKMALPDKVMEIVDPSL 275
             + NEG +LHEF+K   PD +  I++ +L
Sbjct:   878 LVNEGSSLHEFMKSHYPDSLEGIIEQAL 905

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2182870 EMS1 "EXCESS MICROSPOROCYTES1" [Arabidopsis thaliana (taxid:3702)]

 Score = 427 (155.4 bits), Expect = 7.7e-39, P = 7.7e-39
 Identities = 98/280 (35%), Positives = 156/280 (55%)

Query:     9 NMLSMKQQFPMISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK 68
             N+   +Q    +   ++ +AT++FS  N IG GG   VYK  L   ++ VAVK ++  + 
Sbjct:   894 NIAMFEQPLLKVRLGDIVEATDHFSKKNIIGDGGFGTVYKACLPGEKT-VAVKKLSEAKT 952

Query:    69 EASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNG 128
             + +R F AE   L  ++H NL+ ++  CS   F   + K +V+EYM N +L+ WLR   G
Sbjct:   953 QGNREFMAEMETLGKVKHPNLVSLLGYCS---FS--EEKLLVYEYMVNGSLDHWLRNQTG 1007

Query:   129 QLRFL--TQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF 186
              L  L  ++R+ IA+  +  + + HH   P I+H D+K SNILLD D    V D GLA+ 
Sbjct:  1008 MLEVLDWSKRLKIAVGAARGLAFLHHGFIPHIIHRDIKASNILLDGDFEPKVADFGLARL 1067

Query:   187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTD 246
             +      +A E+  +++ I G  GY+ PEYG  ++A+  GDVY+FG++LLE+ T + PT 
Sbjct:  1068 I------SACESHVSTV-IAGTFGYIPPEYGQSARATTKGDVYSFGVILLELVTGKEPTG 1120

Query:   247 AMFNE---GLTLHEFVKMALPDKVMEIVDPSLLLEVTANN 283
               F E   G  +   ++     K ++++DP LL+ V   N
Sbjct:  1121 PDFKESEGGNLVGWAIQKINQGKAVDVIDP-LLVSVALKN 1159

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009556 "microsporogenesis" evidence=IMP

GO:0010234 "tapetal cell fate specification" evidence=IMP

GO:0016020 "membrane" evidence=IDA

GO:0019199 "transmembrane receptor protein kinase activity" evidence=ISS

GO:0005515 "protein binding" evidence=IPI

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 422 (153.6 bits), Expect = 2.5e-38, P = 2.5e-38
 Identities = 93/244 (38%), Positives = 148/244 (60%)

Query:    24 ELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ--KEASRSFAAECNAL 81
             EL +AT++F+ AN IG   +S VYKG L++  +++AVKV+NLK+   E+ + F  E   L
Sbjct:   862 ELEQATDSFNSANIIGSSSLSTVYKGQLEDG-TVIAVKVLNLKEFSAESDKWFYTEAKTL 920

Query:    82 RNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI 141
               ++HRNL+KI+       +E    KA+V  +M+N NLE  +  S   +  L +++++ +
Sbjct:   921 SQLKHRNLVKILGFA----WESGKTKALVLPFMENGNLEDTIHGSAAPIGSLLEKIDLCV 976

Query:   142 DVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASN 201
              ++  I+Y H      IVH DLKP+NILLD D VAHV D G A+ L   E G+   TAS 
Sbjct:   977 HIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARILGFREDGST--TAST 1034

Query:   202 SIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEG--LTLHEFV 259
             S   +G +GY+APE+    K +   DV++FGI+++E+ T++RPT     +   +TL + V
Sbjct:  1035 SA-FEGTIGYLAPEFAYMRKVTTKADVFSFGIIMMELMTKQRPTSLNDEDSQDMTLRQLV 1093

Query:   260 KMAL 263
             + ++
Sbjct:  1094 EKSI 1097

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0016020 "membrane" evidence=ISS;IDA

GO:0016045 "detection of bacterium" evidence=IMP

GO:0005886 "plasma membrane" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0042742 "defense response to bacterium" evidence=RCA;IMP

GO:0052544 "defense response by callose deposition in cell wall" evidence=IMP

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0016310 "phosphorylation" evidence=RCA

GO:0005768 "endosome" evidence=IDA

GO:0006898 "receptor-mediated endocytosis" evidence=IDA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	LOW CONFIDENCE prediction!

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: eugene3.01230100 hypothetical protein (1022 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	331
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	7e-39
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-35
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-33
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-28
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	5e-28
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	5e-28
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	6e-27
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-26
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	5e-26
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-24
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	9e-24
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	6e-22
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-21
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	4e-21
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	4e-21
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	5e-21
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-20
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	8e-20
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-19
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-19
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	5e-19
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	7e-19
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-18
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-17
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-17
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-17
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-17
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	4e-17
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	4e-17
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	8e-17
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	8e-17
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	9e-17
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	9e-17
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-16
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	3e-16
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	3e-16
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	5e-16
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	6e-16
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	8e-16
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-15
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-15
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-15
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	4e-15
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	5e-15
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	8e-15
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-14
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-14
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-14
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-14
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-14
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	3e-14
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	3e-14
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	4e-14
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	5e-14
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	7e-14
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	8e-14
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-13
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-13
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	3e-13
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-13
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	4e-13
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	4e-13
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	4e-13
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	7e-13
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-12
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-12
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-12
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-12
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-12
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	3e-12
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-12
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	6e-12
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	7e-12
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	9e-12
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-11
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-11
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-11
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-11
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-11
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-11
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-11
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-11
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-11
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	3e-11
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	3e-11
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-11
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	4e-11
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	5e-11
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	5e-11
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	5e-11
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	6e-11
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	7e-11
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	9e-11
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	9e-11
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-10
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-10
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-10
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-10
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-10
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-10
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-10
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-10
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-10
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-10
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	3e-10
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	4e-10
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	4e-10
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	6e-10
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	6e-10
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	6e-10
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	8e-10
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	9e-10
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-09
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-09
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-09
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-09
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-09
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-09
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-09
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-09
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-09
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-09
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-09
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-09
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	3e-09
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-09
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	3e-09
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	4e-09
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	4e-09
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	4e-09
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	5e-09
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	5e-09
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	5e-09
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	5e-09
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	6e-09
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-08
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-08
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-08
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-08
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-08
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	1e-08
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-08
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	3e-08
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	3e-08
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-08
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	3e-08
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	4e-08
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	5e-08
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	5e-08
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	5e-08
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	6e-08
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	6e-08
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	6e-08
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	6e-08
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	7e-08
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	7e-08
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	8e-08
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-07
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-07
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-07
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-07
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-07
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-07
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-07
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-07
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-07
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-07
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-07
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-07
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-07
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	2e-07
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-07
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	3e-07
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-07
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	3e-07
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-07
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-07
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	4e-07
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	4e-07
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	5e-07
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	5e-07
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	6e-07
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	6e-07
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	7e-07
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	8e-07
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	9e-07
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-06
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-06
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-06
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-06
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-06
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-06
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-06
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-06
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-06
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-06
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-06
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-06
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-06
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-06
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	3e-06
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	3e-06
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	4e-06
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	5e-06
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	5e-06
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	6e-06
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	6e-06
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	6e-06
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	6e-06
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	7e-06
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	7e-06
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	8e-06
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-05
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-05
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-05
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-05
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-05
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-05
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-05
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-05
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-05
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	3e-05
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-05
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	3e-05
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	3e-05
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	4e-05
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	5e-05
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	5e-05
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	8e-05
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	9e-05
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	9e-05
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	9e-05
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-04
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-04
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-04
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-04
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-04
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-04
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-04
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-04
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-04
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-04
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	3e-04
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	3e-04
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	3e-04
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	3e-04
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	3e-04
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-04
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-04
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	3e-04
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	4e-04
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	4e-04
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	4e-04
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	4e-04
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	4e-04
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	5e-04
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	5e-04
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	5e-04
COG3642	204	COG3642, COG3642, Mn2+-dependent serine/threonine	6e-04
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	6e-04
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	6e-04
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	8e-04
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	8e-04
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	0.001
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	0.001
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	0.001
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	0.001
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	0.002
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	0.002
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	0.002
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	0.002
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	0.003
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	0.004
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	0.004
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	0.004

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  136 bits (345), Expect = 7e-39
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 20/204 (9%)

Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASR-SFAAECNALRNIRHRNLIKIITIC 96
           +G+GG   VY     ++   VA+K++  +   +       E   L+ + H N++K+  + 
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQP 156
              +        +V EY +  +L+  L+++ G+L    + + I + +   +EY H +   
Sbjct: 61  EDENH-----LYLVMEYCEGGSLKDLLKENEGKLS-EDEILRILLQILEGLEYLHSN--- 111

Query: 157 SIVHGDLKPSNILLDQD-IVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPE 215
            I+H DLKP NILLD D     + D GL+K L            S    I G   Y+APE
Sbjct: 112 GIIHRDLKPENILLDSDNGKVKLADFGLSKLL--------TSDKSLLKTIVGTPAYMAPE 163

Query: 216 YGMG-SKASVSGDVYNFGILLLEM 238
             +G    S   D+++ G++L E+
Sbjct: 164 VLLGKGYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  129 bits (326), Expect = 1e-35
 Identities = 63/213 (29%), Positives = 102/213 (47%), Gaps = 25/213 (11%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQ--KEASRSFAAECNALRNIRHRNLIKIIT 94
           K+G G    VYK     +  IVAVK++  +    +  ++   E   LR + H N++++I 
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 95  ICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLT--QRVNIAIDVSFAIEYFHH 152
                 FE  D   +V EY +  +L  +L +       L+  +   IA+ +   +EY H 
Sbjct: 66  A-----FEDKDHLYLVMEYCEGGDLFDYLSRGGP----LSEDEAKKIALQILRGLEYLHS 116

Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
           +    I+H DLKP NILLD++ V  + D GLAK L   +  ++  T        G   Y+
Sbjct: 117 N---GIIHRDLKPENILLDENGVVKIADFGLAKKL--LKSSSSLTT------FVGTPWYM 165

Query: 213 APE-YGMGSKASVSGDVYNFGILLLEMFTRRRP 244
           APE    G+      DV++ G++L E+ T + P
Sbjct: 166 APEVLLGGNGYGPKVDVWSLGVILYELLTGKPP 198

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  123 bits (311), Expect = 2e-33
 Identities = 61/229 (26%), Positives = 102/229 (44%), Gaps = 34/229 (14%)

Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASR-SFAAECNALRNIRHRNLIKIIT 94
            K+G+G    VY     ++  +VA+KV+  K+ +  R     E   L+ ++H N++++  
Sbjct: 5   EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64

Query: 95  ICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQ----SNGQLRFLTQRVNIAIDVSFAIEYF 150
           +     FE  D   +V EY +  +L   L++    S  + RF  +       +  A+EY 
Sbjct: 65  V-----FEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLR------QILSALEYL 113

Query: 151 HHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG 210
           H      IVH DLKP NILLD+D    + D GLA+ L                ++   VG
Sbjct: 114 HSKG---IVHRDLKPENILLDEDGHVKLADFGLARQL------------DPGEKLTTFVG 158

Query: 211 ---YVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLH 256
              Y+APE  +G     + D+++ G++L E+ T + P            
Sbjct: 159 TPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFK 207

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  110 bits (277), Expect = 2e-28
 Identities = 58/213 (27%), Positives = 102/213 (47%), Gaps = 27/213 (12%)

Query: 37  KIGQGGVSIVYKGILDESRSI----VAVKVVNL-KQKEASRSFAAECNALRNIRHRNLIK 91
           K+G+G    VYKG L          VAVK +     ++    F  E   +R + H N++K
Sbjct: 6   KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65

Query: 92  IITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFH 151
           ++ +C   + E      IV EYM+  +L  +LR++  +L  L+  ++ A+ ++  +EY  
Sbjct: 66  LLGVC--TEEEPL---YIVMEYMEGGDLLSYLRKNRPKLS-LSDLLSFALQIARGMEYLE 119

Query: 152 HHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGY 211
                  +H DL   N L+ +++V  + D GL++ L+  +              K  + +
Sbjct: 120 SKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGG-------KLPIRW 169

Query: 212 VAPE---YGMGSKASVSGDVYNFGILLLEMFTR 241
           +APE    G  +  S   DV++FG+LL E+FT 
Sbjct: 170 MAPESLKEGKFTSKS---DVWSFGVLLWEIFTL 199

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  109 bits (274), Expect = 5e-28
 Identities = 57/219 (26%), Positives = 100/219 (45%), Gaps = 29/219 (13%)

Query: 36  NKIGQGGVSIVYKGIL---DESRSIVAVKVVNLKQKEASRS-FAAECNALRNIRHRNLIK 91
            K+G+G    VYKG L   D   + VAVK +     E  R  F  E   ++ + H N+++
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 92  IITICSSID--FEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRF-------LTQRVNIAID 142
           ++ +C+  +  +       +V EYM+  +L  +LR+S             L   ++ AI 
Sbjct: 61  LLGVCTEEEPLY-------LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQ 113

Query: 143 VSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNS 202
           ++  +EY         VH DL   N L+ +D+V  + D GL++ ++  +           
Sbjct: 114 IAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGG--- 167

Query: 203 IEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTR 241
              K  + ++APE       +   DV++FG+LL E+FT 
Sbjct: 168 ---KLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTL 203

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  109 bits (274), Expect = 5e-28
 Identities = 58/213 (27%), Positives = 101/213 (47%), Gaps = 26/213 (12%)

Query: 37  KIGQGGVSIVYKGIL----DESRSIVAVKVVNL-KQKEASRSFAAECNALRNIRHRNLIK 91
           K+G+G    VYKG L    D     VAVK +     ++    F  E   +R + H N++K
Sbjct: 6   KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65

Query: 92  IITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFH 151
           ++ +C   + E      IV EYM   +L  +LR++  +   L+  ++ A+ ++  +EY  
Sbjct: 66  LLGVC--TEEEPL---MIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE 120

Query: 152 HHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGY 211
                  +H DL   N L+ +++V  + D GL++ L+  +              K  + +
Sbjct: 121 SKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGG-------KLPIRW 170

Query: 212 VAPE---YGMGSKASVSGDVYNFGILLLEMFTR 241
           +APE    G  +  S   DV++FG+LL E+FT 
Sbjct: 171 MAPESLKEGKFTSKS---DVWSFGVLLWEIFTL 200

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  106 bits (267), Expect = 6e-27
 Identities = 56/211 (26%), Positives = 101/211 (47%), Gaps = 22/211 (10%)

Query: 37  KIGQGGVSIVYKGILDESRS----IVAVKVVNLK-QKEASRSFAAECNALRNIRHRNLIK 91
           K+G+G    VYKG L          VAVK +     +E    F  E + ++ + H N+++
Sbjct: 6   KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65

Query: 92  IITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFH 151
           ++ +C+    +G     IV EYM   +L  +LR+   +L  L   + +A+ ++  +EY  
Sbjct: 66  LLGVCT----QGEPLY-IVTEYMPGGDLLDFLRKHGEKLT-LKDLLQMALQIAKGMEYLE 119

Query: 152 -HHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG 210
             +     VH DL   N L+ +++V  + D GL++ ++  +              K  + 
Sbjct: 120 SKNF----VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGG------KLPIK 169

Query: 211 YVAPEYGMGSKASVSGDVYNFGILLLEMFTR 241
           ++APE     K +   DV++FG+LL E+FT 
Sbjct: 170 WMAPESLKDGKFTSKSDVWSFGVLLWEIFTL 200

Length = 258

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  104 bits (263), Expect = 2e-26
 Identities = 58/224 (25%), Positives = 95/224 (42%), Gaps = 24/224 (10%)

Query: 32  FSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIK 91
           F    KIG+GG   VYK     +   VA+KV+ L+ KE       E   L+  +H N++K
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 92  IITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFH 151
                 S   +   +  IV E+    +L+  L+ +N  L   +Q   +  ++   +EY H
Sbjct: 62  YYG---SYLKKDELW--IVMEFCSGGSLKDLLKSTNQTL-TESQIAYVCKELLKGLEYLH 115

Query: 152 HHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGY 211
            +    I+H D+K +NILL  D    + D GL+  L                 + G   +
Sbjct: 116 SN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQL---------SDTKARNTMVGTPYW 163

Query: 212 VAPEYGMGSKASVSGDVYNFGILLLEMFTRR------RPTDAMF 249
           +APE   G       D+++ GI  +E+   +       P  A+F
Sbjct: 164 MAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF 207

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  103 bits (260), Expect = 5e-26
 Identities = 50/215 (23%), Positives = 92/215 (42%), Gaps = 24/215 (11%)

Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ--KEASRSFAAECNALRNIRHRNLIKII 93
             +G+G    VY  +  ++  ++AVK V L    +E   +   E   L +++H N+++  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 94  TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLR-FLTQRVNIAIDVSFAIEYFHH 152
                 +    +   I  EY+   +L   L +  G+L   + ++      +   + Y H 
Sbjct: 66  GSERDEEKNTLN---IFLEYVSGGSLSS-LLKKFGKLPEPVIRKY--TRQILEGLAYLHS 119

Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG-- 210
           +    IVH D+K +NIL+D D V  + D G AK L                    + G  
Sbjct: 120 NG---IVHRDIKGANILVDSDGVVKLADFGCAKRL---------GDIETGEGTGSVRGTP 167

Query: 211 -YVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
            ++APE   G +   + D+++ G  ++EM T + P
Sbjct: 168 YWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  100 bits (251), Expect = 1e-24
 Identities = 66/226 (29%), Positives = 108/226 (47%), Gaps = 21/226 (9%)

Query: 32  FSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIK 91
           F+   K+G G    V++G L ++R  VA+K++        + F  E  AL+ +RH++LI 
Sbjct: 8   FTLERKLGSGYFGEVWEG-LWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLIS 66

Query: 92  IITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFH 151
           +  +CS       +   I+ E M+  +L  +LR   GQ+  +   +++A  V+  + Y  
Sbjct: 67  LFAVCS-----VGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE 121

Query: 152 HHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGY 211
                + +H DL   NIL+ +D+V  V D GLA+ +   E      ++   I  K    +
Sbjct: 122 EQ---NSIHRDLAARNILVGEDLVCKVADFGLARLI--KED--VYLSSDKKIPYK----W 170

Query: 212 VAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHE 257
            APE       S   DV++FGILL EMFT       +   G+  HE
Sbjct: 171 TAPEAASHGTFSTKSDVWSFGILLYEMFTY----GQVPYPGMNNHE 212

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  100 bits (248), Expect = 9e-24
 Identities = 69/266 (25%), Positives = 114/266 (42%), Gaps = 24/266 (9%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLK---QKEASRSFAAECNALRNIRH-RNLIKI 92
           K+G+G    VY       R +VA+KV+  K   + +    F  E   L ++ H  N++K+
Sbjct: 7   KLGEGSFGEVYLA---RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL 63

Query: 93  ITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVN-IAIDVSFAIEYFH 151
                   F+      +V EY+   +LE  L++   +          I   +  A+EY H
Sbjct: 64  YDF-----FQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118

Query: 152 HHCQPSIVHGDLKPSNILLDQD-IVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG 210
                 I+H D+KP NILLD+D  V  + D GLAK L   +PG+ +   +      G  G
Sbjct: 119 SKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLL--PDPGSTSSIPALPSTSVGTPG 173

Query: 211 YVAPEYGMGS---KASVSGDVYNFGILLLEMFTRRRPTDA--MFNEGLTLHEFVKMALPD 265
           Y+APE  +G     AS S D+++ GI L E+ T   P +     +      + +      
Sbjct: 174 YMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP 233

Query: 266 KVMEIVDPSLLLEVTANNYSWIEDCL 291
            +   + PS    ++      ++  L
Sbjct: 234 SLASPLSPSNPELISKAASDLLKKLL 259

Length = 384

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 92.8 bits (231), Expect = 6e-22
 Identities = 65/204 (31%), Positives = 100/204 (49%), Gaps = 24/204 (11%)

Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICS 97
           IG+G    V  G     +  VAVK +      A ++F AE + +  +RH NL++++ +  
Sbjct: 14  IGKGEFGDVMLGDYRGQK--VAVKCLKDDSTAA-QAFLAEASVMTTLRHPNLVQLLGVV- 69

Query: 98  SIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPS 157
               +G +   IV EYM   +L  +LR     +  L Q++  A+DV   +EY     + +
Sbjct: 70  ---LQG-NPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKN 122

Query: 158 IVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEI-KGIVGYVAPEY 216
            VH DL   N+L+ +D+VA V D GLAK             AS   +  K  V + APE 
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLAK------------EASQGQDSGKLPVKWTAPEA 170

Query: 217 GMGSKASVSGDVYNFGILLLEMFT 240
               K S   DV++FGILL E+++
Sbjct: 171 LREKKFSTKSDVWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 91.6 bits (228), Expect = 2e-21
 Identities = 64/218 (29%), Positives = 104/218 (47%), Gaps = 24/218 (11%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEAS-RSFAAECNALRNIRHRNLIKIITI 95
           K+G G    V+ G  + + + VAVK   LK    S  +F  E   ++ +RH  L+++  +
Sbjct: 13  KLGAGQFGEVWMGTWNGT-TKVAVKT--LKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAV 69

Query: 96  CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQ 155
           CS  + E      IV EYM   +L  +L+   G+   L Q V++A  ++  + Y      
Sbjct: 70  CS--EEEPI---YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---S 121

Query: 156 PSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG--YEPGTAAETASNSIEIKGIVGYVA 213
            + +H DL   NIL+ +++V  + D GLA+ +    Y     A+       IK    + A
Sbjct: 122 RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAK-----FPIK----WTA 172

Query: 214 PEYGMGSKASVSGDVYNFGILLLEMFTRRR-PTDAMFN 250
           PE     + ++  DV++FGILL E+ T  R P   M N
Sbjct: 173 PEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN 210

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 90.6 bits (226), Expect = 4e-21
 Identities = 53/223 (23%), Positives = 101/223 (45%), Gaps = 34/223 (15%)

Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNL-----KQKEASRSFAAECNALRNIRHRNLI 90
            +IG+G    VY         +  +K ++L     K++E + +   E   L+ + H N+I
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALN---EVKILKKLNHPNII 62

Query: 91  KIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLT--QRVNIAIDVSFAIE 148
           K         FE      IV EY    +L Q +++   + +     Q ++  + +  A++
Sbjct: 63  KYYE-----SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALK 117

Query: 149 YFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEI-KG 207
           Y H      I+H D+KP NI L  + +  +GD G++K L            S+++++ K 
Sbjct: 118 YLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVL------------SSTVDLAKT 162

Query: 208 IVG---YVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDA 247
           +VG   Y++PE       +   D+++ G +L E+ T + P + 
Sbjct: 163 VVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEG 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 90.4 bits (225), Expect = 4e-21
 Identities = 64/236 (27%), Positives = 111/236 (47%), Gaps = 42/236 (17%)

Query: 31  NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL--KQKEASRSFAAECNALRNIRHRN 88
           N+   + IG+G   +VYKG+  E+   VA+K ++L   ++EA +S   E + L+N++H N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 89  LIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNG-----QLRFLTQRVNIAIDV 143
           ++K I        E  D   I+ EY +N +L Q +++           ++ Q       V
Sbjct: 61  IVKYIGS-----IETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQ-------V 108

Query: 144 SFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSI 203
              + Y H   +  ++H D+K +NIL  +D     G + LA F      G A +    S 
Sbjct: 109 LQGLAYLH---EQGVIHRDIKAANILTTKD-----GVVKLADF------GVATKLNDVSK 154

Query: 204 EIKGIVG---YVAPEYGMGSKASVSGDVYNFGILLLEMFTR------RRPTDAMFN 250
           +   +VG   ++APE    S AS + D+++ G  ++E+ T         P  A+F 
Sbjct: 155 DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFR 210

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 90.9 bits (226), Expect = 5e-21
 Identities = 56/215 (26%), Positives = 95/215 (44%), Gaps = 17/215 (7%)

Query: 36  NKIGQGGVSIVYKGIL----DESRSIVAVKVVNLKQKEASRS-FAAECNALRNIRHRNLI 90
            ++G+G    V         D +   VAVK +N   +E  RS F  E   LR + H N++
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 91  KIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYF 150
           K   +C      G     ++ EY+ + +L  +L++   Q+  L + +  +  +   ++Y 
Sbjct: 70  KYKGVCEK---PGGRSLRLIMEYLPSGSLRDYLQRHRDQIN-LKRLLLFSSQICKGMDYL 125

Query: 151 HHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG 210
                   +H DL   NIL++ + +  + D GLAK L                E    + 
Sbjct: 126 GSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVL---PEDKDYYYVKEPGESP--IF 177

Query: 211 YVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPT 245
           + APE    SK S + DV++FG+ L E+FT   P+
Sbjct: 178 WYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPS 212

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 91.4 bits (227), Expect = 3e-20
 Identities = 74/290 (25%), Positives = 134/290 (46%), Gaps = 37/290 (12%)

Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITI 95
           N I +G     YKG   ++     VK +N        S  A+   +  ++H N++K+I +
Sbjct: 696 NVISRGKKGASYKGKSIKNGMQFVVKEIN-DVNSIPSSEIAD---MGKLQHPNIVKLIGL 751

Query: 96  CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQ 155
           C S +   +    ++ EY++ +NL + LR  + +     +R  IAI ++ A+ + H  C 
Sbjct: 752 CRS-EKGAY----LIHEYIEGKNLSEVLRNLSWE-----RRRKIAIGIAKALRFLHCRCS 801

Query: 156 PSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV--GYVA 213
           P++V G+L P  I++D     H+  L L   L                + K  +   YVA
Sbjct: 802 PAVVVGNLSPEKIIIDGKDEPHL-RLSLPGLL--------------CTDTKCFISSAYVA 846

Query: 214 PEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEI-VD 272
           PE       +   D+Y FG++L+E+ T + P DA F    ++ E+ +    D  +++ +D
Sbjct: 847 PETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWID 906

Query: 273 PSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHA 322
           PS+  +V+ N     ++ +V V+   + C+   P  R    DV+  L  A
Sbjct: 907 PSIRGDVSVN-----QNEIVEVMNLALHCTATDPTARPCANDVLKTLESA 951

Length = 968

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 87.2 bits (217), Expect = 8e-20
 Identities = 74/275 (26%), Positives = 116/275 (42%), Gaps = 41/275 (14%)

Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL-------KQKEASRSFAAECNAL- 81
           ++F     IG+G  S V      E+    A+K+++        K K        E   L 
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKI----EKEVLT 56

Query: 82  RNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI 141
           R   H  +IK+    +  D E   F   V EY  N  L Q++R+  G L     R   A 
Sbjct: 57  RLNGHPGIIKLY--YTFQDEENLYF---VLEYAPNGELLQYIRK-YGSLDEKCTRFYAAE 110

Query: 142 DVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASN 201
            +  A+EY H      I+H DLKP NILLD+D+   + D G AK L       + +  + 
Sbjct: 111 ILL-ALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDAT 166

Query: 202 SIEIKGI---------VG---YVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMF 249
           +I+ +           VG   YV+PE      A  S D++  G ++ +M T + P     
Sbjct: 167 NIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGS- 225

Query: 250 NEGLTLHEFVKMAL------PDKVMEIVDPSLLLE 278
           NE LT  + +K+        P    ++++  L+L+
Sbjct: 226 NEYLTFQKILKLEYSFPPNFPPDAKDLIEKLLVLD 260

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 85.4 bits (211), Expect = 2e-19
 Identities = 61/207 (29%), Positives = 98/207 (47%), Gaps = 24/207 (11%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
            IG+G    V +G     +  VAVK  N+K    +++F  E   +  + H+NL++++ + 
Sbjct: 13  IIGEGEFGAVLQGEYTGQK--VAVK--NIKCDVTAQAFLEETAVMTKLHHKNLVRLLGV- 67

Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQP 156
             I   G     IV E M   NL  +LR     L  + Q +  ++DV+  +EY       
Sbjct: 68  --ILHNGL---YIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SK 119

Query: 157 SIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEY 216
            +VH DL   NIL+ +D VA V D GLA+               ++ ++   V + APE 
Sbjct: 120 KLVHRDLAARNILVSEDGVAKVSDFGLAR---------VGSMGVDNSKLP--VKWTAPEA 168

Query: 217 GMGSKASVSGDVYNFGILLLEMFTRRR 243
               K S   DV+++G+LL E+F+  R
Sbjct: 169 LKHKKFSSKSDVWSYGVLLWEVFSYGR 195

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 85.3 bits (211), Expect = 3e-19
 Identities = 61/207 (29%), Positives = 101/207 (48%), Gaps = 20/207 (9%)

Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKE-ASRSFAAECNALRNIRHRNLIKIIT 94
           +K+G G    VY+G+  +    VAVK   LK+       F  E   ++ I+H NL++++ 
Sbjct: 12  HKLGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 69

Query: 95  ICS-SIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHH 153
           +C+    F       I+ E+M   NL  +LR+ N Q       + +A  +S A+EY    
Sbjct: 70  VCTREPPF------YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 123

Query: 154 CQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVA 213
              + +H DL   N L+ ++ +  V D GL++ + G +  TA   A   I+      + A
Sbjct: 124 ---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIK------WTA 173

Query: 214 PEYGMGSKASVSGDVYNFGILLLEMFT 240
           PE    +K S+  DV+ FG+LL E+ T
Sbjct: 174 PESLAYNKFSIKSDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 84.7 bits (210), Expect = 5e-19
 Identities = 64/222 (28%), Positives = 98/222 (44%), Gaps = 21/222 (9%)

Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRNIRHRNLIKII 93
           NKIG G    VY  +  ++  ++AVK + ++    +  +  A E   L  ++H NL+K  
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 94  TICSSIDFEGFDFKAIVF-EYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHH 152
            +      E    K  +F EY     LE+ L         + +   + +     + Y H 
Sbjct: 66  GV------EVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLE--GLAYLHS 117

Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
           H    IVH D+KP+NI LD + V  +GD G A  L      T       S+   G   Y+
Sbjct: 118 H---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKL--KNNTTTMGEEVQSLA--GTPAYM 170

Query: 213 APEYGMGSKASVSG---DVYNFGILLLEMFTRRRPTDAMFNE 251
           APE   G K    G   D+++ G ++LEM T +RP   + NE
Sbjct: 171 APEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE 212

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 84.4 bits (209), Expect = 7e-19
 Identities = 62/218 (28%), Positives = 106/218 (48%), Gaps = 24/218 (11%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEAS-RSFAAECNALRNIRHRNLIKIITI 95
           K+G G    V++G+ + +   VAVK   LK      + F AE   ++ +RH  LI++  +
Sbjct: 13  KLGAGQFGEVWEGLWNNTTP-VAVK--TLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAV 69

Query: 96  CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQ 155
           C+       +   IV E M+  +L ++L+   G+   L Q +++A  V+  + Y      
Sbjct: 70  CTL-----EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ-- 122

Query: 156 PSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG--YEPGTAAETASNSIEIKGIVGYVA 213
            + +H DL   N+L+ ++ +  V D GLA+ +    YE    A         K  + + A
Sbjct: 123 -NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGA---------KFPIKWTA 172

Query: 214 PEYGMGSKASVSGDVYNFGILLLEMFTR-RRPTDAMFN 250
           PE  + ++ S+  DV++FGILL E+ T  R P   M N
Sbjct: 173 PEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN 210

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 82.4 bits (203), Expect = 3e-18
 Identities = 65/216 (30%), Positives = 110/216 (50%), Gaps = 21/216 (9%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEAS-RSFAAECNALRNIRHRNLIKIITI 95
           K+GQG    V+ G  + + + VA+K   LK    S  +F  E   ++ +RH  L+++  +
Sbjct: 13  KLGQGCFGEVWMGTWNGT-TRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 69

Query: 96  CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQ 155
            S       +   IV EYM   +L  +L+   G+   L Q V++A  ++  + Y     +
Sbjct: 70  VSE------EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---R 120

Query: 156 PSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPE 215
            + VH DL+ +NIL+ +++V  V D GLA+ +   E  TA + A   I+      + APE
Sbjct: 121 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIK------WTAPE 173

Query: 216 YGMGSKASVSGDVYNFGILLLEMFTRRR-PTDAMFN 250
             +  + ++  DV++FGILL E+ T+ R P   M N
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 209

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 81.2 bits (201), Expect = 1e-17
 Identities = 59/215 (27%), Positives = 94/215 (43%), Gaps = 33/215 (15%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIR------HRNLI 90
           KIG+G   +VYK     +  IVA+K    K K    S      ALR I+      H N+I
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVAIK----KIKLRFESEGIPKTALREIKLLKELNHPNII 61

Query: 91  KIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRV--NIAIDVSFAIE 148
           K++ +         D   +VFE+M   +L + ++      R L + +  +    +   + 
Sbjct: 62  KLLDVF----RHKGDL-YLVFEFMDT-DLYKLIKDRQ---RGLPESLIKSYLYQLLQGLA 112

Query: 149 YFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGI 208
           + H H    I+H DLKP N+L++ + V  + D GLA+  FG                   
Sbjct: 113 FCHSH---GILHRDLKPENLLINTEGVLKLADFGLAR-SFGSPVRPYTHYVVTRW----- 163

Query: 209 VGYVAPEYGMGSKA-SVSGDVYNFGILLLEMFTRR 242
             Y APE  +G K  S   D+++ G +  E+ +RR
Sbjct: 164 --YRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 81.1 bits (201), Expect = 1e-17
 Identities = 54/215 (25%), Positives = 104/215 (48%), Gaps = 28/215 (13%)

Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAA--ECNALRNIRHRNLIKII 93
            +IG+G    VYK    ++  +VA+K + ++ ++      A  E   L+ +RH N++++ 
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64

Query: 94  TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQ-----SNGQLRFLTQRVNIAIDVSFAIE 148
            I +S   +G  +  +VFEYM + +L   L       +  Q++   +++   +      +
Sbjct: 65  EIVTS-KGKGSIY--MVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGL------Q 114

Query: 149 YFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGI 208
           Y H +    I+H D+K SNIL++ D V  + D GLA+    Y    +A+  +  I +   
Sbjct: 115 YLHSN---GILHRDIKGSNILINNDGVLKLADFGLARP---YTKRNSADYTNRVITL--- 165

Query: 209 VGYVAPEYGMGSKASVSG-DVYNFGILLLEMFTRR 242
             Y  PE  +G+       D+++ G +L E+F  +
Sbjct: 166 -WYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 80.6 bits (199), Expect = 2e-17
 Identities = 60/224 (26%), Positives = 102/224 (45%), Gaps = 27/224 (12%)

Query: 29  TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVV---NLKQKEASRSFAAECNALRNIR 85
             NF    KIG+G  S+VYK I      +VA+K V    +   +A +    E + L+ + 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 86  HRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRV--NIAIDV 143
           H N+IK +   S I+    +   IV E     +L + ++    Q R + +R      + +
Sbjct: 61  HPNVIKYLA--SFIENNELN---IVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQL 115

Query: 144 SFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSI 203
             A+E+ H      I+H D+KP+N+ +    V  +GDLGL +F            +S + 
Sbjct: 116 CSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFF-----------SSKTT 161

Query: 204 EIKGIVG---YVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
               +VG   Y++PE    +  +   D+++ G LL EM   + P
Sbjct: 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 79.6 bits (197), Expect = 3e-17
 Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 26/213 (12%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRS-FAAECNALRNIRHRNLIKIITI 95
            +GQG   +VYK     +  I A+K +++   E  R     E   LR+     ++K    
Sbjct: 8   VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVK---- 63

Query: 96  CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQL--RFLTQRVNIAIDVSFAIEYFH-- 151
           C    ++  +  +IV EYM   +L   L +  G++    L     IA  +   ++Y H  
Sbjct: 64  CYGAFYKEGEI-SIVLEYMDGGSLAD-LLKKVGKIPEPVLAY---IARQILKGLDYLHTK 118

Query: 152 HHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGY 211
            H    I+H D+KPSN+L++      + D G++K L      T  +  +      G V Y
Sbjct: 119 RH----IIHRDIKPSNLLINSKGEVKIADFGISKVL----ENTLDQCNTFV----GTVTY 166

Query: 212 VAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
           ++PE   G   S + D+++ G+ LLE    + P
Sbjct: 167 MSPERIQGESYSYAADIWSLGLTLLECALGKFP 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 79.8 bits (197), Expect = 4e-17
 Identities = 74/308 (24%), Positives = 135/308 (43%), Gaps = 66/308 (21%)

Query: 38  IGQGGVSIVYKG-----ILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNIRHRNL 89
           +G+G    V+ G       +  + +VAVK   LK+    +A + F  E   L N +H N+
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKT--LKETASNDARKDFEREAELLTNFQHENI 70

Query: 90  IKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFL------------TQRV 137
           +K   +C+    EG D   +VFEYM++ +L ++LR       FL            +Q +
Sbjct: 71  VKFYGVCT----EG-DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLL 125

Query: 138 NIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAE 197
            IA+ ++  + Y         VH DL   N L+  D+V  +GD G+++ ++         
Sbjct: 126 QIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVY--------- 173

Query: 198 TASNSIEIKGI----VGYVAPEYGMGSKASVSGDVYNFGILLLEMFTR-RRPTDAMFNEG 252
             ++   + G     + ++ PE  M  K +   DV++FG++L E+FT  ++P   + NE 
Sbjct: 174 -TTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE- 231

Query: 253 LTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEM 312
                        +V+E +    LL+           C   V    + C    P +R+ +
Sbjct: 232 -------------EVIECITQGRLLQRP-------RTCPSEVYDIMLGCWKRDPQQRINI 271

Query: 313 RDVVAKLR 320
           +D+  +L+
Sbjct: 272 KDIHERLQ 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 79.3 bits (196), Expect = 4e-17
 Identities = 62/226 (27%), Positives = 105/226 (46%), Gaps = 34/226 (15%)

Query: 38  IGQGGVSIVYKGILDE-SRSIVAVKVVNLK---QKEASRSFAAECNALRNIRHRNLIKII 93
           IG G    V +G L    +  + V +  LK     +    F  E + +    H N+I++ 
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRL- 70

Query: 94  TICSSIDFEGFDFKA----IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEY 149
                   EG   K+    I+ EYM+N +L+++LR+++G+   + Q V +   ++  ++Y
Sbjct: 71  --------EGVVTKSRPVMIITEYMENGSLDKFLRENDGKFT-VGQLVGMLRGIASGMKY 121

Query: 150 FHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
                    VH DL   NIL++ ++V  V D GL++ L   E      T    I I+   
Sbjct: 122 LSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA--TYTTKGGKIPIR--- 173

Query: 210 GYVAPE---YGMGSKASVSGDVYNFGILLLEMFTR-RRPTDAMFNE 251
            + APE   Y   + AS   DV++FGI++ E+ +   RP   M N+
Sbjct: 174 -WTAPEAIAYRKFTSAS---DVWSFGIVMWEVMSYGERPYWDMSNQ 215

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 78.5 bits (193), Expect = 8e-17
 Identities = 64/206 (31%), Positives = 102/206 (49%), Gaps = 22/206 (10%)

Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICS 97
           IG+G    V  G  D   + VAVK +  K    +++F AE + +  +RH NL++++ +  
Sbjct: 14  IGKGEFGDVMLG--DYRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI- 68

Query: 98  SIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPS 157
            ++ +G  +  IV EYM   +L  +LR     +      +  ++DV  A+EY   +   +
Sbjct: 69  -VEEKGGLY--IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---N 122

Query: 158 IVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYG 217
            VH DL   N+L+ +D VA V D GL K     E  +  +T       K  V + APE  
Sbjct: 123 FVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTG------KLPVKWTAPEAL 171

Query: 218 MGSKASVSGDVYNFGILLLEMFTRRR 243
              K S   DV++FGILL E+++  R
Sbjct: 172 REKKFSTKSDVWSFGILLWEIYSFGR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 78.9 bits (194), Expect = 8e-17
 Identities = 64/228 (28%), Positives = 107/228 (46%), Gaps = 24/228 (10%)

Query: 38  IGQGGVSIVYKGILD---ESRSIVAVKVVNLKQKEASRS-FAAECNALRNIRHRNLIKII 93
           IG G    V++GIL         VA+K +     E  R  F +E + +    H N+I++ 
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72

Query: 94  TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHH 153
            + +      F    I+ EYM+N  L+++LR  +G+     Q V +   ++  ++Y    
Sbjct: 73  GVVTK-----FKPAMIITEYMENGALDKYLRDHDGEFSSY-QLVGMLRGIAAGMKYL--- 123

Query: 154 CQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVA 213
              + VH DL   NIL++ ++   V D GL++ L     GT   T+   I I+    + A
Sbjct: 124 SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYT-TSGGKIPIR----WTA 178

Query: 214 PEYGMGSKASVSGDVYNFGILLLEMFTR-RRPTDAMFNEGLTLHEFVK 260
           PE     K + + DV++FGI++ E+ +   RP   M N     HE +K
Sbjct: 179 PEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-----HEVMK 221

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 78.5 bits (193), Expect = 9e-17
 Identities = 64/216 (29%), Positives = 104/216 (48%), Gaps = 21/216 (9%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEAS-RSFAAECNALRNIRHRNLIKIITI 95
           K+G G    V+ G  +   + VAVK   LK    S  SF  E   ++ +RH  L+++  +
Sbjct: 13  KLGNGQFGEVWMGTWN-GNTKVAVK--TLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAV 69

Query: 96  CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQ 155
            S           IV EYM   +L  +L+   G+   L   V++A  V+  + Y     +
Sbjct: 70  VSEEPI------YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---R 120

Query: 156 PSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPE 215
            + +H DL+ +NIL+   +V  + D GLA+ +   E  TA + A   I+      + APE
Sbjct: 121 MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY-TARQGAKFPIK------WTAPE 173

Query: 216 YGMGSKASVSGDVYNFGILLLEMFTRRR-PTDAMFN 250
             +  + ++  DV++FGILL E+ T+ R P   M N
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN 209

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 78.7 bits (194), Expect = 9e-17
 Identities = 62/216 (28%), Positives = 108/216 (50%), Gaps = 22/216 (10%)

Query: 31  NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAA-ECNALRNIRHRNL 89
           NF    K+G+G  + VYKG    +  IVA+K ++L  +E + S A  E + ++ ++H N 
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHEN- 59

Query: 90  IKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWL--RQSNGQLRFLTQRVNIAIDVSFAI 147
             I+ +   I  E  +   +VFEYM   +L++++      G L   T + +    +   I
Sbjct: 60  --IVRLHDVIHTE--NKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVK-SFTYQLLKGI 113

Query: 148 EYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKG 207
            + H +    ++H DLKP N+L+++     + D GLA+       G    T SN +    
Sbjct: 114 AFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAF-----GIPVNTFSNEVV--- 162

Query: 208 IVGYVAPEYGMGSKA-SVSGDVYNFGILLLEMFTRR 242
            + Y AP+  +GS+  S S D+++ G ++ EM T R
Sbjct: 163 TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 78.3 bits (194), Expect = 1e-16
 Identities = 64/227 (28%), Positives = 106/227 (46%), Gaps = 47/227 (20%)

Query: 32  FSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKE------ASRSFAAECNALRNIR 85
           +    K+G+G   +VYK    ++  IVA+K + L  +E      A R    E + L+ ++
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR----EISLLKELK 56

Query: 86  HRNLIKIITICSSIDFEGFDFK-AIVFEYMQNRNLEQWLRQSNGQL------RFLTQRVN 138
           H N++K++ +  +        K  +VFEY    +L+++L +  G L        + Q + 
Sbjct: 57  HPNIVKLLDVIHTER------KLYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLR 109

Query: 139 IAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAET 198
                   + Y H H    I+H DLKP NIL+++D V  + D GLA+  FG    T    
Sbjct: 110 -------GLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARA-FGIPLRTY--- 155

Query: 199 ASNSIEIKGIVG--YVAPEYGMGSKA-SVSGDVYNFGILLLEMFTRR 242
                    +V   Y APE  +GSK  S + D+++ G +  EM T +
Sbjct: 156 ------THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 76.7 bits (189), Expect = 3e-16
 Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 39/216 (18%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVK------VVNLKQKEASRSFAAECNALRNIRHRNLI 90
           KIG+G    VYKG+L +  + VAVK        +LK+K     F  E   L+   H N++
Sbjct: 2   KIGKGNFGDVYKGVL-KGNTEVAVKTCRSTLPPDLKRK-----FLQEAEILKQYDHPNIV 55

Query: 91  KIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYF 150
           K+I +C  +  +      IV E +   +L  +LR+   +L  + + + +++D +  +EY 
Sbjct: 56  KLIGVC--VQKQPI---YIVMELVPGGSLLTFLRKKKNRLT-VKKLLQMSLDAAAGMEYL 109

Query: 151 HHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASN---SIEIKG 207
                   +H DL   N L+ ++ V  + D G+++     E      T S+    I IK 
Sbjct: 110 ESKN---CIHRDLAARNCLVGENNVLKISDFGMSR-----EEEGGIYTVSDGLKQIPIK- 160

Query: 208 IVGYVAPE---YGMGSKASVSGDVYNFGILLLEMFT 240
              + APE   YG  +  S   DV+++GILL E F+
Sbjct: 161 ---WTAPEALNYGRYTSES---DVWSYGILLWETFS 190

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 76.4 bits (189), Expect = 3e-16
 Identities = 60/215 (27%), Positives = 94/215 (43%), Gaps = 31/215 (14%)

Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVN----LKQKEASRSFAAECNALRNIRHRNLIKII 93
           +G+G    V      ++  + A+KV+     +K+KE   +   E N L  I H  ++K  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLT-ERNILSRINHPFIVK-- 57

Query: 94  TICSSIDFEGFDFKAIVFEYMQN----RNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEY 149
              +    E       V EY        +L +  R S  + RF       A ++  A+EY
Sbjct: 58  LHYAFQTEEKLYL---VLEYAPGGELFSHLSKEGRFSEERARF------YAAEIVLALEY 108

Query: 150 FHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
            H      I++ DLKP NILLD D    + D GLAK        ++  + +N+    G  
Sbjct: 109 LHSL---GIIYRDLKPENILLDADGHIKLTDFGLAK------ELSSEGSRTNTFC--GTP 157

Query: 210 GYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
            Y+APE  +G     + D ++ G+LL EM T + P
Sbjct: 158 EYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 76.2 bits (187), Expect = 5e-16
 Identities = 61/216 (28%), Positives = 109/216 (50%), Gaps = 21/216 (9%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEAS-RSFAAECNALRNIRHRNLIKIITI 95
           K+GQG    V+ G  + + + VA+K   LK       +F  E   ++ +RH  L+ +  +
Sbjct: 13  KLGQGCFGEVWMGTWNGT-TKVAIK--TLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAV 69

Query: 96  CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQ 155
            S       +   IV E+M   +L  +L++ +G+   L Q V++A  ++  + Y     +
Sbjct: 70  VSE------EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---R 120

Query: 156 PSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPE 215
            + +H DL+ +NIL+  ++V  + D GLA+ +   E  TA + A   I+      + APE
Sbjct: 121 MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-TARQGAKFPIK------WTAPE 173

Query: 216 YGMGSKASVSGDVYNFGILLLEMFTRRR-PTDAMFN 250
             +  + ++  DV++FGILL E+ T+ R P   M N
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN 209

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 76.1 bits (187), Expect = 6e-16
 Identities = 54/204 (26%), Positives = 89/204 (43%), Gaps = 26/204 (12%)

Query: 58  VAVKVVNLKQKEASRS---FAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYM 114
           VA+K++    KE S S   F  E   +  + H  L+++  +C+      +    IV EYM
Sbjct: 31  VAIKMI----KEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK-QRPIY----IVTEYM 81

Query: 115 QNRNLEQWLRQSNGQLRFLT-QRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQD 173
            N  L  +LR+     RF   Q + +  DV   + Y         +H DL   N L+D  
Sbjct: 82  SNGCLLNYLRE--HGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQ 136

Query: 174 IVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGI 233
               V D GL++++   E        ++S+  K  V +  PE  + SK S   DV+ FG+
Sbjct: 137 GCVKVSDFGLSRYVLDDE-------YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGV 189

Query: 234 LLLEMFTR-RRPTDAMFNEGLTLH 256
           L+ E+++  + P +   N      
Sbjct: 190 LMWEVYSLGKMPYERFNNSETVEK 213

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 75.6 bits (186), Expect = 8e-16
 Identities = 58/206 (28%), Positives = 100/206 (48%), Gaps = 24/206 (11%)

Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRS---FAAECNALRNIRHRNLIKIIT 94
           +G G   +V+ G        VA+K++    +E + S   F  E   +  + H NL+++  
Sbjct: 12  LGSGQFGVVHLGKWRGKID-VAIKMI----REGAMSEDDFIEEAKVMMKLSHPNLVQLYG 66

Query: 95  ICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHC 154
           +C+    +   F  IV EYM N  L  +LR+  G+L      +++  DV  A+EY   + 
Sbjct: 67  VCTK---QRPIF--IVTEYMANGCLLNYLRERKGKLG-TEWLLDMCSDVCEAMEYLESNG 120

Query: 155 QPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAP 214
               +H DL   N L+ +D V  V D GLA+++   +  T+++        K  V +  P
Sbjct: 121 ---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-TSSQGT------KFPVKWAPP 170

Query: 215 EYGMGSKASVSGDVYNFGILLLEMFT 240
           E    S+ S   DV++FG+L+ E+F+
Sbjct: 171 EVFDYSRFSSKSDVWSFGVLMWEVFS 196

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 75.3 bits (185), Expect = 1e-15
 Identities = 65/223 (29%), Positives = 110/223 (49%), Gaps = 25/223 (11%)

Query: 38  IGQGGVSIVYKGILD---ESRSIVAVKVVNLKQKEASR-SFAAECNALRNIRHRNLIKII 93
           IG G    V +G L    +    VA+K +     E  R  F +E + +    H N+I + 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL- 70

Query: 94  TICSSIDFEGFDFKA----IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEY 149
                   EG   K+    I+ E+M+N  L+ +LRQ++GQ   + Q V +   ++  ++Y
Sbjct: 71  --------EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFT-VIQLVGMLRGIAAGMKY 121

Query: 150 FHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
                + + VH DL   NIL++ ++V  V D GL++FL   E  T+  T ++S+  K  +
Sbjct: 122 L---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL---EDDTSDPTYTSSLGGKIPI 175

Query: 210 GYVAPEYGMGSKASVSGDVYNFGILLLE-MFTRRRPTDAMFNE 251
            + APE     K + + DV+++GI++ E M    RP   M N+
Sbjct: 176 RWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ 218

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 75.0 bits (185), Expect = 1e-15
 Identities = 56/223 (25%), Positives = 93/223 (41%), Gaps = 33/223 (14%)

Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVV---NLKQKEASRSFAAECNALRNIRHRNLIKI 92
             IG+G    V K        I+  K +   N+ +KE  +   +E N LR ++H N   I
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQ-LVSEVNILRELKHPN---I 61

Query: 93  ITICSSIDFEGFDFKA----IVFEYMQNRNLEQWLRQSNGQLRFLTQRV--NIAIDVSFA 146
           +     I     D       IV EY +  +L Q +++   + +++ +     I   +  A
Sbjct: 62  VRYYDRI----IDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLA 117

Query: 147 IEYFHH--HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIE 204
           +   H+      +++H DLKP+NI LD +    +GD GLAK L             +S  
Sbjct: 118 LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL-----------GHDSSF 166

Query: 205 IKGIVG---YVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
            K  VG   Y++PE           D+++ G L+ E+     P
Sbjct: 167 AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 74.9 bits (184), Expect = 2e-15
 Identities = 65/236 (27%), Positives = 114/236 (48%), Gaps = 29/236 (12%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEAS-RSFAAECNALRNIRHRNLIKIITI 95
           K+G G    V+ G  +     VA+K  +LKQ   S  +F AE N ++ ++H  L+++  +
Sbjct: 13  KLGAGQFGEVWMGYYNGHTK-VAIK--SLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAV 69

Query: 96  CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQ 155
            +           I+ EYM+N +L  +L+   G    + + +++A  ++  + +     +
Sbjct: 70  VTQEPI------YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---R 120

Query: 156 PSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPE 215
            + +H DL+ +NIL+ + +   + D GLA+ +   E  TA E A   I+      + APE
Sbjct: 121 KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-TAREGAKFPIK------WTAPE 173

Query: 216 ---YGMGSKASVSGDVYNFGILLLEMFTRRR-PTDAMFNEGL--TLHEFVKMALPD 265
              YG     ++  DV++FGILL E+ T  R P   M N  +   L    +M  PD
Sbjct: 174 AINYGT---FTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPD 226

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 74.2 bits (182), Expect = 4e-15
 Identities = 59/209 (28%), Positives = 103/209 (49%), Gaps = 28/209 (13%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAA--ECNALRNIRHRNLI---K 91
           K+G+G  + VYKGI   +  +VA+KV+++K +E    F A  E + L+ ++H N++    
Sbjct: 12  KLGEGSYATVYKGISRINGQLVALKVISMKTEEGV-PFTAIREASLLKGLKHANIVLLHD 70

Query: 92  IITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFH 151
           II    ++ F        VFEYM   +L Q++ Q  G L     R+     +   + Y H
Sbjct: 71  IIHTKETLTF--------VFEYMHT-DLAQYMIQHPGGLHPYNVRL-FMFQLLRGLAYIH 120

Query: 152 HHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGY 211
                 I+H DLKP N+L     ++++G+L LA F         ++T S+ +     + Y
Sbjct: 121 GQ---HILHRDLKPQNLL-----ISYLGELKLADFGLARAKSIPSQTYSSEVV---TLWY 169

Query: 212 VAPEYGMGS-KASVSGDVYNFGILLLEMF 239
             P+  +G+   S + D++  G + +EM 
Sbjct: 170 RPPDVLLGATDYSSALDIWGAGCIFIEML 198

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 74.1 bits (183), Expect = 5e-15
 Identities = 55/224 (24%), Positives = 97/224 (43%), Gaps = 46/224 (20%)

Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNL---KQKEASRSFAAECNALRNIRHRNLIKIIT 94
           IG G   +V   +   +   VA+K ++       +A R    E   LR++RH N+I ++ 
Sbjct: 8   IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR-EIKLLRHLRHENIIGLLD 66

Query: 95  ICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQ----SNGQLRFLT-Q--RVNIAIDVSFAI 147
           I      E F+   IV E M+  +L + ++     ++  +++   Q  R          +
Sbjct: 67  ILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILR---------GL 116

Query: 148 EYFHHHCQPS--IVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEI 205
           +Y H     S  ++H DLKPSNIL++ +    + D GLA+ +   E      T       
Sbjct: 117 KYLH-----SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT------- 164

Query: 206 KGIVGYV------APEYGMGSKA-SVSGDVYNFGILLLEMFTRR 242
                YV      APE  + S   + + D+++ G +  E+ TR+
Sbjct: 165 ----EYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 72.9 bits (179), Expect = 8e-15
 Identities = 69/269 (25%), Positives = 112/269 (41%), Gaps = 40/269 (14%)

Query: 31  NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAA--ECNALRNIRHRN 88
           +F   NKIG+G   +V+K +    + + A+K ++L +        A  E   L  +    
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60

Query: 89  LIKIITICSSIDFEGFDFKA---IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSF 145
           +I+         +E F  K    IV EY +N +L + L+   G+     Q     I +  
Sbjct: 61  IIRY--------YESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILL 112

Query: 146 AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEI 205
            + + H      I+H D+K  N+ LD      +GDLG+AK L           + N+   
Sbjct: 113 GLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL-----------SDNTNFA 158

Query: 206 KGIVG---YVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMA 262
             IVG   Y++PE       +   DV+  G++L E  T + P DA  N+G         A
Sbjct: 159 NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDAN-NQG---------A 208

Query: 263 LPDKVMEIVDPSLLLEVTANNYSWIEDCL 291
           L  K++  V P +    +      I+ CL
Sbjct: 209 LILKIIRGVFPPVSQMYSQQLAQLIDQCL 237

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 73.0 bits (180), Expect = 1e-14
 Identities = 56/214 (26%), Positives = 105/214 (49%), Gaps = 26/214 (12%)

Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASR---SFAA--ECNALRNIRHRNLI 90
            K+G+G  ++VYK    E+  IVA+K + L +++ ++   +F A  E   L+ ++H N+I
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65

Query: 91  KIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRV-NIAIDVSFAIEY 149
            ++ +     F       +VFE+M+  +LE+ ++  +  +      + +  +     +EY
Sbjct: 66  GLLDV-----FGHKSNINLVFEFMET-DLEKVIK--DKSIVLTPADIKSYMLMTLRGLEY 117

Query: 150 FHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
            H +    I+H DLKP+N+L+  D V  + D GLA+  FG  P    +     +      
Sbjct: 118 LHSN---WILHRDLKPNNLLIASDGVLKLADFGLARS-FGS-PNR--KMTHQVVTR---- 166

Query: 210 GYVAPEYGMGSKA-SVSGDVYNFGILLLEMFTRR 242
            Y APE   G++   V  D+++ G +  E+  R 
Sbjct: 167 WYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 72.0 bits (176), Expect = 2e-14
 Identities = 59/235 (25%), Positives = 107/235 (45%), Gaps = 24/235 (10%)

Query: 31  NFSPANKIGQGGVSIVYKGILDESRSIVAVK---VVNLKQKEASRSFAAECNALRNIRHR 87
           NF    KIG+G  S VY+         VA+K   + +L   +A      E + L+ + H 
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 88  NLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRV--NIAIDVSF 145
           N+IK     S I+    +   IV E     +L + ++    Q R + ++      + +  
Sbjct: 63  NVIKYYA--SFIEDNELN---IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCS 117

Query: 146 AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEI 205
           A+E+ H      ++H D+KP+N+ +    V  +GDLGL +F       ++  TA++S  +
Sbjct: 118 ALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF------SSKTTAAHS--L 166

Query: 206 KGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVK 260
            G   Y++PE    +  +   D+++ G LL EM   + P    + + + L+   K
Sbjct: 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMNLYSLCK 218

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 72.3 bits (177), Expect = 2e-14
 Identities = 55/226 (24%), Positives = 107/226 (47%), Gaps = 40/226 (17%)

Query: 37  KIGQGGVSIVYKG-----ILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIK 91
           ++G+G    V+       + ++ + +VAVK +    + A + F  E   L  ++H+++++
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71

Query: 92  IITICSSIDFEGFDFKAIVFEYMQNRNLEQWLR--------------QSNGQLRFLTQRV 137
              +C+    EG     +VFEYM++ +L ++LR               + GQL  L Q +
Sbjct: 72  FYGVCT----EG-RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLT-LGQML 125

Query: 138 NIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG---YEPGT 194
            IA  ++  + Y         VH DL   N L+ Q +V  +GD G+++ ++    Y  G 
Sbjct: 126 AIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG- 181

Query: 195 AAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
                   + I+    ++ PE  +  K +   D+++FG++L E+FT
Sbjct: 182 ----GRTMLPIR----WMPPESILYRKFTTESDIWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 72.3 bits (177), Expect = 2e-14
 Identities = 52/205 (25%), Positives = 100/205 (48%), Gaps = 38/205 (18%)

Query: 55  RSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYM 114
           + +VAVK +      A + F  E   L N++H +++K   +C     +G D   +VFEYM
Sbjct: 35  KMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCG----DG-DPLIMVFEYM 89

Query: 115 QNRNLEQWLR---------------QSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIV 159
           ++ +L ++LR               Q+ G+L  L+Q ++IA  ++  + Y         V
Sbjct: 90  KHGDLNKFLRAHGPDAMILVDGQPRQAKGELG-LSQMLHIASQIASGMVYL---ASQHFV 145

Query: 160 HGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKG----IVGYVAPE 215
           H DL   N L+  +++  +GD G+++ ++          +++   + G     + ++ PE
Sbjct: 146 HRDLATRNCLVGANLLVKIGDFGMSRDVY----------STDYYRVGGHTMLPIRWMPPE 195

Query: 216 YGMGSKASVSGDVYNFGILLLEMFT 240
             M  K +   DV++FG++L E+FT
Sbjct: 196 SIMYRKFTTESDVWSFGVILWEIFT 220

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 71.3 bits (175), Expect = 2e-14
 Identities = 61/222 (27%), Positives = 97/222 (43%), Gaps = 24/222 (10%)

Query: 31  NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK---QKEASRSFAAECNALRNIRHR 87
           +F    K+G+G    VYK          A+K V+L    QKE   +   E   L ++ H 
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVN-EIRILASVNHP 59

Query: 88  NLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRV--NIAIDVSF 145
           N+I      + +D        IV EY    +L + + +   + + + ++    I I +  
Sbjct: 60  NIISYKE--AFLDGNKL---CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLR 114

Query: 146 AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEI 205
            ++  H      I+H DLK +NILL  + +  +GDLG++K L        A+T       
Sbjct: 115 GLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVL----KKNMAKTQI----- 162

Query: 206 KGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDA 247
            G   Y+APE   G   S   D+++ G LL EM T   P +A
Sbjct: 163 -GTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEA 203

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 71.2 bits (175), Expect = 3e-14
 Identities = 55/219 (25%), Positives = 97/219 (44%), Gaps = 26/219 (11%)

Query: 31  NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK----EASRSFAAECNALRNIRH 86
           +F     IG+G    V      +++ + A+K +N KQK     + R+   E   L+ + H
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMN-KQKCVEKGSVRNVLNERRILQELNH 59

Query: 87  RNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-DVSF 145
             L+ +     S  F+  +   +V + +   +L   L Q   +++F  ++V   I ++  
Sbjct: 60  PFLVNL---WYS--FQDEENMYLVVDLLLGGDLRYHLSQ---KVKFSEEQVKFWICEIVL 111

Query: 146 AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEI 205
           A+EY H      I+H D+KP NILLD+    H+ D  +A  +            + +   
Sbjct: 112 ALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKV---------TPDTLTTST 159

Query: 206 KGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
            G  GY+APE       SV+ D ++ G+   E    +RP
Sbjct: 160 SGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 71.2 bits (175), Expect = 3e-14
 Identities = 57/221 (25%), Positives = 94/221 (42%), Gaps = 33/221 (14%)

Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAA-ECNALRNIRHRNLIKIIT 94
             IG G  ++VY  I   +   VA+K ++L++ + S      E  A+    H N++K  T
Sbjct: 7   EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66

Query: 95  ICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI---DVSFAIEYFH 151
                 F   D   +V  Y+   +L   ++ S  +         IA    +V   +EY H
Sbjct: 67  -----SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGL--DEAIIATVLKEVLKGLEYLH 119

Query: 152 HHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG- 210
            + Q   +H D+K  NILL +D    + D G++  L   + G        +      VG 
Sbjct: 120 SNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASL--ADGGDRTRKVRKT-----FVGT 169

Query: 211 --YVAPE-----YGMGSKASVSGDVYNFGILLLEMFTRRRP 244
             ++APE     +G   KA    D+++FGI  +E+ T   P
Sbjct: 170 PCWMAPEVMEQVHGYDFKA----DIWSFGITAIELATGAAP 206

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 70.7 bits (173), Expect = 4e-14
 Identities = 55/210 (26%), Positives = 98/210 (46%), Gaps = 24/210 (11%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRS---FAAECNALRNIRHRNLIKII 93
           +IG G   +V+ G   E R  VA+K +    +E + S   F  E   +  + H  L+++ 
Sbjct: 11  EIGSGQFGLVWLGYWLEKRK-VAIKTI----REGAMSEEDFIEEAQVMMKLSHPKLVQLY 65

Query: 94  TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHH 153
            +C     E      +VFE+M++  L  +LR   G+    T  + + +DV   + Y    
Sbjct: 66  GVC----TERSPI-CLVFEFMEHGCLSDYLRAQRGKFSQETL-LGMCLDVCEGMAYLESS 119

Query: 154 CQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVA 213
               ++H DL   N L+ ++ V  V D G+ +F+         +  ++S   K  V + +
Sbjct: 120 N---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLD-------DQYTSSTGTKFPVKWSS 169

Query: 214 PEYGMGSKASVSGDVYNFGILLLEMFTRRR 243
           PE    SK S   DV++FG+L+ E+F+  +
Sbjct: 170 PEVFSFSKYSSKSDVWSFGVLMWEVFSEGK 199

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 70.8 bits (173), Expect = 5e-14
 Identities = 60/219 (27%), Positives = 103/219 (47%), Gaps = 21/219 (9%)

Query: 31  NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVN---LKQKEASRSFAAECNALRNIRHR 87
           NF    KIG+G  S VY+      R  VA+K V    +   +A +    E + L+ + H 
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 88  NLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRV--NIAIDVSF 145
           N+IK +   S I+    +   IV E     +L Q ++    Q R + +R      + +  
Sbjct: 63  NVIKYLD--SFIEDNELN---IVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS 117

Query: 146 AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEI 205
           A+E+ H      ++H D+KP+N+ +    V  +GDLGL +F       ++  TA++S  +
Sbjct: 118 AVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF------SSKTTAAHS--L 166

Query: 206 KGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
            G   Y++PE    +  +   D+++ G LL EM   + P
Sbjct: 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 70.6 bits (173), Expect = 7e-14
 Identities = 57/216 (26%), Positives = 106/216 (49%), Gaps = 22/216 (10%)

Query: 31  NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK-QKEASRSFAA-ECNALRNIRHRN 88
           NF    KIG+G   +VYK     +  +VA+K + L  + E   S A  E + L+ + H N
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60

Query: 89  LIKIITICSSIDFEGFDFKA-IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAI 147
           ++K++ +  +      + K  +VFE++ +++L++++  S      L    +    +   +
Sbjct: 61  IVKLLDVIHT------ENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGL 113

Query: 148 EYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKG 207
            + H H    ++H DLKP N+L++ +    + D GLA+       G    T ++ +    
Sbjct: 114 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-----GVPVRTYTHEVV--- 162

Query: 208 IVGYVAPEYGMGSK-ASVSGDVYNFGILLLEMFTRR 242
            + Y APE  +G K  S + D+++ G +  EM TRR
Sbjct: 163 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 69.9 bits (171), Expect = 8e-14
 Identities = 57/223 (25%), Positives = 98/223 (43%), Gaps = 40/223 (17%)

Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQ--KEASRSFAAECNALRNIRHRNLIKIITI 95
           +G+G   IV+       + +V +K + ++Q  K+   +   EC  L+ + H N+I+    
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYY-- 65

Query: 96  CSSIDFEGF-DFKA--IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYF-- 150
                 E F + KA  IV EY     L            ++ +R N  +D    + +F  
Sbjct: 66  ------ENFLEDKALMIVMEYAPGGTLA----------EYIQKRCNSLLDEDTILHFFVQ 109

Query: 151 -----HHHCQPSIVHGDLKPSNILLDQ-DIVAHVGDLGLAKFLFGYEPGTAAETASNSIE 204
                HH     I+H DLK  NILLD+  +V  +GD G++K L          + S +  
Sbjct: 110 ILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL---------SSKSKAYT 160

Query: 205 IKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDA 247
           + G   Y++PE   G   +   D++  G +L E+ + +R  +A
Sbjct: 161 VVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEA 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 69.9 bits (172), Expect = 1e-13
 Identities = 61/220 (27%), Positives = 84/220 (38%), Gaps = 56/220 (25%)

Query: 38  IGQGGVSIVYKGILDESRSIVAVK------VVNLKQKEASRSFAAECNALRNIRHRNLIK 91
           +G G    V       S    A+K      +V LKQ E   +   E   L++IRH  L+ 
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLN---EKRILQSIRHPFLVN 65

Query: 92  IITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQ----SNGQLRFLTQRVNIAIDVSFAI 147
           +        F+      +V EY+    L   LR+         RF       A  V  A+
Sbjct: 66  LYG-----SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFY------AAQVVLAL 114

Query: 148 EYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKG 207
           EY H      IV+ DLKP N+LLD D    + D G AK +   +  T             
Sbjct: 115 EYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRV---KGRT-----------YT 157

Query: 208 IVG---YVAPE------YGMGSKASVSGDVYNFGILLLEM 238
           + G   Y+APE      YG       + D +  GIL+ EM
Sbjct: 158 LCGTPEYLAPEIILSKGYGK------AVDWWALGILIYEM 191

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 68.8 bits (168), Expect = 2e-13
 Identities = 57/199 (28%), Positives = 95/199 (47%), Gaps = 22/199 (11%)

Query: 58  VAVKVVNLKQKEASR-SFAAECNALRNIRHRNLIK---IITICSSIDFEGFDFKAIVFEY 113
           VA+K +     E  R  F +E + +    H N+I    ++T    +         IV EY
Sbjct: 35  VAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV--------MIVTEY 86

Query: 114 MQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQD 173
           M+N +L+ +LR+ +GQ   + Q V +   ++  ++Y         VH DL   NIL++ +
Sbjct: 87  MENGSLDAFLRKHDGQFTVI-QLVGMLRGIASGMKYL---SDMGYVHRDLAARNILVNSN 142

Query: 174 IVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGI 233
           +V  V D GL++ L   +P  A  T    I I+    + APE     K + + DV+++GI
Sbjct: 143 LVCKVSDFGLSRVLED-DPEAAYTTRGGKIPIR----WTAPEAIAYRKFTSASDVWSYGI 197

Query: 234 LLLE-MFTRRRPTDAMFNE 251
           ++ E M    RP   M N+
Sbjct: 198 VMWEVMSYGERPYWEMSNQ 216

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 68.8 bits (169), Expect = 3e-13
 Identities = 57/245 (23%), Positives = 100/245 (40%), Gaps = 45/245 (18%)

Query: 20  ISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECN 79
           +S  +  +   N     KIG+G    VYK     +   VA+K + L+++        E  
Sbjct: 12  VSEGDPRELYKNLE---KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN-EIL 67

Query: 80  ALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSN-----GQLRFLT 134
            +++ +H N++       S       +  +V EYM   +L   + Q+       Q+ ++ 
Sbjct: 68  IMKDCKHPNIVDYY---DSYLVGDELW--VVMEYMDGGSLTDIITQNFVRMNEPQIAYVC 122

Query: 135 QRVNIAIDVSFAIEYFH-HHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPG 193
           + V         +EY H  +     +H D+K  NILL +D     G + LA F      G
Sbjct: 123 REVL------QGLEYLHSQNV----IHRDIKSDNILLSKD-----GSVKLADF------G 161

Query: 194 TAAETASNSIEIKGIVG---YVAPEYGMGSKASVSGDVYNFGILLLEM------FTRRRP 244
            AA+      +   +VG   ++APE           D+++ GI+ +EM      + R  P
Sbjct: 162 FAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP 221

Query: 245 TDAMF 249
             A+F
Sbjct: 222 LRALF 226

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 68.5 bits (168), Expect = 3e-13
 Identities = 48/166 (28%), Positives = 75/166 (45%), Gaps = 28/166 (16%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEA--SRSFAAECNALRNIRHRNLIKIIT 94
           +IG+G   IV+K    E+   VA+K V L++ E         E  AL+  +H  ++K++ 
Sbjct: 7   RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66

Query: 95  ICSSIDFEGFDFKAIVFEYMQN------RNLEQWL--RQSNGQLRFLTQRVNIAIDVSFA 146
           +       GF    +V EYM +      R+ E+ L   Q    +R L +           
Sbjct: 67  V--FPHGSGF---VLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLK----------G 111

Query: 147 IEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEP 192
           + Y H      I+H DLKP+N+L+  D V  + D GLA+     EP
Sbjct: 112 VAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 68.2 bits (167), Expect = 4e-13
 Identities = 60/218 (27%), Positives = 100/218 (45%), Gaps = 40/218 (18%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAA--ECNALRNIRHRNLI---K 91
           K+G+G  + VYKG    +  +VA+K + L+ +E +  F A  E + L++++H N++    
Sbjct: 12  KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA-PFTAIREASLLKDLKHANIVTLHD 70

Query: 92  IITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLR------FLTQRVNIAIDVSF 145
           II    ++          VFEY+   +L+Q++    G L       FL Q +        
Sbjct: 71  IIHTKKTLTL--------VFEYLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLR------- 114

Query: 146 AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEI 205
            + Y H      ++H DLKP N+L+        G+L LA F         ++T SN +  
Sbjct: 115 GLAYCHQR---RVLHRDLKPQNLLIS-----ERGELKLADFGLARAKSVPSKTYSNEVV- 165

Query: 206 KGIVGYVAPEYGMGSKA-SVSGDVYNFGILLLEMFTRR 242
              + Y  P+  +GS   S S D++  G +  EM T R
Sbjct: 166 --TLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 68.3 bits (168), Expect = 4e-13
 Identities = 45/158 (28%), Positives = 72/158 (45%), Gaps = 25/158 (15%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIR-------HRNL 89
           ++G G    VY     E+  +VA+K   +K+K  S     EC  LR ++       H N+
Sbjct: 6   QLGDGTFGSVYLARNKETGELVAIKK--MKKKFYSWE---ECMNLREVKSLRKLNEHPNI 60

Query: 90  IKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRV--NIAIDVSFAI 147
           +K+  +     F   D    VFEYM+  NL Q ++   G+    ++ V  +I   +   +
Sbjct: 61  VKLKEV-----FRENDELYFVFEYMEG-NLYQLMKDRKGKP--FSESVIRSIIYQILQGL 112

Query: 148 EYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAK 185
            + H H      H DLKP N+L+    V  + D GLA+
Sbjct: 113 AHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAR 147

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 68.1 bits (166), Expect = 4e-13
 Identities = 54/216 (25%), Positives = 103/216 (47%), Gaps = 24/216 (11%)

Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRS----FAAECNALRNIRHRNLIKII 93
           +G+G    V +G L++  SI+ V V  +K    +RS    F +E   ++   H N++++I
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 94  TIC-SSIDFEGFDFKAIVFEYMQNRNLEQWL---RQSNGQLRFLTQR-VNIAIDVSFAIE 148
            +C  +++ EG+    ++  +M++ +L  +L   R  +      TQ  V    D++  +E
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 149 YFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG---YEPGTAAETASNSIEI 205
           Y       S +H DL   N +L++++   V D GL+K ++    Y  G  A+     I I
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183

Query: 206 KGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTR 241
           + +   V          +   DV++FG+ + E+ TR
Sbjct: 184 ESLADRV---------YTTKSDVWSFGVTMWEIATR 210

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 67.4 bits (165), Expect = 7e-13
 Identities = 51/206 (24%), Positives = 97/206 (47%), Gaps = 24/206 (11%)

Query: 46  VYKGIL-DESRSI---VAVKVVNLKQKEASRS-FAAECNALRNIRHRNLIKIITICSSID 100
           ++ GIL DE       V VK V     E   +    E   L  + H+N++ I+ +C    
Sbjct: 22  IFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVC---- 77

Query: 101 FEGFDFKAIVFEYMQNRNLEQWLRQ----SNGQLRFLTQR--VNIAIDVSFAIEYFHHHC 154
            E  +   +++ YM   NL+ +L+Q         + L+ +  V++AI ++  + Y H   
Sbjct: 78  IEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR- 136

Query: 155 QPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAP 214
              ++H D+   N ++D+++   + D  L++ LF   P        N  E + +  ++A 
Sbjct: 137 --GVIHKDIAARNCVIDEELQVKITDNALSRDLF---PMDYHCLGDN--ENRPV-KWMAL 188

Query: 215 EYGMGSKASVSGDVYNFGILLLEMFT 240
           E  +  + S + DV++FG+LL E+ T
Sbjct: 189 ESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 66.7 bits (163), Expect = 1e-12
 Identities = 60/213 (28%), Positives = 97/213 (45%), Gaps = 20/213 (9%)

Query: 38  IGQGGVSIVYKGIL---DESRSIVAVKVVN-LKQKEASRSFAAECNALRNIRHRNLIKII 93
           IG+G    VY G L   D  +   AVK +N +   E    F  E   +++  H N++ ++
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 94  TICSSIDFEGFDFKAIVFEYMQNRNLEQWLR--QSNGQLRFLTQRVNIAIDVSFAIEYFH 151
            IC  +  EG     +V  YM++ +L  ++R    N  ++ L   +   + V+  +EY  
Sbjct: 63  GIC--LPSEGSPL--VVLPYMKHGDLRNFIRSETHNPTVKDL---IGFGLQVAKGMEYL- 114

Query: 152 HHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGY 211
                  VH DL   N +LD+     V D GLA+ ++  E      +  N    K  V +
Sbjct: 115 --ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKE----YYSVHNHTGAKLPVKW 168

Query: 212 VAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
           +A E     K +   DV++FG+LL E+ TR  P
Sbjct: 169 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 201

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 66.6 bits (163), Expect = 1e-12
 Identities = 64/227 (28%), Positives = 108/227 (47%), Gaps = 41/227 (18%)

Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNL 89
           ++     ++G G   +V K +   +  I+AVK + L+  EA          ++    R L
Sbjct: 1   DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEA----------IQKQILREL 50

Query: 90  IKIITICSS---IDFEGFDFK----AIVFEYMQNRNLEQWLRQSNGQL--RFLTQRVNIA 140
             I+  C+S   + F G  +     +I  EYM   +L++ L++  G++  R L +   IA
Sbjct: 51  -DILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGK---IA 106

Query: 141 IDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETAS 200
           + V   + Y H   +  I+H D+KPSNIL++       G + L  F      G + +   
Sbjct: 107 VAVLKGLTYLHE--KHKIIHRDVKPSNILVN-----SRGQIKLCDF------GVSGQLV- 152

Query: 201 NSIEIKGIVG---YVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
           NS+  K  VG   Y+APE   G+  SV  D+++ G+ L+E+ T R P
Sbjct: 153 NSLA-KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFP 198

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 67.5 bits (165), Expect = 2e-12
 Identities = 65/229 (28%), Positives = 98/229 (42%), Gaps = 28/229 (12%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVV--NLKQKEA-SRSFAAECNALRNIRHRNLIKII 93
            IG+GG+  VY          VA+K +  +L +     + F  E     ++ H  ++ + 
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68

Query: 94  TICSSID--------FEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSF 145
           +ICS  D         EG+  K+++    Q  +L + L +      FL+    I   +  
Sbjct: 69  SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLS----IFHKICA 124

Query: 146 AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAA------ETA 199
            IEY H      ++H DLKP NILL       + D G A F    E              
Sbjct: 125 TIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181

Query: 200 SNSIEIKG-IVG---YVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
            +S+ I G IVG   Y+APE  +G  AS S D+Y  G++L +M T   P
Sbjct: 182 YSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230

Length = 932

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 65.6 bits (160), Expect = 3e-12
 Identities = 65/242 (26%), Positives = 105/242 (43%), Gaps = 52/242 (21%)

Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASR----------SFAAECNALRNIRHR 87
           IG+G    VY  +   +  ++AVK V L    A R          +  +E   L+++ H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 88  NLIKIITICSSIDFE-GFDFKAIVFEYMQNRNLEQWLRQ----SNGQLRFLTQRVNIAID 142
           N      I   + FE   ++ +I  EY+   ++   LR         +RF T++V     
Sbjct: 69  N------IVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQV----- 117

Query: 143 VSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNS 202
               + Y H      I+H DLK  N+L+D D +  + D G++K         + +   N 
Sbjct: 118 -LEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISK--------KSDDIYDND 165

Query: 203 --IEIKGIVGYVAPE----YGMGSKASVSGDVYNFGILLLEMFTRRRP------TDAMFN 250
             + ++G V ++APE    Y  G  A V  D+++ G ++LEMF  RRP        AMF 
Sbjct: 166 QNMSMQGSVFWMAPEVIHSYSQGYSAKV--DIWSLGCVVLEMFAGRRPWSDEEAIAAMFK 223

Query: 251 EG 252
            G
Sbjct: 224 LG 225

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 65.7 bits (160), Expect = 3e-12
 Identities = 53/192 (27%), Positives = 88/192 (45%), Gaps = 17/192 (8%)

Query: 52  DESRSIVAVKVVNLKQKEASRS-FAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIV 110
           D +  +VAVK +  +  + + S +  E N L+ + H N++K    CS    +G     ++
Sbjct: 30  DGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSE---QGGKGLQLI 86

Query: 111 FEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILL 170
            EY+   +L  +L +    L    Q +  A  +   + Y H       +H DL   N+LL
Sbjct: 87  MEYVPLGSLRDYLPKHKLNL---AQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLL 140

Query: 171 DQDIVAHVGDLGLAKFL-FGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVY 229
           D D +  +GD GLAK +  G+E     E   +       V + A E    +K S + DV+
Sbjct: 141 DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP------VFWYAVECLKENKFSYASDVW 194

Query: 230 NFGILLLEMFTR 241
           +FG+ L E+ T 
Sbjct: 195 SFGVTLYELLTH 206

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 65.9 bits (160), Expect = 3e-12
 Identities = 50/203 (24%), Positives = 96/203 (47%), Gaps = 31/203 (15%)

Query: 52  DESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVF 111
           ++ + +VAVK +      A + F  E   L N++H +++K   +C     EG D   +VF
Sbjct: 32  EQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVC----VEG-DPLIMVF 86

Query: 112 EYMQNRNLEQWLRQSNGQLRFL-----------TQRVNIAIDVSFAIEYFHHHCQPSIVH 160
           EYM++ +L ++LR        +           +Q ++IA  ++  + Y         VH
Sbjct: 87  EYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYL---ASQHFVH 143

Query: 161 GDLKPSNILLDQDIVAHVGDLGLAKFLFG---YEPGTAAETASNSIEIKGIVGYVAPEYG 217
            DL   N L+ ++++  +GD G+++ ++    Y  G         + I+    ++ PE  
Sbjct: 144 RDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVG-----GHTMLPIR----WMPPESI 194

Query: 218 MGSKASVSGDVYNFGILLLEMFT 240
           M  K +   DV++ G++L E+FT
Sbjct: 195 MYRKFTTESDVWSLGVVLWEIFT 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 65.2 bits (159), Expect = 3e-12
 Identities = 58/224 (25%), Positives = 95/224 (42%), Gaps = 28/224 (12%)

Query: 31  NFSPANKIGQG--GVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAA--ECNALRNIRH 86
           ++ P   +G+G  G + +Y+    E  S+V  K VNL +        A  E   L  ++H
Sbjct: 1   HYIPIRVLGKGAFGEATLYRR--TEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQH 58

Query: 87  RNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFA 146
            N+I          F   +   I  EY     L   + +  GQL      +     +  A
Sbjct: 59  PNIIAYYN-----HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSA 113

Query: 147 IEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIK 206
           + Y H   +  I+H D+K  NI L +  +  +GD G++K L     G+    A      +
Sbjct: 114 VSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKIL-----GSEYSMA------E 159

Query: 207 GIVG---YVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDA 247
            +VG   Y++PE   G K +   D++  G +L E+ T +R  DA
Sbjct: 160 TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDA 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 64.2 bits (156), Expect = 6e-12
 Identities = 56/205 (27%), Positives = 97/205 (47%), Gaps = 20/205 (9%)

Query: 38  IGQGGVSIVYKGILDESRSIVAVKVV--NLKQKEASRSFAAECNALRNIRHRNLIKIITI 95
           +G+G    V+KG L + ++ VAVK    +L Q E    F +E   L+   H N++K+I +
Sbjct: 3   LGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQ-ELKIKFLSEARILKQYDHPNIVKLIGV 60

Query: 96  CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQ 155
           C+           IV E +   +   +LR+   +L+   Q V  A+D +  + Y      
Sbjct: 61  CTQ-----RQPIYIVMELVPGGDFLSFLRKKKDELK-TKQLVKFALDAAAGMAYLE---S 111

Query: 156 PSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPE 215
            + +H DL   N L+ ++ V  + D G+++     + G  + +    I IK    + APE
Sbjct: 112 KNCIHRDLAARNCLVGENNVLKISDFGMSR---QEDDGIYSSSGLKQIPIK----WTAPE 164

Query: 216 YGMGSKASVSGDVYNFGILLLEMFT 240
                + S   DV+++GILL E F+
Sbjct: 165 ALNYGRYSSESDVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 64.7 bits (157), Expect = 7e-12
 Identities = 60/209 (28%), Positives = 103/209 (49%), Gaps = 20/209 (9%)

Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAA-ECNALRNIRHRNLIKIIT 94
           +K+G+G  + V+KG    + ++VA+K + L+ +E +   A  E + L+N++H N   I+T
Sbjct: 11  DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHAN---IVT 67

Query: 95  ICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHC 154
           +   I  E      +VFEY+ + +L+Q+L    G L  +         +   + Y H   
Sbjct: 68  LHDIIHTE--RCLTLVFEYLDS-DLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKR- 122

Query: 155 QPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAP 214
              I+H DLKP N+L+++      G+L LA F          +T SN +     + Y  P
Sbjct: 123 --KILHRDLKPQNLLINEK-----GELKLADFGLARAKSVPTKTYSNEVV---TLWYRPP 172

Query: 215 EYGMGS-KASVSGDVYNFGILLLEMFTRR 242
           +  +GS + S   D++  G +L EM T R
Sbjct: 173 DVLLGSTEYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 64.7 bits (157), Expect = 9e-12
 Identities = 59/218 (27%), Positives = 105/218 (48%), Gaps = 34/218 (15%)

Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAA--ECNALRNIRHR 87
           +++    K+G+G  + VYKG    +  +VA+KV+ L+++E +  F A  E + L+ ++H 
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT-PFTAIREASLLKGLKHA 63

Query: 88  NLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLR------FLTQRVNIAI 141
           N++ +  I  +      +   +VFEY+   +L Q++ +  G L       FL Q +    
Sbjct: 64  NIVLLHDIIHTK-----ETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLR--- 114

Query: 142 DVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASN 201
                + Y H   Q  I+H DLKP N+L     ++  G+L LA F         + T SN
Sbjct: 115 ----GLSYIH---QRYILHRDLKPQNLL-----ISDTGELKLADFGLARAKSVPSHTYSN 162

Query: 202 SIEIKGIVGYVAPEYGMGS-KASVSGDVYNFGILLLEM 238
            +     + Y  P+  +GS + S   D++  G + +EM
Sbjct: 163 EVV---TLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEM 197

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 64.3 bits (157), Expect = 1e-11
 Identities = 61/238 (25%), Positives = 99/238 (41%), Gaps = 60/238 (25%)

Query: 31  NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNA---------L 81
            + P   IG G   +V   I   S   VA+K +         +F     A         L
Sbjct: 6   RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKI-------PHAFDVPTLAKRTLRELKIL 58

Query: 82  RNIRHRNLIKIITICSSIDFEGFDFKAI--VFEYMQNRNLEQWLRQSNGQLR------FL 133
           R+ +H N+I I  I       G DFK +  V + M++ +L   +  S+  L       FL
Sbjct: 59  RHFKHDNIIAIRDILRP---PGADFKDVYVVMDLMES-DLHHIIH-SDQPLTEEHIRYFL 113

Query: 134 TQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPG 193
            Q +         ++Y H      ++H DLKPSN+L+++D    +GD G+A+ L      
Sbjct: 114 YQLLR-------GLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGL------ 157

Query: 194 TAAETASNSIEIKGIVG-------YVAPEYGMGS--KASVSGDVYNFGILLLEMFTRR 242
                +S+  E K  +        Y APE  + S  + + + D+++ G +  EM  RR
Sbjct: 158 -----SSSPTEHKYFMTEYVATRWYRAPEL-LLSLPEYTTAIDMWSVGCIFAEMLGRR 209

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 64.0 bits (156), Expect = 1e-11
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 27/210 (12%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVK--VVNLKQKEASRSFAAECNALRNIRHRNLIKIIT 94
            +G+G   +V K    E+  IVA+K  + +   K   +    E   L+ +RH NL+ +I 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLI- 66

Query: 95  ICSSIDFEGFDFKA---IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFH 151
                  E F  K    +VFE++ +  L+   +  NG L     R      +   IE+ H
Sbjct: 67  -------EVFRRKKRLYLVFEFVDHTVLDDLEKYPNG-LDESRVR-KYLFQILRGIEFCH 117

Query: 152 HHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGY 211
            H   +I+H D+KP NIL+ Q  V  + D G A+ L    PG   E  ++ +  +    Y
Sbjct: 118 SH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA--PG---EVYTDYVATR---WY 166

Query: 212 VAPEYGMG-SKASVSGDVYNFGILLLEMFT 240
            APE  +G +K   + D++  G L+ EM T
Sbjct: 167 RAPELLVGDTKYGRAVDIWAVGCLVTEMLT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 63.9 bits (156), Expect = 1e-11
 Identities = 59/223 (26%), Positives = 104/223 (46%), Gaps = 48/223 (21%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQ-KEASRSFAA-ECNALRNIRHRNLIKIIT 94
           KIG+G   +VYK     +  IVA+K + L+   E   S A  E + L+ + H N+++++ 
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65

Query: 95  ICSSIDFEGFDFKA-IVFEYMQNRNLEQWL----RQSNGQLR---FLTQRVNIAIDVSFA 146
           +  S      + K  +VFE++ + +L++++               +L Q +         
Sbjct: 66  VVHS------ENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQ-------G 111

Query: 147 IEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIK 206
           I Y H H    ++H DLKP N+L+D++    + D GLA+  FG             + ++
Sbjct: 112 IAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLAR-AFG-------------VPVR 154

Query: 207 G----IVG--YVAPEYGMGSKA-SVSGDVYNFGILLLEMFTRR 242
                +V   Y APE  +GS+  S   D+++ G +  EM  RR
Sbjct: 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 63.1 bits (153), Expect = 1e-11
 Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 36/215 (16%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVV------NLKQKEASRSFAAECNALRNIRHRNLI 90
           +IG+G    V+ G L    + VAVK        +LK K     F  E   L+   H N++
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAK-----FLQEARILKQYSHPNIV 56

Query: 91  KIITICSSIDFEGFDFKA---IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAI 147
           ++I +C+         K    IV E +Q  +   +LR    +L+ + + + +  + +  +
Sbjct: 57  RLIGVCTQ--------KQPIYIVMELVQGGDFLTFLRTEGPRLK-VKELIQMVENAAAGM 107

Query: 148 EYFH-HHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETAS-NSIEI 205
           EY    HC    +H DL   N L+ +  V  + D G+++     E G  A T     I +
Sbjct: 108 EYLESKHC----IHRDLAARNCLVTEKNVLKISDFGMSR---EEEDGVYASTGGMKQIPV 160

Query: 206 KGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
           K    + APE     + S   DV++FGILL E F+
Sbjct: 161 K----WTAPEALNYGRYSSESDVWSFGILLWEAFS 191

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 63.4 bits (154), Expect = 2e-11
 Identities = 48/190 (25%), Positives = 93/190 (48%), Gaps = 13/190 (6%)

Query: 52  DESRSIVAVKVVNLKQKEA-SRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIV 110
           D +   VAVK +  +           E   LRN+ H N++K   IC+    +G +   ++
Sbjct: 30  DNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE---DGGNGIKLI 86

Query: 111 FEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILL 170
            E++ + +L+++L ++  ++  L Q++  A+ +   ++Y         VH DL   N+L+
Sbjct: 87  MEFLPSGSLKEYLPRNKNKIN-LKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLV 142

Query: 171 DQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYN 230
           + +    +GD GL K +      T  E  +   ++   V + APE  + SK  ++ DV++
Sbjct: 143 ESEHQVKIGDFGLTKAI-----ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWS 197

Query: 231 FGILLLEMFT 240
           FG+ L E+ T
Sbjct: 198 FGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 63.2 bits (154), Expect = 2e-11
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 35/218 (16%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQK-EASRSFAA-ECNALRNIRHRNLIKIIT 94
           KIG+G    V+K    E+  IVA+K V L    E   S A  E   L+ ++H+N++++  
Sbjct: 7   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66

Query: 95  ICSSIDFEGFDFK-AIVFEYMQNRNLEQWLRQSNGQL------RFLTQRVNIAIDVSFAI 147
           +  S      D K  +VFEY  +++L+++    NG +       F+ Q +         +
Sbjct: 67  VLHS------DKKLTLVFEYC-DQDLKKYFDSCNGDIDPEIVKSFMFQLLK-------GL 112

Query: 148 EYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKG 207
            + H H   +++H DLKP N+L++++     G+L LA F      G      S  +    
Sbjct: 113 AFCHSH---NVLHRDLKPQNLLINKN-----GELKLADFGLARAFGIPVRCYSAEVV--- 161

Query: 208 IVGYVAPEYGMGSKA-SVSGDVYNFGILLLEMFTRRRP 244
            + Y  P+   G+K  S S D+++ G +  E+    RP
Sbjct: 162 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 63.1 bits (153), Expect = 2e-11
 Identities = 54/205 (26%), Positives = 101/205 (49%), Gaps = 19/205 (9%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEAS-RSFAAECNALRNIRHRNLIKIITI 95
           K+G G    V+ G  + S + VAVK   LK    S ++F  E N ++ ++H  L+++  +
Sbjct: 13  KLGAGQFGEVWMGYYNNS-TKVAVK--TLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAV 69

Query: 96  CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQ 155
            +  +        I+ EYM   +L  +L+   G    L + ++ +  ++  + Y     +
Sbjct: 70  VTKEEP-----IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---R 121

Query: 156 PSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPE 215
            + +H DL+ +N+L+ + ++  + D GLA+ +   E  TA E A   I+      + APE
Sbjct: 122 KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-TAREGAKFPIK------WTAPE 174

Query: 216 YGMGSKASVSGDVYNFGILLLEMFT 240
                  ++  DV++FGILL E+ T
Sbjct: 175 AINFGSFTIKSDVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 63.5 bits (155), Expect = 2e-11
 Identities = 57/222 (25%), Positives = 93/222 (41%), Gaps = 37/222 (16%)

Query: 31  NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAA--ECNALRNIRHRN 88
            F   N+IG+G   IVY+     S  IVA+K V +  +      ++  E   L N+RH N
Sbjct: 8   EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67

Query: 89  LIKI--ITICSSID--FEGFDFKAIVFEYMQNRNLEQWLRQ--SNGQLRFLTQRVN-IAI 141
           ++++  + +   +D  F       +V EY      EQ L     N    F   +V  + +
Sbjct: 68  IVELKEVVVGKHLDSIF-------LVMEY-----CEQDLASLLDNMPTPFSESQVKCLML 115

Query: 142 DVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASN 201
            +   ++Y H +    I+H DLK SN+LL       + D GLA+  +G            
Sbjct: 116 QLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLAR-TYGLPAKPMTPK--- 168

Query: 202 SIEIKGIVG--YVAPEYGMGSKASVSG-DVYNFGILLLEMFT 240
                 +V   Y APE  +G     +  D++  G +L E+  
Sbjct: 169 ------VVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLA 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 62.7 bits (152), Expect = 2e-11
 Identities = 64/237 (27%), Positives = 108/237 (45%), Gaps = 34/237 (14%)

Query: 31  NFSPANKIGQGGVSIVY--KGILDESRSIVAVKVVNL-----KQKEASRSFAAECNALRN 83
            +    KIG+G    +Y  K   D    ++  K ++L     K+KEAS+    E   L  
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVI--KEIDLTKMPVKEKEASKK---EVILLAK 55

Query: 84  IRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDV 143
           ++H N   I+T  +S    G  F  IV EY    +L + + +  G L    Q ++  + +
Sbjct: 56  MKHPN---IVTFFASFQENGRLF--IVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQI 110

Query: 144 SFAIEYFHHHCQPSIVHGDLKPSNILLDQD-IVAHVGDLGLAKFLFGYEPGTAAETASNS 202
           S  +++ H      I+H D+K  NI L ++ +VA +GD G+A+ L       + E A   
Sbjct: 111 SLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-----NDSMELAYTC 162

Query: 203 IEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFV 259
           +   G   Y++PE       +   D+++ G +L E+ T + P      EG  LH+ V
Sbjct: 163 V---GTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPF-----EGNNLHQLV 211

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 62.4 bits (152), Expect = 3e-11
 Identities = 50/220 (22%), Positives = 96/220 (43%), Gaps = 34/220 (15%)

Query: 38  IGQGGVSIVYKGIL-----DESRSIVAVKVVNLKQKEASR-SFAAECNALRNIRHRNLIK 91
           +GQG   +VY+G+       E  + VA+K VN       R  F  E + ++     ++++
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 92  IITICSSIDFEGFDFKA-IVFEYMQNRNLEQWLRQSNGQLRF--------LTQRVNIAID 142
           ++ + S+           +V E M   +L+ +LR    +           L + + +A +
Sbjct: 74  LLGVVSTGQ------PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAE 127

Query: 143 VSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNS 202
           ++  + Y         VH DL   N ++ +D+   +GD G+ + ++        ET    
Sbjct: 128 IADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIY--------ETDYYR 176

Query: 203 IEIKGI--VGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
              KG+  V ++APE       +   DV++FG++L EM T
Sbjct: 177 KGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 62.5 bits (152), Expect = 3e-11
 Identities = 72/293 (24%), Positives = 117/293 (39%), Gaps = 49/293 (16%)

Query: 47  YKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF 106
           Y  + D +  +VAVK +     E  R F  E   L++++H N++K   +C S        
Sbjct: 25  YDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL-- 82

Query: 107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQR-VNIAIDVSFAIEYFHHHCQPSIVHGDLKP 165
             +V EY+   +L  +L     + R   ++ +  A  +   +EY         VH DL  
Sbjct: 83  -RLVMEYLPYGSLRDYL--QKHRERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLAT 136

Query: 166 SNILLDQDIVAHVGDLGLAKFL-------FGYEPGTAAETASNSIEIKGIVGYVAPEYGM 218
            NIL++ +    +GD GL K L          EPG +             + + APE   
Sbjct: 137 RNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESP------------IFWYAPESLT 184

Query: 219 GSKASVSGDVYNFGILLLEMFT----RRRPTDAMFNEGLTLHEFVKMALPDK--VMEIVD 272
            SK SV+ DV++FG++L E+FT       P            EF++M   DK   M +  
Sbjct: 185 ESKFSVASDVWSFGVVLYELFTYSDKSCSPPA----------EFMRMMGNDKQGQMIVYH 234

Query: 273 PSLLLEVTANNYSW--IEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHAR 323
              L+E+  NN        C   +      C    P +R    ++  ++   R
Sbjct: 235 ---LIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 62.6 bits (152), Expect = 3e-11
 Identities = 57/224 (25%), Positives = 101/224 (45%), Gaps = 39/224 (17%)

Query: 38  IGQGGVSIVYKG----ILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNIRHRNLI 90
           +G G    VY+G    IL      + V V  L++    +  + F  E + + N  H N++
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 91  KIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQ-----LRFLTQRVNIAIDVSF 145
           K++ +C        + + I+ E M+  +L  +LR +  +     L  L + ++I +DV+ 
Sbjct: 63  KLLGVC----LLN-EPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAK 117

Query: 146 AIEYFHHHCQPSIVHGDLKPSNILL-----DQDIVAHVGDLGLAKFLFGYEPGTAAETAS 200
              Y     Q   +H DL   N L+     D D V  +GD GLA+ ++           S
Sbjct: 118 GCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIY----------KS 164

Query: 201 NSIEIKG----IVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
           +    +G     V ++APE  +  K +   DV++FG+L+ E+ T
Sbjct: 165 DYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 62.3 bits (152), Expect = 4e-11
 Identities = 62/262 (23%), Positives = 101/262 (38%), Gaps = 43/262 (16%)

Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVN---LKQKEASRSFAAECNALRNIRHRNLIKIIT 94
           I +G    V+      +  I A+KV+    + +K        E + L   +   ++K+  
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL-- 58

Query: 95  ICSSIDFEGFDFKA---IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFH 151
                 +  F  K    +V EY+   +L   L  + G L     R+ IA ++  A+EY H
Sbjct: 59  ------YYSFQGKKNLYLVMEYLPGGDLASLLE-NVGSLDEDVARIYIA-EIVLALEYLH 110

Query: 152 HHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF-LFGYEPGTAAETASNSIEIKGIVG 210
            +    I+H DLKP NIL+D +    + D GL+K  L   +     +   +   I G   
Sbjct: 111 SN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDK-RIVGTPD 166

Query: 211 YVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEI 270
           Y+APE  +G   S + D ++ G +L E      P    F+              +   EI
Sbjct: 167 YIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPP----FHG-------------ETPEEI 209

Query: 271 VDPSLLLEVTANNYSWIEDCLV 292
                   +      W ED  V
Sbjct: 210 FQ-----NILNGKIEWPEDVEV 226

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 62.0 bits (151), Expect = 5e-11
 Identities = 58/223 (26%), Positives = 89/223 (39%), Gaps = 34/223 (15%)

Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEAS----RSFAAECNALRNIR 85
           N +     +G+G   +V K     +  IVA+K    K+ E      ++   E   LR +R
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIK--KFKESEDDEDVKKTALREVKVLRQLR 58

Query: 86  HRNLIKIITICSSIDFEGFDFKA---IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAID 142
           H N++ +         E F  K    +VFEY++   LE       G      +       
Sbjct: 59  HENIVNLK--------EAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRS--YIWQ 108

Query: 143 VSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNS 202
           +  AI Y H H   +I+H D+KP NIL+ +  V  + D G A+ L        A  AS  
Sbjct: 109 LLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARAL-------RARPASPL 158

Query: 203 IEIKGIVGYVAPEYGMGSK---ASVSGDVYNFGILLLEMFTRR 242
            +      Y APE  +G       V  DV+  G ++ E+    
Sbjct: 159 TDYVATRWYRAPELLVGDTNYGKPV--DVWAIGCIMAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 62.3 bits (152), Expect = 5e-11
 Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 30/217 (13%)

Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNL--KQKEASRSFAAECNALRNIRHRNLIKII 93
           + IG+G   +V       +   VA+K ++    Q    R+   E   LR  +H N+I I+
Sbjct: 11  SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR-EIKILRRFKHENIIGIL 69

Query: 94  TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQ---SNGQLR-FLTQRVNIAIDVSFAIEY 149
            I     FE F+   IV E M+  +L + ++    SN  ++ FL Q +         ++Y
Sbjct: 70  DIIRPPSFESFNDVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILR-------GLKY 121

Query: 150 FHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
            H     +++H DLKPSN+LL+ +    + D GLA+         A     ++  +   V
Sbjct: 122 IH---SANVLHRDLKPSNLLLNTNCDLKICDFGLAR--------IADPEHDHTGFLTEYV 170

Query: 210 G---YVAPEYGMGSKA-SVSGDVYNFGILLLEMFTRR 242
               Y APE  + SK  + + D+++ G +L EM + R
Sbjct: 171 ATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 62.4 bits (151), Expect = 5e-11
 Identities = 59/222 (26%), Positives = 107/222 (48%), Gaps = 32/222 (14%)

Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNL 89
           ++F   +++G G   +V K     S  I+A K+++L+ K A          +RN   R L
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPA----------IRNQIIREL 54

Query: 90  IKIITICSS---IDFEGFDFK----AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAID 142
            +++  C+S   + F G  +     +I  E+M   +L+Q L+++      +  +V+IA+ 
Sbjct: 55  -QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVL 113

Query: 143 VSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNS 202
              A  Y     Q  I+H D+KPSNIL++      + D G++        G   ++ +NS
Sbjct: 114 RGLA--YLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVS--------GQLIDSMANS 161

Query: 203 IEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
               G   Y++PE   G+  SV  D+++ G+ L+E+   R P
Sbjct: 162 F--VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 61.8 bits (150), Expect = 6e-11
 Identities = 50/217 (23%), Positives = 96/217 (44%), Gaps = 25/217 (11%)

Query: 38  IGQGGVSIVYKGILD-ESRSIVAVKVVNLKQKEASRS----FAAECNALRNIRHRNLIKI 92
           +G+G    V +G L  +  S + V V  +K    + S    F +E   +++  H N++K+
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66

Query: 93  ITIC-SSIDFEGFDFKAIVFEYMQNRNLEQWL---RQSNGQLRFLTQR-VNIAIDVSFAI 147
           I +C  +   +      ++  +M++ +L  +L   R      +   Q  +   +D++  +
Sbjct: 67  IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126

Query: 148 EYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG---YEPGTAAETASNSIE 204
           EY  +    + +H DL   N +L +D+   V D GL+K ++    Y  G  A        
Sbjct: 127 EYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIA-------- 175

Query: 205 IKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTR 241
            K  V ++A E       +   DV+ FG+ + E+ TR
Sbjct: 176 -KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATR 211

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 61.2 bits (149), Expect = 7e-11
 Identities = 53/213 (24%), Positives = 85/213 (39%), Gaps = 28/213 (13%)

Query: 37  KIGQGGVSIVYKGILDESRSI---VAVKVV-NLKQKEASRSFAAECNALRNIRHRNLIKI 92
           K+G G   +V +G    S      VAVK + + K  +    F  E   + ++ H NLI++
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 93  --ITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYF 150
             + +   +         +V E     +L   LR+       ++   + A+ ++  + Y 
Sbjct: 62  YGVVLTHPL--------MMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYL 113

Query: 151 HHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG 210
                   +H DL   NILL  D    +GD GL + L         +       +K    
Sbjct: 114 E---SKRFIHRDLAARNILLASDDKVKIGDFGLMRAL-----PQNEDHYVMEEHLKVPFA 165

Query: 211 YVAPE---YGMGSKASVSGDVYNFGILLLEMFT 240
           + APE       S AS   DV+ FG+ L EMFT
Sbjct: 166 WCAPESLRTRTFSHAS---DVWMFGVTLWEMFT 195

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 61.8 bits (150), Expect = 9e-11
 Identities = 60/243 (24%), Positives = 103/243 (42%), Gaps = 35/243 (14%)

Query: 8   SNMLSMKQQFPMISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ 67
           S+  S        S +EL +        N+IG G    VYK I   +  + A+KV+    
Sbjct: 59  SSSASGSAPSAAKSLSELERV-------NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH 111

Query: 68  KEA-SRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQS 126
           ++   R    E   LR++ H N++K    C  + F+      ++ E+M   +LE      
Sbjct: 112 EDTVRRQICREIEILRDVNHPNVVK----CHDM-FDHNGEIQVLLEFMDGGSLEGTHIAD 166

Query: 127 NGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF 186
              L       ++A  +   I Y H      IVH D+KPSN+L++      + D G+++ 
Sbjct: 167 EQFL------ADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRI 217

Query: 187 LFGYEPGTAAETASNSIEIKGIVGYVAPE-----YGMGSKASVSGDVYNFGILLLEMFTR 241
           L        A+T        G + Y++PE        G+    +GD+++ G+ +LE +  
Sbjct: 218 L--------AQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLG 269

Query: 242 RRP 244
           R P
Sbjct: 270 RFP 272

Length = 353

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 61.2 bits (148), Expect = 9e-11
 Identities = 56/215 (26%), Positives = 103/215 (47%), Gaps = 19/215 (8%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           K+G G    V+    ++  + VAVK +         +F AE N ++ ++H  L+K+  + 
Sbjct: 13  KLGAGQFGEVWMATYNK-HTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHAVV 70

Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQP 156
           +       +   I+ E+M   +L  +L+   G  + L + ++ +  ++  + +     Q 
Sbjct: 71  TK------EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QR 121

Query: 157 SIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEY 216
           + +H DL+ +NIL+   +V  + D GLA+ +   E  TA E A   I+      + APE 
Sbjct: 122 NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-TAREGAKFPIK------WTAPEA 174

Query: 217 GMGSKASVSGDVYNFGILLLEMFTR-RRPTDAMFN 250
                 ++  DV++FGILL+E+ T  R P   M N
Sbjct: 175 INFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN 209

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 61.0 bits (148), Expect = 1e-10
 Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 28/209 (13%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRS---FAAECNALRNIRHRNLIKII 93
           ++G G   +V+ G    ++  VA+K +N    E + S   F  E   +  + H  L+++ 
Sbjct: 11  ELGSGQFGVVHLGKW-RAQIKVAIKAIN----EGAMSEEDFIEEAKVMMKLSHPKLVQLY 65

Query: 94  TICSSIDFEGFDFKA--IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFH 151
            +C+         K   IV E+M+N  L  +LRQ  G+L      +++  DV   +EY  
Sbjct: 66  GVCTQQ-------KPLYIVTEFMENGCLLNYLRQRQGKLS-KDMLLSMCQDVCEGMEYLE 117

Query: 152 HHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGY 211
              + S +H DL   N L+    V  V D G+ +++   E        ++S   K  V +
Sbjct: 118 ---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE-------YTSSSGAKFPVKW 167

Query: 212 VAPEYGMGSKASVSGDVYNFGILLLEMFT 240
             PE    SK S   DV++FG+L+ E+FT
Sbjct: 168 SPPEVFNFSKYSSKSDVWSFGVLMWEVFT 196

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 60.9 bits (148), Expect = 1e-10
 Identities = 71/322 (22%), Positives = 133/322 (41%), Gaps = 66/322 (20%)

Query: 24  ELSKATNNFSPANKIGQGGVSIVYKGIL---DESRSIVAVKVVNLKQK---EASRSFAAE 77
           E+  +   F     +G+G    VYKG L   +E  S  +V +  LK+    +  + F  E
Sbjct: 1   EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58

Query: 78  CNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWL-------------- 123
              + +++H N++ ++ +C+           ++FEY+ + +L ++L              
Sbjct: 59  AELMSDLQHPNIVCLLGVCTKEQP-----TCMLFEYLAHGDLHEFLVRNSPHSDVGAESG 113

Query: 124 ----RQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVG 179
               + S     FL    +IAI ++  +EY   H     VH DL   N L+ + +   + 
Sbjct: 114 DETVKSSLDCSDFL----HIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKIS 166

Query: 180 DLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMF 239
           D GL++ ++           S S+     V ++ PE  +  K +   D+++FG++L E+F
Sbjct: 167 DFGLSRDIYS---ADYYRVQSKSLLP---VRWMPPEAILYGKFTTESDIWSFGVVLWEIF 220

Query: 240 TR-RRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTG 298
           +   +P     N+              +V+E++    LL          EDC   V    
Sbjct: 221 SYGLQPYYGFSNQ--------------EVIEMIRSRQLLPCP-------EDCPARVYALM 259

Query: 299 VTCSMESPMERMEMRDVVAKLR 320
           + C  E P  R   +D+  +LR
Sbjct: 260 IECWNEIPARRPRFKDIHTRLR 281

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 61.2 bits (148), Expect = 1e-10
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 32/215 (14%)

Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAA-ECNALRNIRHRNLIKIIT 94
           +K+G+G  + VYKG    + ++VA+K + L+ +E +   A  E + L++++H N   I+T
Sbjct: 12  DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN---IVT 68

Query: 95  ICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLR------FLTQRVNIAIDVSFAIE 148
           +   I  E      +VFEY+ +++L+Q+L      +       FL Q +         + 
Sbjct: 69  LHDIIHTE--KSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQLLR-------GLN 118

Query: 149 YFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGI 208
           Y H      ++H DLKP N+L+++      G+L LA F          +T SN +     
Sbjct: 119 YCHRR---KVLHRDLKPQNLLINER-----GELKLADFGLARAKSIPTKTYSNEVV---T 167

Query: 209 VGYVAPEYGMGS-KASVSGDVYNFGILLLEMFTRR 242
           + Y  P+  +GS   S   D++  G +  EM T R
Sbjct: 168 LWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 60.8 bits (147), Expect = 1e-10
 Identities = 54/191 (28%), Positives = 87/191 (45%), Gaps = 19/191 (9%)

Query: 60  VKVVNLKQKEASRSFAAECNA--LRNIRHRNLIKIITICSSIDFEGFD-FKAIVFEYMQN 116
           +K +NL+        AAE  A  L  ++H N   I+    S  +EG D    IV  + + 
Sbjct: 30  IKKLNLRNASRRERKAAEQEAQLLSQLKHPN---IVAYRES--WEGEDGLLYIVMGFCEG 84

Query: 117 RNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVA 176
            +L   L++  G+L    Q V   + ++ A++Y H   +  I+H DLK  N+ L +  + 
Sbjct: 85  GDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNII 141

Query: 177 HVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLL 236
            VGDLG+A+ L         + AS  I   G   Y++PE       +   DV+  G  + 
Sbjct: 142 KVGDLGIARVL-----ENQCDMASTLI---GTPYYMSPELFSNKPYNYKSDVWALGCCVY 193

Query: 237 EMFTRRRPTDA 247
           EM T +   +A
Sbjct: 194 EMATLKHAFNA 204

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 60.7 bits (148), Expect = 1e-10
 Identities = 61/250 (24%), Positives = 108/250 (43%), Gaps = 38/250 (15%)

Query: 32  FSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEAS--RSFAAECNALRNIR---H 86
           +    +IG+G    VYK     +   VA+K V +   E     S   E   L+ +    H
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60

Query: 87  RNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQ------SNGQLRFLTQRVNIA 140
            N+++++ +C     +      +VFE++ +++L  +L +          ++ L +++   
Sbjct: 61  PNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLMRQLLRG 119

Query: 141 IDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETAS 200
           +D      + H H    IVH DLKP NIL+  D    + D GLA+              S
Sbjct: 120 VD------FLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR------------IYS 158

Query: 201 NSIEIKGIV---GYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHE 257
             + +  +V    Y APE  + S  +   D+++ G +  E+F RRRP     +E   L +
Sbjct: 159 FEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELF-RRRPLFRGTSEADQLDK 217

Query: 258 -FVKMALPDK 266
            F  + LP +
Sbjct: 218 IFDVIGLPSE 227

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 60.5 bits (147), Expect = 2e-10
 Identities = 52/182 (28%), Positives = 79/182 (43%), Gaps = 34/182 (18%)

Query: 62  VVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQ 121
           V+ LKQ++   +   E   L+ + H  +I++    +  D     F  ++ EY+    L  
Sbjct: 39  VIRLKQEQHVHN---EKRVLKEVSHPFIIRLF--WTEHDQR---FLYMLMEYVPGGELFS 90

Query: 122 WLRQ----SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAH 177
           +LR     SN    F    +     V  A+EY H      IV+ DLKP NILLD++    
Sbjct: 91  YLRNSGRFSNSTGLFYASEI-----VC-ALEYLHSK---EIVYRDLKPENILLDKE---- 137

Query: 178 VGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSG-DVYNFGILLL 236
            G + L  F      G A +    +  + G   Y+APE  + SK      D +  GIL+ 
Sbjct: 138 -GHIKLTDF------GFAKKLRDRTWTLCGTPEYLAPEV-IQSKGHNKAVDWWALGILIY 189

Query: 237 EM 238
           EM
Sbjct: 190 EM 191

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 60.4 bits (146), Expect = 2e-10
 Identities = 53/218 (24%), Positives = 98/218 (44%), Gaps = 19/218 (8%)

Query: 32  FSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASR--SFAAECNALRNIR---H 86
           + P  +IG G    VYK     S   VA+K V ++  E     S   E   L+ +    H
Sbjct: 2   YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61

Query: 87  RNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFA 146
            N+++++ +C++   +      +VFE++ +++L  +L +            ++       
Sbjct: 62  PNIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRG 120

Query: 147 IEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIK 206
           +++ H +C   IVH DLKP NIL+       + D GLA+ ++  +        +      
Sbjct: 121 LDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLAR-IYSCQMALTPVVVT------ 170

Query: 207 GIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
             + Y APE  + S  +   D+++ G +  EMF RR+P
Sbjct: 171 --LWYRAPEVLLQSTYATPVDMWSVGCIFAEMF-RRKP 205

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 59.8 bits (145), Expect = 3e-10
 Identities = 61/240 (25%), Positives = 110/240 (45%), Gaps = 46/240 (19%)

Query: 30  NNFSPANKIGQGGVSIVYK----GIL-DESRSIVAVKVVNLKQKEAS----RSFAAECNA 80
           NN      IGQG    V++    G+L  E  ++VAVK+  LK+ EAS      F  E   
Sbjct: 5   NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKM--LKE-EASADMQADFQREAAL 61

Query: 81  LRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLR-----------QSNGQ 129
           +    H N++K++ +C+     G     ++FEYM   +L ++LR            S   
Sbjct: 62  MAEFDHPNIVKLLGVCA----VGKPM-CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSS 116

Query: 130 LRFLTQR---------VNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGD 180
            R              + IA  V+  + Y     +   VH DL   N L+ +++V  + D
Sbjct: 117 ARKCGLNPLPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIAD 173

Query: 181 LGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
            GL++ ++  +   A+E  +++I I+    ++ PE    ++ +   DV+ +G++L E+F+
Sbjct: 174 FGLSRNIYSADYYKASE--NDAIPIR----WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 60.1 bits (146), Expect = 3e-10
 Identities = 62/223 (27%), Positives = 101/223 (45%), Gaps = 29/223 (13%)

Query: 29  TNNFSPANKIGQGGVSIVYKGILDESRSIVAVK-VVNL--KQKEASRSFAAECNALRNIR 85
              + P   IG+G   IV      E+   VA+K + N    + +A R+   E   LR++ 
Sbjct: 4   DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLR-EIKLLRHLD 62

Query: 86  HRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQ----SNGQLR-FLTQRVNIA 140
           H N+I I  I      E F+   IV+E M + +L Q +R     S+   + FL Q +   
Sbjct: 63  HENVIAIKDIMPPPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDDHCQYFLYQLLR-- 119

Query: 141 IDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETAS 200
                 ++Y H     +++H DLKPSN+LL+ +    + D GLA+        T +E   
Sbjct: 120 -----GLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLAR--------TTSEKGD 163

Query: 201 NSIEIKGIVGYVAPEYGMG-SKASVSGDVYNFGILLLEMFTRR 242
              E      Y APE  +  S+ + + DV++ G +  E+  R+
Sbjct: 164 FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 61.0 bits (148), Expect = 3e-10
 Identities = 62/223 (27%), Positives = 95/223 (42%), Gaps = 34/223 (15%)

Query: 58  VAVKVVNLKQKEASRSFA---AECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYM 114
           VA+K++     E     A    E      + H N++ ++   S     G  F   VFEY+
Sbjct: 6   VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLD--SGEAPPGLLFA--VFEYV 61

Query: 115 QNRNLEQWLRQSNGQL------RFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNI 168
             R L + L  ++G L      R + Q       V  A+   H+     IVH DLKP NI
Sbjct: 62  PGRTLREVL-AADGALPAGETGRLMLQ-------VLDALACAHNQ---GIVHRDLKPQNI 110

Query: 169 LLDQDIV---AHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVS 225
           ++ Q  V   A V D G+   L G        T + + E+ G   Y APE   G   + +
Sbjct: 111 MVSQTGVRPHAKVLDFGIGTLLPGVR-DADVATLTRTTEVLGTPTYCAPEQLRGEPVTPN 169

Query: 226 GDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMAL-PDKV 267
            D+Y +G++ LE  T +R    +  +G ++ E +   L P  V
Sbjct: 170 SDLYAWGLIFLECLTGQR---VV--QGASVAEILYQQLSPVDV 207

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 60.0 bits (145), Expect = 3e-10
 Identities = 63/214 (29%), Positives = 93/214 (43%), Gaps = 37/214 (17%)

Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLK----QKEASRSFAAECNALRNIRHRNLIKII 93
           IG+G    VY+    ++R I A+KV++ K    +KE + +        RNI  R L+   
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGE-----RNILVRTLL--- 52

Query: 94  TICSSIDFEGFDFKA-----IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-DVSFAI 147
                I    F F+      +V +YM    L  W  Q  G  RF   R    I ++  A+
Sbjct: 53  DESPFIVGLKFSFQTDSDLYLVTDYMSGGEL-FWHLQKEG--RFSEDRAKFYIAELVLAL 109

Query: 148 EYFHHHCQPSIVHGDLKPSNILLDQDIVAHVG--DLGLAKFLFGYEPGTAAETASNSIEI 205
           E+ H +    IV+ DLKP NILLD     H+   D GL+K              +N+   
Sbjct: 110 EHLHKY---DIVYRDLKPENILLDAT--GHIALCDFGLSK------ANLTDNKTTNT--F 156

Query: 206 KGIVGYVAPEYGMGSKASVSG-DVYNFGILLLEM 238
            G   Y+APE  +  K      D ++ G+L+ EM
Sbjct: 157 CGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEM 190

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 59.4 bits (144), Expect = 4e-10
 Identities = 57/228 (25%), Positives = 103/228 (45%), Gaps = 45/228 (19%)

Query: 31  NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAA--ECNALRNIRHRN 88
           +++   KIG+G   +VYKG   ++  IVA+K + L+ +E      A  E + L+ ++H N
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60

Query: 89  LIKIITICSS-------IDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI 141
           ++ +  +           +F   D K  +    + + ++  L +S     +L Q +    
Sbjct: 61  IVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKS-----YLYQILQ--- 112

Query: 142 DVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASN 201
                I + H      ++H DLKP N+L+D   V  + D GLA+  FG            
Sbjct: 113 ----GILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLAR-AFG------------ 152

Query: 202 SIEIK----GIVG--YVAPEYGMGS-KASVSGDVYNFGILLLEMFTRR 242
            I ++     +V   Y APE  +GS + S   D+++ G +  EM T++
Sbjct: 153 -IPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 59.2 bits (144), Expect = 4e-10
 Identities = 57/238 (23%), Positives = 94/238 (39%), Gaps = 63/238 (26%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           K+G+G    VYK I  E+  +VA+KVV ++  E  +    E + L+      ++K     
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVPVE--EDLQEIIKEISILKQCDSPYIVK----- 62

Query: 97  SSIDFEGFDFKA----IVFEY---------MQNRNLEQWLRQSNGQLRFLTQRVNIAI-- 141
               + G  FK     IV EY         M+  N            + LT+   IA   
Sbjct: 63  ----YYGSYFKNTDLWIVMEYCGAGSVSDIMKITN------------KTLTEE-EIAAIL 105

Query: 142 -DVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETAS 200
                 +EY H +     +H D+K  NILL+++     G   LA F      G + +   
Sbjct: 106 YQTLKGLEYLHSN---KKIHRDIKAGNILLNEE-----GQAKLADF------GVSGQLTD 151

Query: 201 NSIEIKGIVG---YVAPEYGMGSKASVSGDVYNFGILLLEMFTRR------RPTDAMF 249
              +   ++G   ++APE       +   D+++ GI  +EM   +       P  A+F
Sbjct: 152 TMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF 209

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 58.7 bits (142), Expect = 6e-10
 Identities = 39/117 (33%), Positives = 47/117 (40%), Gaps = 11/117 (9%)

Query: 151 HHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG 210
           H H Q  IV+ DLKP N+LLD      + DLGLA  L G +               G  G
Sbjct: 110 HLH-QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR---------AGTPG 159

Query: 211 YVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKV 267
           Y+APE   G     S D +  G  L EM   R P      E +   E  +  L   V
Sbjct: 160 YMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQ-RKEKVEKEELKRRTLEMAV 215

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 58.8 bits (142), Expect = 6e-10
 Identities = 50/211 (23%), Positives = 96/211 (45%), Gaps = 27/211 (12%)

Query: 38  IGQGGVSIVYKGI-LDESRSI---VAVKVVNLKQKEASRSFAAECN---ALRNIRHRNLI 90
           +G G    V+KGI + E  SI   VA+K +  + +   ++F    +   A+ ++ H  ++
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTI--QDRSGRQTFQEITDHMLAMGSLDHAYIV 72

Query: 91  KIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRV-NIAIDVSFAIEY 149
           +++ IC     +      +V +     +L   +RQ    L    QR+ N  + ++  + Y
Sbjct: 73  RLLGICPGASLQ------LVTQLSPLGSLLDHVRQHRDSLD--PQRLLNWCVQIAKGMYY 124

Query: 150 FHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
              H    +VH +L   NILL  D +  + D G+A  L+   P       S   E K  +
Sbjct: 125 LEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY---PDDKKYFYS---EHKTPI 175

Query: 210 GYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
            ++A E  +  + +   DV+++G+ + EM +
Sbjct: 176 KWMALESILFGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 58.9 bits (143), Expect = 6e-10
 Identities = 56/213 (26%), Positives = 105/213 (49%), Gaps = 17/213 (7%)

Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAA--ECNALRNIRHRNLIKII 93
            KIGQG    V+K    +++ IVA+K V ++ ++      A  E   L+ ++H N++ +I
Sbjct: 18  AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 77

Query: 94  TICSSIDFEGFDFKA---IVFEYMQNRNLEQWLRQSNGQLRF-LTQRVNIAIDVSFAIEY 149
            IC +       +K    +VFE+ ++ +L   L  SN  ++F L++   +   +   + Y
Sbjct: 78  EICRTKATPYNRYKGSFYLVFEFCEH-DLAGLL--SNKNVKFTLSEIKKVMKMLLNGLYY 134

Query: 150 FHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
            H +    I+H D+K +NIL+ +D +  + D GLA+  F     +     +N +     +
Sbjct: 135 IHRN---KILHRDMKAANILITKDGILKLADFGLAR-AFSLSKNSKPNRYTNRVV---TL 187

Query: 210 GYVAPEYGMGSKA-SVSGDVYNFGILLLEMFTR 241
            Y  PE  +G +      D++  G ++ EM+TR
Sbjct: 188 WYRPPELLLGERDYGPPIDMWGAGCIMAEMWTR 220

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 58.3 bits (141), Expect = 8e-10
 Identities = 60/231 (25%), Positives = 99/231 (42%), Gaps = 35/231 (15%)

Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICS 97
           +G+G   IVY      ++  +A+K +  +     +    E      ++HRN+++ +   S
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75

Query: 98  SIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNI-AIDVSFAIEYFHHHCQP 156
              F    FK I  E +   +L   LR   G L+   Q +      +   ++Y H +   
Sbjct: 76  ENGF----FK-IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN--- 127

Query: 157 SIVHGDLKPSNILLDQ-DIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPE 215
            IVH D+K  N+L++    V  + D G +K L G  P T  ET        G + Y+APE
Sbjct: 128 QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCT--ET------FTGTLQYMAPE 179

Query: 216 Y------GMGSKASVSGDVYNFGILLLEMFTRR-------RPTDAMFNEGL 253
                  G G+ A    D+++ G  ++EM T +        P  AMF  G+
Sbjct: 180 VIDKGPRGYGAPA----DIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGM 226

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 58.7 bits (143), Expect = 9e-10
 Identities = 70/261 (26%), Positives = 120/261 (45%), Gaps = 65/261 (24%)

Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVV-----NLKQKEASRSFAAECNALRNIR-HRNL 89
            K+G+G   IV+K I   ++ +VA+K +     N    +A R+F  E   L+ +  H N+
Sbjct: 13  QKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRN--ATDAQRTFR-EIMFLQELGDHPNI 69

Query: 90  IKIITICSSIDFEGFDFKA-------IVFEYMQNRNLEQWLRQSNGQLRFLTQRVN---I 139
           +K++ +           KA       +VFEYM+  +L   +R +      + + V+   I
Sbjct: 70  VKLLNV----------IKAENDKDIYLVFEYMET-DLHAVIRAN------ILEDVHKRYI 112

Query: 140 AIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETA 199
              +  A++Y H     +++H DLKPSNILL+ D    + D GLA+ L         E  
Sbjct: 113 MYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSL-----SELEENP 164

Query: 200 SNSIEIKGIVGYVA------PEYGMGSKASVSG-DVYNFGILLLEMFTRRRPTDAMFNEG 252
            N +    +  YVA      PE  +GS     G D+++ G +L EM   +     +F   
Sbjct: 165 ENPV----LTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK----PLFPGT 216

Query: 253 LTLHEFVKMALPDKVMEIVDP 273
            TL++       +K++E++ P
Sbjct: 217 STLNQL------EKIIEVIGP 231

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 58.2 bits (141), Expect = 1e-09
 Identities = 46/161 (28%), Positives = 73/161 (45%), Gaps = 20/161 (12%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVK-VVNLKQKEASRSFAA-ECNALRNIRHRNLIKIIT 94
           KIG+G   +V+K    E+  IVA+K  V  +     +  A  E   L+ ++H NL+ +I 
Sbjct: 8   KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLI- 66

Query: 95  ICSSIDFEGFDFKA---IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFH 151
                  E F  K    +VFEY  +  L +  +   G    L ++  I      A+ + H
Sbjct: 67  -------EVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKK--IIWQTLQAVNFCH 117

Query: 152 -HHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYE 191
            H+C    +H D+KP NIL+ +     + D G A+ L G  
Sbjct: 118 KHNC----IHRDVKPENILITKQGQIKLCDFGFARILTGPG 154

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 58.1 bits (140), Expect = 1e-09
 Identities = 50/219 (22%), Positives = 99/219 (45%), Gaps = 20/219 (9%)

Query: 32  FSPANKIGQGGVSIVYKGI-LDESRSIVAVKVVNLKQKEASRSFAA--ECNALRNIR--- 85
           +    +IG+G    V+K   L      VA+K V ++  E     +   E   LR++    
Sbjct: 3   YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 62

Query: 86  HRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSF 145
           H N++++  +C+    +      +VFE++ +++L  +L +            ++   +  
Sbjct: 63  HPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLR 121

Query: 146 AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEI 205
            +++ H H    +VH DLKP NIL+       + D GLA+ ++ ++    +   +     
Sbjct: 122 GLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR-IYSFQMALTSVVVT----- 172

Query: 206 KGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
              + Y APE  + S  +   D+++ G +  EMF RR+P
Sbjct: 173 ---LWYRAPEVLLQSSYATPVDLWSVGCIFAEMF-RRKP 207

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 58.5 bits (141), Expect = 1e-09
 Identities = 58/222 (26%), Positives = 106/222 (47%), Gaps = 32/222 (14%)

Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNL 89
           ++F   +++G G   +V+K     S  I+A K+++L+ K A          +RN   R L
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPA----------IRNQIIREL 54

Query: 90  IKIITICSS---IDFEGFDFK----AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAID 142
            +++  C+S   + F G  +     +I  E+M   +L+Q L+++      +  +V+IA+ 
Sbjct: 55  -QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI 113

Query: 143 VSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNS 202
                    H     I+H D+KPSNIL++      + D G++        G   ++ +NS
Sbjct: 114 KGLTYLREKH----KIMHRDVKPSNILVNSRGEIKLCDFGVS--------GQLIDSMANS 161

Query: 203 IEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
               G   Y++PE   G+  SV  D+++ G+ L+EM   R P
Sbjct: 162 F--VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 58.2 bits (141), Expect = 1e-09
 Identities = 59/221 (26%), Positives = 101/221 (45%), Gaps = 24/221 (10%)

Query: 32  FSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAA--ECNALRNIRHRNL 89
           F    +IG+G    VYK    ++  +VA+K V L  ++      A  E   LR + HRN+
Sbjct: 9   FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68

Query: 90  IKIITICSSIDFEGFDFKA------IVFEYMQNRNLEQWLRQSNGQLRFLTQRV-NIAID 142
           + +  I +    +  DFK       +VFEYM + +L   L   +G + F    + +    
Sbjct: 69  VNLKEIVTD-KQDALDFKKDKGAFYLVFEYM-DHDLMGLLE--SGLVHFSEDHIKSFMKQ 124

Query: 143 VSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNS 202
           +   + Y H   + + +H D+K SNILL+      + D GLA+    Y    +    +  
Sbjct: 125 LLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARL---YNSEESRPYTNKV 178

Query: 203 IEIKGIVGYVAPEYGMG-SKASVSGDVYNFGILLLEMFTRR 242
           I +     Y  PE  +G  +   + DV++ G +L E+FT++
Sbjct: 179 ITL----WYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 58.0 bits (141), Expect = 1e-09
 Identities = 53/230 (23%), Positives = 86/230 (37%), Gaps = 60/230 (26%)

Query: 32  FSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIK 91
           F+    IG+G    VYK I   +  +VA+KV++L++ E                   + +
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIED--------------IQQ 48

Query: 92  IITICSSID-------FEGF--DFK-AIVFEYMQNRNLEQWLRQSNGQLRFLTQR----- 136
            I   S          +  F    K  I+ EY              G    L +      
Sbjct: 49  EIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC-----------GGGSCLDLLKPGKLDE 97

Query: 137 VNIAI---DVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPG 193
             IA    +V   +EY H   +   +H D+K +NILL ++     GD+ LA F      G
Sbjct: 98  TYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEE-----GDVKLADF------G 143

Query: 194 TAAETASNSIEIKGIVG---YVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
            + +  S   +    VG   ++APE    S      D+++ GI  +E+  
Sbjct: 144 VSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAK 193

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 57.5 bits (139), Expect = 2e-09
 Identities = 56/222 (25%), Positives = 106/222 (47%), Gaps = 25/222 (11%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAA--ECNALRNIRHRNLIKIIT 94
           KIG+G   +VYK     +   +A+K + L+Q++      A  E + L+ ++H N++++  
Sbjct: 9   KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68

Query: 95  ICSSIDFEGFDFKA-IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHH 153
           +  S      + +  +VFEY+ + +L++ +  S    +           +   I Y H H
Sbjct: 69  VVHS------EKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH 121

Query: 154 CQPSIVHGDLKPSNILLDQDIVA-HVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
               ++H DLKP N+L+D+   A  + D GLA+       G    T ++ +     + Y 
Sbjct: 122 ---RVLHRDLKPQNLLIDRRTNALKLADFGLARAF-----GIPVRTFTHEVV---TLWYR 170

Query: 213 APEYGMGSKA-SVSGDVYNFGILLLEMFTRRR--PTDAMFNE 251
           APE  +GS+  S   D+++ G +  EM  ++   P D+  +E
Sbjct: 171 APEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE 212

Length = 294

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 57.7 bits (140), Expect = 2e-09
 Identities = 55/229 (24%), Positives = 100/229 (43%), Gaps = 24/229 (10%)

Query: 28  ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVK-VVNLKQKE-----ASRSFAAECNAL 81
              ++    K+G+G    VYK    ++  +VA+K ++   +K+     A R    E   L
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR----EIKIL 61

Query: 82  RNIRHRNLIKII-TICSSIDFEGFDFKAI--VFEYMQNRNLEQWLRQSNGQLRF-LTQRV 137
           + ++H N++ +I       D       ++  V  YM + +L   L   N  ++   +Q  
Sbjct: 62  KKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLL--ENPSVKLTESQIK 118

Query: 138 NIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAE 197
              + +   I Y H   +  I+H D+K +NIL+D   +  + D GLA+   G  P     
Sbjct: 119 CYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGG 175

Query: 198 TASNSIEIKGIV---GYVAPEYGMGSKA-SVSGDVYNFGILLLEMFTRR 242
               + +   +V    Y  PE  +G +  + + D++  G +  EMFTRR
Sbjct: 176 GGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 57.4 bits (138), Expect = 2e-09
 Identities = 59/262 (22%), Positives = 120/262 (45%), Gaps = 40/262 (15%)

Query: 37  KIGQGGVSIVYKGIL-----DESRSIVAVKVVNLKQKEASR-SFAAECNALRNIRHRNLI 90
           ++GQG   +VY+GI      DE  + VA+K VN       R  F  E + ++     +++
Sbjct: 13  ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72

Query: 91  KIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLR------QSNGQLRF--LTQRVNIAID 142
           +++ + S    +G     ++ E M   +L+ +LR      ++N       L + + +A +
Sbjct: 73  RLLGVVS----QG-QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGE 127

Query: 143 VSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNS 202
           ++  + Y + +     VH DL   N ++ +D    +GD G+ + ++        ET    
Sbjct: 128 IADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY--------ETDYYR 176

Query: 203 IEIKGI--VGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFV 259
              KG+  V +++PE       +   DV++FG++L E+ T   +P   M NE     + +
Sbjct: 177 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE-----QVL 231

Query: 260 KMALPDKVMEIVD--PSLLLEV 279
           +  +   +++  D  P +L E+
Sbjct: 232 RFVMEGGLLDKPDNCPDMLFEL 253

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 57.4 bits (139), Expect = 2e-09
 Identities = 64/279 (22%), Positives = 107/279 (38%), Gaps = 46/279 (16%)

Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK-----QKEASRSFAAECNALRNI 84
                 +++G+G    V K  L  +  I A+K +        QK+  R    E    ++ 
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILR----ELEINKSC 56

Query: 85  RHRNLIKIITIC-----SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVN- 138
           +   ++K          SSI         I  EY +  +L+        +++    R+  
Sbjct: 57  KSPYIVKYYGAFLDESSSSI--------GIAMEYCEGGSLDSIY----KKVKKRGGRIGE 104

Query: 139 -----IAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPG 193
                IA  V   + Y H      I+H D+KPSNILL +     + D G++  L     G
Sbjct: 105 KVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAG 161

Query: 194 TAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGL 253
           T   T+           Y+APE   G   S++ DV++ G+ LLE+   R P        L
Sbjct: 162 TFTGTSF----------YMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPL 211

Query: 254 TLHEFVKMALPDKVMEIVD-PSLLLEVTANNYSWIEDCL 291
              E +   +     E+ D P   ++ +     +I+ CL
Sbjct: 212 GPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCL 250

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 50/209 (23%), Positives = 102/209 (48%), Gaps = 20/209 (9%)

Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAA-ECNALRNIRHRNLIKIIT 94
            K+G+G  + V+KG    + ++VA+K + L+ +E +   A  E + L++++H N++ +  
Sbjct: 12  EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71

Query: 95  ICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHC 154
           I  +          +VFEY+ +++L+Q++      +     ++ +   +   + Y H   
Sbjct: 72  IVHTDKS-----LTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFL-YQILRGLAYCHRR- 123

Query: 155 QPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAP 214
              ++H DLKP N+L+++      G+L LA F          +T SN +     + Y  P
Sbjct: 124 --KVLHRDLKPQNLLINER-----GELKLADFGLARAKSVPTKTYSNEVV---TLWYRPP 173

Query: 215 EYGMG-SKASVSGDVYNFGILLLEMFTRR 242
           +  +G S+ S   D++  G +  EM + R
Sbjct: 174 DVLLGSSEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 56.9 bits (138), Expect = 2e-09
 Identities = 65/216 (30%), Positives = 84/216 (38%), Gaps = 34/216 (15%)

Query: 38  IGQGGVSIVYKGILDESRSIVAVK------VVNLKQKEASRSFAAECNALRNIRHRNLIK 91
           +G GG   V    +       A+K      +V   Q+E   S   E   L    H  ++K
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFS---EKEILEECNHPFIVK 57

Query: 92  IITICSSIDFEGF-DFKAIVF--EYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIE 148
           +        +  F D K I    EY     L   LR   G     T R  IA  V  A E
Sbjct: 58  L--------YRTFKDKKYIYMLMEYCLGGELWTILR-DRGLFDEYTARFYIACVVL-AFE 107

Query: 149 YFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGI 208
           Y H+     I++ DLKP N+LLD +    + D G AK L     G    T        G 
Sbjct: 108 YLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS---GQKTWT------FCGT 155

Query: 209 VGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
             YVAPE  +      S D ++ GILL E+ T R P
Sbjct: 156 PEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 57.0 bits (137), Expect = 2e-09
 Identities = 51/217 (23%), Positives = 99/217 (45%), Gaps = 38/217 (17%)

Query: 32  FSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIK 91
           F+   +IG+G    VYKGI + ++ +VA+K+++L++ E         + + +I+    I 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAE---------DEIEDIQQE--IT 54

Query: 92  IITICSS---IDFEGFDFKA----IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVS 144
           +++ C S     + G   K     I+ EY+   +    L+    +  ++     I  ++ 
Sbjct: 55  VLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIA---TILREIL 111

Query: 145 FAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIE 204
             ++Y H   +   +H D+K +N+LL +      GD+ LA F      G A +     I+
Sbjct: 112 KGLDYLHSERK---IHRDIKAANVLLSEQ-----GDVKLADF------GVAGQLTDTQIK 157

Query: 205 IKGIVG---YVAPEYGMGSKASVSGDVYNFGILLLEM 238
               VG   ++APE    S      D+++ GI  +E+
Sbjct: 158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIEL 194

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 57.0 bits (137), Expect = 3e-09
 Identities = 60/270 (22%), Positives = 113/270 (41%), Gaps = 48/270 (17%)

Query: 32  FSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIK 91
           F+   +IG+G    V+KGI + ++ +VA+K+++L++ E         + + +I+    I 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE---------DEIEDIQQE--IT 54

Query: 92  IITICSS---IDFEGFDFKA----IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVS 144
           +++ C S     + G   K     I+ EY+   +    LR   G      Q   +  ++ 
Sbjct: 55  VLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA--GPFDEF-QIATMLKEIL 111

Query: 145 FAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIE 204
             ++Y H   +   +H D+K +N+LL +      GD+ LA F      G A +     I+
Sbjct: 112 KGLDYLHSEKK---IHRDIKAANVLLSEQ-----GDVKLADF------GVAGQLTDTQIK 157

Query: 205 IKGIVG---YVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKM 261
               VG   ++APE    S      D+++ GI  +E+     P   M    +        
Sbjct: 158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFL----- 212

Query: 262 ALPDKVMEIVDPSLLLEVTANNYSWIEDCL 291
                + +   P+L  E +     +I+ CL
Sbjct: 213 -----IPKNNPPTLTGEFSKPFKEFIDACL 237

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 56.6 bits (136), Expect = 3e-09
 Identities = 64/305 (20%), Positives = 128/305 (41%), Gaps = 56/305 (18%)

Query: 37  KIGQGGVSIVYKGIL----DESRSIVAVKVV-NLKQKEASRSFAAECNALRNIRHRNLIK 91
           ++G+     +YKG L     +   +VA+K + ++   +    F  E + +  + H N++ 
Sbjct: 12  ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71

Query: 92  IITICSSIDFEGFDFKAIVFEYMQNRNLEQWL------------RQSNGQLRFLTQR--- 136
           ++ + +           ++FEY+   +L ++L               +G ++        
Sbjct: 72  LLGVVTQEQP-----VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDF 126

Query: 137 VNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAA 196
           ++IAI ++  +EY   H     VH DL   NIL+ + +   + DLGL++ ++  +     
Sbjct: 127 LHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLHVKISDLGLSREIYSAD---YY 180

Query: 197 ETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTL 255
                S+     + ++ PE  M  K S   D+++FG++L E+F+   +P     N+    
Sbjct: 181 RVQPKSLLP---IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ---- 233

Query: 256 HEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDV 315
                     +V+E+V    LL  +       EDC   +      C  E P  R   +D+
Sbjct: 234 ----------EVIEMVRKRQLLPCS-------EDCPPRMYSLMTECWQEGPSRRPRFKDI 276

Query: 316 VAKLR 320
             +LR
Sbjct: 277 HTRLR 281

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 56.3 bits (136), Expect = 3e-09
 Identities = 53/218 (24%), Positives = 95/218 (43%), Gaps = 35/218 (16%)

Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNL-----KQKEASRSFAAECNALRNIRHRNLIKI 92
           +G G    VY+G+  +     AVK V+L       +EA +    E   L  ++H N+++ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 93  I-TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNG----QLRFLTQRVNIAIDVSFAI 147
           + T          D   I  E +   +L + L++        +R  T+++ + +      
Sbjct: 68  LGTEREE------DNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGL------ 115

Query: 148 EYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKG 207
           EY H     + VH D+K +NIL+D + V  + D G+AK +            S +   KG
Sbjct: 116 EYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQV---------VEFSFAKSFKG 163

Query: 208 IVGYVAPEYGMGSKA-SVSGDVYNFGILLLEMFTRRRP 244
              ++APE         ++ D+++ G  +LEM T + P
Sbjct: 164 SPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPP 201

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 57.0 bits (137), Expect = 4e-09
 Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 31/219 (14%)

Query: 27  KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRH 86
           K   N  P     QG V   Y  +LD + +I  +      Q  A R++  E   ++ + H
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 75

Query: 87  RNLIKIITICS-SIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-DVS 144
           +N+I ++ + +     E F    +V E M + NL Q +     Q+    +R++  +  + 
Sbjct: 76  KNIISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVI-----QMELDHERMSYLLYQML 129

Query: 145 FAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIE 204
             I++ H      I+H DLKPSNI++  D    + D GLA+            TA  S  
Sbjct: 130 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR------------TAGTSFM 174

Query: 205 IKGIV---GYVAPE--YGMGSKASVSGDVYNFGILLLEM 238
           +   V    Y APE   GMG K +V  D+++ G ++ EM
Sbjct: 175 MTPYVVTRYYRAPEVILGMGYKENV--DIWSVGCIMGEM 211

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 56.7 bits (137), Expect = 4e-09
 Identities = 38/163 (23%), Positives = 70/163 (42%), Gaps = 23/163 (14%)

Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICS 97
           +G G   +V+  +  +    VAVK + L   ++ +    E   +R + H N++K+  +  
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72

Query: 98  SI---------DFEGFDFKAIVFEYMQN---RNLEQWLRQSNGQLRFLTQRVNIAIDVSF 145
                           +   IV EYM+      LEQ          F+ Q +        
Sbjct: 73  PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLR------- 125

Query: 146 AIEYFHHHCQPSIVHGDLKPSNILLDQ-DIVAHVGDLGLAKFL 187
            ++Y H     +++H DLKP+N+ ++  D+V  +GD GLA+ +
Sbjct: 126 GLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIV 165

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 56.3 bits (136), Expect = 4e-09
 Identities = 54/216 (25%), Positives = 91/216 (42%), Gaps = 32/216 (14%)

Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRS-FAAECNALRNIRHRNLIKIITIC 96
           IG+G    VY+G    +  +VA+K++NL   +   S    E   L  +R      I    
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITK-- 66

Query: 97  SSIDFEGFDFKA----IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHH 152
               + G   K     I+ EY +  ++   ++      ++++    I  +V  A++Y H 
Sbjct: 67  ----YYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISV---IIREVLVALKYIHK 119

Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG-- 210
                ++H D+K +NIL     V + G++ L  F      G AA    NS +    VG  
Sbjct: 120 V---GVIHRDIKAANIL-----VTNTGNVKLCDF------GVAALLNQNSSKRSTFVGTP 165

Query: 211 -YVAPEYGMGSKA-SVSGDVYNFGILLLEMFTRRRP 244
            ++APE     K      D+++ GI + EM T   P
Sbjct: 166 YWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPP 201

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 56.0 bits (135), Expect = 5e-09
 Identities = 57/228 (25%), Positives = 96/228 (42%), Gaps = 36/228 (15%)

Query: 30  NNFSPANKIGQGGVSIVYKGI-LDESRSIVAVKVVNLKQ--KEASRSFAA---ECNALRN 83
            N+     +GQG    VY    +D  R  +AVK V       E  +   A   E   L+N
Sbjct: 2   TNWRRGKLLGQGAFGRVYLCYDVDTGRE-LAVKQVPFDPDSPETKKEVNALECEIQLLKN 60

Query: 84  IRHRNLIK---IITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIA 140
           ++H  +++    +    ++        +I  EYM   +++  L+        +T++    
Sbjct: 61  LQHERIVQYYGCLRDDETL--------SIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQ 112

Query: 141 IDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETAS 200
           I     +EY H +    IVH D+K +NIL D      +GD G +K L      T   + +
Sbjct: 113 I--LEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL-----QTICSSGT 162

Query: 201 NSIEIKGIVGYVAPE----YGMGSKASVSGDVYNFGILLLEMFTRRRP 244
               + G   +++PE     G G KA    DV++ G  ++EM T + P
Sbjct: 163 GMKSVTGTPYWMSPEVISGEGYGRKA----DVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 55.8 bits (135), Expect = 5e-09
 Identities = 53/218 (24%), Positives = 88/218 (40%), Gaps = 36/218 (16%)

Query: 36  NKIGQGGVSIVYKGIL---DESRSIVAVKVVNLKQKE---ASRSFAAECNALRNIRHRNL 89
            ++G G    V KG+          VAVK   LKQ+      + F  E + +  + H  +
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKT--LKQEHIAAGKKEFLREASVMAQLDHPCI 58

Query: 90  IKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNI---AIDVSFA 146
           +++I +C     E      +V E      L ++L++     R      ++   A  V+  
Sbjct: 59  VRLIGVCKG---EPL---MLVMELAPLGPLLKYLKK-----RREIPVSDLKELAHQVAMG 107

Query: 147 IEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIK 206
           + Y         VH DL   N+LL     A + D G+++ L        A TA      +
Sbjct: 108 MAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAG-----R 159

Query: 207 GIVGYVAPE---YGMGSKASVSGDVYNFGILLLEMFTR 241
             + + APE   YG   K S   DV+++G+ L E F+ 
Sbjct: 160 WPLKWYAPECINYG---KFSSKSDVWSYGVTLWEAFSY 194

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 56.0 bits (135), Expect = 5e-09
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 21/216 (9%)

Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASR---------SFAAECNALRNIRHRN 88
           IG G    VY G+   S  ++AVK V L    AS          + A E   L+ ++H N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 89  LIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIE 148
           +++ +   SS+D +  +   I  EY+   ++   L         L +  N    +   + 
Sbjct: 68  IVQYLG--SSLDADHLN---IFLEYVPGGSVAALLNNYGAFEETLVR--NFVRQILKGLN 120

Query: 149 YFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGI 208
           Y H+     I+H D+K +NIL+D      + D G++K L      T    A  S++  G 
Sbjct: 121 YLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQ--GS 175

Query: 209 VGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
           V ++APE    +  +   D+++ G L++EM T + P
Sbjct: 176 VFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 56.0 bits (135), Expect = 5e-09
 Identities = 56/221 (25%), Positives = 99/221 (44%), Gaps = 30/221 (13%)

Query: 38  IGQGGVSIVYK-GILDESRSIVAVKVVNLK-------QKEASRSFA---AECNALR-NIR 85
           +G G    VYK    +  ++++A+K +N+        ++E  +S     +E   ++  +R
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 86  HRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNL-EQWLRQSNGQLRFLTQRV-NIAIDV 143
           H N+++         F   D   IV + ++   L E +      + RF  +R+ NI + +
Sbjct: 68  HPNIVRYYKT-----FLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQM 122

Query: 144 SFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSI 203
             A+ Y H   +  IVH DL P+NI+L +D    + D GLAK     +    ++  S   
Sbjct: 123 VLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK-----QKQPESKLTS--- 172

Query: 204 EIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
            + G + Y  PE           DV+ FG +L +M T + P
Sbjct: 173 -VVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 56.1 bits (135), Expect = 6e-09
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 35/200 (17%)

Query: 57  IVAVKVVNLK-QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQ 115
           +VAVK++     K A   F  E   +  +++ N+I+++ +C S D        ++ EYM+
Sbjct: 46  LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDP-----LCMITEYME 100

Query: 116 NRNLEQWLRQSNGQLRFLTQRVNI-----------AIDVSFAIEYFHHHCQPSIVHGDLK 164
           N +L Q+L Q   +  F T   NI           A+ ++  ++Y       + VH DL 
Sbjct: 101 NGDLNQFLSQREIESTF-THANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLA 156

Query: 165 PSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKG----IVGYVAPEYGMGS 220
             N L+       + D G+++ L+          + +   I+G     + ++A E  +  
Sbjct: 157 TRNCLVGNHYTIKIADFGMSRNLY----------SGDYYRIQGRAVLPIRWMAWESILLG 206

Query: 221 KASVSGDVYNFGILLLEMFT 240
           K + + DV+ FG+ L EMFT
Sbjct: 207 KFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 61/219 (27%), Positives = 98/219 (44%), Gaps = 31/219 (14%)

Query: 27  KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRH 86
           K   N  P     QG V   Y  IL+ + +I  +      Q  A R++  E   ++ + H
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 82

Query: 87  RNLIKIITICS-SIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-DVS 144
           +N+I ++ + +     E F    IV E M + NL Q +     Q+    +R++  +  + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVI-----QMELDHERMSYLLYQML 136

Query: 145 FAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIE 204
             I++ H      I+H DLKPSNI++  D    + D GLA+            TA  S  
Sbjct: 137 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR------------TAGTSFM 181

Query: 205 IKGIV---GYVAPE--YGMGSKASVSGDVYNFGILLLEM 238
           +   V    Y APE   GMG K +V  D+++ G ++ EM
Sbjct: 182 MTPYVVTRYYRAPEVILGMGYKENV--DIWSVGCIMGEM 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 54.8 bits (132), Expect = 1e-08
 Identities = 39/161 (24%), Positives = 62/161 (38%), Gaps = 45/161 (27%)

Query: 101 FEGFDFKAIVFEYMQNRNL-----------EQWLRQSNGQLRFLTQRVNIAIDVSFAIEY 149
           F+  D+  +V EY+   +            E W +Q      ++ + V         +E 
Sbjct: 66  FQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQ------YIAEVVL-------GVED 112

Query: 150 FHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
            H   Q  I+H D+KP N+L+DQ     + D GL++   G E              K  V
Sbjct: 113 LH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSR--NGLEN-------------KKFV 154

Query: 210 G---YVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDA 247
           G   Y+APE  +G       D ++ G ++ E      P  A
Sbjct: 155 GTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHA 195

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 55.0 bits (132), Expect = 1e-08
 Identities = 54/215 (25%), Positives = 97/215 (45%), Gaps = 27/215 (12%)

Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVV--NLKQKEASRSFAAECNALRNIRHR 87
           N F     +G+G   +V K    E++ IVA+K    + + +E   +   E   LR ++  
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60

Query: 88  NLIKIITICSSIDFEGFDFKA---IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-DV 143
           N++++         E F  +    +VFEY++   LE      NG      ++V   I  +
Sbjct: 61  NIVELK--------EAFRRRGKLYLVFEYVEKNMLELLEEMPNGVP---PEKVRSYIYQL 109

Query: 144 SFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSI 203
             AI + H +    IVH D+KP N+L+  + V  + D G A+ L       +  + +N  
Sbjct: 110 IKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNL-------SEGSNANYT 159

Query: 204 EIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEM 238
           E      Y +PE  +G+    + D+++ G +L E+
Sbjct: 160 EYVATRWYRSPELLLGAPYGKAVDMWSVGCILGEL 194

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 55.0 bits (132), Expect = 1e-08
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 36/207 (17%)

Query: 53  ESRSIVAVKVVNLKQKEASRSFA---AECNALRNI-RHRNLIKIITICSSIDFEGFDFKA 108
           +    VAVK+  LK     +  A   +E   ++ I +H+N+I ++ +C+    EG  +  
Sbjct: 42  DQTVTVAVKM--LKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ---EGPLY-- 94

Query: 109 IVFEYMQNRNLEQWLRQ---------------SNGQLRFLTQRVNIAIDVSFAIEYFHHH 153
           ++ EY    NL ++LR                   QL F    V+ A  V+  +EY    
Sbjct: 95  VIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSF-KDLVSCAYQVARGMEYLESR 153

Query: 154 CQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVA 213
                +H DL   N+L+ +D V  + D GLA+ +  ++     +T++  + +K    ++A
Sbjct: 154 ---RCIHRDLAARNVLVTEDNVMKIADFGLARGV--HDIDYYKKTSNGRLPVK----WMA 204

Query: 214 PEYGMGSKASVSGDVYNFGILLLEMFT 240
           PE       +   DV++FGIL+ E+FT
Sbjct: 205 PEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 54.7 bits (132), Expect = 1e-08
 Identities = 56/236 (23%), Positives = 95/236 (40%), Gaps = 62/236 (26%)

Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIK------ 91
           +G G    VYK    E+    A K++ ++ +E    F  E + L   +H N++       
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 92  -------IITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVS 144
                  +I  C      G    +I+ E      LE+ L +   Q+R++ ++      + 
Sbjct: 73  YENKLWILIEFCD-----GGALDSIMLE------LERGLTE--PQIRYVCRQ------ML 113

Query: 145 FAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIE 204
            A+ + H H    ++H DLK  NILL  D     GD+ LA F      G +A+  S   +
Sbjct: 114 EALNFLHSH---KVIHRDLKAGNILLTLD-----GDVKLADF------GVSAKNKSTLQK 159

Query: 205 IKGIVG---YVAPEYGM---------GSKASVSGDVYNFGILLLEMFTRRRPTDAM 248
               +G   ++APE              KA    D+++ GI L+E+     P   +
Sbjct: 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKA----DIWSLGITLIELAQMEPPHHEL 211

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 55.0 bits (132), Expect = 1e-08
 Identities = 34/135 (25%), Positives = 62/135 (45%), Gaps = 10/135 (7%)

Query: 138 NIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAE 197
           NI  D+   +EY H H    I HGD+KP NI++D +   ++ D G+A     +  G   E
Sbjct: 130 NIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIH--GKHIE 184

Query: 198 TASNSIEI-KGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLH 256
            +    ++ +G + Y   +   G+  +  GD+ + G  +L+    + P     + G  +H
Sbjct: 185 YSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244

Query: 257 ----EFVKMALPDKV 267
               +F+K     K+
Sbjct: 245 AAKCDFIKRLHEGKI 259

Length = 294

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 54.1 bits (130), Expect = 2e-08
 Identities = 33/98 (33%), Positives = 46/98 (46%), Gaps = 11/98 (11%)

Query: 147 IEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIK 206
           +E+ H      I++ DLKP N+LLD D    + DLGLA  L         +  S +    
Sbjct: 110 LEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVEL--------KDGQSKTKGYA 158

Query: 207 GIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
           G  G++APE   G +   S D +  G+ L EM   R P
Sbjct: 159 GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 53.6 bits (129), Expect = 3e-08
 Identities = 49/213 (23%), Positives = 90/213 (42%), Gaps = 21/213 (9%)

Query: 33  SPANKIGQGGVSIVYKGI--LDESRSI-VAVKVVNLKQKEASRS-FAAECNALRNIRHRN 88
           +    IG+G    VY+G+    E+  I VAVK        + R  F  E   +R   H +
Sbjct: 9   TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPH 68

Query: 89  LIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIE 148
           ++K+I + +       +   IV E      L  +L+ +   L   +  +  +  +S A+ 
Sbjct: 69  IVKLIGVITE------NPVWIVMELAPLGELRSYLQVNKYSLDLASL-ILYSYQLSTALA 121

Query: 149 YFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGI 208
           Y         VH D+   N+L+       +GD GL+++L       A++     + IK  
Sbjct: 122 YLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGK---LPIK-- 173

Query: 209 VGYVAPEYGMGSKASVSGDVYNFGILLLEMFTR 241
             ++APE     + + + DV+ FG+ + E+   
Sbjct: 174 --WMAPESINFRRFTSASDVWMFGVCMWEILML 204

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 53.4 bits (128), Expect = 3e-08
 Identities = 54/209 (25%), Positives = 97/209 (46%), Gaps = 22/209 (10%)

Query: 37  KIGQGGVSIVYKGILD--ESRSIVAVKVVNLKQKEAS--RSFAAECNALRNIRHRNLIKI 92
           ++G G    V KG+    +S   VAVK++     + +       E N ++ + +  ++++
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 93  ITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQS-NGQLRFLTQRVNIAIDVSFAIEYFH 151
           I IC +  +       +V E  +   L ++L+++ +   + +T+ V+    VS  ++Y  
Sbjct: 62  IGICEAESW------MLVMELAELGPLNKFLQKNKHVTEKNITELVH---QVSMGMKYLE 112

Query: 152 HHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGY 211
                + VH DL   N+LL     A + D GL+K L   E    A+T       K  V +
Sbjct: 113 ET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG-----KWPVKW 164

Query: 212 VAPEYGMGSKASVSGDVYNFGILLLEMFT 240
            APE     K S   DV++FG+L+ E F+
Sbjct: 165 YAPECMNYYKFSSKSDVWSFGVLMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 53.5 bits (128), Expect = 3e-08
 Identities = 54/217 (24%), Positives = 99/217 (45%), Gaps = 38/217 (17%)

Query: 32  FSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIK 91
           F+   KIG+G    V+KGI + ++ +VA+K+++L++ E         + + +I+    I 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE---------DEIEDIQQE--IT 54

Query: 92  IITICSS---IDFEGFDFKA----IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVS 144
           +++ C S     + G   K     I+ EY+   +    L    G L   TQ   I  ++ 
Sbjct: 55  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP--GPLD-ETQIATILREIL 111

Query: 145 FAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIE 204
             ++Y H   +   +H D+K +N+LL +      G++ LA F      G A +     I+
Sbjct: 112 KGLDYLHSEKK---IHRDIKAANVLLSEH-----GEVKLADF------GVAGQLTDTQIK 157

Query: 205 IKGIVG---YVAPEYGMGSKASVSGDVYNFGILLLEM 238
               VG   ++APE    S      D+++ GI  +E+
Sbjct: 158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIEL 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 53.4 bits (128), Expect = 3e-08
 Identities = 50/195 (25%), Positives = 82/195 (42%), Gaps = 17/195 (8%)

Query: 54  SRSIVAVKVVNL-KQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFE 112
           S    A+K + L K   A      E   L  ++H N   I+    S + +G  +  IV E
Sbjct: 24  SDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPN---IVAFKESFEADGHLY--IVME 78

Query: 113 YMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQ 172
           Y    +L Q ++   G+L      +   + +   +++ H   +  ++H D+K  NI L Q
Sbjct: 79  YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQ 135

Query: 173 DIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFG 232
           +    +GD G A+ L    PG  A T        G   YV PE       +   D+++ G
Sbjct: 136 NGKVKLGDFGSARLL--TSPGAYACTYV------GTPYYVPPEIWENMPYNNKSDIWSLG 187

Query: 233 ILLLEMFTRRRPTDA 247
            +L E+ T + P  A
Sbjct: 188 CILYELCTLKHPFQA 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 53.4 bits (129), Expect = 4e-08
 Identities = 41/166 (24%), Positives = 82/166 (49%), Gaps = 28/166 (16%)

Query: 31  NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL-KQKE-----ASRSFAAECNALRNI 84
            +   N+I +G   +VY+    ++  IVA+K + + K+KE     + R    E N L  +
Sbjct: 6   EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR----EINILLKL 61

Query: 85  RHRNLIKI--ITICSSID--FEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRV-NI 139
           +H N++ +  + + S++D  +       +V EY+++ +L+  +        FL   V  +
Sbjct: 62  QHPNIVTVKEVVVGSNLDKIY-------MVMEYVEH-DLKSLMETMKQ--PFLQSEVKCL 111

Query: 140 AIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAK 185
            + +   + + H +    I+H DLK SN+LL+   +  + D GLA+
Sbjct: 112 MLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAR 154

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 53.2 bits (128), Expect = 5e-08
 Identities = 56/227 (24%), Positives = 99/227 (43%), Gaps = 34/227 (14%)

Query: 31  NFSPANKIGQGGVSIVYKGIL-----DESRSIVAVKVVNLKQKEASRS-FAAECNALRNI 84
           + +    +G G    VY+G+      D     VAVK +     E   S F  E   +   
Sbjct: 7   SITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF 66

Query: 85  RHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSN---GQLRFLTQR--VNI 139
            H+N++++I +     FE    + I+ E M   +L+ +LR++     +   LT +  +  
Sbjct: 67  NHQNIVRLIGVS----FERLP-RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121

Query: 140 AIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQ---DIVAHVGDLGLAKFLFG---YEPG 193
           A DV+   +Y     +   +H D+   N LL       VA + D G+A+ ++    Y  G
Sbjct: 122 ARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKG 178

Query: 194 TAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
             A      + IK    ++ PE  +    +   DV++FG+LL E+F+
Sbjct: 179 GRA-----MLPIK----WMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 53.2 bits (128), Expect = 5e-08
 Identities = 62/214 (28%), Positives = 103/214 (48%), Gaps = 36/214 (16%)

Query: 39  GQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSS 98
           G GGV  V K +   S  I+A K+++L+ K A          +RN   R L K++  C+S
Sbjct: 12  GNGGV--VTKVLHRPSGLIMARKLIHLEIKPA----------IRNQIIREL-KVLHECNS 58

Query: 99  IDFEGFDFKA--------IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYF 150
               GF + A        I  E+M   +L+Q L+++      +  +++IA  V   + Y 
Sbjct: 59  PYIVGF-YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIA--VLRGLTYL 115

Query: 151 HHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG 210
               +  I+H D+KPSNIL++       G++ L  F  G   G   ++ +NS    G   
Sbjct: 116 RE--KHKIMHRDVKPSNILVNSR-----GEIKLCDF--GVS-GQLIDSMANSF--VGTRS 163

Query: 211 YVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
           Y++PE   G+  +V  D+++ G+ L+EM   R P
Sbjct: 164 YMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 53.5 bits (128), Expect = 5e-08
 Identities = 37/132 (28%), Positives = 60/132 (45%), Gaps = 12/132 (9%)

Query: 140 AIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETA 199
           A ++  A+ + H   +  I++ DLK  N+LLD D    + D G+ K   G  PG    T 
Sbjct: 102 AAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKE--GLGPGDTTSTF 156

Query: 200 SNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMF-NEGLTLHEF 258
                  G   Y+APE   G +   S D +  G+L+ EM   R P D +  N  +   ++
Sbjct: 157 C------GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDY 210

Query: 259 VKMALPDKVMEI 270
           +   + +K + I
Sbjct: 211 LFQVILEKPIRI 222

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 53.7 bits (129), Expect = 6e-08
 Identities = 60/220 (27%), Positives = 95/220 (43%), Gaps = 37/220 (16%)

Query: 59  AVKVVNLK---QKEASRSFAAECNALRNIRHRNLIKIITICSSIDF--------EGFDFK 107
           AVKVV+++   + + +R+  AE   L N    +++K    C   DF        E     
Sbjct: 61  AVKVVDMEGMSEADKNRA-QAEVCCLLNCDFFSIVK----CHE-DFAKKDPRNPENVLMI 114

Query: 108 AIVFEYMQNRNLEQWLRQSNGQLR-FLTQRVN-IAIDVSFAIEYFHHHCQPSIVHGDLKP 165
           A+V +Y    +L Q ++      R F       + I V  A+   HH     ++H D+K 
Sbjct: 115 ALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAV---HHVHSKHMIHRDIKS 171

Query: 166 SNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSI--EIKGIVGYVAPEYGMGSKAS 223
           +NILL  + +  +GD G +K          A T S+ +     G   YVAPE       S
Sbjct: 172 ANILLCSNGLVKLGDFGFSKMY--------AATVSDDVGRTFCGTPYYVAPEIWRRKPYS 223

Query: 224 VSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMAL 263
              D+++ G+LL E+ T +RP D     G  + E +   L
Sbjct: 224 KKADMFSLGVLLYELLTLKRPFD-----GENMEEVMHKTL 258

Length = 496

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 52.7 bits (127), Expect = 6e-08
 Identities = 54/213 (25%), Positives = 89/213 (41%), Gaps = 34/213 (15%)

Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITI 95
            +IG G    VYK     +  +VA+KV+ L+  +       E + L+  RH N++     
Sbjct: 9   QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFG- 67

Query: 96  CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQ 155
                +   D   IV EY    +L+   + + G L  L Q   +  +    + Y H    
Sbjct: 68  ----SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSEL-QIAYVCRETLKGLAYLHET-- 120

Query: 156 PSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG---YV 212
              +H D+K +NILL +D     GD+ LA F      G +A+  +   + K  +G   ++
Sbjct: 121 -GKIHRDIKGANILLTED-----GDVKLADF------GVSAQLTATIAKRKSFIGTPYWM 168

Query: 213 APE-------YGMGSKASVSGDVYNFGILLLEM 238
           APE        G   K     D++  GI  +E+
Sbjct: 169 APEVAAVERKGGYDGKC----DIWALGITAIEL 197

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 52.7 bits (126), Expect = 6e-08
 Identities = 58/240 (24%), Positives = 101/240 (42%), Gaps = 43/240 (17%)

Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIIT--- 94
           IG+GG   VY     ++  + A+K ++ K+ +  +      N       R ++ +++   
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALN------ERIMLSLVSTGD 55

Query: 95  ----ICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQ----SNGQLRFLTQRVNIAIDVSFA 146
               +C +  F   D    + + M   +L   L Q    S  ++RF       A ++   
Sbjct: 56  CPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFY------ATEIILG 109

Query: 147 IEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIK 206
           +E+ H+     +V+ DLKP+NILLD+     + DLGLA      +P  +           
Sbjct: 110 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---------- 156

Query: 207 GIVGYVAPE-YGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLT--LHEFVKMAL 263
           G  GY+APE    G+    S D ++ G +L ++     P    F +  T   HE  +M L
Sbjct: 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP----FRQHKTKDKHEIDRMTL 212

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 53.2 bits (128), Expect = 6e-08
 Identities = 55/237 (23%), Positives = 97/237 (40%), Gaps = 27/237 (11%)

Query: 23  AELSKATNNFSPANK-IGQGGVSIVYKGILDESRSIVAVKVVNL----KQKEASRSFAAE 77
                 +  +      +G+G    V K     +  IVA+K V +          R     
Sbjct: 1   NMSFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGM 60

Query: 78  CN----ALRNIRHRNLIKIITICSSID-FEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRF 132
           C      LR ++  N IK   I   +D +   DF  +V + M + +L++ +   + ++R 
Sbjct: 61  CGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVV---DRKIRL 116

Query: 133 LTQRVN-IAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYE 191
              +V  I + +   +   H       +H DL P+NI ++   +  + D GLA+  +GY 
Sbjct: 117 TESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLAR-RYGYP 172

Query: 192 P----GTAAETASNSIEIKGIV---GYVAPEYGMGS-KASVSGDVYNFGILLLEMFT 240
           P     +  ET     E+   V    Y APE  MG+ K   + D+++ G +  E+ T
Sbjct: 173 PYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLT 229

Length = 335

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 52.5 bits (126), Expect = 7e-08
 Identities = 58/218 (26%), Positives = 100/218 (45%), Gaps = 28/218 (12%)

Query: 37  KIGQG--GVSIVYKGILDESRSIVAVKVVNL-----KQKEASRSFAAECNALRNIRHRNL 89
           KIG+G  G +I+ K   D  + ++  K +N+     K++E SR    E   L N++H N 
Sbjct: 7   KIGEGSFGKAILVKSKEDGKQYVI--KEINISKMSPKEREESRK---EVAVLSNMKHPN- 60

Query: 90  IKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEY 149
             I+    S +  G  +  IV +Y +  +L + +    G L    Q ++  + +  A+++
Sbjct: 61  --IVQYQESFEENGNLY--IVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKH 116

Query: 150 FHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
            H      I+H D+K  NI L +D    +GD G+A+ L      +  E A   I   G  
Sbjct: 117 VHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVL-----NSTVELARTCI---GTP 165

Query: 210 GYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDA 247
            Y++PE       +   D++  G +L EM T +   +A
Sbjct: 166 YYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEA 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 52.7 bits (126), Expect = 7e-08
 Identities = 36/105 (34%), Positives = 49/105 (46%), Gaps = 12/105 (11%)

Query: 140 AIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETA 199
           A ++   +E  H   Q  IV+ DLKP NILLD      + DLGLA  +         +T 
Sbjct: 108 AAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHV------PEGQTI 158

Query: 200 SNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
              +   G VGY+APE     + + S D +  G LL EM   + P
Sbjct: 159 KGRV---GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 52.5 bits (126), Expect = 8e-08
 Identities = 51/223 (22%), Positives = 97/223 (43%), Gaps = 28/223 (12%)

Query: 31  NFSPANKIGQGGVSIVY----KGILDES-RSIVAVKVVNLKQKEASRS-FAAECNALRNI 84
           N      +G+G    V+    KGI +E   ++V VK +   + E  +S F  E +  R +
Sbjct: 6   NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65

Query: 85  RHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLT-------QRV 137
            H+N+++++ +C   +        ++ EY    +L+Q+LR +  +   L        Q+V
Sbjct: 66  SHKNVVRLLGLCREAEPH-----YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKV 120

Query: 138 NIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAE 197
            +   ++  +++  +      VH DL   N L+       V  L L+K ++  E      
Sbjct: 121 ALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRN 177

Query: 198 TASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
                      + ++APE       S   DV++FG+L+ E+FT
Sbjct: 178 A-------LIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 53/221 (23%), Positives = 96/221 (43%), Gaps = 35/221 (15%)

Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNI-RHRNLIKII 93
           IG+G    V + ++ +    +   +  LK+   +   R FA E   L  +  H N+I ++
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69

Query: 94  TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQS------------NGQLRFLTQR--VNI 139
             C +    G+ + AI  EY    NL  +LR+S            +G    LT +  +  
Sbjct: 70  GACEN---RGYLYIAI--EYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQF 124

Query: 140 AIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETA 199
           A DV+  ++Y     +   +H DL   N+L+ +++ + + D GL++    Y   T     
Sbjct: 125 ASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLP 181

Query: 200 SNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
                    V ++A E    S  +   DV++FG+LL E+ +
Sbjct: 182 ---------VRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 60/207 (28%), Positives = 87/207 (42%), Gaps = 24/207 (11%)

Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVN----LKQKEASRSFAAECNALRNIRHRNLIKII 93
           IG+G    V         S  AVKV+     LK+KE +   A     L+N++H  L+ + 
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL- 61

Query: 94  TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNI-AIDVSFAIEYFHH 152
                  F+  +    V +Y+    L   L++   +  FL  R    A +V+ AI Y H 
Sbjct: 62  ----HYSFQTAEKLYFVLDYVNGGELFFHLQR---ERCFLEPRARFYAAEVASAIGYLH- 113

Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
               +I++ DLKP NILLD      + D GL K   G EP     T   + E      Y+
Sbjct: 114 --SLNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPE------YL 163

Query: 213 APEYGMGSKASVSGDVYNFGILLLEMF 239
           APE         + D +  G +L EM 
Sbjct: 164 APEVLRKEPYDRTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 52.0 bits (125), Expect = 1e-07
 Identities = 46/215 (21%), Positives = 93/215 (43%), Gaps = 22/215 (10%)

Query: 38  IGQGGVSIVYKGI-LDESRSI---VAVKVVNLKQ-KEASRSFAAECNALRNIRHRNLIKI 92
           +G G    VYKG+ + E   +   VA+KV+  +   +A++    E   + ++ H +++++
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 93  ITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHH 152
           + IC S          ++ + M    L  ++R     +      +N  + ++  + Y   
Sbjct: 75  LGICLSSQV------QLITQLMPLGCLLDYVRNHKDNIGSQYL-LNWCVQIAKGMSYLEE 127

Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
                +VH DL   N+L+       + D GLAK L   E    AE     I+      ++
Sbjct: 128 K---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIK------WM 178

Query: 213 APEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTD 246
           A E  +    +   DV+++G+ + E+ T   +P +
Sbjct: 179 ALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 51.9 bits (124), Expect = 1e-07
 Identities = 50/199 (25%), Positives = 90/199 (45%), Gaps = 30/199 (15%)

Query: 58  VAVKVVNLKQKEASRS-FAAECNALRNI-RHRNLIKIITICSSIDFEGFDFKAIVFEYMQ 115
           VAVK++     E   S   +E   ++ I +H+N+I ++  C+    +G  +  ++ EY  
Sbjct: 53  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ---DGPLY--VIVEYAS 107

Query: 116 NRNLEQWLR--------------QSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHG 161
             NL ++LR              Q   +       V+ A  V+  +EY         +H 
Sbjct: 108 KGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHR 164

Query: 162 DLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSK 221
           DL   N+L+ +D V  + D GLA+ +  +      +T +  + +K    ++APE      
Sbjct: 165 DLAARNVLVTEDNVMKIADFGLARDI--HHIDYYKKTTNGRLPVK----WMAPEALFDRI 218

Query: 222 ASVSGDVYNFGILLLEMFT 240
            +   DV++FG+LL E+FT
Sbjct: 219 YTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 51.6 bits (123), Expect = 1e-07
 Identities = 57/218 (26%), Positives = 96/218 (44%), Gaps = 44/218 (20%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKII--- 93
           ++G G    VYK    E+  + A KV++ K +E    +  E + L +  H N++K++   
Sbjct: 12  ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 94  ----TICSSIDF-EGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIE 148
                +   I+F  G    A++ E      LE+ L +   Q+R + ++    ++   A+ 
Sbjct: 72  YYENNLWILIEFCAGGAVDAVMLE------LERPLTEP--QIRVVCKQ---TLE---ALN 117

Query: 149 YFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGI 208
           Y H   +  I+H DLK  NIL   D     GD+ LA F      G +A+           
Sbjct: 118 YLH---ENKIIHRDLKAGNILFTLD-----GDIKLADF------GVSAKNTRTIQRRDSF 163

Query: 209 VG---YVAPEYGMGSKAS-----VSGDVYNFGILLLEM 238
           +G   ++APE  M   +         DV++ GI L+EM
Sbjct: 164 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 51.7 bits (124), Expect = 1e-07
 Identities = 38/125 (30%), Positives = 56/125 (44%), Gaps = 20/125 (16%)

Query: 149 YFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIE--IK 206
           Y  H     I+H D+KPSNIL     V   G + L  F      G + E   NSI     
Sbjct: 120 YNVHR----IMHRDIKPSNIL-----VNSRGQIKLCDF------GVSGELI-NSIADTFV 163

Query: 207 GIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDK 266
           G   Y++PE   G K +V  DV++ GI ++E+   + P    F+      +   M + D 
Sbjct: 164 GTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFA--FSNIDDDGQDDPMGILDL 221

Query: 267 VMEIV 271
           + +IV
Sbjct: 222 LQQIV 226

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 51.5 bits (124), Expect = 1e-07
 Identities = 40/176 (22%), Positives = 77/176 (43%), Gaps = 41/176 (23%)

Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIR-------HRN 88
            KIG+G  S V K    ++    A+K   +K+   S     + N LR I+       H N
Sbjct: 5   GKIGEGTFSEVLKAQSRKTGKYYAIK--CMKKHFKS---LEQVNNLREIQALRRLSPHPN 59

Query: 89  LIKIITI-------CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLR---FLTQRVN 138
           ++++I +         ++ FE  D    ++E ++ R      ++   + R   ++ Q + 
Sbjct: 60  ILRLIEVLFDRKTGRLALVFELMDMN--LYELIKGR------KRPLPEKRVKSYMYQLLK 111

Query: 139 IAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGT 194
                  ++++ H +    I H D+KP NIL+  DI+  + D G  + ++   P T
Sbjct: 112 -------SLDHMHRN---GIFHRDIKPENILIKDDIL-KLADFGSCRGIYSKPPYT 156

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 51.1 bits (122), Expect = 2e-07
 Identities = 50/187 (26%), Positives = 81/187 (43%), Gaps = 29/187 (15%)

Query: 72  RSFAAECNALRNIRHRNLIK---IITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNG 128
           R F AE   L    H N+++   +IT  +++         IV EYM N  L+ +LR+  G
Sbjct: 51  RGFLAEALTLGQFDHSNIVRLEGVITRGNTM--------MIVTEYMSNGALDSFLRKHEG 102

Query: 129 QLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLF 188
           QL    Q + +   ++  ++Y     +   VH  L    +L++ D+V  +         F
Sbjct: 103 QLV-AGQLMGMLPGLASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISG-------F 151

Query: 189 GYEPGTAAETASNSIEIKGIVGYVAPE---YGMGSKASVSGDVYNFGILLLE-MFTRRRP 244
                  +E    ++  K  V + APE   Y   S AS   DV++FGI++ E M    RP
Sbjct: 152 RRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSAS---DVWSFGIVMWEVMSYGERP 208

Query: 245 TDAMFNE 251
              M  +
Sbjct: 209 YWDMSGQ 215

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 51.3 bits (123), Expect = 2e-07
 Identities = 31/103 (30%), Positives = 52/103 (50%), Gaps = 11/103 (10%)

Query: 142 DVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASN 201
           +++ A+++ H      I++ DLKP NILLD++    + D GL+K         + +    
Sbjct: 106 ELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--------ESIDHEKK 154

Query: 202 SIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
           +    G V Y+APE       + S D ++FG+L+ EM T   P
Sbjct: 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 51.5 bits (123), Expect = 2e-07
 Identities = 60/221 (27%), Positives = 98/221 (44%), Gaps = 35/221 (15%)

Query: 38  IGQGGVSIVYKGIL--DESRSIVAVK-VVNLKQKEASRSFAAECNALRNI-RHRNLIKII 93
           IG+G    V K  +  D  R   A+K +     K+  R FA E   L  +  H N+I ++
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74

Query: 94  TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQS------------NGQLRFLT--QRVNI 139
             C   +  G+ + AI  EY  + NL  +LR+S            N     L+  Q ++ 
Sbjct: 75  GAC---EHRGYLYLAI--EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 129

Query: 140 AIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETA 199
           A DV+  ++Y     Q   +H DL   NIL+ ++ VA + D GL++    Y   T     
Sbjct: 130 AADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 186

Query: 200 SNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
                    V ++A E    S  + + DV+++G+LL E+ +
Sbjct: 187 ---------VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 51.3 bits (123), Expect = 2e-07
 Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 28/224 (12%)

Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAA--ECNALRNIRHR 87
           + +    KIG+G    VYK     +  +VA+K   L+  E      A  E + L+ +   
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60

Query: 88  NLI-KIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFA 146
             I +++ +    +  G     +VFEY+ + +L++++  SNG+               + 
Sbjct: 61  IYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFM-DSNGRGPGRPLPAKTIKSFMYQ 118

Query: 147 IEYFHHHCQP-SIVHGDLKPSNILLDQDI-VAHVGDLGLAKFLFGYEPGTAAETASNSIE 204
           +     HC    ++H DLKP N+L+D+   +  + DLGL +                SI 
Sbjct: 119 LLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF--------------SIP 164

Query: 205 IKG----IVG--YVAPEYGMGSKA-SVSGDVYNFGILLLEMFTR 241
           +K     IV   Y APE  +GS   S   D+++ G +  EM  +
Sbjct: 165 VKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 51.6 bits (123), Expect = 2e-07
 Identities = 52/208 (25%), Positives = 92/208 (44%), Gaps = 34/208 (16%)

Query: 52  DESRSIVAVKVVNLKQKEASRSFA---AECNALRNI-RHRNLIKIITICSSIDFEGFDFK 107
           D+    V V V  LK     +  +   +E   ++ I +H+N+I ++  C+    +G  + 
Sbjct: 39  DKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ---DGPLY- 94

Query: 108 AIVFEYMQNRNLEQWLRQS---------------NGQLRFLTQRVNIAIDVSFAIEYFHH 152
            ++ EY    NL ++LR                   QL F    V+ A  V+  +EY   
Sbjct: 95  -VLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTF-KDLVSCAYQVARGMEYL-- 150

Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
                 +H DL   N+L+ +D V  + D GLA+ +   +     +T +  + +K    ++
Sbjct: 151 -ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNID--YYKKTTNGRLPVK----WM 203

Query: 213 APEYGMGSKASVSGDVYNFGILLLEMFT 240
           APE       +   DV++FG+LL E+FT
Sbjct: 204 APEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 51.5 bits (124), Expect = 2e-07
 Identities = 61/244 (25%), Positives = 90/244 (36%), Gaps = 46/244 (18%)

Query: 32  FSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ----KEASRSFAAECNALRNIRHR 87
           F     +G+G V  V+   L  +  + A+KV++ K+     +  R    E   L  + H 
Sbjct: 3   FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLT-EQEILATLDHP 61

Query: 88  NLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWL-RQSNGQLRFLTQRVNIAIDVSFA 146
               + T+ +S   E   +  +V +Y     L + L RQ    L     R   A +V  A
Sbjct: 62  ---FLPTLYASFQTE--TYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAA-EVLLA 115

Query: 147 IEYFHHHCQPSIVHGDLKPSNILLDQD--------------------IVAHVGDLGLAKF 186
           +EY H      IV+ DLKP NILL +                     +   +        
Sbjct: 116 LEYLH--LL-GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSS 172

Query: 187 LFGYEPGTAAETA---SNSIEIKGIVG---YVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
           +      T +E     SNS      VG   Y+APE   G     + D +  GILL EM  
Sbjct: 173 VNSIPSETFSEEPSFRSNS-----FVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLY 227

Query: 241 RRRP 244
              P
Sbjct: 228 GTTP 231

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 51.0 bits (122), Expect = 2e-07
 Identities = 47/211 (22%), Positives = 101/211 (47%), Gaps = 21/211 (9%)

Query: 38  IGQGGVSIVYKGILDE-------SRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLI 90
           +GQG  + ++KGI  E        ++ V +KV++   +  S SF    + +  + H++L+
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 91  KIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYF 150
               +C        D   +V EY++  +L+ +L++ N  L  ++ ++ +A  +++A+ + 
Sbjct: 63  LNYGVCV-----CGDESIMVQEYVKFGSLDTYLKK-NKNLINISWKLEVAKQLAWALHFL 116

Query: 151 HHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG 210
                  + HG++   N+LL ++     G+    K     +PG +       I ++ I  
Sbjct: 117 E---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKL---SDPGISITVLPKEILLERI-P 169

Query: 211 YVAPEYGMGSKA-SVSGDVYNFGILLLEMFT 240
           +V PE     +  S++ D ++FG  L E+F+
Sbjct: 170 WVPPECIENPQNLSLAADKWSFGTTLWEIFS 200

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 51.2 bits (122), Expect = 2e-07
 Identities = 49/208 (23%), Positives = 91/208 (43%), Gaps = 34/208 (16%)

Query: 52  DESRSIVAVKVVNLKQKEASRSFA---AECNALRNI-RHRNLIKIITICSSIDFEGFDFK 107
           D+ +  V V V  LK     +  +   +E   ++ I +H+N+I ++  C+    +     
Sbjct: 42  DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT----QDGPLY 97

Query: 108 AIVFEYMQNRNLEQWLRQ---------------SNGQLRFLTQRVNIAIDVSFAIEYFHH 152
            IV EY    NL ++LR                 + Q+ F    V+    V+  +EY   
Sbjct: 98  VIV-EYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTF-KDLVSCTYQVARGMEYL-- 153

Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
                 +H DL   N+L+ ++ V  + D GLA+ +   +     +T +  + +K    ++
Sbjct: 154 -ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNID--YYKKTTNGRLPVK----WM 206

Query: 213 APEYGMGSKASVSGDVYNFGILLLEMFT 240
           APE       +   DV++FG+L+ E+FT
Sbjct: 207 APEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 51.1 bits (122), Expect = 3e-07
 Identities = 54/230 (23%), Positives = 102/230 (44%), Gaps = 40/230 (17%)

Query: 38  IGQGGVSIVYKGILDESR-----SIVAVKVVNLKQKEAS---RSFAAECNALRNIRHRNL 89
           +G+G    V K      +     + VAVK+  LK+  +S   R   +E N L+ + H ++
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKM--LKENASSSELRDLLSEFNLLKQVNHPHV 65

Query: 90  IKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQS---------NGQLRFLT------ 134
           IK+   CS    +G     ++ EY +  +L  +LR+S         +   R  +      
Sbjct: 66  IKLYGACSQ---DGPLL--LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120

Query: 135 -QRVNIAIDVSFAIEY---FHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGY 190
            + + +   +SFA +      +  +  +VH DL   N+L+ +     + D GL++ +  Y
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDV--Y 178

Query: 191 EPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
           E  +  + +   I +K    ++A E       +   DV++FG+LL E+ T
Sbjct: 179 EEDSYVKRSKGRIPVK----WMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 51.0 bits (122), Expect = 3e-07
 Identities = 59/218 (27%), Positives = 91/218 (41%), Gaps = 45/218 (20%)

Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLK-QKEASRSFAAECNALRNIRHRNLIKIITIC 96
           +G G    VYK     +R I+AVKV+ L    E  +   +E            ++I+  C
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSE------------LEILYKC 56

Query: 97  SS---IDFEGFDFK----AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEY 149
            S   I F G  F     +I  E+M   +L+ + +     L        IA+ V   + Y
Sbjct: 57  DSPYIIGFYGAFFVENRISICTEFMDGGSLDVYRKIPEHVLG------RIAVAVVKGLTY 110

Query: 150 FHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
                   I+H D+KPSN+L++      + D G++  L             NSI  K  V
Sbjct: 111 L---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV------------NSIA-KTYV 154

Query: 210 G---YVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
           G   Y+APE   G +  +  DV++ GI  +E+   R P
Sbjct: 155 GTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFP 192

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 50.7 bits (121), Expect = 3e-07
 Identities = 47/219 (21%), Positives = 94/219 (42%), Gaps = 29/219 (13%)

Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRS------FAAECNALRNIRHRNL 89
           ++IG G    V  G   E+   ++   V +K+  AS +      F  E    R + H N+
Sbjct: 1   DEIGNGWFGKVLLG---EAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNV 57

Query: 90  IKIITIC-SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQR---VNIAIDVSF 145
           ++ +  C  SI +       +V E+    +L+ +LR + G +  + Q+     +A +V+ 
Sbjct: 58  LQCLGQCIESIPY------LLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVAS 111

Query: 146 AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETAS-NSIE 204
            + + H   Q   +H DL   N  L  D+   +GD GLA       P     T   +++ 
Sbjct: 112 GLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLA---LEQYPEDYYITKDCHAVP 165

Query: 205 IKGIVGYVAPEYG---MGSKASVSGDVYNFGILLLEMFT 240
           ++ +   +    G   +    +   ++++ G+ + E+FT
Sbjct: 166 LRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 50.9 bits (122), Expect = 3e-07
 Identities = 56/206 (27%), Positives = 83/206 (40%), Gaps = 24/206 (11%)

Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVN----LKQKEASRSFAAECNALRNIRHRNLIKII 93
           IG+G    V            AVKV+     LK+KE     A     L+N++H  L+ + 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61

Query: 94  TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNI-AIDVSFAIEYFHH 152
                  F+  D    V +Y+    L   L++   +  F   R    A +++ A+ Y H 
Sbjct: 62  ----HYSFQTADKLYFVLDYVNGGELFFHLQR---ERSFPEPRARFYAAEIASALGYLH- 113

Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
               +I++ DLKP NILLD      + D GL K   G E      T   + E      Y+
Sbjct: 114 --SLNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPE------YL 163

Query: 213 APEYGMGSKASVSGDVYNFGILLLEM 238
           APE         + D +  G +L EM
Sbjct: 164 APEVLRKQPYDRTVDWWCLGAVLYEM 189

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 50.8 bits (121), Expect = 3e-07
 Identities = 59/245 (24%), Positives = 107/245 (43%), Gaps = 31/245 (12%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           KIG+G   IV    +  S  +VAVK ++L++++       E   +R+ +H N++++    
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN-- 84

Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQP 156
               +   D   +V E+++   L   +  +        Q   + + V  A+   H     
Sbjct: 85  ---SYLVGDELWVVMEFLEGGALTDIVTHTRMNEE---QIAAVCLAVLKALSVLHAQ--- 135

Query: 157 SIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG---YVA 213
            ++H D+K  +ILL  D     G + L+ F      G  A+ +      K +VG   ++A
Sbjct: 136 GVIHRDIKSDSILLTHD-----GRVKLSDF------GFCAQVSKEVPRRKSLVGTPYWMA 184

Query: 214 PEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNE-GLTLHEFVKMALPDKV--MEI 270
           PE           D+++ GI+++EM     P    FNE  L   + ++  LP K+  +  
Sbjct: 185 PELISRLPYGPEVDIWSLGIMVIEMVDGEPP---YFNEPPLKAMKMIRDNLPPKLKNLHK 241

Query: 271 VDPSL 275
           V PSL
Sbjct: 242 VSPSL 246

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 50.4 bits (120), Expect = 4e-07
 Identities = 34/106 (32%), Positives = 50/106 (47%), Gaps = 14/106 (13%)

Query: 140 AIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETA 199
           A ++   +E  H   + + V+ DLKP NILLD      + DLGLA  +            
Sbjct: 108 AAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKI----------PE 154

Query: 200 SNSIEIK-GIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
             SI  + G VGY+APE     + ++S D +  G L+ EM   + P
Sbjct: 155 GESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 50.1 bits (119), Expect = 4e-07
 Identities = 52/212 (24%), Positives = 90/212 (42%), Gaps = 18/212 (8%)

Query: 38  IGQGGVSIVYKGI-LDESRSIVAVKV-VNLKQKEASRSFAA---ECNALRNIRHRNLIKI 92
           +GQG    VY    +D  R + A +V  + +  E S+  +A   E   L+N++H    +I
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHE---RI 66

Query: 93  ITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHH 152
           +     +         I  EYM   +++  L+        +T++    I     + Y H 
Sbjct: 67  VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQI--LEGMSYLHS 124

Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
           +    IVH D+K +NIL D      +GD G +K L      T   + +    + G   ++
Sbjct: 125 NM---IVHRDIKGANILRDSAGNVKLGDFGASKRL-----QTICMSGTGIRSVTGTPYWM 176

Query: 213 APEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
           +PE   G       DV++ G  ++EM T + P
Sbjct: 177 SPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 49.9 bits (119), Expect = 5e-07
 Identities = 55/219 (25%), Positives = 95/219 (43%), Gaps = 37/219 (16%)

Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIIT--- 94
           IG+GG   VY     ++  + A+K ++ K+ +  +    E  AL     R ++ +++   
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ---GETLALN---ERIMLSLVSTGD 55

Query: 95  ----ICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQ----SNGQLRFLTQRVNIAIDVSFA 146
               +C S  F   D  + + + M   +L   L Q    S  ++RF       A ++   
Sbjct: 56  CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFY------AAEIILG 109

Query: 147 IEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIK 206
           +E+ H+     +V+ DLKP+NILLD+     + DLGLA      +P  +           
Sbjct: 110 LEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---------- 156

Query: 207 GIVGYVAPE-YGMGSKASVSGDVYNFGILLLEMFTRRRP 244
           G  GY+APE    G     S D ++ G +L ++     P
Sbjct: 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 49.9 bits (119), Expect = 5e-07
 Identities = 56/223 (25%), Positives = 99/223 (44%), Gaps = 25/223 (11%)

Query: 32  FSPANKIGQGGVSIVYKGIL---DESRSIVAVKVVNLKQKEAS--RSFAAECNALRNIRH 86
           F+    +G+G    V +  L   D S   VAVK++      +S    F  E   ++   H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 87  RNLIKIITICSSIDFEG-FDFKAIVFEYMQNRNLEQWLRQSN-GQLRF---LTQRVNIAI 141
            N+IK+I +      +G      ++  +M++ +L  +L  S  G+  F   L   V   I
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120

Query: 142 DVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG---YEPGTAAET 198
           D++  +EY       + +H DL   N +L++++   V D GL+K ++    Y  G A+  
Sbjct: 121 DIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCAS-- 175

Query: 199 ASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTR 241
                  K  V ++A E    +  +   DV+ FG+ + E+ TR
Sbjct: 176 -------KLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTR 211

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 50.0 bits (119), Expect = 6e-07
 Identities = 55/238 (23%), Positives = 101/238 (42%), Gaps = 29/238 (12%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           KIG+G   IV       +   VAVK ++L++++       E   +R+  H N++ +    
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYN-- 86

Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQP 156
               +   D   +V E+++   L   +  +        Q   + + V  A+ Y H+    
Sbjct: 87  ---SYLVGDELWVVMEFLEGGALTDIVTHTRMNEE---QIATVCLSVLRALSYLHNQ--- 137

Query: 157 SIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG---YVA 213
            ++H D+K  +ILL  D     G + L+ F      G  A+ +    + K +VG   ++A
Sbjct: 138 GVIHRDIKSDSILLTSD-----GRIKLSDF------GFCAQVSKEVPKRKSLVGTPYWMA 186

Query: 214 PEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNE-GLTLHEFVKMALPDKVMEI 270
           PE           D+++ GI+++EM     P    FNE  L     ++  LP +V + 
Sbjct: 187 PEVISRLPYGTEVDIWSLGIMVIEMIDGEPP---YFNEPPLQAMRRIRDNLPPRVKDS 241

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 50.1 bits (119), Expect = 6e-07
 Identities = 35/105 (33%), Positives = 50/105 (47%), Gaps = 11/105 (10%)

Query: 142 DVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASN 201
           ++S A+ Y H   +  I++ DLK  N+LLD +    + D G+ K   G  PG   +T S 
Sbjct: 104 EISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE--GLRPG---DTTST 155

Query: 202 SIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTD 246
                G   Y+APE   G     S D +  G+L+ EM   R P D
Sbjct: 156 ---FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 49.6 bits (118), Expect = 7e-07
 Identities = 54/232 (23%), Positives = 103/232 (44%), Gaps = 33/232 (14%)

Query: 37  KIGQGGVSIVYKGILD-----ESRSIVAVKVVNLKQKEASR-SFAAECNALRNIRHRNLI 90
           ++GQG   +VY+G        E+ + VAVK VN       R  F  E + ++     +++
Sbjct: 13  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72

Query: 91  KIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLR-----QSNGQLR---FLTQRVNIAID 142
           +++ + S           +V E M + +L+ +LR       N   R    L + + +A +
Sbjct: 73  RLLGVVSK-----GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 127

Query: 143 VSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNS 202
           ++  + Y +       VH DL   N ++  D    +GD G+ + ++        ET    
Sbjct: 128 IADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIY--------ETDYYR 176

Query: 203 IEIKGI--VGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNE 251
              KG+  V ++APE       + S D+++FG++L E+ +   +P   + NE
Sbjct: 177 KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE 228

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 49.8 bits (119), Expect = 8e-07
 Identities = 58/215 (26%), Positives = 94/215 (43%), Gaps = 27/215 (12%)

Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRS--FAAECNALRNIRHRNLIKIITI 95
           IG+G   +V   I   +   VA+K +N   +  S +     E   LR +RH ++++I  I
Sbjct: 8   IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 67

Query: 96  CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLR------FLTQRVNIAIDVSFAIEY 149
                   F    +VFE M++ +L Q ++ +N  L       FL Q +        A++Y
Sbjct: 68  MLPPSRREFKDIYVVFELMES-DLHQVIK-ANDDLTPEHHQFFLYQLLR-------ALKY 118

Query: 150 FHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
            H     ++ H DLKP NIL + D    + D GLA+  F   P     T     +     
Sbjct: 119 IH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT-----DYVATR 170

Query: 210 GYVAPEY--GMGSKASVSGDVYNFGILLLEMFTRR 242
            Y APE      SK + + D+++ G +  E+ T +
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 49.2 bits (117), Expect = 9e-07
 Identities = 53/214 (24%), Positives = 95/214 (44%), Gaps = 34/214 (15%)

Query: 37  KIGQGGVSIVY-----KGILDESRSIVA-VKVVNLKQKEASRSFAAECNALRNIRHRNLI 90
           ++G+G    VY     K + +E   ++  + V  L   E  ++   E   L  + H  ++
Sbjct: 7   RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQA-NQEAQLLSKLDHPAIV 65

Query: 91  KIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQ--SNGQLRFLTQRVNIAIDVSFAIE 148
           K     S ++ + F    I+ EY + R+L+  L +    G+     Q     I +   + 
Sbjct: 66  KFHA--SFLERDAF---CIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120

Query: 149 YFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGI 208
           Y H   Q  I+H DLK  NI L  +++  +GD G+++ L G     + + A+      G 
Sbjct: 121 YMH---QRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMG-----SCDLATT---FTGT 168

Query: 209 VGYVAPE----YGMGSKASVSGDVYNFGILLLEM 238
             Y++PE     G  SK+    D+++ G +L EM
Sbjct: 169 PYYMSPEALKHQGYDSKS----DIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 32/105 (30%), Positives = 50/105 (47%), Gaps = 11/105 (10%)

Query: 140 AIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETA 199
           A ++   +++ H      IV+ DLK  NILLD D    + D G+ K           +  
Sbjct: 102 AAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCK------ENMLGDAK 152

Query: 200 SNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
           + +    G   Y+APE  +G K + S D ++FG+LL EM   + P
Sbjct: 153 TCTF--CGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 49/195 (25%), Positives = 84/195 (43%), Gaps = 17/195 (8%)

Query: 52  DESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVF 111
           D    +VA K V L  +  +    +E + L    H  ++K        DF+  D   ++ 
Sbjct: 91  DPKEKVVA-KFVMLNDERQAAYARSELHCLAACDHFGIVKHFD-----DFKSDDKLLLIM 144

Query: 112 EYMQNRNLEQWLRQS-NGQLRFLTQRVNIAI-DVSFAIEYFHHHCQPSIVHGDLKPSNIL 169
           EY    +L + ++Q     L F    V +    +  A++  H      ++H DLK +NI 
Sbjct: 145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIF 201

Query: 170 LDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVY 229
           L    +  +GD G +K    Y    + + AS+     G   Y+APE     + S   D++
Sbjct: 202 LMPTGIIKLGDFGFSK---QYSDSVSLDVASS---FCGTPYYLAPELWERKRYSKKADMW 255

Query: 230 NFGILLLEMFTRRRP 244
           + G++L E+ T  RP
Sbjct: 256 SLGVILYELLTLHRP 270

Length = 478

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 49.3 bits (117), Expect = 1e-06
 Identities = 51/212 (24%), Positives = 98/212 (46%), Gaps = 27/212 (12%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           KIG+G   IV       S   VAVK+++L++++       E   +R+ +H+N++++    
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYK-- 85

Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRV-NIAIDVSFAIEYFHHHCQ 155
           S +  E      ++ E++Q   L   +     Q R   +++  +   V  A+ Y H    
Sbjct: 86  SYLVGEEL---WVLMEFLQGGALTDIV----SQTRLNEEQIATVCESVLQALCYLHSQ-- 136

Query: 156 PSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG---YV 212
             ++H D+K  +ILL  D     G + L+ F      G  A+ + +  + K +VG   ++
Sbjct: 137 -GVIHRDIKSDSILLTLD-----GRVKLSDF------GFCAQISKDVPKRKSLVGTPYWM 184

Query: 213 APEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
           APE    +      D+++ GI+++EM     P
Sbjct: 185 APEVISRTPYGTEVDIWSLGIMVIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 48.7 bits (116), Expect = 1e-06
 Identities = 38/121 (31%), Positives = 53/121 (43%), Gaps = 19/121 (15%)

Query: 128 GQLRFLTQRVNI-AIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF 186
           G   F  +R    A +++  +E  H      IV+ DLKP NILLD      + DLGLA  
Sbjct: 95  GNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVE 151

Query: 187 LFGYEPGTAAETASNSIEIK---GIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRR 243
           +   E             I+   G VGY+APE     + + S D +  G L+ EM   + 
Sbjct: 152 IPEGET------------IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKS 199

Query: 244 P 244
           P
Sbjct: 200 P 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 49.0 bits (117), Expect = 1e-06
 Identities = 41/136 (30%), Positives = 62/136 (45%), Gaps = 15/136 (11%)

Query: 110 VFEYMQNRNLEQWLRQSNGQLRFLTQRVNI-AIDVSFAIEYFHHHCQPSIVHGDLKPSNI 168
           V EY+   +L   ++ S    RF   R    A ++   +++ H      I++ DLK  N+
Sbjct: 74  VMEYLNGGDLMFHIQSS---GRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNV 127

Query: 169 LLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDV 228
           LLD+D    + D G+ K     E       AS      G   Y+APE   G K + S D 
Sbjct: 128 LLDKDGHIKIADFGMCK-----ENMNGEGKAST---FCGTPDYIAPEILKGQKYNESVDW 179

Query: 229 YNFGILLLEMFTRRRP 244
           ++FG+LL EM   + P
Sbjct: 180 WSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 48.5 bits (115), Expect = 1e-06
 Identities = 33/87 (37%), Positives = 42/87 (48%), Gaps = 9/87 (10%)

Query: 158 IVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYG 217
           IV+ DLKP NILLD      + DLGLA  +         ET    +   G VGY+APE  
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLAVQI------PEGETVRGRV---GTVGYMAPEVI 173

Query: 218 MGSKASVSGDVYNFGILLLEMFTRRRP 244
              K + S D +  G L+ EM   + P
Sbjct: 174 NNEKYTFSPDWWGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 52/223 (23%), Positives = 88/223 (39%), Gaps = 42/223 (18%)

Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVN---LKQKEASRSFAAECNALRNIRH 86
            +F    ++GQGG   V+     ++  IVA+K +    L +    R    E + L   + 
Sbjct: 1   KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60

Query: 87  RNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQ----SNGQLRFLTQRVNIAID 142
             L+K++       F+  ++  +  EY+   +    L      S    RF         +
Sbjct: 61  EWLVKLL-----YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFY------MAE 109

Query: 143 VSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHV--GDLGLAKFLFGYEPGTAAETAS 200
           +  A++  H   +   +H DLKP N L+D     H+   D GL+K            T +
Sbjct: 110 MFEAVDALH---ELGYIHRDLKPENFLIDAS--GHIKLTDFGLSK---------GIVTYA 155

Query: 201 NSIEIKGIVG---YVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
           NS     +VG   Y+APE   G     + D ++ G +L E   
Sbjct: 156 NS-----VVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLC 193

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 48.6 bits (116), Expect = 2e-06
 Identities = 54/205 (26%), Positives = 98/205 (47%), Gaps = 32/205 (15%)

Query: 53  ESRSIVAVKVV--NLKQKEASRSFAAECNALRNI-RHRNLIKIITICSSIDFEGFDFKAI 109
              S VAVK++  +  +K+ S    +E   ++ I +H+N+I ++ +C+    EG  +  +
Sbjct: 40  NETSTVAVKMLKDDATEKDLS-DLVSEMEMMKMIGKHKNIINLLGVCTQ---EGPLY--V 93

Query: 110 VFEYMQNRNLEQWLRQSNGQLRF------------LTQR--VNIAIDVSFAIEYFHHHCQ 155
           V EY  + NL  +LR       +            LTQ+  V+ A  V+  +E+      
Sbjct: 94  VVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFL---AS 150

Query: 156 PSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPE 215
              +H DL   N+L+ +D V  + D GLA+ +  +      +T +  + +K    ++APE
Sbjct: 151 KKCIHRDLAARNVLVTEDHVMKIADFGLARDI--HHIDYYRKTTNGRLPVK----WMAPE 204

Query: 216 YGMGSKASVSGDVYNFGILLLEMFT 240
                  +   DV++FG+LL E+FT
Sbjct: 205 ALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 48.3 bits (115), Expect = 2e-06
 Identities = 33/107 (30%), Positives = 49/107 (45%), Gaps = 11/107 (10%)

Query: 140 AIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETA 199
           + ++S A+ + H   +  I++ DLK  N+LLD +    + D G+ K   G  PG    T 
Sbjct: 102 SAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE--GIRPGDTTSTF 156

Query: 200 SNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTD 246
                  G   Y+APE   G     S D +  G+L+ EM   R P D
Sbjct: 157 C------GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 48.4 bits (116), Expect = 2e-06
 Identities = 51/236 (21%), Positives = 94/236 (39%), Gaps = 38/236 (16%)

Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVN---LKQKEASRSFAAECNALRNIRH 86
           ++F     IG+G    V+     ++  + A+KV+    + ++       AE + L +   
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60

Query: 87  RNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFA 146
             ++K+    S   F+  +   +V EYM   +L   L +        T R  IA ++  A
Sbjct: 61  PWIVKLY--YS---FQDEEHLYLVMEYMPGGDLMNLLIRK-DVFPEETARFYIA-ELVLA 113

Query: 147 IEYFHHHCQPSIVHGDLKPSNILLDQDIVAHV--GDLGLAK--------FLFGYEPGTAA 196
           ++  H   +   +H D+KP NIL+D D   H+   D GL K          +  +     
Sbjct: 114 LDSVH---KLGFIHRDIKPDNILIDAD--GHIKLADFGLCKKMNKAKDREYYLNDSHNLL 168

Query: 197 ETASNSIEIK-------------GIVGYVAPEYGMGSKASVSGDVYNFGILLLEMF 239
              +  +  +             G   Y+APE   G+   +  D ++ G++L EM 
Sbjct: 169 FRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 48.2 bits (115), Expect = 2e-06
 Identities = 48/222 (21%), Positives = 91/222 (40%), Gaps = 34/222 (15%)

Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITI 95
            KIG+G   IV       +   VAVK ++L++++       E   +R+ +H N++++   
Sbjct: 25  VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEM--- 81

Query: 96  CSSIDFEGF---DFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHH 152
                +  +   D   +V E+++   L   +  +        Q   + + V  A+ + H 
Sbjct: 82  -----YSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE---QIATVCLAVLKALSFLHA 133

Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG-- 210
                ++H D+K  +ILL  D    + D G             A+ +      K +VG  
Sbjct: 134 Q---GVIHRDIKSDSILLTSDGRVKLSDFGF-----------CAQVSKEVPRRKSLVGTP 179

Query: 211 -YVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNE 251
            ++APE           D+++ GI+++EM     P    FNE
Sbjct: 180 YWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPP---YFNE 218

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 48.2 bits (114), Expect = 2e-06
 Identities = 48/211 (22%), Positives = 88/211 (41%), Gaps = 25/211 (11%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           KIGQG    VY  +   +   VA++ +NL+Q+        E   +R  ++ N++  +   
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD-- 84

Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQS---NGQLRFLTQRVNIAIDVSFAIEYFHHH 153
               +   D   +V EY+   +L   + ++    GQ+        +  +   A+E+ H +
Sbjct: 85  ---SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI------AAVCRECLQALEFLHSN 135

Query: 154 CQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVA 213
               ++H D+K  NILL  D    + D       FG+      E +  S  + G   ++A
Sbjct: 136 ---QVIHRDIKSDNILLGMDGSVKLTD-------FGFCAQITPEQSKRS-TMVGTPYWMA 184

Query: 214 PEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
           PE           D+++ GI+ +EM     P
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 48.1 bits (115), Expect = 3e-06
 Identities = 28/108 (25%), Positives = 45/108 (41%), Gaps = 11/108 (10%)

Query: 140 AIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETA 199
           A ++   +++ H      I++ DLK  N+LLD +    + D G+ K   G   G    T 
Sbjct: 102 AAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKE--GILGGVTTSTF 156

Query: 200 SNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDA 247
                  G   Y+APE         + D +  G+LL EM   + P + 
Sbjct: 157 C------GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEG 198

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 48.2 bits (115), Expect = 3e-06
 Identities = 60/233 (25%), Positives = 92/233 (39%), Gaps = 67/233 (28%)

Query: 31  NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIR----- 85
           N  P     QG V   Y  +  ++   VA+K       + SR F    +A R  R     
Sbjct: 20  NLKPIGSGAQGIVCAAYDTVTGQN---VAIK-------KLSRPFQNVTHAKRAYRELVLM 69

Query: 86  ----HRNLIKIITICS-SIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIA 140
               H+N+I ++ + +     E F    +V E M                  L Q + + 
Sbjct: 70  KLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDAN---------------LCQVIQMD 114

Query: 141 ID---VSF-------AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGY 190
           +D   +S+        I++ H      I+H DLKPSNI++  D    + D GLA+     
Sbjct: 115 LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR----- 166

Query: 191 EPGTAAETASNSIEIKGIV---GYVAPE--YGMGSKASVSGDVYNFGILLLEM 238
                  TA  S  +   V    Y APE   GMG K +V  D+++ G ++ EM
Sbjct: 167 -------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENV--DIWSVGCIMGEM 210

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 47.8 bits (113), Expect = 3e-06
 Identities = 52/211 (24%), Positives = 88/211 (41%), Gaps = 25/211 (11%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           KIGQG    VY  I   +   VA+K +NL+Q+        E   +R  ++ N++  +   
Sbjct: 26  KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLD-- 83

Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQS---NGQLRFLTQRVNIAIDVSFAIEYFHHH 153
               +   D   +V EY+   +L   + ++    GQ+  + +    A+D       F H 
Sbjct: 84  ---SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALD-------FLHS 133

Query: 154 CQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVA 213
            Q  ++H D+K  NILL  D    + D       FG+      E +  S  + G   ++A
Sbjct: 134 NQ--VIHRDIKSDNILLGMDGSVKLTD-------FGFCAQITPEQSKRSTMV-GTPYWMA 183

Query: 214 PEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
           PE           D+++ GI+ +EM     P
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 47.7 bits (113), Expect = 3e-06
 Identities = 55/218 (25%), Positives = 90/218 (41%), Gaps = 44/218 (20%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKII--- 93
           ++G G    VYK    E+ ++ A KV+  K +E    +  E   L    H  ++K++   
Sbjct: 19  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78

Query: 94  ----TICSSIDF-EGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIE 148
                +   I+F  G    AI+ E      L++ L +   Q+        I   +  A++
Sbjct: 79  YWDGKLWIMIEFCPGGAVDAIMLE------LDRGLTEPQIQV--------ICRQMLEALQ 124

Query: 149 YFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGI 208
           Y H      I+H DLK  N+LL  D     GD+ LA F      G +A+           
Sbjct: 125 YLH---SMKIIHRDLKAGNVLLTLD-----GDIKLADF------GVSAKNVKTLQRRDSF 170

Query: 209 VG---YVAPEYGM-----GSKASVSGDVYNFGILLLEM 238
           +G   ++APE  M      +      D+++ GI L+EM
Sbjct: 171 IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 47.5 bits (113), Expect = 4e-06
 Identities = 35/103 (33%), Positives = 49/103 (47%), Gaps = 11/103 (10%)

Query: 142 DVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASN 201
           ++S A+E+ H      I++ DLKP NILLD      + D GL K       GT   T   
Sbjct: 108 EISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCK--ESIHEGTVTHTFCG 162

Query: 202 SIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
           +IE      Y+APE  M S    + D ++ G L+ +M T   P
Sbjct: 163 TIE------YMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 47.4 bits (113), Expect = 5e-06
 Identities = 30/105 (28%), Positives = 48/105 (45%), Gaps = 11/105 (10%)

Query: 140 AIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETA 199
           A  V   ++Y H +    IV+ DLK  N+LLD +    + D GL K   G+   T+  T 
Sbjct: 107 AACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTS--TF 161

Query: 200 SNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
             + E      ++APE    +  + + D +  G+L+ EM     P
Sbjct: 162 CGTPE------FLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 47.1 bits (112), Expect = 5e-06
 Identities = 32/108 (29%), Positives = 49/108 (45%), Gaps = 11/108 (10%)

Query: 140 AIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETA 199
           A +V+ A+ + H H    +++ DLK  NILLD +    + D G+ K   G   G    T 
Sbjct: 102 AAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTF 156

Query: 200 SNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDA 247
                  G   Y+APE     +   S D +  G+L+ EM   + P +A
Sbjct: 157 C------GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEA 198

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 47.0 bits (111), Expect = 6e-06
 Identities = 58/221 (26%), Positives = 96/221 (43%), Gaps = 35/221 (15%)

Query: 38  IGQGGVSIVYKGIL--DESRSIVAVKVVNLKQKEAS-RSFAAECNALRNI-RHRNLIKII 93
           IG+G    V K  +  D  R   A+K +     +   R FA E   L  +  H N+I ++
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 94  TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQS------------NGQLRFLTQR--VNI 139
             C      G+ + AI  EY  + NL  +LR+S            N     L+ +  ++ 
Sbjct: 63  GACEH---RGYLYLAI--EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 117

Query: 140 AIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETA 199
           A DV+  ++Y     Q   +H DL   NIL+ ++ VA + D GL++    Y   T     
Sbjct: 118 AADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 174

Query: 200 SNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
                    V ++A E    S  + + DV+++G+LL E+ +
Sbjct: 175 ---------VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 47.0 bits (111), Expect = 6e-06
 Identities = 48/210 (22%), Positives = 97/210 (46%), Gaps = 25/210 (11%)

Query: 38  IGQGGVSIVYKGI-LDESRSI---VAVKVVN-LKQKEASRSFAAECNALRNIRHRNLIKI 92
           +G G    VYKGI + E  ++   VA+K++N     +A+  F  E   + ++ H +L+++
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74

Query: 93  ITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQL--RFLTQRVNIAIDVSFAIEYF 150
           + +C S   +      +V + M +  L  ++ +    +  + L   +N  + ++  + Y 
Sbjct: 75  LGVCLSPTIQ------LVTQLMPHGCLLDYVHEHKDNIGSQLL---LNWCVQIAKGMMYL 125

Query: 151 HHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG 210
               +  +VH DL   N+L+       + D GLA+ L G E    A+     I+      
Sbjct: 126 E---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK------ 176

Query: 211 YVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
           ++A E     K +   DV+++G+ + E+ T
Sbjct: 177 WMALECIHYRKFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 46.6 bits (111), Expect = 6e-06
 Identities = 35/112 (31%), Positives = 58/112 (51%), Gaps = 15/112 (13%)

Query: 139 IAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAET 198
           IA+ +  A+EY H   + S++H D+KPSN+L++++    + D G++    GY   + A+T
Sbjct: 108 IAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGIS----GYLVDSVAKT 161

Query: 199 ASNSIEIKGIVGYVAPEY----GMGSKASVSGDVYNFGILLLEMFTRRRPTD 246
                   G   Y+APE            V  DV++ GI ++E+ T R P D
Sbjct: 162 ID-----AGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD 208

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 47.0 bits (112), Expect = 6e-06
 Identities = 30/92 (32%), Positives = 45/92 (48%), Gaps = 13/92 (14%)

Query: 157 SIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEY 216
            ++H D+KPSNILLD      + D G++  L      + A+T S      G   Y+APE 
Sbjct: 135 GVIHRDVKPSNILLDASGNVKLCDFGISGRLV----DSKAKTRS-----AGCAAYMAPER 185

Query: 217 ----GMGSKASVSGDVYNFGILLLEMFTRRRP 244
                   K  +  DV++ GI L+E+ T + P
Sbjct: 186 IDPPDPNPKYDIRADVWSLGISLVELATGQFP 217

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 46.5 bits (110), Expect = 7e-06
 Identities = 41/151 (27%), Positives = 59/151 (39%), Gaps = 20/151 (13%)

Query: 126 SNGQLRFLTQRV-NIAIDVSFAIEY--------FHHHCQPSIVHGDLKPSNILLDQDIVA 176
           + G L++    V    +++   I Y         H H    IV+ D+KP N+LLD     
Sbjct: 76  NGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH-SMDIVYRDMKPENVLLDDQGNC 134

Query: 177 HVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLL 236
            + DLGLA  L   +  T         +  G  GY+APE       S   D +  G  + 
Sbjct: 135 RLSDLGLAVELKDGKTIT---------QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIY 185

Query: 237 EMFTRRRPTDAMFNEGLTLHEFVKMALPDKV 267
           EM   R P      E +   E  +  L D+V
Sbjct: 186 EMVAGRTPFKD-HKEKVAKEELKRRTLEDEV 215

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 46.6 bits (111), Expect = 7e-06
 Identities = 45/214 (21%), Positives = 90/214 (42%), Gaps = 42/214 (19%)

Query: 58  VAVKVVNLK---QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYM 114
           VAVKV  L+      A   F  E   L  +   N+ +++ +C+           ++ EYM
Sbjct: 49  VAVKV--LRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPP-----LCMIMEYM 101

Query: 115 QNRNLEQWLRQ-------SNGQLRFLTQR--VNIAIDVSFAIEYFHHHCQPSIVHGDLKP 165
           +N +L Q+L++            + L+    + +A  ++  + Y       + VH DL  
Sbjct: 102 ENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLAT 158

Query: 166 SNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAP------EYGMG 219
            N L+ ++    + D G+++ L+          +S+   ++G      P      E  + 
Sbjct: 159 RNCLVGKNYTIKIADFGMSRNLY----------SSDYYRVQGRA--PLPIRWMAWESVLL 206

Query: 220 SKASVSGDVYNFGILLLEMFT--RRRPTDAMFNE 251
            K +   DV+ FG+ L E+ T  R +P + + ++
Sbjct: 207 GKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 46.5 bits (110), Expect = 8e-06
 Identities = 56/207 (27%), Positives = 82/207 (39%), Gaps = 24/207 (11%)

Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVN----LKQKEASRSFAAECNALRNIRHRNLIKII 93
           IG+G    V            AVKV+     LK+KE     +     L+N++H  L+ + 
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL- 61

Query: 94  TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNI-AIDVSFAIEYFHH 152
                  F+  D    V +Y+    L   L++      FL  R    A +++ A+ Y H 
Sbjct: 62  ----HFSFQTADKLYFVLDYINGGELFYHLQRERC---FLEPRARFYAAEIASALGYLH- 113

Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
               +IV+ DLKP NILLD      + D GL K     E      T   + E      Y+
Sbjct: 114 --SLNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPE------YL 163

Query: 213 APEYGMGSKASVSGDVYNFGILLLEMF 239
           APE         + D +  G +L EM 
Sbjct: 164 APEVLHKQPYDRTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 46.1 bits (109), Expect = 1e-05
 Identities = 49/208 (23%), Positives = 87/208 (41%), Gaps = 31/208 (14%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIIT-- 94
           KIGQG    VY  I   +   VA+K +NL+Q+        E   +R  +H N++  +   
Sbjct: 26  KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85

Query: 95  -ICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQS---NGQLRFLTQRVNIAIDVSFAIEYF 150
            +   +         +V EY+   +L   + ++    GQ+        +  +   A+E+ 
Sbjct: 86  LVGDEL--------WVVMEYLAGGSLTDVVTETCMDEGQI------AAVCRECLQALEFL 131

Query: 151 HHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG 210
           H +    ++H D+K  NILL  D    + D       FG+      E +  S  + G   
Sbjct: 132 HSN---QVIHRDIKSDNILLGMDGSVKLTD-------FGFCAQITPEQSKRSTMV-GTPY 180

Query: 211 YVAPEYGMGSKASVSGDVYNFGILLLEM 238
           ++APE           D+++ GI+ +EM
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEM 208

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 46.2 bits (109), Expect = 1e-05
 Identities = 59/213 (27%), Positives = 94/213 (44%), Gaps = 38/213 (17%)

Query: 38  IGQGGVSIVYKGILDESRSI-VAVKVVN---LKQKEASRSFAAECNALRNIRHRNLIKII 93
           IG G   IV     D    I VAVK ++     Q  A R++  E   L+ + H+N+I ++
Sbjct: 29  IGSGAQGIVCAA-FDTVLGINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLL 86

Query: 94  TICS-SIDFEGFDFKAIVFEYMQNRNLEQWLRQS--NGQLRFLTQRVNIAIDVSFAIEYF 150
            + +     E F    +V E M + NL Q +     + ++ +L  ++   I         
Sbjct: 87  NVFTPQKSLEEFQDVYLVMELM-DANLCQVIHMELDHERMSYLLYQMLCGI--------- 136

Query: 151 HHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV- 209
            H     I+H DLKPSNI++  D    + D GLA+            TA  +  +   V 
Sbjct: 137 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR------------TACTNFMMTPYVV 184

Query: 210 --GYVAPE--YGMGSKASVSGDVYNFGILLLEM 238
              Y APE   GMG K +V  D+++ G ++ E+
Sbjct: 185 TRYYRAPEVILGMGYKENV--DIWSVGCIMGEL 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 46.1 bits (110), Expect = 1e-05
 Identities = 51/224 (22%), Positives = 91/224 (40%), Gaps = 52/224 (23%)

Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNA---------LRNIRHRN 88
           +G G    V      ++   VA+K       + SR F +  +A         L+++ H N
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIK-------KLSRPFQSAIHAKRTYRELRLLKHMDHEN 75

Query: 89  LIKIITI-CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQ---SNGQLRFLTQRVNIAIDVS 144
           +I ++ +   +   E F    +V   M   +L   ++    S+  ++FL         + 
Sbjct: 76  VIGLLDVFTPASSLEDFQDVYLVTHLMG-ADLNNIVKCQKLSDDHIQFL------VYQIL 128

Query: 145 FAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIE 204
             ++Y H      I+H DLKPSNI +++D    + D GLA+                  E
Sbjct: 129 RGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLAR--------------HTDDE 171

Query: 205 IKGIVG---YVAPE---YGMGSKASVSGDVYNFGILLLEMFTRR 242
           + G V    Y APE     M    +V  D+++ G ++ E+ T +
Sbjct: 172 MTGYVATRWYRAPEIMLNWMHYNQTV--DIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 46.1 bits (109), Expect = 1e-05
 Identities = 29/88 (32%), Positives = 45/88 (51%), Gaps = 10/88 (11%)

Query: 158 IVHGDLKPSNILLDQDIVAHVGDLGLAK-FLFGYEPGTAAETASNSIEIKGIVGYVAPEY 216
           I++ DLK  N++LD+D    + D G+ K  +FG          + +    G   Y+APE 
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG---------DNRASTFCGTPDYIAPEI 167

Query: 217 GMGSKASVSGDVYNFGILLLEMFTRRRP 244
             G K + S D ++FG+LL EM   + P
Sbjct: 168 LQGLKYTFSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 45.7 bits (109), Expect = 1e-05
 Identities = 54/259 (20%), Positives = 94/259 (36%), Gaps = 65/259 (25%)

Query: 25  LSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNI 84
           L   T  F     IG+G    VYK    ++  +VA+K++++  ++       E N LR  
Sbjct: 1   LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKY 59

Query: 85  -RHRNLIKIITICSSIDFEGFDFKA----------IVFEYMQN---RNLEQWLRQSNGQL 130
             H N+           F G   K           +V E        +L + LR+   +L
Sbjct: 60  SNHPNIA---------TFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRL 110

Query: 131 R------FLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA 184
           +       L + +         + Y H +    ++H D+K  NILL ++      ++ L 
Sbjct: 111 KEEWIAYILRETLR-------GLAYLHEN---KVIHRDIKGQNILLTKN-----AEVKLV 155

Query: 185 KFLFGYEPGTAAETASNSIEIKGIVG---YVAPE-----YGMGSKASVSGDVYNFGILLL 236
            F      G +A+  S        +G   ++APE         +      DV++ GI  +
Sbjct: 156 DF------GVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAI 209

Query: 237 EM------FTRRRPTDAMF 249
           E+           P  A+F
Sbjct: 210 ELADGKPPLCDMHPMRALF 228

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 45.4 bits (107), Expect = 1e-05
 Identities = 50/219 (22%), Positives = 90/219 (41%), Gaps = 18/219 (8%)

Query: 31  NFSPANKIGQGGVSIVYKGILDESRSIVAVKVV--NLKQKEASRSFAA-EC--NALRNIR 85
           N+     +GQG    VY     ++   +AVK V  + +  E S+   A EC    L+N+ 
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62

Query: 86  HRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSF 145
           H  +++                +I  E+M   +++  L+        +T++    I    
Sbjct: 63  HERIVQYYGCLRDPMERTL---SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQI---- 115

Query: 146 AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEI 205
            +E   +     IVH D+K +NIL D      +GD G +K L      T   + +    +
Sbjct: 116 -LEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRL-----QTICLSGTGMKSV 169

Query: 206 KGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
            G   +++PE   G       D+++ G  ++EM T + P
Sbjct: 170 TGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 40/178 (22%), Positives = 67/178 (37%), Gaps = 51/178 (28%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEA--------SRSFAAECNALRNIRHRN 88
            IG+G    VYK      +     K   +K+ +         S+S   E   LR ++H N
Sbjct: 7   CIGRGTYGRVYKAKRKNGKD---GKEYAIKKFKGDKEQYTGISQSACREIALLRELKHEN 63

Query: 89  LIKIITICSS---------IDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQL-------RF 132
           ++ ++ +             D+   D   I+          ++ RQ+             
Sbjct: 64  VVSLVEVFLEHADKSVYLLFDYAEHDLWQII----------KFHRQAKRVSIPPSMVKSL 113

Query: 133 LTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILL----DQDIVAHVGDLGLAKF 186
           L Q +N        + Y H      ++H DLKP+NIL+     +  V  +GDLGLA+ 
Sbjct: 114 LWQILN-------GVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARL 161

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 45.3 bits (107), Expect = 2e-05
 Identities = 35/157 (22%), Positives = 67/157 (42%), Gaps = 20/157 (12%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEA---SRSFAAECNALRNIRHRNLIKII 93
           +IG G    V  G ++   +   V V  L+   +      F  E    R+++H NL++ +
Sbjct: 2   EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61

Query: 94  TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNG------QLRFLTQRVNIAIDVSFAI 147
             C+    E   +  +V E+    +L+ +LR              L +   +A +++  +
Sbjct: 62  GQCT----EVTPY-LLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQR---MACEIALGL 113

Query: 148 EYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA 184
            + H +   + +H DL   N LL  D+   +GD GL+
Sbjct: 114 LHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLS 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 45.2 bits (107), Expect = 2e-05
 Identities = 51/205 (24%), Positives = 76/205 (37%), Gaps = 46/205 (22%)

Query: 52  DESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKII-------TICSSIDFEGF 104
           DE R  V VK V        ++   E + L+ I HR +I +I       T+C  +     
Sbjct: 116 DEQRKKVIVKAVT-----GGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC 170

Query: 105 DFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLK 164
           D    V +      LEQ +      L               A+ Y H      I+H D+K
Sbjct: 171 DLFTYV-DRSGPLPLEQAITIQRRLLE--------------ALAYLH---GRGIIHRDVK 212

Query: 165 PSNILLDQDIVAHVGDLGLAKFL--FGYEP---GTAAETASNSIEIKGIVGYVAPEYGMG 219
             NI LD+   A +GD G A  L      P   G +    +NS E+  +  Y A      
Sbjct: 213 TENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCA------ 266

Query: 220 SKASVSGDVYNFGILLLEMFTRRRP 244
                  D+++ G++L EM  +   
Sbjct: 267 -----KTDIWSAGLVLFEMSVKNVT 286

Length = 392

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 44.7 bits (106), Expect = 3e-05
 Identities = 70/276 (25%), Positives = 116/276 (42%), Gaps = 54/276 (19%)

Query: 38  IGQGGVSIVYKGILDESRSIVAVKVV--NLKQKEASRSFAAECNALRNIRHRNLIKIITI 95
           IG+G    V K +   S +I+AVK +   + +KE  R    + + +  +R  +   I+  
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKR-LLMDLDVV--MRSSDCPYIVKF 68

Query: 96  CSSIDFEG------------FD-FKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAID 142
             ++  EG             D F   V+E +++   E+ L +             IA+ 
Sbjct: 69  YGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGK-------------IAVA 115

Query: 143 VSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF-LFGYEPGTAAETASN 201
              A+ Y     +  I+H D+KPSNILLD++     G++ L  F + G    + A+T   
Sbjct: 116 TVKALNYLKEELK--IIHRDVKPSNILLDRN-----GNIKLCDFGISGQLVDSIAKTRD- 167

Query: 202 SIEIKGIVGYVAPEYGMGSKAS---VSGDVYNFGILLLEMFTRRRPTDAMFNEGL-TLHE 257
                G   Y+APE    S      V  DV++ GI L E+ T + P    +N     L +
Sbjct: 168 ----AGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPK-WNSVFDQLTQ 222

Query: 258 FVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVA 293
            VK   P     I+  S   E + +  ++I  CL+ 
Sbjct: 223 VVKGDPP-----ILSNSEEREFSPSFVNFINLCLIK 253

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 44.9 bits (106), Expect = 3e-05
 Identities = 49/229 (21%), Positives = 96/229 (41%), Gaps = 45/229 (19%)

Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEAS------RSFAAECNALRNIRHRNLIK 91
           +G G  S  Y+    ++ +++AVK V   +  +S       +   E   +  + H ++I+
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 92  II-TICSSIDFEGFDFKAIVFEYMQNRNLEQWLR-----QSNGQLRFLTQRVNIAIDVSF 145
           ++   C    F  F       E+M   ++   L      +    + +  Q       +  
Sbjct: 68  MLGATCEDSHFNLF------VEWMAGGSVSHLLSKYGAFKEAVIINYTEQ-------LLR 114

Query: 146 AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSI-- 203
            + Y H +    I+H D+K +N+L+D    +    L +A F      G AA  A+     
Sbjct: 115 GLSYLHEN---QIIHRDVKGANLLID----STGQRLRIADF------GAAARLAAKGTGA 161

Query: 204 -----EIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDA 247
                ++ G + ++APE   G +   S DV++ G +++EM T + P +A
Sbjct: 162 GEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNA 210

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 44.5 bits (105), Expect = 3e-05
 Identities = 41/198 (20%), Positives = 90/198 (45%), Gaps = 32/198 (16%)

Query: 57  IVAVKVVNLK-QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQ 115
           +VAVK++     K A   F  E   +  ++  N+I+++ +C + D        ++ EYM+
Sbjct: 48  LVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDP-----LCMITEYME 102

Query: 116 NRNLEQWL---------RQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPS 166
           N +L Q+L          +++      +  + +A  ++  ++Y       + VH DL   
Sbjct: 103 NGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATR 159

Query: 167 NILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKG----IVGYVAPEYGMGSKA 222
           N L+ ++    + D G+++ L+          + +   I+G     + +++ E  +  K 
Sbjct: 160 NCLVGKNYTIKIADFGMSRNLY----------SGDYYRIQGRAVLPIRWMSWESILLGKF 209

Query: 223 SVSGDVYNFGILLLEMFT 240
           + + DV+ FG+ L E+ T
Sbjct: 210 TTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 44.8 bits (106), Expect = 3e-05
 Identities = 28/97 (28%), Positives = 40/97 (41%), Gaps = 14/97 (14%)

Query: 142 DVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASN 201
           ++  A EY H      I++ DLKP N+LLD      V D G AK           +    
Sbjct: 126 ELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----------KVPDR 171

Query: 202 SIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEM 238
           +  + G   Y+APE         + D +  G+LL E 
Sbjct: 172 TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEF 208

Length = 329

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 44.2 bits (104), Expect = 4e-05
 Identities = 49/207 (23%), Positives = 91/207 (43%), Gaps = 18/207 (8%)

Query: 37  KIGQGGVSIVYKGILD-ESRSI-VAVKVVNLKQKEASR-SFAAECNALRNIRHRNLIKII 93
           ++G G    V KG+     + I VA+KV+  + +++ R     E   +  + +  ++++I
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 94  TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHH 153
            +C +          +V E      L ++L     ++  ++  V +   VS  ++Y    
Sbjct: 62  GVCEAEAL------MLVMEMASGGPLNKFLSGKKDEIT-VSNVVELMHQVSMGMKYLE-- 112

Query: 154 CQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVA 213
              + VH DL   N+LL     A + D GL+K L   +    A +A      K  + + A
Sbjct: 113 -GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG-----KWPLKWYA 166

Query: 214 PEYGMGSKASVSGDVYNFGILLLEMFT 240
           PE     K S   DV+++GI + E F+
Sbjct: 167 PECINFRKFSSRSDVWSYGITMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 44.2 bits (104), Expect = 5e-05
 Identities = 35/139 (25%), Positives = 62/139 (44%), Gaps = 16/139 (11%)

Query: 109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-DVSFAIEYFHHHCQPSIVHGDLKPSN 167
           ++ +Y+    L   L Q   + RF  Q V I   ++  A+E+ H   +  I++ D+K  N
Sbjct: 82  LILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLEN 135

Query: 168 ILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKA--SVS 225
           ILLD +    + D GL+K           +    +    G + Y+AP+   G       +
Sbjct: 136 ILLDSNGHVVLTDFGLSKEFH-------EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKA 188

Query: 226 GDVYNFGILLLEMFTRRRP 244
            D ++ G+L+ E+ T   P
Sbjct: 189 VDWWSMGVLMYELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 44.1 bits (104), Expect = 5e-05
 Identities = 44/196 (22%), Positives = 79/196 (40%), Gaps = 35/196 (17%)

Query: 53  ESRSIVAVK-------VVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGF- 104
           E R  VA K       V+ + QK  +     E   L+N+ H ++I++     S       
Sbjct: 79  EGRVFVATKPGQPDPVVLKIGQKGTT---LIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135

Query: 105 --DFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGD 162
              + + ++ Y+  R+    + Q+      + ++      +   + Y H      I+H D
Sbjct: 136 LPHYSSDLYTYLTKRSRPLPIDQA-----LIIEK-----QILEGLRYLHAQ---RIIHRD 182

Query: 163 LKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKA 222
           +K  NI ++      +GDLG A+F            A   + + G V   APE     K 
Sbjct: 183 VKTENIFINDVDQVCIGDLGAAQF---------PVVAPAFLGLAGTVETNAPEVLARDKY 233

Query: 223 SVSGDVYNFGILLLEM 238
           +   D+++ GI+L EM
Sbjct: 234 NSKADIWSAGIVLFEM 249

Length = 357

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 43.3 bits (102), Expect = 8e-05
 Identities = 56/227 (24%), Positives = 97/227 (42%), Gaps = 45/227 (19%)

Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEAS-RSFAAECNALRNIRHRNLIKIIT 94
           +++G+G    VYK +   +   +A+K + L+  E+       E + L    H+ +   I 
Sbjct: 7   DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDIL----HKAVSPYI- 61

Query: 95  ICSSIDFEG-FDFKAIVF---EYMQNRNLEQ-------WLRQSNGQLRFLTQRVNIAIDV 143
               +DF G F  +  V+   EYM   +L++               LR +T  V     +
Sbjct: 62  ----VDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAV--VKGL 115

Query: 144 SFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSI 203
            F  E      + +I+H D+KP+N+L++ +    + D G++  L        A  A  +I
Sbjct: 116 KFLKE------EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNL-------VASLAKTNI 162

Query: 204 EIKGIVGYVAPEY----GMGSKA--SVSGDVYNFGILLLEMFTRRRP 244
              G   Y+APE     G       +V  DV++ G+ +LEM   R P
Sbjct: 163 ---GCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 43.2 bits (102), Expect = 9e-05
 Identities = 33/136 (24%), Positives = 61/136 (44%), Gaps = 17/136 (12%)

Query: 109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNI 168
           ++ EY    +L  +LR+       L   ++ +  V+  + +       + +H DL   N+
Sbjct: 116 VITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNV 172

Query: 169 LLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKG----IVGYVAPEYGMGSKASV 224
           LL    +  + D GLA+ +            SN + +KG     V ++APE       + 
Sbjct: 173 LLTHGKIVKICDFGLARDIM---------NDSNYV-VKGNARLPVKWMAPESIFNCVYTF 222

Query: 225 SGDVYNFGILLLEMFT 240
             DV+++GILL E+F+
Sbjct: 223 ESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 43.2 bits (102), Expect = 9e-05
 Identities = 59/225 (26%), Positives = 98/225 (43%), Gaps = 43/225 (19%)

Query: 37  KIGQGGVSIV----YKGILDESRSIVAVK-VVNLKQKE--ASRSFAAECNALRNIR-HRN 88
           ++GQG   IV         +E    VA+K + N+  K+  A R+   E   LR+ R H+N
Sbjct: 7   ELGQGAYGIVCSARNAETSEEET--VAIKKITNVFSKKILAKRALR-ELKLLRHFRGHKN 63

Query: 89  LIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSF--- 145
           +  +  +   +    F+   +  E M+  +L Q +R          Q +  A   SF   
Sbjct: 64  ITCLYDM-DIVFPGNFNELYLYEELMEA-DLHQIIRSG--------QPLTDAHFQSFIYQ 113

Query: 146 ---AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNS 202
               ++Y H     +++H DLKP N+L++ D    + D GLA+   G+          N+
Sbjct: 114 ILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLAR---GFSEN----PGENA 163

Query: 203 IEIKGIVG---YVAPEYGMGSKASVSG--DVYNFGILLLEMFTRR 242
             +   V    Y APE  M S  S +   DV++ G +L E+  R+
Sbjct: 164 GFMTEYVATRWYRAPEI-MLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 43.1 bits (101), Expect = 9e-05
 Identities = 65/318 (20%), Positives = 132/318 (41%), Gaps = 58/318 (18%)

Query: 24  ELSKATNNFSPANKIGQGGVSIVYKGIL-----DESRSIVAVKVVNLKQKEASRS-FAAE 77
           E++ +T  F    ++G+     VYKG L      E    VA+K +  K +   R  F  E
Sbjct: 1   EINLSTVRF--MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58

Query: 78  CNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWL--RQSNGQLRFLTQ 135
                 ++H N++ ++ + +          +++F Y  + +L ++L  R  +  +     
Sbjct: 59  AMMRSRLQHPNIVCLLGVVTKEQP-----LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDD 113

Query: 136 R------------VNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGL 183
                        V+I   ++  +E+   H    +VH DL   N+L+   +   + DLGL
Sbjct: 114 DKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGL 170

Query: 184 AKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTR-R 242
            + ++  +     +   NS+     + +++PE  M  K S+  D++++G++L E+F+   
Sbjct: 171 FREVYAAD---YYKLMGNSLLP---IRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGL 224

Query: 243 RPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCS 302
           +P     N+     + ++M    +V+   D                DC   V    + C 
Sbjct: 225 QPYCGYSNQ-----DVIEMIRNRQVLPCPD----------------DCPAWVYTLMLECW 263

Query: 303 MESPMERMEMRDVVAKLR 320
            E P  R   +D+ ++LR
Sbjct: 264 NEFPSRRPRFKDIHSRLR 281

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 43.3 bits (102), Expect = 1e-04
 Identities = 54/228 (23%), Positives = 89/228 (39%), Gaps = 53/228 (23%)

Query: 29  TNNFSPANKIGQGGVSIVYKGILDESRSIVAVK--VVNLKQKEASRSFAAECNALRNIRH 86
           TN +     +G G   +V       +   VA+K  +        ++    E   L+++RH
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68

Query: 87  RNLIKIITICSS--------IDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVN 138
            N+I +  I  S         +  G D   +    + +R LE+   Q      FL Q   
Sbjct: 69  ENIISLSDIFISPLEDIYFVTELLGTDLHRL----LTSRPLEKQFIQY-----FLYQ--- 116

Query: 139 IAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAET 198
               +   ++Y H      +VH DLKPSNIL++++    + D GLA+             
Sbjct: 117 ----ILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLAR------------- 156

Query: 199 ASNSIEIKGIVGYV------APEYGMG-SKASVSGDVYNFGILLLEMF 239
               I+   + GYV      APE  +   K  V  D+++ G +  EM 
Sbjct: 157 ----IQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEML 200

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 43.0 bits (101), Expect = 1e-04
 Identities = 50/226 (22%), Positives = 102/226 (45%), Gaps = 33/226 (14%)

Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNL---KQKEASRSFAA---ECNALRNIRHRNL 89
             +G+G    VY G+ ++ + ++AVK V L       A + +     E + L++++H N+
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQ-LIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64

Query: 90  IKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEY 149
           ++ +  C   +       +I  E++   ++   L +       +  +    I    A  Y
Sbjct: 65  VQYLGTCLDDNT-----ISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVA--Y 117

Query: 150 FHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
            H++C   +VH D+K +N++L  + +  + D G A+ L            ++S  +K + 
Sbjct: 118 LHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRL-----AWVGLHGTHSNMLKSMH 169

Query: 210 G---YVAPEY----GMGSKASVSGDVYNFGILLLEMFTRRRPTDAM 248
           G   ++APE     G G K+    D+++ G  + EM T + P  +M
Sbjct: 170 GTPYWMAPEVINESGYGRKS----DIWSIGCTVFEMATGKPPLASM 211

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 42.9 bits (101), Expect = 1e-04
 Identities = 38/141 (26%), Positives = 60/141 (42%), Gaps = 20/141 (14%)

Query: 109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-DVSFAIEYFHHHCQPSIVHGDLKPSN 167
           ++ +Y+    L   L Q      F    V + I ++  A+++ H   Q  I++ D+K  N
Sbjct: 82  LILDYVNGGELFTHLYQRE---HFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLEN 135

Query: 168 ILLDQDIVAHV--GDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVS 225
           ILLD +   HV   D GL+K          AE    +    G + Y+APE   G      
Sbjct: 136 ILLDSE--GHVVLTDFGLSKEF-------LAEEEERAYSFCGTIEYMAPEVIRGGSGGHD 186

Query: 226 G--DVYNFGILLLEMFTRRRP 244
              D ++ G+L  E+ T   P
Sbjct: 187 KAVDWWSLGVLTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 43.1 bits (101), Expect = 1e-04
 Identities = 51/231 (22%), Positives = 102/231 (44%), Gaps = 41/231 (17%)

Query: 24  ELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK-----EASRSFAAEC 78
           E+ +   N SP      G V   +     ++++ + V V  L +       A R++  E 
Sbjct: 14  EVPERYQNLSPVGSGAYGSVCAAF-----DTKTGLRVAVKKLSRPFQSIIHAKRTYR-EL 67

Query: 79  NALRNIRHRNLIKIITICS-SIDFEGFDFKAIVFEYMQN--RNLEQWLRQSNGQLRFLTQ 135
             L++++H N+I ++ + + +   E F+   +V   M     N+ +  + ++  ++FL  
Sbjct: 68  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 127

Query: 136 RVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTA 195
           ++         ++Y H      I+H DLKPSN+ +++D    + D GLA+          
Sbjct: 128 QI------LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---------- 168

Query: 196 AETASNSIEIKGIVG---YVAPEYGMG-SKASVSGDVYNFGILLLEMFTRR 242
             T     E+ G V    Y APE  +     + + D+++ G ++ E+ T R
Sbjct: 169 -HTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 43.3 bits (102), Expect = 1e-04
 Identities = 28/86 (32%), Positives = 44/86 (51%), Gaps = 14/86 (16%)

Query: 159 VHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKG----IVGYVAP 214
           +H D+   N+LL    VA + D GLA+ +            SN + +KG     V ++AP
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLARDI---------MNDSNYV-VKGNARLPVKWMAP 283

Query: 215 EYGMGSKASVSGDVYNFGILLLEMFT 240
           E       +V  DV+++GILL E+F+
Sbjct: 284 ESIFDCVYTVQSDVWSYGILLWEIFS 309

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 42.7 bits (100), Expect = 1e-04
 Identities = 58/232 (25%), Positives = 96/232 (41%), Gaps = 45/232 (19%)

Query: 32  FSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFA---AECNALRNIRHRN 88
           F   ++IG G    VY      +  +VAVK ++   K+ +  +     E   L+ ++H N
Sbjct: 23  FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82

Query: 89  LIKIITICSSIDFEGFDFKA----IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVS 144
                    +I+++G   K     +V EY    +    L      L    Q V IA    
Sbjct: 83  ---------TIEYKGCYLKEHTAWLVMEYCLG-SASDLLEVHKKPL----QEVEIAAITH 128

Query: 145 FAIE---YFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASN 201
            A++   Y H H    ++H D+K  NILL +      G + LA F        +A  +S 
Sbjct: 129 GALQGLAYLHSHN---MIHRDIKAGNILLTEP-----GQVKLADF-------GSASKSSP 173

Query: 202 SIEIKGIVGYVAPEYGMG-SKASVSG--DVYNFGILLLEMFTRRRPTDAMFN 250
           +    G   ++APE  +   +    G  DV++ GI  +E+  R+ P   +FN
Sbjct: 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP---LFN 222

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 42.6 bits (100), Expect = 1e-04
 Identities = 53/215 (24%), Positives = 97/215 (45%), Gaps = 39/215 (18%)

Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLK-QKE--ASRSFAAECNALRNIRHRNLIKIIT 94
           +G G    V   I   +   VA+K ++   Q E  A R++  E   L++++H N+I ++ 
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR-ELTLLKHMQHENVIGLLD 81

Query: 95  I-CSSIDFEGFDFKAIVFEYMQNRNLEQ--WLRQSNGQLRFLTQRVNIAIDVSFAIEYFH 151
           +  S++  + F    +V  YMQ  +L++      S  ++++L  ++         ++Y H
Sbjct: 82  VFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHPLSEDKVQYLVYQM------LCGLKYIH 134

Query: 152 HHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV-- 209
                 I+H DLKP N+ +++D    + D GLA+                  E+ G V  
Sbjct: 135 ---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR--------------HADAEMTGYVVT 177

Query: 210 -GYVAPEY---GMGSKASVSGDVYNFGILLLEMFT 240
             Y APE     M    +V  D+++ G ++ EM T
Sbjct: 178 RWYRAPEVILNWMHYNQTV--DIWSVGCIMAEMLT 210

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 42.4 bits (99), Expect = 2e-04
 Identities = 49/191 (25%), Positives = 77/191 (40%), Gaps = 33/191 (17%)

Query: 61  KVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLE 120
           K V + + E + +   E   L+N RH  L  +        F+  D    V EY+    L 
Sbjct: 30  KEVIIAKDEVAHTLT-ESRVLKNTRHPFLTSL-----KYSFQTKDRLCFVMEYVNGGELF 83

Query: 121 QWLRQ----SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVA 176
             L +    S  + RF    +  A+D      Y H      IV+ DLK  N++LD+D   
Sbjct: 84  FHLSRERVFSEDRTRFYGAEIVSALD------YLH---SGKIVYRDLKLENLMLDKDGHI 134

Query: 177 HVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG---YVAPEYGMGSKASVSGDVYNFGI 233
            + D GL K           E  +++  +K   G   Y+APE    +    + D +  G+
Sbjct: 135 KITDFGLCK-----------EGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGV 183

Query: 234 LLLEMFTRRRP 244
           ++ EM   R P
Sbjct: 184 VMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 29/101 (28%), Positives = 47/101 (46%), Gaps = 13/101 (12%)

Query: 157 SIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEY 216
           +IV+ DLKP N+LLD+D    + D G AK +            + +  + G   Y+APE 
Sbjct: 151 NIVYRDLKPENLLLDKDGFIKMTDFGFAKVV-----------DTRTYTLCGTPEYIAPEI 199

Query: 217 GMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHE 257
            +      + D +  GI + E+     P  A  NE L +++
Sbjct: 200 LLNVGHGKAADWWTLGIFIYEILVGCPPFYA--NEPLLIYQ 238

Length = 340

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 42.2 bits (99), Expect = 2e-04
 Identities = 30/101 (29%), Positives = 46/101 (45%), Gaps = 20/101 (19%)

Query: 159 VHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKG----IVGYVAP 214
           +H DL   NILL    +  + D GLA+ +            SN + +KG     V ++AP
Sbjct: 236 IHRDLAARNILLTHGRITKICDFGLARDI---------RNDSNYV-VKGNARLPVKWMAP 285

Query: 215 EYGMGSKASVSGDVYNFGILLLEMFT------RRRPTDAMF 249
           E       +   DV+++GILL E+F+         P D+ F
Sbjct: 286 ESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKF 326

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 41.9 bits (98), Expect = 3e-04
 Identities = 26/82 (31%), Positives = 43/82 (52%), Gaps = 6/82 (7%)

Query: 159 VHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGM 218
           +H DL   NILL ++ V  + D GLA+ +  Y+        S  + +K    ++APE   
Sbjct: 196 IHRDLAARNILLSENNVVKICDFGLARDI--YKDPDYVRKGSARLPLK----WMAPESIF 249

Query: 219 GSKASVSGDVYNFGILLLEMFT 240
               +   DV++FG+LL E+F+
Sbjct: 250 DKVYTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 41.7 bits (98), Expect = 3e-04
 Identities = 45/154 (29%), Positives = 66/154 (42%), Gaps = 29/154 (18%)

Query: 109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNI 168
           +V EY    +L   L +   Q      +  +A ++  AI   H   Q   VH D+KP N+
Sbjct: 78  LVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLA-ELVLAIHSVH---QMGYVHRDIKPENV 133

Query: 169 LLDQDIVAHVGDLGLAKFLFGYEPGTAAE-TASNSIEIKGIVG---YVAPEY------GM 218
           L+D+      G + LA F      G+AA  TA+  +  K  VG   Y+APE         
Sbjct: 134 LIDR-----TGHIKLADF------GSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDG 182

Query: 219 GSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEG 252
                V  D ++ G++  EM   R P    F+EG
Sbjct: 183 KGTYGVECDWWSLGVIAYEMIYGRSP----FHEG 212

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 41.8 bits (98), Expect = 3e-04
 Identities = 46/219 (21%), Positives = 98/219 (44%), Gaps = 42/219 (19%)

Query: 57  IVAVKVVNLKQKEASRS-FAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQ 115
           +VAVK++     + +R+ F  E   L  ++  N+I+++ +C   D        ++ EYM+
Sbjct: 48  LVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDP-----LCMITEYME 102

Query: 116 NRNLEQWLRQ---------------SNGQLRFLTQR--VNIAIDVSFAIEYFHHHCQPSI 158
           N +L Q+L                     L  ++    +++A+ ++  ++Y       + 
Sbjct: 103 NGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNF 159

Query: 159 VHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKG----IVGYVAP 214
           VH DL   N L+ +++   + D G+++ L+          A +   I+G     + ++A 
Sbjct: 160 VHRDLATRNCLVGENLTIKIADFGMSRNLY----------AGDYYRIQGRAVLPIRWMAW 209

Query: 215 EYGMGSKASVSGDVYNFGILLLE--MFTRRRPTDAMFNE 251
           E  +  K + + DV+ FG+ L E  M  + +P   + +E
Sbjct: 210 ECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDE 248

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 41.5 bits (97), Expect = 3e-04
 Identities = 45/172 (26%), Positives = 71/172 (41%), Gaps = 25/172 (14%)

Query: 77  ECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQ----SNGQLRF 132
           E   L+N RH  L  +        F+  D    V EY     L   L +    S  + RF
Sbjct: 45  ENRVLQNSRHPFLTAL-----KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF 99

Query: 133 LTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEP 192
               +  A+D        + H + ++V+ DLK  N++LD+D    + D GL K   G + 
Sbjct: 100 YGAEIVSALD--------YLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKD 149

Query: 193 GTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
           G   +T   + E      Y+APE    +    + D +  G+++ EM   R P
Sbjct: 150 GATMKTFCGTPE------YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 41.6 bits (97), Expect = 3e-04
 Identities = 58/231 (25%), Positives = 99/231 (42%), Gaps = 43/231 (18%)

Query: 32  FSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFA---AECNALRNIRHRN 88
           F+   +IG G    VY      +  +VA+K ++   K+++  +     E   L+ I+H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 89  LIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLT---QRVNIAIDVSF 145
                    SI+++G   +    E+     +E  L  ++  L       Q V IA     
Sbjct: 87  ---------SIEYKGCYLR----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHG 133

Query: 146 AIE---YFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNS 202
           A++   Y H H   +++H D+K  NILL +      G + LA F        +A  AS +
Sbjct: 134 ALQGLAYLHSH---NMIHRDIKAGNILLTEP-----GQVKLADF-------GSASIASPA 178

Query: 203 IEIKGIVGYVAPEYGMG-SKASVSG--DVYNFGILLLEMFTRRRPTDAMFN 250
               G   ++APE  +   +    G  DV++ GI  +E+  R+ P   +FN
Sbjct: 179 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP---LFN 226

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 41.3 bits (97), Expect = 3e-04
 Identities = 54/235 (22%), Positives = 93/235 (39%), Gaps = 51/235 (21%)

Query: 32  FSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFA---AECNALRNIRHRN 88
           F+   +IG G    VY      +  +VA+K ++   K+++  +     E   L+ +RH N
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76

Query: 89  LIKIITICSSIDFEGFDFKA----IVFEYMQNRNLEQWLRQSNGQLRFLT---QRVNIAI 141
                    +I+++G   +     +V EY         L  ++  L       Q V IA 
Sbjct: 77  ---------TIEYKGCYLREHTAWLVMEYC--------LGSASDILEVHKKPLQEVEIAA 119

Query: 142 ---DVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAET 198
                   + Y H H +   +H D+K  NILL +     + D G            +A  
Sbjct: 120 ICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFG------------SASL 164

Query: 199 ASNSIEIKGIVGYVAPEYGMG-SKASVSG--DVYNFGILLLEMFTRRRPTDAMFN 250
            S +    G   ++APE  +   +    G  DV++ GI  +E+  R+ P   +FN
Sbjct: 165 VSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP---LFN 216

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 41.7 bits (98), Expect = 3e-04
 Identities = 27/86 (31%), Positives = 43/86 (50%), Gaps = 8/86 (9%)

Query: 158 IVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYG 217
           I+H D+KP N+L++ + V  + D GLA+     EP  +       +       Y APE  
Sbjct: 124 ILHRDIKPGNLLVNSNCVLKICDFGLARV---EEPDESKHMTQEVVTQY----YRAPEIL 176

Query: 218 MGSKASVSG-DVYNFGILLLEMFTRR 242
           MGS+   S  D+++ G +  E+  RR
Sbjct: 177 MGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 41.6 bits (97), Expect = 3e-04
 Identities = 40/167 (23%), Positives = 76/167 (45%), Gaps = 17/167 (10%)

Query: 24  ELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVN--LKQKEASRSFAAECNAL 81
           E+ +   N +P      G V   Y       R  VAVK ++   +    +R    E   L
Sbjct: 12  EVPERYQNLTPVGSGAYGSVCSAYDT---RLRQKVAVKKLSRPFQSLIHARRTYRELRLL 68

Query: 82  RNIRHRNLIKIITICS-SIDFEGFDFKAIVFEYMQN--RNLEQWLRQSNGQLRFLTQRVN 138
           ++++H N+I ++ + + +   E F+   +V   M     N+ +  + S+  ++FL  ++ 
Sbjct: 69  KHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQL- 127

Query: 139 IAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAK 185
                   ++Y H      I+H DLKPSN+ +++D    + D GLA+
Sbjct: 128 -----LRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR 166

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 41.3 bits (97), Expect = 4e-04
 Identities = 49/215 (22%), Positives = 97/215 (45%), Gaps = 26/215 (12%)

Query: 38  IGQGGVSIVYKGIL------DESRSIVAVKVV--NLKQK-EASRSFAAECNALRNIRHRN 88
           +GQG  + +YKG+L      D       V VV   L      S +F    + +  + H++
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 89  LIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIE 148
           L+K+  +C        D   +V EY++   L+ +L +    +  L  ++++A  ++ A+ 
Sbjct: 63  LVKLYGVCVR------DENIMVEEYVKFGPLDVFLHREKNNVS-LHWKLDVAKQLASALH 115

Query: 149 YFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGI 208
           Y        +VHG++   NIL+ +    +  + G   F+   +PG      S    ++ I
Sbjct: 116 YLEDK---KLVHGNVCGKNILVAR----YGLNEGYVPFIKLSDPGIPITVLSREERVERI 168

Query: 209 VGYVAPEY--GMGSKASVSGDVYNFGILLLEMFTR 241
             ++APE      +  +++ D ++FG  LLE+ + 
Sbjct: 169 -PWIAPECIRNGQASLTIAADKWSFGTTLLEICSN 202

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 41.2 bits (96), Expect = 4e-04
 Identities = 52/220 (23%), Positives = 92/220 (41%), Gaps = 20/220 (9%)

Query: 31  NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK---QKEASRSFAAEC--NALRNIR 85
           N+     +G+G    VY     ++   +AVK V      Q+ +    A EC    L+N+R
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62

Query: 86  HRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSF 145
           H  +++        + +     +I  EYM   +++  L+        +T+R    I    
Sbjct: 63  HDRIVQYYGCLRDPEEKKL---SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQI--LQ 117

Query: 146 AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG-YEPGTAAETASNSIE 204
            + Y H +    IVH D+K +NIL D      +GD G +K +      GT  ++      
Sbjct: 118 GVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS------ 168

Query: 205 IKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
           + G   +++PE   G       DV++    ++EM T + P
Sbjct: 169 VTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 41.6 bits (97), Expect = 4e-04
 Identities = 53/224 (23%), Positives = 100/224 (44%), Gaps = 27/224 (12%)

Query: 24  ELSKATN-NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALR 82
           +++++ N ++   N IG G   +VY+ I  ++   VA+K V    +  +R    E   ++
Sbjct: 59  DINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR----ELLIMK 114

Query: 83  NIRHRNLIKIITICSSIDF---EGFDFKAIVFEYMQ---NRNLEQWLRQSNGQLRFLTQR 136
           N+ H N+I +     +  F   E   F  +V E++    ++ ++ + R ++    FL + 
Sbjct: 115 NLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKL 174

Query: 137 VNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDI-VAHVGDLGLAKFLFGYEPGTA 195
              +  +  A+ Y H      I H DLKP N+L+D +     + D G AK L        
Sbjct: 175 Y--SYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLA------ 223

Query: 196 AETASNSIEIKGIVGYVAPEYGMGSKASVSG-DVYNFGILLLEM 238
                 S+       Y APE  +G+    +  D+++ G ++ EM
Sbjct: 224 ---GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEM 264

Length = 440

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 41.3 bits (97), Expect = 4e-04
 Identities = 48/242 (19%), Positives = 95/242 (39%), Gaps = 32/242 (13%)

Query: 45  IVYKGILD-ESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKI----ITICSSI 99
            +YKGI + +   I   K  +   K        E   LR I   N++KI    I I    
Sbjct: 35  SIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV--- 91

Query: 100 DFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIV 159
             +     +++ EY     L + L +    L F T ++++AID    +   + +   +  
Sbjct: 92  --DDLPRLSLILEYCTRGYLREVLDK-EKDLSFKT-KLDMAIDCCKGLYNLYKYT--NKP 145

Query: 160 HGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEY--G 217
           + +L   + L+ ++    +   GL K L        +     ++     + Y + +    
Sbjct: 146 YKNLTSVSFLVTENYKLKIICHGLEKIL--------SSPPFKNVNF---MVYFSYKMLND 194

Query: 218 MGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLL 277
           + S+ ++  D+Y+ G++L E+FT + P      E LT  E   + +       +     L
Sbjct: 195 IFSEYTIKDDIYSLGVVLWEIFTGKIPF-----ENLTTKEIYDLIINKNNSLKLPLDCPL 249

Query: 278 EV 279
           E+
Sbjct: 250 EI 251

Length = 283

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 41.1 bits (96), Expect = 4e-04
 Identities = 32/105 (30%), Positives = 50/105 (47%), Gaps = 13/105 (12%)

Query: 142 DVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAK-FLFGYEPGTAAETAS 200
           ++  A+E+ H   +  IV+ D+K  NILLD +    + D GL+K FL        +E   
Sbjct: 113 EIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL--------SEEKE 161

Query: 201 NSIEIKGIVGYVAPEYGMGSKASVSG-DVYNFGILLLEMFTRRRP 244
            +    G + Y+APE   G        D ++ GIL+ E+ T   P
Sbjct: 162 RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASP 206

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 41.0 bits (96), Expect = 5e-04
 Identities = 43/156 (27%), Positives = 71/156 (45%), Gaps = 21/156 (13%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASR---SFAAECNALRNIRHRNLIKII 93
           +IG G    V    +     +  V V  LK   +S+    F  + +  R ++H N+++ +
Sbjct: 2   EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61

Query: 94  TICSSIDFEGFDFKAIVFEYMQNRNL------EQWLRQSNGQLRFLTQRVNIAIDVSFAI 147
             C     E   +  +VFEY +  +L      EQW R+ N QL  L QR  +A +++  +
Sbjct: 62  GQC----VEAIPY-LLVFEYCELGDLKSYLSQEQWHRR-NSQLLLL-QR--MACEIAAGV 112

Query: 148 EYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGL 183
            + H H   + +H DL   N  L  D+   VGD G+
Sbjct: 113 THMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGI 145

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 41.2 bits (96), Expect = 5e-04
 Identities = 57/232 (24%), Positives = 95/232 (40%), Gaps = 45/232 (19%)

Query: 32  FSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFA---AECNALRNIRHRN 88
           FS   +IG G    VY      +  +VA+K ++   K+++  +     E   L+ +RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 89  LIKIITICSSIDFEGFDFKA----IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVS 144
                    +I + G   +     +V EY    +    L      L    Q V IA    
Sbjct: 77  ---------TIQYRGCYLREHTAWLVMEYCLG-SASDLLEVHKKPL----QEVEIAAVTH 122

Query: 145 FAIE---YFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASN 201
            A++   Y H H   +++H D+K  NILL +  +  +GD G A  +            +N
Sbjct: 123 GALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM----------APAN 169

Query: 202 SIEIKGIVGYVAPEYGMG-SKASVSG--DVYNFGILLLEMFTRRRPTDAMFN 250
                G   ++APE  +   +    G  DV++ GI  +E+  R+ P   +FN
Sbjct: 170 X--FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP---LFN 216

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 41.0 bits (96), Expect = 5e-04
 Identities = 25/82 (30%), Positives = 42/82 (51%), Gaps = 6/82 (7%)

Query: 159 VHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGM 218
           +H DL   NILL ++ V  + D GLA+ +  Y+           + +K    ++APE   
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLARDI--YKDPDYVRKGDARLPLK----WMAPESIF 248

Query: 219 GSKASVSGDVYNFGILLLEMFT 240
               +   DV++FG+LL E+F+
Sbjct: 249 DKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

 Score = 40.0 bits (94), Expect = 6e-04
 Identities = 40/190 (21%), Positives = 68/190 (35%), Gaps = 53/190 (27%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVV------NLKQKEASRSFAAECNALRNIRHRNLI 90
            I QG  +I+Y        ++V  ++        L +K            LR  R R   
Sbjct: 3   LIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEK------------LRRERTRREA 50

Query: 91  KIITICSS--------IDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAID 142
           +I+              D +  +   IV EY++   L+  L ++           ++  +
Sbjct: 51  RILAKAREAGVPVPIVYDVDPDN-GLIVMEYIEGELLKDALEEARP---------DLLRE 100

Query: 143 VSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNS 202
           V   +   H      IVHGDL  SNI+L    + +  D GL +F             S+ 
Sbjct: 101 VGRLVGKLHKA---GIVHGDLTTSNIILSGGRI-YFIDFGLGEF-------------SDE 143

Query: 203 IEIKGIVGYV 212
           +E K +  +V
Sbjct: 144 VEDKAVDLHV 153

Length = 204

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 41.2 bits (96), Expect = 6e-04
 Identities = 45/174 (25%), Positives = 72/174 (41%), Gaps = 31/174 (17%)

Query: 77  ECNALRNIRHRNLIKIITICSSIDF-----EGFDFKAIVFEYMQNRNLEQWLRQSNGQLR 131
           E  AL  + H N++KI  I  S        + +DF   ++ +M +     W  +      
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFD--LYSFMYDEAF-DWKDRP----- 264

Query: 132 FLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA----KFL 187
            L Q   I   +  A+EY H      ++H D+K  NI L+ D    +GD G A    K  
Sbjct: 265 LLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKER 321

Query: 188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTR 241
             ++ G     A+NS EI    GY               D+++ G++LL+M + 
Sbjct: 322 EAFDYGWVGTVATNSPEILAGDGYCEIT-----------DIWSCGLILLDMLSH 364

Length = 501

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 40.8 bits (95), Expect = 6e-04
 Identities = 25/82 (30%), Positives = 43/82 (52%), Gaps = 6/82 (7%)

Query: 159 VHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGM 218
           +H DL   NILL ++ V  + D GLA+ +  Y+           + +K    ++APE   
Sbjct: 201 IHRDLAARNILLSENNVVKICDFGLARDI--YKDPDYVRKGDARLPLK----WMAPETIF 254

Query: 219 GSKASVSGDVYNFGILLLEMFT 240
               ++  DV++FG+LL E+F+
Sbjct: 255 DRVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 40.3 bits (94), Expect = 8e-04
 Identities = 31/99 (31%), Positives = 47/99 (47%), Gaps = 11/99 (11%)

Query: 146 AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEI 205
           A+E  H   + ++++ DLKP NILLD      + D GL K           +  +N+   
Sbjct: 105 ALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKL------NMKDDDKTNTF-- 153

Query: 206 KGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
            G   Y+APE  +G   + + D +  G+LL EM T   P
Sbjct: 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 40.4 bits (94), Expect = 8e-04
 Identities = 51/222 (22%), Positives = 93/222 (41%), Gaps = 24/222 (10%)

Query: 31  NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNAL--RNIRHRN 88
           +F+    +G+G    V       +  + A+K+  LK+    +    EC  +  R +  ++
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKI--LKKDVVIQDDDVECTMVEKRVLALQD 58

Query: 89  LIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIE 148
               +T   S  F+  D    V EY+   +L   ++Q  G+ +   Q V  A ++S  + 
Sbjct: 59  KPPFLTQLHSC-FQTVDRLYFVMEYVNGGDLMYHIQQV-GKFK-EPQAVFYAAEISVGLF 115

Query: 149 YFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGI 208
           + H   +  I++ DLK  N++LD +    + D G+ K           E   + +  +  
Sbjct: 116 FLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCK-----------EHMVDGVTTRTF 161

Query: 209 VG---YVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDA 247
            G   Y+APE         S D + +G+LL EM   + P D 
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDG 203

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 39.9 bits (93), Expect = 0.001
 Identities = 55/214 (25%), Positives = 86/214 (40%), Gaps = 22/214 (10%)

Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVN---LKQKEASRSFAAECNALRNIRHRNLIKIIT 94
           +G+G    V    L ES  + AVKV+    + Q +       E   L   R+   +  + 
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62

Query: 95  ICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNI-AIDVSFAIEYFHHH 153
            C    F+  D    V E++   +L   +++S    RF   R    A +++ A+ + H  
Sbjct: 63  CC----FQTPDRLFFVMEFVNGGDLMFHIQKSR---RFDEARARFYAAEITSALMFLH-- 113

Query: 154 CQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVA 213
               I++ DLK  N+LLD +    + D G+ K   G   G    T        G   Y+A
Sbjct: 114 -DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFC------GTPDYIA 164

Query: 214 PEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDA 247
           PE         S D +  G+LL EM     P +A
Sbjct: 165 PEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEA 198

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 40.0 bits (93), Expect = 0.001
 Identities = 29/102 (28%), Positives = 46/102 (45%), Gaps = 17/102 (16%)

Query: 146 AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEI 205
           A+EY H      +V+ D+K  N++LD+D    + D GL K           E  S+   +
Sbjct: 107 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-----------EGISDGATM 152

Query: 206 KGIVG---YVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
           K   G   Y+APE    +    + D +  G+++ EM   R P
Sbjct: 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 39.7 bits (92), Expect = 0.001
 Identities = 46/213 (21%), Positives = 89/213 (41%), Gaps = 19/213 (8%)

Query: 32  FSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIK 91
           ++   KIGQG    V+  I   +   VA+K +NL+++        E   ++ +++ N++ 
Sbjct: 21  YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVN 80

Query: 92  IITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFH 151
            +       F   D   +V EY+   +L   + ++        Q   +  +   A+E+ H
Sbjct: 81  FLD-----SFLVGDELFVVMEYLAGGSLTDVVTETCMDE---AQIAAVCRECLQALEFLH 132

Query: 152 HHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGY 211
            +    ++H D+K  N+LL  D    + D       FG+      E +  S  + G   +
Sbjct: 133 AN---QVIHRDIKSDNVLLGMDGSVKLTD-------FGFCAQITPEQSKRSTMV-GTPYW 181

Query: 212 VAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
           +APE           D+++ GI+ +EM     P
Sbjct: 182 MAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 39.8 bits (93), Expect = 0.001
 Identities = 31/101 (30%), Positives = 43/101 (42%), Gaps = 9/101 (8%)

Query: 146 AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEI 205
           AI  F  H +  I++ DLK  N++LD +    + D G+ K       G    T       
Sbjct: 111 AIGLFFLHSK-GIIYRDLKLDNVMLDAEGHIKIADFGMCK--ENIFGGKTTRTFC----- 162

Query: 206 KGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTD 246
            G   Y+APE         S D + FG+LL EM   + P D
Sbjct: 163 -GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 39.2 bits (91), Expect = 0.002
 Identities = 49/214 (22%), Positives = 99/214 (46%), Gaps = 27/214 (12%)

Query: 38  IGQGGVSIVYKGIL-----DESRSI-------VAVKVVNLKQKEASRSFAAECNALRNIR 85
           +G+G  + +Y GIL     DE           V +KV++   ++ S +F    + +R + 
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62

Query: 86  HRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSF 145
           H++++ +  +C   D E      +V E+++   L+ ++ + +  L     +  +A  ++ 
Sbjct: 63  HKHIVLLYGVCVR-DVENI----MVEEFVEFGPLDLFMHRKSDVLT-TPWKFKVAKQLAS 116

Query: 146 AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEI 205
           A+ Y        +VHG++   NILL ++ +    D     F+   +PG      S    +
Sbjct: 117 ALSYLE---DKDLVHGNVCTKNILLAREGI----DGECGPFIKLSDPGIPITVLSRQECV 169

Query: 206 KGIVGYVAPEYGMGSKA-SVSGDVYNFGILLLEM 238
           + I  ++APE    SK  S++ D ++FG  L E+
Sbjct: 170 ERI-PWIAPECVEDSKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 38/151 (25%), Positives = 62/151 (41%), Gaps = 21/151 (13%)

Query: 101 FEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLT-QRVNIAIDVSFAIEYFHHHCQPSIV 159
           F+  D    V EY+   +L   ++Q     RF     V  A +++  + + H      I+
Sbjct: 70  FQTMDRLYFVMEYVNGGDLMYQIQQVG---RFKEPHAVFYAAEIAIGLFFLH---SKGII 123

Query: 160 HGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG---YVAPEY 216
           + DLK  N++LD +    + D G+ K           E   + +  K   G   Y+APE 
Sbjct: 124 YRDLKLDNVMLDSEGHIKIADFGMCK-----------ENMWDGVTTKTFCGTPDYIAPEI 172

Query: 217 GMGSKASVSGDVYNFGILLLEMFTRRRPTDA 247
                   S D + FG+LL EM   + P + 
Sbjct: 173 IAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 203

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 39.2 bits (91), Expect = 0.002
 Identities = 25/82 (30%), Positives = 41/82 (50%), Gaps = 6/82 (7%)

Query: 159 VHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGM 218
           VH DL   N+LL Q  +  + D GLA+ +            S  + +K    ++APE   
Sbjct: 259 VHRDLAARNVLLAQGKIVKICDFGLARDIM--HDSNYVSKGSTFLPVK----WMAPESIF 312

Query: 219 GSKASVSGDVYNFGILLLEMFT 240
            +  +   DV+++GILL E+F+
Sbjct: 313 DNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 39.1 bits (91), Expect = 0.002
 Identities = 35/116 (30%), Positives = 55/116 (47%), Gaps = 25/116 (21%)

Query: 146 AIEYFHHHCQPSIVHGDLKPSNILLD--QDIVAHVGDLGLAKFLFGYEPGTAAETASNSI 203
           AI+Y H   +  I+H D+K  N+L++  +DI   +GD G A F  G      + +     
Sbjct: 272 AIDYIH--GE-GIIHRDIKTENVLVNGPEDIC--LGDFGAACFARG------SWSTPFHY 320

Query: 204 EIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLE-------MFT-----RRRPTDA 247
            I G V   APE   G   + S D+++ G+++ E       +F+      RRP DA
Sbjct: 321 GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDA 376

Length = 461

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 38.9 bits (91), Expect = 0.003
 Identities = 28/123 (22%), Positives = 44/123 (35%), Gaps = 33/123 (26%)

Query: 146 AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL------------FGYEPG 193
           AI+  H       +H D+KP N+LLD      + D GL   L                P 
Sbjct: 113 AIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPS 169

Query: 194 TAAETASNSIEIKG---------------IVG---YVAPEYGMGSKASVSGDVYNFGILL 235
              +  S  +  K                 VG   Y+APE  + +  +   D ++ G+++
Sbjct: 170 NFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIM 229

Query: 236 LEM 238
            EM
Sbjct: 230 YEM 232

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 38.7 bits (90), Expect = 0.004
 Identities = 17/44 (38%), Positives = 27/44 (61%), Gaps = 3/44 (6%)

Query: 142 DVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAK 185
           +V+ A++Y H H    I+H DLKP N+L+  +    + D GL+K
Sbjct: 112 EVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 38.3 bits (89), Expect = 0.004
 Identities = 44/172 (25%), Positives = 66/172 (38%), Gaps = 26/172 (15%)

Query: 77  ECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQ----SNGQLRF 132
           E   L+N RH  L  +        F+  D    V EY     L   L +    S  + RF
Sbjct: 45  ESRVLQNTRHPFLTAL-----KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF 99

Query: 133 LTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEP 192
                    ++  A+ Y H      +V+ DLK  N++LD+D    + D GL K     E 
Sbjct: 100 Y------GAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK-----EG 145

Query: 193 GTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
            +   T        G   Y+APE    +    + D +  G+++ EM   R P
Sbjct: 146 ISDGATMKT---FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 38.1 bits (88), Expect = 0.004
 Identities = 60/244 (24%), Positives = 102/244 (41%), Gaps = 52/244 (21%)

Query: 19  MISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAEC 78
           M+    L   T+ +     IG+G    VYK    +  S+ AVK+++    +      AE 
Sbjct: 11  MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILD-PISDVDEEIEAEY 69

Query: 79  NALRNI-RHRNLIKIITICSSIDFEGFDFKA---------IVFEYMQNRNLEQWLRQSNG 128
           N L+++  H N++K         F G  +KA         +V E     ++ + ++   G
Sbjct: 70  NILQSLPNHPNVVK---------FYGMFYKADKLVGGQLWLVLELCNGGSVTELVK---G 117

Query: 129 QLRFLTQRVNIAIDVSF----AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA 184
            L    QR++ A+ +S+    A+    H     I+H D+K +NILL  +     G + L 
Sbjct: 118 LLI-CGQRLDEAM-ISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTE-----GGVKLV 170

Query: 185 KFLFGYEPGTAAETASNSIEIKGIVG---YVAPE-------YGMGSKASVSGDVYNFGIL 234
            F      G +A+  S  +     VG   ++APE       Y     A    DV++ GI 
Sbjct: 171 DF------GVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARC--DVWSLGIT 222

Query: 235 LLEM 238
            +E+
Sbjct: 223 AIEL 226

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	331
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.95
PLN00181	793	protein SPA1-RELATED; Provisional	99.95
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.94
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.93
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.91
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.9
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.9
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.9
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.9
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.89
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.87
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.86
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.85
PRK12274	218	serine/threonine protein kinase; Provisional	99.83
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.82
smart00090	237	RIO RIO-like kinase.	99.82
PRK10345	210	hypothetical protein; Provisional	99.81
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.81
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.8
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.78
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.77
PRK14879	211	serine/threonine protein kinase; Provisional	99.77
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.73
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.73
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.71
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.7
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.66
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.63
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.58
KOG1243	690	consensus Protein kinase [General function predict	99.56
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.56
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.52
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.47
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.39
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.36
COG4248	637	Uncharacterized protein with protein kinase and he	99.35
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.2
KOG3087	229	consensus Serine/threonine protein kinase [General	99.2
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.2
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.17
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.13
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.11
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.11
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.07
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.06
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.93
PRK09902	216	hypothetical protein; Provisional	98.86
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.76
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.65
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.64
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.58
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.53
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.47
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.4
PF01636	239	APH: Phosphotransferase enzyme family This family	98.37
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.34
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.19
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.16
PLN02876	822	acyl-CoA dehydrogenase	98.09
KOG2268	465	consensus Serine/threonine protein kinase [Signal	98.03
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.99
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.98
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.91
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.88
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.83
PRK05231	319	homoserine kinase; Provisional	97.76
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.72
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.71
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.68
PRK10593	297	hypothetical protein; Provisional	97.67
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.63
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.56
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.2
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.16
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.11
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.09
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.05
PLN02756	418	S-methyl-5-thioribose kinase	96.99
PRK12396	409	5-methylribose kinase; Reviewed	96.99
PLN02236	344	choline kinase	96.89
KOG2270	520	consensus Serine/threonine protein kinase involved	96.86
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.75
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.55
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.44
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.38
PRK11768	325	serine/threonine protein kinase; Provisional	96.2
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.18
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.09
COG2334	331	Putative homoserine kinase type II (protein kinase	95.8
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.73
PRK06148	1013	hypothetical protein; Provisional	95.39
PTZ00384	383	choline kinase; Provisional	94.82
PRK06149	972	hypothetical protein; Provisional	94.59
KOG1236	565	consensus Predicted unusual protein kinase [Genera	94.29

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-52  Score=350.36  Aligned_cols=251  Identities=23%  Similarity=0.319  Sum_probs=210.8

Q ss_pred             CCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc-chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcc-eee
Q 046639           31 NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK-QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFD-FKA  108 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~-~~~  108 (331)
                      +...+..||+|..|+||+++++.|++.+|+|++... +++..+++.+|++++++.+||+||.+++.|.     ..+ .+.
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~-----~~~~~is  154 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFY-----SNGEEIS  154 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEE-----eCCceEE
Confidence            567788999999999999999999999999999544 4566788999999999999999999999963     344 589


Q ss_pred             EEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCCEEecCCCcEEEcccCccccc
Q 046639          109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHH-HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      ++||||++|||.+++...  ..+++.....++.+++.||.|||. .   +|+||||||+||||+..|.|||+|||.+..+
T Consensus       155 I~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~l  229 (364)
T KOG0581|consen  155 ICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGIL  229 (364)
T ss_pred             eehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHh
Confidence            999999999999999765  347889999999999999999996 6   9999999999999999999999999999876


Q ss_pred             ccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchh
Q 046639          188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKV  267 (331)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  267 (331)
                      .+          .......||..|||||.+.++.|+.++||||||+.++|+++|+.||.............+..-+..  
T Consensus       230 vn----------S~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~--  297 (364)
T KOG0581|consen  230 VN----------SIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDE--  297 (364)
T ss_pred             hh----------hhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcC--
Confidence            22          244567799999999999999999999999999999999999999986522233333333222211  


Q ss_pred             hhhcCcccccccccCCcchHH-HHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          268 MEIVDPSLLLEVTANNYSWIE-DCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                         ..|.           .+. .+++++.+++..||++||.+|||+.++++
T Consensus       298 ---ppP~-----------lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  298 ---PPPR-----------LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             ---CCCC-----------CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence               1122           222 37889999999999999999999999975

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.5e-51  Score=364.38  Aligned_cols=248  Identities=23%  Similarity=0.359  Sum_probs=217.4

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc---chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK---QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      .+|..++.||+|||+.||.+++..+|..||+|++...   .....+.+.+|+++.+.|+|||||+++++     |++.++
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~-----FEDs~n   92 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHF-----FEDSNN   92 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeE-----eecCCc
Confidence            6899999999999999999999899999999999743   45667889999999999999999999999     777889


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      +|+|.|.|..++|..++++  .+.+.+.+++.++.||+.||.|||++   +|+|||||..|++++++-+|||+|||+|..
T Consensus        93 VYivLELC~~~sL~el~Kr--rk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~  167 (592)
T KOG0575|consen   93 VYIVLELCHRGSLMELLKR--RKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQ  167 (592)
T ss_pred             eEEEEEecCCccHHHHHHh--cCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeee
Confidence            9999999999999999984  44688999999999999999999999   999999999999999999999999999998


Q ss_pred             cccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcch
Q 046639          187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDK  266 (331)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  266 (331)
                      +        ..+.......+|||.|.|||++....++..+||||+||++|-|+.|++||+..     .+.+.+.      
T Consensus       168 l--------e~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk-----~vkety~------  228 (592)
T KOG0575|consen  168 L--------EYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK-----TVKETYN------  228 (592)
T ss_pred             e--------cCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc-----hHHHHHH------
Confidence            6        23446667889999999999999999999999999999999999999999742     2222221      


Q ss_pred             hhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          267 VMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                                 .+..+.+.++.....+..+|+.++|+.||.+|||+.+|+.
T Consensus       229 -----------~Ik~~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  229 -----------KIKLNEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             -----------HHHhcCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                       1122334555567788999999999999999999999974

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.6e-52  Score=338.23  Aligned_cols=262  Identities=23%  Similarity=0.316  Sum_probs=212.0

Q ss_pred             HHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc--chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCc
Q 046639           27 KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGF  104 (331)
Q Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  104 (331)
                      ....+|.++++||.|.||+||++.+..++..+|.|.+...  +....+.+..|+.+|+.|+|||||+++++-.   .++.
T Consensus        16 ~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f---~~~~   92 (375)
T KOG0591|consen   16 KTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSF---IEDN   92 (375)
T ss_pred             ccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhh---hccc
Confidence            3344699999999999999999999999999999988643  4556688999999999999999999988531   2334


Q ss_pred             ceeeEEEeecCCCCHHHHHHh--ccCCccchHHHHHHHHHHHHHHHHHhhcCCCC--eeecCCCCCCEEecCCCcEEEcc
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQ--SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPS--IVHGDLKPSNILLDQDIVAHVGD  180 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~--ivH~dik~~nilv~~~~~~kl~D  180 (331)
                      ..+++|||+|..|+|.+.++.  ...+.+++..+|+++.|++.||+++|++ .++  |+||||||.||+++.+|.|||+|
T Consensus        93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~-~~r~~VmHRDIKPaNIFl~~~gvvKLGD  171 (375)
T KOG0591|consen   93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSK-IPRGTVMHRDIKPANIFLTANGVVKLGD  171 (375)
T ss_pred             hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcc-ccccceeeccCcchheEEcCCCceeecc
Confidence            558999999999999999986  4556788999999999999999999993 225  99999999999999999999999


Q ss_pred             cCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHH
Q 046639          181 LGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVK  260 (331)
Q Consensus       181 fg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  260 (331)
                      ||+++.+.        .......+..|||.||+||.+...+|+.+|||||+||++|||+.-++||.+.     .+.....
T Consensus       172 fGL~r~l~--------s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-----n~~~L~~  238 (375)
T KOG0591|consen  172 FGLGRFLS--------SKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-----NLLSLCK  238 (375)
T ss_pred             chhHhHhc--------chhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-----cHHHHHH
Confidence            99999872        2223344677999999999999999999999999999999999999999763     2222211


Q ss_pred             hhCcchhhhhcCcccccccccCCcchH-HHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHH
Q 046639          261 MALPDKVMEIVDPSLLLEVTANNYSWI-EDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRH  321 (331)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~  321 (331)
                      ...     .-..|           ..+ +-++..+..|+..|+..||+.||+.-.+++.+..
T Consensus       239 KI~-----qgd~~-----------~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  239 KIE-----QGDYP-----------PLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             HHH-----cCCCC-----------CCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence            111     11111           122 4577889999999999999999996555554443

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-51  Score=349.05  Aligned_cols=254  Identities=20%  Similarity=0.290  Sum_probs=208.5

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccch-------hhHHHHHHHHHHHHcCCCCCcceeeceeeccc
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK-------EASRSFAAECNALRNIRHRNLIKIITICSSID  100 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  100 (331)
                      ....|.+.+.||+|+||.|-+|..+.|++.||||+++....       .......+|+++|++++|||||++.++     
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~-----  244 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDF-----  244 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeee-----
Confidence            45578999999999999999999999999999999964421       122346799999999999999999999     


Q ss_pred             CCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCC---CcEE
Q 046639          101 FEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQD---IVAH  177 (331)
Q Consensus       101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~---~~~k  177 (331)
                      ++.....|+||||++||+|.+.+-...  .+.+.....++.|++.|+.|||++   ||+||||||+|||++.+   ..+|
T Consensus       245 f~~~ds~YmVlE~v~GGeLfd~vv~nk--~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llK  319 (475)
T KOG0615|consen  245 FEVPDSSYMVLEYVEGGELFDKVVANK--YLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLK  319 (475)
T ss_pred             eecCCceEEEEEEecCccHHHHHHhcc--ccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEE
Confidence            566677899999999999999996544  466778889999999999999999   99999999999999866   7899


Q ss_pred             EcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCC---ccchhhHhHHHHHHHHHhCCCCCCcccCCcch
Q 046639          178 VGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKA---SVSGDVYNFGILLLEMFTRRRPTDAMFNEGLT  254 (331)
Q Consensus       178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~---~~~~DiwslG~il~el~~g~~pf~~~~~~~~~  254 (331)
                      |+|||+|+..         .........+|||.|.|||++.+...   ..+.|+||+||+||-+++|.+||.+...+...
T Consensus       320 ItDFGlAK~~---------g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl  390 (475)
T KOG0615|consen  320 ITDFGLAKVS---------GEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSL  390 (475)
T ss_pred             ecccchhhcc---------ccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccH
Confidence            9999999875         24455667899999999999987653   34779999999999999999999875443333


Q ss_pred             HHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          255 LHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ...+.+.....                 ..........+..+|+.+||..||++|||+.|+++
T Consensus       391 ~eQI~~G~y~f-----------------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  391 KEQILKGRYAF-----------------GPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             HHHHhcCcccc-----------------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence            33332222211                 11233467788999999999999999999999875

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=3e-50  Score=353.95  Aligned_cols=261  Identities=26%  Similarity=0.415  Sum_probs=212.3

Q ss_pred             CCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeE
Q 046639           32 FSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ--KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAI  109 (331)
Q Consensus        32 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~l  109 (331)
                      ..+.+.||+|+||+||+|.++++. .||+|++....  ......+.+|+.+|++++|||||+++|+|.+..    ...++
T Consensus        43 l~~~~~iG~G~~g~V~~~~~~g~~-~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~----~~~~i  117 (362)
T KOG0192|consen   43 LPIEEVLGSGSFGTVYKGKWRGTD-VVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPP----GSLCI  117 (362)
T ss_pred             hhhhhhcccCCceeEEEEEeCCce-eEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC----CceEE
Confidence            455567999999999999998332 29999996432  222568999999999999999999999986532    26899


Q ss_pred             EEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCC-eeecCCCCCCEEecCCC-cEEEcccCccccc
Q 046639          110 VFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPS-IVHGDLKPSNILLDQDI-VAHVGDLGLAKFL  187 (331)
Q Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~-ivH~dik~~nilv~~~~-~~kl~Dfg~a~~~  187 (331)
                      ||||+++|+|.+++.......+++..+..++.||+.|+.|||++   + ||||||||+|||++.++ ++||+|||+++..
T Consensus       118 VtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~  194 (362)
T KOG0192|consen  118 VTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREK  194 (362)
T ss_pred             EEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceee
Confidence            99999999999999875556788999999999999999999999   8 99999999999999998 9999999999876


Q ss_pred             ccCCCCCcccccCCceeecccccccCCcccC--CCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcc
Q 046639          188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGM--GSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPD  265 (331)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  265 (331)
                      ....        .......||+.|||||++.  ...|+.|+||||||+++|||++|..||..... ..............
T Consensus       195 ~~~~--------~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~~~~v~~~~~Rp  265 (362)
T KOG0192|consen  195 VISK--------TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQVASAVVVGGLRP  265 (362)
T ss_pred             cccc--------ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHhcCCCC
Confidence            2211        2222367999999999999  56899999999999999999999999987654 22222211111111


Q ss_pred             hhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhhhc
Q 046639          266 KVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETFLG  328 (331)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~~~  328 (331)
                                         ..+..|...+..|+..||+.||+.||++.+|+..|+.+......
T Consensus       266 -------------------~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~  309 (362)
T KOG0192|consen  266 -------------------PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS  309 (362)
T ss_pred             -------------------CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence                               12234788899999999999999999999999999999876654

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-50  Score=342.12  Aligned_cols=201  Identities=28%  Similarity=0.510  Sum_probs=181.8

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc--chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      ..+|...+.||.|+|++||+|+++.++..||||.+.+.  +....+.+..|+.+|+.++|||||.+++++     +..++
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~-----~~~~~   83 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCI-----EDDDF   83 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEE-----ecCCe
Confidence            45799999999999999999999999999999999766  566678899999999999999999999994     55678


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCC------CcEEEcc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQD------IVAHVGD  180 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~------~~~kl~D  180 (331)
                      +++|||||.||+|.+++++.+  .+++..+..++.|++.|+.+||++   +||||||||+|||++..      ..+||+|
T Consensus        84 i~lVMEyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIAD  158 (429)
T KOG0595|consen   84 IYLVMEYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIAD  158 (429)
T ss_pred             EEEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecc
Confidence            999999999999999998765  478899999999999999999999   99999999999999764      4689999


Q ss_pred             cCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcc
Q 046639          181 LGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAM  248 (331)
Q Consensus       181 fg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  248 (331)
                      ||+|+.+         .........+|+|-|||||++..+.|+.|+|+||+|+|||++++|.+||+..
T Consensus       159 FGfAR~L---------~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~  217 (429)
T KOG0595|consen  159 FGFARFL---------QPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE  217 (429)
T ss_pred             cchhhhC---------CchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence            9999987         2444555678999999999999999999999999999999999999999864

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-49  Score=347.90  Aligned_cols=290  Identities=37%  Similarity=0.594  Sum_probs=237.5

Q ss_pred             cCCcccHHHHHHHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeece
Q 046639           16 QFPMISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITI   95 (331)
Q Consensus        16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   95 (331)
                      ....|++.+|..++++|.-...||+|+||.||+|....+ ..||||.+.........++.+|+.++.+++|||+++++|+
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy  139 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY  139 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence            577799999999999999999999999999999998744 7899998864433214459999999999999999999999


Q ss_pred             eecccCCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCc
Q 046639           96 CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIV  175 (331)
Q Consensus        96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~  175 (331)
                      |.+.    +...++|+||+++|+|.+.+.......++|....+|+.+++.||+|||....+.|+|||||+.|||+|++.+
T Consensus       140 C~e~----~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~  215 (361)
T KOG1187|consen  140 CLEG----GEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFN  215 (361)
T ss_pred             EecC----CceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCC
Confidence            8542    226899999999999999997654437899999999999999999999998778999999999999999999


Q ss_pred             EEEcccCcccccccCCCCCcccccCCceee-cccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCccc-CCcc
Q 046639          176 AHVGDLGLAKFLFGYEPGTAAETASNSIEI-KGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMF-NEGL  253 (331)
Q Consensus       176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~-~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-~~~~  253 (331)
                      +||+|||+|+....      .  ....... .||.+|+|||+...+..+.|+||||||++|.||++|+.+.+... ....
T Consensus       216 aKlsDFGLa~~~~~------~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~  287 (361)
T KOG1187|consen  216 AKLSDFGLAKLGPE------G--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGEL  287 (361)
T ss_pred             EEccCccCcccCCc------c--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccc
Confidence            99999999965410      0  1111122 79999999999999999999999999999999999998887543 2233


Q ss_pred             hHHHHHHhhC-cchhhhhcCcccccccccCCcchHH-HHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhh
Q 046639          254 TLHEFVKMAL-PDKVMEIVDPSLLLEVTANNYSWIE-DCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARE  324 (331)
Q Consensus       254 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~  324 (331)
                      .+..|..... ...+.+++|+.+...      .+.. .+...+..++..|++.+|.+||++.+|++.|+.+..
T Consensus       288 ~l~~w~~~~~~~~~~~eiiD~~l~~~------~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  288 SLVEWAKPLLEEGKLREIVDPRLKEG------EYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             cHHHHHHHHHHCcchhheeCCCccCC------CCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence            3555543333 337888899887631      1111 577789999999999999999999999999966553

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.8e-49  Score=323.64  Aligned_cols=270  Identities=20%  Similarity=0.250  Sum_probs=208.6

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc--chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCccee
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      +.|..+.++|+|+||+||+|+++.||+.||||++...  ++...+-.++|+++|+.+.|+|+|.++++     |.....+
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEV-----Frrkrkl   76 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEV-----FRRKRKL   76 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHH-----HHhccee
Confidence            4688899999999999999999999999999999533  23444557999999999999999999999     5667889


Q ss_pred             eEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccc
Q 046639          108 AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      ++|+||| .-++.+-+++... ..+...+.++++|++.|+.|+|++   +++||||||+||+|+.+|.+||+|||+|+.+
T Consensus        77 hLVFE~~-dhTvL~eLe~~p~-G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L  151 (396)
T KOG0593|consen   77 HLVFEYC-DHTVLHELERYPN-GVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTL  151 (396)
T ss_pred             EEEeeec-chHHHHHHHhccC-CCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhh
Confidence            9999999 5566666765443 466788999999999999999999   9999999999999999999999999999987


Q ss_pred             ccCCCCCcccccCCceeecccccccCCcccCC-CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHH-HHhhCcc
Q 046639          188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMG-SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEF-VKMALPD  265 (331)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~-~~~~~~~  265 (331)
                      ..        .......+.-|.+|+|||.+.| -.|+.+.||||+||++.||++|.+.|++..+-+..+.-. .-..+.+
T Consensus       152 ~~--------pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~p  223 (396)
T KOG0593|consen  152 SA--------PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIP  223 (396)
T ss_pred             cC--------CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCH
Confidence            22        3344455678899999999998 569999999999999999999999998754333322111 1123333


Q ss_pred             hhhhhcCcc-ccccc--cc-----CCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          266 KVMEIVDPS-LLLEV--TA-----NNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       266 ~~~~~~~~~-~~~~~--~~-----~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ..+.++... ...-+  +.     ....-.......+.+++..||+.||++|++..+++.
T Consensus       224 rhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  224 RHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             HHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            333333221 11000  00     001111234457899999999999999999999873

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-49  Score=346.79  Aligned_cols=258  Identities=29%  Similarity=0.443  Sum_probs=210.1

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeE
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAI  109 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~l  109 (331)
                      +.++.++.||+|.||+||.|.++++ ..||+|.++.. .-..+.+..|+.+|++|+|++||+++++|..     ++.++|
T Consensus       206 ~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~-----~~piyI  278 (468)
T KOG0197|consen  206 EELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTK-----QEPIYI  278 (468)
T ss_pred             HHHHHHHHhcCCccceEEEEEEcCC-CcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEec-----CCceEE
Confidence            3567788999999999999999844 36999998643 3334668899999999999999999999743     346899


Q ss_pred             EEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccccc
Q 046639          110 VFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG  189 (331)
Q Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~  189 (331)
                      ||||++.|+|.++++...+..+.....+.++.|||+|++||+++   ++|||||...||||+++..+||+|||+|+...+
T Consensus       279 VtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d  355 (468)
T KOG0197|consen  279 VTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGD  355 (468)
T ss_pred             EEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCC
Confidence            99999999999999987777888999999999999999999999   999999999999999999999999999995422


Q ss_pred             CCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhCcchhh
Q 046639          190 YEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMALPDKVM  268 (331)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  268 (331)
                      ..-       .......-...|.|||++..+.++.+|||||||++||||+| |+.||+.+.+..              +.
T Consensus       356 ~~Y-------~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e--------------v~  414 (468)
T KOG0197|consen  356 DEY-------TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE--------------VL  414 (468)
T ss_pred             Cce-------eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH--------------HH
Confidence            110       00111112233999999999999999999999999999999 999998764421              11


Q ss_pred             hhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhh
Q 046639          269 EIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARET  325 (331)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~  325 (331)
                      +.++.....       ..+..|++.+.+||..||+.+|++|||+..+...|+.+...
T Consensus       415 ~~le~GyRl-------p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~  464 (468)
T KOG0197|consen  415 ELLERGYRL-------PRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS  464 (468)
T ss_pred             HHHhccCcC-------CCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence            112222211       22346999999999999999999999999999999887654

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-49  Score=340.42  Aligned_cols=272  Identities=20%  Similarity=0.247  Sum_probs=216.1

Q ss_pred             HHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHH-HHHHHHHHHHcCC-CCCcceeeceeecccCCCc
Q 046639           27 KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASR-SFAAECNALRNIR-HRNLIKIITICSSIDFEGF  104 (331)
Q Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~  104 (331)
                      ...++|.++++||.|.||.||+|+...++..||||.++..-....+ .-++|+..|++++ ||||+++.+++.    +.+
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~----d~~   82 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIR----DND   82 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhh----ccC
Confidence            3456899999999999999999999999999999988644222221 2368999999998 999999999963    333


Q ss_pred             ceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcc
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA  184 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a  184 (331)
                      ..+++||||| ..+|.++++.+ +..+++..+..|+.||+.||+|+|.+   |+.|||+||+|||+..+..+||+|||+|
T Consensus        83 ~~L~fVfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLA  157 (538)
T KOG0661|consen   83 RILYFVFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLA  157 (538)
T ss_pred             ceEeeeHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccc
Confidence            4899999999 78999999987 77899999999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCcccccCCceeecccccccCCcccCC-CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhC
Q 046639          185 KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG-SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMAL  263 (331)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  263 (331)
                      +..         ........+..|.+|+|||++.. +.|+.+.|+||+|||++|+.+-++.|++. ++..++..+.....
T Consensus       158 Rev---------~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~-sE~Dqi~KIc~VLG  227 (538)
T KOG0661|consen  158 REV---------RSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGA-SEIDQIYKICEVLG  227 (538)
T ss_pred             ccc---------ccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCC-cHHHHHHHHHHHhC
Confidence            986         23334456778999999999776 46899999999999999999999999875 23333333332221


Q ss_pred             cc---------hhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          264 PD---------KVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       264 ~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ..         .+....+-++..-..........++..+..+++.+|+++||.+||||.+.++
T Consensus       228 tP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~  290 (538)
T KOG0661|consen  228 TPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQ  290 (538)
T ss_pred             CCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence            11         1111222222222223333555578889999999999999999999999875

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-48  Score=325.86  Aligned_cols=243  Identities=26%  Similarity=0.323  Sum_probs=201.7

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc---chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcc
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK---QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFD  105 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~  105 (331)
                      .++|.+++.||+|+||+|+.++.+.+++.+|+|++++.   .....+...+|..+|..++||.||++...     |.+.+
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ys-----FQt~~   98 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYS-----FQTEE   98 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEe-----cccCC
Confidence            45799999999999999999999999999999999644   23345668899999999999999999888     77889


Q ss_pred             eeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccc
Q 046639          106 FKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAK  185 (331)
Q Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~  185 (331)
                      .+|+|+||+.||.|...+++.+  .+++..+..++..|+.||.|||++   ||+|||+||+|||++.+|+++|+|||+++
T Consensus        99 kLylVld~~~GGeLf~hL~~eg--~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k  173 (357)
T KOG0598|consen   99 KLYLVLDYLNGGELFYHLQREG--RFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCK  173 (357)
T ss_pred             eEEEEEeccCCccHHHHHHhcC--CcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccch
Confidence            9999999999999999997654  477888999999999999999999   99999999999999999999999999998


Q ss_pred             ccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcc
Q 046639          186 FLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPD  265 (331)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  265 (331)
                      ...        .........+||+.|+|||++.+..|+..+|.||||+++|||++|.+||.... ....+..+.....+ 
T Consensus       174 ~~~--------~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~-~~~~~~~I~~~k~~-  243 (357)
T KOG0598|consen  174 EDL--------KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED-VKKMYDKILKGKLP-  243 (357)
T ss_pred             hcc--------cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc-HHHHHHHHhcCcCC-
Confidence            642        22233445789999999999999999999999999999999999999997531 11222222222110 


Q ss_pred             hhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCC
Q 046639          266 KVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERM  310 (331)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp  310 (331)
                                         ..+.-......+++.++|..||++|.
T Consensus       244 -------------------~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  244 -------------------LPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             -------------------CCCccCCHHHHHHHHHHhccCHHHhc
Confidence                               00111345678889999999999996

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-48  Score=337.46  Aligned_cols=260  Identities=26%  Similarity=0.354  Sum_probs=213.4

Q ss_pred             HHHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc---chhhHHHHHHHHHHHHcC-CCCCcceeeceeecccC
Q 046639           26 SKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK---QKEASRSFAAECNALRNI-RHRNLIKIITICSSIDF  101 (331)
Q Consensus        26 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~  101 (331)
                      ....++|..++.||.|+|++|++|+...+++.||||++.+.   ......-...|=.+|.+| .||.|++++..     |
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~T-----F  143 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFT-----F  143 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEE-----e
Confidence            34455799999999999999999999999999999998533   222334456777888888 79999999988     6


Q ss_pred             CCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEccc
Q 046639          102 EGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDL  181 (331)
Q Consensus       102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Df  181 (331)
                      .++..+|+|+||+++|+|.++|++.+  .+++.....++.+|+.||.|||++   |||||||||+|||++++++++|+||
T Consensus       144 QD~~sLYFvLe~A~nGdll~~i~K~G--sfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDF  218 (604)
T KOG0592|consen  144 QDEESLYFVLEYAPNGDLLDLIKKYG--SFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDF  218 (604)
T ss_pred             ecccceEEEEEecCCCcHHHHHHHhC--cchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeec
Confidence            66788999999999999999998764  477888889999999999999999   9999999999999999999999999


Q ss_pred             CcccccccCCCCCc---cc--ccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHH
Q 046639          182 GLAKFLFGYEPGTA---AE--TASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLH  256 (331)
Q Consensus       182 g~a~~~~~~~~~~~---~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~  256 (331)
                      |.|+.+.....+..   ..  .........||..|.+||++..+..++.+|+|+||||||+|+.|.+||.+. ++...+.
T Consensus       219 GsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~-NeyliFq  297 (604)
T KOG0592|consen  219 GSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAA-NEYLIFQ  297 (604)
T ss_pred             cccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccc-cHHHHHH
Confidence            99998865443311   11  111125688999999999999999999999999999999999999999864 3333333


Q ss_pred             HHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          257 EFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      .++...                     ++|+...++...+|+.++|..||.+|+|+++|.+
T Consensus       298 kI~~l~---------------------y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~  337 (604)
T KOG0592|consen  298 KIQALD---------------------YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA  337 (604)
T ss_pred             HHHHhc---------------------ccCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence            333221                     2444556678899999999999999999988754

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-47  Score=326.42  Aligned_cols=266  Identities=19%  Similarity=0.251  Sum_probs=216.4

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchh-hHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKE-ASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      ....|.+.+.||.|..++||+|+...++..||||++..++-. ..+.+.+|+..|+.++||||+.++..|     ..+..
T Consensus        24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sF-----vv~~~   98 (516)
T KOG0582|consen   24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSF-----VVDSE   98 (516)
T ss_pred             CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEE-----Eecce
Confidence            345799999999999999999999999999999999766432 257899999999999999999999885     44578


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      +|+||.|+.+||+.++++..-...+.+..+..++.++++||.|||.+   |.+|||||+.||||+.+|.|||+|||.+..
T Consensus        99 LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~  175 (516)
T KOG0582|consen   99 LWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSAS  175 (516)
T ss_pred             eEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeee
Confidence            99999999999999999997777788999999999999999999999   999999999999999999999999998887


Q ss_pred             cccCCCCCcccccCCceeecccccccCCcccCC--CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCc
Q 046639          187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG--SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALP  264 (331)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  264 (331)
                      +...+   ... ........||+.|+|||++..  ..|+.|+||||||++.+||.+|+.||...++-. .+...+....+
T Consensus       176 l~~~G---~R~-~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk-vLl~tLqn~pp  250 (516)
T KOG0582|consen  176 LFDSG---DRQ-VTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK-VLLLTLQNDPP  250 (516)
T ss_pred             ecccC---cee-eEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH-HHHHHhcCCCC
Confidence            75533   111 111256679999999999655  468999999999999999999999998764321 22222223333


Q ss_pred             chhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          265 DKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ..++...+.           +........+.+++..||+.||.+||||.++++
T Consensus       251 ~~~t~~~~~-----------d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  251 TLLTSGLDK-----------DEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             CcccccCCh-----------HHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            222222221           223345568999999999999999999999975

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=3.2e-47  Score=306.25  Aligned_cols=269  Identities=21%  Similarity=0.295  Sum_probs=213.2

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchh--hHHHHHHHHHHHHcCCCCCcceeeceeecccCCCccee
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKE--ASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      .+|..+++||+|.||.||+|++..|++.||||.++..+..  ......+|+..|+.++|+||+.++++     |...+.+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~-----F~~~~~l   76 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDV-----FPHKSNL   76 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhh-----ccCCCce
Confidence            4799999999999999999999999999999999755332  34567899999999999999999999     5666789


Q ss_pred             eEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccc
Q 046639          108 AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      .+|+||+ ..+|...++... ..+...++..++.++++|++|+|++   .|+||||||.|+|++.+|.+||+|||+|+.+
T Consensus        77 ~lVfEfm-~tdLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f  151 (318)
T KOG0659|consen   77 SLVFEFM-PTDLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFF  151 (318)
T ss_pred             EEEEEec-cccHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhcc
Confidence            9999999 679999998644 4577789999999999999999999   9999999999999999999999999999987


Q ss_pred             ccCCCCCcccccCCceeecccccccCCcccCCC-CCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCc--
Q 046639          188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMGS-KASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALP--  264 (331)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--  264 (331)
                      .....        .......|.+|+|||.+.|. .|+...|+||.|||+.||+.|.+-|++. ++..++..+....-.  
T Consensus       152 ~~p~~--------~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~-sDidQL~~If~~LGTP~  222 (318)
T KOG0659|consen  152 GSPNR--------IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGD-SDIDQLSKIFRALGTPT  222 (318)
T ss_pred             CCCCc--------ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCC-chHHHHHHHHHHcCCCC
Confidence            33221        11122578899999999886 5899999999999999999999888764 333344444332222  


Q ss_pred             ----chhhhhcCcccccccccCC-cchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          265 ----DKVMEIVDPSLLLEVTANN-YSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       265 ----~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                          ..+..+.|......++... ......+.....+|+.+||..||.+|+|+.|+++
T Consensus       223 ~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~  280 (318)
T KOG0659|consen  223 PDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALK  280 (318)
T ss_pred             cccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhc
Confidence                2233333333333222221 1244456677799999999999999999999875

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-47  Score=325.65  Aligned_cols=260  Identities=24%  Similarity=0.357  Sum_probs=207.6

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      ..++..++.||+|+||+||++.+..++...|||.+...+....+.+.+|+.+|++++|||||++++......   ...++
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~---~~~~~   92 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRE---NDEYN   92 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCcccccc---CeeeE
Confidence            456889999999999999999999889999999997665444677999999999999999999999732211   13689


Q ss_pred             EEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecC-CCcEEEcccCccccc
Q 046639          109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQ-DIVAHVGDLGLAKFL  187 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~-~~~~kl~Dfg~a~~~  187 (331)
                      +.|||+++|+|.+++.+.++ .+++..+..+..|++.||+|||++   |++||||||+|||++. ++.+||+|||++...
T Consensus        93 i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~  168 (313)
T KOG0198|consen   93 IFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKL  168 (313)
T ss_pred             eeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccc
Confidence            99999999999999998776 789999999999999999999999   9999999999999999 799999999999875


Q ss_pred             ccCCCCCcccccCCceeecccccccCCcccCCC-CCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcch
Q 046639          188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMGS-KASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDK  266 (331)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  266 (331)
                      ..     ............||+.|+|||+...+ ....++|||||||++.||+||..||.....   ............ 
T Consensus       169 ~~-----~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~---~~~~~~~ig~~~-  239 (313)
T KOG0198|consen  169 ES-----KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFE---EAEALLLIGRED-  239 (313)
T ss_pred             cc-----ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcc---hHHHHHHHhccC-
Confidence            22     11122334457799999999999853 344699999999999999999999976311   111111111000 


Q ss_pred             hhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHH
Q 046639          267 VMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKL  319 (331)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L  319 (331)
                          ..|           .++...+....+++.+|+..+|++||||.++++..
T Consensus       240 ----~~P-----------~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp  277 (313)
T KOG0198|consen  240 ----SLP-----------EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP  277 (313)
T ss_pred             ----CCC-----------CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence                001           22234567788999999999999999999998643

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-47  Score=332.94  Aligned_cols=250  Identities=21%  Similarity=0.296  Sum_probs=210.5

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeE
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAI  109 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~l  109 (331)
                      ..|....+||+|+.|.||.|....++..||||.+........+-+.+|+.+|+..+|+|||++++.|.     ..+.+|+
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Syl-----v~deLWV  347 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYL-----VGDELWV  347 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhc-----ccceeEE
Confidence            46888899999999999999999999999999998877777788999999999999999999999853     3477999


Q ss_pred             EEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccccc
Q 046639          110 VFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG  189 (331)
Q Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~  189 (331)
                      ||||++||+|.+++....   +.+.++..++.+++.||.|||.+   +|+|||||.+|||++.+|.+||+|||++..+. 
T Consensus       348 VMEym~ggsLTDvVt~~~---~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~-  420 (550)
T KOG0578|consen  348 VMEYMEGGSLTDVVTKTR---MTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQIS-  420 (550)
T ss_pred             EEeecCCCchhhhhhccc---ccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccc-
Confidence            999999999999997654   77889999999999999999999   99999999999999999999999999988762 


Q ss_pred             CCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhh
Q 046639          190 YEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVME  269 (331)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  269 (331)
                             ..........|||.|||||+.....|+++.||||||++++||+.|.+||-..  ........+.....     
T Consensus       421 -------~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE--~PlrAlyLIa~ng~-----  486 (550)
T KOG0578|consen  421 -------EEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNE--NPLRALYLIATNGT-----  486 (550)
T ss_pred             -------cccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCC--ChHHHHHHHhhcCC-----
Confidence                   2222445667999999999999999999999999999999999999999531  11111111111111     


Q ss_pred             hcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          270 IVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                         +.+         ...+..+..|.+++.+||+.||++||||.++|+
T Consensus       487 ---P~l---------k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  487 ---PKL---------KNPEKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             ---CCc---------CCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence               111         223456788999999999999999999999986

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-46  Score=330.97  Aligned_cols=251  Identities=21%  Similarity=0.287  Sum_probs=208.0

Q ss_pred             HHHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc----ch-hhHHHHHHHHHHHHcCC-CCCcceeeceeecc
Q 046639           26 SKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK----QK-EASRSFAAECNALRNIR-HRNLIKIITICSSI   99 (331)
Q Consensus        26 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~   99 (331)
                      ....+.|.+++.||+|+||+|+.|.+..++..||+|++...    .. .....+.+|+.+++.++ ||||++++++    
T Consensus        13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev----   88 (370)
T KOG0583|consen   13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEV----   88 (370)
T ss_pred             ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEE----
Confidence            35567899999999999999999999999999999987643    12 23456778999999999 9999999999    


Q ss_pred             cCCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCC-CcEEE
Q 046639          100 DFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQD-IVAHV  178 (331)
Q Consensus       100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~-~~~kl  178 (331)
                       +.....+++||||+.+|+|.+++..  ...+.+..+..++.|+++|++|+|++   ||+||||||+||+++.+ +++||
T Consensus        89 -~~t~~~~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl  162 (370)
T KOG0583|consen   89 -FATPTKIYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKL  162 (370)
T ss_pred             -EecCCeEEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEE
Confidence             5556679999999999999999987  33466789999999999999999999   99999999999999999 99999


Q ss_pred             cccCcccccccCCCCCcccccCCceeecccccccCCcccCCCC-C-ccchhhHhHHHHHHHHHhCCCCCCcccCCcchHH
Q 046639          179 GDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSK-A-SVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLH  256 (331)
Q Consensus       179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~  256 (331)
                      +|||++....        .........+||+.|+|||++.+.. | +.++||||+|++||.|++|..||++... ...+.
T Consensus       163 ~DFG~s~~~~--------~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~-~~l~~  233 (370)
T KOG0583|consen  163 SDFGLSAISP--------GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV-PNLYR  233 (370)
T ss_pred             eccccccccC--------CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH-HHHHH
Confidence            9999998751        2234455678999999999999977 7 5789999999999999999999986211 11111


Q ss_pred             HHHHhhCcchhhhhcCcccccccccCCcchHHHH-HHHHHHhhccccCCCCCCCCcHHHHH
Q 046639          257 EFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDC-LVAVIGTGVTCSMESPMERMEMRDVV  316 (331)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~l~~~cl~~~P~~Rps~~~i~  316 (331)
                      .                     +..+...++..+ ...+.+|+.+||..||.+|+|+.+|+
T Consensus       234 k---------------------i~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  234 K---------------------IRKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL  273 (370)
T ss_pred             H---------------------HhcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence            1                     112222333344 77889999999999999999999998

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.4e-46  Score=325.26  Aligned_cols=271  Identities=24%  Similarity=0.283  Sum_probs=210.3

Q ss_pred             CCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           31 NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ--KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      .|..+++||+|.||.||+|++..+++.||+|.+...+  ++......+|+.+|++|.||||+++.+...+.   ....+|
T Consensus       118 ~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~---~~~siY  194 (560)
T KOG0600|consen  118 SFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK---LSGSIY  194 (560)
T ss_pred             HHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec---CCceEE
Confidence            5888999999999999999999999999999998765  55557788999999999999999999986543   256899


Q ss_pred             EEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccc
Q 046639          109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLF  188 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~  188 (331)
                      +|+||| .-+|.-++.. ++-.++..++..++.|++.||.|+|++   ||+|||||..|||||.+|.+||+|||+|+++.
T Consensus       195 lVFeYM-dhDL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~  269 (560)
T KOG0600|consen  195 LVFEYM-DHDLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYT  269 (560)
T ss_pred             EEEecc-cchhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeecc
Confidence            999999 6699988864 445678899999999999999999999   99999999999999999999999999999773


Q ss_pred             cCCCCCcccccCCceeecccccccCCcccCCC-CCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcch-
Q 046639          189 GYEPGTAAETASNSIEIKGIVGYVAPEYGMGS-KASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDK-  266 (331)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-  266 (331)
                      ...       .........|.+|+|||++.|. .|+.+.|+||.||||.||+.|++.|++.. +-.++..+.+..-... 
T Consensus       270 ~~~-------~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~t-EveQl~kIfklcGSP~e  341 (560)
T KOG0600|consen  270 PSG-------SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRT-EVEQLHKIFKLCGSPTE  341 (560)
T ss_pred             CCC-------CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCcc-HHHHHHHHHHHhCCCCh
Confidence            221       1123455689999999999986 59999999999999999999999998742 3333444433322211 


Q ss_pred             --hh--hhcCcccccc---cccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          267 --VM--EIVDPSLLLE---VTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       267 --~~--~~~~~~~~~~---~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                        +.  .+........   ......+.....+....+|+..+|..||++|.||.++++
T Consensus       342 ~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  342 DYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             hccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence              11  1111000000   000011123345567889999999999999999998874

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.7e-46  Score=329.95  Aligned_cols=247  Identities=26%  Similarity=0.386  Sum_probs=209.2

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc--chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCccee
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      ++|.+.+.||+|.||.||+|+.+.+.+.||+|.+.+.  .....+.+.+|+++++.++||||+.++++     |++..++
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~es-----fEt~~~~   76 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLES-----FETSAHL   76 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHh-----hcccceE
Confidence            6899999999999999999999999999999999644  34456779999999999999999999999     7888999


Q ss_pred             eEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccc
Q 046639          108 AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      ++|+||+.| +|..++....  .++++.+..++.++++||.|||+.   +|+|||+||.||++..+|.+|++|||+|+-+
T Consensus        77 ~vVte~a~g-~L~~il~~d~--~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m  150 (808)
T KOG0597|consen   77 WVVTEYAVG-DLFTILEQDG--KLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAM  150 (808)
T ss_pred             EEEehhhhh-hHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhc
Confidence            999999955 9999997644  478899999999999999999999   9999999999999999999999999999976


Q ss_pred             ccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchh
Q 046639          188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKV  267 (331)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  267 (331)
                      .        .......+..|||.|||||+..+++|+..+|.||+|||+||+++|++||...     .+...++.....  
T Consensus       151 ~--------~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-----si~~Lv~~I~~d--  215 (808)
T KOG0597|consen  151 S--------TNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-----SITQLVKSILKD--  215 (808)
T ss_pred             c--------cCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-----HHHHHHHHHhcC--
Confidence            2        2234455678999999999999999999999999999999999999999642     112222211111  


Q ss_pred             hhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          268 MEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                                     ...++.+....+..++...|.+||.+|.|..+++.
T Consensus       216 ---------------~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  216 ---------------PVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             ---------------CCCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence                           11223356677889999999999999999999874

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-46  Score=303.94  Aligned_cols=238  Identities=22%  Similarity=0.261  Sum_probs=204.3

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcc
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFD  105 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~  105 (331)
                      ..+|.+++.||.|+||.|.+++.+.++..+|+|++++..   ....+...+|-++|+.+.||.++++++.     +.+..
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t-----~~d~~  117 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGT-----FKDNS  117 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEe-----eccCC
Confidence            346999999999999999999999999999999997543   3445667899999999999999999998     45567


Q ss_pred             eeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccc
Q 046639          106 FKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAK  185 (331)
Q Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~  185 (331)
                      ++++||||++||.|.+++++.+  .+++..++.++.||+.||.|||++   +|++||+||+|||+|.+|.+||+|||+|+
T Consensus       118 ~lymvmeyv~GGElFS~Lrk~~--rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK  192 (355)
T KOG0616|consen  118 NLYMVMEYVPGGELFSYLRKSG--RFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAK  192 (355)
T ss_pred             eEEEEEeccCCccHHHHHHhcC--CCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceE
Confidence            8999999999999999997654  478899999999999999999999   99999999999999999999999999998


Q ss_pred             ccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcc
Q 046639          186 FLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPD  265 (331)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  265 (331)
                      ..           .......+|||.|+|||++...+|+.++|.||||+++|||+.|.+||..... ...+..++.     
T Consensus       193 ~v-----------~~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-~~iY~KI~~-----  255 (355)
T KOG0616|consen  193 RV-----------SGRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-IQIYEKILE-----  255 (355)
T ss_pred             Ee-----------cCcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-HHHHHHHHh-----
Confidence            75           2235678899999999999999999999999999999999999999976422 222333222     


Q ss_pred             hhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCC
Q 046639          266 KVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMER  309 (331)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~R  309 (331)
                                      +...|+.-...++.+|+..+|+.|-.+|
T Consensus       256 ----------------~~v~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  256 ----------------GKVKFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             ----------------CcccCCcccCHHHHHHHHHHHhhhhHhh
Confidence                            2224455567788899999999999988

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.3e-45  Score=328.84  Aligned_cols=263  Identities=20%  Similarity=0.306  Sum_probs=203.3

Q ss_pred             hcCCCcCceeeccCeeEEEEeeec-----CCCceEEEEEeeccc-hhhHHHHHHHHHHHHcC-CCCCcceeeceeecccC
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILD-----ESRSIVAVKVVNLKQ-KEASRSFAAECNALRNI-RHRNLIKIITICSSIDF  101 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~  101 (331)
                      .++|.+.+.||+|+||.||+|.+.     .+++.||+|++.... ......+.+|+.++..+ +||||++++++|.    
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~----   81 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACT----   81 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEec----
Confidence            357999999999999999999752     345689999986432 23346688999999999 8999999999874    


Q ss_pred             CCcceeeEEEeecCCCCHHHHHHhcc------------------------------------------------------
Q 046639          102 EGFDFKAIVFEYMQNRNLEQWLRQSN------------------------------------------------------  127 (331)
Q Consensus       102 ~~~~~~~lv~e~~~~~~L~~~l~~~~------------------------------------------------------  127 (331)
                      ......+++|||+++|+|.+++....                                                      
T Consensus        82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (338)
T cd05102          82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ  161 (338)
T ss_pred             CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence            33456799999999999999997532                                                      


Q ss_pred             ------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccccCCCCCcccccCC
Q 046639          128 ------GQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASN  201 (331)
Q Consensus       128 ------~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  201 (331)
                            ...+.+..+..++.|++.||.|||++   +|+||||||+||+++.++.++|+|||+++......      ....
T Consensus       162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~------~~~~  232 (338)
T cd05102         162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDP------DYVR  232 (338)
T ss_pred             hccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCc------chhc
Confidence                  12356677888999999999999999   99999999999999999999999999997642111      0111


Q ss_pred             ceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhCcchhhhhcCcccccccc
Q 046639          202 SIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVT  280 (331)
Q Consensus       202 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (331)
                      .....+++.|+|||++.+..++.++||||||+++|||++ |..||....... .+........        ..       
T Consensus       233 ~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-~~~~~~~~~~--------~~-------  296 (338)
T cd05102         233 KGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-EFCQRLKDGT--------RM-------  296 (338)
T ss_pred             ccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-HHHHHHhcCC--------CC-------
Confidence            122335677999999999899999999999999999997 999997643221 1111111000        00       


Q ss_pred             cCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhh
Q 046639          281 ANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARE  324 (331)
Q Consensus       281 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~  324 (331)
                          ..+..++..+.+|+.+||+.||++|||+.+|++.|+.+.+
T Consensus       297 ----~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         297 ----RAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             ----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence                0112345678999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-46  Score=341.84  Aligned_cols=272  Identities=19%  Similarity=0.228  Sum_probs=219.7

Q ss_pred             HHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCC-CCCcceeece-eecccCCC-
Q 046639           27 KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIR-HRNLIKIITI-CSSIDFEG-  103 (331)
Q Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~-~~~~~~~~-  103 (331)
                      ....+++|.+.|.+|||+.||.|.+...+..||+|++-..+....+.+.+|+.+|+.|. |+|||.+++. .......+ 
T Consensus        34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~  113 (738)
T KOG1989|consen   34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG  113 (738)
T ss_pred             ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence            34567888999999999999999999887999999998778888899999999999996 9999999994 22221222 


Q ss_pred             cceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCc
Q 046639          104 FDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGL  183 (331)
Q Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~  183 (331)
                      .-.++|.||||.+|+|-++++.+-...+.+.++++|+.|++.|+++||.. .+.|+|||||.+||||+.+|+.||||||.
T Consensus       114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGS  192 (738)
T KOG1989|consen  114 VWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGS  192 (738)
T ss_pred             eeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccc
Confidence            34578999999999999999987767799999999999999999999998 56799999999999999999999999999


Q ss_pred             ccccccCC-CCCcccccCCceeecccccccCCccc---CCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHH
Q 046639          184 AKFLFGYE-PGTAAETASNSIEIKGIVGYVAPEYG---MGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFV  259 (331)
Q Consensus       184 a~~~~~~~-~~~~~~~~~~~~~~~~t~~y~aPE~~---~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~  259 (331)
                      |.-..-.. ................|+.|+|||.+   .+.++++|+|||+|||+||.|+....||+....-.       
T Consensus       193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la-------  265 (738)
T KOG1989|consen  193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA-------  265 (738)
T ss_pred             cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee-------
Confidence            87542211 11112222223345579999999975   46789999999999999999999999998641111       


Q ss_pred             HhhCcchhhhhcCcccccccccCCcchH--HHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhh
Q 046639          260 KMALPDKVMEIVDPSLLLEVTANNYSWI--EDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARET  325 (331)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~  325 (331)
                                ++         .+.+.++  ..+...|.+||..||+.||++||++-+|++.+-.+...
T Consensus       266 ----------Il---------ng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~  314 (738)
T KOG1989|consen  266 ----------IL---------NGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK  314 (738)
T ss_pred             ----------EE---------eccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence                      11         1111222  25788999999999999999999999999999887654

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=7.3e-45  Score=318.51  Aligned_cols=257  Identities=19%  Similarity=0.244  Sum_probs=203.6

Q ss_pred             HHHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCC
Q 046639           26 SKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNIRHRNLIKIITICSSIDFE  102 (331)
Q Consensus        26 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  102 (331)
                      +...++|.+++.||+|+||.||+|+.+.||..+|+|++++..   .........|=.+|....+|.||+++..     |.
T Consensus       137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYs-----FQ  211 (550)
T KOG0605|consen  137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYS-----FQ  211 (550)
T ss_pred             cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEE-----ec
Confidence            346678999999999999999999999999999999997553   3445667888999999899999999988     67


Q ss_pred             CcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccC
Q 046639          103 GFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLG  182 (331)
Q Consensus       103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg  182 (331)
                      +..++||||||++||++..+|.+..  .+++..+..++.+++-|+..+|..   |++||||||+|+|||..|++||+|||
T Consensus       212 D~~~LYLiMEylPGGD~mTLL~~~~--~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFG  286 (550)
T KOG0605|consen  212 DKEYLYLIMEYLPGGDMMTLLMRKD--TLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFG  286 (550)
T ss_pred             CCCeeEEEEEecCCccHHHHHHhcC--cCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeecccc
Confidence            7789999999999999999997654  478899999999999999999999   99999999999999999999999999


Q ss_pred             cccccccCCC--------------CC-cccc------------------------cCCceeecccccccCCcccCCCCCc
Q 046639          183 LAKFLFGYEP--------------GT-AAET------------------------ASNSIEIKGIVGYVAPEYGMGSKAS  223 (331)
Q Consensus       183 ~a~~~~~~~~--------------~~-~~~~------------------------~~~~~~~~~t~~y~aPE~~~~~~~~  223 (331)
                      ++.-+.....              .. ....                        .....+..|||.|+|||++.+..|+
T Consensus       287 Ls~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~  366 (550)
T KOG0605|consen  287 LSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYG  366 (550)
T ss_pred             ccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCC
Confidence            9864422000              00 0000                        0011246699999999999999999


Q ss_pred             cchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccC
Q 046639          224 VSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSM  303 (331)
Q Consensus       224 ~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  303 (331)
                      ..+|.||||||+||||.|.+||..... ...+..+......     +.-|       .     -..+.++..+||++||.
T Consensus       367 ~~cDwWSLG~ImyEmLvGyPPF~s~tp-~~T~rkI~nwr~~-----l~fP-------~-----~~~~s~eA~DLI~rll~  428 (550)
T KOG0605|consen  367 KECDWWSLGCIMYEMLVGYPPFCSETP-QETYRKIVNWRET-----LKFP-------E-----EVDLSDEAKDLITRLLC  428 (550)
T ss_pred             ccccHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhhh-----ccCC-------C-----cCcccHHHHHHHHHHhc
Confidence            999999999999999999999976432 2233333221110     0000       0     01344788999999999


Q ss_pred             CCCCCCCc
Q 046639          304 ESPMERME  311 (331)
Q Consensus       304 ~~P~~Rps  311 (331)
                       ||++|..
T Consensus       429 -d~~~RLG  435 (550)
T KOG0605|consen  429 -DPENRLG  435 (550)
T ss_pred             -CHHHhcC
Confidence             9999965

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-45  Score=329.47  Aligned_cols=247  Identities=19%  Similarity=0.309  Sum_probs=214.2

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      +-|+.++.||.|+.|.|-+|++..||+.+|||++....   ......+.+|+-+|+.+.|||++.++++     |++..+
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydV-----we~~~~   86 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDV-----WENKQH   86 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeee-----eccCce
Confidence            45888999999999999999999999999999997552   2234568899999999999999999999     888999


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      +|+|.||+++|-|++++-+.+  ++++..+..++.||+.|+.|+|..   +|+|||+||+|++++..+++||+|||+|..
T Consensus        87 lylvlEyv~gGELFdylv~kG--~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsL  161 (786)
T KOG0588|consen   87 LYLVLEYVPGGELFDYLVRKG--PLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASL  161 (786)
T ss_pred             EEEEEEecCCchhHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeec
Confidence            999999999999999997654  477899999999999999999999   999999999999999999999999999976


Q ss_pred             cccCCCCCcccccCCceeecccccccCCcccCCCCC-ccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcc
Q 046639          187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKA-SVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPD  265 (331)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  265 (331)
                      -         .........+|+|.|+|||+..|.+| +.++||||.|+|||.|++|..||++.     .+...+      
T Consensus       162 e---------~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd-----Nir~LL------  221 (786)
T KOG0588|consen  162 E---------VPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD-----NIRVLL------  221 (786)
T ss_pred             c---------cCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc-----cHHHHH------
Confidence            3         34455566789999999999999998 78999999999999999999999742     222222      


Q ss_pred             hhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          266 KVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                                 .+...+.+..+.+.+.+..+|+.+||..||+.|.|..+|++
T Consensus       222 -----------lKV~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~k  262 (786)
T KOG0588|consen  222 -----------LKVQRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILK  262 (786)
T ss_pred             -----------HHHHcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhh
Confidence                       22334445666778889999999999999999999999986

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-45  Score=294.41  Aligned_cols=281  Identities=18%  Similarity=0.206  Sum_probs=220.5

Q ss_pred             HHHHHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCC
Q 046639           24 ELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEG  103 (331)
Q Consensus        24 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  103 (331)
                      ++....+||++.+.||.|||+-||.++...+++.||+|.+.+...+..+..++|++..++++|||++++++++....-+.
T Consensus        15 tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~   94 (302)
T KOG2345|consen   15 TVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG   94 (302)
T ss_pred             cEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence            44556789999999999999999999999999999999998888778888999999999999999999999987554456


Q ss_pred             cceeeEEEeecCCCCHHHHHHh--ccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEccc
Q 046639          104 FDFKAIVFEYMQNRNLEQWLRQ--SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDL  181 (331)
Q Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Df  181 (331)
                      ....|+++.|+..|+|.+.++.  ..+..+++..++.|+.+++.||.+||... +.+.|+||||.||++++.+.+++.||
T Consensus        95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~  173 (302)
T KOG2345|consen   95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDL  173 (302)
T ss_pred             ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEec
Confidence            6778999999999999999987  34556888999999999999999999992 24999999999999999999999999


Q ss_pred             CcccccccCCC-CCcccccCCceeecccccccCCcccCC---CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHH
Q 046639          182 GLAKFLFGYEP-GTAAETASNSIEIKGIVGYVAPEYGMG---SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHE  257 (331)
Q Consensus       182 g~a~~~~~~~~-~~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~  257 (331)
                      |.++...-.-. +..............|..|+|||.+.-   ...++++|||||||+||.|+.|..||+.....+..+.-
T Consensus       174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaL  253 (302)
T KOG2345|consen  174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLAL  253 (302)
T ss_pred             cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEE
Confidence            99876521111 111111111223447888999998764   45789999999999999999999999754332211110


Q ss_pred             HHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhh
Q 046639          258 FVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHAR  323 (331)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~  323 (331)
                                 ...+..+...  .     -...+..+.+++..||+.||.+||++.+++..++.+.
T Consensus       254 -----------Av~n~q~s~P--~-----~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  254 -----------AVQNAQISIP--N-----SSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             -----------eeeccccccC--C-----CCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence                       0001011000  0     0125678999999999999999999999999988763

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-45  Score=307.40  Aligned_cols=278  Identities=21%  Similarity=0.279  Sum_probs=215.1

Q ss_pred             HHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEee--ccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCc
Q 046639           27 KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVN--LKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGF  104 (331)
Q Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  104 (331)
                      .....|..++.||+|++|.|+.|.+..++..||||.+.  ..+....++..+|+.+++.++|+||+.+.+++.....+..
T Consensus        19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f   98 (359)
T KOG0660|consen   19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF   98 (359)
T ss_pred             eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence            45567787899999999999999999999999999986  5566667888999999999999999999999877556677


Q ss_pred             ceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcc
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA  184 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a  184 (331)
                      +.+|+|+|++ +.+|.+.++.+.  .+...++..++.|++.||.|+|+.   +++|||+||.|++++.+..+||+|||+|
T Consensus        99 ~DvYiV~elM-etDL~~iik~~~--~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLA  172 (359)
T KOG0660|consen   99 NDVYLVFELM-ETDLHQIIKSQQ--DLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLA  172 (359)
T ss_pred             ceeEEehhHH-hhHHHHHHHcCc--cccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccce
Confidence            8899999999 889999996543  477789999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCcccccCCceeecccccccCCcccCC-CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHh--
Q 046639          185 KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG-SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKM--  261 (331)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~--  261 (331)
                      +.....      ........+..|.+|.|||++.. ..|+...||||+|||+.||++|++.|++... -.++..+...  
T Consensus       173 R~~~~~------~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~-v~Ql~lI~~~lG  245 (359)
T KOG0660|consen  173 RYLDKF------FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDY-VHQLQLILELLG  245 (359)
T ss_pred             eecccc------CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCch-HHHHHHHHHhcC
Confidence            986322      22233345678999999998654 6799999999999999999999999986421 1111111111  


Q ss_pred             hCcchhhhhcCc--------ccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          262 ALPDKVMEIVDP--------SLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       262 ~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ..+......+.+        .+.............+..+...+|+.+||..||.+|+|+.|.++
T Consensus       246 tP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  246 TPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             CCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence            111111111110        01111111112333366778899999999999999999999874

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=3.8e-44  Score=311.94  Aligned_cols=252  Identities=22%  Similarity=0.253  Sum_probs=200.1

Q ss_pred             CCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCccee
Q 046639           31 NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      .|.+.+.||+|+||+||+|.+..+++.||+|.+....   ......+.+|+.+++.++|++++++.+++     ...+..
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~-----~~~~~~   75 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAY-----ETKDAL   75 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEE-----ccCCeE
Confidence            4788899999999999999999999999999986432   22234577899999999999999999884     445678


Q ss_pred             eEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccc
Q 046639          108 AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      ++|||++++++|.+.+.......+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++...
T Consensus        76 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~  152 (285)
T cd05631          76 CLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQI  152 (285)
T ss_pred             EEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEc
Confidence            9999999999999888765555678888999999999999999999   9999999999999999999999999998764


Q ss_pred             ccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchh
Q 046639          188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKV  267 (331)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  267 (331)
                      ..         ........||+.|+|||++.+..++.++||||||+++|+|++|..||....... ....... ..... 
T Consensus       153 ~~---------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-~~~~~~~-~~~~~-  220 (285)
T cd05631         153 PE---------GETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV-KREEVDR-RVKED-  220 (285)
T ss_pred             CC---------CCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch-hHHHHHH-Hhhcc-
Confidence            11         111223458899999999999999999999999999999999999997542211 1111111 11000 


Q ss_pred             hhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCc-----HHHHHH
Q 046639          268 MEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERME-----MRDVVA  317 (331)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps-----~~~i~~  317 (331)
                                     ...+.......+.+|+.+||+.||.+||+     +.++++
T Consensus       221 ---------------~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         221 ---------------QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             ---------------cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence                           00112234567889999999999999997     777775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-46  Score=319.52  Aligned_cols=250  Identities=20%  Similarity=0.279  Sum_probs=208.8

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccch-hhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCccee
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK-EASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      ...|+..+.||+|.||.||+|.+..+++.||+|++..+.. .....+..|+.++..++++||.++++.+     -.+..+
T Consensus        12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsy-----l~g~~L   86 (467)
T KOG0201|consen   12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSY-----LKGTKL   86 (467)
T ss_pred             ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhhe-----eecccH
Confidence            3468889999999999999999999999999999976643 3457899999999999999999999984     446789


Q ss_pred             eEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccc
Q 046639          108 AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      +++||||.||++.++++..+  .+.+..+.-++.+++.|+.|||+.   +.+|+|||+.||++..+|.+||+|||.+-.+
T Consensus        87 wiiMey~~gGsv~~lL~~~~--~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql  161 (467)
T KOG0201|consen   87 WIIMEYCGGGSVLDLLKSGN--ILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQL  161 (467)
T ss_pred             HHHHHHhcCcchhhhhccCC--CCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeee
Confidence            99999999999999996543  346677778899999999999999   9999999999999999999999999999765


Q ss_pred             ccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchh
Q 046639          188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKV  267 (331)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  267 (331)
                              ...........|||.|||||++.+..|+.++||||||++.+||++|.+|+....+              ..+
T Consensus       162 --------~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP--------------mrv  219 (467)
T KOG0201|consen  162 --------TNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP--------------MRV  219 (467)
T ss_pred             --------echhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc--------------ceE
Confidence                    2333344678899999999999999999999999999999999999999976432              122


Q ss_pred             hhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          268 MEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ..++......       .+..++.+.|.+++..||..||+.||||.++++
T Consensus       220 lflIpk~~PP-------~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  220 LFLIPKSAPP-------RLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             EEeccCCCCC-------ccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            2222211111       122367788999999999999999999999985

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.7e-45  Score=319.68  Aligned_cols=253  Identities=22%  Similarity=0.298  Sum_probs=214.5

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ--KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      .++|..++++|+|+||.++.++++..++.+++|.+....  ....+...+|+.+++++.|||||.+.+.     |..++.
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds-----~~~~~~   77 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDS-----FEEDGQ   77 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccc-----hhcCCc
Confidence            357999999999999999999999999999999997554  3334578899999999999999999999     444455


Q ss_pred             -eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccc
Q 046639          107 -KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAK  185 (331)
Q Consensus       107 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~  185 (331)
                       ++|||+||+||++.+.+.+..+..+++..+..|+.|++.|+.|||++   +|+|||||+.||+++.++.|+|+|||+|+
T Consensus        78 ~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK  154 (426)
T KOG0589|consen   78 LLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAK  154 (426)
T ss_pred             eEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhh
Confidence             99999999999999999998888899999999999999999999998   99999999999999999999999999999


Q ss_pred             ccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcc
Q 046639          186 FLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPD  265 (331)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  265 (331)
                      .+.        ..........||+.|++||.+.+.+|+.|+|||||||++|||++-+++|............. ...   
T Consensus       155 ~l~--------~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~-~~~---  222 (426)
T KOG0589|consen  155 ILN--------PEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKIN-RGL---  222 (426)
T ss_pred             hcC--------CchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHh-hcc---
Confidence            872        12224556789999999999999999999999999999999999999998653322211111 100   


Q ss_pred             hhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHH
Q 046639          266 KVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAK  318 (331)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~  318 (331)
                                       ....+.....++..++..||+.+|+.||++.+++..
T Consensus       223 -----------------~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  223 -----------------YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             -----------------CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence                             012233567789999999999999999999999876

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=9.9e-44  Score=308.82  Aligned_cols=268  Identities=16%  Similarity=0.245  Sum_probs=208.3

Q ss_pred             hccCCcccHHHHHHHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchh---hHHHHHHHHHHHHcCCCCCcc
Q 046639           14 KQQFPMISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKE---ASRSFAAECNALRNIRHRNLI   90 (331)
Q Consensus        14 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~   90 (331)
                      -....+++..+|.     ......||+|+++.||+|.+  +++.||+|.+......   ..+.+.+|+.++++++||||+
T Consensus         9 ~~~~~~i~~~~i~-----~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv   81 (283)
T PHA02988          9 INDIKCIESDDID-----KYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNIL   81 (283)
T ss_pred             cCcceecCHHHcC-----CCCCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEE
Confidence            3455667777762     33346899999999999998  5889999998654322   246678999999999999999


Q ss_pred             eeeceeecccCCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEe
Q 046639           91 KIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILL  170 (331)
Q Consensus        91 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv  170 (331)
                      ++++++... .......++||||+++|+|.+++....  .+++.....++.+++.|+.+||+..  +++|+||||+||++
T Consensus        82 ~~~g~~~~~-~~~~~~~~lv~Ey~~~g~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill  156 (283)
T PHA02988         82 KIYGFIIDI-VDDLPRLSLILEYCTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLV  156 (283)
T ss_pred             EEeeeEEec-ccCCCceEEEEEeCCCCcHHHHHhhCC--CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEE
Confidence            999987542 123456799999999999999997643  4677888999999999999999743  78899999999999


Q ss_pred             cCCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCC--CCCccchhhHhHHHHHHHHHhCCCCCCcc
Q 046639          171 DQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG--SKASVSGDVYNFGILLLEMFTRRRPTDAM  248 (331)
Q Consensus       171 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~  248 (331)
                      +.++.+||+|||++......           .....++..|+|||++.+  ..++.++||||||+++|||++|..||...
T Consensus       157 ~~~~~~kl~dfg~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~  225 (283)
T PHA02988        157 TENYKLKIICHGLEKILSSP-----------PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL  225 (283)
T ss_pred             CCCCcEEEcccchHhhhccc-----------cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCC
Confidence            99999999999998765211           112347788999999876  67899999999999999999999999754


Q ss_pred             cCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhh
Q 046639          249 FNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARE  324 (331)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~  324 (331)
                      ... ..+.........        +           ..+..++..+.+++.+||+.||++|||+.+|++.|+.++.
T Consensus       226 ~~~-~~~~~i~~~~~~--------~-----------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        226 TTK-EIYDLIINKNNS--------L-----------KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             CHH-HHHHHHHhcCCC--------C-----------CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence            211 111111111000        0           1112467789999999999999999999999999998865

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-45  Score=322.09  Aligned_cols=259  Identities=24%  Similarity=0.367  Sum_probs=206.7

Q ss_pred             CCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc--chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           31 NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      +..+++.||+|.||+||+|.|.+   .||||+++..  .++..+.|.+|+.++++-+|.||+-+.|+|...     . +.
T Consensus       393 ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p-----~-~A  463 (678)
T KOG0193|consen  393 EVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP-----P-LA  463 (678)
T ss_pred             Hhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC-----c-ee
Confidence            47788999999999999999964   3999999755  455678899999999999999999999997543     2 38


Q ss_pred             EEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccc
Q 046639          109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLF  188 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~  188 (331)
                      ||+.+|+|-+|..++.... ..+.+...+.|+.|++.|+.|||.+   +|+|+|||..||++.++++|||+|||++..-.
T Consensus       464 IiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~  539 (678)
T KOG0193|consen  464 IITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT  539 (678)
T ss_pred             eeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeeee
Confidence            9999999999999997654 3577888899999999999999999   99999999999999999999999999998653


Q ss_pred             cCCCCCcccccCCceeecccccccCCcccCC---CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcc
Q 046639          189 GYEPGTAAETASNSIEIKGIVGYVAPEYGMG---SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPD  265 (331)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  265 (331)
                      .+...      .......|...|+|||++..   .+|++.+||||||+++|||++|..||.....+...+ ..-..... 
T Consensus       540 ~w~g~------~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIif-mVGrG~l~-  611 (678)
T KOG0193|consen  540 RWSGE------QQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIF-MVGRGYLM-  611 (678)
T ss_pred             eeccc------cccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEE-EecccccC-
Confidence            33221      12222346667999999764   368999999999999999999999998432221111 10011111 


Q ss_pred             hhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhh
Q 046639          266 KVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARET  325 (331)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~  325 (331)
                                     +.......+|+.++.+|+..||..++++||++.+|+..|+.+..+
T Consensus       612 ---------------pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~  656 (678)
T KOG0193|consen  612 ---------------PDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS  656 (678)
T ss_pred             ---------------ccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence                           111122347899999999999999999999999999988888764

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-44  Score=314.77  Aligned_cols=245  Identities=22%  Similarity=0.247  Sum_probs=199.0

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      ++|.+.+.||+|+||.||+|.+..+++.||+|.+....   ......+.+|+.+++.++||||++++++     +.+...
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~-----~~~~~~   75 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWT-----EHDQRF   75 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhh-----hccCCe
Confidence            47999999999999999999999999999999986432   2334568899999999999999999988     455678


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      .++||||+++++|.+++....  .++...+..++.|++.||+|||++   +++|+||||+||+++.++.++|+|||++..
T Consensus        76 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~  150 (291)
T cd05612          76 LYMLMEYVPGGELFSYLRNSG--RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKK  150 (291)
T ss_pred             EEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchh
Confidence            999999999999999997643  467788889999999999999999   999999999999999999999999999876


Q ss_pred             cccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcch
Q 046639          187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDK  266 (331)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  266 (331)
                      ...           ......|++.|+|||++.+..++.++||||||+++|+|++|..||...... ..........    
T Consensus       151 ~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~----  214 (291)
T cd05612         151 LRD-----------RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF-GIYEKILAGK----  214 (291)
T ss_pred             ccC-----------CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCC----
Confidence            521           112345889999999999988999999999999999999999999753211 1111111100    


Q ss_pred             hhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCc-----HHHHHH
Q 046639          267 VMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERME-----MRDVVA  317 (331)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps-----~~~i~~  317 (331)
                                       ..++......+.+|+.+||+.||.+||+     +.++++
T Consensus       215 -----------------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  253 (291)
T cd05612         215 -----------------LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN  253 (291)
T ss_pred             -----------------cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence                             0111223557889999999999999995     888764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=5.7e-44  Score=311.20  Aligned_cols=270  Identities=21%  Similarity=0.274  Sum_probs=200.5

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCccee
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ--KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      ++|.+.+.||+|+||+||+|++..+++.||+|++....  ......+.+|+.+++.++||||+++++++     ...+..
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~   75 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAF-----RRRGKL   75 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhE-----ecCCEE
Confidence            47999999999999999999999999999999986432  33346678999999999999999999984     455688


Q ss_pred             eEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccc
Q 046639          108 AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      ++||||++++++..+...  ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++...
T Consensus        76 ~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  150 (287)
T cd07848          76 YLVFEYVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNL  150 (287)
T ss_pred             EEEEecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccc
Confidence            999999987666554432  23467788899999999999999999   9999999999999999999999999998765


Q ss_pred             ccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHh--hCcc
Q 046639          188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKM--ALPD  265 (331)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~--~~~~  265 (331)
                      ...       .........+++.|+|||++.+..++.++||||||+++|+|++|.+||....... ........  ..+.
T Consensus       151 ~~~-------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~  222 (287)
T cd07848         151 SEG-------SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEID-QLFTIQKVLGPLPA  222 (287)
T ss_pred             ccc-------ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhhCCCCH
Confidence            211       1111223458889999999998889999999999999999999999997643211 11111110  1110


Q ss_pred             hhhhhc--Cccc-------ccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          266 KVMEIV--DPSL-------LLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       266 ~~~~~~--~~~~-------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ......  ++..       ..........+...++..+.+|+.+||+.||++|||+.++++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         223 EQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             HHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            000000  0000       000000001122235678999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=7.2e-44  Score=310.99  Aligned_cols=274  Identities=19%  Similarity=0.271  Sum_probs=201.4

Q ss_pred             cCCCcCceeeccCeeEEEEeeecC-CCceEEEEEeeccc--hhhHHHHHHHHHHHHcC---CCCCcceeeceeecccCCC
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDE-SRSIVAVKVVNLKQ--KEASRSFAAECNALRNI---RHRNLIKIITICSSIDFEG  103 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~~~  103 (331)
                      ++|.+.+.||+|+||+||+|++.. ++..||+|.+....  ........+|+.+++.+   .||||++++++|.......
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            479999999999999999999854 46789999886432  22233456677777665   6999999999986544445


Q ss_pred             cceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCc
Q 046639          104 FDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGL  183 (331)
Q Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~  183 (331)
                      ....++|||++ .++|.+++.......+++..+..++.|++.||.|||++   +++|+||||+||+++.++.++|+|||+
T Consensus        81 ~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T cd07862          81 ETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL  156 (290)
T ss_pred             CCcEEEEEccC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccc
Confidence            66789999999 56999999876555678889999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhC
Q 046639          184 AKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMAL  263 (331)
Q Consensus       184 a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  263 (331)
                      +.....         ........+++.|+|||++.+..++.++||||||+++|+|++|.+||...... ..+........
T Consensus       157 ~~~~~~---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~-~~~~~i~~~~~  226 (290)
T cd07862         157 ARIYSF---------QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILDVIG  226 (290)
T ss_pred             eEeccC---------CcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH-HHHHHHHHHhC
Confidence            976411         12223445889999999998889999999999999999999999999764221 12222221111


Q ss_pred             cchhhh------hcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          264 PDKVME------IVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       264 ~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ......      ...................+....+.+++.+||+.||++|||+.++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         227 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             CCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            000000      000000000000000111234567889999999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.2e-43  Score=316.36  Aligned_cols=275  Identities=21%  Similarity=0.249  Sum_probs=200.9

Q ss_pred             CCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc--chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           31 NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      +|.+.+.||+|+||.||+|++..++..||+|.+...  .......+.+|+.+++.++||||+++++++...........+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            588999999999999999999999999999998632  223345688999999999999999999987654444455689


Q ss_pred             EEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccc
Q 046639          109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLF  188 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~  188 (331)
                      +|||++ +++|.+++....  .+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||+++...
T Consensus        81 lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~  154 (338)
T cd07859          81 VVFELM-ESDLHQVIKAND--DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAF  154 (338)
T ss_pred             EEEecC-CCCHHHHHHhcc--cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence            999999 679999986543  477888999999999999999999   99999999999999999999999999987542


Q ss_pred             cCCCCCcccccCCceeecccccccCCcccCC--CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHh--hCc
Q 046639          189 GYEPGTAAETASNSIEIKGIVGYVAPEYGMG--SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKM--ALP  264 (331)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~--~~~  264 (331)
                      ....     .........+|+.|+|||++.+  ..++.++||||||+++|+|++|..||....... ........  ..+
T Consensus       155 ~~~~-----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~  228 (338)
T cd07859         155 NDTP-----TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH-QLDLITDLLGTPS  228 (338)
T ss_pred             cccC-----ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH-HHHHHHHHhCCCC
Confidence            1111     1111233568899999999876  678999999999999999999999997532110 01000000  000


Q ss_pred             ch-hhhhcCc-------ccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          265 DK-VMEIVDP-------SLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       265 ~~-~~~~~~~-------~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      .. .......       ................+...+.+++.+||+.||++|||+.++++
T Consensus       229 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         229 PETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             HHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            00 0000000       00000000000111124566889999999999999999999984

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=8e-44  Score=299.49  Aligned_cols=277  Identities=22%  Similarity=0.300  Sum_probs=210.4

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchh--hHHHHHHHHHHHHcCCCCC-cceeeceeeccc-CCCc
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKE--ASRSFAAECNALRNIRHRN-LIKIITICSSID-FEGF  104 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~-~~~~  104 (331)
                      ...|..+++||+|+||+||+|+...+|+.||+|.+......  .-....+|+.+++.++|+| |+.+.+++.... ....
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            44678888999999999999999999999999999766442  3355689999999999999 999999976533 2334


Q ss_pred             ceeeEEEeecCCCCHHHHHHhccC--CccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccC
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQSNG--QLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLG  182 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg  182 (331)
                      ..+++|+|++ ..+|..++.....  ...+...+..++.|++.||+|||++   +|+||||||+||+|+.+|.+||+|||
T Consensus        90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccc
Confidence            4789999999 7799999988553  3566678999999999999999999   99999999999999999999999999


Q ss_pred             cccccccCCCCCcccccCCceeecccccccCCcccCCC-CCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHh
Q 046639          183 LAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGS-KASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKM  261 (331)
Q Consensus       183 ~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  261 (331)
                      +|+...        ..........+|.+|+|||++.+. .|+...||||+|||+.||+++.+.|++... ..++..+...
T Consensus       166 lAra~~--------ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se-~~ql~~If~~  236 (323)
T KOG0594|consen  166 LARAFS--------IPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE-IDQLFRIFRL  236 (323)
T ss_pred             hHHHhc--------CCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH-HHHHHHHHHH
Confidence            998651        122334556689999999999987 689999999999999999999999987644 2222222221


Q ss_pred             -hCc-----chhhhhcCcccccccccCCcchHHH---HHHHHHHhhccccCCCCCCCCcHHHHHHH
Q 046639          262 -ALP-----DKVMEIVDPSLLLEVTANNYSWIED---CLVAVIGTGVTCSMESPMERMEMRDVVAK  318 (331)
Q Consensus       262 -~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~l~~l~~~cl~~~P~~Rps~~~i~~~  318 (331)
                       ..|     +.+....+....-........+...   ......+++.+||+.+|.+|.|+..+++-
T Consensus       237 lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  237 LGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             cCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence             111     1111111211111111111112221   12368899999999999999999999863

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=4.4e-43  Score=311.59  Aligned_cols=269  Identities=21%  Similarity=0.260  Sum_probs=203.2

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCccee
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ-KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      .++|.+.+.||+|+||.||++++..++..+|+|.+.... ......+.+|+.+++.++||||+++++++.     ..+..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~   78 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEI   78 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-----ECCEE
Confidence            468999999999999999999999999999999987543 344567899999999999999999999853     34678


Q ss_pred             eEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccc
Q 046639          108 AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      ++||||+++++|.+++....  .++...+..++.|++.||.|||+..  +++|+||||+||+++.++.++|+|||++...
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  154 (331)
T cd06649          79 SICMEHMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  154 (331)
T ss_pred             EEEeecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccc
Confidence            99999999999999997643  3677888899999999999999862  6999999999999999999999999998754


Q ss_pred             ccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcch-
Q 046639          188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDK-  266 (331)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-  266 (331)
                      ..          .......+++.|+|||++.+..++.++||||||+++|+|++|..||.....  ..+........... 
T Consensus       155 ~~----------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~  222 (331)
T cd06649         155 ID----------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDA--KELEAIFGRPVVDGE  222 (331)
T ss_pred             cc----------cccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHhcccccccc
Confidence            21          112234588899999999998999999999999999999999999965321  11111111100000 


Q ss_pred             ------hhhhcCc------------c-------cccccccC--CcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHH
Q 046639          267 ------VMEIVDP------------S-------LLLEVTAN--NYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAK  318 (331)
Q Consensus       267 ------~~~~~~~------------~-------~~~~~~~~--~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~  318 (331)
                            ......+            .       ....+...  .......+...+.+|+.+||+.||++|||+.+|++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         223 EGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             cCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                  0000000            0       00000000  000001245679999999999999999999999864

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=5.4e-44  Score=296.20  Aligned_cols=270  Identities=20%  Similarity=0.269  Sum_probs=206.4

Q ss_pred             CCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhh--HHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           31 NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEA--SRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      +|.+++.|++|.||.||+|+++.|++.||+|.++.+....  --..++|+.+|.+++|||||.+-.+..-   .+-+.+|
T Consensus        77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG---~~~d~iy  153 (419)
T KOG0663|consen   77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVG---SNMDKIY  153 (419)
T ss_pred             HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEec---cccceee
Confidence            5999999999999999999999999999999998664332  2346799999999999999999888542   3345689


Q ss_pred             EEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccc
Q 046639          109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLF  188 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~  188 (331)
                      +||||| .-+|..++.... +++...++..+..|++.|+.|||.+   .|+|||+|++|+|++..|.+||+|||+|+.+.
T Consensus       154 ~VMe~~-EhDLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg  228 (419)
T KOG0663|consen  154 IVMEYV-EHDLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYG  228 (419)
T ss_pred             eeHHHH-HhhHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhc
Confidence            999999 669999998765 4577788899999999999999999   99999999999999999999999999999872


Q ss_pred             cCCCCCcccccCCceeecccccccCCcccCCCC-CccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcc--
Q 046639          189 GYEPGTAAETASNSIEIKGIVGYVAPEYGMGSK-ASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPD--  265 (331)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--  265 (331)
                      +        ..........|.+|+|||.+.+.. |+.+.|+||+|||+.||+++.+.|++.. +..++..+....-..  
T Consensus       229 s--------p~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~s-E~dQl~~If~llGtPte  299 (419)
T KOG0663|consen  229 S--------PLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKS-EIDQLDKIFKLLGTPSE  299 (419)
T ss_pred             C--------CcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCc-hHHHHHHHHHHhCCCcc
Confidence            2        123344566899999999998864 9999999999999999999999998742 333344443322111  


Q ss_pred             hhhhhcC-ccc--ccccccCCc-----chHHH-HHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          266 KVMEIVD-PSL--LLEVTANNY-----SWIED-CLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       266 ~~~~~~~-~~~--~~~~~~~~~-----~~~~~-~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      .+..... ...  ...++.-.+     .|... ....-++|+..+|..||.+|.||.+.++
T Consensus       300 ~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  300 AIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             ccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence            1110000 000  001111000     01111 3467789999999999999999999864

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=2e-43  Score=310.16  Aligned_cols=271  Identities=20%  Similarity=0.283  Sum_probs=198.1

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccch-hhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCccee
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK-EASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      .++|.+.+.||.|+||+||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++     ......
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~   78 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII-----HTKETL   78 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEE-----ecCCeE
Confidence            3689999999999999999999998999999999864432 2234567899999999999999999984     445678


Q ss_pred             eEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccc
Q 046639          108 AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      ++||||+ .++|.+++.... ..++...+..++.|++.||.|||+.   +|+|+||||+||+++.++.+||+|||++...
T Consensus        79 ~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  153 (303)
T cd07869          79 TLVFEYV-HTDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAK  153 (303)
T ss_pred             EEEEECC-CcCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceec
Confidence            9999999 578888886543 3466788899999999999999999   9999999999999999999999999998753


Q ss_pred             ccCCCCCcccccCCceeecccccccCCcccCCC-CCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcch
Q 046639          188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMGS-KASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDK  266 (331)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  266 (331)
                      ...        ........+++.|+|||++.+. .++.++||||||+++|+|++|..||....+....+...........
T Consensus       154 ~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  225 (303)
T cd07869         154 SVP--------SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPN  225 (303)
T ss_pred             cCC--------CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCC
Confidence            111        1112234578889999998764 5789999999999999999999999864332222222211111000


Q ss_pred             hhh--------hcCcccccccccCCc-c-h-HHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          267 VME--------IVDPSLLLEVTANNY-S-W-IEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       267 ~~~--------~~~~~~~~~~~~~~~-~-~-~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ...        ...+.......+... . + .......+.+|+.+||+.||.+|||+.++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         226 EDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             hhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            000        000000000000000 0 0 0012346789999999999999999999985

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=6.4e-44  Score=315.90  Aligned_cols=242  Identities=19%  Similarity=0.249  Sum_probs=194.4

Q ss_pred             ceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeEEEe
Q 046639           36 NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFE  112 (331)
Q Consensus        36 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~e  112 (331)
                      +.||+|+||.||+|.+..+++.||+|++....   ......+..|+.+++.++||||+++++++     ...+..++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~e   75 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSF-----QTHDRLCFVME   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----EcCCEEEEEEe
Confidence            47999999999999999999999999997432   23345678899999999999999999884     45678899999


Q ss_pred             ecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccccCCC
Q 046639          113 YMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEP  192 (331)
Q Consensus       113 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~~~  192 (331)
                      |+++++|.+++....  .+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++....   
T Consensus        76 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~---  147 (323)
T cd05571          76 YANGGELFFHLSRER--VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS---  147 (323)
T ss_pred             CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCccccc---
Confidence            999999999987543  467888899999999999999999   999999999999999999999999999875311   


Q ss_pred             CCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhhhcC
Q 046639          193 GTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEIVD  272 (331)
Q Consensus       193 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (331)
                           .........||+.|+|||++.+..++.++|||||||++|+|++|..||.....     ..........      +
T Consensus       148 -----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-----~~~~~~~~~~------~  211 (323)
T cd05571         148 -----DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFELILME------E  211 (323)
T ss_pred             -----CCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH-----HHHHHHHHcC------C
Confidence                 11222345689999999999999999999999999999999999999964311     1111111000      0


Q ss_pred             cccccccccCCcchHHHHHHHHHHhhccccCCCCCCCC-----cHHHHHH
Q 046639          273 PSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERM-----EMRDVVA  317 (331)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----s~~~i~~  317 (331)
                                 ..++......+.+++.+||+.||++||     ++.++++
T Consensus       212 -----------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         212 -----------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             -----------CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence                       011223456788999999999999999     7888864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=4.6e-44  Score=317.51  Aligned_cols=245  Identities=19%  Similarity=0.233  Sum_probs=197.8

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcc
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFD  105 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~  105 (331)
                      .++|.+.+.||+|+||.||+|++..+++.||+|.+....   ......+.+|+.+++.++||||+++++++     ...+
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~   91 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSF-----QDEN   91 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----EcCC
Confidence            357999999999999999999999999999999986432   23346688999999999999999999984     4557


Q ss_pred             eeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccc
Q 046639          106 FKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAK  185 (331)
Q Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~  185 (331)
                      ..++||||+++++|.+++....  .++...+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++.
T Consensus        92 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~  166 (329)
T PTZ00263         92 RVYFLLEFVVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAK  166 (329)
T ss_pred             EEEEEEcCCCCChHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCce
Confidence            8899999999999999997643  466788888999999999999999   99999999999999999999999999987


Q ss_pred             ccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcc
Q 046639          186 FLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPD  265 (331)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  265 (331)
                      ....           ......||+.|+|||++.+..++.++|||||||++|+|++|..||.....     ..........
T Consensus       167 ~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-----~~~~~~i~~~  230 (329)
T PTZ00263        167 KVPD-----------RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP-----FRIYEKILAG  230 (329)
T ss_pred             EcCC-----------CcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH-----HHHHHHHhcC
Confidence            6411           11234689999999999999999999999999999999999999964311     1111111100


Q ss_pred             hhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCc-----HHHHH
Q 046639          266 KVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERME-----MRDVV  316 (331)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps-----~~~i~  316 (331)
                      .+                 .++..+...+.+|+.+||+.||.+||+     +.+++
T Consensus       231 ~~-----------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll  269 (329)
T PTZ00263        231 RL-----------------KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVK  269 (329)
T ss_pred             Cc-----------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence            00                 011123456789999999999999997     56665

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1e-43  Score=318.96  Aligned_cols=265  Identities=24%  Similarity=0.276  Sum_probs=208.4

Q ss_pred             CCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCC-C-----CCcceeeceeecccCCCc
Q 046639           31 NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIR-H-----RNLIKIITICSSIDFEGF  104 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~~i~~~~~~~~~~~~~~~  104 (331)
                      +|.+.+.||+|+||.|-+|.+..|++.||||+++. ......+...|+.+|..++ |     -|+|+++++     |.-.
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN-~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~-----F~fr  260 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN-KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDY-----FYFR  260 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeecc-ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeec-----cccc
Confidence            79999999999999999999999999999999973 3555677889999999996 3     389999999     5667


Q ss_pred             ceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCC--CcEEEcccC
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQD--IVAHVGDLG  182 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~--~~~kl~Dfg  182 (331)
                      +++|||+|.+ ..+|.++++.+....+++..+..++.||+.||.+||..   +|||+||||+|||+...  ..+||+|||
T Consensus       261 ~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFG  336 (586)
T KOG0667|consen  261 NHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFG  336 (586)
T ss_pred             cceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecc
Confidence            8999999999 88999999999888899999999999999999999999   99999999999999744  479999999


Q ss_pred             cccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHh-
Q 046639          183 LAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKM-  261 (331)
Q Consensus       183 ~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~-  261 (331)
                      .++..           ......+..+..|+|||++.|.+|+.+.||||||||+.||++|.+.|++. ++..++..+... 
T Consensus       337 SSc~~-----------~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~-ne~DQl~~I~e~l  404 (586)
T KOG0667|consen  337 SSCFE-----------SQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD-NEYDQLARIIEVL  404 (586)
T ss_pred             ccccc-----------CCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC-CHHHHHHHHHHHh
Confidence            99874           22333677888899999999999999999999999999999999989764 233333333221 


Q ss_pred             -hCcchhhh-------hcCc-----c-----------------------cccc-cc---cCCcchHH-HHHHHHHHhhcc
Q 046639          262 -ALPDKVME-------IVDP-----S-----------------------LLLE-VT---ANNYSWIE-DCLVAVIGTGVT  300 (331)
Q Consensus       262 -~~~~~~~~-------~~~~-----~-----------------------~~~~-~~---~~~~~~~~-~~~~~l~~l~~~  300 (331)
                       ..+..+.+       ..+.     .                       .... .+   .+...... ..-..|.+++.+
T Consensus       405 G~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~  484 (586)
T KOG0667|consen  405 GLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKR  484 (586)
T ss_pred             CCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHH
Confidence             11111100       0110     0                       0000 01   11111112 334568999999


Q ss_pred             ccCCCCCCCCcHHHHHH
Q 046639          301 CSMESPMERMEMRDVVA  317 (331)
Q Consensus       301 cl~~~P~~Rps~~~i~~  317 (331)
                      ||.+||.+|+|+.+.++
T Consensus       485 ~L~~dP~~R~tp~qal~  501 (586)
T KOG0667|consen  485 CLEWDPAERITPAQALN  501 (586)
T ss_pred             HhccCchhcCCHHHHhc
Confidence            99999999999999874

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.4e-44  Score=302.77  Aligned_cols=248  Identities=21%  Similarity=0.295  Sum_probs=206.9

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc---chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCc
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK---QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGF  104 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  104 (331)
                      ...+|.+.+.||+|.||+|-+|....+++.||||.++..   +....-.+.+|+++|+.|+||||++++.+     |++.
T Consensus        51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEV-----FENk  125 (668)
T KOG0611|consen   51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEV-----FENK  125 (668)
T ss_pred             hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhh-----hcCC
Confidence            346899999999999999999999999999999999644   34445668899999999999999999999     7888


Q ss_pred             ceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcc
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA  184 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a  184 (331)
                      +.+++||||..+|.|.+++.+++  .+++..+..++.||++|+.|+|.+   +++|||+|.+|||+|.++++||+|||++
T Consensus       126 dKIvivMEYaS~GeLYDYiSer~--~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLS  200 (668)
T KOG0611|consen  126 DKIVIVMEYASGGELYDYISERG--SLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLS  200 (668)
T ss_pred             ceEEEEEEecCCccHHHHHHHhc--cccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchh
Confidence            99999999999999999998765  488899999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCcccccCCceeecccccccCCcccCCCCC-ccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhC
Q 046639          185 KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKA-SVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMAL  263 (331)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  263 (331)
                      ..+         ........++|+|-|.+||+..|.+| ++..|-||||++||.|+.|..||++.     +....+...-
T Consensus       201 Nly---------~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~-----Dhk~lvrQIs  266 (668)
T KOG0611|consen  201 NLY---------ADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR-----DHKRLVRQIS  266 (668)
T ss_pred             hhh---------ccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc-----hHHHHHHHhh
Confidence            876         33344556889999999999999998 78899999999999999999999764     2222221111


Q ss_pred             cchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          264 PDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      .        -.+...          +.+...--|+.+||..||++|.|+.+|..
T Consensus       267 ~--------GaYrEP----------~~PSdA~gLIRwmLmVNP~RRATieDiAs  302 (668)
T KOG0611|consen  267 R--------GAYREP----------ETPSDASGLIRWMLMVNPERRATIEDIAS  302 (668)
T ss_pred             c--------ccccCC----------CCCchHHHHHHHHHhcCcccchhHHHHhh
Confidence            0        011100          11223445778899999999999999874

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-43  Score=306.34  Aligned_cols=261  Identities=20%  Similarity=0.271  Sum_probs=201.4

Q ss_pred             HHHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc--------------hhhHHHHHHHHHHHHcCCCCCcce
Q 046639           26 SKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ--------------KEASRSFAAECNALRNIRHRNLIK   91 (331)
Q Consensus        26 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------------~~~~~~~~~e~~~l~~l~h~~i~~   91 (331)
                      .+..++|.+++.||+|.||.|-+|++..+++.||||++....              ....+...+|+.+|+++.|||||+
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~  172 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK  172 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence            455679999999999999999999999999999999996431              112357889999999999999999


Q ss_pred             eeceeecccCCCcceeeEEEeecCCCCHHHHHHhccCCc-cchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEe
Q 046639           92 IITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQL-RFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILL  170 (331)
Q Consensus        92 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv  170 (331)
                      ++++.-+   ...+.+|+|+|||..|.+...-   .... +.+.++++++.+++.||.|||.+   ||+||||||+|+|+
T Consensus       173 LiEvLDD---P~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl  243 (576)
T KOG0585|consen  173 LIEVLDD---PESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLL  243 (576)
T ss_pred             EEEeecC---cccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEE
Confidence            9998543   3467789999999877765432   2333 78899999999999999999999   99999999999999


Q ss_pred             cCCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCC----CccchhhHhHHHHHHHHHhCCCCCC
Q 046639          171 DQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSK----ASVSGDVYNFGILLLEMFTRRRPTD  246 (331)
Q Consensus       171 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~----~~~~~DiwslG~il~el~~g~~pf~  246 (331)
                      +.+|+|||+|||.+......   .............|||.|+|||...++.    .+.+.||||+|++||.|+.|+.||-
T Consensus       244 ~~~g~VKIsDFGVs~~~~~~---~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~  320 (576)
T KOG0585|consen  244 SSDGTVKISDFGVSNEFPQG---SDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFF  320 (576)
T ss_pred             cCCCcEEeeccceeeecccC---CccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcc
Confidence            99999999999999865222   1112222233477999999999877632    3678999999999999999999996


Q ss_pred             cccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHH
Q 046639          247 AMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAK  318 (331)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~  318 (331)
                      +.. ....+..+.    ...+..-..               .+....+.+|+.+||++||++|.+..+|...
T Consensus       321 ~~~-~~~l~~KIv----n~pL~fP~~---------------pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H  372 (576)
T KOG0585|consen  321 DDF-ELELFDKIV----NDPLEFPEN---------------PEINEDLKDLIKRLLEKDPEQRITLPDIKLH  372 (576)
T ss_pred             cch-HHHHHHHHh----cCcccCCCc---------------ccccHHHHHHHHHHhhcChhheeehhhheec
Confidence            421 111112211    111110000               1356678999999999999999999998643

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.7e-44  Score=302.18  Aligned_cols=269  Identities=23%  Similarity=0.321  Sum_probs=208.6

Q ss_pred             CCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeEE
Q 046639           31 NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIV  110 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv  110 (331)
                      .|.-.+.+|+|+||.||+|....+++.||||..-....-    -..|+.+|+.+.|||||++.-+|....-.+.-...+|
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            577789999999999999999999999999988533321    2478999999999999999988765432224456789


Q ss_pred             EeecCCCCHHHHHHh--ccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCC-CcEEEcccCccccc
Q 046639          111 FEYMQNRNLEQWLRQ--SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQD-IVAHVGDLGLAKFL  187 (331)
Q Consensus       111 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~-~~~kl~Dfg~a~~~  187 (331)
                      |||+ ..+|.+.++.  ..+..++...+.-+.+|++.||+|||+.   ||+||||||.|+|+|.+ |.+||+|||.|+.+
T Consensus       101 leym-P~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen  101 LEYM-PETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHhc-hHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            9999 5599999985  2455677788889999999999999998   99999999999999976 89999999999986


Q ss_pred             ccCCCCCcccccCCceeecccccccCCcccCCC-CCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcch
Q 046639          188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMGS-KASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDK  266 (331)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  266 (331)
                               .......++..|..|+|||.+.|. .|+.+.||||.||++.||+-|++.|++. +...++..+.+....+.
T Consensus       177 ---------~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~-s~~dQL~eIik~lG~Pt  246 (364)
T KOG0658|consen  177 ---------VKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGD-SSVDQLVEIIKVLGTPT  246 (364)
T ss_pred             ---------ccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCC-CHHHHHHHHHHHhCCCC
Confidence                     344555778899999999998885 5999999999999999999999999884 33344444444322211


Q ss_pred             hhh--hcCcc----cccccccCCc--chHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          267 VME--IVDPS----LLLEVTANNY--SWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       267 ~~~--~~~~~----~~~~~~~~~~--~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      -.+  ...+.    ...++....+  -+.....+...+|+.++|+.+|.+|.++.+++.
T Consensus       247 ~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  247 REDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             HHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence            111  11111    1111111111  144467788999999999999999999999873

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.8e-43  Score=300.75  Aligned_cols=264  Identities=24%  Similarity=0.288  Sum_probs=217.2

Q ss_pred             HHHHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCcceeeceeecccC
Q 046639           25 LSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNIRHRNLIKIITICSSIDF  101 (331)
Q Consensus        25 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  101 (331)
                      .....++|++++.||+|.-|+||+++.+.++..+|+|++....   .....+...|-+||+.+.||.++.++..     +
T Consensus        72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~-----f  146 (459)
T KOG0610|consen   72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYAS-----F  146 (459)
T ss_pred             CccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhe-----e
Confidence            3444567999999999999999999999999999999997543   4445668889999999999999999999     6


Q ss_pred             CCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEccc
Q 046639          102 EGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDL  181 (331)
Q Consensus       102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Df  181 (331)
                      +...+.|++||||+||+|..+.+++.+..+++..++.++..++-||.|||..   |||+|||||+||||.++|++-|+||
T Consensus       147 et~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDF  223 (459)
T KOG0610|consen  147 ETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDF  223 (459)
T ss_pred             eccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeec
Confidence            7788999999999999999999999999999999999999999999999999   9999999999999999999999999


Q ss_pred             CcccccccCCC------------------------------C-C-----------------cccccCCceeecccccccC
Q 046639          182 GLAKFLFGYEP------------------------------G-T-----------------AAETASNSIEIKGIVGYVA  213 (331)
Q Consensus       182 g~a~~~~~~~~------------------------------~-~-----------------~~~~~~~~~~~~~t~~y~a  213 (331)
                      .++........                              . .                 .........+..||-.|+|
T Consensus       224 DLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlA  303 (459)
T KOG0610|consen  224 DLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLA  303 (459)
T ss_pred             cccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccccc
Confidence            98764421000                              0 0                 0122234456779999999


Q ss_pred             CcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHH
Q 046639          214 PEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVA  293 (331)
Q Consensus       214 PE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (331)
                      ||++.|+..+.++|.|+||+.+|||+.|..||.+..+. ..+.+++...+.-              +    .. .....+
T Consensus       304 PEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~-~Tl~NIv~~~l~F--------------p----~~-~~vs~~  363 (459)
T KOG0610|consen  304 PEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNK-ETLRNIVGQPLKF--------------P----EE-PEVSSA  363 (459)
T ss_pred             ceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCch-hhHHHHhcCCCcC--------------C----CC-CcchhH
Confidence            99999999999999999999999999999999986443 3344443322210              0    00 135668


Q ss_pred             HHHhhccccCCCCCCCCc----HHHHH
Q 046639          294 VIGTGVTCSMESPMERME----MRDVV  316 (331)
Q Consensus       294 l~~l~~~cl~~~P~~Rps----~~~i~  316 (331)
                      +.+||+++|.+||.+|..    |.||-
T Consensus       364 akDLIr~LLvKdP~kRlg~~rGA~eIK  390 (459)
T KOG0610|consen  364 AKDLIRKLLVKDPSKRLGSKRGAAEIK  390 (459)
T ss_pred             HHHHHHHHhccChhhhhccccchHHhh
Confidence            899999999999999987    66664

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-44  Score=322.09  Aligned_cols=247  Identities=20%  Similarity=0.278  Sum_probs=208.4

Q ss_pred             HHHHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc---chhhHHHHHHHHHHHHcCC-CCCcceeeceeeccc
Q 046639           25 LSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK---QKEASRSFAAECNALRNIR-HRNLIKIITICSSID  100 (331)
Q Consensus        25 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~  100 (331)
                      ......+|++++.||+|.||+|+++..+.+++.+|||.+++.   .....+....|-+++...+ ||.+++++..     
T Consensus       363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~-----  437 (694)
T KOG0694|consen  363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSC-----  437 (694)
T ss_pred             CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccc-----
Confidence            345567899999999999999999999999999999999755   2445677888999888885 9999999998     


Q ss_pred             CCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcc
Q 046639          101 FEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGD  180 (331)
Q Consensus       101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~D  180 (331)
                      |.+.+++++||||+.||++..++   ....+++..+..++..|+.||.|||.+   ||+|||||.+|||+|.+|.+||+|
T Consensus       438 fQT~~~l~fvmey~~Ggdm~~~~---~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiAD  511 (694)
T KOG0694|consen  438 FQTKEHLFFVMEYVAGGDLMHHI---HTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIAD  511 (694)
T ss_pred             cccCCeEEEEEEecCCCcEEEEE---ecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecc
Confidence            78889999999999999955544   334578899999999999999999999   999999999999999999999999


Q ss_pred             cCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHH
Q 046639          181 LGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVK  260 (331)
Q Consensus       181 fg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  260 (331)
                      ||+++...        .........+|||.|+|||++.+..|+.+.|.||||++||||+.|..||++. ++...++.++.
T Consensus       512 FGlcKe~m--------~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gd-dEee~FdsI~~  582 (694)
T KOG0694|consen  512 FGLCKEGM--------GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGD-DEEEVFDSIVN  582 (694)
T ss_pred             cccccccC--------CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHhc
Confidence            99998642        2334556788999999999999999999999999999999999999999864 23333333333


Q ss_pred             hhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcH
Q 046639          261 MALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEM  312 (331)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~  312 (331)
                      ...                     .++..++.+...++.++|.++|++|..+
T Consensus       583 d~~---------------------~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  583 DEV---------------------RYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             CCC---------------------CCCCcccHHHHHHHHHHhccCcccccCC
Confidence            222                     2344577889999999999999999765

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=5.9e-43  Score=307.31  Aligned_cols=263  Identities=21%  Similarity=0.329  Sum_probs=197.2

Q ss_pred             cCCCcCceeeccCeeEEEEeeecC----------------CCceEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCccee
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDE----------------SRSIVAVKVVNLKQ-KEASRSFAAECNALRNIRHRNLIKI   92 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~   92 (331)
                      ++|.+.++||+|+||.||+|.+..                ++..||+|.+.... ......+.+|+.++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            579999999999999999998532                34579999986543 3344678899999999999999999


Q ss_pred             eceeecccCCCcceeeEEEeecCCCCHHHHHHhccC-----------------CccchHHHHHHHHHHHHHHHHHhhcCC
Q 046639           93 ITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNG-----------------QLRFLTQRVNIAIDVSFAIEYFHHHCQ  155 (331)
Q Consensus        93 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----------------~~~~~~~~~~~~~~i~~~l~~LH~~~~  155 (331)
                      ++++.     ..+..++||||+++++|.+++.....                 ..+++..+..++.|++.||.|||+.  
T Consensus        85 ~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~--  157 (304)
T cd05096          85 LGVCV-----DEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL--  157 (304)
T ss_pred             EEEEe-----cCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC--
Confidence            99964     34568999999999999999865321                 2356677889999999999999999  


Q ss_pred             CCeeecCCCCCCEEecCCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHH
Q 046639          156 PSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILL  235 (331)
Q Consensus       156 ~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il  235 (331)
                       +++|+||||+||+++.++.+||+|||++.......      .........++..|+|||++.+..++.++||||||+++
T Consensus       158 -~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l  230 (304)
T cd05096         158 -NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGD------YYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTL  230 (304)
T ss_pred             -CccccCcchhheEEcCCccEEECCCccceecccCc------eeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHH
Confidence             99999999999999999999999999987542111      00111122346779999999888899999999999999


Q ss_pred             HHHHh--CCCCCCcccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHH
Q 046639          236 LEMFT--RRRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMR  313 (331)
Q Consensus       236 ~el~~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~  313 (331)
                      |+|++  +..||......  ................     ...       .....++..+.+|+.+||+.+|.+|||+.
T Consensus       231 ~el~~~~~~~p~~~~~~~--~~~~~~~~~~~~~~~~-----~~~-------~~~~~~~~~~~~li~~cl~~~p~~RPs~~  296 (304)
T cd05096         231 WEILMLCKEQPYGELTDE--QVIENAGEFFRDQGRQ-----VYL-------FRPPPCPQGLYELMLQCWSRDCRERPSFS  296 (304)
T ss_pred             HHHHHccCCCCCCcCCHH--HHHHHHHHHhhhcccc-----ccc-------cCCCCCCHHHHHHHHHHccCCchhCcCHH
Confidence            99987  55677653211  1111111110000000     000       01123567899999999999999999999


Q ss_pred             HHHHHHH
Q 046639          314 DVVAKLR  320 (331)
Q Consensus       314 ~i~~~L~  320 (331)
                      +|.+.|+
T Consensus       297 ~i~~~l~  303 (304)
T cd05096         297 DIHAFLT  303 (304)
T ss_pred             HHHHHHh
Confidence            9998876

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=6.4e-43  Score=304.71  Aligned_cols=273  Identities=19%  Similarity=0.242  Sum_probs=201.5

Q ss_pred             CCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc--hhhHHHHHHHHHHHHcC---CCCCcceeeceeecccCCCcc
Q 046639           31 NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ--KEASRSFAAECNALRNI---RHRNLIKIITICSSIDFEGFD  105 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~~~~~  105 (331)
                      +|.+.+.||+|+||+||+|.+..+++.||+|.+....  ........+|+.+++.+   +||||+++++++.........
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            5889999999999999999999999999999986432  11223455677777665   699999999987654444566


Q ss_pred             eeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccc
Q 046639          106 FKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAK  185 (331)
Q Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~  185 (331)
                      ..++++|++. ++|.+++.......++...+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLAR  156 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCccc
Confidence            7899999995 6999998876555678899999999999999999999   99999999999999999999999999987


Q ss_pred             ccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcc
Q 046639          186 FLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPD  265 (331)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  265 (331)
                      ....         ........++..|+|||++.+..++.++||||+|+++|+|++|.+||...... .............
T Consensus       157 ~~~~---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~~~~~  226 (288)
T cd07863         157 IYSC---------QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-DQLGKIFDLIGLP  226 (288)
T ss_pred             cccC---------cccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH-HHHHHHHHHhCCC
Confidence            6521         11112345788899999999889999999999999999999999999653221 1122222111000


Q ss_pred             hhhhh------cCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          266 KVMEI------VDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       266 ~~~~~------~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      .....      ..................++...+.+++.+||+.||++|||+.+++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         227 PEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             ChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            00000      00000000000011222245667889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=4.4e-43  Score=316.33  Aligned_cols=260  Identities=20%  Similarity=0.291  Sum_probs=200.3

Q ss_pred             hcCCCcCceeeccCeeEEEEeee-----cCCCceEEEEEeeccc-hhhHHHHHHHHHHHHcC-CCCCcceeeceeecccC
Q 046639           29 TNNFSPANKIGQGGVSIVYKGIL-----DESRSIVAVKVVNLKQ-KEASRSFAAECNALRNI-RHRNLIKIITICSSIDF  101 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~  101 (331)
                      .++|.+.+.||+|+||+||+|.+     ..++..||+|+++... ....+.+.+|+.+++.+ +||||++++++|     
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~-----  108 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGAC-----  108 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeee-----
Confidence            34799999999999999999974     3456789999986432 33446688999999999 799999999985     


Q ss_pred             CCcceeeEEEeecCCCCHHHHHHhccC-----------------------------------------------------
Q 046639          102 EGFDFKAIVFEYMQNRNLEQWLRQSNG-----------------------------------------------------  128 (331)
Q Consensus       102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-----------------------------------------------------  128 (331)
                      ...+..++||||+++|+|.+++.....                                                     
T Consensus       109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  188 (375)
T cd05104         109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS  188 (375)
T ss_pred             ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence            445678999999999999999865321                                                     


Q ss_pred             --------------------CccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccc
Q 046639          129 --------------------QLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLF  188 (331)
Q Consensus       129 --------------------~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~  188 (331)
                                          ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++....
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~  265 (375)
T cd05104         189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIR  265 (375)
T ss_pred             cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceecc
Confidence                                1356677889999999999999999   99999999999999999999999999997652


Q ss_pred             cCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhCcchh
Q 046639          189 GYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMALPDKV  267 (331)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  267 (331)
                      ....      ........++..|+|||++.+..++.++||||||+++|+|++ |..||........ ....+.....   
T Consensus       266 ~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~-~~~~~~~~~~---  335 (375)
T cd05104         266 NDSN------YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK-FYKMIKEGYR---  335 (375)
T ss_pred             Cccc------ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH-HHHHHHhCcc---
Confidence            1110      011112234567999999999999999999999999999998 8899976432221 1111111100   


Q ss_pred             hhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHh
Q 046639          268 MEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHA  322 (331)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~  322 (331)
                           +    .       .+...+..+.+|+.+||+.||++|||+.+|++.|++.
T Consensus       336 -----~----~-------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         336 -----M----L-------SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             -----C----C-------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence                 0    0       0011345788999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=5.9e-43  Score=304.95  Aligned_cols=270  Identities=21%  Similarity=0.287  Sum_probs=198.2

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccch-hhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCccee
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK-EASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      .++|.+.+.||.|+||+||+|.+..++..||+|.+..... .....+.+|+.+++.++||||+++++++     ......
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~   78 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII-----HTERCL   78 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEE-----cCCCeE
Confidence            3579999999999999999999999999999999865432 2334677999999999999999999984     445678


Q ss_pred             eEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccc
Q 046639          108 AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      ++|||+++ ++|.+++.... ..++...+..++.|++.||+|||++   +|+|+||||+||+++.++.+||+|||++...
T Consensus        79 ~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~  153 (288)
T cd07871          79 TLVFEYLD-SDLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAK  153 (288)
T ss_pred             EEEEeCCC-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeec
Confidence            99999995 59999886543 3456788889999999999999999   9999999999999999999999999998754


Q ss_pred             ccCCCCCcccccCCceeecccccccCCcccCC-CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCc--
Q 046639          188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMG-SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALP--  264 (331)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--  264 (331)
                      ...        ........+++.|+|||++.+ ..++.++||||+|+++|+|++|..||...... ............  
T Consensus       154 ~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~  224 (288)
T cd07871         154 SVP--------TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVK-EELHLIFRLLGTPT  224 (288)
T ss_pred             cCC--------CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCC
Confidence            111        111223457888999998865 56899999999999999999999999753221 111111111100  


Q ss_pred             -chhhhhcCcc-----cccccc-cCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          265 -DKVMEIVDPS-----LLLEVT-ANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       265 -~~~~~~~~~~-----~~~~~~-~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                       ..........     ...... .............+.+|+.+||+.||.+|||+.|+++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         225 EETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             hHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence             0000000000     000000 0000011123456789999999999999999999974

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-43  Score=337.07  Aligned_cols=267  Identities=25%  Similarity=0.373  Sum_probs=215.2

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCC-----CceEEEEEeecc-chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCC
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDES-----RSIVAVKVVNLK-QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFE  102 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  102 (331)
                      ..+-+....||+|+||.||.|.....     ...||+|.+... +......+++|..+|+.++||||++++|+|.+    
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~----  766 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD----  766 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC----
Confidence            34567778999999999999998543     234889988533 45566789999999999999999999999854    


Q ss_pred             CcceeeEEEeecCCCCHHHHHHhc-----cCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEE
Q 046639          103 GFDFKAIVFEYMQNRNLEQWLRQS-----NGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAH  177 (331)
Q Consensus       103 ~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~k  177 (331)
                       ....+|++|||++|+|..+|++.     ....+.+...+.++.||++|+.||+++   ++|||||..+|+|++....||
T Consensus       767 -~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VK  842 (1025)
T KOG1095|consen  767 -SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVK  842 (1025)
T ss_pred             -CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEE
Confidence             46679999999999999999874     244578889999999999999999999   999999999999999999999


Q ss_pred             EcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHH
Q 046639          178 VGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLH  256 (331)
Q Consensus       178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~  256 (331)
                      |+|||+|+.+....      +........-...|||||.+..+.++.++||||||+++||+++ |..||+...+..... 
T Consensus       843 IaDFGlArDiy~~~------yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~-  915 (1025)
T KOG1095|consen  843 IADFGLARDIYDKD------YYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLL-  915 (1025)
T ss_pred             EcccchhHhhhhch------heeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHH-
Confidence            99999999653221      1111111122345999999999999999999999999999999 999998753322211 


Q ss_pred             HHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhhhcCC
Q 046639          257 EFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETFLGTR  330 (331)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~~~~~  330 (331)
                      .+....           ++         ..+..|+..+.++|.+||+.+|++||++..|++.+..+.+.+.++.
T Consensus       916 ~~~~gg-----------RL---------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~  969 (1025)
T KOG1095|consen  916 DVLEGG-----------RL---------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTI  969 (1025)
T ss_pred             HHHhCC-----------cc---------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCc
Confidence            111111           11         2234689999999999999999999999999999999999887764

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-43  Score=312.57  Aligned_cols=253  Identities=18%  Similarity=0.225  Sum_probs=201.2

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      ++|.+.+.||+|+||.||+|++..+++.||+|++....   ......+..|+.++..++||||+++++++     ...+.
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~-----~~~~~   75 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAF-----QDDEY   75 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEE-----EcCCE
Confidence            47999999999999999999999999999999997442   23345688899999999999999999884     44567


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      .++||||+++++|.+++....  .+++..+..++.|++.||.+||+.   +++|+||||+||+++.++.+||+|||++..
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~  150 (333)
T cd05600          76 LYLAMEYVPGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKG  150 (333)
T ss_pred             EEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCcc
Confidence            899999999999999996543  467788899999999999999999   999999999999999999999999999876


Q ss_pred             cccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcch
Q 046639          187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDK  266 (331)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  266 (331)
                      ...           ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ...........  .
T Consensus       151 ~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~--~  216 (333)
T cd05600         151 IVT-----------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN-ETWENLKYWKE--T  216 (333)
T ss_pred             ccc-----------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHH-HHHHHHHhccc--c
Confidence            411           223456889999999999999999999999999999999999999753211 11111111000  0


Q ss_pred             hhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          267 VMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                         ...+...        .....+...+.+++.+||..+|.+|||+.++++
T Consensus       217 ---~~~~~~~--------~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~  256 (333)
T cd05600         217 ---LQRPVYD--------DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKN  256 (333)
T ss_pred             ---ccCCCCC--------ccccccCHHHHHHHHHHhhChhhhcCCHHHHHh
Confidence               0000000        000134567889999999999999999999985

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-43  Score=281.94  Aligned_cols=249  Identities=20%  Similarity=0.306  Sum_probs=214.5

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcc
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFD  105 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~  105 (331)
                      .++|.+++.||+|.||.||.|+.+.++..||+|++-++.   ....+++.+|+++-+.|+||||++++++     |.+..
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~-----fhd~~   95 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGY-----FHDSK   95 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhh-----eeccc
Confidence            346999999999999999999999999999999985442   3334778999999999999999999999     56678


Q ss_pred             eeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccc
Q 046639          106 FKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAK  185 (331)
Q Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~  185 (331)
                      ..|+++||..+|++...+.......++......+..|++.|+.|+|.+   +++||||||+|+|++.+|..|++|||-+.
T Consensus        96 riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV  172 (281)
T KOG0580|consen   96 RIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSV  172 (281)
T ss_pred             eeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCcee
Confidence            899999999999999999977777788899999999999999999999   99999999999999999999999999876


Q ss_pred             ccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcc
Q 046639          186 FLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPD  265 (331)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  265 (331)
                      .-          ........+||..|+|||...+..++...|+|++|++.||++.|.+||.... ....+..+.+.... 
T Consensus       173 ~~----------p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYkrI~k~~~~-  240 (281)
T KOG0580|consen  173 HA----------PSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYKRIRKVDLK-  240 (281)
T ss_pred             ec----------CCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHHHHHHcccc-
Confidence            52          2344556789999999999999999999999999999999999999998754 44445444443322 


Q ss_pred             hhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          266 KVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                                          ++........+++.+|+..+|.+|.+..|+++
T Consensus       241 --------------------~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~  272 (281)
T KOG0580|consen  241 --------------------FPSTISGGAADLISRLLVKNPIERLALTEVMD  272 (281)
T ss_pred             --------------------CCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence                                22345567889999999999999999999875

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.3e-42  Score=301.91  Aligned_cols=257  Identities=24%  Similarity=0.449  Sum_probs=202.7

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCC-----ceEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCC
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESR-----SIVAVKVVNLKQ-KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEG  103 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  103 (331)
                      ++|.+.+.||+|++|.||+|.+...+     ..+++|.+.... ......+.+|+.+++.++||||+++++++     ..
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~-----~~   79 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVC-----TK   79 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEE-----cC
Confidence            36899999999999999999876544     679999886443 33446688999999999999999999985     34


Q ss_pred             cceeeEEEeecCCCCHHHHHHhccC--------------CccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEE
Q 046639          104 FDFKAIVFEYMQNRNLEQWLRQSNG--------------QLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNIL  169 (331)
Q Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nil  169 (331)
                      ....+++||++++++|.+++.....              ..+++..++.++.|++.||.+||+.   +++|+||||+||+
T Consensus        80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil  156 (283)
T cd05048          80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCL  156 (283)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEE
Confidence            4568999999999999999976421              3467788889999999999999999   9999999999999


Q ss_pred             ecCCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcc
Q 046639          170 LDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAM  248 (331)
Q Consensus       170 v~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~  248 (331)
                      ++.++.++|+|||++.......      .........+++.|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus       157 ~~~~~~~~L~dfg~~~~~~~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~  230 (283)
T cd05048         157 VGEGLTVKISDFGLSRDIYSAD------YYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGF  230 (283)
T ss_pred             EcCCCcEEECCCcceeeccccc------cccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCC
Confidence            9999999999999987642111      1111122335677999999988889999999999999999998 99999754


Q ss_pred             cCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHH
Q 046639          249 FNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRH  321 (331)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~  321 (331)
                      ...  .....+...            ...       .....++..+.+|+.+||+.||.+|||+.+|++.|+.
T Consensus       231 ~~~--~~~~~i~~~------------~~~-------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         231 SNQ--EVIEMIRSR------------QLL-------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             CHH--HHHHHHHcC------------CcC-------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            221  111111110            000       1123567889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=4.1e-43  Score=310.68  Aligned_cols=242  Identities=20%  Similarity=0.256  Sum_probs=193.2

Q ss_pred             ceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeEEEe
Q 046639           36 NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFE  112 (331)
Q Consensus        36 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~e  112 (331)
                      +.||+|+||.||++.+..++..||+|.+....   ......+..|+.+++.++||||+++++++     ...+..++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~E   75 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHDRLCFVME   75 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCEEEEEEe
Confidence            47999999999999999999999999986432   23345677899999999999999999884     44567899999


Q ss_pred             ecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccccCCC
Q 046639          113 YMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEP  192 (331)
Q Consensus       113 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~~~  192 (331)
                      |+++++|..++....  .+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++.....   
T Consensus        76 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~---  147 (323)
T cd05595          76 YANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS---  147 (323)
T ss_pred             CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccC---
Confidence            999999999886543  467788999999999999999999   999999999999999999999999999865311   


Q ss_pred             CCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhhhcC
Q 046639          193 GTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEIVD  272 (331)
Q Consensus       193 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (331)
                           .........||+.|+|||++.+..++.++||||||+++|+|++|..||.....     ...........      
T Consensus       148 -----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~-----~~~~~~~~~~~------  211 (323)
T cd05595         148 -----DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----ERLFELILMEE------  211 (323)
T ss_pred             -----CCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH-----HHHHHHHhcCC------
Confidence                 11112234588999999999999999999999999999999999999964321     11111110000      


Q ss_pred             cccccccccCCcchHHHHHHHHHHhhccccCCCCCCCC-----cHHHHHH
Q 046639          273 PSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERM-----EMRDVVA  317 (331)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----s~~~i~~  317 (331)
                                 ..++..+.+.+.+++.+||+.||.+||     ++.++++
T Consensus       212 -----------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         212 -----------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             -----------CCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence                       011223456788999999999999998     7888764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-44  Score=313.48  Aligned_cols=262  Identities=26%  Similarity=0.388  Sum_probs=215.7

Q ss_pred             hhccCCcccHHHHHHHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCccee
Q 046639           13 MKQQFPMISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKI   92 (331)
Q Consensus        13 ~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~   92 (331)
                      .++..+-+++++|..       ++.||.|+.|.||+|+..  ++.||||.++.-       -..++..|++|+|+||+.+
T Consensus       114 qq~e~WeiPFe~IsE-------LeWlGSGaQGAVF~Grl~--netVAVKKV~el-------kETdIKHLRkLkH~NII~F  177 (904)
T KOG4721|consen  114 QQEELWEIPFEEISE-------LEWLGSGAQGAVFLGRLH--NETVAVKKVREL-------KETDIKHLRKLKHPNIITF  177 (904)
T ss_pred             hhhhhccCCHHHhhh-------hhhhccCcccceeeeecc--CceehhHHHhhh-------hhhhHHHHHhccCcceeeE
Confidence            345677888887654       579999999999999986  778999977522       2367889999999999999


Q ss_pred             eceeecccCCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecC
Q 046639           93 ITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQ  172 (331)
Q Consensus        93 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~  172 (331)
                      .|+|...     .-+|||||||..|-|..+++...  .+.......|..+|+.|+.|||.+   .|+|||||.-||||+.
T Consensus       178 kGVCtqs-----PcyCIiMEfCa~GqL~~VLka~~--~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~  247 (904)
T KOG4721|consen  178 KGVCTQS-----PCYCIIMEFCAQGQLYEVLKAGR--PITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISY  247 (904)
T ss_pred             eeeecCC-----ceeEEeeeccccccHHHHHhccC--ccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeec
Confidence            9999765     35799999999999999997644  466788889999999999999999   9999999999999999


Q ss_pred             CCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCc
Q 046639          173 DIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEG  252 (331)
Q Consensus       173 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~  252 (331)
                      +..|||+|||-++..         ........+.||..|||||++.+++.++|.||||||++||||+||..||.+.....
T Consensus       248 ~d~VKIsDFGTS~e~---------~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA  318 (904)
T KOG4721|consen  248 DDVVKISDFGTSKEL---------SDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA  318 (904)
T ss_pred             cceEEeccccchHhh---------hhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe
Confidence            999999999988875         22344556789999999999999999999999999999999999999997643221


Q ss_pred             chHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhhhcC
Q 046639          253 LTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETFLGT  329 (331)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~~~~  329 (331)
                      .-+             ..-...+..       ..+..|++.|.-|+++||+..|.+||++.+|+.-|+-+...+..+
T Consensus       319 IIw-------------GVGsNsL~L-------pvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pell~~  375 (904)
T KOG4721|consen  319 IIW-------------GVGSNSLHL-------PVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPELLST  375 (904)
T ss_pred             eEE-------------eccCCcccc-------cCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHHhcc
Confidence            111             111111111       344578999999999999999999999999999999887776543

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.6e-42  Score=298.35  Aligned_cols=256  Identities=25%  Similarity=0.368  Sum_probs=204.6

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeE
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAI  109 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~l  109 (331)
                      ..|.+.+.||.|++|.||+|.+..++..+|+|.+... ......+.+|+.+++.++|+|++++++++     ......++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l   79 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPPFYI   79 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEE-----cCCCCcEE
Confidence            3588889999999999999999988999999998643 33346688999999999999999999985     34467899


Q ss_pred             EEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccccc
Q 046639          110 VFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG  189 (331)
Q Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~  189 (331)
                      +||++++++|.+++.......+++..+..++.|++.||++||++   +++|+||||+||+++.++.++|+|||++.....
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~  156 (263)
T cd05052          80 ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG  156 (263)
T ss_pred             EEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence            99999999999999776555678888899999999999999999   999999999999999999999999999876522


Q ss_pred             CCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhCcchhh
Q 046639          190 YEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMALPDKVM  268 (331)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  268 (331)
                      ..       .........+..|+|||.+.+..++.++||||||+++|+|++ |..||+....  ..........      
T Consensus       157 ~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--~~~~~~~~~~------  221 (263)
T cd05052         157 DT-------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQVYELLEKG------  221 (263)
T ss_pred             ce-------eeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHCC------
Confidence            11       011112223557999999998899999999999999999998 9999865321  1111111100      


Q ss_pred             hhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHh
Q 046639          269 EIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHA  322 (331)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~  322 (331)
                        ..+           .....++..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       222 --~~~-----------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         222 --YRM-----------ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             --CCC-----------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence              000           11123567899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.3e-42  Score=299.29  Aligned_cols=257  Identities=20%  Similarity=0.272  Sum_probs=201.0

Q ss_pred             hcCCCcCceeeccCeeEEEEeeec---CCCceEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCc
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILD---ESRSIVAVKVVNLKQ-KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGF  104 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  104 (331)
                      .++|.+.+.||+|+||.||+|.+.   ..+..||+|.++... ......+.+|+.+++.++||||+++++++     ...
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~   78 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVI-----TRG   78 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEE-----ecC
Confidence            457999999999999999999864   456789999987543 33346688999999999999999999985     345


Q ss_pred             ceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcc
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA  184 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a  184 (331)
                      +..++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.++++|||.+
T Consensus        79 ~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~  154 (266)
T cd05064          79 NTMMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRL  154 (266)
T ss_pred             CCcEEEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccc
Confidence            67899999999999999997643 3467888999999999999999999   9999999999999999999999999977


Q ss_pred             cccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhC
Q 046639          185 KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMAL  263 (331)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~  263 (331)
                      ......       .........++..|+|||.+.+..++.++||||||+++|++++ |..||......  ..........
T Consensus       155 ~~~~~~-------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--~~~~~~~~~~  225 (266)
T cd05064         155 QEDKSE-------AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--DVIKAVEDGF  225 (266)
T ss_pred             cccccc-------chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHHHCCC
Confidence            543110       0011112224567999999999999999999999999999775 99999754211  1111111000


Q ss_pred             cchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHh
Q 046639          264 PDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHA  322 (331)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~  322 (331)
                              ..           ..+..++..+.+++.+||+.+|++|||+.+|++.|+++
T Consensus       226 --------~~-----------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         226 --------RL-----------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             --------CC-----------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence                    00           11124667789999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.2e-42  Score=309.11  Aligned_cols=262  Identities=21%  Similarity=0.313  Sum_probs=203.3

Q ss_pred             cCCCcCceeeccCeeEEEEeeecC-----CCceEEEEEeeccc-hhhHHHHHHHHHHHHcC-CCCCcceeeceeecccCC
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDE-----SRSIVAVKVVNLKQ-KEASRSFAAECNALRNI-RHRNLIKIITICSSIDFE  102 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~  102 (331)
                      ++|.+.+.||+|+||.||+|.+..     +++.||+|++.... ......+..|+.++.++ .|+||++++++|.    .
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~----~   82 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACT----K   82 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEe----c
Confidence            479999999999999999997543     45789999986443 23345678899999999 7999999999874    3


Q ss_pred             CcceeeEEEeecCCCCHHHHHHhccC------------------------------------------------------
Q 046639          103 GFDFKAIVFEYMQNRNLEQWLRQSNG------------------------------------------------------  128 (331)
Q Consensus       103 ~~~~~~lv~e~~~~~~L~~~l~~~~~------------------------------------------------------  128 (331)
                      .+..+++++||+++++|.+++.....                                                      
T Consensus        83 ~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (337)
T cd05054          83 PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG  162 (337)
T ss_pred             CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence            34678899999999999999864221                                                      


Q ss_pred             -----CccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccccCCCCCcccccCCce
Q 046639          129 -----QLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSI  203 (331)
Q Consensus       129 -----~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~  203 (331)
                           ..+++..+..++.|++.||+|||+.   +|+|+||||+||+++.++.++|+|||++..+.....      .....
T Consensus       163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~------~~~~~  233 (337)
T cd05054         163 DELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD------YVRKG  233 (337)
T ss_pred             hHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcc------hhhcc
Confidence                 2467788899999999999999999   999999999999999999999999999986521110      01111


Q ss_pred             eecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhCcchhhhhcCcccccccccC
Q 046639          204 EIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTAN  282 (331)
Q Consensus       204 ~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (331)
                      ...++..|+|||++.+..++.++|||||||++|+|++ |..||....... .+..........                 
T Consensus       234 ~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~-----------------  295 (337)
T cd05054         234 DARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-EFCRRLKEGTRM-----------------  295 (337)
T ss_pred             CCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-HHHHHHhccCCC-----------------
Confidence            2335567999999999999999999999999999998 999997532211 111111111000                 


Q ss_pred             CcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhh
Q 046639          283 NYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARE  324 (331)
Q Consensus       283 ~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~  324 (331)
                        ..+..+...+.+++.+||+.+|++|||+.+|++.|+.+.+
T Consensus       296 --~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         296 --RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             --CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence              0011245678999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=8.4e-43  Score=314.24  Aligned_cols=260  Identities=20%  Similarity=0.307  Sum_probs=200.3

Q ss_pred             cCCCcCceeeccCeeEEEEeeecC-----CCceEEEEEeeccc-hhhHHHHHHHHHHHHcC-CCCCcceeeceeecccCC
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDE-----SRSIVAVKVVNLKQ-KEASRSFAAECNALRNI-RHRNLIKIITICSSIDFE  102 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~  102 (331)
                      ++|.+.+.||+|+||.||+|++..     +...||+|.+.... ......+.+|+.+++.+ +|+||++++++|     .
T Consensus        38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~-----~  112 (374)
T cd05106          38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGAC-----T  112 (374)
T ss_pred             HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEe-----c
Confidence            479999999999999999998643     33579999986443 33446688999999999 899999999985     4


Q ss_pred             CcceeeEEEeecCCCCHHHHHHhcc-------------------------------------------------------
Q 046639          103 GFDFKAIVFEYMQNRNLEQWLRQSN-------------------------------------------------------  127 (331)
Q Consensus       103 ~~~~~~lv~e~~~~~~L~~~l~~~~-------------------------------------------------------  127 (331)
                      .....++||||+++|+|.+++....                                                       
T Consensus       113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (374)
T cd05106         113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS  192 (374)
T ss_pred             CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence            4567899999999999999986421                                                       


Q ss_pred             -------------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccccCCCCC
Q 046639          128 -------------GQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGT  194 (331)
Q Consensus       128 -------------~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~~~~~  194 (331)
                                   ...+++..+..++.|++.||.|||++   +++||||||+||+++.++.++|+|||+++.......  
T Consensus       193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~--  267 (374)
T cd05106         193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN--  267 (374)
T ss_pred             ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc--
Confidence                         12356677889999999999999999   999999999999999999999999999876521110  


Q ss_pred             cccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhCcchhhhhcCc
Q 046639          195 AAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMALPDKVMEIVDP  273 (331)
Q Consensus       195 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (331)
                          ........++..|+|||++.+..++.++||||||+++|+|++ |..||....... ...........        +
T Consensus       268 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~~~~~~~~~~--------~  334 (374)
T cd05106         268 ----YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KFYKMVKRGYQ--------M  334 (374)
T ss_pred             ----eeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HHHHHHHcccC--------c
Confidence                001111224567999999988899999999999999999997 999997643221 11111111000        0


Q ss_pred             ccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhh
Q 046639          274 SLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHAR  323 (331)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~  323 (331)
                                 ......+..+.+++.+||+.||++|||+.+|++.|+++.
T Consensus       335 -----------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         335 -----------SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             -----------cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence                       000113467889999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-43  Score=310.49  Aligned_cols=239  Identities=20%  Similarity=0.271  Sum_probs=190.9

Q ss_pred             eeccCeeEEEEeeecCCCceEEEEEeecc---chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeEEEeec
Q 046639           38 IGQGGVSIVYKGILDESRSIVAVKVVNLK---QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYM  114 (331)
Q Consensus        38 lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~  114 (331)
                      ||+|+||+||+|.+..+++.||+|++...   .......+..|+.+++.++||||+++++++     ...+..++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~   75 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSF-----QSPEKLYLVLAFI   75 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEE-----ecCCeEEEEEcCC
Confidence            79999999999999999999999998643   233345678899999999999999999884     4456789999999


Q ss_pred             CCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccccCCCCC
Q 046639          115 QNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGT  194 (331)
Q Consensus       115 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~~~~~  194 (331)
                      ++++|.+++....  .+++..+..++.|++.||.|||++   +++||||||+||+++.++.++|+|||++.....     
T Consensus        76 ~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~-----  145 (312)
T cd05585          76 NGGELFHHLQREG--RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMK-----  145 (312)
T ss_pred             CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCcc-----
Confidence            9999999997643  467788899999999999999999   999999999999999999999999999875311     


Q ss_pred             cccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhhhcCcc
Q 046639          195 AAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPS  274 (331)
Q Consensus       195 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (331)
                         .........||+.|+|||++.+..++.++||||||+++|+|++|..||....     ...........         
T Consensus       146 ---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~-----~~~~~~~~~~~---------  208 (312)
T cd05585         146 ---DDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN-----VNEMYRKILQE---------  208 (312)
T ss_pred             ---CCCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC-----HHHHHHHHHcC---------
Confidence               1112233568999999999999999999999999999999999999997531     11111111110         


Q ss_pred             cccccccCCcchHHHHHHHHHHhhccccCCCCCCCCc---HHHHH
Q 046639          275 LLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERME---MRDVV  316 (331)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps---~~~i~  316 (331)
                              ...++..+...+.+++.+||+.||.+||+   +.+++
T Consensus       209 --------~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l  245 (312)
T cd05585         209 --------PLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIK  245 (312)
T ss_pred             --------CCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence                    00122234567889999999999999986   45554

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=5.3e-43  Score=310.51  Aligned_cols=242  Identities=21%  Similarity=0.260  Sum_probs=193.7

Q ss_pred             ceeeccCeeEEEEeeecCCCceEEEEEeecc---chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeEEEe
Q 046639           36 NKIGQGGVSIVYKGILDESRSIVAVKVVNLK---QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFE  112 (331)
Q Consensus        36 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~e  112 (331)
                      +.||+|+||.||++.+..+++.||+|++...   .......+.+|+.+++.+.||||+++.+++     ...+..++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~lv~E   75 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSF-----QTKDRLCFVME   75 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCEEEEEEe
Confidence            4699999999999999999999999999643   223345678899999999999999999884     45678899999


Q ss_pred             ecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccccCCC
Q 046639          113 YMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEP  192 (331)
Q Consensus       113 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~~~  192 (331)
                      |+++++|.+++....  .+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++.....   
T Consensus        76 y~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~---  147 (328)
T cd05593          76 YVNGGELFFHLSRER--VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGIT---  147 (328)
T ss_pred             CCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCC---
Confidence            999999999886543  467888999999999999999999   999999999999999999999999999875311   


Q ss_pred             CCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhhhcC
Q 046639          193 GTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEIVD  272 (331)
Q Consensus       193 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (331)
                           .........||+.|+|||++.+..++.++||||||+++|+|++|..||.....     ...........      
T Consensus       148 -----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~-----~~~~~~~~~~~------  211 (328)
T cd05593         148 -----DAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFELILMED------  211 (328)
T ss_pred             -----cccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH-----HHHHHHhccCC------
Confidence                 11122234689999999999998999999999999999999999999964311     11111111000      


Q ss_pred             cccccccccCCcchHHHHHHHHHHhhccccCCCCCCCC-----cHHHHHH
Q 046639          273 PSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERM-----EMRDVVA  317 (331)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----s~~~i~~  317 (331)
                                 ..++......+.+++.+||+.||.+||     ++.++++
T Consensus       212 -----------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  250 (328)
T cd05593         212 -----------IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR  250 (328)
T ss_pred             -----------ccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence                       011123456788999999999999997     8888874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.8e-42  Score=306.55  Aligned_cols=201  Identities=24%  Similarity=0.342  Sum_probs=172.9

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc-chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCccee
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK-QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      .++|.+.++||+|+||.||++.+..++..+|+|.+... .......+.+|+.+++.++|+||++++++|.     ..+..
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~   78 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEI   78 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEE-----ECCEE
Confidence            46899999999999999999999999999999988754 3344567899999999999999999999964     35678


Q ss_pred             eEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccc
Q 046639          108 AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      ++||||+++++|.+++....  .++...+..++.|++.||.|||+..  +++|+||||+||+++.++.+||+|||++...
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~  154 (333)
T cd06650          79 SICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  154 (333)
T ss_pred             EEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhh
Confidence            99999999999999997643  3667888899999999999999752  7999999999999999999999999998754


Q ss_pred             ccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcc
Q 046639          188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAM  248 (331)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  248 (331)
                      ..          .......++..|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus       155 ~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~  205 (333)
T cd06650         155 ID----------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP  205 (333)
T ss_pred             hh----------hccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence            11          1112345788899999999888999999999999999999999999753

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=4.1e-42  Score=296.26  Aligned_cols=260  Identities=23%  Similarity=0.306  Sum_probs=205.8

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc---chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK---QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      ++|.+.+.||+|+||.||+|++..+++.||+|.+...   .......+.+|+.+++.++|||++++++++.     ..+.
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~   76 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFI-----EDNE   76 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEE-----ECCe
Confidence            5799999999999999999999989999999987532   3344566889999999999999999999853     3467


Q ss_pred             eeEEEeecCCCCHHHHHHhc--cCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcc
Q 046639          107 KAIVFEYMQNRNLEQWLRQS--NGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA  184 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a  184 (331)
                      .++++|++++++|.+++...  ....++...+..++.|++.||+|||++   +++|+||+|+||+++.++.++|+|||++
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~  153 (267)
T cd08228          77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLG  153 (267)
T ss_pred             EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccc
Confidence            89999999999999988642  233467788899999999999999999   9999999999999999999999999998


Q ss_pred             cccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCc
Q 046639          185 KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALP  264 (331)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  264 (331)
                      .......        .......+++.|+|||.+.+..++.++|+||+|+++|+|++|..||................   
T Consensus       154 ~~~~~~~--------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~---  222 (267)
T cd08228         154 RFFSSKT--------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQ---  222 (267)
T ss_pred             eeccchh--------HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhc---
Confidence            7652111        11112347778999999988889999999999999999999999986432221111111110   


Q ss_pred             chhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhh
Q 046639          265 DKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHAR  323 (331)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~  323 (331)
                           ...+..          ....+...+.+++.+||+.+|++|||+.+|++.+++++
T Consensus       223 -----~~~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         223 -----CDYPPL----------PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             -----CCCCCC----------ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence                 001100          11234567899999999999999999999999998864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.6e-42  Score=312.15  Aligned_cols=265  Identities=18%  Similarity=0.199  Sum_probs=197.4

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      .++|.+.+.||+|+||.||+|.+..+++.||+|...      ...+.+|+.+++.++||||+++++++     ......+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~~~  159 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTF-----TYNKFTC  159 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEE-----EECCeeE
Confidence            357999999999999999999999999999999653      23467899999999999999999985     3456789


Q ss_pred             EEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccc
Q 046639          109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLF  188 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~  188 (331)
                      +|+|++ .++|..++....  .+++..++.++.|++.||.|||++   +|+||||||+||+++.++.++|+|||++....
T Consensus       160 lv~e~~-~~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~  233 (391)
T PHA03212        160 LILPRY-KTDLYCYLAAKR--NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPV  233 (391)
T ss_pred             EEEecC-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccc
Confidence            999999 678988886543  467788999999999999999999   99999999999999999999999999987531


Q ss_pred             cCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCC------cchHHHHHHhh
Q 046639          189 GYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNE------GLTLHEFVKMA  262 (331)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~~~~~~~  262 (331)
                      ..       .........||+.|+|||++.+..++.++||||||+++|+|++|..||-.....      ...+.......
T Consensus       234 ~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~  306 (391)
T PHA03212        234 DI-------NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRS  306 (391)
T ss_pred             cc-------cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHh
Confidence            11       111223456899999999999999999999999999999999999876432111      11111111111


Q ss_pred             Ccc--h--------hhhhc---Ccccccc-cccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          263 LPD--K--------VMEIV---DPSLLLE-VTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       263 ~~~--~--------~~~~~---~~~~~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ...  .        +....   ....... .....+......+..+.+|+.+||+.||.+|||+.|+++
T Consensus       307 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        307 GTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             cCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence            000  0        00000   0000000 000011122245668999999999999999999999984

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2e-42  Score=313.21  Aligned_cols=264  Identities=19%  Similarity=0.270  Sum_probs=203.9

Q ss_pred             HHhcCCCcCceeeccCeeEEEEeeecC-----CCceEEEEEeeccch-hhHHHHHHHHHHHHcCC-CCCcceeeceeecc
Q 046639           27 KATNNFSPANKIGQGGVSIVYKGILDE-----SRSIVAVKVVNLKQK-EASRSFAAECNALRNIR-HRNLIKIITICSSI   99 (331)
Q Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~   99 (331)
                      ...++|.+++.||+|+||+||+|.+..     ++..||+|.+..... ...+.+.+|+.+++.+. ||||++++++|   
T Consensus        34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~---  110 (400)
T cd05105          34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC---  110 (400)
T ss_pred             ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE---
Confidence            346689999999999999999998743     234699999864433 33467899999999996 99999999995   


Q ss_pred             cCCCcceeeEEEeecCCCCHHHHHHhcc----------------------------------------------------
Q 046639          100 DFEGFDFKAIVFEYMQNRNLEQWLRQSN----------------------------------------------------  127 (331)
Q Consensus       100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------------------------------------------  127 (331)
                        ......++||||+++|+|.+++....                                                    
T Consensus       111 --~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (400)
T cd05105         111 --TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY  188 (400)
T ss_pred             --ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence              44567899999999999999886531                                                    


Q ss_pred             ------------------------------------------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCC
Q 046639          128 ------------------------------------------GQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKP  165 (331)
Q Consensus       128 ------------------------------------------~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~  165 (331)
                                                                ...+++..+..++.|++.||.|||+.   +++|+||||
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp  265 (400)
T cd05105         189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAA  265 (400)
T ss_pred             chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCh
Confidence                                                      12356667788999999999999999   999999999


Q ss_pred             CCEEecCCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCC
Q 046639          166 SNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRP  244 (331)
Q Consensus       166 ~nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p  244 (331)
                      +||+++.++.++|+|||++........      ........+++.|+|||.+.+..++.++||||||+++|+|++ |..|
T Consensus       266 ~Nill~~~~~~kL~DfGla~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P  339 (400)
T cd05105         266 RNVLLAQGKIVKICDFGLARDIMHDSN------YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTP  339 (400)
T ss_pred             HhEEEeCCCEEEEEeCCcceecccccc------ccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence            999999999999999999876522111      111122345677999999998899999999999999999997 9999


Q ss_pred             CCcccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhh
Q 046639          245 TDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARE  324 (331)
Q Consensus       245 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~  324 (331)
                      |............. ...        ...           .....++..+.+++.+||+.+|++|||+.+|.+.|+.+.+
T Consensus       340 ~~~~~~~~~~~~~~-~~~--------~~~-----------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         340 YPGMIVDSTFYNKI-KSG--------YRM-----------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             CcccchhHHHHHHH-hcC--------CCC-----------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence            97542221111111 000        000           1112456788999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=4.1e-43  Score=312.32  Aligned_cols=246  Identities=19%  Similarity=0.234  Sum_probs=196.6

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCC-ceEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCc
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESR-SIVAVKVVNLKQ---KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGF  104 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  104 (331)
                      .++|.+.+.||+|+||.||+|.+..++ ..||+|.+....   ......+.+|+.+++.++||||+++++++     ...
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~  103 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSF-----KDE  103 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEE-----EeC
Confidence            346999999999999999999876554 689999986432   23345678999999999999999999995     445


Q ss_pred             ceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcc
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA  184 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a  184 (331)
                      +..++||||+++++|.+++....  .+++..+..++.|++.||.|||++   +++||||||+||+++.++.++|+|||++
T Consensus       104 ~~~~lv~Ey~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a  178 (340)
T PTZ00426        104 SYLYLVLEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFA  178 (340)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCC
Confidence            67899999999999999997643  467788889999999999999999   9999999999999999999999999998


Q ss_pred             cccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCc
Q 046639          185 KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALP  264 (331)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  264 (331)
                      ....           .......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ............ 
T Consensus       179 ~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-~~~~~~i~~~~~-  245 (340)
T PTZ00426        179 KVVD-----------TRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP-LLIYQKILEGII-  245 (340)
T ss_pred             eecC-----------CCcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH-HHHHHHHhcCCC-
Confidence            7641           112245689999999999998899999999999999999999999975321 111111111000 


Q ss_pred             chhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCC-----cHHHHHH
Q 046639          265 DKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERM-----EMRDVVA  317 (331)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----s~~~i~~  317 (331)
                                          .++......+.+++.+||+.||++|+     |++++++
T Consensus       246 --------------------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~  283 (340)
T PTZ00426        246 --------------------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE  283 (340)
T ss_pred             --------------------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence                                01112345678899999999999995     8888864

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.8e-42  Score=320.42  Aligned_cols=267  Identities=21%  Similarity=0.265  Sum_probs=209.2

Q ss_pred             cHHHHHHHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc--chhhHHHHHHHHHHHHcCCCCCcceeeceeec
Q 046639           21 SYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRNIRHRNLIKIITICSS   98 (331)
Q Consensus        21 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   98 (331)
                      +.+++....++|.+.+.||+|+||+||+|.+..+++.||+|.+...  .......+.+|+.++..++|+|++++...+..
T Consensus        23 d~~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~  102 (496)
T PTZ00283         23 DEATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAK  102 (496)
T ss_pred             CcccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceec
Confidence            3456666778999999999999999999999999999999998654  23445668899999999999999998876543


Q ss_pred             ccC---CCcceeeEEEeecCCCCHHHHHHhc--cCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCC
Q 046639           99 IDF---EGFDFKAIVFEYMQNRNLEQWLRQS--NGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQD  173 (331)
Q Consensus        99 ~~~---~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~  173 (331)
                      .+.   .....+++||||+++|+|.+++...  ....++...+..++.|++.||.|||+.   +|+||||||+||+++.+
T Consensus       103 ~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~  179 (496)
T PTZ00283        103 KDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSN  179 (496)
T ss_pred             ccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCC
Confidence            221   1122468999999999999999753  234577788899999999999999999   99999999999999999


Q ss_pred             CcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcc
Q 046639          174 IVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGL  253 (331)
Q Consensus       174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~  253 (331)
                      +.+||+|||+++.+....      .........||+.|+|||++.+..++.++||||||+++|+|++|..||....    
T Consensus       180 ~~vkL~DFGls~~~~~~~------~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~----  249 (496)
T PTZ00283        180 GLVKLGDFGFSKMYAATV------SDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN----  249 (496)
T ss_pred             CCEEEEecccCeeccccc------cccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC----
Confidence            999999999997652211      1112234568999999999999999999999999999999999999996431    


Q ss_pred             hHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          254 TLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                       ............    ..            ..+..++..+.+++.+||+.||.+|||+.++++
T Consensus       250 -~~~~~~~~~~~~----~~------------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~  296 (496)
T PTZ00283        250 -MEEVMHKTLAGR----YD------------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN  296 (496)
T ss_pred             -HHHHHHHHhcCC----CC------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence             112221111100    00            111235667899999999999999999999975

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-42  Score=299.79  Aligned_cols=252  Identities=23%  Similarity=0.269  Sum_probs=199.6

Q ss_pred             CCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCccee
Q 046639           31 NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      +|.+.+.||+|+||+||++.+..+++.||+|.+....   ......+.+|+.+++.++||||+++++.+     ......
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~   75 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ETKDAL   75 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeee-----cCCCeE
Confidence            4888999999999999999999899999999986432   22234567899999999999999999884     445679


Q ss_pred             eEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccc
Q 046639          108 AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      ++||||+++++|.+++.......+++..+..++.|++.|+.|||+.   +++|+||||+||++++++.++|+|||++...
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~  152 (285)
T cd05605          76 CLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEI  152 (285)
T ss_pred             EEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceec
Confidence            9999999999999988765555678889999999999999999999   9999999999999999999999999998764


Q ss_pred             ccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchh
Q 046639          188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKV  267 (331)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  267 (331)
                      ..         ........|++.|+|||++.+..++.++||||+|+++|+|++|..||...... ...... ...+... 
T Consensus       153 ~~---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~-~~~~~~-~~~~~~~-  220 (285)
T cd05605         153 PE---------GETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK-VKREEV-ERRVKED-  220 (285)
T ss_pred             CC---------CCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh-hHHHHH-HHHhhhc-
Confidence            11         11112345788999999999888999999999999999999999999753211 111111 1111000 


Q ss_pred             hhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCC-----cHHHHHH
Q 046639          268 MEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERM-----EMRDVVA  317 (331)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----s~~~i~~  317 (331)
                          .           ..+....+..+.+|+.+||+.||.+||     ++.++++
T Consensus       221 ----~-----------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         221 ----Q-----------EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             ----c-----------cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence                0           011123456788999999999999999     8888864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.5e-42  Score=298.07  Aligned_cols=255  Identities=27%  Similarity=0.435  Sum_probs=206.4

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeE
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAI  109 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~l  109 (331)
                      .+|.+.+.||.|++|.||+|.+.. +..+++|.+..........+..|+.+++.++|+|++++++++     ......++
T Consensus         6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~l   79 (261)
T cd05148           6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVC-----SVGEPVYI   79 (261)
T ss_pred             HHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeE-----ecCCCeEE
Confidence            469999999999999999999986 788999999766665567789999999999999999999985     44567899


Q ss_pred             EEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccccc
Q 046639          110 VFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG  189 (331)
Q Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~  189 (331)
                      |||++++++|.+++....+..+++..+..++.|++.|+.+||+.   +++|+||+|+||+++.++.++|+|||.+.....
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~  156 (261)
T cd05148          80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKE  156 (261)
T ss_pred             EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCC
Confidence            99999999999999876666678889999999999999999999   999999999999999999999999999876521


Q ss_pred             CCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhCcchhh
Q 046639          190 YEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMALPDKVM  268 (331)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  268 (331)
                      ..        .......++..|+|||...+..++.++||||||+++|+|++ |..||...... ..+..... ..     
T Consensus       157 ~~--------~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~-~~~~~~~~-~~-----  221 (261)
T cd05148         157 DV--------YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH-EVYDQITA-GY-----  221 (261)
T ss_pred             cc--------ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH-HHHHHHHh-CC-----
Confidence            11        11112234567999999988889999999999999999998 89999654211 11111110 00     


Q ss_pred             hhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHh
Q 046639          269 EIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHA  322 (331)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~  322 (331)
                         ..           .....++..+.+++.+||+.+|.+|||+.+|++.|+.+
T Consensus       222 ---~~-----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         222 ---RM-----------PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             ---cC-----------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence               00           01123456788999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=9.5e-43  Score=308.59  Aligned_cols=245  Identities=21%  Similarity=0.285  Sum_probs=192.2

Q ss_pred             CCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHH---HcCCCCCcceeeceeecccCCCcc
Q 046639           32 FSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNAL---RNIRHRNLIKIITICSSIDFEGFD  105 (331)
Q Consensus        32 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l---~~l~h~~i~~~~~~~~~~~~~~~~  105 (331)
                      |.+.+.||+|+||.||+|.+..+++.||+|+++...   ....+.+..|..++   +.++||||+++++++     ...+
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~-----~~~~   75 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF-----QTED   75 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEE-----EcCC
Confidence            678899999999999999999999999999996432   22335566676655   456799999999984     4567


Q ss_pred             eeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccc
Q 046639          106 FKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAK  185 (331)
Q Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~  185 (331)
                      ..++||||+++++|...+..   ..+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++.
T Consensus        76 ~~~lv~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~  149 (324)
T cd05589          76 HVCFVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK  149 (324)
T ss_pred             EEEEEEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCc
Confidence            88999999999999988854   2477889999999999999999999   99999999999999999999999999886


Q ss_pred             ccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcc
Q 046639          186 FLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPD  265 (331)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  265 (331)
                      ....        .........|++.|+|||.+.+..++.++||||||+++|+|++|..||...... ..........   
T Consensus       150 ~~~~--------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~-~~~~~i~~~~---  217 (324)
T cd05589         150 EGMG--------FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE-EVFDSIVNDE---  217 (324)
T ss_pred             cCCC--------CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCC---
Confidence            4311        112223456889999999999999999999999999999999999999753211 1111111100   


Q ss_pred             hhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCC-----cHHHHHH
Q 046639          266 KVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERM-----EMRDVVA  317 (331)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----s~~~i~~  317 (331)
                                        ..++..++..+.+++.+||+.||.+||     ++.++++
T Consensus       218 ------------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         218 ------------------VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             ------------------CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence                              011123456788999999999999999     4666654

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=8.5e-42  Score=297.68  Aligned_cols=263  Identities=22%  Similarity=0.406  Sum_probs=206.7

Q ss_pred             hcCCCcCceeeccCeeEEEEeee-----cCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCC
Q 046639           29 TNNFSPANKIGQGGVSIVYKGIL-----DESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEG  103 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  103 (331)
                      .++|.+.+.||.|+||+||++.+     ..++..+|+|.+..........+.+|+.++++++|||++++++++.     .
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~   78 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV-----E   78 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----c
Confidence            45799999999999999999985     2345679999887665566677999999999999999999999853     4


Q ss_pred             cceeeEEEeecCCCCHHHHHHhcc-----------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecC
Q 046639          104 FDFKAIVFEYMQNRNLEQWLRQSN-----------GQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQ  172 (331)
Q Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~  172 (331)
                      .+..++|+|++++++|.+++....           ...+++..++.++.|++.||++||+.   +++|+||||+||+++.
T Consensus        79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~  155 (288)
T cd05093          79 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGE  155 (288)
T ss_pred             CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEcc
Confidence            567899999999999999997532           12477888999999999999999999   9999999999999999


Q ss_pred             CCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCC
Q 046639          173 DIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNE  251 (331)
Q Consensus       173 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~  251 (331)
                      ++.++|+|||++.......      .........++..|+|||.+.+..++.++||||||+++|+|++ |..||......
T Consensus       156 ~~~~kl~dfg~~~~~~~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~  229 (288)
T cd05093         156 NLLVKIGDFGMSRDVYSTD------YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN  229 (288)
T ss_pred             CCcEEeccCCccccccCCc------eeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999987542111      1111122334677999999998889999999999999999998 99998654211


Q ss_pred             cchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhh
Q 046639          252 GLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETF  326 (331)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~  326 (331)
                           ...........     .           .....++..+.+|+.+||+.+|.+|||+.+|.+.|+.+..+.
T Consensus       230 -----~~~~~i~~~~~-----~-----------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~  283 (288)
T cd05093         230 -----EVIECITQGRV-----L-----------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS  283 (288)
T ss_pred             -----HHHHHHHcCCc-----C-----------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence                 11111111000     0           001123457899999999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=3.8e-42  Score=315.81  Aligned_cols=271  Identities=21%  Similarity=0.297  Sum_probs=195.8

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccC---CCcc
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDF---EGFD  105 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---~~~~  105 (331)
                      .++|.+++.||+|+||.||+|.+..+++.||+|.+....    ....+|+.+++.++||||+++.+++....+   ....
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            457999999999999999999999899999999885332    123479999999999999999887643222   2233


Q ss_pred             eeeEEEeecCCCCHHHHHHh--ccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCC-cEEEcccC
Q 046639          106 FKAIVFEYMQNRNLEQWLRQ--SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDI-VAHVGDLG  182 (331)
Q Consensus       106 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~-~~kl~Dfg  182 (331)
                      .+++||||++ ++|.+++..  .....+++..+..++.|++.||.|||+.   +|+||||||+||+++.++ .+||+|||
T Consensus       141 ~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFG  216 (440)
T PTZ00036        141 FLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFG  216 (440)
T ss_pred             EEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccc
Confidence            5779999995 588887764  2345577888999999999999999999   999999999999999665 79999999


Q ss_pred             cccccccCCCCCcccccCCceeecccccccCCcccCCC-CCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHh
Q 046639          183 LAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGS-KASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKM  261 (331)
Q Consensus       183 ~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  261 (331)
                      +++.+..         ........+|+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.... ..+......
T Consensus       217 la~~~~~---------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~-~~~~~i~~~  286 (440)
T PTZ00036        217 SAKNLLA---------GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV-DQLVRIIQV  286 (440)
T ss_pred             cchhccC---------CCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHH
Confidence            9986521         1122234678899999998764 6899999999999999999999999754221 122222211


Q ss_pred             hCc--chhhhhcCcccc----cccccC--CcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          262 ALP--DKVMEIVDPSLL----LEVTAN--NYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       262 ~~~--~~~~~~~~~~~~----~~~~~~--~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ...  ........+...    ......  ...++...+..+.+|+.+||+.||.+|||+.++++
T Consensus       287 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        287 LGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             hCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence            110  000000011000    000000  00111234567899999999999999999999983

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=7.6e-43  Score=299.57  Aligned_cols=251  Identities=27%  Similarity=0.447  Sum_probs=192.3

Q ss_pred             cCceeeccCeeEEEEeeec----CCCceEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           34 PANKIGQGGVSIVYKGILD----ESRSIVAVKVVNLKQ-KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        34 ~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      +.+.||.|.||.||+|.+.    ..+..|+||.++... ......+.+|++.+++++||||++++++|.     ..+..+
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~-----~~~~~~   77 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCI-----ENEPLF   77 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEE-----SSSSEE
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccc-----cccccc
Confidence            4678999999999999997    456789999996543 334678999999999999999999999975     334589


Q ss_pred             EEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccc
Q 046639          109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLF  188 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~  188 (331)
                      +|+||+++++|.+++.......+++..+..++.|++.||.|||++   +++|++|+++||+++.++.+||+|||++....
T Consensus        78 lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~  154 (259)
T PF07714_consen   78 LVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPIS  154 (259)
T ss_dssp             EEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETT
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc
Confidence            999999999999999987566788899999999999999999999   99999999999999999999999999997651


Q ss_pred             cCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhCcchh
Q 046639          189 GYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMALPDKV  267 (331)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  267 (331)
                      ...      .............|+|||.+.+..++.++||||||+++|||++ |..||....  .......+......  
T Consensus       155 ~~~------~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~--~~~~~~~~~~~~~~--  224 (259)
T PF07714_consen  155 EKS------KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD--NEEIIEKLKQGQRL--  224 (259)
T ss_dssp             TSS------SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC--HHHHHHHHHTTEET--
T ss_pred             ccc------ccccccccccccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccc--
Confidence            110      0111122335567999999988889999999999999999999 789986541  11111111111000  


Q ss_pred             hhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHH
Q 046639          268 MEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKL  319 (331)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L  319 (331)
                                       ..+..++..+.+++..||+.+|++|||+.+|++.|
T Consensus       225 -----------------~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  225 -----------------PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             -----------------TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             -----------------eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence                             11123567788999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=2e-43  Score=325.21  Aligned_cols=263  Identities=24%  Similarity=0.435  Sum_probs=214.5

Q ss_pred             hcCCCcCceeeccCeeEEEEeeec-----CCCceEEEEEeeccchh-hHHHHHHHHHHHHcCCCCCcceeeceeecccCC
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILD-----ESRSIVAVKVVNLKQKE-ASRSFAAECNALRNIRHRNLIKIITICSSIDFE  102 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  102 (331)
                      +++....+.||+|+||+||+|+..     .....||||.++..... ...+|.+|++++..++|||||+++|+|.     
T Consensus       485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~-----  559 (774)
T KOG1026|consen  485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCR-----  559 (774)
T ss_pred             hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEc-----
Confidence            445667789999999999999873     34567999999866665 6788999999999999999999999974     


Q ss_pred             CcceeeEEEeecCCCCHHHHHHhcc--------CCc----cchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEe
Q 046639          103 GFDFKAIVFEYMQNRNLEQWLRQSN--------GQL----RFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILL  170 (331)
Q Consensus       103 ~~~~~~lv~e~~~~~~L~~~l~~~~--------~~~----~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv  170 (331)
                      .++.+++|+||+..|+|.+++..+.        +..    ++..+.+.++.||+.|+.||-++   .+|||||..+|+||
T Consensus       560 ~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLV  636 (774)
T KOG1026|consen  560 EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLV  636 (774)
T ss_pred             cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhcee
Confidence            3567899999999999999998632        223    67788899999999999999999   99999999999999


Q ss_pred             cCCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCccc
Q 046639          171 DQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMF  249 (331)
Q Consensus       171 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~  249 (331)
                      +++-.|||+|||+++...+.+      +........-...|||||.+..+.++.+|||||+|++|||+++ |..||.+..
T Consensus       637 ge~l~VKIsDfGLsRdiYssD------YYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS  710 (774)
T KOG1026|consen  637 GENLVVKISDFGLSRDIYSSD------YYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS  710 (774)
T ss_pred             ccceEEEecccccchhhhhhh------hhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc
Confidence            999999999999999764322      2222212233455999999999999999999999999999999 999998764


Q ss_pred             CCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhh
Q 046639          250 NEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETF  326 (331)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~  326 (331)
                      ++. .+..+-...            +        .+.+++|+..+.+||..||+.+|.+||++.||-.+|+..-++.
T Consensus       711 n~E-VIe~i~~g~------------l--------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s  766 (774)
T KOG1026|consen  711 NQE-VIECIRAGQ------------L--------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS  766 (774)
T ss_pred             hHH-HHHHHHcCC------------c--------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence            431 111111111            1        1455789999999999999999999999999999999876653

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=5.1e-42  Score=297.73  Aligned_cols=257  Identities=26%  Similarity=0.465  Sum_probs=201.6

Q ss_pred             hcCCCcCceeeccCeeEEEEeeec-----CCCceEEEEEeeccchh-hHHHHHHHHHHHHcCCCCCcceeeceeecccCC
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILD-----ESRSIVAVKVVNLKQKE-ASRSFAAECNALRNIRHRNLIKIITICSSIDFE  102 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  102 (331)
                      .++|.+.+.||+|+||.||+|.+.     .+++.||+|.+...... ....+.+|+++++.+.|+|++++++++     .
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~   78 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVC-----T   78 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEE-----e
Confidence            356999999999999999999874     34678999998655433 457789999999999999999999995     3


Q ss_pred             CcceeeEEEeecCCCCHHHHHHhcc------------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEe
Q 046639          103 GFDFKAIVFEYMQNRNLEQWLRQSN------------GQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILL  170 (331)
Q Consensus       103 ~~~~~~lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv  170 (331)
                      .....++|||++++++|.+++....            ...+++..+..++.|++.|+.+||++   +++|+||||+||++
T Consensus        79 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili  155 (280)
T cd05049          79 EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLV  155 (280)
T ss_pred             cCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEE
Confidence            4467899999999999999997642            23466778889999999999999999   99999999999999


Q ss_pred             cCCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCccc
Q 046639          171 DQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMF  249 (331)
Q Consensus       171 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~  249 (331)
                      +.++.++|+|||++.......      .........+++.|+|||++.+..++.++||||||+++|+|++ |..||....
T Consensus       156 ~~~~~~kl~d~g~~~~~~~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~  229 (280)
T cd05049         156 GYDLVVKIGDFGMSRDVYTTD------YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS  229 (280)
T ss_pred             cCCCeEEECCcccceecccCc------ceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence            999999999999987542111      0011122235677999999999999999999999999999998 999986532


Q ss_pred             CCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHH
Q 046639          250 NEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLR  320 (331)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~  320 (331)
                      ..  ........   ..         ..       .....++..+.+++.+||+.||++|||+.||++.|+
T Consensus       230 ~~--~~~~~~~~---~~---------~~-------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         230 NE--EVIECITQ---GR---------LL-------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             HH--HHHHHHHc---CC---------cC-------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence            21  11111110   00         00       011234567899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-42  Score=311.19  Aligned_cols=259  Identities=20%  Similarity=0.278  Sum_probs=202.1

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      ++|.+.+.||+|+||+||+|.+..+++.||+|++....   ......+..|+.++..++|+||++++++     +...+.
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~-----~~~~~~   75 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYS-----FQDEEH   75 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhh-----eecCCe
Confidence            47999999999999999999999999999999996442   2344568889999999999999999988     455678


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      .++||||+++++|.+++.+.  ..++...+..++.|++.||+|||+.   |++|+||||+||+++.++.++|+|||++..
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~  150 (350)
T cd05573          76 LYLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKK  150 (350)
T ss_pred             EEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCcc
Confidence            99999999999999999765  3577888999999999999999999   999999999999999999999999999976


Q ss_pred             cccCCCC---------------------CcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCC
Q 046639          187 LFGYEPG---------------------TAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPT  245 (331)
Q Consensus       187 ~~~~~~~---------------------~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf  245 (331)
                      .......                     .............||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf  230 (350)
T cd05573         151 MNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPF  230 (350)
T ss_pred             CcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCC
Confidence            5322100                     0000011223456899999999999999999999999999999999999999


Q ss_pred             CcccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCc-HHHHHH
Q 046639          246 DAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERME-MRDVVA  317 (331)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps-~~~i~~  317 (331)
                      ...... .........  ...   ...+       .     ...+++.+.+++.+||+ +|.+||+ +.++++
T Consensus       231 ~~~~~~-~~~~~i~~~--~~~---~~~p-------~-----~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~  284 (350)
T cd05573         231 YSDTLQ-ETYNKIINW--KES---LRFP-------P-----DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKS  284 (350)
T ss_pred             CCCCHH-HHHHHHhcc--CCc---ccCC-------C-----CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence            754211 111111100  000   0000       0     00145678899999997 9999999 999985

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=4.1e-42  Score=308.02  Aligned_cols=249  Identities=21%  Similarity=0.319  Sum_probs=192.8

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCccee
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ-KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      .++|..++.||+|+||+||+|.+..+++.||+|++.... ......+.+|+.+++.++|+||+++++++     ...+..
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~  147 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF-----DHNGEI  147 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEe-----ccCCeE
Confidence            346888899999999999999999899999999986443 33446788999999999999999999984     556778


Q ss_pred             eEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccc
Q 046639          108 AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      ++||||+++++|.+..      ......+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++...
T Consensus       148 ~lv~e~~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~  218 (353)
T PLN00034        148 QVLLEFMDGGSLEGTH------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRIL  218 (353)
T ss_pred             EEEEecCCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceec
Confidence            9999999999986532      234566778999999999999999   9999999999999999999999999998765


Q ss_pred             ccCCCCCcccccCCceeecccccccCCcccCC-----CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhh
Q 046639          188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMG-----SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMA  262 (331)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  262 (331)
                      ...        ........||..|+|||++..     ...+.++|||||||++|+|++|..||....  ...+.......
T Consensus       219 ~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~--~~~~~~~~~~~  288 (353)
T PLN00034        219 AQT--------MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR--QGDWASLMCAI  288 (353)
T ss_pred             ccc--------cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCC--CccHHHHHHHH
Confidence            211        111123458899999998743     234568999999999999999999997321  11222111111


Q ss_pred             CcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          263 LPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ...     ..+           .....+...+.+|+.+||+.||++|||+.|+++
T Consensus       289 ~~~-----~~~-----------~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~  327 (353)
T PLN00034        289 CMS-----QPP-----------EAPATASREFRHFISCCLQREPAKRWSAMQLLQ  327 (353)
T ss_pred             hcc-----CCC-----------CCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            000     000           111235567899999999999999999999986

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.8e-42  Score=306.82  Aligned_cols=242  Identities=19%  Similarity=0.255  Sum_probs=191.1

Q ss_pred             CCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc---chhhHHHHHHHHHHHHcCCCC-CcceeeceeecccCCCcce
Q 046639           31 NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK---QKEASRSFAAECNALRNIRHR-NLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~~~~  106 (331)
                      +|.+++.||+|+||.||+|.+..+++.||+|++...   .......+..|..++..+.|+ +|+.+++++     ...+.
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~   75 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QTMDR   75 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEE-----EcCCE
Confidence            488999999999999999999999999999998643   223445678899999999765 577777763     44567


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      .++||||+++++|.+++....  .+++..+..++.|++.||.|||++   +|+|+||||+||+++.++.++|+|||++..
T Consensus        76 ~~lv~E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~  150 (324)
T cd05587          76 LYFVMEYVNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKE  150 (324)
T ss_pred             EEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCccee
Confidence            899999999999999986543  366788899999999999999999   999999999999999999999999999864


Q ss_pred             cccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcch
Q 046639          187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDK  266 (331)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  266 (331)
                      ...        .........||+.|+|||++.+..++.++||||+|+++|+|++|..||...... ..+.....    . 
T Consensus       151 ~~~--------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-~~~~~i~~----~-  216 (324)
T cd05587         151 NIF--------GGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED-ELFQSIME----H-  216 (324)
T ss_pred             cCC--------CCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-HHHHHHHc----C-
Confidence            311        112233456899999999999999999999999999999999999999753211 11111100    0 


Q ss_pred             hhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcH
Q 046639          267 VMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEM  312 (331)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~  312 (331)
                           .           ..++......+.+++.+||..||.+|+++
T Consensus       217 -----~-----------~~~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         217 -----N-----------VSYPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             -----C-----------CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence                 0           01112345678899999999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=7.2e-42  Score=307.20  Aligned_cols=273  Identities=19%  Similarity=0.194  Sum_probs=199.9

Q ss_pred             HHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc--chhhHHHHHHHHHHHHcCCCCCcceeeceeeccc-CCC
Q 046639           27 KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRNIRHRNLIKIITICSSID-FEG  103 (331)
Q Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~  103 (331)
                      ...++|.+.+.||+|+||.||+|.+..++..||+|.+...  .......+.+|+.+++.++||||+++++++.... ...
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   97 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE   97 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence            3457899999999999999999999999999999998643  3334566789999999999999999999875322 223


Q ss_pred             cceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCc
Q 046639          104 FDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGL  183 (331)
Q Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~  183 (331)
                      ....++|||++ .++|.+.+..    .++...+..++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||+
T Consensus        98 ~~~~~lv~e~~-~~~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~  169 (359)
T cd07876          98 FQDVYLVMELM-DANLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  169 (359)
T ss_pred             cceeEEEEeCC-CcCHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCC
Confidence            34579999999 5577777643    256678888999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhC
Q 046639          184 AKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMAL  263 (331)
Q Consensus       184 a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  263 (331)
                      +.....         ........+|+.|+|||++.+..++.++||||||+++|+|++|..||..... ...+........
T Consensus       170 a~~~~~---------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~-~~~~~~~~~~~~  239 (359)
T cd07876         170 ARTACT---------NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDH-IDQWNKVIEQLG  239 (359)
T ss_pred             cccccc---------CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcC
Confidence            875411         1112234578899999999999999999999999999999999999975421 111111111100


Q ss_pred             cc----------hhhhhcC--ccccc----cc-----ccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          264 PD----------KVMEIVD--PSLLL----EV-----TANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       264 ~~----------~~~~~~~--~~~~~----~~-----~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ..          .+.....  +....    +.     ..............+.+|+.+||+.||++|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  314 (359)
T cd07876         240 TPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR  314 (359)
T ss_pred             CCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence            00          0000000  00000    00     00000111123466889999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-42  Score=311.61  Aligned_cols=259  Identities=17%  Similarity=0.228  Sum_probs=198.4

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      ++|.+.+.||+|+||+||+|++..+++.||+|++....   ......+.+|+.+++.++||||+++++++     ...+.
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~   75 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSF-----QDENY   75 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCe
Confidence            47999999999999999999999999999999996432   23345678899999999999999999984     45678


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      .++||||+++++|.+++....  .++...+..++.|++.||.|||++   +++||||||+||+++.++.++|+|||++..
T Consensus        76 ~~lv~E~~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~  150 (364)
T cd05599          76 LYLIMEYLPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTG  150 (364)
T ss_pred             EEEEECCCCCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeeccccee
Confidence            999999999999999997643  477888999999999999999999   999999999999999999999999999876


Q ss_pred             cccCCCCCcccc------------------------------cCCceeecccccccCCcccCCCCCccchhhHhHHHHHH
Q 046639          187 LFGYEPGTAAET------------------------------ASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLL  236 (331)
Q Consensus       187 ~~~~~~~~~~~~------------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~  236 (331)
                      +...........                              ........||+.|+|||++.+..++.++|||||||++|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~  230 (364)
T cd05599         151 LKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMY  230 (364)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHH
Confidence            422111000000                              00111245899999999999999999999999999999


Q ss_pred             HHHhCCCCCCcccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCc---HH
Q 046639          237 EMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERME---MR  313 (331)
Q Consensus       237 el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps---~~  313 (331)
                      +|++|..||...... .........  ...        +  .++..     ..+.+.+.+++.+|+. +|.+|++   +.
T Consensus       231 el~~G~~Pf~~~~~~-~~~~~i~~~--~~~--------~--~~~~~-----~~~s~~~~~li~~ll~-~p~~R~~~~~~~  291 (364)
T cd05599         231 EMLVGYPPFCSDNPQ-ETYRKIINW--KET--------L--QFPDE-----VPLSPEAKDLIKRLCC-EAERRLGNNGVN  291 (364)
T ss_pred             HhhcCCCCCCCCCHH-HHHHHHHcC--CCc--------c--CCCCC-----CCCCHHHHHHHHHHcc-CHhhcCCCCCHH
Confidence            999999999753211 111111100  000        0  00000     0234567888888996 9999998   88


Q ss_pred             HHHH
Q 046639          314 DVVA  317 (331)
Q Consensus       314 ~i~~  317 (331)
                      ++++
T Consensus       292 ~ll~  295 (364)
T cd05599         292 EIKS  295 (364)
T ss_pred             HHhc
Confidence            8765

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=6.7e-42  Score=296.64  Aligned_cols=248  Identities=20%  Similarity=0.247  Sum_probs=193.6

Q ss_pred             eeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeEEEeec
Q 046639           38 IGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYM  114 (331)
Q Consensus        38 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~  114 (331)
                      ||+|+||+||++.+..+++.||+|.+....   ......+..|+++++.++||||+++.+++     ......++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~-----~~~~~~~lv~e~~   75 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAF-----ESKTHLCLVMSLM   75 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEE-----ecCCeEEEEEecC
Confidence            799999999999999999999999985322   12233456799999999999999999884     4567889999999


Q ss_pred             CCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccccCCCCC
Q 046639          115 QNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGT  194 (331)
Q Consensus       115 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~~~~~  194 (331)
                      ++++|.+++.......+++..+..++.|++.||.+||+.   +++|+||||+||+++.++.++|+|||++.....     
T Consensus        76 ~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~-----  147 (277)
T cd05607          76 NGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKD-----  147 (277)
T ss_pred             CCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCC-----
Confidence            999999998766555677888889999999999999999   999999999999999999999999999876521     


Q ss_pred             cccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhhhcCcc
Q 046639          195 AAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPS  274 (331)
Q Consensus       195 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (331)
                          ........++..|+|||++.+..++.++||||+|+++|+|++|..||....... .............        
T Consensus       148 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~--------  214 (277)
T cd05607         148 ----GKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV-AKEELKRRTLEDE--------  214 (277)
T ss_pred             ----CceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh-hHHHHHHHhhccc--------
Confidence                111123457889999999998889999999999999999999999997532211 1111111111100        


Q ss_pred             cccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHH
Q 046639          275 LLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKL  319 (331)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L  319 (331)
                      ..        .....+...+.+|+.+||+.||++||++.++++.+
T Consensus       215 ~~--------~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         215 VK--------FEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             cc--------cccccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence            00        00012456789999999999999999998776443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=6.2e-42  Score=294.23  Aligned_cols=255  Identities=22%  Similarity=0.380  Sum_probs=201.4

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeE
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAI  109 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~l  109 (331)
                      ++|++.++||+|++|.||+|.+. ++..||+|.+.... ...+.+.+|+.+++.++|+|++++++.+     ...+..++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l   78 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVV-----TKEEPIYI   78 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEE-----cCCCCcEE
Confidence            46999999999999999999875 45679999876432 3356788999999999999999999884     44567899


Q ss_pred             EEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccccc
Q 046639          110 VFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG  189 (331)
Q Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~  189 (331)
                      ++|++++++|.+++........++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        79 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05072          79 ITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIED  155 (261)
T ss_pred             EEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCC
Confidence            99999999999999876555677888899999999999999999   999999999999999999999999999976522


Q ss_pred             CCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhCcchhh
Q 046639          190 YEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMALPDKVM  268 (331)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  268 (331)
                      ...       .......++..|+|||+..+..++.++||||||+++|+|++ |..||......  ..........     
T Consensus       156 ~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~~~-----  221 (261)
T cd05072         156 NEY-------TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--DVMSALQRGY-----  221 (261)
T ss_pred             Cce-------eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--HHHHHHHcCC-----
Confidence            110       01112234567999999988889999999999999999998 99999653211  1111111100     


Q ss_pred             hhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHh
Q 046639          269 EIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHA  322 (331)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~  322 (331)
                         ..           .....++..+.+++.+||+.+|++|||+.+|.+.|+.+
T Consensus       222 ---~~-----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         222 ---RM-----------PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             ---CC-----------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence               00           01112456788999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.7e-42  Score=319.26  Aligned_cols=252  Identities=18%  Similarity=0.234  Sum_probs=201.1

Q ss_pred             CCCcCceeeccCeeEEEEeeecCC-CceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeE
Q 046639           31 NFSPANKIGQGGVSIVYKGILDES-RSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAI  109 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~l  109 (331)
                      .|.+.+.||+|++|.||+|....+ +..||+|.+..........+..|+.+++.++||||+++++++     ...+..++
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~-----~~~~~~~l  142 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDF-----KSDDKLLL  142 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEE-----EECCEEEE
Confidence            499999999999999999998776 778899987655555556678899999999999999999985     44568999


Q ss_pred             EEeecCCCCHHHHHHhc--cCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccc
Q 046639          110 VFEYMQNRNLEQWLRQS--NGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       110 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      ||||+++++|.+++...  ....++...+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++...
T Consensus       143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~  219 (478)
T PTZ00267        143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQY  219 (478)
T ss_pred             EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence            99999999999988652  233567788889999999999999999   9999999999999999999999999999865


Q ss_pred             ccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchh
Q 046639          188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKV  267 (331)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  267 (331)
                      ....      .........||+.|+|||++.+..++.++|||||||++|+|++|..||.....     ........... 
T Consensus       220 ~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-----~~~~~~~~~~~-  287 (478)
T PTZ00267        220 SDSV------SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ-----REIMQQVLYGK-  287 (478)
T ss_pred             CCcc------ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCC-
Confidence            2211      11122345689999999999999999999999999999999999999964311     11111110000 


Q ss_pred             hhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          268 MEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                         ..            .++..+...+.+++.+||+.+|++|||+.+++.
T Consensus       288 ---~~------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        288 ---YD------------PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             ---CC------------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence               00            111234567899999999999999999999874

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=7.7e-43  Score=309.31  Aligned_cols=242  Identities=19%  Similarity=0.247  Sum_probs=192.5

Q ss_pred             ceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeEEEe
Q 046639           36 NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFE  112 (331)
Q Consensus        36 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~e  112 (331)
                      +.||+|+||.||++.+..+++.||+|++....   ......+..|+.+++.++||||+++.+++     ...+..++|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~-----~~~~~~~lv~E   75 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-----QTHDRLCFVME   75 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEE-----EcCCEEEEEEe
Confidence            47999999999999999999999999997432   23345677899999999999999999884     45568899999


Q ss_pred             ecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCCEEecCCCcEEEcccCcccccccCC
Q 046639          113 YMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHH-HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYE  191 (331)
Q Consensus       113 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~~  191 (331)
                      |+++++|..++....  .+++..+..++.|++.||.|||+ .   +++||||||+||+++.++.+||+|||++.....  
T Consensus        76 ~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~--  148 (325)
T cd05594          76 YANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK--  148 (325)
T ss_pred             CCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCC--
Confidence            999999999886543  46788899999999999999997 7   999999999999999999999999999875311  


Q ss_pred             CCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhhhc
Q 046639          192 PGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEIV  271 (331)
Q Consensus       192 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (331)
                            .........||+.|+|||++.+..++.++||||||+++|+|++|..||.....     ...........     
T Consensus       149 ------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~-----~~~~~~i~~~~-----  212 (325)
T cd05594         149 ------DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFELILMEE-----  212 (325)
T ss_pred             ------CCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH-----HHHHHHHhcCC-----
Confidence                  11112234589999999999998999999999999999999999999965321     11111110000     


Q ss_pred             CcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCC-----cHHHHHH
Q 046639          272 DPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERM-----EMRDVVA  317 (331)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----s~~~i~~  317 (331)
                                  ..++....+.+.+++.+||+.||++|+     ++.++++
T Consensus       213 ------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  251 (325)
T cd05594         213 ------------IRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ  251 (325)
T ss_pred             ------------CCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence                        011122456788999999999999996     8888874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=3.3e-42  Score=311.57  Aligned_cols=259  Identities=19%  Similarity=0.230  Sum_probs=195.0

Q ss_pred             CCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCccee
Q 046639           31 NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      .|.+++.||+|+||+||+|++..+++.||+|++....   ......+..|+.+++.++|+||+++++++     ...+..
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~-----~~~~~~   76 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSF-----QDKDNL   76 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEE-----ecCCEE
Confidence            6889999999999999999999999999999996432   33446688999999999999999999985     445679


Q ss_pred             eEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccc
Q 046639          108 AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      ++||||+++++|.+++....  .+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||++...
T Consensus        77 ~lv~E~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~  151 (381)
T cd05626          77 YFVMDYIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGF  151 (381)
T ss_pred             EEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence            99999999999999997643  467788888999999999999999   9999999999999999999999999997643


Q ss_pred             ccCCCCCcc---------------------------------------cccCCceeecccccccCCcccCCCCCccchhh
Q 046639          188 FGYEPGTAA---------------------------------------ETASNSIEIKGIVGYVAPEYGMGSKASVSGDV  228 (331)
Q Consensus       188 ~~~~~~~~~---------------------------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di  228 (331)
                      .........                                       ..........||+.|+|||++.+..++.++||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Di  231 (381)
T cd05626         152 RWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDW  231 (381)
T ss_pred             ccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccce
Confidence            111000000                                       00001123468999999999999899999999


Q ss_pred             HhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhcc--ccCCCC
Q 046639          229 YNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVT--CSMESP  306 (331)
Q Consensus       229 wslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--cl~~~P  306 (331)
                      |||||++|||++|..||........ .......  ...+          .++     ....+.+.+.+|+.+  |+..+|
T Consensus       232 wSlG~il~elltG~~Pf~~~~~~~~-~~~i~~~--~~~~----------~~~-----~~~~~s~~~~dli~~ll~~~~~~  293 (381)
T cd05626         232 WSVGVILFEMLVGQPPFLAPTPTET-QLKVINW--ENTL----------HIP-----PQVKLSPEAVDLITKLCCSAEER  293 (381)
T ss_pred             eehhhHHHHHHhCCCCCcCCCHHHH-HHHHHcc--cccc----------CCC-----CCCCCCHHHHHHHHHHccCcccc
Confidence            9999999999999999975322111 1111100  0000          000     001234556667766  456666


Q ss_pred             CCCCcHHHHHH
Q 046639          307 MERMEMRDVVA  317 (331)
Q Consensus       307 ~~Rps~~~i~~  317 (331)
                      ..||++.+++.
T Consensus       294 ~~R~~~~~~l~  304 (381)
T cd05626         294 LGRNGADDIKA  304 (381)
T ss_pred             cCCCCHHHHhc
Confidence            67999999975

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-42  Score=309.76  Aligned_cols=260  Identities=22%  Similarity=0.312  Sum_probs=207.3

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCC----ceEEEEEeec---cchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCC
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESR----SIVAVKVVNL---KQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFE  102 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  102 (331)
                      ++..+.++||+|+||.||+|.....+    .+||+|..+.   ........+.+|+++|+.++||||++++|++.     
T Consensus       157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~-----  231 (474)
T KOG0194|consen  157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV-----  231 (474)
T ss_pred             cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc-----
Confidence            35566699999999999999986432    2389998874   33666788999999999999999999999964     


Q ss_pred             CcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccC
Q 046639          103 GFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLG  182 (331)
Q Consensus       103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg  182 (331)
                      ....+++|||+|+||+|.+++++... .++..+...++.+.+.||+|||++   +++||||-.+|+|++.++.+||+|||
T Consensus       232 ~~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFG  307 (474)
T KOG0194|consen  232 LEEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFG  307 (474)
T ss_pred             CCCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccc
Confidence            35678999999999999999988664 577889999999999999999999   99999999999999999999999999


Q ss_pred             cccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHH-H
Q 046639          183 LAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFV-K  260 (331)
Q Consensus       183 ~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~-~  260 (331)
                      +++...        ..........-...|+|||.+....+++++||||||+++||+++ |..||.+....  .....+ .
T Consensus       308 Ls~~~~--------~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--~v~~kI~~  377 (474)
T KOG0194|consen  308 LSRAGS--------QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--EVKAKIVK  377 (474)
T ss_pred             cccCCc--------ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--HHHHHHHh
Confidence            987641        11111111123345999999999999999999999999999999 88999876332  111111 1


Q ss_pred             hhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhhh
Q 046639          261 MALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETFL  327 (331)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~~  327 (331)
                      ...+.                   ..+...+..+..++.+||..+|++|||+.++.+.|+.+.....
T Consensus       378 ~~~r~-------------------~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  378 NGYRM-------------------PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             cCccC-------------------CCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence            11111                   1111356778889999999999999999999999998876644

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=3e-41  Score=290.82  Aligned_cols=260  Identities=23%  Similarity=0.311  Sum_probs=206.3

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc---chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK---QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      ++|++.+.||+|++|.||+|.+..+++.||+|.++..   .......+.+|+.++++++|++++++++.+.     ..+.
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~-----~~~~   76 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFI-----ENNE   76 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeee-----cCCe
Confidence            5799999999999999999999989999999988632   2334567889999999999999999999853     3467


Q ss_pred             eeEEEeecCCCCHHHHHHhc--cCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcc
Q 046639          107 KAIVFEYMQNRNLEQWLRQS--NGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA  184 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a  184 (331)
                      .++||||+++++|.+++...  ....++...+..++.+++.|+++||+.   +++|+||+|+||+++.++.++|+|||++
T Consensus        77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~  153 (267)
T cd08224          77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLG  153 (267)
T ss_pred             EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEecccee
Confidence            89999999999999998752  234567888999999999999999999   9999999999999999999999999998


Q ss_pred             cccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCc
Q 046639          185 KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALP  264 (331)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  264 (331)
                      .......        .......+++.|+|||.+.+..++.++|+||||+++|+|++|..||.....   ...+.......
T Consensus       154 ~~~~~~~--------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~  222 (267)
T cd08224         154 RFFSSKT--------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---NLYSLCKKIEK  222 (267)
T ss_pred             eeccCCC--------cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc---cHHHHHhhhhc
Confidence            7652111        111233477889999999888899999999999999999999999864321   11111111000


Q ss_pred             chhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhh
Q 046639          265 DKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHAR  323 (331)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~  323 (331)
                               ......      ....+...+.+++.+||..+|++|||+.+|++.|+.++
T Consensus       223 ---------~~~~~~------~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         223 ---------CDYPPL------PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             ---------CCCCCC------ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence                     000000      01134567889999999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=5.7e-42  Score=317.73  Aligned_cols=274  Identities=21%  Similarity=0.236  Sum_probs=195.2

Q ss_pred             cHHHHHHHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCC------CCcceeec
Q 046639           21 SYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRH------RNLIKIIT   94 (331)
Q Consensus        21 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~~   94 (331)
                      ...++....++|.+.+.||+|+||+||+|.+..+++.||||+++.. .........|+.+++.++|      .+++.+++
T Consensus       120 ~~~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~  198 (467)
T PTZ00284        120 LGEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV-PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQR  198 (467)
T ss_pred             cCCccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc-hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEE
Confidence            3445555678999999999999999999999989999999998633 2233445567777777654      45777777


Q ss_pred             eeecccCCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCCEEecCC
Q 046639           95 ICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHH-HCQPSIVHGDLKPSNILLDQD  173 (331)
Q Consensus        95 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~~~~ivH~dik~~nilv~~~  173 (331)
                      ++.    ....+.++|||++ +++|.+++.+..  .+++..+..++.|++.||.|||+ .   +|+||||||+|||++.+
T Consensus       199 ~~~----~~~~~~~iv~~~~-g~~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~  268 (467)
T PTZ00284        199 YFQ----NETGHMCIVMPKY-GPCLLDWIMKHG--PFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETS  268 (467)
T ss_pred             EEE----cCCceEEEEEecc-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecC
Confidence            753    2345789999998 889999887643  47778899999999999999997 6   99999999999999876


Q ss_pred             C----------------cEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHH
Q 046639          174 I----------------VAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLE  237 (331)
Q Consensus       174 ~----------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~e  237 (331)
                      +                .+||+|||.+...           ........||+.|+|||++.+..++.++|||||||++||
T Consensus       269 ~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~-----------~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~e  337 (467)
T PTZ00284        269 DTVVDPVTNRALPPDPCRVRICDLGGCCDE-----------RHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYE  337 (467)
T ss_pred             CcccccccccccCCCCceEEECCCCccccC-----------ccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHH
Confidence            5                4999999987532           111224568999999999999999999999999999999


Q ss_pred             HHhCCCCCCcccCCcchHHHHHH--hhCcchhhh---------hc----------CcccccccccCCcchHHHHHHHHHH
Q 046639          238 MFTRRRPTDAMFNEGLTLHEFVK--MALPDKVME---------IV----------DPSLLLEVTANNYSWIEDCLVAVIG  296 (331)
Q Consensus       238 l~~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~---------~~----------~~~~~~~~~~~~~~~~~~~~~~l~~  296 (331)
                      |++|..||...... ..+..+..  ...+..+..         ..          ++.....+.........-....+.+
T Consensus       338 lltG~~pf~~~~~~-~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  416 (467)
T PTZ00284        338 LYTGKLLYDTHDNL-EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCD  416 (467)
T ss_pred             HHhCCCCCCCCChH-HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHH
Confidence            99999999754221 11111101  001111000         00          0000000000000000011356789


Q ss_pred             hhccccCCCCCCCCcHHHHHH
Q 046639          297 TGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       297 l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      |+.+||+.||++|||+.|+++
T Consensus       417 li~~mL~~dP~~R~ta~e~L~  437 (467)
T PTZ00284        417 LIYGLLHYDRQKRLNARQMTT  437 (467)
T ss_pred             HHHHhCCcChhhCCCHHHHhc
Confidence            999999999999999999986

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.5e-41  Score=292.81  Aligned_cols=260  Identities=23%  Similarity=0.293  Sum_probs=205.7

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc---chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK---QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      ++|.+.+.||+|++|.||+|.+..+++.+++|.+...   .......+.+|+.+++.+.|+|++++++++     ...+.
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~   76 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASF-----IEDNE   76 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhhee-----EeCCe
Confidence            4789999999999999999999889999999987643   223346788999999999999999999985     34567


Q ss_pred             eeEEEeecCCCCHHHHHHhc--cCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcc
Q 046639          107 KAIVFEYMQNRNLEQWLRQS--NGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA  184 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a  184 (331)
                      .+++||++++++|.+++...  ....+++..++.++.|++.|+++||+.   +++|+||+|+||+++.++.++|+|||++
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~  153 (267)
T cd08229          77 LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLG  153 (267)
T ss_pred             EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhh
Confidence            89999999999999998742  234567888899999999999999999   9999999999999999999999999988


Q ss_pred             cccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCc
Q 046639          185 KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALP  264 (331)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  264 (331)
                      .......        .......++..|+|||++.+..++.++|+||||+++|+|++|..||.....+   .......   
T Consensus       154 ~~~~~~~--------~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~---  219 (267)
T cd08229         154 RFFSSKT--------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LYSLCKK---  219 (267)
T ss_pred             hccccCC--------cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch---HHHHhhh---
Confidence            7652111        1112345778899999998888999999999999999999999999643221   1111110   


Q ss_pred             chhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhh
Q 046639          265 DKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHAR  323 (331)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~  323 (331)
                        +.....+..          ....+...+.+++.+||+.+|.+|||+.+|++.++++.
T Consensus       220 --~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         220 --IEQCDYPPL----------PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             --hhcCCCCCC----------CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence              000001100          01235668999999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.3e-41  Score=300.46  Aligned_cols=259  Identities=19%  Similarity=0.313  Sum_probs=201.3

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCc----eEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCc
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRS----IVAVKVVNLKQ-KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGF  104 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  104 (331)
                      .+|++.+.||+|+||+||+|.+..++.    .||+|.+.... ......+.+|+.+++.+.||||++++++|..      
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~------   80 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT------   80 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC------
Confidence            469999999999999999999865544    48999986443 3445678899999999999999999998743      


Q ss_pred             ceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcc
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA  184 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a  184 (331)
                      ...++++|++++|+|.+++.... ..++....+.++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++
T Consensus        81 ~~~~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a  156 (316)
T cd05108          81 STVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLA  156 (316)
T ss_pred             CCceeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccc
Confidence            24679999999999999997643 2356778889999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhC
Q 046639          185 KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMAL  263 (331)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~  263 (331)
                      +.......      ........++..|+|||++.+..++.++||||||+++|||++ |..||.+....  ..........
T Consensus       157 ~~~~~~~~------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~--~~~~~~~~~~  228 (316)
T cd05108         157 KLLGADEK------EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILEKGE  228 (316)
T ss_pred             ccccCCCc------ceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHhCCC
Confidence            86522111      001111224567999999999999999999999999999998 99999653211  1111111110


Q ss_pred             cchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhh
Q 046639          264 PDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARET  325 (331)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~  325 (331)
                      .          .         .....+...+.+++.+||+.+|++|||+.+++..|..+...
T Consensus       229 ~----------~---------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~  271 (316)
T cd05108         229 R----------L---------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  271 (316)
T ss_pred             C----------C---------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence            0          0         00112455788999999999999999999999998887654

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.8e-42  Score=304.99  Aligned_cols=237  Identities=22%  Similarity=0.259  Sum_probs=188.4

Q ss_pred             ceeeccCeeEEEEeeecCCCceEEEEEeecc---chhhHHHHHHHHHHHHcC-CCCCcceeeceeecccCCCcceeeEEE
Q 046639           36 NKIGQGGVSIVYKGILDESRSIVAVKVVNLK---QKEASRSFAAECNALRNI-RHRNLIKIITICSSIDFEGFDFKAIVF  111 (331)
Q Consensus        36 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~lv~  111 (331)
                      +.||+|+||+||+|++..+++.||+|++...   .......+..|..++..+ .||||+++++++     ...+..++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~-----~~~~~~~iv~   75 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCF-----QTPDRLFFVM   75 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEE-----EcCCEEEEEE
Confidence            4799999999999999999999999998643   223345677888888876 699999999984     4567789999


Q ss_pred             eecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccccCC
Q 046639          112 EYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYE  191 (331)
Q Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~~  191 (331)
                      ||+++++|.+++....  .++...+..++.|++.||.|||++   +++||||||+||+++.++.++|+|||++.....  
T Consensus        76 Ey~~~g~L~~~i~~~~--~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~--  148 (320)
T cd05590          76 EFVNGGDLMFHIQKSR--RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF--  148 (320)
T ss_pred             cCCCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc--
Confidence            9999999999987643  467788899999999999999999   999999999999999999999999999865311  


Q ss_pred             CCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhhhc
Q 046639          192 PGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEIV  271 (331)
Q Consensus       192 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (331)
                            .........||+.|+|||++.+..++.++||||||+++|+|++|..||.....     ............    
T Consensus       149 ------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-----~~~~~~i~~~~~----  213 (320)
T cd05590         149 ------NGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-----DDLFEAILNDEV----  213 (320)
T ss_pred             ------CCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-----HHHHHHHhcCCC----
Confidence                  11122334689999999999998999999999999999999999999975321     111111111000    


Q ss_pred             CcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcH
Q 046639          272 DPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEM  312 (331)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~  312 (331)
                                   ..+..+...+.+++.+||+.||.+||++
T Consensus       214 -------------~~~~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         214 -------------VYPTWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             -------------CCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence                         1111235578899999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.1e-41  Score=305.51  Aligned_cols=273  Identities=19%  Similarity=0.201  Sum_probs=200.6

Q ss_pred             HHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc--chhhHHHHHHHHHHHHcCCCCCcceeeceeeccc-CCC
Q 046639           27 KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRNIRHRNLIKIITICSSID-FEG  103 (331)
Q Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~  103 (331)
                      ...++|.+.+.||+|+||.||+|.+..+++.||+|.+...  .......+.+|+.+++.++||||+++++++.... ...
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            3557899999999999999999999989999999998643  3334466788999999999999999999875322 233


Q ss_pred             cceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCc
Q 046639          104 FDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGL  183 (331)
Q Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~  183 (331)
                      ....++|||++ .++|.+.+..    .++...+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||+
T Consensus        94 ~~~~~lv~e~~-~~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~  165 (355)
T cd07874          94 FQDVYLVMELM-DANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_pred             cceeEEEhhhh-cccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcc
Confidence            45679999999 5578777753    256778889999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhC
Q 046639          184 AKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMAL  263 (331)
Q Consensus       184 a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  263 (331)
                      ++....         ........+|+.|+|||++.+..++.++||||||+++|+|++|..||..... ...+........
T Consensus       166 ~~~~~~---------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~~~~~~~  235 (355)
T cd07874         166 ARTAGT---------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY-IDQWNKVIEQLG  235 (355)
T ss_pred             cccCCC---------ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhC
Confidence            975411         1122234688899999999998999999999999999999999999975321 111111111100


Q ss_pred             ----------cchhhhhcC----------cccc-cccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          264 ----------PDKVMEIVD----------PSLL-LEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       264 ----------~~~~~~~~~----------~~~~-~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                                ...+.....          +... .................+.+|+.+||+.||++|||+.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~  310 (355)
T cd07874         236 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ  310 (355)
T ss_pred             CCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence                      000000000          0000 00000001111123456789999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-41  Score=291.83  Aligned_cols=256  Identities=25%  Similarity=0.392  Sum_probs=201.8

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      .++|++.+.||+|++|.||+|.+. +++.||+|.++... .....+.+|+.++++++|+|++++++++     ...+..+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~   77 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVC-----TLEEPIY   77 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEE-----ecCCCee
Confidence            457999999999999999999975 45679999986443 2345688999999999999999999984     4456789


Q ss_pred             EEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccc
Q 046639          109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLF  188 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~  188 (331)
                      ++||++++++|.+++....+..+++..+..++.|++.|+.+||++   +++|+||+|+||+++.++.++|+|||++....
T Consensus        78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~  154 (261)
T cd05068          78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIK  154 (261)
T ss_pred             eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEcc
Confidence            999999999999999876655678899999999999999999999   99999999999999999999999999998752


Q ss_pred             cCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhCcchh
Q 046639          189 GYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMALPDKV  267 (331)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  267 (331)
                      ...       .........+..|+|||+..+..++.++||||||+++|+|++ |..||.....  ............   
T Consensus       155 ~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~~~~~~~---  222 (261)
T cd05068         155 EDI-------YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN--AEVLQQVDQGYR---  222 (261)
T ss_pred             CCc-------ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHHcCCC---
Confidence            110       000111122346999999998899999999999999999999 9999965321  111111110000   


Q ss_pred             hhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHh
Q 046639          268 MEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHA  322 (331)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~  322 (331)
                           .           .....++..+.+++.+||+.+|.+||++.+|++.|+.+
T Consensus       223 -----~-----------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         223 -----M-----------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             -----C-----------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence                 0           01123456789999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1e-41  Score=307.54  Aligned_cols=273  Identities=19%  Similarity=0.228  Sum_probs=198.6

Q ss_pred             CCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc--chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           31 NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      +|.+.+.||+|+||+||+|.+..+++.||+|.+...  +......+.+|+.+++.++|+||+++++++...+.......+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            478899999999999999999889999999988543  233446788999999999999999999997544323334789


Q ss_pred             EEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccc
Q 046639          109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLF  188 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~  188 (331)
                      +|+|++ .++|.+++...  ..++...+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++....
T Consensus        81 lv~e~~-~~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~  154 (372)
T cd07853          81 VVTELM-QSDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEE  154 (372)
T ss_pred             EEeecc-ccCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecc
Confidence            999999 56888887543  3477888999999999999999999   99999999999999999999999999997642


Q ss_pred             cCCCCCcccccCCceeecccccccCCcccCCC-CCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchh
Q 046639          189 GYEPGTAAETASNSIEIKGIVGYVAPEYGMGS-KASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKV  267 (331)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  267 (331)
                      ...       ........+++.|+|||++.+. .++.++||||+||++|+|++|..||...... ..+............
T Consensus       155 ~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~g~~~~  226 (372)
T cd07853         155 PDE-------SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI-QQLDLITDLLGTPSL  226 (372)
T ss_pred             cCc-------cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH-HHHHHHHHHcCCCCH
Confidence            111       1112233478889999998875 4789999999999999999999999754221 111111110000000


Q ss_pred             h----------hhc-CcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          268 M----------EIV-DPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       268 ~----------~~~-~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      .          ..+ ......................+.+|+.+||+.||.+|||+.++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  287 (372)
T cd07853         227 EAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA  287 (372)
T ss_pred             HHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence            0          000 0000000000000111233567889999999999999999999985

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=4.6e-42  Score=303.03  Aligned_cols=241  Identities=22%  Similarity=0.290  Sum_probs=188.4

Q ss_pred             ceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHHcC-CCCCcceeeceeecccCCCcceeeEEE
Q 046639           36 NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNI-RHRNLIKIITICSSIDFEGFDFKAIVF  111 (331)
Q Consensus        36 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~lv~  111 (331)
                      +.||+|+||+||+|.+..+++.||+|.++...   .........|..++... .||||+++++++     ......++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~-----~~~~~~~lv~   75 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTF-----QTKEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence            47999999999999999999999999987432   22334455667777654 799999999884     4556889999


Q ss_pred             eecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccccCC
Q 046639          112 EYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYE  191 (331)
Q Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~~  191 (331)
                      ||+++++|.+++....  .++...+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++.....  
T Consensus        76 e~~~gg~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~--  148 (316)
T cd05592          76 EYLNGGDLMFHIQSSG--RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMN--  148 (316)
T ss_pred             cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCC--
Confidence            9999999999987643  467788899999999999999999   999999999999999999999999999875411  


Q ss_pred             CCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhhhc
Q 046639          192 PGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEIV  271 (331)
Q Consensus       192 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (331)
                            .........||+.|+|||++.+..++.++||||||+++|+|++|..||.....     ..........      
T Consensus       149 ------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~-----~~~~~~i~~~------  211 (316)
T cd05592         149 ------GEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE-----DELFDSILND------  211 (316)
T ss_pred             ------CCCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHcC------
Confidence                  11222345689999999999998999999999999999999999999975321     1111110000      


Q ss_pred             CcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHH-HHH
Q 046639          272 DPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMR-DVV  316 (331)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~-~i~  316 (331)
                      .+           .++..+...+.+++.+||+.+|.+||++. +++
T Consensus       212 ~~-----------~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         212 RP-----------HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             CC-----------CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            00           11122455678899999999999999875 453

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=3.4e-41  Score=288.62  Aligned_cols=250  Identities=22%  Similarity=0.313  Sum_probs=202.3

Q ss_pred             CCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc--chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           31 NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      +|.+.+.||+|++|.||+|.+..++..|++|.+...  .......+.+|+.+++.++|||++++++++     ...+..+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~   75 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESF-----LDKGKLN   75 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeee-----ccCCEEE
Confidence            478889999999999999999999999999998643  344556788999999999999999999985     4456789


Q ss_pred             EEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccc
Q 046639          109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLF  188 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~  188 (331)
                      +|||++++++|.+++.......++...++.++.|++.||.+||+.   +++|+||+|+||+++.++.++|+|||++....
T Consensus        76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~  152 (256)
T cd08529          76 IVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS  152 (256)
T ss_pred             EEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceecc
Confidence            999999999999999876556678888999999999999999999   99999999999999999999999999987652


Q ss_pred             cCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhh
Q 046639          189 GYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVM  268 (331)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  268 (331)
                      ..        ........+++.|+|||+..+..++.++|+||||+++|+|++|..||.....  .   .........   
T Consensus       153 ~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~---~~~~~~~~~---  216 (256)
T cd08529         153 DN--------TNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ--G---ALILKIIRG---  216 (256)
T ss_pred             Cc--------cchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--H---HHHHHHHcC---
Confidence            11        1111233577889999999998899999999999999999999999965321  1   111110000   


Q ss_pred             hhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          269 EIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                            ...       .....+...+.+++.+||+.+|++||++.++++
T Consensus       217 ------~~~-------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  252 (256)
T cd08529         217 ------VFP-------PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR  252 (256)
T ss_pred             ------CCC-------CCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence                  000       111234567899999999999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2.2e-41  Score=295.54  Aligned_cols=261  Identities=23%  Similarity=0.410  Sum_probs=205.6

Q ss_pred             cCCCcCceeeccCeeEEEEeeec-----CCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCc
Q 046639           30 NNFSPANKIGQGGVSIVYKGILD-----ESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGF  104 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  104 (331)
                      ++|.+.+.||+|+||.||+|.+.     .++..+++|.+..........+.+|+.+++.++|+||+++++++     ...
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~   79 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVC-----GDG   79 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEE-----ccC
Confidence            46889999999999999999863     34566899988766555567789999999999999999999985     345


Q ss_pred             ceeeEEEeecCCCCHHHHHHhcc--------------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEe
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQSN--------------GQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILL  170 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv  170 (331)
                      ...++||||+++++|.+++....              ...+++..++.++.|++.|+++||++   +++|+||||+||++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~  156 (291)
T cd05094          80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLV  156 (291)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEE
Confidence            67899999999999999997532              12367788999999999999999999   99999999999999


Q ss_pred             cCCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCccc
Q 046639          171 DQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMF  249 (331)
Q Consensus       171 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~  249 (331)
                      +.++.++|+|||++.......      .........++..|+|||.+.+..++.++||||||+++|+|++ |..||....
T Consensus       157 ~~~~~~~l~dfg~a~~~~~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  230 (291)
T cd05094         157 GANLLVKIGDFGMSRDVYSTD------YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS  230 (291)
T ss_pred             ccCCcEEECCCCcccccCCCc------eeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence            999999999999987642111      1111223345678999999999899999999999999999998 999986532


Q ss_pred             CCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhh
Q 046639          250 NEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARET  325 (331)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~  325 (331)
                      ..  ...+....   ...         .       .....++..+.+++.+||+.+|++|||+.+|++.|+.+...
T Consensus       231 ~~--~~~~~~~~---~~~---------~-------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         231 NT--EVIECITQ---GRV---------L-------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             HH--HHHHHHhC---CCC---------C-------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence            11  11111100   000         0       01112456788999999999999999999999999998664

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=4.5e-42  Score=303.41  Aligned_cols=242  Identities=20%  Similarity=0.256  Sum_probs=192.5

Q ss_pred             ceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHHcC-CCCCcceeeceeecccCCCcceeeEEE
Q 046639           36 NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNI-RHRNLIKIITICSSIDFEGFDFKAIVF  111 (331)
Q Consensus        36 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~lv~  111 (331)
                      +.||+|+||+||+|.+..++..||+|++....   ......+..|..++..+ .||||+++++++     ...+..++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~-----~~~~~~~lv~   75 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCF-----QTKDRLFFVM   75 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence            47999999999999999999999999997432   23345577888888887 699999999984     4556899999


Q ss_pred             eecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccccCC
Q 046639          112 EYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYE  191 (331)
Q Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~~  191 (331)
                      ||+++++|..++....  .+++..+..++.|++.||+|||++   +++|+||||+||+++.++.++|+|||++.....  
T Consensus        76 e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--  148 (318)
T cd05570          76 EYVNGGDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL--  148 (318)
T ss_pred             cCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCc--
Confidence            9999999999986543  477888999999999999999999   999999999999999999999999999864311  


Q ss_pred             CCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhhhc
Q 046639          192 PGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEIV  271 (331)
Q Consensus       192 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (331)
                            .........+++.|+|||++.+..++.++||||||+++|+|++|..||.....     ..........      
T Consensus       149 ------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~-----~~~~~~i~~~------  211 (318)
T cd05570         149 ------GGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE-----DELFQSILED------  211 (318)
T ss_pred             ------CCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH-----HHHHHHHHcC------
Confidence                  11122234588999999999999999999999999999999999999965321     1111110000      


Q ss_pred             CcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcH-----HHHHH
Q 046639          272 DPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEM-----RDVVA  317 (331)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~-----~~i~~  317 (331)
                      .           ..++..+...+.+|+.+||+.||.+|||+     .++++
T Consensus       212 ~-----------~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         212 E-----------VRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             C-----------CCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            0           01112345678899999999999999999     77764

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.7e-41  Score=295.03  Aligned_cols=269  Identities=22%  Similarity=0.314  Sum_probs=202.3

Q ss_pred             CC-CcCceeeccCeeEEEEee----ecCCCceEEEEEeeccch-hhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCc
Q 046639           31 NF-SPANKIGQGGVSIVYKGI----LDESRSIVAVKVVNLKQK-EASRSFAAECNALRNIRHRNLIKIITICSSIDFEGF  104 (331)
Q Consensus        31 ~y-~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  104 (331)
                      +| .+.+.||+|+||+||.+.    ...++..||+|.+..... .....+.+|+.+++.++|||++++++++..   ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~   80 (283)
T cd05080           4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSE---QGG   80 (283)
T ss_pred             hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCC
Confidence            45 899999999999998765    345678899999865432 344668899999999999999999998643   234


Q ss_pred             ceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcc
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA  184 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a  184 (331)
                      ...+++||++++++|.+++...   .+++..++.++.|++.||.+||++   +++|+||||+||+++.++.++|+|||++
T Consensus        81 ~~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~  154 (283)
T cd05080          81 KGLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLA  154 (283)
T ss_pred             ceEEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccc
Confidence            5678999999999999999653   377899999999999999999999   9999999999999999999999999998


Q ss_pred             cccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhC-
Q 046639          185 KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMAL-  263 (331)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~-  263 (331)
                      ........     .........++..|+|||.+.+..++.++||||||+++|+|++|..||......   +........ 
T Consensus       155 ~~~~~~~~-----~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~---~~~~~~~~~~  226 (283)
T cd05080         155 KAVPEGHE-----YYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK---FEEMIGPKQG  226 (283)
T ss_pred             cccCCcch-----hhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch---hhhhhccccc
Confidence            76521110     000111123455699999998888999999999999999999999998653221   111111100 


Q ss_pred             ---cchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhh
Q 046639          264 ---PDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHAR  323 (331)
Q Consensus       264 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~  323 (331)
                         ...+....+....       ......++..+.+++.+||+.+|++|||+.+|++.|+.+.
T Consensus       227 ~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         227 QMTVVRLIELLERGMR-------LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             ccchhhhhhhhhcCCC-------CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence               0011111111110       0112345678999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=3.2e-42  Score=304.80  Aligned_cols=242  Identities=20%  Similarity=0.233  Sum_probs=190.8

Q ss_pred             ceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHHcC-CCCCcceeeceeecccCCCcceeeEEE
Q 046639           36 NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNI-RHRNLIKIITICSSIDFEGFDFKAIVF  111 (331)
Q Consensus        36 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~lv~  111 (331)
                      +.||+|+||.||+|++..+++.||+|++....   ......+..|..++..+ .||||+++++++     ...+..++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~-----~~~~~~~lv~   75 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCF-----QTKDRLFFVM   75 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCeEEEEE
Confidence            46999999999999999999999999986432   23345567888888866 799999999984     4556789999


Q ss_pred             eecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccccCC
Q 046639          112 EYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYE  191 (331)
Q Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~~  191 (331)
                      ||+++++|...+....  .+++..+..++.|++.||.|||++   +++||||||+||+++.++.++|+|||++.....  
T Consensus        76 E~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~--  148 (321)
T cd05591          76 EYVNGGDLMFQIQRSR--KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGIL--  148 (321)
T ss_pred             eCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceeccc--
Confidence            9999999999986543  467788889999999999999999   999999999999999999999999999875311  


Q ss_pred             CCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhhhc
Q 046639          192 PGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEIV  271 (331)
Q Consensus       192 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (331)
                            .........||+.|+|||++.+..++.++||||||+++|+|++|..||..... ...+........        
T Consensus       149 ------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~-~~~~~~i~~~~~--------  213 (321)
T cd05591         149 ------NGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE-DDLFESILHDDV--------  213 (321)
T ss_pred             ------CCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH-HHHHHHHHcCCC--------
Confidence                  11112234588999999999998999999999999999999999999975321 111111111000        


Q ss_pred             CcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCC-------cHHHHHH
Q 046639          272 DPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERM-------EMRDVVA  317 (331)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-------s~~~i~~  317 (331)
                                   .++..+...+.+++.+||+.||++||       ++.++++
T Consensus       214 -------------~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         214 -------------LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             -------------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence                         01112346788999999999999999       7777763

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.9e-41  Score=294.79  Aligned_cols=273  Identities=22%  Similarity=0.324  Sum_probs=203.9

Q ss_pred             hcCCCcCceeeccCeeEEEEeee----cCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCc
Q 046639           29 TNNFSPANKIGQGGVSIVYKGIL----DESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGF  104 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  104 (331)
                      ..+|.+.+.||+|+||+||+|..    ..++..||+|.+..........+.+|+.+++.++|||++++.+++..   .+.
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~   79 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYS---AGR   79 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEcc---CCC
Confidence            35799999999999999999874    45788999999876666666788999999999999999999998643   234


Q ss_pred             ceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcc
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA  184 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a  184 (331)
                      ...++|+||+++++|.+++.... ..+++..+..++.|++.||++||+.   +++|+||||+||+++.++.++|+|||++
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~  155 (284)
T cd05081          80 RNLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLT  155 (284)
T ss_pred             CceEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccc
Confidence            56799999999999999997543 2467788899999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCc
Q 046639          185 KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALP  264 (331)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  264 (331)
                      ........     .........++..|+|||++.+..++.++||||||+++|||++|..|+.....   .+.........
T Consensus       156 ~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~---~~~~~~~~~~~  227 (284)
T cd05081         156 KVLPQDKE-----YYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA---EFMRMMGNDKQ  227 (284)
T ss_pred             ccccCCCc-----ceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch---hhhhhcccccc
Confidence            86522111     00001111233459999999888899999999999999999998877543211   11110000000


Q ss_pred             -----chhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhh
Q 046639          265 -----DKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHAR  323 (331)
Q Consensus       265 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~  323 (331)
                           ..+........       .......++..+.+|+.+||+.+|++|||+.+|++.|+.++
T Consensus       228 ~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~  284 (284)
T cd05081         228 GQMIVYHLIELLKNNG-------RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR  284 (284)
T ss_pred             cccchHHHHHHHhcCC-------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence                 00000000000       00112235667999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.6e-41  Score=294.75  Aligned_cols=246  Identities=22%  Similarity=0.261  Sum_probs=192.1

Q ss_pred             eeccCeeEEEEeeecCCCceEEEEEeeccch---hhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeEEEeec
Q 046639           38 IGQGGVSIVYKGILDESRSIVAVKVVNLKQK---EASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYM  114 (331)
Q Consensus        38 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~  114 (331)
                      ||+|+||+||++.+..+++.+|+|.+.....   .....+..|+.+++.+.|+||+++.+++     ......++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~   75 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAF-----QTKTDLCLVMTIM   75 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEE-----cCCCeEEEEEeCC
Confidence            6999999999999999999999999864322   2235567899999999999999998884     4556789999999


Q ss_pred             CCCCHHHHHHhc--cCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccccCCC
Q 046639          115 QNRNLEQWLRQS--NGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEP  192 (331)
Q Consensus       115 ~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~~~  192 (331)
                      ++++|.+.+...  ....+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++......  
T Consensus        76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~--  150 (280)
T cd05608          76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG--  150 (280)
T ss_pred             CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCC--
Confidence            999999887542  334577888999999999999999999   9999999999999999999999999998764211  


Q ss_pred             CCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhhhcC
Q 046639          193 GTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEIVD  272 (331)
Q Consensus       193 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (331)
                            ........||+.|+|||++.+..++.++||||||+++|+|++|..||....... ............       
T Consensus       151 ------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~-------  216 (280)
T cd05608         151 ------QSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELKQRILND-------  216 (280)
T ss_pred             ------CccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch-hHHHHHHhhccc-------
Confidence                  111223468889999999999999999999999999999999999997532211 111111111000       


Q ss_pred             cccccccccCCcchHHHHHHHHHHhhccccCCCCCCCC-----cHHHHHH
Q 046639          273 PSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERM-----EMRDVVA  317 (331)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----s~~~i~~  317 (331)
                                ...+...++..+.+++.+||+.||++||     |+.++++
T Consensus       217 ----------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         217 ----------SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             ----------CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence                      0011223566788999999999999999     6677764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.1e-41  Score=303.01  Aligned_cols=252  Identities=21%  Similarity=0.252  Sum_probs=194.3

Q ss_pred             CCCcCceeeccCeeEEEEeeec---CCCceEEEEEeeccc----hhhHHHHHHHHHHHHcCC-CCCcceeeceeecccCC
Q 046639           31 NFSPANKIGQGGVSIVYKGILD---ESRSIVAVKVVNLKQ----KEASRSFAAECNALRNIR-HRNLIKIITICSSIDFE  102 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~  102 (331)
                      +|.+.+.||+|+||+||++++.   .+++.||+|++....    ......+..|+.+++.++ |++|+.++++     +.
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~-----~~   75 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYA-----FQ   75 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEE-----Ee
Confidence            4889999999999999998874   478899999986432    223456788999999995 9999999888     45


Q ss_pred             CcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccC
Q 046639          103 GFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLG  182 (331)
Q Consensus       103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg  182 (331)
                      ..+..++||||+++++|.+++....  .+++..+..++.|++.||.|||++   +++||||||+||+++.++.++|+|||
T Consensus        76 ~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG  150 (332)
T cd05614          76 TEAKLHLILDYVSGGEMFTHLYQRD--NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFG  150 (332)
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCc
Confidence            5667899999999999999986543  467788899999999999999999   99999999999999999999999999


Q ss_pred             cccccccCCCCCcccccCCceeecccccccCCcccCCC-CCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHh
Q 046639          183 LAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGS-KASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKM  261 (331)
Q Consensus       183 ~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  261 (331)
                      +++.....       .........||+.|+|||++.+. .++.++||||||+++|+|++|..||........ .......
T Consensus       151 ~~~~~~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~~~~~  222 (332)
T cd05614         151 LSKEFLSE-------EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT-QSEVSRR  222 (332)
T ss_pred             CCcccccc-------CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC-HHHHHHH
Confidence            98754211       11122235689999999998875 478899999999999999999999975322211 1111111


Q ss_pred             hCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCC-----cHHHHHH
Q 046639          262 ALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERM-----EMRDVVA  317 (331)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----s~~~i~~  317 (331)
                      ...      .++           .+.......+.+++.+||+.||++||     ++.++++
T Consensus       223 ~~~------~~~-----------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         223 ILK------CDP-----------PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             Hhc------CCC-----------CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence            100      011           11122456788999999999999999     6667763

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.9e-41  Score=290.19  Aligned_cols=251  Identities=19%  Similarity=0.250  Sum_probs=202.2

Q ss_pred             CCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc-chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeE
Q 046639           31 NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK-QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAI  109 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~l  109 (331)
                      +|.+.+.||.|+||.||++.+..++..+|+|.++.. .....+.+.+|+.+++.++|+|++++.+.+     ...+..++
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l   75 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF-----EADGHLYI   75 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EECCEEEE
Confidence            588899999999999999999999999999998643 233456788899999999999999999984     45678999


Q ss_pred             EEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccccc
Q 046639          110 VFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG  189 (331)
Q Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~  189 (331)
                      ++||+++++|.+++.......++...+..++.|++.||.+||+.   +++|+||+|+||+++.++.++++|||.+.....
T Consensus        76 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  152 (255)
T cd08219          76 VMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS  152 (255)
T ss_pred             EEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecc
Confidence            99999999999999775556677888999999999999999999   999999999999999999999999999876521


Q ss_pred             CCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhh
Q 046639          190 YEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVME  269 (331)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  269 (331)
                      .        ........+++.|+|||++.+..++.++|+||||+++|+|++|..||....     .............  
T Consensus       153 ~--------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~-----~~~~~~~~~~~~~--  217 (255)
T cd08219         153 P--------GAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS-----WKNLILKVCQGSY--  217 (255)
T ss_pred             c--------ccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC-----HHHHHHHHhcCCC--
Confidence            1        111223457888999999998889999999999999999999999996431     1111111100000  


Q ss_pred             hcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHH
Q 046639          270 IVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAK  318 (331)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~  318 (331)
                        .            .....+...+.+++.+||+.||++|||+.+|+.+
T Consensus       218 --~------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         218 --K------------PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             --C------------CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence              0            0112244568899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.4e-41  Score=293.01  Aligned_cols=255  Identities=17%  Similarity=0.212  Sum_probs=198.9

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      .++|.+.+.||+|+||.||+|.+..+++.||+|++..........+.+|+.+++.++|||++++++++.     ..+..+
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~-----~~~~~~   82 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL-----SREKLW   82 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEE-----eCCEEE
Confidence            347999999999999999999998899999999997655445566889999999999999999999853     346789


Q ss_pred             EEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccc
Q 046639          109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLF  188 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~  188 (331)
                      +|||++++++|.+++....  .++...+..++.|++.|+.+||+.   +++|+||+|+||+++.++.++|+|||++....
T Consensus        83 iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~  157 (267)
T cd06646          83 ICMEYCGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKIT  157 (267)
T ss_pred             EEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeec
Confidence            9999999999999986543  467788899999999999999999   99999999999999999999999999987652


Q ss_pred             cCCCCCcccccCCceeecccccccCCcccC---CCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcc
Q 046639          189 GYEPGTAAETASNSIEIKGIVGYVAPEYGM---GSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPD  265 (331)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  265 (331)
                      ..        ........+++.|+|||.+.   ...++.++|+||+|+++|+|++|..||.......... ....     
T Consensus       158 ~~--------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~-~~~~-----  223 (267)
T cd06646         158 AT--------IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-LMSK-----  223 (267)
T ss_pred             cc--------ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe-eeec-----
Confidence            11        11112345778899999874   3457889999999999999999999985432111000 0000     


Q ss_pred             hhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHH
Q 046639          266 KVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAK  318 (331)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~  318 (331)
                        .....+..         ......+..+.+++.+||+.+|++|||+.+|++.
T Consensus       224 --~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  265 (267)
T cd06646         224 --SNFQPPKL---------KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH  265 (267)
T ss_pred             --CCCCCCCC---------ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence              00000000         0011345678999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=3.1e-41  Score=290.73  Aligned_cols=258  Identities=25%  Similarity=0.347  Sum_probs=202.1

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCC---CceEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCc
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDES---RSIVAVKVVNLKQ-KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGF  104 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  104 (331)
                      .++|++.+.||+|+||+||+|.+..+   ...||+|.+.... ......+..|+.+++.++||||+++++++     ...
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~   77 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVV-----TKS   77 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEE-----ecC
Confidence            35799999999999999999998643   4579999886443 33446688999999999999999999984     445


Q ss_pred             ceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcc
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA  184 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a  184 (331)
                      +..+++||++++++|.+++....+ .+++..+..++.|++.|+.+||+.   +++|+||+|+||+++.++.++|+|||++
T Consensus        78 ~~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~  153 (266)
T cd05033          78 RPVMIITEYMENGSLDKFLRENDG-KFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLS  153 (266)
T ss_pred             CceEEEEEcCCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchh
Confidence            678999999999999999976443 467888999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhC
Q 046639          185 KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMAL  263 (331)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~  263 (331)
                      ........      ........++..|+|||.+.+..++.++||||||+++|+|++ |..||......  ..........
T Consensus       154 ~~~~~~~~------~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~~~  225 (266)
T cd05033         154 RRLEDSEA------TYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ--DVIKAVEDGY  225 (266)
T ss_pred             hccccccc------ceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH--HHHHHHHcCC
Confidence            87631110      001111224567999999998899999999999999999998 99998653211  1111111000


Q ss_pred             cchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHh
Q 046639          264 PDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHA  322 (331)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~  322 (331)
                      .       .            .....++..+.+++.+||+.+|++||++.+|++.|+++
T Consensus       226 ~-------~------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         226 R-------L------------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             C-------C------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            0       0            00123456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-42  Score=309.78  Aligned_cols=259  Identities=16%  Similarity=0.190  Sum_probs=195.8

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      ++|.+++.||+|+||+||+|.+..+++.||+|.+....   ......+.+|+.+++.++||||+++++++     .+...
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~   75 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSF-----QDAQY   75 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCe
Confidence            47999999999999999999999999999999986432   23345678899999999999999999985     45668


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      .++||||+++++|.+++...  ..++...+..++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||+++.
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~  150 (377)
T cd05629          76 LYLIMEFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTG  150 (377)
T ss_pred             eEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecccccc
Confidence            99999999999999999654  3467788889999999999999999   999999999999999999999999999864


Q ss_pred             cccCCCCC--------cccc-------------------------------cCCceeecccccccCCcccCCCCCccchh
Q 046639          187 LFGYEPGT--------AAET-------------------------------ASNSIEIKGIVGYVAPEYGMGSKASVSGD  227 (331)
Q Consensus       187 ~~~~~~~~--------~~~~-------------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~D  227 (331)
                      +.......        ....                               ........||+.|+|||++.+..++.++|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D  230 (377)
T cd05629         151 FHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECD  230 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCcee
Confidence            32110000        0000                               00001246899999999999999999999


Q ss_pred             hHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCC
Q 046639          228 VYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPM  307 (331)
Q Consensus       228 iwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~  307 (331)
                      ||||||++|||++|..||..... ...+.......  ..   .       .++.     ...+...+.+++.+||+ +|.
T Consensus       231 iwSlGvil~elltG~~Pf~~~~~-~~~~~~i~~~~--~~---~-------~~p~-----~~~~s~~~~dli~~lL~-~~~  291 (377)
T cd05629         231 WWSLGAIMFECLIGWPPFCSENS-HETYRKIINWR--ET---L-------YFPD-----DIHLSVEAEDLIRRLIT-NAE  291 (377)
T ss_pred             eEecchhhhhhhcCCCCCCCCCH-HHHHHHHHccC--Cc---c-------CCCC-----CCCCCHHHHHHHHHHhc-CHh
Confidence            99999999999999999965321 11111111100  00   0       0000     01234568889999997 777


Q ss_pred             CC---CcHHHHHH
Q 046639          308 ER---MEMRDVVA  317 (331)
Q Consensus       308 ~R---ps~~~i~~  317 (331)
                      +|   +|+.++++
T Consensus       292 ~r~~r~~~~~~l~  304 (377)
T cd05629         292 NRLGRGGAHEIKS  304 (377)
T ss_pred             hcCCCCCHHHHhc
Confidence            65   58988875

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=6.5e-42  Score=303.07  Aligned_cols=243  Identities=23%  Similarity=0.298  Sum_probs=190.6

Q ss_pred             CceeeccCeeEEEEeeec---CCCceEEEEEeeccc----hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCccee
Q 046639           35 ANKIGQGGVSIVYKGILD---ESRSIVAVKVVNLKQ----KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        35 ~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      ++.||+|+||.||++++.   .+++.||+|++....    ......+..|+.+++.++||||+++++++     ..++..
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~~   75 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAF-----QTGGKL   75 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEE-----ecCCeE
Confidence            368999999999999863   478899999986432    22335577899999999999999999884     445678


Q ss_pred             eEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccc
Q 046639          108 AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      ++||||+++++|.+++....  .+....+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++...
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  150 (323)
T cd05584          76 YLILEYLSGGELFMHLEREG--IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKES  150 (323)
T ss_pred             EEEEeCCCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeec
Confidence            99999999999999997643  356677888999999999999999   9999999999999999999999999998653


Q ss_pred             ccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchh
Q 046639          188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKV  267 (331)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  267 (331)
                      ..        .........||+.|+|||++.+..++.++||||||+++|+|++|..||.....     ........... 
T Consensus       151 ~~--------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~-----~~~~~~~~~~~-  216 (323)
T cd05584         151 IH--------EGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR-----KKTIDKILKGK-  216 (323)
T ss_pred             cc--------CCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH-----HHHHHHHHcCC-
Confidence            11        11112234588999999999998899999999999999999999999975321     11111111000 


Q ss_pred             hhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCC-----cHHHHHH
Q 046639          268 MEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERM-----EMRDVVA  317 (331)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----s~~~i~~  317 (331)
                                      ...+..+...+.+++.+||+.+|++||     ++.++++
T Consensus       217 ----------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         217 ----------------LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             ----------------CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence                            011122456788999999999999999     7888765

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.1e-41  Score=302.16  Aligned_cols=243  Identities=21%  Similarity=0.283  Sum_probs=189.3

Q ss_pred             ceeeccCeeEEEEeeecCCCceEEEEEeecc---chhhHHHHHHHHHHHHcC-CCCCcceeeceeecccCCCcceeeEEE
Q 046639           36 NKIGQGGVSIVYKGILDESRSIVAVKVVNLK---QKEASRSFAAECNALRNI-RHRNLIKIITICSSIDFEGFDFKAIVF  111 (331)
Q Consensus        36 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~lv~  111 (331)
                      +.||+|+||+||+|.+..+++.+|+|++...   .......+..|..++..+ +||||+++++++     ...+..++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv~   75 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QTESRLFFVI   75 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEE-----EeCCEEEEEE
Confidence            4799999999999999999999999999743   233445677888888876 799999999984     4456889999


Q ss_pred             eecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccccCC
Q 046639          112 EYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYE  191 (331)
Q Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~~  191 (331)
                      ||+++++|..++....  .++...+..++.|++.||.|||++   +++||||||+||+++.++.++|+|||++.....  
T Consensus        76 E~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~--  148 (329)
T cd05618          76 EYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--  148 (329)
T ss_pred             eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccC--
Confidence            9999999999886543  477888999999999999999999   999999999999999999999999999865311  


Q ss_pred             CCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCc---chHHHHHHhhCcchhh
Q 046639          192 PGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEG---LTLHEFVKMALPDKVM  268 (331)
Q Consensus       192 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~  268 (331)
                            .........||+.|+|||++.+..++.++||||||+++|+|++|..||.......   .............   
T Consensus       149 ------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~---  219 (329)
T cd05618         149 ------PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE---  219 (329)
T ss_pred             ------CCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc---
Confidence                  1112233568999999999999999999999999999999999999996422111   1111111110000   


Q ss_pred             hhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcH
Q 046639          269 EIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEM  312 (331)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~  312 (331)
                                   ....++..+...+.+++.+||+.||.+|||+
T Consensus       220 -------------~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         220 -------------KQIRIPRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             -------------CCCCCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence                         0001122345678899999999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.4e-41  Score=301.67  Aligned_cols=243  Identities=21%  Similarity=0.272  Sum_probs=189.5

Q ss_pred             ceeeccCeeEEEEeeecCCCceEEEEEeecc---chhhHHHHHHHHHHHHcC-CCCCcceeeceeecccCCCcceeeEEE
Q 046639           36 NKIGQGGVSIVYKGILDESRSIVAVKVVNLK---QKEASRSFAAECNALRNI-RHRNLIKIITICSSIDFEGFDFKAIVF  111 (331)
Q Consensus        36 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~lv~  111 (331)
                      +.||+|+||.||+|.+..+++.||+|+++..   .......+..|..++..+ +||||+++++++     ...+..++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~-----~~~~~~~lv~   75 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCF-----QTESRLFFVI   75 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEE-----EcCCEEEEEE
Confidence            4799999999999999999999999999743   223345678899999988 699999999984     4456789999


Q ss_pred             eecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccccCC
Q 046639          112 EYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYE  191 (331)
Q Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~~  191 (331)
                      ||+++++|.+++.+..  .+++..+..++.|++.||.|||++   +++||||||+||+++.++.++|+|||++.....  
T Consensus        76 e~~~~g~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~--  148 (329)
T cd05588          76 EFVSGGDLMFHMQRQR--KLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR--  148 (329)
T ss_pred             eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCcccccccc--
Confidence            9999999999886543  477889999999999999999999   999999999999999999999999999864211  


Q ss_pred             CCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCc---chHHHHHHhhCcchhh
Q 046639          192 PGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEG---LTLHEFVKMALPDKVM  268 (331)
Q Consensus       192 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~  268 (331)
                            .........||+.|+|||++.+..++.++||||||+++|+|++|..||.......   ....+.........  
T Consensus       149 ------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--  220 (329)
T cd05588         149 ------PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK--  220 (329)
T ss_pred             ------CCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC--
Confidence                  1122234568999999999999999999999999999999999999996432111   11111111100000  


Q ss_pred             hhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcH
Q 046639          269 EIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEM  312 (331)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~  312 (331)
                                    ....+..+...+.+++.+||+.||.+|||+
T Consensus       221 --------------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~  250 (329)
T cd05588         221 --------------QIRIPRSLSVKASSVLKGFLNKDPKERLGC  250 (329)
T ss_pred             --------------CCCCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence                          001112245678899999999999999983

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=5e-42  Score=303.83  Aligned_cols=242  Identities=18%  Similarity=0.242  Sum_probs=191.4

Q ss_pred             CCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHHcC-CCCCcceeeceeecccCCCcce
Q 046639           31 NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNI-RHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      +|.+.+.||+|+||+||+|++..+++.||+|++....   .........|..++..+ .|++++++++++     ...+.
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~   75 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCF-----QTMDR   75 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEE-----ecCCE
Confidence            4889999999999999999999999999999987432   22334566788888777 488888888874     44567


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      .++||||+++++|.+.+....  .+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++..
T Consensus        76 ~~lv~E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~  150 (323)
T cd05616          76 LYFVMEYVNGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE  150 (323)
T ss_pred             EEEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCcee
Confidence            899999999999999986543  367788999999999999999999   999999999999999999999999999875


Q ss_pred             cccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcch
Q 046639          187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDK  266 (331)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  266 (331)
                      ...        .........||+.|+|||++.+..++.++|||||||++|+|++|..||...... ..........    
T Consensus       151 ~~~--------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~-~~~~~i~~~~----  217 (323)
T cd05616         151 NMW--------DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-ELFQSIMEHN----  217 (323)
T ss_pred             cCC--------CCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH-HHHHHHHhCC----
Confidence            311        111223456899999999999999999999999999999999999999753211 1111111100    


Q ss_pred             hhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcH
Q 046639          267 VMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEM  312 (331)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~  312 (331)
                                       ..++......+.+++.+||+.+|.+|+++
T Consensus       218 -----------------~~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         218 -----------------VAYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             -----------------CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence                             01112345678899999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.9e-41  Score=294.93  Aligned_cols=252  Identities=24%  Similarity=0.283  Sum_probs=199.7

Q ss_pred             CCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCccee
Q 046639           31 NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      +|.+.+.||+|+||+||++.+..+++.||+|.+....   ......+.+|+.+++.++|++++.+++.+     ...+..
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~   75 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAY-----ETKDAL   75 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEE-----ecCCEE
Confidence            4778899999999999999999999999999886432   22234577899999999999999999885     445678


Q ss_pred             eEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccc
Q 046639          108 AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      ++||||+++++|.+++.......++...+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++...
T Consensus        76 ~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~  152 (285)
T cd05630          76 CLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV  152 (285)
T ss_pred             EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeec
Confidence            9999999999999998765555678888999999999999999999   9999999999999999999999999998754


Q ss_pred             ccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchh
Q 046639          188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKV  267 (331)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  267 (331)
                      ..         ........|+..|+|||++.+..++.++||||+|+++|+|++|..||.......  .......... ..
T Consensus       153 ~~---------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~--~~~~~~~~~~-~~  220 (285)
T cd05630         153 PE---------GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI--KREEVERLVK-EV  220 (285)
T ss_pred             CC---------CccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc--hHHHHHhhhh-hh
Confidence            11         111123458899999999999899999999999999999999999997532211  0011110000 00


Q ss_pred             hhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCc-----HHHHHH
Q 046639          268 MEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERME-----MRDVVA  317 (331)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps-----~~~i~~  317 (331)
                          ..           .+...+...+.+|+.+||+.||++|||     +.++++
T Consensus       221 ----~~-----------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         221 ----QE-----------EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             ----hh-----------hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence                00           111234567889999999999999999     888876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2e-41  Score=304.93  Aligned_cols=273  Identities=18%  Similarity=0.195  Sum_probs=200.7

Q ss_pred             HHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc--chhhHHHHHHHHHHHHcCCCCCcceeeceeeccc-CCC
Q 046639           27 KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRNIRHRNLIKIITICSSID-FEG  103 (331)
Q Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~  103 (331)
                      ...++|.+.+.||+|+||.||+|.+..+++.||+|.+...  .......+.+|+.+++.++||||+++++++.... +..
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~  100 (364)
T cd07875          21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE  100 (364)
T ss_pred             chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence            3467899999999999999999999999999999998643  2334466789999999999999999998864322 233


Q ss_pred             cceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCc
Q 046639          104 FDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGL  183 (331)
Q Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~  183 (331)
                      ....++|||++ .++|.+.+..    .++...+..++.|++.||.+||++   +|+||||||+||+++.++.+||+|||+
T Consensus       101 ~~~~~lv~e~~-~~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~  172 (364)
T cd07875         101 FQDVYIVMELM-DANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  172 (364)
T ss_pred             cCeEEEEEeCC-CCCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCC
Confidence            45679999999 5688887753    256678889999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhC
Q 046639          184 AKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMAL  263 (331)
Q Consensus       184 a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  263 (331)
                      ++....         ........+|+.|+|||++.+..++.++|||||||++|+|++|..||..... ...+........
T Consensus       173 a~~~~~---------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~~~~~~~~~~  242 (364)
T cd07875         173 ARTAGT---------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH-IDQWNKVIEQLG  242 (364)
T ss_pred             ccccCC---------CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcC
Confidence            975411         1112234578899999999999999999999999999999999999975421 111222211110


Q ss_pred             c--chhhhhcCcc----------c--------cccc-ccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          264 P--DKVMEIVDPS----------L--------LLEV-TANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       264 ~--~~~~~~~~~~----------~--------~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      .  ........+.          .        .... ..............+.+|+.+||+.||.+|||+.++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~  317 (364)
T cd07875         243 TPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  317 (364)
T ss_pred             CCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            0  0000000000          0        0000 00000011112356889999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-41  Score=302.11  Aligned_cols=253  Identities=21%  Similarity=0.289  Sum_probs=211.9

Q ss_pred             HHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchh---hHHHHHHHHHHHHcCC-CCCcceeeceeecccCC
Q 046639           27 KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKE---ASRSFAAECNALRNIR-HRNLIKIITICSSIDFE  102 (331)
Q Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~  102 (331)
                      .....|.+.+.||.|.||.||.|+...+++.+|+|.+......   ....+.+|+.+|+.+. ||||+.+.++     ++
T Consensus        32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~-----~e  106 (382)
T KOG0032|consen   32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDA-----FE  106 (382)
T ss_pred             cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEE-----EE
Confidence            4556799999999999999999999999999999999755432   3467899999999998 9999999999     56


Q ss_pred             CcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCC----CcEEE
Q 046639          103 GFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQD----IVAHV  178 (331)
Q Consensus       103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~----~~~kl  178 (331)
                      +...+++|||++.||.|.+.+...  . .++..+..++.|++.++.|||+.   |++|||+||+|+++...    +.+++
T Consensus       107 ~~~~~~lvmEL~~GGeLfd~i~~~--~-~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~  180 (382)
T KOG0032|consen  107 DPDSVYLVMELCEGGELFDRIVKK--H-YSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKL  180 (382)
T ss_pred             cCCeEEEEEEecCCchHHHHHHHc--c-CCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEE
Confidence            667899999999999999999876  2 78899999999999999999999   99999999999999533    47999


Q ss_pred             cccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHH
Q 046639          179 GDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEF  258 (331)
Q Consensus       179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  258 (331)
                      +|||++...         .........+||+.|+|||++.+.+|+..+||||+|+++|.|++|.+||.+...... ....
T Consensus       181 ~DFGla~~~---------~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~-~~~i  250 (382)
T KOG0032|consen  181 IDFGLAKFI---------KPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEI-FLAI  250 (382)
T ss_pred             eeCCCceEc---------cCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHH-HHHH
Confidence            999999886         124566678899999999999999999999999999999999999999986532222 2222


Q ss_pred             HHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          259 VKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      .....              .+..   .........+.+++..||..||..|+|+.++++
T Consensus       251 ~~~~~--------------~f~~---~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  251 LRGDF--------------DFTS---EPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             HcCCC--------------CCCC---CCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence            11111              1111   222356778899999999999999999999987

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=5.8e-42  Score=308.52  Aligned_cols=254  Identities=17%  Similarity=0.194  Sum_probs=197.5

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCc
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGF  104 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  104 (331)
                      ..++|.+.+.||+|+||.||+|++..+++.||+|.+....   ......+..|+.+++.++||||++++++     +...
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~-----~~~~  115 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYA-----FQDD  115 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEE-----EecC
Confidence            4567999999999999999999999999999999986432   2233457789999999999999999988     4556


Q ss_pred             ceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcc
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA  184 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a  184 (331)
                      ...++||||+++++|.+++...   .++...+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++
T Consensus       116 ~~~~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~  189 (370)
T cd05596         116 KYLYMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTC  189 (370)
T ss_pred             CEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccce
Confidence            7899999999999999998653   356677888999999999999999   9999999999999999999999999998


Q ss_pred             cccccCCCCCcccccCCceeecccccccCCcccCCC----CCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHH
Q 046639          185 KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGS----KASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVK  260 (331)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~----~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  260 (331)
                      .......       ........||+.|+|||++.+.    .++.++|||||||++|+|++|..||..... ...+.....
T Consensus       190 ~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-~~~~~~i~~  261 (370)
T cd05596         190 MKMDANG-------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-VGTYSKIMD  261 (370)
T ss_pred             eeccCCC-------cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH-HHHHHHHHc
Confidence            7642111       1112234689999999998653    378899999999999999999999975321 111111111


Q ss_pred             hhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCC--CCcHHHHHH
Q 046639          261 MALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPME--RMEMRDVVA  317 (331)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--Rps~~~i~~  317 (331)
                      ....            ..++.     ...++..+.+++.+||+.+|.+  |||+.++++
T Consensus       262 ~~~~------------~~~~~-----~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~  303 (370)
T cd05596         262 HKNS------------LTFPD-----DIEISKQAKDLICAFLTDREVRLGRNGVDEIKS  303 (370)
T ss_pred             CCCc------------CCCCC-----cCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence            0000            00000     0124567889999999999988  999999964

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=4.8e-41  Score=302.16  Aligned_cols=209  Identities=20%  Similarity=0.260  Sum_probs=174.4

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      ++|.+.+.||+|+||+||+|.+..+++.||+|++....   ......+..|+.++..++|++|+++++.+     .+...
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~-----~~~~~   75 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSF-----QDKLN   75 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCCe
Confidence            47999999999999999999999999999999996432   23345678899999999999999999984     45678


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      +++||||+++++|.+++.+..  .++...+..++.|++.||.|||++   +|+||||||+||+++.++.++|+|||+++.
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~  150 (363)
T cd05628          76 LYLIMEFLPGGDMMTLLMKKD--TLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTG  150 (363)
T ss_pred             EEEEEcCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCccc
Confidence            899999999999999997643  477888999999999999999999   999999999999999999999999999875


Q ss_pred             cccCCCCCc---------------------------ccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHH
Q 046639          187 LFGYEPGTA---------------------------AETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMF  239 (331)
Q Consensus       187 ~~~~~~~~~---------------------------~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~  239 (331)
                      .........                           ...........||+.|+|||++.+..++.++|||||||++|+|+
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell  230 (363)
T cd05628         151 LKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML  230 (363)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHH
Confidence            422110000                           00000112356999999999999999999999999999999999


Q ss_pred             hCCCCCCcc
Q 046639          240 TRRRPTDAM  248 (331)
Q Consensus       240 ~g~~pf~~~  248 (331)
                      +|..||...
T Consensus       231 ~G~~Pf~~~  239 (363)
T cd05628         231 IGYPPFCSE  239 (363)
T ss_pred             hCCCCCCCC
Confidence            999999753

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=5.5e-41  Score=290.05  Aligned_cols=261  Identities=22%  Similarity=0.384  Sum_probs=199.6

Q ss_pred             CCcCceeeccCeeEEEEeeecCCCc--eEEEEEeecc--chhhHHHHHHHHHHHHcCCCCCcceeeceeecccC-CCcce
Q 046639           32 FSPANKIGQGGVSIVYKGILDESRS--IVAVKVVNLK--QKEASRSFAAECNALRNIRHRNLIKIITICSSIDF-EGFDF  106 (331)
Q Consensus        32 y~~~~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~~~~  106 (331)
                      |.+.+.||+|+||.||+|.+..++.  .+|+|.++..  .......+..|+.+++.++|+||+++++++..... .....
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            4678999999999999999876665  6899988643  34445678899999999999999999998753221 22335


Q ss_pred             eeEEEeecCCCCHHHHHHhc----cCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccC
Q 046639          107 KAIVFEYMQNRNLEQWLRQS----NGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLG  182 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg  182 (331)
                      .++++||+++++|.+++...    ....+++.....++.|++.||+|||++   +++|+||||+||+++.++.++|+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence            78999999999999987532    233467888899999999999999999   99999999999999999999999999


Q ss_pred             cccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHh
Q 046639          183 LAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKM  261 (331)
Q Consensus       183 ~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~  261 (331)
                      ++..+.....      ........+++.|+|||...+..++.++||||||+++|+|++ |..||.....  .........
T Consensus       158 ~~~~~~~~~~------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~~~~~~~~  229 (272)
T cd05075         158 LSKKIYNGDY------YRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN--SEIYDYLRQ  229 (272)
T ss_pred             cccccCcccc------eecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHc
Confidence            9986522110      011112235567999999999889999999999999999999 8899965321  111111111


Q ss_pred             hCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHh
Q 046639          262 ALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHA  322 (331)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~  322 (331)
                      ...        .           .....+...+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus       230 ~~~--------~-----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         230 GNR--------L-----------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CCC--------C-----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            000        0           01113456689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=2.5e-41  Score=290.72  Aligned_cols=255  Identities=26%  Similarity=0.412  Sum_probs=200.6

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      .++|++.++||+|++|.||+|.+..+. .||+|.+..... ....+.+|+.+++.++|+|++++++.+.      ....+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~------~~~~~   76 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS------EEPIY   76 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC------CCCcE
Confidence            357999999999999999999887554 599999864322 2356889999999999999999988742      24468


Q ss_pred             EEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccc
Q 046639          109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLF  188 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~  188 (331)
                      +|||++++++|.+++....+..+++..+..++.|++.||++||+.   +++|+||+|+||+++.++.++|+|||.+..+.
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~  153 (262)
T cd05071          77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIE  153 (262)
T ss_pred             EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecc
Confidence            999999999999999875555577888999999999999999999   99999999999999999999999999987652


Q ss_pred             cCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhCcchh
Q 046639          189 GYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMALPDKV  267 (331)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  267 (331)
                      ...       ........++..|+|||+..+..++.++||||||+++|+|++ |..||....... ..... ...     
T Consensus       154 ~~~-------~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~-~~~~~-~~~-----  219 (262)
T cd05071         154 DNE-------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-VLDQV-ERG-----  219 (262)
T ss_pred             ccc-------cccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH-HHHHH-hcC-----
Confidence            111       111112335667999999988889999999999999999999 888986542111 11110 000     


Q ss_pred             hhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHh
Q 046639          268 MEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHA  322 (331)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~  322 (331)
                         ...           ....+++..+.+++.+||+.+|++|||+.++++.|+..
T Consensus       220 ---~~~-----------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         220 ---YRM-----------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             ---CCC-----------CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence               000           11124567789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=9.5e-42  Score=300.95  Aligned_cols=241  Identities=22%  Similarity=0.317  Sum_probs=189.1

Q ss_pred             ceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHHcC-CCCCcceeeceeecccCCCcceeeEEE
Q 046639           36 NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNI-RHRNLIKIITICSSIDFEGFDFKAIVF  111 (331)
Q Consensus        36 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~lv~  111 (331)
                      +.||+|+||+||+|.+..+++.||+|+++...   .........|..++... .||||+++++++     ...+..++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv~   75 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTF-----QTKENLFFVM   75 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEE-----EeCCEEEEEE
Confidence            47999999999999999999999999987432   22334566777887764 899999999984     4456789999


Q ss_pred             eecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccccCC
Q 046639          112 EYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYE  191 (331)
Q Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~~  191 (331)
                      ||+++++|.+++....  .+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....  
T Consensus        76 ey~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~--  148 (316)
T cd05619          76 EYLNGGDLMFHIQSCH--KFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENML--  148 (316)
T ss_pred             eCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCC--
Confidence            9999999999997543  467788889999999999999999   999999999999999999999999999864311  


Q ss_pred             CCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhhhc
Q 046639          192 PGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEIV  271 (331)
Q Consensus       192 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (331)
                            .........||+.|+|||++.+..++.++||||+||++|+|++|..||.....  ..........         
T Consensus       149 ------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~--~~~~~~i~~~---------  211 (316)
T cd05619         149 ------GDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE--EELFQSIRMD---------  211 (316)
T ss_pred             ------CCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhC---------
Confidence                  11122345689999999999998999999999999999999999999975321  1111111100         


Q ss_pred             CcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHH-HHH
Q 046639          272 DPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMR-DVV  316 (331)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~-~i~  316 (331)
                      .+           .++..+...+.+++.+||+.||.+||++. ++.
T Consensus       212 ~~-----------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         212 NP-----------CYPRWLTREAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             CC-----------CCCccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence            00           01112345678999999999999999997 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=4.4e-41  Score=287.43  Aligned_cols=249  Identities=25%  Similarity=0.339  Sum_probs=194.4

Q ss_pred             ceeeccCeeEEEEeeecCCCceEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeEEEeec
Q 046639           36 NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ-KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYM  114 (331)
Q Consensus        36 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~  114 (331)
                      +.||+|+||.||+|.+..+++.+|+|.+.... ......+.+|+.+++.++||||++++++|     ......++||||+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~   75 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC-----TQKQPIYIVMELV   75 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----cCCCCeEEEEeec
Confidence            47999999999999998899999999875433 33456789999999999999999999985     3446789999999


Q ss_pred             CCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccccCCCCC
Q 046639          115 QNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGT  194 (331)
Q Consensus       115 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~~~~~  194 (331)
                      ++++|.+++.... ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.......   
T Consensus        76 ~~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~---  148 (252)
T cd05084          76 QGGDFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGV---  148 (252)
T ss_pred             cCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCccccccc---
Confidence            9999999996533 3467788899999999999999999   99999999999999999999999999987542110   


Q ss_pred             cccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhCcchhhhhcCc
Q 046639          195 AAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMALPDKVMEIVDP  273 (331)
Q Consensus       195 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (331)
                         ..........+..|+|||.+.+..++.++||||||+++|+|++ |..||......  ...........         
T Consensus       149 ---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~--~~~~~~~~~~~---------  214 (252)
T cd05084         149 ---YASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ--QTREAIEQGVR---------  214 (252)
T ss_pred             ---ccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH--HHHHHHHcCCC---------
Confidence               0000111123456999999998889999999999999999998 88888643221  11111110000         


Q ss_pred             ccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHH
Q 046639          274 SLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLR  320 (331)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~  320 (331)
                         .       .....++..+.+++.+||+.+|++|||+.+|++.|.
T Consensus       215 ---~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         215 ---L-------PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             ---C-------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence               0       111234667899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2.8e-41  Score=301.38  Aligned_cols=263  Identities=21%  Similarity=0.337  Sum_probs=200.6

Q ss_pred             cCCCcCceeeccCeeEEEEeee-----cCCCceEEEEEeeccc-hhhHHHHHHHHHHHHcC-CCCCcceeeceeecccCC
Q 046639           30 NNFSPANKIGQGGVSIVYKGIL-----DESRSIVAVKVVNLKQ-KEASRSFAAECNALRNI-RHRNLIKIITICSSIDFE  102 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~  102 (331)
                      ++|.+.+.||+|+||+||+|.+     ..+++.||||+++... ......+.+|+.++..+ .|+||++++++|..    
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~----   82 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK----   82 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeec----
Confidence            4799999999999999999985     3467899999996543 23346688999999999 68999999998743    


Q ss_pred             CcceeeEEEeecCCCCHHHHHHhccC------------------------------------------------------
Q 046639          103 GFDFKAIVFEYMQNRNLEQWLRQSNG------------------------------------------------------  128 (331)
Q Consensus       103 ~~~~~~lv~e~~~~~~L~~~l~~~~~------------------------------------------------------  128 (331)
                      .+...+++|||+++++|.+++.....                                                      
T Consensus        83 ~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (343)
T cd05103          83 PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE  162 (343)
T ss_pred             CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence            34567899999999999999865321                                                      


Q ss_pred             -----------CccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccccCCCCCccc
Q 046639          129 -----------QLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAE  197 (331)
Q Consensus       129 -----------~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~  197 (331)
                                 ..+++.....++.|++.||+|||++   +++|+||||+||+++.++.++|+|||++.......      
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~------  233 (343)
T cd05103         163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDP------  233 (343)
T ss_pred             hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCc------
Confidence                       1245667788999999999999999   99999999999999999999999999987642111      


Q ss_pred             ccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhCcchhhhhcCcccc
Q 046639          198 TASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLL  276 (331)
Q Consensus       198 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (331)
                      .........+++.|+|||.+.+..++.++||||||+++|+|++ |..||....... ...........        .   
T Consensus       234 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~~~~~~~~~--------~---  301 (343)
T cd05103         234 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EFCRRLKEGTR--------M---  301 (343)
T ss_pred             chhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-HHHHHHhccCC--------C---
Confidence            0011112234567999999988889999999999999999997 999987542211 11111110000        0   


Q ss_pred             cccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhh
Q 046639          277 LEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARET  325 (331)
Q Consensus       277 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~  325 (331)
                       ..       +......+.+++..||+.+|++|||+.+|++.|+.+.+.
T Consensus       302 -~~-------~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~  342 (343)
T cd05103         302 -RA-------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  342 (343)
T ss_pred             -CC-------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence             00       011234688999999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=3e-41  Score=293.00  Aligned_cols=265  Identities=22%  Similarity=0.335  Sum_probs=207.4

Q ss_pred             HHhcCCCcCceeeccCeeEEEEeeecC----CCceEEEEEeecc-chhhHHHHHHHHHHHHcCCCCCcceeeceeecccC
Q 046639           27 KATNNFSPANKIGQGGVSIVYKGILDE----SRSIVAVKVVNLK-QKEASRSFAAECNALRNIRHRNLIKIITICSSIDF  101 (331)
Q Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  101 (331)
                      ...++|.+.+.||+|+||.||+|.+..    ++..|++|.+... .......+.+|+.+++.++|+|++++++++.    
T Consensus         3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~----   78 (280)
T cd05043           3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCI----   78 (280)
T ss_pred             cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe----
Confidence            456789999999999999999999875    3578999988633 3344567889999999999999999999874    


Q ss_pred             CCcceeeEEEeecCCCCHHHHHHhccC------CccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCc
Q 046639          102 EGFDFKAIVFEYMQNRNLEQWLRQSNG------QLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIV  175 (331)
Q Consensus       102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~  175 (331)
                      ......+++++++++++|.+++.....      ..++...++.++.|++.||.|||+.   +++|+||+|+||+++.++.
T Consensus        79 ~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~  155 (280)
T cd05043          79 EDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQ  155 (280)
T ss_pred             cCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCc
Confidence            334567899999999999999976422      4577888999999999999999999   9999999999999999999


Q ss_pred             EEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcch
Q 046639          176 AHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLT  254 (331)
Q Consensus       176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~  254 (331)
                      ++|+|||+++.+.....      ........++..|+|||++.+..++.++||||||+++|++++ |..||....  ...
T Consensus       156 ~kl~d~g~~~~~~~~~~------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--~~~  227 (280)
T cd05043         156 VKITDNALSRDLFPMDY------HCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID--PFE  227 (280)
T ss_pred             EEECCCCCcccccCCce------EEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC--HHH
Confidence            99999999976522110      001112234567999999998889999999999999999999 999996531  111


Q ss_pred             HHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhh
Q 046639          255 LHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARET  325 (331)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~  325 (331)
                      .........        ..           .....++..+.+++.+||+.+|++|||+.++++.|..+.+.
T Consensus       228 ~~~~~~~~~--------~~-----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~  279 (280)
T cd05043         228 MAAYLKDGY--------RL-----------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ  279 (280)
T ss_pred             HHHHHHcCC--------CC-----------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence            222111110        00           01123456789999999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-43  Score=282.38  Aligned_cols=253  Identities=19%  Similarity=0.261  Sum_probs=203.5

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcc
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ--KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFD  105 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~  105 (331)
                      ..++|.+-+.||+|+|+.|+++.+..||+.+|+|++....  ....+.+.+|+++.+.++||||+++.+.     +.+..
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~t-----i~~~~   83 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS-----IQEES   83 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhh-----hcccc
Confidence            3457999999999999999999999999999999985332  2345779999999999999999999998     66678


Q ss_pred             eeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEec---CCCcEEEcccC
Q 046639          106 FKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLD---QDIVAHVGDLG  182 (331)
Q Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~---~~~~~kl~Dfg  182 (331)
                      +.++|+|++.|++|..-|-.+  ...++..+..+..||++||+|+|.+   +|||||+||+|+++.   ...-+||+|||
T Consensus        84 ~~ylvFe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FG  158 (355)
T KOG0033|consen   84 FHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFG  158 (355)
T ss_pred             eeEEEEecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccc
Confidence            899999999999997666443  2355667778999999999999999   999999999999994   33468999999


Q ss_pred             cccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhh
Q 046639          183 LAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMA  262 (331)
Q Consensus       183 ~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  262 (331)
                      +|....         .........|||.|+|||++...+|+..+|||+.|+|||-|+.|.+||.+... ...+..+....
T Consensus       159 vAi~l~---------~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~-~rlye~I~~g~  228 (355)
T KOG0033|consen  159 LAIEVN---------DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-HRLYEQIKAGA  228 (355)
T ss_pred             eEEEeC---------CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH-HHHHHHHhccc
Confidence            998762         33445567799999999999999999999999999999999999999975311 11222222222


Q ss_pred             CcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          263 LPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ...      ++           .......+...+|+.+||..||.+|.|+.|.+.
T Consensus       229 yd~------~~-----------~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  229 YDY------PS-----------PEWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             cCC------CC-----------cccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence            111      11           112245667889999999999999999998764

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.9e-41  Score=289.10  Aligned_cols=261  Identities=22%  Similarity=0.368  Sum_probs=200.8

Q ss_pred             CCcCceeeccCeeEEEEeeecC---CCceEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCcceeeceeecccC-CCcc
Q 046639           32 FSPANKIGQGGVSIVYKGILDE---SRSIVAVKVVNLKQ--KEASRSFAAECNALRNIRHRNLIKIITICSSIDF-EGFD  105 (331)
Q Consensus        32 y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~~~  105 (331)
                      |.+++.||+|+||.||.|.+..   ++..||+|.++...  ......+.+|+..++.++|+|++++++++..... ....
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            6788999999999999998754   34789999987442  3334678899999999999999999998754321 2334


Q ss_pred             eeeEEEeecCCCCHHHHHHhc----cCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEccc
Q 046639          106 FKAIVFEYMQNRNLEQWLRQS----NGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDL  181 (331)
Q Consensus       106 ~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Df  181 (331)
                      ..++++||+++++|..++...    ....+++..+..++.|++.||.|||+.   +++|+||||+||++++++.++|+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence            579999999999999998553    223577788899999999999999999   9999999999999999999999999


Q ss_pred             CcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHH
Q 046639          182 GLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVK  260 (331)
Q Consensus       182 g~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~  260 (331)
                      |+++.......      .........+..|+|||.+.+..++.++||||||+++|||++ |..||......  ...+...
T Consensus       158 g~~~~~~~~~~------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~--~~~~~~~  229 (273)
T cd05035         158 GLSKKIYSGDY------YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH--EIYDYLR  229 (273)
T ss_pred             cceeecccccc------ccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHH
Confidence            99886522111      011111224567999999988889999999999999999999 88998653221  1111111


Q ss_pred             hhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHh
Q 046639          261 MALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHA  322 (331)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~  322 (331)
                      ...        ..           .....+...+.+++.+||+.||.+|||+.+|++.|+.+
T Consensus       230 ~~~--------~~-----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         230 HGN--------RL-----------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             cCC--------CC-----------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            100        00           11123566899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=7.4e-42  Score=301.73  Aligned_cols=241  Identities=20%  Similarity=0.252  Sum_probs=189.0

Q ss_pred             ceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHHcC-CCCCcceeeceeecccCCCcceeeEEE
Q 046639           36 NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNI-RHRNLIKIITICSSIDFEGFDFKAIVF  111 (331)
Q Consensus        36 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~lv~  111 (331)
                      +.||+|+||.||+|.+..++..||+|.++...   .........|..++... .||+|+++++++     ...+..++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~~~lv~   75 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTF-----QTKEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEE-----EeCCEEEEEE
Confidence            47999999999999999999999999996432   22334566777887754 899999999984     4557899999


Q ss_pred             eecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccccCC
Q 046639          112 EYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYE  191 (331)
Q Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~~  191 (331)
                      ||+++++|.+++....  .++...+..++.|++.||+|||++   +++||||||+||+++.++.++|+|||++.....  
T Consensus        76 E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~--  148 (316)
T cd05620          76 EFLNGGDLMFHIQDKG--RFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF--  148 (316)
T ss_pred             CCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeeccc--
Confidence            9999999999987643  467788889999999999999999   999999999999999999999999999864211  


Q ss_pred             CCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhhhc
Q 046639          192 PGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEIV  271 (331)
Q Consensus       192 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (331)
                            .........||+.|+|||++.+..++.++||||||+++|+|++|..||.....  ..........         
T Consensus       149 ------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~--~~~~~~~~~~---------  211 (316)
T cd05620         149 ------GDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE--DELFESIRVD---------  211 (316)
T ss_pred             ------CCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--HHHHHHHHhC---------
Confidence                  11122345689999999999999999999999999999999999999965321  1111111100         


Q ss_pred             CcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHH-HHH
Q 046639          272 DPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMR-DVV  316 (331)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~-~i~  316 (331)
                      .+           .++..+...+.+++.+||+.||++||++. +++
T Consensus       212 ~~-----------~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         212 TP-----------HYPRWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             CC-----------CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            00           11112455788999999999999999985 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=2.6e-41  Score=323.48  Aligned_cols=268  Identities=22%  Similarity=0.293  Sum_probs=204.5

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc---chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK---QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      ++|.+.++||+|+||.||+|.+..+++.||+|.+...   .......+.+|+.+++.++||||+++++++     ...+.
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~-----~d~~~   76 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSIC-----SDGDP   76 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEE-----eeCCE
Confidence            5899999999999999999999999999999998643   233446788999999999999999999985     34567


Q ss_pred             eeEEEeecCCCCHHHHHHhcc---------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEE
Q 046639          107 KAIVFEYMQNRNLEQWLRQSN---------GQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAH  177 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~k  177 (331)
                      .+++|||+++++|.+++....         ....++..+..++.|++.||++||++   +|+||||||+||+++.++.++
T Consensus        77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vK  153 (932)
T PRK13184         77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVV  153 (932)
T ss_pred             EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEE
Confidence            899999999999999986421         12234566788999999999999999   999999999999999999999


Q ss_pred             EcccCcccccccCCCCC----------cccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCc
Q 046639          178 VGDLGLAKFLFGYEPGT----------AAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDA  247 (331)
Q Consensus       178 l~Dfg~a~~~~~~~~~~----------~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  247 (331)
                      |+|||++..........          ............||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus       154 LiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~  233 (932)
T PRK13184        154 ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR  233 (932)
T ss_pred             EEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence            99999998652111000          00111122235689999999999999999999999999999999999999975


Q ss_pred             ccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCC-cHHHHHHHHHHhhh
Q 046639          248 MFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERM-EMRDVVAKLRHARE  324 (331)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-s~~~i~~~L~~~~~  324 (331)
                      .........    ...       ..+...        .-..++++.+.+++.+||+.||++|| +++++++.|+...+
T Consensus       234 ~~~~ki~~~----~~i-------~~P~~~--------~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq  292 (932)
T PRK13184        234 KKGRKISYR----DVI-------LSPIEV--------APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ  292 (932)
T ss_pred             cchhhhhhh----hhc-------cChhhc--------cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            322111110    000       000000        00123556788999999999999995 67778887777654

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.6e-41  Score=292.74  Aligned_cols=254  Identities=18%  Similarity=0.219  Sum_probs=199.2

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      .++|.+.+.||+|+||.||+|.+..+++.||+|.++.........+.+|+.+++.++|||++++++.+     ...+..+
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~-----~~~~~~~   82 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSY-----LRRDKLW   82 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEE-----EeCCEEE
Confidence            34799999999999999999999999999999998766555556678899999999999999999985     4456789


Q ss_pred             EEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccc
Q 046639          109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLF  188 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~  188 (331)
                      ++||++++++|.+++....  .++...+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||++....
T Consensus        83 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd06645          83 ICMEFCGGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQIT  157 (267)
T ss_pred             EEEeccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEcc
Confidence            9999999999999986543  467888999999999999999999   99999999999999999999999999987642


Q ss_pred             cCCCCCcccccCCceeecccccccCCcccC---CCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcc
Q 046639          189 GYEPGTAAETASNSIEIKGIVGYVAPEYGM---GSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPD  265 (331)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  265 (331)
                      .        .........+++.|+|||++.   ...++.++|+||||+++|+|++|..||......... ........  
T Consensus       158 ~--------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~-~~~~~~~~--  226 (267)
T cd06645         158 A--------TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-FLMTKSNF--  226 (267)
T ss_pred             C--------cccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH-HhhhccCC--
Confidence            1        111122345788899999874   456889999999999999999999998643211111 00000000  


Q ss_pred             hhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          266 KVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                           ..+..         .....++..+.+++.+||+.+|++|||+.+|++
T Consensus       227 -----~~~~~---------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         227 -----QPPKL---------KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             -----CCCcc---------cccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence                 00000         000123456889999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=7e-42  Score=309.76  Aligned_cols=209  Identities=20%  Similarity=0.270  Sum_probs=172.9

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      ++|.+++.||+|+||+||+|++..+++.||+|++....   ......+.+|+.+++.+.|+||+++++.+     .+.+.
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~-----~~~~~   75 (382)
T cd05625           1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSF-----QDKDN   75 (382)
T ss_pred             CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEE-----EeCCE
Confidence            36899999999999999999999999999999986432   23346688999999999999999999985     44568


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      .++||||+++++|.+++.+..  .++...+..++.|++.||.|||++   +|+||||||+||+++.+|.++|+|||++..
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~  150 (382)
T cd05625          76 LYFVMDYIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTG  150 (382)
T ss_pred             EEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcc
Confidence            999999999999999997643  466788889999999999999999   999999999999999999999999999754


Q ss_pred             cccCCCCCc---------------------------------------ccccCCceeecccccccCCcccCCCCCccchh
Q 046639          187 LFGYEPGTA---------------------------------------AETASNSIEIKGIVGYVAPEYGMGSKASVSGD  227 (331)
Q Consensus       187 ~~~~~~~~~---------------------------------------~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D  227 (331)
                      +........                                       ...........||+.|+|||++.+..++.++|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~D  230 (382)
T cd05625         151 FRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD  230 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeee
Confidence            311000000                                       00000112346899999999999999999999


Q ss_pred             hHhHHHHHHHHHhCCCCCCcc
Q 046639          228 VYNFGILLLEMFTRRRPTDAM  248 (331)
Q Consensus       228 iwslG~il~el~~g~~pf~~~  248 (331)
                      ||||||++|||++|..||...
T Consensus       231 iwSlGvil~elltG~~Pf~~~  251 (382)
T cd05625         231 WWSVGVILYEMLVGQPPFLAQ  251 (382)
T ss_pred             EEechHHHHHHHhCCCCCCCC
Confidence            999999999999999999753

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=4.7e-42  Score=305.03  Aligned_cols=253  Identities=20%  Similarity=0.210  Sum_probs=197.6

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      ++|.+.+.||+|+||+||+|.+..+++.||+|+++...   ......+..|+.+++.+.|+||+++++++     ...+.
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~-----~~~~~   75 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAF-----QDKDN   75 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCe
Confidence            47999999999999999999999999999999997442   23445678899999999999999999884     44567


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      .++||||+++++|.+++.+.. ..+++..+..++.|++.||.+||+.   +|+||||||+||+++.++.+||+|||++..
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~  151 (330)
T cd05601          76 LYLVMEYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAAR  151 (330)
T ss_pred             EEEEECCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeE
Confidence            899999999999999997652 3467788889999999999999999   999999999999999999999999999976


Q ss_pred             cccCCCCCcccccCCceeecccccccCCcccC------CCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHH
Q 046639          187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGM------GSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVK  260 (331)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  260 (331)
                      .....       ........+|+.|+|||++.      +..++.++||||||+++|+|++|..||...... ..+.....
T Consensus       152 ~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-~~~~~i~~  223 (330)
T cd05601         152 LTANK-------MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA-KTYNNIMN  223 (330)
T ss_pred             CCCCC-------ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH-HHHHHHHc
Confidence            52111       11122345889999999986      456789999999999999999999999653211 11111111


Q ss_pred             hhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          261 MALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ..            ....++     ........+.+|+..||+ +|.+|||+.++++
T Consensus       224 ~~------------~~~~~~-----~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         224 FQ------------RFLKFP-----EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             CC------------CccCCC-----CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            00            000000     001235567889999998 9999999999874

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1e-41  Score=306.85  Aligned_cols=278  Identities=16%  Similarity=0.185  Sum_probs=206.6

Q ss_pred             CcccchhhhhccCCcc--cHHHHHHHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHH
Q 046639            5 HKDSNMLSMKQQFPMI--SYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECN   79 (331)
Q Consensus         5 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~   79 (331)
                      ++.+||..-.+.+...  ...++....++|.+.+.||+|+||.||+|++..+++.+|+|++....   ......+.+|..
T Consensus        16 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~   95 (371)
T cd05622          16 RKNKNIDNFLNRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD   95 (371)
T ss_pred             cccchHHHHHHHhhhHhhHHhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHH
Confidence            3444555444444332  34556666789999999999999999999999999999999986422   223345778999


Q ss_pred             HHHcCCCCCcceeeceeecccCCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCee
Q 046639           80 ALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIV  159 (331)
Q Consensus        80 ~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~iv  159 (331)
                      +++.++||||+++++.+     ......++||||+++++|.+++....   ++...+..++.|++.||.|||++   +|+
T Consensus        96 i~~~~~hp~iv~~~~~~-----~~~~~~~lv~Ey~~gg~L~~~~~~~~---~~~~~~~~~~~qi~~aL~~LH~~---~iv  164 (371)
T cd05622          96 IMAFANSPWVVQLFYAF-----QDDRYLYMVMEYMPGGDLVNLMSNYD---VPEKWARFYTAEVVLALDAIHSM---GFI  164 (371)
T ss_pred             HHHhCCCCCCCeEEEEE-----EcCCEEEEEEcCCCCCcHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHHHC---CEE
Confidence            99999999999999884     45678999999999999999986532   56777888999999999999999   999


Q ss_pred             ecCCCCCCEEecCCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCC----CCccchhhHhHHHHH
Q 046639          160 HGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGS----KASVSGDVYNFGILL  235 (331)
Q Consensus       160 H~dik~~nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~----~~~~~~DiwslG~il  235 (331)
                      ||||||+||+++.++.+||+|||++......       .........||+.|+|||++.+.    .++.++|||||||++
T Consensus       165 HrDLkp~NIll~~~~~ikL~DfG~a~~~~~~-------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvil  237 (371)
T cd05622         165 HRDVKPDNMLLDKSGHLKLADFGTCMKMNKE-------GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL  237 (371)
T ss_pred             eCCCCHHHEEECCCCCEEEEeCCceeEcCcC-------CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHH
Confidence            9999999999999999999999999765211       11112245689999999998754    378899999999999


Q ss_pred             HHHHhCCCCCCcccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCC--CCcHH
Q 046639          236 LEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPME--RMEMR  313 (331)
Q Consensus       236 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--Rps~~  313 (331)
                      |+|++|..||..... ...+..+.....   .....              ........+.+++..||..++.+  |+++.
T Consensus       238 yell~G~~Pf~~~~~-~~~~~~i~~~~~---~~~~~--------------~~~~~s~~~~~li~~~L~~~~~r~~r~~~~  299 (371)
T cd05622         238 YEMLVGDTPFYADSL-VGTYSKIMNHKN---SLTFP--------------DDNDISKEAKNLICAFLTDREVRLGRNGVE  299 (371)
T ss_pred             HHHHhCCCCCCCCCH-HHHHHHHHcCCC---cccCC--------------CcCCCCHHHHHHHHHHcCChhhhcCCCCHH
Confidence            999999999975321 111111111000   00000              01134567888999999844433  67888


Q ss_pred             HHHHH
Q 046639          314 DVVAK  318 (331)
Q Consensus       314 ~i~~~  318 (331)
                      ++++.
T Consensus       300 ei~~h  304 (371)
T cd05622         300 EIKRH  304 (371)
T ss_pred             HHhcC
Confidence            88763

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=3.5e-41  Score=288.76  Aligned_cols=250  Identities=27%  Similarity=0.342  Sum_probs=199.5

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeE
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAI  109 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~l  109 (331)
                      .+|.+.+.||+|++|.||++...  +..+++|.+...  .....+.+|+.+++.++|+|++++++++    +...+..++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~----~~~~~~~~l   77 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVI----VEEKGGLYI   77 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEE----EcCCCceEE
Confidence            46999999999999999999875  667999988533  2345688999999999999999999875    334456899


Q ss_pred             EEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccccc
Q 046639          110 VFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG  189 (331)
Q Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~  189 (331)
                      ++|++++++|.+++.......+++.....++.|++.||++||++   +++|+||||+||+++.++.++|+|||++.....
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  154 (256)
T cd05082          78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  154 (256)
T ss_pred             EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccc
Confidence            99999999999999876655677888999999999999999999   999999999999999999999999999875421


Q ss_pred             CCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhCcchhh
Q 046639          190 YEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMALPDKVM  268 (331)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  268 (331)
                      .           .....++..|+|||++.+..++.++||||||+++|+|++ |..||.....  ...........     
T Consensus       155 ~-----------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~--~~~~~~~~~~~-----  216 (256)
T cd05082         155 T-----------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPRVEKGY-----  216 (256)
T ss_pred             c-----------CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHhcCC-----
Confidence            1           111223456999999988889999999999999999997 9999864311  11111111000     


Q ss_pred             hhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHh
Q 046639          269 EIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHA  322 (331)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~  322 (331)
                         .+           .....++..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       217 ---~~-----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         217 ---KM-----------DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             ---CC-----------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence               00           11224567889999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=3.4e-41  Score=295.76  Aligned_cols=260  Identities=20%  Similarity=0.333  Sum_probs=202.4

Q ss_pred             hcCCCcCceeeccCeeEEEEeee-----cCCCceEEEEEeeccc-hhhHHHHHHHHHHHHcC-CCCCcceeeceeecccC
Q 046639           29 TNNFSPANKIGQGGVSIVYKGIL-----DESRSIVAVKVVNLKQ-KEASRSFAAECNALRNI-RHRNLIKIITICSSIDF  101 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~  101 (331)
                      .++|.+.+.||+|+||.||+|.+     ..++..+|+|.++... ......+.+|+.+++++ +|+||+++++++.    
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~----  109 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACT----  109 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEe----
Confidence            35799999999999999999975     2345689999886443 33446788999999999 7999999999853    


Q ss_pred             CCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEccc
Q 046639          102 EGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDL  181 (331)
Q Consensus       102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Df  181 (331)
                       ..+..+++|||+++++|.+++.......+++..+..++.|++.||.|||++   +++|+||||+||+++.++.++++||
T Consensus       110 -~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~df  185 (302)
T cd05055         110 -IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDF  185 (302)
T ss_pred             -cCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCC
Confidence             345689999999999999999765544578889999999999999999999   9999999999999999999999999


Q ss_pred             CcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHH
Q 046639          182 GLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVK  260 (331)
Q Consensus       182 g~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~  260 (331)
                      |++........      ........++..|+|||.+.+..++.++||||+|+++|+|++ |..||....... .......
T Consensus       186 g~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~-~~~~~~~  258 (302)
T cd05055         186 GLARDIMNDSN------YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS-KFYKLIK  258 (302)
T ss_pred             cccccccCCCc------eeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH-HHHHHHH
Confidence            99876521110      001112235677999999998899999999999999999998 999987543211 1111111


Q ss_pred             hhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHh
Q 046639          261 MALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHA  322 (331)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~  322 (331)
                      ...        ...           ........+.+++.+||+.+|++|||+.+|++.|+++
T Consensus       259 ~~~--------~~~-----------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         259 EGY--------RMA-----------QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             cCC--------cCC-----------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            000        000           0011245789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-41  Score=288.71  Aligned_cols=253  Identities=21%  Similarity=0.275  Sum_probs=199.6

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc-----hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCc
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ-----KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGF  104 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  104 (331)
                      ++|.+.+.||+|++|.||.|.+..+++++|+|.+....     ......+.+|+.+++.++||||+++++++     ...
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~   76 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCL-----RDD   76 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ccC
Confidence            47999999999999999999998899999999886432     12235688899999999999999999994     445


Q ss_pred             ceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcc
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA  184 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a  184 (331)
                      ...++++|++++++|.+++....  .++...+..++.|++.||.+||..   +++|+||+|+||+++.++.++|+|||++
T Consensus        77 ~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~  151 (263)
T cd06625          77 ETLSIFMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGAS  151 (263)
T ss_pred             CeEEEEEEECCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccc
Confidence            68999999999999999997643  366788889999999999999999   9999999999999999999999999998


Q ss_pred             cccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCc
Q 046639          185 KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALP  264 (331)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  264 (331)
                      .......     ..........++..|+|||++.+..++.++||||||+++|+|++|..||.....    ..........
T Consensus       152 ~~~~~~~-----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~~~~~~  222 (263)
T cd06625         152 KRLQTIC-----SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA----MAAIFKIATQ  222 (263)
T ss_pred             eeccccc-----cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch----HHHHHHHhcc
Confidence            7542110     111111234467789999999998899999999999999999999999965311    1111110000


Q ss_pred             chhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          265 DKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      .     ..           ...+..+...+.+++.+||..+|.+|||+.++++
T Consensus       223 ~-----~~-----------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  259 (263)
T cd06625         223 P-----TN-----------PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLR  259 (263)
T ss_pred             C-----CC-----------CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhh
Confidence            0     00           0112235567889999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.8e-41  Score=293.10  Aligned_cols=259  Identities=18%  Similarity=0.256  Sum_probs=202.2

Q ss_pred             HHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcC-CCCCcceeeceeecccCC-Cc
Q 046639           27 KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNI-RHRNLIKIITICSSIDFE-GF  104 (331)
Q Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~-~~  104 (331)
                      +..+.|.+.+.||+|+||.||+|.+..+++.+|+|.+.... .....+..|+.+++++ .|+|++++++++...... ..
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            45678999999999999999999999999999999986543 2345678899999998 699999999997653322 13


Q ss_pred             ceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcc
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA  184 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a  184 (331)
                      ...+++||++++++|.+++.......+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.++|+|||++
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~  158 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVS  158 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCc
Confidence            5689999999999999999875555677888999999999999999999   9999999999999999999999999998


Q ss_pred             cccccCCCCCcccccCCceeecccccccCCcccC-----CCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHH
Q 046639          185 KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGM-----GSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFV  259 (331)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~  259 (331)
                      ......        ........+++.|+|||++.     +..++.++||||+|+++|+|++|..||......    ....
T Consensus       159 ~~~~~~--------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~----~~~~  226 (272)
T cd06637         159 AQLDRT--------VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM----RALF  226 (272)
T ss_pred             eecccc--------cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH----HHHH
Confidence            754111        11223345788899999976     335788999999999999999999999643211    1111


Q ss_pred             HhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          260 KMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      .. ...     ..+..          ....++..+.+|+.+||+.+|.+|||+.++++
T Consensus       227 ~~-~~~-----~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         227 LI-PRN-----PAPRL----------KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             HH-hcC-----CCCCC----------CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            00 000     00000          01124557889999999999999999999874

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=3.5e-41  Score=293.02  Aligned_cols=257  Identities=23%  Similarity=0.396  Sum_probs=198.5

Q ss_pred             cCCCcCceeeccCeeEEEEeeec----CCCceEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCc
Q 046639           30 NNFSPANKIGQGGVSIVYKGILD----ESRSIVAVKVVNLKQ-KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGF  104 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  104 (331)
                      ++|++.+.||+|+||+||+|.+.    .++..+++|.+.... ......+.+|+.+++.++||||+++++++     ...
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~   79 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVV-----TQE   79 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEE-----ecC
Confidence            46888999999999999999853    456789999986433 33446788999999999999999999984     445


Q ss_pred             ceeeEEEeecCCCCHHHHHHhcc---------------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEE
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQSN---------------GQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNIL  169 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nil  169 (331)
                      ...+++|||+++++|.+++....               ...+++.....++.|++.||.|||++   +++|+||||+||+
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nil  156 (283)
T cd05090          80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNIL  156 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEE
Confidence            67899999999999999986422               22366778889999999999999999   9999999999999


Q ss_pred             ecCCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcc
Q 046639          170 LDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAM  248 (331)
Q Consensus       170 v~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~  248 (331)
                      ++.++.++|+|||++........      ........++..|+|||++.+..++.++||||||+++|+|++ |..||...
T Consensus       157 i~~~~~~kl~dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~  230 (283)
T cd05090         157 IGEQLHVKISDLGLSREIYSADY------YRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGF  230 (283)
T ss_pred             EcCCCcEEeccccccccccCCcc------eecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence            99999999999999976521110      111122334567999999988889999999999999999998 99998653


Q ss_pred             cCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHH
Q 046639          249 FNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRH  321 (331)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~  321 (331)
                      ..  ...........   .         .       .....++..+.+++.+||+.+|++||++.+|++.|..
T Consensus       231 ~~--~~~~~~~~~~~---~---------~-------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         231 SN--QEVIEMVRKRQ---L---------L-------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             CH--HHHHHHHHcCC---c---------C-------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            21  11111111100   0         0       0112345678899999999999999999999988864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=3.8e-41  Score=293.12  Aligned_cols=252  Identities=20%  Similarity=0.250  Sum_probs=198.4

Q ss_pred             CCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCccee
Q 046639           31 NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      .|+..+.||+|+||+||+|.+..+++.+|+|.+....   ......+.+|+.+++.++|++++.+.+.+     ..++..
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~   75 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAY-----ETKDAL   75 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEE-----ecCCEE
Confidence            3778899999999999999999999999999986432   22334578899999999999999998884     445678


Q ss_pred             eEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccc
Q 046639          108 AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      +++||++++++|.+++.......+++..+..++.|++.||.|||+.   +|+|+||||+||+++.++.++|+|||++...
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~  152 (285)
T cd05632          76 CLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKI  152 (285)
T ss_pred             EEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceec
Confidence            9999999999999988765555688899999999999999999999   9999999999999999999999999988654


Q ss_pred             ccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchh
Q 046639          188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKV  267 (331)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  267 (331)
                      ..         ........|+..|+|||++.+..++.++|+||||+++|+|++|..||...... ........ ......
T Consensus       153 ~~---------~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~-~~~~~~~~-~~~~~~  221 (285)
T cd05632         153 PE---------GESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEK-VKREEVDR-RVLETE  221 (285)
T ss_pred             CC---------CCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHH-hhhccc
Confidence            11         11112345889999999999889999999999999999999999999753211 11111111 110000


Q ss_pred             hhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCc-----HHHHHH
Q 046639          268 MEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERME-----MRDVVA  317 (331)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps-----~~~i~~  317 (331)
                           .           .+...+...+.+|+..||+.||++||+     +.++++
T Consensus       222 -----~-----------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         222 -----E-----------VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             -----c-----------ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence                 0           111234556789999999999999999     667665

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2.7e-41  Score=297.44  Aligned_cols=269  Identities=19%  Similarity=0.281  Sum_probs=197.3

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccch-hhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK-EASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      ++|.+.+.||+|+||+||+|.+..+++.||+|.+..... .....+.+|+.+++.++||||+++++++     ..++..+
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~   80 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV-----HTDKSLT   80 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEE-----eeCCeEE
Confidence            579999999999999999999998999999999864432 2234577899999999999999999985     3456789


Q ss_pred             EEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccc
Q 046639          109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLF  188 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~  188 (331)
                      +||||++ ++|.+++.... ..++...+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++....
T Consensus        81 lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  155 (309)
T cd07872          81 LVFEYLD-KDLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKS  155 (309)
T ss_pred             EEEeCCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecC
Confidence            9999995 58888886543 3466788889999999999999999   99999999999999999999999999987541


Q ss_pred             cCCCCCcccccCCceeecccccccCCcccCC-CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCc--c
Q 046639          189 GYEPGTAAETASNSIEIKGIVGYVAPEYGMG-SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALP--D  265 (331)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~  265 (331)
                      ..        ........+++.|+|||++.+ ..++.++||||||+++|+|++|..||....... ...........  .
T Consensus       156 ~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~  226 (309)
T cd07872         156 VP--------TKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED-ELHLIFRLLGTPTE  226 (309)
T ss_pred             CC--------ccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCH
Confidence            11        111122346888999998865 458999999999999999999999997542211 11111111000  0


Q ss_pred             h-hhhhcCccccc--cccc----CCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          266 K-VMEIVDPSLLL--EVTA----NNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       266 ~-~~~~~~~~~~~--~~~~----~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      . ...........  +...    ........+...+.+|+.+||+.||.+|||+.++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         227 ETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             HHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            0 00000000000  0000    000111234567889999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=7.8e-41  Score=292.88  Aligned_cols=260  Identities=23%  Similarity=0.326  Sum_probs=201.1

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCc--eEEEEEeecc-chhhHHHHHHHHHHHHcC-CCCCcceeeceeecccCCCcc
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRS--IVAVKVVNLK-QKEASRSFAAECNALRNI-RHRNLIKIITICSSIDFEGFD  105 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~  105 (331)
                      ++|.+.+.||+|+||.||+|.+..++.  .+++|.++.. .....+.+.+|+.++.++ .||||+++++++     ...+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~-----~~~~   76 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGAC-----ENRG   76 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEE-----ccCC
Confidence            579999999999999999999876554  4688877632 333446788999999999 699999999985     4456


Q ss_pred             eeeEEEeecCCCCHHHHHHhcc--------------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEec
Q 046639          106 FKAIVFEYMQNRNLEQWLRQSN--------------GQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLD  171 (331)
Q Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~  171 (331)
                      ..++++|++++++|.+++....              ...+++..+..++.|++.||++||+.   +++|+||||+||+++
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~  153 (297)
T cd05089          77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVG  153 (297)
T ss_pred             cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEEC
Confidence            7899999999999999997532              12467788899999999999999999   999999999999999


Q ss_pred             CCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccC
Q 046639          172 QDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFN  250 (331)
Q Consensus       172 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~  250 (331)
                      .++.+||+|||++.....         .........+..|+|||+..+..++.++||||||+++|+|++ |..||.....
T Consensus       154 ~~~~~kl~dfg~~~~~~~---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~  224 (297)
T cd05089         154 ENLASKIADFGLSRGEEV---------YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC  224 (297)
T ss_pred             CCCeEEECCcCCCccccc---------eeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence            999999999998853210         001111122446999999998889999999999999999997 9999965321


Q ss_pred             CcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhhh
Q 046639          251 EGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETFL  327 (331)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~~  327 (331)
                           .........         ....       .....++..+.+|+.+||+.+|.+|||+.++++.|+.+.+...
T Consensus       225 -----~~~~~~~~~---------~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~  280 (297)
T cd05089         225 -----AELYEKLPQ---------GYRM-------EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK  280 (297)
T ss_pred             -----HHHHHHHhc---------CCCC-------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence                 111111100         0000       0112345678899999999999999999999999998887654

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2.4e-41  Score=295.53  Aligned_cols=264  Identities=23%  Similarity=0.352  Sum_probs=203.6

Q ss_pred             HHHHhcCCCcCceeeccCeeEEEEeeecCC-----CceEEEEEeeccc-hhhHHHHHHHHHHHHcC-CCCCcceeeceee
Q 046639           25 LSKATNNFSPANKIGQGGVSIVYKGILDES-----RSIVAVKVVNLKQ-KEASRSFAAECNALRNI-RHRNLIKIITICS   97 (331)
Q Consensus        25 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~   97 (331)
                      +....++|.+.+.||+|++|.||++.+...     ...+|+|.+.... ......+.+|+.+++.+ +|+||+++++++ 
T Consensus         7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~-   85 (293)
T cd05053           7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC-   85 (293)
T ss_pred             cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE-
Confidence            344556899999999999999999987643     3689999886432 33445688999999999 799999999985 


Q ss_pred             cccCCCcceeeEEEeecCCCCHHHHHHhc--------------cCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCC
Q 046639           98 SIDFEGFDFKAIVFEYMQNRNLEQWLRQS--------------NGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDL  163 (331)
Q Consensus        98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--------------~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~di  163 (331)
                          ...+..+++|||+++++|.+++...              ....+++..++.++.|++.||+|||+.   +++|+||
T Consensus        86 ----~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dl  158 (293)
T cd05053          86 ----TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDL  158 (293)
T ss_pred             ----cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Ccccccc
Confidence                3456789999999999999999752              234577788899999999999999999   9999999


Q ss_pred             CCCCEEecCCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CC
Q 046639          164 KPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RR  242 (331)
Q Consensus       164 k~~nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~  242 (331)
                      ||+||+++.++.++|+|||++..+.....      ........++..|+|||++.+..++.++||||||+++|+|++ |.
T Consensus       159 kp~Nil~~~~~~~kL~Dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~  232 (293)
T cd05053         159 AARNVLVTEDHVMKIADFGLARDIHHIDY------YRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGG  232 (293)
T ss_pred             ceeeEEEcCCCeEEeCccccccccccccc------eeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCC
Confidence            99999999999999999999976522110      001111223456999999988899999999999999999997 99


Q ss_pred             CCCCcccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHh
Q 046639          243 RPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHA  322 (331)
Q Consensus       243 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~  322 (331)
                      .||.....  ...........            ..       .....+...+.+|+.+||+.+|.+|||+.++++.|+.+
T Consensus       233 ~p~~~~~~--~~~~~~~~~~~------------~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~  291 (293)
T cd05053         233 SPYPGIPV--EELFKLLKEGY------------RM-------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM  291 (293)
T ss_pred             CCCCCCCH--HHHHHHHHcCC------------cC-------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence            99865321  11111111000            00       11123456788999999999999999999999999876


Q ss_pred             h
Q 046639          323 R  323 (331)
Q Consensus       323 ~  323 (331)
                      .
T Consensus       292 ~  292 (293)
T cd05053         292 L  292 (293)
T ss_pred             h
Confidence            4

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=4.4e-41  Score=291.98  Aligned_cols=257  Identities=23%  Similarity=0.396  Sum_probs=201.0

Q ss_pred             hcCCCcCceeeccCeeEEEEeee-----cCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCC
Q 046639           29 TNNFSPANKIGQGGVSIVYKGIL-----DESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEG  103 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  103 (331)
                      .++|...++||+|+||.||++..     ..++..+++|.+..........+.+|+.+++.++|+||+++++++     ..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~   78 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVC-----TE   78 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEE-----ec
Confidence            45788999999999999999974     235668999988766666667899999999999999999999985     34


Q ss_pred             cceeeEEEeecCCCCHHHHHHhccC-------------CccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEe
Q 046639          104 FDFKAIVFEYMQNRNLEQWLRQSNG-------------QLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILL  170 (331)
Q Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv  170 (331)
                      ....+++||++++++|.+++.....             ..+++..+..++.|++.|++|||+.   +++|+||||+||++
T Consensus        79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~  155 (280)
T cd05092          79 GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLV  155 (280)
T ss_pred             CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEE
Confidence            4668999999999999999976432             2467788899999999999999999   99999999999999


Q ss_pred             cCCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCccc
Q 046639          171 DQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMF  249 (331)
Q Consensus       171 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~  249 (331)
                      ++++.++|+|||++.......      .........+++.|+|||.+.+..++.++||||||+++|+|++ |.+||....
T Consensus       156 ~~~~~~kL~dfg~~~~~~~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~  229 (280)
T cd05092         156 GQGLVVKIGDFGMSRDIYSTD------YYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLS  229 (280)
T ss_pred             cCCCCEEECCCCceeEcCCCc------eeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCC
Confidence            999999999999987542110      0011112234567999999999899999999999999999998 999986432


Q ss_pred             CCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHH
Q 046639          250 NEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLR  320 (331)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~  320 (331)
                      ..  ...........        .           ..+..++..+.+++.+||+.||.+||++.+|++.|+
T Consensus       230 ~~--~~~~~~~~~~~--------~-----------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         230 NT--EAIECITQGRE--------L-----------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             HH--HHHHHHHcCcc--------C-----------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            11  11111000000        0           111234567889999999999999999999998886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.8e-41  Score=289.71  Aligned_cols=253  Identities=25%  Similarity=0.386  Sum_probs=199.0

Q ss_pred             CCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHH--HHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeE
Q 046639           32 FSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASR--SFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAI  109 (331)
Q Consensus        32 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~l  109 (331)
                      |++.+.||+|+||+||++.+..+++.+|+|.+.........  ....|+.+++.++||||+++++++.     .....++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~~   75 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQ-----DDNYLYI   75 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEE-----ESSEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccc-----ccccccc
Confidence            67889999999999999999999999999999866544332  3456999999999999999999954     3567899


Q ss_pred             EEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccccc
Q 046639          110 VFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG  189 (331)
Q Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~  189 (331)
                      +||++++++|.+++...  ..++...+..++.|++.||.+||+.   +++|+||||+||+++.++.++|+|||.+...  
T Consensus        76 v~~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~--  148 (260)
T PF00069_consen   76 VMEYCPGGSLQDYLQKN--KPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKL--  148 (260)
T ss_dssp             EEEEETTEBHHHHHHHH--SSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEES--
T ss_pred             ccccccccccccccccc--ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc--
Confidence            99999888999999732  3467899999999999999999999   9999999999999999999999999998753  


Q ss_pred             CCCCCcccccCCceeecccccccCCcccC-CCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhh
Q 046639          190 YEPGTAAETASNSIEIKGIVGYVAPEYGM-GSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVM  268 (331)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  268 (331)
                            ...........++..|+|||+.. +..++.++||||+|+++|+|++|..||...  ..................
T Consensus       149 ------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~--~~~~~~~~~~~~~~~~~~  220 (260)
T PF00069_consen  149 ------SENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES--NSDDQLEIIEKILKRPLP  220 (260)
T ss_dssp             ------TSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS--SHHHHHHHHHHHHHTHHH
T ss_pred             ------cccccccccccccccccccccccccccccccccccccccccccccccccccccc--cchhhhhhhhhccccccc
Confidence                  11223333455788899999998 788999999999999999999999999764  111111111111111110


Q ss_pred             hhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          269 EIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ....             ........+.+++.+||+.||++|||+.++++
T Consensus       221 ~~~~-------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  221 SSSQ-------------QSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             HHTT-------------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             cccc-------------ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0000             00011378999999999999999999999974

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=4.4e-42  Score=310.50  Aligned_cols=259  Identities=18%  Similarity=0.203  Sum_probs=194.8

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      +.|++++.||+|+||+||+|++..+++.||+|++....   ......+.+|+.+++.++|+||+++++.+     ...+.
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~   75 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSF-----QDKDN   75 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCE
Confidence            46999999999999999999999999999999986432   22345678899999999999999999884     55678


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      +++||||+++++|.+++....  .++...+..++.|++.||+|||++   +|+||||||+||+++.++.++|+|||++..
T Consensus        76 ~~lv~E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~  150 (376)
T cd05598          76 LYFVMDYIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTG  150 (376)
T ss_pred             EEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcc
Confidence            999999999999999997643  466788888999999999999999   999999999999999999999999999753


Q ss_pred             cccCCCCCc-----------------------------------ccccCCceeecccccccCCcccCCCCCccchhhHhH
Q 046639          187 LFGYEPGTA-----------------------------------AETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNF  231 (331)
Q Consensus       187 ~~~~~~~~~-----------------------------------~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Diwsl  231 (331)
                      +........                                   ...........||+.|+|||++.+..++.++|||||
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  230 (376)
T cd05598         151 FRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV  230 (376)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeec
Confidence            311000000                                   000001123468999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCC-
Q 046639          232 GILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERM-  310 (331)
Q Consensus       232 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-  310 (331)
                      ||++|+|++|..||........ .......  ...        .  .+     .....+...+.+++.+|+ .+|.+|+ 
T Consensus       231 Gvilyell~G~~Pf~~~~~~~~-~~~i~~~--~~~--------~--~~-----~~~~~~s~~~~~li~~l~-~~p~~R~~  291 (376)
T cd05598         231 GVILYEMLVGQPPFLADTPAET-QLKVINW--ETT--------L--HI-----PSQAKLSREASDLILRLC-CGAEDRLG  291 (376)
T ss_pred             cceeeehhhCCCCCCCCCHHHH-HHHHhcc--Ccc--------c--cC-----CCCCCCCHHHHHHHHHHh-cCHhhcCC
Confidence            9999999999999975422111 1111000  000        0  00     000123455667777765 5999999 


Q ss_pred             --cHHHHHH
Q 046639          311 --EMRDVVA  317 (331)
Q Consensus       311 --s~~~i~~  317 (331)
                        |+.++++
T Consensus       292 ~~t~~ell~  300 (376)
T cd05598         292 KNGADEIKA  300 (376)
T ss_pred             CCCHHHHhC
Confidence              8888874

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=5.2e-41  Score=291.05  Aligned_cols=258  Identities=19%  Similarity=0.376  Sum_probs=197.8

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecC-----CCceEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCcceeeceeecccC
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDE-----SRSIVAVKVVNLKQ-KEASRSFAAECNALRNIRHRNLIKIITICSSIDF  101 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  101 (331)
                      ..++|++.+.||+|++|.||+|.+..     ++..||+|.+.... ......+.+|+.+++.++|+||+++++++     
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----   78 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV-----   78 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-----
Confidence            45679999999999999999998642     45679999885332 23445688999999999999999999985     


Q ss_pred             CCcceeeEEEeecCCCCHHHHHHhccC--------CccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCC
Q 046639          102 EGFDFKAIVFEYMQNRNLEQWLRQSNG--------QLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQD  173 (331)
Q Consensus       102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~  173 (331)
                      ......++|||++++++|.+++.....        ..+.+..+..++.|++.||.|||+.   +++|+||||+||+++.+
T Consensus        79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~  155 (277)
T cd05062          79 SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED  155 (277)
T ss_pred             cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCC
Confidence            445678999999999999999975321        2245667888999999999999999   99999999999999999


Q ss_pred             CcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCc
Q 046639          174 IVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEG  252 (331)
Q Consensus       174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~  252 (331)
                      +.++|+|||++........      ........+++.|+|||++.+..++.++||||||+++|+|++ |..||...... 
T Consensus       156 ~~~~l~dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~-  228 (277)
T cd05062         156 FTVKIGDFGMTRDIYETDY------YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE-  228 (277)
T ss_pred             CCEEECCCCCccccCCcce------eecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-
Confidence            9999999999875421110      011111234667999999998899999999999999999999 78898653211 


Q ss_pred             chHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHH
Q 046639          253 LTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLR  320 (331)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~  320 (331)
                          ............                .....++..+.+++.+||+.+|++|||+.++++.|+
T Consensus       229 ----~~~~~~~~~~~~----------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         229 ----QVLRFVMEGGLL----------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             ----HHHHHHHcCCcC----------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence                111111000000                111234567899999999999999999999998876

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=4.6e-41  Score=288.05  Aligned_cols=251  Identities=25%  Similarity=0.392  Sum_probs=194.9

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeE
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAI  109 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~l  109 (331)
                      ++|.+.+.||+|+||.||++.+. .+..+|+|.+... ......+.+|+.+++.++||||+++++++     ......++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~i   76 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVC-----TQQKPLYI   76 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEE-----ccCCCEEE
Confidence            45889999999999999999886 4457999987533 22345688899999999999999999985     34567899


Q ss_pred             EEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccccc
Q 046639          110 VFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG  189 (331)
Q Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~  189 (331)
                      ||||+++++|.+++..... .+++..+..++.|++.||.|||++   +++|+||+|+||+++.++.++|+|||.+.....
T Consensus        77 v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~  152 (256)
T cd05114          77 VTEFMENGCLLNYLRQRQG-KLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD  152 (256)
T ss_pred             EEEcCCCCcHHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCC
Confidence            9999999999999875433 467788899999999999999999   999999999999999999999999998876421


Q ss_pred             CCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhCcchhh
Q 046639          190 YEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMALPDKVM  268 (331)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  268 (331)
                      ..       ........++..|+|||++.+..++.++||||||+++|+|++ |..||.....  ............    
T Consensus       153 ~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~--~~~~~~i~~~~~----  219 (256)
T cd05114         153 DE-------YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN--YEVVEMISRGFR----  219 (256)
T ss_pred             Cc-------eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHCCCC----
Confidence            11       011112234557999999998889999999999999999999 8999964321  111111111000    


Q ss_pred             hhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHH
Q 046639          269 EIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKL  319 (331)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L  319 (331)
                       ...+              ......+.+++.+||+.+|++|||+.++++.|
T Consensus       220 -~~~~--------------~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         220 -LYRP--------------KLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             -CCCC--------------CCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence             0000              11235689999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.3e-41  Score=301.14  Aligned_cols=272  Identities=17%  Similarity=0.215  Sum_probs=199.1

Q ss_pred             HHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccch--hhHHHHHHHHHHHHcCCCCCcceeeceeeccc-CCC
Q 046639           27 KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK--EASRSFAAECNALRNIRHRNLIKIITICSSID-FEG  103 (331)
Q Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~  103 (331)
                      ...++|.+++.||+|+||+||+|.+..+++.||+|.+.....  .....+.+|+.+++.++||||+++++++.... ...
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            345789999999999999999999999999999999864322  23355778999999999999999998864321 122


Q ss_pred             cceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCc
Q 046639          104 FDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGL  183 (331)
Q Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~  183 (331)
                      ....+++++++ +++|.+++...   .++...+..++.|++.||.|||+.   +|+|+||||+||+++.++.+||+|||+
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~  164 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVKCQ---KLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGL  164 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCcc
Confidence            34578999988 88999888542   377889999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCcccccCCceeecccccccCCcccCC-CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhh
Q 046639          184 AKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG-SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMA  262 (331)
Q Consensus       184 a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  262 (331)
                      +.....           ......+|+.|+|||++.+ ..++.++||||||+++|+|++|..||...... ..+.......
T Consensus       165 ~~~~~~-----------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~  232 (343)
T cd07878         165 ARQADD-----------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI-DQLKRIMEVV  232 (343)
T ss_pred             ceecCC-----------CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHh
Confidence            876421           1123457889999999877 56899999999999999999999999753211 1111111111


Q ss_pred             Cc--chhhhhcCcccc----c---cccc-CCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          263 LP--DKVMEIVDPSLL----L---EVTA-NNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       263 ~~--~~~~~~~~~~~~----~---~~~~-~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ..  ......+.....    .   .... ..........+.+.+|+.+||+.||.+|||+.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         233 GTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             CCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            00  000000000000    0   0000 000111123456789999999999999999999984

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=4.2e-41  Score=291.67  Aligned_cols=257  Identities=21%  Similarity=0.331  Sum_probs=198.9

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecC-----CCceEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCC
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDE-----SRSIVAVKVVNLKQ-KEASRSFAAECNALRNIRHRNLIKIITICSSIDFE  102 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  102 (331)
                      .++|.+.+.||+|++|.||+|.+..     ++..|++|.+.... ......+..|+.+++.++|+||+++++++.     
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----   79 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSF-----   79 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----
Confidence            4579999999999999999999976     67889999886443 333456889999999999999999999853     


Q ss_pred             CcceeeEEEeecCCCCHHHHHHhccC-----CccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCC---
Q 046639          103 GFDFKAIVFEYMQNRNLEQWLRQSNG-----QLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDI---  174 (331)
Q Consensus       103 ~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~---  174 (331)
                      .....++|||++++++|.+++.....     ..+++..+..++.|++.||.|||++   +++|+||+|+||+++.++   
T Consensus        80 ~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~  156 (277)
T cd05036          80 ERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGR  156 (277)
T ss_pred             cCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCc
Confidence            34567899999999999999976432     2477888899999999999999999   999999999999998655   


Q ss_pred             cEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcc
Q 046639          175 VAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGL  253 (331)
Q Consensus       175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~  253 (331)
                      .++|+|||+++......      ..........+..|+|||++.+..++.++|||||||++|+|++ |..||+.....  
T Consensus       157 ~~kl~dfg~~~~~~~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~--  228 (277)
T cd05036         157 VAKIADFGMARDIYRAS------YYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ--  228 (277)
T ss_pred             ceEeccCccccccCCcc------ceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--
Confidence            58999999987652111      0001111123456999999998899999999999999999997 99999753221  


Q ss_pred             hHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHH
Q 046639          254 TLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLR  320 (331)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~  320 (331)
                      ...........                   ...+..++..+.+++.+||+.+|++|||+.+|++.|.
T Consensus       229 ~~~~~~~~~~~-------------------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         229 EVMEFVTGGGR-------------------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             HHHHHHHcCCc-------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            11111111000                   0111234567899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=3.5e-41  Score=294.90  Aligned_cols=251  Identities=20%  Similarity=0.246  Sum_probs=200.8

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      ..+|.+.+.||+|++|.||+|.+..+++.+++|.+..........+.+|+.+++.+.|+|++++++.+.     .....+
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~-----~~~~~~   93 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDELW   93 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEE-----eCCEEE
Confidence            458999999999999999999998899999999997665555677889999999999999999999854     346789


Q ss_pred             EEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccc
Q 046639          109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLF  188 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~  188 (331)
                      +||||+++++|.+++...   .++...+..++.|++.||++||+.   +++|+||+|+||+++.++.++|+|||++....
T Consensus        94 lv~e~~~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~  167 (296)
T cd06654          94 VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  167 (296)
T ss_pred             EeecccCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcc
Confidence            999999999999998643   356788889999999999999999   99999999999999999999999999887541


Q ss_pred             cCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhh
Q 046639          189 GYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVM  268 (331)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  268 (331)
                      ..        ........+++.|+|||.+.+..++.++||||||+++|+|++|..||........ ...... ...    
T Consensus       168 ~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~-~~~~~~-~~~----  233 (296)
T cd06654         168 PE--------QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIAT-NGT----  233 (296)
T ss_pred             cc--------ccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh-HHHHhc-CCC----
Confidence            11        1111223577889999999888899999999999999999999999965322111 111000 000    


Q ss_pred             hhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          269 EIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                          +..         .........+.+++.+||..+|++|||+.+|++
T Consensus       234 ----~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         234 ----PEL---------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             ----CCC---------CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence                000         011234466889999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=6.4e-41  Score=294.21  Aligned_cols=259  Identities=25%  Similarity=0.345  Sum_probs=199.0

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCce--EEEEEeecc-chhhHHHHHHHHHHHHcC-CCCCcceeeceeecccCCCcc
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSI--VAVKVVNLK-QKEASRSFAAECNALRNI-RHRNLIKIITICSSIDFEGFD  105 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~  105 (331)
                      ++|.+.+.||+|+||.||+|.+..++..  +++|.+... .......+.+|+.++.++ +|+|++++++++     ...+
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~-----~~~~   81 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EHRG   81 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEE-----CCCC
Confidence            3689999999999999999998766654  566666432 233446688899999999 899999999985     4456


Q ss_pred             eeeEEEeecCCCCHHHHHHhcc--------------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEec
Q 046639          106 FKAIVFEYMQNRNLEQWLRQSN--------------GQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLD  171 (331)
Q Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~  171 (331)
                      ..++||||+++++|.+++....              ...+++..++.++.|++.|+++||+.   +++|+||||+||+++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~  158 (303)
T cd05088          82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVG  158 (303)
T ss_pred             CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEec
Confidence            7899999999999999997532              22467788999999999999999999   999999999999999


Q ss_pred             CCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccC
Q 046639          172 QDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFN  250 (331)
Q Consensus       172 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~  250 (331)
                      .++.++|+|||++....         ..........+..|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus       159 ~~~~~kl~dfg~~~~~~---------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~  229 (303)
T cd05088         159 ENYVAKIADFGLSRGQE---------VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC  229 (303)
T ss_pred             CCCcEEeCccccCcccc---------hhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh
Confidence            99999999999885321         0001111123456999999988889999999999999999998 9999964322


Q ss_pred             CcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhh
Q 046639          251 EGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETF  326 (331)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~  326 (331)
                      .  .........            ...       .....+...+.+|+.+||+.+|++|||+.++++.|..+.+..
T Consensus       230 ~--~~~~~~~~~------------~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~  284 (303)
T cd05088         230 A--ELYEKLPQG------------YRL-------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  284 (303)
T ss_pred             H--HHHHHHhcC------------CcC-------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            1  111111000            000       011123457889999999999999999999999998876654

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.1e-40  Score=289.37  Aligned_cols=259  Identities=19%  Similarity=0.297  Sum_probs=199.5

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCc----eEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCc
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRS----IVAVKVVNLKQ-KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGF  104 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  104 (331)
                      .+|.+.+.||+|+||+||+|.+..++.    .+++|.+.... ......+..|+..++.+.||||+++++++.      .
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~------~   80 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP------G   80 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC------C
Confidence            468899999999999999999876665    47777775332 223356778888999999999999999853      2


Q ss_pred             ceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcc
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA  184 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a  184 (331)
                      ...++++|++++++|.+++.... ..+++.....++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++
T Consensus        81 ~~~~~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~  156 (279)
T cd05111          81 ASLQLVTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVA  156 (279)
T ss_pred             CccEEEEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccc
Confidence            34678999999999999997643 2467888999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhC
Q 046639          185 KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMAL  263 (331)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~  263 (331)
                      +......      .........++..|+|||.+.+..++.++||||||+++|||++ |..||.+...  ....+......
T Consensus       157 ~~~~~~~------~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--~~~~~~~~~~~  228 (279)
T cd05111         157 DLLYPDD------KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP--HEVPDLLEKGE  228 (279)
T ss_pred             eeccCCC------cccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHCCC
Confidence            7642111      0111122346677999999998899999999999999999998 9999975421  11222211110


Q ss_pred             cchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhh
Q 046639          264 PDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARET  325 (331)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~  325 (331)
                      ..     ..              ...+...+.+++.+||..+|.+|||+.++++.|..+.+.
T Consensus       229 ~~-----~~--------------~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~  271 (279)
T cd05111         229 RL-----AQ--------------PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD  271 (279)
T ss_pred             cC-----CC--------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence            00     00              012345678889999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=8.1e-41  Score=290.17  Aligned_cols=260  Identities=20%  Similarity=0.295  Sum_probs=202.5

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCc----eEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCc
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRS----IVAVKVVNLKQ-KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGF  104 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  104 (331)
                      ++|.+.+.||+|+||+||+|.+..++.    +||+|.+.... ......+.+|+.+++.+.|+||+++++++..      
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~------   80 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT------   80 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC------
Confidence            478999999999999999999876665    48999886443 3345678899999999999999999998742      


Q ss_pred             ceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcc
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA  184 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a  184 (331)
                      ...++++|++++|+|.+++.... ..+++.....++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++
T Consensus        81 ~~~~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~  156 (279)
T cd05109          81 STVQLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLA  156 (279)
T ss_pred             CCcEEEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCce
Confidence            23679999999999999997543 3467788999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhC
Q 046639          185 KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMAL  263 (331)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~  263 (331)
                      +.......      ........+++.|+|||...+..++.++||||||+++|||++ |..||.....  ......+....
T Consensus       157 ~~~~~~~~------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~~~~~~  228 (279)
T cd05109         157 RLLDIDET------EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA--REIPDLLEKGE  228 (279)
T ss_pred             eecccccc------eeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHCCC
Confidence            86521110      001111234567999999998899999999999999999998 9999865321  11111111110


Q ss_pred             cchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhh
Q 046639          264 PDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETF  326 (331)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~  326 (331)
                      ..                   .....+...+.+++.+||+.||++||++.++++.|+.+....
T Consensus       229 ~~-------------------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05109         229 RL-------------------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP  272 (279)
T ss_pred             cC-------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence            00                   001234567889999999999999999999999998876654

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.5e-41  Score=305.47  Aligned_cols=259  Identities=17%  Similarity=0.191  Sum_probs=197.5

Q ss_pred             HHHHHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc---chhhHHHHHHHHHHHHcCCCCCcceeeceeeccc
Q 046639           24 ELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK---QKEASRSFAAECNALRNIRHRNLIKIITICSSID  100 (331)
Q Consensus        24 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  100 (331)
                      .+....++|++.+.||+|+||.||+|.+..+++.+|+|++...   .......+.+|+.+++.++||||++++++     
T Consensus        37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~-----  111 (370)
T cd05621          37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCA-----  111 (370)
T ss_pred             hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEE-----
Confidence            3444457899999999999999999999999999999998632   12233457789999999999999999998     


Q ss_pred             CCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcc
Q 046639          101 FEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGD  180 (331)
Q Consensus       101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~D  180 (331)
                      +..+...++||||+++++|.+++...   .++...+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|
T Consensus       112 ~~~~~~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~D  185 (370)
T cd05621         112 FQDDKYLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLAD  185 (370)
T ss_pred             EEcCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEe
Confidence            45567899999999999999999653   366788889999999999999999   999999999999999999999999


Q ss_pred             cCcccccccCCCCCcccccCCceeecccccccCCcccCCCC----CccchhhHhHHHHHHHHHhCCCCCCcccCCcchHH
Q 046639          181 LGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSK----ASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLH  256 (331)
Q Consensus       181 fg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~----~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~  256 (331)
                      ||++.......       ........||+.|+|||++.+..    ++.++||||+|+++|+|++|..||..... ...+.
T Consensus       186 FG~a~~~~~~~-------~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~-~~~~~  257 (370)
T cd05621         186 FGTCMKMDETG-------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL-VGTYS  257 (370)
T ss_pred             cccceecccCC-------ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH-HHHHH
Confidence            99997652111       11123456899999999987643    78899999999999999999999975321 11111


Q ss_pred             HHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCC--CCcHHHHHHH
Q 046639          257 EFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPME--RMEMRDVVAK  318 (331)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--Rps~~~i~~~  318 (331)
                      ........            ..++     ........+.+++..||..+|..  |+|+.++++.
T Consensus       258 ~i~~~~~~------------~~~p-----~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         258 KIMDHKNS------------LNFP-----EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             HHHhCCcc------------cCCC-----CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            11110000            0000     00123556778888899855543  8899998763

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=7.2e-41  Score=294.54  Aligned_cols=265  Identities=21%  Similarity=0.277  Sum_probs=200.6

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc-chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK-QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      ++|.+.+.||+|+||.||++.+..++..+|+|.+... .......+.+|+++++.++||||+++++++     ..++..+
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~   75 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAF-----YSDGEIS   75 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----eeCCEEE
Confidence            3699999999999999999999999999999988654 233446688999999999999999999985     4456889


Q ss_pred             EEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccc
Q 046639          109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLF  188 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~  188 (331)
                      +||||+++++|.+++...  ..++...+..++.|++.||.|||+..  +++|+||+|+||+++.++.++|+|||++....
T Consensus        76 lv~ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  151 (308)
T cd06615          76 ICMEHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  151 (308)
T ss_pred             EEeeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccc
Confidence            999999999999999764  34677888899999999999999732  89999999999999999999999999886541


Q ss_pred             cCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhh
Q 046639          189 GYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVM  268 (331)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  268 (331)
                      .          .......++..|+|||++.+..++.++|+||||+++|+|++|..||....  .................
T Consensus       152 ~----------~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~  219 (308)
T cd06615         152 D----------SMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD--AKELEAMFGRPVSEGEA  219 (308)
T ss_pred             c----------cccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc--hhhHHHhhcCccccccc
Confidence            1          11123457888999999988889999999999999999999999996432  11111111111000000


Q ss_pred             ---------------------hhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHH
Q 046639          269 ---------------------EIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAK  318 (331)
Q Consensus       269 ---------------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~  318 (331)
                                           ...+.. .....+.  .....+...+.+++.+||+.+|++|||+.+|++.
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         220 KESHRPVSGHPPDSPRPMAIFELLDYI-VNEPPPK--LPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             cCCcccccCCCCCccchhhHHHHHHHH-hcCCCcc--CcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                                 000000 0000000  0001245578999999999999999999999865

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-40  Score=286.23  Aligned_cols=254  Identities=21%  Similarity=0.267  Sum_probs=203.0

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeE
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAI  109 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~l  109 (331)
                      ++|.+.+.||.|++|.||+|.+..++..+++|.+..........+.+|+.+++.++|||++++++.+     ......++
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~l   77 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSY-----LRRDKLWI   77 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEE-----EeCCEEEE
Confidence            5799999999999999999999888999999999876666677899999999999999999999984     44567899


Q ss_pred             EEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccccc
Q 046639          110 VFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG  189 (331)
Q Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~  189 (331)
                      +||++++++|.+++.... ..++...+..++.|++.|+.+||+.   +++|+||+|+||+++.++.++|+|||.+.....
T Consensus        78 ~~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  153 (262)
T cd06613          78 VMEYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTA  153 (262)
T ss_pred             EEeCCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhh
Confidence            999999999999987642 3467888999999999999999999   999999999999999999999999999876521


Q ss_pred             CCCCCcccccCCceeecccccccCCcccCCC---CCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcch
Q 046639          190 YEPGTAAETASNSIEIKGIVGYVAPEYGMGS---KASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDK  266 (331)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  266 (331)
                      .        ........++..|+|||...+.   .++.++|+||||+++|+|++|..||........ ..........  
T Consensus       154 ~--------~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~-~~~~~~~~~~--  222 (262)
T cd06613         154 T--------IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA-LFLISKSNFP--  222 (262)
T ss_pred             h--------hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhccCC--
Confidence            1        1111234577789999998776   789999999999999999999999965321111 1111000000  


Q ss_pred             hhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          267 VMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                           .+..         ......+..+.+++.+||+.+|.+|||+.+|+.
T Consensus       223 -----~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         223 -----PPKL---------KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             -----Cccc---------cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                 0000         112235567899999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=7.7e-41  Score=294.26  Aligned_cols=263  Identities=22%  Similarity=0.320  Sum_probs=203.0

Q ss_pred             cCCCcCceeeccCeeEEEEeeecC-------CCceEEEEEeeccc-hhhHHHHHHHHHHHHcC-CCCCcceeeceeeccc
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDE-------SRSIVAVKVVNLKQ-KEASRSFAAECNALRNI-RHRNLIKIITICSSID  100 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~  100 (331)
                      ++|.+.+.||+|+||.||+|.+..       +...+|+|.+.... ......+..|+.+++.+ +|+|++++++++.   
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~---   94 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT---   94 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe---
Confidence            579999999999999999998743       23469999987442 33345688899999999 7999999999853   


Q ss_pred             CCCcceeeEEEeecCCCCHHHHHHhccC--------------CccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCC
Q 046639          101 FEGFDFKAIVFEYMQNRNLEQWLRQSNG--------------QLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPS  166 (331)
Q Consensus       101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~  166 (331)
                        ..+..++|||++++++|.+++.....              ..+++..+..++.|++.||.|||+.   +++|+||||+
T Consensus        95 --~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~  169 (307)
T cd05098          95 --QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAAR  169 (307)
T ss_pred             --cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHH
Confidence              34578999999999999999976432              2467788899999999999999999   9999999999


Q ss_pred             CEEecCCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCC
Q 046639          167 NILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPT  245 (331)
Q Consensus       167 nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf  245 (331)
                      ||+++.++.++|+|||.+........      ........++..|+|||++.+..++.++||||||+++|+|++ |..||
T Consensus       170 Nill~~~~~~kL~dfg~a~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~  243 (307)
T cd05098         170 NVLVTEDNVMKIADFGLARDIHHIDY------YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY  243 (307)
T ss_pred             heEEcCCCcEEECCCcccccccccch------hhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCC
Confidence            99999999999999999875421100      000111123457999999988889999999999999999998 88898


Q ss_pred             CcccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhh
Q 046639          246 DAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARET  325 (331)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~  325 (331)
                      .....  ...........            .       .+.+..+...+.+++.+||+.+|++|||+.+|++.|+.+.+.
T Consensus       244 ~~~~~--~~~~~~~~~~~------------~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~  302 (307)
T cd05098         244 PGVPV--EELFKLLKEGH------------R-------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL  302 (307)
T ss_pred             CcCCH--HHHHHHHHcCC------------C-------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence            64311  11111111100            0       011223566888999999999999999999999999998876


Q ss_pred             hh
Q 046639          326 FL  327 (331)
Q Consensus       326 ~~  327 (331)
                      ..
T Consensus       303 ~~  304 (307)
T cd05098         303 TS  304 (307)
T ss_pred             hh
Confidence            44

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-41  Score=295.39  Aligned_cols=249  Identities=17%  Similarity=0.283  Sum_probs=211.4

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ--KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      -+-|.+.+.||+|.|..|-+|++..||..||||++.+..  ......+..|++.|+.++|||||++|++     .+....
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEV-----iDTQTK   91 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEV-----IDTQTK   91 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeeh-----hcccce
Confidence            346899999999999999999999999999999997654  3334668899999999999999999999     788899


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEec-CCCcEEEcccCccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLD-QDIVAHVGDLGLAK  185 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~-~~~~~kl~Dfg~a~  185 (331)
                      +|+|+|.=.+|+|.++|.+.. ..+.+..+.+++.||+.|+.|+|+.   .+||||+||+|+.+- .-|-|||.|||++.
T Consensus        92 lyLiLELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSN  167 (864)
T KOG4717|consen   92 LYLILELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSN  167 (864)
T ss_pred             EEEEEEecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccc
Confidence            999999999999999998744 3477889999999999999999999   999999999999875 67899999999987


Q ss_pred             ccccCCCCCcccccCCceeecccccccCCcccCCCCC-ccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCc
Q 046639          186 FLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKA-SVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALP  264 (331)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  264 (331)
                      .+         .+.......+|+..|.|||++.|..| -++.||||||+|||.|+.|++||+...+..            
T Consensus       168 kf---------~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE------------  226 (864)
T KOG4717|consen  168 KF---------QPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE------------  226 (864)
T ss_pred             cC---------CCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh------------
Confidence            65         34455556789999999999999998 468999999999999999999998643221            


Q ss_pred             chhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          265 DKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                       .+..+.|.+         ++.+.....+..+|+..||..||.+|.|..+|..
T Consensus       227 -TLTmImDCK---------YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  227 -TLTMIMDCK---------YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             -hhhhhhccc---------ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence             122223322         3555677888899999999999999999999874

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.6e-41  Score=300.63  Aligned_cols=238  Identities=23%  Similarity=0.237  Sum_probs=185.6

Q ss_pred             ceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHH-HHHcCCCCCcceeeceeecccCCCcceeeEEE
Q 046639           36 NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECN-ALRNIRHRNLIKIITICSSIDFEGFDFKAIVF  111 (331)
Q Consensus        36 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~  111 (331)
                      +.||+|+||+||+|.+..+++.||+|++....   ......+..|.. +++.++||||+++++.+     ...+..++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~-----~~~~~~~lv~   75 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTADKLYFVL   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEE-----EeCCEEEEEE
Confidence            47999999999999999999999999986432   122234455554 56778999999999884     4456789999


Q ss_pred             eecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccccCC
Q 046639          112 EYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYE  191 (331)
Q Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~~  191 (331)
                      ||+++++|..++....  .+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++.....  
T Consensus        76 e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~--  148 (323)
T cd05575          76 DYVNGGELFFHLQRER--SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE--  148 (323)
T ss_pred             cCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCccccc--
Confidence            9999999999987543  467788889999999999999999   999999999999999999999999999865311  


Q ss_pred             CCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhhhc
Q 046639          192 PGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEIV  271 (331)
Q Consensus       192 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (331)
                            .........||+.|+|||++.+..++.++||||||+++|+|++|..||.....     ...........     
T Consensus       149 ------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-----~~~~~~i~~~~-----  212 (323)
T cd05575         149 ------HSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT-----AEMYDNILNKP-----  212 (323)
T ss_pred             ------CCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH-----HHHHHHHHcCC-----
Confidence                  11122334689999999999999999999999999999999999999975321     11111111000     


Q ss_pred             CcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHH
Q 046639          272 DPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMR  313 (331)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~  313 (331)
                       .           .........+.+++.+||+.||.+||++.
T Consensus       213 -~-----------~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         213 -L-----------RLKPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             -C-----------CCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence             0           01112355788999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=6.4e-41  Score=291.25  Aligned_cols=266  Identities=19%  Similarity=0.258  Sum_probs=207.9

Q ss_pred             ccHHHHHHHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcC-CCCCcceeeceeec
Q 046639           20 ISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNI-RHRNLIKIITICSS   98 (331)
Q Consensus        20 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~   98 (331)
                      +++.++....+.|.+.+.||.|+||.||+|.+..+++.+|+|++..... ....+..|+.+++++ .|+|++++++++..
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   84 (282)
T cd06636           6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYGAFIK   84 (282)
T ss_pred             hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH-HHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence            4667777788899999999999999999999998999999999865433 345678899999998 69999999998743


Q ss_pred             ccC-CCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEE
Q 046639           99 IDF-EGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAH  177 (331)
Q Consensus        99 ~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~k  177 (331)
                      ... ......+++|||+++++|.+++.......++...+..++.|++.|++|||+.   +++|+||+|+||+++.++.++
T Consensus        85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~  161 (282)
T cd06636          85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVK  161 (282)
T ss_pred             ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEE
Confidence            211 2346789999999999999999876555677778889999999999999999   999999999999999999999


Q ss_pred             EcccCcccccccCCCCCcccccCCceeecccccccCCcccC-----CCCCccchhhHhHHHHHHHHHhCCCCCCcccCCc
Q 046639          178 VGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGM-----GSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEG  252 (331)
Q Consensus       178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~  252 (331)
                      |+|||++......        ........+++.|+|||.+.     +..++.++||||||+++|+|++|..||...... 
T Consensus       162 l~dfg~~~~~~~~--------~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~-  232 (282)
T cd06636         162 LVDFGVSAQLDRT--------VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM-  232 (282)
T ss_pred             EeeCcchhhhhcc--------ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH-
Confidence            9999998754111        11223345788899999875     345788999999999999999999999653211 


Q ss_pred             chHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          253 LTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                         ......      .....+..          ....++..+.+++.+||+.||.+|||+.+|++
T Consensus       233 ---~~~~~~------~~~~~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         233 ---RALFLI------PRNPPPKL----------KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             ---hhhhhH------hhCCCCCC----------cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence               111000      00000000          01235568999999999999999999999974

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-40  Score=284.95  Aligned_cols=251  Identities=29%  Similarity=0.381  Sum_probs=202.1

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      .++|.+.+.||.|++|.||+|...  ++.||+|.+..... ....+.+|+.+++.++|+|++++++++     ......+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~   76 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVV-----LQGNPLY   76 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEE-----cCCCCeE
Confidence            457999999999999999999875  77899999975544 456788999999999999999999985     3356789


Q ss_pred             EEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccc
Q 046639          109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLF  188 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~  188 (331)
                      +|||++++++|.+++.......+++..+..++.|++.||.+||+.   +++|+||+|+||+++.++.++|+|||.++...
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~  153 (256)
T cd05039          77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEAS  153 (256)
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccc
Confidence            999999999999999876655678899999999999999999999   99999999999999999999999999987651


Q ss_pred             cCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhCcchh
Q 046639          189 GYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMALPDKV  267 (331)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  267 (331)
                      ...           .....+..|+|||.+.+..++.++||||||+++|+|++ |..||......  ..........    
T Consensus       154 ~~~-----------~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~~~----  216 (256)
T cd05039         154 QGQ-----------DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPHVEKGY----  216 (256)
T ss_pred             ccc-----------ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHhcCC----
Confidence            110           01223456999999988889999999999999999997 99998643211  1111111100    


Q ss_pred             hhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHh
Q 046639          268 MEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHA  322 (331)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~  322 (331)
                          ..           ..+..++..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       217 ----~~-----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         217 ----RM-----------EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             ----CC-----------CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence                00           11123457789999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.4e-42  Score=304.31  Aligned_cols=240  Identities=21%  Similarity=0.256  Sum_probs=189.6

Q ss_pred             CceeeccCeeEEEEeee---cCCCceEEEEEeeccch--hhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeE
Q 046639           35 ANKIGQGGVSIVYKGIL---DESRSIVAVKVVNLKQK--EASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAI  109 (331)
Q Consensus        35 ~~~lg~G~~g~V~~~~~---~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~l  109 (331)
                      ++.||+|+||.||++.+   ..+++.||+|++.....  .....+..|+.++++++||||+++++++     ...+..++
T Consensus         1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~~l   75 (318)
T cd05582           1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAF-----QTEGKLYL   75 (318)
T ss_pred             CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEE-----EcCCEEEE
Confidence            36899999999999876   35788999999975432  2234567899999999999999999984     44567899


Q ss_pred             EEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccccc
Q 046639          110 VFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG  189 (331)
Q Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~  189 (331)
                      ||||+++++|.+++.+..  .+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        76 v~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~  150 (318)
T cd05582          76 ILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESID  150 (318)
T ss_pred             EEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCC
Confidence            999999999999986543  477889999999999999999999   999999999999999999999999999875421


Q ss_pred             CCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhh
Q 046639          190 YEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVME  269 (331)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  269 (331)
                      .        ........|++.|+|||++.+..++.++||||||+++|+|++|..||.....     ...........   
T Consensus       151 ~--------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~-----~~~~~~i~~~~---  214 (318)
T cd05582         151 H--------EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR-----KETMTMILKAK---  214 (318)
T ss_pred             C--------CCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH-----HHHHHHHHcCC---
Confidence            1        1122345688999999999988899999999999999999999999975321     11111100000   


Q ss_pred             hcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHH
Q 046639          270 IVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRD  314 (331)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~  314 (331)
                                    ...+..+...+.+++.+||+.||++|||+.+
T Consensus       215 --------------~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         215 --------------LGMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             --------------CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence                          0111234567889999999999999999655

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=6.8e-41  Score=297.15  Aligned_cols=274  Identities=16%  Similarity=0.136  Sum_probs=198.4

Q ss_pred             cCceeecc--CeeEEEEeeecCCCceEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeE
Q 046639           34 PANKIGQG--GVSIVYKGILDESRSIVAVKVVNLKQ--KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAI  109 (331)
Q Consensus        34 ~~~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~l  109 (331)
                      ++++||+|  ++++||++.++.+++.||+|.+....  ......+.+|+.+++.++||||+++++++.     .++..++
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~-----~~~~~~l   76 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFI-----ADNELWV   76 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE-----ECCEEEE
Confidence            46789999  78999999999999999999986542  344466888999999999999999999964     3467899


Q ss_pred             EEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccccc
Q 046639          110 VFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG  189 (331)
Q Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~  189 (331)
                      ||||+++++|.+++.......+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+++.||+.+.....
T Consensus        77 v~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~  153 (327)
T cd08227          77 VTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMIN  153 (327)
T ss_pred             EEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhcccc
Confidence            99999999999999765545577888999999999999999999   999999999999999999999999986544321


Q ss_pred             CCCCCcccccCCceeecccccccCCcccCC--CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchh
Q 046639          190 YEPGTAAETASNSIEIKGIVGYVAPEYGMG--SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKV  267 (331)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  267 (331)
                      ....... .........++..|+|||++.+  ..++.++|||||||++|+|++|..||.......... .......+...
T Consensus       154 ~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~-~~~~~~~~~~~  231 (327)
T cd08227         154 HGQRLRV-VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL-EKLNGTVPCLL  231 (327)
T ss_pred             ccccccc-cccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHH-HHhcCCccccc
Confidence            1111000 0011122346677999999876  458999999999999999999999997543222111 11111111000


Q ss_pred             h-------h--------hcCccccc----------ccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          268 M-------E--------IVDPSLLL----------EVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       268 ~-------~--------~~~~~~~~----------~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      .       .        ..+.....          ............+.+.+.+++.+||+.||++|||+.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         232 DTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             cccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence            0       0        00000000          0000001122345678999999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.2e-41  Score=290.50  Aligned_cols=257  Identities=21%  Similarity=0.370  Sum_probs=199.7

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCC-----CceEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCC
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDES-----RSIVAVKVVNLKQ-KEASRSFAAECNALRNIRHRNLIKIITICSSIDFE  102 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  102 (331)
                      .++|.+.+.||+|+||.||+|.+...     +..||+|.+.... ......+.+|+.+++.++|+|++++++++     .
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~   79 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVV-----S   79 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEE-----c
Confidence            35799999999999999999988643     4789999985432 33345688999999999999999999985     4


Q ss_pred             CcceeeEEEeecCCCCHHHHHHhccC--------CccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCC
Q 046639          103 GFDFKAIVFEYMQNRNLEQWLRQSNG--------QLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDI  174 (331)
Q Consensus       103 ~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~  174 (331)
                      .....++|||++++++|.+++.....        ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++
T Consensus        80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~  156 (277)
T cd05032          80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDL  156 (277)
T ss_pred             CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCC
Confidence            45678999999999999999975321        2356778889999999999999999   999999999999999999


Q ss_pred             cEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcc
Q 046639          175 VAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGL  253 (331)
Q Consensus       175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~  253 (331)
                      .++|+|||+++.......      ........++..|+|||.+.+..++.++||||||+++|++++ |..||.....  .
T Consensus       157 ~~kl~dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--~  228 (277)
T cd05032         157 TVKIGDFGMTRDIYETDY------YRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN--E  228 (277)
T ss_pred             CEEECCcccchhhccCcc------cccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH--H
Confidence            999999999876522111      011112235667999999988889999999999999999998 9999864321  1


Q ss_pred             hHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHH
Q 046639          254 TLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLR  320 (331)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~  320 (331)
                      .........   .     .           ...+..++..+.+++.+||+.+|++|||+.++++.|+
T Consensus       229 ~~~~~~~~~---~-----~-----------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         229 EVLKFVIDG---G-----H-----------LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             HHHHHHhcC---C-----C-----------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            111111100   0     0           0111234678899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.2e-41  Score=301.71  Aligned_cols=241  Identities=22%  Similarity=0.247  Sum_probs=186.5

Q ss_pred             ceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHH-HHHcCCCCCcceeeceeecccCCCcceeeEEE
Q 046639           36 NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECN-ALRNIRHRNLIKIITICSSIDFEGFDFKAIVF  111 (331)
Q Consensus        36 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~  111 (331)
                      +.||+|+||+||+|++..+++.||+|++....   ......+..|.. +++.++|+||+++++++     ...+..++||
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~-----~~~~~~~lv~   75 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-----QTADKLYFVL   75 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEE-----EcCCeEEEEE
Confidence            47999999999999999999999999986432   122233444444 56778999999999884     4556789999


Q ss_pred             eecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccccCC
Q 046639          112 EYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYE  191 (331)
Q Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~~  191 (331)
                      ||+++++|.+++....  .+....+..++.|++.||.|||++   ||+||||||+||+++.++.++|+|||++.....  
T Consensus        76 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~--  148 (325)
T cd05602          76 DYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIE--  148 (325)
T ss_pred             eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCccccc--
Confidence            9999999999997543  356677888999999999999999   999999999999999999999999999875311  


Q ss_pred             CCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhhhc
Q 046639          192 PGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEIV  271 (331)
Q Consensus       192 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (331)
                            .........||+.|+|||++.+..++.++||||||+++|+|++|..||...... ..+........        
T Consensus       149 ------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~~--------  213 (325)
T cd05602         149 ------HNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-EMYDNILNKPL--------  213 (325)
T ss_pred             ------CCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH-HHHHHHHhCCc--------
Confidence                  111223456899999999999999999999999999999999999999653211 11111111000        


Q ss_pred             CcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHH
Q 046639          272 DPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVV  316 (331)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~  316 (331)
                                   ....+....+.+++.+||+.+|.+||++.+.+
T Consensus       214 -------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         214 -------------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             -------------CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence                         01112456788999999999999999987544

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-40  Score=285.08  Aligned_cols=251  Identities=20%  Similarity=0.326  Sum_probs=195.8

Q ss_pred             ceeeccCeeEEEEeeecCCC---ceEEEEEeeccch-hhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeEEE
Q 046639           36 NKIGQGGVSIVYKGILDESR---SIVAVKVVNLKQK-EASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVF  111 (331)
Q Consensus        36 ~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~  111 (331)
                      ++||+|+||.||+|.+..++   ..+|+|.+..... .....+.+|+.+++.+.|+|++++++++.      ....++||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~~~~~~v~   74 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK------GEPLMLVM   74 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc------CCceEEEE
Confidence            47999999999999875544   7899999864433 34567889999999999999999999753      23568999


Q ss_pred             eecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccccCC
Q 046639          112 EYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYE  191 (331)
Q Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~~  191 (331)
                      |++++++|.+++....  .+++..+..++.|++.|+++||..   +++|+||||+||+++.++.++|+|||+++......
T Consensus        75 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~  149 (257)
T cd05060          75 ELAPLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGS  149 (257)
T ss_pred             EeCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCC
Confidence            9999999999997654  567889999999999999999999   99999999999999999999999999987652211


Q ss_pred             CCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhCcchhhhh
Q 046639          192 PGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMALPDKVMEI  270 (331)
Q Consensus       192 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  270 (331)
                      .     .........++..|+|||...+..++.++||||||+++|+|++ |..||.....  ............      
T Consensus       150 ~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--~~~~~~~~~~~~------  216 (257)
T cd05060         150 D-----YYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEVIAMLESGER------  216 (257)
T ss_pred             c-----ccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHHcCCc------
Confidence            1     0001111123456999999998899999999999999999998 9999975422  112221111100      


Q ss_pred             cCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhh
Q 046639          271 VDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHAR  323 (331)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~  323 (331)
                                   ...+..++..+.+++.+||+.+|++|||+.+|++.|+.+.
T Consensus       217 -------------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         217 -------------LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             -------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence                         0111234568899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=6e-41  Score=287.36  Aligned_cols=252  Identities=24%  Similarity=0.355  Sum_probs=195.8

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeE
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAI  109 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~l  109 (331)
                      ++|++.+.||+|++|+||.|.+.. +..+|+|.+.... .....+.+|+.++++++||||+++++++.     .....++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   76 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT-----KQRPIYI   76 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEc-----cCCCcEE
Confidence            458999999999999999998764 4469999886432 22356889999999999999999999863     3456799


Q ss_pred             EEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccccc
Q 046639          110 VFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG  189 (331)
Q Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~  189 (331)
                      +||++.+++|.+++..... .+++..++.++.|++.||++||+.   +++|+||+|+||+++.++.++|+|||.+.....
T Consensus        77 v~e~~~~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~  152 (256)
T cd05113          77 VTEYMSNGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD  152 (256)
T ss_pred             EEEcCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCC
Confidence            9999999999999976433 567888999999999999999999   999999999999999999999999999876421


Q ss_pred             CCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhCcchhh
Q 046639          190 YEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMALPDKVM  268 (331)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  268 (331)
                      ..       ........++..|+|||.+.+..++.++||||||+++|+|++ |..||......  ...........    
T Consensus       153 ~~-------~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~~~~----  219 (256)
T cd05113         153 DE-------YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS--ETVEKVSQGLR----  219 (256)
T ss_pred             Cc-------eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHHhcCCC----
Confidence            11       011112234567999999988889999999999999999998 99998653211  11111110000    


Q ss_pred             hhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHH
Q 046639          269 EIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLR  320 (331)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~  320 (331)
                          .           .........+.+++.+||+.+|.+|||+.+|++.|+
T Consensus       220 ----~-----------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         220 ----L-----------YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             ----C-----------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence                0           000113467899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.2e-40  Score=286.01  Aligned_cols=253  Identities=26%  Similarity=0.431  Sum_probs=198.7

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeE
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAI  109 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~l  109 (331)
                      ++|.+.+.||+|++|.||+|.+. ++..+|+|.+..... ....+.+|+.++++++|++++++++++.      ....++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~------~~~~~l   77 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS------EEPIYI   77 (260)
T ss_pred             HHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC------CCCcEE
Confidence            47999999999999999999876 455689998864332 3456889999999999999999998752      234789


Q ss_pred             EEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccccc
Q 046639          110 VFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG  189 (331)
Q Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~  189 (331)
                      +||++++++|.+++.......+++..+..++.|++.||.+||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05070          78 VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIED  154 (260)
T ss_pred             EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence            99999999999999775555578889999999999999999999   999999999999999999999999999976521


Q ss_pred             CCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhCcchhh
Q 046639          190 YEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMALPDKVM  268 (331)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  268 (331)
                      ..       ........++..|+|||.+.+..++.++||||||+++|+|++ |..||.....  ...........     
T Consensus       155 ~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--~~~~~~~~~~~-----  220 (260)
T cd05070         155 NE-------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN--REVLEQVERGY-----  220 (260)
T ss_pred             cc-------cccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHHcCC-----
Confidence            11       011112224556999999988889999999999999999999 8999965321  11111111000     


Q ss_pred             hhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHH
Q 046639          269 EIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRH  321 (331)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~  321 (331)
                         ..           .....++..+.+++.+||..+|++|||+.++.+.|+.
T Consensus       221 ---~~-----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         221 ---RM-----------PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             ---CC-----------CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence               00           1112345679999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2.7e-41  Score=299.00  Aligned_cols=242  Identities=20%  Similarity=0.258  Sum_probs=190.5

Q ss_pred             CCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHHcCC-CCCcceeeceeecccCCCcce
Q 046639           31 NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNIR-HRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      +|...+.||+|+||+||+|.+..+++.||+|++....   ......+..|..++..+. |++++++.++     +...+.
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~-----~~~~~~   75 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSC-----FQTVDR   75 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeE-----EecCCE
Confidence            4778899999999999999999999999999986432   233455778888888886 5677777777     444567


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      .++||||+++++|.+++....  .+++..+..++.|++.||.|||++   +++|+||||+||+++.++.++|+|||++..
T Consensus        76 ~~lv~Ey~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~  150 (323)
T cd05615          76 LYFVMEYVNGGDLMYHIQQVG--KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE  150 (323)
T ss_pred             EEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccc
Confidence            899999999999999986543  477889999999999999999999   999999999999999999999999999875


Q ss_pred             cccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcch
Q 046639          187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDK  266 (331)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  266 (331)
                      ...        .........||+.|+|||++.+..++.++||||+|+++|+|++|..||...... ..........    
T Consensus       151 ~~~--------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-~~~~~i~~~~----  217 (323)
T cd05615         151 HMV--------DGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED-ELFQSIMEHN----  217 (323)
T ss_pred             cCC--------CCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCC----
Confidence            311        111223345889999999999989999999999999999999999999754211 1111111100    


Q ss_pred             hhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcH
Q 046639          267 VMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEM  312 (331)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~  312 (331)
                                       ..++..+...+.+++.+||+.+|.+|++.
T Consensus       218 -----------------~~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         218 -----------------VSYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             -----------------CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence                             01112345577889999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-40  Score=291.16  Aligned_cols=263  Identities=22%  Similarity=0.329  Sum_probs=196.3

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCC--------------CceEEEEEeecc-chhhHHHHHHHHHHHHcCCCCCcceeec
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDES--------------RSIVAVKVVNLK-QKEASRSFAAECNALRNIRHRNLIKIIT   94 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~--------------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~   94 (331)
                      ++|.+.+.||+|+||.||+|.+..+              ...||+|.+... .......+.+|++++++++|+|++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            5799999999999999999987543              235899988643 2334466889999999999999999999


Q ss_pred             eeecccCCCcceeeEEEeecCCCCHHHHHHhccC----------CccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCC
Q 046639           95 ICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNG----------QLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLK  164 (331)
Q Consensus        95 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----------~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik  164 (331)
                      ++     ......++||||+++++|.+++.....          ...++..++.++.|++.||+|||+.   +++|+|||
T Consensus        85 ~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlk  156 (295)
T cd05097          85 VC-----VSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLA  156 (295)
T ss_pred             EE-----cCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccC
Confidence            95     345678999999999999999865321          1356778889999999999999999   99999999


Q ss_pred             CCCEEecCCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh--CC
Q 046639          165 PSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT--RR  242 (331)
Q Consensus       165 ~~nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~--g~  242 (331)
                      |+||+++.++.+||+|||++.......      .........++..|+|||+..+..++.++||||||+++++|++  |.
T Consensus       157 p~Nill~~~~~~kl~dfg~~~~~~~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~  230 (295)
T cd05097         157 TRNCLVGNHYTIKIADFGMSRNLYSGD------YYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKE  230 (295)
T ss_pred             hhhEEEcCCCcEEecccccccccccCc------ceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCC
Confidence            999999999999999999987542110      0111112234567999999988889999999999999999998  66


Q ss_pred             CCCCcccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHH
Q 046639          243 RPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLR  320 (331)
Q Consensus       243 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~  320 (331)
                      .||....... ............      ......       .....++..+.+|+.+||+.+|++|||+.+|++.|+
T Consensus       231 ~p~~~~~~~~-~~~~~~~~~~~~------~~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         231 QPYSLLSDEQ-VIENTGEFFRNQ------GRQIYL-------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             CCCcccChHH-HHHHHHHhhhhc------cccccC-------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            7776432111 111110000000      000000       001124568999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-42  Score=307.19  Aligned_cols=246  Identities=20%  Similarity=0.281  Sum_probs=205.1

Q ss_pred             eeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeEEEeecCC
Q 046639           37 KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQN  116 (331)
Q Consensus        37 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~  116 (331)
                      .||+|.||+||.|++..|+...|||.+...+....+.+..|+.+.+.++|.|||+++|.     +..+++.-|.||-++|
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs-----~senGf~kIFMEqVPG  656 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGS-----VSENGFFKIFMEQVPG  656 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhc-----cCCCCeEEEEeecCCC
Confidence            79999999999999999999999999988888888889999999999999999999999     4556788899999999


Q ss_pred             CCHHHHHHhc-cCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEec-CCCcEEEcccCcccccccCCCCC
Q 046639          117 RNLEQWLRQS-NGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLD-QDIVAHVGDLGLAKFLFGYEPGT  194 (331)
Q Consensus       117 ~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~-~~~~~kl~Dfg~a~~~~~~~~~~  194 (331)
                      |+|.++++.. +.-.-.+.....+..||++||.|||.+   .|||||||-+|++|+ -.|.+||+|||-++.+       
T Consensus       657 GSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRL-------  726 (1226)
T KOG4279|consen  657 GSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRL-------  726 (1226)
T ss_pred             CcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhh-------
Confidence            9999999863 332335677778899999999999999   999999999999996 6789999999988776       


Q ss_pred             cccccCCceeecccccccCCcccCCCC--CccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhhhcC
Q 046639          195 AAETASNSIEIKGIVGYVAPEYGMGSK--ASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEIVD  272 (331)
Q Consensus       195 ~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (331)
                       ....+....+.||..|||||++..++  |+.++|||||||++.||.||++||....+........-    .    -   
T Consensus       727 -AginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVG----m----y---  794 (1226)
T KOG4279|consen  727 -AGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVG----M----Y---  794 (1226)
T ss_pred             -ccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhc----c----e---
Confidence             23345556678999999999998865  78999999999999999999999987644332221110    0    0   


Q ss_pred             cccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          273 PSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                              +.....+.+...+...++.+|...||.+||+|+++++
T Consensus       795 --------KvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  795 --------KVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             --------ecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence                    0011334567778888999999999999999999974

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.5e-40  Score=285.58  Aligned_cols=253  Identities=25%  Similarity=0.409  Sum_probs=198.6

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeE
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAI  109 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~l  109 (331)
                      ++|.+.+.||.|++|.||+|.+..+. .+|+|.+.... ...+.+.+|+.+++.++|+|++++++++.      .+..++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~~   77 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS------EEPIYI   77 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc------CCCcEE
Confidence            46999999999999999999887554 58999875332 33456889999999999999999988742      245789


Q ss_pred             EEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccccc
Q 046639          110 VFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG  189 (331)
Q Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~  189 (331)
                      +||++++++|.+++.......+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||.+.....
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05069          78 VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIED  154 (260)
T ss_pred             EEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccC
Confidence            99999999999999875555577888899999999999999999   999999999999999999999999999976521


Q ss_pred             CCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhCcchhh
Q 046639          190 YEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMALPDKVM  268 (331)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  268 (331)
                      ..       ........++..|+|||...+..++.++||||||+++|+|++ |..||......  ..........     
T Consensus       155 ~~-------~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~~-----  220 (260)
T cd05069         155 NE-------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR--EVLEQVERGY-----  220 (260)
T ss_pred             Cc-------ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCC-----
Confidence            11       011112235567999999988889999999999999999999 99999753221  1111111100     


Q ss_pred             hhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHH
Q 046639          269 EIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRH  321 (331)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~  321 (331)
                         .+           ......+..+.+++.+||+.+|++||++.+|++.|+.
T Consensus       221 ---~~-----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         221 ---RM-----------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             ---CC-----------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence               00           0112345678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.5e-40  Score=290.16  Aligned_cols=259  Identities=22%  Similarity=0.348  Sum_probs=199.9

Q ss_pred             CCCcCceeeccCeeEEEEeeecC-----CCceEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCc
Q 046639           31 NFSPANKIGQGGVSIVYKGILDE-----SRSIVAVKVVNLKQ-KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGF  104 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  104 (331)
                      +|.+.+.||+|+||.||+|.+..     ....+++|.+.... ......+.+|+.+++.++||||+++++.+.     ..
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~   75 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACS-----QD   75 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEe-----cC
Confidence            47889999999999999998743     23568888876443 233467889999999999999999999853     34


Q ss_pred             ceeeEEEeecCCCCHHHHHHhcc----------------------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecC
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQSN----------------------GQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGD  162 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~----------------------~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~d  162 (331)
                      +..++++|++.+++|.+++....                      ...+++..++.++.|++.||.+||+.   +++|+|
T Consensus        76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~d  152 (290)
T cd05045          76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRD  152 (290)
T ss_pred             CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhh
Confidence            56899999999999999986521                      12466778899999999999999999   999999


Q ss_pred             CCCCCEEecCCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-C
Q 046639          163 LKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-R  241 (331)
Q Consensus       163 ik~~nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g  241 (331)
                      |||+||++++++.++|+|||+++.......      ........++..|+|||...+..++.++||||||+++|+|++ |
T Consensus       153 ikp~nill~~~~~~kl~dfg~~~~~~~~~~------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g  226 (290)
T cd05045         153 LAARNVLVAEGRKMKISDFGLSRDVYEEDS------YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLG  226 (290)
T ss_pred             hhhheEEEcCCCcEEeccccccccccCccc------hhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcC
Confidence            999999999999999999999876421111      011112234567999999988889999999999999999998 9


Q ss_pred             CCCCCcccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHH
Q 046639          242 RRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRH  321 (331)
Q Consensus       242 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~  321 (331)
                      ..||.....  ...........            ..       ..+..+...+.+++.+||+.+|++||++.++++.|++
T Consensus       227 ~~p~~~~~~--~~~~~~~~~~~------------~~-------~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~  285 (290)
T cd05045         227 GNPYPGIAP--ERLFNLLKTGY------------RM-------ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEK  285 (290)
T ss_pred             CCCCCCCCH--HHHHHHHhCCC------------CC-------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence            999965321  11111111100            00       1112345678899999999999999999999999998


Q ss_pred             hhh
Q 046639          322 ARE  324 (331)
Q Consensus       322 ~~~  324 (331)
                      +..
T Consensus       286 ~~~  288 (290)
T cd05045         286 MMV  288 (290)
T ss_pred             HHh
Confidence            764

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.2e-42  Score=306.28  Aligned_cols=261  Identities=22%  Similarity=0.328  Sum_probs=213.6

Q ss_pred             ccHHHHHHHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEee----ccchhhHHHHHHHHHHHHcCCCCCcceeece
Q 046639           20 ISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVN----LKQKEASRSFAAECNALRNIRHRNLIKIITI   95 (331)
Q Consensus        20 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   95 (331)
                      ..+-+.++..+-.+....||+|+|-+||+|.+..+|..||=--++    ...+...+++..|+.+|+.|+||||++++.+
T Consensus        30 ~~~ve~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~S  109 (632)
T KOG0584|consen   30 SEFVEKDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDS  109 (632)
T ss_pred             ccccccCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeh
Confidence            334455555555566689999999999999999899887733222    1245566889999999999999999999999


Q ss_pred             eecccCCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecC-CC
Q 046639           96 CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQ-DI  174 (331)
Q Consensus        96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~-~~  174 (331)
                      +.+..   ...+.+|+|.+..|+|..++++...  .....+..|+.||++||.|||++ .|+|+|||||-+||+|++ -|
T Consensus       110 W~d~~---n~~in~iTEL~TSGtLr~Y~kk~~~--vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G  183 (632)
T KOG0584|consen  110 WVDTD---NKTINFITELFTSGTLREYRKKHRR--VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLG  183 (632)
T ss_pred             eecCC---CceeeeeeecccCCcHHHHHHHhcc--CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcC
Confidence            76543   2457899999999999999988654  56789999999999999999998 679999999999999985 48


Q ss_pred             cEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcch
Q 046639          175 VAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLT  254 (331)
Q Consensus       175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~  254 (331)
                      .|||+|+|+|..+          ......+..|||.|||||... +.|++..||||||+++.||+|+..||....+...-
T Consensus       184 ~VKIGDLGLAtl~----------r~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQI  252 (632)
T KOG0584|consen  184 EVKIGDLGLATLL----------RKSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQI  252 (632)
T ss_pred             ceeecchhHHHHh----------hccccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHH
Confidence            9999999999986          234445588999999999987 78999999999999999999999999987766666


Q ss_pred             HHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          255 LHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      +.....+..|.-+...-|                   +++.++|.+||.. ..+|||+.|+++
T Consensus       253 YKKV~SGiKP~sl~kV~d-------------------Pevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  253 YKKVTSGIKPAALSKVKD-------------------PEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             HHHHHcCCCHHHhhccCC-------------------HHHHHHHHHHhcC-chhccCHHHHhh
Confidence            666555555544433333                   4678899999999 999999999974

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1e-40  Score=294.87  Aligned_cols=200  Identities=22%  Similarity=0.286  Sum_probs=160.8

Q ss_pred             CceeeccCeeEEEEeeec--CCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeEEEe
Q 046639           35 ANKIGQGGVSIVYKGILD--ESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFE  112 (331)
Q Consensus        35 ~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~e  112 (331)
                      +.+||+|+||+||+|++.  .+++.+|+|.+....  ....+.+|+.+++.++||||+++++++..   ......++++|
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~~lv~e   80 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLS---HADRKVWLLFD   80 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEec---CCCcEEEEEEe
Confidence            568999999999999965  467889999885432  23456789999999999999999998643   23456899999


Q ss_pred             ecCCCCHHHHHHhcc-------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEe----cCCCcEEEccc
Q 046639          113 YMQNRNLEQWLRQSN-------GQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILL----DQDIVAHVGDL  181 (331)
Q Consensus       113 ~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv----~~~~~~kl~Df  181 (331)
                      ++ +++|.+++....       ...++...+..++.|++.||.|||++   +|+|+||||+||++    +.++.+||+||
T Consensus        81 ~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07868          81 YA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             cc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence            99 669988876421       22467788899999999999999999   99999999999999    45678999999


Q ss_pred             CcccccccCCCCCcccccCCceeecccccccCCcccCCC-CCccchhhHhHHHHHHHHHhCCCCCCcc
Q 046639          182 GLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGS-KASVSGDVYNFGILLLEMFTRRRPTDAM  248 (331)
Q Consensus       182 g~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~  248 (331)
                      |+++......     ..........+|+.|+|||++.+. .++.++||||+||++|+|++|.+||...
T Consensus       157 G~a~~~~~~~-----~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         157 GFARLFNSPL-----KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             CceeccCCCC-----ccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            9997652211     111122345688999999998774 5899999999999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.6e-40  Score=293.11  Aligned_cols=264  Identities=21%  Similarity=0.340  Sum_probs=203.1

Q ss_pred             cCCCcCceeeccCeeEEEEeeec-------CCCceEEEEEeeccc-hhhHHHHHHHHHHHHcC-CCCCcceeeceeeccc
Q 046639           30 NNFSPANKIGQGGVSIVYKGILD-------ESRSIVAVKVVNLKQ-KEASRSFAAECNALRNI-RHRNLIKIITICSSID  100 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~  100 (331)
                      ++|.+.+.||+|+||.||+|.+.       .....+|+|.+.... ......+..|+.+++.+ .||||+++++++.   
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~---   88 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT---   88 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc---
Confidence            57999999999999999999763       234578999886432 33456688999999999 5999999999853   


Q ss_pred             CCCcceeeEEEeecCCCCHHHHHHhcc--------------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCC
Q 046639          101 FEGFDFKAIVFEYMQNRNLEQWLRQSN--------------GQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPS  166 (331)
Q Consensus       101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~  166 (331)
                        .....+++|||+++++|.+++....              ...+++..+..++.|++.||.|||++   |++|+||||+
T Consensus        89 --~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~  163 (314)
T cd05099          89 --QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAAR  163 (314)
T ss_pred             --cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeeccccce
Confidence              3456899999999999999997632              23467788889999999999999999   9999999999


Q ss_pred             CEEecCCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCC
Q 046639          167 NILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPT  245 (331)
Q Consensus       167 nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf  245 (331)
                      ||+++.++.++|+|||.++.......      ........++..|+|||++.+..++.++||||||+++|+|++ |..||
T Consensus       164 Nill~~~~~~kL~Dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~  237 (314)
T cd05099         164 NVLVTEDNVMKIADFGLARGVHDIDY------YKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPY  237 (314)
T ss_pred             eEEEcCCCcEEEcccccccccccccc------ccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCC
Confidence            99999999999999999976521110      001111123456999999988889999999999999999999 88998


Q ss_pred             CcccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhh
Q 046639          246 DAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARET  325 (331)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~  325 (331)
                      .....  ..........   ..                ......++..+.+++.+||+.+|++|||+.++++.|+.+...
T Consensus       238 ~~~~~--~~~~~~~~~~---~~----------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~  296 (314)
T cd05099         238 PGIPV--EELFKLLREG---HR----------------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA  296 (314)
T ss_pred             CCCCH--HHHHHHHHcC---CC----------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence            65321  1111111100   00                011123456788999999999999999999999999999876


Q ss_pred             hhc
Q 046639          326 FLG  328 (331)
Q Consensus       326 ~~~  328 (331)
                      +.+
T Consensus       297 ~~~  299 (314)
T cd05099         297 VSE  299 (314)
T ss_pred             hcC
Confidence            544

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1e-40  Score=289.96  Aligned_cols=250  Identities=21%  Similarity=0.262  Sum_probs=197.4

Q ss_pred             CCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeEEE
Q 046639           32 FSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVF  111 (331)
Q Consensus        32 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~  111 (331)
                      |.+.+.||+|+||.||+|.+..++..+++|.+..........+.+|+.+++.+.|+|++++++++.     ..+..++|+
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-----~~~~~~~v~   81 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY-----YENNLWILI   81 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEe-----eCCEEEEEE
Confidence            778899999999999999999999999999987666666677889999999999999999999853     346789999


Q ss_pred             eecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccccCC
Q 046639          112 EYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYE  191 (331)
Q Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~~  191 (331)
                      ||+++++|..++... ...+++..+..++.|++.||.+||+.   +++|+||+|+||+++.++.++|+|||++...... 
T Consensus        82 e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~-  156 (282)
T cd06643          82 EFCAGGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-  156 (282)
T ss_pred             EecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccc-
Confidence            999999999887643 23577888999999999999999999   9999999999999999999999999998754211 


Q ss_pred             CCCcccccCCceeecccccccCCcccC-----CCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcch
Q 046639          192 PGTAAETASNSIEIKGIVGYVAPEYGM-----GSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDK  266 (331)
Q Consensus       192 ~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  266 (331)
                             ........+++.|+|||++.     +..++.++||||+|+++|+|++|..||....... .........    
T Consensus       157 -------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~~~~~~~----  224 (282)
T cd06643         157 -------IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR-VLLKIAKSE----  224 (282)
T ss_pred             -------ccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH-HHHHHhhcC----
Confidence                   11122345788899999974     3457889999999999999999999997532111 111111100    


Q ss_pred             hhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          267 VMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                           .+..         .....++..+.+++.+||+.+|.+|||+.++++
T Consensus       225 -----~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         225 -----PPTL---------AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             -----CCCC---------CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                 0000         011124567889999999999999999999874

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=3.2e-40  Score=282.88  Aligned_cols=251  Identities=21%  Similarity=0.296  Sum_probs=201.0

Q ss_pred             CCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           31 NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ--KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      .|.+.+.||.|++|.||++.+..+++.+|+|.+....  ....+.+.+|+.++++++|+|++++.+.+.    .....++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~~   76 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWE----GEDGLLY   76 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeec----CCCCEEE
Confidence            4889999999999999999999889999999986432  234456889999999999999999988742    2345679


Q ss_pred             EEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccc
Q 046639          109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLF  188 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~  188 (331)
                      +++|++++++|.+++.......+++..+..++.+++.|+.+||+.   +++|+||+|+||+++.++.++|+|||++....
T Consensus        77 lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~  153 (257)
T cd08223          77 IVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLE  153 (257)
T ss_pred             EEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEec
Confidence            999999999999999876556678899999999999999999999   99999999999999999999999999987652


Q ss_pred             cCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhh
Q 046639          189 GYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVM  268 (331)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  268 (331)
                      ...        .......+++.|+|||+..+..++.++||||||+++++|++|..||....... ..........     
T Consensus       154 ~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~-~~~~~~~~~~-----  219 (257)
T cd08223         154 NQC--------DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS-LVYRIIEGKL-----  219 (257)
T ss_pred             ccC--------CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHhcCC-----
Confidence            211        11223447888999999999899999999999999999999999996432110 1111111100     


Q ss_pred             hhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          269 EIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                          +           .........+.+++.+||+.+|++|||+.++++
T Consensus       220 ----~-----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         220 ----P-----------PMPKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             ----C-----------CCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                0           111234567889999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.4e-40  Score=289.73  Aligned_cols=268  Identities=19%  Similarity=0.243  Sum_probs=205.7

Q ss_pred             ccHHHHHHHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcC-CCCCcceeeceeec
Q 046639           20 ISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNI-RHRNLIKIITICSS   98 (331)
Q Consensus        20 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~   98 (331)
                      +.+..+....++|.+.+.||+|+||.||+|.+..+++.+|+|++.... .....+.+|+.+++.+ +|+|++++++++..
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   86 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK   86 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence            344555567889999999999999999999999899999999875432 2235577899999999 69999999998765


Q ss_pred             ccCCCcceeeEEEeecCCCCHHHHHHh--ccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcE
Q 046639           99 IDFEGFDFKAIVFEYMQNRNLEQWLRQ--SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVA  176 (331)
Q Consensus        99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~  176 (331)
                      .....++..++||||+++++|.+++..  .....+++..+..++.|++.||.+||+.   +++|+||||+||+++.++.+
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~  163 (286)
T cd06638          87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGV  163 (286)
T ss_pred             cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCE
Confidence            444556778999999999999998864  2234567788889999999999999999   99999999999999999999


Q ss_pred             EEcccCcccccccCCCCCcccccCCceeecccccccCCcccCC-----CCCccchhhHhHHHHHHHHHhCCCCCCcccCC
Q 046639          177 HVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG-----SKASVSGDVYNFGILLLEMFTRRRPTDAMFNE  251 (331)
Q Consensus       177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~g~~pf~~~~~~  251 (331)
                      +|+|||++......        ........+++.|+|||++..     ..++.++||||+|+++|+|++|..||......
T Consensus       164 kl~dfg~~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~  235 (286)
T cd06638         164 KLVDFGVSAQLTST--------RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM  235 (286)
T ss_pred             EEccCCceeecccC--------CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh
Confidence            99999998765211        111223357888999998753     45788999999999999999999998653211


Q ss_pred             cchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHH
Q 046639          252 GLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAK  318 (331)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~  318 (331)
                          ...... ...     ..+..         .....+...+.+++.+||+.+|++|||+.+|++.
T Consensus       236 ----~~~~~~-~~~-----~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         236 ----RALFKI-PRN-----PPPTL---------HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             ----HHHhhc-ccc-----CCCcc---------cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence                111100 000     00000         0011234568899999999999999999999864

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.3e-40  Score=290.74  Aligned_cols=252  Identities=21%  Similarity=0.261  Sum_probs=199.6

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeE
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAI  109 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~l  109 (331)
                      +.|.+++.||.|+||.||+|.+..++..+++|.+..........+..|+.+++.++|+|++++++.+.     ..+..++
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   86 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY-----WDGKLWI   86 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEE-----eCCeEEE
Confidence            57999999999999999999999999999999998776666778899999999999999999999853     3467899


Q ss_pred             EEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccccc
Q 046639          110 VFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG  189 (331)
Q Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~  189 (331)
                      ||||+++++|..++.+.. ..+++..+..++.|++.++.+||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        87 v~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  162 (292)
T cd06644          87 MIEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK  162 (292)
T ss_pred             EEecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccc
Confidence            999999999988876533 3467889999999999999999999   999999999999999999999999998865311


Q ss_pred             CCCCCcccccCCceeecccccccCCcccC-----CCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCc
Q 046639          190 YEPGTAAETASNSIEIKGIVGYVAPEYGM-----GSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALP  264 (331)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  264 (331)
                              .........+++.|+|||++.     ...++.++||||||+++|+|++|..||...... ........   .
T Consensus       163 --------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-~~~~~~~~---~  230 (292)
T cd06644         163 --------TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-RVLLKIAK---S  230 (292)
T ss_pred             --------cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH-HHHHHHhc---C
Confidence                    111222345778899999974     345688999999999999999999998653211 11111100   0


Q ss_pred             chhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          265 DKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                            ..+..         .....+...+.+++.+||+.+|++||++.++++
T Consensus       231 ------~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         231 ------EPPTL---------SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             ------CCccC---------CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence                  00000         011234556889999999999999999999975

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=6.3e-41  Score=291.43  Aligned_cols=257  Identities=22%  Similarity=0.357  Sum_probs=198.8

Q ss_pred             cCCCcCceeeccCeeEEEEeeecC-----CCceEEEEEeeccch-hhHHHHHHHHHHHHcCCCCCcceeeceeecccCCC
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDE-----SRSIVAVKVVNLKQK-EASRSFAAECNALRNIRHRNLIKIITICSSIDFEG  103 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  103 (331)
                      .+|.+.+.||+|+||+||+|.+..     .+..||+|.+..... .....+..|+.++..++||||+++++++     ..
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~-----~~   79 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVV-----TK   79 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEE-----cC
Confidence            358888999999999999998754     357899999875433 3346688999999999999999999985     44


Q ss_pred             cceeeEEEeecCCCCHHHHHHhcc--------------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEE
Q 046639          104 FDFKAIVFEYMQNRNLEQWLRQSN--------------GQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNIL  169 (331)
Q Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nil  169 (331)
                      ....++++|++.+++|.+++....              ...+++..+..++.|++.||.+||+.   +++|+||||+||+
T Consensus        80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil  156 (283)
T cd05091          80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVL  156 (283)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheE
Confidence            456899999999999999985321              22466777889999999999999999   9999999999999


Q ss_pred             ecCCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcc
Q 046639          170 LDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAM  248 (331)
Q Consensus       170 v~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~  248 (331)
                      +++++.+||+|||+++......      .........+++.|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus       157 ~~~~~~~kl~Dfg~~~~~~~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~  230 (283)
T cd05091         157 VFDKLNVKISDLGLFREVYAAD------YYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY  230 (283)
T ss_pred             ecCCCceEecccccccccccch------heeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Confidence            9999999999999987642111      0111122334677999999988889999999999999999998 88888653


Q ss_pred             cCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHH
Q 046639          249 FNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRH  321 (331)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~  321 (331)
                      ..     ............                .....+++..+.+++.+||+.+|++||++.+|++.|+.
T Consensus       231 ~~-----~~~~~~i~~~~~----------------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         231 SN-----QDVIEMIRNRQV----------------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             CH-----HHHHHHHHcCCc----------------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            21     111111111000                01123466778999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.8e-40  Score=291.49  Aligned_cols=267  Identities=20%  Similarity=0.328  Sum_probs=204.8

Q ss_pred             HHhcCCCcCceeeccCeeEEEEeeec-------CCCceEEEEEeeccc-hhhHHHHHHHHHHHHcC-CCCCcceeeceee
Q 046639           27 KATNNFSPANKIGQGGVSIVYKGILD-------ESRSIVAVKVVNLKQ-KEASRSFAAECNALRNI-RHRNLIKIITICS   97 (331)
Q Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~   97 (331)
                      ....+|.+.+.||+|+||.||+|++.       ..+..+|+|.+.... ......+.+|+.+++.+ +||||+++++++.
T Consensus        12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   91 (304)
T cd05101          12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT   91 (304)
T ss_pred             ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence            33557999999999999999999753       234579999886432 33456788999999999 7999999999853


Q ss_pred             cccCCCcceeeEEEeecCCCCHHHHHHhcc--------------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCC
Q 046639           98 SIDFEGFDFKAIVFEYMQNRNLEQWLRQSN--------------GQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDL  163 (331)
Q Consensus        98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~di  163 (331)
                           .....+++|||+++++|.+++....              ...+++..+..++.|++.||.|||++   +++|+||
T Consensus        92 -----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dl  163 (304)
T cd05101          92 -----QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDL  163 (304)
T ss_pred             -----cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeeccc
Confidence                 4467899999999999999997642              13456777889999999999999999   9999999


Q ss_pred             CCCCEEecCCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CC
Q 046639          164 KPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RR  242 (331)
Q Consensus       164 k~~nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~  242 (331)
                      ||+||+++.++.++|+|||++........      ........++..|+|||++.+..++.++||||||+++|+|++ |.
T Consensus       164 kp~Nili~~~~~~kl~D~g~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~  237 (304)
T cd05101         164 AARNVLVTENNVMKIADFGLARDVNNIDY------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG  237 (304)
T ss_pred             ccceEEEcCCCcEEECCCccceecccccc------cccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCC
Confidence            99999999999999999999876521111      011112234567999999988889999999999999999998 78


Q ss_pred             CCCCcccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHh
Q 046639          243 RPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHA  322 (331)
Q Consensus       243 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~  322 (331)
                      .||....     ............     .    .       .....++..+.+++.+||+.+|.+|||+.+|++.|+++
T Consensus       238 ~p~~~~~-----~~~~~~~~~~~~-----~----~-------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~  296 (304)
T cd05101         238 SPYPGIP-----VEELFKLLKEGH-----R----M-------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRI  296 (304)
T ss_pred             CCcccCC-----HHHHHHHHHcCC-----c----C-------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHH
Confidence            8886432     111111110000     0    0       11124567899999999999999999999999999988


Q ss_pred             hhhhhc
Q 046639          323 RETFLG  328 (331)
Q Consensus       323 ~~~~~~  328 (331)
                      ...-.+
T Consensus       297 ~~~~~~  302 (304)
T cd05101         297 LTLTTN  302 (304)
T ss_pred             HHhhhc
Confidence            765443

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2e-40  Score=285.93  Aligned_cols=259  Identities=25%  Similarity=0.372  Sum_probs=200.5

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCc---eEEEEEeecc-chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCc
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRS---IVAVKVVNLK-QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGF  104 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  104 (331)
                      .++|+..+.||+|++|.||+|.+..++.   .+++|.+... .......+..|+.+++.++|+|++++.+++     ...
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~   78 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVV-----TKF   78 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----ccC
Confidence            3478899999999999999999865443   7999988644 233456788999999999999999999985     445


Q ss_pred             ceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcc
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA  184 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a  184 (331)
                      +..++|||++++++|.+++.... ..+++.....++.|++.|+.+||+.   +++|+||||+||+++.++.++|+|||++
T Consensus        79 ~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~  154 (268)
T cd05063          79 KPAMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLS  154 (268)
T ss_pred             CCcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccc
Confidence            67899999999999999997543 3467788899999999999999999   9999999999999999999999999998


Q ss_pred             cccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhC
Q 046639          185 KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMAL  263 (331)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~  263 (331)
                      .........     .........+..|+|||++.+..++.++||||||+++|+|++ |..||.....  ...........
T Consensus       155 ~~~~~~~~~-----~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~--~~~~~~i~~~~  227 (268)
T cd05063         155 RVLEDDPEG-----TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN--HEVMKAINDGF  227 (268)
T ss_pred             eeccccccc-----ceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH--HHHHHHHhcCC
Confidence            765221110     000111112346999999988889999999999999999997 9999964321  11111111000


Q ss_pred             cchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHh
Q 046639          264 PDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHA  322 (331)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~  322 (331)
                             ..            ....+++..+.+++.+||+.+|++||++.+|++.|+++
T Consensus       228 -------~~------------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         228 -------RL------------PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             -------CC------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                   00            11123566789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1e-40  Score=301.91  Aligned_cols=261  Identities=19%  Similarity=0.255  Sum_probs=200.3

Q ss_pred             hcCCCcCceeeccCeeEEEEeeec-----CCCceEEEEEeeccc-hhhHHHHHHHHHHHHcCC-CCCcceeeceeecccC
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILD-----ESRSIVAVKVVNLKQ-KEASRSFAAECNALRNIR-HRNLIKIITICSSIDF  101 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~  101 (331)
                      .++|.+++.||+|+||.||+|++.     .+++.||+|+++... ....+.+..|+.++..+. ||||++++++|.    
T Consensus        36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~----  111 (401)
T cd05107          36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT----  111 (401)
T ss_pred             HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc----
Confidence            346899999999999999999864     345689999997543 233456889999999997 999999999864    


Q ss_pred             CCcceeeEEEeecCCCCHHHHHHhccC-----------------------------------------------------
Q 046639          102 EGFDFKAIVFEYMQNRNLEQWLRQSNG-----------------------------------------------------  128 (331)
Q Consensus       102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-----------------------------------------------------  128 (331)
                       .....++||||+++|+|.+++.+...                                                     
T Consensus       112 -~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (401)
T cd05107         112 -KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV  190 (401)
T ss_pred             -cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence             34578999999999999999975321                                                     


Q ss_pred             -------------------------------------------CccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCC
Q 046639          129 -------------------------------------------QLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKP  165 (331)
Q Consensus       129 -------------------------------------------~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~  165 (331)
                                                                 ..+++.....++.|++.||.|||+.   +++|+||||
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp  267 (401)
T cd05107         191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAA  267 (401)
T ss_pred             chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCc
Confidence                                                       1245566778999999999999999   999999999


Q ss_pred             CCEEecCCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCC
Q 046639          166 SNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRP  244 (331)
Q Consensus       166 ~nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p  244 (331)
                      +||+++.++.++|+|||+++.......      ........++..|+|||.+.+..++.++||||||+++|||++ |..|
T Consensus       268 ~NiLl~~~~~~kL~DfGla~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P  341 (401)
T cd05107         268 RNVLICEGKLVKICDFGLARDIMRDSN------YISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTP  341 (401)
T ss_pred             ceEEEeCCCEEEEEecCcceecccccc------cccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCC
Confidence            999999999999999999876421110      011112335677999999998889999999999999999998 8899


Q ss_pred             CCcccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhh
Q 046639          245 TDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHAR  323 (331)
Q Consensus       245 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~  323 (331)
                      |.......... .......        .+           ..+..+...+.+|+.+||+.+|.+||++.+|++.|+.+.
T Consensus       342 ~~~~~~~~~~~-~~~~~~~--------~~-----------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         342 YPELPMNEQFY-NAIKRGY--------RM-----------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             CCCCCchHHHH-HHHHcCC--------CC-----------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            86542221111 1111000        00           011124568899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=7.5e-41  Score=292.92  Aligned_cols=253  Identities=20%  Similarity=0.233  Sum_probs=202.0

Q ss_pred             HHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           27 KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      ....+|.+.+.||+|++|.||+|.+..++..||+|.+........+.+.+|+.+++.++|+|++++++++     .....
T Consensus        16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~   90 (297)
T cd06656          16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY-----LVGDE   90 (297)
T ss_pred             ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCCE
Confidence            3446899999999999999999999889999999999765555556788999999999999999999985     44567


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      .++||||+++++|.+++.+.   .++...+..++.|++.||.+||+.   +++|+||+|+||+++.++.++|+|||++..
T Consensus        91 ~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~  164 (297)
T cd06656          91 LWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQ  164 (297)
T ss_pred             EEEeecccCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceE
Confidence            89999999999999998653   356778889999999999999999   999999999999999999999999998875


Q ss_pred             cccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcch
Q 046639          187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDK  266 (331)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  266 (331)
                      ....        ........+++.|+|||.+.+..++.++|+||||+++|+|++|..||........... ....     
T Consensus       165 ~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~-~~~~-----  230 (297)
T cd06656         165 ITPE--------QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-IATN-----  230 (297)
T ss_pred             ccCC--------ccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee-eccC-----
Confidence            4111        1111233577889999999998899999999999999999999999965322111000 0000     


Q ss_pred             hhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          267 VMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                          ..+.         ..........+.+++.+||+.+|++|||+.+|++
T Consensus       231 ----~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         231 ----GTPE---------LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             ----CCCC---------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                0000         0111234566888999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1e-40  Score=291.88  Aligned_cols=250  Identities=19%  Similarity=0.241  Sum_probs=200.8

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeE
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAI  109 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~l  109 (331)
                      .+|.+.+.||.|++|.||+|.+..+++.|++|.+..........+.+|+.+++.++|+|++++++++     ......++
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~l   93 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSF-----LVGDELFV   93 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeE-----ecCceEEE
Confidence            4699999999999999999999889999999999766555567788999999999999999999985     44567899


Q ss_pred             EEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccccc
Q 046639          110 VFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG  189 (331)
Q Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~  189 (331)
                      |+|++++++|.+++...   .+++..+..++.|++.|+++||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        94 v~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~  167 (296)
T cd06655          94 VMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP  167 (296)
T ss_pred             EEEecCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence            99999999999998653   367889999999999999999999   999999999999999999999999998875421


Q ss_pred             CCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhh
Q 046639          190 YEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVME  269 (331)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  269 (331)
                      .        ........+++.|+|||.+.+..++.++||||||+++|+|++|..||........ ...... ....    
T Consensus       168 ~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~-~~~~~~-~~~~----  233 (296)
T cd06655         168 E--------QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LYLIAT-NGTP----  233 (296)
T ss_pred             c--------cccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHh-cCCc----
Confidence            1        1111223477889999999988899999999999999999999999965321110 111000 0000    


Q ss_pred             hcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          270 IVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                          .+         .....+...+.+++.+||..+|.+|||+.+|++
T Consensus       234 ----~~---------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         234 ----EL---------QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             ----cc---------CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                00         111234567889999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.4e-40  Score=285.62  Aligned_cols=254  Identities=22%  Similarity=0.385  Sum_probs=200.5

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      .++|.+.++||+|+||.||+|... +++.||+|.+..... ....+.+|+.+++.++|+|++++++++.      .+..+
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~   76 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT------QEPIY   76 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc------cCCcE
Confidence            457999999999999999999875 567899998864332 3456889999999999999999998742      24579


Q ss_pred             EEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccc
Q 046639          109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLF  188 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~  188 (331)
                      ++||++++++|.+++....+..++......++.|++.||.+||+.   +++|+||+|+||+++.++.++|+|||++....
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  153 (260)
T cd05067          77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIE  153 (260)
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecC
Confidence            999999999999999776656678888999999999999999999   99999999999999999999999999987652


Q ss_pred             cCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhCcchh
Q 046639          189 GYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMALPDKV  267 (331)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  267 (331)
                      ..       .........++..|+|||++.+..++.++||||||+++|+|++ |..||.....  ............   
T Consensus       154 ~~-------~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~~---  221 (260)
T cd05067         154 DN-------EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN--PEVIQNLERGYR---  221 (260)
T ss_pred             CC-------CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh--HHHHHHHHcCCC---
Confidence            11       0011112234567999999998889999999999999999998 9999975421  111111111000   


Q ss_pred             hhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHH
Q 046639          268 MEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRH  321 (331)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~  321 (331)
                           .           .....++.++.+++.+||+.+|++|||+.+++..|+.
T Consensus       222 -----~-----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         222 -----M-----------PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             -----C-----------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence                 0           0011235679999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=9e-41  Score=321.10  Aligned_cols=258  Identities=20%  Similarity=0.273  Sum_probs=199.3

Q ss_pred             HHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc--chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCc
Q 046639           27 KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGF  104 (331)
Q Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  104 (331)
                      ...++|.+++.||.|+||+||+|.+..++..+|+|.+...  .......+..|+.+++.+.||||+++++++..   ...
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d---e~~   86 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLN---KAN   86 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEe---cCC
Confidence            4456899999999999999999999999999999998643  23345678899999999999999999998643   234


Q ss_pred             ceeeEEEeecCCCCHHHHHHhc--cCCccchHHHHHHHHHHHHHHHHHhhcCC----CCeeecCCCCCCEEecC------
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQS--NGQLRFLTQRVNIAIDVSFAIEYFHHHCQ----PSIVHGDLKPSNILLDQ------  172 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~~----~~ivH~dik~~nilv~~------  172 (331)
                      ..+++||||+++++|.+++...  ....+++..++.++.||+.||.|||+...    .+|+|+||||+|||++.      
T Consensus        87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg  166 (1021)
T PTZ00266         87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG  166 (1021)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence            5689999999999999999753  23457889999999999999999998510    15999999999999964      


Q ss_pred             -----------CCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCC--CCCccchhhHhHHHHHHHHH
Q 046639          173 -----------DIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG--SKASVSGDVYNFGILLLEMF  239 (331)
Q Consensus       173 -----------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~el~  239 (331)
                                 .+.+||+|||++..+..         ........||+.|+|||++.+  ..++.++||||||||||+|+
T Consensus       167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~---------~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELL  237 (1021)
T PTZ00266        167 KITAQANNLNGRPIAKIGDFGLSKNIGI---------ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC  237 (1021)
T ss_pred             cccccccccCCCCceEEccCCccccccc---------cccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHH
Confidence                       34589999999976411         111223468999999999864  45889999999999999999


Q ss_pred             hCCCCCCcccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          240 TRRRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       240 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      +|..||.....    ...........       +.+.          ....+..+.+|+..||+.+|.+|||+.+++.
T Consensus       238 TGk~PF~~~~~----~~qli~~lk~~-------p~lp----------i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        238 SGKTPFHKANN----FSQLISELKRG-------PDLP----------IKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             HCCCCCCcCCc----HHHHHHHHhcC-------CCCC----------cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            99999964321    11111110000       0000          0123467889999999999999999999983

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.8e-40  Score=288.03  Aligned_cols=250  Identities=22%  Similarity=0.291  Sum_probs=195.0

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc-chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK-QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      ++|.+.+.||+|++|.||+|.+..++..||+|.+... .......+.+|+.++++++|||++++++.+.     ..+..+
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~   75 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFF-----VENRIS   75 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEE-----ECCEEE
Confidence            3688899999999999999999999999999998644 2334466889999999999999999999964     345678


Q ss_pred             EEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccc
Q 046639          109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLF  188 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~  188 (331)
                      +|||++++++|..+.      .++...+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++....
T Consensus        76 lv~e~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~  146 (279)
T cd06619          76 ICTEFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV  146 (279)
T ss_pred             EEEecCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecc
Confidence            999999999987553      245677889999999999999999   99999999999999999999999999987541


Q ss_pred             cCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchH--HHHHHhhCcch
Q 046639          189 GYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTL--HEFVKMALPDK  266 (331)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~--~~~~~~~~~~~  266 (331)
                      .          .......++..|+|||++.+..++.++|+||||+++|+|++|..||..........  .........  
T Consensus       147 ~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--  214 (279)
T cd06619         147 N----------SIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVD--  214 (279)
T ss_pred             c----------ccccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhc--
Confidence            1          11223457888999999999889999999999999999999999997543221111  011100000  


Q ss_pred             hhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHH
Q 046639          267 VMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAK  318 (331)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~  318 (331)
                         ...+...          .......+.+++.+||+.+|++||++.++++.
T Consensus       215 ---~~~~~~~----------~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         215 ---EDPPVLP----------VGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             ---cCCCCCC----------CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence               0000000          01134568899999999999999999999753

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-40  Score=285.23  Aligned_cols=256  Identities=25%  Similarity=0.405  Sum_probs=201.7

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCccee
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      ..++|.+.+.||+|++|.||+|.+. ++..+|+|.+.... .....+.+|+.+++.++|+|++++++++     ......
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~   76 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVC-----SEEEPI   76 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeee-----ecCCce
Confidence            3568999999999999999999976 45679999886433 3346688999999999999999999984     444668


Q ss_pred             eEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccc
Q 046639          108 AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      +++||++++++|.+++....+..+++..+..++.+++.|+.+||++   +++|+||+|+||+++.++.++|+|||++...
T Consensus        77 ~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~  153 (261)
T cd05034          77 YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLI  153 (261)
T ss_pred             EEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceec
Confidence            9999999999999999876656678889999999999999999999   9999999999999999999999999998765


Q ss_pred             ccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhCcch
Q 046639          188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMALPDK  266 (331)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~  266 (331)
                      ...       ..........+..|+|||.+.+..++.++|+||||+++++|++ |..||.....  ............  
T Consensus       154 ~~~-------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~--~~~~~~~~~~~~--  222 (261)
T cd05034         154 EDD-------EYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN--REVLEQVERGYR--  222 (261)
T ss_pred             cch-------hhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCC--
Confidence            210       0011111223457999999998889999999999999999998 9999965321  111111110000  


Q ss_pred             hhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHH
Q 046639          267 VMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRH  321 (331)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~  321 (331)
                            .           .....++..+.+++.+||+.+|++||++.++.+.|+.
T Consensus       223 ------~-----------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         223 ------M-----------PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             ------C-----------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence                  0           0011235678999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=2.5e-40  Score=289.55  Aligned_cols=264  Identities=20%  Similarity=0.325  Sum_probs=196.6

Q ss_pred             cCCCcCceeeccCeeEEEEeeec----------------CCCceEEEEEeecc-chhhHHHHHHHHHHHHcCCCCCccee
Q 046639           30 NNFSPANKIGQGGVSIVYKGILD----------------ESRSIVAVKVVNLK-QKEASRSFAAECNALRNIRHRNLIKI   92 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~----------------~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~   92 (331)
                      ++|++.+.||+|+||.||++.+.                .+...+|+|.+... .......+.+|+.+++.++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            57999999999999999998643                23456899998644 23345678899999999999999999


Q ss_pred             eceeecccCCCcceeeEEEeecCCCCHHHHHHhccC---------CccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCC
Q 046639           93 ITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNG---------QLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDL  163 (331)
Q Consensus        93 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~di  163 (331)
                      ++++     ......+++||++++++|.+++.....         ..+++..+..++.|++.||++||+.   +++|+||
T Consensus        85 ~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl  156 (296)
T cd05095          85 LAVC-----ITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDL  156 (296)
T ss_pred             EEEE-----ecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccC
Confidence            9985     334568999999999999999976332         2355677899999999999999999   9999999


Q ss_pred             CCCCEEecCCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh--C
Q 046639          164 KPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT--R  241 (331)
Q Consensus       164 k~~nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~--g  241 (331)
                      ||+||+++.++.++|+|||++..+....      .........++..|+|||...++.++.++||||||+++|||++  |
T Consensus       157 kp~Nili~~~~~~~l~dfg~~~~~~~~~------~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~  230 (296)
T cd05095         157 ATRNCLVGKNYTIKIADFGMSRNLYSGD------YYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCK  230 (296)
T ss_pred             ChheEEEcCCCCEEeccCcccccccCCc------ceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCC
Confidence            9999999999999999999987542111      0011111223567999999888889999999999999999998  7


Q ss_pred             CCCCCcccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHH
Q 046639          242 RRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRH  321 (331)
Q Consensus       242 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~  321 (331)
                      ..||........ .... .......    ......        .....++..+.+|+.+||+.||.+|||+.+|++.|++
T Consensus       231 ~~p~~~~~~~~~-~~~~-~~~~~~~----~~~~~~--------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         231 EQPYSQLSDEQV-IENT-GEFFRDQ----GRQVYL--------PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             CCCccccChHHH-HHHH-HHHHhhc----cccccC--------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            788864322111 1000 0000000    000000        0112355789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.2e-40  Score=285.58  Aligned_cols=259  Identities=25%  Similarity=0.348  Sum_probs=200.2

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCC---ceEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCc
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESR---SIVAVKVVNLKQ-KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGF  104 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  104 (331)
                      .++|++.+.||+|+||.||+|.+..++   ..+|+|.++... ......+.+|+.+++.++||||+++++++     ...
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~   77 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TKS   77 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecC
Confidence            357999999999999999999886433   379999886432 33456789999999999999999999985     445


Q ss_pred             ceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcc
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA  184 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a  184 (331)
                      +..++|||++++++|.+++..... .+++..+..++.|++.|+++||++   +++|+||||+||+++.++.++|+|||++
T Consensus        78 ~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~  153 (267)
T cd05066          78 KPVMIVTEYMENGSLDAFLRKHDG-QFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLS  153 (267)
T ss_pred             CccEEEEEcCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcc
Confidence            678999999999999999976443 467788899999999999999999   9999999999999999999999999998


Q ss_pred             cccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhC
Q 046639          185 KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMAL  263 (331)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~  263 (331)
                      ..+.....     .........++..|+|||.+.+..++.++|+||||+++|++++ |..||......  ..........
T Consensus       154 ~~~~~~~~-----~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~--~~~~~~~~~~  226 (267)
T cd05066         154 RVLEDDPE-----AAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ--DVIKAIEEGY  226 (267)
T ss_pred             cccccccc-----eeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH--HHHHHHhCCC
Confidence            76522110     0001111123456999999998889999999999999999886 99998653211  1111111100


Q ss_pred             cchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHh
Q 046639          264 PDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHA  322 (331)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~  322 (331)
                              ..           .....++..+.+++.+||+.+|.+|||+.++++.|+++
T Consensus       227 --------~~-----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         227 --------RL-----------PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             --------cC-----------CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence                    00           00113456788999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.2e-40  Score=289.86  Aligned_cols=271  Identities=20%  Similarity=0.327  Sum_probs=200.9

Q ss_pred             cCCCcCceeeccCeeEEEEeee----cCCCceEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCc
Q 046639           30 NNFSPANKIGQGGVSIVYKGIL----DESRSIVAVKVVNLKQ-KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGF  104 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  104 (331)
                      +.|.+.+.||+|+||.||.|..    ..++..||+|.+.... ......+.+|+.+++.+.|||++++.+++...   +.
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~   80 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED---GG   80 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC---CC
Confidence            4689999999999999999974    4568889999986443 33446789999999999999999999986432   23


Q ss_pred             ceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcc
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA  184 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a  184 (331)
                      ...++||||+++++|.+++.+.. ..+++..+..++.|++.||.+||++   +++|+||||+||+++.++.++|+|||++
T Consensus        81 ~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~  156 (284)
T cd05079          81 NGIKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT  156 (284)
T ss_pred             CceEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccc
Confidence            56789999999999999997543 2467888999999999999999999   9999999999999999999999999998


Q ss_pred             cccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhh-C
Q 046639          185 KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMA-L  263 (331)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~-~  263 (331)
                      ........     .........++..|+|||++.+..++.++||||||+++|+|+++..|+.....   ......... .
T Consensus       157 ~~~~~~~~-----~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~---~~~~~~~~~~~  228 (284)
T cd05079         157 KAIETDKE-----YYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMT---LFLKMIGPTHG  228 (284)
T ss_pred             cccccCcc-----ceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccc---hhhhhcccccc
Confidence            76521111     00111223456679999999888899999999999999999998766432110   000000000 0


Q ss_pred             c---chhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHh
Q 046639          264 P---DKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHA  322 (331)
Q Consensus       264 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~  322 (331)
                      .   ............       .+....++..+.+|+.+||+.+|++|||+.++++.|+.+
T Consensus       229 ~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         229 QMTVTRLVRVLEEGKR-------LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             cccHHHHHHHHHcCcc-------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            0   000000000000       011123567899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2.6e-40  Score=283.56  Aligned_cols=250  Identities=24%  Similarity=0.338  Sum_probs=193.8

Q ss_pred             ceeeccCeeEEEEeee--cCCCceEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeEEE
Q 046639           36 NKIGQGGVSIVYKGIL--DESRSIVAVKVVNLKQ--KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVF  111 (331)
Q Consensus        36 ~~lg~G~~g~V~~~~~--~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~  111 (331)
                      +.||+|+||+||+|.+  ..++..+|+|+++...  ....+.+..|+.+++.+.|+||+++++++.      ....++||
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~~~~lv~   74 (257)
T cd05116           1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE------AESWMLVM   74 (257)
T ss_pred             CcCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc------CCCcEEEE
Confidence            3689999999999975  4567889999986443  334567889999999999999999999853      23468999


Q ss_pred             eecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccccCC
Q 046639          112 EYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYE  191 (331)
Q Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~~  191 (331)
                      |++++++|.+++....  .+++.....++.|++.||.+||++   +++|+||||.||+++.++.++|+|||++.......
T Consensus        75 e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~  149 (257)
T cd05116          75 ELAELGPLNKFLQKNK--HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADE  149 (257)
T ss_pred             ecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCC
Confidence            9999999999996543  467788999999999999999999   99999999999999999999999999987652111


Q ss_pred             CCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhCcchhhhh
Q 046639          192 PGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMALPDKVMEI  270 (331)
Q Consensus       192 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  270 (331)
                      .     .........++..|+|||.+....++.++|+||||+++|||++ |..||.....  ..........        
T Consensus       150 ~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~i~~~--------  214 (257)
T cd05116         150 N-----YYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG--NEVTQMIESG--------  214 (257)
T ss_pred             C-----eeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHCC--------
Confidence            1     0011111223567999999988889999999999999999998 9999975321  1111111110        


Q ss_pred             cCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHh
Q 046639          271 VDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHA  322 (331)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~  322 (331)
                          ...       +.+..++..+.+++.+||+.||++||++.+|.+.|+..
T Consensus       215 ----~~~-------~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         215 ----ERM-------ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             ----CCC-------CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence                000       11123556788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-40  Score=284.80  Aligned_cols=250  Identities=26%  Similarity=0.379  Sum_probs=195.0

Q ss_pred             CCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeEE
Q 046639           31 NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIV  110 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv  110 (331)
                      +|++.+.||+|++|.||+|.+. ++..+|+|++.... .....+.+|+.+++.++|+|++++++++     ...+..++|
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv   77 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVC-----TKQRPIFIV   77 (256)
T ss_pred             HcchhhhhccCCCceEEEeEec-CCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEE-----cCCCceEEE
Confidence            5889999999999999999886 45679999885332 2234577899999999999999999984     445678999


Q ss_pred             EeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccccC
Q 046639          111 FEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGY  190 (331)
Q Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~  190 (331)
                      ||++++++|.+++..... .+++..+..++.|++.|+++||+.   +++|+||||+||+++.++.++|+|||+++...+.
T Consensus        78 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~  153 (256)
T cd05059          78 TEYMANGCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD  153 (256)
T ss_pred             EecCCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccc
Confidence            999999999999976433 567888999999999999999999   9999999999999999999999999998764211


Q ss_pred             CCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhCcchhhh
Q 046639          191 EPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMALPDKVME  269 (331)
Q Consensus       191 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  269 (331)
                      .       ........++..|+|||.+.+..++.++||||||+++|+|++ |..||......  .........       
T Consensus       154 ~-------~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~~-------  217 (256)
T cd05059         154 Q-------YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS--EVVESVSAG-------  217 (256)
T ss_pred             c-------ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH--HHHHHHHcC-------
Confidence            0       001111123346999999998899999999999999999999 89999653221  111111100       


Q ss_pred             hcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHH
Q 046639          270 IVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKL  319 (331)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L  319 (331)
                       ...           .....++..+.+++.+||+.+|++|||+.++++.|
T Consensus       218 -~~~-----------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         218 -YRL-----------YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             -CcC-----------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence             000           01122566899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2.6e-40  Score=285.42  Aligned_cols=260  Identities=25%  Similarity=0.367  Sum_probs=200.6

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCc---eEEEEEeecc-chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcc
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRS---IVAVKVVNLK-QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFD  105 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~  105 (331)
                      ++|++.+.||+|+||.||+|.+..+++   .||+|.+... .......+..|+.+++.+.||||+++++++     ..+.
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~~~   78 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TKSR   78 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEE-----CCCC
Confidence            458899999999999999999876554   6999998654 344557799999999999999999999984     4556


Q ss_pred             eeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccc
Q 046639          106 FKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAK  185 (331)
Q Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~  185 (331)
                      ..++|||++++++|.+++.... ..+++..++.++.|++.||++||++   +++|+||+|+||+++.++.++|+|||++.
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~  154 (269)
T cd05065          79 PVMIITEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSR  154 (269)
T ss_pred             ceEEEEecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCcccc
Confidence            7899999999999999987643 3467788999999999999999999   99999999999999999999999999987


Q ss_pred             ccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhCc
Q 046639          186 FLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMALP  264 (331)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~  264 (331)
                      .........   ..........+..|+|||.+.+..++.++||||||+++||+++ |..||......  .......... 
T Consensus       155 ~~~~~~~~~---~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~--~~~~~i~~~~-  228 (269)
T cd05065         155 FLEDDTSDP---TYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--DVINAIEQDY-  228 (269)
T ss_pred             ccccCcccc---ccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH--HHHHHHHcCC-
Confidence            652211100   0000001112346999999998899999999999999999886 99998653211  1111111000 


Q ss_pred             chhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHh
Q 046639          265 DKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHA  322 (331)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~  322 (331)
                             .  .         ....+++..+.+++.+||+.+|.+||++.+|+..|+.+
T Consensus       229 -------~--~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         229 -------R--L---------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             -------c--C---------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                   0  0         11123566788999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=5e-40  Score=281.51  Aligned_cols=251  Identities=23%  Similarity=0.282  Sum_probs=203.3

Q ss_pred             CCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc--chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           31 NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      +|+..+.||.|+||.||.++...++..+++|.+...  .......+.+|+.++++++|+||+++++++     ......+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~   75 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHF-----MDDNTLL   75 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEE-----ecCCeEE
Confidence            588999999999999999999999999999998654  244456788999999999999999999995     4456789


Q ss_pred             EEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccc
Q 046639          109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLF  188 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~  188 (331)
                      ++||++++++|.+++.......++...+..++.|++.++.+||+.   +++|+||+|+||+++.++.++|+|||++....
T Consensus        76 ~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~  152 (256)
T cd08221          76 IEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILG  152 (256)
T ss_pred             EEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcc
Confidence            999999999999999876555678889999999999999999999   99999999999999999999999999987652


Q ss_pred             cCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhh
Q 046639          189 GYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVM  268 (331)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  268 (331)
                      ...        .......+++.|.|||...+..++.++||||||+++|+|++|..||...... ...........+    
T Consensus       153 ~~~--------~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-~~~~~~~~~~~~----  219 (256)
T cd08221         153 SEY--------SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL-NLVVKIVQGNYT----  219 (256)
T ss_pred             ccc--------ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHcCCCC----
Confidence            111        1223345788899999998888899999999999999999999999642111 111111110000    


Q ss_pred             hhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHH
Q 046639          269 EIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAK  318 (331)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~  318 (331)
                                      .....+...+.+++.+||+.+|++|||+.++++.
T Consensus       220 ----------------~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         220 ----------------PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             ----------------CCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence                            0112345678899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=3.8e-40  Score=284.29  Aligned_cols=257  Identities=19%  Similarity=0.269  Sum_probs=198.9

Q ss_pred             HHHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcc
Q 046639           26 SKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFD  105 (331)
Q Consensus        26 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~  105 (331)
                      ..+.+++.....||+|+||.||+|.+..++..|++|.+........+.+.+|+.+++.++|+||+++++++     ..++
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~   78 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD-----SENG   78 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeee-----ccCC
Confidence            34556666678999999999999999889999999998766666667889999999999999999999985     3456


Q ss_pred             eeeEEEeecCCCCHHHHHHhccCC-ccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecC-CCcEEEcccCc
Q 046639          106 FKAIVFEYMQNRNLEQWLRQSNGQ-LRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQ-DIVAHVGDLGL  183 (331)
Q Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~-~~~~kl~Dfg~  183 (331)
                      ..++++|++++++|.+++...... ..+...+..++.|++.|+++||+.   +++|+||+|+||+++. ++.++|+|||.
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~  155 (268)
T cd06624          79 FFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGT  155 (268)
T ss_pred             EEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchh
Confidence            789999999999999999764221 125677888999999999999999   9999999999999976 67999999999


Q ss_pred             ccccccCCCCCcccccCCceeecccccccCCcccCCCC--CccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHh
Q 046639          184 AKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSK--ASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKM  261 (331)
Q Consensus       184 a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  261 (331)
                      +.......        .......+++.|+|||++.+..  ++.++||||+|+++|+|++|..||.............   
T Consensus       156 ~~~~~~~~--------~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~---  224 (268)
T cd06624         156 SKRLAGIN--------PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKV---  224 (268)
T ss_pred             heecccCC--------CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhh---
Confidence            87542111        1112234778899999986643  7889999999999999999999996532211111000   


Q ss_pred             hCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          262 ALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ....     ..           ...+..+...+.+++.+||+.+|.+|||+.+|++
T Consensus       225 ~~~~-----~~-----------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         225 GMFK-----IH-----------PEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             hhhc-----cC-----------CCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence            0000     00           0112235567889999999999999999999975

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=2.2e-40  Score=289.81  Aligned_cols=264  Identities=20%  Similarity=0.333  Sum_probs=199.7

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCC----------------ceEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCcce
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESR----------------SIVAVKVVNLKQ-KEASRSFAAECNALRNIRHRNLIK   91 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----------------~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~   91 (331)
                      ..+|.+.+.||+|+||.||+|.+..++                ..||+|.+.... ......+.+|+.+++.++|||+++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            457999999999999999998875433                568999986443 344567889999999999999999


Q ss_pred             eeceeecccCCCcceeeEEEeecCCCCHHHHHHhcc---------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecC
Q 046639           92 IITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSN---------GQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGD  162 (331)
Q Consensus        92 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~d  162 (331)
                      +++++.     .+...++++|++++++|.+++....         ...+++..++.++.|++.||++||+.   +++|+|
T Consensus        84 ~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~d  155 (296)
T cd05051          84 LLGVCT-----VDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRD  155 (296)
T ss_pred             EEEEEe-----cCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccc
Confidence            999853     3467899999999999999997643         12567888999999999999999999   999999


Q ss_pred             CCCCCEEecCCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh--
Q 046639          163 LKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT--  240 (331)
Q Consensus       163 ik~~nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~--  240 (331)
                      |||+||+++.++.++|+|||++.......      .........++..|+|||.+.+..++.++||||||+++|+|++  
T Consensus       156 lkp~Nili~~~~~~~l~dfg~~~~~~~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~  229 (296)
T cd05051         156 LATRNCLVGKNYTIKIADFGMSRNLYSSD------YYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLC  229 (296)
T ss_pred             cchhceeecCCCceEEccccceeecccCc------ceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcC
Confidence            99999999999999999999987542111      0111122335667999999988889999999999999999998  


Q ss_pred             CCCCCCcccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHH
Q 046639          241 RRRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLR  320 (331)
Q Consensus       241 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~  320 (331)
                      |..||...... ..+..........      ......       .....++..+.+++.+||+.+|.+|||+.+|++.|.
T Consensus       230 ~~~p~~~~~~~-~~~~~~~~~~~~~------~~~~~~-------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         230 REQPYEHLTDQ-QVIENAGHFFRDD------GRQIYL-------PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             CCCCCCCcChH-HHHHHHHhccccc------cccccC-------CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            67777543211 1111111100000      000000       011234567999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=3.5e-40  Score=282.75  Aligned_cols=250  Identities=22%  Similarity=0.348  Sum_probs=193.2

Q ss_pred             eeeccCeeEEEEeeec--CCCceEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeEEEee
Q 046639           37 KIGQGGVSIVYKGILD--ESRSIVAVKVVNLKQ-KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEY  113 (331)
Q Consensus        37 ~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~e~  113 (331)
                      .||+|+||.||+|.+.  .++..||+|++.... ....+.+.+|+.++++++|+||+++++++..      ...++||||
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~------~~~~lv~e~   75 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA------EALMLVMEM   75 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC------CCeEEEEEe
Confidence            4899999999999875  345579999986543 3334668899999999999999999998632      357899999


Q ss_pred             cCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccccCCCC
Q 046639          114 MQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPG  193 (331)
Q Consensus       114 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~~~~  193 (331)
                      +++++|.+++.... ..+++..++.++.|++.||.+||++   +++|+||||+||+++.++.++|+|||++........ 
T Consensus        76 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~-  150 (257)
T cd05115          76 ASGGPLNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDS-  150 (257)
T ss_pred             CCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCcc-
Confidence            99999999986532 3567889999999999999999999   999999999999999999999999999875421111 


Q ss_pred             CcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhCcchhhhhcC
Q 046639          194 TAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMALPDKVMEIVD  272 (331)
Q Consensus       194 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (331)
                          .........++..|+|||.+.+..++.++||||||+++|++++ |..||......  .....+....         
T Consensus       151 ----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~---------  215 (257)
T cd05115         151 ----YYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP--EVMSFIEQGK---------  215 (257)
T ss_pred             ----ceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHHHCCC---------
Confidence                0001111123467999999988889999999999999999996 99999754221  1111111100         


Q ss_pred             cccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHh
Q 046639          273 PSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHA  322 (331)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~  322 (331)
                         ..       ..+..+..++.+++.+||+.+|++||++.+|.+.|+.+
T Consensus       216 ---~~-------~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         216 ---RL-------DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             ---CC-------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence               00       11224567899999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.4e-40  Score=290.38  Aligned_cols=267  Identities=21%  Similarity=0.244  Sum_probs=205.4

Q ss_pred             ccHHHHHHHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcC-CCCCcceeeceeec
Q 046639           20 ISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNI-RHRNLIKIITICSS   98 (331)
Q Consensus        20 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~   98 (331)
                      +...++....++|.+.+.||+|++|.||+|.+..+++.+|+|.+.... .....+..|+.+++++ +|||++++++++..
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            344566667889999999999999999999999899999999986432 2335577899999998 79999999999865


Q ss_pred             ccCCCcceeeEEEeecCCCCHHHHHHh--ccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcE
Q 046639           99 IDFEGFDFKAIVFEYMQNRNLEQWLRQ--SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVA  176 (331)
Q Consensus        99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~  176 (331)
                      .+....+..++||||+++++|.++++.  .....+++..++.++.|++.||.+||+.   +++|+||||+||+++.++.+
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~  167 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGV  167 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCE
Confidence            433344678999999999999998864  2334577888999999999999999999   99999999999999999999


Q ss_pred             EEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCC-----CCccchhhHhHHHHHHHHHhCCCCCCcccCC
Q 046639          177 HVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGS-----KASVSGDVYNFGILLLEMFTRRRPTDAMFNE  251 (331)
Q Consensus       177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~DiwslG~il~el~~g~~pf~~~~~~  251 (331)
                      +|+|||++.......        .......++..|+|||.+...     .++.++||||||+++|+|++|..||......
T Consensus       168 kl~dfg~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~  239 (291)
T cd06639         168 KLVDFGVSAQLTSTR--------LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV  239 (291)
T ss_pred             EEeecccchhccccc--------ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH
Confidence            999999987652111        111223477889999987543     3688999999999999999999999754211


Q ss_pred             cchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          252 GLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      . ....... ...        +..         .........+.+++.+||+.+|++||++.++++
T Consensus       240 ~-~~~~~~~-~~~--------~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         240 K-TLFKIPR-NPP--------PTL---------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             H-HHHHHhc-CCC--------CCC---------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            1 1111100 000        000         001223456899999999999999999999975

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2.8e-40  Score=285.43  Aligned_cols=259  Identities=20%  Similarity=0.305  Sum_probs=202.5

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCC---CceEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCc
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDES---RSIVAVKVVNLKQ-KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGF  104 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  104 (331)
                      ..+|.+.+.||+|++|.||+|.+...   ...+++|...... ....+.+.+|+.+++.+.|||++++++++..      
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~------   78 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE------   78 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC------
Confidence            45689999999999999999987533   4578999886554 4455678999999999999999999998642      


Q ss_pred             ceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcc
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA  184 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a  184 (331)
                      ...++|||++++++|.+++.... ..+++..+..++.|++.||.+||+.   +++|+||||+||+++.++.++|+|||++
T Consensus        79 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~  154 (270)
T cd05056          79 NPVWIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLS  154 (270)
T ss_pred             CCcEEEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCcee
Confidence            34689999999999999997643 2467888999999999999999999   9999999999999999999999999998


Q ss_pred             cccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhC
Q 046639          185 KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMAL  263 (331)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~  263 (331)
                      .......       ........++..|+|||.+.+..++.++||||||++++++++ |..||.......  ........ 
T Consensus       155 ~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--~~~~~~~~-  224 (270)
T cd05056         155 RYLEDES-------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND--VIGRIENG-  224 (270)
T ss_pred             eeccccc-------ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHHcC-
Confidence            7652210       001112223457999999988889999999999999999996 999997543211  11111100 


Q ss_pred             cchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhh
Q 046639          264 PDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARET  325 (331)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~  325 (331)
                             ...           ..+..++..+.+++.+||..+|++|||+.++++.|+.+.+.
T Consensus       225 -------~~~-----------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~  268 (270)
T cd05056         225 -------ERL-----------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE  268 (270)
T ss_pred             -------CcC-----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence                   000           11123566899999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.5e-40  Score=289.32  Aligned_cols=269  Identities=21%  Similarity=0.290  Sum_probs=196.6

Q ss_pred             CCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           31 NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ--KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      +|++.+.||.|++|.||+|.+..++..||+|.+....  ......+.+|+.+++.++|||++++++++     ..+...+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~   75 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVL-----MQESRLY   75 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEE-----eeCCeEE
Confidence            4888999999999999999999899999999986442  22345678899999999999999999995     4456789


Q ss_pred             EEEeecCCCCHHHHHHhcc-CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccc
Q 046639          109 IVFEYMQNRNLEQWLRQSN-GQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      +|||+++ ++|.+++.... +..++...+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++...
T Consensus        76 ~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  151 (285)
T cd07861          76 LIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAF  151 (285)
T ss_pred             EEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeec
Confidence            9999995 68988887633 35577888999999999999999999   9999999999999999999999999998754


Q ss_pred             ccCCCCCcccccCCceeecccccccCCcccCCC-CCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCc--
Q 046639          188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMGS-KASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALP--  264 (331)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--  264 (331)
                      ...        ........+++.|+|||++.+. .++.++||||||+++|+|++|..||........ ..........  
T Consensus       152 ~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~-~~~~~~~~~~~~  222 (285)
T cd07861         152 GIP--------VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ-LFRIFRILGTPT  222 (285)
T ss_pred             CCC--------cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHHhCCCC
Confidence            111        1111223467889999987654 578999999999999999999999975322111 1111110000  


Q ss_pred             chh----hhhcCccc-cccc-ccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          265 DKV----MEIVDPSL-LLEV-TANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       265 ~~~----~~~~~~~~-~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ...    ....+... .... ..........+..++.+++.+||+.||.+|||+.+|++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         223 EDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             hhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            000    00000000 0000 00000111235667889999999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.5e-40  Score=294.87  Aligned_cols=244  Identities=22%  Similarity=0.274  Sum_probs=189.9

Q ss_pred             ceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHHcC-CCCCcceeeceeecccCCCcceeeEEE
Q 046639           36 NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNI-RHRNLIKIITICSSIDFEGFDFKAIVF  111 (331)
Q Consensus        36 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~lv~  111 (331)
                      +.||+|+||+||+|.+..+++.||+|++....   ......+..|..++.++ .||+|+.+++++     ...+..++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~   75 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCF-----QTTSRLFLVI   75 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEE-----EeCCEEEEEE
Confidence            47999999999999999999999999997432   23345678899999888 599999999984     4456789999


Q ss_pred             eecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccccCC
Q 046639          112 EYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYE  191 (331)
Q Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~~  191 (331)
                      ||+++++|..++....  .+++..+..++.|++.||.|||++   +++|+||||+||+++.++.++|+|||++.....  
T Consensus        76 e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--  148 (327)
T cd05617          76 EYVNGGDLMFHMQRQR--KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG--  148 (327)
T ss_pred             eCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccC--
Confidence            9999999999886543  477889999999999999999999   999999999999999999999999999864311  


Q ss_pred             CCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcc-hHHHHHHhhCcchhhhh
Q 046639          192 PGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGL-TLHEFVKMALPDKVMEI  270 (331)
Q Consensus       192 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~  270 (331)
                            .........||+.|+|||++.+..++.++||||||+++|+|++|..||........ .............    
T Consensus       149 ------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~----  218 (327)
T cd05617         149 ------PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK----  218 (327)
T ss_pred             ------CCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC----
Confidence                  11122345689999999999999999999999999999999999999964322111 1111111100000    


Q ss_pred             cCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHH
Q 046639          271 VDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMR  313 (331)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~  313 (331)
                                  ....+...+..+.+++.+||+.||.+|++++
T Consensus       219 ------------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~  249 (327)
T cd05617         219 ------------PIRIPRFLSVKASHVLKGFLNKDPKERLGCQ  249 (327)
T ss_pred             ------------CCCCCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence                        0011122345678999999999999999864

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=2.5e-40  Score=290.28  Aligned_cols=270  Identities=20%  Similarity=0.255  Sum_probs=198.0

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccch-hhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCccee
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK-EASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      .++|.+.+.||.|+||.||+|.+..++..||+|.+..... .....+.+|+.+++.++||||+++++++     ...+..
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~-----~~~~~~   79 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII-----HTEKSL   79 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEE-----ecCCeE
Confidence            3579999999999999999999998999999999864432 2234577899999999999999999995     445678


Q ss_pred             eEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccc
Q 046639          108 AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      ++|||+++ ++|.+++.... ..++...+..++.|++.||.+||+.   +++|+||||+||+++.++.++|+|||++...
T Consensus        80 ~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  154 (301)
T cd07873          80 TLVFEYLD-KDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAK  154 (301)
T ss_pred             EEEEeccc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhcc
Confidence            99999995 69999887643 2466788899999999999999999   9999999999999999999999999998754


Q ss_pred             ccCCCCCcccccCCceeecccccccCCcccCCC-CCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhC---
Q 046639          188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMGS-KASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMAL---  263 (331)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~---  263 (331)
                      ...        ........+++.|+|||.+.+. .++.++||||||+++|+|++|.+||...... ...........   
T Consensus       155 ~~~--------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~-~~~~~~~~~~~~~~  225 (301)
T cd07873         155 SIP--------TKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE-EQLHFIFRILGTPT  225 (301)
T ss_pred             CCC--------CCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHcCCCC
Confidence            111        1111223467889999997764 4788999999999999999999999754221 11111111100   


Q ss_pred             cchhhhhcCcccccc--cccCC----cchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          264 PDKVMEIVDPSLLLE--VTANN----YSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       264 ~~~~~~~~~~~~~~~--~~~~~----~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ...+...........  .....    ......+...+.+|+.+||+.||.+|||+.++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         226 EETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             hhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            000000000000000  00000    0111234567889999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-40  Score=286.34  Aligned_cols=248  Identities=22%  Similarity=0.285  Sum_probs=200.1

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ-KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      ++|.+.+.||.|++|.||+|.+..++..+|+|.+.... ......+.+|+.+++.++|+|++++.+++.     +....+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   75 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFL-----KGSKLW   75 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEE-----ECCeEE
Confidence            47899999999999999999999999999999987553 334466889999999999999999999853     346789


Q ss_pred             EEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccc
Q 046639          109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLF  188 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~  188 (331)
                      +|+|++++++|.+++...   .+++..+..++.|++.|+.+||+.   +++|+||+|+||+++.++.++|+|||++....
T Consensus        76 ~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~  149 (274)
T cd06609          76 IIMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLT  149 (274)
T ss_pred             EEEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeec
Confidence            999999999999999754   567889999999999999999999   99999999999999999999999999998762


Q ss_pred             cCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhh
Q 046639          189 GYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVM  268 (331)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  268 (331)
                      ...        .......+++.|+|||++.+..++.++||||||+++|+|++|..||.....  ..........      
T Consensus       150 ~~~--------~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~--~~~~~~~~~~------  213 (274)
T cd06609         150 STM--------SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP--MRVLFLIPKN------  213 (274)
T ss_pred             ccc--------cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch--HHHHHHhhhc------
Confidence            211        122234577789999999988899999999999999999999999965321  1111000000      


Q ss_pred             hhcCcccccccccCCcchHHH-HHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          269 EIVDPSLLLEVTANNYSWIED-CLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~-~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                        ..+..           ... ++..+.+++.+||..+|++|||+.++++
T Consensus       214 --~~~~~-----------~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         214 --NPPSL-----------EGNKFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             --CCCCC-----------cccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence              00100           011 4557888999999999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2.2e-40  Score=283.62  Aligned_cols=250  Identities=22%  Similarity=0.271  Sum_probs=201.2

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeE
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAI  109 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~l  109 (331)
                      ++|.+.+.||.|++|.||+|.+..+++.+++|.+.....  ...+.+|+.+++.++|+|++++++++     ......++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~l   75 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSY-----FKNTDLWI   75 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeee-----ecCCcEEE
Confidence            579999999999999999999998889999999864433  67789999999999999999999985     44577899


Q ss_pred             EEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccccc
Q 046639          110 VFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG  189 (331)
Q Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~  189 (331)
                      ++|++++++|.+++.... ..+++..+..++.|++.|+.+||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        76 ~~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~  151 (256)
T cd06612          76 VMEYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD  151 (256)
T ss_pred             EEecCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhccc
Confidence            999999999999986533 3567889999999999999999999   999999999999999999999999999876521


Q ss_pred             CCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhh
Q 046639          190 YEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVME  269 (331)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  269 (331)
                      ..        .......++..|+|||.+.+..++.++||||||+++|+|++|..||..........     ....     
T Consensus       152 ~~--------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~-----~~~~-----  213 (256)
T cd06612         152 TM--------AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF-----MIPN-----  213 (256)
T ss_pred             Cc--------cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh-----hhcc-----
Confidence            11        11223346778999999988889999999999999999999999997532211100     0000     


Q ss_pred             hcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          270 IVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                          ..     .........+...+.+++.+||+.+|++|||+.+|++
T Consensus       214 ----~~-----~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         214 ----KP-----PPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             ----CC-----CCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence                00     0001112234567899999999999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-40  Score=289.18  Aligned_cols=253  Identities=20%  Similarity=0.286  Sum_probs=201.2

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeE
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAI  109 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~l  109 (331)
                      ++|.+.+.||.|++|.||+|.+..++..+|+|.+..........+..|+.++++++|+|++++++++     ......++
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l   79 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAY-----FYENKLWI   79 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEE-----ecCCeEEE
Confidence            4699999999999999999999888999999999876666667788999999999999999999985     44567899


Q ss_pred             EEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccccc
Q 046639          110 VFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG  189 (331)
Q Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~  189 (331)
                      |||++++++|.+++.... ..+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||.+.....
T Consensus        80 v~e~~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~  155 (280)
T cd06611          80 LIEFCDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS  155 (280)
T ss_pred             EeeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcc
Confidence            999999999999987643 3477889999999999999999999   999999999999999999999999998765411


Q ss_pred             CCCCCcccccCCceeecccccccCCcccC-----CCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCc
Q 046639          190 YEPGTAAETASNSIEIKGIVGYVAPEYGM-----GSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALP  264 (331)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  264 (331)
                              .........+++.|+|||.+.     ...++.++|+||||+++|+|++|..||....... .....    ..
T Consensus       156 --------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~-~~~~~----~~  222 (280)
T cd06611         156 --------TLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR-VLLKI----LK  222 (280)
T ss_pred             --------cccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH-HHHHH----hc
Confidence                    111222345788899999875     3456789999999999999999999997542111 11111    00


Q ss_pred             chhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHH
Q 046639          265 DKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAK  318 (331)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~  318 (331)
                      .     ..+.+         .....+...+.+++.+||+.+|.+|||+.++++.
T Consensus       223 ~-----~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         223 S-----EPPTL---------DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             C-----CCCCc---------CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence            0     00000         0112345578899999999999999999999753

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=5e-40  Score=286.50  Aligned_cols=260  Identities=20%  Similarity=0.365  Sum_probs=198.1

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeec-----CCCceEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCcceeeceeecccC
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILD-----ESRSIVAVKVVNLKQ-KEASRSFAAECNALRNIRHRNLIKIITICSSIDF  101 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  101 (331)
                      ...+|.+.+.||+|+||.||+|..+     ..+..||+|.+.... ......+.+|+.+++.++|+|++++++++     
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----   78 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVV-----   78 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-----
Confidence            3467999999999999999998764     235579999876443 22334578899999999999999999985     


Q ss_pred             CCcceeeEEEeecCCCCHHHHHHhcc--------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCC
Q 046639          102 EGFDFKAIVFEYMQNRNLEQWLRQSN--------GQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQD  173 (331)
Q Consensus       102 ~~~~~~~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~  173 (331)
                      ......++||||+++++|.+++....        ........+..++.|++.||.|||++   +++|+||||+||+++.+
T Consensus        79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~  155 (288)
T cd05061          79 SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHD  155 (288)
T ss_pred             cCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCC
Confidence            34456899999999999999997532        12234567788999999999999999   99999999999999999


Q ss_pred             CcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCc
Q 046639          174 IVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEG  252 (331)
Q Consensus       174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~  252 (331)
                      +.++|+|||+++......      .........++..|+|||.+.+..++.++||||||+++|+|++ |..||.....  
T Consensus       156 ~~~~L~Dfg~~~~~~~~~------~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~--  227 (288)
T cd05061         156 FTVKIGDFGMTRDIYETD------YYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN--  227 (288)
T ss_pred             CcEEECcCCccccccccc------cccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence            999999999987542111      0111112234567999999998889999999999999999998 7889865321  


Q ss_pred             chHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHh
Q 046639          253 LTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHA  322 (331)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~  322 (331)
                         .+........        ..        ......+...+.+++.+||+.+|++|||+.++++.|++.
T Consensus       228 ---~~~~~~~~~~--------~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         228 ---EQVLKFVMDG--------GY--------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             ---HHHHHHHHcC--------CC--------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence               1111111000        00        011123456899999999999999999999999988874

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6e-40  Score=294.22  Aligned_cols=197  Identities=21%  Similarity=0.308  Sum_probs=164.4

Q ss_pred             HHHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcc
Q 046639           26 SKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFD  105 (331)
Q Consensus        26 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~  105 (331)
                      .....+|.+.+.||+|+||.||+|.+..++..||+|+....      ....|+.+++.++|+||+++++++.     ...
T Consensus        62 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~  130 (357)
T PHA03209         62 VVASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLV-----SGA  130 (357)
T ss_pred             hhhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEE-----eCC
Confidence            34456799999999999999999999989999999975322      2346899999999999999999854     346


Q ss_pred             eeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccc
Q 046639          106 FKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAK  185 (331)
Q Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~  185 (331)
                      ..++|+|++ .++|.+++.... ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||+++
T Consensus       131 ~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~  205 (357)
T PHA03209        131 ITCMVLPHY-SSDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQ  205 (357)
T ss_pred             eeEEEEEcc-CCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCcccc
Confidence            789999999 678988886533 3477889999999999999999999   99999999999999999999999999987


Q ss_pred             ccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCC-CCCc
Q 046639          186 FLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRR-PTDA  247 (331)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~-pf~~  247 (331)
                      ...         .........||+.|+|||++.+..++.++||||||+++|||+++.. +|..
T Consensus       206 ~~~---------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~  259 (357)
T PHA03209        206 FPV---------VAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFED  259 (357)
T ss_pred             ccc---------cCcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccC
Confidence            531         1112223458899999999999999999999999999999998544 4443

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.9e-40  Score=288.48  Aligned_cols=269  Identities=20%  Similarity=0.267  Sum_probs=196.9

Q ss_pred             CCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           31 NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ--KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      +|.+.+.||+|++|.||+|.+..++..+|+|.+....  ......+.+|+.+++.++|+|+++++++     +.+....+
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~-----~~~~~~~~   75 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV-----LHSDKKLT   75 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHH-----hccCCceE
Confidence            5888999999999999999999999999999986432  2223557789999999999999999998     45567789


Q ss_pred             EEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccc
Q 046639          109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLF  188 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~  188 (331)
                      +++||+. ++|.+++.... ..+++..+..++.|++.||.+||+.   +++|+||+|+||+++.++.++|+|||++....
T Consensus        76 lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~  150 (284)
T cd07839          76 LVFEYCD-QDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFG  150 (284)
T ss_pred             EEEecCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccC
Confidence            9999995 68888876533 3477889999999999999999999   99999999999999999999999999987541


Q ss_pred             cCCCCCcccccCCceeecccccccCCcccCCC-CCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcc--
Q 046639          189 GYEPGTAAETASNSIEIKGIVGYVAPEYGMGS-KASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPD--  265 (331)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--  265 (331)
                      ..        ........+++.|+|||++.+. .++.++||||||+++|+|++|..||.........+..........  
T Consensus       151 ~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  222 (284)
T cd07839         151 IP--------VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE  222 (284)
T ss_pred             CC--------CCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCCh
Confidence            11        1111223467889999998764 478999999999999999999988643322222222211111000  


Q ss_pred             ----hhhhhcCcccccccccCC--cchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          266 ----KVMEIVDPSLLLEVTANN--YSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       266 ----~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                          ......+...........  ......+...+.+++.+||+.||.+|||+.++++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         223 ESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             HHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence                000111111011100000  0111235667889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=2.8e-40  Score=283.25  Aligned_cols=251  Identities=23%  Similarity=0.323  Sum_probs=196.7

Q ss_pred             ceeeccCeeEEEEeeecC-CC--ceEEEEEeeccch-hhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeEEE
Q 046639           36 NKIGQGGVSIVYKGILDE-SR--SIVAVKVVNLKQK-EASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVF  111 (331)
Q Consensus        36 ~~lg~G~~g~V~~~~~~~-~~--~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~  111 (331)
                      +.||+|++|.||+|.+.. ++  ..||+|.+..... ...+.+..|+.++++++|+|++++++.+.     . ...++++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~-~~~~~v~   74 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVL-----T-HPLMMVT   74 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEc-----C-CeEEEEE
Confidence            478999999999999854 33  3689999876655 55678999999999999999999999853     2 6789999


Q ss_pred             eecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccccCC
Q 046639          112 EYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYE  191 (331)
Q Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~~  191 (331)
                      |++++++|.+++.......+++..++.++.|++.||.+||++   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~  151 (257)
T cd05040          75 ELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNE  151 (257)
T ss_pred             EecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccc
Confidence            999999999999875434578889999999999999999999   99999999999999999999999999998752211


Q ss_pred             CCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhCcchhhhh
Q 046639          192 PGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMALPDKVMEI  270 (331)
Q Consensus       192 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  270 (331)
                      .     .........++..|+|||.+.+..++.++||||||+++|+|++ |..||.......  .........       
T Consensus       152 ~-----~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~~-------  217 (257)
T cd05040         152 D-----HYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ--ILKKIDKEG-------  217 (257)
T ss_pred             c-----ceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHhcC-------
Confidence            1     0111112345677999999998899999999999999999998 999996432111  111111000       


Q ss_pred             cCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHH
Q 046639          271 VDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLR  320 (331)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~  320 (331)
                        ...         .....++..+.+++.+||+.+|++|||+.+|++.|.
T Consensus       218 --~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         218 --ERL---------ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             --CcC---------CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence              000         011234567899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=7e-41  Score=296.79  Aligned_cols=241  Identities=22%  Similarity=0.220  Sum_probs=186.7

Q ss_pred             ceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHH-HHHcCCCCCcceeeceeecccCCCcceeeEEE
Q 046639           36 NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECN-ALRNIRHRNLIKIITICSSIDFEGFDFKAIVF  111 (331)
Q Consensus        36 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~  111 (331)
                      +.||+|+||+||+|.+..+++.+|+|++....   ......+..|.. +++.++||||+++++++     ...+..++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~-----~~~~~~~lv~   75 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTTEKLYFVL   75 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEE-----ecCCEEEEEE
Confidence            46999999999999999999999999986432   223344555554 46778999999999884     4456889999


Q ss_pred             eecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccccCC
Q 046639          112 EYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYE  191 (331)
Q Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~~  191 (331)
                      ||+++++|..++....  .+++..+..++.|++.||.|||++   |++|+||||+||+++.++.++|+|||++.....  
T Consensus        76 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~--  148 (325)
T cd05604          76 DFVNGGELFFHLQRER--SFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA--  148 (325)
T ss_pred             cCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCC--
Confidence            9999999999886533  467888899999999999999999   999999999999999999999999999864311  


Q ss_pred             CCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhhhc
Q 046639          192 PGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEIV  271 (331)
Q Consensus       192 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (331)
                            .........||+.|+|||++.+..++.++||||||+++|+|++|..||.....     ...........+    
T Consensus       149 ------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-----~~~~~~~~~~~~----  213 (325)
T cd05604         149 ------QSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV-----AEMYDNILHKPL----  213 (325)
T ss_pred             ------CCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH-----HHHHHHHHcCCc----
Confidence                  11122345689999999999999999999999999999999999999965321     111111110000    


Q ss_pred             CcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHH
Q 046639          272 DPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVV  316 (331)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~  316 (331)
                                   .........+.+++.+||+.+|.+||++.+.+
T Consensus       214 -------------~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~  245 (325)
T cd05604         214 -------------VLRPGASLTAWSILEELLEKDRQRRLGAKEDF  245 (325)
T ss_pred             -------------cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence                         00012345678899999999999999886433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=4.9e-40  Score=282.06  Aligned_cols=250  Identities=26%  Similarity=0.452  Sum_probs=199.8

Q ss_pred             ceeeccCeeEEEEeeecCC---CceEEEEEeeccchh-hHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeEEE
Q 046639           36 NKIGQGGVSIVYKGILDES---RSIVAVKVVNLKQKE-ASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVF  111 (331)
Q Consensus        36 ~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~  111 (331)
                      +.||+|+||.||+|.+...   +..+++|.+...... ....+.+|+.+++.++|+|++++++++.     .....+++|
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~lv~   75 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCT-----EEEPLYLVL   75 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeec-----CCCceEEEE
Confidence            4799999999999999755   889999999755433 3577899999999999999999999853     367789999


Q ss_pred             eecCCCCHHHHHHhcc-------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcc
Q 046639          112 EYMQNRNLEQWLRQSN-------GQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA  184 (331)
Q Consensus       112 e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a  184 (331)
                      |++++++|.+++....       ...+++..++.++.|++.||.+||++   +++|+||+|+||+++.++.++|+|||.+
T Consensus        76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~  152 (262)
T cd00192          76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLS  152 (262)
T ss_pred             EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEcccccc
Confidence            9999999999998742       35578899999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhC
Q 046639          185 KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMAL  263 (331)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~  263 (331)
                      ........      ........++..|+|||.+.+..++.++||||||+++++|++ |..||.....  .........  
T Consensus       153 ~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~~~~--  222 (262)
T cd00192         153 RDVYDDDY------YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN--EEVLEYLRK--  222 (262)
T ss_pred             cccccccc------cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHHc--
Confidence            87632111      112223446778999999988889999999999999999999 6999976421  111111110  


Q ss_pred             cchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHH
Q 046639          264 PDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLR  320 (331)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~  320 (331)
                       .     ..           ...+..++..+.+++.+||+.+|.+|||+.++++.|+
T Consensus       223 -~-----~~-----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         223 -G-----YR-----------LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             -C-----CC-----------CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence             0     00           0112234678999999999999999999999998763

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.1e-40  Score=295.02  Aligned_cols=238  Identities=24%  Similarity=0.250  Sum_probs=184.5

Q ss_pred             ceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHH-HHHcCCCCCcceeeceeecccCCCcceeeEEE
Q 046639           36 NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECN-ALRNIRHRNLIKIITICSSIDFEGFDFKAIVF  111 (331)
Q Consensus        36 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~  111 (331)
                      +.||+|+||.||+|++..+++.||+|++....   ......+..|.. +++.++||||+++++++     ...+..++||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~-----~~~~~~~lv~   75 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSF-----QTAEKLYFVL   75 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCEEEEEE
Confidence            47999999999999999999999999986432   222334555554 57888999999999884     4456789999


Q ss_pred             eecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccccCC
Q 046639          112 EYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYE  191 (331)
Q Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~~  191 (331)
                      ||+++++|...+...  ..++...+..++.|++.||.|||+.   +|+|+||||+||+++.++.+||+|||++.....  
T Consensus        76 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~--  148 (321)
T cd05603          76 DYVNGGELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE--  148 (321)
T ss_pred             cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCC--
Confidence            999999999888653  3466778888999999999999999   999999999999999999999999999864311  


Q ss_pred             CCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhhhc
Q 046639          192 PGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEIV  271 (331)
Q Consensus       192 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (331)
                            .........||+.|+|||++.+..++.++|||||||++|+|++|..||.....     ............    
T Consensus       149 ------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~i~~~~~----  213 (321)
T cd05603         149 ------PEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV-----SQMYDNILHKPL----  213 (321)
T ss_pred             ------CCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH-----HHHHHHHhcCCC----
Confidence                  11122334688999999999998999999999999999999999999965321     111111110000    


Q ss_pred             CcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHH
Q 046639          272 DPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMR  313 (331)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~  313 (331)
                                   .++......+.+++.+||+.+|.+||++.
T Consensus       214 -------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         214 -------------QLPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             -------------CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence                         11112345688999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-40  Score=285.05  Aligned_cols=259  Identities=20%  Similarity=0.263  Sum_probs=202.8

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcC-CCCCcceeeceeecccC-CCcc
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNI-RHRNLIKIITICSSIDF-EGFD  105 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~-~~~~  105 (331)
                      ..++|.+.+.||+|++|.||+|.+..+++.+++|++..... ....+.+|+.+++++ .|+|++++++++..... ....
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            45789999999999999999999988899999999875543 346688999999999 69999999999765432 3456


Q ss_pred             eeeEEEeecCCCCHHHHHHhcc--CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCc
Q 046639          106 FKAIVFEYMQNRNLEQWLRQSN--GQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGL  183 (331)
Q Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~  183 (331)
                      ..++|||++++++|.+++....  ...++...+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||+
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~  159 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGV  159 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCcc
Confidence            7899999999999999987633  45577888999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCcccccCCceeecccccccCCcccCC-----CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHH
Q 046639          184 AKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG-----SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEF  258 (331)
Q Consensus       184 a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  258 (331)
                      +......        ........++..|+|||++..     ..++.++||||||+++++|++|..||...... ......
T Consensus       160 ~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~  230 (275)
T cd06608         160 SAQLDST--------LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM-RALFKI  230 (275)
T ss_pred             ceecccc--------hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH-HHHHHh
Confidence            8764211        111223457888999998754     34678999999999999999999999643211 111111


Q ss_pred             HHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          259 VKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ..    .     ..+..         .....+...+.+++.+||..||++|||+.++++
T Consensus       231 ~~----~-----~~~~~---------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         231 PR----N-----PPPTL---------KSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             hc----c-----CCCCC---------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            00    0     00000         111235567889999999999999999999975

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=9.7e-41  Score=299.93  Aligned_cols=209  Identities=20%  Similarity=0.263  Sum_probs=173.9

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      ++|.+.+.||+|+||+||+|.+..+++.||+|++....   ......+..|..++..++|++|+++++.+     ...+.
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----~~~~~   75 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSF-----QDKRN   75 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCE
Confidence            36899999999999999999999999999999996432   23345678899999999999999999884     55678


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      .++||||+++++|.+++.+..  .++...+..++.|++.||.+||++   +|+||||||+||+++.++.++|+|||++..
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~  150 (360)
T cd05627          76 LYLIMEFLPGGDMMTLLMKKD--TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTG  150 (360)
T ss_pred             EEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcc
Confidence            999999999999999997543  467788899999999999999999   999999999999999999999999999875


Q ss_pred             cccCCCCCc---------------------------ccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHH
Q 046639          187 LFGYEPGTA---------------------------AETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMF  239 (331)
Q Consensus       187 ~~~~~~~~~---------------------------~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~  239 (331)
                      .........                           ...........||+.|+|||++.+..++.++|||||||++|+|+
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~  230 (360)
T cd05627         151 LKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML  230 (360)
T ss_pred             cccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecc
Confidence            422110000                           00000112346899999999999999999999999999999999


Q ss_pred             hCCCCCCcc
Q 046639          240 TRRRPTDAM  248 (331)
Q Consensus       240 ~g~~pf~~~  248 (331)
                      +|..||...
T Consensus       231 tG~~Pf~~~  239 (360)
T cd05627         231 IGYPPFCSE  239 (360)
T ss_pred             cCCCCCCCC
Confidence            999999753

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4.5e-40  Score=285.99  Aligned_cols=275  Identities=23%  Similarity=0.332  Sum_probs=204.3

Q ss_pred             cCCCcCceeeccCeeEEEEeeec----CCCceEEEEEeeccchh-hHHHHHHHHHHHHcCCCCCcceeeceeecccCCCc
Q 046639           30 NNFSPANKIGQGGVSIVYKGILD----ESRSIVAVKVVNLKQKE-ASRSFAAECNALRNIRHRNLIKIITICSSIDFEGF  104 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  104 (331)
                      +.|.+.+.||+|+||.||+|.+.    .++..+|+|.+...... ....+.+|+.+++.+.|+|++++++++..   ...
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~---~~~   80 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEK---PGG   80 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeec---CCC
Confidence            46888999999999999999864    34789999999755443 45779999999999999999999998643   225


Q ss_pred             ceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcc
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA  184 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a  184 (331)
                      ...+++||++++++|.+++..... .+++..+..++.|++.||.+||++   +++|+||+|+||+++.++.++|+|||.+
T Consensus        81 ~~~~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~  156 (284)
T cd05038          81 RSLRLIMEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLA  156 (284)
T ss_pred             CceEEEEecCCCCCHHHHHHhCcc-ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccc
Confidence            568999999999999999976442 467888899999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHh-hC
Q 046639          185 KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKM-AL  263 (331)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~-~~  263 (331)
                      ........     .........++..|+|||.+.+..++.++||||||+++|+|++|..||................ ..
T Consensus       157 ~~~~~~~~-----~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd05038         157 KVLPEDKD-----YYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMI  231 (284)
T ss_pred             cccccCCc-----ceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccccccccc
Confidence            87521110     0001111223455999999988889999999999999999999999986532221110000000 00


Q ss_pred             cchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhh
Q 046639          264 PDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHAR  323 (331)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~  323 (331)
                      ...+...+.....       ......++..+.+++.+||+.+|++|||+.+|++.|+.++
T Consensus       232 ~~~~~~~~~~~~~-------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~  284 (284)
T cd05038         232 VTRLLELLKEGER-------LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR  284 (284)
T ss_pred             HHHHHHHHHcCCc-------CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence            0000000000000       0112245678999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-40  Score=290.54  Aligned_cols=260  Identities=23%  Similarity=0.286  Sum_probs=203.4

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccch---hhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK---EASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      ++|.+.+.||+|++|+||+|.+..+++.+|+|.+.....   .....+..|+.+++.++|+||+++++.+     .....
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~   75 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASF-----QTETY   75 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeee-----ecCCE
Confidence            368999999999999999999998899999999875432   2446688999999999999999999984     45677


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      .++|||++.+++|.+++....+..+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++..
T Consensus        76 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~  152 (316)
T cd05574          76 LCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQ  152 (316)
T ss_pred             EEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhc
Confidence            89999999999999999876656678888999999999999999999   999999999999999999999999999875


Q ss_pred             cccCCCCCcc---------------------cccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCC
Q 046639          187 LFGYEPGTAA---------------------ETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPT  245 (331)
Q Consensus       187 ~~~~~~~~~~---------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf  245 (331)
                      ..........                     ..........|+..|+|||++.+..++.++||||||+++|+|++|..||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf  232 (316)
T cd05574         153 SDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPF  232 (316)
T ss_pred             ccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCC
Confidence            4221110000                     0011122345788899999999888999999999999999999999999


Q ss_pred             CcccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCc----HHHHHH
Q 046639          246 DAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERME----MRDVVA  317 (331)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps----~~~i~~  317 (331)
                      ...... ..+........          ..         ......+..+.+++.+||+.+|++|||    +.+++.
T Consensus       233 ~~~~~~-~~~~~~~~~~~----------~~---------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         233 KGSNRD-ETFSNILKKEV----------TF---------PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             CCCchH-HHHHHHhcCCc----------cC---------CCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            754221 11111110000          00         000114678999999999999999999    777765

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=5.8e-40  Score=281.14  Aligned_cols=250  Identities=20%  Similarity=0.293  Sum_probs=201.4

Q ss_pred             CCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc--chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           31 NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      +|++.+.||+|+||.+|.+.+..+++.+|+|.+...  .......+.+|+.+++.++|+|+++++++     +...+..+
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~-----~~~~~~~~   75 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES-----FEENGNLY   75 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEee-----ecCCCeEE
Confidence            588999999999999999999989999999998643  23344678899999999999999999998     45567889


Q ss_pred             EEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccc
Q 046639          109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLF  188 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~  188 (331)
                      +|+|++++++|.+.+.......++...+..++.|++.|+.+||+.   +++|+||+|+||+++.++.++|+|||++....
T Consensus        76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~  152 (256)
T cd08218          76 IVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLN  152 (256)
T ss_pred             EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecC
Confidence            999999999999999775555567888899999999999999999   99999999999999999999999999987642


Q ss_pred             cCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhh
Q 046639          189 GYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVM  268 (331)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  268 (331)
                      ..        ........+++.|+|||++.+..++.++|+||||+++++|++|..||....     ............  
T Consensus       153 ~~--------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-----~~~~~~~~~~~~--  217 (256)
T cd08218         153 ST--------VELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN-----MKNLVLKIIRGS--  217 (256)
T ss_pred             cc--------hhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC-----HHHHHHHHhcCC--
Confidence            11        111123347788999999988889999999999999999999999986421     111111111000  


Q ss_pred             hhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          269 EIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                         .+           .....+...+.+++.+||+.+|++||++.+|++
T Consensus       218 ---~~-----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         218 ---YP-----------PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             ---CC-----------CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence               00           111234567899999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.9e-40  Score=283.94  Aligned_cols=254  Identities=22%  Similarity=0.310  Sum_probs=199.0

Q ss_pred             CCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccch---------hhHHHHHHHHHHHHcCCCCCcceeeceeecccC
Q 046639           31 NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK---------EASRSFAAECNALRNIRHRNLIKIITICSSIDF  101 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  101 (331)
                      +|.+...||+|++|.||+|.+..+++.+|+|.+.....         ...+.+..|+.+++.++||||+++++++     
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----   75 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSS-----   75 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----
Confidence            58889999999999999999988899999998854321         1235688999999999999999999985     


Q ss_pred             CCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEccc
Q 046639          102 EGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDL  181 (331)
Q Consensus       102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Df  181 (331)
                      ......++++|++++++|.+++....  .++...+..++.|++.||.+||+.   +++|+||+|+||+++.++.++|+||
T Consensus        76 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~df  150 (267)
T cd06628          76 LDADHLNIFLEYVPGGSVAALLNNYG--AFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDF  150 (267)
T ss_pred             EeCCccEEEEEecCCCCHHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEeccc
Confidence            44567899999999999999997643  466788889999999999999999   9999999999999999999999999


Q ss_pred             CcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHh
Q 046639          182 GLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKM  261 (331)
Q Consensus       182 g~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  261 (331)
                      |.+.........  ...........++..|+|||.+.+..++.++|+||||+++|+|++|..||.....    .......
T Consensus       151 g~~~~~~~~~~~--~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~  224 (267)
T cd06628         151 GISKKLEANSLS--TKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ----LQAIFKI  224 (267)
T ss_pred             CCCccccccccc--CCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH----HHHHHHH
Confidence            998876321110  0111112234577889999999988899999999999999999999999975321    1111100


Q ss_pred             hCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          262 ALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                            .....+           ..+..+...+.+++.+||+.+|.+||++.+|++
T Consensus       225 ------~~~~~~-----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         225 ------GENASP-----------EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             ------hccCCC-----------cCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence                  000011           111234567889999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.1e-40  Score=285.66  Aligned_cols=253  Identities=17%  Similarity=0.220  Sum_probs=197.9

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc-chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK-QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      ++|.+++.||+|++|.||+|.+..++..+|+|.+... .......+.+|+.++++++|+||+++++.+     ...+..+
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~   75 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF-----FIEGAVY   75 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhhe-----ecCCeEE
Confidence            4689999999999999999999989999999988654 334456788999999999999999999984     4457889


Q ss_pred             EEEeecCCCCHHHHHHhcc-CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccc
Q 046639          109 IVFEYMQNRNLEQWLRQSN-GQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      +||||+++++|.+++.... ...+++..+..++.|++.||.|||+..  +++|+||+|+||+++.++.++|+|||++...
T Consensus        76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  153 (286)
T cd06622          76 MCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNL  153 (286)
T ss_pred             EEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            9999999999999987531 235778899999999999999999632  8999999999999999999999999998754


Q ss_pred             ccCCCCCcccccCCceeecccccccCCcccCCC------CCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHh
Q 046639          188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMGS------KASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKM  261 (331)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~------~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  261 (331)
                      ..          .......+++.|+|||.+.+.      .++.++|+||||+++|+|++|..||......  ........
T Consensus       154 ~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~  221 (286)
T cd06622         154 VA----------SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA--NIFAQLSA  221 (286)
T ss_pred             cC----------CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh--hHHHHHHH
Confidence            11          111123467789999998554      3478999999999999999999999653211  11111110


Q ss_pred             hCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          262 ALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ....     ..           ...+.++...+.+++.+||+.+|++||++.++++
T Consensus       222 ~~~~-----~~-----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         222 IVDG-----DP-----------PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             Hhhc-----CC-----------CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence            0000     00           0122245677889999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=8.5e-40  Score=283.47  Aligned_cols=249  Identities=19%  Similarity=0.263  Sum_probs=201.0

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ-KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      ..|...+.||.|++|.||+|.+..++..||+|.+.... ......+.+|+.+++.+.|+|++++++++.     .....+
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   78 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KGTKLW   78 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----ECCEEE
Confidence            46888999999999999999998889999999987543 344567889999999999999999999853     456789


Q ss_pred             EEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccc
Q 046639          109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLF  188 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~  188 (331)
                      +|||++++++|.+++...   .++...+..++.|++.|+++||+.   +++|+||+|+||+++.++.++++|||++....
T Consensus        79 lv~e~~~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~  152 (277)
T cd06640          79 IIMEYLGGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLT  152 (277)
T ss_pred             EEEecCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceecc
Confidence            999999999999998643   366778889999999999999999   99999999999999999999999999987652


Q ss_pred             cCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhh
Q 046639          189 GYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVM  268 (331)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  268 (331)
                      ...        .......++..|+|||++.+..++.++|+||||+++|+|++|..||........  ....         
T Consensus       153 ~~~--------~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~---------  213 (277)
T cd06640         153 DTQ--------IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV--LFLI---------  213 (277)
T ss_pred             CCc--------cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH--hhhh---------
Confidence            111        112223467789999999888899999999999999999999999975422110  0000         


Q ss_pred             hhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHH
Q 046639          269 EIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAK  318 (331)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~  318 (331)
                         ....       .......++..+.+++.+||+.+|.+||++.++++.
T Consensus       214 ---~~~~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         214 ---PKNN-------PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             ---hcCC-------CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence               0000       012234567789999999999999999999999765

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=5.3e-40  Score=281.26  Aligned_cols=249  Identities=21%  Similarity=0.325  Sum_probs=200.1

Q ss_pred             CCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc--chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           31 NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      +|.+.+.||+|++|.||+|.+..++..+|+|.+...  .......+.+|+.+++.++|||++++++.+     ...+..+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~   75 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENF-----LEDKALM   75 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeE-----ecCCEEE
Confidence            588899999999999999999989999999998654  233456788999999999999999999884     4567789


Q ss_pred             EEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCC-CcEEEcccCccccc
Q 046639          109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQD-IVAHVGDLGLAKFL  187 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~-~~~kl~Dfg~a~~~  187 (331)
                      +|||++++++|.+++.......+++..+..++.+++.++.+||++   +++|+||+|+||+++.+ +.++|+|||.+...
T Consensus        76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~  152 (256)
T cd08220          76 IVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKIL  152 (256)
T ss_pred             EEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceec
Confidence            999999999999999876555678888999999999999999999   99999999999999855 46899999998765


Q ss_pred             ccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchh
Q 046639          188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKV  267 (331)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  267 (331)
                      ...         .......++..|+|||.+.+..++.++||||||+++|+|++|..||......  ..........    
T Consensus       153 ~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~--~~~~~~~~~~----  217 (256)
T cd08220         153 SSK---------SKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP--ALVLKIMSGT----  217 (256)
T ss_pred             CCC---------ccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH--HHHHHHHhcC----
Confidence            211         1122345778899999999888999999999999999999999999653211  1111100000    


Q ss_pred             hhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          268 MEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                                     .......+...+.+++.+||+.+|++|||+.++++
T Consensus       218 ---------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         218 ---------------FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             ---------------CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                           00111234567889999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-40  Score=295.70  Aligned_cols=262  Identities=22%  Similarity=0.346  Sum_probs=210.5

Q ss_pred             HHHHhcCCCcCceeeccCeeEEEEeeecC----CCceEEEEEeec-cchhhHHHHHHHHHHHHcCCCCCcceeeceeecc
Q 046639           25 LSKATNNFSPANKIGQGGVSIVYKGILDE----SRSIVAVKVVNL-KQKEASRSFAAECNALRNIRHRNLIKIITICSSI   99 (331)
Q Consensus        25 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vavK~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   99 (331)
                      ....++.....+.||.|-||.||+|....    ..-.||||.-+. ..++..+.++.|+.+|+.+.||||++++|+|.. 
T Consensus       384 yel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-  462 (974)
T KOG4257|consen  384 YELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-  462 (974)
T ss_pred             ceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-
Confidence            33444455666899999999999999842    234588898765 345667889999999999999999999999865 


Q ss_pred             cCCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEc
Q 046639          100 DFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVG  179 (331)
Q Consensus       100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~  179 (331)
                           ...++|||.++.|.|.++++.+.. .++......++.|++.||+|||+.   ++|||||...||+|....-|||+
T Consensus       463 -----~P~WivmEL~~~GELr~yLq~nk~-sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLa  533 (974)
T KOG4257|consen  463 -----QPMWIVMELAPLGELREYLQQNKD-SLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLA  533 (974)
T ss_pred             -----cceeEEEecccchhHHHHHHhccc-cchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeec
Confidence                 458999999999999999987554 466777889999999999999999   99999999999999999999999


Q ss_pred             ccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHH
Q 046639          180 DLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEF  258 (331)
Q Consensus       180 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~  258 (331)
                      |||+++.+.+..-       .......-...|+|||-+.-..++.++|||-||+++||++. |.-||.+..+.+.     
T Consensus       534 DFGLSR~~ed~~y-------YkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV-----  601 (974)
T KOG4257|consen  534 DFGLSRYLEDDAY-------YKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV-----  601 (974)
T ss_pred             ccchhhhccccch-------hhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce-----
Confidence            9999998743211       11112223345999999999999999999999999999998 9999987543221     


Q ss_pred             HHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhh
Q 046639          259 VKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARE  324 (331)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~  324 (331)
                               ...+...       +.-..+.+|++.|..|+.+||..+|.+||.+.+|...|+.+.+
T Consensus       602 ---------I~~iEnG-------eRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  602 ---------IGHIENG-------ERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             ---------EEEecCC-------CCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence                     0111111       1114556899999999999999999999999999999998876

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-40  Score=294.06  Aligned_cols=202  Identities=21%  Similarity=0.280  Sum_probs=170.0

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc---chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK---QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      ++|.+.+.||+|+||+||++.+..+++.||+|++...   .......+..|..++..++|+||+++++++     ...+.
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~   75 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAF-----QDENN   75 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEE-----ecCCe
Confidence            4799999999999999999999999999999998642   223345578899999999999999999984     45678


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      .++||||+++++|.+++.+.. ..++...+..++.|++.||+|||++   +++|+||||+||+++.++.++|+|||++..
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  151 (331)
T cd05597          76 LYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLR  151 (331)
T ss_pred             EEEEEecCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceee
Confidence            999999999999999997532 3467788889999999999999999   999999999999999999999999999876


Q ss_pred             cccCCCCCcccccCCceeecccccccCCcccCC-----CCCccchhhHhHHHHHHHHHhCCCCCCc
Q 046639          187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG-----SKASVSGDVYNFGILLLEMFTRRRPTDA  247 (331)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~g~~pf~~  247 (331)
                      .....       ........||+.|+|||++.+     ..++.++||||+||++|+|++|..||..
T Consensus       152 ~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~  210 (331)
T cd05597         152 LLADG-------TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA  210 (331)
T ss_pred             cCCCC-------CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence            42111       111122458999999999863     4578899999999999999999999965

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=7.5e-40  Score=282.77  Aligned_cols=250  Identities=25%  Similarity=0.338  Sum_probs=192.5

Q ss_pred             ceeeccCeeEEEEeeecCCCc--eEEEEEeecc-chhhHHHHHHHHHHHHcC-CCCCcceeeceeecccCCCcceeeEEE
Q 046639           36 NKIGQGGVSIVYKGILDESRS--IVAVKVVNLK-QKEASRSFAAECNALRNI-RHRNLIKIITICSSIDFEGFDFKAIVF  111 (331)
Q Consensus        36 ~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~lv~  111 (331)
                      +.||+|+||.||+|.+..++.  .+++|.+... .......+..|+.++.++ .|||++++++++.     ..+..+++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-----~~~~~~lv~   75 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HRGYLYLAI   75 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEe-----cCCCceEEE
Confidence            468999999999999977665  4678877533 234456788999999999 7999999999853     345689999


Q ss_pred             eecCCCCHHHHHHhcc--------------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEE
Q 046639          112 EYMQNRNLEQWLRQSN--------------GQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAH  177 (331)
Q Consensus       112 e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~k  177 (331)
                      |++++++|.+++....              ...+++..+..++.|++.|++|||+.   +++|+||||+||+++.++.++
T Consensus        76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~k  152 (270)
T cd05047          76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAK  152 (270)
T ss_pred             EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEE
Confidence            9999999999997532              12467788899999999999999999   999999999999999999999


Q ss_pred             EcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHH
Q 046639          178 VGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLH  256 (331)
Q Consensus       178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~  256 (331)
                      |+|||++.....         .........+..|+|||++.+..++.++||||||+++|+|++ |..||.....     .
T Consensus       153 l~dfgl~~~~~~---------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-----~  218 (270)
T cd05047         153 IADFGLSRGQEV---------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-----A  218 (270)
T ss_pred             ECCCCCccccch---------hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH-----H
Confidence            999998753210         001111223456999999988889999999999999999997 9999965321     1


Q ss_pred             HHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhh
Q 046639          257 EFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHAR  323 (331)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~  323 (331)
                      ........         ....       +....+...+.+++.+||+.+|.+|||+.++++.|+.+.
T Consensus       219 ~~~~~~~~---------~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         219 ELYEKLPQ---------GYRL-------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             HHHHHHhC---------CCCC-------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            11111100         0000       011234567889999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.2e-39  Score=280.12  Aligned_cols=252  Identities=21%  Similarity=0.259  Sum_probs=201.3

Q ss_pred             CCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc--chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           31 NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      +|.+.+.||.|++|.||++.+..++..+|+|.+...  .......+..|+.+++.++|+|++++++++..   ......+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~~~   77 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIID---RSNQTLY   77 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeec---CCCCEEE
Confidence            488899999999999999999989999999998643  23445668899999999999999999987642   3345679


Q ss_pred             EEEeecCCCCHHHHHHhc--cCCccchHHHHHHHHHHHHHHHHHh-----hcCCCCeeecCCCCCCEEecCCCcEEEccc
Q 046639          109 IVFEYMQNRNLEQWLRQS--NGQLRFLTQRVNIAIDVSFAIEYFH-----HHCQPSIVHGDLKPSNILLDQDIVAHVGDL  181 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~LH-----~~~~~~ivH~dik~~nilv~~~~~~kl~Df  181 (331)
                      ++||++++++|.+++...  ....+++..++.++.|++.||.+||     +.   +++|+||+|+||+++.++.++|+||
T Consensus        78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~  154 (265)
T cd08217          78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDF  154 (265)
T ss_pred             EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEecc
Confidence            999999999999999763  2345778889999999999999999     77   9999999999999999999999999


Q ss_pred             CcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHh
Q 046639          182 GLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKM  261 (331)
Q Consensus       182 g~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  261 (331)
                      |++.......        .......+++.|+|||.+.+..++.++|+||||+++++|++|..||....  ..........
T Consensus       155 g~~~~~~~~~--------~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~  224 (265)
T cd08217         155 GLAKILGHDS--------SFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN--QLQLASKIKE  224 (265)
T ss_pred             cccccccCCc--------ccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC--HHHHHHHHhc
Confidence            9988652111        11223457888999999998889999999999999999999999997532  1111111110


Q ss_pred             hCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          262 ALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      .        ..+           .........+.+++.+||+.+|++|||+.+|++
T Consensus       225 ~--------~~~-----------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~  261 (265)
T cd08217         225 G--------KFR-----------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ  261 (265)
T ss_pred             C--------CCC-----------CCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence            0        000           112234567899999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.7e-40  Score=283.40  Aligned_cols=259  Identities=19%  Similarity=0.319  Sum_probs=201.9

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCc----eEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCc
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRS----IVAVKVVNLKQ-KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGF  104 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  104 (331)
                      .+|.+.+.||+|+||+||+|.+..++.    .+|+|.+.... ......+.+|+.+++.++|+|+++++++|..      
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------   80 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS------   80 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec------
Confidence            578999999999999999999865554    68999876443 3344678899999999999999999998743      


Q ss_pred             ceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcc
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA  184 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a  184 (331)
                      ...++|+|++++++|.+++..... .+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.++|+|||++
T Consensus        81 ~~~~~v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~  156 (279)
T cd05057          81 SQVQLITQLMPLGCLLDYVRNHKD-NIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLA  156 (279)
T ss_pred             CceEEEEecCCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccc
Confidence            467899999999999999976433 367889999999999999999998   9999999999999999999999999999


Q ss_pred             cccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhC
Q 046639          185 KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMAL  263 (331)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~  263 (331)
                      ........      ........++..|+|||.+....++.++|+||||+++|++++ |..||.....  ...........
T Consensus       157 ~~~~~~~~------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~  228 (279)
T cd05057         157 KLLDVDEK------EYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA--VEIPDLLEKGE  228 (279)
T ss_pred             ccccCccc------ceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH--HHHHHHHhCCC
Confidence            86521110      000111223457999999988889999999999999999998 9999975421  11111111100


Q ss_pred             cchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhh
Q 046639          264 PDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARET  325 (331)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~  325 (331)
                      .     .              ..+..+...+.+++.+||..+|.+|||+.++++.|+.+.+.
T Consensus       229 ~-----~--------------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~  271 (279)
T cd05057         229 R-----L--------------PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD  271 (279)
T ss_pred             C-----C--------------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence            0     0              11112445688999999999999999999999999987553

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3e-39  Score=281.49  Aligned_cols=262  Identities=23%  Similarity=0.264  Sum_probs=201.2

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccch-hhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK-EASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      ++|...+.||.|++|.||+|.+..+++.+|+|.+..... .....+.+|+++++.++||||++++++|..   ...+.++
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~~~   77 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLD---ESSSSIG   77 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEc---cCCCeEE
Confidence            468889999999999999999998999999999874432 345678899999999999999999998743   2345689


Q ss_pred             EEEeecCCCCHHHHHHh--ccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          109 IVFEYMQNRNLEQWLRQ--SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      +|||++++++|.+++..  .....++...+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++..
T Consensus        78 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~  154 (287)
T cd06621          78 IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGE  154 (287)
T ss_pred             EEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccc
Confidence            99999999999998764  2234467788889999999999999999   999999999999999999999999999865


Q ss_pred             cccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcch
Q 046639          187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDK  266 (331)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  266 (331)
                      ...          .......++..|+|||.+.+..++.++||||||+++|+|++|..||...........+.........
T Consensus       155 ~~~----------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  224 (287)
T cd06621         155 LVN----------SLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP  224 (287)
T ss_pred             ccc----------cccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCC
Confidence            421          1111234677799999999889999999999999999999999999764221111111111111100


Q ss_pred             hhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          267 VMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                           .+.+....     .........+.+++.+||+.+|.+|||+.||++
T Consensus       225 -----~~~~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         225 -----NPELKDEP-----GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             -----chhhccCC-----CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence                 00000000     000123567889999999999999999999987

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-41  Score=297.75  Aligned_cols=258  Identities=24%  Similarity=0.376  Sum_probs=213.6

Q ss_pred             CCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeEE
Q 046639           31 NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIV  110 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv  110 (331)
                      +.+.-.+||.|.||.||.|.|+...--||||.++ ++.-..+.|+.|+.+|+.+.|||+|+++++|..     +...|||
T Consensus       268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLK-EDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~-----EpPFYIi  341 (1157)
T KOG4278|consen  268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTH-----EPPFYII  341 (1157)
T ss_pred             heeeeeccCCCcccceeeeeeeccceeeehhhhh-hcchhHHHHHHHHHHHHhhcCccHHHHhhhhcc-----CCCeEEE
Confidence            4666689999999999999999877789999996 445566889999999999999999999999854     3457999


Q ss_pred             EeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccccC
Q 046639          111 FEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGY  190 (331)
Q Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~  190 (331)
                      +|||.+|+|.+++++.+...++.-..+.++.||.+|+.||..+   +++||||...|+||.++..||++|||+++.+...
T Consensus       342 TEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgD  418 (1157)
T KOG4278|consen  342 TEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGD  418 (1157)
T ss_pred             EecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcCC
Confidence            9999999999999998888888788889999999999999999   9999999999999999999999999999998322


Q ss_pred             CCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhCcchhhh
Q 046639          191 EPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMALPDKVME  269 (331)
Q Consensus       191 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  269 (331)
                      .       ............|.|||-+....++.|+|||+||++|||+.| |-.||++..     +.+.+         .
T Consensus       419 T-------YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid-----lSqVY---------~  477 (1157)
T KOG4278|consen  419 T-------YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQVY---------G  477 (1157)
T ss_pred             c-------eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc-----HHHHH---------H
Confidence            1       112222223455999999999999999999999999999999 889997642     22221         1


Q ss_pred             hcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhh
Q 046639          270 IVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARET  325 (331)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~  325 (331)
                      ++...+.-       +-++.|++.+.+||..||+++|.+||++.|+-+.++.+..+
T Consensus       478 LLEkgyRM-------~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~  526 (1157)
T KOG4278|consen  478 LLEKGYRM-------DGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS  526 (1157)
T ss_pred             HHhccccc-------cCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence            12212211       22346999999999999999999999999999999887654

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=8.1e-40  Score=291.10  Aligned_cols=260  Identities=22%  Similarity=0.348  Sum_probs=200.2

Q ss_pred             cCCCcCceeeccCeeEEEEeeecC-------CCceEEEEEeeccc-hhhHHHHHHHHHHHHcC-CCCCcceeeceeeccc
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDE-------SRSIVAVKVVNLKQ-KEASRSFAAECNALRNI-RHRNLIKIITICSSID  100 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~  100 (331)
                      .+|++++.||+|+||.||+|.+..       +...||+|.+.... ......+.+|+.+++++ +|+||++++++|.   
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~---   88 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT---   88 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc---
Confidence            469999999999999999998643       22368999886432 33456788999999999 7999999999863   


Q ss_pred             CCCcceeeEEEeecCCCCHHHHHHhcc--------------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCC
Q 046639          101 FEGFDFKAIVFEYMQNRNLEQWLRQSN--------------GQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPS  166 (331)
Q Consensus       101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~  166 (331)
                        ..+..++++||+++++|.+++.+..              ...+++..+..++.|++.||+|||++   +++|+||||+
T Consensus        89 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~  163 (334)
T cd05100          89 --QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAAR  163 (334)
T ss_pred             --cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccc
Confidence              3457899999999999999997632              22366778889999999999999999   9999999999


Q ss_pred             CEEecCCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCC
Q 046639          167 NILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPT  245 (331)
Q Consensus       167 nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf  245 (331)
                      ||+++.++.++|+|||+++.......      ........++..|+|||++.+..++.++||||||+++|+|++ |..||
T Consensus       164 Nill~~~~~~kL~Dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~  237 (334)
T cd05100         164 NVLVTEDNVMKIADFGLARDVHNIDY------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY  237 (334)
T ss_pred             eEEEcCCCcEEECCcccceecccccc------cccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCC
Confidence            99999999999999999876521110      001111223456999999999899999999999999999998 88898


Q ss_pred             CcccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhh
Q 046639          246 DAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARE  324 (331)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~  324 (331)
                      ....     ............         ..       +.+..+...+.+++.+||+.+|++|||+.++++.|+.+..
T Consensus       238 ~~~~-----~~~~~~~~~~~~---------~~-------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~  295 (334)
T cd05100         238 PGIP-----VEELFKLLKEGH---------RM-------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT  295 (334)
T ss_pred             CCCC-----HHHHHHHHHcCC---------CC-------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence            6532     111111110000         00       1112345678899999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=5.6e-40  Score=282.62  Aligned_cols=254  Identities=22%  Similarity=0.329  Sum_probs=202.3

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ-KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      ++|.+.+.||.|++|.||+|.+..+++.+++|.+.... ......+.+|+.+++.+.||||+++++.+     ...+..+
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~   75 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF-----YNNGDIS   75 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheee-----ecCCEEE
Confidence            36888899999999999999999999999999986553 34456788999999999999999999985     3347789


Q ss_pred             EEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCCEEecCCCcEEEcccCccccc
Q 046639          109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHH-HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      +++|++++++|.+++.... ..++...+..++.|++.|+++||+ .   +++|+||+|+||+++.++.++|+|||.+...
T Consensus        76 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~  151 (265)
T cd06605          76 ICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQL  151 (265)
T ss_pred             EEEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhh
Confidence            9999999899999997653 456778888999999999999999 8   9999999999999999999999999988754


Q ss_pred             ccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchh
Q 046639          188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKV  267 (331)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  267 (331)
                      ...          ......++..|+|||.+.+..++.++||||||+++|+|++|..||...........+........  
T Consensus       152 ~~~----------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--  219 (265)
T cd06605         152 VNS----------LAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNE--  219 (265)
T ss_pred             HHH----------HhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcC--
Confidence            211          11115577889999999998999999999999999999999999975432222222222211111  


Q ss_pred             hhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          268 MEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                         ..+.+.          ...+...+.+++.+||..+|++|||+.+++.
T Consensus       220 ---~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         220 ---PPPRLP----------SGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             ---CCCCCC----------hhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence               000000          0115667899999999999999999999974

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-42  Score=283.16  Aligned_cols=249  Identities=21%  Similarity=0.288  Sum_probs=209.3

Q ss_pred             CCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeEE
Q 046639           31 NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIV  110 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv  110 (331)
                      -|.++.+||+|+||.||+|.++.+|+.+|||.+...  ...+.+..|+.+++++..|++|++++.+     -....+++|
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSY-----FK~sDLWIV  106 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSY-----FKHSDLWIV  106 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhh-----ccCCceEee
Confidence            488899999999999999999999999999987543  4567899999999999999999999985     334568999


Q ss_pred             EeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccccC
Q 046639          111 FEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGY  190 (331)
Q Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~  190 (331)
                      ||||..|+..++++-+ ++.+.+..+..++...++||.|||..   .-+|||||..|||++-+|+.||+|||.|-.+   
T Consensus       107 MEYCGAGSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQL---  179 (502)
T KOG0574|consen  107 MEYCGAGSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQL---  179 (502)
T ss_pred             hhhcCCCcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchh---
Confidence            9999999999999754 45678899999999999999999999   9999999999999999999999999998654   


Q ss_pred             CCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhhh
Q 046639          191 EPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEI  270 (331)
Q Consensus       191 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  270 (331)
                           .......+...|||.|+|||++..-.|+.++||||||++..||..|++||.+..+-              .....
T Consensus       180 -----TDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM--------------RAIFM  240 (502)
T KOG0574|consen  180 -----TDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM--------------RAIFM  240 (502)
T ss_pred             -----hhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc--------------ceeEe
Confidence                 34445566788999999999999889999999999999999999999999754210              00000


Q ss_pred             cCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          271 VDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      +.     .-++..+.-++..+..+.+++++||-.+|++|.|+.++++
T Consensus       241 IP-----T~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  241 IP-----TKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             cc-----CCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence            00     0112222345667888999999999999999999999876

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=8.6e-40  Score=285.04  Aligned_cols=258  Identities=23%  Similarity=0.398  Sum_probs=198.7

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecC-----CCceEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCC
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDE-----SRSIVAVKVVNLKQ-KEASRSFAAECNALRNIRHRNLIKIITICSSIDFE  102 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  102 (331)
                      .++|.+.+.||+|+||.||+|.+..     ++..+|+|.+.... ......+.+|+.+++.+.|||++++++++     .
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~-----~   78 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVC-----A   78 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEE-----c
Confidence            4579999999999999999998743     57789999986543 33446688999999999999999999985     3


Q ss_pred             CcceeeEEEeecCCCCHHHHHHhcc--------------------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecC
Q 046639          103 GFDFKAIVFEYMQNRNLEQWLRQSN--------------------GQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGD  162 (331)
Q Consensus       103 ~~~~~~lv~e~~~~~~L~~~l~~~~--------------------~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~d  162 (331)
                      .....++++|++++++|.+++....                    ...++...++.++.|++.||.+||..   +++|+|
T Consensus        79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~d  155 (288)
T cd05050          79 VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRD  155 (288)
T ss_pred             CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---Ceeccc
Confidence            4457899999999999999997532                    12356677889999999999999999   999999


Q ss_pred             CCCCCEEecCCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-C
Q 046639          163 LKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-R  241 (331)
Q Consensus       163 ik~~nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g  241 (331)
                      |+|+||+++.++.++|+|||++........      .........+..|+|||.+.+..++.++||||||+++|+|++ |
T Consensus       156 l~p~nil~~~~~~~~l~dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~  229 (288)
T cd05050         156 LATRNCLVGENMVVKIADFGLSRNIYSADY------YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG  229 (288)
T ss_pred             ccHhheEecCCCceEECccccceecccCcc------ccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCC
Confidence            999999999999999999999875421110      011111223456999999988899999999999999999998 8


Q ss_pred             CCCCCcccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHH
Q 046639          242 RRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRH  321 (331)
Q Consensus       242 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~  321 (331)
                      ..||......     ..........        ..        .....++..+.+++.+||+.+|++|||+.||++.|++
T Consensus       230 ~~p~~~~~~~-----~~~~~~~~~~--------~~--------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         230 MQPYYGMAHE-----EVIYYVRDGN--------VL--------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             CCCCCCCCHH-----HHHHHHhcCC--------CC--------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            8888543211     1111110000        00        0112345678999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=8.4e-40  Score=285.49  Aligned_cols=270  Identities=20%  Similarity=0.287  Sum_probs=194.8

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchh-hHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKE-ASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      ++|.+.+.||.|++|.||+|.+..+++.||+|.+...... ....+.+|+.+++.++|+||+++++++     ......+
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~   79 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII-----HTKKTLT   79 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEE-----ecCCeEE
Confidence            5799999999999999999999888999999998644322 224467899999999999999999984     4456889


Q ss_pred             EEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccc
Q 046639          109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLF  188 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~  188 (331)
                      +||||+. ++|.+++..... .+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++....
T Consensus        80 lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  154 (291)
T cd07844          80 LVFEYLD-TDLKQYMDDCGG-GLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKS  154 (291)
T ss_pred             EEEecCC-CCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccC
Confidence            9999996 599998876443 567788999999999999999999   99999999999999999999999999986531


Q ss_pred             cCCCCCcccccCCceeecccccccCCcccCC-CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCc---
Q 046639          189 GYEPGTAAETASNSIEIKGIVGYVAPEYGMG-SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALP---  264 (331)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~---  264 (331)
                      ..        ........++..|+|||++.+ ..++.++||||+|+++|+|++|..||...................   
T Consensus       155 ~~--------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (291)
T cd07844         155 VP--------SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTE  226 (291)
T ss_pred             CC--------CccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCCh
Confidence            10        011111235677999999875 457899999999999999999999997543221112111111000   


Q ss_pred             chhhhhcCcc-----cccccccC-CcchHHHH--HHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          265 DKVMEIVDPS-----LLLEVTAN-NYSWIEDC--LVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       265 ~~~~~~~~~~-----~~~~~~~~-~~~~~~~~--~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ..........     ........ ........  ...+.+++.+||+.+|++|||+.++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         227 ETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             hhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence            0000000000     00000000 00000011  256789999999999999999999874

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=5.4e-40  Score=286.79  Aligned_cols=251  Identities=19%  Similarity=0.265  Sum_probs=198.7

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeE
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAI  109 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~l  109 (331)
                      +.|.....||+|+||.||++.+..++..||+|.+..........+.+|+.+++.++|+|++++++.+     ...+..++
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~-----~~~~~~~l   96 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY-----LVGDELWV   96 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHhe-----ecCCeEEE
Confidence            3456667899999999999999888999999998766655667788999999999999999999985     44567899


Q ss_pred             EEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccccc
Q 046639          110 VFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG  189 (331)
Q Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~  189 (331)
                      |||++++++|.+++...   .+++..+..++.|++.|+.+||++   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        97 v~e~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~  170 (292)
T cd06658          97 VMEFLEGGALTDIVTHT---RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK  170 (292)
T ss_pred             EEeCCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccc
Confidence            99999999999988543   366788999999999999999999   999999999999999999999999999875421


Q ss_pred             CCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhh
Q 046639          190 YEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVME  269 (331)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  269 (331)
                      .        ........++..|+|||.+.+..++.++||||||+++|+|++|..||.....  ..........       
T Consensus       171 ~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--~~~~~~~~~~-------  233 (292)
T cd06658         171 E--------VPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP--LQAMRRIRDN-------  233 (292)
T ss_pred             c--------cccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhc-------
Confidence            1        1112234578889999999888899999999999999999999999964321  1111111110       


Q ss_pred             hcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHH
Q 046639          270 IVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAK  318 (331)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~  318 (331)
                       ..+...         ........+.+++.+||..||.+|||+.++++.
T Consensus       234 -~~~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         234 -LPPRVK---------DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             -CCCccc---------cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence             111100         011234568889999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=7.8e-41  Score=286.98  Aligned_cols=240  Identities=21%  Similarity=0.365  Sum_probs=185.0

Q ss_pred             ceeeccCeeEEEEeeecCCCc-------eEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           36 NKIGQGGVSIVYKGILDESRS-------IVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        36 ~~lg~G~~g~V~~~~~~~~~~-------~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      +.||.|+||+||+|.+...+.       .+++|.+........+.+..|+.+++.+.|||++++++++.     .....+
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~-----~~~~~~   75 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCV-----CGDESI   75 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEE-----eCCCcE
Confidence            479999999999998865433       48888876554555567889999999999999999999964     345678


Q ss_pred             EEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCc--------EEEcc
Q 046639          109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIV--------AHVGD  180 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~--------~kl~D  180 (331)
                      +||||+++++|.+++..... .+++..+..++.|++.||+|||++   +++|+||||+||+++.++.        ++++|
T Consensus        76 lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d  151 (258)
T cd05078          76 MVQEYVKFGSLDTYLKKNKN-LINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD  151 (258)
T ss_pred             EEEecCCCCcHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecc
Confidence            99999999999999976433 467788889999999999999999   9999999999999987765        68999


Q ss_pred             cCcccccccCCCCCcccccCCceeecccccccCCcccCCC-CCccchhhHhHHHHHHHHHhCC-CCCCcccCCcchHHHH
Q 046639          181 LGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGS-KASVSGDVYNFGILLLEMFTRR-RPTDAMFNEGLTLHEF  258 (331)
Q Consensus       181 fg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~-~pf~~~~~~~~~~~~~  258 (331)
                      ||.+....            ......++..|+|||++.+. .++.++||||||+++|+|++|. .||......  .....
T Consensus       152 ~g~~~~~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~--~~~~~  217 (258)
T cd05078         152 PGISITVL------------PKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ--KKLQF  217 (258)
T ss_pred             cccccccC------------CchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH--HHHHH
Confidence            99876531            11223467789999998874 5799999999999999999984 565432111  11111


Q ss_pred             HHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHH
Q 046639          259 VKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKL  319 (331)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L  319 (331)
                      ....          .           ..+......+.+|+.+||+.+|++|||+.+|++.|
T Consensus       218 ~~~~----------~-----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l  257 (258)
T cd05078         218 YEDR----------H-----------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL  257 (258)
T ss_pred             HHcc----------c-----------cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence            1100          0           01111235688999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.1e-39  Score=280.83  Aligned_cols=255  Identities=19%  Similarity=0.288  Sum_probs=197.1

Q ss_pred             CCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc------hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCc
Q 046639           31 NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ------KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGF  104 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  104 (331)
                      +|++.+.||+|+||+||+|.+. +++.+|+|.+....      ......+.+|+++++.++|+||+++++++     ...
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~   74 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTC-----LDD   74 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEe-----ecC
Confidence            5889999999999999999874 77889999886432      22335688999999999999999999995     344


Q ss_pred             ceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcc
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA  184 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a  184 (331)
                      +..++++|++++++|.+++.+..  .++...+..++.|++.||++||+.   +++|+||+|+||+++.++.++|+|||++
T Consensus        75 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~  149 (265)
T cd06631          75 NTISIFMEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCA  149 (265)
T ss_pred             CeEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhh
Confidence            68899999999999999997643  356788889999999999999999   9999999999999999999999999998


Q ss_pred             cccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCc
Q 046639          185 KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALP  264 (331)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  264 (331)
                      .........  ...........++..|+|||++.+..++.++||||||+++|+|++|..||......    .........
T Consensus       150 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~----~~~~~~~~~  223 (265)
T cd06631         150 RRLAWVGLH--GTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL----AAMFYIGAH  223 (265)
T ss_pred             Hhhhhcccc--ccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH----HHHHHhhhc
Confidence            765221111  01111222345788899999999888999999999999999999999999753211    111100000


Q ss_pred             chhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          265 DKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      .    ...+           .....+...+.+++.+||+.+|.+|||+.++++
T Consensus       224 ~----~~~~-----------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         224 R----GLMP-----------RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             c----CCCC-----------CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            0    0000           011234567889999999999999999999874

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.4e-39  Score=280.53  Aligned_cols=254  Identities=20%  Similarity=0.271  Sum_probs=195.7

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc-----hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCc
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ-----KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGF  104 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  104 (331)
                      .+|.+.+.||+|++|.||+|.+..++..|++|.+....     ......+.+|+.+++.++||||+++++++..   ...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~   78 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRD---RAE   78 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEc---CCC
Confidence            47999999999999999999999899999999886432     2234568899999999999999999988542   224


Q ss_pred             ceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcc
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA  184 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a  184 (331)
                      ...++++|++++++|.+++....  .++....+.++.|++.||++||+.   +++|+||+|+||+++.++.++|+|||++
T Consensus        79 ~~~~l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~  153 (266)
T cd06651          79 KTLTIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGAS  153 (266)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCc
Confidence            56789999999999999996543  366788889999999999999999   9999999999999999999999999998


Q ss_pred             cccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCc
Q 046639          185 KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALP  264 (331)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  264 (331)
                      .......     ..........++..|+|||++.+..++.++||||+|+++|+|++|..||.....    ..........
T Consensus       154 ~~~~~~~-----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~----~~~~~~~~~~  224 (266)
T cd06651         154 KRLQTIC-----MSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA----MAAIFKIATQ  224 (266)
T ss_pred             ccccccc-----ccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch----HHHHHHHhcC
Confidence            7542110     011111234477889999999988899999999999999999999999975321    1111110000


Q ss_pred             chhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          265 DKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      .     ..+           .++......+.+++ +||..+|++|||+.+|++
T Consensus       225 ~-----~~~-----------~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         225 P-----TNP-----------QLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             C-----CCC-----------CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            0     011           11223445566676 688899999999999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.5e-39  Score=279.40  Aligned_cols=254  Identities=23%  Similarity=0.388  Sum_probs=199.1

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      ..+|.+.+.||+|+||.||++.+. .+..+++|.+... ......+.+|+.+++.++|+|++++.+.+.     . ...+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~-~~~~   76 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVT-----K-EPIY   76 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEc-----C-CCeE
Confidence            457999999999999999999865 4456899988643 333467889999999999999999998853     2 4578


Q ss_pred             EEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccc
Q 046639          109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLF  188 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~  188 (331)
                      ++||++++++|.+++........++..+..++.|++.||.+||+.   +++|+||+|+||+++.++.++|+|||.+....
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~  153 (260)
T cd05073          77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIE  153 (260)
T ss_pred             EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeecc
Confidence            999999999999999876555677788889999999999999999   99999999999999999999999999987642


Q ss_pred             cCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhCcchh
Q 046639          189 GYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMALPDKV  267 (331)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  267 (331)
                      ...       ........++..|+|||++.+..++.++|+||||++++++++ |..||......  ............  
T Consensus       154 ~~~-------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~~~~~--  222 (260)
T cd05073         154 DNE-------YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIRALERGYRM--  222 (260)
T ss_pred             CCC-------cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHhCCCCC--
Confidence            111       011112234566999999998889999999999999999998 99999753211  111111111000  


Q ss_pred             hhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHH
Q 046639          268 MEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRH  321 (331)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~  321 (331)
                                       ......+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus       223 -----------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         223 -----------------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             -----------------CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                             0011234578899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.6e-39  Score=279.35  Aligned_cols=256  Identities=23%  Similarity=0.373  Sum_probs=192.1

Q ss_pred             ceeeccCeeEEEEeeecC---CCceEEEEEeecc-chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeEEE
Q 046639           36 NKIGQGGVSIVYKGILDE---SRSIVAVKVVNLK-QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVF  111 (331)
Q Consensus        36 ~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~  111 (331)
                      +.||+|+||.||+|.+..   ....+|+|.+... .......+.+|+.+++.++|||++++++++..    .++..++++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~~lv~   76 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLP----SEGSPLVVL   76 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeec----CCCCcEEEE
Confidence            468999999999998643   3457999988533 33445678899999999999999999997642    335578999


Q ss_pred             eecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccccCC
Q 046639          112 EYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYE  191 (331)
Q Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~~  191 (331)
                      |++.+++|.+++..... ...+.....++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||+++......
T Consensus        77 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~  152 (262)
T cd05058          77 PYMKHGDLRNFIRSETH-NPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKE  152 (262)
T ss_pred             ecCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCc
Confidence            99999999999976433 245567788999999999999999   99999999999999999999999999987542211


Q ss_pred             CCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhCcchhhhh
Q 046639          192 PGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMALPDKVMEI  270 (331)
Q Consensus       192 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  270 (331)
                      .    ..........++..|+|||.+.+..++.++||||||+++|||++ |.+||.....  ..........        
T Consensus       153 ~----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--~~~~~~~~~~--------  218 (262)
T cd05058         153 Y----YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS--FDITVYLLQG--------  218 (262)
T ss_pred             c----eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHhcC--------
Confidence            0    00011112235667999999988889999999999999999999 4666654211  1111111000        


Q ss_pred             cCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhh
Q 046639          271 VDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARE  324 (331)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~  324 (331)
                      ..+           .....++..+.+++.+||+.+|++||++.+|++.|+++..
T Consensus       219 ~~~-----------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         219 RRL-----------LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             CCC-----------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence            000           0011234578899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5e-40  Score=298.29  Aligned_cols=267  Identities=19%  Similarity=0.174  Sum_probs=195.4

Q ss_pred             hcCCCcCceeeccCeeEEEEeeec--CCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILD--ESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      ..+|.+.+.||.|+||.||+|...  .++..|++|.+...     ....+|+.+++.++||||+++++++     .....
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~  160 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAY-----RWKST  160 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeE-----eeCCE
Confidence            457999999999999999999764  35678999987533     2345799999999999999999884     44567


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      .+++||++ .++|.+++...  ..+++..+..++.|++.||.|||++   +|+||||||+||+++.++.++|+|||++..
T Consensus       161 ~~lv~e~~-~~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~  234 (392)
T PHA03207        161 VCMVMPKY-KCDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACK  234 (392)
T ss_pred             EEEEehhc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccc
Confidence            89999999 57899988433  3477889999999999999999999   999999999999999999999999999976


Q ss_pred             cccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCc--chHHHHHHhhCc
Q 046639          187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEG--LTLHEFVKMALP  264 (331)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~  264 (331)
                      ....      ..........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.....  ..+.........
T Consensus       235 ~~~~------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~  308 (392)
T PHA03207        235 LDAH------PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQV  308 (392)
T ss_pred             cCcc------cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhcc
Confidence            5221      11112234568999999999999999999999999999999999999997543321  112222211110


Q ss_pred             chhh--h-----------hcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          265 DKVM--E-----------IVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       265 ~~~~--~-----------~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ....  .           ...............-........+.+++.+||..||++|||+.+++.
T Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~  374 (392)
T PHA03207        309 HPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS  374 (392)
T ss_pred             CccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence            0000  0           000000000000000000123456788999999999999999999985

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=5.7e-40  Score=284.56  Aligned_cols=247  Identities=19%  Similarity=0.276  Sum_probs=198.1

Q ss_pred             CCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeE
Q 046639           31 NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ-KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAI  109 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~l  109 (331)
                      .|.+.+.||+|++|.||+|.+..++..||+|.+.... ......+.+|+.+++.++|||++++++.+     ......++
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l   79 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY-----LKGTKLWI   79 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhccc-----ccCCceEE
Confidence            4778889999999999999998889999999986443 34456788999999999999999999984     44567899


Q ss_pred             EEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccccc
Q 046639          110 VFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG  189 (331)
Q Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~  189 (331)
                      |+|++++++|.+++..   ..+++..+..++.|++.|+.|||++   +++|+||+|+||+++.++.++++|||++.....
T Consensus        80 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06642          80 IMEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD  153 (277)
T ss_pred             EEEccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccC
Confidence            9999999999998854   2467788899999999999999999   999999999999999999999999999876521


Q ss_pred             CCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhh
Q 046639          190 YEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVME  269 (331)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  269 (331)
                      .        ........++..|+|||.+.+..++.++||||||+++|+|++|..||.......  ........       
T Consensus       154 ~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~-------  216 (277)
T cd06642         154 T--------QIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR--VLFLIPKN-------  216 (277)
T ss_pred             c--------chhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh--HHhhhhcC-------
Confidence            1        111122346778999999998889999999999999999999999986432211  00000000       


Q ss_pred             hcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          270 IVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                       ..+           .....+...+.+++.+||+.+|++|||+.++++
T Consensus       217 -~~~-----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06642         217 -SPP-----------TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK  252 (277)
T ss_pred             -CCC-----------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence             000           111234567889999999999999999999997

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1e-39  Score=288.42  Aligned_cols=200  Identities=22%  Similarity=0.294  Sum_probs=159.8

Q ss_pred             CceeeccCeeEEEEeeecC--CCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeEEEe
Q 046639           35 ANKIGQGGVSIVYKGILDE--SRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFE  112 (331)
Q Consensus        35 ~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~e  112 (331)
                      +.+||+|+||+||+|.+..  ++..||+|.+....  ....+.+|+.+++.++||||+++++++..   ......++|+|
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~~lv~e   80 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLS---HSDRKVWLLFD   80 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEec---cCCCeEEEEEe
Confidence            4689999999999999653  56789999885432  23457789999999999999999998753   33457899999


Q ss_pred             ecCCCCHHHHHHhc-------cCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEe----cCCCcEEEccc
Q 046639          113 YMQNRNLEQWLRQS-------NGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILL----DQDIVAHVGDL  181 (331)
Q Consensus       113 ~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv----~~~~~~kl~Df  181 (331)
                      ++ +++|.+++...       ....+++..+..++.|++.||.|||+.   +++|+||||+||++    +.++.+||+||
T Consensus        81 ~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07867          81 YA-EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             ee-CCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence            99 56888887532       122467778889999999999999999   99999999999999    56679999999


Q ss_pred             CcccccccCCCCCcccccCCceeecccccccCCcccCCC-CCccchhhHhHHHHHHHHHhCCCCCCcc
Q 046639          182 GLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGS-KASVSGDVYNFGILLLEMFTRRRPTDAM  248 (331)
Q Consensus       182 g~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~  248 (331)
                      |+++.......     .........+|+.|+|||++.+. .++.++||||||+++|+|++|.+||...
T Consensus       157 G~a~~~~~~~~-----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         157 GFARLFNSPLK-----PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             cceeccCCCcc-----cccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            99986522111     11122334578899999998764 5799999999999999999999999754

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=8.3e-40  Score=284.57  Aligned_cols=256  Identities=20%  Similarity=0.275  Sum_probs=201.8

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCccee
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ-KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      .++|++.+.||+|++|+||++.+..+++.+|+|++.... ......+.+|+.+++.++||||+++++.+.     ..+..
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~   78 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFL-----NENNI   78 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEe-----cCCEE
Confidence            457999999999999999999999899999999886543 344567889999999999999999999954     34678


Q ss_pred             eEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccc
Q 046639          108 AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      ++||||+++++|.+++.+..  .+++..+..++.+++.|+.|||+..  +++|+||+|+||+++.++.++|+|||++...
T Consensus        79 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~  154 (284)
T cd06620          79 CMCMEFMDCGSLDRIYKKGG--PIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGEL  154 (284)
T ss_pred             EEEEecCCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccch
Confidence            99999999999999987643  4677888999999999999999742  8999999999999999999999999988654


Q ss_pred             ccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcc------hHHHHHHh
Q 046639          188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGL------TLHEFVKM  261 (331)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~------~~~~~~~~  261 (331)
                      ...          ......++..|+|||++.+..++.++||||||+++|+|++|..||........      ........
T Consensus       155 ~~~----------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  224 (284)
T cd06620         155 INS----------IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQ  224 (284)
T ss_pred             hhh----------ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHH
Confidence            111          11134578889999999888899999999999999999999999976433211      01111111


Q ss_pred             hCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHH
Q 046639          262 ALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAK  318 (331)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~  318 (331)
                      ....     ..+..    .      ...++..+.+|+.+||+.||++|||+.++++.
T Consensus       225 ~~~~-----~~~~~----~------~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~  266 (284)
T cd06620         225 IVQE-----PPPRL----P------SSDFPEDLRDFVDACLLKDPTERPTPQQLCAM  266 (284)
T ss_pred             Hhhc-----cCCCC----C------chhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            1100     00000    0      01255678899999999999999999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=8.5e-40  Score=284.43  Aligned_cols=269  Identities=22%  Similarity=0.302  Sum_probs=197.9

Q ss_pred             CCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           31 NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ--KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      +|.+.+.||.|++|.||+|.+..++..||+|.+....  ......+.+|++++++++|||++++++++     .+....+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~   75 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY   75 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhc-----ccCCcEE
Confidence            4889999999999999999999899999999886443  22335688999999999999999999984     4566789


Q ss_pred             EEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccc
Q 046639          109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLF  188 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~  188 (331)
                      +||||+ .++|.+++.......+++..+..++.|++.||+|||..   +++|+||+|+||+++.++.++|+|||++....
T Consensus        76 ~v~e~~-~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~  151 (284)
T cd07860          76 LVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG  151 (284)
T ss_pred             EEeecc-ccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcc
Confidence            999999 46899998776666678889999999999999999999   99999999999999999999999999987541


Q ss_pred             cCCCCCcccccCCceeecccccccCCcccCCCC-CccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhh-Ccc-
Q 046639          189 GYEPGTAAETASNSIEIKGIVGYVAPEYGMGSK-ASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMA-LPD-  265 (331)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~-~~~-  265 (331)
                      ...        .......+++.|+|||+..+.. ++.++||||||+++|+|++|..||....... ......... .+. 
T Consensus       152 ~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~-~~~~~~~~~~~~~~  222 (284)
T cd07860         152 VPV--------RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLGTPDE  222 (284)
T ss_pred             cCc--------cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCCh
Confidence            110        1111223577899999877644 6889999999999999999999997532211 111111111 000 


Q ss_pred             hhhhhcC--cccccccc----cCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          266 KVMEIVD--PSLLLEVT----ANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       266 ~~~~~~~--~~~~~~~~----~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      .......  +.....+.    .............+.+++.+||+.||.+|||+.++++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         223 VVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             hhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence            0000000  00000000    0000111234556789999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=9.1e-40  Score=280.98  Aligned_cols=240  Identities=19%  Similarity=0.346  Sum_probs=184.2

Q ss_pred             ceeeccCeeEEEEeeecC------------CCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCC
Q 046639           36 NKIGQGGVSIVYKGILDE------------SRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEG  103 (331)
Q Consensus        36 ~~lg~G~~g~V~~~~~~~------------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  103 (331)
                      +.||+|+||.||+|....            ....+++|.+..........+..|+.+++.++||||+++++++.     .
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~-----~   75 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCV-----R   75 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEe-----c
Confidence            468999999999998632            23358889876555555567888999999999999999999964     3


Q ss_pred             cceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCc-------E
Q 046639          104 FDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIV-------A  176 (331)
Q Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~-------~  176 (331)
                      ....+++||++++++|..++.... ..+++..+..++.|++.|++|||++   +++|+||||+||+++.++.       +
T Consensus        76 ~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~  151 (262)
T cd05077          76 DVENIMVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFI  151 (262)
T ss_pred             CCCCEEEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCcee
Confidence            456789999999999998886533 3467788899999999999999999   9999999999999987664       8


Q ss_pred             EEcccCcccccccCCCCCcccccCCceeecccccccCCcccC-CCCCccchhhHhHHHHHHHHH-hCCCCCCcccCCcch
Q 046639          177 HVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGM-GSKASVSGDVYNFGILLLEMF-TRRRPTDAMFNEGLT  254 (331)
Q Consensus       177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~DiwslG~il~el~-~g~~pf~~~~~~~~~  254 (331)
                      +++|||++....            ......++..|+|||++. +..++.++||||||+++|+|+ +|..||......  .
T Consensus       152 ~l~d~g~~~~~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~--~  217 (262)
T cd05077         152 KLSDPGIPITVL------------SRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA--E  217 (262)
T ss_pred             EeCCCCCCcccc------------CcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh--H
Confidence            999999886541            112234677899999886 466899999999999999998 588887643111  1


Q ss_pred             HHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHH
Q 046639          255 LHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKL  319 (331)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L  319 (331)
                      .........                     .........+.+|+.+||+.||++||++.+|++.|
T Consensus       218 ~~~~~~~~~---------------------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         218 KERFYEGQC---------------------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             HHHHHhcCc---------------------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            111111000                     00011245688999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-40  Score=292.81  Aligned_cols=255  Identities=23%  Similarity=0.315  Sum_probs=196.8

Q ss_pred             HHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEee--ccchhhHHHHHHHHHHHHcCC-CCCcceeeceeecccCCC
Q 046639           27 KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVN--LKQKEASRSFAAECNALRNIR-HRNLIKIITICSSIDFEG  103 (331)
Q Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~  103 (331)
                      ...+.|.++++||+||.+.||++.... .+.||+|.+.  ..+......+.+|+..|.+|+ |.+|+++++|     .-.
T Consensus       358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DY-----Ev~  431 (677)
T KOG0596|consen  358 VKGREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDY-----EVT  431 (677)
T ss_pred             ECcchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeee-----ecc
Confidence            456789999999999999999998753 4456777653  335556678999999999995 9999999999     556


Q ss_pred             cceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCc
Q 046639          104 FDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGL  183 (331)
Q Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~  183 (331)
                      ++.+|+|||+= ..+|..++++.......+ ..+.++.|++.|+.+.|..   ||||.||||.|+++- .|.+||+|||+
T Consensus       432 d~~lYmvmE~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDFGI  505 (677)
T KOG0596|consen  432 DGYLYMVMECG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDFGI  505 (677)
T ss_pred             CceEEEEeecc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeeech
Confidence            78999999976 789999999876655444 5678889999999999999   999999999999997 67999999999


Q ss_pred             ccccccCCCCCcccccCCceeecccccccCCcccCCC-----------CCccchhhHhHHHHHHHHHhCCCCCCcccCCc
Q 046639          184 AKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGS-----------KASVSGDVYNFGILLLEMFTRRRPTDAMFNEG  252 (331)
Q Consensus       184 a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-----------~~~~~~DiwslG~il~el~~g~~pf~~~~~~~  252 (331)
                      |.-+..      .........-.||+.||+||.+...           ..+.++||||||||||+|+.|++||+...+  
T Consensus       506 A~aI~~------DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n--  577 (677)
T KOG0596|consen  506 ANAIQP------DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN--  577 (677)
T ss_pred             hcccCc------cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH--
Confidence            987622      2223334456799999999987542           246789999999999999999999975311  


Q ss_pred             chHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          253 LTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                           .+.     ++..+.+|....+++.-..      ..++.++|+.||.+||.+|||..++++
T Consensus       578 -----~~a-----Kl~aI~~P~~~Iefp~~~~------~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  578 -----QIA-----KLHAITDPNHEIEFPDIPE------NDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             -----HHH-----HHHhhcCCCccccccCCCC------chHHHHHHHHHHhcCcccCCCcHHHhc
Confidence                 111     2233344432222211100      112899999999999999999999985

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=2.3e-40  Score=294.10  Aligned_cols=255  Identities=19%  Similarity=0.196  Sum_probs=192.9

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc---chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK---QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      ++|.+.+.||+|+||+||++++..+++.||+|++...   .......+.+|..++..+.|++|+++++++     ...+.
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~-----~~~~~   75 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAF-----QDENY   75 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCE
Confidence            4799999999999999999999999999999998642   222334577899999999999999999984     45678


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      .++||||+++++|.+++.+.. ..++...+..++.|++.||.+||++   +|+|+||||+||+++.++.+||+|||++..
T Consensus        76 ~~lv~Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~  151 (331)
T cd05624          76 LYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLK  151 (331)
T ss_pred             EEEEEeCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceee
Confidence            899999999999999997633 2466788889999999999999999   999999999999999999999999999876


Q ss_pred             cccCCCCCcccccCCceeecccccccCCcccCC-----CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHh
Q 046639          187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG-----SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKM  261 (331)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  261 (331)
                      .....       ........||+.|+|||++.+     +.++.++||||||+++|+|++|..||.....     ......
T Consensus       152 ~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~-----~~~~~~  219 (331)
T cd05624         152 MNQDG-------TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL-----VETYGK  219 (331)
T ss_pred             ccCCC-------ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH-----HHHHHH
Confidence            52111       111123458999999999875     4678899999999999999999999964321     111111


Q ss_pred             hCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCC--CCcHHHHHH
Q 046639          262 ALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPME--RMEMRDVVA  317 (331)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--Rps~~~i~~  317 (331)
                      .....        ....++    ....+++..+.+++.+||+..+.+  |+++.++++
T Consensus       220 i~~~~--------~~~~~p----~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~  265 (331)
T cd05624         220 IMNHE--------ERFQFP----SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK  265 (331)
T ss_pred             HHcCC--------CcccCC----CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence            10000        000000    111234567888888888865544  457777754

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=6.8e-41  Score=270.93  Aligned_cols=254  Identities=24%  Similarity=0.339  Sum_probs=205.5

Q ss_pred             HHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc--------hhhHHHHHHHHHHHHcC-CCCCcceeeceee
Q 046639           27 KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ--------KEASRSFAAECNALRNI-RHRNLIKIITICS   97 (331)
Q Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~   97 (331)
                      ..-+.|.--+.||.|..++|-++.++.++..+|+|++....        .+..+.-..|+.+|+++ .||+|+++.++  
T Consensus        14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~--   91 (411)
T KOG0599|consen   14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV--   91 (411)
T ss_pred             hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee--
Confidence            45567888899999999999999999999999999986332        12234556799999998 59999999999  


Q ss_pred             cccCCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEE
Q 046639           98 SIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAH  177 (331)
Q Consensus        98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~k  177 (331)
                         +++..++++|+|.++.|.|.+++...  -.+++.....++.|+.+|+.|||.+   +|||||+||+|||++++-+++
T Consensus        92 ---yes~sF~FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~  163 (411)
T KOG0599|consen   92 ---YESDAFVFLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIK  163 (411)
T ss_pred             ---ccCcchhhhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceE
Confidence               67778899999999999999999653  3478889999999999999999999   999999999999999999999


Q ss_pred             EcccCcccccccCCCCCcccccCCceeecccccccCCcccCC------CCCccchhhHhHHHHHHHHHhCCCCCCcccCC
Q 046639          178 VGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG------SKASVSGDVYNFGILLLEMFTRRRPTDAMFNE  251 (331)
Q Consensus       178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~  251 (331)
                      |+|||+++.+         .........+|||+|+|||.+..      ..|+...|+||+|+|+|.|+.|.+||-.- ..
T Consensus       164 isDFGFa~~l---------~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR-kQ  233 (411)
T KOG0599|consen  164 ISDFGFACQL---------EPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR-KQ  233 (411)
T ss_pred             Eeccceeecc---------CCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH-HH
Confidence            9999999876         45566778899999999998653      35788999999999999999999998421 00


Q ss_pred             cchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          252 GLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      -..+..+....     .         .+.   +....+......+|+.+||+.||.+|.|+.|.+.
T Consensus       234 mlMLR~ImeGk-----y---------qF~---speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  234 MLMLRMIMEGK-----Y---------QFR---SPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             HHHHHHHHhcc-----c---------ccC---CcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence            00000000000     0         011   1223467788999999999999999999999875

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.5e-39  Score=284.94  Aligned_cols=268  Identities=21%  Similarity=0.267  Sum_probs=198.8

Q ss_pred             CCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchh-----hHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcc
Q 046639           31 NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKE-----ASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFD  105 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~  105 (331)
                      +|.+.+.||.|++|.||+|.+..+++.||+|.+......     ....+..|+.+++.++|+|++++++++     ....
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~   75 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVF-----GHKS   75 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhhee-----ecCC
Confidence            588899999999999999999988999999999654322     345577899999999999999999995     3456


Q ss_pred             eeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccc
Q 046639          106 FKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAK  185 (331)
Q Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~  185 (331)
                      ..++|||++ +++|.+++.... ..+++..+..++.|+++||.+||++   +++|+||+|+||+++.++.++|+|||++.
T Consensus        76 ~~~lv~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~  150 (298)
T cd07841          76 NINLVFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLAR  150 (298)
T ss_pred             EEEEEEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeee
Confidence            789999999 999999997644 3577888999999999999999999   99999999999999999999999999987


Q ss_pred             ccccCCCCCcccccCCceeecccccccCCcccCC-CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCc
Q 046639          186 FLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG-SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALP  264 (331)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  264 (331)
                      ......        .......+++.|+|||.+.+ ..++.++||||||+++|+|++|.+||...... ..+.........
T Consensus       151 ~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~-~~~~~~~~~~~~  221 (298)
T cd07841         151 SFGSPN--------RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI-DQLGKIFEALGT  221 (298)
T ss_pred             eccCCC--------ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH-HHHHHHHHHcCC
Confidence            652211        11122345677999998865 45789999999999999999998888653221 111111111000


Q ss_pred             ---chhh---hhcCccccc-ccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          265 ---DKVM---EIVDPSLLL-EVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       265 ---~~~~---~~~~~~~~~-~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                         ....   ...+..... ................+.+++.+||+.+|++|||+.++++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~  281 (298)
T cd07841         222 PTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE  281 (298)
T ss_pred             CchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence               0000   000000000 0000011122345678899999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=8e-40  Score=283.26  Aligned_cols=256  Identities=21%  Similarity=0.364  Sum_probs=199.7

Q ss_pred             cCCCcCceeeccCeeEEEEeeecC-----CCceEEEEEeeccchh-hHHHHHHHHHHHHcCCCCCcceeeceeecccCCC
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDE-----SRSIVAVKVVNLKQKE-ASRSFAAECNALRNIRHRNLIKIITICSSIDFEG  103 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  103 (331)
                      ++|.+.+.||.|+||+||+|+...     +.+.+++|.+...... ....+.+|++++++++|+|++++++++     ..
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~   79 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLC-----RE   79 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEE-----CC
Confidence            579999999999999999999753     3567999988654433 456789999999999999999999985     44


Q ss_pred             cceeeEEEeecCCCCHHHHHHhccC-------CccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcE
Q 046639          104 FDFKAIVFEYMQNRNLEQWLRQSNG-------QLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVA  176 (331)
Q Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~  176 (331)
                      ....++|||++++++|.+++.....       ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+
T Consensus        80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~  156 (275)
T cd05046          80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREV  156 (275)
T ss_pred             CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcE
Confidence            4668999999999999999976441       1478889999999999999999999   99999999999999999999


Q ss_pred             EEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchH
Q 046639          177 HVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTL  255 (331)
Q Consensus       177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~  255 (331)
                      +++|||++......       .........++..|+|||.+.+..++.++||||||+++|+|++ |..||......  ..
T Consensus       157 ~l~~~~~~~~~~~~-------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~--~~  227 (275)
T cd05046         157 KVSLLSLSKDVYNS-------EYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE--EV  227 (275)
T ss_pred             EEcccccccccCcc-------cccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH--HH
Confidence            99999988643111       1111222335667999999988889999999999999999998 88898643211  11


Q ss_pred             HHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHH
Q 046639          256 HEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLR  320 (331)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~  320 (331)
                      ......   ....               ......++..+.+++.+||+.+|.+|||+.++++.|.
T Consensus       228 ~~~~~~---~~~~---------------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         228 LNRLQA---GKLE---------------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             HHHHHc---CCcC---------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            111110   0000               0011235568999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=8.6e-40  Score=291.17  Aligned_cols=277  Identities=19%  Similarity=0.233  Sum_probs=202.6

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc-chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCccee
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK-QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      .++|.+.+.||+|++|.||+|.+..+++.||+|.+... .......+.+|+.+++.++|+|++++++++....+......
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            46899999999999999999999999999999998633 23344667889999999999999999998766555556678


Q ss_pred             eEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccc
Q 046639          108 AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      ++++|++ .++|.+.+...   .+++..+..++.|++.||.+||+.   +++|+||||+||+++.++.++|+|||++...
T Consensus        84 ~lv~e~~-~~~l~~~~~~~---~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~  156 (336)
T cd07849          84 YIVQELM-ETDLYKLIKTQ---HLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIA  156 (336)
T ss_pred             EEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeec
Confidence            9999999 56888887543   477788999999999999999999   9999999999999999999999999998765


Q ss_pred             ccCCCCCcccccCCceeecccccccCCcccCC-CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhh---C
Q 046639          188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMG-SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMA---L  263 (331)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~---~  263 (331)
                      .....     .........+++.|+|||.+.+ ..++.++||||+|+++|+|++|..||...... ..........   .
T Consensus       157 ~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~-~~~~~~~~~~~~~~  230 (336)
T cd07849         157 DPEHD-----HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL-HQLNLILGVLGTPS  230 (336)
T ss_pred             ccccc-----ccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHcCCCC
Confidence            22111     1112223457888999998654 56899999999999999999999999653211 1111111000   0


Q ss_pred             cchhhhhcCcccc---ccccc----CCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHH
Q 046639          264 PDKVMEIVDPSLL---LEVTA----NNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAK  318 (331)
Q Consensus       264 ~~~~~~~~~~~~~---~~~~~----~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~  318 (331)
                      +.....+.+....   .....    ............+.+++.+||+.+|++|||+.++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         231 QEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             HHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            0111111110000   00000    0001112345678999999999999999999999864

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.1e-39  Score=283.90  Aligned_cols=269  Identities=21%  Similarity=0.276  Sum_probs=198.3

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCccee
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ--KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      ++|.+.+.||+|++|.||+|.+..+++.||+|.+....  ....+.+.+|+.+++.++|+|++++++++     ......
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~   75 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVF-----RRKRKL   75 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEE-----eeCCEE
Confidence            47999999999999999999999899999999886432  22335578999999999999999999985     445678


Q ss_pred             eEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccc
Q 046639          108 AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      ++||||+++++|..++....  .+++..+..++.|++.||.+||+.   +++|+||+|+||+++.++.++|+|||++...
T Consensus        76 ~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  150 (286)
T cd07847          76 HLVFEYCDHTVLNELEKNPR--GVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARIL  150 (286)
T ss_pred             EEEEeccCccHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceec
Confidence            99999998888887765432  467888999999999999999999   9999999999999999999999999999765


Q ss_pred             ccCCCCCcccccCCceeecccccccCCcccCC-CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHH--hhCc
Q 046639          188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMG-SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVK--MALP  264 (331)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~--~~~~  264 (331)
                      .....        ......++..|+|||++.+ ..++.++||||||+++|+|++|..||.+........ ....  ....
T Consensus       151 ~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~  221 (286)
T cd07847         151 TGPGD--------DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLY-LIRKTLGDLI  221 (286)
T ss_pred             CCCcc--------cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHHHhCCCC
Confidence            22110        1122346778999999876 457899999999999999999999997643221111 1111  0000


Q ss_pred             chhhhhcCcc-c----c-c--ccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          265 DKVMEIVDPS-L----L-L--EVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       265 ~~~~~~~~~~-~----~-~--~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      .......+.. .    . .  ................+.+++.+||+.+|++|||+.++++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         222 PRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             hHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            0000000000 0    0 0  0000000112234577899999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.1e-39  Score=279.21  Aligned_cols=247  Identities=28%  Similarity=0.399  Sum_probs=196.0

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeE
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAI  109 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~l  109 (331)
                      .+|.+.+.||+|+||.||++..  +++.+|+|.+....  ....+.+|+.+++.++|||++++++++..      +..++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~------~~~~~   75 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILH------NGLYI   75 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcC------CCcEE
Confidence            3599999999999999999875  57789999886432  33568899999999999999999998642      23689


Q ss_pred             EEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccccc
Q 046639          110 VFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG  189 (331)
Q Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~  189 (331)
                      +||++++++|.+++.......+++.....++.|++.|+.+||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~  152 (254)
T cd05083          76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSM  152 (254)
T ss_pred             EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccc
Confidence            99999999999999876555677888899999999999999999   999999999999999999999999999865311


Q ss_pred             CCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhCcchhh
Q 046639          190 YEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMALPDKVM  268 (331)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  268 (331)
                      .           ......+..|+|||.+.+..++.++|+||||+++|+|++ |..||......  ..........     
T Consensus       153 ~-----------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~-----  214 (254)
T cd05083         153 G-----------VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK--EVKECVEKGY-----  214 (254)
T ss_pred             c-----------CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH--HHHHHHhCCC-----
Confidence            0           111223456999999988889999999999999999998 99999653211  1111111100     


Q ss_pred             hhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHH
Q 046639          269 EIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRH  321 (331)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~  321 (331)
                             ..       .....++..+.+++.+||+.+|++|||+.+|++.|+.
T Consensus       215 -------~~-------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         215 -------RM-------EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             -------CC-------CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence                   00       0112345678899999999999999999999988763

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.5e-40  Score=302.10  Aligned_cols=267  Identities=19%  Similarity=0.195  Sum_probs=194.1

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      ...|.+.+.||+|+||.||+|.+..+++.||+|....      ....+|+.++++++|+||+++++++.     ..+..+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~-----~~~~~~  236 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRV-----VGGLTC  236 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEE-----ECCEEE
Confidence            4479999999999999999999999999999996432      23568999999999999999999853     346789


Q ss_pred             EEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccc
Q 046639          109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLF  188 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~  188 (331)
                      +|||++ .++|.+++.... ..+++..+..++.|++.||.|||++   +|+|+||||+||+++.++.++|+|||+++...
T Consensus       237 lv~e~~-~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~  311 (461)
T PHA03211        237 LVLPKY-RSDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFAR  311 (461)
T ss_pred             EEEEcc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecc
Confidence            999999 579988886543 3578899999999999999999999   99999999999999999999999999997652


Q ss_pred             cCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCC------cchHHHHHHhh
Q 046639          189 GYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNE------GLTLHEFVKMA  262 (331)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~~~~~~~  262 (331)
                      ....      ........||..|+|||++.+..++.++|||||||++|||++|..|+-.....      ...+...+...
T Consensus       312 ~~~~------~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~  385 (461)
T PHA03211        312 GSWS------TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQA  385 (461)
T ss_pred             cccc------cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhh
Confidence            2111      11122346899999999999999999999999999999999987654221110      11112222111


Q ss_pred             Cc--chhhhhcCcccc------------cccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          263 LP--DKVMEIVDPSLL------------LEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       263 ~~--~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ..  ..........+.            .......+.........+.+|+.+||+.||.+|||+.|+++
T Consensus       386 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~  454 (461)
T PHA03211        386 QVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR  454 (461)
T ss_pred             ccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence            00  000000000000            00000000101122346889999999999999999999985

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.5e-39  Score=278.14  Aligned_cols=256  Identities=21%  Similarity=0.306  Sum_probs=200.2

Q ss_pred             CCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc------hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCc
Q 046639           31 NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ------KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGF  104 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  104 (331)
                      +|+.++.||+|++|.||+|.+..++..+|+|.+....      ......+..|+.+++.++|+|++++++++     ...
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~   75 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGAT-----CED   75 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhcee-----ccC
Confidence            5888999999999999999999899999999986433      22346788999999999999999999994     455


Q ss_pred             ceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCC-cEEEcccCc
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDI-VAHVGDLGL  183 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~-~~kl~Dfg~  183 (331)
                      +..++|+|++++++|.+++.+..  .+++..+..++.|++.||.+||++   +++|+||+|+||+++.++ .++|+|||.
T Consensus        76 ~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~  150 (268)
T cd06630          76 SHFNLFVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGA  150 (268)
T ss_pred             CeEEEEEeccCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccc
Confidence            67899999999999999997543  467788899999999999999999   999999999999998776 699999999


Q ss_pred             ccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhC
Q 046639          184 AKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMAL  263 (331)
Q Consensus       184 a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  263 (331)
                      +.........    .........++..|+|||.+.+..++.++|+||+|+++++|++|..||....... ..........
T Consensus       151 ~~~~~~~~~~----~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~  225 (268)
T cd06630         151 AARLAAKGTG----AGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN-HLALIFKIAS  225 (268)
T ss_pred             cccccccccc----CCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc-hHHHHHHHhc
Confidence            8776322110    0111223457888999999988889999999999999999999999996432111 1111100000


Q ss_pred             cchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          264 PDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      .     .           ...+........+.+++.+||+.+|++|||+.++++
T Consensus       226 ~-----~-----------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         226 A-----T-----------TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             c-----C-----------CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            0     0           001222345677889999999999999999999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-41  Score=273.57  Aligned_cols=254  Identities=20%  Similarity=0.277  Sum_probs=206.3

Q ss_pred             HhcCCCcC-ceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcC-CCCCcceeeceeecccCCCcc
Q 046639           28 ATNNFSPA-NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNI-RHRNLIKIITICSSIDFEGFD  105 (331)
Q Consensus        28 ~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~  105 (331)
                      .+++|++. ++||-|-.|.|-.+.++.|++.+|+|++...     ....+|+++.-.. .|||||.+++++... +.+..
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs-~~~rk  132 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENS-YQGRK  132 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhh-ccCce
Confidence            44566665 5899999999999999999999999988522     2345677766665 599999999998655 56667


Q ss_pred             eeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEec---CCCcEEEcccC
Q 046639          106 FKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLD---QDIVAHVGDLG  182 (331)
Q Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~---~~~~~kl~Dfg  182 (331)
                      .+.+|||.++||.|.+.++.++...+.+..+..|..||..|+.|||+.   +|.||||||+|+|.+   .+..+||+|||
T Consensus       133 cLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfG  209 (400)
T KOG0604|consen  133 CLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFG  209 (400)
T ss_pred             eeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccc
Confidence            788999999999999999999999999999999999999999999999   999999999999996   45679999999


Q ss_pred             cccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhh
Q 046639          183 LAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMA  262 (331)
Q Consensus       183 ~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  262 (331)
                      +|+.-         .........+.||.|.|||++-.+.|+.++|+||+|+++|-|+.|.+||.......          
T Consensus       210 FAK~t---------~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a----------  270 (400)
T KOG0604|consen  210 FAKET---------QEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA----------  270 (400)
T ss_pred             ccccc---------CCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc----------
Confidence            99864         12233445668999999999999999999999999999999999999998653321          


Q ss_pred             CcchhhhhcCcccccccccCCcchH----HHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          263 LPDKVMEIVDPSLLLEVTANNYSWI----EDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                              +.|....++..+.++|+    ...+.+..++++.+|..+|++|.|+.+++.
T Consensus       271 --------ispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  271 --------ISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             --------CChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence                    11222222222222332    356778899999999999999999999874

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.9e-39  Score=280.14  Aligned_cols=254  Identities=20%  Similarity=0.327  Sum_probs=185.9

Q ss_pred             ceeeccCeeEEEEeeec--CCCceEEEEEeeccch-hhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeEEEe
Q 046639           36 NKIGQGGVSIVYKGILD--ESRSIVAVKVVNLKQK-EASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFE  112 (331)
Q Consensus        36 ~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~e  112 (331)
                      +.||+|+||.||+|.+.  .++..+|+|.+..... .....+.+|+.+++.++||||+++++++.     .....++|||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e   75 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCT-----EVTPYLLVME   75 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----CCCCcEEEEE
Confidence            36899999999999864  3556799998865432 33356888999999999999999999853     3456799999


Q ss_pred             ecCCCCHHHHHHhcc---CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccccc
Q 046639          113 YMQNRNLEQWLRQSN---GQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG  189 (331)
Q Consensus       113 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~  189 (331)
                      |+++++|.+++....   ....+...+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~  152 (269)
T cd05087          76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYK  152 (269)
T ss_pred             CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccC
Confidence            999999999997532   22345566778999999999999999   999999999999999999999999999864311


Q ss_pred             CCCCCcccccCCceeecccccccCCcccCCC-------CCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHh
Q 046639          190 YEPGTAAETASNSIEIKGIVGYVAPEYGMGS-------KASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKM  261 (331)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-------~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~  261 (331)
                      ..      .........++..|+|||++.+.       .++.++||||||+++|+|++ |..||........ . ..   
T Consensus       153 ~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~-~-~~---  221 (269)
T cd05087         153 ED------YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV-L-TY---  221 (269)
T ss_pred             cc------eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH-H-HH---
Confidence            10      01111223466779999987642       35789999999999999996 9999975432211 1 11   


Q ss_pred             hCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHH
Q 046639          262 ALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLR  320 (331)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~  320 (331)
                      ...........+...           ......+.+++..|| .+|++|||+.+|+..|+
T Consensus       222 ~~~~~~~~~~~~~~~-----------~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         222 TVREQQLKLPKPRLK-----------LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             HhhcccCCCCCCccC-----------CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            111111111111111           123446788889999 58999999999998775

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2.1e-39  Score=277.69  Aligned_cols=252  Identities=27%  Similarity=0.467  Sum_probs=198.4

Q ss_pred             CCcCceeeccCeeEEEEeeecCCC----ceEEEEEeeccchh-hHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           32 FSPANKIGQGGVSIVYKGILDESR----SIVAVKVVNLKQKE-ASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        32 y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      +.+.+.||.|+||.||+|.+...+    ..||+|.+...... ....+..|+.+++.++|+|++++++++     ...+.
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~   75 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVC-----TEEEP   75 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEE-----cCCCe
Confidence            457889999999999999998655    88999999654433 557789999999999999999999985     33467


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      .+++||++++++|.+++.......+++..+..++.|++.||++||+.   +++|+||+|+||+++.++.++|+|||++..
T Consensus        76 ~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~  152 (258)
T smart00219       76 LMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRD  152 (258)
T ss_pred             eEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCcee
Confidence            89999999999999999765543377889999999999999999999   999999999999999999999999999876


Q ss_pred             cccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhCcc
Q 046639          187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMALPD  265 (331)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~  265 (331)
                      ......       .......+++.|+|||.+.+..++.++||||+|+++++|++ |..||....  ............. 
T Consensus       153 ~~~~~~-------~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~--~~~~~~~~~~~~~-  222 (258)
T smart00219      153 LYDDDY-------YKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS--NEEVLEYLKKGYR-  222 (258)
T ss_pred             cccccc-------cccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHhcCCC-
Confidence            522110       00101226678999999988889999999999999999998 888886521  1111111110000 


Q ss_pred             hhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHH
Q 046639          266 KVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKL  319 (331)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L  319 (331)
                                 .       .....++..+.+++.+||+.+|++|||+.++++.|
T Consensus       223 -----------~-------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      223 -----------L-------PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             -----------C-------CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                       0       11112566799999999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.5e-39  Score=282.98  Aligned_cols=269  Identities=21%  Similarity=0.243  Sum_probs=200.7

Q ss_pred             CCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           31 NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ--KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      +|.+.+.||.|++|.||+|.+..++..||+|++....  ......+.+|+.+++.++|||++++++++     ......+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~   75 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVF-----PHGSGFV   75 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCeeE
Confidence            5889999999999999999998899999999987554  33446788999999999999999999985     4456789


Q ss_pred             EEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccc
Q 046639          109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLF  188 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~  188 (331)
                      +|+|++ +++|.+++.... ..+++..++.++.|++.||++||+.   +++|+||+|+||+++.++.++|+|||++....
T Consensus        76 ~v~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~  150 (286)
T cd07832          76 LVMEYM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFS  150 (286)
T ss_pred             EEeccc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeeccccc
Confidence            999999 999999987644 4577889999999999999999999   99999999999999999999999999987652


Q ss_pred             cCCCCCcccccCCceeecccccccCCcccCCC-CCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcch-
Q 046639          189 GYEPGTAAETASNSIEIKGIVGYVAPEYGMGS-KASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDK-  266 (331)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-  266 (331)
                      ....       .......++..|+|||.+.+. .++.++||||+|+++++|++|.+||..... ...+........... 
T Consensus       151 ~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~-~~~~~~~~~~~~~~~~  222 (286)
T cd07832         151 EEEP-------RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND-IEQLAIVFRTLGTPNE  222 (286)
T ss_pred             CCCC-------CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH-HHHHHHHHHHcCCCCh
Confidence            2110       112234578889999998654 468999999999999999999888865321 111222111110000 


Q ss_pred             --hhhhcCccccccc--cc----CCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          267 --VMEIVDPSLLLEV--TA----NNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       267 --~~~~~~~~~~~~~--~~----~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                        .............  ..    .......+....+.+++.+||+.+|.+|||+.++++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         223 ETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             HHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence              0000000000000  00    000111234578999999999999999999999975

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-39  Score=276.55  Aligned_cols=248  Identities=24%  Similarity=0.374  Sum_probs=194.1

Q ss_pred             ceeeccCeeEEEEeeecCCCceEEEEEeeccchh-hHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeEEEeec
Q 046639           36 NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKE-ASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYM  114 (331)
Q Consensus        36 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~  114 (331)
                      ++||+|++|.||+|.+.. ++.|++|.+...... ....+.+|+.+++.+.|+||+++++++     ......++|+|++
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~v~e~~   74 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC-----VQKQPIYIVMELV   74 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEE-----ecCCCeEEEEEcC
Confidence            479999999999999977 889999988655433 456789999999999999999999985     4456789999999


Q ss_pred             CCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccccCCCCC
Q 046639          115 QNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGT  194 (331)
Q Consensus       115 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~~~~~  194 (331)
                      ++++|.+++..... .++...+..++.+++.++.+||++   +++|+||+|+||+++.++.++|+|||.+.......   
T Consensus        75 ~~~~l~~~l~~~~~-~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~---  147 (251)
T cd05041          75 PGGSLLTFLRKKKN-RLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGI---  147 (251)
T ss_pred             CCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCc---
Confidence            99999999976432 466788889999999999999999   99999999999999999999999999987542110   


Q ss_pred             cccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhCcchhhhhcCc
Q 046639          195 AAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMALPDKVMEIVDP  273 (331)
Q Consensus       195 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (331)
                         ..........+..|+|||.+.++.++.++|+||||+++|+|++ |..||......  ...........         
T Consensus       148 ---~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~--~~~~~~~~~~~---------  213 (251)
T cd05041         148 ---YTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ--QTRERIESGYR---------  213 (251)
T ss_pred             ---ceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH--HHHHHHhcCCC---------
Confidence               0001111223456999999988889999999999999999999 88888654211  11111110000         


Q ss_pred             ccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHH
Q 046639          274 SLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLR  320 (331)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~  320 (331)
                       .         .....++..+.+++.+||+.+|.+|||+.+|++.|+
T Consensus       214 -~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         214 -M---------PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             -C---------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence             0         111234568999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=5.5e-40  Score=291.85  Aligned_cols=256  Identities=19%  Similarity=0.194  Sum_probs=192.8

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc---chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK---QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      ++|.+.+.||+|+||+||++++..+++.+|+|++...   .......+..|..++..+.|++|+++.+.+     .....
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~   75 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAF-----QDENN   75 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEE-----ecCCE
Confidence            4799999999999999999999999999999998632   122334577899999999999999999884     45567


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      .++||||+++++|.+++.+.. ..++...+..++.|++.||.+||+.   +++||||||+||+++.++.++|+|||++..
T Consensus        76 ~~lv~ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~  151 (332)
T cd05623          76 LYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLK  151 (332)
T ss_pred             EEEEEeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchhee
Confidence            899999999999999997633 2467788889999999999999999   999999999999999999999999999875


Q ss_pred             cccCCCCCcccccCCceeecccccccCCcccC-----CCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHh
Q 046639          187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGM-----GSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKM  261 (331)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  261 (331)
                      .....       ........||+.|+|||++.     ...++.++||||||+++|+|++|..||....     .......
T Consensus       152 ~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~-----~~~~~~~  219 (332)
T cd05623         152 LMEDG-------TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES-----LVETYGK  219 (332)
T ss_pred             cccCC-------cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC-----HHHHHHH
Confidence            42111       11112345899999999986     3457899999999999999999999996431     1111111


Q ss_pred             hCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCC--CCcHHHHHHH
Q 046639          262 ALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPME--RMEMRDVVAK  318 (331)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--Rps~~~i~~~  318 (331)
                      ....        .....++    .....+...+.+|+.+||..++..  |+++.++++-
T Consensus       220 i~~~--------~~~~~~p----~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         220 IMNH--------KERFQFP----AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             HhCC--------CccccCC----CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            1000        0000000    111234567788888888655444  6888888653

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=3.3e-39  Score=277.92  Aligned_cols=254  Identities=19%  Similarity=0.228  Sum_probs=195.9

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc-----hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCc
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ-----KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGF  104 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  104 (331)
                      ++|++.+.||+|+||.||.|.+..+++.||+|.+....     ....+.+.+|+.+++.+.||||+++++++.+.   ..
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~   78 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDP---ME   78 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccC---CC
Confidence            57999999999999999999999999999999885331     22346788899999999999999999975321   13


Q ss_pred             ceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcc
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA  184 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a  184 (331)
                      ..++++||++++++|.+++....  .++...+..++.|++.||.+||+.   +++|+||+|+||+++.++.++|+|||++
T Consensus        79 ~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~  153 (265)
T cd06652          79 RTLSIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGAS  153 (265)
T ss_pred             ceEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccc
Confidence            46789999999999999987543  356777889999999999999999   9999999999999999999999999998


Q ss_pred             cccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCc
Q 046639          185 KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALP  264 (331)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  264 (331)
                      .......     ..........++..|+|||++.+..++.++||||||+++|+|++|..||.....    ..........
T Consensus       154 ~~~~~~~-----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~----~~~~~~~~~~  224 (265)
T cd06652         154 KRLQTIC-----LSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA----MAAIFKIATQ  224 (265)
T ss_pred             ccccccc-----ccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch----HHHHHHHhcC
Confidence            7642111     011112234578889999999888899999999999999999999999964311    1111111000


Q ss_pred             chhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          265 DKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      .     ..+           ..+......+.+++.+||. +|.+||++.+|++
T Consensus       225 ~-----~~~-----------~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         225 P-----TNP-----------VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             C-----CCC-----------CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence            0     000           1122345567788888885 9999999999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.6e-39  Score=278.63  Aligned_cols=260  Identities=21%  Similarity=0.260  Sum_probs=203.4

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ-KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      ++|++.+.||.|++|+||+|.+..++..+++|.+.... ......+.+|+.+++.++|+|++++++.+     ......+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~   75 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF-----VVGDELW   75 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEE-----eeCCEEE
Confidence            47999999999999999999998889999999986443 23457789999999999999999999884     4456789


Q ss_pred             EEEeecCCCCHHHHHHhccC-CccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccc
Q 046639          109 IVFEYMQNRNLEQWLRQSNG-QLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      +++|++++++|.+++..... ..+++..+..++.|++.|+++||+.   +++|+||+|+||++++++.++|+|||++..+
T Consensus        76 iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~  152 (267)
T cd06610          76 LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASL  152 (267)
T ss_pred             EEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHh
Confidence            99999999999999976432 4577888999999999999999999   9999999999999999999999999998876


Q ss_pred             ccCCCCCcccccCCceeecccccccCCcccCCC-CCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcch
Q 046639          188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMGS-KASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDK  266 (331)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  266 (331)
                      .......    ........++..|+|||.+... .++.++|+||||+++|+|++|..||....... .+.......    
T Consensus       153 ~~~~~~~----~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-~~~~~~~~~----  223 (267)
T cd06610         153 ADGGDRT----RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-VLMLTLQND----  223 (267)
T ss_pred             ccCcccc----ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-hHHHHhcCC----
Confidence            3322110    0112334578889999998776 78999999999999999999999997542211 111111110    


Q ss_pred             hhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          267 VMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                           .+.+...      .....++..+.+++.+||+.||++|||+.+|++
T Consensus       224 -----~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         224 -----PPSLETG------ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             -----CCCcCCc------cccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                 0000000      001245678899999999999999999999975

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.9e-39  Score=290.91  Aligned_cols=272  Identities=19%  Similarity=0.210  Sum_probs=200.6

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc--chhhHHHHHHHHHHHHcCCCCCcceeeceeeccc-CCCc
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRNIRHRNLIKIITICSSID-FEGF  104 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~~  104 (331)
                      ..++|.+.+.||+|+||.||+|.+..+++.||+|.+...  .......+.+|+.+++.++|+|++++++++.... +.+.
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            457899999999999999999999999999999998533  3334456778999999999999999999865322 2334


Q ss_pred             ceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcc
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA  184 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a  184 (331)
                      ...++|||++ .++|.+.+...    ++...+..++.|++.||++||+.   +++|+||||+||+++.++.++|+|||++
T Consensus        94 ~~~~lv~e~~-~~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~  165 (353)
T cd07850          94 QDVYLVMELM-DANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA  165 (353)
T ss_pred             CcEEEEEecc-CCCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCccc
Confidence            5679999999 56888887543    66788889999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhC-
Q 046639          185 KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMAL-  263 (331)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~-  263 (331)
                      ......         .......++..|+|||.+.+..++.++||||||+++|+|++|..||..... ...+........ 
T Consensus       166 ~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~-~~~~~~~~~~~~~  235 (353)
T cd07850         166 RTAGTS---------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDH-IDQWNKIIEQLGT  235 (353)
T ss_pred             eeCCCC---------CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHHhcCC
Confidence            764211         112223477889999999999999999999999999999999999975321 111111111000 


Q ss_pred             -cchhhhhcCcccc------------------cc--cccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          264 -PDKVMEIVDPSLL------------------LE--VTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       264 -~~~~~~~~~~~~~------------------~~--~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                       +............                  ..  ...............+.+++.+||+.||++|||+.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         236 PSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             CCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence             0000000000000                  00  000000001234567889999999999999999999984

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=2.1e-39  Score=281.82  Aligned_cols=252  Identities=21%  Similarity=0.295  Sum_probs=191.5

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc-hhhHHHHHHHHHH-HHcCCCCCcceeeceeecccCCCccee
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ-KEASRSFAAECNA-LRNIRHRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      ++|.+.+.||+|+||.||+|++..+++.||+|.++... ......+..|+.+ ++.+.|||++++++++.     ..+..
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~-----~~~~~   75 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALF-----REGDV   75 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEe-----cCCcE
Confidence            47899999999999999999999999999999986542 2233445556665 55668999999999853     34568


Q ss_pred             eEEEeecCCCCHHHHHHhc--cCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccc
Q 046639          108 AIVFEYMQNRNLEQWLRQS--NGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAK  185 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~  185 (331)
                      +++||++ .++|.+++...  ....+++..++.++.|++.||.|||++.  +++|+||||+||+++.++.+||+|||.+.
T Consensus        76 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~  152 (283)
T cd06617          76 WICMEVM-DTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISG  152 (283)
T ss_pred             EEEhhhh-cccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeeccccc
Confidence            9999999 57898888652  3345788889999999999999999843  89999999999999999999999999987


Q ss_pred             ccccCCCCCcccccCCceeecccccccCCcccCC----CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHh
Q 046639          186 FLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG----SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKM  261 (331)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~----~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  261 (331)
                      .+...         .......++..|+|||.+.+    ..++.++|+||||+++|+|++|..||................
T Consensus       153 ~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~  223 (283)
T cd06617         153 YLVDS---------VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEE  223 (283)
T ss_pred             ccccc---------cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhc
Confidence            65211         11122347788999998865    456889999999999999999999996432211111111110


Q ss_pred             hCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          262 ALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                               ..+...          ...++..+.+++.+||..+|++|||+.+|++
T Consensus       224 ---------~~~~~~----------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         224 ---------PSPQLP----------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             ---------CCCCCC----------ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                     000000          0124567899999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-41  Score=295.62  Aligned_cols=245  Identities=22%  Similarity=0.284  Sum_probs=200.6

Q ss_pred             CCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc---chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCccee
Q 046639           31 NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK---QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      .|.-++.||.|+||.||-|++..+...||||.+...   ..+...+++.|+.+|+.++|||++.+-++|..     +...
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr-----e~Ta  101 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR-----EHTA  101 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeec-----cchH
Confidence            466788999999999999999999999999998755   34556789999999999999999999998643     3457


Q ss_pred             eEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccc
Q 046639          108 AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      |+||||| -||-.+++.-.. +++.+-.+..|..+.+.||+|||+.   +.+|||||..|||+++.|.|||+|||.|..+
T Consensus       102 WLVMEYC-lGSAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~  176 (948)
T KOG0577|consen  102 WLVMEYC-LGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIM  176 (948)
T ss_pred             HHHHHHH-hccHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhc
Confidence            9999999 789999987543 4567788899999999999999999   9999999999999999999999999999765


Q ss_pred             ccCCCCCcccccCCceeecccccccCCcccC---CCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCc
Q 046639          188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGM---GSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALP  264 (331)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  264 (331)
                                  ...+++.|||.|||||++.   .+.|+-++||||||++..||...++|+-.+..  -.....+...  
T Consensus       177 ------------~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA--MSALYHIAQN--  240 (948)
T KOG0577|consen  177 ------------APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MSALYHIAQN--  240 (948)
T ss_pred             ------------CchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH--HHHHHHHHhc--
Confidence                        4456788999999999865   46799999999999999999999999744311  1111111111  


Q ss_pred             chhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          265 DKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                            -.|.+.          ..+.+..|..++..||+.-|.+|||+.+++.
T Consensus       241 ------esPtLq----------s~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  241 ------ESPTLQ----------SNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             ------CCCCCC----------CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence                  112221          1246678889999999999999999988764

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=3.1e-39  Score=281.92  Aligned_cols=272  Identities=21%  Similarity=0.292  Sum_probs=195.5

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccch-hhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK-EASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      +..+|.+.+.||+|+||.||+|.+..++..||+|.+..... .....+.+|+.+++.++|+||+++.+++     .....
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~~~~   77 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII-----HTKET   77 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEE-----ecCCe
Confidence            34689999999999999999999998899999999864432 2234567899999999999999999984     44567


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      .++|+|++ .++|.+++.... ..++...+..++.|++.||.+||+.   +++|+||||+||+++.++.++|+|||++..
T Consensus        78 ~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~  152 (291)
T cd07870          78 LTFVFEYM-HTDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARA  152 (291)
T ss_pred             EEEEEecc-cCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccc
Confidence            89999999 578887775433 2355677888999999999999999   999999999999999999999999999875


Q ss_pred             cccCCCCCcccccCCceeecccccccCCcccCCC-CCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhh-Cc
Q 046639          187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGS-KASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMA-LP  264 (331)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~-~~  264 (331)
                      .....        .......+++.|+|||++.+. .++.++||||||+++|+|++|..||.........+...+... .+
T Consensus       153 ~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~  224 (291)
T cd07870         153 KSIPS--------QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVP  224 (291)
T ss_pred             cCCCC--------CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCC
Confidence            42111        111223467889999998764 578899999999999999999999975433222222221110 00


Q ss_pred             chh-----hhhcC--cccccccccCCcch-H--HHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          265 DKV-----MEIVD--PSLLLEVTANNYSW-I--EDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       265 ~~~-----~~~~~--~~~~~~~~~~~~~~-~--~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ...     ....+  +............. .  ......+.+++.+||..||.+|||+.+++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         225 TEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             ChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence            000     00000  00000000000000 0  012456789999999999999999999873

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=3.2e-39  Score=277.64  Aligned_cols=252  Identities=22%  Similarity=0.313  Sum_probs=203.7

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccch-hhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK-EASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      ++|.+.+.||.|++|.||+|.+..+++.+++|++..... .....+.+|+..+..++|+|++++++++     ...+..+
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~   75 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF-----YKEGEIS   75 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----ccCCeEE
Confidence            468899999999999999999999999999999876544 4457789999999999999999999985     4457789


Q ss_pred             EEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCCEEecCCCcEEEcccCccccc
Q 046639          109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHH-HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      +|+|++++++|.+++...  ..++...+..++.|++.|+.+||+ .   +++|+||+|+||+++.++.++|+|||.+...
T Consensus        76 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~  150 (264)
T cd06623          76 IVLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVL  150 (264)
T ss_pred             EEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceec
Confidence            999999999999999764  347788899999999999999999 8   9999999999999999999999999998765


Q ss_pred             ccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchh
Q 046639          188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKV  267 (331)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  267 (331)
                      ....        .......++..|+|||.+.+..++.++|+||||+++|+|++|..||.....  .............  
T Consensus       151 ~~~~--------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~--~~~~~~~~~~~~~--  218 (264)
T cd06623         151 ENTL--------DQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ--PSFFELMQAICDG--  218 (264)
T ss_pred             ccCC--------CcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc--cCHHHHHHHHhcC--
Confidence            2111        111234577889999999998899999999999999999999999976432  1111111111100  


Q ss_pred             hhhcCcccccccccCCcchHHH-HHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          268 MEIVDPSLLLEVTANNYSWIED-CLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                         ..+           ..... ++..+.+++.+||+.+|++|||+.++++
T Consensus       219 ---~~~-----------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~  255 (264)
T cd06623         219 ---PPP-----------SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ  255 (264)
T ss_pred             ---CCC-----------CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence               000           11112 5568999999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=4e-39  Score=277.06  Aligned_cols=255  Identities=25%  Similarity=0.349  Sum_probs=199.7

Q ss_pred             CCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccch--hhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           31 NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK--EASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      +|.+.+.||+|++|.||+|.+..+++.+++|.+.....  .....+..|+.+++.++|+||+++++.+     ...+..+
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~   75 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVE-----VHREKVY   75 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeE-----ecCCEEE
Confidence            58899999999999999999988899999999875544  3567899999999999999999999984     4456789


Q ss_pred             EEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccc
Q 046639          109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLF  188 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~  188 (331)
                      +|+|++++++|.+++....  .+++..+..++.+++.|+.+||+.   +++|+||+|+||+++.++.++|+|||++....
T Consensus        76 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~  150 (264)
T cd06626          76 IFMEYCSGGTLEELLEHGR--ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLK  150 (264)
T ss_pred             EEEecCCCCcHHHHHhhcC--CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccC
Confidence            9999999999999997543  366788889999999999999999   99999999999999999999999999988753


Q ss_pred             cCCCCCcccccCCceeecccccccCCcccCCCC---CccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcc
Q 046639          189 GYEPGTAAETASNSIEIKGIVGYVAPEYGMGSK---ASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPD  265 (331)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~---~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  265 (331)
                      .....    .........++..|+|||++.+..   ++.++||||||+++|++++|..||........ ........   
T Consensus       151 ~~~~~----~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~-~~~~~~~~---  222 (264)
T cd06626         151 NNTTT----MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ-IMFHVGAG---  222 (264)
T ss_pred             CCCCc----ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH-HHHHHhcC---
Confidence            22111    001012245678899999988766   88999999999999999999999975421111 11100000   


Q ss_pred             hhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          266 KVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                           ..+...         ....+...+.+++.+||+.+|.+|||+.+++.
T Consensus       223 -----~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         223 -----HKPPIP---------DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             -----CCCCCC---------cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                 000000         01123567789999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=4.3e-39  Score=274.78  Aligned_cols=247  Identities=26%  Similarity=0.347  Sum_probs=191.4

Q ss_pred             ceeeccCeeEEEEeeecCCCceEEEEEeeccch-hhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeEEEeec
Q 046639           36 NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK-EASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYM  114 (331)
Q Consensus        36 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~  114 (331)
                      +.||+|++|.||+|... ++..+|+|.+..... .....+.+|+.+++.+.|||++++++++.     .....++|||++
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~   74 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT-----QRQPIYIVMELV   74 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEe-----cCCccEEEEECC
Confidence            47899999999999865 677899998865432 33456889999999999999999999864     345689999999


Q ss_pred             CCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccccCCCCC
Q 046639          115 QNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGT  194 (331)
Q Consensus       115 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~~~~~  194 (331)
                      ++++|.+++.... ..+.+..+..++.|++.+|.++|+.   +++|+||+|+||+++.++.++|+|||++.......   
T Consensus        75 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~---  147 (250)
T cd05085          75 PGGDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI---  147 (250)
T ss_pred             CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccc---
Confidence            9999999987543 2456788899999999999999999   99999999999999999999999999986531110   


Q ss_pred             cccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhCcchhhhhcCc
Q 046639          195 AAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMALPDKVMEIVDP  273 (331)
Q Consensus       195 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (331)
                          ........++..|+|||++.+..++.++||||||+++|++++ |..||......  .........        ...
T Consensus       148 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~--~~~~~~~~~--------~~~  213 (250)
T cd05085         148 ----YSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ--QAREQVEKG--------YRM  213 (250)
T ss_pred             ----cccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH--HHHHHHHcC--------CCC
Confidence                011111223566999999988889999999999999999998 99999754211  111111100        000


Q ss_pred             ccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHH
Q 046639          274 SLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLR  320 (331)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~  320 (331)
                                 .....++..+.+++.+||+.+|++|||+.++++.|.
T Consensus       214 -----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         214 -----------SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             -----------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence                       011124567899999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=4.1e-39  Score=275.97  Aligned_cols=248  Identities=22%  Similarity=0.322  Sum_probs=197.7

Q ss_pred             CCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc-----hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcc
Q 046639           31 NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ-----KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFD  105 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~  105 (331)
                      +|+..+.||+|++|+||+|.+..++..|++|.+....     ......+.+|+.+++.++|+|++++++++     ....
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~   75 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE-----REED   75 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE-----ecCC
Confidence            5788899999999999999998889999999986543     23456789999999999999999999984     4456


Q ss_pred             eeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccc
Q 046639          106 FKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAK  185 (331)
Q Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~  185 (331)
                      ..++++||+++++|.+++....  .+++..+..++.|++.|+++||+.   +++|+||+|+||+++.++.++|+|||.+.
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~  150 (258)
T cd06632          76 NLYIFLELVPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAK  150 (258)
T ss_pred             eEEEEEEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccce
Confidence            7899999999999999997643  366788889999999999999999   99999999999999999999999999887


Q ss_pred             ccccCCCCCcccccCCceeecccccccCCcccCCCC-CccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCc
Q 046639          186 FLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSK-ASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALP  264 (331)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  264 (331)
                      ......         ......++..|+|||.+.... ++.++|+||||+++|+|++|..||.....    ..........
T Consensus       151 ~~~~~~---------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~----~~~~~~~~~~  217 (258)
T cd06632         151 QVVEFS---------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG----VAAVFKIGRS  217 (258)
T ss_pred             eccccc---------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH----HHHHHHHHhc
Confidence            642111         122345778899999987766 89999999999999999999999975431    1111110000


Q ss_pred             chhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          265 DKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ..         ..       .....+...+.+++.+||+.+|++|||+.+++.
T Consensus       218 ~~---------~~-------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         218 KE---------LP-------PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             cc---------CC-------CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence            00         00       111234567888999999999999999999974

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.8e-39  Score=277.28  Aligned_cols=239  Identities=22%  Similarity=0.386  Sum_probs=186.6

Q ss_pred             ceeeccCeeEEEEeeecCCC----------ceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcc
Q 046639           36 NKIGQGGVSIVYKGILDESR----------SIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFD  105 (331)
Q Consensus        36 ~~lg~G~~g~V~~~~~~~~~----------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~  105 (331)
                      +.||+|+||.||+|.+..++          ..+++|.+...... ...+.+|+.+++.++|||++++++++..      .
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~   73 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR------D   73 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec------C
Confidence            47999999999999997666          35788877544333 5678899999999999999999998643      3


Q ss_pred             eeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCC-------cEEE
Q 046639          106 FKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDI-------VAHV  178 (331)
Q Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~-------~~kl  178 (331)
                      ..++|||++++++|.+++..... .++...+..++.|++.||.|||+.   +++|+||||+||+++.++       .++|
T Consensus        74 ~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl  149 (259)
T cd05037          74 ENIMVEEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKL  149 (259)
T ss_pred             CcEEEEEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEe
Confidence            46899999999999999976543 467788899999999999999999   999999999999999887       7999


Q ss_pred             cccCcccccccCCCCCcccccCCceeecccccccCCcccCCC--CCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchH
Q 046639          179 GDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGS--KASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTL  255 (331)
Q Consensus       179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~  255 (331)
                      +|||++.....            .....++..|+|||++.+.  .++.++||||||+++|+|++ |..||......  ..
T Consensus       150 ~Dfg~a~~~~~------------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~--~~  215 (259)
T cd05037         150 SDPGIPITVLS------------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS--EK  215 (259)
T ss_pred             CCCCccccccc------------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch--hH
Confidence            99999876411            1123355679999998876  78999999999999999999 57777654211  11


Q ss_pred             HHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHH
Q 046639          256 HEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLR  320 (331)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~  320 (331)
                      .......  .        .. .          ......+.+++.+||..+|.+|||+.+|++.|+
T Consensus       216 ~~~~~~~--~--------~~-~----------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         216 ERFYQDQ--H--------RL-P----------MPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             HHHHhcC--C--------CC-C----------CCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            1111100  0        00 0          001167889999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=3e-39  Score=283.62  Aligned_cols=260  Identities=21%  Similarity=0.322  Sum_probs=199.9

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCc----eEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCc
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRS----IVAVKVVNLKQ-KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGF  104 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  104 (331)
                      ++|++.+.||+|+||.||+|.+..++.    .+|+|.+.... ......+.+|+.+++.+.||||++++++|..      
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~------   80 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS------   80 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC------
Confidence            468899999999999999999876665    47888876443 2333467899999999999999999998742      


Q ss_pred             ceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcc
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA  184 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a  184 (331)
                      ...++++|++++++|.+++.... ..++...+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++
T Consensus        81 ~~~~~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~  156 (303)
T cd05110          81 PTIQLVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLA  156 (303)
T ss_pred             CCceeeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccc
Confidence            23578999999999999987543 2356778889999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhC
Q 046639          185 KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMAL  263 (331)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~  263 (331)
                      +.......      ........++..|+|||.+.+..++.++||||||+++|+|++ |..||.....  ...........
T Consensus       157 ~~~~~~~~------~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--~~~~~~~~~~~  228 (303)
T cd05110         157 RLLEGDEK------EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--REIPDLLEKGE  228 (303)
T ss_pred             ccccCccc------ccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHCCC
Confidence            86521110      011112234567999999998899999999999999999997 8999865321  11222211110


Q ss_pred             cchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhh
Q 046639          264 PDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETF  326 (331)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~  326 (331)
                      ..                   .....+...+.+++..||..+|++||++.++++.|+.+.+..
T Consensus       229 ~~-------------------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~  272 (303)
T cd05110         229 RL-------------------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP  272 (303)
T ss_pred             CC-------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence            00                   001123456889999999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=3e-39  Score=282.35  Aligned_cols=270  Identities=19%  Similarity=0.234  Sum_probs=191.0

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCC---CceEEEEEeeccchhhH-----------HHHHHHHHHHHcCCCCCcceee
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDES---RSIVAVKVVNLKQKEAS-----------RSFAAECNALRNIRHRNLIKII   93 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~~i~~~~   93 (331)
                      ..++|.+.+.||+|+||+||+|.+..+   +..+|+|+.........           .....+...+..+.|+++++++
T Consensus        10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~   89 (294)
T PHA02882         10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY   89 (294)
T ss_pred             CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence            346899999999999999999998776   66777776543322111           1122334455667899999999


Q ss_pred             ceeecccCCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCC
Q 046639           94 TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQD  173 (331)
Q Consensus        94 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~  173 (331)
                      +.+.... ......+++++.+ ..++.+.+....  ..+...+..++.|++.||.|||+.   +++||||||+||+++.+
T Consensus        90 ~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~  162 (294)
T PHA02882         90 GCGSFKR-CRMYYRFILLEKL-VENTKEIFKRIK--CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGN  162 (294)
T ss_pred             EeeeEec-CCceEEEEEEehh-ccCHHHHHHhhc--cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCC
Confidence            8654321 1123457888887 567777775532  234677889999999999999999   99999999999999999


Q ss_pred             CcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcc
Q 046639          174 IVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGL  253 (331)
Q Consensus       174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~  253 (331)
                      +.++|+|||+++.+..... .............||+.|+|||+..+..++.++||||||+++|+|++|..||........
T Consensus       163 ~~~~l~DFGla~~~~~~~~-~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~  241 (294)
T PHA02882        163 NRGYIIDYGIASHFIIHGK-HIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN  241 (294)
T ss_pred             CcEEEEEcCCceeeccCCc-ccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence            9999999999987632111 111111122234689999999999999999999999999999999999999986532222


Q ss_pred             hHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHH
Q 046639          254 TLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKL  319 (331)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L  319 (331)
                      ..... ....   +..+.....          ...++++.+.+++..||+.+|++||++.+|++.|
T Consensus       242 ~~~~~-~~~~---~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        242 LIHAA-KCDF---IKRLHEGKI----------KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HHHHh-HHHH---HHHhhhhhh----------ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            11111 1000   000011100          1123567899999999999999999999999876

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.9e-39  Score=280.73  Aligned_cols=239  Identities=21%  Similarity=0.322  Sum_probs=182.8

Q ss_pred             eeeccCeeEEEEeeecC------------------------CCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCccee
Q 046639           37 KIGQGGVSIVYKGILDE------------------------SRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKI   92 (331)
Q Consensus        37 ~lg~G~~g~V~~~~~~~------------------------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~   92 (331)
                      .||+|+||.||+|....                        ....|++|++..........+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999997521                        224588998865555555678889999999999999999


Q ss_pred             eceeecccCCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecC
Q 046639           93 ITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQ  172 (331)
Q Consensus        93 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~  172 (331)
                      +++|..     ....++||||+++++|..++.... ..+++..+..++.|++.||.|||++   +++|+||||+||+++.
T Consensus        82 ~~~~~~-----~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~  152 (274)
T cd05076          82 HGVCVR-----GSENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLAR  152 (274)
T ss_pred             EEEEEe-----CCceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEec
Confidence            999643     456789999999999999986533 3466788889999999999999999   9999999999999976


Q ss_pred             CC-------cEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCC-CCCccchhhHhHHHHHHHHH-hCCC
Q 046639          173 DI-------VAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG-SKASVSGDVYNFGILLLEMF-TRRR  243 (331)
Q Consensus       173 ~~-------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~-~g~~  243 (331)
                      .+       .++++|||.+.....            .....++..|+|||.+.+ ..++.++||||||+++|||+ +|..
T Consensus       153 ~~~~~~~~~~~kl~d~g~~~~~~~------------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~  220 (274)
T cd05076         153 LGLAEGTSPFIKLSDPGVSFTALS------------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEV  220 (274)
T ss_pred             cCcccCccceeeecCCcccccccc------------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            44       379999998754311            112246677999998865 56899999999999999995 6999


Q ss_pred             CCCcccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHH
Q 046639          244 PTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKL  319 (331)
Q Consensus       244 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L  319 (331)
                      ||.......  .........          .           .+......+.+++.+||+.+|++|||+.+|++.|
T Consensus       221 p~~~~~~~~--~~~~~~~~~----------~-----------~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         221 PLKERTPSE--KERFYEKKH----------R-----------LPEPSCKELATLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             CccccChHH--HHHHHHhcc----------C-----------CCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence            986542211  111111100          0           0011224688899999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2e-39  Score=283.89  Aligned_cols=249  Identities=20%  Similarity=0.252  Sum_probs=197.1

Q ss_pred             CCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeEE
Q 046639           31 NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIV  110 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv  110 (331)
                      .|.....||+|+||.||+|.+..+++.||+|.+..........+.+|+.+++.+.|||++++++.+     ..++..+++
T Consensus        22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~iv   96 (297)
T cd06659          22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY-----LVGEELWVL   96 (297)
T ss_pred             hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhhe-----eeCCeEEEE
Confidence            455566899999999999999888999999998765555556788999999999999999999985     345678999


Q ss_pred             EeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccccC
Q 046639          111 FEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGY  190 (331)
Q Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~  190 (331)
                      +|++++++|.+++...   .+++..+..++.|++.||++||+.   +++|+||+|+||+++.++.++|+|||++......
T Consensus        97 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~  170 (297)
T cd06659          97 MEFLQGGALTDIVSQT---RLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD  170 (297)
T ss_pred             EecCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccc
Confidence            9999999999987542   367788999999999999999999   9999999999999999999999999998754211


Q ss_pred             CCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhhh
Q 046639          191 EPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEI  270 (331)
Q Consensus       191 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  270 (331)
                              ........++..|+|||++.+..++.++||||||+++|+|++|..||.....  .............     
T Consensus       171 --------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~-----  235 (297)
T cd06659         171 --------VPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP--VQAMKRLRDSPPP-----  235 (297)
T ss_pred             --------cccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHhccCCC-----
Confidence                    1112234578889999999988899999999999999999999999964211  1111111110000     


Q ss_pred             cCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          271 VDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                         ..         .........+.+++.+||+.+|.+||++.+|++
T Consensus       236 ---~~---------~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~  270 (297)
T cd06659         236 ---KL---------KNAHKISPVLRDFLERMLTREPQERATAQELLD  270 (297)
T ss_pred             ---Cc---------cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence               00         001123456888999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.6e-39  Score=279.63  Aligned_cols=255  Identities=22%  Similarity=0.334  Sum_probs=196.3

Q ss_pred             CCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccch----------hhHHHHHHHHHHHHcCCCCCcceeeceeeccc
Q 046639           31 NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK----------EASRSFAAECNALRNIRHRNLIKIITICSSID  100 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  100 (331)
                      +|.+.+.||.|++|.||+|.+..+++.+|+|.+.....          ...+.+..|+.+++.++|+|++++++++    
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~----   77 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFE----   77 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEe----
Confidence            58889999999999999999988899999998854311          1234578899999999999999999985    


Q ss_pred             CCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcc
Q 046639          101 FEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGD  180 (331)
Q Consensus       101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~D  180 (331)
                       ...+..++|||++++++|.+++...  ..++...+..++.|++.||.+||++   +++|+||+|+||+++.++.++++|
T Consensus        78 -~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d  151 (272)
T cd06629          78 -TTEEYLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISD  151 (272)
T ss_pred             -ccCCceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEee
Confidence             4456789999999999999999765  3467788889999999999999999   999999999999999999999999


Q ss_pred             cCcccccccCCCCCcccccCCceeecccccccCCcccCCCC--CccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHH
Q 046639          181 LGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSK--ASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEF  258 (331)
Q Consensus       181 fg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  258 (331)
                      ||++.......      .........++..|+|||.+....  ++.++|+||||+++|++++|..||.....    ....
T Consensus       152 ~~~~~~~~~~~------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~----~~~~  221 (272)
T cd06629         152 FGISKKSDDIY------DNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA----IAAM  221 (272)
T ss_pred             ccccccccccc------cccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch----HHHH
Confidence            99987642111      111122344778899999987654  78999999999999999999999964211    1111


Q ss_pred             HHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          259 VKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ..... .........           .....++..+.+++.+||+.+|++|||+.+|++
T Consensus       222 ~~~~~-~~~~~~~~~-----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         222 FKLGN-KRSAPPIPP-----------DVSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             HHhhc-cccCCcCCc-----------cccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            11000 000000000           111235678899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2.7e-39  Score=279.04  Aligned_cols=250  Identities=26%  Similarity=0.406  Sum_probs=192.2

Q ss_pred             ceeeccCeeEEEEeeecCCC------ceEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           36 NKIGQGGVSIVYKGILDESR------SIVAVKVVNLKQ-KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        36 ~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      +.||+|++|.||+|.+....      ..+++|.+.... ......+.+|+.+++.++||||+++++++     ......+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~   75 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVC-----LLNEPQY   75 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeee-----cCCCCeE
Confidence            36899999999999886433      678999875432 23456788999999999999999999985     3345689


Q ss_pred             EEEeecCCCCHHHHHHhc-----cCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCC-----cEEE
Q 046639          109 IVFEYMQNRNLEQWLRQS-----NGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDI-----VAHV  178 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~-----~~kl  178 (331)
                      ++||++++++|.+++...     ....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++     .+++
T Consensus        76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l  152 (269)
T cd05044          76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKI  152 (269)
T ss_pred             EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEE
Confidence            999999999999999753     223467788899999999999999999   999999999999999877     8999


Q ss_pred             cccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHH
Q 046639          179 GDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHE  257 (331)
Q Consensus       179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~  257 (331)
                      +|||++.......      .........++..|+|||++.+..++.++||||||+++|+|++ |..||.....  .....
T Consensus       153 ~dfg~~~~~~~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~--~~~~~  224 (269)
T cd05044         153 GDFGLARDIYKSD------YYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN--QEVLQ  224 (269)
T ss_pred             CCccccccccccc------ccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH--HHHHH
Confidence            9999987652111      0011112234567999999999899999999999999999998 9999964321  11111


Q ss_pred             HHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHH
Q 046639          258 FVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLR  320 (331)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~  320 (331)
                      ....            ..       .......++..+.+++.+||+.+|.+||++.+|++.|.
T Consensus       225 ~~~~------------~~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         225 HVTA------------GG-------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             HHhc------------CC-------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            1100            00       00111234567889999999999999999999998875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=2.1e-39  Score=283.26  Aligned_cols=252  Identities=21%  Similarity=0.249  Sum_probs=200.4

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      .++|.+.+.||+|+||.||++.+..++..+++|.+........+.+.+|+.+++.++|||++++++.+.     ..+..+
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-----~~~~~~   92 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL-----VGDELW   92 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheee-----eCCcEE
Confidence            468999999999999999999998888999999987555555577889999999999999999999853     345789


Q ss_pred             EEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccc
Q 046639          109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLF  188 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~  188 (331)
                      +|+|++++++|.+++.+.   .++...+..++.|++.|+++||+.   +++|+||+|+||+++.++.++|+|||++....
T Consensus        93 lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~  166 (293)
T cd06647          93 VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  166 (293)
T ss_pred             EEEecCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccc
Confidence            999999999999998653   356778889999999999999999   99999999999999999999999999886542


Q ss_pred             cCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhh
Q 046639          189 GYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVM  268 (331)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  268 (331)
                      ..        ........+++.|+|||.+.+..++.++|+||||+++|++++|..||........ .... ....     
T Consensus       167 ~~--------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~-~~~~-~~~~-----  231 (293)
T cd06647         167 PE--------QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LYLI-ATNG-----  231 (293)
T ss_pred             cc--------ccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh-eeeh-hcCC-----
Confidence            11        1111233577889999999888899999999999999999999999965321110 0000 0000     


Q ss_pred             hhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHH
Q 046639          269 EIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAK  318 (331)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~  318 (331)
                         .+         ...........+.+++.+||..+|++||++.+++..
T Consensus       232 ---~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         232 ---TP---------ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             ---CC---------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               00         001112345578899999999999999999999853

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.7e-39  Score=278.56  Aligned_cols=248  Identities=22%  Similarity=0.290  Sum_probs=200.0

Q ss_pred             CCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCccee
Q 046639           31 NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      +|.+.+.||.|+||.||+|.+..++..||+|.+....   ....+.+.+|+.++++++|||++++++.     +.+....
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-----~~~~~~~   75 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYS-----FQDEENM   75 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHh-----hcCCCeE
Confidence            5889999999999999999999899999999996442   2345778999999999999999999988     4566789


Q ss_pred             eEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccc
Q 046639          108 AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      ++|+|++.+++|.+++...  ..++...+..++.|++.||.+||.+   +++|+||+|+||+++.++.++|+|||.+...
T Consensus        76 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~  150 (258)
T cd05578          76 YLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKV  150 (258)
T ss_pred             EEEEeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeeccccccc
Confidence            9999999999999999765  3467788999999999999999999   9999999999999999999999999988764


Q ss_pred             ccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchh
Q 046639          188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKV  267 (331)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  267 (331)
                      ...         .......++..|+|||.+.+..++.++|+||||+++|+|++|..||......  ...........   
T Consensus       151 ~~~---------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~---  216 (258)
T cd05578         151 TPD---------TLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT--IRDQIRAKQET---  216 (258)
T ss_pred             CCC---------ccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc--HHHHHHHHhcc---
Confidence            211         1122344777899999998888999999999999999999999999754322  11111111110   


Q ss_pred             hhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcH--HHHH
Q 046639          268 MEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEM--RDVV  316 (331)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~--~~i~  316 (331)
                         ..           ...+...+..+.+++.+||+.||.+||++  .+++
T Consensus       217 ---~~-----------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         217 ---AD-----------VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             ---cc-----------ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence               00           01112345788899999999999999999  6654

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-39  Score=280.79  Aligned_cols=268  Identities=21%  Similarity=0.297  Sum_probs=197.1

Q ss_pred             CCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeE
Q 046639           32 FSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ--KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAI  109 (331)
Q Consensus        32 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~l  109 (331)
                      |.+.+.||.|++|.||+|.+..++..||+|++....  ......+.+|+.+++.++|||++++++++     ...+..++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~-----~~~~~~~i   75 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVV-----HSENKLYL   75 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhhee-----ccCCeEEE
Confidence            678899999999999999999899999999986543  22235678899999999999999999995     44578899


Q ss_pred             EEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccccc
Q 046639          110 VFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG  189 (331)
Q Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~  189 (331)
                      ++|++ +++|.+++.......+++..+..++.|++.||.+||++   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        76 v~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~  151 (283)
T cd07835          76 VFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGV  151 (283)
T ss_pred             EEecc-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCC
Confidence            99999 57999999776545678899999999999999999999   999999999999999999999999999875411


Q ss_pred             CCCCCcccccCCceeecccccccCCcccCCC-CCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhC-cch-
Q 046639          190 YEPGTAAETASNSIEIKGIVGYVAPEYGMGS-KASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMAL-PDK-  266 (331)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~-~~~-  266 (331)
                      ..        .......+++.|+|||++.+. .++.++||||||+++|+|++|..||....... .......... +.. 
T Consensus       152 ~~--------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~  222 (283)
T cd07835         152 PV--------RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID-QLFRIFRTLGTPDED  222 (283)
T ss_pred             Cc--------cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChH
Confidence            10        111122357789999987664 57899999999999999999999997532211 1111111100 000 


Q ss_pred             hh-h-hcCcccccccc----cCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          267 VM-E-IVDPSLLLEVT----ANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       267 ~~-~-~~~~~~~~~~~----~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      .. . ...+.....+.    .............+.+++.+||+.+|++|||+.++++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         223 VWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             HhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            00 0 00000000000    0001112234467889999999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=4.5e-39  Score=278.22  Aligned_cols=261  Identities=22%  Similarity=0.353  Sum_probs=196.8

Q ss_pred             CCcCceeeccCeeEEEEeeec---CCCceEEEEEeecc--chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCC-cc
Q 046639           32 FSPANKIGQGGVSIVYKGILD---ESRSIVAVKVVNLK--QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEG-FD  105 (331)
Q Consensus        32 y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~-~~  105 (331)
                      |.+.+.||+|+||+||+|.+.   .++..+|+|.+...  .....+.+.+|+.+++.++|||++++++++......+ ..
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            678899999999999999864   35788999988643  3344567889999999999999999999865422111 12


Q ss_pred             eeeEEEeecCCCCHHHHHHhcc----CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEccc
Q 046639          106 FKAIVFEYMQNRNLEQWLRQSN----GQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDL  181 (331)
Q Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Df  181 (331)
                      ..+++++++.+++|.+++....    ...++......++.|++.|++|||+.   +++|+||||+||+++.++.++|+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence            3478899999999998875321    12356778899999999999999999   9999999999999999999999999


Q ss_pred             CcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHH
Q 046639          182 GLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVK  260 (331)
Q Consensus       182 g~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~  260 (331)
                      |+++......      .........+++.|++||.+.+..++.++||||||+++|+|++ |..||......  .......
T Consensus       158 g~~~~~~~~~------~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~--~~~~~~~  229 (273)
T cd05074         158 GLSKKIYSGD------YYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS--EIYNYLI  229 (273)
T ss_pred             cccccccCCc------ceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH--HHHHHHH
Confidence            9987642111      0011112234567999999988889999999999999999999 88998653221  1111111


Q ss_pred             hhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHh
Q 046639          261 MALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHA  322 (331)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~  322 (331)
                      ..  .      ..           .....++..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       230 ~~--~------~~-----------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         230 KG--N------RL-----------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             cC--C------cC-----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            00  0      00           00112456799999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=6.5e-39  Score=276.41  Aligned_cols=252  Identities=20%  Similarity=0.258  Sum_probs=196.0

Q ss_pred             cHHHHHHHhcCCCcCcee--eccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcC-CCCCcceeeceee
Q 046639           21 SYAELSKATNNFSPANKI--GQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNI-RHRNLIKIITICS   97 (331)
Q Consensus        21 ~~~~~~~~~~~y~~~~~l--g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~   97 (331)
                      +..++....++|.+.+.+  |.|+||.||++....++..+|+|.+........     |+.....+ +|+|++++++.+.
T Consensus         5 ~~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~   79 (267)
T PHA03390          5 SLSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVT   79 (267)
T ss_pred             HHHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEe
Confidence            455666677788888887  999999999999999999999999864422211     22222222 6999999999854


Q ss_pred             cccCCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCC-cE
Q 046639           98 SIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDI-VA  176 (331)
Q Consensus        98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~-~~  176 (331)
                           ..+..++||||+++++|.+++....  .+++..+..++.|++.||.+||+.   +++|+||+|+||+++.++ .+
T Consensus        80 -----~~~~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~  149 (267)
T PHA03390         80 -----TLKGHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRI  149 (267)
T ss_pred             -----cCCeeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeE
Confidence                 3457899999999999999997653  578899999999999999999999   999999999999999988 99


Q ss_pred             EEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHH
Q 046639          177 HVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLH  256 (331)
Q Consensus       177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~  256 (331)
                      +|+|||++.....            .....++..|+|||++.+..++.++||||+|+++|+|++|..||...........
T Consensus       150 ~l~dfg~~~~~~~------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~  217 (267)
T PHA03390        150 YLCDYGLCKIIGT------------PSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLE  217 (267)
T ss_pred             EEecCccceecCC------------CccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHH
Confidence            9999999876411            1123477889999999998999999999999999999999999985433332222


Q ss_pred             HHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCc-HHHHHH
Q 046639          257 EFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERME-MRDVVA  317 (331)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps-~~~i~~  317 (331)
                      .+.... ..                 ....+..+...+.+++.+||+.+|.+||+ +.++++
T Consensus       218 ~~~~~~-~~-----------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        218 SLLKRQ-QK-----------------KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             HHHHhh-cc-----------------cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            222111 00                 00122245677899999999999999996 588863

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=3.7e-39  Score=283.31  Aligned_cols=263  Identities=20%  Similarity=0.237  Sum_probs=199.9

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      ++|.+.+.||+|+||.||++.+..+++.|++|.+....   ......+.+|+.+++.++||||+++++.+     ...+.
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~   75 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSF-----ETKRH   75 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ecCCE
Confidence            47899999999999999999999999999999886443   22345678999999999999999999884     45668


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      .++|||++++++|.+++....  .+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||+++.
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~  150 (305)
T cd05609          76 LCMVMEYVEGGDCATLLKNIG--ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKI  150 (305)
T ss_pred             EEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccc
Confidence            899999999999999996643  467788889999999999999999   999999999999999999999999998864


Q ss_pred             cccCCCCC-------cccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHH
Q 046639          187 LFGYEPGT-------AAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFV  259 (331)
Q Consensus       187 ~~~~~~~~-------~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~  259 (331)
                      ........       ............++..|+|||.+.+..++.++|+||||+++|+|++|..||.+...     ....
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~-----~~~~  225 (305)
T cd05609         151 GLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-----EELF  225 (305)
T ss_pred             cCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHH
Confidence            21100000       00000011123467789999999888899999999999999999999999964321     1111


Q ss_pred             HhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHH
Q 046639          260 KMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRH  321 (331)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~  321 (331)
                      ........   ..+..           ...++..+.+++.+||+.+|++||++.++.+.|+.
T Consensus       226 ~~~~~~~~---~~~~~-----------~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         226 GQVISDDI---EWPEG-----------DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             HHHHhccc---CCCCc-----------cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            11100000   00000           01245678999999999999999997766666655

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-40  Score=291.17  Aligned_cols=241  Identities=22%  Similarity=0.224  Sum_probs=183.0

Q ss_pred             eeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHHcC---CCCCcceeeceeecccCCCcceeeEEE
Q 046639           38 IGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNI---RHRNLIKIITICSSIDFEGFDFKAIVF  111 (331)
Q Consensus        38 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~~~~~~~~lv~  111 (331)
                      ||+|+||+||+|++..+++.||+|++....   .........|..++...   .||+|++++++     +......++||
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~-----~~~~~~~~lv~   75 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFS-----FQTDSDLYLVT   75 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEE-----EecCCeEEEEE
Confidence            799999999999999999999999986432   12223345566666655   69999999988     45557789999


Q ss_pred             eecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccccCC
Q 046639          112 EYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYE  191 (331)
Q Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~~  191 (331)
                      ||+++++|.+++....  .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.++|+|||++.....  
T Consensus        76 e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~--  148 (330)
T cd05586          76 DYMSGGELFWHLQKEG--RFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLT--  148 (330)
T ss_pred             cCCCCChHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCC--
Confidence            9999999999986543  467888999999999999999999   999999999999999999999999999865311  


Q ss_pred             CCCcccccCCceeecccccccCCcccCCC-CCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhhh
Q 046639          192 PGTAAETASNSIEIKGIVGYVAPEYGMGS-KASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEI  270 (331)
Q Consensus       192 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  270 (331)
                            .........||+.|+|||++.+. .++.++||||||+++|+|++|..||.....     ...........    
T Consensus       149 ------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~-----~~~~~~i~~~~----  213 (330)
T cd05586         149 ------DNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT-----QQMYRNIAFGK----  213 (330)
T ss_pred             ------CCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH-----HHHHHHHHcCC----
Confidence                  11112345689999999998764 479999999999999999999999965311     11111110000    


Q ss_pred             cCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCC----cHHHHHH
Q 046639          271 VDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERM----EMRDVVA  317 (331)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp----s~~~i~~  317 (331)
                        ..+..          ......+.+++.+||+.||.+||    ++.++++
T Consensus       214 --~~~~~----------~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         214 --VRFPK----------NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             --CCCCC----------ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence              00000          01345678899999999999998    4555543

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=2.5e-39  Score=281.72  Aligned_cols=269  Identities=24%  Similarity=0.288  Sum_probs=197.7

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCccee
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ--KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      ++|.+.+.||+|++|.||+|.+..+++.||+|.+....  ....+.+.+|+.+++.++|||++++++++     ......
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~   75 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF-----RRKKRL   75 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhc-----ccCCeE
Confidence            46899999999999999999998889999999875332  22345678899999999999999999994     556788


Q ss_pred             eEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccc
Q 046639          108 AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      ++|+||+++++|..+.....  .+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++...
T Consensus        76 ~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~  150 (286)
T cd07846          76 YLVFEFVDHTVLDDLEKYPN--GLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL  150 (286)
T ss_pred             EEEEecCCccHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeec
Confidence            99999999888888765432  367889999999999999999999   9999999999999999999999999998764


Q ss_pred             ccCCCCCcccccCCceeecccccccCCcccCC-CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHh--hCc
Q 046639          188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMG-SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKM--ALP  264 (331)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~--~~~  264 (331)
                      ....        .......++..|+|||++.+ ..++.++||||||+++|+|++|.+||..... ..........  ...
T Consensus       151 ~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~-~~~~~~~~~~~~~~~  221 (286)
T cd07846         151 AAPG--------EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD-IDQLYHIIKCLGNLI  221 (286)
T ss_pred             cCCc--------cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch-HHHHHHHHHHhCCCc
Confidence            2111        11122346788999999876 3478899999999999999999999964321 1111111110  000


Q ss_pred             chhhhhcCc------ccccccc--cCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          265 DKVMEIVDP------SLLLEVT--ANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       265 ~~~~~~~~~------~~~~~~~--~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      .......+.      .......  .........++..+.+++.+||+.+|++|||+.+|++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         222 PRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             hhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            000000000      0000000  0000111245677999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=2.6e-39  Score=282.30  Aligned_cols=244  Identities=23%  Similarity=0.245  Sum_probs=197.2

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      ++|.+.+.||+|++|.||++.+..+++.+|+|.+....   ......+.+|+.+++.+.||||+++++++     .....
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~   75 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSF-----QDDSN   75 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCe
Confidence            47999999999999999999999899999999986432   23446688999999999999999999984     45567


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      .++|||++++++|.+++...  ..++...+..++.|++.||.+||+.   +++|+||+|+||+++.++.++|+|||++..
T Consensus        76 ~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~  150 (290)
T cd05580          76 LYLVMEYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKR  150 (290)
T ss_pred             EEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccc
Confidence            89999999999999999765  3467888899999999999999999   999999999999999999999999999876


Q ss_pred             cccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcch
Q 046639          187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDK  266 (331)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  266 (331)
                      ....           .....+++.|+|||.+.+..++.++||||||+++|+|++|..||....     ........... 
T Consensus       151 ~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~-  213 (290)
T cd05580         151 VKGR-----------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN-----PIQIYEKILEG-  213 (290)
T ss_pred             cCCC-----------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHhcC-
Confidence            5211           223357888999999988888999999999999999999999996532     11111110000 


Q ss_pred             hhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCC-----cHHHHH
Q 046639          267 VMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERM-----EMRDVV  316 (331)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----s~~~i~  316 (331)
                           ..           .++......+.+++.+||..+|.+|+     ++.+++
T Consensus       214 -----~~-----------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~  252 (290)
T cd05580         214 -----KV-----------RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK  252 (290)
T ss_pred             -----Cc-----------cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence                 00           11112346788999999999999999     777775

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.1e-38  Score=277.64  Aligned_cols=249  Identities=19%  Similarity=0.268  Sum_probs=197.9

Q ss_pred             CCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeEE
Q 046639           31 NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIV  110 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv  110 (331)
                      +|...+.||+|++|.||++.+..+++.+++|.+..........+.+|+.+++.+.|||++++++++.     ..+..+++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~-----~~~~~~~v   94 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL-----VGDELWVV   94 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEE-----cCCeEEEE
Confidence            4666789999999999999998889999999987665555567889999999999999999999853     45678999


Q ss_pred             EeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccccC
Q 046639          111 FEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGY  190 (331)
Q Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~  190 (331)
                      +|++++++|.+++..   ..++...+..++.|++.|+++||+.   +++|+||+|+||+++.++.++|+|||.+..... 
T Consensus        95 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~-  167 (285)
T cd06648          95 MEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK-  167 (285)
T ss_pred             EeccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhcc-
Confidence            999999999999876   2367788899999999999999999   999999999999999999999999998765411 


Q ss_pred             CCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhhh
Q 046639          191 EPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEI  270 (331)
Q Consensus       191 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  270 (331)
                             .........+++.|+|||.+.+..++.++||||||+++|+|++|..||.....  ...........       
T Consensus       168 -------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~--~~~~~~~~~~~-------  231 (285)
T cd06648         168 -------EVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP--LQAMKRIRDNL-------  231 (285)
T ss_pred             -------CCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH--HHHHHHHHhcC-------
Confidence                   11112234578889999999888899999999999999999999999864211  11111111000       


Q ss_pred             cCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          271 VDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                       .+..         .....+...+.+++.+||+.+|++|||+.++++
T Consensus       232 -~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         232 -PPKL---------KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             -CCCC---------cccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence             0000         001124567899999999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.3e-38  Score=274.86  Aligned_cols=254  Identities=21%  Similarity=0.306  Sum_probs=183.8

Q ss_pred             ceeeccCeeEEEEeeecC--CCceEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeEEEe
Q 046639           36 NKIGQGGVSIVYKGILDE--SRSIVAVKVVNLKQ-KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFE  112 (331)
Q Consensus        36 ~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~e  112 (331)
                      +.||+|+||+||+|....  ....+++|.+.... ......+.+|+.+++.++|+||+++++.+.     .....++|||
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~-----~~~~~~lv~e   75 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCI-----ESIPYLLVLE   75 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEEC-----CCCceEEEEE
Confidence            469999999999997532  34578888775443 233456789999999999999999999853     4467899999


Q ss_pred             ecCCCCHHHHHHhccC---CccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccccc
Q 046639          113 YMQNRNLEQWLRQSNG---QLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG  189 (331)
Q Consensus       113 ~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~  189 (331)
                      ++++++|.+++.....   ...++.....++.|++.|++|||++   +++|+||||+||+++.++.+||+|||++.....
T Consensus        76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~  152 (269)
T cd05042          76 FCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYP  152 (269)
T ss_pred             eCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEecccccccccc
Confidence            9999999999976432   2234567788999999999999999   999999999999999999999999999864311


Q ss_pred             CCCCCcccccCCceeecccccccCCcccC-------CCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHh
Q 046639          190 YEPGTAAETASNSIEIKGIVGYVAPEYGM-------GSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKM  261 (331)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-------~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~  261 (331)
                      .      ..........++..|+|||+..       ...++.++||||||+++|+|++ |..||....... ....... 
T Consensus       153 ~------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~~~~~-  224 (269)
T cd05042         153 E------DYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-VLKQVVR-  224 (269)
T ss_pred             c------hheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH-HHHHHhh-
Confidence            0      0000112223456799999864       3456889999999999999999 788886542211 1111111 


Q ss_pred             hCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHH
Q 046639          262 ALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLR  320 (331)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~  320 (331)
                         ........+.           ....+...+.+++..|| .||++|||+.+|++.|.
T Consensus       225 ---~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         225 ---EQDIKLPKPQ-----------LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             ---ccCccCCCCc-----------ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence               1111111111           11234556677788888 59999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=2e-38  Score=276.09  Aligned_cols=272  Identities=20%  Similarity=0.256  Sum_probs=200.7

Q ss_pred             CCcCceeeccCeeEEEEeeecCCCceEEEEEeeccch--hhHHHHHHHHHHHHcC---CCCCcceeeceeecccCCCcce
Q 046639           32 FSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK--EASRSFAAECNALRNI---RHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        32 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      |.+.+.||+|++|.||+|++..++..+|+|.+.....  .....+.+|+.+++.+   .|+|++++++++...+......
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            6788999999999999999988899999999964422  2234566777777665   5999999999986654334445


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      .+++||++. ++|.+++.......+++..++.++.|++.||.+||+.   +++|+||+|+||+++.++.++|+|||.+..
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCccee
Confidence            899999995 5899988775555678899999999999999999999   999999999999999999999999999876


Q ss_pred             cccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcch
Q 046639          187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDK  266 (331)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  266 (331)
                      ....         .......++..|+|||++.+..++.++|+||||+++|+|++|.+||..... ......+........
T Consensus       157 ~~~~---------~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~  226 (287)
T cd07838         157 YSFE---------MALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE-ADQLDKIFDVIGLPS  226 (287)
T ss_pred             ccCC---------cccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh-HHHHHHHHHHcCCCC
Confidence            5211         111223467789999999998999999999999999999999999975322 222222222111000


Q ss_pred             hhhhc-C-----cccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          267 VMEIV-D-----PSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       267 ~~~~~-~-----~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ..... .     ................+....+.+++.+||+.||.+||++.+++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         227 EEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             hHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            00000 0     000011111112223345678899999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=7.2e-39  Score=274.40  Aligned_cols=250  Identities=20%  Similarity=0.304  Sum_probs=199.1

Q ss_pred             CCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           31 NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ--KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      +|.+.+.||+|++|.||+|.+..++..+|+|.+....  ......+.+|+.+++.++|+|++++++.+     ......+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~-----~~~~~~~   75 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASF-----QENGRLF   75 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhhee-----ccCCeEE
Confidence            5888999999999999999999999999999986542  23345678999999999999999999984     4556889


Q ss_pred             EEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCC-cEEEcccCccccc
Q 046639          109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDI-VAHVGDLGLAKFL  187 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~-~~kl~Dfg~a~~~  187 (331)
                      +++|++++++|.+++.......+++.....++.|++.|+.+||+.   +++|+||+|+||+++.++ .++|+|||.+...
T Consensus        76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~  152 (257)
T cd08225          76 IVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL  152 (257)
T ss_pred             EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhc
Confidence            999999999999999876655677888999999999999999999   999999999999999886 4699999988765


Q ss_pred             ccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchh
Q 046639          188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKV  267 (331)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  267 (331)
                      ....        .......+++.|+|||+..+..++.++|+||||+++|+|++|..||....     .............
T Consensus       153 ~~~~--------~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~  219 (257)
T cd08225         153 NDSM--------ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-----LHQLVLKICQGYF  219 (257)
T ss_pred             cCCc--------ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHHhcccC
Confidence            2111        11122357888999999988889999999999999999999999996431     1111111111100


Q ss_pred             hhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          268 MEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                          .            .........+.+++.+||+.+|++|||+.+|++
T Consensus       220 ----~------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         220 ----A------------PISPNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             ----C------------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence                0            001123457889999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.1e-38  Score=276.51  Aligned_cols=247  Identities=20%  Similarity=0.278  Sum_probs=197.7

Q ss_pred             CCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeE
Q 046639           31 NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ-KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAI  109 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~l  109 (331)
                      -|.+.+.||.|+||.||+|.+..++..+|+|.+.... ......+.+|+.+++.++|||++++++.+     ..+...++
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~l   79 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY-----LKDTKLWI   79 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEE-----EeCCeEEE
Confidence            4888999999999999999998889999999886443 33446688999999999999999999985     44567899


Q ss_pred             EEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccccc
Q 046639          110 VFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG  189 (331)
Q Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~  189 (331)
                      ||||+++++|.+++...   .++...+..++.|++.++.+||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        80 v~e~~~~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06641          80 IMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD  153 (277)
T ss_pred             EEEeCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceeccc
Confidence            99999999999998643   367788899999999999999999   999999999999999999999999999876421


Q ss_pred             CCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhh
Q 046639          190 YEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVME  269 (331)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  269 (331)
                      .        ........++..|+|||.+.+..++.++|+||||+++|+|++|..||......  ..........      
T Consensus       154 ~--------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~------  217 (277)
T cd06641         154 T--------QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM--KVLFLIPKNN------  217 (277)
T ss_pred             c--------hhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH--HHHHHHhcCC------
Confidence            1        11122235777899999998888899999999999999999999999643211  1111110000      


Q ss_pred             hcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          270 IVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                        .+           .....++..+.+++.+||+.+|.+||++.++++
T Consensus       218 --~~-----------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  252 (277)
T cd06641         218 --PP-----------TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK  252 (277)
T ss_pred             --CC-----------CCCcccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence              00           111234567889999999999999999999998

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=4.5e-39  Score=286.32  Aligned_cols=277  Identities=20%  Similarity=0.272  Sum_probs=202.7

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ--KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      .++|.+.+.||.|++|.||+|.+..++..||+|.+....  ......+.+|+.+++.++||||+++++++.... .....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~   82 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKD   82 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCce
Confidence            368999999999999999999999999999999986432  233466788999999999999999999865432 34567


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      .++|+||+ +++|.+++...  ..+++..+..++.|++.||++||+.   +++|+||||+||+++.++.++|+|||++..
T Consensus        83 ~~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~  156 (334)
T cd07855          83 VYVVMDLM-ESDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARG  156 (334)
T ss_pred             EEEEEehh-hhhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEeccccccee
Confidence            89999999 56999998643  3478899999999999999999999   999999999999999999999999999876


Q ss_pred             cccCCCCCcccccCCceeecccccccCCcccCC-CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHh--hC
Q 046639          187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG-SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKM--AL  263 (331)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~--~~  263 (331)
                      .......    .........++..|+|||.+.+ ..++.++||||||+++|+|++|..||...... .........  ..
T Consensus       157 ~~~~~~~----~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~-~~~~~~~~~~g~~  231 (334)
T cd07855         157 LSSSPTE----HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV-HQLKLILSVLGSP  231 (334)
T ss_pred             ecccCcC----CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH-HHHHHHHHHhCCC
Confidence            5322111    1111123457888999998765 45889999999999999999999999754221 111111111  00


Q ss_pred             cchhhhhcC-c-------ccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          264 PDKVMEIVD-P-------SLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       264 ~~~~~~~~~-~-------~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      +........ .       .................+..+.+++.+||+.+|++|||+.+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         232 SEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             hhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            100000000 0       00000000000112235678999999999999999999999886

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=4.3e-39  Score=279.04  Aligned_cols=245  Identities=22%  Similarity=0.279  Sum_probs=192.3

Q ss_pred             eeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeEEEeec
Q 046639           38 IGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYM  114 (331)
Q Consensus        38 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~  114 (331)
                      ||+|+||+||+|.+..+++.+|+|.+....   ......+.+|+.+++.++|||++++++++     ...+..++||||+
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~   75 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAF-----ETKDDLCLVMTLM   75 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEE-----ecCCeEEEEEecC
Confidence            689999999999999899999999986432   22334567899999999999999999884     4456789999999


Q ss_pred             CCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccccCCCCC
Q 046639          115 QNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGT  194 (331)
Q Consensus       115 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~~~~~  194 (331)
                      ++++|.+++.......++...+..++.|++.||.+||+.   +++|+||+|+||+++.++.++|+|||.+.....     
T Consensus        76 ~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~-----  147 (277)
T cd05577          76 NGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKG-----  147 (277)
T ss_pred             CCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhcc-----
Confidence            999999999776555678888999999999999999999   999999999999999999999999999876421     


Q ss_pred             cccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhhhcCcc
Q 046639          195 AAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPS  274 (331)
Q Consensus       195 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (331)
                          ........++..|+|||.+.+..++.++||||||+++++|++|..||....... .......... ..        
T Consensus       148 ----~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~-~~--------  213 (277)
T cd05577         148 ----GKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV-EKEELKRRTL-EM--------  213 (277)
T ss_pred             ----CCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc-cHHHHHhccc-cc--------
Confidence                111223346778999999988889999999999999999999999996542211 1111111100 00        


Q ss_pred             cccccccCCcchHHHHHHHHHHhhccccCCCCCCCC-----cHHHHHH
Q 046639          275 LLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERM-----EMRDVVA  317 (331)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----s~~~i~~  317 (331)
                              ...........+.+++.+||+.+|.+||     ++.++++
T Consensus       214 --------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         214 --------AVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             --------cccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence                    0011123466788999999999999999     6666764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=9.2e-39  Score=281.34  Aligned_cols=272  Identities=22%  Similarity=0.271  Sum_probs=197.2

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchh--hHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKE--ASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      .++|.+.+.||.|++|.||+|.+..+++.||+|.+......  ......+|+.+++.++|+|++++++++..   ...+.
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~   82 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVG---KHLDS   82 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEec---CCCCe
Confidence            45799999999999999999999999999999998644322  22345689999999999999999998642   22356


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      .++|||++ .++|.+++.... ..+++..+..++.|++.||.+||+.   +++|+||+|+||+++.++.++|+|||++..
T Consensus        83 ~~lv~e~~-~~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~  157 (309)
T cd07845          83 IFLVMEYC-EQDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLART  157 (309)
T ss_pred             EEEEEecC-CCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeee
Confidence            79999999 468998887543 3567888999999999999999999   999999999999999999999999999876


Q ss_pred             cccCCCCCcccccCCceeecccccccCCcccCC-CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCc-
Q 046639          187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG-SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALP-  264 (331)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-  264 (331)
                      .....        .......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||..... ...+......... 
T Consensus       158 ~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~-~~~~~~~~~~~~~~  228 (309)
T cd07845         158 YGLPA--------KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE-IEQLDLIIQLLGTP  228 (309)
T ss_pred             cCCcc--------CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCC
Confidence            52111        11122235677999999865 4578999999999999999999999975322 1112211111000 


Q ss_pred             -chhhh-hcCccccc--ccccCCcch----HHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          265 -DKVME-IVDPSLLL--EVTANNYSW----IEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       265 -~~~~~-~~~~~~~~--~~~~~~~~~----~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                       ..... ........  .........    .....+.+.+++.+||+.||++|||+.+++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         229 NESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             ChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence             00000 00000000  000000000    1123567889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=8.3e-39  Score=279.74  Aligned_cols=275  Identities=19%  Similarity=0.256  Sum_probs=197.5

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccch--hhHHHHHHHHHHHHcCC-CCCcceeeceeecccCCCcce
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK--EASRSFAAECNALRNIR-HRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      ++|.+.+.||+|+||.||+|.+..+++.||+|.+.....  .....+.+|+.+++.+. |+|++++++++...+......
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            479999999999999999999999999999998864432  22356788999999995 699999999876543333445


Q ss_pred             eeEEEeecCCCCHHHHHHhcc---CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecC-CCcEEEcccC
Q 046639          107 KAIVFEYMQNRNLEQWLRQSN---GQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQ-DIVAHVGDLG  182 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~-~~~~kl~Dfg  182 (331)
                      .++||||++ ++|.+++....   ...+++..+..++.|++.||.|||++   +++|+||+|+||+++. ++.++|+|||
T Consensus        81 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLD-SDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccC-cCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence            799999996 58988886532   23568889999999999999999999   9999999999999998 8899999999


Q ss_pred             cccccccCCCCCcccccCCceeecccccccCCcccCC-CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHh
Q 046639          183 LAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG-SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKM  261 (331)
Q Consensus       183 ~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  261 (331)
                      ++..+....        .......+++.|+|||++.+ ..++.++||||||+++|+|++|..||....... ........
T Consensus       157 ~~~~~~~~~--------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~  227 (295)
T cd07837         157 LGRAFSIPV--------KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ-QLLHIFKL  227 (295)
T ss_pred             cceecCCCc--------cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHH
Confidence            987542111        11112245778999998765 457899999999999999999999997532211 11111110


Q ss_pred             h-Ccch-----hhhhcCcccccccc-cCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          262 A-LPDK-----VMEIVDPSLLLEVT-ANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       262 ~-~~~~-----~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      . .+..     .............. .............+.+++.+||+.||.+|||+.+++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         228 LGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             hCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            0 0000     00000000000000 0000111235667899999999999999999999874

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.9e-38  Score=273.78  Aligned_cols=253  Identities=23%  Similarity=0.345  Sum_probs=196.5

Q ss_pred             CCCcCceeeccCeeEEEEeeecC-CCceEEEEEeecc----------chhhHHHHHHHHHHHHc-CCCCCcceeeceeec
Q 046639           31 NFSPANKIGQGGVSIVYKGILDE-SRSIVAVKVVNLK----------QKEASRSFAAECNALRN-IRHRNLIKIITICSS   98 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~----------~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~   98 (331)
                      .|++.+.||+|+||.||+|.+.. +++.+|+|.+...          .......+..|+.++.+ ++|+|++++++++  
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~--   78 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTF--   78 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeE--
Confidence            48889999999999999999987 6789999987532          22233557788888875 6899999999985  


Q ss_pred             ccCCCcceeeEEEeecCCCCHHHHHHh--ccCCccchHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCCEEecCCCc
Q 046639           99 IDFEGFDFKAIVFEYMQNRNLEQWLRQ--SNGQLRFLTQRVNIAIDVSFAIEYFHH-HCQPSIVHGDLKPSNILLDQDIV  175 (331)
Q Consensus        99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~~~~ivH~dik~~nilv~~~~~  175 (331)
                         ...+..+++|||+++++|.+++..  .....++...++.++.|++.+|.+||+ .   +++|+||+|+||+++.++.
T Consensus        79 ---~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~  152 (269)
T cd08528          79 ---LENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDK  152 (269)
T ss_pred             ---ccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCc
Confidence               445688999999999999998864  233457778889999999999999996 5   8999999999999999999


Q ss_pred             EEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchH
Q 046639          176 AHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTL  255 (331)
Q Consensus       176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~  255 (331)
                      ++|+|||.+......         .......++..|+|||.+.+..++.++|+||||+++|+|++|..||.....  ...
T Consensus       153 ~~l~dfg~~~~~~~~---------~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~--~~~  221 (269)
T cd08528         153 VTITDFGLAKQKQPE---------SKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM--LSL  221 (269)
T ss_pred             EEEecccceeecccc---------cccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH--HHH
Confidence            999999998764211         122234577889999999988899999999999999999999999864311  111


Q ss_pred             HHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHH
Q 046639          256 HEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLR  320 (331)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~  320 (331)
                      ........       ..+     ..      ...+...+.+++.+||+.||++||++.++.+.++
T Consensus       222 ~~~~~~~~-------~~~-----~~------~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         222 ATKIVEAV-------YEP-----LP------EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             HHHHhhcc-------CCc-----CC------cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            11100000       000     00      0123467889999999999999999999998775

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-40  Score=302.03  Aligned_cols=260  Identities=25%  Similarity=0.364  Sum_probs=210.2

Q ss_pred             CCCcCceeeccCeeEEEEeeecCCC---ceEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           31 NFSPANKIGQGGVSIVYKGILDESR---SIVAVKVVNLKQ-KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      ...|.+.||.|.||+|++|+.+..+   ..||||.++.-- .....+|+.|+.||-++.||||+++.|+     ......
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGV-----VTks~P  704 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGV-----VTKSKP  704 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEE-----EecCce
Confidence            3467799999999999999986544   579999997543 4456789999999999999999999999     455677


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      +.||+|||++|+|..+++.+.++ +...+...++..|+.|+.||-..   ++|||||...||||+.+..+|++|||+++.
T Consensus       705 vMIiTEyMENGsLDsFLR~~DGq-ftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRv  780 (996)
T KOG0196|consen  705 VMIITEYMENGSLDSFLRQNDGQ-FTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV  780 (996)
T ss_pred             eEEEhhhhhCCcHHHHHhhcCCc-eEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceee
Confidence            89999999999999999988776 66788889999999999999999   999999999999999999999999999998


Q ss_pred             cccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhCcc
Q 046639          187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMALPD  265 (331)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~  265 (331)
                      +.+.... .......    .=...|.|||.+....++.+|||||+|+++||.++ |..||=++.+.+  ..+.+..    
T Consensus       781 ledd~~~-~ytt~GG----KIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd--VIkaIe~----  849 (996)
T KOG0196|consen  781 LEDDPEA-AYTTLGG----KIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD--VIKAIEQ----  849 (996)
T ss_pred             cccCCCc-cccccCC----ccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH--HHHHHHh----
Confidence            7432210 0000000    01234999999999999999999999999999887 999998775432  1111111    


Q ss_pred             hhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhh
Q 046639          266 KVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARET  325 (331)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~  325 (331)
                            +.++.         -+-+|+.+|.+||..||++|-..||.+.+|+..|+++...
T Consensus       850 ------gyRLP---------pPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn  894 (996)
T KOG0196|consen  850 ------GYRLP---------PPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN  894 (996)
T ss_pred             ------ccCCC---------CCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence                  11111         1136999999999999999999999999999999998654

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.1e-38  Score=273.29  Aligned_cols=251  Identities=24%  Similarity=0.410  Sum_probs=194.1

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeE
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAI  109 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~l  109 (331)
                      .+|++.+.||.|++|.||+|.+. ++..+|+|.+.... .....+.+|+.+++.++||+++++++++     ......++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~   76 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVC-----TERSPICL   76 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEE-----ccCCceEE
Confidence            46888999999999999999886 46679999886332 2235688899999999999999999984     44567899


Q ss_pred             EEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccccc
Q 046639          110 VFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG  189 (331)
Q Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~  189 (331)
                      ++|++++++|.+++....+ .+++..+..++.|++.++++||+.   +++|+||+|+||+++.++.++|+|||.+.....
T Consensus        77 v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  152 (256)
T cd05112          77 VFEFMEHGCLSDYLRAQRG-KFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLD  152 (256)
T ss_pred             EEEcCCCCcHHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeeccc
Confidence            9999999999999875432 356788889999999999999999   999999999999999999999999999875421


Q ss_pred             CCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhCcchhh
Q 046639          190 YEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMALPDKVM  268 (331)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  268 (331)
                      ..       ........++..|+|||.+.+..++.++||||||+++|+|++ |..||.....  ...........     
T Consensus       153 ~~-------~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~-----  218 (256)
T cd05112         153 DQ-------YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN--SEVVETINAGF-----  218 (256)
T ss_pred             Cc-------ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH--HHHHHHHhCCC-----
Confidence            10       011112224467999999988889999999999999999998 9999964321  11111110000     


Q ss_pred             hhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHH
Q 046639          269 EIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKL  319 (331)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L  319 (331)
                      ....+              ...+..+.+|+.+||+.+|++|||+.++++.|
T Consensus       219 ~~~~~--------------~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         219 RLYKP--------------RLASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             CCCCC--------------CCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence            00001              11346789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-39  Score=292.66  Aligned_cols=282  Identities=21%  Similarity=0.231  Sum_probs=209.8

Q ss_pred             CCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc-chhhHHHHHHHHHHHHcCCCCCcceeeceeeccc-CCCcceee
Q 046639           31 NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK-QKEASRSFAAECNALRNIRHRNLIKIITICSSID-FEGFDFKA  108 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~~~~~~  108 (331)
                      .+..-+.||+|+||.||+|+++.+|+.||||.++.. .....+...+|+++|++++|+|||+++++-.... .-.....+
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            344567999999999999999999999999998643 3445577889999999999999999998732211 11133468


Q ss_pred             EEEeecCCCCHHHHHHh-ccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEec--CCC--cEEEcccCc
Q 046639          109 IVFEYMQNRNLEQWLRQ-SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLD--QDI--VAHVGDLGL  183 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~--~~~--~~kl~Dfg~  183 (331)
                      +|||||.+|||...+++ .+...+++...+.++.+++.|+.|||.+   ||+||||||.||++-  .+|  ..||+|||+
T Consensus        94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            99999999999999987 4555688999999999999999999999   999999999999993  323  579999999


Q ss_pred             ccccccCCCCCcccccCCceeecccccccCCcccC-CCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHH--H
Q 046639          184 AKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGM-GSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFV--K  260 (331)
Q Consensus       184 a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~--~  260 (331)
                      |+..         .......+..||..|++||+.. ++.|+.-+|.||||+++|+.+||..||-............+  .
T Consensus       171 Arel---------~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~  241 (732)
T KOG4250|consen  171 AREL---------DDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHII  241 (732)
T ss_pred             cccC---------CCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhh
Confidence            9976         3445677888999999999998 48899999999999999999999999987644432111111  1


Q ss_pred             hhCcchhhhhcCcc-----cccccccCCcchHHHHHHHHHHhhccccCCCCCCCC--cHHHHHHHHHHhhh
Q 046639          261 MALPDKVMEIVDPS-----LLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERM--EMRDVVAKLRHARE  324 (331)
Q Consensus       261 ~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp--s~~~i~~~L~~~~~  324 (331)
                      ...+..+.......     ......+............+..++..+|..+|.+|-  ...+....+..+.+
T Consensus       242 tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~  312 (732)
T KOG4250|consen  242 TKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN  312 (732)
T ss_pred             ccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence            11111111111111     111111112222334445577788889999999998  77777766666554

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=8e-39  Score=278.76  Aligned_cols=270  Identities=22%  Similarity=0.292  Sum_probs=198.4

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc--chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCccee
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      ++|.+.+.||+|++|.||+|.+..+++.|++|.++..  .......+.+|+.+++.++|+||+++++++.     ..+..
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~   75 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFR-----RKGRL   75 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEE-----ECCEE
Confidence            4799999999999999999999989999999988643  2334467899999999999999999999953     35678


Q ss_pred             eEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccc
Q 046639          108 AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      ++++||++++.+..+..+.  ..++...+..++.|++.|+.+||..   +++|+||+|+||+++.++.++|+|||++...
T Consensus        76 ~iv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~  150 (288)
T cd07833          76 YLVFEYVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARAL  150 (288)
T ss_pred             EEEEecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeeccccc
Confidence            9999999776665555432  3367888999999999999999999   9999999999999999999999999998765


Q ss_pred             ccCCCCCcccccCCceeecccccccCCcccCCC-CCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHh--hCc
Q 046639          188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMGS-KASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKM--ALP  264 (331)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~--~~~  264 (331)
                      .....       .......++..|+|||++.+. .++.++||||||+++|+|++|..||....... ........  ..+
T Consensus       151 ~~~~~-------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~  222 (288)
T cd07833         151 RARPA-------SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID-QLYLIQKCLGPLP  222 (288)
T ss_pred             CCCcc-------ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCC
Confidence            22111       112234567889999999887 78999999999999999999999997542211 11111000  000


Q ss_pred             chhhhhc--Cccccc-ccccC------CcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          265 DKVMEIV--DPSLLL-EVTAN------NYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       265 ~~~~~~~--~~~~~~-~~~~~------~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      .......  ++.... .....      ...+...++..+.+++.+||..+|++|||+.++++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         223 PSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             HHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            0000000  000000 00000      00111234678999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=4.8e-38  Score=271.19  Aligned_cols=254  Identities=21%  Similarity=0.312  Sum_probs=182.7

Q ss_pred             ceeeccCeeEEEEeeecC--CCceEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeEEEe
Q 046639           36 NKIGQGGVSIVYKGILDE--SRSIVAVKVVNLKQ-KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFE  112 (331)
Q Consensus        36 ~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~e  112 (331)
                      +.||+|+||+||+|....  ....+++|.+.... ......+.+|+.+++.++|||++++++.|.     .....++|||
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~-----~~~~~~lv~e   75 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCV-----EAIPYLLVFE   75 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEec-----CCCccEEEEe
Confidence            469999999999997643  23356677665433 334567899999999999999999999864     3456899999


Q ss_pred             ecCCCCHHHHHHhcc--CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccccC
Q 046639          113 YMQNRNLEQWLRQSN--GQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGY  190 (331)
Q Consensus       113 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~  190 (331)
                      |+++++|.+++.+..  ....+...+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++......
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~  152 (268)
T cd05086          76 YCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKE  152 (268)
T ss_pred             cCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcc
Confidence            999999999997632  23345566778999999999999999   9999999999999999999999999987542110


Q ss_pred             CCCCcccccCCceeecccccccCCcccCC-------CCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhh
Q 046639          191 EPGTAAETASNSIEIKGIVGYVAPEYGMG-------SKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMA  262 (331)
Q Consensus       191 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~  262 (331)
                            ..........++..|+|||++..       ..++.++||||||+++|+|++ |..||..... ...+.....  
T Consensus       153 ------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-~~~~~~~~~--  223 (268)
T cd05086         153 ------DYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-REVLNHVIK--  223 (268)
T ss_pred             ------hhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHh--
Confidence                  00111123446778999998743       245789999999999999997 5678854321 111111111  


Q ss_pred             CcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHH
Q 046639          263 LPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLR  320 (331)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~  320 (331)
                        .......++...           ......+.+++..|| .+|++|||+.+|++.|.
T Consensus       224 --~~~~~~~~~~~~-----------~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         224 --DQQVKLFKPQLE-----------LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             --hcccccCCCccC-----------CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence              111111222221           113456777888899 67999999999998774

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.2e-38  Score=276.80  Aligned_cols=267  Identities=18%  Similarity=0.214  Sum_probs=193.0

Q ss_pred             CCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc-hhhHHHHHHHHHHHHcCC-CCCcceeeceeecccCCCcceeeE
Q 046639           32 FSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ-KEASRSFAAECNALRNIR-HRNLIKIITICSSIDFEGFDFKAI  109 (331)
Q Consensus        32 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~l  109 (331)
                      |++.+.||+|++|.||+|.+..++..+|+|.++... .........|+.++.++. |+|++++++++.+.   ..+..++
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~---~~~~~~l   77 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDR---KTGRLAL   77 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecC---CCCcEEE
Confidence            678899999999999999999899999999886432 222234457888898885 99999999986432   2257899


Q ss_pred             EEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccccc
Q 046639          110 VFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG  189 (331)
Q Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~  189 (331)
                      |+|+++ ++|.+.+.... ..+++..+..++.|++.||.+||+.   +++|+||+|+||+++. +.++|+|||++.....
T Consensus        78 v~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~  151 (282)
T cd07831          78 VFELMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYS  151 (282)
T ss_pred             EEecCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence            999995 68888886543 3567889999999999999999999   9999999999999999 9999999999876521


Q ss_pred             CCCCCcccccCCceeecccccccCCcccCC-CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHh--hCcch
Q 046639          190 YEPGTAAETASNSIEIKGIVGYVAPEYGMG-SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKM--ALPDK  266 (331)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~--~~~~~  266 (331)
                      .         .......++..|+|||++.+ ..++.++||||||+++|+|++|..||....... ........  ..+..
T Consensus       152 ~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~-~~~~~~~~~~~~~~~  221 (282)
T cd07831         152 K---------PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD-QIAKIHDVLGTPDAE  221 (282)
T ss_pred             C---------CCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH-HHHHHHHHcCCCCHH
Confidence            1         11112346788999997654 457889999999999999999999997532211 11111110  00110


Q ss_pred             hhhhcCcc------cccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          267 VMEIVDPS------LLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       267 ~~~~~~~~------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      +.......      ...............++..+.+++.+||+.+|++|||+.++++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         222 VLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             HHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            10000000      0000000011122345788999999999999999999999975

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=3.5e-39  Score=281.20  Aligned_cols=254  Identities=21%  Similarity=0.245  Sum_probs=192.7

Q ss_pred             CCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc-hhhHHHHHHHHHHHHcCC-CCCcceeeceeecccCCCcceee
Q 046639           31 NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ-KEASRSFAAECNALRNIR-HRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      +|...+.||+|+||.||++.+..+++.+|+|.+.... ......+.+|+.++.++. |+||+++++++     ..+...+
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~-----~~~~~~~   79 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGAL-----FREGDCW   79 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEE-----ecCCcEE
Confidence            4667789999999999999999999999999986443 234466889999999996 99999999985     3346678


Q ss_pred             EEEeecCCCCHHHHHH---hccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccc
Q 046639          109 IVFEYMQNRNLEQWLR---QSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAK  185 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~  185 (331)
                      ++||++ ++++.++..   ......+++..+..++.|++.||+|||+..  +++|+||||+||+++.++.++|+|||++.
T Consensus        80 ~~~e~~-~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~  156 (288)
T cd06616          80 ICMELM-DISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISG  156 (288)
T ss_pred             EEEecc-cCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhH
Confidence            999998 556655443   223355778889999999999999999743  89999999999999999999999999987


Q ss_pred             ccccCCCCCcccccCCceeecccccccCCcccCCC---CCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhh
Q 046639          186 FLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGS---KASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMA  262 (331)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  262 (331)
                      .....         .......++..|+|||++.+.   .++.++||||+|+++|+|++|..||....   ..... ....
T Consensus       157 ~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~---~~~~~-~~~~  223 (288)
T cd06616         157 QLVDS---------IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN---SVFDQ-LTQV  223 (288)
T ss_pred             HhccC---------CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc---hHHHH-Hhhh
Confidence            65211         111223477889999998776   68999999999999999999999997532   11111 1110


Q ss_pred             CcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          263 LPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ..     ...+.+..       .....++..+.+|+.+||+.+|++|||+.+|++
T Consensus       224 ~~-----~~~~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~  266 (288)
T cd06616         224 VK-----GDPPILSN-------SEEREFSPSFVNFINLCLIKDESKRPKYKELLE  266 (288)
T ss_pred             cC-----CCCCcCCC-------cCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00     00011100       111235668999999999999999999999986

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=9.7e-39  Score=279.08  Aligned_cols=271  Identities=18%  Similarity=0.246  Sum_probs=197.4

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccch--hhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCccee
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK--EASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      ++|.+.+.||.|++|.||+|.+..+++.+++|.++....  .....+.+|+.++++++||||+++.+++...   .....
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---~~~~~   81 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGS---NLDKI   81 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEec---CCCcE
Confidence            479999999999999999999998999999999864432  2234567899999999999999999986432   23678


Q ss_pred             eEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccc
Q 046639          108 AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      ++|+|+++ ++|.+++..... .+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++...
T Consensus        82 ~lv~e~~~-~~L~~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~  156 (293)
T cd07843          82 YMVMEYVE-HDLKSLMETMKQ-PFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREY  156 (293)
T ss_pred             EEEehhcC-cCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeec
Confidence            99999995 599998876433 577889999999999999999999   9999999999999999999999999998765


Q ss_pred             ccCCCCCcccccCCceeecccccccCCcccCCC-CCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCc--
Q 046639          188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMGS-KASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALP--  264 (331)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--  264 (331)
                      ....        .......+++.|+|||.+.+. .++.++|+||+|+++|+|++|..||...... ............  
T Consensus       157 ~~~~--------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~~~~~~  227 (293)
T cd07843         157 GSPL--------KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI-DQLNKIFKLLGTPT  227 (293)
T ss_pred             cCCc--------cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCc
Confidence            2211        111223467789999998764 4689999999999999999999999754221 111111111000  


Q ss_pred             c-hhh---hhcCcc--ccccc--ccCCcchHHH-HHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          265 D-KVM---EIVDPS--LLLEV--TANNYSWIED-CLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       265 ~-~~~---~~~~~~--~~~~~--~~~~~~~~~~-~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      . ...   ......  .....  ..-...+... ....+.+++.+||+.+|++|||+.|+++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         228 EKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             hHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence            0 000   000000  00000  0000011111 3667889999999999999999999974

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-38  Score=280.21  Aligned_cols=275  Identities=18%  Similarity=0.231  Sum_probs=197.7

Q ss_pred             CCCcCceeeccCeeEEEEeeecC--CCceEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcc
Q 046639           31 NFSPANKIGQGGVSIVYKGILDE--SRSIVAVKVVNLKQ---KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFD  105 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~  105 (331)
                      +|.+.+.||+|++|.||+|.+..  ++..||+|.+....   ......+.+|+.+++.++|||++++++++..   ....
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~   77 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLE---HADK   77 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeC---CCCc
Confidence            48889999999999999999987  78999999997532   3444667889999999999999999999753   2236


Q ss_pred             eeeEEEeecCCCCHHHHHHhcc---CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecC----CCcEEE
Q 046639          106 FKAIVFEYMQNRNLEQWLRQSN---GQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQ----DIVAHV  178 (331)
Q Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~----~~~~kl  178 (331)
                      ..++|||+++ ++|.+++....   ...++...++.++.|++.||.|||+.   +++|+||||+||+++.    ++.+||
T Consensus        78 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl  153 (316)
T cd07842          78 SVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKI  153 (316)
T ss_pred             eEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEE
Confidence            7899999994 57888776422   22567788899999999999999999   9999999999999999    999999


Q ss_pred             cccCcccccccCCCCCcccccCCceeecccccccCCcccCCC-CCccchhhHhHHHHHHHHHhCCCCCCcccCCcc----
Q 046639          179 GDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGS-KASVSGDVYNFGILLLEMFTRRRPTDAMFNEGL----  253 (331)
Q Consensus       179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~----  253 (331)
                      +|||++........     .........+++.|+|||++.+. .++.++||||||+++++|++|.+||........    
T Consensus       154 ~Dfg~~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~  228 (316)
T cd07842         154 GDLGLARLFNAPLK-----PLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNP  228 (316)
T ss_pred             CCCccccccCCCcc-----cccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccch
Confidence            99999876522111     11122334578889999987664 578999999999999999999999976533220    


Q ss_pred             ----hHHHHHHhhCcc------------hhhhhcCcccccccc-cCCcchHH---HHHHHHHHhhccccCCCCCCCCcHH
Q 046639          254 ----TLHEFVKMALPD------------KVMEIVDPSLLLEVT-ANNYSWIE---DCLVAVIGTGVTCSMESPMERMEMR  313 (331)
Q Consensus       254 ----~~~~~~~~~~~~------------~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~l~~l~~~cl~~~P~~Rps~~  313 (331)
                          ............            ............... ........   .....+.+++.+||+.||++|||+.
T Consensus       229 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~  308 (316)
T cd07842         229 FQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAE  308 (316)
T ss_pred             hHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHH
Confidence                011111100000            000000000000000 00001011   2445789999999999999999999


Q ss_pred             HHHH
Q 046639          314 DVVA  317 (331)
Q Consensus       314 ~i~~  317 (331)
                      ++++
T Consensus       309 eil~  312 (316)
T cd07842         309 EALE  312 (316)
T ss_pred             HHhc
Confidence            9974

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-40  Score=278.18  Aligned_cols=269  Identities=20%  Similarity=0.248  Sum_probs=205.8

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCC--C----CcceeeceeecccC
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRH--R----NLIKIITICSSIDF  101 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~----~i~~~~~~~~~~~~  101 (331)
                      ..++|.+...+|+|.||.|-.+.++.++..||||+++.. ....++..-|++++.++.+  |    .++++.++     +
T Consensus        87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~w-----F  160 (415)
T KOG0671|consen   87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDW-----F  160 (415)
T ss_pred             cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehh-----h
Confidence            478999999999999999999999999999999999633 4455667889999999942  2    35666666     5


Q ss_pred             CCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecC---------
Q 046639          102 EGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQ---------  172 (331)
Q Consensus       102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~---------  172 (331)
                      +-.++.|+|+|.+ |.|+.+++..++..+++..++..++.|+++++++||+.   +++|.|+||+||++..         
T Consensus       161 dyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~  236 (415)
T KOG0671|consen  161 DYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNP  236 (415)
T ss_pred             hccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEecc
Confidence            6678899999999 88999999999999999999999999999999999999   9999999999999921         


Q ss_pred             -----------CCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhC
Q 046639          173 -----------DIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTR  241 (331)
Q Consensus       173 -----------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g  241 (331)
                                 +..++++|||.|.+-           .........|..|.|||++.+-+++.++||||+||||+|+.+|
T Consensus       237 k~~~~~~r~~ks~~I~vIDFGsAtf~-----------~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG  305 (415)
T KOG0671|consen  237 KKKVCFIRPLKSTAIKVIDFGSATFD-----------HEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTG  305 (415)
T ss_pred             CCccceeccCCCcceEEEecCCccee-----------ccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeecc
Confidence                       335899999999763           2333566788899999999999999999999999999999999


Q ss_pred             CCCCCcccCCcch-HHHHHHhhCcchhhhhc------Ccc-cc-------------cccccC---CcchHHHHHHHHHHh
Q 046639          242 RRPTDAMFNEGLT-LHEFVKMALPDKVMEIV------DPS-LL-------------LEVTAN---NYSWIEDCLVAVIGT  297 (331)
Q Consensus       242 ~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~------~~~-~~-------------~~~~~~---~~~~~~~~~~~l~~l  297 (331)
                      ...|+...+.... .-+-+-..+|.....-.      ... +.             .+.+..   .-.-.+.....|++|
T Consensus       306 ~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDL  385 (415)
T KOG0671|consen  306 ETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDL  385 (415)
T ss_pred             ceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHH
Confidence            9999876432211 11111122232222211      000 00             000000   001112344569999


Q ss_pred             hccccCCCCCCCCcHHHHHH
Q 046639          298 GVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       298 ~~~cl~~~P~~Rps~~~i~~  317 (331)
                      +++||..||.+|+|+.|+++
T Consensus       386 l~~mL~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  386 LRRMLEFDPARRITLREALS  405 (415)
T ss_pred             HHHHHccCccccccHHHHhc
Confidence            99999999999999999874

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-38  Score=275.04  Aligned_cols=248  Identities=21%  Similarity=0.287  Sum_probs=195.5

Q ss_pred             CCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc-hhhHHHHHHHHHHHHcCC---CCCcceeeceeecccCCCcce
Q 046639           31 NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ-KEASRSFAAECNALRNIR---HRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      .|.+.+.||.|++|.||+|.+..+++.+|+|.+.... ......+.+|+.+++.+.   |||++++++++     .....
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~-----~~~~~   76 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSY-----LKGPR   76 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeee-----eeCCE
Confidence            5888999999999999999998899999999986542 334466888999999986   99999999985     34567


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      .++|||++++++|.+++...   .+++..+..++.|++.||.+||+.   +++|+||+|+||+++.++.++|+|||++..
T Consensus        77 ~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  150 (277)
T cd06917          77 LWIIMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAAL  150 (277)
T ss_pred             EEEEEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceee
Confidence            89999999999999998653   467888999999999999999999   999999999999999999999999999876


Q ss_pred             cccCCCCCcccccCCceeecccccccCCcccCC-CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcc
Q 046639          187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG-SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPD  265 (331)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  265 (331)
                      .....        .......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||......     .... .   
T Consensus       151 ~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-----~~~~-~---  213 (277)
T cd06917         151 LNQNS--------SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF-----RAMM-L---  213 (277)
T ss_pred             cCCCc--------cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh-----hhhh-c---
Confidence            52211        11223357788999998765 45789999999999999999999999653211     0000 0   


Q ss_pred             hhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          266 KVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                       ......+.+.    .      ......+.+++.+||+.||++||++.+++.
T Consensus       214 -~~~~~~~~~~----~------~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         214 -IPKSKPPRLE----D------NGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             -cccCCCCCCC----c------ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence             0000001110    0      014567889999999999999999999975

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=6.4e-39  Score=285.66  Aligned_cols=275  Identities=22%  Similarity=0.262  Sum_probs=202.2

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc--chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      .++|.+.+.||+|++|+||+|.+..++..||+|.+...  .......+.+|+.+++.++|+||+++++++..........
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            46899999999999999999999999999999988643  2333456778999999999999999999876544344456


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      .++++|++ +++|.+++...  ..++...+..++.|++.||.+||++   +++|+||+|+||+++.++.++|+|||++..
T Consensus        84 ~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~  157 (337)
T cd07858          84 VYIVYELM-DTDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLART  157 (337)
T ss_pred             EEEEEeCC-CCCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence            89999999 57999988654  3477888999999999999999999   999999999999999999999999999876


Q ss_pred             cccCCCCCcccccCCceeecccccccCCcccCC-CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhh---
Q 046639          187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG-SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMA---  262 (331)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~---  262 (331)
                      .....        .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||...... ..........   
T Consensus       158 ~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~  228 (337)
T cd07858         158 TSEKG--------DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV-HQLKLITELLGSP  228 (337)
T ss_pred             cCCCc--------ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHHHhCCC
Confidence            42110        11223346778999998765 46889999999999999999999999753211 1111111100   


Q ss_pred             CcchhhhhcCcccc-------cccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHH
Q 046639          263 LPDKVMEIVDPSLL-------LEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAK  318 (331)
Q Consensus       263 ~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~  318 (331)
                      .+.......+....       ............++...+.+++.+||+.+|++|||+.++++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         229 SEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             ChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence            00000000000000       000000011122456778999999999999999999999865

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.4e-38  Score=277.17  Aligned_cols=254  Identities=22%  Similarity=0.278  Sum_probs=202.6

Q ss_pred             HHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           27 KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      ...+.|.+.+.||+|++|.||+|.+..++..+++|.+..... ....+.+|+.+++.++|+|++++++.+.     ....
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~   89 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYL-----VGDE   89 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEE-----ECCE
Confidence            456679999999999999999999998899999999975544 4566889999999999999999999854     3467


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      .++++|++++++|.+++.... ..++...+..++.|++.||++||+.   |++|+||+|+||+++.++.++|+|||++..
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~  165 (286)
T cd06614          90 LWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQ  165 (286)
T ss_pred             EEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhh
Confidence            899999999999999998754 3577888999999999999999998   999999999999999999999999998865


Q ss_pred             cccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcch
Q 046639          187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDK  266 (331)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  266 (331)
                      .....        .......++..|+|||.+.+..++.++|+||||+++|+|++|..||....... ..........+  
T Consensus       166 ~~~~~--------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~-~~~~~~~~~~~--  234 (286)
T cd06614         166 LTKEK--------SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR-ALFLITTKGIP--  234 (286)
T ss_pred             hccch--------hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhcCCC--
Confidence            42111        11122346778999999988889999999999999999999999986432111 01110000000  


Q ss_pred             hhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          267 VMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                             .         ......+...+.+++.+||+.+|.+|||+.+|++
T Consensus       235 -------~---------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         235 -------P---------LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             -------C---------CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence                   0         0111224567889999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=2.2e-38  Score=281.24  Aligned_cols=280  Identities=17%  Similarity=0.200  Sum_probs=197.9

Q ss_pred             ceeecc--CeeEEEEeeecCCCceEEEEEeecc--chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeEEE
Q 046639           36 NKIGQG--GVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVF  111 (331)
Q Consensus        36 ~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~  111 (331)
                      ..||+|  ++|+||.+.+..+++.||+|++...  .....+.+.+|+.+++.++||||+++++++     ..++..++|+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~-----~~~~~~~~v~   78 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVF-----TTGSWLWVIS   78 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeE-----ecCCceEEEE
Confidence            456666  8999999999999999999998643  233456788999999999999999999995     4456789999


Q ss_pred             eecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccccCC
Q 046639          112 EYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYE  191 (331)
Q Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~~  191 (331)
                      |++.+++|.+++.+.....+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++++||+.+.......
T Consensus        79 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~  155 (328)
T cd08226          79 PFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNG  155 (328)
T ss_pred             ecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccC
Confidence            999999999999876555677888889999999999999999   99999999999999999999999998654332111


Q ss_pred             CCCcccccCCceeecccccccCCcccCCC--CCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhh
Q 046639          192 PGTAAETASNSIEIKGIVGYVAPEYGMGS--KASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVME  269 (331)
Q Consensus       192 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  269 (331)
                      ... ...........++..|+|||++.+.  .++.++||||||+++|+|++|..||........ ...............
T Consensus       156 ~~~-~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~  233 (328)
T cd08226         156 QKA-KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM-LLQKLKGPPYSPLDI  233 (328)
T ss_pred             ccc-cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH-HHHHhcCCCCCCccc
Confidence            110 0000111112345679999998764  478999999999999999999999976432211 111111000000000


Q ss_pred             hcC--------------------cccc----cccc--cCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH--HHHH
Q 046639          270 IVD--------------------PSLL----LEVT--ANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA--KLRH  321 (331)
Q Consensus       270 ~~~--------------------~~~~----~~~~--~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~--~L~~  321 (331)
                      ...                    ....    ....  .-.......+...+.+|+.+||+.||++|||+.++++  ++..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~  313 (328)
T cd08226         234 TTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQ  313 (328)
T ss_pred             cccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHH
Confidence            000                    0000    0000  0001223457788999999999999999999999973  4444


Q ss_pred             hhhh
Q 046639          322 ARET  325 (331)
Q Consensus       322 ~~~~  325 (331)
                      +.+.
T Consensus       314 ~~~~  317 (328)
T cd08226         314 VKEQ  317 (328)
T ss_pred             HHHh
Confidence            4443

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2.5e-38  Score=278.51  Aligned_cols=280  Identities=21%  Similarity=0.281  Sum_probs=197.9

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCcceeeceeecccC---C
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ--KEASRSFAAECNALRNIRHRNLIKIITICSSIDF---E  102 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---~  102 (331)
                      ..++|.+.+.||+|++|.||+|.+..+++.||+|.+....  ........+|+.++++++||||++++++|.....   .
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence            3457999999999999999999999999999999886432  2223456789999999999999999998765322   1


Q ss_pred             CcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccC
Q 046639          103 GFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLG  182 (331)
Q Consensus       103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg  182 (331)
                      .....++|||++ +++|.+.+.... ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||
T Consensus        90 ~~~~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg  164 (310)
T cd07865          90 YKGSFYLVFEFC-EHDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFG  164 (310)
T ss_pred             CCceEEEEEcCC-CcCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCC
Confidence            234569999999 568888886543 3467889999999999999999999   99999999999999999999999999


Q ss_pred             cccccccCCCCCcccccCCceeecccccccCCcccCCCC-CccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHH-
Q 046639          183 LAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSK-ASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVK-  260 (331)
Q Consensus       183 ~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~-  260 (331)
                      ++..........    ........++..|+|||.+.+.. ++.++||||||+++|+|++|..||...... ........ 
T Consensus       165 ~~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~-~~~~~~~~~  239 (310)
T cd07865         165 LARAFSLSKNSK----PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ-HQLTLISQL  239 (310)
T ss_pred             CcccccCCcccC----CCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHH
Confidence            998653222111    11122334677899999887653 688999999999999999999999753221 11111111 


Q ss_pred             -hhCcchhhhhcC-cccc--cccccCCcchHH------HHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          261 -MALPDKVMEIVD-PSLL--LEVTANNYSWIE------DCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       261 -~~~~~~~~~~~~-~~~~--~~~~~~~~~~~~------~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                       ...+..+....+ ....  ............      .....+.+++.+||+.||++|||+.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         240 CGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             hCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence             111111000000 0000  000000000000      12345678999999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.8e-38  Score=279.21  Aligned_cols=247  Identities=21%  Similarity=0.257  Sum_probs=193.6

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcc
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFD  105 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~  105 (331)
                      ..+|.+.+.||+|++|+||+|.+..+++.||+|.+....   ......+.+|+.+++.++|||++++.++|.     ...
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~-----~~~   88 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYL-----REH   88 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEE-----eCC
Confidence            346999999999999999999998889999999886432   233456889999999999999999999964     345


Q ss_pred             eeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccc
Q 046639          106 FKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAK  185 (331)
Q Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~  185 (331)
                      ..++|+|++. +++.+++.... ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.
T Consensus        89 ~~~lv~e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~  163 (307)
T cd06607          89 TAWLVMEYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSAS  163 (307)
T ss_pred             eEEEEHHhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcce
Confidence            6899999994 68888776433 3467888899999999999999999   99999999999999999999999999886


Q ss_pred             ccccCCCCCcccccCCceeecccccccCCcccC---CCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhh
Q 046639          186 FLFGYEPGTAAETASNSIEIKGIVGYVAPEYGM---GSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMA  262 (331)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  262 (331)
                      ....            .....+++.|+|||++.   ...++.++||||||+++|+|++|..||.......  ........
T Consensus       164 ~~~~------------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~--~~~~~~~~  229 (307)
T cd06607         164 LVSP------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--ALYHIAQN  229 (307)
T ss_pred             ecCC------------CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH--HHHHHhcC
Confidence            5411            11234677899999874   3568899999999999999999999986432111  00000000


Q ss_pred             CcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          263 LPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                              ..+..          ....+...+.+++.+||+.+|++||++.+|+.
T Consensus       230 --------~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  266 (307)
T cd06607         230 --------DSPTL----------SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK  266 (307)
T ss_pred             --------CCCCC----------CchhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                    00000          01235567899999999999999999999986

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-39  Score=264.02  Aligned_cols=252  Identities=20%  Similarity=0.248  Sum_probs=197.8

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc-chhhHHHHHHHHHHHHcCC-CCCcceeeceeecccCCCccee
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK-QKEASRSFAAECNALRNIR-HRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      ++...+..||.|..|.||+++.+.++...|||.+... +.+...+++..+.++..-. .|.||+.+|+|.     .+..+
T Consensus        92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi-----~n~dV  166 (391)
T KOG0983|consen   92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFI-----TNTDV  166 (391)
T ss_pred             HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEe-----eCchH
Confidence            3455678999999999999999999999999998654 4455677888888877764 899999999954     34567


Q ss_pred             eEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccc
Q 046639          108 AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      ++.||.+ ..-+..++++ ..+++++..+.++...+++||.||..++  +|+|||+||+|||+|+.|++|++|||++-.+
T Consensus       167 ~IcMelM-s~C~ekLlkr-ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrl  242 (391)
T KOG0983|consen  167 FICMELM-STCAEKLLKR-IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRL  242 (391)
T ss_pred             HHHHHHH-HHHHHHHHHH-hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeeccccccee
Confidence            8999988 5566666654 3445777788899999999999999988  9999999999999999999999999999776


Q ss_pred             ccCCCCCcccccCCceeecccccccCCcccCCC---CCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCc
Q 046639          188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMGS---KASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALP  264 (331)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  264 (331)
                      .         +......-.|-+.|||||.+...   .|+.++||||||++++||.||+.||.....+-..+...+...  
T Consensus       243 v---------dSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~e--  311 (391)
T KOG0983|consen  243 V---------DSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEE--  311 (391)
T ss_pred             e---------cccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcC--
Confidence            3         23333344588889999998753   588999999999999999999999987544333333322211  


Q ss_pred             chhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          265 DKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                             .|.+...         ...++.+.+++..||++|+.+||...++++
T Consensus       312 -------PP~L~~~---------~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  312 -------PPLLPGH---------MGFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             -------CCCCCcc---------cCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence                   1222211         125677899999999999999999999875

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-40  Score=282.65  Aligned_cols=251  Identities=24%  Similarity=0.271  Sum_probs=204.3

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCc
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGF  104 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  104 (331)
                      ..+.|+..+.||+|+||.||.++.+.||+.+|.|.+....   .......++|-.+|.+++.+.||.+-..     +++.
T Consensus       183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYA-----feTk  257 (591)
T KOG0986|consen  183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYA-----FETK  257 (591)
T ss_pred             cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeee-----ecCC
Confidence            4457889999999999999999999999999999885442   2223447889999999999988877655     7888


Q ss_pred             ceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcc
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA  184 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a  184 (331)
                      +.+++|+..|+||+|.-.|-..++..+++..+..++.+|+.||.+||..   +||+||+||+|||+|+.|+++|+|+|+|
T Consensus       258 d~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLA  334 (591)
T KOG0986|consen  258 DALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLA  334 (591)
T ss_pred             CceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceE
Confidence            9999999999999999888877777899999999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCc
Q 046639          185 KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALP  264 (331)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  264 (331)
                      ..+.         .........||.+|||||++.++.|+.+.|.|||||+||||+.|+.||..-- +. .-...+     
T Consensus       335 vei~---------~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~K-eK-vk~eEv-----  398 (591)
T KOG0986|consen  335 VEIP---------EGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRK-EK-VKREEV-----  398 (591)
T ss_pred             EecC---------CCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhh-hh-hhHHHH-----
Confidence            9872         2223334479999999999999999999999999999999999999996421 00 001011     


Q ss_pred             chhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHH
Q 046639          265 DKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMR  313 (331)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~  313 (331)
                             +.+..    .....+.+..+++..+|.+..|..||.+|....
T Consensus       399 -------drr~~----~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  399 -------DRRTL----EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             -------HHHHh----cchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence                   11111    011134456778899999999999999996543

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.7e-38  Score=276.17  Aligned_cols=269  Identities=22%  Similarity=0.305  Sum_probs=198.2

Q ss_pred             CCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccch-hhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeE
Q 046639           31 NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK-EASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAI  109 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~l  109 (331)
                      +|.+.+.||.|++|.||+|++..++..||+|.+..... .....+.+|+.+++.++|+|++++++++.     ..+..++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   75 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIH-----TENKLML   75 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEe-----eCCcEEE
Confidence            58899999999999999999998999999999875532 23456778999999999999999999953     4467899


Q ss_pred             EEeecCCCCHHHHHHhcc-CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccc
Q 046639          110 VFEYMQNRNLEQWLRQSN-GQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLF  188 (331)
Q Consensus       110 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~  188 (331)
                      |||+++ ++|.+++.... ...+++..+..++.|++.||.+||+.   +++|+||+|+||+++.++.++|+|||++....
T Consensus        76 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~  151 (284)
T cd07836          76 VFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFG  151 (284)
T ss_pred             EEecCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhc
Confidence            999996 58998886533 24578889999999999999999999   99999999999999999999999999987541


Q ss_pred             cCCCCCcccccCCceeecccccccCCcccCCC-CCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhC-c--
Q 046639          189 GYEPGTAAETASNSIEIKGIVGYVAPEYGMGS-KASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMAL-P--  264 (331)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~-~--  264 (331)
                      ..        ........++..|+|||++.+. .++.++||||||+++|+|++|..||....... .......... +  
T Consensus       152 ~~--------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~  222 (284)
T cd07836         152 IP--------VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED-QLLKIFRIMGTPTE  222 (284)
T ss_pred             CC--------ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCCh
Confidence            11        0111223467789999988664 46889999999999999999999997643221 1111111100 0  


Q ss_pred             chhhhhcC-ccccccccc----CCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          265 DKVMEIVD-PSLLLEVTA----NNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       265 ~~~~~~~~-~~~~~~~~~----~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ........ +.....+..    ........+...+.+++.+||+.||.+||++.++++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         223 STWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             hhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            00000000 000000000    001122244667889999999999999999999974

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=3.4e-38  Score=269.99  Aligned_cols=250  Identities=22%  Similarity=0.353  Sum_probs=202.1

Q ss_pred             CCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccch--hhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           31 NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK--EASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      +|.+.+.||.|++|.||++.+..++..+++|.+.....  .....+..|+++++.++|+|++++.+.+     ......+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~-----~~~~~~~   75 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESF-----EEKGKLC   75 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEE-----ecCCEEE
Confidence            58889999999999999999998999999999875533  4556788999999999999999999985     3347889


Q ss_pred             EEEeecCCCCHHHHHHhcc--CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          109 IVFEYMQNRNLEQWLRQSN--GQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      +++|++++++|.+++....  ...++...+..++.+++.|+.+||+.   +++|+||+|+||+++.++.++|+|||.+..
T Consensus        76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~  152 (258)
T cd08215          76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKV  152 (258)
T ss_pred             EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceee
Confidence            9999999999999998753  45678899999999999999999999   999999999999999999999999999876


Q ss_pred             cccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcch
Q 046639          187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDK  266 (331)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  266 (331)
                      .....        .......+++.|+|||...+..++.++|+||+|+++++|++|..||....     ............
T Consensus       153 ~~~~~--------~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-----~~~~~~~~~~~~  219 (258)
T cd08215         153 LSSTV--------DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN-----LLELALKILKGQ  219 (258)
T ss_pred             cccCc--------ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc-----HHHHHHHHhcCC
Confidence            42111        12223457888999999988889999999999999999999999996432     111111111100


Q ss_pred             hhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          267 VMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      .     +           .....+...+.+++.+||..+|++|||+.++++
T Consensus       220 ~-----~-----------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         220 Y-----P-----------PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             C-----C-----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            0     0           011134567889999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=5.4e-38  Score=277.06  Aligned_cols=273  Identities=18%  Similarity=0.135  Sum_probs=193.7

Q ss_pred             CcCceeeccCeeEEEEeeecCCCceEEEEEeecc--chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeEE
Q 046639           33 SPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIV  110 (331)
Q Consensus        33 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv  110 (331)
                      .+++.+|.|++  ||.++...+++.||+|++...  .......+..|+.+++.++|+||+++++++     ......+++
T Consensus         5 ~i~~~~~~~~~--v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~-----~~~~~~~~~   77 (314)
T cd08216           5 LIGKCFEDLMI--VHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF-----IVDSELYVV   77 (314)
T ss_pred             hhhHhhcCCce--EEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhhee-----ecCCeEEEE
Confidence            34444544444  555566668999999998754  344557799999999999999999999984     445678999


Q ss_pred             EeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccccC
Q 046639          111 FEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGY  190 (331)
Q Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~  190 (331)
                      ||++++++|.+++.......++...+..++.|++.||.|||+.   +|+|+||||+||+++.++.++++||+.+......
T Consensus        78 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~  154 (314)
T cd08216          78 SPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKH  154 (314)
T ss_pred             EeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccc
Confidence            9999999999999876555677888899999999999999999   9999999999999999999999999988765322


Q ss_pred             CCCCcccccCCceeecccccccCCcccCC--CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhh
Q 046639          191 EPGTAAETASNSIEIKGIVGYVAPEYGMG--SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVM  268 (331)
Q Consensus       191 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  268 (331)
                      .... ...........++..|+|||++.+  ..++.++|+||+|+++|+|++|..||.......... .......+..+.
T Consensus       155 ~~~~-~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~  232 (314)
T cd08216         155 GKRQ-RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLL-EKVRGTVPCLLD  232 (314)
T ss_pred             cccc-cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhccCccccc
Confidence            2111 111122233446778999999876  358899999999999999999999997543221111 111111110000


Q ss_pred             hhcCccc------------c-cccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          269 EIVDPSL------------L-LEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       269 ~~~~~~~------------~-~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ....+..            . .................+.+++.+||+.||++|||+.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         233 KSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             cCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence            0000000            0 00000111222345567889999999999999999999985

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=8.6e-39  Score=285.34  Aligned_cols=275  Identities=18%  Similarity=0.261  Sum_probs=197.6

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeeccc--------
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSID--------  100 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--------  100 (331)
                      .++|.+.+.||.|++|.||+|.+..++..||+|.+........+.+.+|+.+++.++|||++++++.+....        
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            478999999999999999999999999999999997766666677889999999999999999998754321        


Q ss_pred             -CCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEec-CCCcEEE
Q 046639          101 -FEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLD-QDIVAHV  178 (331)
Q Consensus       101 -~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~-~~~~~kl  178 (331)
                       +......++|+|+++ ++|.+++...   .+++..+..++.|++.||.+||+.   +++|+||||+||+++ .++.+++
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl  156 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLEQG---PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKI  156 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEE
Confidence             112245789999995 6898888543   367789999999999999999999   999999999999997 4567899


Q ss_pred             cccCcccccccCCCCCcccccCCceeecccccccCCcccCC-CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHH
Q 046639          179 GDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG-SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHE  257 (331)
Q Consensus       179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~  257 (331)
                      +|||.+........     .........++..|+|||.+.+ ..++.++||||||+++|+|++|..||....... ....
T Consensus       157 ~dfg~~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-~~~~  230 (342)
T cd07854         157 GDFGLARIVDPHYS-----HKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE-QMQL  230 (342)
T ss_pred             CCcccceecCCccc-----cccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHH
Confidence            99999876421111     0011112346778999998654 457889999999999999999999997542211 1111


Q ss_pred             HHHhhCcchhh-------hhcCcccc---cccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          258 FVKMALPDKVM-------EIVDPSLL---LEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       258 ~~~~~~~~~~~-------~~~~~~~~---~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      .... .+....       ........   .................+.+++.+||+.||.+|||+.+++.
T Consensus       231 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         231 ILES-VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             HHHh-cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            1111 000000       00000000   00000000111234567889999999999999999999973

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.7e-38  Score=277.71  Aligned_cols=270  Identities=20%  Similarity=0.290  Sum_probs=195.3

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccch--hhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCccee
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK--EASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      ++|.+.+.||.|++|+||+|.+..+++.||+|.+.....  .....+.+|+.+++.++|+|++++++++     ......
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~   76 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVV-----HSEKRL   76 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEE-----ecCCeE
Confidence            579999999999999999999998999999998864422  2335678899999999999999999995     445688


Q ss_pred             eEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecC-CCcEEEcccCcccc
Q 046639          108 AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQ-DIVAHVGDLGLAKF  186 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~-~~~~kl~Dfg~a~~  186 (331)
                      ++||||+ +++|.+++........+...+..++.|++.||.+||++   +++|+||+|+||+++. ++.+||+|||++..
T Consensus        77 ~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~  152 (294)
T PLN00009         77 YLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARA  152 (294)
T ss_pred             EEEEecc-cccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccc
Confidence            9999999 56888888765554456778889999999999999999   9999999999999985 55799999999875


Q ss_pred             cccCCCCCcccccCCceeecccccccCCcccCC-CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhC-c
Q 046639          187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG-SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMAL-P  264 (331)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~-~  264 (331)
                      ....        ........+++.|+|||++.+ ..++.++||||+|+++|+|++|..||....... .......... +
T Consensus       153 ~~~~--------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~-~~~~~~~~~~~~  223 (294)
T PLN00009        153 FGIP--------VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID-ELFKIFRILGTP  223 (294)
T ss_pred             cCCC--------ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCC
Confidence            4110        111122346778999998766 457899999999999999999999997542211 1111111000 0


Q ss_pred             -chhhh----hcCcc-ccccc-ccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          265 -DKVME----IVDPS-LLLEV-TANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       265 -~~~~~----~~~~~-~~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                       .....    ..+.. ..... ..............+.+++.+||+.+|++||++.++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        224 NEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             ChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence             00000    00000 00000 00000111234556889999999999999999999985

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=5.2e-38  Score=315.52  Aligned_cols=267  Identities=26%  Similarity=0.436  Sum_probs=206.2

Q ss_pred             HHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           27 KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      .....|...+.||+|+||.||+|++..++..||+|.+......    ...|+.++++++||||++++++|..     ...
T Consensus       687 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~-----~~~  757 (968)
T PLN00113        687 DILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRS-----EKG  757 (968)
T ss_pred             HHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEc-----CCC
Confidence            3345688889999999999999999889999999988633221    2346889999999999999999743     356


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      .++||||+++++|.++++.     +++..+..++.|++.|++|||....++++||||||+||+++.++.+++. |+....
T Consensus       758 ~~lv~Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~  831 (968)
T PLN00113        758 AYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGL  831 (968)
T ss_pred             CEEEEeCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccc
Confidence            7999999999999999953     6778889999999999999995544499999999999999998888774 554432


Q ss_pred             cccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCc-c
Q 046639          187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALP-D  265 (331)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~  265 (331)
                      ..            ......+++.|+|||++.+..++.++||||||+++|||++|+.||+...........+...... .
T Consensus       832 ~~------------~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  899 (968)
T PLN00113        832 LC------------TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDC  899 (968)
T ss_pred             cc------------cCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCcc
Confidence            20            1112257788999999999999999999999999999999999997554444444444332221 1


Q ss_pred             hhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhh
Q 046639          266 KVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARET  325 (331)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~  325 (331)
                      ......++.+...     .....+....+.+++.+||+.+|++|||+.+|++.|+.+.+.
T Consensus       900 ~~~~~~~~~~~~~-----~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  954 (968)
T PLN00113        900 HLDMWIDPSIRGD-----VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS  954 (968)
T ss_pred             chhheeCccccCC-----CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence            2233334433221     122345667889999999999999999999999999998763

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.4e-39  Score=286.63  Aligned_cols=253  Identities=21%  Similarity=0.270  Sum_probs=207.5

Q ss_pred             HHHHHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCcceeeceeecccC
Q 046639           24 ELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ--KEASRSFAAECNALRNIRHRNLIKIITICSSIDF  101 (331)
Q Consensus        24 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  101 (331)
                      +.......|.+...||+|.|++|.+|++.-++..||||++....  ....+.+.+|+++|+.++||||++++.+     .
T Consensus        50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v-----~  124 (596)
T KOG0586|consen   50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSV-----I  124 (596)
T ss_pred             cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeee-----e
Confidence            33445668999999999999999999999999999999997653  3344668999999999999999999999     6


Q ss_pred             CCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEccc
Q 046639          102 EGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDL  181 (331)
Q Consensus       102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Df  181 (331)
                      +....+|+||||+.+|.+.+++.+.+.  .....+...+.|+++|+.|+|++   +|||||||++|++++.+-++||+||
T Consensus       125 ~t~~~lylV~eya~~ge~~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDf  199 (596)
T KOG0586|consen  125 ETEATLYLVMEYASGGELFDYLVKHGR--MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADF  199 (596)
T ss_pred             eecceeEEEEEeccCchhHHHHHhccc--chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeecc
Confidence            667889999999999999999987654  44478889999999999999999   9999999999999999999999999


Q ss_pred             CcccccccCCCCCcccccCCceeecccccccCCcccCCCCC-ccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHH
Q 046639          182 GLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKA-SVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVK  260 (331)
Q Consensus       182 g~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  260 (331)
                      |++..+         .........+|+++|.|||++.+..| ++.+|+||+|++||-|+.|..||++..-          
T Consensus       200 gfS~~~---------~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l----------  260 (596)
T KOG0586|consen  200 GFSTFF---------DYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL----------  260 (596)
T ss_pred             ccceee---------cccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc----------
Confidence            999887         34455566789999999999999887 7899999999999999999999986311          


Q ss_pred             hhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          261 MALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                             ..+-.+.+..++.     .+.-......+|++++|-.+|.+|++.+++.+
T Consensus       261 -------k~Lr~rvl~gk~r-----Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  261 -------KELRPRVLRGKYR-----IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             -------ccccchheeeeec-----ccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence                   1111111111110     01112234567888899999999999999875

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-38  Score=270.69  Aligned_cols=254  Identities=19%  Similarity=0.239  Sum_probs=197.8

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc-----chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCc
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK-----QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGF  104 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  104 (331)
                      .+|.+.+.||+|++|.||+|.+..++..||+|.+...     .......+.+|+.+++.++|+|++++++.+..   ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~---~~~   78 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRD---PEE   78 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEc---CCC
Confidence            5799999999999999999999999999999987532     22344678899999999999999999998643   223


Q ss_pred             ceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcc
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA  184 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a  184 (331)
                      ...++++|++++++|.+++....  .++......++.|++.||.+||+.   +++|+||+|+||+++.++.++|+|||++
T Consensus        79 ~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~  153 (264)
T cd06653          79 KKLSIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGAS  153 (264)
T ss_pred             CEEEEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccc
Confidence            56789999999999999986543  356788889999999999999999   9999999999999999999999999998


Q ss_pred             cccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCc
Q 046639          185 KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALP  264 (331)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  264 (331)
                      +......     ..........++..|+|||++.+..++.++|+||||+++|+|++|..||.....    ..........
T Consensus       154 ~~~~~~~-----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~  224 (264)
T cd06653         154 KRIQTIC-----MSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA----MAAIFKIATQ  224 (264)
T ss_pred             ccccccc-----ccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH----HHHHHHHHcC
Confidence            7652111     011111234578889999999988899999999999999999999999965311    1111111100


Q ss_pred             chhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          265 DKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      .     ..+           ..+......+.+++.+||+ +|..|||+.+++.
T Consensus       225 ~-----~~~-----------~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         225 P-----TKP-----------MLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             C-----CCC-----------CCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence            0     000           1223355678899999999 5799999998864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=2.6e-38  Score=276.07  Aligned_cols=248  Identities=20%  Similarity=0.291  Sum_probs=196.4

Q ss_pred             CCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeEEE
Q 046639           32 FSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVF  111 (331)
Q Consensus        32 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~  111 (331)
                      |....+||+|++|.||++....++..||+|.+..........+.+|+.+++.++|+|++++++.+     ...+..+++|
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~   96 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY-----LVGDELWVVM   96 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEE-----EeCCEEEEEE
Confidence            44456899999999999999989999999998655555566789999999999999999999985     3456789999


Q ss_pred             eecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccccCC
Q 046639          112 EYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYE  191 (331)
Q Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~~  191 (331)
                      |++++++|.+++...   .+++..+..++.|++.|+++||+.   +++|+||+|+||+++.++.++|+|||++...... 
T Consensus        97 e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~-  169 (292)
T cd06657          97 EFLEGGALTDIVTHT---RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-  169 (292)
T ss_pred             ecCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccc-
Confidence            999999999987543   356788899999999999999999   9999999999999999999999999987654211 


Q ss_pred             CCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhhhc
Q 046639          192 PGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEIV  271 (331)
Q Consensus       192 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (331)
                             ........+++.|+|||...+..++.++|+||+|+++|+|++|..||.....  ...........+...    
T Consensus       170 -------~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~----  236 (292)
T cd06657         170 -------VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMIRDNLPPKL----  236 (292)
T ss_pred             -------cccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhhCCccc----
Confidence                   1112334578889999999888889999999999999999999999864211  111111111111100    


Q ss_pred             CcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          272 DPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                                   .....+...+.+++.+||+.+|.+||++.++++
T Consensus       237 -------------~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         237 -------------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             -------------CCcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence                         011224556788999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-40  Score=316.33  Aligned_cols=255  Identities=24%  Similarity=0.317  Sum_probs=203.1

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchh--hHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKE--ASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      +-++..+..||.|.||.||.|.+..+|...|+|.++.....  ....+.+|..++..++|||+|+++|+     -...+.
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGV-----EvHRek 1308 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGV-----EVHREK 1308 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCce-----eecHHH
Confidence            33677788999999999999999999999999998655332  33568899999999999999999998     344456


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      ++|.||||++|+|.++++...  ..++.....+..|++.|++|||+.   |||||||||.||+++.+|.+|++|||.|..
T Consensus      1309 v~IFMEyC~~GsLa~ll~~gr--i~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~k 1383 (1509)
T KOG4645|consen 1309 VYIFMEYCEGGSLASLLEHGR--IEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVK 1383 (1509)
T ss_pred             HHHHHHHhccCcHHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeE
Confidence            789999999999999996543  355666667888999999999999   999999999999999999999999999998


Q ss_pred             cccCCCCCcccccCCceeecccccccCCcccCCC---CCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhC
Q 046639          187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGS---KASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMAL  263 (331)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  263 (331)
                      +.+..    ...........||+.|||||++.+.   ....+.|||||||++.||+||+.||....++=.-......++ 
T Consensus      1384 i~~~~----~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh- 1458 (1509)
T KOG4645|consen 1384 IKNNA----QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGH- 1458 (1509)
T ss_pred             ecCch----hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccC-
Confidence            74432    1222344567899999999998764   457789999999999999999999987644322111111112 


Q ss_pred             cchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          264 PDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                              .|           ..+.....+-.+++..||+.||.+|.++.|+++
T Consensus      1459 --------~P-----------q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1459 --------KP-----------QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred             --------CC-----------CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence                    12           222345667788889999999999999987764

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-39  Score=284.45  Aligned_cols=265  Identities=21%  Similarity=0.304  Sum_probs=205.8

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccch-hhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCccee
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK-EASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      +....+.++||+|-||+|.+|+.. .+..||+|+++.... ..+.++..|+.+|.+++||||+.++++|...     +.+
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~D-----ePi  610 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQD-----DPL  610 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecC-----Cch
Confidence            346788899999999999999886 368899999975543 3458899999999999999999999998653     568


Q ss_pred             eEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccc
Q 046639          108 AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      ++++||++.|+|.+++..+......-.....++.||++|++||.+.   ++||||+.+.|+|+++++++||+|||+++-+
T Consensus       611 cmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~l  687 (807)
T KOG1094|consen  611 CMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNL  687 (807)
T ss_pred             HHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCccccccc
Confidence            9999999999999999876433333345567999999999999999   9999999999999999999999999999854


Q ss_pred             ccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh--CCCCCCcccCCcchHHHHHHhhCcc
Q 046639          188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT--RRRPTDAMFNEGLTLHEFVKMALPD  265 (331)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~--g~~pf~~~~~~~~~~~~~~~~~~~~  265 (331)
                      .+.      ..........-...|+|+|.+..+.++.++|+|+||+++||+++  ...||....++...-  -..     
T Consensus       688 ysg------~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vve--n~~-----  754 (807)
T KOG1094|consen  688 YSG------DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVE--NAG-----  754 (807)
T ss_pred             ccC------CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHH--hhh-----
Confidence            211      11222222333456999999999999999999999999999887  667887654432211  111     


Q ss_pred             hhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHh
Q 046639          266 KVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHA  322 (331)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~  322 (331)
                         ..++..-...    .-..+.-|+..+.+|+.+||+.+..+|||++++...|.+.
T Consensus       755 ---~~~~~~~~~~----~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  755 ---EFFRDQGRQV----VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             ---hhcCCCCcce----eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence               1111110000    1123345888899999999999999999999999887764

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=3.9e-38  Score=269.69  Aligned_cols=254  Identities=22%  Similarity=0.320  Sum_probs=202.6

Q ss_pred             CCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccch--hhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           31 NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK--EASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      +|++.+.||+|++|.||+|.+..+++.+++|.+.....  .....+.+|+.++++++|+|++++++.+....   ....+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~   77 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLN   77 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEE
Confidence            47888999999999999999998999999999865542  44577899999999999999999999864321   26789


Q ss_pred             EEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccc
Q 046639          109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLF  188 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~  188 (331)
                      +++|++++++|.+++....  .+++..++.++.|++.|+++||+.   +++|+||+|+||+++.++.++|+|||.+....
T Consensus        78 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~  152 (260)
T cd06606          78 IFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLG  152 (260)
T ss_pred             EEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecc
Confidence            9999999999999997654  577889999999999999999998   99999999999999999999999999988762


Q ss_pred             cCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhh
Q 046639          189 GYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVM  268 (331)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  268 (331)
                      .....      .......++..|+|||...+..++.++||||||+++++|++|..||.....   .........      
T Consensus       153 ~~~~~------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~------  217 (260)
T cd06606         153 DIETG------EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN---PMAALYKIG------  217 (260)
T ss_pred             ccccc------ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---hHHHHHhcc------
Confidence            22110      012234577789999999888899999999999999999999999976431   111111110      


Q ss_pred             hhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          269 EIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                         .....       ...+......+.+++.+||+.+|++||++.++++
T Consensus       218 ---~~~~~-------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         218 ---SSGEP-------PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             ---ccCCC-------cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence               00000       0122234678999999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=3.8e-38  Score=273.36  Aligned_cols=242  Identities=21%  Similarity=0.252  Sum_probs=183.3

Q ss_pred             eeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHH---cCCCCCcceeeceeecccCCCcceeeEE
Q 046639           37 KIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALR---NIRHRNLIKIITICSSIDFEGFDFKAIV  110 (331)
Q Consensus        37 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~---~l~h~~i~~~~~~~~~~~~~~~~~~~lv  110 (331)
                      .||+|+||.||++.+..+++.+|+|.+....   .........|..+++   ...|++++.+++++     ...+..++|
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv   75 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAF-----HTPDKLCFI   75 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEE-----ecCCeEEEE
Confidence            4899999999999999899999999885432   111222334443333   34799999998884     445678999


Q ss_pred             EeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccccC
Q 046639          111 FEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGY  190 (331)
Q Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~  190 (331)
                      |||+++++|.+++....  .+++..+..++.|++.||.+||+.   +++|+||||+||+++.++.++|+|||++..... 
T Consensus        76 ~e~~~~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~-  149 (279)
T cd05633          76 LDLMNGGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSK-  149 (279)
T ss_pred             EecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccc-
Confidence            99999999999986543  477889999999999999999999   999999999999999999999999999865411 


Q ss_pred             CCCCcccccCCceeecccccccCCcccC-CCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhh
Q 046639          191 EPGTAAETASNSIEIKGIVGYVAPEYGM-GSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVME  269 (331)
Q Consensus       191 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  269 (331)
                               .......++..|+|||... +..++.++||||+|+++|+|++|..||..........  .......     
T Consensus       150 ---------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~--~~~~~~~-----  213 (279)
T cd05633         150 ---------KKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE--IDRMTLT-----  213 (279)
T ss_pred             ---------cCccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH--HHHHhhc-----
Confidence                     1112235888999999886 4568999999999999999999999997543222111  1111100     


Q ss_pred             hcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCC-----cHHHHHH
Q 046639          270 IVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERM-----EMRDVVA  317 (331)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----s~~~i~~  317 (331)
                       ...           .....++..+.+++.+||+.||.+||     |++++++
T Consensus       214 -~~~-----------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~  254 (279)
T cd05633         214 -VNV-----------ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE  254 (279)
T ss_pred             -CCc-----------CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence             000           11223556788999999999999999     5888876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-39  Score=290.56  Aligned_cols=251  Identities=22%  Similarity=0.327  Sum_probs=205.8

Q ss_pred             CCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeEE
Q 046639           31 NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIV  110 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv  110 (331)
                      .+.|+..||-|+||.||+|..+.++-..|-|++.....+..++++-|++||..+.||+|+++++.     +.-++.++++
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~a-----yy~enkLwil  107 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSA-----YYFENKLWIL  107 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHH-----HhccCceEEE
Confidence            56778899999999999999998888889999988888888999999999999999999999998     4556789999


Q ss_pred             EeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccccC
Q 046639          111 FEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGY  190 (331)
Q Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~  190 (331)
                      .|||.||-...++-.-+ ..+...++..++.|++.||.|||++   +|+|||||..|||++.+|.++|+|||.+...   
T Consensus       108 iEFC~GGAVDaimlEL~-r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn---  180 (1187)
T KOG0579|consen  108 IEFCGGGAVDAIMLELG-RVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKN---  180 (1187)
T ss_pred             EeecCCchHhHHHHHhc-cccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccc---
Confidence            99999988888876543 4577899999999999999999999   9999999999999999999999999987643   


Q ss_pred             CCCCcccccCCceeecccccccCCcccC-----CCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcc
Q 046639          191 EPGTAAETASNSIEIKGIVGYVAPEYGM-----GSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPD  265 (331)
Q Consensus       191 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  265 (331)
                           .........++|||.|||||+..     ..+|+.++||||||++|.||..+.+|-....    ....+++..-+.
T Consensus       181 -----~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln----pMRVllKiaKSe  251 (1187)
T KOG0579|consen  181 -----KSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN----PMRVLLKIAKSE  251 (1187)
T ss_pred             -----hhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc----hHHHHHHHhhcC
Confidence                 23334556788999999999854     4689999999999999999999999976431    111222211111


Q ss_pred             hhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          266 KVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                            .|.+.         -+......|.+++..||..||+.||++.++++
T Consensus       252 ------PPTLl---------qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  252 ------PPTLL---------QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             ------CCccc---------CcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence                  11111         11245667889999999999999999999975

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.2e-38  Score=273.98  Aligned_cols=251  Identities=23%  Similarity=0.323  Sum_probs=194.1

Q ss_pred             eeccCeeEEEEeeecCCCceEEEEEeeccch---hhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeEEEeec
Q 046639           38 IGQGGVSIVYKGILDESRSIVAVKVVNLKQK---EASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYM  114 (331)
Q Consensus        38 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~  114 (331)
                      ||.|++|.||++++..+++.+++|.+.....   .....+.+|+.+++.++|+|++++++.     +......++++|++
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~-----~~~~~~~~lv~e~~   75 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYS-----FQGKKNLYLVMEYL   75 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHh-----eecCcEEEEEEecC
Confidence            6899999999999998899999999864433   445678899999999999999999887     45567789999999


Q ss_pred             CCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccccCCCCC
Q 046639          115 QNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGT  194 (331)
Q Consensus       115 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~~~~~  194 (331)
                      ++++|.+++....  .+++..+..++.|++.||++||..   +++|+||+|+||+++.++.++|+|||++..........
T Consensus        76 ~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~  150 (265)
T cd05579          76 PGGDLASLLENVG--SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQIN  150 (265)
T ss_pred             CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccc
Confidence            9999999997644  467888999999999999999999   99999999999999999999999999987642211100


Q ss_pred             cccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhhhcCcc
Q 046639          195 AAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPS  274 (331)
Q Consensus       195 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (331)
                      ............++..|+|||...+..++.++||||||+++++|++|..||......     ..........        
T Consensus       151 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-----~~~~~~~~~~--------  217 (265)
T cd05579         151 LNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE-----EIFQNILNGK--------  217 (265)
T ss_pred             cccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHhcCC--------
Confidence            000011222345677899999998888999999999999999999999999653211     1111100000        


Q ss_pred             cccccccCCcchHHH--HHHHHHHhhccccCCCCCCCCcHHHHHHHHH
Q 046639          275 LLLEVTANNYSWIED--CLVAVIGTGVTCSMESPMERMEMRDVVAKLR  320 (331)
Q Consensus       275 ~~~~~~~~~~~~~~~--~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~  320 (331)
                               ..+...  .+..+.+++.+||+.+|++|||+..+.+.|+
T Consensus       218 ---------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         218 ---------IEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             ---------cCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence                     011111  2567899999999999999999966655554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=2.3e-38  Score=282.13  Aligned_cols=276  Identities=22%  Similarity=0.314  Sum_probs=200.0

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeec--cchhhHHHHHHHHHHHHcC-CCCCcceeeceeecccCCCc
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL--KQKEASRSFAAECNALRNI-RHRNLIKIITICSSIDFEGF  104 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~  104 (331)
                      ..++|.+.+.||+|++|.||+|.+..++..+|+|.+..  ........+..|+.+++.+ +|+||+++++++..   ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~---~~~   81 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA---END   81 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeecc---CCC
Confidence            45679999999999999999999988899999998843  2233445677899999999 99999999998643   224


Q ss_pred             ceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcc
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA  184 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a  184 (331)
                      ...++|||+++ ++|.+++...   .+.+.....++.|++.||.+||+.   +++|+||+|+||+++.++.++|+|||++
T Consensus        82 ~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~  154 (337)
T cd07852          82 KDIYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLA  154 (337)
T ss_pred             ceEEEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccch
Confidence            46799999995 6999988653   466778888999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCcccccCCceeecccccccCCcccCC-CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhC
Q 046639          185 KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG-SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMAL  263 (331)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  263 (331)
                      ..........   .........++..|+|||.+.+ ..++.++||||||+++|+|++|..||........ .........
T Consensus       155 ~~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~-~~~~~~~~~  230 (337)
T cd07852         155 RSLSELEENP---ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ-LEKIIEVIG  230 (337)
T ss_pred             hccccccccc---cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhC
Confidence            8653221110   1112223457888999998765 4578899999999999999999999975422111 111111100


Q ss_pred             c--c---------hhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHH
Q 046639          264 P--D---------KVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAK  318 (331)
Q Consensus       264 ~--~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~  318 (331)
                      .  .         ......+ ................++..+.+++.+||+.+|++|||+.++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         231 PPSAEDIESIKSPFAATMLD-SLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             CCCHHHHHHHHhhhHHHhhh-hcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            0  0         0000000 000000000111122356788999999999999999999999863

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.7e-38  Score=282.21  Aligned_cols=282  Identities=20%  Similarity=0.238  Sum_probs=206.4

Q ss_pred             CCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           31 NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ--KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      +|.+.+.||.|++|.||+|.+..++..+|+|.+....  ....+.+.+|+.+++.++|+|++++.+++...........+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            5889999999999999999998889999999986543  34456788999999999999999999987544333345789


Q ss_pred             EEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccc
Q 046639          109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLF  188 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~  188 (331)
                      ++||+++ ++|.+++....  .+++..+..++.|++.||++||+.   +++|+||||+||+++.++.++|+|||++....
T Consensus        81 lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~  154 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVD  154 (330)
T ss_pred             EEecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence            9999995 68999886543  577888999999999999999999   99999999999999999999999999998752


Q ss_pred             cCCCCCcccccCCceeecccccccCCcccCCC-CCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcch-
Q 046639          189 GYEPGTAAETASNSIEIKGIVGYVAPEYGMGS-KASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDK-  266 (331)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-  266 (331)
                      .....     ........++..|+|||.+.+. .++.++|+||||+++|+|++|.+||....... .+........... 
T Consensus       155 ~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~~~  228 (330)
T cd07834         155 PDEDE-----KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID-QLNLIVEVLGTPSE  228 (330)
T ss_pred             ccccc-----cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHhcCCCCh
Confidence            21110     1112234578889999999887 78999999999999999999999997643211 1111111100000 


Q ss_pred             -hhhhcCccccccc--------ccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH--HHHHhhh
Q 046639          267 -VMEIVDPSLLLEV--------TANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA--KLRHARE  324 (331)
Q Consensus       267 -~~~~~~~~~~~~~--------~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~--~L~~~~~  324 (331)
                       .............        ...........+..+.+++.+||+.+|++|||+.++++  +++....
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~  297 (330)
T cd07834         229 EDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD  297 (330)
T ss_pred             hHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence             0000000000000        00000111234667899999999999999999999987  3554443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-38  Score=271.06  Aligned_cols=277  Identities=20%  Similarity=0.284  Sum_probs=215.9

Q ss_pred             HHHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHc--CCCCCcceeeceeecccCCC
Q 046639           26 SKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRN--IRHRNLIKIITICSSIDFEG  103 (331)
Q Consensus        26 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~~~~~  103 (331)
                      +...++..+.+.||+|.||+||+|.|+  |+.||||++.-.++   +.+.+|.++.+.  ++|+||+.+++.=.... ..
T Consensus       207 RTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~-gs  280 (513)
T KOG2052|consen  207 RTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDN-GS  280 (513)
T ss_pred             HhhhheeEEEEEecCccccceeecccc--CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCC-Cc
Confidence            455568889999999999999999998  77899999963333   344566666555  59999999887632111 22


Q ss_pred             cceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcC-----CCCeeecCCCCCCEEecCCCcEEE
Q 046639          104 FDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHC-----QPSIVHGDLKPSNILLDQDIVAHV  178 (331)
Q Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~-----~~~ivH~dik~~nilv~~~~~~kl  178 (331)
                      -..++||++|.+.|||.|++.+..   +.....++++..++.||++||...     -|.|.|||||+.||||..+|...|
T Consensus       281 ~TQLwLvTdYHe~GSL~DyL~r~t---v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I  357 (513)
T KOG2052|consen  281 WTQLWLVTDYHEHGSLYDYLNRNT---VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI  357 (513)
T ss_pred             eEEEEEeeecccCCcHHHHHhhcc---CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence            345899999999999999998743   667888999999999999999753     368999999999999999999999


Q ss_pred             cccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCC------ccchhhHhHHHHHHHHHh----------CC
Q 046639          179 GDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKA------SVSGDVYNFGILLLEMFT----------RR  242 (331)
Q Consensus       179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~------~~~~DiwslG~il~el~~----------g~  242 (331)
                      +|+|+|.......    .......+...||..|||||++.....      -..+||||||.++||++.          -+
T Consensus       358 ADLGLAv~h~~~t----~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~  433 (513)
T KOG2052|consen  358 ADLGLAVRHDSDT----DTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQ  433 (513)
T ss_pred             eeceeeEEecccC----CcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhc
Confidence            9999998763322    223345566789999999999876421      235899999999999987          24


Q ss_pred             CCCCcccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHh
Q 046639          243 RPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHA  322 (331)
Q Consensus       243 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~  322 (331)
                      +||.+..+.+..+.+..+..+-.++...+++.          ....++...+.+||+.||..||.-|-||--|.++|.++
T Consensus       434 ~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnr----------W~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l  503 (513)
T KOG2052|consen  434 LPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNR----------WKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKL  503 (513)
T ss_pred             CCcccCCCCCCCHHHHhcceeecccCCCCCcc----------cccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHH
Confidence            68888877777777766555544443333332          22347889999999999999999999999999999998


Q ss_pred             hhh
Q 046639          323 RET  325 (331)
Q Consensus       323 ~~~  325 (331)
                      .++
T Consensus       504 ~~~  506 (513)
T KOG2052|consen  504 SNS  506 (513)
T ss_pred             hcC
Confidence            864

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.3e-38  Score=296.56  Aligned_cols=274  Identities=20%  Similarity=0.234  Sum_probs=185.9

Q ss_pred             HHhcCCCcCceeeccCeeEEEEeeecCCC-ceEEEE------------------EeeccchhhHHHHHHHHHHHHcCCCC
Q 046639           27 KATNNFSPANKIGQGGVSIVYKGILDESR-SIVAVK------------------VVNLKQKEASRSFAAECNALRNIRHR   87 (331)
Q Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK------------------~~~~~~~~~~~~~~~e~~~l~~l~h~   87 (331)
                      ...++|.+++.||+|+||+||+|..+... ...+.|                  .+. ........+.+|+.+++.++|+
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hp  223 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHE  223 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCC
Confidence            44578999999999999999998764322 111111                  111 1223345688999999999999


Q ss_pred             CcceeeceeecccCCCcceeeEEEeecCCCCHHHHHHhcc---CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCC
Q 046639           88 NLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSN---GQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLK  164 (331)
Q Consensus        88 ~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik  164 (331)
                      ||+++++++     ...+..+++++++ +++|.+++....   ........+..++.|++.||.|||++   +|+|||||
T Consensus       224 nIv~l~~~~-----~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLK  294 (501)
T PHA03210        224 NILKIEEIL-----RSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIK  294 (501)
T ss_pred             CcCcEeEEE-----EECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCC
Confidence            999999995     4456789999999 668887775422   11223456778999999999999999   99999999


Q ss_pred             CCCEEecCCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCC-
Q 046639          165 PSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRR-  243 (331)
Q Consensus       165 ~~nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~-  243 (331)
                      |+|||++.++.+||+|||++..+...       .........||..|+|||++.+..++.++|||||||++|||++|.. 
T Consensus       295 P~NILl~~~~~vkL~DFGla~~~~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~  367 (501)
T PHA03210        295 LENIFLNCDGKIVLGDFGTAMPFEKE-------REAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFC  367 (501)
T ss_pred             HHHEEECCCCCEEEEeCCCceecCcc-------cccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence            99999999999999999999865211       1112223568999999999999999999999999999999999875 


Q ss_pred             CCCcccCC-cchHHHHHHhh------Ccc---hhhhhcCcccccccccCCcchHH--HHHHHHHHhhccccCCCCCCCCc
Q 046639          244 PTDAMFNE-GLTLHEFVKMA------LPD---KVMEIVDPSLLLEVTANNYSWIE--DCLVAVIGTGVTCSMESPMERME  311 (331)
Q Consensus       244 pf~~~~~~-~~~~~~~~~~~------~~~---~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~l~~~cl~~~P~~Rps  311 (331)
                      |+...... ...+.......      .+.   .+...+.................  .....+.+++.+||+.||.+|||
T Consensus       368 p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rps  447 (501)
T PHA03210        368 PIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPG  447 (501)
T ss_pred             CccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcC
Confidence            44332111 11122211110      000   01111110000000000001111  12345778889999999999999


Q ss_pred             HHHHHH
Q 046639          312 MRDVVA  317 (331)
Q Consensus       312 ~~~i~~  317 (331)
                      +.|+++
T Consensus       448 a~elL~  453 (501)
T PHA03210        448 AAELLA  453 (501)
T ss_pred             HHHHhh
Confidence            999985

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=4.7e-38  Score=268.13  Aligned_cols=250  Identities=24%  Similarity=0.310  Sum_probs=200.3

Q ss_pred             CCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeEE
Q 046639           31 NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIV  110 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv  110 (331)
                      .|.+.+.||+|++|.||++.+..++..+++|.+..........+.+|+.+++.+.|++++++++++     ......+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~l~   75 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSY-----LKKDELWIV   75 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEE-----ecCCeEEEE
Confidence            478889999999999999999888999999999766555667889999999999999999999985     334678999


Q ss_pred             EeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccccC
Q 046639          111 FEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGY  190 (331)
Q Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~  190 (331)
                      +|++++++|.+++.... ..+++..+..++.|++.|+.+||..   +++|+||+|+||+++.++.++|+|||.+......
T Consensus        76 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  151 (253)
T cd05122          76 MEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT  151 (253)
T ss_pred             EecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence            99999999999997653 3467888999999999999999998   9999999999999999999999999988765211


Q ss_pred             CCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhhh
Q 046639          191 EPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEI  270 (331)
Q Consensus       191 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  270 (331)
                      .         ......++..|+|||.+.+..++.++|+||||+++++|++|..||......  .........   .....
T Consensus       152 ~---------~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~---~~~~~  217 (253)
T cd05122         152 K---------ARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM--KALFKIATN---GPPGL  217 (253)
T ss_pred             c---------cccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH--HHHHHHHhc---CCCCc
Confidence            0         023445778899999998888999999999999999999999999653211  000000100   00000


Q ss_pred             cCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          271 VDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ..              ...+...+.+++.+||+.||.+|||+.++++
T Consensus       218 ~~--------------~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         218 RN--------------PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             Cc--------------ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            00              0113567899999999999999999999974

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-39  Score=270.17  Aligned_cols=243  Identities=21%  Similarity=0.245  Sum_probs=200.5

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCc
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGF  104 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  104 (331)
                      ..++|..++.||+|.||+|.+++.+.+++.+|+|+++++.   ......-+.|-++|+..+||.+..+-..     +...
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYs-----FQt~  240 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYS-----FQTQ  240 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhh-----hccC
Confidence            4568999999999999999999999999999999997542   2333445688999999999998877555     6777


Q ss_pred             ceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcc
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA  184 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a  184 (331)
                      +++|+||||..||.|.-.+.+.  ..+++.....+...|+.||.|||++   +||+||+|.+|.+++.+|++||.|||++
T Consensus       241 drlCFVMeyanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLC  315 (516)
T KOG0690|consen  241 DRLCFVMEYANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLC  315 (516)
T ss_pred             ceEEEEEEEccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccc
Confidence            8999999999999999888653  3477788889999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCc
Q 046639          185 KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALP  264 (331)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  264 (331)
                      +.-        ..........+|||.|+|||++....|+...|.|.+|+++|||+.|+.||....  ...+...+-   .
T Consensus       316 KE~--------I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~d--h~kLFeLIl---~  382 (516)
T KOG0690|consen  316 KEE--------IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKD--HEKLFELIL---M  382 (516)
T ss_pred             hhc--------ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccc--hhHHHHHHH---h
Confidence            763        334456667899999999999999999999999999999999999999997532  112222111   0


Q ss_pred             chhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCC
Q 046639          265 DKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERM  310 (331)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp  310 (331)
                                       ..-.|+....++...|+..+|..||.+|.
T Consensus       383 -----------------ed~kFPr~ls~eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  383 -----------------EDLKFPRTLSPEAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             -----------------hhccCCccCCHHHHHHHHHHhhcChHhhc
Confidence                             01134445667788899999999999995

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=4.7e-38  Score=270.26  Aligned_cols=243  Identities=24%  Similarity=0.285  Sum_probs=193.0

Q ss_pred             eeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeEEEeec
Q 046639           38 IGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYM  114 (331)
Q Consensus        38 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~  114 (331)
                      ||.|++|.||+|.+..+++.+++|.+....   ......+.+|+.+++.++||||+++++.+     ..+...++++|++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~   75 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTF-----KDKKYIYMLMEYC   75 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeE-----EcCCccEEEEecC
Confidence            689999999999999889999999986432   23446789999999999999999999984     4456789999999


Q ss_pred             CCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccccCCCCC
Q 046639          115 QNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGT  194 (331)
Q Consensus       115 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~~~~~  194 (331)
                      ++++|.+++.+..  .++...+..++.|++.||.+||+.   +++|+||+|+||+++.++.++|+|||++......    
T Consensus        76 ~~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~----  146 (262)
T cd05572          76 LGGELWTILRDRG--LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG----  146 (262)
T ss_pred             CCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCcc----
Confidence            9999999997643  367788889999999999999999   9999999999999999999999999998765211    


Q ss_pred             cccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhhhcCcc
Q 046639          195 AAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPS  274 (331)
Q Consensus       195 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (331)
                           .......+++.|+|||.+.+..++.++|+||+|+++|+|++|..||.....+...   ......        ...
T Consensus       147 -----~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~~--------~~~  210 (262)
T cd05572         147 -----QKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPME---IYNDIL--------KGN  210 (262)
T ss_pred             -----cccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHH---HHHHHh--------ccC
Confidence                 1122345778899999998888999999999999999999999999765321111   111100        000


Q ss_pred             cccccccCCcchHHHHHHHHHHhhccccCCCCCCCCc-----HHHHHH
Q 046639          275 LLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERME-----MRDVVA  317 (331)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps-----~~~i~~  317 (331)
                             ....++..+...+.+++.+||+.+|++||+     +.++++
T Consensus       211 -------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         211 -------GKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             -------CCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence                   000112223567899999999999999999     777765

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-38  Score=272.30  Aligned_cols=267  Identities=21%  Similarity=0.244  Sum_probs=195.3

Q ss_pred             CCcCceeeccCeeEEEEeeecCCCceEEEEEeeccch-hhHHHHHHHHHHHHcCC-CCCcceeeceeecccCCCcceeeE
Q 046639           32 FSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK-EASRSFAAECNALRNIR-HRNLIKIITICSSIDFEGFDFKAI  109 (331)
Q Consensus        32 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~l  109 (331)
                      |.+.+.||.|++|+||+|....+++.|++|.+..... .......+|+..++++. |+|++++++++     ...+..++
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~-----~~~~~~~l   75 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVF-----RENDELYF   75 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHh-----hcCCcEEE
Confidence            6788999999999999999988899999998864322 12234567899999998 99999999985     44678899


Q ss_pred             EEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccccc
Q 046639          110 VFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG  189 (331)
Q Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~  189 (331)
                      |||++ +++|.+.+.......+++..+..++.|++.+|.+||++   +++|+||+|+||+++.++.++|+|||.+.....
T Consensus        76 v~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~  151 (283)
T cd07830          76 VFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRS  151 (283)
T ss_pred             EEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccC
Confidence            99999 88999998776555678899999999999999999999   999999999999999999999999999876421


Q ss_pred             CCCCCcccccCCceeecccccccCCcccCC-CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCc---c
Q 046639          190 YEPGTAAETASNSIEIKGIVGYVAPEYGMG-SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALP---D  265 (331)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~---~  265 (331)
                      .         .......++..|+|||++.+ ..++.++|+||||+++++|++|..||....... ...........   .
T Consensus       152 ~---------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~  221 (283)
T cd07830         152 R---------PPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEID-QLYKICSVLGTPTKQ  221 (283)
T ss_pred             C---------CCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHH-HHHHHHHhcCCCChh
Confidence            1         11122346778999998754 457899999999999999999999996542211 11111110000   0


Q ss_pred             h------hhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          266 K------VMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       266 ~------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      .      ...........................+.+++.+||+.+|++|||+.|++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         222 DWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             hhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            0      000000000000000001111122467889999999999999999999874

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=9.3e-38  Score=275.87  Aligned_cols=247  Identities=21%  Similarity=0.257  Sum_probs=193.3

Q ss_pred             CCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc---chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCccee
Q 046639           31 NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK---QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      .|...+.||+|+||.||+|.+..++..+|+|.+...   .......+.+|+.+++.++|+|++++++++.     .....
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~  100 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYL-----REHTA  100 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-----eCCeE
Confidence            488899999999999999999889999999998643   2334457889999999999999999999854     34568


Q ss_pred             eEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccc
Q 046639          108 AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      ++||||+. ++|.+.+... ...+++..+..++.|++.|+.+||+.   +++|+||+|+||+++.++.++|+|||++...
T Consensus       101 ~lv~e~~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~  175 (317)
T cd06635         101 WLVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIA  175 (317)
T ss_pred             EEEEeCCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCcccc
Confidence            99999995 5888877543 33467888899999999999999999   9999999999999999999999999987653


Q ss_pred             ccCCCCCcccccCCceeecccccccCCcccC---CCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCc
Q 046639          188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGM---GSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALP  264 (331)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  264 (331)
                      .            ......+++.|+|||++.   ++.++.++||||||+++|+|++|..||...... ...........+
T Consensus       176 ~------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-~~~~~~~~~~~~  242 (317)
T cd06635         176 S------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQNESP  242 (317)
T ss_pred             C------------CcccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHhccCC
Confidence            1            112234777899999873   456889999999999999999999998653111 111111111100


Q ss_pred             chhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHH
Q 046639          265 DKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKL  319 (331)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L  319 (331)
                               .          .....+...+.+++.+||+.+|.+||++.+|++.+
T Consensus       243 ---------~----------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~  278 (317)
T cd06635         243 ---------T----------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM  278 (317)
T ss_pred             ---------C----------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence                     0          00112455788999999999999999999998754

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-38  Score=273.50  Aligned_cols=270  Identities=19%  Similarity=0.248  Sum_probs=197.9

Q ss_pred             CCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeE
Q 046639           32 FSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ--KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAI  109 (331)
Q Consensus        32 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~l  109 (331)
                      |.+.+.||.|++|.||+|.+..++..+|+|.+....  ......+.+|+.+++.++|+|++++++++....   .+..++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~l   77 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG---KGSIYM   77 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC---CCcEEE
Confidence            678899999999999999999889999999997653  334466889999999999999999999964321   367899


Q ss_pred             EEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccccc
Q 046639          110 VFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG  189 (331)
Q Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~  189 (331)
                      |+|+++ ++|.+++.... ..+++..++.++.|++.||++||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        78 v~e~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~  152 (287)
T cd07840          78 VFEYMD-HDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTK  152 (287)
T ss_pred             Eecccc-ccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccC
Confidence            999995 59999886543 3577888999999999999999999   999999999999999999999999999986522


Q ss_pred             CCCCCcccccCCceeecccccccCCcccCC-CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhh
Q 046639          190 YEPGTAAETASNSIEIKGIVGYVAPEYGMG-SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVM  268 (331)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  268 (331)
                      ...       .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||..... .................
T Consensus       153 ~~~-------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~-~~~~~~~~~~~~~~~~~  224 (287)
T cd07840         153 RNS-------ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE-LEQLEKIFELCGSPTDE  224 (287)
T ss_pred             CCc-------ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCchh
Confidence            211       11122345677999998765 4578999999999999999999999975432 11122221111100000


Q ss_pred             hhcC--c-------ccccccccCCcchHHH-HHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          269 EIVD--P-------SLLLEVTANNYSWIED-CLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       269 ~~~~--~-------~~~~~~~~~~~~~~~~-~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ....  .       ................ ++..+.+++.+||+.+|.+|||+.++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         225 NWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             hccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            0000  0       0000000000011112 3678999999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1e-37  Score=267.04  Aligned_cols=248  Identities=25%  Similarity=0.265  Sum_probs=199.6

Q ss_pred             CCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc--chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           31 NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      +|++.+.||.|++|.||++.+..++..+++|.+...  .......+.+|+.+++.++|+||+++.+++     ......+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~   75 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAF-----LDGNKLC   75 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhh-----ccCCEEE
Confidence            588999999999999999999989999999998643  233456678899999999999999999884     4457889


Q ss_pred             EEEeecCCCCHHHHHHhc--cCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          109 IVFEYMQNRNLEQWLRQS--NGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      +|+|++++++|.+++...  ....++...++.++.|++.||++||+.   +++|+||+|+||+++.++.++|+|||++..
T Consensus        76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~  152 (256)
T cd08530          76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKV  152 (256)
T ss_pred             EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhh
Confidence            999999999999998762  234567788899999999999999999   999999999999999999999999999876


Q ss_pred             cccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcch
Q 046639          187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDK  266 (331)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  266 (331)
                      ....          ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||......  ........     
T Consensus       153 ~~~~----------~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~--~~~~~~~~-----  215 (256)
T cd08530         153 LKKN----------MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ--DLRYKVQR-----  215 (256)
T ss_pred             hccC----------CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHhc-----
Confidence            5221          111234677899999999988999999999999999999999999754211  11111100     


Q ss_pred             hhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          267 VMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                             ....       .........+.+++.+||+.+|++|||+.++++
T Consensus       216 -------~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         216 -------GKYP-------PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             -------CCCC-------CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                   0000       111245567899999999999999999999975

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.4e-38  Score=281.79  Aligned_cols=276  Identities=16%  Similarity=0.205  Sum_probs=202.2

Q ss_pred             HHHHHHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCcceeeceeeccc
Q 046639           23 AELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ--KEASRSFAAECNALRNIRHRNLIKIITICSSID  100 (331)
Q Consensus        23 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  100 (331)
                      .++....++|.+.+.||+|+||.||+|.+..+++.||+|.+....  ......+.+|+.+++.++|+||+++++++....
T Consensus        10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~   89 (345)
T cd07877          10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR   89 (345)
T ss_pred             HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence            456667889999999999999999999998899999999986432  223456788999999999999999999865322


Q ss_pred             -CCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEc
Q 046639          101 -FEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVG  179 (331)
Q Consensus       101 -~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~  179 (331)
                       +......+++++++ +++|.+++...   .+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+
T Consensus        90 ~~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~  162 (345)
T cd07877          90 SLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKIL  162 (345)
T ss_pred             cccccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEe
Confidence             22334578888887 88999888643   367788999999999999999999   99999999999999999999999


Q ss_pred             ccCcccccccCCCCCcccccCCceeecccccccCCcccCC-CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHH
Q 046639          180 DLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG-SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEF  258 (331)
Q Consensus       180 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  258 (331)
                      |||++....           .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||..... ...+...
T Consensus       163 dfg~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~-~~~~~~~  230 (345)
T cd07877         163 DFGLARHTD-----------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH-IDQLKLI  230 (345)
T ss_pred             ccccccccc-----------ccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHH
Confidence            999987531           11123457788999998766 5688999999999999999999999965322 1112221


Q ss_pred             HHhhC--cchhhhhcCcccc-------ccccc-CCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          259 VKMAL--PDKVMEIVDPSLL-------LEVTA-NNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       259 ~~~~~--~~~~~~~~~~~~~-------~~~~~-~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      .....  +............       ..... ............+.+++.+||+.||.+|||+.+++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  299 (345)
T cd07877         231 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  299 (345)
T ss_pred             HHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence            11110  0111100000000       00000 000111124567889999999999999999999874

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.3e-38  Score=267.94  Aligned_cols=248  Identities=26%  Similarity=0.391  Sum_probs=200.2

Q ss_pred             CCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccch--hhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           31 NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK--EASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      +|.+.+.||+|++|.||++.+..++++|++|.+.....  .....+.+|++++++++|+|++++++++     .+.+..+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~   75 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSI-----ETSDSLY   75 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEE-----EeCCEEE
Confidence            58889999999999999999998899999999865543  4557789999999999999999999985     3456789


Q ss_pred             EEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccc
Q 046639          109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLF  188 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~  188 (331)
                      +++|++++++|.+++...  ..+++..+..++.|++.|+.+||+.   +++|+||+|+||+++.++.++|+|||.+....
T Consensus        76 ~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~  150 (254)
T cd06627          76 IILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLN  150 (254)
T ss_pred             EEEecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecC
Confidence            999999999999999765  3577889999999999999999999   99999999999999999999999999998652


Q ss_pred             cCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhh
Q 046639          189 GYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVM  268 (331)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  268 (331)
                      ...        .......++..|+|||...+..++.++||||+|+++|+|++|..||.....    ......... .   
T Consensus       151 ~~~--------~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~----~~~~~~~~~-~---  214 (254)
T cd06627         151 DVS--------KDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP----MAALFRIVQ-D---  214 (254)
T ss_pred             CCc--------ccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH----HHHHHHHhc-c---
Confidence            211        112334577889999998888889999999999999999999999965321    111111100 0   


Q ss_pred             hhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          269 EIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                        ..+           .........+.+++.+||..+|++|||+.+++.
T Consensus       215 --~~~-----------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         215 --DHP-----------PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             --CCC-----------CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence              000           111234567889999999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-37  Score=270.80  Aligned_cols=267  Identities=20%  Similarity=0.271  Sum_probs=199.0

Q ss_pred             CCcCceeeccCeeEEEEeeecCCCceEEEEEeeccch--hhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeE
Q 046639           32 FSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK--EASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAI  109 (331)
Q Consensus        32 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~l  109 (331)
                      |.+.+.||.|++|.||+|.+..++..+++|.+.....  .....+.+|+.+++.++|+|++++++++     ......++
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~   75 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVF-----RHKGDLYL   75 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhh-----ccCCCEEE
Confidence            6778999999999999999988999999999864432  2456788899999999999999999984     44577899


Q ss_pred             EEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccccc
Q 046639          110 VFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG  189 (331)
Q Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~  189 (331)
                      ++|+++ ++|.+++.... ..+++..+..++.|++.||.+||+.   +++|+||+|+||+++.++.++|+|||.+.....
T Consensus        76 v~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~  150 (283)
T cd05118          76 VFEFMD-TDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGS  150 (283)
T ss_pred             EEeccC-CCHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCC
Confidence            999995 58988887643 3567889999999999999999999   999999999999999999999999999876521


Q ss_pred             CCCCCcccccCCceeecccccccCCcccCCC-CCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCc---c
Q 046639          190 YEPGTAAETASNSIEIKGIVGYVAPEYGMGS-KASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALP---D  265 (331)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~---~  265 (331)
                      ..        .......++..|+|||.+.+. .++.++|+||||+++|+|++|..||....... ...........   .
T Consensus       151 ~~--------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~-~~~~~~~~~~~~~~~  221 (283)
T cd05118         151 PV--------RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID-QLFKIFRTLGTPDPE  221 (283)
T ss_pred             Cc--------ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCCCchH
Confidence            11        111123467789999998876 78999999999999999999999996542211 11111111000   0


Q ss_pred             hhhhhcC------cccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          266 KVMEIVD------PSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       266 ~~~~~~~------~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      .......      ................+++..+.+++.+||+.||.+||++.+++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         222 VWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence            0000000      000000000011222356788999999999999999999999974

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-39  Score=264.93  Aligned_cols=265  Identities=17%  Similarity=0.260  Sum_probs=213.5

Q ss_pred             CceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCC-CCCcceeeceeecccCCCcceeeEEEee
Q 046639           35 ANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIR-HRNLIKIITICSSIDFEGFDFKAIVFEY  113 (331)
Q Consensus        35 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~lv~e~  113 (331)
                      .+.||+|+++.|-.++...++..||||++.+.....+.+..+|++++...+ |+||++++++     |+++...|+|||.
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLief-----FEdd~~FYLVfEK  157 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEF-----FEDDTRFYLVFEK  157 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHH-----hcccceEEEEEec
Confidence            358999999999999999999999999998776667788999999999995 9999999999     7888899999999


Q ss_pred             cCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCC---cEEEcccCcccccccC
Q 046639          114 MQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDI---VAHVGDLGLAKFLFGY  190 (331)
Q Consensus       114 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~---~~kl~Dfg~a~~~~~~  190 (331)
                      +.||+|.+.|.++.  -+.+..+..+..+|+.||.+||.+   ||.|||+||+|||...-.   -|||+||.+..-+.-.
T Consensus       158 m~GGplLshI~~~~--~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~  232 (463)
T KOG0607|consen  158 MRGGPLLSHIQKRK--HFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLN  232 (463)
T ss_pred             ccCchHHHHHHHhh--hccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccC
Confidence            99999999997754  377888999999999999999999   999999999999996544   4899999887654222


Q ss_pred             CCCCcccccCCceeecccccccCCcccC-----CCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcc
Q 046639          191 EPGTAAETASNSIEIKGIVGYVAPEYGM-----GSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPD  265 (331)
Q Consensus       191 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  265 (331)
                      ..-+ ....+......|+..|||||+..     ...|+.++|.||||+|||-|++|.+||.+....+-.++.       .
T Consensus       233 ~~~s-pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdr-------G  304 (463)
T KOG0607|consen  233 NDCS-PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDR-------G  304 (463)
T ss_pred             CCCC-CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccC-------C
Confidence            2111 22333444567888999999743     246899999999999999999999999988665554433       2


Q ss_pred             hhhhhcCcccccccccCCcchHH----HHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          266 KVMEIVDPSLLLEVTANNYSWIE----DCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ......-..+...+..+.++|++    ..+.+..+|+..+|..++.+|.++.+++.
T Consensus       305 e~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  305 EVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             CccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            33333334455566666666666    45556788999999999999999988875

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=6.7e-38  Score=274.20  Aligned_cols=253  Identities=23%  Similarity=0.289  Sum_probs=191.6

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc-hhhHHHHHHHHHHHHcC-CCCCcceeeceeecccCCCcce
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ-KEASRSFAAECNALRNI-RHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      .++|.+.+.||+|++|.||+|.+..+++.||+|.+.... ......+..|+.++... .|+||+++++++.     ....
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~   88 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFI-----TDSD   88 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeee-----cCCe
Confidence            357999999999999999999999889999999986443 23345566777766666 4999999999953     4567


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCCEEecCCCcEEEcccCccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHH-HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAK  185 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~  185 (331)
                      .+++||++ +++|.+++..... .+++..+..++.|++.|++|||+ .   +++|+||+|+||+++.++.++|+|||++.
T Consensus        89 ~~~v~e~~-~~~l~~l~~~~~~-~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg~~~  163 (296)
T cd06618          89 VFICMELM-STCLDKLLKRIQG-PIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGISG  163 (296)
T ss_pred             EEEEeecc-CcCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECccccch
Confidence            89999998 5688887765333 57778888999999999999997 5   89999999999999999999999999987


Q ss_pred             ccccCCCCCcccccCCceeecccccccCCcccCCCC----CccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHh
Q 046639          186 FLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSK----ASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKM  261 (331)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~----~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  261 (331)
                      .+...         .......++..|+|||.+.+..    ++.++||||||+++|+|++|..||.........+......
T Consensus       164 ~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~  234 (296)
T cd06618         164 RLVDS---------KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQE  234 (296)
T ss_pred             hccCC---------CcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcC
Confidence            64211         1111223677899999987653    7889999999999999999999996432111111111110


Q ss_pred             hCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHH
Q 046639          262 ALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAK  318 (331)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~  318 (331)
                      ..         +..         .....+...+.+++.+||+.||.+|||+.++++.
T Consensus       235 ~~---------~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         235 EP---------PSL---------PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             CC---------CCC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            00         000         0001245678999999999999999999999753

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-39  Score=288.61  Aligned_cols=253  Identities=21%  Similarity=0.323  Sum_probs=203.2

Q ss_pred             CCCcCceeeccCeeEEEEeeecC---CCceEEEEEeeccchh-hHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           31 NFSPANKIGQGGVSIVYKGILDE---SRSIVAVKVVNLKQKE-ASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      ..+.+++||+|.||.|++|.|..   +...||||.+...... ...+|+.|+.+|.+|+|+|+++++|+...      ..
T Consensus       111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~------qp  184 (1039)
T KOG0199|consen  111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD------QP  184 (1039)
T ss_pred             HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc------ch
Confidence            35567899999999999999963   3447999999755444 55789999999999999999999998542      45


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      ..+|||.++.|+|.+.+.+.....+.......++.||+.|+.||.++   ++||||+...|+++-....|||+|||+.+-
T Consensus       185 ~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRa  261 (1039)
T KOG0199|consen  185 AMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRA  261 (1039)
T ss_pred             hhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceec
Confidence            67999999999999999986666677788889999999999999999   999999999999999999999999999987


Q ss_pred             cccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhCcc
Q 046639          187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMALPD  265 (331)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~  265 (331)
                      +....     ....-.......+.|.|||.+....++.++|||++|+++|||++ |..||.+....              
T Consensus       262 Lg~ne-----d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~--------------  322 (1039)
T KOG0199|consen  262 LGENE-----DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI--------------  322 (1039)
T ss_pred             cCCCC-----cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH--------------
Confidence            63221     11111222334567999999999999999999999999999999 88999764221              


Q ss_pred             hhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHH
Q 046639          266 KVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAK  318 (331)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~  318 (331)
                      .+...+|.....       .-+..|+..+.+++..||..+|.+|||+..|.+.
T Consensus       323 qIL~~iD~~erL-------pRPk~csedIY~imk~cWah~paDRptFsair~~  368 (1039)
T KOG0199|consen  323 QILKNIDAGERL-------PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED  368 (1039)
T ss_pred             HHHHhccccccC-------CCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence            111122211111       2335799999999999999999999999999743

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=3.6e-38  Score=273.37  Aligned_cols=256  Identities=25%  Similarity=0.361  Sum_probs=201.6

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc---chhhHHHHHHHHHHHHcCC-CCCcceeeceeecccCCCcc
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK---QKEASRSFAAECNALRNIR-HRNLIKIITICSSIDFEGFD  105 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~  105 (331)
                      ++|.+.+.||+|++|.||+|.+..++..+|+|++...   .......+..|+.+++.+. |+||++++++     +...+
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~-----~~~~~   75 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYT-----FQDEE   75 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHH-----hcCCc
Confidence            4799999999999999999999989999999998642   2333466888999999998 9999999998     45567


Q ss_pred             eeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccc
Q 046639          106 FKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAK  185 (331)
Q Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~  185 (331)
                      ..++|||++++++|.+++.+..  .+++..+..++.|++.||.+||+.   +++|+||+|+||+++.++.++++|||++.
T Consensus        76 ~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~  150 (280)
T cd05581          76 NLYFVLEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAK  150 (280)
T ss_pred             eEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCcccc
Confidence            8899999999999999997654  478899999999999999999999   99999999999999999999999999987


Q ss_pred             ccccCCCCC------------cccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcc
Q 046639          186 FLFGYEPGT------------AAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGL  253 (331)
Q Consensus       186 ~~~~~~~~~------------~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~  253 (331)
                      .........            ............++..|+|||+..+..++.++|+||||++++++++|..||..... ..
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-~~  229 (280)
T cd05581         151 VLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE-YL  229 (280)
T ss_pred             ccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH-HH
Confidence            653222110            00011223344577889999999888899999999999999999999999975421 11


Q ss_pred             hHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcH----HHHHH
Q 046639          254 TLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEM----RDVVA  317 (331)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~----~~i~~  317 (331)
                      .+.....                     ....+....+..+.+++.+||+.+|.+|||+    .++++
T Consensus       230 ~~~~~~~---------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         230 TFQKILK---------------------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             HHHHHHh---------------------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            1111100                     0001112235678899999999999999999    66653

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=8.6e-38  Score=275.26  Aligned_cols=283  Identities=19%  Similarity=0.250  Sum_probs=198.8

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchh--hHHHHHHHHHHHHcCCCCCcceeeceeecccC---CC
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKE--ASRSFAAECNALRNIRHRNLIKIITICSSIDF---EG  103 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---~~  103 (331)
                      .++|.+.+.||.|++|.||+|.+..+++.+|+|.+......  ......+|+.+++.++|+||+++++++.....   ..
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            46899999999999999999999999999999998643221  22456789999999999999999988643321   22


Q ss_pred             cceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCc
Q 046639          104 FDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGL  183 (331)
Q Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~  183 (331)
                      ....++|+||+ .++|.+.+... ...+++..+..++.|++.||++||+.   +++|+||+|+||+++.++.++|+|||+
T Consensus        87 ~~~~~lv~~~~-~~~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~  161 (311)
T cd07866          87 RGSVYMVTPYM-DHDLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGL  161 (311)
T ss_pred             CceEEEEEecC-CcCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCcc
Confidence            44579999999 55787777543 33577889999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCccc---ccCCceeecccccccCCcccCCC-CCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHH
Q 046639          184 AKFLFGYEPGTAAE---TASNSIEIKGIVGYVAPEYGMGS-KASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFV  259 (331)
Q Consensus       184 a~~~~~~~~~~~~~---~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~  259 (331)
                      +.............   .........+++.|+|||.+.+. .++.++||||||+++|+|++|.+||...... .......
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~-~~~~~~~  240 (311)
T cd07866         162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI-DQLHLIF  240 (311)
T ss_pred             chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHH
Confidence            97653222111100   11112234567889999987654 5789999999999999999999999753221 1111111


Q ss_pred             HhhCcch---------hhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          260 KMALPDK---------VMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       260 ~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      .......         +....+.....................+.+++.+||+.+|++|||+.+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            1110000         000000000000000000111123367889999999999999999999874

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-38  Score=242.08  Aligned_cols=267  Identities=21%  Similarity=0.300  Sum_probs=205.1

Q ss_pred             CCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchh--hHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           31 NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKE--ASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      +|..+++||+|.+|+||+|++..+++.||+|.++..+..  .-...++|+-+++.++|.||++++++     ...+..+.
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dv-----lhsdkklt   77 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV-----LHSDKKLT   77 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhh-----hccCceeE
Confidence            577889999999999999999999999999999765432  23567899999999999999999999     66678899


Q ss_pred             EEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccc
Q 046639          109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLF  188 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~  188 (331)
                      +|+|+| ..+|..+....++ .+....+..++.|++.||.++|+.   +++|||+||.|.+|+.+|..|++|||+++-+.
T Consensus        78 lvfe~c-dqdlkkyfdslng-~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafg  152 (292)
T KOG0662|consen   78 LVFEFC-DQDLKKYFDSLNG-DLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFG  152 (292)
T ss_pred             EeHHHh-hHHHHHHHHhcCC-cCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcC
Confidence            999999 7799988877554 356788899999999999999999   99999999999999999999999999998751


Q ss_pred             cCCCCCcccccCCceeecccccccCCcccCCCC-CccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhC-c-
Q 046639          189 GYEPGTAAETASNSIEIKGIVGYVAPEYGMGSK-ASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMAL-P-  264 (331)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~-~-  264 (331)
                              ...........|.+|.+|.++.+.. |+.+.|+||.|||+.|+.. |.+.|++..-.+. +..+..... + 
T Consensus       153 --------ipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddq-lkrif~~lg~p~  223 (292)
T KOG0662|consen  153 --------IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ-LKRIFRLLGTPT  223 (292)
T ss_pred             --------CceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHH-HHHHHHHhCCCc
Confidence                    2223444556789999999998865 8999999999999999998 7777876543332 222222111 1 


Q ss_pred             ----chhhhhcCcccccccccCCcchH---HHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          265 ----DKVMEIVDPSLLLEVTANNYSWI---EDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       265 ----~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                          ..+..+.|.....-++... +|.   ......-.+|+...|.-+|.+|.++.+.++
T Consensus       224 ed~wps~t~lpdyk~yp~ypatt-swsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  224 EDQWPSMTKLPDYKPYPIYPATT-SWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             cccCCccccCCCCcccCCccccc-hHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence                2233344443333222211 111   122223467888899999999999998764

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=5.8e-38  Score=278.27  Aligned_cols=271  Identities=20%  Similarity=0.250  Sum_probs=198.3

Q ss_pred             HHHHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc--chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCC
Q 046639           25 LSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFE  102 (331)
Q Consensus        25 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  102 (331)
                      +..+.++|.+.+.||.|+||.||+|.+..++..||+|.+...  .......+..|+.+++.++|||++++.+++.    .
T Consensus         5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~----~   80 (328)
T cd07856           5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFI----S   80 (328)
T ss_pred             eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEe----c
Confidence            445678999999999999999999999999999999987532  2334466789999999999999999999863    2


Q ss_pred             CcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccC
Q 046639          103 GFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLG  182 (331)
Q Consensus       103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg  182 (331)
                      .....++++|++ +++|.++++..   .++...+..++.|++.||.+||+.   +++|+||+|+||+++.++.++|+|||
T Consensus        81 ~~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg  153 (328)
T cd07856          81 PLEDIYFVTELL-GTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFG  153 (328)
T ss_pred             CCCcEEEEeehh-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccc
Confidence            345678999999 77999888643   356677788999999999999999   99999999999999999999999999


Q ss_pred             cccccccCCCCCcccccCCceeecccccccCCcccCC-CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHh
Q 046639          183 LAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG-SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKM  261 (331)
Q Consensus       183 ~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  261 (331)
                      .+....           .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||....... ........
T Consensus       154 ~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~-~~~~~~~~  221 (328)
T cd07856         154 LARIQD-----------PQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVN-QFSIITDL  221 (328)
T ss_pred             cccccC-----------CCcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHH
Confidence            987531           11112345777999998765 568999999999999999999999997542211 11111000


Q ss_pred             --hCcchhhh-hcCc---ccccccc----cCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHH
Q 046639          262 --ALPDKVME-IVDP---SLLLEVT----ANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAK  318 (331)
Q Consensus       262 --~~~~~~~~-~~~~---~~~~~~~----~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~  318 (331)
                        ..+..+.. ..+.   .......    ....+....+...+.+++.+||+.+|++|||+.+++..
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         222 LGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             hCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence              00111000 0000   0000000    00001112345788999999999999999999998753

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.6e-38  Score=268.67  Aligned_cols=246  Identities=18%  Similarity=0.233  Sum_probs=187.5

Q ss_pred             CceeeccCeeEEEEeeecCCCceEEEEEeeccch---hhHHHHHHHHHHH-HcCCCCCcceeeceeecccCCCcceeeEE
Q 046639           35 ANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK---EASRSFAAECNAL-RNIRHRNLIKIITICSSIDFEGFDFKAIV  110 (331)
Q Consensus        35 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~~~~~~~~~~~lv  110 (331)
                      ++.||.|++|.||+|.+..+++.||+|.+.....   .....+..|..++ ....|+|++++++++     ...+..++|
T Consensus         1 ~~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv   75 (260)
T cd05611           1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF-----QSKDYLYLV   75 (260)
T ss_pred             CccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeE-----EcCCeEEEE
Confidence            3579999999999999998999999999864422   1223344555444 345899999999985     445678999


Q ss_pred             EeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccccC
Q 046639          111 FEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGY  190 (331)
Q Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~  190 (331)
                      +||+++++|.+++....  .+++..+..++.|++.||.+||+.   +++|+||+|+||+++.++.++|+|||++..... 
T Consensus        76 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-  149 (260)
T cd05611          76 MEYLNGGDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-  149 (260)
T ss_pred             EeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-
Confidence            99999999999997643  467788899999999999999999   999999999999999999999999998865311 


Q ss_pred             CCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhhh
Q 046639          191 EPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEI  270 (331)
Q Consensus       191 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  270 (331)
                                 .....+++.|+|||.+.+..++.++||||||+++|+|++|..||...... ..+.........      
T Consensus       150 -----------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~------  211 (260)
T cd05611         150 -----------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD-AVFDNILSRRIN------  211 (260)
T ss_pred             -----------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHhcccC------
Confidence                       12234777899999998888899999999999999999999999653211 111111110000      


Q ss_pred             cCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHH
Q 046639          271 VDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLR  320 (331)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~  320 (331)
                      ..           ......++..+.+++.+||+.+|++|||+.++.+.|.
T Consensus       212 ~~-----------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~  250 (260)
T cd05611         212 WP-----------EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS  250 (260)
T ss_pred             CC-----------CcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence            00           0111235677899999999999999998876655443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.1e-38  Score=278.72  Aligned_cols=275  Identities=17%  Similarity=0.237  Sum_probs=196.9

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc--chhhHHHHHHHHHHHHcCCCCCcceeeceeeccc-CCCcc
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRNIRHRNLIKIITICSSID-FEGFD  105 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~~~  105 (331)
                      .++|.+.+.||+|++|.||+|++..+++.||+|.+...  .......+.+|+.+++.++|+||+++++++.... .....
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            37899999999999999999999889999999988643  2223456789999999999999999999875432 12234


Q ss_pred             eeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccc
Q 046639          106 FKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAK  185 (331)
Q Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~  185 (331)
                      ..++|+|++ ..+|.++..    ..+++..+..++.|++.||++||+.   +++|+||+|+||+++.++.++|+|||++.
T Consensus        94 ~~~lv~e~~-~~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~  165 (342)
T cd07879          94 DFYLVMPYM-QTDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLAR  165 (342)
T ss_pred             eEEEEeccc-ccCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence            568999999 457777652    2467788899999999999999999   99999999999999999999999999986


Q ss_pred             ccccCCCCCcccccCCceeecccccccCCcccCC-CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhh-C
Q 046639          186 FLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG-SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMA-L  263 (331)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~-~  263 (331)
                      ...           .......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...... ..+....... .
T Consensus       166 ~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~-~~~~~~~~~~~~  233 (342)
T cd07879         166 HAD-----------AEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-DQLTQILKVTGV  233 (342)
T ss_pred             CCC-----------CCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCC
Confidence            531           11122346778999999876 45889999999999999999999999753211 1111111100 0


Q ss_pred             c-chhhhhcCcccc-------ccccc-CCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH--HHHHhh
Q 046639          264 P-DKVMEIVDPSLL-------LEVTA-NNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA--KLRHAR  323 (331)
Q Consensus       264 ~-~~~~~~~~~~~~-------~~~~~-~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~--~L~~~~  323 (331)
                      + ............       ..... ............+.+++.+||+.||.+|||+.+++.  .++..+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~  304 (342)
T cd07879         234 PGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR  304 (342)
T ss_pred             CCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence            0 000000000000       00000 000111124456889999999999999999999983  355443

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=2.1e-37  Score=271.79  Aligned_cols=278  Identities=21%  Similarity=0.249  Sum_probs=198.8

Q ss_pred             HHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCcceeeceeeccc----
Q 046639           27 KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ--KEASRSFAAECNALRNIRHRNLIKIITICSSID----  100 (331)
Q Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----  100 (331)
                      ...++|.+.+.||.|++|.||+|.+..+++.||+|.++...  ......+.+|+.+++.++|||++++++++....    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            34568999999999999999999999889999999986543  223356778999999999999999999875432    


Q ss_pred             -CCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEc
Q 046639          101 -FEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVG  179 (331)
Q Consensus       101 -~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~  179 (331)
                       .......++|+|++++ ++.+.+... ...+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.+||+
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~  158 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLA  158 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeC
Confidence             1223478999999954 777777653 33567889999999999999999999   99999999999999999999999


Q ss_pred             ccCcccccccCCCCCcccccCCceeecccccccCCcccCC-CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHH
Q 046639          180 DLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG-SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEF  258 (331)
Q Consensus       180 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  258 (331)
                      |||++........       .......++..|+|||.+.+ ..++.++||||||+++|+|++|.+||.... .......+
T Consensus       159 dfg~~~~~~~~~~-------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~-~~~~~~~~  230 (302)
T cd07864         159 DFGLARLYNSEES-------RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQ-ELAQLELI  230 (302)
T ss_pred             cccccccccCCcc-------cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHH
Confidence            9999876522111       11111235667999998765 357889999999999999999999997532 11112222


Q ss_pred             HHhhC---cchhhhhcCcccccc------cccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          259 VKMAL---PDKVMEIVDPSLLLE------VTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       259 ~~~~~---~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      .....   +..............      ............+..+.+++.+||+.+|.+|||+.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         231 SRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             HHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            11111   100000000000000      000000111124567899999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.1e-38  Score=302.03  Aligned_cols=266  Identities=22%  Similarity=0.292  Sum_probs=197.5

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCcceeeceeeccc------
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ-KEASRSFAAECNALRNIRHRNLIKIITICSSID------  100 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------  100 (331)
                      ..++|..++.||+||||.||+++++-+|+.||||++.... ......+.+|+.++.+++|||+|+++..+....      
T Consensus       477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~  556 (1351)
T KOG1035|consen  477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL  556 (1351)
T ss_pred             HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence            4457889999999999999999999999999999997553 344567899999999999999999984441100      


Q ss_pred             -------------------------------------------------------------------------------C
Q 046639          101 -------------------------------------------------------------------------------F  101 (331)
Q Consensus       101 -------------------------------------------------------------------------------~  101 (331)
                                                                                                     .
T Consensus       557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~  636 (1351)
T KOG1035|consen  557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS  636 (1351)
T ss_pred             cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence                                                                                           0


Q ss_pred             ---------------------CCc--------ceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhh
Q 046639          102 ---------------------EGF--------DFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHH  152 (331)
Q Consensus       102 ---------------------~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~  152 (331)
                                           ..+        -.+||-||||+..++.+++.++.... .....+.++.+|++||+|+|+
T Consensus       637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYIH~  715 (1351)
T KOG1035|consen  637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYIHD  715 (1351)
T ss_pred             CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHHHh
Confidence                                 001        34789999998888888887644321 346788999999999999999


Q ss_pred             cCCCCeeecCCCCCCEEecCCCcEEEcccCcccccc----c------CCCCCcccccCCceeecccccccCCcccCCCC-
Q 046639          153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLF----G------YEPGTAAETASNSIEIKGIVGYVAPEYGMGSK-  221 (331)
Q Consensus       153 ~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~----~------~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-  221 (331)
                      +   ||+||||||.||+++.++.|||+|||+|+...    +      .................||.-|+|||++.+.. 
T Consensus       716 ~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~  792 (1351)
T KOG1035|consen  716 Q---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS  792 (1351)
T ss_pred             C---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence            9   99999999999999999999999999998732    1      11111122222445567999999999988754 


Q ss_pred             --CccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhc
Q 046639          222 --ASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGV  299 (331)
Q Consensus       222 --~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  299 (331)
                        |+.|+|+||||+|++||+.   ||+..-.+...+.+.-...+|..                 .+|..+..+.=.+++.
T Consensus       793 ~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~-----------------~~f~~~~~~~e~slI~  852 (1351)
T KOG1035|consen  793 NKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEP-----------------ADFFDPEHPEEASLIR  852 (1351)
T ss_pred             ccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCC-----------------cccccccchHHHHHHH
Confidence              9999999999999999995   57543222222222211111111                 2333334445567888


Q ss_pred             cccCCCCCCCCcHHHHHH
Q 046639          300 TCSMESPMERMEMRDVVA  317 (331)
Q Consensus       300 ~cl~~~P~~Rps~~~i~~  317 (331)
                      +|++.||.+||||.|++.
T Consensus       853 ~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  853 WLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             HHhcCCCccCCCHHHHhh
Confidence            999999999999999984

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=8.9e-39  Score=262.93  Aligned_cols=284  Identities=20%  Similarity=0.254  Sum_probs=204.3

Q ss_pred             cHHHHHHHhcCCCcCceeeccCeeEEEEeeecCCC----ceEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCcceeec
Q 046639           21 SYAELSKATNNFSPANKIGQGGVSIVYKGILDESR----SIVAVKVVNLKQ--KEASRSFAAECNALRNIRHRNLIKIIT   94 (331)
Q Consensus        21 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~   94 (331)
                      +..+=......|.....||+|.+|.||+|....++    ..+|+|.++.+.  .......-+|+.+++.++|||++.+..
T Consensus        15 ser~rve~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~   94 (438)
T KOG0666|consen   15 SERERVEDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVK   94 (438)
T ss_pred             hhhhhHHHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHH
Confidence            33333345567999999999999999999765443    278999886442  344566789999999999999999999


Q ss_pred             eeecccCCCcceeeEEEeecCCCCHHHHHHhc---cCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEec
Q 046639           95 ICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQS---NGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLD  171 (331)
Q Consensus        95 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~  171 (331)
                      ++..    .+..+++++||. .-+|.++|+..   ....++......+++||+.|+.|||++   =|+|||+||.||+|.
T Consensus        95 Vfl~----~d~~v~l~fdYA-EhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvm  166 (438)
T KOG0666|consen   95 VFLS----HDKKVWLLFDYA-EHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVM  166 (438)
T ss_pred             HHhc----cCceEEEEehhh-hhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEe
Confidence            9744    357899999999 56999999863   234577788899999999999999999   999999999999998


Q ss_pred             CC----CcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCC-CccchhhHhHHHHHHHHHhCCCCCC
Q 046639          172 QD----IVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSK-ASVSGDVYNFGILLLEMFTRRRPTD  246 (331)
Q Consensus       172 ~~----~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~  246 (331)
                      .+    |.|||+|||+++.+.+.-     .+.........|.+|+|||.+.|.. |+.+.||||+|||+.||++-.+.|.
T Consensus       167 gdgperG~VKIaDlGlaR~~~~pl-----kpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~  241 (438)
T KOG0666|consen  167 GDGPERGRVKIADLGLARLFNNPL-----KPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFK  241 (438)
T ss_pred             ccCCccCeeEeecccHHHHhhccc-----cccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCcccc
Confidence            77    899999999999874322     2222344567899999999999865 8999999999999999999999887


Q ss_pred             cccCCc--------chHHHHHHhhCc------chhhhhcCc-ccccccccCCc------chHH---HHHHHHHHhhcccc
Q 046639          247 AMFNEG--------LTLHEFVKMALP------DKVMEIVDP-SLLLEVTANNY------SWIE---DCLVAVIGTGVTCS  302 (331)
Q Consensus       247 ~~~~~~--------~~~~~~~~~~~~------~~~~~~~~~-~~~~~~~~~~~------~~~~---~~~~~l~~l~~~cl  302 (331)
                      +.....        .++..+....-.      ..+....+. .+..++....+      .+..   .-.+...+|+.++|
T Consensus       242 g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL  321 (438)
T KOG0666|consen  242 GREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLL  321 (438)
T ss_pred             chhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHh
Confidence            542111        112222211111      001111111 11111111111      0000   11223678999999


Q ss_pred             CCCCCCCCcHHHHHH
Q 046639          303 MESPMERMEMRDVVA  317 (331)
Q Consensus       303 ~~~P~~Rps~~~i~~  317 (331)
                      ..||-+|.|+.+.++
T Consensus       322 ~yDP~kRIta~qAle  336 (438)
T KOG0666|consen  322 TYDPIKRITAEQALE  336 (438)
T ss_pred             ccCchhhccHHHHhc
Confidence            999999999999875

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2.1e-37  Score=268.61  Aligned_cols=242  Identities=21%  Similarity=0.240  Sum_probs=183.9

Q ss_pred             eeeccCeeEEEEeeecCCCceEEEEEeeccch---hhHHHHHHHH---HHHHcCCCCCcceeeceeecccCCCcceeeEE
Q 046639           37 KIGQGGVSIVYKGILDESRSIVAVKVVNLKQK---EASRSFAAEC---NALRNIRHRNLIKIITICSSIDFEGFDFKAIV  110 (331)
Q Consensus        37 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~---~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv  110 (331)
                      .||+|+||.||+|.+..+++.||+|.+.....   ........|.   ..++...||+++.+.+.     +......++|
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~-----~~~~~~~~~v   75 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYA-----FHTPDKLSFI   75 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeee-----eecCCEEEEE
Confidence            48999999999999988999999999864321   1111233333   34444579999999888     4455678999


Q ss_pred             EeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccccC
Q 046639          111 FEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGY  190 (331)
Q Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~  190 (331)
                      |||+++++|.+++...  ..+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++......
T Consensus        76 ~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~  150 (278)
T cd05606          76 LDLMNGGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK  150 (278)
T ss_pred             EecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCcc
Confidence            9999999999988653  3578899999999999999999999   9999999999999999999999999998754211


Q ss_pred             CCCCcccccCCceeecccccccCCcccCCC-CCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhh
Q 046639          191 EPGTAAETASNSIEIKGIVGYVAPEYGMGS-KASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVME  269 (331)
Q Consensus       191 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  269 (331)
                                ......++..|+|||++.++ .++.++||||+|+++|+|++|..||.........  ........     
T Consensus       151 ----------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~--~~~~~~~~-----  213 (278)
T cd05606         151 ----------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--EIDRMTLT-----  213 (278)
T ss_pred             ----------CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH--HHHHHhhc-----
Confidence                      11223588889999998754 6899999999999999999999999754222111  11100000     


Q ss_pred             hcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCC-----cHHHHHH
Q 046639          270 IVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERM-----EMRDVVA  317 (331)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----s~~~i~~  317 (331)
                       ..+           .++..++..+.+++.+||..+|.+||     ++.++++
T Consensus       214 -~~~-----------~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         214 -MAV-----------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             -cCC-----------CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence             000           11223456788999999999999999     9999974

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-37  Score=277.75  Aligned_cols=270  Identities=16%  Similarity=0.225  Sum_probs=198.7

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc--chhhHHHHHHHHHHHHcCCCCCcceeeceeeccc-CCCc
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRNIRHRNLIKIITICSSID-FEGF  104 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~~  104 (331)
                      ..++|.+.+.||+|++|.||+|.+..++..||+|.+...  .......+.+|+.+++.++||||+++++++.... ....
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            466899999999999999999999999999999988533  2333456889999999999999999999864321 1122


Q ss_pred             ceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcc
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA  184 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a  184 (331)
                      ...++|||++ +++|.+++...   .+++..+..++.|++.||.+||+.   +++|+||+|+||+++.++.++|+|||++
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~  165 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMKHE---KLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA  165 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccc
Confidence            3468999999 88999888642   467888999999999999999999   9999999999999999999999999998


Q ss_pred             cccccCCCCCcccccCCceeecccccccCCcccCC-CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhC
Q 046639          185 KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG-SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMAL  263 (331)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  263 (331)
                      .....           ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...... ..+........
T Consensus       166 ~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-~~~~~~~~~~~  233 (343)
T cd07880         166 RQTDS-----------EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL-DQLMEIMKVTG  233 (343)
T ss_pred             ccccc-----------CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcC
Confidence            75411           1122346788999998876 45789999999999999999999999753211 11111111111


Q ss_pred             c--chhhhhcCcccc----cccc----cCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHH
Q 046639          264 P--DKVMEIVDPSLL----LEVT----ANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVV  316 (331)
Q Consensus       264 ~--~~~~~~~~~~~~----~~~~----~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~  316 (331)
                      .  ......+.....    ...+    ........++...+.+++.+||+.||.+|||+.+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l  296 (343)
T cd07880         234 TPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEAL  296 (343)
T ss_pred             CCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHh
Confidence            0  000000000000    0000    000112234566789999999999999999999998

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2.1e-37  Score=275.79  Aligned_cols=277  Identities=17%  Similarity=0.220  Sum_probs=196.3

Q ss_pred             hcCCCc-CceeeccCeeEEEEeeecCCCceEEEEEeeccchhh--------------HHHHHHHHHHHHcCCCCCcceee
Q 046639           29 TNNFSP-ANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEA--------------SRSFAAECNALRNIRHRNLIKII   93 (331)
Q Consensus        29 ~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~~i~~~~   93 (331)
                      .++|.. .+.||.|++|+||+|.+..+++.||+|.+.......              ...+.+|+.+++.++|+|+++++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV   86 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence            356764 577999999999999999899999999986432211              12477899999999999999999


Q ss_pred             ceeecccCCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCC
Q 046639           94 TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQD  173 (331)
Q Consensus        94 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~  173 (331)
                      +++     ...+..++|||++. ++|.+++....  .++......++.|++.||.+||+.   +++|+||+|+||+++.+
T Consensus        87 ~~~-----~~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~  155 (335)
T PTZ00024         87 DVY-----VEGDFINLVMDIMA-SDLKKVVDRKI--RLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSK  155 (335)
T ss_pred             EEE-----ecCCcEEEEEeccc-cCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCC
Confidence            985     44567899999995 69999986533  467788899999999999999999   99999999999999999


Q ss_pred             CcEEEcccCcccccccCCCCCc------ccccCCceeecccccccCCcccCCC-CCccchhhHhHHHHHHHHHhCCCCCC
Q 046639          174 IVAHVGDLGLAKFLFGYEPGTA------AETASNSIEIKGIVGYVAPEYGMGS-KASVSGDVYNFGILLLEMFTRRRPTD  246 (331)
Q Consensus       174 ~~~kl~Dfg~a~~~~~~~~~~~------~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~  246 (331)
                      +.++|+|||.+...........      ...........+++.|+|||.+.+. .++.++||||||+++|+|++|..||.
T Consensus       156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~  235 (335)
T PTZ00024        156 GICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFP  235 (335)
T ss_pred             CCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            9999999999876531110000      0001111223467789999998764 46899999999999999999999997


Q ss_pred             cccCCcchHHHHHHhhCcchhhhhcC----ccc---ccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          247 AMFNEGLTLHEFVKMALPDKVMEIVD----PSL---LLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~---~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ..... ..+.................    +..   ..............+...+.+++.+||+.+|++|||+.+++.
T Consensus       236 ~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        236 GENEI-DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             CCCHH-HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            54321 11222211110000000000    000   000000111112234567889999999999999999999985

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.3e-38  Score=279.86  Aligned_cols=274  Identities=17%  Similarity=0.227  Sum_probs=200.2

Q ss_pred             HHHHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc--chhhHHHHHHHHHHHHcCCCCCcceeeceeecccC-
Q 046639           25 LSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRNIRHRNLIKIITICSSIDF-  101 (331)
Q Consensus        25 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-  101 (331)
                      +....++|.+.+.||+|++|.||+|.+..++..||+|.+...  .......+.+|+.+++.+.|+|++++.+++...+. 
T Consensus        10 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07851          10 VWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSL   89 (343)
T ss_pred             eecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccc
Confidence            345567899999999999999999999989999999988643  23344667889999999999999999887543221 


Q ss_pred             CCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEccc
Q 046639          102 EGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDL  181 (331)
Q Consensus       102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Df  181 (331)
                      ......++|+|++ +++|.+++..   ..+++..+..++.|++.||.+||+.   +++|+||+|+||+++.++.++|+||
T Consensus        90 ~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~df  162 (343)
T cd07851          90 EDFQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDF  162 (343)
T ss_pred             cccccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccc
Confidence            2233479999999 7899999865   2477888999999999999999999   9999999999999999999999999


Q ss_pred             CcccccccCCCCCcccccCCceeecccccccCCcccCC-CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHH
Q 046639          182 GLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG-SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVK  260 (331)
Q Consensus       182 g~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  260 (331)
                      |++.....           ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||...... ..+.....
T Consensus       163 g~~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~-~~~~~i~~  230 (343)
T cd07851         163 GLARHTDD-----------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI-DQLKRIMN  230 (343)
T ss_pred             cccccccc-----------cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHH
Confidence            99876411           1222346778999998765 36789999999999999999999999753221 11111111


Q ss_pred             hhC--cchhhhhcCcccc----ccc----ccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          261 MAL--PDKVMEIVDPSLL----LEV----TANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       261 ~~~--~~~~~~~~~~~~~----~~~----~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ...  +..+.........    ...    ..............+.+++.+||+.+|++|||+.+|++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         231 LVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             hcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence            100  0000000000000    000    00000111123668999999999999999999999975

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2.2e-37  Score=272.38  Aligned_cols=247  Identities=21%  Similarity=0.266  Sum_probs=192.4

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc---chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK---QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      +.|...+.||.|++|.||+|++..++..+++|.+...   .......+.+|+.+++.++|+|++++.+++.     ....
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~   89 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL-----REHT   89 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEE-----cCCe
Confidence            3588889999999999999999988999999988632   2333456788999999999999999999864     3467


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      .++|+|++. ++|.+++.... ..++...+..++.|++.|+.+||+.   +++|+||+|+||+++.++.++|+|||++..
T Consensus        90 ~~lv~e~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  164 (308)
T cd06634          90 AWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASI  164 (308)
T ss_pred             eEEEEEccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCccccee
Confidence            899999995 68888775433 3467788889999999999999999   999999999999999999999999998875


Q ss_pred             cccCCCCCcccccCCceeecccccccCCcccC---CCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhC
Q 046639          187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGM---GSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMAL  263 (331)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  263 (331)
                      ...            .....+++.|+|||.+.   ...++.++||||||+++|+|++|..||....... ..........
T Consensus       165 ~~~------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~~~  231 (308)
T cd06634         165 MAP------------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNES  231 (308)
T ss_pred             ecC------------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH-HHHHHhhcCC
Confidence            411            11234677899999874   3567889999999999999999999986532111 0111110000


Q ss_pred             cchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHH
Q 046639          264 PDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAK  318 (331)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~  318 (331)
                               +.          .....+...+.+++.+||+.+|++||++.++++.
T Consensus       232 ---------~~----------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~  267 (308)
T cd06634         232 ---------PA----------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (308)
T ss_pred             ---------CC----------cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence                     00          0012345678899999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=5.5e-37  Score=270.43  Aligned_cols=244  Identities=23%  Similarity=0.284  Sum_probs=190.2

Q ss_pred             CCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           32 FSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        32 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      |...+.||+|++|+||+|.+..++..|++|.+....   ......+.+|+.+++.++|||++++++++.     +....+
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~   97 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYL-----KEHTAW   97 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEE-----eCCEEE
Confidence            677788999999999999998899999999986432   233456888999999999999999999954     346789


Q ss_pred             EEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccc
Q 046639          109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLF  188 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~  188 (331)
                      +|||++ .++|.+++.... ..+++..+..++.|++.|+.+||+.   +++|+||+|+||+++.++.++|+|||++... 
T Consensus        98 lv~e~~-~~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~-  171 (313)
T cd06633          98 LVMEYC-LGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKS-  171 (313)
T ss_pred             EEEecC-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCccc-
Confidence            999999 568888876533 3467788889999999999999999   9999999999999999999999999987542 


Q ss_pred             cCCCCCcccccCCceeecccccccCCcccC---CCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcc
Q 046639          189 GYEPGTAAETASNSIEIKGIVGYVAPEYGM---GSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPD  265 (331)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  265 (331)
                                 .......++..|+|||++.   ...++.++||||||+++|+|++|..||....... ..........  
T Consensus       172 -----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~-~~~~~~~~~~--  237 (313)
T cd06633         172 -----------SPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNDS--  237 (313)
T ss_pred             -----------CCCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhcCC--
Confidence                       1111345778899999974   4568889999999999999999999986532111 1111110000  


Q ss_pred             hhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          266 KVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                             +..          ........+.+++.+||+.+|.+||++.+++.
T Consensus       238 -------~~~----------~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~  272 (313)
T cd06633         238 -------PTL----------QSNEWTDSFRGFVDYCLQKIPQERPASAELLR  272 (313)
T ss_pred             -------CCC----------CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                   000          00123456888999999999999999999985

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-39  Score=260.99  Aligned_cols=280  Identities=19%  Similarity=0.268  Sum_probs=208.7

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccch--hhHHHHHHHHHHHHcCCCCCcceeeceeecccCC---C
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK--EASRSFAAECNALRNIRHRNLIKIITICSSIDFE---G  103 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~---~  103 (331)
                      .+.|....+||+|.||.||+|+...+++.||+|++-.+++  ..-....+|+.+|..+.|+|++.++++|.+-.-.   .
T Consensus        16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~   95 (376)
T KOG0669|consen   16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD   95 (376)
T ss_pred             chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence            3467788999999999999999999999999998754433  2335578999999999999999999999764322   2


Q ss_pred             cceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCc
Q 046639          104 FDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGL  183 (331)
Q Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~  183 (331)
                      ....++|+.+| ..+|..++... ...+++.++.+++.++++||+|+|..   .|+|||+|+.|++|+.+|++||+|||+
T Consensus        96 r~t~ylVf~~c-ehDLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGl  170 (376)
T KOG0669|consen   96 RATFYLVFDFC-EHDLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGL  170 (376)
T ss_pred             cceeeeeHHHh-hhhHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecccc
Confidence            33479999999 56999988643 24578899999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCcccccCCceeecccccccCCcccCCC-CCccchhhHhHHHHHHHHHhCCCCCCcccCCcc-hHHHHHHh
Q 046639          184 AKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGS-KASVSGDVYNFGILLLEMFTRRRPTDAMFNEGL-TLHEFVKM  261 (331)
Q Consensus       184 a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~  261 (331)
                      ++.+.-.....    .........|.+|++||.+.|. .|+++.|||+.|||+.||+++.+.|++...... .+...+-.
T Consensus       171 ar~fs~~~n~~----kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcG  246 (376)
T KOG0669|consen  171 ARAFSTSKNVV----KPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCG  246 (376)
T ss_pred             ccceecccccC----CCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhc
Confidence            98764332221    1223345578999999999885 589999999999999999999999987543322 11122212


Q ss_pred             hCcchhhhhcC-cccccc-----cccCCcchHHHHHH------HHHHhhccccCCCCCCCCcHHHHHH
Q 046639          262 ALPDKVMEIVD-PSLLLE-----VTANNYSWIEDCLV------AVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       262 ~~~~~~~~~~~-~~~~~~-----~~~~~~~~~~~~~~------~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      .+...+....+ -.+...     .+.+...-+.+..+      ...+|+..+|..||.+|+++.+++.
T Consensus       247 s~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln  314 (376)
T KOG0669|consen  247 SITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN  314 (376)
T ss_pred             cCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence            22222111111 111111     22233333344444      6789999999999999999999874

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-37  Score=266.38  Aligned_cols=267  Identities=21%  Similarity=0.285  Sum_probs=196.8

Q ss_pred             CCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeE
Q 046639           32 FSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ--KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAI  109 (331)
Q Consensus        32 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~l  109 (331)
                      |.+.+.||+|++|.||+|....+++.+|+|.+....  ......+..|+.+++.++|+|++++++++     ......++
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~~   75 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVI-----HTERKLYL   75 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhh-----hcCCceEE
Confidence            567789999999999999999999999999987553  33346678899999999999999999984     44578899


Q ss_pred             EEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccccc
Q 046639          110 VFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG  189 (331)
Q Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~  189 (331)
                      |+|+++ ++|.+++.... ..+++..+..++.|++.||.+||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        76 v~e~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~  150 (282)
T cd07829          76 VFEYCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGI  150 (282)
T ss_pred             EecCcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCC
Confidence            999995 69999998653 3477889999999999999999999   999999999999999999999999999876521


Q ss_pred             CCCCCcccccCCceeecccccccCCcccCCC-CCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCc--ch
Q 046639          190 YEPGTAAETASNSIEIKGIVGYVAPEYGMGS-KASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALP--DK  266 (331)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~  266 (331)
                      ..        .......++..|+|||.+.+. .++.++||||||+++|+|++|..||...... ............  ..
T Consensus       151 ~~--------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  221 (282)
T cd07829         151 PL--------RTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI-DQLFKIFQILGTPTEE  221 (282)
T ss_pred             Cc--------cccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHHHhCCCcHH
Confidence            11        111122346679999998776 7899999999999999999999999653211 111111111100  00


Q ss_pred             hh-hhcCc----ccccccccC-CcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          267 VM-EIVDP----SLLLEVTAN-NYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       267 ~~-~~~~~----~~~~~~~~~-~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      .. ...+-    ......... ...........+.+++.+||+.+|++||++.+++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         222 SWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             HHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            00 00000    000000000 00111123567999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-37  Score=269.25  Aligned_cols=272  Identities=23%  Similarity=0.299  Sum_probs=206.6

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCC--------CCCcceeeceeecccC
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIR--------HRNLIKIITICSSIDF  101 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------h~~i~~~~~~~~~~~~  101 (331)
                      ++|.+.++||-|.|++||+|.+..+.+.||+|+.+ ......+..+.|+.+|+.++        ..+||++++.|.-. .
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvK-SAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs-G  155 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVK-SAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS-G  155 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEe-hhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec-C
Confidence            79999999999999999999999999999999986 43455677889999999983        34799999998755 4


Q ss_pred             CCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCC--------
Q 046639          102 EGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQD--------  173 (331)
Q Consensus       102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~--------  173 (331)
                      .++.++|+|+|++ |-+|..+|.+...+.++...+..|+.||+.||.|||...  ||+|.||||+|||+..+        
T Consensus       156 pNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~e~~~~~~~  232 (590)
T KOG1290|consen  156 PNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCSTEIDPAKDA  232 (590)
T ss_pred             CCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeeccccchhhhh
Confidence            6778999999999 999999999998889999999999999999999999998  99999999999999111        


Q ss_pred             ---C----------------------------------------------------------------------------
Q 046639          174 ---I----------------------------------------------------------------------------  174 (331)
Q Consensus       174 ---~----------------------------------------------------------------------------  174 (331)
                         +                                                                            
T Consensus       233 ~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~  312 (590)
T KOG1290|consen  233 REAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGN  312 (590)
T ss_pred             hhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCcc
Confidence               0                                                                            


Q ss_pred             -------------------------------------------------------------------------------c
Q 046639          175 -------------------------------------------------------------------------------V  175 (331)
Q Consensus       175 -------------------------------------------------------------------------------~  175 (331)
                                                                                                     .
T Consensus       313 ~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~  392 (590)
T KOG1290|consen  313 ESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIR  392 (590)
T ss_pred             ccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCcccee
Confidence                                                                                           0


Q ss_pred             EEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcc--
Q 046639          176 AHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGL--  253 (331)
Q Consensus       176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--  253 (331)
                      +||+|||-|+..           .......+.|..|+|||++.+..|+..+||||++|++|||+||...|+.-..++-  
T Consensus       393 vKIaDlGNACW~-----------~khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~r  461 (590)
T KOG1290|consen  393 VKIADLGNACWV-----------HKHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSR  461 (590)
T ss_pred             EEEeeccchhhh-----------hhhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCc
Confidence            011111111100           0111123367889999999999999999999999999999999999976533321  


Q ss_pred             ---hHHHHHH--hhCcchh-------hhhcCc------------ccccccccCCcchHHHHHHHHHHhhccccCCCCCCC
Q 046639          254 ---TLHEFVK--MALPDKV-------MEIVDP------------SLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMER  309 (331)
Q Consensus       254 ---~~~~~~~--~~~~~~~-------~~~~~~------------~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~R  309 (331)
                         .+..++.  ..+|..+       .++++.            --..++....+.|..+...++.+++.-||+.+|++|
T Consensus       462 DEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR  541 (590)
T KOG1290|consen  462 DEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKR  541 (590)
T ss_pred             cHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCcccc
Confidence               1222221  1222111       111111            111233445678888899999999999999999999


Q ss_pred             CcHHHHHH
Q 046639          310 MEMRDVVA  317 (331)
Q Consensus       310 ps~~~i~~  317 (331)
                      |||.+.++
T Consensus       542 ~tA~~cl~  549 (590)
T KOG1290|consen  542 PTAAQCLK  549 (590)
T ss_pred             ccHHHHhc
Confidence            99999874

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.4e-36  Score=270.11  Aligned_cols=275  Identities=20%  Similarity=0.248  Sum_probs=195.2

Q ss_pred             CCCcCceeeccCeeEEEEeeecCC--CceEEEEEeecc--chhhHHHHHHHHHHHHcC-CCCCcceeeceeecccCCCcc
Q 046639           31 NFSPANKIGQGGVSIVYKGILDES--RSIVAVKVVNLK--QKEASRSFAAECNALRNI-RHRNLIKIITICSSIDFEGFD  105 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~--~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~  105 (331)
                      +|++.+.||+|+||.||++.+..+  +..||+|.+...  .......+.+|+.+++++ .||||+++++.+... .....
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-~~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVF-PGNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeec-cccCC
Confidence            588899999999999999999877  889999988632  222345678899999999 599999999875432 13335


Q ss_pred             eeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccc
Q 046639          106 FKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAK  185 (331)
Q Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~  185 (331)
                      ..+++++++ +++|.+++...  ..+++..+..++.|++.||.+||++   +++|+||||+||+++.++.++|+|||++.
T Consensus        80 ~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~  153 (332)
T cd07857          80 ELYLYEELM-EADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLAR  153 (332)
T ss_pred             cEEEEEecc-cCCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence            578899998 57999988643  3477888999999999999999999   99999999999999999999999999997


Q ss_pred             ccccCCCCCcccccCCceeecccccccCCcccCC-CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhC-
Q 046639          186 FLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG-SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMAL-  263 (331)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~-  263 (331)
                      ........    .........+++.|+|||++.+ ..++.++||||+|+++|+|++|.+||...... ........... 
T Consensus       154 ~~~~~~~~----~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~  228 (332)
T cd07857         154 GFSENPGE----NAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV-DQLNQILQVLGT  228 (332)
T ss_pred             eccccccc----ccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH-HHHHHHHHHhCC
Confidence            65321110    1111223467889999998765 56899999999999999999999999753211 11111111000 


Q ss_pred             c--chhhhhcCcccc---c---ccc-cCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          264 P--DKVMEIVDPSLL---L---EVT-ANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       264 ~--~~~~~~~~~~~~---~---~~~-~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      +  ..+.....+...   .   ... .........+...+.+++.+||+.||.+|||+.++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         229 PDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             CCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0  000000000000   0   000 0000011123567889999999999999999999874

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=5.9e-37  Score=267.14  Aligned_cols=257  Identities=19%  Similarity=0.250  Sum_probs=195.6

Q ss_pred             CCCcCceeeccCeeEEEEeeec---CCCceEEEEEeeccc----hhhHHHHHHHHHHHHcC-CCCCcceeeceeecccCC
Q 046639           31 NFSPANKIGQGGVSIVYKGILD---ESRSIVAVKVVNLKQ----KEASRSFAAECNALRNI-RHRNLIKIITICSSIDFE  102 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~  102 (331)
                      +|.+.+.||+|++|.||++.+.   .++..||+|.+....    ......+.+|+.++..+ .||+++++++.     +.
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~-----~~   75 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYA-----FQ   75 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhhee-----ee
Confidence            4888999999999999999864   356889999986432    22335678899999999 59999999988     45


Q ss_pred             CcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccC
Q 046639          103 GFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLG  182 (331)
Q Consensus       103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg  182 (331)
                      .....++||||+++++|.+++...  ..+++..+..++.|++.+|.+||+.   +++|+||+|+||+++.++.++|+|||
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg  150 (288)
T cd05583          76 TDTKLHLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFG  150 (288)
T ss_pred             cCCEEEEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECc
Confidence            556789999999999999998653  3466788889999999999999999   99999999999999999999999999


Q ss_pred             cccccccCCCCCcccccCCceeecccccccCCcccCCCC--CccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHH
Q 046639          183 LAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSK--ASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVK  260 (331)
Q Consensus       183 ~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  260 (331)
                      ++......       .........++..|+|||...+..  .+.++||||||+++|+|++|..||...... ........
T Consensus       151 ~~~~~~~~-------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-~~~~~~~~  222 (288)
T cd05583         151 LSKEFLAE-------EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ-NSQSEISR  222 (288)
T ss_pred             cccccccc-------cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc-chHHHHHH
Confidence            98764211       111112344778899999987755  788999999999999999999999642111 11111111


Q ss_pred             hhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHh
Q 046639          261 MALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHA  322 (331)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~  322 (331)
                      .....      .+           .....+...+.+++.+||+.+|++|||+.++.+.|+..
T Consensus       223 ~~~~~------~~-----------~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~  267 (288)
T cd05583         223 RILKS------KP-----------PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP  267 (288)
T ss_pred             HHHcc------CC-----------CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence            11000      00           11122446788999999999999999998887766554

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1e-36  Score=261.65  Aligned_cols=249  Identities=20%  Similarity=0.285  Sum_probs=192.8

Q ss_pred             CCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc-----chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcc
Q 046639           31 NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK-----QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFD  105 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~  105 (331)
                      +|.+.+.||+|++|+||++.+..++..+++|+++..     .......+..|+.+++.++|||++++++++     ....
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~   75 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASF-----LERD   75 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHH-----hcCC
Confidence            588999999999999999999877766767766421     122334567789999999999999999984     4456


Q ss_pred             eeeEEEeecCCCCHHHHHHh--ccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCc
Q 046639          106 FKAIVFEYMQNRNLEQWLRQ--SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGL  183 (331)
Q Consensus       106 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~  183 (331)
                      ..++|+||+++++|.+++..  .....+++..+..++.|++.|+.+||+.   +++|+||+|+||+++. +.++|+|||.
T Consensus        76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~  151 (260)
T cd08222          76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGV  151 (260)
T ss_pred             ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCc
Confidence            78999999999999998865  2334577888999999999999999999   9999999999999975 5799999999


Q ss_pred             ccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhC
Q 046639          184 AKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMAL  263 (331)
Q Consensus       184 a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  263 (331)
                      +.......        .......+++.|+|||...+..++.++|+||||+++|+|++|..||....     .........
T Consensus       152 ~~~~~~~~--------~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~-----~~~~~~~~~  218 (260)
T cd08222         152 SRLLMGSC--------DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN-----FLSVVLRIV  218 (260)
T ss_pred             eeecCCCc--------ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHHH
Confidence            87652211        11223446778999999988888999999999999999999999986421     111111110


Q ss_pred             cchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          264 PDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                           ....+           .....++..+.+++.+||+.+|++||++.++++
T Consensus       219 -----~~~~~-----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         219 -----EGPTP-----------SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             -----cCCCC-----------CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence                 00011           122345678899999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-38  Score=277.60  Aligned_cols=243  Identities=20%  Similarity=0.284  Sum_probs=194.6

Q ss_pred             ceeeccCeeEEEEeeecCCCceEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeEEEee
Q 046639           36 NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ--KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEY  113 (331)
Q Consensus        36 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~e~  113 (331)
                      +.||+|.||+||-|+++.+|+.||||++.+..  ......+.+|+.+|+.+.||.||.+...     ++..+.+++|||.
T Consensus       570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M-----~ET~ervFVVMEK  644 (888)
T KOG4236|consen  570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECM-----FETPERVFVVMEK  644 (888)
T ss_pred             hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEe-----ecCCceEEEEehh
Confidence            68999999999999999999999999996442  2334678999999999999999999887     6778899999999


Q ss_pred             cCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCC---CcEEEcccCcccccccC
Q 046639          114 MQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQD---IVAHVGDLGLAKFLFGY  190 (331)
Q Consensus       114 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~---~~~kl~Dfg~a~~~~~~  190 (331)
                      + .|+..+.|-......+++.....++.||+.||.|||.+   +|+|+|+||+|||+...   .++||+|||+|+++   
T Consensus       645 l-~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiI---  717 (888)
T KOG4236|consen  645 L-HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARII---  717 (888)
T ss_pred             h-cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeec---
Confidence            9 55666666555555677888888999999999999999   99999999999999644   47999999999987   


Q ss_pred             CCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhhh
Q 046639          191 EPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEI  270 (331)
Q Consensus       191 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  270 (331)
                            ..........|||.|+|||++..+.|+.+-|+||.|+|+|--++|..||..    +.++.+.+...-     ..
T Consensus       718 ------gEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE----dEdIndQIQNAa-----FM  782 (888)
T KOG4236|consen  718 ------GEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE----DEDINDQIQNAA-----FM  782 (888)
T ss_pred             ------chhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC----ccchhHHhhccc-----cc
Confidence                  233444567799999999999999999999999999999999999999964    333433332110     00


Q ss_pred             cCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHH
Q 046639          271 VDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVV  316 (331)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~  316 (331)
                      ..+.           -..+......+|+...|+..-.+|-|...-+
T Consensus       783 yPp~-----------PW~eis~~AidlIn~LLqVkm~kRysvdk~l  817 (888)
T KOG4236|consen  783 YPPN-----------PWSEISPEAIDLINNLLQVKMRKRYSVDKSL  817 (888)
T ss_pred             cCCC-----------chhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence            0111           1124556678888888888888888776543

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.8e-36  Score=264.41  Aligned_cols=252  Identities=20%  Similarity=0.266  Sum_probs=191.4

Q ss_pred             CCCcCceeeccCeeEEEEeeec---CCCceEEEEEeeccc----hhhHHHHHHHHHHHHcC-CCCCcceeeceeecccCC
Q 046639           31 NFSPANKIGQGGVSIVYKGILD---ESRSIVAVKVVNLKQ----KEASRSFAAECNALRNI-RHRNLIKIITICSSIDFE  102 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~  102 (331)
                      +|++.+.||.|+||.||.|.+.   .++..||+|.+....    ....+.+.+|+.+++.+ .|++|+.+++.+     .
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~   75 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-----Q   75 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe-----e
Confidence            4888999999999999999874   378899999986432    12335678899999999 599999998874     4


Q ss_pred             CcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccC
Q 046639          103 GFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLG  182 (331)
Q Consensus       103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg  182 (331)
                      .+...++|+|++++++|.+++....  .++...+..++.|++.||.+||+.   +++|+||+|+||+++.++.++|+|||
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg  150 (290)
T cd05613          76 TDTKLHLILDYINGGELFTHLSQRE--RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFG  150 (290)
T ss_pred             cCCeEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCc
Confidence            4567899999999999999997643  466788888899999999999999   99999999999999999999999999


Q ss_pred             cccccccCCCCCcccccCCceeecccccccCCcccCCC--CCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHH
Q 046639          183 LAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGS--KASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVK  260 (331)
Q Consensus       183 ~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  260 (331)
                      ++.......       ........++..|+|||.+.+.  .++.++||||||+++|+|++|..||..... .........
T Consensus       151 ~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-~~~~~~~~~  222 (290)
T cd05613         151 LSKEFHEDE-------VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE-KNSQAEISR  222 (290)
T ss_pred             cceeccccc-------ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc-cccHHHHHH
Confidence            987642111       1112234578889999998753  468899999999999999999999964211 111111111


Q ss_pred             hhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCC-----cHHHHHH
Q 046639          261 MALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERM-----EMRDVVA  317 (331)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----s~~~i~~  317 (331)
                      .....      .+           .++..+...+.+++.+||+.+|++||     ++.++++
T Consensus       223 ~~~~~------~~-----------~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         223 RILKS------EP-----------PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             Hhhcc------CC-----------CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence            10000      00           11123456788999999999999997     6666654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-37  Score=291.32  Aligned_cols=210  Identities=20%  Similarity=0.285  Sum_probs=181.5

Q ss_pred             cHHHHHHHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeec---cchhhHHHHHHHHHHHHcCCCCCcceeeceee
Q 046639           21 SYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL---KQKEASRSFAAECNALRNIRHRNLIKIITICS   97 (331)
Q Consensus        21 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   97 (331)
                      ...+++-...+|.+++.||+|+||.|..++++.|++.||+|++++   -.......|..|=.+|..-+.+=|+++.-.  
T Consensus        66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyA--  143 (1317)
T KOG0612|consen   66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYA--  143 (1317)
T ss_pred             HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHH--
Confidence            456777778899999999999999999999999999999999975   234445667788888888788888887766  


Q ss_pred             cccCCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEE
Q 046639           98 SIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAH  177 (331)
Q Consensus        98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~k  177 (331)
                         |.++.++|+||||++||+|..++.+..  .+++..+..++..++-||..+|+.   |+|||||||+|||+|..|++|
T Consensus       144 ---FQD~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHik  215 (1317)
T KOG0612|consen  144 ---FQDERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIK  215 (1317)
T ss_pred             ---hcCccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEe
Confidence               777889999999999999999998765  688899999999999999999999   999999999999999999999


Q ss_pred             EcccCcccccccCCCCCcccccCCceeecccccccCCcccC----C-CCCccchhhHhHHHHHHHHHhCCCCCCc
Q 046639          178 VGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGM----G-SKASVSGDVYNFGILLLEMFTRRRPTDA  247 (331)
Q Consensus       178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~----~-~~~~~~~DiwslG~il~el~~g~~pf~~  247 (331)
                      |+|||.+-.+...+.       -......|||.|.+||++.    + +.|+..+|.||+|+++|||+.|..||..
T Consensus       216 LADFGsClkm~~dG~-------V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa  283 (1317)
T KOG0612|consen  216 LADFGSCLKMDADGT-------VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA  283 (1317)
T ss_pred             eccchhHHhcCCCCc-------EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence            999998887733222       2334456999999999875    2 5689999999999999999999999974

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-36  Score=256.05  Aligned_cols=237  Identities=27%  Similarity=0.303  Sum_probs=189.4

Q ss_pred             eeccCeeEEEEeeecCCCceEEEEEeeccch---hhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeEEEeec
Q 046639           38 IGQGGVSIVYKGILDESRSIVAVKVVNLKQK---EASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYM  114 (331)
Q Consensus        38 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~  114 (331)
                      ||.|++|.||++.+..+++.+++|.+.....   .....+..|+.+++.++|+|++++++.     +..+...+++||++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-----~~~~~~~~~v~e~~   75 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYA-----FQTEEKLYLVLEYA   75 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHH-----eecCCeeEEEEecC
Confidence            6899999999999988899999999864422   244578899999999999999999988     45667899999999


Q ss_pred             CCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccccCCCCC
Q 046639          115 QNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGT  194 (331)
Q Consensus       115 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~~~~~  194 (331)
                      ++++|.+++....  .+++.....++.|++.|+.+||+.   +++|+||+|+||+++.++.++|+|||++.......   
T Consensus        76 ~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~---  147 (250)
T cd05123          76 PGGELFSHLSKEG--RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG---  147 (250)
T ss_pred             CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC---
Confidence            9999999997643  467888899999999999999998   99999999999999999999999999987652111   


Q ss_pred             cccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhhhcCcc
Q 046639          195 AAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPS  274 (331)
Q Consensus       195 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (331)
                           .......++..|+|||...+..++.++|+||||+++|++++|..||.....     ..........        .
T Consensus       148 -----~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~~~~--------~  209 (250)
T cd05123         148 -----SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-----KEIYEKILKD--------P  209 (250)
T ss_pred             -----CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHhcC--------C
Confidence                 122334577789999999888889999999999999999999999965321     1111111100        0


Q ss_pred             cccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHH
Q 046639          275 LLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRD  314 (331)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~  314 (331)
                               ..+....+..+.+++.+||..||++|||+.+
T Consensus       210 ---------~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         210 ---------LRFPEFLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             ---------CCCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence                     0111223567889999999999999999944

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-37  Score=273.21  Aligned_cols=241  Identities=22%  Similarity=0.222  Sum_probs=195.2

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcC-CCCCcceeeceeecccCCCcce
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNI-RHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      ....|.....+|.|+|+.|-.+.+..+++..++|++.....    +..+|+.++... .|||++++.+.     +.+..+
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v-----~~~~~~  390 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDV-----YEDGKE  390 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecce-----ecCCce
Confidence            35678899999999999999999999999999999975522    234566666666 69999999999     566788


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEe-cCCCcEEEcccCccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILL-DQDIVAHVGDLGLAK  185 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv-~~~~~~kl~Dfg~a~  185 (331)
                      .++|||.+.++-+.+.+....   .....+..|+.+++.|+.|||++   |+||||+||+|||+ +..|+++|+|||.++
T Consensus       391 ~~~v~e~l~g~ell~ri~~~~---~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~  464 (612)
T KOG0603|consen  391 IYLVMELLDGGELLRRIRSKP---EFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWS  464 (612)
T ss_pred             eeeeehhccccHHHHHHHhcc---hhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhh
Confidence            999999999988888876533   22266778999999999999999   99999999999999 689999999999998


Q ss_pred             ccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcc
Q 046639          186 FLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPD  265 (331)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  265 (331)
                      .....           ....+-|..|.|||++....|++++|+||||++||+|++|+.||...+.+    .++.....+.
T Consensus       465 ~~~~~-----------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~----~ei~~~i~~~  529 (612)
T KOG0603|consen  465 ELERS-----------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG----IEIHTRIQMP  529 (612)
T ss_pred             hCchh-----------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch----HHHHHhhcCC
Confidence            65111           22335677899999999999999999999999999999999999876544    2222211111


Q ss_pred             hhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          266 KVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                                         .+....+....+|+.+||+.||.+||++.++..
T Consensus       530 -------------------~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  530 -------------------KFSECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             -------------------ccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence                               111356778999999999999999999999863

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-36  Score=260.35  Aligned_cols=280  Identities=22%  Similarity=0.269  Sum_probs=198.5

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcC--CCCCcceeeceeecccCCCcce
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNI--RHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      .......+.||+|.||.||+|...  ++.||||++...   ..+.+.+|-++.+..  .|+||+++++.-..-. .....
T Consensus       209 l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t-~~~~e  282 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGT-ADRME  282 (534)
T ss_pred             CCchhhHHHhhcCccceeehhhcc--CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCC-ccccc
Confidence            445677889999999999999986  689999999733   345677777777764  7999999998732211 11336


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCC------CCeeecCCCCCCEEecCCCcEEEcc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQ------PSIVHGDLKPSNILLDQDIVAHVGD  180 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~------~~ivH~dik~~nilv~~~~~~kl~D  180 (331)
                      ++||++|.+.|+|.++++.+-   ++|.....++..++.||+|||....      ++|+|||||+.||||..|++..|+|
T Consensus       283 ywLVt~fh~kGsL~dyL~~nt---isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD  359 (534)
T KOG3653|consen  283 YWLVTEFHPKGSLCDYLKANT---ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD  359 (534)
T ss_pred             eeEEeeeccCCcHHHHHHhcc---ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence            899999999999999997643   7889999999999999999997653      5899999999999999999999999


Q ss_pred             cCcccccccCCCCCcccccCCceeecccccccCCcccCCCC-Cc-----cchhhHhHHHHHHHHHhCCCCCC-cccCC-c
Q 046639          181 LGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSK-AS-----VSGDVYNFGILLLEMFTRRRPTD-AMFNE-G  252 (331)
Q Consensus       181 fg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~-----~~~DiwslG~il~el~~g~~pf~-~~~~~-~  252 (331)
                      ||+|..+....     .. .....-.||..|||||++.+.. +.     .+.||||+|.+||||++...-+. +..++ .
T Consensus       360 FGLAl~~~p~~-----~~-~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yq  433 (534)
T KOG3653|consen  360 FGLALRLEPGK-----PQ-GDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQ  433 (534)
T ss_pred             cceeEEecCCC-----CC-cchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCccc
Confidence            99999874111     11 1112256999999999988743 22     36899999999999999554332 11111 1


Q ss_pred             chHHHHHHhhCc-chhhhhcCcc-cccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhh
Q 046639          253 LTLHEFVKMALP-DKVMEIVDPS-LLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARET  325 (331)
Q Consensus       253 ~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~  325 (331)
                      ..+...+..+.. ..+...+-.. ....++ ..+-. ......+.+.++.||..||+-|.|++=+.+++..+...
T Consensus       434 lpfe~evG~hPt~e~mq~~VV~kK~RP~~p-~~W~~-h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~  506 (534)
T KOG3653|consen  434 LPFEAEVGNHPTLEEMQELVVRKKQRPKIP-DAWRK-HAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML  506 (534)
T ss_pred             CchhHHhcCCCCHHHHHHHHHhhccCCCCh-hhhhc-CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence            122222222221 1111111111 111110 00000 13456688899999999999999999999998887654

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=7.2e-36  Score=286.53  Aligned_cols=148  Identities=26%  Similarity=0.389  Sum_probs=130.3

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc---chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcc
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK---QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFD  105 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~  105 (331)
                      .++|.+.++||+|+||+||+|.+..+++.||+|++...   .......+..|+.++..++|+||+++++++     ....
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~   77 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL-----QSAN   77 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEE-----EECC
Confidence            46899999999999999999999999999999998643   233446788999999999999999999874     4456


Q ss_pred             eeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccc
Q 046639          106 FKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAK  185 (331)
Q Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~  185 (331)
                      ..++||||+.+++|.+++....  .+....++.++.|++.||.|||..   +|+|+||||+|||++.++.++|+|||+++
T Consensus        78 ~~~lVmEy~~g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          78 NVYLVMEYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            7899999999999999997543  366788899999999999999999   99999999999999999999999999886


Q ss_pred             c
Q 046639          186 F  186 (331)
Q Consensus       186 ~  186 (331)
                      .
T Consensus       153 ~  153 (669)
T cd05610         153 V  153 (669)
T ss_pred             c
Confidence            3

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-37  Score=262.08  Aligned_cols=245  Identities=20%  Similarity=0.249  Sum_probs=197.4

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHHcCC-CCCcceeeceeecccCCC
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNIR-HRNLIKIITICSSIDFEG  103 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~  103 (331)
                      ...+|..+..||+|+||+|.+|..+++.+.+|||+++...   ....+.-+.|-++|.... -|.++++...     +..
T Consensus       347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHSc-----FQT  421 (683)
T KOG0696|consen  347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSC-----FQT  421 (683)
T ss_pred             eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHH-----hhh
Confidence            3347999999999999999999999999999999987441   222233455667766654 6677777766     566


Q ss_pred             cceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCc
Q 046639          104 FDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGL  183 (331)
Q Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~  183 (331)
                      -+.+|+||||+.||+|--.+++.+.  +.++.+..++..|+-||-+||++   ||++||||.+|||++.+|++||+|||+
T Consensus       422 mDRLyFVMEyvnGGDLMyhiQQ~Gk--FKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGm  496 (683)
T KOG0696|consen  422 MDRLYFVMEYVNGGDLMYHIQQVGK--FKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGM  496 (683)
T ss_pred             hhheeeEEEEecCchhhhHHHHhcc--cCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccc
Confidence            6889999999999999988876553  55688889999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhC
Q 046639          184 AKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMAL  263 (331)
Q Consensus       184 a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  263 (331)
                      ++.-        ..........+|||.|+|||++..++|+.++|.||+|++||||+.|++||++.. ++..+..+.... 
T Consensus       497 cKEn--------i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeD-E~elF~aI~ehn-  566 (683)
T KOG0696|consen  497 CKEN--------IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED-EDELFQAIMEHN-  566 (683)
T ss_pred             cccc--------ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHHcc-
Confidence            9753        233455567889999999999999999999999999999999999999998742 222233322222 


Q ss_pred             cchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcH
Q 046639          264 PDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEM  312 (331)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~  312 (331)
                                          ..++...+.+..++....|...|.+|...
T Consensus       567 --------------------vsyPKslSkEAv~ickg~ltK~P~kRLGc  595 (683)
T KOG0696|consen  567 --------------------VSYPKSLSKEAVAICKGLLTKHPGKRLGC  595 (683)
T ss_pred             --------------------CcCcccccHHHHHHHHHHhhcCCccccCC
Confidence                                13445567788888899999999999643

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-38  Score=253.53  Aligned_cols=253  Identities=21%  Similarity=0.213  Sum_probs=192.6

Q ss_pred             CcCceeeccCeeEEEEeeecCCCceEEEEEeeccch-hhHHHHHHHHHHHHcC-CCCCcceeeceeecccCCCcceeeEE
Q 046639           33 SPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK-EASRSFAAECNALRNI-RHRNLIKIITICSSIDFEGFDFKAIV  110 (331)
Q Consensus        33 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~lv  110 (331)
                      .-+..||.|+||+|++-.++.+++..|||.+...+. ....+++.|.+...+- +.||||+++|.+     -.++.-|+.
T Consensus        67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~-----F~EGdcWiC  141 (361)
T KOG1006|consen   67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGAL-----FSEGDCWIC  141 (361)
T ss_pred             HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhh-----hcCCceeee
Confidence            345689999999999999999999999999986655 4456788888865554 699999999995     445667999


Q ss_pred             EeecCCCCHHHHHHh---ccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccc
Q 046639          111 FEYMQNRNLEQWLRQ---SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       111 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      ||.+ ..||..+.+.   -....+++.....+....+.||.||....  .|+|||+||+|||++..|.+||+|||++-.+
T Consensus       142 MELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqL  218 (361)
T KOG1006|consen  142 MELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQL  218 (361)
T ss_pred             HHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhH
Confidence            9999 7788776554   23345777777788888999999998775  9999999999999999999999999998765


Q ss_pred             ccCCCCCcccccCCceeecccccccCCcccCC--CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcc
Q 046639          188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMG--SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPD  265 (331)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  265 (331)
                      .         .+.......|-.+|+|||.+..  ..|+.+|||||||++|+|+.||..||....+--.++...+....+.
T Consensus       219 v---------~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~  289 (361)
T KOG1006|consen  219 V---------DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPI  289 (361)
T ss_pred             H---------HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCe
Confidence            2         2222233447778999999865  3589999999999999999999999986543222222222222221


Q ss_pred             hhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          266 KVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      -+    .+...           .+....+..++..||.+|..+||...++.+
T Consensus       290 l~----~~~~~-----------~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  290 LL----FDKEC-----------VHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             ec----Ccccc-----------cccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence            11    10000           134567888999999999999999999875

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=7.2e-36  Score=252.94  Aligned_cols=222  Identities=17%  Similarity=0.080  Sum_probs=173.6

Q ss_pred             cCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeEEEeecCCCCHH
Q 046639           41 GGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLE  120 (331)
Q Consensus        41 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~  120 (331)
                      |.+|.||++++..+++.+|+|.+.....     ...|...+....|||++++++++     ......+++||++++++|.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-----~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~   73 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-----YSRERLTIIPHCVPNMVCLHKYI-----VSEDSVFLVLQHAEGGKLW   73 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh-----hhhHHHHHHhcCCCceeehhhhe-----ecCCeEEEEEecCCCCCHH
Confidence            8999999999999999999999865432     22344444555799999999984     4456789999999999999


Q ss_pred             HHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccccCCCCCcccccC
Q 046639          121 QWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETAS  200 (331)
Q Consensus       121 ~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  200 (331)
                      +++.+..  .+++..+..++.|++.||.+||+.   +++|+||||+||+++.++.++++|||.+.....           
T Consensus        74 ~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~-----------  137 (237)
T cd05576          74 SHISKFL--NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED-----------  137 (237)
T ss_pred             HHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccc-----------
Confidence            9987643  367888999999999999999999   999999999999999999999999998765411           


Q ss_pred             CceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhhhcCcccccccc
Q 046639          201 NSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVT  280 (331)
Q Consensus       201 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (331)
                      ......++..|+|||...+..++.++|+||+|+++|+|++|..|+.......               .....    .   
T Consensus       138 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~---------------~~~~~----~---  195 (237)
T cd05576         138 SCDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI---------------NTHTT----L---  195 (237)
T ss_pred             ccccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc---------------ccccc----c---
Confidence            1112234567999999988889999999999999999999998875321100               00000    0   


Q ss_pred             cCCcchHHHHHHHHHHhhccccCCCCCCCCcHHH
Q 046639          281 ANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRD  314 (331)
Q Consensus       281 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~  314 (331)
                          ..+..+...+.+++.+||+.||.+|||+++
T Consensus       196 ----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~  225 (237)
T cd05576         196 ----NIPEWVSEEARSLLQQLLQFNPTERLGAGV  225 (237)
T ss_pred             ----CCcccCCHHHHHHHHHHccCCHHHhcCCCc
Confidence                111224567889999999999999999743

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-35  Score=279.22  Aligned_cols=258  Identities=24%  Similarity=0.380  Sum_probs=202.1

Q ss_pred             CCCcCceeeccCeeEEEEeeec---C----CCceEEEEEeecc-chhhHHHHHHHHHHHHcCC-CCCcceeeceeecccC
Q 046639           31 NFSPANKIGQGGVSIVYKGILD---E----SRSIVAVKVVNLK-QKEASRSFAAECNALRNIR-HRNLIKIITICSSIDF  101 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~---~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~  101 (331)
                      +..+.+.||.|.||.|++|.-.   .    ....||||.++.. .......+..|+.+|+.+. |+|++.++++|..   
T Consensus       297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~---  373 (609)
T KOG0200|consen  297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ---  373 (609)
T ss_pred             hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc---
Confidence            3466679999999999999753   1    1457999998644 2345577999999999995 9999999999854   


Q ss_pred             CCcceeeEEEeecCCCCHHHHHHhcc------C--------CccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCC
Q 046639          102 EGFDFKAIVFEYMQNRNLEQWLRQSN------G--------QLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSN  167 (331)
Q Consensus       102 ~~~~~~~lv~e~~~~~~L~~~l~~~~------~--------~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~n  167 (331)
                        .+.+++|+||+..|+|.++++...      .        ..+.....+.+++||+.|+.||++.   +++|||+...|
T Consensus       374 --~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRN  448 (609)
T KOG0200|consen  374 --DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARN  448 (609)
T ss_pred             --CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhhhh
Confidence              567899999999999999998755      0        1367788899999999999999999   99999999999


Q ss_pred             EEecCCCcEEEcccCcccccccCCCCCcccccCCceeecc--cccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCC
Q 046639          168 ILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKG--IVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRP  244 (331)
Q Consensus       168 ilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~--t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p  244 (331)
                      |+++.+..+||+|||+|+.......       .......+  ...|+|||.+....|+.++||||+|++|||+++ |..|
T Consensus       449 VLi~~~~~~kIaDFGlar~~~~~~~-------y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~P  521 (609)
T KOG0200|consen  449 VLITKNKVIKIADFGLARDHYNKDY-------YRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTP  521 (609)
T ss_pred             EEecCCCEEEEccccceeccCCCCc-------eEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCC
Confidence            9999999999999999986421110       00011111  223999999999999999999999999999999 9999


Q ss_pred             CCcccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhh
Q 046639          245 TDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHAR  323 (331)
Q Consensus       245 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~  323 (331)
                      |++....... ...++.            ....       ..+..|..++.++|..||+.+|++||++.++.+.++...
T Consensus       522 Yp~~~~~~~l-~~~l~~------------G~r~-------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l  580 (609)
T KOG0200|consen  522 YPGIPPTEEL-LEFLKE------------GNRM-------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL  580 (609)
T ss_pred             CCCCCcHHHH-HHHHhc------------CCCC-------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence            9763211111 111111            1110       233467889999999999999999999999999999854

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-35  Score=272.25  Aligned_cols=262  Identities=19%  Similarity=0.237  Sum_probs=215.6

Q ss_pred             HHHHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcC-CCCCcceeeceeecccCCC
Q 046639           25 LSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNI-RHRNLIKIITICSSIDFEG  103 (331)
Q Consensus        25 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~  103 (331)
                      +..-+..|.+.+.||.|.+|.||+++...+++..|+|+.... .+..+.+..|.++++.+ .|||++..++++.-..-..
T Consensus        14 lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~   92 (953)
T KOG0587|consen   14 LPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGN   92 (953)
T ss_pred             CCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCC
Confidence            334455799999999999999999999999999999998644 44456688899999998 4999999999987666677


Q ss_pred             cceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCc
Q 046639          104 FDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGL  183 (331)
Q Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~  183 (331)
                      ++.+|+|||||.+||.-++++...+..+.+..+..|+..++.|+.+||.+   .++|||||-.||+++.+|.|||+|||.
T Consensus        93 ~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGv  169 (953)
T KOG0587|consen   93 GDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGV  169 (953)
T ss_pred             CCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeee
Confidence            88999999999999999999987788899999999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCcccccCCceeecccccccCCcccCCC-----CCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHH
Q 046639          184 AKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGS-----KASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEF  258 (331)
Q Consensus       184 a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  258 (331)
                      +....        .+....+...|||.|||||++...     .|+..+|+||||++..||..|.+|+-++.+-..     
T Consensus       170 SaQld--------sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra-----  236 (953)
T KOG0587|consen  170 SAQLD--------STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA-----  236 (953)
T ss_pred             eeeee--------cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh-----
Confidence            87762        333445566799999999997653     367789999999999999999999876532110     


Q ss_pred             HHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          259 VKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      +-     .+.....|.+.         -+......|.+++..||..|-++||+..++++
T Consensus       237 LF-----~IpRNPPPkLk---------rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  237 LF-----LIPRNPPPKLK---------RPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             hc-----cCCCCCCcccc---------chhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            00     00111112221         13456788999999999999999999999874

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-35  Score=270.44  Aligned_cols=257  Identities=23%  Similarity=0.330  Sum_probs=204.3

Q ss_pred             CCcCceeeccCeeEEEEeeecCC----CceEEEEEee-ccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           32 FSPANKIGQGGVSIVYKGILDES----RSIVAVKVVN-LKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        32 y~~~~~lg~G~~g~V~~~~~~~~----~~~vavK~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      .+..++||+|+||+||+|.|...    ..+||+|++. .........++.|+.+|.++.|||+++++++|...      .
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s------~  771 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLS------T  771 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccc------h
Confidence            45568999999999999999543    3579999884 33455668899999999999999999999998643      3


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      +.||+++++.|+|.++++.... .+.....+.|..||++|+.|||.+   ++|||||-..|+||..-..+|+.|||+++.
T Consensus       772 ~qlvtq~mP~G~LlDyvr~hr~-~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~l  847 (1177)
T KOG1025|consen  772 LQLVTQLMPLGCLLDYVREHRD-NIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKL  847 (1177)
T ss_pred             HHHHHHhcccchHHHHHHHhhc-cccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhc
Confidence            7899999999999999987543 456688899999999999999999   999999999999999999999999999987


Q ss_pred             cccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhCcc
Q 046639          187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMALPD  265 (331)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~  265 (331)
                      .....      .......-...+.|+|-|.+....|+.++||||||+++||++| |..||.+...+  .+.++++.    
T Consensus       848 l~~d~------~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~--eI~dlle~----  915 (1177)
T KOG1025|consen  848 LAPDE------KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE--EIPDLLEK----  915 (1177)
T ss_pred             cCccc------ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH--HhhHHHhc----
Confidence            62211      1111112223455899999999999999999999999999999 99999775332  11222111    


Q ss_pred             hhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhh
Q 046639          266 KVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARET  325 (331)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~  325 (331)
                           .+ ++         +.+..|...+.-++.+||..|++.||++.++...+.+....
T Consensus       916 -----ge-RL---------sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard  960 (1177)
T KOG1025|consen  916 -----GE-RL---------SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD  960 (1177)
T ss_pred             -----cc-cC---------CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence                 01 01         22345888899999999999999999999999988876543

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=5.3e-35  Score=274.23  Aligned_cols=272  Identities=19%  Similarity=0.161  Sum_probs=172.0

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCC----CceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeec-ccCC
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDES----RSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSS-IDFE  102 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~  102 (331)
                      ..++|.+.+.||+|+||+||+|.+..+    +..||+|.+......  +....+  .++...+.++..+...+.. ....
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            567899999999999999999999888    889999987533221  111111  1122222222222222111 1113


Q ss_pred             CcceeeEEEeecCCCCHHHHHHhccCC------------------ccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCC
Q 046639          103 GFDFKAIVFEYMQNRNLEQWLRQSNGQ------------------LRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLK  164 (331)
Q Consensus       103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~------------------~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik  164 (331)
                      .....++|+||+.+++|.+++......                  ......+..++.|++.||.|||+.   +|+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence            456789999999999999998753211                  011234557899999999999999   99999999


Q ss_pred             CCCEEecC-CCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCC----------------------C
Q 046639          165 PSNILLDQ-DIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGS----------------------K  221 (331)
Q Consensus       165 ~~nilv~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~----------------------~  221 (331)
                      |+|||++. ++.+||+|||++..+...       .........+++.|+|||.+...                      .
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~-------~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~  355 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVG-------INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLN  355 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccc-------cccCCcccccCCCccChHHhhccCCCCCCccccccccccchhcccc
Confidence            99999985 579999999999764211       11223345688899999965322                      2


Q ss_pred             CccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCc--chhhhhcCcccccccccCCcchHHHHHHHHHHhhc
Q 046639          222 ASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALP--DKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGV  299 (331)
Q Consensus       222 ~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  299 (331)
                      ++.++|||||||++|||+++..+++..   ...+...+.....  ..+.....+....+. ....+..+.......+|+.
T Consensus       356 ~~~k~DVwSlGviL~el~~~~~~~~~~---~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~d~~~~~~~dLi~  431 (566)
T PLN03225        356 LPDRFDIYSAGLIFLQMAFPNLRSDSN---LIQFNRQLKRNDYDLVAWRKLVEPRASPDL-RRGFEVLDLDGGAGWELLK  431 (566)
T ss_pred             CCCCcccHHHHHHHHHHHhCcCCCchH---HHHHHHHHHhcCCcHHHHHHhhccccchhh-hhhhhhccccchHHHHHHH
Confidence            345679999999999999977665321   1111111111000  011111111110000 0001111222334568999


Q ss_pred             cccCCCCCCCCcHHHHHH
Q 046639          300 TCSMESPMERMEMRDVVA  317 (331)
Q Consensus       300 ~cl~~~P~~Rps~~~i~~  317 (331)
                      +||+.||.+|||+.++++
T Consensus       432 ~mL~~dP~kR~ta~e~L~  449 (566)
T PLN03225        432 SMMRFKGRQRISAKAALA  449 (566)
T ss_pred             HHccCCcccCCCHHHHhC
Confidence            999999999999999985

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-36  Score=255.84  Aligned_cols=265  Identities=22%  Similarity=0.302  Sum_probs=199.0

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc--c-----hhhHHHHHHHHHHHHcCCCCCcceeeceeeccc
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--Q-----KEASRSFAAECNALRNIRHRNLIKIITICSSID  100 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  100 (331)
                      ...+|-++..||+|||+.||+|.+...++.||+|+-...  .     ....+...+|.++.+.|.||.||++++++.   
T Consensus       461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfs---  537 (775)
T KOG1151|consen  461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFS---  537 (775)
T ss_pred             hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeee---
Confidence            345799999999999999999999989999999986432  1     222345678999999999999999999974   


Q ss_pred             CCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEec---CCCcEE
Q 046639          101 FEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLD---QDIVAH  177 (331)
Q Consensus       101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~---~~~~~k  177 (331)
                       -+....|-|+|||+|.+|.-+++...  .+++..+..|++||++||.||... .++|+|-||||.|||+.   ..|.+|
T Consensus       538 -lDtdsFCTVLEYceGNDLDFYLKQhk--lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIK  613 (775)
T KOG1151|consen  538 -LDTDSFCTVLEYCEGNDLDFYLKQHK--LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIK  613 (775)
T ss_pred             -eccccceeeeeecCCCchhHHHHhhh--hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeE
Confidence             22345689999999999999997654  477899999999999999999987 66899999999999995   447899


Q ss_pred             EcccCcccccccCCCCCcccccCCceeecccccccCCcccCCC----CCccchhhHhHHHHHHHHHhCCCCCCcccCCcc
Q 046639          178 VGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGS----KASVSGDVYNFGILLLEMFTRRRPTDAMFNEGL  253 (331)
Q Consensus       178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~----~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~  253 (331)
                      |.|||+++++.+...++- ..........||.+|++||++--+    .++.+.||||+|+|+|..+.|+-||......  
T Consensus       614 ITDFGLSKIMdddSy~~v-dGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ--  690 (775)
T KOG1151|consen  614 ITDFGLSKIMDDDSYNSV-DGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ--  690 (775)
T ss_pred             eeecchhhhccCCccCcc-cceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH--
Confidence            999999999854432221 112233446699999999986532    3688999999999999999999999754222  


Q ss_pred             hHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHH
Q 046639          254 TLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVV  316 (331)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~  316 (331)
                        .+++....--+..+.-       ++.     -.....+..+++++||+.--++|....++.
T Consensus       691 --QdILqeNTIlkAtEVq-------FP~-----KPvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  691 --QDILQENTILKATEVQ-------FPP-----KPVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             --HHHHhhhchhcceecc-------CCC-----CCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence              1121111100000000       000     012345677888999999999998887765

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-36  Score=261.01  Aligned_cols=242  Identities=21%  Similarity=0.262  Sum_probs=200.4

Q ss_pred             CCCcCceeeccCeeEEEEeeecCCCceEEEEEeec---cchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCccee
Q 046639           31 NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL---KQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      ++.++..||-|+||.|=++..+.....+|+|++++   .+....+.+..|-++|...+.|.||+++..     +.+..++
T Consensus       421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrT-----frd~kyv  495 (732)
T KOG0614|consen  421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRT-----FRDSKYV  495 (732)
T ss_pred             hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHH-----hccchhh
Confidence            46677899999999999988875555578887753   355566778899999999999999999998     6777889


Q ss_pred             eEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccc
Q 046639          108 AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      |++||-|-||.|...++.++  .+.......++..+++|+.|||++   ||++||+||+|.+++.+|-+||.|||+|+.+
T Consensus       496 YmLmEaClGGElWTiLrdRg--~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki  570 (732)
T KOG0614|consen  496 YMLMEACLGGELWTILRDRG--SFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKI  570 (732)
T ss_pred             hhhHHhhcCchhhhhhhhcC--CcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHh
Confidence            99999999999999997654  366788889999999999999999   9999999999999999999999999999987


Q ss_pred             ccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchh
Q 046639          188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKV  267 (331)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  267 (331)
                               ......-..+|||.|.|||++.+...+.++|.||||+++|||++|.+||.+.. .-..+..+++..     
T Consensus       571 ---------~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~d-pmktYn~ILkGi-----  635 (732)
T KOG0614|consen  571 ---------GSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVD-PMKTYNLILKGI-----  635 (732)
T ss_pred             ---------ccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCc-hHHHHHHHHhhh-----
Confidence                     34455567889999999999999999999999999999999999999998642 222233332221     


Q ss_pred             hhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCc
Q 046639          268 MEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERME  311 (331)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps  311 (331)
                          |          ...|+....+...+|+.++...+|.+|..
T Consensus       636 ----d----------~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  636 ----D----------KIEFPRRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             ----h----------hhhcccccchhHHHHHHHHHhcCcHhhhc
Confidence                1          11344556677888888999999999975

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=5e-34  Score=241.65  Aligned_cols=239  Identities=23%  Similarity=0.308  Sum_probs=189.3

Q ss_pred             CeeEEEEeeecCCCceEEEEEeeccchhh-HHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeEEEeecCCCCHH
Q 046639           42 GVSIVYKGILDESRSIVAVKVVNLKQKEA-SRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLE  120 (331)
Q Consensus        42 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~  120 (331)
                      +||.||+|.+..+++.+++|++....... ...+.+|+..+++++|+|++++++.+.     .....++++|++++++|.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~l~~e~~~~~~L~   75 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFE-----DEDKLYLVMEYCDGGDLF   75 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhhee-----eCCEEEEEEeCCCCCCHH
Confidence            58999999999889999999997554433 578899999999999999999999854     346789999999888999


Q ss_pred             HHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccccCCCCCcccccC
Q 046639          121 QWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETAS  200 (331)
Q Consensus       121 ~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  200 (331)
                      +++.....  ++......++.+++.++.+||..   +++|+||+|.||+++.++.++++|||.+......         .
T Consensus        76 ~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~---------~  141 (244)
T smart00220       76 DLLKKRGR--LSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPG---------G  141 (244)
T ss_pred             HHHHhccC--CCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeeccc---------c
Confidence            99976443  67788999999999999999999   9999999999999999999999999999875211         1


Q ss_pred             CceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhhhcCcccccccc
Q 046639          201 NSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVT  280 (331)
Q Consensus       201 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (331)
                      ......++..|++||...+..++.++||||||++++++++|..||...... ....+.........              
T Consensus       142 ~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~-~~~~~~~~~~~~~~--------------  206 (244)
T smart00220      142 LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL-LELFKKIGKPKPPF--------------  206 (244)
T ss_pred             ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHhccCCCC--------------
Confidence            223345777899999998888999999999999999999999999653111 11111111100000              


Q ss_pred             cCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          281 ANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       281 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                         ......+...+.+++.+||..+|++||++.++++
T Consensus       207 ---~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      207 ---PPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             ---ccccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence               0000014567889999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-35  Score=226.25  Aligned_cols=214  Identities=24%  Similarity=0.317  Sum_probs=174.3

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc-hhhHHHHHHHHHHHHcC-CCCCcceeeceeecccCCCccee
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ-KEASRSFAAECNALRNI-RHRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      +....+..||+|++|.|-+.++..+|...|+|.+...- ....+++++|+++..+. ..|.+|.++|.     ......+
T Consensus        46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa-----~~regdv  120 (282)
T KOG0984|consen   46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGA-----LFREGDV  120 (282)
T ss_pred             hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehh-----hhccccE
Confidence            34555679999999999999999999999999997553 34456788999988776 59999999997     5566789


Q ss_pred             eEEEeecCCCCHHHHHHh--ccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccc
Q 046639          108 AIVFEYMQNRNLEQWLRQ--SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAK  185 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~  185 (331)
                      ++.||.+ ..||..+-++  ..+...++..+.+++..+++||.|||++-  .++|||+||.|||++.+|+||++|||++-
T Consensus       121 wIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG  197 (282)
T KOG0984|consen  121 WICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISG  197 (282)
T ss_pred             EEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccce
Confidence            9999999 7799887765  45566788888999999999999999986  89999999999999999999999999998


Q ss_pred             ccccCCCCCcccccCCceeecccccccCCcccCC----CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHH
Q 046639          186 FLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG----SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVK  260 (331)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~----~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  260 (331)
                      ++.++         -......|-.+|+|||.+..    ..|+.++||||||+++.||.+++.||+.....-+++...+.
T Consensus       198 ~L~dS---------iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe  267 (282)
T KOG0984|consen  198 YLVDS---------IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE  267 (282)
T ss_pred             eehhh---------hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence            76321         11122346677999998654    46899999999999999999999999876555444444443

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-34  Score=239.21  Aligned_cols=250  Identities=22%  Similarity=0.294  Sum_probs=196.7

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc---chhhHHHHHHHHHHHHcC-CCCCcceeeceeecccCCC
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK---QKEASRSFAAECNALRNI-RHRNLIKIITICSSIDFEG  103 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~  103 (331)
                      ..++|.++..||+|++.+|..++...|.+.+|+|+++++   ..+...-...|-.+...- +||.+|.+...     +..
T Consensus       248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhsc-----fqt  322 (593)
T KOG0695|consen  248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSC-----FQT  322 (593)
T ss_pred             ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhh-----hcc
Confidence            345799999999999999999999999999999999744   334445566777777776 69999988876     677


Q ss_pred             cceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCc
Q 046639          104 FDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGL  183 (331)
Q Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~  183 (331)
                      +..+++|.||++||+|--.++++.  .++++++..+...|+-||.|||+.   ||++||+|.+|++++..|++||.|+|+
T Consensus       323 esrlffvieyv~ggdlmfhmqrqr--klpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygm  397 (593)
T KOG0695|consen  323 ESRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGM  397 (593)
T ss_pred             cceEEEEEEEecCcceeeehhhhh--cCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccch
Confidence            889999999999999987775543  588899999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcc--cCCcchHHHHHHh
Q 046639          184 AKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAM--FNEGLTLHEFVKM  261 (331)
Q Consensus       184 a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~--~~~~~~~~~~~~~  261 (331)
                      ++.-        ..+.......+|||.|.|||++.+..|+.+.|.|+||++++||+.|+.||+..  .+.+....+++-.
T Consensus       398 cke~--------l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfq  469 (593)
T KOG0695|consen  398 CKEG--------LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQ  469 (593)
T ss_pred             hhcC--------CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHH
Confidence            9763        23334455678999999999999999999999999999999999999999743  3333333333322


Q ss_pred             hCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCc
Q 046639          262 ALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERME  311 (331)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps  311 (331)
                      .+..+...+..                ..+.....+++.-|++||.+|..
T Consensus       470 vilekqiripr----------------slsvkas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  470 VILEKQIRIPR----------------SLSVKASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             HHhhhcccccc----------------eeehhhHHHHHHhhcCCcHHhcC
Confidence            22211111111                12223445666788899998853

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=1.2e-34  Score=253.14  Aligned_cols=270  Identities=19%  Similarity=0.241  Sum_probs=203.8

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCC------CCCcceeeceeecccC
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIR------HRNLIKIITICSSIDF  101 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~  101 (331)
                      ...+|.+....|+|-|++|..|.++.-+..||||+|. .+....+.=+.|+++|++|+      --|+++++..     |
T Consensus       430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIR-nNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~-----F  503 (752)
T KOG0670|consen  430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIR-NNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRH-----F  503 (752)
T ss_pred             hcceeEEEeccccceeeeeeeccccCCCCeeEEEEee-cchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHH-----h
Confidence            3468999999999999999999998888899999996 44445556678999999995      2377888777     6


Q ss_pred             CCcceeeEEEeecCCCCHHHHHHhc-cCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCC-cEEEc
Q 046639          102 EGFDFKAIVFEYMQNRNLEQWLRQS-NGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDI-VAHVG  179 (331)
Q Consensus       102 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~-~~kl~  179 (331)
                      ...+++|+|+|.+ ..+|.+++++. .+-.+....+..++.|+.-||.+|...   ||+|+||||+||||++.. .+|||
T Consensus       504 ~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLC  579 (752)
T KOG0670|consen  504 KHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLC  579 (752)
T ss_pred             hhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeec
Confidence            6678999999999 78999999984 344677889999999999999999999   999999999999999664 67999


Q ss_pred             ccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcc-hHHHH
Q 046639          180 DLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGL-TLHEF  258 (331)
Q Consensus       180 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~  258 (331)
                      |||.|.....          .....+..+..|.|||++.|-+|+...|+||+||+||||.||+..|++..+..- .+.--
T Consensus       580 DfGSA~~~~e----------neitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me  649 (752)
T KOG0670|consen  580 DFGSASFASE----------NEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFME  649 (752)
T ss_pred             cCcccccccc----------ccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHH
Confidence            9999976521          122233455569999999999999999999999999999999999987544321 11111


Q ss_pred             HHhhCcchhhh---------------------------------hcCc-c-ccccc--ccCCcchHHHHHHHHHHhhccc
Q 046639          259 VKMALPDKVME---------------------------------IVDP-S-LLLEV--TANNYSWIEDCLVAVIGTGVTC  301 (331)
Q Consensus       259 ~~~~~~~~~~~---------------------------------~~~~-~-~~~~~--~~~~~~~~~~~~~~l~~l~~~c  301 (331)
                      ++...|..+..                                 .+.| . +...+  ......-......+|.+|+.+|
T Consensus       650 ~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkm  729 (752)
T KOG0670|consen  650 LKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKM  729 (752)
T ss_pred             hcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHH
Confidence            22222211110                                 0111 0 00000  1112233335667899999999


Q ss_pred             cCCCCCCCCcHHHHHH
Q 046639          302 SMESPMERMEMRDVVA  317 (331)
Q Consensus       302 l~~~P~~Rps~~~i~~  317 (331)
                      |..||++|.|..+.++
T Consensus       730 l~LdP~KRit~nqAL~  745 (752)
T KOG0670|consen  730 LILDPEKRITVNQALK  745 (752)
T ss_pred             hccChhhcCCHHHHhc
Confidence            9999999999998874

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-33  Score=252.21  Aligned_cols=217  Identities=20%  Similarity=0.243  Sum_probs=177.6

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccch---hhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcc
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK---EASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFD  105 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~  105 (331)
                      ..-|..++.||-|+||+|.+++...|...||+|.+.+.+-   ........|-.||..-.++=||+++-.     |.+.+
T Consensus       628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyyS-----FQDkd  702 (1034)
T KOG0608|consen  628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYS-----FQDKD  702 (1034)
T ss_pred             ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEE-----eccCC
Confidence            3458889999999999999999999999999999875532   233446678889999899999999888     67788


Q ss_pred             eeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccc
Q 046639          106 FKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAK  185 (331)
Q Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~  185 (331)
                      .+|+||+|++||++-.++-+.+  .+++..+..++..+..|+.+.|..   |++||||||+|||||.+|++||.|||++.
T Consensus       703 nLYFVMdYIPGGDmMSLLIrmg--IFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCT  777 (1034)
T KOG0608|consen  703 NLYFVMDYIPGGDMMSLLIRMG--IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCT  777 (1034)
T ss_pred             ceEEEEeccCCccHHHHHHHhc--cCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccc
Confidence            9999999999999999987644  467788889999999999999999   99999999999999999999999999987


Q ss_pred             ccccCCCC-------Ccccc---------------------------cCCceeecccccccCCcccCCCCCccchhhHhH
Q 046639          186 FLFGYEPG-------TAAET---------------------------ASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNF  231 (331)
Q Consensus       186 ~~~~~~~~-------~~~~~---------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Diwsl  231 (331)
                      -+.+.-.+       +...+                           ....-...||+.|+|||++....|+..+|.||.
T Consensus       778 GfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~  857 (1034)
T KOG0608|consen  778 GFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSV  857 (1034)
T ss_pred             cceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHh
Confidence            54321111       00000                           001113458999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCcccCCcchH
Q 046639          232 GILLLEMFTRRRPTDAMFNEGLTL  255 (331)
Q Consensus       232 G~il~el~~g~~pf~~~~~~~~~~  255 (331)
                      |+|||||+.|++||.......+.+
T Consensus       858 gvil~em~~g~~pf~~~tp~~tq~  881 (1034)
T KOG0608|consen  858 GVILYEMLVGQPPFLADTPGETQY  881 (1034)
T ss_pred             hHHHHHHhhCCCCccCCCCCccee
Confidence            999999999999998765554443

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=7.9e-33  Score=253.67  Aligned_cols=272  Identities=18%  Similarity=0.196  Sum_probs=179.9

Q ss_pred             HHhcCCCcCceeeccCeeEEEEeeec----------------CCCceEEEEEeeccchhhHHH--------------HHH
Q 046639           27 KATNNFSPANKIGQGGVSIVYKGILD----------------ESRSIVAVKVVNLKQKEASRS--------------FAA   76 (331)
Q Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~~----------------~~~~~vavK~~~~~~~~~~~~--------------~~~   76 (331)
                      -..++|.+.++||+|+||+||+|.+.                ..++.||||.+........+.              ...
T Consensus       142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v  221 (507)
T PLN03224        142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV  221 (507)
T ss_pred             ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence            35678999999999999999999752                245679999986544332222              234


Q ss_pred             HHHHHHcCCCCC-----cceeeceeeccc---CCCcceeeEEEeecCCCCHHHHHHhccC--------------------
Q 046639           77 ECNALRNIRHRN-----LIKIITICSSID---FEGFDFKAIVFEYMQNRNLEQWLRQSNG--------------------  128 (331)
Q Consensus        77 e~~~l~~l~h~~-----i~~~~~~~~~~~---~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------------  128 (331)
                      |+.++.+++|.+     ++.++++|....   ....+..++|+||+++++|.+++....+                    
T Consensus       222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~  301 (507)
T PLN03224        222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM  301 (507)
T ss_pred             HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence            666666665544     466677764321   1123567999999999999999864211                    


Q ss_pred             --CccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccccCCCCCcccccCCceeec
Q 046639          129 --QLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIK  206 (331)
Q Consensus       129 --~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~  206 (331)
                        ...++..+..++.|++.+|.|||+.   +++|+||||+||+++.++.++|+|||++..+...       .........
T Consensus       302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~-------~~~~~~~g~  371 (507)
T PLN03224        302 PQDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTG-------INFNPLYGM  371 (507)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccC-------CccCccccC
Confidence              1234566778999999999999999   9999999999999999999999999998754211       011111223


Q ss_pred             ccccccCCcccCCCC--------------------C--ccchhhHhHHHHHHHHHhCCC-CCCcccCCcchHHHHHHhhC
Q 046639          207 GIVGYVAPEYGMGSK--------------------A--SVSGDVYNFGILLLEMFTRRR-PTDAMFNEGLTLHEFVKMAL  263 (331)
Q Consensus       207 ~t~~y~aPE~~~~~~--------------------~--~~~~DiwslG~il~el~~g~~-pf~~~~~~~~~~~~~~~~~~  263 (331)
                      +++.|+|||.+....                    +  ..+.||||+||++++|++|.. ||.....-....... ....
T Consensus       372 ~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~-~~~~  450 (507)
T PLN03224        372 LDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQY-DNDL  450 (507)
T ss_pred             CCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhc-cchH
Confidence            478899999875432                    1  124699999999999999875 664321111100000 0000


Q ss_pred             cchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCC---CCCCcHHHHHH
Q 046639          264 PDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESP---MERMEMRDVVA  317 (331)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P---~~Rps~~~i~~  317 (331)
                       ..+.......       -..+....+.....+|+.+||..+|   .+|+|+.|+++
T Consensus       451 -~~~r~~~~~~-------~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        451 -NRWRMYKGQK-------YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             -HHHHhhcccC-------CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence             0000000000       0012233456788899999999766   68999999974

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-34  Score=241.69  Aligned_cols=271  Identities=22%  Similarity=0.298  Sum_probs=209.0

Q ss_pred             HHHHHHHhcCCCcCceeeccCeeEEEEeeecCC-----CceEEEEEeecc-chhhHHHHHHHHHHHHcCCCCCcceeece
Q 046639           22 YAELSKATNNFSPANKIGQGGVSIVYKGILDES-----RSIVAVKVVNLK-QKEASRSFAAECNALRNIRHRNLIKIITI   95 (331)
Q Consensus        22 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   95 (331)
                      .+++.....+++....+.+|.||.||.|+++..     .+.|-+|.++.. ..-....++.|.-.+..+.|||+.++.++
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V  355 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV  355 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence            456777777888888999999999999988642     334556666422 23344668889999999999999999999


Q ss_pred             eecccCCCcceeeEEEeecCCCCHHHHHHh------ccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEE
Q 046639           96 CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQ------SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNIL  169 (331)
Q Consensus        96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~------~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nil  169 (331)
                      +    .++....++++.+...|+|..++..      ...+.+.-.+...++.|++.|++|||..   +++|.||...|.+
T Consensus       356 ~----ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCv  428 (563)
T KOG1024|consen  356 S----IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCV  428 (563)
T ss_pred             E----eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcce
Confidence            8    4556778899999988999999983      2233445566778999999999999999   9999999999999


Q ss_pred             ecCCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcc
Q 046639          170 LDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAM  248 (331)
Q Consensus       170 v~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~  248 (331)
                      |++...|||+|=.+++.++..      .+.+.....-....||+||.+....|+..+|+||||+++|||++ |+.||.+.
T Consensus       429 Idd~LqVkltDsaLSRDLFP~------DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeI  502 (563)
T KOG1024|consen  429 IDDQLQVKLTDSALSRDLFPG------DYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEI  502 (563)
T ss_pred             ehhheeEEeccchhccccCcc------cccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCcccc
Confidence            999999999999998876321      11222222223445999999999999999999999999999999 99999754


Q ss_pred             cCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhh
Q 046639          249 FNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETF  326 (331)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~  326 (331)
                      ++  .....++++.          .++         ..+.+|+++|+.+|..||...|++||+++++...|+.....+
T Consensus       503 DP--fEm~~ylkdG----------yRl---------aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql  559 (563)
T KOG1024|consen  503 DP--FEMEHYLKDG----------YRL---------AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL  559 (563)
T ss_pred             CH--HHHHHHHhcc----------cee---------cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence            22  1111121111          111         223479999999999999999999999999999999876554

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7e-35  Score=236.30  Aligned_cols=272  Identities=19%  Similarity=0.255  Sum_probs=194.7

Q ss_pred             CcCceeeccCeeEEEEeeecCCCceEEEEEeec--cchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeEE
Q 046639           33 SPANKIGQGGVSIVYKGILDESRSIVAVKVVNL--KQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIV  110 (331)
Q Consensus        33 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv  110 (331)
                      .-.+.||.|+||.||.+.+-++++.||+|.+..  .+....+.+.+|+.++..++|.|++..+++..-...+-...+|++
T Consensus        56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~  135 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL  135 (449)
T ss_pred             CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence            345799999999999999999999999998742  234445778899999999999999999888654433445567899


Q ss_pred             EeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccccC
Q 046639          111 FEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGY  190 (331)
Q Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~  190 (331)
                      +|.+ ..+|-.+|  -..+.++...+.-+++||+.||.|||+.   +|+||||||.|.+++.+...||+|||+++...  
T Consensus       136 TELm-QSDLHKII--VSPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee--  207 (449)
T KOG0664|consen  136 TELM-QSDLHKII--VSPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWD--  207 (449)
T ss_pred             HHHH-Hhhhhhee--ccCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccc--
Confidence            9998 56777777  4455677889999999999999999999   99999999999999999999999999998642  


Q ss_pred             CCCCcccccCCceeecccccccCCcccCCCC-CccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHH--hhCcchh
Q 046639          191 EPGTAAETASNSIEIKGIVGYVAPEYGMGSK-ASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVK--MALPDKV  267 (331)
Q Consensus       191 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~--~~~~~~~  267 (331)
                           ............|..|.|||++.|.. |+...||||.|||+.||+..+..|+...+ ...+.-+..  .......
T Consensus       208 -----~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~P-iqQL~lItdLLGTPs~Ea  281 (449)
T KOG0664|consen  208 -----QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGP-IEQLQMIIDLLGTPSQEA  281 (449)
T ss_pred             -----hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccCh-HHHHHHHHHHhCCCcHHH
Confidence                 12223333445788899999999865 89999999999999999999988875322 111111111  1111111


Q ss_pred             hh---------hcCcccccccccCCcch--HHHHHHHHHHhhccccCCCCCCCCcHHHHHHH
Q 046639          268 ME---------IVDPSLLLEVTANNYSW--IEDCLVAVIGTGVTCSMESPMERMEMRDVVAK  318 (331)
Q Consensus       268 ~~---------~~~~~~~~~~~~~~~~~--~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~  318 (331)
                      +.         .+.......-....++.  +.+-..+-..+.+.++..||++|.+..+.+.-
T Consensus       282 Mr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~  343 (449)
T KOG0664|consen  282 MKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQH  343 (449)
T ss_pred             HHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence            11         01100000000001111  11223345667788999999999998877643

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=6e-34  Score=251.48  Aligned_cols=198  Identities=23%  Similarity=0.340  Sum_probs=172.7

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc--------hhhHHHHHHHHHHHHcCC---CCCcceeeceee
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ--------KEASRSFAAECNALRNIR---HRNLIKIITICS   97 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~   97 (331)
                      ...|+.++.+|.|+||.|+.|.++.+...|+||.+.+++        ....-....|+.||..++   |+||++++++  
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf--  637 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF--  637 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe--
Confidence            346999999999999999999999999999999986542        122233667999999997   9999999999  


Q ss_pred             cccCCCcceeeEEEeec-CCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcE
Q 046639           98 SIDFEGFDFKAIVFEYM-QNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVA  176 (331)
Q Consensus        98 ~~~~~~~~~~~lv~e~~-~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~  176 (331)
                         |++.+++|++||.. ++.+|.++|.....  +.+..+..|+.|++.|+++||+.   ||||||||-+|+.++.+|-+
T Consensus       638 ---FEddd~yyl~te~hg~gIDLFd~IE~kp~--m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~  709 (772)
T KOG1152|consen  638 ---FEDDDYYYLETEVHGEGIDLFDFIEFKPR--MDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFV  709 (772)
T ss_pred             ---eecCCeeEEEecCCCCCcchhhhhhccCc--cchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeE
Confidence               78888999999986 56899999976554  77889999999999999999999   99999999999999999999


Q ss_pred             EEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCC-ccchhhHhHHHHHHHHHhCCCCCC
Q 046639          177 HVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKA-SVSGDVYNFGILLLEMFTRRRPTD  246 (331)
Q Consensus       177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~  246 (331)
                      ||+|||.|.+.          .........||..|.|||++.|..| +..-|||++|++||.++....||.
T Consensus       710 klidfgsaa~~----------ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  710 KLIDFGSAAYT----------KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             EEeeccchhhh----------cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            99999998764          2234456779999999999999887 677899999999999999999985

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=4.5e-33  Score=220.30  Aligned_cols=264  Identities=20%  Similarity=0.290  Sum_probs=197.4

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCC-CCCcceeeceeecccCCCccee
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIR-HRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      .++|.+.+++|+|.+++||.|+...+++.++||+++..   ..+.+.+|+.+|..+. ||||+.++++..+..   ...+
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~---Sktp  110 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPE---SKTP  110 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCcc---ccCc
Confidence            45799999999999999999999889999999999733   3456889999999996 999999999976432   4456


Q ss_pred             eEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCC-CcEEEcccCcccc
Q 046639          108 AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQD-IVAHVGDLGLAKF  186 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~-~~~kl~Dfg~a~~  186 (331)
                      .+++|++++.+...+...     +.-..+..++.++++||.|+|+.   ||.|||+||.|++|+.. -.++|+|+|+|.+
T Consensus       111 aLiFE~v~n~Dfk~ly~t-----l~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEF  182 (338)
T KOG0668|consen  111 SLIFEYVNNTDFKQLYPT-----LTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  182 (338)
T ss_pred             hhHhhhhccccHHHHhhh-----hchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhh
Confidence            899999999888887643     45567888999999999999999   99999999999999854 4689999999988


Q ss_pred             cccCCCCCcccccCCceeecccccccCCcccCC-CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcc
Q 046639          187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG-SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPD  265 (331)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  265 (331)
                      +         ......+-...+..|--||.+-. ..|+.+-|+|||||++..|+..+.||-...+...++..+.+.....
T Consensus       183 Y---------Hp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~  253 (338)
T KOG0668|consen  183 Y---------HPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTD  253 (338)
T ss_pred             c---------CCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChH
Confidence            6         22222233334555788998765 5589999999999999999999999754444444444443332222


Q ss_pred             hhhhh-------cCcccc-----------cccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          266 KVMEI-------VDPSLL-----------LEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       266 ~~~~~-------~~~~~~-----------~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      .+...       ++|...           ..+..+...  .-..++..+|+.+.|..|..+|+||.|.+.
T Consensus       254 el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~--hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  254 ELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQ--HLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             HHHHHHHHHccCCChhHhhHhhccccccHHHhCCcccc--ccCChHHHHHHHHHHhhccccccchHHHhc
Confidence            22211       122111           111111111  112467889999999999999999999864

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-33  Score=232.89  Aligned_cols=270  Identities=19%  Similarity=0.203  Sum_probs=198.9

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc--chhhHHHHHHHHHHHHcCCCCCcceeeceeecc-cCCCcc
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRNIRHRNLIKIITICSSI-DFEGFD  105 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~~  105 (331)
                      ..+|.-++.+|.|.- .|..+-+.-.+++||+|....+  +....++..+|..++..++|+|+++++.++.-. ..+...
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            347888999999999 7888889889999999987433  334456788999999999999999999987532 233455


Q ss_pred             eeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccc
Q 046639          106 FKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAK  185 (331)
Q Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~  185 (331)
                      ..|+|||++ ..+|.+.+..    .+.-..+..+++|++.|+.+||+.   ||+||||||+||++..++.+||.|||+|+
T Consensus        95 e~y~v~e~m-~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar  166 (369)
T KOG0665|consen   95 EVYLVMELM-DANLCQVILM----ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLAR  166 (369)
T ss_pred             hHHHHHHhh-hhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhc
Confidence            679999999 8899999873    245677889999999999999999   99999999999999999999999999997


Q ss_pred             ccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCc-
Q 046639          186 FLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALP-  264 (331)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-  264 (331)
                      .-         ........+..|..|.|||++.+..+.+.+||||+||++.||++|+..|++.. ...++......... 
T Consensus       167 ~e---------~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d-~idQ~~ki~~~lgtp  236 (369)
T KOG0665|consen  167 TE---------DTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD-HIDQWNKIIEQLGTP  236 (369)
T ss_pred             cc---------CcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch-HHHHHHHHHHHhcCC
Confidence            53         22234556778888999999999889999999999999999999999997421 11111111111000 


Q ss_pred             ---------chhhhhcC--cc-----cccccccCCc----chHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          265 ---------DKVMEIVD--PS-----LLLEVTANNY----SWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       265 ---------~~~~~~~~--~~-----~~~~~~~~~~----~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                               ........  ++     ....+++..+    +...--...+.+|+.+||-.||++|.|+++++.
T Consensus       237 d~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  237 DPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             CHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence                     00000000  00     0011111100    000112335789999999999999999999874

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-34  Score=259.98  Aligned_cols=242  Identities=24%  Similarity=0.323  Sum_probs=182.9

Q ss_pred             cCceeeccCeeE-EEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcC-CCCCcceeeceeecccCCCcceeeEEE
Q 046639           34 PANKIGQGGVSI-VYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNI-RHRNLIKIITICSSIDFEGFDFKAIVF  111 (331)
Q Consensus        34 ~~~~lg~G~~g~-V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~lv~  111 (331)
                      --+.+|.|+.|+ ||+|...  ++.||||.+-.   +......+|+..|+.- .||||+++++.     -.+..+.||+.
T Consensus       513 ~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~-----E~d~qF~YIal  582 (903)
T KOG1027|consen  513 PKEILGYGSNGTVVFRGVYE--GREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCS-----EQDRQFLYIAL  582 (903)
T ss_pred             cHHHcccCCCCcEEEEEeeC--CceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEee-----ccCCceEEEEe
Confidence            346788998876 8999885  88999998752   2334567899999887 59999999887     66678999999


Q ss_pred             eecCCCCHHHHHHhccCCccch---HHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecC---C--CcEEEcccCc
Q 046639          112 EYMQNRNLEQWLRQSNGQLRFL---TQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQ---D--IVAHVGDLGL  183 (331)
Q Consensus       112 e~~~~~~L~~~l~~~~~~~~~~---~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~---~--~~~kl~Dfg~  183 (331)
                      |.| ..+|.+++... ......   ...+..+.|+++||++||+.   +||||||||.||||+.   +  ..++|+|||+
T Consensus       583 ELC-~~sL~dlie~~-~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfgl  657 (903)
T KOG1027|consen  583 ELC-ACSLQDLIESS-GLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGL  657 (903)
T ss_pred             hHh-hhhHHHHHhcc-ccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccccc
Confidence            999 77999999873 111111   23467888999999999999   9999999999999975   3  3689999999


Q ss_pred             ccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhC-CCCCCcccCCcchHHHHHHhh
Q 046639          184 AKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTR-RRPTDAMFNEGLTLHEFVKMA  262 (331)
Q Consensus       184 a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g-~~pf~~~~~~~~~~~~~~~~~  262 (331)
                      ++.+.....     .........||.+|+|||++....-+.++||||+||++|+.++| ..||++.-.++..   ++...
T Consensus       658 sKkl~~~~s-----S~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~N---Il~~~  729 (903)
T KOG1027|consen  658 SKKLAGGKS-----SFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQAN---ILTGN  729 (903)
T ss_pred             ccccCCCcc-----hhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhh---hhcCc
Confidence            998743322     22224456699999999999998888899999999999999995 8999864322111   11110


Q ss_pred             CcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHH
Q 046639          263 LPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVV  316 (331)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~  316 (331)
                      .           .....     .-..+|  +..+|+.+|++.+|..||+|.+|+
T Consensus       730 ~-----------~L~~L-----~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL  765 (903)
T KOG1027|consen  730 Y-----------TLVHL-----EPLPDC--EAKDLISRMLNPDPQLRPSATDVL  765 (903)
T ss_pred             c-----------ceeee-----ccCchH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence            0           00000     001123  788999999999999999999997

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.3e-32  Score=220.39  Aligned_cols=267  Identities=18%  Similarity=0.222  Sum_probs=201.5

Q ss_pred             hhhhhccCCcccHHHHHHHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCC-CCC
Q 046639           10 MLSMKQQFPMISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIR-HRN   88 (331)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~   88 (331)
                      ..-.++.+|++.++.+... +.|+|.+.+|+|.||.+-+|+++.++..+++|-+..+- ...+++.+|..---.|. |.|
T Consensus         5 ~~g~ih~I~~~el~kv~l~-d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~h   82 (378)
T KOG1345|consen    5 DGGQIHLIPMEELKKVDLE-DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQH   82 (378)
T ss_pred             CCCcccccccccccccchh-hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchh
Confidence            3445667888877766544 48999999999999999999999999999999886553 34466888887655664 999


Q ss_pred             cceeeceeecccCCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCE
Q 046639           89 LIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNI  168 (331)
Q Consensus        89 i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~ni  168 (331)
                      |+..+++.    |...+.+++++||++.|+|.+-+...   .+-+.....++.|+++|+.|+|++   ++||||||.+||
T Consensus        83 Ii~tY~va----Fqt~d~YvF~qE~aP~gdL~snv~~~---GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNi  152 (378)
T KOG1345|consen   83 IIDTYEVA----FQTSDAYVFVQEFAPRGDLRSNVEAA---GIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENI  152 (378)
T ss_pred             hhHHHHHH----hhcCceEEEeeccCccchhhhhcCcc---cccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceE
Confidence            99998875    66677899999999999999988653   355677889999999999999999   999999999999


Q ss_pred             Eec--CCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCC---CC--CccchhhHhHHHHHHHHHhC
Q 046639          169 LLD--QDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG---SK--ASVSGDVYNFGILLLEMFTR  241 (331)
Q Consensus       169 lv~--~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~---~~--~~~~~DiwslG~il~el~~g  241 (331)
                      ||-  +.-.|||+|||..+..           .........+..|.+||....   +.  ..+.+|+|.||++++.+++|
T Consensus       153 Lif~~df~rvKlcDFG~t~k~-----------g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG  221 (378)
T KOG1345|consen  153 LIFDADFYRVKLCDFGLTRKV-----------GTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTG  221 (378)
T ss_pred             EEecCCccEEEeeeccccccc-----------CceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecC
Confidence            994  3348999999998754           111112234455889987543   22  37889999999999999999


Q ss_pred             CCCCCcccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHH
Q 046639          242 RRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMR  313 (331)
Q Consensus       242 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~  313 (331)
                      ..||+.....+..+.++..-...      ..+.+...+        ......+.++.++-|..+|++|--..
T Consensus       222 ~~PWQka~~~d~~Y~~~~~w~~r------k~~~~P~~F--------~~fs~~a~r~Fkk~lt~~~~drcki~  279 (378)
T KOG1345|consen  222 KFPWQKASIMDKPYWEWEQWLKR------KNPALPKKF--------NPFSEKALRLFKKSLTPRFKDRCKIW  279 (378)
T ss_pred             CCcchhhhccCchHHHHHHHhcc------cCccCchhh--------cccCHHHHHHHHHhcCCcccccchhH
Confidence            99999766666666665432211      111222111        23455677888888999999994333

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=5.4e-33  Score=249.08  Aligned_cols=252  Identities=20%  Similarity=0.238  Sum_probs=203.4

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeE
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAI  109 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~l  109 (331)
                      .+|..++.+|+|.+|.||++++..+++..|+|+++........-+..|+-+++..+||||+.+++.+..     ...+++
T Consensus        15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr-----~dklwi   89 (829)
T KOG0576|consen   15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLR-----RDKLWI   89 (829)
T ss_pred             cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhh-----hcCcEE
Confidence            479999999999999999999999999999999998877777788899999999999999999999543     457899


Q ss_pred             EEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccccc
Q 046639          110 VFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG  189 (331)
Q Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~  189 (331)
                      +||||.+|+|.+.-  ....++++.++...+...+.+++|||++   +=+|||||-.||++++.|.+|+.|||.+-.+  
T Consensus        90 cMEycgggslQdiy--~~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqi--  162 (829)
T KOG0576|consen   90 CMEYCGGGSLQDIY--HVTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQI--  162 (829)
T ss_pred             EEEecCCCccccee--eecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhh--
Confidence            99999999999987  3445688888999999999999999999   9999999999999999999999999988665  


Q ss_pred             CCCCCcccccCCceeecccccccCCccc---CCCCCccchhhHhHHHHHHHHHhCCCCCCc-ccCCcchHHHHHHhhCcc
Q 046639          190 YEPGTAAETASNSIEIKGIVGYVAPEYG---MGSKASVSGDVYNFGILLLEMFTRRRPTDA-MFNEGLTLHEFVKMALPD  265 (331)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~---~~~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~~~~~~~~~~  265 (331)
                            ...-....+++||+.|+|||+.   ..+.|+..+|||++|+...|+-.-++|.-+ ...+..   ......   
T Consensus       163 ------tati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l---~LmTkS---  230 (829)
T KOG0576|consen  163 ------TATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRAL---FLMTKS---  230 (829)
T ss_pred             ------hhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHH---HHhhcc---
Confidence                  2344556678899999999974   356799999999999999999988887422 111100   000000   


Q ss_pred             hhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          266 KVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                          ..+|....+        .......|.++++.||-.+|.+|||+..+++
T Consensus       231 ----~~qpp~lkD--------k~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  231 ----GFQPPTLKD--------KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             ----CCCCCcccC--------CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence                011111111        1134567889999999999999999998764

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=3e-30  Score=213.51  Aligned_cols=211  Identities=25%  Similarity=0.436  Sum_probs=178.6

Q ss_pred             eeccCeeEEEEeeecCCCceEEEEEeeccchh-hHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeEEEeecCC
Q 046639           38 IGQGGVSIVYKGILDESRSIVAVKVVNLKQKE-ASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQN  116 (331)
Q Consensus        38 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~  116 (331)
                      ||+|.+|.||++....+++.+++|++...... ....+.+|+..++.+.|++++++++++     ......++++|++.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~~~~e~~~~   75 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF-----EDENHLYLVMEYCEG   75 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeee-----ecCCeEEEEEecCCC
Confidence            68999999999999888999999999755432 346788999999999999999999985     334678999999988


Q ss_pred             CCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecC-CCcEEEcccCcccccccCCCCCc
Q 046639          117 RNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQ-DIVAHVGDLGLAKFLFGYEPGTA  195 (331)
Q Consensus       117 ~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~-~~~~kl~Dfg~a~~~~~~~~~~~  195 (331)
                      ++|.+++.... ..++......++.+++.++.+||+.   +++|+||+|.||+++. ++.++|+|||.+........   
T Consensus        76 ~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~---  148 (215)
T cd00180          76 GSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS---  148 (215)
T ss_pred             CcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc---
Confidence            99999997642 2466788999999999999999999   9999999999999999 89999999999876521110   


Q ss_pred             ccccCCceeecccccccCCcccCCC-CCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhhhcCcc
Q 046639          196 AETASNSIEIKGIVGYVAPEYGMGS-KASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPS  274 (331)
Q Consensus       196 ~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (331)
                           ......+...|++||..... .++.++|+|++|+++++|                                    
T Consensus       149 -----~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------  187 (215)
T cd00180         149 -----LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------  187 (215)
T ss_pred             -----hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------
Confidence                 12234467779999998877 788999999999999999                                    


Q ss_pred             cccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHH
Q 046639          275 LLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAK  318 (331)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~  318 (331)
                                       ..+.+++..|++.+|++||++.++++.
T Consensus       188 -----------------~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 -----------------PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             -----------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence                             357788889999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.97  E-value=4.4e-31  Score=225.95  Aligned_cols=278  Identities=24%  Similarity=0.318  Sum_probs=203.6

Q ss_pred             HHHHhcCCCcCceeeccCeeEEEEeeecC---CCceEEEEEeeccchhhHHHHHHHHHHHHcCC-CCCcceeeceeeccc
Q 046639           25 LSKATNNFSPANKIGQGGVSIVYKGILDE---SRSIVAVKVVNLKQKEASRSFAAECNALRNIR-HRNLIKIITICSSID  100 (331)
Q Consensus        25 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~  100 (331)
                      +....+.|...++||.|.|++||++.+..   .++.||+|.+......  ..+.+|+++|..+. +.||+++.+.     
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~-----  103 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGC-----  103 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhh-----
Confidence            33456679999999999999999999976   7889999988654332  45889999999995 9999999998     


Q ss_pred             CCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCC-CcEEEc
Q 046639          101 FEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQD-IVAHVG  179 (331)
Q Consensus       101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~-~~~kl~  179 (331)
                      +..++.+++|+||++.....++...     ++...+..+++.++.||+++|.+   |||||||||.|++.+.. +.-.|.
T Consensus       104 ~rnnd~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~Lv  175 (418)
T KOG1167|consen  104 FRNNDQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLV  175 (418)
T ss_pred             hccCCeeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEE
Confidence            6778899999999999999998865     45688899999999999999999   99999999999999854 567899


Q ss_pred             ccCcccccccCC------C------CC------------------------cccccCCceeecccccccCCcccCCCC-C
Q 046639          180 DLGLAKFLFGYE------P------GT------------------------AAETASNSIEIKGIVGYVAPEYGMGSK-A  222 (331)
Q Consensus       180 Dfg~a~~~~~~~------~------~~------------------------~~~~~~~~~~~~~t~~y~aPE~~~~~~-~  222 (331)
                      |||+|.......      .      ..                        ............||++|.|||++...+ -
T Consensus       176 DFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Q  255 (418)
T KOG1167|consen  176 DFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQ  255 (418)
T ss_pred             echhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCc
Confidence            999998322110      0      00                        000111122355999999999988755 6


Q ss_pred             ccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCc---chhhhhcCc--------------------cc-ccc
Q 046639          223 SVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALP---DKVMEIVDP--------------------SL-LLE  278 (331)
Q Consensus       223 ~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~---~~~~~~~~~--------------------~~-~~~  278 (331)
                      +.+.||||.|+|+..++++..||-...++...+..+....-.   .+.....+.                    .+ ...
T Consensus       256 ttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~  335 (418)
T KOG1167|consen  256 TTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIES  335 (418)
T ss_pred             CCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhh
Confidence            889999999999999999999996655554444443221111   111111110                    00 011


Q ss_pred             ccc------CCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          279 VTA------NNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       279 ~~~------~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      +.+      ....+.+-.+..+.+|+.+||..||.+|.|+.+.++
T Consensus       336 ~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk  380 (418)
T KOG1167|consen  336 IYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK  380 (418)
T ss_pred             cccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence            111      111233334457899999999999999999999875

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=1.6e-29  Score=211.83  Aligned_cols=200  Identities=29%  Similarity=0.451  Sum_probs=169.6

Q ss_pred             CCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchh-hHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeEE
Q 046639           32 FSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKE-ASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIV  110 (331)
Q Consensus        32 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv  110 (331)
                      |.+.+.||.|++|+||++....+++.+++|.+...... ....+.+|+..++.++|+|++++++++.     .....+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~-----~~~~~~~v   75 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFE-----DPEPLYLV   75 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeee-----cCCceEEE
Confidence            56788999999999999999988899999999765544 5678899999999999999999999853     34678999


Q ss_pred             EeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccccC
Q 046639          111 FEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGY  190 (331)
Q Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~  190 (331)
                      +|++++++|.+++...... ++......++.+++.++.+||..   +++|+|++|.||+++.++.++|+|||.+......
T Consensus        76 ~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~  151 (225)
T smart00221       76 MEYCEGGDLFDYLRKKGGK-LSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRD  151 (225)
T ss_pred             EeccCCCCHHHHHHhcccC-CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCc
Confidence            9999988999999764432 56788889999999999999999   9999999999999999999999999998876221


Q ss_pred             CCCCcccccCCceeecccccccCCccc-CCCCCccchhhHhHHHHHHHHHhCCCCCCc
Q 046639          191 EPGTAAETASNSIEIKGIVGYVAPEYG-MGSKASVSGDVYNFGILLLEMFTRRRPTDA  247 (331)
Q Consensus       191 ~~~~~~~~~~~~~~~~~t~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~g~~pf~~  247 (331)
                      .       ........++..|++||.. ....++.++|+|+||+++++|++|..||..
T Consensus       152 ~-------~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      152 L-------AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             c-------cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            1       0022234567779999998 666788899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=1.2e-27  Score=193.25  Aligned_cols=170  Identities=20%  Similarity=0.207  Sum_probs=128.5

Q ss_pred             CCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccccCCCCCcc
Q 046639          117 RNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAA  196 (331)
Q Consensus       117 ~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~  196 (331)
                      |+|.+++... +..+++..++.++.|++.||.|||+.   +      ||+||+++.++.+++  ||++......      
T Consensus         1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~------   62 (176)
T smart00750        1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPE------   62 (176)
T ss_pred             CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeeccc------
Confidence            6899999754 34578999999999999999999998   6      999999999999999  9998765210      


Q ss_pred             cccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhhhcCcccc
Q 046639          197 ETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLL  276 (331)
Q Consensus       197 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (331)
                             ...||+.|+|||++.+..++.++||||||+++|||++|..||.....................      +.  
T Consensus        63 -------~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------~~--  127 (176)
T smart00750       63 -------QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADD------PR--  127 (176)
T ss_pred             -------cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCC------cc--
Confidence                   114788999999999999999999999999999999999999654322222222222111110      00  


Q ss_pred             cccccCCcchHHHHHH--HHHHhhccccCCCCCCCCcHHHHHHHHHHhhhh
Q 046639          277 LEVTANNYSWIEDCLV--AVIGTGVTCSMESPMERMEMRDVVAKLRHARET  325 (331)
Q Consensus       277 ~~~~~~~~~~~~~~~~--~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~  325 (331)
                            ..........  .+.+++.+||+.+|.+|||+.++++.+......
T Consensus       128 ------~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~  172 (176)
T smart00750      128 ------DRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE  172 (176)
T ss_pred             ------ccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence                  0011122333  689999999999999999999999988776543

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=5.6e-27  Score=206.91  Aligned_cols=271  Identities=18%  Similarity=0.215  Sum_probs=201.8

Q ss_pred             CCCcCceeeccCeeEEEEeeecCCC-ceEEEEEeeccchhhHHHHHHHHHHHHcCCC----CCcceeeceeecccCCCcc
Q 046639           31 NFSPANKIGQGGVSIVYKGILDESR-SIVAVKVVNLKQKEASRSFAAECNALRNIRH----RNLIKIITICSSIDFEGFD  105 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h----~~i~~~~~~~~~~~~~~~~  105 (331)
                      +|.+.++||+|+||.||.|.+..++ ..+|+|............+..|..++..+..    +++..+++...    ....
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~~   94 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STED   94 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----CCCc
Confidence            8999999999999999999987664 6788888765433322367788888888863    57888877732    3556


Q ss_pred             eeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCC-----CcEEEcc
Q 046639          106 FKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQD-----IVAHVGD  180 (331)
Q Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~-----~~~kl~D  180 (331)
                      +.++||+.+ |.+|.++........++...+..++.|++.+|.++|+.   |++||||||.|+++...     -.+.|.|
T Consensus        95 ~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llD  170 (322)
T KOG1164|consen   95 FNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLD  170 (322)
T ss_pred             eeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEe
Confidence            789999999 99999998777667889999999999999999999999   99999999999999865     3689999


Q ss_pred             cCccc--ccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHH
Q 046639          181 LGLAK--FLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEF  258 (331)
Q Consensus       181 fg~a~--~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  258 (331)
                      ||+++  .+...................||..|.++.+..+...+.+.|+||++.++.+++.|..||........ ....
T Consensus       171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-~~~~  249 (322)
T KOG1164|consen  171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-KSKF  249 (322)
T ss_pred             cCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-HHHH
Confidence            99998  33222221112222223456799999999999999999999999999999999999999976433211 1111


Q ss_pred             HHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhh
Q 046639          259 VKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETF  326 (331)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~  326 (331)
                       ........   ..+            +....+..+.+++..+-..+...+|....+...|+......
T Consensus       250 -~~~~~~~~---~~~------------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~  301 (322)
T KOG1164|consen  250 -EKDPRKLL---TDR------------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE  301 (322)
T ss_pred             -HHHhhhhc---ccc------------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence             11110000   000            11123455666666667789999999999999988776653

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.95  E-value=3.4e-28  Score=238.84  Aligned_cols=206  Identities=16%  Similarity=0.168  Sum_probs=136.2

Q ss_pred             CCC-CCcceeeceeeccc--CCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 046639           84 IRH-RNLIKIITICSSID--FEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVH  160 (331)
Q Consensus        84 l~h-~~i~~~~~~~~~~~--~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH  160 (331)
                      ++| +||++++++|..-.  .......+.++|++ +++|.+++... ...++...+..++.||+.||+|||++   ||+|
T Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---gIvH  103 (793)
T PLN00181         29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQ---GIVV  103 (793)
T ss_pred             hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhC---Ceee
Confidence            344 46666777642111  11223567788888 77999999753 34578889999999999999999999   9999


Q ss_pred             cCCCCCCEEecCCCc-------------------EEEcccCcccccccCCCCC--------cccccCCceeecccccccC
Q 046639          161 GDLKPSNILLDQDIV-------------------AHVGDLGLAKFLFGYEPGT--------AAETASNSIEIKGIVGYVA  213 (331)
Q Consensus       161 ~dik~~nilv~~~~~-------------------~kl~Dfg~a~~~~~~~~~~--------~~~~~~~~~~~~~t~~y~a  213 (331)
                      |||||+|||++..|.                   +|++|||+++.........        ............||+.|+|
T Consensus       104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A  183 (793)
T PLN00181        104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS  183 (793)
T ss_pred             ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence            999999999965444                   4555555554321000000        0000001112357889999


Q ss_pred             CcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHH
Q 046639          214 PEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVA  293 (331)
Q Consensus       214 PE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (331)
                      ||++.+..++.++|||||||+||||++|..|+...   ...........        ..+..            ......
T Consensus       184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~---~~~~~~~~~~~--------~~~~~------------~~~~~~  240 (793)
T PLN00181        184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEK---SRTMSSLRHRV--------LPPQI------------LLNWPK  240 (793)
T ss_pred             hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhH---HHHHHHHHHhh--------cChhh------------hhcCHH
Confidence            99999999999999999999999999988886431   11111111111        01100            011233


Q ss_pred             HHHhhccccCCCCCCCCcHHHHHH
Q 046639          294 VIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       294 l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ...++.+||+.+|.+|||+.+|++
T Consensus       241 ~~~~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        241 EASFCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HHHHHHHhCCCChhhCcChHHHhh
Confidence            457778899999999999999975

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=2.7e-26  Score=191.14  Aligned_cols=271  Identities=15%  Similarity=0.167  Sum_probs=210.6

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCC-CCCcceeeceeecccCCCcceee
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIR-HRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      -+|+++++||+|.||+++.|.+.-++++||||.-....  ...++..|.+..+.|. .+.|..++-+     ...+.+-.
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYF-----GqeG~~Ni  100 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYF-----GQEGKYNI  100 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeee-----ccccchhh
Confidence            37999999999999999999999999999999765443  2356788999999885 7888888766     45556678


Q ss_pred             EEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCC-----cEEEcccCc
Q 046639          109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDI-----VAHVGDLGL  183 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~-----~~kl~Dfg~  183 (331)
                      +|+|.+ |.||.|+..-.+. .++...+..++.|++.-+.++|++   .+|+|||||+|+||..-+     .+.++|||+
T Consensus       101 LVidLL-GPSLEDLFD~CgR-~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGm  175 (449)
T KOG1165|consen  101 LVIDLL-GPSLEDLFDLCGR-RFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGM  175 (449)
T ss_pred             hhhhhh-CcCHHHHHHHhcC-cccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccc
Confidence            999999 9999999886554 478899999999999999999999   999999999999996433     588999999


Q ss_pred             ccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHH--HHHh
Q 046639          184 AKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHE--FVKM  261 (331)
Q Consensus       184 a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~--~~~~  261 (331)
                      |+.+.+.......+. ....+..||..||+--...|..-+.+.|+=|||-++++.+.|..||++.-.+......  +-..
T Consensus       176 AK~YrDp~TkqHIPY-rE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~  254 (449)
T KOG1165|consen  176 AKEYRDPKTKQHIPY-REHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGET  254 (449)
T ss_pred             hhhhcCccccccCcc-ccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccc
Confidence            999877766555544 4456778999999999999999999999999999999999999999987544333222  1111


Q ss_pred             hCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhhhcC
Q 046639          262 ALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETFLGT  329 (331)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~~~~  329 (331)
                      .....+..                .-+..+.++..-+....+.+=++-|+..-+...+..+.+....+
T Consensus       255 Kr~T~i~~----------------Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t  306 (449)
T KOG1165|consen  255 KRSTPIEV----------------LCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGET  306 (449)
T ss_pred             cccCCHHH----------------HHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCc
Confidence            11222211                22234455655566666667788899988888877777665443

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=2.8e-26  Score=202.21  Aligned_cols=177  Identities=19%  Similarity=0.131  Sum_probs=132.6

Q ss_pred             HHHHHHhcCCCcCceeeccCeeEEEEeeecC-CCceEEEEEeecc-----chhhHHHHHHHHHHHHcCCCCCcceeecee
Q 046639           23 AELSKATNNFSPANKIGQGGVSIVYKGILDE-SRSIVAVKVVNLK-----QKEASRSFAAECNALRNIRHRNLIKIITIC   96 (331)
Q Consensus        23 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   96 (331)
                      ..+....++|.+.+.||+|+||+||+|.+.. +++.+|||++...     .......+.+|+.+++.++|+|++..+.. 
T Consensus        11 ~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~-   89 (365)
T PRK09188         11 DQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA-   89 (365)
T ss_pred             cccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE-
Confidence            3455667789999999999999999999876 6777899986422     22345668999999999999999853322 


Q ss_pred             ecccCCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCC-CCCCEEecCCCc
Q 046639           97 SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDL-KPSNILLDQDIV  175 (331)
Q Consensus        97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~di-k~~nilv~~~~~  175 (331)
                          .   +..++||||++|++|... .  ..      ....++.+++.+|.+||+.   ||+|||| ||+||+++.++.
T Consensus        90 ----~---~~~~LVmE~~~G~~L~~~-~--~~------~~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~  150 (365)
T PRK09188         90 ----T---GKDGLVRGWTEGVPLHLA-R--PH------GDPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGE  150 (365)
T ss_pred             ----c---CCcEEEEEccCCCCHHHh-C--cc------chHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCC
Confidence                1   346899999999999632 1  11      0135788999999999999   9999999 999999999999


Q ss_pred             EEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCC
Q 046639          176 AHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG  219 (331)
Q Consensus       176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~  219 (331)
                      ++|+|||+|+.+...................+++.|.|||.+..
T Consensus       151 ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        151 AAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             EEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            99999999997643222111111111124567788999998654

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=7.2e-26  Score=180.82  Aligned_cols=270  Identities=17%  Similarity=0.187  Sum_probs=202.9

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCC-CCcceeeceeecccCCCccee
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRH-RNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      .+.|.++++||+|+||.+|.|....+|..||||+-...  .....+..|..+.+.+++ ..|..+..+     ..+..+-
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y-----~~e~~yn   86 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHY-----GTEKDYN   86 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhh-----ccccccc
Confidence            35899999999999999999999999999999977432  233457889999999874 445545444     4455677


Q ss_pred             eEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCC---CcEEEcccCcc
Q 046639          108 AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQD---IVAHVGDLGLA  184 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~---~~~kl~Dfg~a  184 (331)
                      ++||+.+ |.||.++.+.... .++....+.++-|++.-+.|+|.+   +++||||||+|++..-+   ..+.++|||+|
T Consensus        87 vlVMdLL-GPsLEdLfnfC~R-~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLa  161 (341)
T KOG1163|consen   87 VLVMDLL-GPSLEDLFNFCSR-RFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLA  161 (341)
T ss_pred             eeeeecc-CccHHHHHHHHhh-hhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccch
Confidence            8999999 9999999987543 367889999999999999999999   99999999999999643   46899999999


Q ss_pred             cccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcc--hHHHHHHhh
Q 046639          185 KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGL--TLHEFVKMA  262 (331)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~  262 (331)
                      +.+.+.......+. .......||..|.+--...+-.-+...|+=|+|.+|.....|..||++......  .+..+....
T Consensus       162 Kky~d~~t~~HIpy-re~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK  240 (341)
T KOG1163|consen  162 KKYRDIRTRQHIPY-REDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKK  240 (341)
T ss_pred             hhhccccccccCcc-ccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhh
Confidence            99866555443333 344556799999998887777788899999999999999999999998754432  233444444


Q ss_pred             CcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhhh
Q 046639          263 LPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETFL  327 (331)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~~  327 (331)
                      .+..+..+..                ..+.++.-.+..|-..-=++-|+..-+.+.++-+...+.
T Consensus       241 ~s~~ie~LC~----------------G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln  289 (341)
T KOG1163|consen  241 MSTPIEVLCK----------------GFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLN  289 (341)
T ss_pred             cCCCHHHHhC----------------CCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhcc
Confidence            3333322221                123345555556666666777888877777776665543

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.93  E-value=7.7e-27  Score=189.62  Aligned_cols=251  Identities=20%  Similarity=0.292  Sum_probs=190.5

Q ss_pred             CCcCceeeccCeeEEEEeeecCCCceEEEEEeecc--chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeE
Q 046639           32 FSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAI  109 (331)
Q Consensus        32 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~l  109 (331)
                      .....+|.....|+.|+|+|+++.  ++.|++...  .....+++..|.-.++.+.||||..+++.|.+     ..++.+
T Consensus       192 lnl~tkl~e~hsgelwrgrwqgnd--ivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacns-----ppnlv~  264 (448)
T KOG0195|consen  192 LNLITKLAESHSGELWRGRWQGND--IVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNS-----PPNLVI  264 (448)
T ss_pred             hhhhhhhccCCCcccccccccCcc--hhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccC-----CCCceE
Confidence            445568889999999999998665  556776533  34556789999999999999999999999754     467899


Q ss_pred             EEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccccc
Q 046639          110 VFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG  189 (331)
Q Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~  189 (331)
                      ++.|++.|+|..++....+-...-.++..++.+++.|++|||+.. +-|.-.-+++..++|+++-+.+|. .+-+++.  
T Consensus       265 isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltaris-mad~kfs--  340 (448)
T KOG0195|consen  265 ISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARIS-MADTKFS--  340 (448)
T ss_pred             eeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhhee-cccceee--
Confidence            999999999999999887777888899999999999999999995 234445788999999999887762 2222221  


Q ss_pred             CCCCCcccccCCceeecccccccCCcccCCCCC---ccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcch
Q 046639          190 YEPGTAAETASNSIEIKGIVGYVAPEYGMGSKA---SVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDK  266 (331)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~---~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  266 (331)
                                .........|.|++||.+...+-   -.++|+|||++++|||.|...||.+..+-.....-.        
T Consensus       341 ----------fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia--------  402 (448)
T KOG0195|consen  341 ----------FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA--------  402 (448)
T ss_pred             ----------eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh--------
Confidence                      11112335677999999887653   457999999999999999999998754322221111        


Q ss_pred             hhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhh
Q 046639          267 VMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHAR  323 (331)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~  323 (331)
                           -..+...+++       ...+.+.+|+.-|++.||.+||.+..|+-.|++..
T Consensus       403 -----leglrv~ipp-------gis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  403 -----LEGLRVHIPP-------GISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             -----hccccccCCC-------CccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence                 1122223322       24567788888899999999999999999888764

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.91  E-value=5.7e-25  Score=206.15  Aligned_cols=257  Identities=17%  Similarity=0.163  Sum_probs=184.9

Q ss_pred             CcCceeeccCeeEEEEeeecCCCceEEEEEeec-----cchhhH-HHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           33 SPANKIGQGGVSIVYKGILDESRSIVAVKVVNL-----KQKEAS-RSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        33 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~-~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      .....+|.|++|.|+.+.........+.|.+..     ...... ..+..|+-+-..+.|+|++..+..+.+.    ...
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~----~~~  396 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEI----DGI  396 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhc----ccc
Confidence            456799999999887777654444444444321     111111 2256677777778999998887775332    222


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                       .-.||||++ +|..++...  ..+....+..++.|++.|+.|+|+.   |+.|||+|++|+++..+|.+||+|||.+..
T Consensus       397 -~~~mE~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~v  469 (601)
T KOG0590|consen  397 -LQSMEYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASV  469 (601)
T ss_pred             -hhhhhcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCccee
Confidence             233999988 999999764  2355677788999999999999999   999999999999999999999999998876


Q ss_pred             cccCCCCCcccccCCceeecccccccCCcccCCCCCcc-chhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcc
Q 046639          187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASV-SGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPD  265 (331)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  265 (331)
                      +.-...    ..........|+.+|+|||++.+..|.+ ..||||.|++++.|.+|+.||.........+...       
T Consensus       470 f~~~~e----~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~-------  538 (601)
T KOG0590|consen  470 FRYPWE----KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN-------  538 (601)
T ss_pred             eccCcc----hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh-------
Confidence            522111    1123445577899999999999998865 5899999999999999999997654444332000       


Q ss_pred             hhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          266 KVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                            ......+...+........+..-..++.+||+.+|.+|.|+++|++
T Consensus       539 ------~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  539 ------NYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             ------ccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence                  0011111122223444566777889999999999999999999985

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.90  E-value=2.5e-22  Score=177.50  Aligned_cols=263  Identities=27%  Similarity=0.348  Sum_probs=192.8

Q ss_pred             CCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchh---hHHHHHHHHHHHHcCCCC-CcceeeceeecccCCCccee
Q 046639           32 FSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKE---ASRSFAAECNALRNIRHR-NLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        32 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~~~~~  107 (331)
                      |.+.+.||.|+|+.||.+.+.   ..+++|.+......   ....+.+|+.++..+.|+ +++.+.+.+     ......
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~   73 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFF-----QDEGSL   73 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEE-----ecCCEE
Confidence            778899999999999999987   67889988644322   356788999999999988 799999985     333447


Q ss_pred             eEEEeecCCCCHHHHHHhccC-CccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCC-cEEEcccCccc
Q 046639          108 AIVFEYMQNRNLEQWLRQSNG-QLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDI-VAHVGDLGLAK  185 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~-~~kl~Dfg~a~  185 (331)
                      +++++++.++++.+++..... ..........+..|++.++.++|..   +++|||+||+||+++..+ .++++|||.+.
T Consensus        74 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~  150 (384)
T COG0515          74 YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAK  150 (384)
T ss_pred             EEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcce
Confidence            999999999999977765432 2466788899999999999999999   999999999999999988 79999999997


Q ss_pred             ccccCCCCCcccccCCceeecccccccCCcccCC---CCCccchhhHhHHHHHHHHHhCCCCCCcccCC--cchHHHHHH
Q 046639          186 FLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG---SKASVSGDVYNFGILLLEMFTRRRPTDAMFNE--GLTLHEFVK  260 (331)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~~~~~  260 (331)
                      ............  .......++..|+|||.+.+   ..++...|+||+|++++++++|..||......  .........
T Consensus       151 ~~~~~~~~~~~~--~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~  228 (384)
T COG0515         151 LLPDPGSTSSIP--ALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIIL  228 (384)
T ss_pred             ecCCCCcccccc--ccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHH
Confidence            542111100000  13456678999999999987   57889999999999999999999997654331  112222211


Q ss_pred             hhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHH
Q 046639          261 MALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAK  318 (331)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~  318 (331)
                      .....        ...........   ......+.+++..|+..+|..|.+..+....
T Consensus       229 ~~~~~--------~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         229 ELPTP--------SLASPLSPSNP---ELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             hcCCc--------ccccccCcccc---chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            11111        00000000000   2234567888889999999999998887654

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=1.6e-23  Score=178.63  Aligned_cols=206  Identities=20%  Similarity=0.222  Sum_probs=152.7

Q ss_pred             CCCCcceeeceeecc----------------------cCCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHH
Q 046639           85 RHRNLIKIITICSSI----------------------DFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAID  142 (331)
Q Consensus        85 ~h~~i~~~~~~~~~~----------------------~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~  142 (331)
                      +|||||.+.++|.+.                      .......+|+||..+ ..+|.+++-.+.   .+......++.|
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~---~s~r~~~~~laQ  349 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH---RSYRTGRVILAQ  349 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC---CchHHHHHHHHH
Confidence            499999998877433                      123355689999999 679999997654   344667778899


Q ss_pred             HHHHHHHHhhcCCCCeeecCCCCCCEEec--CCC--cEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccC
Q 046639          143 VSFAIEYFHHHCQPSIVHGDLKPSNILLD--QDI--VAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGM  218 (331)
Q Consensus       143 i~~~l~~LH~~~~~~ivH~dik~~nilv~--~~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~  218 (331)
                      +++|+.|||.+   ||.|||+|++||++.  +|+  ..+++|||++--  +...+...+..+......|.-.-+|||+..
T Consensus       350 lLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLA--d~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t  424 (598)
T KOG4158|consen  350 LLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLA--DDNHGLQLPYESDEVDLGGNAKLMAPEIAT  424 (598)
T ss_pred             HHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeee--ccccccccccccccccCCCcceecchhhhh
Confidence            99999999999   999999999999994  333  578999998742  334445566666677777888899999976


Q ss_pred             CCC------CccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHH
Q 046639          219 GSK------ASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLV  292 (331)
Q Consensus       219 ~~~------~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (331)
                      ..+      .-.++|.|+.|.+.||+++...||.....-......+-...+                    ...++.|++
T Consensus       425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qL--------------------Palp~~vpp  484 (598)
T KOG4158|consen  425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQL--------------------PALPSRVPP  484 (598)
T ss_pred             cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhC--------------------CCCcccCCh
Confidence            432      135899999999999999999999763221222222211111                    134456788


Q ss_pred             HHHHhhccccCCCCCCCCcHHHHHHHH
Q 046639          293 AVIGTGVTCSMESPMERMEMRDVVAKL  319 (331)
Q Consensus       293 ~l~~l~~~cl~~~P~~Rps~~~i~~~L  319 (331)
                      .+.+|+...|+.||.+|++..-....|
T Consensus       485 ~~rqlV~~lL~r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  485 VARQLVFDLLKRDPSKRVSPNIAANVL  511 (598)
T ss_pred             HHHHHHHHHhcCCccccCCccHHHhHH
Confidence            899999999999999999987655544

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.90  E-value=1.2e-24  Score=205.47  Aligned_cols=250  Identities=20%  Similarity=0.195  Sum_probs=177.3

Q ss_pred             CCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchh----hHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           31 NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKE----ASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      +|...+.||.+.|-+|.+|++.+ | .|+||++-..++.    ...+.+.|+. ...+++||++++--+     ......
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e-G-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~-----~~t~kA   95 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE-G-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKV-----LVTDKA   95 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC-c-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHH-----HHhhHH
Confidence            78888999999999999999873 3 4889998655422    2233444555 555689999998776     555666


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      .|+|-+|. .-+|.|.+..++  .+...+.+.|++|++.||..+|..   ||+|||||.+||||+.=+.+.|+||...+.
T Consensus        96 AylvRqyv-khnLyDRlSTRP--FL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKP  169 (1431)
T KOG1240|consen   96 AYLVRQYV-KHNLYDRLSTRP--FLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKP  169 (1431)
T ss_pred             HHHHHHHH-hhhhhhhhccch--HHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCC
Confidence            78888888 669999996554  466778889999999999999999   999999999999999999999999987765


Q ss_pred             cccCCCCCcccccCCceeecccccccCCcccCC----------CC-CccchhhHhHHHHHHHHHh-CCCCCCcccCCcch
Q 046639          187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG----------SK-ASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLT  254 (331)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~----------~~-~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~  254 (331)
                      ..-+..++..... .......-..|.|||.+-.          .+ .+++.||||+||++.||++ |++||...     +
T Consensus       170 tYLPeDNPadf~f-FFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-----Q  243 (1431)
T KOG1240|consen  170 TYLPEDNPADFTF-FFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-----Q  243 (1431)
T ss_pred             ccCCCCCcccceE-EEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-----H
Confidence            4322222211111 1111122344999997543          12 5789999999999999999 89999532     1


Q ss_pred             HHHHHHh--hCc-chhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHH
Q 046639          255 LHEFVKM--ALP-DKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKL  319 (331)
Q Consensus       255 ~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L  319 (331)
                      +-.+...  ..+ ..+..+.|                   ..+..++..|++.||++|.+|.+.++.-
T Consensus       244 L~aYr~~~~~~~e~~Le~Ied-------------------~~~Rnlil~Mi~rdPs~RlSAedyL~~y  292 (1431)
T KOG1240|consen  244 LLAYRSGNADDPEQLLEKIED-------------------VSLRNLILSMIQRDPSKRLSAEDYLQKY  292 (1431)
T ss_pred             HHhHhccCccCHHHHHHhCcC-------------------ccHHHHHHHHHccCchhccCHHHHHHhh
Confidence            1111111  011 11111111                   1366788889999999999999998763

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.90  E-value=1.4e-23  Score=177.53  Aligned_cols=240  Identities=19%  Similarity=0.189  Sum_probs=150.3

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHHcCCC----------CCcceeece
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNIRH----------RNLIKIITI   95 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h----------~~i~~~~~~   95 (331)
                      .+++...+.||.|+++.||.+.+..|++.+|+|++....   ....+.+.+|.-....+.+          -.++..++.
T Consensus        11 ~r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~   90 (288)
T PF14531_consen   11 PRTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDL   90 (288)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEE
T ss_pred             ceEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEE
Confidence            346777899999999999999999999999999986443   2234556666555444322          122222222


Q ss_pred             eeccc-------CC--Ccc---eeeEEEeecCCCCHHHHHHh---ccC--CccchHHHHHHHHHHHHHHHHHhhcCCCCe
Q 046639           96 CSSID-------FE--GFD---FKAIVFEYMQNRNLEQWLRQ---SNG--QLRFLTQRVNIAIDVSFAIEYFHHHCQPSI  158 (331)
Q Consensus        96 ~~~~~-------~~--~~~---~~~lv~e~~~~~~L~~~l~~---~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i  158 (331)
                      ..-..       -.  +..   +.+++|+.+ .++|.+++..   ...  ..........+..|++..+++||+.   |+
T Consensus        91 ~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---Gl  166 (288)
T PF14531_consen   91 LRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GL  166 (288)
T ss_dssp             EEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             EEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ce
Confidence            11000       00  011   336778877 6799888653   221  1233344456668999999999999   99


Q ss_pred             eecCCCCCCEEecCCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCC--------CCCccchhhHh
Q 046639          159 VHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG--------SKASVSGDVYN  230 (331)
Q Consensus       159 vH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~Diws  230 (331)
                      +|+||+|+|++++.+|.+.|+||+......           ........+..|.|||....        -.++.+.|.|+
T Consensus       167 VHgdi~~~nfll~~~G~v~Lg~F~~~~r~g-----------~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~  235 (288)
T PF14531_consen  167 VHGDIKPENFLLDQDGGVFLGDFSSLVRAG-----------TRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQ  235 (288)
T ss_dssp             EEST-SGGGEEE-TTS-EEE--GGGEEETT-----------EEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHH
T ss_pred             EecccceeeEEEcCCCCEEEcChHHHeecC-----------ceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHH
Confidence            999999999999999999999998776531           11111224456889987533        24688999999


Q ss_pred             HHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCC
Q 046639          231 FGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMER  309 (331)
Q Consensus       231 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~R  309 (331)
                      ||+++|.|++|..||+..........                         ....+. +.+..+..|+..+|+.||++|
T Consensus       236 LG~~ly~lWC~~lPf~~~~~~~~~~~-------------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  236 LGITLYSLWCGRLPFGLSSPEADPEW-------------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHHHHHHHHSS-STCCCGGGSTSGG-------------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HHHHHHHHHHccCCCCCCCccccccc-------------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            99999999999999986533221110                         001122 577889999999999999988

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.89  E-value=3.2e-23  Score=170.44  Aligned_cols=177  Identities=14%  Similarity=0.123  Sum_probs=131.7

Q ss_pred             HHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchh---hHHH------HHHHHHHHHcCCCCCcceeeceee
Q 046639           27 KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKE---ASRS------FAAECNALRNIRHRNLIKIITICS   97 (331)
Q Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~------~~~e~~~l~~l~h~~i~~~~~~~~   97 (331)
                      ...++|++.+.+|.|+||.||.+..  ++..+|+|.+......   ....      +.+|+..+.++.|++|..+.+++.
T Consensus        28 ~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~  105 (232)
T PRK10359         28 FLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL  105 (232)
T ss_pred             HhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence            3467999999999999999999765  3667999999643222   1122      678999999999999999988754


Q ss_pred             cccC---CCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCC
Q 046639           98 SIDF---EGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDI  174 (331)
Q Consensus        98 ~~~~---~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~  174 (331)
                      ....   .-.+..+++|||++|.+|.++..      .+.    ....+++.++..+|..   |++|+|++|.||+++.+|
T Consensus       106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g  172 (232)
T PRK10359        106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG  172 (232)
T ss_pred             ecccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC
Confidence            3211   11345789999999999988742      111    2455899999999999   999999999999999988


Q ss_pred             cEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHH
Q 046639          175 VAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMF  239 (331)
Q Consensus       175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~  239 (331)
                       ++|+|||.......         .           .....+.....++.++|+||||+++....
T Consensus       173 -i~liDfg~~~~~~e---------~-----------~a~d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 -LRIIDLSGKRCTAQ---------R-----------KAKDRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             -EEEEECCCcccccc---------h-----------hhHHHHHHHhHhcccccccceeEeehHHH
Confidence             99999998764310         0           00011333445667899999999887654

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.87  E-value=5.9e-22  Score=160.99  Aligned_cols=139  Identities=14%  Similarity=0.104  Sum_probs=105.8

Q ss_pred             CceeeccCeeEEEEeeecCCCceEEEEEeeccchhh--------------------------HHHHHHHHHHHHcCCCCC
Q 046639           35 ANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEA--------------------------SRSFAAECNALRNIRHRN   88 (331)
Q Consensus        35 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~e~~~l~~l~h~~   88 (331)
                      ...||+|++|.||+|.+. +|++||+|+++......                          ......|+..+..+.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            568999999999999987 89999999996432110                          012345999999998777


Q ss_pred             cceeeceeecccCCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHH-hhcCCCCeeecCCCCCC
Q 046639           89 LIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYF-HHHCQPSIVHGDLKPSN  167 (331)
Q Consensus        89 i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~L-H~~~~~~ivH~dik~~n  167 (331)
                      +.....+.    .   ...++||||++++++.......  ..++...+..++.|++.+|.++ |+.   ||+|+||||+|
T Consensus        81 v~~p~~~~----~---~~~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~N  148 (190)
T cd05147          81 IPCPEPIL----L---KSHVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYN  148 (190)
T ss_pred             CCCCcEEE----e---cCCEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHH
Confidence            63322221    1   1237999999887776543222  3467788899999999999999 688   99999999999


Q ss_pred             EEecCCCcEEEcccCccccc
Q 046639          168 ILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       168 ilv~~~~~~kl~Dfg~a~~~  187 (331)
                      |+++ ++.++|+|||+|...
T Consensus       149 Ili~-~~~v~LiDFG~a~~~  167 (190)
T cd05147         149 LLYH-DGKLYIIDVSQSVEH  167 (190)
T ss_pred             EEEE-CCcEEEEEccccccC
Confidence            9998 578999999998753

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.86  E-value=6.2e-21  Score=155.55  Aligned_cols=139  Identities=19%  Similarity=0.133  Sum_probs=107.4

Q ss_pred             cCceeeccCeeEEEEeeecCCCceEEEEEeeccchh--------------------------hHHHHHHHHHHHHcCCCC
Q 046639           34 PANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKE--------------------------ASRSFAAECNALRNIRHR   87 (331)
Q Consensus        34 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~e~~~l~~l~h~   87 (331)
                      +...||+|++|.||+|.+. +|+.||||+++.....                          .......|...+.++.++
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   79 (190)
T cd05145           1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA   79 (190)
T ss_pred             CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence            4678999999999999987 8999999998744211                          012245788999999888


Q ss_pred             CcceeeceeecccCCCcceeeEEEeecCCCCHHHH-HHhccCCccchHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCC
Q 046639           88 NLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQW-LRQSNGQLRFLTQRVNIAIDVSFAIEYFHH-HCQPSIVHGDLKP  165 (331)
Q Consensus        88 ~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~-l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~~~~ivH~dik~  165 (331)
                      ++.....+..       ...++|||+++++++... +..   ..++......++.|++.++.++|+ .   |++|+||||
T Consensus        80 ~i~~p~~~~~-------~~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP  146 (190)
T cd05145          80 GVPVPEPILL-------KKNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSE  146 (190)
T ss_pred             CCCCceEEEe-------cCCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCCh
Confidence            7643333211       124799999987755433 332   235567888999999999999999 8   999999999


Q ss_pred             CCEEecCCCcEEEcccCccccc
Q 046639          166 SNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       166 ~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      +||+++ ++.++|+|||++...
T Consensus       147 ~NIll~-~~~~~liDFG~a~~~  167 (190)
T cd05145         147 YNILYH-DGKPYIIDVSQAVEL  167 (190)
T ss_pred             hhEEEE-CCCEEEEEcccceec
Confidence            999999 889999999999764

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.85  E-value=1.2e-20  Score=181.07  Aligned_cols=201  Identities=17%  Similarity=0.198  Sum_probs=156.7

Q ss_pred             HHHHHHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCC---CCCcceeeceeecc
Q 046639           23 AELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIR---HRNLIKIITICSSI   99 (331)
Q Consensus        23 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~   99 (331)
                      .+.......|.|-+.||.|++|+||+|.... ++.||+|+-+..+.   ..+.--.+++.+|+   -+.|..+...+.  
T Consensus       691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~--  764 (974)
T KOG1166|consen  691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHV--  764 (974)
T ss_pred             ceeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHc--
Confidence            3444556789999999999999999999986 99999997754432   23333344555555   233333333321  


Q ss_pred             cCCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecC-------
Q 046639          100 DFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQ-------  172 (331)
Q Consensus       100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~-------  172 (331)
                       +  .+..++|+||.+.|+|.++++  ..+.+++..++.+..|++..+.+||..   +|||+||||+|+++..       
T Consensus       765 -~--~~~S~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~  836 (974)
T KOG1166|consen  765 -F--QNASVLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSD  836 (974)
T ss_pred             -c--CCcceeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCc
Confidence             2  233579999999999999997  555678888999999999999999999   9999999999999942       


Q ss_pred             CCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCC
Q 046639          173 DIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRR  243 (331)
Q Consensus       173 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~  243 (331)
                      ..-++|+|||.+..+.-      ..........++|-.+-.+|...|.+|+...|.|+|+.+++.|+.|+.
T Consensus       837 ~~~l~lIDfG~siDm~l------fp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  837 SKGLYLIDFGRSIDMKL------FPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             ccceEEEecccceeeeE------cCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            33589999999987722      233346667788889999999999999999999999999999999863

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.83  E-value=3.8e-20  Score=149.14  Aligned_cols=191  Identities=14%  Similarity=0.024  Sum_probs=134.5

Q ss_pred             CCcCceeeccCeeEEEEeeecCCCceEEEEEeeccch----hhHHHHHHHHHHHHcCC-CCCcceeeceeecccCCCcce
Q 046639           32 FSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK----EASRSFAAECNALRNIR-HRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        32 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      +.+...|++|+||+|+.+..  .+.+++.+.+.....    .....+.+|+++|+++. |+++++++++         +.
T Consensus         4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~---------~~   72 (218)
T PRK12274          4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW---------DG   72 (218)
T ss_pred             cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE---------cC
Confidence            34577999999999997765  577787776653321    12235789999999995 5788888876         23


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCC-CCCCEEecCCCcEEEcccCccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDL-KPSNILLDQDIVAHVGDLGLAK  185 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~di-k~~nilv~~~~~~kl~Dfg~a~  185 (331)
                      .+++|||+.|.+|.+....         ....++.|++.+|.++|..   ||+|+|| ||+||+++.+|.++|+|||++.
T Consensus        73 ~~lvmeyI~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~  140 (218)
T PRK12274         73 RHLDRSYLAGAAMYQRPPR---------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAV  140 (218)
T ss_pred             EEEEEeeecCccHHhhhhh---------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCce
Confidence            5899999999998765421         1134677999999999999   9999999 7999999999999999999998


Q ss_pred             ccccCCCCC----cccccCC--ceeecccccccCCcccCC--CCCccchhhHhHHHHHHHHHhCCCCCC
Q 046639          186 FLFGYEPGT----AAETASN--SIEIKGIVGYVAPEYGMG--SKASVSGDVYNFGILLLEMFTRRRPTD  246 (331)
Q Consensus       186 ~~~~~~~~~----~~~~~~~--~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~  246 (331)
                      .... ....    ...+-.+  ......++.+++|+...-  ..--...+.++.|.-+|.++|+..++-
T Consensus       141 ~~~~-~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~  208 (218)
T PRK12274        141 RGNP-RARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW  208 (218)
T ss_pred             ecCC-cchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence            5411 0000    0000000  011224566777764222  222256799999999999999988753

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.82  E-value=1.1e-21  Score=176.81  Aligned_cols=226  Identities=19%  Similarity=0.185  Sum_probs=173.3

Q ss_pred             eeeccCeeEEEEeee---cCCCceEEEEEeeccchhhH--HHHHHHHHHHHcCC-CCCcceeeceeecccCCCcceeeEE
Q 046639           37 KIGQGGVSIVYKGIL---DESRSIVAVKVVNLKQKEAS--RSFAAECNALRNIR-HRNLIKIITICSSIDFEGFDFKAIV  110 (331)
Q Consensus        37 ~lg~G~~g~V~~~~~---~~~~~~vavK~~~~~~~~~~--~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~lv  110 (331)
                      .+|+|.+|.|++++.   ...+..+|+|..++......  ..-..|-.++...+ ||.++.+...     +..+...+++
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhya-----fqt~~kl~l~   75 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYA-----FQTDGKLYLI   75 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeee-----eccccchhHh
Confidence            378999999997665   23567788888764422111  12334666777775 9999988777     6667889999


Q ss_pred             EeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccccC
Q 046639          111 FEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGY  190 (331)
Q Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~  190 (331)
                      +++..++.|...+.....  ..+.....+...++-++.++|..   +++|+|+|++||+++.+|++++.|||+++.... 
T Consensus        76 ld~~rgg~lft~l~~~~~--f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~-  149 (612)
T KOG0603|consen   76 LDFLRGGDLFTRLSKEVM--FDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVK-  149 (612)
T ss_pred             hhhcccchhhhccccCCc--hHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHh-
Confidence            999999999888765433  55666777888999999999999   999999999999999999999999999987521 


Q ss_pred             CCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhhh
Q 046639          191 EPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEI  270 (331)
Q Consensus       191 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  270 (331)
                                 ....+||..|+|||+..  ....++|.||+|++.++|++|..||..     .....+.+.         
T Consensus       150 -----------~~~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-----~~~~~Il~~---------  202 (612)
T KOG0603|consen  150 -----------EKIACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-----DTMKRILKA---------  202 (612)
T ss_pred             -----------hhhcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-----HHHHHHhhh---------
Confidence                       11117899999999988  567789999999999999999999975     112222221         


Q ss_pred             cCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcH
Q 046639          271 VDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEM  312 (331)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~  312 (331)
                                  ...++........+++..++..+|.+|.-.
T Consensus       203 ------------~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  203 ------------ELEMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             ------------ccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence                        113445667778888889999999999765

>smart00090 RIO RIO-like kinase

Probab=99.82  E-value=8.1e-20  Score=153.46  Aligned_cols=159  Identities=19%  Similarity=0.134  Sum_probs=121.5

Q ss_pred             hccCCcccHHHHHHHhcCCCcCceeeccCeeEEEEee-ecCCCceEEEEEeeccchh-----------------------
Q 046639           14 KQQFPMISYAELSKATNNFSPANKIGQGGVSIVYKGI-LDESRSIVAVKVVNLKQKE-----------------------   69 (331)
Q Consensus        14 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~~vavK~~~~~~~~-----------------------   69 (331)
                      ...+-+.+...+.+...-|.+.+.||+|++|.||+|. +..+++.||+|++......                       
T Consensus        12 ~~~~~~~~~~~~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   91 (237)
T smart00090       12 LDGRTRLALYSLLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRK   91 (237)
T ss_pred             cChHHHHHHHHHHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHH
Confidence            3444456677777888889999999999999999998 6678999999998643210                       


Q ss_pred             -hHHHHHHHHHHHHcCCCC--CcceeeceeecccCCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHH
Q 046639           70 -ASRSFAAECNALRNIRHR--NLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFA  146 (331)
Q Consensus        70 -~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~  146 (331)
                       ....+..|+..+.++.+.  .+.++++.         ...++|||++++.+|........  .........++.|++.+
T Consensus        92 ~~~~~~~~E~~~L~~L~~~~i~~p~~~~~---------~~~~lV~E~~~g~~L~~~~~~~~--~~~~~~~~~i~~qi~~~  160 (237)
T smart00090       92 LVRLWAEKEFRNLQRLYEAGVPVPKPIAW---------RRNVLVMEFIGGDGLPAPRLKDV--EPEEEEEFELYDDILEE  160 (237)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCeeeEe---------cCceEEEEEecCCcccccccccC--CcchHHHHHHHHHHHHH
Confidence             112356899999999753  33333332         12479999998888876542222  23445567899999999


Q ss_pred             HHHHhhcCCCC-eeecCCCCCCEEecCCCcEEEcccCccccc
Q 046639          147 IEYFHHHCQPS-IVHGDLKPSNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       147 l~~LH~~~~~~-ivH~dik~~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      +.+||..   + ++|+||||+||+++ ++.++|+|||.+...
T Consensus       161 l~~LH~~---g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      161 MRKLYKE---GELVHGDLSEYNILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             HHHHHhc---CCEEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence            9999999   9 99999999999999 889999999998753

>PRK10345 hypothetical protein; Provisional

Probab=99.81  E-value=3.9e-19  Score=145.84  Aligned_cols=139  Identities=17%  Similarity=0.225  Sum_probs=105.2

Q ss_pred             CcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcC-----CCCCcceeeceeecccCCCcce-
Q 046639           33 SPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNI-----RHRNLIKIITICSSIDFEGFDF-  106 (331)
Q Consensus        33 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~~~~-  106 (331)
                      .-.+.||+|++|.||.  +..+... +||++........+.+.+|+.+++.+     .||||+++++++...  .+.+. 
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~--~g~g~v   79 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETD--CGTGYV   79 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeC--CCCeEE
Confidence            4467999999999995  5545554 69988765444557789999999999     579999999996442  11133 


Q ss_pred             eeEEEee--cCCCCHHHHHHhccCCccchHHHHHHHHHHHHHH-HHHhhcCCCCeeecCCCCCCEEecC----CCcEEEc
Q 046639          107 KAIVFEY--MQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAI-EYFHHHCQPSIVHGDLKPSNILLDQ----DIVAHVG  179 (331)
Q Consensus       107 ~~lv~e~--~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l-~~LH~~~~~~ivH~dik~~nilv~~----~~~~kl~  179 (331)
                      ..+|+||  +.+++|.+++++..   +++.  ..++.+++.++ .|||++   +|+||||||+||+++.    ++.++|+
T Consensus        80 ~~~I~e~~G~~~~tL~~~l~~~~---~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~Li  151 (210)
T PRK10345         80 YDVIADFDGKPSITLTEFAEQCR---YEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVC  151 (210)
T ss_pred             EEEEecCCCCcchhHHHHHHccc---ccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEE
Confidence            3478999  55799999996532   3333  35677888777 999999   9999999999999974    3479999


Q ss_pred             ccCcc
Q 046639          180 DLGLA  184 (331)
Q Consensus       180 Dfg~a  184 (331)
                      ||+.+
T Consensus       152 Dg~G~  156 (210)
T PRK10345        152 DNIGE  156 (210)
T ss_pred             ECCCC
Confidence            95433

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.81  E-value=1.1e-19  Score=163.47  Aligned_cols=219  Identities=24%  Similarity=0.305  Sum_probs=158.8

Q ss_pred             HHcCCCCCcceeeceeecccCCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCe-e
Q 046639           81 LRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSI-V  159 (331)
Q Consensus        81 l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i-v  159 (331)
                      |+.+.|.|+.++++.+.+     +...++|.++|..|+|.+.+... ...+++.....+..+++.|+.|||..   .| .
T Consensus         1 l~~l~h~n~~~f~g~~~~-----~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~   71 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVD-----GPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNS---PIGY   71 (484)
T ss_pred             CcccchhhhhhheeeEec-----CCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcC---ccee
Confidence            356789999999999754     26789999999999999999863 34466777788999999999999987   44 9


Q ss_pred             ecCCCCCCEEecCCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCC-------CccchhhHhHH
Q 046639          160 HGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSK-------ASVSGDVYNFG  232 (331)
Q Consensus       160 H~dik~~nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-------~~~~~DiwslG  232 (331)
                      |+.+++.|.+++....+|+.|||+......      ..............-|.|||.+.+..       .+.++||||+|
T Consensus        72 hg~l~s~nClvd~~w~lklt~~Gl~~~~~~------~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~  145 (484)
T KOG1023|consen   72 HGALKSSNCLVDSRWVLKLTDFGLNSLLEE------TAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFG  145 (484)
T ss_pred             eeeeccccceeeeeEEEEechhhhcccccc------cccccccchhHHHHhccCHHHhcccccccccccccccCCeehHH
Confidence            999999999999999999999999876532      01111111122344599999987631       46779999999


Q ss_pred             HHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcH
Q 046639          233 ILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEM  312 (331)
Q Consensus       233 ~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~  312 (331)
                      ++++|+++...||+........ ...+..     +.....+...+.+..     ..+..+.+..++..||..+|.+||++
T Consensus       146 ii~~ei~~r~~~~~~~~~~~~~-~eii~~-----~~~~~~~~~rP~i~~-----~~e~~~~l~~l~~~cw~e~P~~rPs~  214 (484)
T KOG1023|consen  146 IIMYEILFRSGPFDLRNLVEDP-DEIILR-----VKKGGSNPFRPSIEL-----LNELPPELLLLVARCWEEIPEKRPSI  214 (484)
T ss_pred             HHHHHHHhccCccccccccCCh-HHHHHH-----HHhcCCCCcCcchhh-----hhhcchHHHHHHHHhcccChhhCccH
Confidence            9999999999999864333322 122111     111011111111111     11445579999999999999999999


Q ss_pred             HHHHHHHHHhhhh
Q 046639          313 RDVVAKLRHARET  325 (331)
Q Consensus       313 ~~i~~~L~~~~~~  325 (331)
                      .+|-..++.+...
T Consensus       215 ~~i~~~~~~~~~~  227 (484)
T KOG1023|consen  215 EQIRSKLLTINKG  227 (484)
T ss_pred             HHHHhhhhhhccc
Confidence            9999988877654

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.80  E-value=1.9e-20  Score=165.69  Aligned_cols=178  Identities=28%  Similarity=0.402  Sum_probs=129.5

Q ss_pred             ceeeEEEeecCCCCHHHHHHh-ccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCc
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQ-SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGL  183 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~  183 (331)
                      .++++.|++|.-.+|.+|+.. ......++.....++.|++.|+.|   +   +.+|+|+||.||+...+..+||+|||+
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl  402 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL  402 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence            357899999999999999974 445556778888999999999999   6   999999999999999999999999999


Q ss_pred             ccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhh
Q 046639          184 AKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMA  262 (331)
Q Consensus       184 a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~  262 (331)
                      ........  .............||..|++||.+.+..|+.++||||||+||+|++. -..+|.    ....+.++-...
T Consensus       403 ~ts~~~~~--~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e----r~~t~~d~r~g~  476 (516)
T KOG1033|consen  403 VTSQDKDE--TVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE----RIATLTDIRDGI  476 (516)
T ss_pred             eeecccCC--cccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH----HHHhhhhhhcCC
Confidence            87663322  11122233445669999999999999999999999999999999997 333332    222222221222


Q ss_pred             CcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHH
Q 046639          263 LPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRD  314 (331)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~  314 (331)
                      ++.        .           +..+. +.=..|+.++|...|.+||++.+
T Consensus       477 ip~--------~-----------~~~d~-p~e~~ll~~lls~~p~~RP~~~~  508 (516)
T KOG1033|consen  477 IPP--------E-----------FLQDY-PEEYTLLQQLLSPSPEERPSAIE  508 (516)
T ss_pred             CCh--------H-----------HhhcC-cHHHHHHHHhcCCCcccCchHHH
Confidence            111        0           11111 12245677899999999994443

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.78  E-value=3.2e-18  Score=140.63  Aligned_cols=145  Identities=26%  Similarity=0.223  Sum_probs=112.2

Q ss_pred             HHHHHHHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchh----------------------hHHHHHHHHH
Q 046639           22 YAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKE----------------------ASRSFAAECN   79 (331)
Q Consensus        22 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~e~~   79 (331)
                      ..++......|.+.+.||+|++|.||++... +++.||||++......                      .......|+.
T Consensus         7 ~~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~   85 (198)
T cd05144           7 LHTLVKRGVVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFA   85 (198)
T ss_pred             HHHHHHcCchhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHH
Confidence            4456666667999999999999999999875 7899999987643210                      1123567888


Q ss_pred             HHHcCCCCC--cceeeceeecccCCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCC
Q 046639           80 ALRNIRHRN--LIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPS  157 (331)
Q Consensus        80 ~l~~l~h~~--i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~  157 (331)
                      ++..+.+++  +...++.         ...++|||++++++|..+...        .....++.+++.++.++|..   +
T Consensus        86 ~l~~l~~~~i~v~~~~~~---------~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~---g  145 (198)
T cd05144          86 ALKALYEEGFPVPKPIDW---------NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKH---G  145 (198)
T ss_pred             HHHHHHHcCCCCCceeec---------CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHC---C
Confidence            888887764  3333322         235899999999998776421        23456888999999999998   9


Q ss_pred             eeecCCCCCCEEecCCCcEEEcccCccccc
Q 046639          158 IVHGDLKPSNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       158 ivH~dik~~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      ++|+||+|+||+++.++.++|+|||.+...
T Consensus       146 i~H~Dl~p~Nill~~~~~~~liDfg~~~~~  175 (198)
T cd05144         146 IIHGDLSEFNILVDDDEKIYIIDWPQMVST  175 (198)
T ss_pred             CCcCCCCcccEEEcCCCcEEEEECCccccC
Confidence            999999999999999999999999998643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.77  E-value=1.5e-19  Score=171.06  Aligned_cols=219  Identities=22%  Similarity=0.260  Sum_probs=149.1

Q ss_pred             HHHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcc
Q 046639           26 SKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFD  105 (331)
Q Consensus        26 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~  105 (331)
                      ......|..++.|..|++|.||.++++.+.+++|+|+-+ .+.           +++     ||....           +
T Consensus        79 ~p~e~df~~IklisngAygavylvrh~~trqrfa~kiNk-q~l-----------ilR-----nilt~a-----------~  130 (1205)
T KOG0606|consen   79 APSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK-QNL-----------ILR-----NILTFA-----------G  130 (1205)
T ss_pred             CCCccccceeEeeccCCCCceeeeeccccccchhhcccc-cch-----------hhh-----cccccc-----------C
Confidence            345568999999999999999999999999999995332 221           111     111111           1


Q ss_pred             eeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccc
Q 046639          106 FKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAK  185 (331)
Q Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~  185 (331)
                      +.++|      |+=..+++..+.  ++.        +++.++.|||+.   +|+|||+||+|.+|+.-|++|++|||+++
T Consensus       131 npfvv------gDc~tllk~~g~--lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk  191 (1205)
T KOG0606|consen  131 NPFVV------GDCATLLKNIGP--LPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSK  191 (1205)
T ss_pred             Cccee------chhhhhcccCCC--Ccc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhh
Confidence            12233      333333432222  221        337899999999   99999999999999999999999999987


Q ss_pred             ccccCCCC-----Cc--ccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHH
Q 046639          186 FLFGYEPG-----TA--AETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEF  258 (331)
Q Consensus       186 ~~~~~~~~-----~~--~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  258 (331)
                      ...-....     ..  ..........+||+.|.|||++....|+..+|+|++|+|+|+.+.|+.||.+...+ ..+..+
T Consensus       192 ~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpe-elfg~v  270 (1205)
T KOG0606|consen  192 KGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE-ELFGQV  270 (1205)
T ss_pred             hhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHH-HHHhhh
Confidence            65211111     00  11112223467999999999999999999999999999999999999999764222 223333


Q ss_pred             HHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCC
Q 046639          259 VKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERM  310 (331)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp  310 (331)
                      +...+.-  .+. |               ....++..+++.++|+.+|..|-
T Consensus       271 isd~i~w--pE~-d---------------ea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  271 ISDDIEW--PEE-D---------------EALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             hhhhccc--ccc-C---------------cCCCHHHHHHHHHHHHhChHhhc
Confidence            3322210  000 1               23456788899999999999994

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.77  E-value=4.7e-18  Score=141.21  Aligned_cols=135  Identities=20%  Similarity=0.280  Sum_probs=107.9

Q ss_pred             CceeeccCeeEEEEeeecCCCceEEEEEeeccch--------hhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           35 ANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK--------EASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        35 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      ++.||+|++|.||+|.+  .+..+++|.......        .....+.+|+.++..+.|+++.....++.     ....
T Consensus         1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~-----~~~~   73 (211)
T PRK14879          1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFV-----DPEN   73 (211)
T ss_pred             CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEE-----eCCC
Confidence            36799999999999988  466789997643211        11245778999999999888766655532     2345


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      .+++||+++|++|.+++....     . ....++.+++.+|.++|+.   +++|+|++|.||+++ ++.++++|||++..
T Consensus        74 ~~lv~e~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         74 FIIVMEYIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             CEEEEEEeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            689999999999999986432     1 6678899999999999999   999999999999999 78899999998864

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.73  E-value=2e-17  Score=136.06  Aligned_cols=130  Identities=25%  Similarity=0.348  Sum_probs=101.0

Q ss_pred             eeeccCeeEEEEeeecCCCceEEEEEeeccc---h-----hhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           37 KIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---K-----EASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        37 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      .||+|++|+||+|.+  ++..+++|......   .     .....+.+|+.+++.+.|+++.....++.     .....+
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~-----~~~~~~   73 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDV-----DPDNKT   73 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEE-----ECCCCE
Confidence            489999999999986  46789999864221   1     11255778999999998776543333321     123458


Q ss_pred             EEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      ++||+++|++|.+++.....         .++.+++.+|.+||+.   +++|+|++|.||+++ ++.++++|||++..
T Consensus        74 lv~e~~~g~~l~~~~~~~~~---------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        74 IVMEYIEGKPLKDVIEEGND---------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             EEEEEECCccHHHHHhhcHH---------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            99999999999998754211         6888999999999999   999999999999999 88999999998864

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.73  E-value=2.3e-17  Score=155.32  Aligned_cols=140  Identities=24%  Similarity=0.320  Sum_probs=108.7

Q ss_pred             HHHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc--c------hhhHHHHHHHHHHHHcCCCCCcceeeceee
Q 046639           26 SKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--Q------KEASRSFAAECNALRNIRHRNLIKIITICS   97 (331)
Q Consensus        26 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   97 (331)
                      ......|...+.||+|+||+||+|.+....  +++|.....  .      ......+.+|+.+++.++|++++....++.
T Consensus       329 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~  406 (535)
T PRK09605        329 EEVKRRKIPDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDV  406 (535)
T ss_pred             cccccccCccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEE
Confidence            344455677899999999999999886443  444432111  1      112355789999999999999887665532


Q ss_pred             cccCCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEE
Q 046639           98 SIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAH  177 (331)
Q Consensus        98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~k  177 (331)
                      .     ....++||||+++++|.+++.          ....++.+++.+|.+||+.   +++|+|+||+||++ .++.++
T Consensus       407 ~-----~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~  467 (535)
T PRK09605        407 D-----PEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLY  467 (535)
T ss_pred             e-----CCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEE
Confidence            2     334689999999999999874          2456888999999999999   99999999999999 578899


Q ss_pred             EcccCcccc
Q 046639          178 VGDLGLAKF  186 (331)
Q Consensus       178 l~Dfg~a~~  186 (331)
                      |+|||+++.
T Consensus       468 liDFGla~~  476 (535)
T PRK09605        468 LIDFGLGKY  476 (535)
T ss_pred             EEeCccccc
Confidence            999999875

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.71  E-value=1.1e-18  Score=164.04  Aligned_cols=258  Identities=19%  Similarity=0.207  Sum_probs=189.5

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecC-CCceEEEEEeeccc--hhhHHHHHHHHHHHHcCC-CCCcceeeceeecccCCCc
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDE-SRSIVAVKVVNLKQ--KEASRSFAAECNALRNIR-HRNLIKIITICSSIDFEGF  104 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~  104 (331)
                      ...|.+.+.||+|+++.|-...... +...+|+|.+....  .........|..+-+.+. |+|++.+++.     ....
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~-----~~~~   93 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEP-----SSSP   93 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCc-----cCCC
Confidence            4578889999999999998877743 44456677665443  233344556777777776 9999999998     5666


Q ss_pred             ceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHh-hcCCCCeeecCCCCCCEEecCCC-cEEEcccC
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFH-HHCQPSIVHGDLKPSNILLDQDI-VAHVGDLG  182 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH-~~~~~~ivH~dik~~nilv~~~~-~~kl~Dfg  182 (331)
                      ...++.+++..++++.+.+........+...+-.++.|+..++.|+| ..   ++.|+||||+|.+++..+ ..++.|||
T Consensus        94 ~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~  170 (601)
T KOG0590|consen   94 RSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFG  170 (601)
T ss_pred             cccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCch
Confidence            77899999999999999884322223444666778999999999999 77   999999999999999999 99999999


Q ss_pred             cccccccCCCCCcccccCCceeecc-cccccCCcccCCC-CCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHH
Q 046639          183 LAKFLFGYEPGTAAETASNSIEIKG-IVGYVAPEYGMGS-KASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVK  260 (331)
Q Consensus       183 ~a~~~~~~~~~~~~~~~~~~~~~~~-t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  260 (331)
                      +|..+...     ...........| ++.|.|||...+. ...+..|+||.|+++.-+++|..|+.........+..+..
T Consensus       171 ~At~~~~~-----~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~  245 (601)
T KOG0590|consen  171 LATAYRNK-----NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKS  245 (601)
T ss_pred             hhcccccc-----CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecc
Confidence            99876331     122233334556 9999999999885 4578899999999999999999999766554433333322


Q ss_pred             hhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHH
Q 046639          261 MALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVV  316 (331)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~  316 (331)
                      ....      ..           ............+++..++..+|..|.+..++.
T Consensus       246 ~~~~------~~-----------~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  246 NKGR------FT-----------QLPWNSISDQAHDLLHKILKENPSNRLSIEELK  284 (601)
T ss_pred             cccc------cc-----------cCccccCChhhhhcccccccCCchhcccccccc
Confidence            2100      00           011122344567777889999999999988764

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.70  E-value=1.5e-16  Score=129.61  Aligned_cols=136  Identities=21%  Similarity=0.260  Sum_probs=94.9

Q ss_pred             cCceeeccCeeEEEEeeecCCCceEEEEEeeccchhh--HHH----------------------HHHHHHHHHcCCCC--
Q 046639           34 PANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEA--SRS----------------------FAAECNALRNIRHR--   87 (331)
Q Consensus        34 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~----------------------~~~e~~~l~~l~h~--   87 (331)
                      +.+.||+|+||+||+|.+. +++.||||++.......  ...                      ...|...+..+.+.  
T Consensus         1 ~~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~   79 (187)
T cd05119           1 VGGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV   79 (187)
T ss_pred             CCcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence            3578999999999999987 78899999986432211  111                      12445555554332  


Q ss_pred             CcceeeceeecccCCCcceeeEEEeecCCCCHHH-HHHhccCCccchHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCC
Q 046639           88 NLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQ-WLRQSNGQLRFLTQRVNIAIDVSFAIEYFHH-HCQPSIVHGDLKP  165 (331)
Q Consensus        88 ~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~~~~ivH~dik~  165 (331)
                      .+.+.++.         ...++|||+++++++.. .+....   . ...+..++.+++.++.++|. .   +++|+||+|
T Consensus        80 ~~~~~~~~---------~~~~lv~e~~~g~~~~~~~l~~~~---~-~~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p  143 (187)
T cd05119          80 PVPKPIDL---------NRHVLVMEFIGGDGIPAPRLKDVR---L-LEDPEELYDQILELMRKLYREA---GLVHGDLSE  143 (187)
T ss_pred             CCCceEec---------CCCEEEEEEeCCCCccChhhhhhh---h-cccHHHHHHHHHHHHHHHhhcc---CcCcCCCCh
Confidence            23333332         23589999998844321 111111   1 15567889999999999999 7   999999999


Q ss_pred             CCEEecCCCcEEEcccCccccc
Q 046639          166 SNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       166 ~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      +||+++ ++.++++|||.+...
T Consensus       144 ~Nili~-~~~~~liDfg~a~~~  164 (187)
T cd05119         144 YNILVD-DGKVYIIDVPQAVEI  164 (187)
T ss_pred             hhEEEE-CCcEEEEECcccccc
Confidence            999999 899999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.66  E-value=6.6e-16  Score=120.96  Aligned_cols=135  Identities=19%  Similarity=0.249  Sum_probs=108.2

Q ss_pred             cCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCC--CCcceeeceeecccCCCcceeeEEE
Q 046639           34 PANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRH--RNLIKIITICSSIDFEGFDFKAIVF  111 (331)
Q Consensus        34 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~~~~~~lv~  111 (331)
                      +.+.||.|.++.||++....  ..+++|.......  ...+..|+.+++.+.+  .++++++.+.     ...+..++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~-----~~~~~~~~v~   72 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASG-----ESDGWSYLLM   72 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEc-----CCCCccEEEE
Confidence            46789999999999999853  6789998854433  4568889999999976  5888887763     3346689999


Q ss_pred             eecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          112 EYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      |++++..+..+         +......++.+++.+++.+|.....+++|+|++|.||+++..+.+++.||+.+..
T Consensus        73 e~~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          73 EWIEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             EecCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            99988777654         2345566788999999999986334799999999999999989999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.63  E-value=5.1e-15  Score=124.65  Aligned_cols=139  Identities=19%  Similarity=0.140  Sum_probs=101.6

Q ss_pred             Cceee-ccCeeEEEEeeecCCCceEEEEEeeccc-------------hhhHHHHHHHHHHHHcCCCCCc--ceeeceeec
Q 046639           35 ANKIG-QGGVSIVYKGILDESRSIVAVKVVNLKQ-------------KEASRSFAAECNALRNIRHRNL--IKIITICSS   98 (331)
Q Consensus        35 ~~~lg-~G~~g~V~~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~i--~~~~~~~~~   98 (331)
                      ...|| .|+.|+||.+...  +..++||.+....             ......+.+|+.++..+.|+++  +..+++...
T Consensus        36 ~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~  113 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV  113 (239)
T ss_pred             CceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence            34676 7888888887764  6678999875321             1122457889999999988774  555555321


Q ss_pred             ccCCCcceeeEEEeecCC-CCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEE
Q 046639           99 IDFEGFDFKAIVFEYMQN-RNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAH  177 (331)
Q Consensus        99 ~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~k  177 (331)
                      . .......++|||++++ .+|.+++...   .++..    .+.+++.++.+||..   ||+|+||||.|||++.++.++
T Consensus       114 ~-~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~  182 (239)
T PRK01723        114 R-HGLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFW  182 (239)
T ss_pred             e-cCcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEE
Confidence            1 1111234699999987 6999988642   22222    356899999999999   999999999999999999999


Q ss_pred             EcccCcccc
Q 046639          178 VGDLGLAKF  186 (331)
Q Consensus       178 l~Dfg~a~~  186 (331)
                      |+|||.+..
T Consensus       183 LIDfg~~~~  191 (239)
T PRK01723        183 LIDFDRGEL  191 (239)
T ss_pred             EEECCCccc
Confidence            999998865

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.58  E-value=5.9e-15  Score=123.81  Aligned_cols=205  Identities=20%  Similarity=0.348  Sum_probs=141.5

Q ss_pred             CCCCCcceeeceeecccCCCcceeeEEEeecCCCCHHHHHHh--ccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 046639           84 IRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQ--SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHG  161 (331)
Q Consensus        84 l~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~  161 (331)
                      +-|.|+++...++.+.-.++.....+++||+..|++.+++++  ..+..++.....+|+.||++||+|||+. .|.++|+
T Consensus       124 lvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~Ppiihg  202 (458)
T KOG1266|consen  124 LVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPPIIHG  202 (458)
T ss_pred             HHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCccccC
Confidence            358999999999877666667778899999999999999987  3455677778889999999999999997 6789999


Q ss_pred             CCCCCCEEecCCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhC
Q 046639          162 DLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTR  241 (331)
Q Consensus       162 dik~~nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g  241 (331)
                      ++.-+.|++..+|.+|++--.-....    ..-............+.++|.+||.-..-+.+-.+|||++|+...+|..|
T Consensus       203 nlTc~tifiq~ngLIkig~~ap~s~h----~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail  278 (458)
T KOG1266|consen  203 NLTCDTIFIQHNGLIKIGSVAPDSTH----PSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL  278 (458)
T ss_pred             CcchhheeecCCceEEecccCccccc----hhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence            99999999999999998432111100    00000011111123356779999997777778899999999999999998


Q ss_pred             CCCCCcccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          242 RRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       242 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ..--....  ....   ....+.......-+..                   =..++..|++-.|..||++.+++-
T Consensus       279 Eiq~tnse--S~~~---~ee~ia~~i~~len~l-------------------qr~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  279 EIQSTNSE--SKVE---VEENIANVIIGLENGL-------------------QRGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             eeccCCCc--ceee---hhhhhhhheeeccCcc-------------------ccCcCcccccCCCCCCcchhhhhc
Confidence            76432211  1111   1111111111111111                   113446799999999999998863

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.56  E-value=7e-14  Score=127.84  Aligned_cols=186  Identities=18%  Similarity=0.261  Sum_probs=136.9

Q ss_pred             CCcCceeeccCeeEEE-EeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeEE
Q 046639           32 FSPANKIGQGGVSIVY-KGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIV  110 (331)
Q Consensus        32 y~~~~~lg~G~~g~V~-~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv  110 (331)
                      |++ ...+-++.+ +| .|..+.++.+|.|...+..+.+......+-+..|+.++||||+++++.     ++..+..|+|
T Consensus        15 Y~l-e~~~~~~~a-~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t-----~e~~~~~ylv   87 (690)
T KOG1243|consen   15 YDL-EETAFSSEA-LWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDT-----TEEEGTLYLV   87 (690)
T ss_pred             ccc-ccccCCCcc-cccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhh-----hcccCceEEE
Confidence            555 444444444 44 466677888999999877766555667788999999999999999998     6777899999


Q ss_pred             EeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccccC
Q 046639          111 FEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGY  190 (331)
Q Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~  190 (331)
                      +|.+.  .|...+++..     ......-++||+.||.+||...  +++|++|+-+.|+|+..|.+||++|.++......
T Consensus        88 TErV~--Pl~~~lk~l~-----~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~  158 (690)
T KOG1243|consen   88 TERVR--PLETVLKELG-----KEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGF  158 (690)
T ss_pred             eeccc--cHHHHHHHhH-----HHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccC
Confidence            99984  6777776644     2444556779999999998655  9999999999999999999999999988654222


Q ss_pred             CCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCC
Q 046639          191 EPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRR  243 (331)
Q Consensus       191 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~  243 (331)
                      ..        .......--.|..|+......  -..|.|.||+++++++.|..
T Consensus       159 ~~--------~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng~~  201 (690)
T KOG1243|consen  159 NA--------PAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNGSL  201 (690)
T ss_pred             Cc--------ccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCccc
Confidence            11        000111112256666543332  34699999999999999933

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.56  E-value=4.3e-15  Score=134.26  Aligned_cols=253  Identities=21%  Similarity=0.218  Sum_probs=179.4

Q ss_pred             hcCCCcCceeec--cCeeEEEEeee--cCCCceEEEEEeecc--chhhHHHHHHHHHHHHcCC-CCCcceeeceeecccC
Q 046639           29 TNNFSPANKIGQ--GGVSIVYKGIL--DESRSIVAVKVVNLK--QKEASRSFAAECNALRNIR-HRNLIKIITICSSIDF  101 (331)
Q Consensus        29 ~~~y~~~~~lg~--G~~g~V~~~~~--~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~  101 (331)
                      ...+.+.+.+|.  |.+|.||.+..  ..++..+|+|.-+..  .+.....-.+|+.-.+.+. |++.++....     +
T Consensus       113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~-----~  187 (524)
T KOG0601|consen  113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPA-----W  187 (524)
T ss_pred             hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcc-----c
Confidence            345777889999  99999999998  788889999974322  2233333456667666664 8998885555     7


Q ss_pred             CCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHH----HHHHHhhcCCCCeeecCCCCCCEEecCC-CcE
Q 046639          102 EGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSF----AIEYFHHHCQPSIVHGDLKPSNILLDQD-IVA  176 (331)
Q Consensus       102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~----~l~~LH~~~~~~ivH~dik~~nilv~~~-~~~  176 (331)
                      ++.+..++-+|.+ +.+|.++..... ..++....+..+.+...    |+.++|+.   +++|.|++|+||+...+ ...
T Consensus       188 e~~~~lfiqtE~~-~~sl~~~~~~~~-~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~  262 (524)
T KOG0601|consen  188 EGSGILFIQTELC-GESLQSYCHTPC-NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSC  262 (524)
T ss_pred             ccCCcceeeeccc-cchhHHhhhccc-ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheeccccccee
Confidence            8888999999999 778888876432 23455677778888888    99999999   99999999999999999 789


Q ss_pred             EEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHH
Q 046639          177 HVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLH  256 (331)
Q Consensus       177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~  256 (331)
                      +++|||+...+.+..   ............+...|++||.+.+ -++..+|+|++|.++.+...+..+....-  ...+.
T Consensus       263 ~~~df~~v~~i~~~~---~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~--~~~W~  336 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGN---FSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGK--NSSWS  336 (524)
T ss_pred             ecCCcceeEEccCCc---cccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCC--CCCcc
Confidence            999999988763222   1122222233356777999999755 67889999999999999998776543210  01111


Q ss_pred             HHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHH
Q 046639          257 EFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVV  316 (331)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~  316 (331)
                      ..-...++.                   ++.+.-...+...+.+|++.+|..|++++.+.
T Consensus       337 ~~r~~~ip~-------------------e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~  377 (524)
T KOG0601|consen  337 QLRQGYIPL-------------------EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT  377 (524)
T ss_pred             ccccccCch-------------------hhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence            110001111                   12222334455578889999999999998775

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.52  E-value=2.1e-13  Score=124.66  Aligned_cols=164  Identities=15%  Similarity=0.221  Sum_probs=109.7

Q ss_pred             hhhhccCCcccHHHHHHHhc------------CCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhH-------
Q 046639           11 LSMKQQFPMISYAELSKATN------------NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEAS-------   71 (331)
Q Consensus        11 ~~~~~~~~~~~~~~~~~~~~------------~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-------   71 (331)
                      ...+..-|.++++++....+            .|. .+.||+|+.|.||+|+.. +|+.||||+.+.......       
T Consensus        87 ~~Lqd~v~p~~~~~~~~~l~~elg~~~~~~F~~fd-~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l  164 (437)
T TIGR01982        87 SLLQDRVPPFDFKVARKVIEAALGGPLEELFAEFE-EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALL  164 (437)
T ss_pred             HHHhcCCCCCCHHHHHHHHHHHhCcCHHHHHhhCC-CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHH
Confidence            34566677777766655433            222 367999999999999875 788999999853211100       


Q ss_pred             ---------------------------H------HHHHHHHHHHcC----CCCCcceeeceeecccCCCcceeeEEEeec
Q 046639           72 ---------------------------R------SFAAECNALRNI----RHRNLIKIITICSSIDFEGFDFKAIVFEYM  114 (331)
Q Consensus        72 ---------------------------~------~~~~e~~~l~~l----~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~  114 (331)
                                                 .      ++.+|+..+.++    ++.+-+.+..++.+    .....++||||+
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~----~~~~~vLvmE~i  240 (437)
T TIGR01982       165 YRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRREAANASELGENFKNDPGVYVPEVYWD----RTSERVLTMEWI  240 (437)
T ss_pred             HHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehh----hcCCceEEEEeE
Confidence                                       0      133444444444    23334455555422    123468999999


Q ss_pred             CCCCHHHHHHhccCCccchHHHHHHHHHHHH-HHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccc
Q 046639          115 QNRNLEQWLRQSNGQLRFLTQRVNIAIDVSF-AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       115 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~-~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      +|++|.++....... .   ....++..++. .+..+|..   |++|+|++|.||+++.++.++++|||++..+
T Consensus       241 ~G~~L~~~~~~~~~~-~---~~~~ia~~~~~~~l~ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l  307 (437)
T TIGR01982       241 DGIPLSDIAALDEAG-L---DRKALAENLARSFLNQVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRL  307 (437)
T ss_pred             CCcccccHHHHHhcC-C---CHHHHHHHHHHHHHHHHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence            999999876532111 1   12345555555 46778888   9999999999999999999999999998765

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.47  E-value=7.6e-13  Score=122.50  Aligned_cols=161  Identities=16%  Similarity=0.193  Sum_probs=103.6

Q ss_pred             hhhccCCcccHHHHHHHh------------cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccch-----------
Q 046639           12 SMKQQFPMISYAELSKAT------------NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK-----------   68 (331)
Q Consensus        12 ~~~~~~~~~~~~~~~~~~------------~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----------   68 (331)
                      +.++.-|.++++++....            ..|.. +.||+|+.|.||+|+...+|+.||||+.+....           
T Consensus        90 ~Lqd~vpp~~~~~~~~~ie~elG~~~~~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~  168 (537)
T PRK04750         90 LLQDRVPPFDGALARAIIEKALGGPVEEWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMY  168 (537)
T ss_pred             HHHcCCCCCCHHHHHHHHHHHhCCCHHHHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHH
Confidence            456667777776554433            34665 799999999999999987799999999863310           


Q ss_pred             -----------------------hhHHHH------HHHHHHHHcC----CCCCcceeeceeecccCCCcceeeEEEeecC
Q 046639           69 -----------------------EASRSF------AAECNALRNI----RHRNLIKIITICSSIDFEGFDFKAIVFEYMQ  115 (331)
Q Consensus        69 -----------------------~~~~~~------~~e~~~l~~l----~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~  115 (331)
                                             +..+.+      ..|+.-+.++    .+...+.+..++.    +-....++||||+.
T Consensus       169 ~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~----d~st~~VLvmE~i~  244 (537)
T PRK04750        169 RLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYW----DYCSETVMVMERMY  244 (537)
T ss_pred             HHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeec----ccCCCceEEEeeec
Confidence                                   111222      3333333333    2334444444432    22345689999999


Q ss_pred             CCCHHHHH--HhccC--CccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCC----cEEEcccCccccc
Q 046639          116 NRNLEQWL--RQSNG--QLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDI----VAHVGDLGLAKFL  187 (331)
Q Consensus       116 ~~~L~~~l--~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~----~~kl~Dfg~a~~~  187 (331)
                      |+.+.++-  ...+.  ..+....+..++.|+       ...   |++|+|++|.||+++.+|    .++++|||++..+
T Consensus       245 G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l  314 (537)
T PRK04750        245 GIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-------FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL  314 (537)
T ss_pred             CccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence            99998753  22211  112222233333343       345   999999999999999888    9999999998765

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.39  E-value=8e-12  Score=100.87  Aligned_cols=137  Identities=15%  Similarity=0.155  Sum_probs=96.6

Q ss_pred             CceeeccCeeEEEEeeecC------CCceEEEEEeeccc------------h----------hhHHH----HHHHHHHHH
Q 046639           35 ANKIGQGGVSIVYKGILDE------SRSIVAVKVVNLKQ------------K----------EASRS----FAAECNALR   82 (331)
Q Consensus        35 ~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~------------~----------~~~~~----~~~e~~~l~   82 (331)
                      ...||.|--+.||.|....      .+..+|||+.+...            +          .....    ...|++.|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            4579999999999998653      35789999885220            0          11112    347999999


Q ss_pred             cCC--CCCcceeeceeecccCCCcceeeEEEeecCCCCHH-HHHHhccCCccchHHHHHHHHHHHHHHHHH-hhcCCCCe
Q 046639           83 NIR--HRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLE-QWLRQSNGQLRFLTQRVNIAIDVSFAIEYF-HHHCQPSI  158 (331)
Q Consensus        83 ~l~--h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~-~~l~~~~~~~~~~~~~~~~~~~i~~~l~~L-H~~~~~~i  158 (331)
                      ++.  .-++..++++         ...++|||++.+..+. ..++..   .++......++.+++.++..+ |..   ++
T Consensus        82 rl~~~Gv~vP~pi~~---------~~~~lvME~Ig~~~~~~~~Lkd~---~~~~~~~~~i~~~i~~~l~~l~H~~---gl  146 (197)
T cd05146          82 RMQKAGIPCPEVVVL---------KKHVLVMSFIGDDQVPAPKLKDA---KLNDEEMKNAYYQVLSMMKQLYKEC---NL  146 (197)
T ss_pred             HHHHcCCCCCeEEEe---------cCCEEEEEEcCCCCccchhhhcc---ccCHHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence            985  3456666654         3457999999654332 122221   133344566788999999988 788   99


Q ss_pred             eecCCCCCCEEecCCCcEEEcccCccccc
Q 046639          159 VHGDLKPSNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       159 vH~dik~~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      +|+|+++.||+++ ++.++|+|||.+...
T Consensus       147 VHGDLs~~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         147 VHADLSEYNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             ecCCCCHHHEEEE-CCcEEEEECCCceeC
Confidence            9999999999997 467999999987653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.36  E-value=2.8e-12  Score=102.54  Aligned_cols=131  Identities=15%  Similarity=0.101  Sum_probs=93.3

Q ss_pred             CceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcc-eeeceeecccCCCcceeeEEEee
Q 046639           35 ANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLI-KIITICSSIDFEGFDFKAIVFEY  113 (331)
Q Consensus        35 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~~~~~~lv~e~  113 (331)
                      .+.|+.|.++.||++...  +..+++|+...... ....+..|+.+++.+.+.+++ +++...     .  ...++|||+
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~-----~--~~~~lv~e~   72 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD-----P--ETGVLITEF   72 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe-----C--CCCeEEEEe
Confidence            457889999999998875  67899998753321 223457888988888654443 344331     1  224799999


Q ss_pred             cCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcC--CCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          114 MQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHC--QPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       114 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      ++|.++.+.-       .   .....+.+++.+++.||+..  ..+++|+|++|.||+++ ++.++++||+.+..
T Consensus        73 i~G~~l~~~~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          73 IEGSELLTED-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cCCCcccccc-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            9998876530       0   11235678999999999982  11259999999999999 66899999998753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.35  E-value=5.3e-11  Score=103.77  Aligned_cols=274  Identities=14%  Similarity=0.119  Sum_probs=166.3

Q ss_pred             CCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcC-CCCCcceeeceeecc--cCCCcceee
Q 046639           32 FSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNI-RHRNLIKIITICSSI--DFEGFDFKA  108 (331)
Q Consensus        32 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~~~~~~  108 (331)
                      ...+..||+|+-+.+|..-...+   .+-|++....+....+..   ..|... .||-+-.-+.|-...  .-.......
T Consensus        13 i~~gr~LgqGgea~ly~l~e~~d---~VAKIYh~Pppa~~aqk~---a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iG   86 (637)
T COG4248          13 IPPGRPLGQGGEADLYTLGEVRD---QVAKIYHAPPPAAQAQKV---AELAATPDAPLLNYRVAWPQATLHGGRRGKVIG   86 (637)
T ss_pred             cCCCccccCCccceeeecchhhc---hhheeecCCCchHHHHHH---HHhccCCCCcchhhhhcccHHHhhCCCccceeE
Confidence            45577899999999996544322   345888766554433332   223333 355432212111110  012233366


Q ss_pred             EEEeecCCC-CHHHHHH----hccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCc
Q 046639          109 IVFEYMQNR-NLEQWLR----QSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGL  183 (331)
Q Consensus       109 lv~e~~~~~-~L~~~l~----~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~  183 (331)
                      +.|..+.+. ....+.+    ++......|......+..++.+.+.||..   |.+-+|++++|+|+++++.|+|.|-..
T Consensus        87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDs  163 (637)
T COG4248          87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDS  163 (637)
T ss_pred             EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccc
Confidence            788877653 2222221    13344466777888999999999999999   999999999999999999999998665


Q ss_pred             ccccccCCCCCcccccCCceeecccccccCCcccC-----CCCCccchhhHhHHHHHHHHHhC-CCCCCcccCCc---ch
Q 046639          184 AKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGM-----GSKASVSGDVYNFGILLLEMFTR-RRPTDAMFNEG---LT  254 (331)
Q Consensus       184 a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~~g-~~pf~~~~~~~---~~  254 (331)
                      ....         ..........|.+.|.+||...     +-..+...|-|.||+++++++.| +.||.+.....   ..
T Consensus       164 fqi~---------~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p  234 (637)
T COG4248         164 FQIN---------ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNP  234 (637)
T ss_pred             eeec---------cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCc
Confidence            4432         1122233445788899999855     33456789999999999999886 99997642211   11


Q ss_pred             HH-HHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCC--CCCCCcHHHHHHHHHHhhhhhhc
Q 046639          255 LH-EFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMES--PMERMEMRDVVAKLRHARETFLG  328 (331)
Q Consensus       255 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~--P~~Rps~~~i~~~L~~~~~~~~~  328 (331)
                      +. ++.......-    .+..-.....+.. .-..-.++.+..|..+|....  +.-|||++.++..|..+.+.+..
T Consensus       235 ~E~~Ia~g~f~ya----~~~~~g~~p~P~~-~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~  306 (637)
T COG4248         235 LETDIAHGRFAYA----SDQRRGLKPPPRS-IPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKK  306 (637)
T ss_pred             chhhhhcceeeec----hhccCCCCCCCCC-CChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhh
Confidence            11 1111111100    0000000000111 111234456667777787654  67899999999999999988754

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.20  E-value=1.8e-11  Score=111.02  Aligned_cols=248  Identities=17%  Similarity=0.118  Sum_probs=166.0

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeec-CCCceEEEEEeeccchhhH--HHHHHHHHHHHcC-CCCCcceeeceeecccCCC
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILD-ESRSIVAVKVVNLKQKEAS--RSFAAECNALRNI-RHRNLIKIITICSSIDFEG  103 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~--~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~  103 (331)
                      ...+|..+..||.|.|+.|+.+..+ .++..|++|.+........  ..-+.|+.+...+ .|.+++.....     |..
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~-----W~~  337 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSS-----WSQ  337 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCC-----ccc
Confidence            3447888999999999999987765 6777888887643322222  2234566666666 48888887766     444


Q ss_pred             cceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCC-CcEEEcccC
Q 046639          104 FDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQD-IVAHVGDLG  182 (331)
Q Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~-~~~kl~Dfg  182 (331)
                      ....++-.|||+++++...+.-  ..-+.....+.+..|++.++.++|++   .++|+|++|+||++..+ +..+++||+
T Consensus       338 ~r~~~ip~e~~~~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~  412 (524)
T KOG0601|consen  338 LRQGYIPLEFCEGGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFG  412 (524)
T ss_pred             cccccCchhhhcCcchhhhhHH--HHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccc
Confidence            4556789999988888766522  11244566678888999999999999   99999999999999876 778999999


Q ss_pred             cccccccCCCCCcccccCCceeecccccc-cCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHh
Q 046639          183 LAKFLFGYEPGTAAETASNSIEIKGIVGY-VAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKM  261 (331)
Q Consensus       183 ~a~~~~~~~~~~~~~~~~~~~~~~~t~~y-~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  261 (331)
                      +...+..          ........+..| .++.......+..+.|++|||..+.+..++.+.-...    .....    
T Consensus       413 ~~t~~~~----------~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~----~~~~~----  474 (524)
T KOG0601|consen  413 CWTRLAF----------SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG----VQSLT----  474 (524)
T ss_pred             cccccce----------ecccccccccccccchhhccccccccccccccccccccccccCcccCccc----cccee----
Confidence            8864211          011111122223 3555666677899999999999999999887543211    01111    


Q ss_pred             hCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHH
Q 046639          262 ALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLR  320 (331)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~  320 (331)
                           ++....+..            ......+..+...+...++..||++.++....+
T Consensus       475 -----i~~~~~p~~------------~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~  516 (524)
T KOG0601|consen  475 -----IRSGDTPNL------------PGLKLQLQVLLKVMINPDRKRRPSAVELSLHSE  516 (524)
T ss_pred             -----eecccccCC------------CchHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence                 111111111            112255667777889999999999988765443

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.20  E-value=3.1e-10  Score=88.51  Aligned_cols=143  Identities=21%  Similarity=0.207  Sum_probs=100.5

Q ss_pred             cCceeeccCeeEEEEeeecCCCceEEEEEee-----ccc---hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcc
Q 046639           34 PANKIGQGGVSIVYKGILDESRSIVAVKVVN-----LKQ---KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFD  105 (331)
Q Consensus        34 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~-----~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~  105 (331)
                      .+..+-+|+-+.|+++.+.  |+.+.||-=.     .+.   .-..++..+|++.+.++.--.|.-.--++     -+.+
T Consensus        11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~-----~D~~   83 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIF-----IDTY   83 (229)
T ss_pred             cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEE-----EecC
Confidence            5788999999999999885  7777777421     111   11235567899999887532222221121     1223


Q ss_pred             eeeEEEeecCC-CCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCC---cEEEccc
Q 046639          106 FKAIVFEYMQN-RNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDI---VAHVGDL  181 (331)
Q Consensus       106 ~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~---~~kl~Df  181 (331)
                      .-.++|||++| .++.+++...............++.++-..+.-||.+   +++|+|+..+||++..++   .+.++||
T Consensus        84 ~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdf  160 (229)
T KOG3087|consen   84 GGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDF  160 (229)
T ss_pred             CCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEee
Confidence            44799999965 4888888775444333344468888999999999999   999999999999997655   4589999


Q ss_pred             Ccccc
Q 046639          182 GLAKF  186 (331)
Q Consensus       182 g~a~~  186 (331)
                      |++..
T Consensus       161 gls~~  165 (229)
T KOG3087|consen  161 GLSSV  165 (229)
T ss_pred             cchhc
Confidence            99864

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.20  E-value=2.7e-10  Score=89.18  Aligned_cols=129  Identities=27%  Similarity=0.324  Sum_probs=91.9

Q ss_pred             ceeeccCeeEEEEeeecCCCceEEEEEeecc---chh-----hHHHHHHHHHHHHcCCC--CCcceeeceeecccCCCcc
Q 046639           36 NKIGQGGVSIVYKGILDESRSIVAVKVVNLK---QKE-----ASRSFAAECNALRNIRH--RNLIKIITICSSIDFEGFD  105 (331)
Q Consensus        36 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~-----~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~~~  105 (331)
                      ..+++|+-+.++.+.+.  +.++++|.=..+   .++     ....-.+|+.++.++.-  -+...++++       +..
T Consensus         2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv-------D~~   72 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV-------DPD   72 (204)
T ss_pred             chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE-------cCC
Confidence            46789999999998774  545666642111   111     12445678999888752  333344443       123


Q ss_pred             eeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccc
Q 046639          106 FKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAK  185 (331)
Q Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~  185 (331)
                      ...++|||++|..|.+.+....         ..++..+-.-+.-||..   ||+|+|+.++||+++.++ +.++|||++.
T Consensus        73 ~~~I~me~I~G~~lkd~l~~~~---------~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~  139 (204)
T COG3642          73 NGLIVMEYIEGELLKDALEEAR---------PDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGE  139 (204)
T ss_pred             CCEEEEEEeCChhHHHHHHhcc---------hHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCccc
Confidence            4579999999999998986541         33556677778899999   999999999999998765 8889999986


Q ss_pred             c
Q 046639          186 F  186 (331)
Q Consensus       186 ~  186 (331)
                      .
T Consensus       140 ~  140 (204)
T COG3642         140 F  140 (204)
T ss_pred             c
Confidence            4

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.17  E-value=1.3e-11  Score=118.17  Aligned_cols=258  Identities=19%  Similarity=0.216  Sum_probs=165.4

Q ss_pred             HHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccch---hhHHHHHHHHHHHHcCCCCCcceeeceeecccCCC
Q 046639           27 KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK---EASRSFAAECNALRNIRHRNLIKIITICSSIDFEG  103 (331)
Q Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  103 (331)
                      .....+.+.+-+.+|.++.++.+.-..++...+.++......   ...+....+-.++-...+|-++....-     +.-
T Consensus       801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s-----~~~  875 (1205)
T KOG0606|consen  801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPS-----FPC  875 (1205)
T ss_pred             CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCC-----CCC
Confidence            344567788899999999999988877775555555432211   111111111112111123333322221     233


Q ss_pred             cceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCc
Q 046639          104 FDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGL  183 (331)
Q Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~  183 (331)
                      ....+++++++.+++|...+...+.  .+..........+..++.+||+.   .+.|+|++|.|.++..+|..++.||+.
T Consensus       876 rsP~~L~~~~~~~~~~~Skl~~~~~--~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t  950 (1205)
T KOG0606|consen  876 RSPLPLVGHYLNGGDLPSKLHNSGC--LSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGT  950 (1205)
T ss_pred             CCCcchhhHHhccCCchhhhhcCCC--cccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccc
Confidence            4567899999999999999876542  33344555667788999999998   899999999999999999999999983


Q ss_pred             cccccc------CC-C-----------CC-----cccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh
Q 046639          184 AKFLFG------YE-P-----------GT-----AAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT  240 (331)
Q Consensus       184 a~~~~~------~~-~-----------~~-----~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~  240 (331)
                      .....-      .. .           ..     ............+|+.|.+||.+.+......+|.|+.|+++++.++
T Consensus       951 ~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~ 1030 (1205)
T KOG0606|consen  951 LSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLT 1030 (1205)
T ss_pred             ccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhc
Confidence            322210      00 0           00     0001122334568999999999999999999999999999999999


Q ss_pred             CCCCCCcccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHH
Q 046639          241 RRRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMR  313 (331)
Q Consensus       241 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~  313 (331)
                      |.+||.....+. .+..+.....+-                  ..-.........+++...+..+|.+|..+.
T Consensus      1031 g~pp~na~tpq~-~f~ni~~~~~~~------------------p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1031 GIPPFNAETPQQ-IFENILNRDIPW------------------PEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCCCCCcchhh-hhhccccCCCCC------------------CCCccccChhhhhhhhhhhccCchhccCcc
Confidence            999997653322 112221111110                  011122344566777788888999997665

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.13  E-value=5e-10  Score=92.86  Aligned_cols=150  Identities=26%  Similarity=0.203  Sum_probs=109.4

Q ss_pred             CCcccHHHHHHHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc----------------------hhhHHHH
Q 046639           17 FPMISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ----------------------KEASRSF   74 (331)
Q Consensus        17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------------------~~~~~~~   74 (331)
                      |-...+..+.....=+.++.+||-|--|.||.|.+. .+.++|||.-+.-.                      .......
T Consensus        78 yD~LAL~~l~~r~~ve~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A  156 (304)
T COG0478          78 YDALALHALVKRGIVEAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAA  156 (304)
T ss_pred             hhHHHHHHHHHcChHHhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHH
Confidence            334456666676667888999999999999999986 77889999753210                      1123446


Q ss_pred             HHHHHHHHcCCCC--CcceeeceeecccCCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhh
Q 046639           75 AAECNALRNIRHR--NLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHH  152 (331)
Q Consensus        75 ~~e~~~l~~l~h~--~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~  152 (331)
                      .+|..+|..|...  .+...+++         +..++|||+++|..|...--       .....-.++..|+.-+..+-.
T Consensus       157 ~rEf~~L~~L~~~G~~VP~P~~~---------nRHaVvMe~ieG~eL~~~r~-------~~en~~~il~~il~~~~~~~~  220 (304)
T COG0478         157 EREFEALQRLYPEGVKVPKPIAW---------NRHAVVMEYIEGVELYRLRL-------DVENPDEILDKILEEVRKAYR  220 (304)
T ss_pred             HHHHHHHHHhhhcCCCCCCcccc---------ccceeeeehcccceeecccC-------cccCHHHHHHHHHHHHHHHHH
Confidence            7899999998655  77777776         56689999998877765431       112223344555555555556


Q ss_pred             cCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       153 ~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      .   |+||+|+++-||+++++|.+.++||--+..
T Consensus       221 ~---GiVHGDlSefNIlV~~dg~~~vIDwPQ~v~  251 (304)
T COG0478         221 R---GIVHGDLSEFNILVTEDGDIVVIDWPQAVP  251 (304)
T ss_pred             c---CccccCCchheEEEecCCCEEEEeCccccc
Confidence            6   999999999999999999999999976543

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.11  E-value=1.4e-09  Score=87.62  Aligned_cols=123  Identities=24%  Similarity=0.235  Sum_probs=79.5

Q ss_pred             EEEeeecCCCceEEEEEeeccc--------------------------hhhHHHHHHHHHHHHcCCCC--Ccceeeceee
Q 046639           46 VYKGILDESRSIVAVKVVNLKQ--------------------------KEASRSFAAECNALRNIRHR--NLIKIITICS   97 (331)
Q Consensus        46 V~~~~~~~~~~~vavK~~~~~~--------------------------~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~   97 (331)
                      ||.|... .+..+|+|+.....                          ........+|.+.|.++...  ++..++.+  
T Consensus         2 Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~--   78 (188)
T PF01163_consen    2 VYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY--   78 (188)
T ss_dssp             EEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred             EEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence            7888774 56789999875320                          01124467899999999755  56666654  


Q ss_pred             cccCCCcceeeEEEeecC--CCCHHHHHHhccCCccchHHHHHHHHHHHHHHHH-HhhcCCCCeeecCCCCCCEEecCCC
Q 046639           98 SIDFEGFDFKAIVFEYMQ--NRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEY-FHHHCQPSIVHGDLKPSNILLDQDI  174 (331)
Q Consensus        98 ~~~~~~~~~~~lv~e~~~--~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~-LH~~~~~~ivH~dik~~nilv~~~~  174 (331)
                             ...++||||++  |..+..+....    +.......++.+++..+.. +|..   |++|+|+++.||+++++ 
T Consensus        79 -------~~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-  143 (188)
T PF01163_consen   79 -------NRNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-  143 (188)
T ss_dssp             -------ETTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-
T ss_pred             -------eCCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-
Confidence                   23479999997  65555544322    1123445677788885555 5787   99999999999999977 


Q ss_pred             cEEEcccCcccc
Q 046639          175 VAHVGDLGLAKF  186 (331)
Q Consensus       175 ~~kl~Dfg~a~~  186 (331)
                      .+.++|||.+..
T Consensus       144 ~~~iIDf~qav~  155 (188)
T PF01163_consen  144 KVYIIDFGQAVD  155 (188)
T ss_dssp             CEEE--GTTEEE
T ss_pred             eEEEEecCccee
Confidence            899999998865

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.11  E-value=8.2e-10  Score=92.22  Aligned_cols=146  Identities=19%  Similarity=0.250  Sum_probs=101.8

Q ss_pred             CceeeccCeeEEEEeeecCCCceEEEEEeeccch-hhHHHHHHHHHHHHcCCC--CCcceeeceeecccCCCcceeeEEE
Q 046639           35 ANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK-EASRSFAAECNALRNIRH--RNLIKIITICSSIDFEGFDFKAIVF  111 (331)
Q Consensus        35 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~~~~~~lv~  111 (331)
                      .+.|+.|..+.||++... +++.+++|....... .....+..|+.+++.+.+  ..+.+++.+....  ...+..++||
T Consensus         3 ~~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~--~~~~~~~~v~   79 (223)
T cd05154           3 VRQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDP--SVLGTPFYVM   79 (223)
T ss_pred             ceecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCC--CccCCceEEE
Confidence            357899999999999875 357899998754322 134567899999999865  3456666653221  1113568999


Q ss_pred             eecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcC-------------------------------------
Q 046639          112 EYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHC-------------------------------------  154 (331)
Q Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~-------------------------------------  154 (331)
                      |+++|.++.+.+..   ..++......++.+++.+|+.||+..                                     
T Consensus        80 e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (223)
T cd05154          80 ERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA  156 (223)
T ss_pred             EEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence            99999888765421   12344555566667777777776421                                     


Q ss_pred             ----------------CCCeeecCCCCCCEEecC--CCcEEEcccCcccc
Q 046639          155 ----------------QPSIVHGDLKPSNILLDQ--DIVAHVGDLGLAKF  186 (331)
Q Consensus       155 ----------------~~~ivH~dik~~nilv~~--~~~~kl~Dfg~a~~  186 (331)
                                      ...++|+|+.+.||+++.  ++.+.|+||+.+..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                            136899999999999998  66789999998764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.07  E-value=7.9e-09  Score=92.60  Aligned_cols=174  Identities=14%  Similarity=0.140  Sum_probs=130.8

Q ss_pred             CeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeEEEeecCC-CCHH
Q 046639           42 GVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQN-RNLE  120 (331)
Q Consensus        42 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~~L~  120 (331)
                      ...+.|++....+|..|++|+++............-+++++++.|.|+|++.+++...- .+...+++|++|+++ ++|.
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~t-F~D~SlvlvYDYyP~s~TL~  366 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYT-FGDLSLVLVYDYYPSSPTLY  366 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhc-cCcceEEEEEecCCCCchHH
Confidence            34678999998899999999995443333333455688999999999999999877432 334568999999875 6777


Q ss_pred             HHHHh-------------ccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccc
Q 046639          121 QWLRQ-------------SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       121 ~~l~~-------------~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      ++--.             ..+...++..+|.++.|+..||+++|+.   |+.-+=+.+.+|+++++-.++|..+|.....
T Consensus       367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl  443 (655)
T KOG3741|consen  367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVL  443 (655)
T ss_pred             HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeee
Confidence            76432             1233466788999999999999999999   9999999999999999989999988877654


Q ss_pred             ccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCC
Q 046639          188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP  244 (331)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p  244 (331)
                      ....                    .  |-+.+   ..+-|.=.||.++..|.+|..-
T Consensus       444 ~~d~--------------------~--~~le~---~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  444 QEDP--------------------T--EPLES---QQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             cCCC--------------------C--cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence            1100                    0  11111   2345888999999999999643

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.06  E-value=9.1e-09  Score=87.80  Aligned_cols=146  Identities=14%  Similarity=0.009  Sum_probs=95.4

Q ss_pred             ceeeccCeeEEEEeeecCCCceEEEEEeeccchh-hH----------HHHHHHHHHHHcCCC--CCcceeeceeecccCC
Q 046639           36 NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKE-AS----------RSFAAECNALRNIRH--RNLIKIITICSSIDFE  102 (331)
Q Consensus        36 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~----------~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~  102 (331)
                      +.+-......|.++..  .|+.+.||......-. ..          ....+|...+.++..  -..+..+.+.......
T Consensus        28 e~v~~~~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~  105 (268)
T PRK15123         28 EVFRELEGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP  105 (268)
T ss_pred             cEEecCCCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence            3444334444556655  4678999976422211 11          136678888877732  2223333332211111


Q ss_pred             CcceeeEEEeecCCC-CHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecC-------CC
Q 046639          103 GFDFKAIVFEYMQNR-NLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQ-------DI  174 (331)
Q Consensus       103 ~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~-------~~  174 (331)
                      .....++|||++++. +|.+++...............++.+++..++.||..   |++|+|+++.||+++.       ++
T Consensus       106 ~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~  182 (268)
T PRK15123        106 ATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDL  182 (268)
T ss_pred             ccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCc
Confidence            133468999999875 899998643223344456678999999999999999   9999999999999975       46


Q ss_pred             cEEEcccCcccc
Q 046639          175 VAHVGDLGLAKF  186 (331)
Q Consensus       175 ~~kl~Dfg~a~~  186 (331)
                      .+.++||+.+..
T Consensus       183 ~~~LIDl~r~~~  194 (268)
T PRK15123        183 KLSVIDLHRAQI  194 (268)
T ss_pred             eEEEEECCcccc
Confidence            789999998753

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.93  E-value=2.4e-10  Score=105.45  Aligned_cols=155  Identities=13%  Similarity=0.205  Sum_probs=99.4

Q ss_pred             HHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccccCCCCCc-ccccCCceeecccccccCCcccCCC
Q 046639          142 DVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTA-AETASNSIEIKGIVGYVAPEYGMGS  220 (331)
Q Consensus       142 ~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~~~~~~-~~~~~~~~~~~~t~~y~aPE~~~~~  220 (331)
                      +++.|+.++|...  ++||++|.|++|.++..|.+||++|+++........-.. .-+...+........|.|||++.+.
T Consensus       107 ~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~  184 (700)
T KOG2137|consen  107 NVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT  184 (700)
T ss_pred             cccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence            4559999999876  999999999999999999999999998765422111000 0111111122234569999999998


Q ss_pred             CCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhc
Q 046639          221 KASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGV  299 (331)
Q Consensus       221 ~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  299 (331)
                      ..+.++|+||+|+++|.+.. |...+.......  ....         ....+..-..       .+..+.+.++.+=+.
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~--~~~~---------~~~~~~~~~~-------~~s~~~p~el~~~l~  246 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLL--SYSF---------SRNLLNAGAF-------GYSNNLPSELRESLK  246 (700)
T ss_pred             cccccccceeeeeEEEEEecCCcchhhccCCcc--hhhh---------hhcccccccc-------cccccCcHHHHHHHH
Confidence            88999999999999999994 555554321111  1110         0000100000       111234555666667


Q ss_pred             cccCCCCCCCCcHHHHH
Q 046639          300 TCSMESPMERMEMRDVV  316 (331)
Q Consensus       300 ~cl~~~P~~Rps~~~i~  316 (331)
                      +++..++.-||++..+.
T Consensus       247 k~l~~~~~~rp~~~~l~  263 (700)
T KOG2137|consen  247 KLLNGDSAVRPTLDLLL  263 (700)
T ss_pred             HHhcCCcccCcchhhhh
Confidence            78899999999776654

>PRK09902 hypothetical protein; Provisional

Probab=98.86  E-value=6.9e-08  Score=78.34  Aligned_cols=143  Identities=17%  Similarity=0.122  Sum_probs=101.3

Q ss_pred             eeccCeeEEEEeeecCCCceEEEEEeecc------chhhHHHHHHHHHHHHcCCC--CCcceeeceeecccCCCcceeeE
Q 046639           38 IGQGGVSIVYKGILDESRSIVAVKVVNLK------QKEASRSFAAECNALRNIRH--RNLIKIITICSSIDFEGFDFKAI  109 (331)
Q Consensus        38 lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~~~~~~l  109 (331)
                      -|+||.|.|+.....  |..+-+|.-..-      -+-....+.+|...++.+..  -.+.++. ++...-.......+|
T Consensus        26 ~~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L  102 (216)
T PRK09902         26 YRRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL  102 (216)
T ss_pred             cCCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence            456888889987664  335667754300      02244668899999998852  2244444 332111222445689


Q ss_pred             EEeecCC-CCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCc--EEEcccCcccc
Q 046639          110 VFEYMQN-RNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIV--AHVGDLGLAKF  186 (331)
Q Consensus       110 v~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~--~kl~Dfg~a~~  186 (331)
                      |+|-+.+ .+|.+++....-...+......++.+++..++-||..   |+.|+|+.+.||+++.+|.  +.++||.-++.
T Consensus       103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            9998843 7899998765444455666778999999999999999   9999999999999986676  99999987654

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.76  E-value=2e-07  Score=76.85  Aligned_cols=108  Identities=25%  Similarity=0.253  Sum_probs=79.1

Q ss_pred             HHHHHHHHHHcCC--CCCcceeeceeecccCCCcceeeEEEeecCC-CCHHHHHHhccCCccchHHHHHHHHHHHHHHHH
Q 046639           73 SFAAECNALRNIR--HRNLIKIITICSSIDFEGFDFKAIVFEYMQN-RNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEY  149 (331)
Q Consensus        73 ~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~  149 (331)
                      ...+|...+..+.  .-.++..+.+..... ......++|||.+++ .+|.+++.....  .+......++.+++..++-
T Consensus        57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~-~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~~  133 (206)
T PF06293_consen   57 RAKREWRNLQRLREAGIPTPEPVAYGERRK-GGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIAK  133 (206)
T ss_pred             HHHHHHHHHHHHHHcCCCCCcEEEEEEEcC-CCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHHH
Confidence            4667777766663  223444444433221 112455899999987 489999876333  3345667899999999999


Q ss_pred             HhhcCCCCeeecCCCCCCEEecCCC---cEEEcccCcccc
Q 046639          150 FHHHCQPSIVHGDLKPSNILLDQDI---VAHVGDLGLAKF  186 (331)
Q Consensus       150 LH~~~~~~ivH~dik~~nilv~~~~---~~kl~Dfg~a~~  186 (331)
                      ||..   |++|+|+++.|||++.++   .+.++||+.++.
T Consensus       134 lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  134 LHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            9999   999999999999999887   899999998765

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.65  E-value=5.8e-07  Score=73.28  Aligned_cols=142  Identities=17%  Similarity=0.167  Sum_probs=89.1

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHH---------HHHHHHHHHcCCC---CCcceeece
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRS---------FAAECNALRNIRH---RNLIKIITI   95 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~e~~~l~~l~h---~~i~~~~~~   95 (331)
                      ..++|.+.+.+-......|.+..-  .+..+++|..........+.         ..+.+..+.++..   .....++.+
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~  106 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA  106 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence            345788888888777777776555  46778899876443222111         2223333333322   222222222


Q ss_pred             eecccCCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCc
Q 046639           96 CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIV  175 (331)
Q Consensus        96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~  175 (331)
                      ..--.+.-....+++|||++|..|.+...      +..    .++-.+..++.-+|..   |++|+|..|.|++++.++ 
T Consensus       107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~~-  172 (229)
T PF06176_consen  107 AEKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNNG-  172 (229)
T ss_pred             eeeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECCc-
Confidence            22111222344568999999988877542      111    2445677889999999   999999999999999655 


Q ss_pred             EEEcccCccc
Q 046639          176 AHVGDLGLAK  185 (331)
Q Consensus       176 ~kl~Dfg~a~  185 (331)
                      ++++||+..+
T Consensus       173 i~iID~~~k~  182 (229)
T PF06176_consen  173 IRIIDTQGKR  182 (229)
T ss_pred             EEEEECcccc
Confidence            8899998654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.64  E-value=1.8e-07  Score=72.89  Aligned_cols=130  Identities=22%  Similarity=0.231  Sum_probs=95.0

Q ss_pred             CCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCccee-eceeecccCCCcceeeEE
Q 046639           32 FSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKI-ITICSSIDFEGFDFKAIV  110 (331)
Q Consensus        32 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~~~~~~~lv  110 (331)
                      -...+.|++|.+|.||+|.++  +..+|+|+-..  +.....+..|++++..+.-.++.+= +.+         +..++.
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~--ds~r~~l~kEakiLeil~g~~~~p~vy~y---------g~~~i~   90 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEWR--GGEVALKVRRR--DSPRRNLEKEAKILEILAGEGVTPEVYFY---------GEDFIR   90 (201)
T ss_pred             hhhhhhhhcccccEEEEeecc--CceEEEEEecC--CcchhhHHHHHHHHHHhhhcCCCceEEEe---------chhhhh
Confidence            455689999999999999997  55889997643  3445678999999999876555433 333         233466


Q ss_pred             EeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCC-CCCEEecCCCcEEEcccCcccc
Q 046639          111 FEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLK-PSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik-~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      |||+.|..|.++-...         -.+....+++.-.-|...   ||-|+.|+ |...++..++.+.|+||..|..
T Consensus        91 me~i~G~~L~~~~~~~---------~rk~l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          91 MEYIDGRPLGKLEIGG---------DRKHLLRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hhhhcCcchhhhhhcc---------cHHHHHHHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            9999888888765321         123445677887778888   99999998 4555555566899999998874

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.58  E-value=4e-07  Score=84.28  Aligned_cols=165  Identities=16%  Similarity=0.245  Sum_probs=102.8

Q ss_pred             hhhhccCCcccHHHHHHHh------------cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc-----------
Q 046639           11 LSMKQQFPMISYAELSKAT------------NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ-----------   67 (331)
Q Consensus        11 ~~~~~~~~~~~~~~~~~~~------------~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----------   67 (331)
                      -..+...|+++.++.....            .+|. -+.|+.++-|.||+|+.. +|+.||||+.+..-           
T Consensus        95 ~~LQD~vpp~~~~~~~~iie~eLG~~iee~F~eF~-~~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il  172 (517)
T COG0661          95 AKLQDRVPPFPFEEAERIIEEELGRPIEELFSEFE-PEPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLL  172 (517)
T ss_pred             HHhhcCCCCCCHHHHHHHHHHHhCCCHHHHHHHcC-CCchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHH
Confidence            3456777888777655433            2232 267889999999999997 58999999875320           


Q ss_pred             -----------------------hhhHHH------HHHHHHHHHcC----CCCCcceeeceeecccCCCcceeeEEEeec
Q 046639           68 -----------------------KEASRS------FAAECNALRNI----RHRNLIKIITICSSIDFEGFDFKAIVFEYM  114 (331)
Q Consensus        68 -----------------------~~~~~~------~~~e~~~l~~l----~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~  114 (331)
                                             .+..+.      +..|+.-+.++    ....-+.+..++    ++-.+.-+++|||+
T Consensus       173 ~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~----we~t~~~VLtmE~i  248 (517)
T COG0661         173 RRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRREAANAERFRENFKDDPDVYVPKVY----WEYTTRRVLTMEWI  248 (517)
T ss_pred             HHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceee----hhccCCcEEEEEee
Confidence                                   011111      33344444443    222233444444    33345568999999


Q ss_pred             CCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccc
Q 046639          115 QNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       115 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      +|..+.+...-.. ...+...+...+.++.  +..+-..   |++|.|..|.||+++.+|.+.+.|||+...+
T Consensus       249 ~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~~d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l  315 (517)
T COG0661         249 DGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLLRD---GFFHADPHPGNILVRSDGRIVLLDFGIVGRL  315 (517)
T ss_pred             CCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHHhc---CccccCCCccceEEecCCcEEEEcCcceecC
Confidence            9999988843222 1233233332222221  1222223   9999999999999999999999999988765

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.53  E-value=2.3e-06  Score=70.64  Aligned_cols=152  Identities=20%  Similarity=0.170  Sum_probs=99.7

Q ss_pred             ccHHHHHHHhcCCCcCceee---ccCeeEEEEeeecCCCceEEEEEeeccchhh------------------------HH
Q 046639           20 ISYAELSKATNNFSPANKIG---QGGVSIVYKGILDESRSIVAVKVVNLKQKEA------------------------SR   72 (331)
Q Consensus        20 ~~~~~~~~~~~~y~~~~~lg---~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------------------------~~   72 (331)
                      .....|....++..+-...|   +|-.+.||+|.. .++..+|+|+++......                        ..
T Consensus        35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~  113 (268)
T COG1718          35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFA  113 (268)
T ss_pred             HHHHHHHHHhcCCceeeeEeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHH
Confidence            35566667777777766555   566678999876 367889999986431110                        01


Q ss_pred             HHHHHHHHHHcCC--CCCcceeeceeecccCCCcceeeEEEeecCCC-CHHHHHHhccCCccchHHHHHHHHHHHHHHHH
Q 046639           73 SFAAECNALRNIR--HRNLIKIITICSSIDFEGFDFKAIVFEYMQNR-NLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEY  149 (331)
Q Consensus        73 ~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~  149 (331)
                      -...|+.-|+++.  +-.+.+.+.+         ....+||||+... .-.-.++..   .+.......+..+++..+.-
T Consensus       114 W~~kEf~NL~R~~eAGVrvP~Pi~~---------~~nVLvMEfIg~~g~pAP~LkDv---~~e~~e~~~~~~~~v~~~~~  181 (268)
T COG1718         114 WARKEFRNLKRAYEAGVRVPEPIAF---------RNNVLVMEFIGDDGLPAPRLKDV---PLELEEAEGLYEDVVEYMRR  181 (268)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCceee---------cCCeEEEEeccCCCCCCCCcccC---CcCchhHHHHHHHHHHHHHH
Confidence            1345666676663  4445555554         2347999999432 111122211   12223466677788888888


Q ss_pred             HhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccc
Q 046639          150 FHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       150 LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      |-...  ++||+||+.=|||+. ++.+.++||+-|...
T Consensus       182 l~~~a--~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~  216 (268)
T COG1718         182 LYKEA--GLVHGDLSEYNILVH-DGEPYIIDVSQAVTI  216 (268)
T ss_pred             HHHhc--CcccccchhhheEEE-CCeEEEEECcccccc
Confidence            87733  999999999999999 889999999987653

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.47  E-value=2.8e-06  Score=71.04  Aligned_cols=139  Identities=15%  Similarity=0.186  Sum_probs=78.9

Q ss_pred             ceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCC--cceeeceeecccCCCcceeeEEEee
Q 046639           36 NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRN--LIKIITICSSIDFEGFDFKAIVFEY  113 (331)
Q Consensus        36 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~~~~~~lv~e~  113 (331)
                      ..||+|..+.||+.    .+..+++|......  ....+.+|.++++.+..-.  +.+++.++     +..+...+|||+
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~-----~~~~~~glv~e~   75 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLV-----EDGGRLGLIYEL   75 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEE-----ecCCeeeeeeee
Confidence            58999999999984    23457788875322  2345688999998875322  34555553     233446789999


Q ss_pred             cCCCC-HHHHH--------------Hh-----cc--CCccchHHHHH-HHH----------HHHH-HHHHHhhc-CCCCe
Q 046639          114 MQNRN-LEQWL--------------RQ-----SN--GQLRFLTQRVN-IAI----------DVSF-AIEYFHHH-CQPSI  158 (331)
Q Consensus       114 ~~~~~-L~~~l--------------~~-----~~--~~~~~~~~~~~-~~~----------~i~~-~l~~LH~~-~~~~i  158 (331)
                      ++|.+ +...+              .+     +.  ........... +..          .+.. ...+|... ..+.+
T Consensus        76 i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~  155 (226)
T TIGR02172        76 IVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTC  155 (226)
T ss_pred             cCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCce
Confidence            98853 21111              11     00  00011111100 000          0001 11111111 12367


Q ss_pred             eecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          159 VHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       159 vH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      +|+|+.|.||++++++ +.++||+.+..
T Consensus       156 ~HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       156 LHGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             EecCCCCCcEEEcCCC-cEEEechhcCc
Confidence            9999999999999888 88999998753

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.40  E-value=4.2e-06  Score=77.43  Aligned_cols=164  Identities=19%  Similarity=0.245  Sum_probs=103.9

Q ss_pred             chhhhhccCCcccHHHHHHHhc------------CCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc---------
Q 046639            9 NMLSMKQQFPMISYAELSKATN------------NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---------   67 (331)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~------------~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------   67 (331)
                      .|-.++...|+++++++....+            .|. .+.||..+.|.||+|+.+. |+.||||+-+..-         
T Consensus       129 ~L~~LqD~~Pp~~~ee~~~i~e~ElG~~ie~if~~f~-~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~  206 (538)
T KOG1235|consen  129 TLSELQDQAPPFPWEEAFKIFEEELGAPIEDIFSEFD-EEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLR  206 (538)
T ss_pred             HHHHHhccCCCCCHHHHHHHHHHHhCCCHHHHHHhcC-cchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHH
Confidence            4667889999999998776533            122 3788999999999999985 8899999865220         


Q ss_pred             ----------------------hhhHHHHHHHHHHHH----------cCCCCC---cceeeceeecccCCCcceeeEEEe
Q 046639           68 ----------------------KEASRSFAAECNALR----------NIRHRN---LIKIITICSSIDFEGFDFKAIVFE  112 (331)
Q Consensus        68 ----------------------~~~~~~~~~e~~~l~----------~l~h~~---i~~~~~~~~~~~~~~~~~~~lv~e  112 (331)
                                            ++..+.+..|++..+          .+.|-+   -+.+..++    ++-....+++||
T Consensus       207 ~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy----~~~st~RVLtME  282 (538)
T KOG1235|consen  207 NLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVY----WDLSTKRVLTME  282 (538)
T ss_pred             HHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHHhHHHHHHHHHhcccccceeCCeeh----hhcCcceEEEEE
Confidence                                  122222333333222          223444   22233443    333355789999


Q ss_pred             ecCCCCHHHH--HHhccCCccchHHHHHHHHHHHHHHHHH-hhcCCCCeeecCCCCCCEEecC----CCcEEEcccCccc
Q 046639          113 YMQNRNLEQW--LRQSNGQLRFLTQRVNIAIDVSFAIEYF-HHHCQPSIVHGDLKPSNILLDQ----DIVAHVGDLGLAK  185 (331)
Q Consensus       113 ~~~~~~L~~~--l~~~~~~~~~~~~~~~~~~~i~~~l~~L-H~~~~~~ivH~dik~~nilv~~----~~~~kl~Dfg~a~  185 (331)
                      |++|..+.++  +.+.+   ++...   ++..+..+...+ -..   |++|+|=.|.||++..    ++.+.+.|||+..
T Consensus       283 ~~~G~~i~Dl~~i~~~g---i~~~~---i~~~l~~~~~~qIf~~---GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~  353 (538)
T KOG1235|consen  283 YVDGIKINDLDAIDKRG---ISPHD---ILNKLVEAYLEQIFKT---GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYA  353 (538)
T ss_pred             ecCCccCCCHHHHHHcC---CCHHH---HHHHHHHHHHHHHHhc---CCccCCCCCCcEEEecCCCCCccEEEEcccccc
Confidence            9999777665  33332   33333   333333333322 222   9999999999999983    6789999999987


Q ss_pred             cc
Q 046639          186 FL  187 (331)
Q Consensus       186 ~~  187 (331)
                      .+
T Consensus       354 ~i  355 (538)
T KOG1235|consen  354 VI  355 (538)
T ss_pred             cc
Confidence            65

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.37  E-value=5.7e-06  Score=69.45  Aligned_cols=146  Identities=21%  Similarity=0.246  Sum_probs=82.2

Q ss_pred             CceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCC--CcceeeceeecccCCCcceeeEEEe
Q 046639           35 ANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHR--NLIKIITICSSIDFEGFDFKAIVFE  112 (331)
Q Consensus        35 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~~~~~~~~~~lv~e  112 (331)
                      ++.++.|..+.||.+....  ..+++|.....  .....+..|..+++.+...  .+..++..+..  .......+++|+
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~--~~~~~~~~~~~~   75 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTS--DEFNGFPYLLME   75 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEE--TEETSEEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeeccc--ccccccceEEEE
Confidence            4678999999999988864  47889987533  4456677888888887532  34555553322  122334789999


Q ss_pred             ecCCCCHHH----------------HHHh---c--cCCccchHH---------HHHH------------HHHHHH-HHHH
Q 046639          113 YMQNRNLEQ----------------WLRQ---S--NGQLRFLTQ---------RVNI------------AIDVSF-AIEY  149 (331)
Q Consensus       113 ~~~~~~L~~----------------~l~~---~--~~~~~~~~~---------~~~~------------~~~i~~-~l~~  149 (331)
                      +++|..+..                .+..   .  .........         ....            ...+.. .+..
T Consensus        76 ~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (239)
T PF01636_consen   76 YIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQE  155 (239)
T ss_dssp             EESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHH
T ss_pred             EeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHH
Confidence            999887777                1111   1  000000000         0000            011122 2333


Q ss_pred             Hhhc----CCCCeeecCCCCCCEEec-CCCcEEEcccCcccc
Q 046639          150 FHHH----CQPSIVHGDLKPSNILLD-QDIVAHVGDLGLAKF  186 (331)
Q Consensus       150 LH~~----~~~~ivH~dik~~nilv~-~~~~~kl~Dfg~a~~  186 (331)
                      ++..    ....++|+|+.|.||+++ .++.+.|+||+.+..
T Consensus       156 ~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  156 LEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             HHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence            3321    123799999999999999 566667999998753

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.34  E-value=8.7e-08  Score=88.17  Aligned_cols=205  Identities=15%  Similarity=0.073  Sum_probs=136.9

Q ss_pred             hhhhhccCCcccHHHHHHHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCC-
Q 046639           10 MLSMKQQFPMISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRN-   88 (331)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~-   88 (331)
                      .+.++..|.....+|-   +.-|...+-+++|+++++++.+...+.-.+ .+.+...     ....-++++|.+++||| 
T Consensus       225 ~LmTkS~~qpp~lkDk---~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-----l~~rl~~eLLdK~n~P~~  295 (829)
T KOG0576|consen  225 FLMTKSGFQPPTLKDK---TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-----LSRRLAIELLDKVNNPNP  295 (829)
T ss_pred             HHhhccCCCCCcccCC---ccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-----hhhHHHHHHHHHccCCCC
Confidence            3455666655555543   334445568899999999998876554333 5555333     33456789999999999 


Q ss_pred             cceeeceeecccCCCcceeeEEEeecCCC-CHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCC
Q 046639           89 LIKIITICSSIDFEGFDFKAIVFEYMQNR-NLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSN  167 (331)
Q Consensus        89 i~~~~~~~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~n  167 (331)
                      .+..++.     .+.+...+++++++.++ +-...+.. ....+.......+...-..+++++|+.   .=+|+|    |
T Consensus       296 ~v~~~~d-----~~~E~~~~i~~~i~s~~rs~~~~~~~-se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~  362 (829)
T KOG0576|consen  296 VVRYLED-----YDGEDYLWIPMRICSTGRSSALEMTV-SEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----N  362 (829)
T ss_pred             ccccccc-----CCcccccchhhhhhcCCccccccCCh-hhHhhhhhhhhhhhhhhcccccccccc---cccCcc----c
Confidence            4444443     56677889999999665 22221111 001111223335555667788999976   557887    7


Q ss_pred             EEecCCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCC
Q 046639          168 ILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTD  246 (331)
Q Consensus       168 ilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~  246 (331)
                      |+..+ +..+.+||+....+.         .........+++.++|||+.....+....|.|++|.-..++.-|.+|-.
T Consensus       363 ~l~s~-~~~~~~~~~v~~~L~---------~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  363 ILGSE-EEVKLLDFAVPPQLT---------RTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             ccccc-cccccccccCCcccC---------cccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence            76654 678999999876551         1114455678999999999999999999999999987778888877753

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.19  E-value=2.2e-05  Score=66.61  Aligned_cols=140  Identities=14%  Similarity=0.083  Sum_probs=79.6

Q ss_pred             eeeccCe-eEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCC-CCCcceeeceeecccCCCcceeeEEEeec
Q 046639           37 KIGQGGV-SIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIR-HRNLIKIITICSSIDFEGFDFKAIVFEYM  114 (331)
Q Consensus        37 ~lg~G~~-g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~lv~e~~  114 (331)
                      .|..|.+ ..||+....  +..+.+|+.....   ...+..|+.+++.+. +--+.+++.+.     ...+..++|||++
T Consensus         5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~-----~~~~~~~lv~e~i   74 (244)
T cd05150           5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYG-----SDDGRAWLLTSAV   74 (244)
T ss_pred             ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEE-----ecCCccEEEEEee
Confidence            4555555 778988654  3567888775332   334667888888874 33344555543     2224568999999


Q ss_pred             CCCCHHHHHH----------------h---cc--CCccc--hHHHHHHHH--------------------HHHHHHHHHh
Q 046639          115 QNRNLEQWLR----------------Q---SN--GQLRF--LTQRVNIAI--------------------DVSFAIEYFH  151 (331)
Q Consensus       115 ~~~~L~~~l~----------------~---~~--~~~~~--~~~~~~~~~--------------------~i~~~l~~LH  151 (331)
                      +|.++.+...                +   ..  .....  .........                    .+...+..|-
T Consensus        75 ~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  154 (244)
T cd05150          75 PGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELE  154 (244)
T ss_pred             CCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHH
Confidence            9877764421                0   00  00000  000000000                    0111111221


Q ss_pred             h----cCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          152 H----HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       152 ~----~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      .    ...+.++|+|+.|.||++++++.+.|+||+.+..
T Consensus       155 ~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         155 ATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             hhCCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            1    1124799999999999999988788999997753

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.16  E-value=9.3e-06  Score=65.69  Aligned_cols=104  Identities=21%  Similarity=0.152  Sum_probs=79.3

Q ss_pred             HHHHHHHHcCCC-CCcceeeceeecccCCCcceeeEEEeecCCCCHHHHHHh-ccCCccchHHHHHHHHHHHHHHHHHhh
Q 046639           75 AAECNALRNIRH-RNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQ-SNGQLRFLTQRVNIAIDVSFAIEYFHH  152 (331)
Q Consensus        75 ~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~  152 (331)
                      .+|.-+++.+.+ +++++++|+|..         ++++|+...+++...... ...-..+|..+.+++.+++..+.+++.
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~---------~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~   77 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR---------FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDH   77 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC---------EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhc
Confidence            357788888864 699999999832         578999976655321000 001125689999999999999999998


Q ss_pred             cCCCCeeecCCCCCCEEecCCCcEEEcccCccccc
Q 046639          153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       153 ~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      .....+..+|++++|+.++++|.+|++|...+...
T Consensus        78 ~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   78 GPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             CCCCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            65547888999999999999999999999876544

Proteins in this uncharacterised family are described as transmembrane proteins.

>PLN02876 acyl-CoA dehydrogenase

Probab=98.09  E-value=5.5e-05  Score=75.36  Aligned_cols=82  Identities=13%  Similarity=0.276  Sum_probs=54.6

Q ss_pred             CceeeccCeeEEEEeeecCCC--ceEEEEEeeccc-hhhHHHHHHHHHHHHcCC-CCCc--ceeeceeecccCCCcceee
Q 046639           35 ANKIGQGGVSIVYKGILDESR--SIVAVKVVNLKQ-KEASRSFAAECNALRNIR-HRNL--IKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        35 ~~~lg~G~~g~V~~~~~~~~~--~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i--~~~~~~~~~~~~~~~~~~~  108 (331)
                      .+.++.|.+..+|+......+  ..+++|+..... ......+.+|+.+++.+. |.++  .+++.+|.+.  ...+..+
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~--~v~G~~f  120 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDA--SVIGTAF  120 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCC--CcCCCce
Confidence            577889999999988765322  457777654321 122356889999999985 6654  6666665432  1224568


Q ss_pred             EEEeecCCCC
Q 046639          109 IVFEYMQNRN  118 (331)
Q Consensus       109 lv~e~~~~~~  118 (331)
                      +|||+++|..
T Consensus       121 lVME~v~G~~  130 (822)
T PLN02876        121 YIMEYLEGRI  130 (822)
T ss_pred             EEEEecCCcc
Confidence            9999998754

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=98.03  E-value=6.8e-06  Score=70.42  Aligned_cols=147  Identities=20%  Similarity=0.206  Sum_probs=102.5

Q ss_pred             CCcccHHHHHHHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccch----------------------hhHHHH
Q 046639           17 FPMISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK----------------------EASRSF   74 (331)
Q Consensus        17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~   74 (331)
                      |-...++.+.....-+.++++||-|--+-+|.+-+. .|.+.++|+-..-..                      -.+-..
T Consensus        79 yDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa  157 (465)
T KOG2268|consen   79 YDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAA  157 (465)
T ss_pred             chHHHHHHHHhcchhhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHH
Confidence            344567777777778899999999999999998875 566788886432110                      011224


Q ss_pred             HHHHHHHHcCC-CC-CcceeeceeecccCCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhh
Q 046639           75 AAECNALRNIR-HR-NLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHH  152 (331)
Q Consensus        75 ~~e~~~l~~l~-h~-~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~  152 (331)
                      ..|...|+.|. |- -+.+.+++         +..++|||++.|..|.+.-.-.        ..-.+...++.-+--|-.
T Consensus       158 ~kEfafmkaL~e~gfpVPkpiD~---------~RH~Vvmelv~g~Pl~~v~~v~--------d~~~ly~~lm~~Iv~la~  220 (465)
T KOG2268|consen  158 TKEFAFMKALYERGFPVPKPIDH---------NRHCVVMELVDGYPLRQVRHVE--------DPPTLYDDLMGLIVRLAN  220 (465)
T ss_pred             HHHHHHHHHHHHcCCCCCCcccc---------cceeeHHHhhcccceeeeeecC--------ChHHHHHHHHHHHHHHHH
Confidence            56777777774 22 23444444         4568999999998887754221        122344445555566666


Q ss_pred             cCCCCeeecCCCCCCEEecCCCcEEEcccCcc
Q 046639          153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA  184 (331)
Q Consensus       153 ~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a  184 (331)
                      .   |+||+|.+-=||++++++.++++||--.
T Consensus       221 ~---GlIHgDFNEFNimv~dd~~i~vIDFPQm  249 (465)
T KOG2268|consen  221 H---GLIHGDFNEFNIMVKDDDKIVVIDFPQM  249 (465)
T ss_pred             c---CceecccchheeEEecCCCEEEeechHh
Confidence            6   9999999999999999999999999744

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.99  E-value=0.00072  Score=61.07  Aligned_cols=76  Identities=20%  Similarity=0.162  Sum_probs=51.0

Q ss_pred             CceeeccCeeEEEEeeecCCCceEEEEEeecc-------chhhHHHHHHHHHHHHcCC---CCCcceeeceeecccCCCc
Q 046639           35 ANKIGQGGVSIVYKGILDESRSIVAVKVVNLK-------QKEASRSFAAECNALRNIR---HRNLIKIITICSSIDFEGF  104 (331)
Q Consensus        35 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~~  104 (331)
                      .+.||.|....||++....+++.++||.-...       .+-.......|.+.|+.+.   ..++++++.+.       .
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D-------~  103 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD-------E  103 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC-------C
Confidence            46899999999999998644457899974311       0223455677888888763   34566666652       2


Q ss_pred             ceeeEEEeecCCC
Q 046639          105 DFKAIVFEYMQNR  117 (331)
Q Consensus       105 ~~~~lv~e~~~~~  117 (331)
                      ...++|||++++.
T Consensus       104 ~~~~lVME~L~~~  116 (401)
T PRK09550        104 ELAVTVMEDLSDH  116 (401)
T ss_pred             CCCEEEEecCCCc
Confidence            3457999999753

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.98  E-value=9.3e-05  Score=62.38  Aligned_cols=30  Identities=33%  Similarity=0.542  Sum_probs=25.9

Q ss_pred             CeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          157 SIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       157 ~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      .++|+|+.+.|+++++++..-|+||+.+..
T Consensus       165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             eEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            699999999999998776667999998754

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.91  E-value=6e-05  Score=64.44  Aligned_cols=138  Identities=13%  Similarity=0.059  Sum_probs=76.0

Q ss_pred             eeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCc-ceeeceeecccCCCcceeeEEEeecC
Q 046639           37 KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNL-IKIITICSSIDFEGFDFKAIVFEYMQ  115 (331)
Q Consensus        37 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~~~~~~lv~e~~~  115 (331)
                      .+..|-...+|+...  +++.+++|..........-....|..+++.+....+ .+++..+         ..++|+|+++
T Consensus         3 ~~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~---------~~~~v~e~i~   71 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH--PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN---------EHWLLVEWLE   71 (256)
T ss_pred             cCCCcCcCCeEEEEe--CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe---------CCEEEEEecc
Confidence            456678888998763  466788887643322221235678888888854333 3333331         1368999998


Q ss_pred             CCCHHH--------------HHHh---c--cCCccchH-HHHHHHHHH---------HHHHHHHhhc-----CCCCeeec
Q 046639          116 NRNLEQ--------------WLRQ---S--NGQLRFLT-QRVNIAIDV---------SFAIEYFHHH-----CQPSIVHG  161 (331)
Q Consensus       116 ~~~L~~--------------~l~~---~--~~~~~~~~-~~~~~~~~i---------~~~l~~LH~~-----~~~~ivH~  161 (331)
                      |..+..              .+.+   .  ........ .+..+..++         ...+..+-..     ....++|+
T Consensus        72 G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~  151 (256)
T TIGR02721        72 GEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHM  151 (256)
T ss_pred             CcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecC
Confidence            866432              1111   1  11111111 111111111         1111112111     12368999


Q ss_pred             CCCCCCEEecCCCcEEEcccCcccc
Q 046639          162 DLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       162 dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      |+.|.||++++++ +.++||..+..
T Consensus       152 Dl~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       152 DVHAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             CCCcCcEEEeCCC-CEEEeccccCc
Confidence            9999999999877 68999998754

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.88  E-value=4.8e-05  Score=75.17  Aligned_cols=199  Identities=19%  Similarity=0.145  Sum_probs=130.9

Q ss_pred             HHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhh
Q 046639           73 SFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHH  152 (331)
Q Consensus        73 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~  152 (331)
                      ....|...+.+..|+|+..++.+....-+.+ -...+..+++...++.+.+..-.  ..+....+.+..+..+|++++|+
T Consensus       228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g-~~~~v~~~~~s~~~~~~~~q~v~--~i~~~~~r~~~~~~~~GL~~~h~  304 (1351)
T KOG1035|consen  228 TTEIELESLSKIAHDNLGGYFVYGLERLFRG-IVLDVLQEICSKVELRSLLQSVG--SIPLETLRILHQKLLEGLAYLHS  304 (1351)
T ss_pred             HHHHHHHHHHhhccccccceeEEeehhhcch-HHHHHHHhhcCccchHHHHhhcc--ccCHHHHHHHHHHHhhhHHHHHH
Confidence            3456777788889999999988865432221 23345678888888888886544  46668888899999999999999


Q ss_pred             cCCCCeeecCCCCC---CEEecCCCcEEEc--ccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCcc--c
Q 046639          153 HCQPSIVHGDLKPS---NILLDQDIVAHVG--DLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASV--S  225 (331)
Q Consensus       153 ~~~~~ivH~dik~~---nilv~~~~~~kl~--Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~--~  225 (331)
                      .   ...|.-+...   +.-++..+.+.++  ||+......+.         ...........+-+||.........  .
T Consensus       305 ~---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~---------~~~~~~~~~~~~~~~e~~~~~~~~~~r~  372 (1351)
T KOG1035|consen  305 L---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDN---------EKSFSDLLAEIRNADEDLKENTAKKSRL  372 (1351)
T ss_pred             h---ccceeEEecccccccccCccceeecchhhhcccccCCCc---------ccchhhcCccccccccccccccchhhhh
Confidence            8   5555555444   4455666677766  88877665222         2222222334477788776665544  4


Q ss_pred             hhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCC
Q 046639          226 GDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMES  305 (331)
Q Consensus       226 ~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~  305 (331)
                      .|+|.+|..+..+..|..+-...        .        .+..+.+               ..+...+.+...+|+..+
T Consensus       373 ~dL~~lgll~~~~~~~~~i~~~~--------~--------~~~~~l~---------------~~~~~~~~d~~~~~~~~~  421 (1351)
T KOG1035|consen  373 TDLWCLGLLLLQLSQGEDISEKS--------A--------VPVSLLD---------------VLSTSELLDALPKCLDED  421 (1351)
T ss_pred             hHHHHHHHHHhhhhhcCcccccc--------c--------chhhhhc---------------cccchhhhhhhhhhcchh
Confidence            79999999999999876553211        0        0000000               011114566677899999


Q ss_pred             CCCCCcHHHHHH
Q 046639          306 PMERMEMRDVVA  317 (331)
Q Consensus       306 P~~Rps~~~i~~  317 (331)
                      +++|+++.++++
T Consensus       422 ~~~Rl~~~~ll~  433 (1351)
T KOG1035|consen  422 SEERLSALELLT  433 (1351)
T ss_pred             hhhccchhhhhh
Confidence            999999999875

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.83  E-value=0.00045  Score=56.24  Aligned_cols=133  Identities=21%  Similarity=0.261  Sum_probs=87.3

Q ss_pred             CceeeccCeeEEEEeeecCCCceEEEEEeeccc----------------hhhHHHHHHHHHHHHcCC------CCCccee
Q 046639           35 ANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ----------------KEASRSFAAECNALRNIR------HRNLIKI   92 (331)
Q Consensus        35 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~e~~~l~~l~------h~~i~~~   92 (331)
                      ...||+|+.-.||.--+   +...+||+.....                .........|+.-...+.      +.+|.++
T Consensus         6 ~~~i~~G~~R~cy~HP~---dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    6 SDLIAQGGERDCYQHPD---DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CcccccCCCceEEECCC---CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            46899999999996443   3346789886554                122344555665555544      8899999


Q ss_pred             eceeecccCCCcceeeEEEeecCC------CCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCC
Q 046639           93 ITICSSIDFEGFDFKAIVFEYMQN------RNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPS  166 (331)
Q Consensus        93 ~~~~~~~~~~~~~~~~lv~e~~~~------~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~  166 (331)
                      +|+     .++..-+.+|+|.+.+      .+|.+++.+..   ++.    .+...+-.-..+|-..   +|+.+|++|.
T Consensus        83 ~G~-----veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~---~~~----~~~~~L~~f~~~l~~~---~Iv~~dl~~~  147 (199)
T PF10707_consen   83 YGF-----VETNLGLGLVVELIRDADGNISPTLEDYLKEGG---LTE----ELRQALDEFKRYLLDH---HIVIRDLNPH  147 (199)
T ss_pred             eEE-----EecCCceEEEEEEEECCCCCcCccHHHHHHcCC---ccH----HHHHHHHHHHHHHHHc---CCeecCCCcc
Confidence            998     5555667888888742      56777774432   222    2333344455667777   8999999999


Q ss_pred             CEEecCCC----cEEEcc-cCccc
Q 046639          167 NILLDQDI----VAHVGD-LGLAK  185 (331)
Q Consensus       167 nilv~~~~----~~kl~D-fg~a~  185 (331)
                      ||++..++    .+.|+| ||...
T Consensus       148 NIv~~~~~~~~~~lvlIDG~G~~~  171 (199)
T PF10707_consen  148 NIVVQRRDSGEFRLVLIDGLGEKE  171 (199)
T ss_pred             cEEEEecCCCceEEEEEeCCCCcc
Confidence            99995332    466666 56443

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PRK05231 homoserine kinase; Provisional

Probab=97.76  E-value=0.00059  Score=60.34  Aligned_cols=165  Identities=10%  Similarity=0.088  Sum_probs=85.6

Q ss_pred             CCcccHHHHHHHhcCCCc-----CceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCC--c
Q 046639           17 FPMISYAELSKATNNFSP-----ANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRN--L   89 (331)
Q Consensus        17 ~~~~~~~~~~~~~~~y~~-----~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i   89 (331)
                      |-..+..++.....+|.+     .+.++.|....+|..... ++ .+++|++....   ...+..|+.++..+....  +
T Consensus         4 yt~ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~-~g-~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpv   78 (319)
T PRK05231          4 YTDVSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTT-QG-EYVLTLFERLT---AEDLPFFLGLMQHLAARGVPV   78 (319)
T ss_pred             cccCCHHHHHHHHHhcCCchhhccchhccccccceEEEEeC-CC-cEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCC
Confidence            445667777777677866     345666777789987653 33 58889875212   223444555555553111  2


Q ss_pred             ceeeceeec-ccCCCcceeeEEEeecCCCCH-----------HHHHHh---cc-C------C--cc-chHHHHH------
Q 046639           90 IKIITICSS-IDFEGFDFKAIVFEYMQNRNL-----------EQWLRQ---SN-G------Q--LR-FLTQRVN------  138 (331)
Q Consensus        90 ~~~~~~~~~-~~~~~~~~~~lv~e~~~~~~L-----------~~~l~~---~~-~------~--~~-~~~~~~~------  138 (331)
                      .+++..... .-....+..++++++++|..+           .+.+.+   .. .      .  .+ .+.....      
T Consensus        79 P~~i~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~  158 (319)
T PRK05231         79 PAPVARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFL  158 (319)
T ss_pred             CcceeCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhcc
Confidence            233221000 001123457899999987643           111211   00 0      0  00 0111100      


Q ss_pred             ------HHHH-HHHHHHHHhhc----CCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          139 ------IAID-VSFAIEYFHHH----CQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       139 ------~~~~-i~~~l~~LH~~----~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                            .+.+ +...+..+...    -..+++|+|+.+.||+++++...-|+||+.+..
T Consensus       159 ~~~~~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        159 ADEQAALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             ChhHHHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence                  1111 11112222210    123899999999999999766668999998754

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.72  E-value=0.00045  Score=60.74  Aligned_cols=166  Identities=17%  Similarity=0.179  Sum_probs=89.5

Q ss_pred             CCcccHHHHHHHhcCCCc-----CceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCC--c
Q 046639           17 FPMISYAELSKATNNFSP-----ANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRN--L   89 (331)
Q Consensus        17 ~~~~~~~~~~~~~~~y~~-----~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i   89 (331)
                      |-+.+..+|...-++|.+     .+.++.|....+|++... ++ .+++|+......  ...+..|+.++..+....  +
T Consensus         4 ~~~~~~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~-~~-~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pv   79 (307)
T TIGR00938         4 YTSVSDEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTD-VG-RYILTLYEKRVK--AEELPFFLALTTHLAARGLPV   79 (307)
T ss_pred             cccCCHHHHHHHHHhcCCCCceeccccCCccccceEEEEeC-CC-cEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCC
Confidence            445666777777667765     345667777789987643 33 577897754211  233455666666663222  3


Q ss_pred             ceeeceeecc-cCCCcceeeEEEeecCCCCHH-----------HHHHh---c-cC--C-------ccchHHHH-------
Q 046639           90 IKIITICSSI-DFEGFDFKAIVFEYMQNRNLE-----------QWLRQ---S-NG--Q-------LRFLTQRV-------  137 (331)
Q Consensus        90 ~~~~~~~~~~-~~~~~~~~~lv~e~~~~~~L~-----------~~l~~---~-~~--~-------~~~~~~~~-------  137 (331)
                      .+++...... .....+..++++++++|..+.           ..+.+   . .+  .       ...|....       
T Consensus        80 p~~i~t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~  159 (307)
T TIGR00938        80 PKPVKSRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAA  159 (307)
T ss_pred             CccccCCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcc
Confidence            3333321100 012235678999999874431           11111   0 00  0       00000000       


Q ss_pred             -----HHHHHHHHHHHHHhh----cCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          138 -----NIAIDVSFAIEYFHH----HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       138 -----~~~~~i~~~l~~LH~----~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                           .....+...+.++..    ....+++|+|+.+.|++++.++.+.|+||+.+..
T Consensus       160 ~~l~~~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       160 PQLEAHMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             cccCHHHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence                 001112233444432    1124899999999999999888778999998753

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.71  E-value=0.00045  Score=55.93  Aligned_cols=130  Identities=20%  Similarity=0.303  Sum_probs=89.1

Q ss_pred             cCCCcCceeeccCe-eEEEEeeecCCCceEEEEEee---ccch------------------hhHHHHHHHHHHHHcCC--
Q 046639           30 NNFSPANKIGQGGV-SIVYKGILDESRSIVAVKVVN---LKQK------------------EASRSFAAECNALRNIR--   85 (331)
Q Consensus        30 ~~y~~~~~lg~G~~-g~V~~~~~~~~~~~vavK~~~---~~~~------------------~~~~~~~~e~~~l~~l~--   85 (331)
                      .++..++.||.|.- |.||+++..  ++.+|+|++.   ...+                  .....+.+|.+...+|+  
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            67899999999999 999999885  7799999932   1111                  12245788888888774  


Q ss_pred             -CCCc--ceeeceeecc-------------cCCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHH
Q 046639           86 -HRNL--IKIITICSSI-------------DFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEY  149 (331)
Q Consensus        86 -h~~i--~~~~~~~~~~-------------~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~  149 (331)
                       +.++  ++.+||..=.             .........||.|+.+...           .+..    .-+.++..-+..
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~----~~~~~~~~dl~~  179 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQI----RDIPQMLRDLKI  179 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccch----hHHHHHHHHHHH
Confidence             4455  8888875311             0011223357888775433           1111    233467777888


Q ss_pred             HhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcc
Q 046639          150 FHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA  184 (331)
Q Consensus       150 LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a  184 (331)
                      +|..   ||+-+|+++.|..     .-+|+|||.+
T Consensus       180 ~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  180 LHKL---GIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHC---CeeeccCcccccc-----CCEEEecccC
Confidence            9999   9999999999997     3477899854

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.68  E-value=0.00037  Score=58.69  Aligned_cols=75  Identities=19%  Similarity=0.250  Sum_probs=46.3

Q ss_pred             CceeeccCeeEEEEeeecC-CCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCC-cceeeceeecccCCCcceeeEEEe
Q 046639           35 ANKIGQGGVSIVYKGILDE-SRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRN-LIKIITICSSIDFEGFDFKAIVFE  112 (331)
Q Consensus        35 ~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~~~~~~lv~e  112 (331)
                      ++.|..|-...+|++.... .+..|++|+.... .........|+.+++.+.... .++++..     ..    -.++||
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~-~~~~~d~~~E~~~~~~l~~~gl~P~v~~~-----~~----~~~l~e   72 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNK-TELIIDRERELRIHKLLSKHGLAPKLYAT-----FQ----NGLIYE   72 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCC-ccceecHHHHHHHHHHHHhCCCCCeEEEE-----eC----CcEEEE
Confidence            3567788888999886542 2467888977533 222223457888888875333 3334332     11    148999


Q ss_pred             ecCCCCH
Q 046639          113 YMQNRNL  119 (331)
Q Consensus       113 ~~~~~~L  119 (331)
                      |++|.++
T Consensus        73 ~i~G~~l   79 (235)
T cd05157          73 FIPGRTL   79 (235)
T ss_pred             eeCCCcC
Confidence            9988665

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK10593 hypothetical protein; Provisional

Probab=97.67  E-value=0.0015  Score=57.03  Aligned_cols=82  Identities=6%  Similarity=-0.009  Sum_probs=54.3

Q ss_pred             CCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCC---CCcceeeceeecccCCCcceee
Q 046639           32 FSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRH---RNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        32 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h---~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      ..-.+.||.|..+.||..... ++ .+++|..+.  ......+..|+..++.+..   ..+.+++++|..  ....+..+
T Consensus        16 ~~~~~~i~~G~~~~vy~~~~~-~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~--~~~~g~~~   89 (297)
T PRK10593         16 LSRVECISEQPYAALWALYDS-QG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTH--EQSPGPDV   89 (297)
T ss_pred             hheeeecCCccceeEEEEEcC-CC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEecc--CCcCCCeE
Confidence            334568999999999987653 23 466777532  1122467889999988852   357777776532  12235579


Q ss_pred             EEEeecCCCCH
Q 046639          109 IVFEYMQNRNL  119 (331)
Q Consensus       109 lv~e~~~~~~L  119 (331)
                      +|||++++.++
T Consensus        90 LVmE~i~G~~~  100 (297)
T PRK10593         90 LLLERLRGVSV  100 (297)
T ss_pred             EEEeccCCEec
Confidence            99999988654

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.63  E-value=0.00072  Score=59.05  Aligned_cols=147  Identities=16%  Similarity=0.104  Sum_probs=80.9

Q ss_pred             CceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCC--cceeeceeecc-cCCCcceeeEEE
Q 046639           35 ANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRN--LIKIITICSSI-DFEGFDFKAIVF  111 (331)
Q Consensus        35 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~-~~~~~~~~~lv~  111 (331)
                      .+.+..|....+|+....  +..+++|+....   ....+..|+.++..+.+..  +.+++...... -....+..++++
T Consensus        19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~   93 (296)
T cd05153          19 FEGISAGIENTNYFVTTD--SGRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV   93 (296)
T ss_pred             eecccCccccceEEEEeC--CCcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence            456777877889987653  346888987532   2345667788777774322  33433321000 012234568999


Q ss_pred             eecCCCCHHH-----------HHHh---c--c--CC-----ccchHHHH----------HHHHHHHHHHHHHhh----cC
Q 046639          112 EYMQNRNLEQ-----------WLRQ---S--N--GQ-----LRFLTQRV----------NIAIDVSFAIEYFHH----HC  154 (331)
Q Consensus       112 e~~~~~~L~~-----------~l~~---~--~--~~-----~~~~~~~~----------~~~~~i~~~l~~LH~----~~  154 (331)
                      ++++|..+..           .+.+   .  .  ..     ...+....          .....+..++..+..    ..
T Consensus        94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~  173 (296)
T cd05153          94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL  173 (296)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence            9998866421           1111   0  0  00     00000000          011112233444432    11


Q ss_pred             CCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          155 QPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       155 ~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      ..+++|+|+.|.|+++++++.+.|+||+.+..
T Consensus       174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         174 PRGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            23799999999999999887778999998754

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.56  E-value=0.00029  Score=64.23  Aligned_cols=167  Identities=17%  Similarity=0.193  Sum_probs=97.2

Q ss_pred             HHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHH
Q 046639           71 SRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYF  150 (331)
Q Consensus        71 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~L  150 (331)
                      ..+++....+++.+.|+|..+++++..    .......+|+|++ +.||.+.+..+.....          ++.      
T Consensus        26 s~~ilgr~~~lktl~~~~l~~yl~~~r----~~~~r~IVV~e~~-~~Sled~~~~~~l~~~----------s~~------   84 (725)
T KOG1093|consen   26 SIQILGRFQYLKSLQHDNLCQYLDFSR----GKHERVIVVMEHY-TMSLEDILKTGNLKDE----------SLL------   84 (725)
T ss_pred             HHHHhhhhHHHHhhcCccceeeEeeec----CccceEEEEehhh-ccchHHHHHhcccchh----------hhc------
Confidence            456778889999999999999888743    2234578999999 8899999876542111          111      


Q ss_pred             hhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHh
Q 046639          151 HHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYN  230 (331)
Q Consensus       151 H~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Diws  230 (331)
                       ..   ++.|-++            .+.+| .++..                        |  |-     +..+|+||||
T Consensus        85 -~~---~~~~~~~------------~~~td-~~~t~------------------------~--~~-----~~~pKsdVws  116 (725)
T KOG1093|consen   85 -AH---GVLHLNI------------IYITD-HFLTK------------------------Y--PS-----PIGPKSDVWS  116 (725)
T ss_pred             -cc---ccceehh------------hhccc-ccccc------------------------C--CC-----CCCcchhhhh
Confidence             11   4433322            22223 11100                        0  10     1124999999


Q ss_pred             HHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCC
Q 046639          231 FGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERM  310 (331)
Q Consensus       231 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp  310 (331)
                      +|.++.++.-|...+.....  ......+....       .++... .....+..+.-+|...+.++...|+-..|..||
T Consensus       117 l~~i~~el~L~~~l~~~~~~--s~~l~~i~k~~-------~~d~~~-~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~  186 (725)
T KOG1093|consen  117 LGFIILELYLGISLEAELTE--SEYLEILLKYY-------TDDQEL-LSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRP  186 (725)
T ss_pred             HHHHHHHHHHhhHHHHHHHH--HHHHHHHHHhc-------cCchhH-HHHHHHHHHHHhhhHhHHHHhccCCcccccccc
Confidence            99999999998766643211  11111111100       011000 011112245557888899999999999999998


Q ss_pred             cHHHHH
Q 046639          311 EMRDVV  316 (331)
Q Consensus       311 s~~~i~  316 (331)
                      ...+..
T Consensus       187 l~~~~~  192 (725)
T KOG1093|consen  187 LPMELS  192 (725)
T ss_pred             chhHHh
Confidence            665543

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.20  E-value=0.0053  Score=53.64  Aligned_cols=143  Identities=15%  Similarity=0.175  Sum_probs=85.7

Q ss_pred             CCcCceeeccCeeEEEEeeecCCCceEEEEEee-ccchhhHHHHHHHHHHHHcCCC--CCcceeeceeecccCCCcceee
Q 046639           32 FSPANKIGQGGVSIVYKGILDESRSIVAVKVVN-LKQKEASRSFAAECNALRNIRH--RNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        32 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~-~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      ..+.+.+..|....+|.....  ++.+++..-. ...........+|+.+++.+.-  --+...++.|..-  . -+..+
T Consensus        27 ~~~v~~~~~G~sn~t~~~~~~--~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~--~-~g~pf  101 (321)
T COG3173          27 LLIVEEISGGWSNDTFRLGDT--GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEG--Y-LGTPF  101 (321)
T ss_pred             CceeeeccCCcccceEEEecC--CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccC--C-CCCce
Confidence            334455544555556655553  6778888221 1223344667788888888742  2233445554321  1 25678


Q ss_pred             EEEeecCCCCHHHHHHhccCCccchHHHHHHHH-HHHHHHHHHhhcC---------------------------------
Q 046639          109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-DVSFAIEYFHHHC---------------------------------  154 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~-~i~~~l~~LH~~~---------------------------------  154 (331)
                      .||++++|..+.+-....       .....++. .+...|+.||+-.                                 
T Consensus       102 ~v~~~veGe~~~~~~~~~-------~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~  174 (321)
T COG3173         102 YVMEWVEGEVVWSALPPE-------SLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELG  174 (321)
T ss_pred             EEEEEecceeccCcCCcc-------cchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhcc
Confidence            999999875443322110       11112222 5556666666533                                 


Q ss_pred             ----------------------CCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          155 ----------------------QPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       155 ----------------------~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                                            .+.++|+|+.+.|++++.++-+=+.||+++..
T Consensus       175 ~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         175 GRIPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             CCCchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence                                  14899999999999999888888999998875

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.16  E-value=0.0043  Score=53.73  Aligned_cols=75  Identities=16%  Similarity=0.198  Sum_probs=42.4

Q ss_pred             CcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCC---CCCcceeeceeecccCCCcceeeE
Q 046639           33 SPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIR---HRNLIKIITICSSIDFEGFDFKAI  109 (331)
Q Consensus        33 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~~~~~~l  109 (331)
                      +-.+.++.|.-..+|+..  .+++.+.+|+-..   .....+..|+.-|+.|.   .-.+++++.+..     ..+..++
T Consensus        20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~-----~~~~~fL   89 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGE-----YDDDAFL   89 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE------SSCCEE
T ss_pred             eeeEecCCCChhheEEEE--CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEe-----ecCCceE
Confidence            345678888889999876  4677899998762   22344667777777773   445666776632     2234589


Q ss_pred             EEeecCCC
Q 046639          110 VFEYMQNR  117 (331)
Q Consensus       110 v~e~~~~~  117 (331)
                      ++|+++.+
T Consensus        90 lle~l~~~   97 (288)
T PF03881_consen   90 LLEFLEMG   97 (288)
T ss_dssp             EEE-----
T ss_pred             EEEeecCC
Confidence            99999655

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.11  E-value=0.0056  Score=52.85  Aligned_cols=31  Identities=42%  Similarity=0.622  Sum_probs=25.8

Q ss_pred             CCeeecCCCCCCEEecCCCc-EEEcccCcccc
Q 046639          156 PSIVHGDLKPSNILLDQDIV-AHVGDLGLAKF  186 (331)
Q Consensus       156 ~~ivH~dik~~nilv~~~~~-~kl~Dfg~a~~  186 (331)
                      +.++|+|+.+.||++++++. .-|+||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            36899999999999997555 46999998864

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.09  E-value=0.0064  Score=53.27  Aligned_cols=75  Identities=25%  Similarity=0.285  Sum_probs=45.6

Q ss_pred             ceeeccCeeEEEEeeecC------CCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCc-ceeeceeecccCCCcceee
Q 046639           36 NKIGQGGVSIVYKGILDE------SRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNL-IKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        36 ~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~~~~~~  108 (331)
                      +.+..|-...+|++....      +++.+++|+..... ........|..+++.+....+ .+++..+     .    -.
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~-----~----~~   73 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIF-----P----NG   73 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEe-----C----CC
Confidence            456667777899887543      25778899875432 233456788888888753322 3344432     1    13


Q ss_pred             EEEeecCCCCHH
Q 046639          109 IVFEYMQNRNLE  120 (331)
Q Consensus       109 lv~e~~~~~~L~  120 (331)
                      .|+||++|.++.
T Consensus        74 ~v~e~i~G~~l~   85 (302)
T cd05156          74 RIEEFIPSRTLT   85 (302)
T ss_pred             chhheeCCCcCC
Confidence            578888776553

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.05  E-value=0.09  Score=46.85  Aligned_cols=73  Identities=16%  Similarity=0.183  Sum_probs=46.2

Q ss_pred             eeeccCeeEEEEeeecCCCceEEEEEee----c---cchhhHHHHHHHHHHHHcCC--CC-CcceeeceeecccCCCcce
Q 046639           37 KIGQGGVSIVYKGILDESRSIVAVKVVN----L---KQKEASRSFAAECNALRNIR--HR-NLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        37 ~lg~G~~g~V~~~~~~~~~~~vavK~~~----~---~~~~~~~~~~~e~~~l~~l~--h~-~i~~~~~~~~~~~~~~~~~  106 (331)
                      .||-|....||++....+++.++||--.    .   ..+-...+..-|...|+...  -| .+++++.+       +...
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~-------D~e~   74 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF-------DTEM   74 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE-------cccc
Confidence            5799999999999975443578888642    1   11233345567778877763  33 45555544       2234


Q ss_pred             eeEEEeecCC
Q 046639          107 KAIVFEYMQN  116 (331)
Q Consensus       107 ~~lv~e~~~~  116 (331)
                      ..+|||+++.
T Consensus        75 ~~~vMEdL~~   84 (370)
T TIGR01767        75 AVTVMEDLSH   84 (370)
T ss_pred             ceehHhhCcc
Confidence            4689999854

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.99  E-value=0.17  Score=46.00  Aligned_cols=74  Identities=15%  Similarity=0.196  Sum_probs=47.8

Q ss_pred             cCceeeccCeeEEEEeeecCCCceEEEEEeec----cc---hhhHHHHHHHHHHHHcCC---CCCcceeeceeecccCCC
Q 046639           34 PANKIGQGGVSIVYKGILDESRSIVAVKVVNL----KQ---KEASRSFAAECNALRNIR---HRNLIKIITICSSIDFEG  103 (331)
Q Consensus        34 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~----~~---~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~  103 (331)
                      ..+.||.|....||+....  ++.++||.-..    ..   +....+...|+..|+.+.   ..++.+++.++.      
T Consensus        36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de------  107 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR------  107 (418)
T ss_pred             eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC------
Confidence            3568899999999998763  34588887541    11   112334445567666653   347777887753      


Q ss_pred             cceeeEEEeecCC
Q 046639          104 FDFKAIVFEYMQN  116 (331)
Q Consensus       104 ~~~~~lv~e~~~~  116 (331)
                       +..+++||++++
T Consensus       108 -d~~vlvME~L~~  119 (418)
T PLN02756        108 -TMALIGMRYLEP  119 (418)
T ss_pred             -CCCEEEEeecCC
Confidence             234788999966

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.99  E-value=0.02  Score=51.50  Aligned_cols=75  Identities=17%  Similarity=0.202  Sum_probs=48.2

Q ss_pred             CceeeccCeeEEEEeeecCCCceEEEEEee------ccchhhHHHHHHHHHHHHcCC--CC-CcceeeceeecccCCCcc
Q 046639           35 ANKIGQGGVSIVYKGILDESRSIVAVKVVN------LKQKEASRSFAAECNALRNIR--HR-NLIKIITICSSIDFEGFD  105 (331)
Q Consensus        35 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~------~~~~~~~~~~~~e~~~l~~l~--h~-~i~~~~~~~~~~~~~~~~  105 (331)
                      .+.||-|.-..||++.+...++.++||--.      ...+-...+..-|.+.|+...  -| .+++++.+       +..
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~-------D~e  106 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF-------DSV  106 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE-------CcH
Confidence            568899999999999874334568888532      112333456677888888763  34 45555554       223


Q ss_pred             eeeEEEeecCC
Q 046639          106 FKAIVFEYMQN  116 (331)
Q Consensus       106 ~~~lv~e~~~~  116 (331)
                      ...+|||+++.
T Consensus       107 ~~~~vMEdL~~  117 (409)
T PRK12396        107 MNCCVMEDLSD  117 (409)
T ss_pred             HhhHHHHhCcc
Confidence            44688998853

>PLN02236 choline kinase

Probab=96.89  E-value=0.0089  Score=53.39  Aligned_cols=142  Identities=15%  Similarity=0.176  Sum_probs=77.7

Q ss_pred             CceeeccCeeEEEEeeecC----CCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCc-ceeeceeecccCCCcceeeE
Q 046639           35 ANKIGQGGVSIVYKGILDE----SRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNL-IKIITICSSIDFEGFDFKAI  109 (331)
Q Consensus        35 ~~~lg~G~~g~V~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~~~~~~l  109 (331)
                      .+.+..|-...+|++....    +++.|++|+...... ..-...+|..+++.+..-++ .++++.     +.+    ..
T Consensus        41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~-~~idR~~E~~~~~~l~~~gl~P~~~~~-----~~~----g~  110 (344)
T PLN02236         41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE-LFFDRDDEIRTFECMSRHGQGPRLLGR-----FPN----GR  110 (344)
T ss_pred             EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC-eeechHHHHHHHHHHHHcCCCCceEEE-----ECC----ce
Confidence            3455557778899886432    246788998754332 22223678888888753333 234443     222    25


Q ss_pred             EEeecCCCCHHHH--------------HHh---cc--C-C-ccchHHHHHHHHHH-----------------HHHHHHH-
Q 046639          110 VFEYMQNRNLEQW--------------LRQ---SN--G-Q-LRFLTQRVNIAIDV-----------------SFAIEYF-  150 (331)
Q Consensus       110 v~e~~~~~~L~~~--------------l~~---~~--~-~-~~~~~~~~~~~~~i-----------------~~~l~~L-  150 (331)
                      |++|+++.+|...              +.+   ..  . . ...+..+..+..++                 ...+..| 
T Consensus       111 v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~  190 (344)
T PLN02236        111 VEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLE  190 (344)
T ss_pred             EEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHH
Confidence            7888877665311              111   00  0 0 11122222332111                 1111111 


Q ss_pred             ---hh-cCCCCeeecCCCCCCEEecC-CCcEEEcccCcccc
Q 046639          151 ---HH-HCQPSIVHGDLKPSNILLDQ-DIVAHVGDLGLAKF  186 (331)
Q Consensus       151 ---H~-~~~~~ivH~dik~~nilv~~-~~~~kl~Dfg~a~~  186 (331)
                         .. .....++|+|+++.||++++ ++.+.++||..+..
T Consensus       191 ~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        191 KELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             HHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence               11 11237999999999999986 46899999998754

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.86  E-value=0.013  Score=51.82  Aligned_cols=136  Identities=17%  Similarity=0.185  Sum_probs=89.5

Q ss_pred             ceeeccCeeEEEEeeecCCCceEEEEEeecc------------------------chhh--HHHHHHHHHHHHcCCCCCc
Q 046639           36 NKIGQGGVSIVYKGILDESRSIVAVKVVNLK------------------------QKEA--SRSFAAECNALRNIRHRNL   89 (331)
Q Consensus        36 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------------------------~~~~--~~~~~~e~~~l~~l~h~~i   89 (331)
                      ..|..|--+-||.|... +|..+|||+++-.                        ++..  .--...|.+-|.++....|
T Consensus       150 GCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI  228 (520)
T KOG2270|consen  150 GCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI  228 (520)
T ss_pred             cccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence            46777888889998775 6667999988522                        1111  1224667787887765443


Q ss_pred             ceeeceeecccCCCcceeeEEEeecCCCCH--HHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCC
Q 046639           90 IKIITICSSIDFEGFDFKAIVFEYMQNRNL--EQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSN  167 (331)
Q Consensus        90 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L--~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~n  167 (331)
                      .-..-+..       ...+|||+|+ |.+-  .-.++.   ..++...+..+..+++.-+..|-..+  ++||.||+--|
T Consensus       229 P~PePIlL-------k~hVLVM~Fl-Grdgw~aPkLKd---~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN  295 (520)
T KOG2270|consen  229 PCPEPILL-------KNHVLVMEFL-GRDGWAAPKLKD---ASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFN  295 (520)
T ss_pred             CCCCceee-------ecceEeeeec-cCCCCcCccccc---ccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhh
Confidence            32222211       2347999999 4332  222222   22445567778888888888887766  99999999999


Q ss_pred             EEecCCCcEEEcccCcccc
Q 046639          168 ILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       168 ilv~~~~~~kl~Dfg~a~~  186 (331)
                      +|+- +|.+.++|-+-+..
T Consensus       296 ~Lyh-dG~lyiIDVSQSVE  313 (520)
T KOG2270|consen  296 LLYH-DGKLYIIDVSQSVE  313 (520)
T ss_pred             heEE-CCEEEEEEcccccc
Confidence            9986 56788889886643

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.75  E-value=0.00035  Score=71.23  Aligned_cols=161  Identities=14%  Similarity=-0.039  Sum_probs=109.5

Q ss_pred             HHHHHHHHHcCCCCCcceeeceeecccCCCcceeeEEEeecCCCCHHHHHHhccCCccchH-HHHHHHHHH-HHHHHHHh
Q 046639           74 FAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLT-QRVNIAIDV-SFAIEYFH  151 (331)
Q Consensus        74 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~-~~~~~~~~i-~~~l~~LH  151 (331)
                      ...|..-++...|+++...+.-.   ........+..++++.+|.+.+.+-+......+.. ......+++ +......|
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~rI---~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~l 1352 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRI---PPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVIL 1352 (2724)
T ss_pred             hhhhhhhhhhhhceeeecccccC---CCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhh
Confidence            44455555556788877665432   12334456789999999999999976432221111 111222333 55555555


Q ss_pred             hcCC--CCeeecCCCCCCEEecCCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhH
Q 046639          152 HHCQ--PSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVY  229 (331)
Q Consensus       152 ~~~~--~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Diw  229 (331)
                      +..+  .-.+|+++++-|.+|..+-.++++++|+.++.        .+.........+++.|++|+....-.++.++|+|
T Consensus      1353 s~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIk--------np~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdil 1424 (2724)
T KOG1826|consen 1353 SLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIK--------NPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDIL 1424 (2724)
T ss_pred             hcccCCccchhhhhhhhccceecCCccccccccccccc--------CchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHH
Confidence            5542  24688999999999999999999999999842        1222333444566778888888777888889999


Q ss_pred             hHHHHHHHHHhCCCCC
Q 046639          230 NFGILLLEMFTRRRPT  245 (331)
Q Consensus       230 slG~il~el~~g~~pf  245 (331)
                      ..|+-+|+...|..+|
T Consensus      1425 r~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1425 RRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred             HHHHHHHHHhcccHHH
Confidence            9999999998888776

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.55  E-value=0.014  Score=51.45  Aligned_cols=75  Identities=12%  Similarity=0.145  Sum_probs=60.6

Q ss_pred             CCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEccc
Q 046639          102 EGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDL  181 (331)
Q Consensus       102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Df  181 (331)
                      .+..+.|++|++- |+++.-.-      ...+.++..++++.+..++-+..+.  ..-|||+.-.||+|+ .|+|.|+||
T Consensus       296 de~~y~yl~~kdh-gt~is~ik------~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDf  365 (488)
T COG5072         296 DETLYLYLHFKDH-GTPISIIK------ADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDF  365 (488)
T ss_pred             CCceEEEEEEecC-Cceeeeee------cccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEe
Confidence            3445567788876 66665321      2346788899999999999999886  889999999999999 999999999


Q ss_pred             Ccccc
Q 046639          182 GLAKF  186 (331)
Q Consensus       182 g~a~~  186 (331)
                      .+++.
T Consensus       366 klsRl  370 (488)
T COG5072         366 KLSRL  370 (488)
T ss_pred             eeeec
Confidence            99984

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.44  E-value=0.036  Score=48.78  Aligned_cols=31  Identities=29%  Similarity=0.367  Sum_probs=27.9

Q ss_pred             CCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          156 PSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       156 ~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      .+++|+|+.++|+++++++.+.++||..++.
T Consensus       196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       196 TVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            4899999999999999999999999998754

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.38  E-value=0.012  Score=48.62  Aligned_cols=30  Identities=33%  Similarity=0.565  Sum_probs=21.7

Q ss_pred             CeeecCCCCCCEEe-cCCCcEEEcccCcccc
Q 046639          157 SIVHGDLKPSNILL-DQDIVAHVGDLGLAKF  186 (331)
Q Consensus       157 ~ivH~dik~~nilv-~~~~~~kl~Dfg~a~~  186 (331)
                      .++|+|+.+.||++ +.++.++++||..|..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            79999999999999 8889999999998754

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.20  E-value=0.25  Score=43.75  Aligned_cols=102  Identities=11%  Similarity=0.054  Sum_probs=56.9

Q ss_pred             hccCCcccHHHHHHHhcCCCcC-----ceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCC
Q 046639           14 KQQFPMISYAELSKATNNFSPA-----NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRN   88 (331)
Q Consensus        14 ~~~~~~~~~~~~~~~~~~y~~~-----~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~   88 (331)
                      .+.++.++...+..+...+-+.     ..|+ +.-..||+.... ++..+++|+.... ......+..|+..+..+....
T Consensus         5 ~~~~~~l~p~~~~~a~~~~g~~~~~~~~~l~-s~eN~vy~v~~~-~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~g   81 (325)
T PRK11768          5 AFPFQTLTPDLILDALESLGLRVDGRLLALN-SYENRVYQFGDE-DGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAE   81 (325)
T ss_pred             CCCCCCCChHHHHHHHHHcCCCCccceEeec-cccceEEEEecC-CCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCC
Confidence            4678888888888888877543     1222 344568887653 4556888987522 223345667777777663211


Q ss_pred             --cceeeceeecccCCCcceeeEEEeecCCCC
Q 046639           89 --LIKIITICSSIDFEGFDFKAIVFEYMQNRN  118 (331)
Q Consensus        89 --i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~  118 (331)
                        ++.....-...-...++..+.++++++|..
T Consensus        82 ipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~  113 (325)
T PRK11768         82 IPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA  113 (325)
T ss_pred             CCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence              222111100000111345678999987653

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.18  E-value=0.032  Score=45.81  Aligned_cols=88  Identities=15%  Similarity=0.203  Sum_probs=57.1

Q ss_pred             HHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHh
Q 046639           72 RSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFH  151 (331)
Q Consensus        72 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH  151 (331)
                      .-+.++.+++.++.  .|+++..       ++...+.++.|.|-.           ....+    ..++.--+++|...|
T Consensus       103 ~~y~nky~v~Armh--GilrL~N-------Dn~~~yGvIlE~Cy~-----------~~i~~----~N~i~agi~~L~~fH  158 (308)
T PF07387_consen  103 ALYFNKYRVFARMH--GILRLKN-------DNNYKYGVILERCYK-----------IKINF----SNFITAGIKDLMDFH  158 (308)
T ss_pred             hhhhhhhhHHHHhh--heeEeec-------CCCceeEEEEeeccC-----------cccch----hHHHHHhHHHHHHhh
Confidence            34567777777642  2233321       133456789999821           11111    122222357788889


Q ss_pred             hcCCCCeeecCCCCCCEEecCCCcEEEcccCcc
Q 046639          152 HHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA  184 (331)
Q Consensus       152 ~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a  184 (331)
                      +. +.+.+|+|-.|+|||-+..|-+||.|-++.
T Consensus       159 ~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~L  190 (308)
T PF07387_consen  159 SE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCL  190 (308)
T ss_pred             cc-CCCeecCCCChhheeecCCCCEEecChhhh
Confidence            65 349999999999999999999999998754

The function of this family is unknown.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.09  E-value=0.032  Score=49.59  Aligned_cols=30  Identities=20%  Similarity=0.351  Sum_probs=25.9

Q ss_pred             CeeecCCCCCCEEecC-CCcEEEcccCcccc
Q 046639          157 SIVHGDLKPSNILLDQ-DIVAHVGDLGLAKF  186 (331)
Q Consensus       157 ~ivH~dik~~nilv~~-~~~~kl~Dfg~a~~  186 (331)
                      ..+|+|+.+.||++++ ++.++++||..|..
T Consensus       183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             EEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            5899999999999975 57899999998754

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.80  E-value=0.39  Score=42.51  Aligned_cols=157  Identities=17%  Similarity=0.189  Sum_probs=83.9

Q ss_pred             HHHHHhcCCCcC-----ceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCC---CCCcceee--
Q 046639           24 ELSKATNNFSPA-----NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIR---HRNLIKII--   93 (331)
Q Consensus        24 ~~~~~~~~y~~~-----~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~--   93 (331)
                      ++..+...|..+     ..|.+ .-..+|+.... ++ .+++|+....  .....+..|...+..+.   .+-.+++.  
T Consensus        15 ~~~~~l~~~~~g~~~~~~~l~s-~eN~~f~~~~~-~g-~~iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~   89 (331)
T COG2334          15 EAAAALEAYHYGLDGSLRGLNS-EENSNFRVQTE-DG-RYILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSL   89 (331)
T ss_pred             HHHHHHHhcCcCcccccccccc-ccCceEEEEec-CC-CeEEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCC
Confidence            344444445443     23333 34457876664 33 3488888644  34456777888888773   22222211  


Q ss_pred             -ceeecccCCCcceeeEEEeecCCCCHHH------------HHHh-----ccC--------CccchH----HH-------
Q 046639           94 -TICSSIDFEGFDFKAIVFEYMQNRNLEQ------------WLRQ-----SNG--------QLRFLT----QR-------  136 (331)
Q Consensus        94 -~~~~~~~~~~~~~~~lv~e~~~~~~L~~------------~l~~-----~~~--------~~~~~~----~~-------  136 (331)
                       |-.... .....+.+.++++++|..+..            .+.+     .+.        ....|.    ..       
T Consensus        90 dG~~l~~-~~~~~r~a~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~  168 (331)
T COG2334          90 DGELLEA-LSGGPRPAALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLV  168 (331)
T ss_pred             Ccchhhh-ccCCceeEEEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhccc
Confidence             111100 111137788999998877762            1100     000        011111    00       


Q ss_pred             --HHHHHHHHHHHHHHhhcCC----C-C--eeecCCCCCCEEecCCCc-EEEcccCcccc
Q 046639          137 --VNIAIDVSFAIEYFHHHCQ----P-S--IVHGDLKPSNILLDQDIV-AHVGDLGLAKF  186 (331)
Q Consensus       137 --~~~~~~i~~~l~~LH~~~~----~-~--ivH~dik~~nilv~~~~~-~kl~Dfg~a~~  186 (331)
                        .....++...+..+.....    . +  +||+|+.|.||+++.+.. +-+.||+.+..
T Consensus       169 ~~~~l~a~~~~~~~~~~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~  228 (331)
T COG2334         169 EPEDLRAALLAALDRLLARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY  228 (331)
T ss_pred             CchhhHHHHHHHHHHHHhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence              0123344444444443321    1 3  999999999999998874 88999998764

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.73  E-value=0.35  Score=40.16  Aligned_cols=75  Identities=20%  Similarity=0.291  Sum_probs=46.3

Q ss_pred             ceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCC---CCCcceeeceeecccCCCcceeeEEEe
Q 046639           36 NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIR---HRNLIKIITICSSIDFEGFDFKAIVFE  112 (331)
Q Consensus        36 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~~~~~~lv~e  112 (331)
                      +.+..|.--..|...+.  ..++.+|.-.   .+....+..|+.-|+.+.   .-.+.+++.+     -...++.|+|+|
T Consensus        22 ~~v~gG~inea~~v~dg--~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~-----G~~~~~sylVle   91 (286)
T COG3001          22 EEVSGGDINEAWRLRDG--TDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAV-----GASRDHSYLVLE   91 (286)
T ss_pred             cccCCccccceeEeecC--CcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEe-----cCCCCeeEEEEe
Confidence            34444544555555442  4467778543   333445666776666663   4566666666     556678899999


Q ss_pred             ecCCCCHH
Q 046639          113 YMQNRNLE  120 (331)
Q Consensus       113 ~~~~~~L~  120 (331)
                      +++.+.+.
T Consensus        92 ~L~~~~~d   99 (286)
T COG3001          92 YLPTGPLD   99 (286)
T ss_pred             eccCCCCC
Confidence            99876553

>PRK06148 hypothetical protein; Provisional

Probab=95.39  E-value=0.42  Score=49.11  Aligned_cols=105  Identities=13%  Similarity=0.186  Sum_probs=54.8

Q ss_pred             hhccCCcccHHHHHH-HhcCCCcC---ceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCC---
Q 046639           13 MKQQFPMISYAELSK-ATNNFSPA---NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIR---   85 (331)
Q Consensus        13 ~~~~~~~~~~~~~~~-~~~~y~~~---~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---   85 (331)
                      +...-|.++..++.. ..+.|-+.   +.|+ |..-.+|+.... ++..+++|+.+....  ...+..|...+..+.   
T Consensus         4 ~~~~~p~~s~~~~~~~~~~~ygl~~~~~~L~-s~~d~nf~v~~~-~g~~yVLKi~~~~~~--~~~~~~q~~~L~hL~~~~   79 (1013)
T PRK06148          4 LSHPAPEFTTKDAEALLAQHFGISATATPLD-GERDLNFRLTTD-DGADYILKIVNPSEP--RVESDFQTAALDHLAAVA   79 (1013)
T ss_pred             CCCCCCCCCHHHHHHHHHHHcCCceEEeecC-CcCCceEEEEeC-CCCeEEEEEcCCccc--hhHHHHHHHHHHHHHhhC
Confidence            445567777777744 34466653   3454 344667776543 566789999864322  223334445554442   


Q ss_pred             ----CCCcceeec-e-eeccc-CCCcceeeEEEeecCCCCHHH
Q 046639           86 ----HRNLIKIIT-I-CSSID-FEGFDFKAIVFEYMQNRNLEQ  121 (331)
Q Consensus        86 ----h~~i~~~~~-~-~~~~~-~~~~~~~~lv~e~~~~~~L~~  121 (331)
                          -|.+++..+ - ..... ..+....+.+++|++|..+.+
T Consensus        80 ~glpvP~~i~t~~G~~~~~v~~~~G~~~~vrLl~~l~G~~l~~  122 (1013)
T PRK06148         80 PDLPVPRLIPSLSGASLASAQDPDGEPRLLRLLSWLPGTPLAE  122 (1013)
T ss_pred             CCCCcCeeeecCCCCeEEEeecCCCceEEEEEEeccCCCcHHh
Confidence                222222211 0 00100 122225678899999877755

>PTZ00384 choline kinase; Provisional

Probab=94.82  E-value=0.21  Score=45.29  Aligned_cols=75  Identities=19%  Similarity=0.258  Sum_probs=43.1

Q ss_pred             CceeeccCeeEEEEeeecCCC-c-----eEEEEEeeccchhhHHHHHHHHHHHHcCCCCCc-ceeeceeecccCCCccee
Q 046639           35 ANKIGQGGVSIVYKGILDESR-S-----IVAVKVVNLKQKEASRSFAAECNALRNIRHRNL-IKIITICSSIDFEGFDFK  107 (331)
Q Consensus        35 ~~~lg~G~~g~V~~~~~~~~~-~-----~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~~~~~  107 (331)
                      .+.|..|-...+|++...... .     .|.++... ......-.-..|+.+++.+...++ .++++.     +.    -
T Consensus        55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g-~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~-----f~----~  124 (383)
T PTZ00384         55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSS-TYNSLVIDNDLQYNIAKLLGDNNFGPKIIGR-----FG----D  124 (383)
T ss_pred             EEEeCCcccceEEEEEecCCCCCccccceEEEEecc-CCCceEeccHHHHHHHHHHHhCCCCCeEEEe-----cC----C
Confidence            456666888899998654221 1     24444332 222222234578888888864444 444444     21    2


Q ss_pred             eEEEeecCCCCH
Q 046639          108 AIVFEYMQNRNL  119 (331)
Q Consensus       108 ~lv~e~~~~~~L  119 (331)
                      +++.||++|.+|
T Consensus       125 g~l~efIeGr~l  136 (383)
T PTZ00384        125 FTIQEWVEGNTM  136 (383)
T ss_pred             EEEEEEeccccC
Confidence            589999988665

>PRK06149 hypothetical protein; Provisional

Probab=94.59  E-value=0.63  Score=47.72  Aligned_cols=106  Identities=14%  Similarity=0.222  Sum_probs=61.4

Q ss_pred             chhhhhccCCcccHHHHHHHh-cCCCcC---ceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcC
Q 046639            9 NMLSMKQQFPMISYAELSKAT-NNFSPA---NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNI   84 (331)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~-~~y~~~---~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l   84 (331)
                      .|..+...-|.++..++.... +.|.+.   ..|+.+.. .+|+....  +..+++|+.+....  ...+..|...+..|
T Consensus         6 ~~~~~~~~~p~ls~~~~~~ll~~~ygl~~~~~~L~s~~d-~nf~v~t~--~~~yVLKi~~~~~~--~~~l~~e~~~l~hL   80 (972)
T PRK06149          6 LIDRSSLPAPDVSEAQAERILAEHYGLSGTLTELGSQQD-RNFRVDSD--GGRFVLKICHAAYA--AVELEAQHAALRHL   80 (972)
T ss_pred             hhccCCCCCCCCCHHHHHHHHHHhcCCceEEEecCCcCc-ceEEEEec--CCcEEEEeCCccCC--hHHHHHHHHHHHHH
Confidence            455667788999999998888 688873   45554443 57876543  34688898863322  13455566666555


Q ss_pred             CC----CCcceeece-----eecccCCCcceeeEEEeecCCCCH
Q 046639           85 RH----RNLIKIITI-----CSSIDFEGFDFKAIVFEYMQNRNL  119 (331)
Q Consensus        85 ~h----~~i~~~~~~-----~~~~~~~~~~~~~lv~e~~~~~~L  119 (331)
                      ..    -.+.+++-.     +......+....+.+++|++|..+
T Consensus        81 ~~~~~glpvp~pi~t~~G~~~~~~~~~g~~~~vrL~~~l~G~~~  124 (972)
T PRK06149         81 AEREPALRVPVVIPALDGEELLTLDVRGQGLRVRLLDYLPGQPL  124 (972)
T ss_pred             HhhCCCCCCceeeECCCCCeEEEEecCCceEEEEEEEecCCccc
Confidence            21    122222211     111111233456789999987554

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=94.29  E-value=0.3  Score=44.05  Aligned_cols=61  Identities=18%  Similarity=0.137  Sum_probs=43.8

Q ss_pred             eeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEec
Q 046639          106 FKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLD  171 (331)
Q Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~  171 (331)
                      ..+++-+|..|.++..+++...+   ++.....++.-.+.|+-.+--..  +.+|.|+.|.||++.
T Consensus       319 ~~vl~E~~~~Gl~v~~~v~~~~~---pe~l~kkva~lg~~AllkMl~vD--NFvHaDlHPGNVlir  379 (565)
T KOG1236|consen  319 DLVLVETYERGLSVLRFVKWKSQ---PEALVKKVAKLGVNALLKMLIVD--NFVHADLHPGNVLIR  379 (565)
T ss_pred             cceeeeeccccccHHhhhhcccC---hHHHHHHHHHHHHHHHHHHHHhh--cceecccCCCcEEEE
Confidence            34577778889999999876543   23455566665666666554443  899999999999995

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	331
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		6e-30
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		3e-29
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-23
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		4e-23
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-20
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-20
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		5e-20
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-18
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-17
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		4e-17
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		5e-17
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		5e-17
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		6e-17
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		7e-17
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		8e-17
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		9e-17
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		9e-17
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		9e-17
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		9e-17
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		9e-17
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-16
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-16
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-16
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-16
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-16
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-16
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-16
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-16
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-16
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		3e-16
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		3e-16
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		4e-16
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		4e-16
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		5e-16
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		5e-16
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-16
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		5e-16
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-16
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		5e-16
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		6e-16
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		6e-16
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		6e-16
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		6e-16
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		6e-16
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		6e-16
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		7e-16
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		7e-16
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-16
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-15
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-15
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		3e-15
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-15
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		7e-15
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		7e-15
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-14
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-14
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-14
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-14
2pl0_A	289	Lck Bound To Imatinib Length = 289		4e-14
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		4e-14
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		4e-14
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		5e-14
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		5e-14
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		7e-14
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		8e-14
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		8e-14
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		9e-14
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-13
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-13
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-13
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-13
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-13
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-13
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-13
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-13
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-13
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-13
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-13
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-13
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-13
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-13
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-13
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		3e-13
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-13
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-13
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-13
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		4e-13
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		5e-13
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		5e-13
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		5e-13
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		5e-13
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		5e-13
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		7e-13
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		7e-13
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		7e-13
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		7e-13
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		7e-13
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		7e-13
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		8e-13
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		8e-13
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		8e-13
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		8e-13
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		8e-13
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		8e-13
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		8e-13
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-12
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-12
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-12
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-12
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-12
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-12
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-12
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-12
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-12
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-12
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-12
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-12
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-12
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-12
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-12
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-12
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-12
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		3e-12
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-12
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		3e-12
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-12
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		3e-12
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		3e-12
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		3e-12
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		3e-12
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-12
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		3e-12
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		4e-12
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		4e-12
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		4e-12
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		4e-12
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-12
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		4e-12
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		4e-12
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		4e-12
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		4e-12
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		4e-12
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		4e-12
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		4e-12
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		4e-12
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		5e-12
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		5e-12
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		5e-12
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		5e-12
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-12
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		5e-12
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		5e-12
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		5e-12
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		5e-12
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		6e-12
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		6e-12
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		6e-12
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		6e-12
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		6e-12
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		6e-12
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		6e-12
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-12
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		7e-12
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		7e-12
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		7e-12
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		7e-12
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		8e-12
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		8e-12
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		8e-12
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		9e-12
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		9e-12
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		9e-12
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		9e-12
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		9e-12
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		9e-12
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-11
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-11
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-11
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-11
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-11
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-11
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-11
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-11
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-11
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-11
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-11
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-11
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-11
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-11
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-11
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-11
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-11
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-11
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-11
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-11
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-11
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-11
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-11
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-11
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-11
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-11
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-11
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-11
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-11
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-11
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-11
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-11
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-11
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-11
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-11
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-11
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-11
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-11
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-11
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-11
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-11
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-11
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-11
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-11
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-11
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-11
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		3e-11
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-11
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-11
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-11
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-11
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-11
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		4e-11
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		7e-11
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		8e-11
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		9e-11
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-10
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-10
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-10
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-10
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-10
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-10
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-10
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		4e-10
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		5e-10
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		5e-10
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		6e-10
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		6e-10
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		7e-10
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		7e-10
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-09
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		1e-09
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-09
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-09
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-09
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-09
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-09
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-09
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-09
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-09
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-09
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-09
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-09
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-09
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-09
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-09
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-09
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-09
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-09
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-09
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-09
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-09
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-09
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-09
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-09
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-09
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-09
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-09
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-09
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-09
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-09
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-09
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-09
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-09
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-09
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		3e-09
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		3e-09
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		3e-09
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		3e-09
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		3e-09
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-09
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		3e-09
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		3e-09
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		4e-09
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		4e-09
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		4e-09
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		4e-09
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		4e-09
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		4e-09
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-09
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		5e-09
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		5e-09
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		5e-09
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-09
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		5e-09
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-09
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-09
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-09
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		5e-09
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		5e-09
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		6e-09
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-09
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		6e-09
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		6e-09
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		6e-09
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		6e-09
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		6e-09
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		6e-09
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		6e-09
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		6e-09
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		6e-09
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		6e-09
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		6e-09
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		6e-09
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		6e-09
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		6e-09
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		6e-09
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		6e-09
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		6e-09
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		7e-09
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		7e-09
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		7e-09
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-09
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		7e-09
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		7e-09
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		8e-09
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		8e-09
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		9e-09
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		9e-09
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		9e-09
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		9e-09
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		9e-09
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		9e-09
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-08
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-08
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-08
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-08
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-08
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-08
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-08
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		1e-08
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-08
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-08
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-08
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		1e-08
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-08
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-08
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-08
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-08
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-08
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-08
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-08
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		3e-08
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		3e-08
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		3e-08
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-08
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-08
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		3e-08
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-08
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-08
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		3e-08
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		4e-08
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-08
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-08
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		4e-08
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-08
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		4e-08
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-08
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		4e-08
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		4e-08
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		4e-08
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		5e-08
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		5e-08
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		5e-08
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		5e-08
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		5e-08
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		6e-08
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		6e-08
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		6e-08
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		6e-08
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		6e-08
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		6e-08
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		7e-08
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		7e-08
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		7e-08
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		7e-08
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		8e-08
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		8e-08
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		8e-08
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		8e-08
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		8e-08
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		8e-08
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		8e-08
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		8e-08
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		8e-08
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		8e-08
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		9e-08
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		9e-08
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		9e-08
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		9e-08
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		9e-08
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		9e-08
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		9e-08
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-07
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-07
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-07
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		1e-07
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-07
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-07
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-07
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-07
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-07
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-07
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-07
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-07
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-07
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-07
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-07
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-07
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-07
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-07
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-07
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-07
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-07
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-07
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-07
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-07
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-07
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-07
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-07
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-07
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-07
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-07
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-07
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-07
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-07
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-07
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-07
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-07
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-07
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		3e-07
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-07
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		3e-07
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		3e-07
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-07
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		3e-07
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		3e-07
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		3e-07
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		4e-07
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		4e-07
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		4e-07
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		4e-07
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		4e-07
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		4e-07
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-07
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		5e-07
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		5e-07
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-07
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		5e-07
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		5e-07
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		5e-07
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		5e-07
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		5e-07
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		5e-07
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		5e-07
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		5e-07
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		5e-07
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		5e-07
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		5e-07
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		6e-07
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		6e-07
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		6e-07
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		6e-07
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		6e-07
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		7e-07
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		7e-07
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		8e-07
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-07
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		8e-07
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		8e-07
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		8e-07
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		8e-07
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		8e-07
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		9e-07
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		9e-07
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		9e-07
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-07
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		9e-07
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-06
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-06
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-06
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-06
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-06
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-06
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		1e-06
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-06
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-06
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-06
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-06
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-06
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-06
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-06
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-06
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-06
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-06
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-06
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-06
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-06
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-06
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-06
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-06
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-06
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-06
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-06
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-06
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-06
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-06
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-06
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-06
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-06
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-06
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-06
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-06
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-06
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-06
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-06
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-06
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-06
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-06
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-06
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-06
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-06
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-06
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-06
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-06
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-06
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-06
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-06
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-06
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-06
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-06
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-06
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-06
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-06
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-06
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-06
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-06
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-06
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-06
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-06
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-06
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-06
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-06
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-06
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		3e-06
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-06
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-06
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		3e-06
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-06
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-06
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-06
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		3e-06
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		3e-06
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		3e-06
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		3e-06
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		3e-06
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		3e-06
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		3e-06
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-06
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-06
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		4e-06
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		4e-06
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		4e-06
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		4e-06
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		4e-06
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		4e-06
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-06
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		4e-06
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		4e-06
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		4e-06
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		4e-06
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		4e-06
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		4e-06
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		5e-06
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		5e-06
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		5e-06
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-06
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		5e-06
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		5e-06
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		5e-06
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-06
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		6e-06
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		6e-06
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-06
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		6e-06
3a7f_A	303	Human Mst3 Kinase Length = 303		6e-06
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-06
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		6e-06
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		6e-06
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-06
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-06
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		7e-06
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		7e-06
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		7e-06
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		7e-06
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-06
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		8e-06
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-06
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-06
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		9e-06
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		9e-06
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		9e-06
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		9e-06
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-05
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-05
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-05
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-05
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-05
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-05
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-05
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-05
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-05
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-05
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-05
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-05
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-05
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-05
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-05
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-05
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-05
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-05
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-05
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-05
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		2e-05
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-05
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-05
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-05
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-05
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		2e-05
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-05
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-05
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		3e-05
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		3e-05
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		3e-05
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		3e-05
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		3e-05
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-05
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		3e-05
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		3e-05
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		3e-05
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-05
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		3e-05
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-05
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		3e-05
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		3e-05
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		4e-05
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		4e-05
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		4e-05
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		4e-05
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		4e-05
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		4e-05
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		4e-05
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		4e-05
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		4e-05
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		4e-05
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-05
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		4e-05
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		4e-05
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		4e-05
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		4e-05
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		4e-05
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		4e-05
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		4e-05
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		4e-05
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-05
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		4e-05
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		5e-05
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		5e-05
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		5e-05
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		5e-05
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		5e-05
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		5e-05
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-05
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-05
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		6e-05
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		7e-05
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		7e-05
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		8e-05
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		8e-05
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		8e-05
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		8e-05
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		8e-05
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		8e-05
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		8e-05
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		8e-05
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		8e-05
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		9e-05
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		9e-05
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		9e-05
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		9e-05
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		9e-05
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		9e-05
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		9e-05
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		9e-05
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		9e-05
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		9e-05
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-04
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		1e-04
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-04
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-04
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-04
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-04
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-04
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		1e-04
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-04
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-04
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-04
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-04
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		1e-04
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		1e-04
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		1e-04
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-04
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-04
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-04
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-04
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-04
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		1e-04
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-04
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-04
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		1e-04
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-04
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-04
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-04
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-04
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-04
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-04
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-04
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-04
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-04
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-04
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-04
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-04
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-04
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-04
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-04
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-04
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-04
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-04
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-04
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-04
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-04
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-04
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-04
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-04
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-04
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-04
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-04
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-04
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-04
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-04
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-04
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-04
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-04
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-04
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-04
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-04
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-04
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-04
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-04
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-04
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-04
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-04
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-04
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-04
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-04
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-04
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-04
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-04
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-04
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-04
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-04
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-04
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-04
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-04
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-04
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-04
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-04
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-04
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-04
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-04
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-04
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-04
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-04
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-04
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-04
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		3e-04
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-04
3hec_A	348	P38 In Complex With Imatinib Length = 348		3e-04
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-04
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		3e-04
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-04
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		3e-04
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-04
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		3e-04
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-04
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-04
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-04
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		3e-04
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-04
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		3e-04
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		3e-04
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		3e-04
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		3e-04
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		3e-04
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		3e-04
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		3e-04
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-04
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		3e-04
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		3e-04
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-04
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-04
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		3e-04
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		3e-04
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		3e-04
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		4e-04
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		4e-04
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-04
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		4e-04
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		4e-04
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		4e-04
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		4e-04
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		4e-04
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		4e-04
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		4e-04
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		4e-04
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		4e-04
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		4e-04
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		4e-04
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		4e-04
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		4e-04
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		4e-04
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-04
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		4e-04
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		4e-04
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		4e-04
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-04
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		4e-04
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		4e-04
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		4e-04
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		4e-04
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		4e-04
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		4e-04
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		4e-04
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-04
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		5e-04
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		5e-04
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-04
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		5e-04
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-04
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		5e-04
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		5e-04
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		5e-04
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		5e-04
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		5e-04
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		5e-04
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		5e-04
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		5e-04
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		5e-04
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		5e-04
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		5e-04
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		5e-04
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		6e-04
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		6e-04
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		6e-04
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		6e-04
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		6e-04
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-04
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		6e-04
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		6e-04
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		6e-04
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		6e-04
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-04
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		6e-04
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		6e-04
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		6e-04
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		6e-04
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		7e-04
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		7e-04
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		7e-04
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		7e-04
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		7e-04
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		7e-04
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		8e-04
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		8e-04
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		9e-04
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		9e-04
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		9e-04
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		9e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  128 bits (321), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 89/268 (33%), Positives = 142/268 (52%), Gaps = 22/268 (8%)
Query: 16  QFPMISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASR-SF 74
           Q    S  EL  A++NFS  N +G+GG   VYKG L +  ++VAVK +  ++ +     F
Sbjct: 24  QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADG-TLVAVKRLKEERXQGGELQF 82
Query: 75  AAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQ---SNGQLR 131
             E   +    HRNL+++   C +        + +V+ YM N ++   LR+   S   L 
Sbjct: 83  QTEVEMISMAVHRNLLRLRGFCMTPTE-----RLLVYPYMANGSVASCLRERPESQPPLD 137
Query: 132 FLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYE 191
           +  +R  IA+  +  + Y H HC P I+H D+K +NILLD++  A VGD GLAK L  Y+
Sbjct: 138 W-PKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYK 195
Query: 192 PGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMF-- 249
                        ++G +G++APEY    K+S   DV+ +G++LLE+ T +R  D     
Sbjct: 196 DXHVXXA------VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLA 249
Query: 250 -NEGLTLHEFVKMALPDKVME-IVDPSL 275
            ++ + L ++VK  L +K +E +VD  L
Sbjct: 250 NDDDVMLLDWVKGLLKEKKLEALVDVDL 277

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  125 bits (314), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 88/268 (32%), Positives = 140/268 (52%), Gaps = 22/268 (8%)
Query: 16  QFPMISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASR-SF 74
           Q    S  EL  A++NF   N +G+GG   VYKG L +   +VAVK +  ++ +     F
Sbjct: 16  QLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADG-XLVAVKRLKEERTQGGELQF 74
Query: 75  AAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQ---SNGQLR 131
             E   +    HRNL+++   C +        + +V+ YM N ++   LR+   S   L 
Sbjct: 75  QTEVEMISMAVHRNLLRLRGFCMTPTE-----RLLVYPYMANGSVASCLRERPESQPPLD 129
Query: 132 FLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYE 191
           +  +R  IA+  +  + Y H HC P I+H D+K +NILLD++  A VGD GLAK L  Y+
Sbjct: 130 W-PKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYK 187
Query: 192 PGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMF-- 249
                        ++G +G++APEY    K+S   DV+ +G++LLE+ T +R  D     
Sbjct: 188 DXHVXXA------VRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLA 241
Query: 250 -NEGLTLHEFVKMALPDKVME-IVDPSL 275
            ++ + L ++VK  L +K +E +VD  L
Sbjct: 242 NDDDVMLLDWVKGLLKEKKLEALVDVDL 269

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 92/329 (27%), Positives = 153/329 (46%), Gaps = 30/329 (9%)
Query: 2   KPAHKDSNMLSMKQQFPMISY----AELSKATNNFSPANKIGQGGVSIVYKGILDESRSI 57
           K  +  ++ LS     P  SY     +L +ATNNF     IG G    VYKG+L +  + 
Sbjct: 7   KATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDG-AK 65
Query: 58  VAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNR 117
           VA+K    +  +    F  E   L   RH +L+ +I  C        +   ++++YM+N 
Sbjct: 66  VALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE-----RNEMILIYKYMENG 120
Query: 118 NLEQWLRQSNGQLRFLT--QRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIV 175
           NL++ L  S+     ++  QR+ I I  +  + Y H     +I+H D+K  NILLD++ V
Sbjct: 121 NLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFV 177
Query: 176 AHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILL 235
             + D G++K       GT  +       +KG +GY+ PEY +  + +   DVY+FG++L
Sbjct: 178 PKITDFGISK------KGTELDQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVL 231
Query: 236 LEMFTRRRP-TDAMFNEGLTLHEF-VKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVA 293
            E+   R     ++  E + L E+ V+     ++ +IVDP+L  ++   +     D    
Sbjct: 232 FEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGD---- 287
Query: 294 VIGTGVTCXXXXXXXXXXXXDVVAKLRHA 322
              T V C            DV+ KL +A
Sbjct: 288 ---TAVKCLALSSEDRPSMGDVLWKLEYA 313

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  105 bits (261), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 92/329 (27%), Positives = 152/329 (46%), Gaps = 30/329 (9%)
Query: 2   KPAHKDSNMLSMKQQFPMISY----AELSKATNNFSPANKIGQGGVSIVYKGILDESRSI 57
           K  +  ++ LS     P  SY     +L +ATNNF     IG G    VYKG+L +  + 
Sbjct: 7   KATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDG-AK 65
Query: 58  VAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNR 117
           VA+K    +  +    F  E   L   RH +L+ +I  C        +   ++++YM+N 
Sbjct: 66  VALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE-----RNEMILIYKYMENG 120
Query: 118 NLEQWLRQSNGQLRFLT--QRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIV 175
           NL++ L  S+     ++  QR+ I I  +  + Y H     +I+H D+K  NILLD++ V
Sbjct: 121 NLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFV 177
Query: 176 AHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILL 235
             + D G++K       GT          +KG +GY+ PEY +  + +   DVY+FG++L
Sbjct: 178 PKITDFGISK------KGTELGQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVL 231
Query: 236 LEMFTRRRP-TDAMFNEGLTLHEF-VKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVA 293
            E+   R     ++  E + L E+ V+     ++ +IVDP+L  ++   +     D    
Sbjct: 232 FEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGD---- 287
Query: 294 VIGTGVTCXXXXXXXXXXXXDVVAKLRHA 322
              T V C            DV+ KL +A
Sbjct: 288 ---TAVKCLALSSEDRPSMGDVLWKLEYA 313

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/241 (31%), Positives = 120/241 (49%), Gaps = 38/241 (15%)
Query: 16  QFPMISYAELSKATNNFSP------ANKIGQGGVSIVYKGILDESRSIVAVK----VVNL 65
           +F   S+ EL   TNNF         NK+G+GG  +VYKG ++   + VAVK    +V++
Sbjct: 11  RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN--NTTVAVKKLAAMVDI 68
Query: 66  KQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQ 125
             +E  + F  E   +   +H NL++++   S    +G D   +V+ YM N +L   L  
Sbjct: 69  TTEELKQQFDQEIKVMAKCQHENLVELLGFSS----DGDDL-CLVYVYMPNGSLLDRLSC 123
Query: 126 SNGQLRF-LTQRVNIAIDVSFAIEYFH--HHCQPSIVHGDLKPSNILLDQDIVAHVGDLG 182
            +G        R  IA   +  I + H  HH     +H D+K +NILLD+   A + D G
Sbjct: 124 LDGTPPLSWHMRCKIAQGAANGINFLHENHH-----IHRDIKSANILLDEAFTAKISDFG 178
Query: 183 LAKFLFGYEPGTAAETASNSIEIKGIVG---YVAPEYGMGSKASVSGDVYNFGILLLEMF 239
           LA+         A+E  + ++    IVG   Y+APE  +  + +   D+Y+FG++LLE+ 
Sbjct: 179 LAR---------ASEKFAQTVMXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEII 228
Query: 240 T 240
           T
Sbjct: 229 T 229

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 75/241 (31%), Positives = 120/241 (49%), Gaps = 38/241 (15%)
Query: 16  QFPMISYAELSKATNNFSP------ANKIGQGGVSIVYKGILDESRSIVAVK----VVNL 65
           +F   S+ EL   TNNF         NK+G+GG  +VYKG ++   + VAVK    +V++
Sbjct: 11  RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN--NTTVAVKKLAAMVDI 68
Query: 66  KQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQ 125
             +E  + F  E   +   +H NL++++   S    +G D   +V+ YM N +L   L  
Sbjct: 69  TTEELKQQFDQEIKVMAKCQHENLVELLGFSS----DGDDL-CLVYVYMPNGSLLDRLSC 123
Query: 126 SNGQLRF-LTQRVNIAIDVSFAIEYFH--HHCQPSIVHGDLKPSNILLDQDIVAHVGDLG 182
            +G        R  IA   +  I + H  HH     +H D+K +NILLD+   A + D G
Sbjct: 124 LDGTPPLSWHMRCKIAQGAANGINFLHENHH-----IHRDIKSANILLDEAFTAKISDFG 178
Query: 183 LAKFLFGYEPGTAAETASNSIEIKGIVG---YVAPEYGMGSKASVSGDVYNFGILLLEMF 239
           LA+         A+E  + ++    IVG   Y+APE  +  + +   D+Y+FG++LLE+ 
Sbjct: 179 LAR---------ASEKFAQTVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEII 228
Query: 240 T 240
           T
Sbjct: 229 T 229

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 75/241 (31%), Positives = 119/241 (49%), Gaps = 38/241 (15%)
Query: 16  QFPMISYAELSKATNNFSP------ANKIGQGGVSIVYKGILDESRSIVAVK----VVNL 65
           +F   S+ EL   TNNF         NK+G+GG  +VYKG ++   + VAVK    +V++
Sbjct: 5   RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN--NTTVAVKKLAAMVDI 62
Query: 66  KQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQ 125
             +E  + F  E   +   +H NL++++   S    +G D   +V+ YM N +L   L  
Sbjct: 63  TTEELKQQFDQEIKVMAKCQHENLVELLGFSS----DGDDL-CLVYVYMPNGSLLDRLSC 117
Query: 126 SNGQLRF-LTQRVNIAIDVSFAIEYFH--HHCQPSIVHGDLKPSNILLDQDIVAHVGDLG 182
            +G        R  IA   +  I + H  HH     +H D+K +NILLD+   A + D G
Sbjct: 118 LDGTPPLSWHMRCKIAQGAANGINFLHENHH-----IHRDIKSANILLDEAFTAKISDFG 172
Query: 183 LAKFLFGYEPGTAAETASNSIEIKGIVG---YVAPEYGMGSKASVSGDVYNFGILLLEMF 239
           LA+         A+E  +  +    IVG   Y+APE  +  + +   D+Y+FG++LLE+ 
Sbjct: 173 LAR---------ASEKFAQXVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEII 222
Query: 240 T 240
           T
Sbjct: 223 T 223

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/241 (30%), Positives = 115/241 (47%), Gaps = 38/241 (15%)
Query: 16  QFPMISYAELSKATNNFSP------ANKIGQGGVSIVYKGILDESRSIVAVK----VVNL 65
           +F   S+ EL   TNNF         NK G+GG  +VYKG ++   + VAVK    +V++
Sbjct: 2   RFHSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVN--NTTVAVKKLAAMVDI 59
Query: 66  KQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQ 125
             +E  + F  E       +H NL++++   S    +G D   +V+ Y  N +L   L  
Sbjct: 60  TTEELKQQFDQEIKVXAKCQHENLVELLGFSS----DGDDL-CLVYVYXPNGSLLDRLSC 114
Query: 126 SNGQLRF-LTQRVNIAIDVSFAIEYFH--HHCQPSIVHGDLKPSNILLDQDIVAHVGDLG 182
            +G        R  IA   +  I + H  HH     +H D+K +NILLD+   A + D G
Sbjct: 115 LDGTPPLSWHXRCKIAQGAANGINFLHENHH-----IHRDIKSANILLDEAFTAKISDFG 169
Query: 183 LAKFLFGYEPGTAAETASNSIEIKGIVG---YVAPEYGMGSKASVSGDVYNFGILLLEMF 239
           LA+         A+E  +  +    IVG   Y APE  +  + +   D+Y+FG++LLE+ 
Sbjct: 170 LAR---------ASEKFAQXVXXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEII 219
Query: 240 T 240
           T
Sbjct: 220 T 220

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 107/215 (49%), Gaps = 19/215 (8%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           K+GQG    V+ G  + + + VA+K +      +  +F  E   ++ +RH  L+++  + 
Sbjct: 15  KLGQGCFGEVWMGTWNGT-TRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 72
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQP 156
           S           IV EYM   +L  +L+   G+   L Q V++A  ++  + Y       
Sbjct: 73  SEEPI------XIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM--- 123
Query: 157 SIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEY 216
           + VH DL+ +NIL+ +++V  V D GLA+ +   E  TA + A   I+      + APE 
Sbjct: 124 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-XTARQGAKFPIK------WTAPEA 176
Query: 217 GMGSKASVSGDVYNFGILLLEMFTRRR-PTDAMFN 250
            +  + ++  DV++FGILL E+ T+ R P   M N
Sbjct: 177 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 211

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 107/215 (49%), Gaps = 19/215 (8%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           K+GQG    V+ G  + + + VA+K +      +  +F  E   ++ +RH  L+++  + 
Sbjct: 25  KLGQGCFGEVWMGTWNGT-TRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQP 156
           S           IV EYM   +L  +L+   G+   L Q V++A  ++  + Y       
Sbjct: 83  SEEPI------YIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM--- 133
Query: 157 SIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEY 216
           + VH DL+ +NIL+ +++V  V D GLA+ +   E  TA + A   I+      + APE 
Sbjct: 134 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-XTARQGAKFPIK------WTAPEA 186
Query: 217 GMGSKASVSGDVYNFGILLLEMFTRRR-PTDAMFN 250
            +  + ++  DV++FGILL E+ T+ R P   M N
Sbjct: 187 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 221

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 107/215 (49%), Gaps = 19/215 (8%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           K+GQG    V+ G  + + + VA+K +      +  +F  E   ++ +RH  L+++  + 
Sbjct: 18  KLGQGCFGEVWMGTWNGT-TRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 75
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQP 156
           S           IV EYM   +L  +L+   G+   L Q V++A  ++  + Y       
Sbjct: 76  SEEPI------YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM--- 126
Query: 157 SIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEY 216
           + VH DL+ +NIL+ +++V  V D GLA+ +   E  TA + A   I+      + APE 
Sbjct: 127 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIK------WTAPEA 179
Query: 217 GMGSKASVSGDVYNFGILLLEMFTRRR-PTDAMFN 250
            +  + ++  DV++FGILL E+ T+ R P   M N
Sbjct: 180 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 214

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 107/215 (49%), Gaps = 19/215 (8%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           K+GQG    V+ G  + + + VA+K +      +  +F  E   ++ IRH  L+++  + 
Sbjct: 25  KLGQGCFGEVWMGTWNGT-TRVAIKTLK-PGTMSPEAFLQEAQVMKKIRHEKLVQLYAVV 82
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQP 156
           S           IV EYM   +L  +L+   G+   L Q V++A  ++  + Y       
Sbjct: 83  SEEPI------YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM--- 133
Query: 157 SIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEY 216
           + VH DL+ +NIL+ +++V  V D GLA+ +   E  TA + A   I+      + APE 
Sbjct: 134 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIK------WTAPEA 186
Query: 217 GMGSKASVSGDVYNFGILLLEMFTRRR-PTDAMFN 250
            +  + ++  DV++FGILL E+ T+ R P   M N
Sbjct: 187 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 221

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 107/215 (49%), Gaps = 19/215 (8%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           K+GQG    V+ G  + + + VA+K +      +  +F  E   ++ +RH  L+++  + 
Sbjct: 22  KLGQGCFGEVWMGTWNGT-TRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 79
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQP 156
           S           IV EYM   +L  +L+   G+   L Q V+++  ++  + Y       
Sbjct: 80  SEEPI------YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERM--- 130
Query: 157 SIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEY 216
           + VH DL+ +NIL+ +++V  V D GLA+ +   E  TA + A   I+      + APE 
Sbjct: 131 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-WTARQGAKFPIK------WTAPEA 183
Query: 217 GMGSKASVSGDVYNFGILLLEMFTRRR-PTDAMFN 250
            +  + ++  DV++FGILL E+ T+ R P   M N
Sbjct: 184 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 218

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 107/215 (49%), Gaps = 19/215 (8%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           K+GQG    V+ G  + + + VA+K +      +  +F  E   ++ +RH  L+++  + 
Sbjct: 25  KLGQGCFGEVWMGTWNGT-TRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQP 156
           S           IV EYM   +L  +L+   G+   L Q V++A  ++  + Y       
Sbjct: 83  SEEPI------YIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM--- 133
Query: 157 SIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEY 216
           + VH DL+ +NIL+ +++V  V D GLA+ +   E  TA + A   I+      + APE 
Sbjct: 134 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIK------WTAPEA 186
Query: 217 GMGSKASVSGDVYNFGILLLEMFTRRR-PTDAMFN 250
            +  + ++  DV++FGILL E+ T+ R P   M N
Sbjct: 187 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 221

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 107/215 (49%), Gaps = 19/215 (8%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           K+GQG    V+ G  + + + VA+K +      +  +F  E   ++ +RH  L+++  + 
Sbjct: 14  KLGQGCFGEVWMGTWNGT-TRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 71
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQP 156
           S           IV EYM   +L  +L+   G+   L Q V++A  ++  + Y       
Sbjct: 72  SEEPI------YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM--- 122
Query: 157 SIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEY 216
           + VH DL+ +NIL+ +++V  V D GLA+ +   E  TA + A   I+      + APE 
Sbjct: 123 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIK------WTAPEA 175
Query: 217 GMGSKASVSGDVYNFGILLLEMFTRRR-PTDAMFN 250
            +  + ++  DV++FGILL E+ T+ R P   M N
Sbjct: 176 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 210

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 107/215 (49%), Gaps = 19/215 (8%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           K+GQG    V+ G  + + + VA+K +      +  +F  E   ++ +RH  L+++  + 
Sbjct: 191 KLGQGCFGEVWMGTWNGT-TRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQP 156
           S           IV EYM   +L  +L+   G+   L Q V++A  ++  + Y       
Sbjct: 249 SEEPI------YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM--- 299
Query: 157 SIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEY 216
           + VH DL+ +NIL+ +++V  V D GLA+ +   E  TA + A   I+      + APE 
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIK------WTAPEA 352
Query: 217 GMGSKASVSGDVYNFGILLLEMFTRRR-PTDAMFN 250
            +  + ++  DV++FGILL E+ T+ R P   M N
Sbjct: 353 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 387

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 107/215 (49%), Gaps = 19/215 (8%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           K+GQG    V+ G  + + + VA+K +      +  +F  E   ++ +RH  L+++  + 
Sbjct: 16  KLGQGCFGEVWMGTWNGT-TRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 73
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQP 156
           S           IV EYM   +L  +L+   G+   L Q V++A  ++  + Y       
Sbjct: 74  SEEPI------YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM--- 124
Query: 157 SIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEY 216
           + VH DL+ +NIL+ +++V  V D GLA+ +   E  TA + A   I+      + APE 
Sbjct: 125 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIK------WTAPEA 177
Query: 217 GMGSKASVSGDVYNFGILLLEMFTRRR-PTDAMFN 250
            +  + ++  DV++FGILL E+ T+ R P   M N
Sbjct: 178 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 212

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 107/215 (49%), Gaps = 19/215 (8%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           K+GQG    V+ G  + + + VA+K +      +  +F  E   ++ +RH  L+++  + 
Sbjct: 25  KLGQGCFGEVWMGTWNGT-TRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQP 156
           S           IV EYM   +L  +L+   G+   L Q V++A  ++  + Y       
Sbjct: 83  SEEPI------YIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM--- 133
Query: 157 SIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEY 216
           + VH DL+ +NIL+ +++V  V D GLA+ +   E  TA + A   I+      + APE 
Sbjct: 134 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIK------WTAPEA 186
Query: 217 GMGSKASVSGDVYNFGILLLEMFTRRR-PTDAMFN 250
            +  + ++  DV++FGILL E+ T+ R P   M N
Sbjct: 187 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 221

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 107/215 (49%), Gaps = 19/215 (8%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           K+GQG    V+ G  + + + VA+K +      +  +F  E   ++ +RH  L+++  + 
Sbjct: 191 KLGQGCFGEVWMGTWNGT-TRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQP 156
           S           IV EYM   +L  +L+   G+   L Q V++A  ++  + Y       
Sbjct: 249 SEEPI------YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM--- 299
Query: 157 SIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEY 216
           + VH DL+ +NIL+ +++V  V D GLA+ +   E  TA + A   I+      + APE 
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIK------WTAPEA 352
Query: 217 GMGSKASVSGDVYNFGILLLEMFTRRR-PTDAMFN 250
            +  + ++  DV++FGILL E+ T+ R P   M N
Sbjct: 353 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 387

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 107/215 (49%), Gaps = 19/215 (8%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           K+GQG    V+ G  + + + VA+K +      +  +F  E   ++ +RH  L+++  + 
Sbjct: 25  KLGQGCFGEVWMGTWNGT-TRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQP 156
           S           IV EYM   +L  +L+   G+   L Q V++A  ++  + Y       
Sbjct: 83  SEEPI------YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM--- 133
Query: 157 SIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEY 216
           + VH DL+ +NIL+ +++V  V D GLA+ +   E  TA + A   I+      + APE 
Sbjct: 134 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIK------WTAPEA 186
Query: 217 GMGSKASVSGDVYNFGILLLEMFTRRR-PTDAMFN 250
            +  + ++  DV++FGILL E+ T+ R P   M N
Sbjct: 187 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 221

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 107/215 (49%), Gaps = 19/215 (8%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           K+GQG    V+ G  + + + VA+K +      +  +F  E   ++ +RH  L+++  + 
Sbjct: 22  KLGQGCFGEVWMGTWNGT-TRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 79
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQP 156
           S           IV EYM   +L  +L+   G+   L Q V+++  ++  + Y       
Sbjct: 80  SEEPI------YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERM--- 130
Query: 157 SIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEY 216
           + VH DL+ +NIL+ +++V  V D GLA+ +   E  TA + A   I+      + APE 
Sbjct: 131 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIK------WTAPEA 183
Query: 217 GMGSKASVSGDVYNFGILLLEMFTRRR-PTDAMFN 250
            +  + ++  DV++FGILL E+ T+ R P   M N
Sbjct: 184 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 218

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 106/215 (49%), Gaps = 19/215 (8%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           K+GQG    V+ G  + + + VA+K +      +  +F  E   ++ +RH  L+++  + 
Sbjct: 25  KLGQGCFGEVWMGTWNGT-TRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQP 156
           S           IV EYM    L  +L+   G+   L Q V++A  ++  + Y       
Sbjct: 83  SEEPI------YIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM--- 133
Query: 157 SIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEY 216
           + VH DL+ +NIL+ +++V  V D GLA+ +   E  TA + A   I+      + APE 
Sbjct: 134 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIK------WTAPEA 186
Query: 217 GMGSKASVSGDVYNFGILLLEMFTRRR-PTDAMFN 250
            +  + ++  DV++FGILL E+ T+ R P   M N
Sbjct: 187 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 221

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 107/215 (49%), Gaps = 19/215 (8%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           K+GQG    V+ G  + + + VA+K +      +  +F  E   ++ +RH  L+++  + 
Sbjct: 274 KLGQGCFGEVWMGTWNGT-TRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQP 156
           S           IV EYM   +L  +L+   G+   L Q V++A  ++  + Y       
Sbjct: 332 SEEPI------YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM--- 382
Query: 157 SIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEY 216
           + VH DL+ +NIL+ +++V  V D GLA+ +   E  TA + A   I+      + APE 
Sbjct: 383 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIK------WTAPEA 435
Query: 217 GMGSKASVSGDVYNFGILLLEMFTRRR-PTDAMFN 250
            +  + ++  DV++FGILL E+ T+ R P   M N
Sbjct: 436 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 470

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 106/224 (47%), Gaps = 18/224 (8%)
Query: 18  PMISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAE 77
           P  +Y +      + +  +K+G G    VY+G+  +    VAVK +     E    F  E
Sbjct: 2   PSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKE 60
Query: 78  CNALRNIRHRNLIKIITICS-SIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQR 136
              ++ I+H NL++++ +C+    F       I+ E+M   NL  +LR+ N Q       
Sbjct: 61  AAVMKEIKHPNLVQLLGVCTREPPF------YIIIEFMTYGNLLDYLRECNRQEVNAVVL 114
Query: 137 VNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAA 196
           + +A  +S A+EY     + + +H DL   N L+ ++ +  V D GL++ + G       
Sbjct: 115 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG------- 164
Query: 197 ETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
           +T +     K  + + APE    +K S+  DV+ FG+LL E+ T
Sbjct: 165 DTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 107/215 (49%), Gaps = 19/215 (8%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           K+GQG    V+ G  + + + VA+K +      +  +F  E   ++ +RH  L+++  + 
Sbjct: 191 KLGQGCFGEVWMGTWNGT-TRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQP 156
           S           IV EYM   +L  +L+   G+   L Q V++A  ++  + Y       
Sbjct: 249 SEEPI------YIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM--- 299
Query: 157 SIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEY 216
           + VH DL+ +NIL+ +++V  V D GLA+ +   E  TA + A   I+      + APE 
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIK------WTAPEA 352
Query: 217 GMGSKASVSGDVYNFGILLLEMFTRRR-PTDAMFN 250
            +  + ++  DV++FGILL E+ T+ R P   M N
Sbjct: 353 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 387

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 106/215 (49%), Gaps = 19/215 (8%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           K+GQG    V+ G  + + + VA+K +      +  +F  E   ++ +RH  L+++  + 
Sbjct: 25  KLGQGCFGEVWMGTWNGT-TRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQP 156
           S           IV EYM    L  +L+   G+   L Q V++A  ++  + Y       
Sbjct: 83  SEEPI------YIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM--- 133
Query: 157 SIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEY 216
           + VH DL+ +NIL+ +++V  V D GLA+ +   E  TA + A   I+      + APE 
Sbjct: 134 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIK------WTAPEA 186
Query: 217 GMGSKASVSGDVYNFGILLLEMFTRRR-PTDAMFN 250
            +  + ++  DV++FGILL E+ T+ R P   M N
Sbjct: 187 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 221

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 106/215 (49%), Gaps = 19/215 (8%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           K+GQG    V+ G  + + + VA+K +      +  +F  E   ++ +RH  L+++  + 
Sbjct: 25  KLGQGCFGEVWMGTWNGT-TRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQP 156
           S           IV EYM   +L  +L+   G+   L Q V++A  ++  + Y       
Sbjct: 83  SEEPI------YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM--- 133
Query: 157 SIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEY 216
           + VH DL  +NIL+ +++V  V D GLA+ +   E  TA + A   I+      + APE 
Sbjct: 134 NYVHRDLAAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIK------WTAPEA 186
Query: 217 GMGSKASVSGDVYNFGILLLEMFTRRR-PTDAMFN 250
            +  + ++  DV++FGILL E+ T+ R P   M N
Sbjct: 187 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 221

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 106/224 (47%), Gaps = 18/224 (8%)
Query: 18  PMISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAE 77
           P  +Y +      + +  +K+G G    VY+G+  +    VAVK +     E    F  E
Sbjct: 5   PSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKE 63
Query: 78  CNALRNIRHRNLIKIITICS-SIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQR 136
              ++ I+H NL++++ +C+    F       I+ E+M   NL  +LR+ N Q       
Sbjct: 64  AAVMKEIKHPNLVQLLGVCTREPPF------YIITEFMTYGNLLDYLRECNRQEVNAVVL 117
Query: 137 VNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAA 196
           + +A  +S A+EY     + + +H DL   N L+ ++ +  V D GL++ + G       
Sbjct: 118 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG------- 167
Query: 197 ETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
           +T +     K  + + APE    +K S+  DV+ FG+LL E+ T
Sbjct: 168 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 211

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 100/206 (48%), Gaps = 18/206 (8%)
Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITI 95
           +K+G G    VY+G+  +    VAVK +     E    F  E   ++ I+H NL++++ +
Sbjct: 17  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLGV 75
Query: 96  CS-SIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHC 154
           C+    F       I+ E+M   NL  +LR+ N Q       + +A  +S A+EY     
Sbjct: 76  CTREPPF------YIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--- 126
Query: 155 QPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAP 214
           + + +H DL   N L+ ++ +  V D GL++ + G       +T +     K  + + AP
Sbjct: 127 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-------DTXTAHAGAKFPIKWTAP 179
Query: 215 EYGMGSKASVSGDVYNFGILLLEMFT 240
           E    +K S+  DV+ FG+LL E+ T
Sbjct: 180 ESLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 105/221 (47%), Gaps = 18/221 (8%)
Query: 21  SYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNA 80
           +Y +      + +  +K+G G    VY+G+  +    VAVK +     E    F  E   
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAV 67
Query: 81  LRNIRHRNLIKIITICS-SIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNI 139
           ++ I+H NL++++ +C+    F       I+ E+M   NL  +LR+ N Q       + +
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPF------YIIIEFMTYGNLLDYLRECNRQEVNAVVLLYM 121
Query: 140 AIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETA 199
           A  +S A+EY     + + +H DL   N L+ ++ +  V D GL++ + G       +T 
Sbjct: 122 ATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-------DTY 171
Query: 200 SNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
           +     K  + + APE    +K S+  DV+ FG+LL E+ T
Sbjct: 172 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 105/221 (47%), Gaps = 18/221 (8%)
Query: 21  SYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNA 80
           +Y +      + +  +K+G G    VY+G+  +    VAVK +     E    F  E   
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAV 62
Query: 81  LRNIRHRNLIKIITICS-SIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNI 139
           ++ I+H NL++++ +C+    F       I+ E+M   NL  +LR+ N Q       + +
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPF------YIIIEFMTYGNLLDYLRECNRQEVSAVVLLYM 116
Query: 140 AIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETA 199
           A  +S A+EY     + + +H DL   N L+ ++ +  V D GL++ + G       +T 
Sbjct: 117 ATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-------DTY 166
Query: 200 SNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
           +     K  + + APE    +K S+  DV+ FG+LL E+ T
Sbjct: 167 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 105/221 (47%), Gaps = 18/221 (8%)
Query: 21  SYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNA 80
           +Y +      + +  +K+G G    VY+G+  +    VAVK +     E    F  E   
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAV 62
Query: 81  LRNIRHRNLIKIITICS-SIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNI 139
           ++ I+H NL++++ +C+    F       I+ E+M   NL  +LR+ N Q       + +
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPF------YIIIEFMTYGNLLDYLRECNRQEVSAVVLLYM 116
Query: 140 AIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETA 199
           A  +S A+EY     + + +H DL   N L+ ++ +  V D GL++ + G       +T 
Sbjct: 117 ATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-------DTY 166
Query: 200 SNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
           +     K  + + APE    +K S+  DV+ FG+LL E+ T
Sbjct: 167 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 105/221 (47%), Gaps = 18/221 (8%)
Query: 21  SYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNA 80
           +Y +      + +  +K+G G    VY+G+  +    VAVK +     E    F  E   
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAV 67
Query: 81  LRNIRHRNLIKIITICS-SIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNI 139
           ++ I+H NL++++ +C+    F       I+ E+M   NL  +LR+ N Q       + +
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPF------YIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 121
Query: 140 AIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETA 199
           A  +S A+EY     + + +H DL   N L+ ++ +  V D GL++ + G       +T 
Sbjct: 122 ATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-------DTX 171
Query: 200 SNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
           +     K  + + APE    +K S+  DV+ FG+LL E+ T
Sbjct: 172 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 106/215 (49%), Gaps = 19/215 (8%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           K+GQG    V+ G  + + + VA+K +      +  +F  E   ++ +RH  L+++  + 
Sbjct: 192 KLGQGCFGEVWMGTWNGT-TRVAIKTLK-PGNMSPEAFLQEAQVMKKLRHEKLVQLYAVV 249
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQP 156
           S           IV EYM   +L  +L+   G+   L Q V++A  ++  + Y       
Sbjct: 250 SEEPI------YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM--- 300
Query: 157 SIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEY 216
           + VH DL+ +NIL+ +++V  V D GL + +   E  TA + A   I+      + APE 
Sbjct: 301 NYVHRDLRAANILVGENLVCKVADFGLGRLIEDNE-YTARQGAKFPIK------WTAPEA 353
Query: 217 GMGSKASVSGDVYNFGILLLEMFTRRR-PTDAMFN 250
            +  + ++  DV++FGILL E+ T+ R P   M N
Sbjct: 354 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 388

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 105/221 (47%), Gaps = 18/221 (8%)
Query: 21  SYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNA 80
           +Y +      + +  +K+G G    VY+G+  +    VAVK +     E    F  E   
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAV 67
Query: 81  LRNIRHRNLIKIITICS-SIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNI 139
           ++ I+H NL++++ +C+    F       I+ E+M   NL  +LR+ N Q       + +
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPF------YIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 121
Query: 140 AIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETA 199
           A  +S A+EY     + + +H DL   N L+ ++ +  V D GL++ + G       +T 
Sbjct: 122 ATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-------DTY 171
Query: 200 SNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
           +     K  + + APE    +K S+  DV+ FG+LL E+ T
Sbjct: 172 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 100/206 (48%), Gaps = 18/206 (8%)
Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITI 95
           +K+G G    VY+G+  +    VAVK +     E    F  E   ++ I+H NL++++ +
Sbjct: 17  HKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLGV 75
Query: 96  CS-SIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHC 154
           C+    F       I+ E+M   NL  +LR+ N Q       + +A  +S A+EY     
Sbjct: 76  CTREPPF------YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--- 126
Query: 155 QPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAP 214
           + + +H DL   N L+ ++ +  V D GL++ + G       +T +     K  + + AP
Sbjct: 127 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-------DTXTAHAGAKFPIKWTAP 179
Query: 215 EYGMGSKASVSGDVYNFGILLLEMFT 240
           E    +K S+  DV+ FG+LL E+ T
Sbjct: 180 ESLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 105/221 (47%), Gaps = 18/221 (8%)
Query: 21  SYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNA 80
           +Y +      + +  +K+G G    VY+G+  +    VAVK +     E    F  E   
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAV 62
Query: 81  LRNIRHRNLIKIITICS-SIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNI 139
           ++ I+H NL++++ +C+    F       I+ E+M   NL  +LR+ N Q       + +
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPF------YIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 116
Query: 140 AIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETA 199
           A  +S A+EY     + + +H DL   N L+ ++ +  V D GL++ + G       +T 
Sbjct: 117 ATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-------DTY 166
Query: 200 SNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
           +     K  + + APE    +K S+  DV+ FG+LL E+ T
Sbjct: 167 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 105/221 (47%), Gaps = 18/221 (8%)
Query: 21  SYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNA 80
           +Y +      + +  +K+G G    VY+G+  +    VAVK +     E    F  E   
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAV 64
Query: 81  LRNIRHRNLIKIITICS-SIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNI 139
           ++ I+H NL++++ +C+    F       I+ E+M   NL  +LR+ N Q       + +
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPF------YIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 118
Query: 140 AIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETA 199
           A  +S A+EY     + + +H DL   N L+ ++ +  V D GL++ + G       +T 
Sbjct: 119 ATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-------DTY 168
Query: 200 SNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
           +     K  + + APE    +K S+  DV+ FG+LL E+ T
Sbjct: 169 TAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 105/221 (47%), Gaps = 18/221 (8%)
Query: 21  SYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNA 80
           +Y +      + +  +K+G G    VY+G+  +    VAVK +     E    F  E   
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAV 67
Query: 81  LRNIRHRNLIKIITICS-SIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNI 139
           ++ I+H NL++++ +C+    F       I+ E+M   NL  +LR+ N Q       + +
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPF------YIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 121
Query: 140 AIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETA 199
           A  +S A+EY     + + +H DL   N L+ ++ +  V D GL++ + G       +T 
Sbjct: 122 ATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-------DTY 171
Query: 200 SNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
           +     K  + + APE    +K S+  DV+ FG+LL E+ T
Sbjct: 172 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 105/221 (47%), Gaps = 18/221 (8%)
Query: 21  SYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNA 80
           +Y +      + +  +K+G G    VY+G+  +    VAVK +     E    F  E   
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAV 62
Query: 81  LRNIRHRNLIKIITICS-SIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNI 139
           ++ I+H NL++++ +C+    F       I+ E+M   NL  +LR+ N Q       + +
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPF------YIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 116
Query: 140 AIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETA 199
           A  +S A+EY     + + +H DL   N L+ ++ +  V D GL++ + G       +T 
Sbjct: 117 ATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-------DTY 166
Query: 200 SNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
           +     K  + + APE    +K S+  DV+ FG+LL E+ T
Sbjct: 167 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 105/221 (47%), Gaps = 18/221 (8%)
Query: 21  SYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNA 80
           +Y +      + +  +K+G G    VY+G+  +    VAVK +     E    F  E   
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 62
Query: 81  LRNIRHRNLIKIITICS-SIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNI 139
           ++ I+H NL++++ +C+    F       I+ E+M   NL  +LR+ N Q       + +
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPF------YIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 116
Query: 140 AIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETA 199
           A  +S A+EY     + + +H DL   N L+ ++ +  V D GL++ + G       +T 
Sbjct: 117 ATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-------DTY 166
Query: 200 SNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
           +     K  + + APE    +K S+  DV+ FG+LL E+ T
Sbjct: 167 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 105/221 (47%), Gaps = 18/221 (8%)
Query: 21  SYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNA 80
           +Y +      + +  +K+G G    VY+G+  +    VAVK +     E    F  E   
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAV 64
Query: 81  LRNIRHRNLIKIITICS-SIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNI 139
           ++ I+H NL++++ +C+    F       I+ E+M   NL  +LR+ N Q       + +
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPF------YIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 118
Query: 140 AIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETA 199
           A  +S A+EY     + + +H DL   N L+ ++ +  V D GL++ + G       +T 
Sbjct: 119 ATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-------DTY 168
Query: 200 SNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
           +     K  + + APE    +K S+  DV+ FG+LL E+ T
Sbjct: 169 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 105/221 (47%), Gaps = 18/221 (8%)
Query: 21  SYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNA 80
           +Y +      + +  +K+G G    VY+G+  +    VAVK +     E    F  E   
Sbjct: 5   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAV 63
Query: 81  LRNIRHRNLIKIITICS-SIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNI 139
           ++ I+H NL++++ +C+    F       I+ E+M   NL  +LR+ N Q       + +
Sbjct: 64  MKEIKHPNLVQLLGVCTREPPF------YIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 117
Query: 140 AIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETA 199
           A  +S A+EY     + + +H DL   N L+ ++ +  V D GL++ + G       +T 
Sbjct: 118 ATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-------DTY 167
Query: 200 SNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
           +     K  + + APE    +K S+  DV+ FG+LL E+ T
Sbjct: 168 TAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 105/221 (47%), Gaps = 18/221 (8%)
Query: 21  SYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNA 80
           +Y +      + +  +K+G G    VY+G+  +    VAVK +     E    F  E   
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAV 62
Query: 81  LRNIRHRNLIKIITICS-SIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNI 139
           ++ I+H NL++++ +C+    F       I+ E+M   NL  +LR+ N Q       + +
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPF------YIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 116
Query: 140 AIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETA 199
           A  +S A+EY     + + +H DL   N L+ ++ +  V D GL++ + G       +T 
Sbjct: 117 ATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-------DTY 166
Query: 200 SNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
           +     K  + + APE    +K S+  DV+ FG+LL E+ T
Sbjct: 167 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 105/221 (47%), Gaps = 18/221 (8%)
Query: 21  SYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNA 80
           +Y +      + +  +K+G G    VY+G+  +    VAVK +     E    F  E   
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAV 64
Query: 81  LRNIRHRNLIKIITICS-SIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNI 139
           ++ I+H NL++++ +C+    F       I+ E+M   NL  +LR+ N Q       + +
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPF------YIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 118
Query: 140 AIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETA 199
           A  +S A+EY     + + +H DL   N L+ ++ +  V D GL++ + G       +T 
Sbjct: 119 ATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-------DTY 168
Query: 200 SNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
           +     K  + + APE    +K S+  DV+ FG+LL E+ T
Sbjct: 169 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 105/221 (47%), Gaps = 18/221 (8%)
Query: 21  SYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNA 80
           +Y +      + +  +K+G G    VY+G+  +    VAVK +     E    F  E   
Sbjct: 17  NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAV 75
Query: 81  LRNIRHRNLIKIITICS-SIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNI 139
           ++ I+H NL++++ +C+    F       I+ E+M   NL  +LR+ N Q       + +
Sbjct: 76  MKEIKHPNLVQLLGVCTREPPF------YIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 129
Query: 140 AIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETA 199
           A  +S A+EY     + + +H DL   N L+ ++ +  V D GL++ + G       +T 
Sbjct: 130 ATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-------DTY 179
Query: 200 SNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
           +     K  + + APE    +K S+  DV+ FG+LL E+ T
Sbjct: 180 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 220

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 105/221 (47%), Gaps = 18/221 (8%)
Query: 21  SYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNA 80
           +Y +      + +  +K+G G    VY+G+  +    VAVK +     E    F  E   
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAV 67
Query: 81  LRNIRHRNLIKIITICS-SIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNI 139
           ++ I+H NL++++ +C+    F       I+ E+M   NL  +LR+ N Q       + +
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPF------YIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 121
Query: 140 AIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETA 199
           A  +S A+EY     + + +H DL   N L+ ++ +  V D GL++ + G       +T 
Sbjct: 122 ATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-------DTY 171
Query: 200 SNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
           +     K  + + APE    +K S+  DV+ FG+LL E+ T
Sbjct: 172 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 100/206 (48%), Gaps = 18/206 (8%)
Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITI 95
           +K+G G    VY+G+  +    VAVK +     E    F  E   ++ I+H NL++++ +
Sbjct: 17  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLGV 75
Query: 96  CS-SIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHC 154
           C+    F       I+ E+M   NL  +LR+ N Q       + +A  +S A+EY     
Sbjct: 76  CTREPPF------YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--- 126
Query: 155 QPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAP 214
           + + +H DL   N L+ ++ +  V D GL++ + G       +T +     K  + + AP
Sbjct: 127 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-------DTFTAHAGAKFPIKWTAP 179
Query: 215 EYGMGSKASVSGDVYNFGILLLEMFT 240
           E    +K S+  DV+ FG+LL E+ T
Sbjct: 180 ESLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 110/229 (48%), Gaps = 25/229 (10%)
Query: 38  IGQGGVSIVYKGILDESRS----IVAVKVVNLKQKEASR-SFAAECNALRNIRHRNLIKI 92
           IG G    VYKG+L  S       VA+K +     E  R  F  E   +    H N+I++
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 93  ITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHH 152
             + S      +    I+ EYM+N  L+++LR+ +G+   L Q V +   ++  ++Y  +
Sbjct: 112 EGVISK-----YKPMMIITEYMENGALDKFLREKDGEFSVL-QLVGMLRGIAAGMKYLAN 165
Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
               + VH DL   NIL++ ++V  V D GL++ L   +P     T+   I I+    + 
Sbjct: 166 M---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED-DPEATYTTSGGKIPIR----WT 217
Query: 213 APEYGMGSKASVSGDVYNFGILLLEMFTR-RRPTDAMFNEGLTLHEFVK 260
           APE     K + + DV++FGI++ E+ T   RP   + N     HE +K
Sbjct: 218 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-----HEVMK 261

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 16/205 (7%)
Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITI 95
           +K+G G    VY G+  +    VAVK +     E    F  E   ++ I+H NL++++ +
Sbjct: 38  HKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLGV 96
Query: 96  CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQ 155
           C+    E   +  IV EYM   NL  +LR+ N +       + +A  +S A+EY     +
Sbjct: 97  CT---LEPPFY--IVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLE---K 148
Query: 156 PSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPE 215
            + +H DL   N L+ ++ V  V D GL++ + G       +T +     K  + + APE
Sbjct: 149 KNFIHRDLAARNCLVGENHVVKVADFGLSRLMTG-------DTYTAHAGAKFPIKWTAPE 201
Query: 216 YGMGSKASVSGDVYNFGILLLEMFT 240
               +  S+  DV+ FG+LL E+ T
Sbjct: 202 SLAYNTFSIKSDVWAFGVLLWEIAT 226

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 107/218 (49%), Gaps = 24/218 (11%)
Query: 32  FSPANKIGQGGVSIVY---KGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRN 88
           +   +K+G GG+S VY     IL+   +I A+ +   +++E  + F  E +    + H+N
Sbjct: 13  YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 89  LIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAI- 147
           ++ +I +      E  D   +V EY++   L +++ +S+G L      V+ AI+ +  I 
Sbjct: 73  IVSMIDVD-----EEDDCYYLVMEYIEGPTLSEYI-ESHGPLS-----VDTAINFTNQIL 121
Query: 148 EYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETA-SNSIEIK 206
           +   H     IVH D+KP NIL+D +    + D G+AK L        +ET+ + +  + 
Sbjct: 122 DGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL--------SETSLTQTNHVL 173
Query: 207 GIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
           G V Y +PE   G       D+Y+ GI+L EM     P
Sbjct: 174 GTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 18/206 (8%)
Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITI 95
           +K+G G    VY+G+  +    VAVK +     E    F  E   ++ I+H NL++++ +
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLGV 284
Query: 96  CS-SIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHC 154
           C+    F       I+ E+M   NL  +LR+ N Q       + +A  +S A+EY     
Sbjct: 285 CTREPPF------YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--- 335
Query: 155 QPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAP 214
           + + +H +L   N L+ ++ +  V D GL++ + G       +T +     K  + + AP
Sbjct: 336 KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG-------DTYTAHAGAKFPIKWTAP 388
Query: 215 EYGMGSKASVSGDVYNFGILLLEMFT 240
           E    +K S+  DV+ FG+LL E+ T
Sbjct: 389 ESLAYNKFSIKSDVWAFGVLLWEIAT 414

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 18/206 (8%)
Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITI 95
           +K+G G    VY+G+  +    VAVK +     E    F  E   ++ I+H NL++++ +
Sbjct: 265 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLGV 323
Query: 96  CS-SIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHC 154
           C+    F       I+ E+M   NL  +LR+ N Q       + +A  +S A+EY     
Sbjct: 324 CTREPPF------YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--- 374
Query: 155 QPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAP 214
           + + +H +L   N L+ ++ +  V D GL++ + G       +T +     K  + + AP
Sbjct: 375 KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG-------DTYTAHAGAKFPIKWTAP 427
Query: 215 EYGMGSKASVSGDVYNFGILLLEMFT 240
           E    +K S+  DV+ FG+LL E+ T
Sbjct: 428 ESLAYNKFSIKSDVWAFGVLLWEIAT 453

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/250 (29%), Positives = 116/250 (46%), Gaps = 30/250 (12%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICS 97
           IG+G    V  G  D   + VAVK +  K    +++F AE + +  +RH NL++++ +  
Sbjct: 14  IGKGEFGDVMLG--DYRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI- 68
Query: 98  SIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPS 157
            ++ +G  +  IV EYM   +L  +LR     +      +  ++DV  A+EY   +   +
Sbjct: 69  -VEEKGGLY--IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---N 122
Query: 158 IVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYG 217
            VH DL   N+L+ +D VA V D GL K           E +S     K  V + APE  
Sbjct: 123 FVHRDLAARNVLVSEDNVAKVSDFGLTK-----------EASSTQDTGKLPVKWTAPEAL 171
Query: 218 MGSKASVSGDVYNFGILLLEMFTRRR---PTDAMFNEGLTLHEFVKMALPDKVMEIVDPS 274
              K S   DV++FGILL E+++  R   P   + +    + +  KM  PD       P 
Sbjct: 172 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGC-----PP 226
Query: 275 LLLEVTANNY 284
            + EV  N +
Sbjct: 227 AVYEVMKNCW 236

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 101/206 (49%), Gaps = 22/206 (10%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICS 97
           IG+G    V  G  D   + VAVK +  K    +++F AE + +  +RH NL++++ +  
Sbjct: 201 IGKGEFGDVMLG--DYRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI- 255
Query: 98  SIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPS 157
            ++ +G  +  IV EYM   +L  +LR     +      +  ++DV  A+EY   +   +
Sbjct: 256 -VEEKGGLY--IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---N 309
Query: 158 IVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYG 217
            VH DL   N+L+ +D VA V D GL K           E +S     K  V + APE  
Sbjct: 310 FVHRDLAARNVLVSEDNVAKVSDFGLTK-----------EASSTQDTGKLPVKWTAPEAL 358
Query: 218 MGSKASVSGDVYNFGILLLEMFTRRR 243
              K S   DV++FGILL E+++  R
Sbjct: 359 REKKFSTKSDVWSFGILLWEIYSFGR 384

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/250 (29%), Positives = 116/250 (46%), Gaps = 30/250 (12%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICS 97
           IG+G    V  G  D   + VAVK +  K    +++F AE + +  +RH NL++++ +  
Sbjct: 29  IGKGEFGDVMLG--DYRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI- 83
Query: 98  SIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPS 157
            ++ +G  +  IV EYM   +L  +LR     +      +  ++DV  A+EY   +   +
Sbjct: 84  -VEEKGGLY--IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---N 137
Query: 158 IVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYG 217
            VH DL   N+L+ +D VA V D GL K           E +S     K  V + APE  
Sbjct: 138 FVHRDLAARNVLVSEDNVAKVSDFGLTK-----------EASSTQDTGKLPVKWTAPEAL 186
Query: 218 MGSKASVSGDVYNFGILLLEMFTRRR---PTDAMFNEGLTLHEFVKMALPDKVMEIVDPS 274
              K S   DV++FGILL E+++  R   P   + +    + +  KM  PD       P 
Sbjct: 187 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGC-----PP 241
Query: 275 LLLEVTANNY 284
            + EV  N +
Sbjct: 242 AVYEVMKNCW 251

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 103/211 (48%), Gaps = 19/211 (9%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASR--SFAAECNALRNIRHRNLIKIIT 94
           KIG G    V++   +   S VAVK++  +   A R   F  E   ++ +RH N++  + 
Sbjct: 44  KIGAGSFGTVHRA--EWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 95  ICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRF-LTQRVNIAIDVSFAIEYFHHH 153
             +          +IV EY+   +L + L +S  + +    +R+++A DV+  + Y H+ 
Sbjct: 102 AVTQPPN-----LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 154 CQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVA 213
             P IVH +LK  N+L+D+     V D GL++          A T  +S    G   ++A
Sbjct: 157 -NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--------KASTFLSSKSAAGTPEWMA 207
Query: 214 PEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
           PE      ++   DVY+FG++L E+ T ++P
Sbjct: 208 PEVLRDEPSNEKSDVYSFGVILWELATLQQP 238

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 70/266 (26%), Positives = 122/266 (45%), Gaps = 24/266 (9%)
Query: 8   SNMLSMKQQFPMISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ 67
           S+M + K Q P     E            ++G G    V+ G  +   + VAVK  +LKQ
Sbjct: 2   SHMQTQKPQKPWWE-DEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVK--SLKQ 57
Query: 68  KEASR-SFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQS 126
              S  +F AE N ++ ++H+ L+++  + +           I+ EYM+N +L  +L+  
Sbjct: 58  GSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI------YIITEYMENGSLVDFLKTP 111
Query: 127 NGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF 186
           +G    + + +++A  ++  + +       + +H DL+ +NIL+   +   + D GLA+ 
Sbjct: 112 SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARL 168
Query: 187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRR-PT 245
           +   E  TA E A   I+      + APE       ++  DV++FGILL E+ T  R P 
Sbjct: 169 IEDNE-YTAREGAKFPIK------WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 221
Query: 246 DAMFNEGL--TLHEFVKMALPDKVME 269
             M N  +   L    +M  PD   E
Sbjct: 222 PGMTNPEVIQNLERGYRMVRPDNCPE 247

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 102/215 (47%), Gaps = 19/215 (8%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           ++G G    V+ G  +   + VA+K +      +  SF  E   ++ ++H  L+++  + 
Sbjct: 16  RLGNGQFGEVWMGTWN-GNTKVAIKTLK-PGTMSPESFLEEAQIMKKLKHDKLVQLYAVV 73
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQP 156
           S           IV EYM   +L  +L+   G+   L   V++A  V+  + Y       
Sbjct: 74  SEEPI------YIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM--- 124
Query: 157 SIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEY 216
           + +H DL+ +NIL+   ++  + D GLA+ +   E  TA + A   I+      + APE 
Sbjct: 125 NYIHRDLRSANILVGNGLICKIADFGLARLIEDNE-XTARQGAKFPIK------WTAPEA 177
Query: 217 GMGSKASVSGDVYNFGILLLEMFTRRR-PTDAMFN 250
            +  + ++  DV++FGILL E+ T+ R P   M N
Sbjct: 178 ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN 212

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 72/250 (28%), Positives = 116/250 (46%), Gaps = 30/250 (12%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICS 97
           IG+G    V  G  D   + VAVK +  K    +++F AE + +  +RH NL++++ +  
Sbjct: 20  IGKGEFGDVMLG--DYRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI- 74
Query: 98  SIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPS 157
            ++ +G  +  IV EYM   +L  +LR     +      +  ++DV  A+EY   +   +
Sbjct: 75  -VEEKGGLY--IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---N 128
Query: 158 IVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYG 217
            VH DL   N+L+ +D VA V D GL K           E +S     K  V + APE  
Sbjct: 129 FVHRDLAARNVLVSEDNVAKVSDFGLTK-----------EASSTQDTGKLPVKWTAPEAL 177
Query: 218 MGSKASVSGDVYNFGILLLEMFTRRR---PTDAMFNEGLTLHEFVKMALPDKVMEIVDPS 274
             +  S   DV++FGILL E+++  R   P   + +    + +  KM  PD       P 
Sbjct: 178 REAAFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGC-----PP 232
Query: 275 LLLEVTANNY 284
            + EV  N +
Sbjct: 233 AVYEVMKNCW 242

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 19/211 (9%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASR--SFAAECNALRNIRHRNLIKIIT 94
           KIG G    V++   +   S VAVK++  +   A R   F  E   ++ +RH N++  + 
Sbjct: 44  KIGAGSFGTVHRA--EWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 95  ICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRF-LTQRVNIAIDVSFAIEYFHHH 153
             +          +IV EY+   +L + L +S  + +    +R+++A DV+  + Y H+ 
Sbjct: 102 AVTQPPN-----LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 154 CQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVA 213
             P IVH DLK  N+L+D+     V D GL++          A     S    G   ++A
Sbjct: 157 -NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--------KASXFLXSKXAAGTPEWMA 207
Query: 214 PEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
           PE      ++   DVY+FG++L E+ T ++P
Sbjct: 208 PEVLRDEPSNEKSDVYSFGVILWELATLQQP 238

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 114/238 (47%), Gaps = 23/238 (9%)
Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASR-SFAAECNALRNIRHRNLIKIIT 94
            ++G G    V+ G  +   + VAVK  +LKQ   S  +F AE N ++ ++H+ L+++  
Sbjct: 19  ERLGAGQAGEVWMGYYN-GHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 95  ICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHC 154
           + +           I+ EYM+N +L  +L+  +G    + + +++A  ++  + +     
Sbjct: 76  VVTQEPI------YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER- 128
Query: 155 QPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAP 214
             + +H DL+ +NIL+   +   + D GLA+ +   E  TA E A   I+      + AP
Sbjct: 129 --NYIHRDLRAANILVSDTLSCKIADFGLARLIEDAE-XTAREGAKFPIK------WTAP 179
Query: 215 EYGMGSKASVSGDVYNFGILLLEMFTRRR-PTDAMFNEGL--TLHEFVKMALPDKVME 269
           E       ++  DV++FGILL E+ T  R P   M N  +   L    +M  PD   E
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE 237

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 114/237 (48%), Gaps = 23/237 (9%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASR-SFAAECNALRNIRHRNLIKIITI 95
           ++G G    V+ G  +   + VAVK  +LKQ   S  +F AE N ++ ++H+ L+++  +
Sbjct: 28  RLGAGQFGEVWMGYYN-GHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 84
Query: 96  CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQ 155
            +           I+ EYM+N +L  +L+  +G    + + +++A  ++  + +      
Sbjct: 85  VTQEPI------YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER-- 136
Query: 156 PSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPE 215
            + +H DL+ +NIL+   +   + D GLA+ +   E  TA E A   I+      + APE
Sbjct: 137 -NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-XTAREGAKFPIK------WTAPE 188
Query: 216 YGMGSKASVSGDVYNFGILLLEMFTRRR-PTDAMFNEGL--TLHEFVKMALPDKVME 269
                  ++  DV++FGILL E+ T  R P   M N  +   L    +M  PD   E
Sbjct: 189 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE 245

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 114/237 (48%), Gaps = 23/237 (9%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASR-SFAAECNALRNIRHRNLIKIITI 95
           ++G G    V+ G  +   + VAVK  +LKQ   S  +F AE N ++ ++H+ L+++  +
Sbjct: 29  RLGAGQFGEVWMGYYN-GHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 85
Query: 96  CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQ 155
            +           I+ EYM+N +L  +L+  +G    + + +++A  ++  + +      
Sbjct: 86  VTQEPI------YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER-- 137
Query: 156 PSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPE 215
            + +H DL+ +NIL+   +   + D GLA+ +   E  TA E A   I+      + APE
Sbjct: 138 -NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-XTAREGAKFPIK------WTAPE 189
Query: 216 YGMGSKASVSGDVYNFGILLLEMFTRRR-PTDAMFNEGL--TLHEFVKMALPDKVME 269
                  ++  DV++FGILL E+ T  R P   M N  +   L    +M  PD   E
Sbjct: 190 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE 246

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 114/237 (48%), Gaps = 23/237 (9%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASR-SFAAECNALRNIRHRNLIKIITI 95
           ++G G    V+ G  +   + VAVK  +LKQ   S  +F AE N ++ ++H+ L+++  +
Sbjct: 26  RLGAGQFGEVWMGYYN-GHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 82
Query: 96  CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQ 155
            +           I+ EYM+N +L  +L+  +G    + + +++A  ++  + +      
Sbjct: 83  VTQEPI------YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER-- 134
Query: 156 PSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPE 215
            + +H DL+ +NIL+   +   + D GLA+ +   E  TA E A   I+      + APE
Sbjct: 135 -NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-XTAREGAKFPIK------WTAPE 186
Query: 216 YGMGSKASVSGDVYNFGILLLEMFTRRR-PTDAMFNEGL--TLHEFVKMALPDKVME 269
                  ++  DV++FGILL E+ T  R P   M N  +   L    +M  PD   E
Sbjct: 187 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE 243

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 114/237 (48%), Gaps = 23/237 (9%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASR-SFAAECNALRNIRHRNLIKIITI 95
           ++G G    V+ G  +   + VAVK  +LKQ   S  +F AE N ++ ++H+ L+++  +
Sbjct: 20  RLGAGQFGEVWMGYYN-GHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 96  CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQ 155
            +           I+ EYM+N +L  +L+  +G    + + +++A  ++  + +      
Sbjct: 77  VTQEPI------YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER-- 128
Query: 156 PSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPE 215
            + +H DL+ +NIL+   +   + D GLA+ +   E  TA E A   I+      + APE
Sbjct: 129 -NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-XTAREGAKFPIK------WTAPE 180
Query: 216 YGMGSKASVSGDVYNFGILLLEMFTRRR-PTDAMFNEGL--TLHEFVKMALPDKVME 269
                  ++  DV++FGILL E+ T  R P   M N  +   L    +M  PD   E
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE 237

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 114/237 (48%), Gaps = 23/237 (9%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEAS-RSFAAECNALRNIRHRNLIKIITI 95
           ++G G    V+ G  +   + VAVK  +LKQ   S  +F AE N ++ ++H+ L+++  +
Sbjct: 22  RLGAGQFGEVWMGYYN-GHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 78
Query: 96  CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQ 155
            +           I+ EYM+N +L  +L+  +G    + + +++A  ++  + +      
Sbjct: 79  VTQEPI------YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER-- 130
Query: 156 PSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPE 215
            + +H DL+ +NIL+   +   + D GLA+ +   E  TA E A   I+      + APE
Sbjct: 131 -NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-XTAREGAKFPIK------WTAPE 182
Query: 216 YGMGSKASVSGDVYNFGILLLEMFTRRR-PTDAMFNEGL--TLHEFVKMALPDKVME 269
                  ++  DV++FGILL E+ T  R P   M N  +   L    +M  PD   E
Sbjct: 183 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE 239

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 114/237 (48%), Gaps = 23/237 (9%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEAS-RSFAAECNALRNIRHRNLIKIITI 95
           ++G G    V+ G  +   + VAVK  +LKQ   S  +F AE N ++ ++H+ L+++  +
Sbjct: 21  RLGAGQFGEVWMGYYN-GHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 77
Query: 96  CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQ 155
            +           I+ EYM+N +L  +L+  +G    + + +++A  ++  + +      
Sbjct: 78  VTQEPI------YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER-- 129
Query: 156 PSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPE 215
            + +H DL+ +NIL+   +   + D GLA+ +   E  TA E A   I+      + APE
Sbjct: 130 -NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-XTAREGAKFPIK------WTAPE 181
Query: 216 YGMGSKASVSGDVYNFGILLLEMFTRRR-PTDAMFNEGL--TLHEFVKMALPDKVME 269
                  ++  DV++FGILL E+ T  R P   M N  +   L    +M  PD   E
Sbjct: 182 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE 238

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 114/237 (48%), Gaps = 23/237 (9%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEAS-RSFAAECNALRNIRHRNLIKIITI 95
           ++G G    V+ G  +   + VAVK  +LKQ   S  +F AE N ++ ++H+ L+++  +
Sbjct: 20  RLGAGQFGEVWMGYYN-GHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 96  CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQ 155
            +           I+ EYM+N +L  +L+  +G    + + +++A  ++  + +      
Sbjct: 77  VTQEPI------YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER-- 128
Query: 156 PSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPE 215
            + +H DL+ +NIL+   +   + D GLA+ +   E  TA E A   I+      + APE
Sbjct: 129 -NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-XTAREGAKFPIK------WTAPE 180
Query: 216 YGMGSKASVSGDVYNFGILLLEMFTRRR-PTDAMFNEGL--TLHEFVKMALPDKVME 269
                  ++  DV++FGILL E+ T  R P   M N  +   L    +M  PD   E
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE 237

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 114/237 (48%), Gaps = 23/237 (9%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEAS-RSFAAECNALRNIRHRNLIKIITI 95
           ++G G    V+ G  +   + VAVK  +LKQ   S  +F AE N ++ ++H+ L+++  +
Sbjct: 25  RLGAGQFGEVWMGYYN-GHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 81
Query: 96  CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQ 155
            +           I+ EYM+N +L  +L+  +G    + + +++A  ++  + +      
Sbjct: 82  VTQEPI------YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER-- 133
Query: 156 PSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPE 215
            + +H DL+ +NIL+   +   + D GLA+ +   E  TA E A   I+      + APE
Sbjct: 134 -NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIK------WTAPE 185
Query: 216 YGMGSKASVSGDVYNFGILLLEMFTRRR-PTDAMFNEGL--TLHEFVKMALPDKVME 269
                  ++  DV++FGILL E+ T  R P   M N  +   L    +M  PD   E
Sbjct: 186 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE 242

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 114/237 (48%), Gaps = 23/237 (9%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEAS-RSFAAECNALRNIRHRNLIKIITI 95
           ++G G    V+ G  +   + VAVK  +LKQ   S  +F AE N ++ ++H+ L+++  +
Sbjct: 26  RLGAGQFGEVWMGYYN-GHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 82
Query: 96  CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQ 155
            +           I+ EYM+N +L  +L+  +G    + + +++A  ++  + +      
Sbjct: 83  VTQEPI------YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER-- 134
Query: 156 PSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPE 215
            + +H DL+ +NIL+   +   + D GLA+ +   E  TA E A   I+      + APE
Sbjct: 135 -NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIK------WTAPE 186
Query: 216 YGMGSKASVSGDVYNFGILLLEMFTRRR-PTDAMFNEGL--TLHEFVKMALPDKVME 269
                  ++  DV++FGILL E+ T  R P   M N  +   L    +M  PD   E
Sbjct: 187 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE 243

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 101/224 (45%), Gaps = 30/224 (13%)
Query: 35  ANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRNIRHRNLIKI 92
             +IG G    VYKG   +    VAVK++N+     +  ++F  E   LR  RH N++  
Sbjct: 17  GQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL- 72
Query: 93  ITICSSIDFEGFDFK---AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEY 149
                   F G+  K   AIV ++ +  +L   L  S  +   + + ++IA   +  ++Y
Sbjct: 73  --------FMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFE-MKKLIDIARQTARGMDY 123
Query: 150 FHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
            H     SI+H DLK +NI L +D    +GD GLA     +      E  S SI      
Sbjct: 124 LH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSIL----- 175
Query: 210 GYVAPE---YGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFN 250
            ++APE       +  S   DVY FGI+L E+ T + P   + N
Sbjct: 176 -WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 218

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 24/211 (11%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICS 97
           +G+G   +V K         VA+K   ++ +   ++F  E   L  + H N++K+   C 
Sbjct: 16  VGRGAFGVVCKAKWRAKD--VAIK--QIESESERKAFIVELRQLSRVNHPNIVKLYGAC- 70
Query: 98  SIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLT--QRVNIAIDVSFAIEYFHHHCQ 155
                  +   +V EY +  +L   L  +   L + T    ++  +  S  + Y H    
Sbjct: 71  ------LNPVCLVMEYAEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQP 123
Query: 156 PSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPE 215
            +++H DLKP N+LL    VA    L +  F      GTA +  ++    KG   ++APE
Sbjct: 124 KALIHRDLKPPNLLL----VAGGTVLKICDF------GTACDIQTHMTNNKGSAAWMAPE 173
Query: 216 YGMGSKASVSGDVYNFGILLLEMFTRRRPTD 246
              GS  S   DV+++GI+L E+ TRR+P D
Sbjct: 174 VFEGSNYSEKCDVFSWGIILWEVITRRKPFD 204

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 114/237 (48%), Gaps = 23/237 (9%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEAS-RSFAAECNALRNIRHRNLIKIITI 95
           ++G G    V+ G  +   + VAVK  +LKQ   S  +F AE N ++ ++H+ L+++  +
Sbjct: 20  RLGAGQFGEVWMGYYN-GHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 96  CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQ 155
            +           I+ EYM+N +L  +L+  +G    + + +++A  ++  + +      
Sbjct: 77  VTQEPI------YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER-- 128
Query: 156 PSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPE 215
            + +H DL+ +NIL+   +   + D GLA+ +   E  TA E A   I+      + APE
Sbjct: 129 -NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIK------WTAPE 180
Query: 216 YGMGSKASVSGDVYNFGILLLEMFTRRR-PTDAMFNEGL--TLHEFVKMALPDKVME 269
                  ++  DV++FGILL E+ T  R P   M N  +   L    +M  PD   E
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE 237

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 114/237 (48%), Gaps = 23/237 (9%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEAS-RSFAAECNALRNIRHRNLIKIITI 95
           ++G G    V+ G  +   + VAVK  +LKQ   S  +F AE N ++ ++H+ L+++  +
Sbjct: 15  RLGAGQFGEVWMGYYN-GHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 71
Query: 96  CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQ 155
            +           I+ EYM+N +L  +L+  +G    + + +++A  ++  + +      
Sbjct: 72  VTQEPI------YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER-- 123
Query: 156 PSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPE 215
            + +H DL+ +NIL+   +   + D GLA+ +   E  TA E A   I+      + APE
Sbjct: 124 -NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIK------WTAPE 175
Query: 216 YGMGSKASVSGDVYNFGILLLEMFTRRR-PTDAMFNEGL--TLHEFVKMALPDKVME 269
                  ++  DV++FGILL E+ T  R P   M N  +   L    +M  PD   E
Sbjct: 176 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE 232

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 24/211 (11%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICS 97
           +G+G   +V K         VA+K   ++ +   ++F  E   L  + H N++K+   C 
Sbjct: 17  VGRGAFGVVCKAKWRAKD--VAIK--QIESESERKAFIVELRQLSRVNHPNIVKLYGAC- 71
Query: 98  SIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLT--QRVNIAIDVSFAIEYFHHHCQ 155
                  +   +V EY +  +L   L  +   L + T    ++  +  S  + Y H    
Sbjct: 72  ------LNPVCLVMEYAEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQP 124
Query: 156 PSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPE 215
            +++H DLKP N+LL    VA    L +  F      GTA +  ++    KG   ++APE
Sbjct: 125 KALIHRDLKPPNLLL----VAGGTVLKICDF------GTACDIQTHMTNNKGSAAWMAPE 174
Query: 216 YGMGSKASVSGDVYNFGILLLEMFTRRRPTD 246
              GS  S   DV+++GI+L E+ TRR+P D
Sbjct: 175 VFEGSNYSEKCDVFSWGIILWEVITRRKPFD 205

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 102/225 (45%), Gaps = 30/225 (13%)
Query: 35  ANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRNIRHRNLIKI 92
             +IG G    VYKG   +    VAVK++N+     +  ++F  E   LR  RH N++  
Sbjct: 18  GQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL- 73
Query: 93  ITICSSIDFEGFDFK---AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEY 149
                   F G+  K   AIV ++ +  +L   L     +   + + ++IA   +  ++Y
Sbjct: 74  --------FMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMI-KLIDIARQTAQGMDY 124
Query: 150 FHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
            H     SI+H DLK +NI L +D+   +GD GLA     +      E  S SI      
Sbjct: 125 LH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL----- 176
Query: 210 GYVAPEY-GMGSK--ASVSGDVYNFGILLLEMFTRRRPTDAMFNE 251
            ++APE   M  K   S   DVY FGI+L E+ T + P   + N 
Sbjct: 177 -WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 220

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 102/225 (45%), Gaps = 30/225 (13%)
Query: 35  ANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRNIRHRNLIKI 92
             +IG G    VYKG   +    VAVK++N+     +  ++F  E   LR  RH N++  
Sbjct: 15  GQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL- 70
Query: 93  ITICSSIDFEGFDFK---AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEY 149
                   F G+  K   AIV ++ +  +L   L     +   + + ++IA   +  ++Y
Sbjct: 71  --------FMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMI-KLIDIARQTAQGMDY 121
Query: 150 FHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
            H     SI+H DLK +NI L +D+   +GD GLA     +      E  S SI      
Sbjct: 122 LH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL----- 173
Query: 210 GYVAPEY-GMGSK--ASVSGDVYNFGILLLEMFTRRRPTDAMFNE 251
            ++APE   M  K   S   DVY FGI+L E+ T + P   + N 
Sbjct: 174 -WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 217

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 102/225 (45%), Gaps = 30/225 (13%)
Query: 35  ANKIGQGGVSIVYKGILDESRSIVAVKVVNL--KQKEASRSFAAECNALRNIRHRNLIKI 92
             +IG G    VYKG   +    VAVK++N+     +  ++F  E   LR  RH N++  
Sbjct: 13  GQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL- 68
Query: 93  ITICSSIDFEGFDFK---AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEY 149
                   F G+  K   AIV ++ +  +L   L     +   + + ++IA   +  ++Y
Sbjct: 69  --------FMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMI-KLIDIARQTAQGMDY 119
Query: 150 FHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
            H     SI+H DLK +NI L +D+   +GD GLA     +      E  S SI      
Sbjct: 120 LH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL----- 171
Query: 210 GYVAPEY-GMGSK--ASVSGDVYNFGILLLEMFTRRRPTDAMFNE 251
            ++APE   M  K   S   DVY FGI+L E+ T + P   + N 
Sbjct: 172 -WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 215

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 102/225 (45%), Gaps = 30/225 (13%)
Query: 35  ANKIGQGGVSIVYKGILDESRSIVAVKVVNL--KQKEASRSFAAECNALRNIRHRNLIKI 92
             +IG G    VYKG   +    VAVK++N+     +  ++F  E   LR  RH N++  
Sbjct: 18  GQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL- 73
Query: 93  ITICSSIDFEGFDFK---AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEY 149
                   F G+  K   AIV ++ +  +L   L     +   + + ++IA   +  ++Y
Sbjct: 74  --------FMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMI-KLIDIARQTAQGMDY 124
Query: 150 FHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
            H     SI+H DLK +NI L +D+   +GD GLA     +      E  S SI      
Sbjct: 125 LH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL----- 176
Query: 210 GYVAPEY-GMGSK--ASVSGDVYNFGILLLEMFTRRRPTDAMFNE 251
            ++APE   M  K   S   DVY FGI+L E+ T + P   + N 
Sbjct: 177 -WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 220

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 101/222 (45%), Gaps = 24/222 (10%)
Query: 35  ANKIGQGGVSIVYKGILDESRSIVAVKVVNL--KQKEASRSFAAECNALRNIRHRNLIKI 92
             +IG G    VYKG   +    VAVK++N+     +  ++F  E   LR  RH N++  
Sbjct: 13  GQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69
Query: 93  ITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHH 152
           +   ++         AIV ++ +  +L   L     +   + + ++IA   +  ++Y H 
Sbjct: 70  MGYSTAPQL------AIVTQWCEGSSLYHHLHIIETKFEMI-KLIDIARQTAQGMDYLH- 121
Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
               SI+H DLK +NI L +D+   +GD GLA     +      E  S SI       ++
Sbjct: 122 --AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL------WM 173
Query: 213 APEY-GMGSK--ASVSGDVYNFGILLLEMFTRRRPTDAMFNE 251
           APE   M  K   S   DVY FGI+L E+ T + P   + N 
Sbjct: 174 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 215

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 102/225 (45%), Gaps = 30/225 (13%)
Query: 35  ANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRNIRHRNLIKI 92
             +IG G    VYKG   +    VAVK++N+     +  ++F  E   LR  RH N++  
Sbjct: 40  GQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL- 95
Query: 93  ITICSSIDFEGFDFK---AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEY 149
                   F G+  K   AIV ++ +  +L   L     +   + + ++IA   +  ++Y
Sbjct: 96  --------FMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMI-KLIDIARQTAQGMDY 146
Query: 150 FHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
            H     SI+H DLK +NI L +D+   +GD GLA     +      E  S SI      
Sbjct: 147 LH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL----- 198
Query: 210 GYVAPEY-GMGSK--ASVSGDVYNFGILLLEMFTRRRPTDAMFNE 251
            ++APE   M  K   S   DVY FGI+L E+ T + P   + N 
Sbjct: 199 -WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 242

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 101/224 (45%), Gaps = 30/224 (13%)
Query: 35  ANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRNIRHRNLIKI 92
             +IG G    VYKG   +    VAVK++N+     +  ++F  E   LR  RH N++  
Sbjct: 29  GQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL- 84
Query: 93  ITICSSIDFEGFDFK---AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEY 149
                   F G+  K   AIV ++ +  +L   L  S  +   + + ++IA   +  ++Y
Sbjct: 85  --------FMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFE-MKKLIDIARQTARGMDY 135
Query: 150 FHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
            H     SI+H DLK +NI L +D    +GD GLA     +      E  S SI      
Sbjct: 136 LH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSIL----- 187
Query: 210 GYVAPE---YGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFN 250
            ++APE       +  S   DVY FGI+L E+ T + P   + N
Sbjct: 188 -WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 230

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 102/225 (45%), Gaps = 30/225 (13%)
Query: 35  ANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRNIRHRNLIKI 92
             +IG G    VYKG   +    VAVK++N+     +  ++F  E   LR  RH N++  
Sbjct: 41  GQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL- 96
Query: 93  ITICSSIDFEGFDFK---AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEY 149
                   F G+  K   AIV ++ +  +L   L     +   + + ++IA   +  ++Y
Sbjct: 97  --------FMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMI-KLIDIARQTAQGMDY 147
Query: 150 FHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
            H     SI+H DLK +NI L +D+   +GD GLA     +      E  S SI      
Sbjct: 148 LH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL----- 199
Query: 210 GYVAPEY-GMGSK--ASVSGDVYNFGILLLEMFTRRRPTDAMFNE 251
            ++APE   M  K   S   DVY FGI+L E+ T + P   + N 
Sbjct: 200 -WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 243

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 101/216 (46%), Gaps = 26/216 (12%)
Query: 35  ANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRNIRHRNLIKI 92
             +IG G    VYKG   +    VAVK++N+     +  ++F  E   LR  RH N++  
Sbjct: 29  GQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 85
Query: 93  ITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHH 152
           +   ++         AIV ++ +  +L   L  S  +   + + ++IA   +  ++Y H 
Sbjct: 86  MGYSTAPQL------AIVTQWCEGSSLYHHLHASETKFE-MKKLIDIARQTARGMDYLH- 137
Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIE-IKGIVGY 211
               SI+H DLK +NI L +D    +GD GLA          +  + S+  E + G + +
Sbjct: 138 --AKSIIHRDLKSNNIFLHEDNTVKIGDFGLAT-------EKSRWSGSHQFEQLSGSILW 188
Query: 212 VAPE---YGMGSKASVSGDVYNFGILLLEMFTRRRP 244
           +APE       +  S   DVY FGI+L E+ T + P
Sbjct: 189 MAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 105/225 (46%), Gaps = 32/225 (14%)
Query: 35  ANKIGQGGVSIVYKGILDESRSIVAVKVVNL--KQKEASRSFAAECNALRNIRHRNLIKI 92
             +IG G    VYKG   +    VAVK++N+     +  ++F  E   LR  RH N++  
Sbjct: 13  GQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL- 68
Query: 93  ITICSSIDFEGFDFK---AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEY 149
                   F G+  K   AIV ++ +  +L   L     +   + + ++IA   +  ++Y
Sbjct: 69  --------FMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMI-KLIDIARQTAQGMDY 119
Query: 150 FHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIE-IKGI 208
            H     SI+H DLK +NI L +D+   +GD GLA          +  + S+  E + G 
Sbjct: 120 LH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLAT-------EKSRWSGSHQFEQLSGS 169
Query: 209 VGYVAPEY-GMGSK--ASVSGDVYNFGILLLEMFTRRRPTDAMFN 250
           + ++APE   M  K   S   DVY FGI+L E+ T + P   + N
Sbjct: 170 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 214

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 105/226 (46%), Gaps = 32/226 (14%)
Query: 35  ANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRNIRHRNLIKI 92
             +IG G    VYKG   +    VAVK++N+     +  ++F  E   LR  RH N++  
Sbjct: 33  GQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL- 88
Query: 93  ITICSSIDFEGFDFK---AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEY 149
                   F G+  K   AIV ++ +  +L   L     +   + + ++IA   +  ++Y
Sbjct: 89  --------FMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMI-KLIDIARQTAQGMDY 139
Query: 150 FHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIE-IKGI 208
            H     SI+H DLK +NI L +D+   +GD GLA          +  + S+  E + G 
Sbjct: 140 LH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLAT-------EKSRWSGSHQFEQLSGS 189
Query: 209 VGYVAPEY-GMGSK--ASVSGDVYNFGILLLEMFTRRRPTDAMFNE 251
           + ++APE   M  K   S   DVY FGI+L E+ T + P   + N 
Sbjct: 190 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 235

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 103/200 (51%), Gaps = 22/200 (11%)
Query: 58  VAVKVVNLKQKEASR-SFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA----IVFE 112
           VA+K +     E  R  F +E + +    H N+I +         EG   K+    I+ E
Sbjct: 64  VAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHL---------EGVVTKSTPVMIITE 114
Query: 113 YMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQ 172
           +M+N +L+ +LRQ++GQ   + Q V +   ++  ++Y       + VH DL   NIL++ 
Sbjct: 115 FMENGSLDSFLRQNDGQFTVI-QLVGMLRGIAAGMKYL---ADMNYVHRDLAARNILVNS 170
Query: 173 DIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFG 232
           ++V  V D GL++FL   E  T+  T ++++  K  + + APE     K + + DV+++G
Sbjct: 171 NLVCKVSDFGLSRFL---EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYG 227
Query: 233 ILLLEMFTR-RRPTDAMFNE 251
           I++ E+ +   RP   M N+
Sbjct: 228 IVMWEVMSYGERPYWDMTNQ 247

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 105/226 (46%), Gaps = 32/226 (14%)
Query: 35  ANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRNIRHRNLIKI 92
             +IG G    VYKG   +    VAVK++N+     +  ++F  E   LR  RH N++  
Sbjct: 41  GQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL- 96
Query: 93  ITICSSIDFEGFDFK---AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEY 149
                   F G+  K   AIV ++ +  +L   L     +   + + ++IA   +  ++Y
Sbjct: 97  --------FMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMI-KLIDIARQTAQGMDY 147
Query: 150 FHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIE-IKGI 208
            H     SI+H DLK +NI L +D+   +GD GLA          +  + S+  E + G 
Sbjct: 148 LH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLAT-------EKSRWSGSHQFEQLSGS 197
Query: 209 VGYVAPEY-GMGSKA--SVSGDVYNFGILLLEMFTRRRPTDAMFNE 251
           + ++APE   M  K   S   DVY FGI+L E+ T + P   + N 
Sbjct: 198 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 243

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 105/228 (46%), Gaps = 33/228 (14%)
Query: 36  NKIGQGGVSIV----YKGILDESRSIVAVKVVNLKQKEASRS---FAAECNALRNIRHRN 88
            ++G G   +V    +KG  D     VAVK++    KE S S   F  E   +  + H  
Sbjct: 14  KELGSGQFGVVKLGKWKGQYD-----VAVKMI----KEGSMSEDEFFQEAQTMMKLSHPK 64
Query: 89  LIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIE 148
           L+K   +CS  ++  +    IV EY+ N  L  +LR S+G+    +Q + +  DV   + 
Sbjct: 65  LVKFYGVCSK-EYPIY----IVTEYISNGCLLNYLR-SHGKGLEPSQLLEMCYDVCEGMA 118
Query: 149 YFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGI 208
           +   H     +H DL   N L+D+D+   V D G+ +++         +   +S+  K  
Sbjct: 119 FLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD-------DQYVSSVGTKFP 168
Query: 209 VGYVAPEYGMGSKASVSGDVYNFGILLLEMFTR-RRPTDAMFNEGLTL 255
           V + APE     K S   DV+ FGIL+ E+F+  + P D   N  + L
Sbjct: 169 VKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVL 216

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 114/237 (48%), Gaps = 23/237 (9%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASR-SFAAECNALRNIRHRNLIKIITI 95
           ++G G    V+ G  +   + VAVK  +LKQ   S  +F AE N ++ ++H+ L+++  +
Sbjct: 16  RLGAGQFGEVWMGYYN-GHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 72
Query: 96  CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQ 155
            +           I+ EYM+N +L  +L+  +G    + + +++A  ++  + +      
Sbjct: 73  VTQEPI------YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER-- 124
Query: 156 PSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPE 215
            + +H +L+ +NIL+   +   + D GLA+ +   E  TA E A   I+      + APE
Sbjct: 125 -NYIHRNLRAANILVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIK------WTAPE 176
Query: 216 YGMGSKASVSGDVYNFGILLLEMFTRRR-PTDAMFNEGL--TLHEFVKMALPDKVME 269
                  ++  DV++FGILL E+ T  R P   M N  +   L    +M  PD   E
Sbjct: 177 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE 233

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 98/208 (47%), Gaps = 16/208 (7%)
Query: 37  KIGQGGVSIV----YKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKI 92
           ++G+G    V    Y  + D +  +VAVK +    +E  R F  E   L++++H N++K 
Sbjct: 16  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 75
Query: 93  ITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHH 152
             +C S    G     ++ EY+   +L  +L++   ++  + + +     +   +EY   
Sbjct: 76  KGVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERIDHI-KLLQYTSQICKGMEYL-- 129
Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
                 +H DL   NIL++ +    +GD GL K L   +     +    S      + + 
Sbjct: 130 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES-----PIFWY 183
Query: 213 APEYGMGSKASVSGDVYNFGILLLEMFT 240
           APE    SK SV+ DV++FG++L E+FT
Sbjct: 184 APESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 30/215 (13%)
Query: 37  KIGQGGVSIV----YKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKI 92
           ++G+G    V    Y  + D +  +VAVK +    +E  R F  E   L++++H N++K 
Sbjct: 21  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 80
Query: 93  ITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHH 152
             +C S    G     ++ EY+             G LR   Q+    ID    ++Y   
Sbjct: 81  KGVCYSA---GRRNLKLIMEYL-----------PYGSLRDYLQKHKERIDHIKLLQYTSQ 126
Query: 153 HCQ-------PSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEI 205
            C+          +H DL   NIL++ +    +GD GL K L   +     +    S   
Sbjct: 127 ICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES--- 183
Query: 206 KGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
              + + APE    SK SV+ DV++FG++L E+FT
Sbjct: 184 --PIFWYAPESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 30/215 (13%)
Query: 37  KIGQGGVSIV----YKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKI 92
           ++G+G    V    Y  + D +  +VAVK +    +E  R F  E   L++++H N++K 
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 93  ITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHH 152
             +C S    G     ++ EY+             G LR   Q+    ID    ++Y   
Sbjct: 80  KGVCYSA---GRRNLKLIMEYL-----------PYGSLRDYLQKHKERIDHIKLLQYTSQ 125
Query: 153 HCQ-------PSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEI 205
            C+          +H DL   NIL++ +    +GD GL K L   +     +    S   
Sbjct: 126 ICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES--- 182
Query: 206 KGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
              + + APE    SK SV+ DV++FG++L E+FT
Sbjct: 183 --PIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 98/209 (46%), Gaps = 16/209 (7%)
Query: 36  NKIGQGGVSIV----YKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIK 91
            ++G+G    V    Y  + D +  +VAVK +    +E  R F  E   L++++H N++K
Sbjct: 14  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 73
Query: 92  IITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFH 151
              +C S    G     ++ EY+   +L  +L++   ++  + + +     +   +EY  
Sbjct: 74  YKGVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERIDHI-KLLQYTSQICKGMEYL- 128
Query: 152 HHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGY 211
                  +H DL   NIL++ +    +GD GL K L   +     +    S      + +
Sbjct: 129 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES-----PIFW 181
Query: 212 VAPEYGMGSKASVSGDVYNFGILLLEMFT 240
            APE    SK SV+ DV++FG++L E+FT
Sbjct: 182 YAPESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 98/208 (47%), Gaps = 16/208 (7%)
Query: 37  KIGQGGVSIV----YKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKI 92
           ++G+G    V    Y  + D +  +VAVK +    +E  R F  E   L++++H N++K 
Sbjct: 23  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 82
Query: 93  ITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHH 152
             +C S    G     ++ EY+   +L  +L++   ++  + + +     +   +EY   
Sbjct: 83  KGVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERIDHI-KLLQYTSQICKGMEYL-- 136
Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
                 +H DL   NIL++ +    +GD GL K L   +     +    S      + + 
Sbjct: 137 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES-----PIFWY 190
Query: 213 APEYGMGSKASVSGDVYNFGILLLEMFT 240
           APE    SK SV+ DV++FG++L E+FT
Sbjct: 191 APESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 98/208 (47%), Gaps = 16/208 (7%)
Query: 37  KIGQGGVSIV----YKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKI 92
           ++G+G    V    Y  + D +  +VAVK +    +E  R F  E   L++++H N++K 
Sbjct: 22  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 81
Query: 93  ITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHH 152
             +C S    G     ++ EY+   +L  +L++   ++  + + +     +   +EY   
Sbjct: 82  KGVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERIDHI-KLLQYTSQICKGMEYL-- 135
Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
                 +H DL   NIL++ +    +GD GL K L   +     +    S      + + 
Sbjct: 136 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES-----PIFWY 189
Query: 213 APEYGMGSKASVSGDVYNFGILLLEMFT 240
           APE    SK SV+ DV++FG++L E+FT
Sbjct: 190 APESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 30/215 (13%)
Query: 37  KIGQGGVSIV----YKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKI 92
           ++G+G    V    Y  + D +  +VAVK +    +E  R F  E   L++++H N++K 
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 93  ITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHH 152
             +C S    G     ++ EY+             G LR   Q+    ID    ++Y   
Sbjct: 77  KGVCYSA---GRRNLKLIMEYL-----------PYGSLRDYLQKHKERIDHIKLLQYTSQ 122
Query: 153 HCQ-------PSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEI 205
            C+          +H DL   NIL++ +    +GD GL K L   +     +    S   
Sbjct: 123 ICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES--- 179
Query: 206 KGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
              + + APE    SK SV+ DV++FG++L E+FT
Sbjct: 180 --PIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 98/209 (46%), Gaps = 16/209 (7%)
Query: 36  NKIGQGGVSIV----YKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIK 91
            ++G+G    V    Y  + D +  +VAVK +    +E  R F  E   L++++H N++K
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 92  IITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFH 151
              +C S    G     ++ EY+   +L  +L++   ++  + + +     +   +EY  
Sbjct: 107 YKGVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERIDHI-KLLQYTSQICKGMEYL- 161
Query: 152 HHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGY 211
                  +H DL   NIL++ +    +GD GL K L   +     +    S      + +
Sbjct: 162 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES-----PIFW 214
Query: 212 VAPEYGMGSKASVSGDVYNFGILLLEMFT 240
            APE    SK SV+ DV++FG++L E+FT
Sbjct: 215 YAPESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 98/208 (47%), Gaps = 16/208 (7%)
Query: 37  KIGQGGVSIV----YKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKI 92
           ++G+G    V    Y  + D +  +VAVK +    +E  R F  E   L++++H N++K 
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 93  ITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHH 152
             +C S    G     ++ EY+   +L  +L++   ++  + + +     +   +EY   
Sbjct: 77  KGVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERIDHI-KLLQYTSQICKGMEYL-- 130
Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
                 +H DL   NIL++ +    +GD GL K L   +     +    S      + + 
Sbjct: 131 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES-----PIFWY 184
Query: 213 APEYGMGSKASVSGDVYNFGILLLEMFT 240
           APE    SK SV+ DV++FG++L E+FT
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 99/215 (46%), Gaps = 30/215 (13%)
Query: 37  KIGQGGVSIV----YKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKI 92
           ++G+G    V    Y  + D +  +VAVK +    +E  R F  E   L++++H N++K 
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 93  ITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHH 152
             +C S    G     ++ EY+   +L  +L++   ++  + + +     +   +EY   
Sbjct: 77  KGVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERIDHI-KLLQYTSQICKGMEYL-- 130
Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAK-------FLFGYEPGTAAETASNSIEI 205
                 +H DL   NIL++ +    +GD GL K       F    EPG +          
Sbjct: 131 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESP--------- 180
Query: 206 KGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
              + + APE    SK SV+ DV++FG++L E+FT
Sbjct: 181 ---IFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 98/208 (47%), Gaps = 16/208 (7%)
Query: 37  KIGQGGVSIV----YKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKI 92
           ++G+G    V    Y  + D +  +VAVK +    +E  R F  E   L++++H N++K 
Sbjct: 35  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 93  ITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHH 152
             +C S    G     ++ EY+   +L  +L++   ++  + + +     +   +EY   
Sbjct: 95  KGVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERIDHI-KLLQYTSQICKGMEYL-- 148
Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
                 +H DL   NIL++ +    +GD GL K L   +     +    S      + + 
Sbjct: 149 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES-----PIFWY 202
Query: 213 APEYGMGSKASVSGDVYNFGILLLEMFT 240
           APE    SK SV+ DV++FG++L E+FT
Sbjct: 203 APESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 98/208 (47%), Gaps = 16/208 (7%)
Query: 37  KIGQGGVSIV----YKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKI 92
           ++G+G    V    Y  + D +  +VAVK +    +E  R F  E   L++++H N++K 
Sbjct: 24  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 83
Query: 93  ITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHH 152
             +C S    G     ++ EY+   +L  +L++   ++  + + +     +   +EY   
Sbjct: 84  KGVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERIDHI-KLLQYTSQICKGMEYL-- 137
Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
                 +H DL   NIL++ +    +GD GL K L   +     +    S      + + 
Sbjct: 138 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES-----PIFWY 191
Query: 213 APEYGMGSKASVSGDVYNFGILLLEMFT 240
           APE    SK SV+ DV++FG++L E+FT
Sbjct: 192 APESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 98/208 (47%), Gaps = 16/208 (7%)
Query: 37  KIGQGGVSIV----YKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKI 92
           ++G+G    V    Y  + D +  +VAVK +    +E  R F  E   L++++H N++K 
Sbjct: 35  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 93  ITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHH 152
             +C S    G     ++ EY+   +L  +L++   ++  + + +     +   +EY   
Sbjct: 95  KGVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERIDHI-KLLQYTSQICKGMEYL-- 148
Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
                 +H DL   NIL++ +    +GD GL K L   +     +    S      + + 
Sbjct: 149 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES-----PIFWY 202
Query: 213 APEYGMGSKASVSGDVYNFGILLLEMFT 240
           APE    SK SV+ DV++FG++L E+FT
Sbjct: 203 APESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 99/208 (47%), Gaps = 16/208 (7%)
Query: 37  KIGQGGVSIV----YKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKI 92
           ++G+G    V    Y  + D +  +VAVK +    +E  R F  E   L++++H N++K 
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 93  ITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHH 152
             +C S    G     ++ E++   +L ++L++   ++  + + +     +   +EY   
Sbjct: 80  KGVCYSA---GRRNLKLIMEFLPYGSLREYLQKHKERIDHI-KLLQYTSQICKGMEYL-- 133
Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
                 +H DL   NIL++ +    +GD GL K L   +     +    S      + + 
Sbjct: 134 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES-----PIFWY 187
Query: 213 APEYGMGSKASVSGDVYNFGILLLEMFT 240
           APE    SK SV+ DV++FG++L E+FT
Sbjct: 188 APESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 103/222 (46%), Gaps = 19/222 (8%)
Query: 28  ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAA--ECNALRNIR 85
           AT+ + P  +IG G    VYK     S   VA+K V +   E     +   E   LR + 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 86  ---HRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAID 142
              H N+++++ +C++   +      +VFE++ +++L  +L ++           ++   
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 143 VSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNS 202
               +++ H +C   IVH DLKP NIL+       + D GLA+ ++ Y+   A    +  
Sbjct: 121 FLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR-IYSYQMALAPVVVT-- 174
Query: 203 IEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
                 + Y APE  + S  +   D+++ G +  EMF RR+P
Sbjct: 175 ------LWYRAPEVLLQSTYATPVDMWSVGCIFAEMF-RRKP 209

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 110/218 (50%), Gaps = 21/218 (9%)
Query: 28  ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFA-AECNALRNIRH 86
           +++ F    K+G G  + VYKG+   +   VA+K V L  +E + S A  E + ++ ++H
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 87  RNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWL--RQSNGQLRFLTQRVNIAIDVS 144
            N++++  +  +      +   +VFE+M N +L++++  R      R L   +N+     
Sbjct: 63  ENIVRLYDVIHTE-----NKLTLVFEFMDN-DLKKYMDSRTVGNTPRGL--ELNLVKYFQ 114
Query: 145 FAIEYFHHHCQPS-IVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSI 203
           + +      C  + I+H DLKP N+L+++     +GD GLA+       G    T S+ +
Sbjct: 115 WQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAF-----GIPVNTFSSEV 169
Query: 204 EIKGIVGYVAPEYGMGSKA-SVSGDVYNFGILLLEMFT 240
                + Y AP+  MGS+  S S D+++ G +L EM T
Sbjct: 170 V---TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMIT 204

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/245 (27%), Positives = 114/245 (46%), Gaps = 29/245 (11%)
Query: 18  PMISYAELSKATN--NFSPANKIGQGGVSIVYKGILD-ESRSIVAVKVVNLK---QKEAS 71
           P  +  E +K  +  N S    +G G    V  G L   S+  ++V +  LK    ++  
Sbjct: 31  PTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR 90
Query: 72  RSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA----IVFEYMQNRNLEQWLRQSN 127
           R F  E + +    H N+I++         EG   K+    IV EYM+N +L+ +LR+ +
Sbjct: 91  RDFLGEASIMGQFDHPNIIRL---------EGVVTKSKPVMIVTEYMENGSLDSFLRKHD 141
Query: 128 GQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL 187
            Q   + Q V +   ++  ++Y         VH DL   NIL++ ++V  V D GLA+ L
Sbjct: 142 AQFTVI-QLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLARVL 197
Query: 188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTR-RRPTD 246
              +P  A  T    I I+    + +PE     K + + DV+++GI+L E+ +   RP  
Sbjct: 198 ED-DPEAAYTTRGGKIPIR----WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYW 252
Query: 247 AMFNE 251
            M N+
Sbjct: 253 EMSNQ 257

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 99/219 (45%), Gaps = 20/219 (9%)
Query: 35  ANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIIT 94
           + +IG G    VYKG      ++  +KVV+    E  ++F  E   LR  RH N++  + 
Sbjct: 41  STRIGSGSFGTVYKGKWHGDVAVKILKVVD-PTPEQFQAFRNEVAVLRKTRHVNILLFMG 99
Query: 95  ICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHC 154
             +       D  AIV ++ +  +L + L     + +   Q ++IA   +  ++Y H   
Sbjct: 100 YMTK------DNLAIVTQWCEGSSLYKHLHVQETKFQMF-QLIDIARQTAQGMDYLH--- 149
Query: 155 QPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAP 214
             +I+H D+K +NI L + +   +GD GLA     +      E  +      G V ++AP
Sbjct: 150 AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPT------GSVLWMAP 203
Query: 215 E---YGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFN 250
           E       +  S   DVY++GI+L E+ T   P   + N
Sbjct: 204 EVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN 242

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 96/220 (43%), Gaps = 30/220 (13%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRS-FAAECNALRNIRHRNLIKIITI 95
           ++G GG   V + I  ++   VA+K    +    +R  +  E   ++ + H N++    +
Sbjct: 21  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 96  CSSID-FEGFDFKAIVFEYMQNRNLEQWLRQ-------SNGQLRFLTQRVNIAIDVSFAI 147
              +      D   +  EY +  +L ++L Q         G +R L        D+S A+
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS------DISSAL 134
Query: 148 EYFHHHCQPSIVHGDLKPSNILLD---QDIVAHVGDLGLAKFLFGYEPGTAAETASNSIE 204
            Y H +    I+H DLKP NI+L    Q ++  + DLG AK L   E  T         E
Sbjct: 135 RYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCT---------E 182
Query: 205 IKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
             G + Y+APE     K +V+ D ++FG L  E  T  RP
Sbjct: 183 FVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 222

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 96/220 (43%), Gaps = 30/220 (13%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRS-FAAECNALRNIRHRNLIKIITI 95
           ++G GG   V + I  ++   VA+K    +    +R  +  E   ++ + H N++    +
Sbjct: 22  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 81
Query: 96  CSSID-FEGFDFKAIVFEYMQNRNLEQWLRQ-------SNGQLRFLTQRVNIAIDVSFAI 147
              +      D   +  EY +  +L ++L Q         G +R L        D+S A+
Sbjct: 82  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS------DISSAL 135
Query: 148 EYFHHHCQPSIVHGDLKPSNILLD---QDIVAHVGDLGLAKFLFGYEPGTAAETASNSIE 204
            Y H +    I+H DLKP NI+L    Q ++  + DLG AK L   E  T         E
Sbjct: 136 RYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCT---------E 183
Query: 205 IKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
             G + Y+APE     K +V+ D ++FG L  E  T  RP
Sbjct: 184 FVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 223

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 110/220 (50%), Gaps = 19/220 (8%)
Query: 38  IGQGGVSIVYKGILD---ESRSIVAVKVVNLKQKEASR-SFAAECNALRNIRHRNLIKII 93
           IG G    V +G L    +  S VA+K +     E  R  F +E + +    H N+I++ 
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 83
Query: 94  -TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHH 152
             + +S+         I+ E+M+N  L+ +LR ++GQ   + Q V +   ++  + Y   
Sbjct: 84  GVVTNSMPV------MILTEFMENGALDSFLRLNDGQFTVI-QLVGMLRGIASGMRYL-- 134
Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
             + S VH DL   NIL++ ++V  V D GL++FL   E  ++  T ++S+  K  + + 
Sbjct: 135 -AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFL---EENSSDPTETSSLGGKIPIRWT 190
Query: 213 APEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNE 251
           APE     K + + D +++GI++ E+ +   RP   M N+
Sbjct: 191 APEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQ 230

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 99/207 (47%), Gaps = 38/207 (18%)
Query: 53  ESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFE 112
           + + +VAVK +      A + F  E   L N++H +++K   +C        D   +VFE
Sbjct: 43  KDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGD-----GDPLIMVFE 97
Query: 113 YMQNRNLEQWL---------------RQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPS 157
           YM++ +L ++L               RQ+ G+L  L+Q ++IA  ++  + Y        
Sbjct: 98  YMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG-LSQMLHIASQIASGMVYL---ASQH 153
Query: 158 IVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKG----IVGYVA 213
            VH DL   N L+  +++  +GD G+++ ++          +++   + G     + ++ 
Sbjct: 154 FVHRDLATRNCLVGANLLVKIGDFGMSRDVY----------STDYYRVGGHTMLPIRWMP 203
Query: 214 PEYGMGSKASVSGDVYNFGILLLEMFT 240
           PE  M  K +   DV++FG++L E+FT
Sbjct: 204 PESIMYRKFTTESDVWSFGVILWEIFT 230

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 97/208 (46%), Gaps = 16/208 (7%)
Query: 37  KIGQGGVSIV----YKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKI 92
           ++G+G    V    Y  + D +  +VAVK +    +E  R F  E   L++++H N++K 
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 93  ITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHH 152
             +C S    G     ++ EY+   +L  +L Q++ +     + +     +   +EY   
Sbjct: 80  KGVCYSA---GRRNLKLIMEYLPYGSLRDYL-QAHAERIDHIKLLQYTSQICKGMEYL-- 133
Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
                 +H DL   NIL++ +    +GD GL K L   +     +    S      + + 
Sbjct: 134 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES-----PIFWY 187
Query: 213 APEYGMGSKASVSGDVYNFGILLLEMFT 240
           APE    SK SV+ DV++FG++L E+FT
Sbjct: 188 APESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 110/235 (46%), Gaps = 24/235 (10%)
Query: 31  NFSPANKIGQGGVSIVYKG--ILDE-SRSIVAVKVVNLKQKEASRSFAAECNALRNIRHR 87
           NF    KIG+G  S VY+   +LD    ++  V++ +L   +A      E + L+ + H 
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 88  NLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRV--NIAIDVSF 145
           N+IK     S I+    +   IV E     +L + ++    Q R + +R      + +  
Sbjct: 93  NVIKYYA--SFIEDNELN---IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCS 147
Query: 146 AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEI 205
           A+E+ H      ++H D+KP+N+ +    V  +GDLGL +F       ++  TA++S  +
Sbjct: 148 ALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF------SSKTTAAHS--L 196
Query: 206 KGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVK 260
            G   Y++PE    +  +   D+++ G LL EM   + P    + + + L+   K
Sbjct: 197 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMNLYSLCK 248

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 109/220 (49%), Gaps = 19/220 (8%)
Query: 38  IGQGGVSIVYKGILD---ESRSIVAVKVVNLKQKEASR-SFAAECNALRNIRHRNLIKII 93
           IG G    V +G L    +  S VA+K +     E  R  F +E + +    H N+I++ 
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 81
Query: 94  -TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHH 152
             + +S+         I+ E+M+N  L+ +LR ++GQ   + Q V +   ++  + Y   
Sbjct: 82  GVVTNSMPV------MILTEFMENGALDSFLRLNDGQFTVI-QLVGMLRGIASGMRYLAE 134
Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
               S VH DL   NIL++ ++V  V D GL++FL   E  ++  T ++S+  K  + + 
Sbjct: 135 M---SYVHRDLAARNILVNSNLVCKVSDFGLSRFL---EENSSDPTYTSSLGGKIPIRWT 188
Query: 213 APEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNE 251
           APE     K + + D +++GI++ E+ +   RP   M N+
Sbjct: 189 APEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQ 228

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 108/231 (46%), Gaps = 27/231 (11%)
Query: 30  NNFSPANKIGQGGVSIVYKGILD-ESRSIVAVKVVNLK---QKEASRSFAAECNALRNIR 85
            N S    +G G    V  G L   S+  ++V +  LK    ++  R F  E + +    
Sbjct: 33  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 92
Query: 86  HRNLIKIITICSSIDFEGFDFKA----IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI 141
           H N+I++         EG   K+    IV EYM+N +L+ +LR+ + Q   + Q V +  
Sbjct: 93  HPNIIRL---------EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI-QLVGMLR 142
Query: 142 DVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASN 201
            ++  ++Y         VH DL   NIL++ ++V  V D GL++ L   +P  A  T   
Sbjct: 143 GIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLED-DPEAAYTTRGG 198
Query: 202 SIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTR-RRPTDAMFNE 251
            I I+    + +PE     K + + DV+++GI+L E+ +   RP   M N+
Sbjct: 199 KIPIR----WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ 245

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 108/231 (46%), Gaps = 27/231 (11%)
Query: 30  NNFSPANKIGQGGVSIVYKGILD-ESRSIVAVKVVNLK---QKEASRSFAAECNALRNIR 85
            N S    +G G    V  G L   S+  ++V +  LK    ++  R F  E + +    
Sbjct: 16  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 75
Query: 86  HRNLIKIITICSSIDFEGFDFKA----IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI 141
           H N+I++         EG   K+    IV EYM+N +L+ +LR+ + Q   + Q V +  
Sbjct: 76  HPNIIRL---------EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI-QLVGMLR 125
Query: 142 DVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASN 201
            ++  ++Y         VH DL   NIL++ ++V  V D GL++ L   +P  A  T   
Sbjct: 126 GIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLED-DPEAAYTTRGG 181
Query: 202 SIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTR-RRPTDAMFNE 251
            I I+    + +PE     K + + DV+++GI+L E+ +   RP   M N+
Sbjct: 182 KIPIR----WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ 228

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 103/222 (46%), Gaps = 19/222 (8%)
Query: 29  TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKE--ASRSFAAECNALRNIRH 86
           +++F   + +G+G   +V       +  IVA+K +    K   A R+   E   L++ +H
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKH 68
Query: 87  RNLIKIITICSSIDFEGFDFKAIVFEYMQ---NRNLEQWLRQSNGQLRFLTQRVNIAIDV 143
            N+I I  I     FE F+   I+ E MQ   +R +   +   +    F+ Q +      
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLR----- 123
Query: 144 SFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNS- 202
             A++  H     +++H DLKPSN+L++ +    V D GLA+ +       +  T   S 
Sbjct: 124 --AVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 203 -IEIKGIVGYVAPEYGMGS-KASVSGDVYNFGILLLEMFTRR 242
            +E      Y APE  + S K S + DV++ G +L E+F RR
Sbjct: 179 MVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/245 (27%), Positives = 114/245 (46%), Gaps = 29/245 (11%)
Query: 18  PMISYAELSKATN--NFSPANKIGQGGVSIVYKGILD-ESRSIVAVKVVNLK---QKEAS 71
           P  +  E +K  +  N S    +G G    V  G L   S+  ++V +  LK    ++  
Sbjct: 31  PTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR 90
Query: 72  RSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA----IVFEYMQNRNLEQWLRQSN 127
           R F  E + +    H N+I++         EG   K+    IV EYM+N +L+ +LR+ +
Sbjct: 91  RDFLGEASIMGQFDHPNIIRL---------EGVVTKSKPVMIVTEYMENGSLDSFLRKHD 141
Query: 128 GQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL 187
            Q   + Q V +   ++  ++Y         VH DL   NIL++ ++V  V D GL++ L
Sbjct: 142 AQFTVI-QLVGMLRGIASGMKYLSDM---GFVHRDLAARNILINSNLVCKVSDFGLSRVL 197
Query: 188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTR-RRPTD 246
              +P  A  T    I I+    + +PE     K + + DV+++GI+L E+ +   RP  
Sbjct: 198 ED-DPEAAYTTRGGKIPIR----WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYW 252
Query: 247 AMFNE 251
            M N+
Sbjct: 253 EMSNQ 257

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 105/222 (47%), Gaps = 19/222 (8%)
Query: 28  ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAA--ECNALRNIR 85
           AT+ + P  +IG G    VYK     S   VA+K V +   E     +   E   LR + 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 86  ---HRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAID 142
              H N+++++ +C++   +      +VFE++ +++L  +L ++           ++   
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 143 VSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNS 202
               +++ H +C   IVH DLKP NIL+       + D GLA+ ++ Y      + A + 
Sbjct: 121 FLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR-IYSY------QMALDP 170
Query: 203 IEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
           + +   + Y APE  + S  +   D+++ G +  EMF RR+P
Sbjct: 171 VVV--TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF-RRKP 209

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 99/234 (42%), Gaps = 23/234 (9%)
Query: 23  AELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALR 82
           +E S   +N      IG+G    VYKG LDE    VAVKV +   ++   +F  E N  R
Sbjct: 6   SEPSLDLDNLKLLELIGRGRYGAVYKGSLDER--PVAVKVFSFANRQ---NFINEKNIYR 60
Query: 83  N--IRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIA 140
              + H N+ + I     +  +G     +V EY  N +L ++L               +A
Sbjct: 61  VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDW---VSSCRLA 117
Query: 141 IDVSFAIEYFH------HHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGT 194
             V+  + Y H       H +P+I H DL   N+L+  D    + D GL+  L G     
Sbjct: 118 HSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVR 177
Query: 195 AAETASNSIEIKGIVGYVAPEYGMGS-------KASVSGDVYNFGILLLEMFTR 241
             E  + +I   G + Y+APE   G+        A    D+Y  G++  E+F R
Sbjct: 178 PGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 18/211 (8%)
Query: 58  VAVKVVNLKQKEASR-SFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQN 116
           VA+K +     E  R  F +E + +    H N+I++  + +           IV EYM+N
Sbjct: 80  VAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR-----GRLAMIVTEYMEN 134
Query: 117 RNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVA 176
            +L+ +LR  +GQ   + Q V +   V   + Y         VH DL   N+L+D ++V 
Sbjct: 135 GSLDTFLRTHDGQFTIM-QLVGMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVC 190
Query: 177 HVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLL 236
            V D GL++ L   +P  A  T    I I+    + APE       S + DV++FG+++ 
Sbjct: 191 KVSDFGLSRVLED-DPDAAXTTTGGKIPIR----WTAPEAIAFRTFSSASDVWSFGVVMW 245
Query: 237 EMFTR-RRPTDAMFNEGL--TLHEFVKMALP 264
           E+     RP   M N  +  ++ E  ++  P
Sbjct: 246 EVLAYGERPYWNMTNRDVISSVEEGYRLPAP 276

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 98/200 (49%), Gaps = 24/200 (12%)
Query: 58  VAVKVVNLKQKEASR-SFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA----IVFE 112
           VA+K + +   E  R  F  E + +    H N+I +         EG   K+    IV E
Sbjct: 53  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHL---------EGVVTKSKPVMIVTE 103
Query: 113 YMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQ 172
           YM+N +L+ +L++++GQ   + Q V +   +S  ++Y         VH DL   NIL++ 
Sbjct: 104 YMENGSLDTFLKKNDGQFTVI-QLVGMLRGISAGMKYLSDM---GYVHRDLAARNILINS 159
Query: 173 DIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFG 232
           ++V  V D GL++ L   +P  A  T    I I+    + APE     K + + DV+++G
Sbjct: 160 NLVCKVSDFGLSRVLED-DPEAAYTTRGGKIPIR----WTAPEAIAFRKFTSASDVWSYG 214
Query: 233 ILLLEMFTR-RRPTDAMFNE 251
           I++ E+ +   RP   M N+
Sbjct: 215 IVMWEVVSYGERPYWEMTNQ 234

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/245 (27%), Positives = 114/245 (46%), Gaps = 29/245 (11%)
Query: 18  PMISYAELSKATN--NFSPANKIGQGGVSIVYKGILD-ESRSIVAVKVVNLK---QKEAS 71
           P  +  E +K  +  N S    +G G    V  G L   S+  ++V +  LK    ++  
Sbjct: 31  PTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR 90
Query: 72  RSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA----IVFEYMQNRNLEQWLRQSN 127
           R F  E + +    H N+I++         EG   K+    IV EYM+N +L+ +LR+ +
Sbjct: 91  RDFLGEASIMGQFDHPNIIRL---------EGVVTKSKPVMIVTEYMENGSLDSFLRKHD 141
Query: 128 GQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL 187
            Q   + Q V +   ++  ++Y         VH DL   NIL++ ++V  V D GL++ L
Sbjct: 142 AQFTVI-QLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVL 197
Query: 188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTR-RRPTD 246
              +P  A  T    I I+    + +PE     K + + DV+++GI+L E+ +   RP  
Sbjct: 198 ED-DPEAAYTTRGGKIPIR----WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYW 252
Query: 247 AMFNE 251
            M N+
Sbjct: 253 EMSNQ 257

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/245 (27%), Positives = 114/245 (46%), Gaps = 29/245 (11%)
Query: 18  PMISYAELSKATN--NFSPANKIGQGGVSIVYKGILD-ESRSIVAVKVVNLK---QKEAS 71
           P  +  E +K  +  N S    +G G    V  G L   S+  ++V +  LK    ++  
Sbjct: 31  PTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR 90
Query: 72  RSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA----IVFEYMQNRNLEQWLRQSN 127
           R F  E + +    H N+I++         EG   K+    IV EYM+N +L+ +LR+ +
Sbjct: 91  RDFLGEASIMGQFDHPNIIRL---------EGVVTKSKPVMIVTEYMENGSLDSFLRKHD 141
Query: 128 GQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL 187
            Q   + Q V +   ++  ++Y         VH DL   NIL++ ++V  V D GL++ L
Sbjct: 142 AQFTVI-QLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVL 197
Query: 188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTR-RRPTD 246
              +P  A  T    I I+    + +PE     K + + DV+++GI+L E+ +   RP  
Sbjct: 198 ED-DPEAAYTTRGGKIPIR----WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYW 252
Query: 247 AMFNE 251
            M N+
Sbjct: 253 EMSNQ 257

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/245 (27%), Positives = 114/245 (46%), Gaps = 29/245 (11%)
Query: 18  PMISYAELSKATN--NFSPANKIGQGGVSIVYKGILD-ESRSIVAVKVVNLK---QKEAS 71
           P  +  E +K  +  N S    +G G    V  G L   S+  ++V +  LK    ++  
Sbjct: 29  PTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR 88
Query: 72  RSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA----IVFEYMQNRNLEQWLRQSN 127
           R F  E + +    H N+I++         EG   K+    IV EYM+N +L+ +LR+ +
Sbjct: 89  RDFLGEASIMGQFDHPNIIRL---------EGVVTKSKPVMIVTEYMENGSLDSFLRKHD 139
Query: 128 GQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL 187
            Q   + Q V +   ++  ++Y         VH DL   NIL++ ++V  V D GL++ L
Sbjct: 140 AQFTVI-QLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVL 195
Query: 188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTR-RRPTD 246
              +P  A  T    I I+    + +PE     K + + DV+++GI+L E+ +   RP  
Sbjct: 196 ED-DPEAAYTTRGGKIPIR----WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYW 250
Query: 247 AMFNE 251
            M N+
Sbjct: 251 EMSNQ 255

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/245 (27%), Positives = 114/245 (46%), Gaps = 29/245 (11%)
Query: 18  PMISYAELSKATN--NFSPANKIGQGGVSIVYKGILD-ESRSIVAVKVVNLK---QKEAS 71
           P  +  E +K  +  N S    +G G    V  G L   S+  ++V +  LK    ++  
Sbjct: 31  PTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR 90
Query: 72  RSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA----IVFEYMQNRNLEQWLRQSN 127
           R F  E + +    H N+I++         EG   K+    IV EYM+N +L+ +LR+ +
Sbjct: 91  RDFLGEASIMGQFDHPNIIRL---------EGVVTKSKPVMIVTEYMENGSLDSFLRKHD 141
Query: 128 GQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL 187
            Q   + Q V +   ++  ++Y         VH DL   NIL++ ++V  V D GL++ L
Sbjct: 142 AQFTVI-QLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVL 197
Query: 188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTR-RRPTD 246
              +P  A  T    I I+    + +PE     K + + DV+++GI+L E+ +   RP  
Sbjct: 198 ED-DPEAAYTTRGGKIPIR----WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYW 252
Query: 247 AMFNE 251
            M N+
Sbjct: 253 EMSNQ 257

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/245 (27%), Positives = 114/245 (46%), Gaps = 29/245 (11%)
Query: 18  PMISYAELSKATN--NFSPANKIGQGGVSIVYKGILD-ESRSIVAVKVVNLK---QKEAS 71
           P  +  E +K  +  N S    +G G    V  G L   S+  ++V +  LK    ++  
Sbjct: 31  PTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR 90
Query: 72  RSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA----IVFEYMQNRNLEQWLRQSN 127
           R F  E + +    H N+I++         EG   K+    IV EYM+N +L+ +LR+ +
Sbjct: 91  RDFLGEASIMGQFDHPNIIRL---------EGVVTKSKPVMIVTEYMENGSLDSFLRKHD 141
Query: 128 GQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL 187
            Q   + Q V +   ++  ++Y         VH DL   NIL++ ++V  V D GL++ L
Sbjct: 142 AQFTVI-QLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVL 197
Query: 188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTR-RRPTD 246
              +P  A  T    I I+    + +PE     K + + DV+++GI+L E+ +   RP  
Sbjct: 198 ED-DPEAAYTTRGGKIPIR----WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYW 252
Query: 247 AMFNE 251
            M N+
Sbjct: 253 EMSNQ 257

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 102/229 (44%), Gaps = 42/229 (18%)
Query: 31  NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVN---LKQKEASRSFAAECNALRNIRHR 87
           N+     +G+G    V       +   VA+K++N   L + +       E + LR +RH 
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 68
Query: 88  NLIKIITICSS-------IDFEGFDFKAIVFEYMQNRNL--EQWLRQSNGQLRFLTQRVN 138
           ++IK+  +  S       I++ G +    +F+Y+  R+   EQ  R      RF  Q ++
Sbjct: 69  HIIKLYDVIKSKDEIIMVIEYAGNE----LFDYIVQRDKMSEQEAR------RFFQQIIS 118
Query: 139 IAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAET 198
                  A+EY H H    IVH DLKP N+LLD+ +   + D GL+  +     G   +T
Sbjct: 119 -------AVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM---TDGNFLKT 165
Query: 199 ASNSIEIKGIVGYVAPEYGMGS-KASVSGDVYNFGILLLEMFTRRRPTD 246
           +  S        Y APE   G   A    DV++ G++L  M  RR P D
Sbjct: 166 SCGS------PNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 208

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 93/212 (43%), Gaps = 26/212 (12%)
Query: 35  ANKIGQGGVSIVYKGILDESRSIVAVKVV------NLKQKEASRSFAAECNALRNIRHRN 88
             +IG+G    V+ G L    ++VAVK        +LK K     F  E   L+   H N
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAK-----FLQEARILKQYSHPN 173
Query: 89  LIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIE 148
           ++++I +C+           IV E +Q  +   +LR    +LR  T  + +  D +  +E
Sbjct: 174 IVRLIGVCTQKQP-----IYIVMELVQGGDFLTFLRTEGARLRVKT-LLQMVGDAAAGME 227
Query: 149 YFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGI 208
           Y    C    +H DL   N L+ +  V  + D G+++     E       AS  +  +  
Sbjct: 228 YLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSR-----EEADGVXAASGGLR-QVP 278
Query: 209 VGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
           V + APE     + S   DV++FGILL E F+
Sbjct: 279 VKWTAPEALNYGRYSSESDVWSFGILLWETFS 310

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 102/229 (44%), Gaps = 42/229 (18%)
Query: 31  NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVN---LKQKEASRSFAAECNALRNIRHR 87
           N+     +G+G    V       +   VA+K++N   L + +       E + LR +RH 
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 64
Query: 88  NLIKIITICSS-------IDFEGFDFKAIVFEYMQNRNL--EQWLRQSNGQLRFLTQRVN 138
           ++IK+  +  S       I++ G +    +F+Y+  R+   EQ  R      RF  Q ++
Sbjct: 65  HIIKLYDVIKSKDEIIMVIEYAGNE----LFDYIVQRDKMSEQEAR------RFFQQIIS 114
Query: 139 IAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAET 198
                  A+EY H H    IVH DLKP N+LLD+ +   + D GL+  +     G   +T
Sbjct: 115 -------AVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM---TDGNFLKT 161
Query: 199 ASNSIEIKGIVGYVAPEYGMGS-KASVSGDVYNFGILLLEMFTRRRPTD 246
           +  S        Y APE   G   A    DV++ G++L  M  RR P D
Sbjct: 162 SCGS------PNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 204

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 102/229 (44%), Gaps = 42/229 (18%)
Query: 31  NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVN---LKQKEASRSFAAECNALRNIRHR 87
           N+     +G+G    V       +   VA+K++N   L + +       E + LR +RH 
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 73
Query: 88  NLIKIITICSS-------IDFEGFDFKAIVFEYMQNRNL--EQWLRQSNGQLRFLTQRVN 138
           ++IK+  +  S       I++ G +    +F+Y+  R+   EQ  R      RF  Q ++
Sbjct: 74  HIIKLYDVIKSKDEIIMVIEYAGNE----LFDYIVQRDKMSEQEAR------RFFQQIIS 123
Query: 139 IAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAET 198
                  A+EY H H    IVH DLKP N+LLD+ +   + D GL+  +     G   +T
Sbjct: 124 -------AVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM---TDGNFLKT 170
Query: 199 ASNSIEIKGIVGYVAPEYGMGS-KASVSGDVYNFGILLLEMFTRRRPTD 246
           +  S        Y APE   G   A    DV++ G++L  M  RR P D
Sbjct: 171 SCGS------PNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 213

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 102/229 (44%), Gaps = 42/229 (18%)
Query: 31  NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVN---LKQKEASRSFAAECNALRNIRHR 87
           N+     +G+G    V       +   VA+K++N   L + +       E + LR +RH 
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 74
Query: 88  NLIKIITICSS-------IDFEGFDFKAIVFEYMQNRNL--EQWLRQSNGQLRFLTQRVN 138
           ++IK+  +  S       I++ G +    +F+Y+  R+   EQ  R      RF  Q ++
Sbjct: 75  HIIKLYDVIKSKDEIIMVIEYAGNE----LFDYIVQRDKMSEQEAR------RFFQQIIS 124
Query: 139 IAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAET 198
                  A+EY H H    IVH DLKP N+LLD+ +   + D GL+  +     G   +T
Sbjct: 125 -------AVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM---TDGNFLKT 171
Query: 199 ASNSIEIKGIVGYVAPEYGMGS-KASVSGDVYNFGILLLEMFTRRRPTD 246
           +  S        Y APE   G   A    DV++ G++L  M  RR P D
Sbjct: 172 SCGS------PNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 214

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/245 (27%), Positives = 113/245 (46%), Gaps = 29/245 (11%)
Query: 18  PMISYAELSKATN--NFSPANKIGQGGVSIVYKGILD-ESRSIVAVKVVNLK---QKEAS 71
           P  +  E +K  +  N S    +G G    V  G L   S+  ++V +  LK    ++  
Sbjct: 31  PTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR 90
Query: 72  RSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA----IVFEYMQNRNLEQWLRQSN 127
           R F  E + +    H N+I++         EG   K+    IV EYM+N +L+ +LR+ +
Sbjct: 91  RDFLGEASIMGQFDHPNIIRL---------EGVVTKSKPVMIVTEYMENGSLDSFLRKHD 141
Query: 128 GQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL 187
            Q   + Q V +   ++  ++Y         VH DL   NIL++ ++V  V D GL + L
Sbjct: 142 AQFTVI-QLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVL 197
Query: 188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTR-RRPTD 246
              +P  A  T    I I+    + +PE     K + + DV+++GI+L E+ +   RP  
Sbjct: 198 ED-DPEAAYTTRGGKIPIR----WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYW 252
Query: 247 AMFNE 251
            M N+
Sbjct: 253 EMSNQ 257

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 18/211 (8%)
Query: 58  VAVKVVNLKQKEASR-SFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQN 116
           VA+K +     E  R  F +E + +    H N+I++  + +           IV EYM+N
Sbjct: 80  VAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR-----GRLAMIVTEYMEN 134
Query: 117 RNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVA 176
            +L+ +LR  +GQ   + Q V +   V   + Y         VH DL   N+L+D ++V 
Sbjct: 135 GSLDTFLRTHDGQFTIM-QLVGMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVC 190
Query: 177 HVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLL 236
            V D GL++ L   +P  A  T    I I+    + APE       S + DV++FG+++ 
Sbjct: 191 KVSDFGLSRVLED-DPDAAYTTTGGKIPIR----WTAPEAIAFRTFSSASDVWSFGVVMW 245
Query: 237 EMFTR-RRPTDAMFNEGL--TLHEFVKMALP 264
           E+     RP   M N  +  ++ E  ++  P
Sbjct: 246 EVLAYGERPYWNMTNRDVISSVEEGYRLPAP 276

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 107/229 (46%), Gaps = 34/229 (14%)
Query: 20  ISYAELSKATNNFSPANKIGQGGVSIV----YKGILDESRSIVAVKVVNLKQKEASRS-- 73
           + Y        + +   ++G G   +V    ++G  D     VA+K++    KE S S  
Sbjct: 14  LGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYD-----VAIKMI----KEGSMSED 64
Query: 74  -FAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRF 132
            F  E   + N+ H  L+++  +C+    +   F  I+ EYM N  L  +LR+   + RF
Sbjct: 65  EFIEEAKVMMNLSHEKLVQLYGVCTK---QRPIF--IITEYMANGCLLNYLREM--RHRF 117
Query: 133 LTQRV-NIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYE 191
            TQ++  +  DV  A+EY         +H DL   N L++   V  V D GL++++   E
Sbjct: 118 QTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174
Query: 192 PGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
                   ++S+  K  V +  PE  M SK S   D++ FG+L+ E+++
Sbjct: 175 -------ETSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 102/200 (51%), Gaps = 22/200 (11%)
Query: 58  VAVKVVNLKQKEASR-SFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA----IVFE 112
           VA+K +     E  R  F +E + +    H N+I +         EG   K+    I+ E
Sbjct: 38  VAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHL---------EGVVTKSTPVMIITE 88
Query: 113 YMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQ 172
           +M+N +L+ +LRQ++GQ   + Q V +   ++  ++Y       + VH  L   NIL++ 
Sbjct: 89  FMENGSLDSFLRQNDGQFTVI-QLVGMLRGIAAGMKYL---ADMNYVHRALAARNILVNS 144
Query: 173 DIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFG 232
           ++V  V D GL++FL   E  T+  T ++++  K  + + APE     K + + DV+++G
Sbjct: 145 NLVCKVSDFGLSRFL---EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYG 201
Query: 233 ILLLEMFTR-RRPTDAMFNE 251
           I++ E+ +   RP   M N+
Sbjct: 202 IVMWEVMSYGERPYWDMTNQ 221

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 92/184 (50%), Gaps = 21/184 (11%)
Query: 72  RSFAAECNALRNIRHRNLIK---IITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNG 128
           R F +E + +    H N+I    ++T C  +         I+ EYM+N +L+ +LR+++G
Sbjct: 54  RDFLSEASIMGQFDHPNIIHLEGVVTKCKPV--------MIITEYMENGSLDAFLRKNDG 105
Query: 129 QLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLF 188
           +   + Q V +   +   ++Y       S VH DL   NIL++ ++V  V D G+++ L 
Sbjct: 106 RFTVI-QLVGMLRGIGSGMKYLSDM---SYVHRDLAARNILVNSNLVCKVSDFGMSRVLE 161
Query: 189 GYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTR-RRPTDA 247
             +P  A  T    I I+    + APE     K + + DV+++GI++ E+ +   RP   
Sbjct: 162 D-DPEAAYTTRGGKIPIR----WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD 216
Query: 248 MFNE 251
           M N+
Sbjct: 217 MSNQ 220

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 97/208 (46%), Gaps = 24/208 (11%)
Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRS---FAAECNALRNIRHRNLIKI 92
            +IG G   +V+ G    ++  VA+K +    KE S S   F  E   +  + H  L+++
Sbjct: 33  QEIGSGQFGLVHLGYW-LNKDKVAIKTI----KEGSMSEDDFIEEAEVMMKLSHPKLVQL 87
Query: 93  ITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHH 152
             +C     E      +VFE+M++  L  +LR   G     T  + + +DV   + Y   
Sbjct: 88  YGVC----LEQAPI-CLVFEFMEHGCLSDYLRTQRGLFAAET-LLGMCLDVCEGMAYLEE 141
Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
            C   ++H DL   N L+ ++ V  V D G+ +F+         +  ++S   K  V + 
Sbjct: 142 AC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-------DQYTSSTGTKFPVKWA 191
Query: 213 APEYGMGSKASVSGDVYNFGILLLEMFT 240
           +PE    S+ S   DV++FG+L+ E+F+
Sbjct: 192 SPEVFSFSRYSSKSDVWSFGVLMWEVFS 219

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 93/212 (43%), Gaps = 26/212 (12%)
Query: 35  ANKIGQGGVSIVYKGILDESRSIVAVKVV------NLKQKEASRSFAAECNALRNIRHRN 88
             +IG+G    V+ G L    ++VAVK        +LK K     F  E   L+   H N
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAK-----FLQEARILKQYSHPN 173
Query: 89  LIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIE 148
           ++++I +C+           IV E +Q  +   +LR    +LR  T  + +  D +  +E
Sbjct: 174 IVRLIGVCTQKQP-----IYIVMELVQGGDFLTFLRTEGARLRVKT-LLQMVGDAAAGME 227
Query: 149 YFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGI 208
           Y    C    +H DL   N L+ +  V  + D G+++     E       AS  +  +  
Sbjct: 228 YLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSR-----EEADGVYAASGGLR-QVP 278
Query: 209 VGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
           V + APE     + S   DV++FGILL E F+
Sbjct: 279 VKWTAPEALNYGRYSSESDVWSFGILLWETFS 310

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 108/226 (47%), Gaps = 27/226 (11%)
Query: 29  TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKE--ASRSFAAECNALRNIRH 86
           +++F   + +G+G   +V       +  IVA+K +    K   A R+   E   L++ +H
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKH 68
Query: 87  RNLIKIITICSSIDFEGFDFKAIVFEYMQ---NRNLEQWLRQSNGQLRFLTQRVNIAIDV 143
            N+I I  I     FE F+   I+ E MQ   +R +   +   +    F+ Q +      
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLR----- 123
Query: 144 SFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSI 203
             A++  H     +++H DLKPSN+L++ +    V D GLA+ +      +AA+ +  + 
Sbjct: 124 --AVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARII----DESAADNSEPTG 174
Query: 204 EIKGIVGYV------APEYGMGS-KASVSGDVYNFGILLLEMFTRR 242
           +  G+  YV      APE  + S K S + DV++ G +L E+F RR
Sbjct: 175 QQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 95/192 (49%), Gaps = 17/192 (8%)
Query: 52  DESRSIVAVKVVNLKQKEASRSFA---AECNALRNIRHRNLIKIITICSSIDFEGFDFKA 108
           D +   VAVK  +LK +      A    E   LRN+ H N++K   IC+    +G +   
Sbjct: 47  DNTGEQVAVK--SLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE---DGGNGIK 101
Query: 109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNI 168
           ++ E++ + +L+++L ++  ++  L Q++  A+ +   ++Y         VH DL   N+
Sbjct: 102 LIMEFLPSGSLKEYLPKNKNKIN-LKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNV 157
Query: 169 LLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDV 228
           L++ +    +GD GL K +      T  E  +   +    V + APE  M SK  ++ DV
Sbjct: 158 LVESEHQVKIGDFGLTKAI-----ETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDV 212
Query: 229 YNFGILLLEMFT 240
           ++FG+ L E+ T
Sbjct: 213 WSFGVTLHELLT 224

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 34/213 (15%)
Query: 36  NKIGQGGVSIV----YKGILDESRSIVAVKVVNLKQKEASRS---FAAECNALRNIRHRN 88
            ++G G   +V    ++G  D     VA+K++    KE S S   F  E   + N+ H  
Sbjct: 10  KELGTGQFGVVKYGKWRGQYD-----VAIKMI----KEGSMSEDEFIEEAKVMMNLSHEK 60
Query: 89  LIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRV-NIAIDVSFAI 147
           L+++  +C+    +   F  I+ EYM N  L  +LR+     RF TQ++  +  DV  A+
Sbjct: 61  LVQLYGVCTK---QRPIF--IITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAM 113
Query: 148 EYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKG 207
           EY         +H DL   N L++   V  V D GL++++   E        ++S+  K 
Sbjct: 114 EYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-------YTSSVGSKF 163
Query: 208 IVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
            V +  PE  M SK S   D++ FG+L+ E+++
Sbjct: 164 PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 196

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 95/192 (49%), Gaps = 17/192 (8%)
Query: 52  DESRSIVAVKVVNLKQKEASRSFA---AECNALRNIRHRNLIKIITICSSIDFEGFDFKA 108
           D +   VAVK  +LK +      A    E   LRN+ H N++K   IC+    +G +   
Sbjct: 35  DNTGEQVAVK--SLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE---DGGNGIK 89
Query: 109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNI 168
           ++ E++ + +L+++L ++  ++  L Q++  A+ +   ++Y         VH DL   N+
Sbjct: 90  LIMEFLPSGSLKEYLPKNKNKIN-LKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNV 145
Query: 169 LLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDV 228
           L++ +    +GD GL K +      T  E  +   +    V + APE  M SK  ++ DV
Sbjct: 146 LVESEHQVKIGDFGLTKAI-----ETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDV 200
Query: 229 YNFGILLLEMFT 240
           ++FG+ L E+ T
Sbjct: 201 WSFGVTLHELLT 212

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 34/213 (15%)
Query: 36  NKIGQGGVSIV----YKGILDESRSIVAVKVVNLKQKEASRS---FAAECNALRNIRHRN 88
            ++G G   +V    ++G  D     VA+K++    KE S S   F  E   + N+ H  
Sbjct: 14  KELGTGQFGVVKYGKWRGQYD-----VAIKMI----KEGSMSEDEFIEEAKVMMNLSHEK 64
Query: 89  LIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRV-NIAIDVSFAI 147
           L+++  +C+    +   F  I+ EYM N  L  +LR+     RF TQ++  +  DV  A+
Sbjct: 65  LVQLYGVCTK---QRPIF--IITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAM 117
Query: 148 EYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKG 207
           EY         +H DL   N L++   V  V D GL++++   E        ++S+  K 
Sbjct: 118 EYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-------YTSSVGSKF 167
Query: 208 IVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
            V +  PE  M SK S   D++ FG+L+ E+++
Sbjct: 168 PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 200

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 107/229 (46%), Gaps = 34/229 (14%)
Query: 20  ISYAELSKATNNFSPANKIGQGGVSIV----YKGILDESRSIVAVKVVNLKQKEASRS-- 73
           + Y        + +   ++G G   +V    ++G  D     VA+K++    KE S S  
Sbjct: 14  LGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYD-----VAIKMI----KEGSMSED 64
Query: 74  -FAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRF 132
            F  E   + N+ H  L+++  +C+    +   F  I+ EYM N  L  +LR+   + RF
Sbjct: 65  EFIEEAKVMMNLSHEKLVQLYGVCTK---QRPIF--IITEYMANGCLLNYLREM--RHRF 117
Query: 133 LTQRV-NIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYE 191
            TQ++  +  DV  A+EY         +H DL   N L++   V  V D GL++++   E
Sbjct: 118 QTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174
Query: 192 PGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
                   ++S+  K  V +  PE  M SK S   D++ FG+L+ E+++
Sbjct: 175 -------YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 92/184 (50%), Gaps = 21/184 (11%)
Query: 72  RSFAAECNALRNIRHRNLIK---IITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNG 128
           R F +E + +    H N+I    ++T C  +         I+ EYM+N +L+ +LR+++G
Sbjct: 75  RDFLSEASIMGQFDHPNIIHLEGVVTKCKPV--------MIITEYMENGSLDAFLRKNDG 126
Query: 129 QLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLF 188
           +   + Q V +   +   ++Y       S VH DL   NIL++ ++V  V D G+++ L 
Sbjct: 127 RFTVI-QLVGMLRGIGSGMKYLSDM---SAVHRDLAARNILVNSNLVCKVSDFGMSRVLE 182
Query: 189 GYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTR-RRPTDA 247
             +P  A  T    I I+    + APE     K + + DV+++GI++ E+ +   RP   
Sbjct: 183 D-DPEAAYTTRGGKIPIR----WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD 237
Query: 248 MFNE 251
           M N+
Sbjct: 238 MSNQ 241

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 119/244 (48%), Gaps = 24/244 (9%)
Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL-KQKEASRSFA-AECNALRNIRHR 87
            NF    KIG+G   +VYK     +  +VA+K + L  + E   S A  E + L+ + H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 88  NLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAI 147
           N++K++ +   I  E   +  +VFE++ +++L++++  S      L    +    +   +
Sbjct: 63  NIVKLLDV---IHTENKLY--LVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 116
Query: 148 EYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKG 207
            + H H    ++H DLKP N+L++ +    + D GLA+       G    T ++ +    
Sbjct: 117 SFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-----GVPVRTYTHEVV--- 165
Query: 208 IVGYVAPEYGMGSK-ASVSGDVYNFGILLLEMFTRRR--PTDAMFNEGLTLHEFVKMALP 264
            + Y APE  +G K  S + D+++ G +  EM TRR   P D+  ++   +  F  +  P
Sbjct: 166 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLGTP 223
Query: 265 DKVM 268
           D+V+
Sbjct: 224 DEVV 227

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 92/184 (50%), Gaps = 21/184 (11%)
Query: 72  RSFAAECNALRNIRHRNLIK---IITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNG 128
           R F +E + +    H N+I    ++T C  +         I+ EYM+N +L+ +LR+++G
Sbjct: 60  RDFLSEASIMGQFDHPNIIHLEGVVTKCKPV--------MIITEYMENGSLDAFLRKNDG 111
Query: 129 QLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLF 188
           +   + Q V +   +   ++Y       S VH DL   NIL++ ++V  V D G+++ L 
Sbjct: 112 RFTVI-QLVGMLRGIGSGMKYLSDM---SYVHRDLAARNILVNSNLVCKVSDFGMSRVLE 167
Query: 189 GYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTR-RRPTDA 247
             +P  A  T    I I+    + APE     K + + DV+++GI++ E+ +   RP   
Sbjct: 168 D-DPEAAYTTRGGKIPIR----WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD 222
Query: 248 MFNE 251
           M N+
Sbjct: 223 MSNQ 226

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 99/215 (46%), Gaps = 30/215 (13%)
Query: 37  KIGQGGVSIV----YKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKI 92
           ++G+G    V    Y  + D +  +VAVK +    +E  R F  E   L++++H N++K 
Sbjct: 18  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 77
Query: 93  ITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHH 152
             +C S    G     ++ EY+   +L  +L++   ++  + + +     +   +EY   
Sbjct: 78  KGVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERIDHI-KLLQYTSQICKGMEYL-- 131
Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG-------YEPGTAAETASNSIEI 205
                 +H +L   NIL++ +    +GD GL K L          EPG +          
Sbjct: 132 -GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESP--------- 181
Query: 206 KGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
              + + APE    SK SV+ DV++FG++L E+FT
Sbjct: 182 ---IFWYAPESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 120/246 (48%), Gaps = 24/246 (9%)
Query: 28  ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL-KQKEASRSFA-AECNALRNIR 85
           +  NF    KIG+G   +VYK     +  +VA+K + L  + E   S A  E + L+ + 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 86  HRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSF 145
           H N++K++ +   I  E   +  +VFE++ +++L++++  S      L    +    +  
Sbjct: 62  HPNIVKLLDV---IHTENKLY--LVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQ 115
Query: 146 AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEI 205
            + + H H    ++H DLKP N+L++ +    + D GLA+       G    T ++ +  
Sbjct: 116 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-----GVPVRTYTHEVV- 166
Query: 206 KGIVGYVAPEYGMGSK-ASVSGDVYNFGILLLEMFTRRR--PTDAMFNEGLTLHEFVKMA 262
              + Y APE  +G K  S + D+++ G +  EM TRR   P D+  ++   +  F  + 
Sbjct: 167 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLG 222
Query: 263 LPDKVM 268
            PD+V+
Sbjct: 223 TPDEVV 228

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 119/244 (48%), Gaps = 24/244 (9%)
Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL-KQKEASRSFA-AECNALRNIRHR 87
            NF    KIG+G   +VYK     +  +VA+K + L  + E   S A  E + L+ + H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 88  NLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAI 147
           N++K++ +   I  E   +  +VFE++ +++L++++  S      L    +    +   +
Sbjct: 63  NIVKLLDV---IHTENKLY--LVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 116
Query: 148 EYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKG 207
            + H H    ++H DLKP N+L++ +    + D GLA+       G    T ++ +    
Sbjct: 117 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-----GVPVRTYTHEVV--- 165
Query: 208 IVGYVAPEYGMGSK-ASVSGDVYNFGILLLEMFTRRR--PTDAMFNEGLTLHEFVKMALP 264
            + Y APE  +G K  S + D+++ G +  EM TRR   P D+  ++   +  F  +  P
Sbjct: 166 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLGTP 223
Query: 265 DKVM 268
           D+V+
Sbjct: 224 DEVV 227

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 119/244 (48%), Gaps = 24/244 (9%)
Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL-KQKEASRSFA-AECNALRNIRHR 87
            NF    KIG+G   +VYK     +  +VA+K + L  + E   S A  E + L+ + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 88  NLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAI 147
           N++K++ +   I  E   +  +VFE++ +++L++++  S      L    +    +   +
Sbjct: 62  NIVKLLDV---IHTENKLY--LVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 115
Query: 148 EYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKG 207
            + H H    ++H DLKP N+L++ +    + D GLA+       G    T ++ +    
Sbjct: 116 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-----GVPVRTYTHEVV--- 164
Query: 208 IVGYVAPEYGMGSK-ASVSGDVYNFGILLLEMFTRRR--PTDAMFNEGLTLHEFVKMALP 264
            + Y APE  +G K  S + D+++ G +  EM TRR   P D+  ++   +  F  +  P
Sbjct: 165 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLGTP 222
Query: 265 DKVM 268
           D+V+
Sbjct: 223 DEVV 226

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 110/237 (46%), Gaps = 21/237 (8%)
Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITI 95
            K+G G    V+    ++  + VAVK +      +  +F AE N ++ ++H  L+K+  +
Sbjct: 21  KKLGAGQFGEVWMATYNK-HTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAV 78
Query: 96  CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQ 155
            +           I+ E+M   +L  +L+   G  + L + ++ +  ++  + +     Q
Sbjct: 79  VTKEPI------YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---Q 129
Query: 156 PSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPE 215
            + +H DL+ +NIL+   +V  + D GLA+ +   E  TA E A   I+      + APE
Sbjct: 130 RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-YTAREGAKFPIK------WTAPE 182
Query: 216 YGMGSKASVSGDVYNFGILLLEMFTRRR-PTDAMFNEGL--TLHEFVKMALPDKVME 269
                  ++  DV++FGILL+E+ T  R P   M N  +   L    +M  P+   E
Sbjct: 183 AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPE 239

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 119/244 (48%), Gaps = 24/244 (9%)
Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL-KQKEASRSFA-AECNALRNIRHR 87
            NF    KIG+G   +VYK     +  +VA+K + L  + E   S A  E + L+ + H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 88  NLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAI 147
           N++K++ +   I  E   +  +VFE++ +++L++++  S      L    +    +   +
Sbjct: 63  NIVKLLDV---IHTENKLY--LVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 116
Query: 148 EYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKG 207
            + H H    ++H DLKP N+L++ +    + D GLA+       G    T ++ +    
Sbjct: 117 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-----GVPVRTYTHEVV--- 165
Query: 208 IVGYVAPEYGMGSK-ASVSGDVYNFGILLLEMFTRRR--PTDAMFNEGLTLHEFVKMALP 264
            + Y APE  +G K  S + D+++ G +  EM TRR   P D+  ++   +  F  +  P
Sbjct: 166 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLGTP 223
Query: 265 DKVM 268
           D+V+
Sbjct: 224 DEVV 227

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 106/229 (46%), Gaps = 34/229 (14%)
Query: 20  ISYAELSKATNNFSPANKIGQGGVSIV----YKGILDESRSIVAVKVVNLKQKEASRS-- 73
           + Y        + +   ++G G   +V    ++G  D     VA+K++    KE S S  
Sbjct: 5   LGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYD-----VAIKMI----KEGSMSED 55
Query: 74  -FAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRF 132
            F  E   + N+ H  L+++  +C+    +   F  I+ EYM N  L  +LR+     RF
Sbjct: 56  EFIEEAKVMMNLSHEKLVQLYGVCTK---QRPIF--IITEYMANGCLLNYLREMRH--RF 108
Query: 133 LTQRV-NIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYE 191
            TQ++  +  DV  A+EY         +H DL   N L++   V  V D GL++++   E
Sbjct: 109 QTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 165
Query: 192 PGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
                   ++S+  K  V +  PE  M SK S   D++ FG+L+ E+++
Sbjct: 166 -------YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 207

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 119/244 (48%), Gaps = 24/244 (9%)
Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL-KQKEASRSFA-AECNALRNIRHR 87
            NF    KIG+G   +VYK     +  +VA+K + L  + E   S A  E + L+ + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 88  NLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAI 147
           N++K++ +   I  E   +  +VFE++ +++L++++  S      L    +    +   +
Sbjct: 62  NIVKLLDV---IHTENKLY--LVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 115
Query: 148 EYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKG 207
            + H H    ++H DLKP N+L++ +    + D GLA+       G    T ++ +    
Sbjct: 116 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-----GVPVRTYTHEVV--- 164
Query: 208 IVGYVAPEYGMGSK-ASVSGDVYNFGILLLEMFTRRR--PTDAMFNEGLTLHEFVKMALP 264
            + Y APE  +G K  S + D+++ G +  EM TRR   P D+  ++   +  F  +  P
Sbjct: 165 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLGTP 222
Query: 265 DKVM 268
           D+V+
Sbjct: 223 DEVV 226

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 34/213 (15%)
Query: 36  NKIGQGGVSIV----YKGILDESRSIVAVKVVNLKQKEASRS---FAAECNALRNIRHRN 88
            ++G G   +V    ++G  D     VA+K++    KE S S   F  E   + N+ H  
Sbjct: 15  KELGTGQFGVVKYGKWRGQYD-----VAIKMI----KEGSMSEDEFIEEAKVMMNLSHEK 65
Query: 89  LIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRV-NIAIDVSFAI 147
           L+++  +C+    +   F  I+ EYM N  L  +LR+     RF TQ++  +  DV  A+
Sbjct: 66  LVQLYGVCTK---QRPIF--IITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAM 118
Query: 148 EYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKG 207
           EY         +H DL   N L++   V  V D GL++++   E        ++S+  K 
Sbjct: 119 EYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-------YTSSVGSKF 168
Query: 208 IVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
            V +  PE  M SK S   D++ FG+L+ E+++
Sbjct: 169 PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 201

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 119/244 (48%), Gaps = 24/244 (9%)
Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK-QKEASRSFA-AECNALRNIRHR 87
            NF    KIG+G   +VYK     +  +VA+K + L  + E   S A  E + L+ + H 
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 88  NLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAI 147
           N++K++ +   I  E   +  +VFE++ +++L++++  S      L    +    +   +
Sbjct: 67  NIVKLLDV---IHTENKLY--LVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 120
Query: 148 EYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKG 207
            + H H    ++H DLKP N+L++ +    + D GLA+       G    T ++ +    
Sbjct: 121 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-----GVPVRTYTHEVV--- 169
Query: 208 IVGYVAPEYGMGSK-ASVSGDVYNFGILLLEMFTRRR--PTDAMFNEGLTLHEFVKMALP 264
            + Y APE  +G K  S + D+++ G +  EM TRR   P D+  ++   +  F  +  P
Sbjct: 170 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLGTP 227
Query: 265 DKVM 268
           D+V+
Sbjct: 228 DEVV 231

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 102/222 (45%), Gaps = 19/222 (8%)
Query: 28  ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAA--ECNALRNIR 85
           AT+ + P  +IG G    VYK     S   VA+K V +   E     +   E   LR + 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 86  ---HRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAID 142
              H N+++++ +C++   +      +VFE++ +++L  +L ++           ++   
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 143 VSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNS 202
               +++ H +C   IVH DLKP NIL+       + D GLA+ ++ Y+           
Sbjct: 121 FLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR-IYSYQ--------MAL 168
Query: 203 IEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
             +   + Y APE  + S  +   D+++ G +  EMF RR+P
Sbjct: 169 FPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF-RRKP 209

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 118/244 (48%), Gaps = 24/244 (9%)
Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL-KQKEASRSFA-AECNALRNIRHR 87
            NF    KIG+G   +VYK     +  +VA+K + L  + E   S A  E + L+ + H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 88  NLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAI 147
           N++K++ +  + +        +VFE++ +++L++++  S      L    +    +   +
Sbjct: 70  NIVKLLDVIHTENK-----LYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 123
Query: 148 EYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKG 207
            + H H    ++H DLKP N+L++ +    + D GLA+       G    T ++ +    
Sbjct: 124 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-----GVPVRTYTHEVV--- 172
Query: 208 IVGYVAPEYGMGSK-ASVSGDVYNFGILLLEMFTRRR--PTDAMFNEGLTLHEFVKMALP 264
            + Y APE  +G K  S + D+++ G +  EM TRR   P D+  ++   +  F  +  P
Sbjct: 173 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLGTP 230
Query: 265 DKVM 268
           D+V+
Sbjct: 231 DEVV 234

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 118/244 (48%), Gaps = 24/244 (9%)
Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL-KQKEASRSFA-AECNALRNIRHR 87
            NF    KIG+G   +VYK     +  +VA+K + L  + E   S A  E + L+ + H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 88  NLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAI 147
           N++K++ +  + +        +VFE++ +++L++++  S      L    +    +   +
Sbjct: 63  NIVKLLDVIHTENK-----LYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 116
Query: 148 EYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKG 207
            + H H    ++H DLKP N+L++ +    + D GLA+       G    T ++ +    
Sbjct: 117 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-----GVPVRTYTHEVV--- 165
Query: 208 IVGYVAPEYGMGSK-ASVSGDVYNFGILLLEMFTRRR--PTDAMFNEGLTLHEFVKMALP 264
            + Y APE  +G K  S + D+++ G +  EM TRR   P D+  ++   +  F  +  P
Sbjct: 166 TLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLGTP 223
Query: 265 DKVM 268
           D+V+
Sbjct: 224 DEVV 227

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 118/244 (48%), Gaps = 24/244 (9%)
Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL-KQKEASRSFA-AECNALRNIRHR 87
            NF    KIG+G   +VYK     +  +VA+K + L  + E   S A  E + L+ + H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 88  NLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAI 147
           N++K++ +  + +        +VFE++ +++L++++  S      L    +    +   +
Sbjct: 70  NIVKLLDVIHTENK-----LYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 123
Query: 148 EYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKG 207
            + H H    ++H DLKP N+L++ +    + D GLA+       G    T ++ +    
Sbjct: 124 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-----GVPVRTYTHEVV--- 172
Query: 208 IVGYVAPEYGMGSK-ASVSGDVYNFGILLLEMFTRRR--PTDAMFNEGLTLHEFVKMALP 264
            + Y APE  +G K  S + D+++ G +  EM TRR   P D+  ++   +  F  +  P
Sbjct: 173 TLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLGTP 230
Query: 265 DKVM 268
           D+V+
Sbjct: 231 DEVV 234

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 102/222 (45%), Gaps = 19/222 (8%)
Query: 29  TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKE--ASRSFAAECNALRNIRH 86
           +++F   + +G+G   +V       +  IVA+K +    K   A R+   E   L++ +H
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKH 68
Query: 87  RNLIKIITICSSIDFEGFDFKAIVFEYMQ---NRNLEQWLRQSNGQLRFLTQRVNIAIDV 143
            N+I I  I     FE F+   I+ E MQ   +R +   +   +    F+ Q +      
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLR----- 123
Query: 144 SFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNS- 202
             A++  H     +++H DLKPSN+L++ +    V D GLA+ +       +  T   S 
Sbjct: 124 --AVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 203 -IEIKGIVGYVAPEYGMGS-KASVSGDVYNFGILLLEMFTRR 242
             E      Y APE  + S K S + DV++ G +L E+F RR
Sbjct: 179 MTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 102/214 (47%), Gaps = 22/214 (10%)
Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAA--ECNALRNIRHR 87
             +    K+G+G   +VYK    + R IVA+K + L  ++      A  E + L+ + H 
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGR-IVALKRIRLDAEDEGIPSTAIREISLLKELHHP 79
Query: 88  NLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAI 147
           N++ +I +  S          +VFE+M+ ++L++ L ++   L    Q   I I +   +
Sbjct: 80  NIVSLIDVIHS-----ERCLTLVFEFME-KDLKKVLDENKTGL----QDSQIKIYLYQLL 129
Query: 148 EYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKG 207
               H  Q  I+H DLKP N+L++ D    + D GLA+       G    + ++ +    
Sbjct: 130 RGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAF-----GIPVRSYTHEVV--- 181
Query: 208 IVGYVAPEYGMGSKA-SVSGDVYNFGILLLEMFT 240
            + Y AP+  MGSK  S S D+++ G +  EM T
Sbjct: 182 TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMIT 215

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 96/213 (45%), Gaps = 20/213 (9%)
Query: 38  IGQGGVSIVYKGIL---DESRSIVAVKVVN-LKQKEASRSFAAECNALRNIRHRNLIKII 93
           IG+G    VY G L   D  +   AVK +N +        F  E   +++  H N++ ++
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 94  TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQS--NGQLRFLTQRVNIAIDVSFAIEYFH 151
            IC  +  EG     +V  YM++ +L  ++R    N  ++ L   +   + V+  ++Y  
Sbjct: 97  GIC--LRSEGSPL--VVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKYL- 148
Query: 152 HHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGY 211
                  VH DL   N +LD+     V D GLA+ ++  E      +  N    K  V +
Sbjct: 149 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE----XXSVHNKTGAKLPVKW 202
Query: 212 VAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
           +A E     K +   DV++FG+LL E+ TR  P
Sbjct: 203 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 102/214 (47%), Gaps = 22/214 (10%)
Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAA--ECNALRNIRHR 87
             +    K+G+G   +VYK    + R IVA+K + L  ++      A  E + L+ + H 
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGR-IVALKRIRLDAEDEGIPSTAIREISLLKELHHP 79
Query: 88  NLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAI 147
           N++ +I +  S          +VFE+M+ ++L++ L ++   L    Q   I I +   +
Sbjct: 80  NIVSLIDVIHS-----ERCLTLVFEFME-KDLKKVLDENKTGL----QDSQIKIYLYQLL 129
Query: 148 EYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKG 207
               H  Q  I+H DLKP N+L++ D    + D GLA+       G    + ++ +    
Sbjct: 130 RGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAF-----GIPVRSYTHEVV--- 181
Query: 208 IVGYVAPEYGMGSKA-SVSGDVYNFGILLLEMFT 240
            + Y AP+  MGSK  S S D+++ G +  EM T
Sbjct: 182 TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMIT 215

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 110/237 (46%), Gaps = 21/237 (8%)
Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITI 95
            K+G G    V+    ++  + VAVK +      +  +F AE N ++ ++H  L+K+  +
Sbjct: 194 KKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 96  CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQ 155
            +           I+ E+M   +L  +L+   G  + L + ++ +  ++  + +     Q
Sbjct: 252 VTKEPI------YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---Q 302
Query: 156 PSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPE 215
            + +H DL+ +NIL+   +V  + D GLA+ +   E  TA E A   I+      + APE
Sbjct: 303 RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-YTAREGAKFPIK------WTAPE 355
Query: 216 YGMGSKASVSGDVYNFGILLLEMFTRRR-PTDAMFNEGL--TLHEFVKMALPDKVME 269
                  ++  DV++FGILL+E+ T  R P   M N  +   L    +M  P+   E
Sbjct: 356 AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPE 412

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 119/246 (48%), Gaps = 24/246 (9%)
Query: 28  ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL-KQKEASRSFA-AECNALRNIR 85
           +  NF    KIG+G   +VYK     +  +VA+K + L  + E   S A  E + L+ + 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 86  HRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSF 145
           H N++K++ +   I  E   +  +VFE++ +++L++++  S      L    +    +  
Sbjct: 63  HPNIVKLLDV---IHTENKLY--LVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQ 116
Query: 146 AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEI 205
            + + H H    ++H DLKP N+L++ +    + D GLA+       G    T  + +  
Sbjct: 117 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-----GVPVRTYXHEVV- 167
Query: 206 KGIVGYVAPEYGMGSK-ASVSGDVYNFGILLLEMFTRRR--PTDAMFNEGLTLHEFVKMA 262
              + Y APE  +G K  S + D+++ G +  EM TRR   P D+  ++   +  F  + 
Sbjct: 168 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLG 223
Query: 263 LPDKVM 268
            PD+V+
Sbjct: 224 TPDEVV 229

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 119/246 (48%), Gaps = 24/246 (9%)
Query: 28  ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL-KQKEASRSFA-AECNALRNIR 85
           +  NF    KIG+G   +VYK     +  +VA+K + L  + E   S A  E + L+ + 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 86  HRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSF 145
           H N++K++ +   I  E   +  +VFE++ +++L++++  S      L    +    +  
Sbjct: 63  HPNIVKLLDV---IHTENKLY--LVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQ 116
Query: 146 AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEI 205
            + + H H    ++H DLKP N+L++ +    + D GLA+       G    T  + +  
Sbjct: 117 GLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAF-----GVPVRTYXHEVV- 167
Query: 206 KGIVGYVAPEYGMGSK-ASVSGDVYNFGILLLEMFTRRR--PTDAMFNEGLTLHEFVKMA 262
              + Y APE  +G K  S + D+++ G +  EM TRR   P D+  ++   +  F  + 
Sbjct: 168 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLG 223
Query: 263 LPDKVM 268
            PD+V+
Sbjct: 224 TPDEVV 229

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 119/246 (48%), Gaps = 24/246 (9%)
Query: 28  ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL-KQKEASRSFA-AECNALRNIR 85
           +  NF    KIG+G   +VYK     +  +VA+K + L  + E   S A  E + L+ + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 86  HRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSF 145
           H N++K++ +   I  E   +  +VFE++ +++L++++  S      L    +    +  
Sbjct: 61  HPNIVKLLDV---IHTENKLY--LVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 146 AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEI 205
            + + H H    ++H DLKP N+L++ +    + D GLA+       G    T  + +  
Sbjct: 115 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-----GVPVRTYXHEVV- 165
Query: 206 KGIVGYVAPEYGMGSK-ASVSGDVYNFGILLLEMFTRRR--PTDAMFNEGLTLHEFVKMA 262
              + Y APE  +G K  S + D+++ G +  EM TRR   P D+  ++   +  F  + 
Sbjct: 166 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLG 221
Query: 263 LPDKVM 268
            PD+V+
Sbjct: 222 TPDEVV 227

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 119/246 (48%), Gaps = 24/246 (9%)
Query: 28  ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL-KQKEASRSFA-AECNALRNIR 85
           +  NF    KIG+G   +VYK     +  +VA+K + L  + E   S A  E + L+ + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 86  HRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSF 145
           H N++K++ +   I  E   +  +VFE++ +++L++++  S      L    +    +  
Sbjct: 64  HPNIVKLLDV---IHTENKLY--LVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQ 117
Query: 146 AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEI 205
            + + H H    ++H DLKP N+L++ +    + D GLA+       G    T  + +  
Sbjct: 118 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-----GVPVRTYXHEVV- 168
Query: 206 KGIVGYVAPEYGMGSK-ASVSGDVYNFGILLLEMFTRRR--PTDAMFNEGLTLHEFVKMA 262
              + Y APE  +G K  S + D+++ G +  EM TRR   P D+  ++   +  F  + 
Sbjct: 169 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLG 224
Query: 263 LPDKVM 268
            PD+V+
Sbjct: 225 TPDEVV 230

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 119/246 (48%), Gaps = 24/246 (9%)
Query: 28  ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL-KQKEASRSFA-AECNALRNIR 85
           +  NF    KIG+G   +VYK     +  +VA+K + L  + E   S A  E + L+ + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 86  HRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSF 145
           H N++K++ +   I  E   +  +VFE++ +++L++++  S      L    +    +  
Sbjct: 61  HPNIVKLLDV---IHTENKLY--LVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 146 AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEI 205
            + + H H    ++H DLKP N+L++ +    + D GLA+       G    T  + +  
Sbjct: 115 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-----GVPVRTYXHEVV- 165
Query: 206 KGIVGYVAPEYGMGSK-ASVSGDVYNFGILLLEMFTRRR--PTDAMFNEGLTLHEFVKMA 262
              + Y APE  +G K  S + D+++ G +  EM TRR   P D+  ++   +  F  + 
Sbjct: 166 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLG 221
Query: 263 LPDKVM 268
            PD+V+
Sbjct: 222 TPDEVV 227

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 119/246 (48%), Gaps = 24/246 (9%)
Query: 28  ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL-KQKEASRSFA-AECNALRNIR 85
           +  NF    KIG+G   +VYK     +  +VA+K + L  + E   S A  E + L+ + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 86  HRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSF 145
           H N++K++ +   I  E   +  +VFE++ +++L++++  S      L    +    +  
Sbjct: 64  HPNIVKLLDV---IHTENKLY--LVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQ 117
Query: 146 AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEI 205
            + + H H    ++H DLKP N+L++ +    + D GLA+       G    T  + +  
Sbjct: 118 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-----GVPVRTYXHEVV- 168
Query: 206 KGIVGYVAPEYGMGSK-ASVSGDVYNFGILLLEMFTRRR--PTDAMFNEGLTLHEFVKMA 262
              + Y APE  +G K  S + D+++ G +  EM TRR   P D+  ++   +  F  + 
Sbjct: 169 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLG 224
Query: 263 LPDKVM 268
            PD+V+
Sbjct: 225 TPDEVV 230

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 119/246 (48%), Gaps = 24/246 (9%)
Query: 28  ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL-KQKEASRSFA-AECNALRNIR 85
           +  NF    KIG+G   +VYK     +  +VA+K + L  + E   S A  E + L+ + 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 86  HRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSF 145
           H N++K++ +   I  E   +  +VFE++ +++L++++  S      L    +    +  
Sbjct: 63  HPNIVKLLDV---IHTENKLY--LVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQ 116
Query: 146 AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEI 205
            + + H H    ++H DLKP N+L++ +    + D GLA+       G    T  + +  
Sbjct: 117 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-----GVPVRTYXHEVV- 167
Query: 206 KGIVGYVAPEYGMGSK-ASVSGDVYNFGILLLEMFTRRR--PTDAMFNEGLTLHEFVKMA 262
              + Y APE  +G K  S + D+++ G +  EM TRR   P D+  ++   +  F  + 
Sbjct: 168 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLG 223
Query: 263 LPDKVM 268
            PD+V+
Sbjct: 224 TPDEVV 229

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 118/244 (48%), Gaps = 24/244 (9%)
Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL-KQKEASRSFA-AECNALRNIRHR 87
            NF    KIG+G   +VYK     +  +VA+K + L  + E   S A  E + L+ + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 88  NLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAI 147
           N++K++ +   I  E   +  +VFE++ +++L++++  S      L    +    +   +
Sbjct: 62  NIVKLLDV---IHTENKLY--LVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 115
Query: 148 EYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKG 207
            + H H    ++H DLKP N+L++ +    + D GLA+       G    T  + +    
Sbjct: 116 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-----GVPVRTYXHEVV--- 164
Query: 208 IVGYVAPEYGMGSK-ASVSGDVYNFGILLLEMFTRRR--PTDAMFNEGLTLHEFVKMALP 264
            + Y APE  +G K  S + D+++ G +  EM TRR   P D+  ++   +  F  +  P
Sbjct: 165 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLGTP 222
Query: 265 DKVM 268
           D+V+
Sbjct: 223 DEVV 226

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 119/246 (48%), Gaps = 24/246 (9%)
Query: 28  ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL-KQKEASRSFA-AECNALRNIR 85
           +  NF    KIG+G   +VYK     +  +VA+K + L  + E   S A  E + L+ + 
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 86  HRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSF 145
           H N++K++ +   I  E   +  +VFE++ +++L++++  S      L    +    +  
Sbjct: 65  HPNIVKLLDV---IHTENKLY--LVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQ 118
Query: 146 AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEI 205
            + + H H    ++H DLKP N+L++ +    + D GLA+       G    T  + +  
Sbjct: 119 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-----GVPVRTYXHEVV- 169
Query: 206 KGIVGYVAPEYGMGSK-ASVSGDVYNFGILLLEMFTRRR--PTDAMFNEGLTLHEFVKMA 262
              + Y APE  +G K  S + D+++ G +  EM TRR   P D+  ++   +  F  + 
Sbjct: 170 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLG 225
Query: 263 LPDKVM 268
            PD+V+
Sbjct: 226 TPDEVV 231

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 95/205 (46%), Gaps = 18/205 (8%)
Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITI 95
            +IG G   +V+ G    ++  VA+K +  +   +   F  E   +  + H  L+++  +
Sbjct: 11  QEIGSGQFGLVHLGYW-LNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 68
Query: 96  CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQ 155
           C     E      +VFE+M++  L  +LR   G     T  + + +DV   + Y    C 
Sbjct: 69  C----LEQAPI-CLVFEFMEHGCLSDYLRTQRGLFAAET-LLGMCLDVCEGMAYLEEAC- 121
Query: 156 PSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPE 215
             ++H DL   N L+ ++ V  V D G+ +F+         +  ++S   K  V + +PE
Sbjct: 122 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-------DQYTSSTGTKFPVKWASPE 172
Query: 216 YGMGSKASVSGDVYNFGILLLEMFT 240
               S+ S   DV++FG+L+ E+F+
Sbjct: 173 VFSFSRYSSKSDVWSFGVLMWEVFS 197

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 119/246 (48%), Gaps = 24/246 (9%)
Query: 28  ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL-KQKEASRSFA-AECNALRNIR 85
           +  NF    KIG+G   +VYK     +  +VA+K + L  + E   S A  E + L+ + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 86  HRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSF 145
           H N++K++ +   I  E   +  +VFE++ +++L++++  S      L    +    +  
Sbjct: 61  HPNIVKLLDV---IHTENKLY--LVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 146 AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEI 205
            + + H H    ++H DLKP N+L++ +    + D GLA+       G    T  + +  
Sbjct: 115 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-----GVPVRTYXHEVV- 165
Query: 206 KGIVGYVAPEYGMGSK-ASVSGDVYNFGILLLEMFTRRR--PTDAMFNEGLTLHEFVKMA 262
              + Y APE  +G K  S + D+++ G +  EM TRR   P D+  ++   +  F  + 
Sbjct: 166 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLG 221
Query: 263 LPDKVM 268
            PD+V+
Sbjct: 222 TPDEVV 227

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 119/246 (48%), Gaps = 24/246 (9%)
Query: 28  ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL-KQKEASRSFA-AECNALRNIR 85
           +  NF    KIG+G   +VYK     +  +VA+K + L  + E   S A  E + L+ + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 86  HRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSF 145
           H N++K++ +   I  E   +  +VFE++ +++L++++  S      L    +    +  
Sbjct: 61  HPNIVKLLDV---IHTENKLY--LVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 146 AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEI 205
            + + H H    ++H DLKP N+L++ +    + D GLA+       G    T  + +  
Sbjct: 115 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-----GVPVRTYXHEVV- 165
Query: 206 KGIVGYVAPEYGMGSK-ASVSGDVYNFGILLLEMFTRRR--PTDAMFNEGLTLHEFVKMA 262
              + Y APE  +G K  S + D+++ G +  EM TRR   P D+  ++   +  F  + 
Sbjct: 166 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLG 221
Query: 263 LPDKVM 268
            PD+V+
Sbjct: 222 TPDEVV 227

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 118/244 (48%), Gaps = 24/244 (9%)
Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL-KQKEASRSFA-AECNALRNIRHR 87
            NF    KIG+G   +VYK     +  +VA+K + L  + E   S A  E + L+ + H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 88  NLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAI 147
           N++K++ +   I  E   +  +VFE++ +++L++++  S      L    +    +   +
Sbjct: 64  NIVKLLDV---IHTENKLY--LVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 117
Query: 148 EYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKG 207
            + H H    ++H DLKP N+L++ +    + D GLA+       G    T  + +    
Sbjct: 118 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-----GVPVRTYXHEVV--- 166
Query: 208 IVGYVAPEYGMGSK-ASVSGDVYNFGILLLEMFTRRR--PTDAMFNEGLTLHEFVKMALP 264
            + Y APE  +G K  S + D+++ G +  EM TRR   P D+  ++   +  F  +  P
Sbjct: 167 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLGTP 224
Query: 265 DKVM 268
           D+V+
Sbjct: 225 DEVV 228

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 119/246 (48%), Gaps = 24/246 (9%)
Query: 28  ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL-KQKEASRSFA-AECNALRNIR 85
           +  NF    KIG+G   +VYK     +  +VA+K + L  + E   S A  E + L+ + 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 86  HRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSF 145
           H N++K++ +   I  E   +  +VFE++ +++L++++  S      L    +    +  
Sbjct: 62  HPNIVKLLDV---IHTENKLY--LVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQ 115
Query: 146 AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEI 205
            + + H H    ++H DLKP N+L++ +    + D GLA+       G    T  + +  
Sbjct: 116 GLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAF-----GVPVRTYXHEVV- 166
Query: 206 KGIVGYVAPEYGMGSK-ASVSGDVYNFGILLLEMFTRRR--PTDAMFNEGLTLHEFVKMA 262
              + Y APE  +G K  S + D+++ G +  EM TRR   P D+  ++   +  F  + 
Sbjct: 167 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLG 222
Query: 263 LPDKVM 268
            PD+V+
Sbjct: 223 TPDEVV 228

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 119/246 (48%), Gaps = 24/246 (9%)
Query: 28  ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL-KQKEASRSFA-AECNALRNIR 85
           +  NF    KIG+G   +VYK     +  +VA+K + L  + E   S A  E + L+ + 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 86  HRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSF 145
           H N++K++ +   I  E   +  +VFE++ +++L++++  S      L    +    +  
Sbjct: 62  HPNIVKLLDV---IHTENKLY--LVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQ 115
Query: 146 AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEI 205
            + + H H    ++H DLKP N+L++ +    + D GLA+       G    T  + +  
Sbjct: 116 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-----GVPVRTYXHEVV- 166
Query: 206 KGIVGYVAPEYGMGSK-ASVSGDVYNFGILLLEMFTRRR--PTDAMFNEGLTLHEFVKMA 262
              + Y APE  +G K  S + D+++ G +  EM TRR   P D+  ++   +  F  + 
Sbjct: 167 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLG 222
Query: 263 LPDKVM 268
            PD+V+
Sbjct: 223 TPDEVV 228

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 95/205 (46%), Gaps = 18/205 (8%)
Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITI 95
            +IG G   +V+ G    ++  VA+K +  +   +   F  E   +  + H  L+++  +
Sbjct: 13  QEIGSGQFGLVHLGYW-LNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 70
Query: 96  CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQ 155
           C     E      +VFE+M++  L  +LR   G     T  + + +DV   + Y    C 
Sbjct: 71  C----LEQAPI-CLVFEFMEHGCLSDYLRTQRGLFAAET-LLGMCLDVCEGMAYLEEAC- 123
Query: 156 PSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPE 215
             ++H DL   N L+ ++ V  V D G+ +F+         +  ++S   K  V + +PE
Sbjct: 124 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-------DQYTSSTGTKFPVKWASPE 174
Query: 216 YGMGSKASVSGDVYNFGILLLEMFT 240
               S+ S   DV++FG+L+ E+F+
Sbjct: 175 VFSFSRYSSKSDVWSFGVLMWEVFS 199

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 118/244 (48%), Gaps = 24/244 (9%)
Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL-KQKEASRSFA-AECNALRNIRHR 87
            NF    KIG+G   +VYK     +  +VA+K + L  + E   S A  E + L+ + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 88  NLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAI 147
           N++K++ +   I  E   +  +VFE++ +++L++++  S      L    +    +   +
Sbjct: 62  NIVKLLDV---IHTENKLY--LVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 115
Query: 148 EYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKG 207
            + H H    ++H DLKP N+L++ +    + D GLA+       G    T  + +    
Sbjct: 116 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-----GVPVRTYXHEVV--- 164
Query: 208 IVGYVAPEYGMGSK-ASVSGDVYNFGILLLEMFTRRR--PTDAMFNEGLTLHEFVKMALP 264
            + Y APE  +G K  S + D+++ G +  EM TRR   P D+  ++   +  F  +  P
Sbjct: 165 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLGTP 222
Query: 265 DKVM 268
           D+V+
Sbjct: 223 DEVV 226

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/231 (22%), Positives = 106/231 (45%), Gaps = 38/231 (16%)
Query: 30  NNFSPANKIGQGGVSIV-----YKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNI 84
           +N     ++G+G    V     Y    ++ + +VAVK +      A + F  E   L N+
Sbjct: 13  HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL 72
Query: 85  RHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFL----------- 133
           +H +++K   +C     EG D   +VFEYM++ +L ++LR        +           
Sbjct: 73  QHEHIVKFYGVC----VEG-DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQ 127
Query: 134 TQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPG 193
           +Q ++IA  ++  + Y         VH DL   N L+ ++++  +GD G+++ ++     
Sbjct: 128 SQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVY----- 179
Query: 194 TAAETASNSIEIKG----IVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
                +++   + G     + ++ PE  M  K +   DV++ G++L E+FT
Sbjct: 180 -----STDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 225

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 95/205 (46%), Gaps = 18/205 (8%)
Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITI 95
            +IG G   +V+ G    ++  VA+K +  +   +   F  E   +  + H  L+++  +
Sbjct: 16  QEIGSGQFGLVHLGYW-LNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 73
Query: 96  CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQ 155
           C     E      +VFE+M++  L  +LR   G     T  + + +DV   + Y    C 
Sbjct: 74  C----LEQAPI-CLVFEFMEHGCLSDYLRTQRGLFAAETL-LGMCLDVCEGMAYLEEAC- 126
Query: 156 PSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPE 215
             ++H DL   N L+ ++ V  V D G+ +F+         +  ++S   K  V + +PE
Sbjct: 127 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-------DQYTSSTGTKFPVKWASPE 177
Query: 216 YGMGSKASVSGDVYNFGILLLEMFT 240
               S+ S   DV++FG+L+ E+F+
Sbjct: 178 VFSFSRYSSKSDVWSFGVLMWEVFS 202

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 104/227 (45%), Gaps = 22/227 (9%)
Query: 26  SKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASR-----SFAAECNA 80
           S AT+ + P  +IG G    VYK     S   VA+K V +            S   E   
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64
Query: 81  LRNIR---HRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRV 137
           LR +    H N+++++ +C++   +      +VFE++ +++L  +L ++           
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIK 123
Query: 138 NIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAE 197
           ++       +++ H +C   IVH DLKP NIL+       + D GLA+ ++ Y      +
Sbjct: 124 DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR-IYSY------Q 173
Query: 198 TASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
            A   + +   + Y APE  + S  +   D+++ G +  EMF RR+P
Sbjct: 174 MALTPVVV--TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF-RRKP 217

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/236 (24%), Positives = 106/236 (44%), Gaps = 40/236 (16%)
Query: 28  ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEAS-------RSFAAECNA 80
           A N      +IG+GG  +V+KG L + +S+VA+K + L   E         + F  E   
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 81  LRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIA 140
           + N+ H N++K+  +  +          +V E++   +L   L      +++ + ++ + 
Sbjct: 77  MSNLNHPNIVKLYGLMHNP-------PRMVMEFVPCGDLYHRLLDKAHPIKW-SVKLRLM 128
Query: 141 IDVSFAIEYFHHHCQPSIVHGDLKPSNILL-----DQDIVAHVGDLGLAKFLFGYEPGTA 195
           +D++  IEY  +   P IVH DL+  NI L     +  + A V D GL++          
Sbjct: 129 LDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ---------- 177
Query: 196 AETASNSIEIKGIVG---YVAPEYGMGSKASVS--GDVYNFGILLLEMFTRRRPTD 246
                +   + G++G   ++APE     + S +   D Y+F ++L  + T   P D
Sbjct: 178 ----QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/246 (25%), Positives = 117/246 (47%), Gaps = 24/246 (9%)
Query: 28  ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL-KQKEASRSFA-AECNALRNIR 85
           +  NF    KIG+G   +VYK     +  +VA+K + L  + E   S A  E + L+ + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 86  HRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSF 145
           H N++K++ +  + +        +VFE++ +++L+ ++  S      L    +    +  
Sbjct: 61  HPNIVKLLDVIHTENK-----LYLVFEFL-HQDLKDFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 146 AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEI 205
            + + H H    ++H DLKP N+L++ +    + D GLA+       G    T  + +  
Sbjct: 115 GLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAF-----GVPVRTYXHEVV- 165
Query: 206 KGIVGYVAPEYGMGSK-ASVSGDVYNFGILLLEMFTRRR--PTDAMFNEGLTLHEFVKMA 262
              + Y APE  +G K  S + D+++ G +  EM TRR   P D+  ++   +  F  + 
Sbjct: 166 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLG 221
Query: 263 LPDKVM 268
            PD+V+
Sbjct: 222 TPDEVV 227

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 16/211 (7%)
Query: 38  IGQGGVSIVYKGIL---DESRSIVAVKVVN-LKQKEASRSFAAECNALRNIRHRNLIKII 93
           IG+G    VY G L   D  +   AVK +N +        F  E   +++  H N++ ++
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 94  TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHH 153
            IC  +  EG     +V  YM++ +L  ++R        +   +   + V+  ++Y    
Sbjct: 96  GIC--LRSEGSPL--VVLPYMKHGDLRNFIRNETHNPT-VKDLIGFGLQVAKGMKYL--- 147
Query: 154 CQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVA 213
                VH DL   N +LD+     V D GLA+ ++  E      +  N    K  V ++A
Sbjct: 148 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE----YYSVHNKTGAKLPVKWMA 203
Query: 214 PEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
            E     K +   DV++FG+LL E+ TR  P
Sbjct: 204 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 102/213 (47%), Gaps = 20/213 (9%)
Query: 38  IGQGGVSIVYKG-ILDESRSIVAVKVVNLK---QKEASRSFAAECNALRNIRHRNLIKII 93
           IG+G   +VY G  +D++++ +   + +L    + +   +F  E   +R + H N++ +I
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 94  TICSSIDFEGFDFKAIVFEYMQNRNLEQWLR--QSNGQLRFLTQRVNIAIDVSFAIEYFH 151
            I   +  EG     ++  YM + +L Q++R  Q N  ++ L   ++  + V+  +EY  
Sbjct: 89  GIM--LPPEGL--PHVLLPYMCHGDLLQFIRSPQRNPTVKDL---ISFGLQVARGMEYL- 140
Query: 152 HHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGY 211
              +   VH DL   N +LD+     V D GLA+ +   E  +  +     + +K    +
Sbjct: 141 --AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVK----W 194
Query: 212 VAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
            A E     + +   DV++FG+LL E+ TR  P
Sbjct: 195 TALESLQTYRFTTKSDVWSFGVLLWELLTRGAP 227

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 16/211 (7%)
Query: 38  IGQGGVSIVYKGIL---DESRSIVAVKVVN-LKQKEASRSFAAECNALRNIRHRNLIKII 93
           IG+G    VY G L   D  +   AVK +N +        F  E   +++  H N++ ++
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 94  TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHH 153
            IC  +  EG     +V  YM++ +L  ++R        +   +   + V+  ++Y    
Sbjct: 93  GIC--LRSEGSPL--VVLPYMKHGDLRNFIRNETHNPT-VKDLIGFGLQVAKGMKYL--- 144
Query: 154 CQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVA 213
                VH DL   N +LD+     V D GLA+ ++  E      +  N    K  V ++A
Sbjct: 145 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE----YYSVHNKTGAKLPVKWMA 200
Query: 214 PEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
            E     K +   DV++FG+LL E+ TR  P
Sbjct: 201 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 231

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 119/246 (48%), Gaps = 24/246 (9%)
Query: 28  ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK-QKEASRSFA-AECNALRNIR 85
           +  NF    KIG+G   +VYK     +  +VA+K + L  + E   S A  E + L+ + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 86  HRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSF 145
           H N++K++ +   I  E   +  +VFE++ +++L++++  S      L    +    +  
Sbjct: 64  HPNIVKLLDV---IHTENKLY--LVFEHV-DQDLKKFMDASALTGIPLPLIKSYLFQLLQ 117
Query: 146 AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEI 205
            + + H H    ++H DLKP N+L++ +    + D GLA+       G    T  + +  
Sbjct: 118 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-----GVPVRTYXHEVV- 168
Query: 206 KGIVGYVAPEYGMGSK-ASVSGDVYNFGILLLEMFTRRR--PTDAMFNEGLTLHEFVKMA 262
              + Y APE  +G K  S + D+++ G +  EM TRR   P D+  ++   +  F  + 
Sbjct: 169 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLG 224
Query: 263 LPDKVM 268
            PD+V+
Sbjct: 225 TPDEVV 230

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 16/211 (7%)
Query: 38  IGQGGVSIVYKGIL---DESRSIVAVKVVN-LKQKEASRSFAAECNALRNIRHRNLIKII 93
           IG+G    VY G L   D  +   AVK +N +        F  E   +++  H N++ ++
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 115
Query: 94  TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHH 153
            IC  +  EG     +V  YM++ +L  ++R        +   +   + V+  ++Y    
Sbjct: 116 GIC--LRSEGSPL--VVLPYMKHGDLRNFIRNETHNPT-VKDLIGFGLQVAKGMKYL--- 167
Query: 154 CQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVA 213
                VH DL   N +LD+     V D GLA+ ++  E      +  N    K  V ++A
Sbjct: 168 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE----YYSVHNKTGAKLPVKWMA 223
Query: 214 PEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
            E     K +   DV++FG+LL E+ TR  P
Sbjct: 224 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 254

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 96/213 (45%), Gaps = 20/213 (9%)
Query: 38  IGQGGVSIVYKGIL---DESRSIVAVKVVN-LKQKEASRSFAAECNALRNIRHRNLIKII 93
           IG+G    VY G L   D  +   AVK +N +        F  E   +++  H N++ ++
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 116
Query: 94  TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQS--NGQLRFLTQRVNIAIDVSFAIEYFH 151
            IC  +  EG     +V  YM++ +L  ++R    N  ++ L   +   + V+  ++Y  
Sbjct: 117 GIC--LRSEGSPL--VVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKYL- 168
Query: 152 HHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGY 211
                  VH DL   N +LD+     V D GLA+ ++  E      +  N    K  V +
Sbjct: 169 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE----YYSVHNKTGAKLPVKW 222
Query: 212 VAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
           +A E     K +   DV++FG+LL E+ TR  P
Sbjct: 223 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 255

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 104/233 (44%), Gaps = 34/233 (14%)
Query: 28  ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEAS-------RSFAAECNA 80
           A N      +IG+GG  +V+KG L + +S+VA+K + L   E         + F  E   
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 81  LRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIA 140
           + N+ H N++K+  +  +          +V E++   +L   L      +++ + ++ + 
Sbjct: 77  MSNLNHPNIVKLYGLMHNP-------PRMVMEFVPCGDLYHRLLDKAHPIKW-SVKLRLM 128
Query: 141 IDVSFAIEYFHHHCQPSIVHGDLKPSNILL-----DQDIVAHVGDLGLAKFLFGYEPGTA 195
           +D++  IEY  +   P IVH DL+  NI L     +  + A V D            GT+
Sbjct: 129 LDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADF-----------GTS 176
Query: 196 AETASNSIEIKGIVGYVAPEYGMGSKASVS--GDVYNFGILLLEMFTRRRPTD 246
            ++  +   + G   ++APE     + S +   D Y+F ++L  + T   P D
Sbjct: 177 QQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 16/211 (7%)
Query: 38  IGQGGVSIVYKGIL---DESRSIVAVKVVN-LKQKEASRSFAAECNALRNIRHRNLIKII 93
           IG+G    VY G L   D  +   AVK +N +        F  E   +++  H N++ ++
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 89
Query: 94  TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHH 153
            IC  +  EG     +V  YM++ +L  ++R        +   +   + V+  ++Y    
Sbjct: 90  GIC--LRSEGSPL--VVLPYMKHGDLRNFIRNETHNPT-VKDLIGFGLQVAKGMKYL--- 141
Query: 154 CQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVA 213
                VH DL   N +LD+     V D GLA+ ++  E      +  N    K  V ++A
Sbjct: 142 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE----YYSVHNKTGAKLPVKWMA 197
Query: 214 PEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
            E     K +   DV++FG+LL E+ TR  P
Sbjct: 198 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 228

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 16/211 (7%)
Query: 38  IGQGGVSIVYKGIL---DESRSIVAVKVVN-LKQKEASRSFAAECNALRNIRHRNLIKII 93
           IG+G    VY G L   D  +   AVK +N +        F  E   +++  H N++ ++
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 94  TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHH 153
            IC  +  EG     +V  YM++ +L  ++R        +   +   + V+  ++Y    
Sbjct: 98  GIC--LRSEGSPL--VVLPYMKHGDLRNFIRNETHNPT-VKDLIGFGLQVAKGMKYL--- 149
Query: 154 CQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVA 213
                VH DL   N +LD+     V D GLA+ ++  E      +  N    K  V ++A
Sbjct: 150 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE----YYSVHNKTGAKLPVKWMA 205
Query: 214 PEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
            E     K +   DV++FG+LL E+ TR  P
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 16/211 (7%)
Query: 38  IGQGGVSIVYKGIL---DESRSIVAVKVVN-LKQKEASRSFAAECNALRNIRHRNLIKII 93
           IG+G    VY G L   D  +   AVK +N +        F  E   +++  H N++ ++
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 94  TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHH 153
            IC  +  EG     +V  YM++ +L  ++R        +   +   + V+  ++Y    
Sbjct: 97  GIC--LRSEGSPL--VVLPYMKHGDLRNFIRNETHNPT-VKDLIGFGLQVAKGMKYL--- 148
Query: 154 CQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVA 213
                VH DL   N +LD+     V D GLA+ ++  E      +  N    K  V ++A
Sbjct: 149 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE----YYSVHNKTGAKLPVKWMA 204
Query: 214 PEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
            E     K +   DV++FG+LL E+ TR  P
Sbjct: 205 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 16/211 (7%)
Query: 38  IGQGGVSIVYKGIL---DESRSIVAVKVVN-LKQKEASRSFAAECNALRNIRHRNLIKII 93
           IG+G    VY G L   D  +   AVK +N +        F  E   +++  H N++ ++
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 94  TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHH 153
            IC  +  EG     +V  YM++ +L  ++R        +   +   + V+  ++Y    
Sbjct: 98  GIC--LRSEGSPL--VVLPYMKHGDLRNFIRNETHNPT-VKDLIGFGLQVAKGMKYL--- 149
Query: 154 CQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVA 213
                VH DL   N +LD+     V D GLA+ ++  E      +  N    K  V ++A
Sbjct: 150 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE----YYSVHNKTGAKLPVKWMA 205
Query: 214 PEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
            E     K +   DV++FG+LL E+ TR  P
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 94/211 (44%), Gaps = 16/211 (7%)
Query: 38  IGQGGVSIVYKGIL---DESRSIVAVKVVN-LKQKEASRSFAAECNALRNIRHRNLIKII 93
           IG+G    VY G L   D  +   AVK +N +        F  E   +++  H N++ ++
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 102
Query: 94  TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHH 153
            IC  +  EG     +V  YM++ +L  ++R        +   +   + V+  +++    
Sbjct: 103 GIC--LRSEGSPL--VVLPYMKHGDLRNFIRNETHNPT-VKDLIGFGLQVAKGMKFL--- 154
Query: 154 CQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVA 213
                VH DL   N +LD+     V D GLA+ ++  E     ++  N    K  V ++A
Sbjct: 155 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE----FDSVHNKTGAKLPVKWMA 210
Query: 214 PEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
            E     K +   DV++FG+LL E+ TR  P
Sbjct: 211 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 241

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 16/211 (7%)
Query: 38  IGQGGVSIVYKGIL---DESRSIVAVKVVN-LKQKEASRSFAAECNALRNIRHRNLIKII 93
           IG+G    VY G L   D  +   AVK +N +        F  E   +++  H N++ ++
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 94  TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHH 153
            IC  +  EG     +V  YM++ +L  ++R        +   +   + V+  ++Y    
Sbjct: 95  GIC--LRSEGSPL--VVLPYMKHGDLRNFIRNETHNPT-VKDLIGFGLQVAKGMKYL--- 146
Query: 154 CQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVA 213
                VH DL   N +LD+     V D GLA+ ++  E      +  N    K  V ++A
Sbjct: 147 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE----YYSVHNKTGAKLPVKWMA 202
Query: 214 PEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
            E     K +   DV++FG+LL E+ TR  P
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 233

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 118/246 (47%), Gaps = 24/246 (9%)
Query: 28  ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL-KQKEASRSFA-AECNALRNIR 85
           +  NF    KIG+G   +VYK     +  +VA+K + L  + E   S A  E + L+ + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 86  HRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSF 145
           H N++K++ +   I  E   +  +VFE++ +++L+ ++  S      L    +    +  
Sbjct: 64  HPNIVKLLDV---IHTENKLY--LVFEFL-HQDLKTFMDASALTGIPLPLIKSYLFQLLQ 117
Query: 146 AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEI 205
            + + H H    ++H DLKP N+L++ +    + D GLA+       G    T  + +  
Sbjct: 118 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-----GVPVRTYXHEVV- 168
Query: 206 KGIVGYVAPEYGMGSK-ASVSGDVYNFGILLLEMFTRRR--PTDAMFNEGLTLHEFVKMA 262
              + Y APE  +G K  S + D+++ G +  EM TRR   P D+  ++   +  F  + 
Sbjct: 169 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLG 224
Query: 263 LPDKVM 268
            PD+V+
Sbjct: 225 TPDEVV 230

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/226 (22%), Positives = 105/226 (46%), Gaps = 40/226 (17%)
Query: 37  KIGQGGVSIVYKG-----ILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIK 91
           ++G+G    V+       + ++ + +VAVK +    + A + F  E   L  ++H+++++
Sbjct: 25  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 84
Query: 92  IITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLT-------------QRVN 138
              +C+    EG     +VFEYM++ +L ++LR      + L              Q + 
Sbjct: 85  FFGVCT----EGRPL-LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLA 139
Query: 139 IAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAET 198
           +A  V+  + Y         VH DL   N L+ Q +V  +GD G+++ ++          
Sbjct: 140 VASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIY---------- 186
Query: 199 ASNSIEIKG----IVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
           +++   + G     + ++ PE  +  K +   DV++FG++L E+FT
Sbjct: 187 STDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 232

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 94/211 (44%), Gaps = 16/211 (7%)
Query: 38  IGQGGVSIVYKGIL---DESRSIVAVKVVN-LKQKEASRSFAAECNALRNIRHRNLIKII 93
           IG+G    VY G L   D  +   AVK +N +        F  E   +++  H N++ ++
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 94  TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHH 153
            IC  +  EG     +V  YM++ +L  ++R        +   +   + V+  +++    
Sbjct: 96  GIC--LRSEGSPL--VVLPYMKHGDLRNFIRNETHNPT-VKDLIGFGLQVAKGMKFL--- 147
Query: 154 CQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVA 213
                VH DL   N +LD+     V D GLA+ ++  E     ++  N    K  V ++A
Sbjct: 148 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE----FDSVHNKTGAKLPVKWMA 203
Query: 214 PEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
            E     K +   DV++FG+LL E+ TR  P
Sbjct: 204 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 118/244 (48%), Gaps = 24/244 (9%)
Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL-KQKEASRSFA-AECNALRNIRHR 87
            NF    KIG+G   +VYK     +  +VA+K + L  + E   S A  E + L+ + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 88  NLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAI 147
           N++K++ +   I  E   +  +VFE++ +++L+ ++  S      L    +    +   +
Sbjct: 62  NIVKLLDV---IHTENKLY--LVFEHV-HQDLKTFMDASALTGIPLPLIKSYLFQLLQGL 115
Query: 148 EYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKG 207
            + H H    ++H DLKP N+L++ +    + D GLA+       G    T ++ +    
Sbjct: 116 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-----GVPVRTYTHEVV--- 164
Query: 208 IVGYVAPEYGMGSK-ASVSGDVYNFGILLLEMFTRRR--PTDAMFNEGLTLHEFVKMALP 264
            + Y APE  +G K  S + D+++ G +  EM TRR   P D+  ++   +  F  +  P
Sbjct: 165 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLGTP 222
Query: 265 DKVM 268
           D+V+
Sbjct: 223 DEVV 226

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 94/211 (44%), Gaps = 16/211 (7%)
Query: 38  IGQGGVSIVYKGIL---DESRSIVAVKVVN-LKQKEASRSFAAECNALRNIRHRNLIKII 93
           IG+G    VY G L   D  +   AVK +N +        F  E   +++  H N++ ++
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 94  TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHH 153
            IC  +  EG     +V  YM++ +L  ++R        +   +   + V+  +++    
Sbjct: 98  GIC--LRSEGSPL--VVLPYMKHGDLRNFIRNETHNPT-VKDLIGFGLQVAKGMKFL--- 149
Query: 154 CQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVA 213
                VH DL   N +LD+     V D GLA+ ++  E     ++  N    K  V ++A
Sbjct: 150 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE----FDSVHNKTGAKLPVKWMA 205
Query: 214 PEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
            E     K +   DV++FG+LL E+ TR  P
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 94/211 (44%), Gaps = 16/211 (7%)
Query: 38  IGQGGVSIVYKGIL---DESRSIVAVKVVN-LKQKEASRSFAAECNALRNIRHRNLIKII 93
           IG+G    VY G L   D  +   AVK +N +        F  E   +++  H N++ ++
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 94  TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHH 153
            IC  +  EG     +V  YM++ +L  ++R        +   +   + V+  +++    
Sbjct: 99  GIC--LRSEGSPL--VVLPYMKHGDLRNFIRNETHNPT-VKDLIGFGLQVAKGMKFL--- 150
Query: 154 CQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVA 213
                VH DL   N +LD+     V D GLA+ ++  E     ++  N    K  V ++A
Sbjct: 151 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE----FDSVHNKTGAKLPVKWMA 206
Query: 214 PEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
            E     K +   DV++FG+LL E+ TR  P
Sbjct: 207 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 118/246 (47%), Gaps = 24/246 (9%)
Query: 28  ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL-KQKEASRSFA-AECNALRNIR 85
           +  NF    KIG+G   +VYK     +  +VA+K + L  + E   S A  E + L+ + 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 86  HRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSF 145
           H N++K++ +   I  E   +  +VFE++ + +L++++  S      L    +    +  
Sbjct: 62  HPNIVKLLDV---IHTENKLY--LVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQLLQ 115
Query: 146 AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEI 205
            + + H H    ++H DLKP N+L++ +    + D GLA+       G    T  + +  
Sbjct: 116 GLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAF-----GVPVRTYXHEVV- 166
Query: 206 KGIVGYVAPEYGMGSK-ASVSGDVYNFGILLLEMFTRRR--PTDAMFNEGLTLHEFVKMA 262
              + Y APE  +G K  S + D+++ G +  EM TRR   P D+  ++   +  F  + 
Sbjct: 167 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLG 222
Query: 263 LPDKVM 268
            PD+V+
Sbjct: 223 TPDEVV 228

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/226 (22%), Positives = 105/226 (46%), Gaps = 40/226 (17%)
Query: 37  KIGQGGVSIVYKG-----ILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIK 91
           ++G+G    V+       + ++ + +VAVK +    + A + F  E   L  ++H+++++
Sbjct: 19  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 78
Query: 92  IITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLT-------------QRVN 138
              +C+    EG     +VFEYM++ +L ++LR      + L              Q + 
Sbjct: 79  FFGVCT----EGRPL-LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLA 133
Query: 139 IAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAET 198
           +A  V+  + Y         VH DL   N L+ Q +V  +GD G+++ ++          
Sbjct: 134 VASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIY---------- 180
Query: 199 ASNSIEIKG----IVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
           +++   + G     + ++ PE  +  K +   DV++FG++L E+FT
Sbjct: 181 STDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 226

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 94/211 (44%), Gaps = 16/211 (7%)
Query: 38  IGQGGVSIVYKGIL---DESRSIVAVKVVN-LKQKEASRSFAAECNALRNIRHRNLIKII 93
           IG+G    VY G L   D  +   AVK +N +        F  E   +++  H N++ ++
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 94  TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHH 153
            IC  +  EG     +V  YM++ +L  ++R        +   +   + V+  +++    
Sbjct: 98  GIC--LRSEGSPL--VVLPYMKHGDLRNFIRNETHNPT-VKDLIGFGLQVAKGMKFL--- 149
Query: 154 CQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVA 213
                VH DL   N +LD+     V D GLA+ ++  E     ++  N    K  V ++A
Sbjct: 150 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE----FDSVHNKTGAKLPVKWMA 205
Query: 214 PEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
            E     K +   DV++FG+LL E+ TR  P
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 94/211 (44%), Gaps = 16/211 (7%)
Query: 38  IGQGGVSIVYKGIL---DESRSIVAVKVVN-LKQKEASRSFAAECNALRNIRHRNLIKII 93
           IG+G    VY G L   D  +   AVK +N +        F  E   +++  H N++ ++
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 94  TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHH 153
            IC  +  EG     +V  YM++ +L  ++R        +   +   + V+  +++    
Sbjct: 157 GIC--LRSEGSPL--VVLPYMKHGDLRNFIRNETHNPT-VKDLIGFGLQVAKGMKFL--- 208
Query: 154 CQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVA 213
                VH DL   N +LD+     V D GLA+ ++  E     ++  N    K  V ++A
Sbjct: 209 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE----FDSVHNKTGAKLPVKWMA 264
Query: 214 PEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
            E     K +   DV++FG+LL E+ TR  P
Sbjct: 265 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 295

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 118/246 (47%), Gaps = 24/246 (9%)
Query: 28  ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL-KQKEASRSFA-AECNALRNIR 85
           +  NF    KIG+G   +VYK     +  +VA+K + L  + E   S A  E + L+ + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 86  HRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSF 145
           H N++K++ +   I  E   +  +VFE++ + +L++++  S      L    +    +  
Sbjct: 64  HPNIVKLLDV---IHTENKLY--LVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQLLQ 117
Query: 146 AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEI 205
            + + H H    ++H DLKP N+L++ +    + D GLA+       G    T  + +  
Sbjct: 118 GLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAF-----GVPVRTYXHEVV- 168
Query: 206 KGIVGYVAPEYGMGSK-ASVSGDVYNFGILLLEMFTRRR--PTDAMFNEGLTLHEFVKMA 262
              + Y APE  +G K  S + D+++ G +  EM TRR   P D+  ++   +  F  + 
Sbjct: 169 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLG 224
Query: 263 LPDKVM 268
            PD+V+
Sbjct: 225 TPDEVV 230

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 97/206 (47%), Gaps = 35/206 (16%)
Query: 52  DESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVF 111
           ++ + +VAVK +    + A + F  E   L  ++H+++++   +C+    EG     +VF
Sbjct: 68  EQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCT----EGRPL-LMVF 122
Query: 112 EYMQNRNLEQWLRQSNGQLRFLT-------------QRVNIAIDVSFAIEYFHHHCQPSI 158
           EYM++ +L ++LR      + L              Q + +A  V+  + Y         
Sbjct: 123 EYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHF 179
Query: 159 VHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKG----IVGYVAP 214
           VH DL   N L+ Q +V  +GD G+++ ++          +++   + G     + ++ P
Sbjct: 180 VHRDLATRNCLVGQGLVVKIGDFGMSRDIY----------STDYYRVGGRTMLPIRWMPP 229
Query: 215 EYGMGSKASVSGDVYNFGILLLEMFT 240
           E  +  K +   DV++FG++L E+FT
Sbjct: 230 ESILYRKFTTESDVWSFGVVLWEIFT 255

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 107/231 (46%), Gaps = 27/231 (11%)
Query: 30  NNFSPANKIGQGGVSIVYKGILD-ESRSIVAVKVVNLK---QKEASRSFAAECNALRNIR 85
            N S    +G G    V  G L   S+  ++V +  LK    ++  R F  E + +    
Sbjct: 16  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 75
Query: 86  HRNLIKIITICSSIDFEGFDFKA----IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI 141
           H N+I++         EG   K+    IV E M+N +L+ +LR+ + Q   + Q V +  
Sbjct: 76  HPNIIRL---------EGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVI-QLVGMLR 125
Query: 142 DVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASN 201
            ++  ++Y         VH DL   NIL++ ++V  V D GL++ L   +P  A  T   
Sbjct: 126 GIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLED-DPEAAYTTRGG 181
Query: 202 SIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTR-RRPTDAMFNE 251
            I I+    + +PE     K + + DV+++GI+L E+ +   RP   M N+
Sbjct: 182 KIPIR----WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ 228

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 34/213 (15%)
Query: 36  NKIGQGGVSIV----YKGILDESRSIVAVKVVNLKQKEASRS---FAAECNALRNIRHRN 88
            ++G G   +V    ++G  D     VA+K++    KE S S   F  E   + N+ H  
Sbjct: 15  KELGTGQFGVVKYGKWRGQYD-----VAIKMI----KEGSMSEDEFIEEAKVMMNLSHEK 65
Query: 89  LIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRV-NIAIDVSFAI 147
           L+++  +C+    +   F  I+ EYM N  L  +LR+     RF TQ++  +  DV  A+
Sbjct: 66  LVQLYGVCTK---QRPIF--IITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAM 118
Query: 148 EYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKG 207
           EY         +H DL   N L++   V  V D GL++++   E        ++S   K 
Sbjct: 119 EYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-------YTSSRGSKF 168
Query: 208 IVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
            V +  PE  M SK S   D++ FG+L+ E+++
Sbjct: 169 PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 201

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 96/205 (46%), Gaps = 18/205 (8%)
Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITI 95
            +IG G   +V+ G    ++  VA+K +  +   +   F  E   +  + H  L+++  +
Sbjct: 13  QEIGSGQFGLVHLGYW-LNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 70
Query: 96  CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQ 155
           C     E      +VFE+M++  L  +LR   G     T  + + +DV   + Y     +
Sbjct: 71  C----LEQAPI-CLVFEFMEHGCLSDYLRTQRGLFAAET-LLGMCLDVCEGMAYLE---E 121
Query: 156 PSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPE 215
            S++H DL   N L+ ++ V  V D G+ +F+         +  ++S   K  V + +PE
Sbjct: 122 ASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-------DQYTSSTGTKFPVKWASPE 174
Query: 216 YGMGSKASVSGDVYNFGILLLEMFT 240
               S+ S   DV++FG+L+ E+F+
Sbjct: 175 VFSFSRYSSKSDVWSFGVLMWEVFS 199

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/244 (25%), Positives = 118/244 (48%), Gaps = 24/244 (9%)
Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL-KQKEASRSFA-AECNALRNIRHR 87
            NF    KIG+G   +VYK     +  +VA+  + L  + E   S A  E + L+ + H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 88  NLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAI 147
           N++K++ +   I  E   +  +VFE++ +++L++++  S      L    +    +   +
Sbjct: 63  NIVKLLDV---IHTENKLY--LVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 116
Query: 148 EYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKG 207
            + H H    ++H DLKP N+L++ +    + D GLA+       G    T ++ +    
Sbjct: 117 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-----GVPVRTYTHEVV--- 165
Query: 208 IVGYVAPEYGMGSK-ASVSGDVYNFGILLLEMFTRRR--PTDAMFNEGLTLHEFVKMALP 264
            + Y APE  +G K  S + D+++ G +  EM TRR   P D+  ++   +  F  +  P
Sbjct: 166 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLGTP 223
Query: 265 DKVM 268
           D+V+
Sbjct: 224 DEVV 227

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/244 (25%), Positives = 118/244 (48%), Gaps = 24/244 (9%)
Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL-KQKEASRSFA-AECNALRNIRHR 87
            NF    KIG+G   +VYK     +  +VA+  + L  + E   S A  E + L+ + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 88  NLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAI 147
           N++K++ +   I  E   +  +VFE++ +++L++++  S      L    +    +   +
Sbjct: 62  NIVKLLDV---IHTENKLY--LVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 115
Query: 148 EYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKG 207
            + H H    ++H DLKP N+L++ +    + D GLA+       G    T ++ +    
Sbjct: 116 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-----GVPVRTYTHEVV--- 164
Query: 208 IVGYVAPEYGMGSK-ASVSGDVYNFGILLLEMFTRRR--PTDAMFNEGLTLHEFVKMALP 264
            + Y APE  +G K  S + D+++ G +  EM TRR   P D+  ++   +  F  +  P
Sbjct: 165 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLGTP 222
Query: 265 DKVM 268
           D+V+
Sbjct: 223 DEVV 226

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 113/245 (46%), Gaps = 29/245 (11%)
Query: 18  PMISYAELSKATN--NFSPANKIGQGGVSIVYKGILD-ESRSIVAVKVVNLK---QKEAS 71
           P  +  E +K  +  N S    +G G    V  G L   S+  ++V +  LK    ++  
Sbjct: 31  PTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR 90
Query: 72  RSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA----IVFEYMQNRNLEQWLRQSN 127
           R F  E + +    H N+I++         EG   K+    IV E M+N +L+ +LR+ +
Sbjct: 91  RDFLGEASIMGQFDHPNIIRL---------EGVVTKSKPVMIVTEXMENGSLDSFLRKHD 141
Query: 128 GQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL 187
            Q   + Q V +   ++  ++Y         VH DL   NIL++ ++V  V D GL++ L
Sbjct: 142 AQFTVI-QLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVL 197
Query: 188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTR-RRPTD 246
              +P  A  T    I I+    + +PE     K + + DV+++GI+L E+ +   RP  
Sbjct: 198 ED-DPEAAYTTRGGKIPIR----WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYW 252
Query: 247 AMFNE 251
            M N+
Sbjct: 253 EMSNQ 257

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 113/245 (46%), Gaps = 29/245 (11%)
Query: 18  PMISYAELSKATN--NFSPANKIGQGGVSIVYKGILD-ESRSIVAVKVVNLK---QKEAS 71
           P  +  E +K  +  N S    +G G    V  G L   S+  ++V +  LK    ++  
Sbjct: 31  PTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR 90
Query: 72  RSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA----IVFEYMQNRNLEQWLRQSN 127
           R F  E + +    H N+I++         EG   K+    IV E M+N +L+ +LR+ +
Sbjct: 91  RDFLGEASIMGQFDHPNIIRL---------EGVVTKSKPVMIVTEXMENGSLDSFLRKHD 141
Query: 128 GQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL 187
            Q   + Q V +   ++  ++Y         VH DL   NIL++ ++V  V D GL++ L
Sbjct: 142 AQFTVI-QLVGMLRGIASGMKYLSDM---GAVHRDLAARNILINSNLVCKVSDFGLSRVL 197
Query: 188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTR-RRPTD 246
              +P  A  T    I I+    + +PE     K + + DV+++GI+L E+ +   RP  
Sbjct: 198 ED-DPEAAYTTRGGKIPIR----WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYW 252
Query: 247 AMFNE 251
            M N+
Sbjct: 253 EMSNQ 257

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 117/246 (47%), Gaps = 24/246 (9%)
Query: 28  ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL-KQKEASRSFA-AECNALRNIR 85
           +  NF    KIG+G   +VYK     +  +VA+K + L  + E   S A  E + L+ + 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 86  HRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSF 145
           H N++K++ +   I  E   +  +VFE++ + +L+ ++  S      L    +    +  
Sbjct: 63  HPNIVKLLDV---IHTENKLY--LVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQ 116
Query: 146 AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEI 205
            + + H H    ++H DLKP N+L++ +    + D GLA+       G    T  + +  
Sbjct: 117 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-----GVPVRTYXHEVV- 167
Query: 206 KGIVGYVAPEYGMGSK-ASVSGDVYNFGILLLEMFTRRR--PTDAMFNEGLTLHEFVKMA 262
              + Y APE  +G K  S + D+++ G +  EM TRR   P D+  ++   +  F  + 
Sbjct: 168 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLG 223
Query: 263 LPDKVM 268
            PD+V+
Sbjct: 224 TPDEVV 229

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 117/246 (47%), Gaps = 24/246 (9%)
Query: 28  ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL-KQKEASRSFA-AECNALRNIR 85
           +  NF    KIG+G   +VYK     +  +VA+K + L  + E   S A  E + L+ + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 86  HRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSF 145
           H N++K++ +   I  E   +  +VFE++ + +L+ ++  S      L    +    +  
Sbjct: 64  HPNIVKLLDV---IHTENKLY--LVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQ 117
Query: 146 AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEI 205
            + + H H    ++H DLKP N+L++ +    + D GLA+       G    T  + +  
Sbjct: 118 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-----GVPVRTYXHEVV- 168
Query: 206 KGIVGYVAPEYGMGSK-ASVSGDVYNFGILLLEMFTRRR--PTDAMFNEGLTLHEFVKMA 262
              + Y APE  +G K  S + D+++ G +  EM TRR   P D+  ++   +  F  + 
Sbjct: 169 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLG 224
Query: 263 LPDKVM 268
            PD+V+
Sbjct: 225 TPDEVV 230

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 99/226 (43%), Gaps = 22/226 (9%)
Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRS-FAAECNALRNIRHRN 88
            +F P   +G+GG  +V++          A+K + L  +E +R     E  AL  + H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 89  LIKIITIC----SSIDFEGFDFKAIVFEYMQ---NRNLEQWLRQSNGQL----RFLTQRV 137
           +++         ++   +    K  ++  MQ     NL+ W+   NG+     R  +  +
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM---NGRCTIEERERSVCL 121
Query: 138 NIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL-FGYEPGTAA 196
           +I + ++ A+E+ H      ++H DLKPSNI    D V  VGD GL   +    E  T  
Sbjct: 122 HIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 197 ETASNSIEIKGIVG---YVAPEYGMGSKASVSGDVYNFGILLLEMF 239
                     G VG   Y++PE   G+  S   D+++ G++L E+ 
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 93/211 (44%), Gaps = 16/211 (7%)
Query: 38  IGQGGVSIVYKGIL---DESRSIVAVKVVN-LKQKEASRSFAAECNALRNIRHRNLIKII 93
           IG+G    VY G L   D  +   AVK +N +        F  E   +++  H N++ ++
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 94  TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHH 153
            IC  +  EG     +V  YM++ +L  ++R        +   +   + V+  +++    
Sbjct: 99  GIC--LRSEGSPL--VVLPYMKHGDLRNFIRNETHNPT-VKDLIGFGLQVAKGMKFL--- 150
Query: 154 CQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVA 213
                VH DL   N +LD+     V D GLA+ +   E     ++  N    K  V ++A
Sbjct: 151 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKE----FDSVHNKTGAKLPVKWMA 206
Query: 214 PEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
            E     K +   DV++FG+LL E+ TR  P
Sbjct: 207 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 105/236 (44%), Gaps = 40/236 (16%)
Query: 28  ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEAS-------RSFAAECNA 80
           A N      +IG+GG  +V+KG L + +S+VA+K + L   E         + F  E   
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 81  LRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIA 140
           + N+ H N++K+  +  +          +V E++   +L   L      +++ + ++ + 
Sbjct: 77  MSNLNHPNIVKLYGLMHNP-------PRMVMEFVPCGDLYHRLLDKAHPIKW-SVKLRLM 128
Query: 141 IDVSFAIEYFHHHCQPSIVHGDLKPSNILL-----DQDIVAHVGDLGLAKFLFGYEPGTA 195
           +D++  IEY  +   P IVH DL+  NI L     +  + A V D  L++          
Sbjct: 129 LDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ---------- 177
Query: 196 AETASNSIEIKGIVG---YVAPEYGMGSKASVS--GDVYNFGILLLEMFTRRRPTD 246
                +   + G++G   ++APE     + S +   D Y+F ++L  + T   P D
Sbjct: 178 ----QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 97/217 (44%), Gaps = 26/217 (11%)
Query: 38  IGQGGVSIVYKGIL---DESRSIVAVKVVNL---KQKEASRSFAAECNALRNIRHRNLIK 91
           +G+G    V +G L   D +   VAVK + L    Q+E    F +E   +++  H N+I+
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIE-EFLSEAACMKDFSHPNVIR 100
Query: 92  IITICSSIDFEGFDFKAIVFEYMQNRNLEQWL---RQSNGQLRFLTQRV-NIAIDVSFAI 147
           ++ +C  +  +G     ++  +M+  +L  +L   R   G      Q +    +D++  +
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160
Query: 148 EYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG---YEPGTAAETASNSIE 204
           EY  +    + +H DL   N +L  D+   V D GL+K ++    Y  G  A+     I 
Sbjct: 161 EYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 217
Query: 205 IKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTR 241
           I+ +   V          +   DV+ FG+ + E+ TR
Sbjct: 218 IESLADRV---------YTSKSDVWAFGVTMWEIATR 245

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 102/213 (47%), Gaps = 30/213 (14%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEAS-----RSFAAECNALRNIRHRNLIKI 92
           +G+G  + VYK     +  IVA+K + L  +  +     R+   E   L+ + H N+I +
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 93  ITICSSIDFEGFDFKA---IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEY 149
           +        + F  K+   +VF++M+  +LE  ++ ++  L     +  + + +   +EY
Sbjct: 78  L--------DAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQ-GLEY 127
Query: 150 FHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
            H H    I+H DLKP+N+LLD++ V  + D GLAK       G+      + +  +   
Sbjct: 128 LHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSF-----GSPNRAYXHQVVTR--- 176
Query: 210 GYVAPEYGMGSKA-SVSGDVYNFGILLLEMFTR 241
            Y APE   G++   V  D++  G +L E+  R
Sbjct: 177 WYRAPELLFGARMYGVGVDMWAVGCILAELLLR 209

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 94/205 (45%), Gaps = 18/205 (8%)
Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITI 95
            +IG G   +V+ G    ++  VA+K +  +   +   F  E   +  + H  L+++  +
Sbjct: 14  QEIGSGQFGLVHLGYW-LNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 96  CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQ 155
           C     E      +V E+M++  L  +LR   G     T  + + +DV   + Y    C 
Sbjct: 72  C----LEQAPI-CLVTEFMEHGCLSDYLRTQRGLFAAET-LLGMCLDVCEGMAYLEEAC- 124
Query: 156 PSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPE 215
             ++H DL   N L+ ++ V  V D G+ +F+         +  ++S   K  V + +PE
Sbjct: 125 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-------DQYTSSTGTKFPVKWASPE 175
Query: 216 YGMGSKASVSGDVYNFGILLLEMFT 240
               S+ S   DV++FG+L+ E+F+
Sbjct: 176 VFSFSRYSSKSDVWSFGVLMWEVFS 200

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 100/206 (48%), Gaps = 19/206 (9%)
Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEAS-RSFAAECNALRNIRHRNLIKIIT 94
            ++G G    V+ G  + S + VAVK   LK    S ++F  E N ++ ++H  L+++  
Sbjct: 19  KRLGAGQFGEVWMGYYNNS-TKVAVK--TLKPGTMSVQAFLEEANLMKTLQHDKLVRLYA 75
Query: 95  ICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHC 154
           + +  +        I+ EYM   +L  +L+   G    L + ++ +  ++  + Y     
Sbjct: 76  VVTREEP-----IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK- 129
Query: 155 QPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAP 214
             + +H DL+ +N+L+ + ++  + D GLA+ +   E  TA E A   I+      + AP
Sbjct: 130 --NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE-YTAREGAKFPIK------WTAP 180
Query: 215 EYGMGSKASVSGDVYNFGILLLEMFT 240
           E       ++  DV++FGILL E+ T
Sbjct: 181 EAINFGCFTIKSDVWSFGILLYEIVT 206

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/237 (23%), Positives = 105/237 (44%), Gaps = 31/237 (13%)
Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITI 95
            K+G G    V+    ++  + VAVK +      +  +F AE N ++ ++H  L+K+  +
Sbjct: 188 KKLGAGQFGEVWMATYNK-HTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAV 245
Query: 96  CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQ 155
            +           I+ E+M   +L  +L+   G  + L + ++ +  ++  + +     Q
Sbjct: 246 VTKEPI------YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---Q 296
Query: 156 PSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPE 215
            + +H DL+ +NIL+   +V  + D GLA+                 +  K  + + APE
Sbjct: 297 RNYIHRDLRAANILVSASLVCKIADFGLAR-----------------VGAKFPIKWTAPE 339
Query: 216 YGMGSKASVSGDVYNFGILLLEMFTRRR-PTDAMFNEGL--TLHEFVKMALPDKVME 269
                  ++  DV++FGILL+E+ T  R P   M N  +   L    +M  P+   E
Sbjct: 340 AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPE 396

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 90/204 (44%), Gaps = 20/204 (9%)
Query: 41  GGVSI-VYKGILDESRSIVAVKVVNLKQKEASRS-FAAECNALRNIRHRNLIKIITICSS 98
           G VS+  Y    D +  +VAVK +        RS +  E + LR + H ++IK    C  
Sbjct: 45  GKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCED 104
Query: 99  IDFEGFDFKAIVFEYMQNRNLEQWL-RQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPS 157
               G     +V EY+   +L  +L R S G    L Q +  A  +   + Y H      
Sbjct: 105 A---GAASLQLVMEYVPLGSLRDYLPRHSIG----LAQLLLFAQQICEGMAYLHAQ---H 154
Query: 158 IVHGDLKPSNILLDQDIVAHVGDLGLAKFLF-GYEPGTAAETASNSIEIKGIVGYVAPEY 216
            +H DL   N+LLD D +  +GD GLAK +  G+E     E   +       V + APE 
Sbjct: 155 YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSP------VFWYAPEC 208
Query: 217 GMGSKASVSGDVYNFGILLLEMFT 240
               K   + DV++FG+ L E+ T
Sbjct: 209 LKEYKFYYASDVWSFGVTLYELLT 232

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 101/221 (45%), Gaps = 20/221 (9%)
Query: 32  FSPANKI-----GQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRH 86
           F P++ I     G+G      K    E+  ++ +K +    +E  R+F  E   +R + H
Sbjct: 7   FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEH 66
Query: 87  RNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFA 146
            N++K I +        F     + EY++   L   ++  + Q  + +QRV+ A D++  
Sbjct: 67  PNVLKFIGVLYKDKRLNF-----ITEYIKGGTLRGIIKSMDSQYPW-SQRVSFAKDIASG 120
Query: 147 IEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG--YEP-GTAAETASNSI 203
           + Y H     +I+H DL   N L+ ++    V D GLA+ +     +P G  +    +  
Sbjct: 121 MAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRK 177
Query: 204 EIKGIVG---YVAPEYGMGSKASVSGDVYNFGILLLEMFTR 241
           +   +VG   ++APE   G       DV++FGI+L E+  R
Sbjct: 178 KRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGR 218

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 103/223 (46%), Gaps = 38/223 (17%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVN---LKQKEASRSFAAECNALRNIRHRNLIKIIT 94
           +G+G    V      +++  VA+K ++   LK+ +       E + L+ +RH ++IK+  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 95  ICSS-------IDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAI 147
           + ++       I++ G +    +F+Y+  +   + + +  G+ RF  Q       +  AI
Sbjct: 77  VITTPTDIVMVIEYAGGE----LFDYIVEK---KRMTEDEGR-RFFQQ-------IICAI 121
Query: 148 EYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKG 207
           EY H H    IVH DLKP N+LLD ++   + D GL+  +     G   +T+  S     
Sbjct: 122 EYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD---GNFLKTSCGS----- 170
Query: 208 IVGYVAPEYGMGS-KASVSGDVYNFGILLLEMFTRRRPTDAMF 249
              Y APE   G   A    DV++ GI+L  M   R P D  F
Sbjct: 171 -PNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF 212

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 108/239 (45%), Gaps = 32/239 (13%)
Query: 62  VVNLKQKEASRSFAAECNALRNIRHRNLIKIIT----ICSSIDFEGF--------DFKAI 109
           VV  ++   SR +A +    R+I   N +  +T    + S +D   F        D + +
Sbjct: 48  VVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL 107
Query: 110 VF--EYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSN 167
            F   Y +N  L +++R+  G       R   A  VS A+EY H      I+H DLKP N
Sbjct: 108 YFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVS-ALEYLHGK---GIIHRDLKPEN 162
Query: 168 ILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGD 227
           ILL++D+   + D G AK L    P +    A+  +   G   YV+PE      A  S D
Sbjct: 163 ILLNEDMHIQITDFGTAKVL---SPESKQARANXFV---GTAQYVSPELLTEKSACKSSD 216
Query: 228 VYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMA--LPDKVM----EIVDPSLLLEVT 280
           ++  G ++ ++     P  A  NEGL   + +K+    P+K      ++V+  L+L+ T
Sbjct: 217 LWALGCIIYQLVAGLPPFRAG-NEGLIFAKIIKLEYDFPEKFFPKARDLVEKLLVLDAT 274

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 108/239 (45%), Gaps = 32/239 (13%)
Query: 62  VVNLKQKEASRSFAAECNALRNIRHRNLIKIIT----ICSSIDFEGF--------DFKAI 109
           VV  ++   SR +A +    R+I   N +  +T    + S +D   F        D + +
Sbjct: 48  VVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL 107
Query: 110 VF--EYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSN 167
            F   Y +N  L +++R+  G       R   A  VS A+EY H      I+H DLKP N
Sbjct: 108 YFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVS-ALEYLHGK---GIIHRDLKPEN 162
Query: 168 ILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGD 227
           ILL++D+   + D G AK L    P +    A+  +   G   YV+PE      A  S D
Sbjct: 163 ILLNEDMHIQITDFGTAKVL---SPESKQARANXFV---GTAQYVSPELLTEKSAXKSSD 216
Query: 228 VYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMA--LPDKVM----EIVDPSLLLEVT 280
           ++  G ++ ++     P  A  NEGL   + +K+    P+K      ++V+  L+L+ T
Sbjct: 217 LWALGCIIYQLVAGLPPFRAG-NEGLIFAKIIKLEYDFPEKFFPKARDLVEKLLVLDAT 274

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 91/204 (44%), Gaps = 20/204 (9%)
Query: 41  GGVSI-VYKGILDESRSIVAVKVVNLKQKEASRS-FAAECNALRNIRHRNLIKIITICSS 98
           G VS+  Y    D +  +VAVK +        RS +  E + LR + H ++IK    C  
Sbjct: 28  GKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCED 87
Query: 99  IDFEGFDFKAIVFEYMQNRNLEQWL-RQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPS 157
              +G     +V EY+   +L  +L R S G    L Q +  A  +   + Y H      
Sbjct: 88  ---QGEKSLQLVMEYVPLGSLRDYLPRHSIG----LAQLLLFAQQICEGMAYLHSQ---H 137
Query: 158 IVHGDLKPSNILLDQDIVAHVGDLGLAKFLF-GYEPGTAAETASNSIEIKGIVGYVAPEY 216
            +H +L   N+LLD D +  +GD GLAK +  G+E     E   +       V + APE 
Sbjct: 138 YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP------VFWYAPEC 191
Query: 217 GMGSKASVSGDVYNFGILLLEMFT 240
               K   + DV++FG+ L E+ T
Sbjct: 192 LKEYKFYYASDVWSFGVTLYELLT 215

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 101/222 (45%), Gaps = 25/222 (11%)
Query: 38  IGQGGVSIVYKGILD-ESRSIVAVKVVNLK---QKEASRSFAAECNALRNIRHRNLIK-- 91
           IG G    V  G L    +  VAV +  LK    ++  R F  E + +    H N++   
Sbjct: 51  IGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLE 110
Query: 92  -IITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYF 150
            ++T    +         IV E+M+N  L+ +LR+ +GQ   + Q V +   ++  + Y 
Sbjct: 111 GVVTRGKPV--------MIVIEFMENGALDAFLRKHDGQFTVI-QLVGMLRGIAAGMRYL 161
Query: 151 HHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG 210
                   VH DL   NIL++ ++V  V D GL++ +   +P     T    I ++    
Sbjct: 162 ---ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIED-DPEAVYTTTGGKIPVR---- 213
Query: 211 YVAPEYGMGSKASVSGDVYNFGILLLEMFTR-RRPTDAMFNE 251
           + APE     K + + DV+++GI++ E+ +   RP   M N+
Sbjct: 214 WTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ 255

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 91/204 (44%), Gaps = 20/204 (9%)
Query: 41  GGVSI-VYKGILDESRSIVAVKVVNLKQKEASRS-FAAECNALRNIRHRNLIKIITICSS 98
           G VS+  Y    D +  +VAVK +        RS +  E + LR + H ++IK    C  
Sbjct: 28  GKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCED 87
Query: 99  IDFEGFDFKAIVFEYMQNRNLEQWL-RQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPS 157
              +G     +V EY+   +L  +L R S G    L Q +  A  +   + Y H      
Sbjct: 88  ---QGEKSLQLVMEYVPLGSLRDYLPRHSIG----LAQLLLFAQQICEGMAYLHAQ---H 137
Query: 158 IVHGDLKPSNILLDQDIVAHVGDLGLAKFLF-GYEPGTAAETASNSIEIKGIVGYVAPEY 216
            +H +L   N+LLD D +  +GD GLAK +  G+E     E   +       V + APE 
Sbjct: 138 YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP------VFWYAPEC 191
Query: 217 GMGSKASVSGDVYNFGILLLEMFT 240
               K   + DV++FG+ L E+ T
Sbjct: 192 LKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 102/209 (48%), Gaps = 20/209 (9%)
Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFA-AECNALRNIRHRNLIKIIT 94
           +K+G+G  + VYKG    + ++VA+K + L+ +E +   A  E + L++++H N   I+T
Sbjct: 8   DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN---IVT 64
Query: 95  ICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHC 154
           +   I  E      +VFEY+ +++L+Q+L      +     ++ +   +   + Y H   
Sbjct: 65  LHDIIHTE--KSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLFL-FQLLRGLAYCHRQ- 119
Query: 155 QPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAP 214
              ++H DLKP N+L+++      G+L LA F          +T  N +     + Y  P
Sbjct: 120 --KVLHRDLKPQNLLINER-----GELKLADFGLARAKSIPTKTYDNEV---VTLWYRPP 169
Query: 215 EYGMGS-KASVSGDVYNFGILLLEMFTRR 242
           +  +GS   S   D++  G +  EM T R
Sbjct: 170 DILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 100/206 (48%), Gaps = 19/206 (9%)
Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEAS-RSFAAECNALRNIRHRNLIKIIT 94
            K+G G    V+ G  + S + VAVK   LK    S ++F  E N ++ ++H  L+++  
Sbjct: 18  KKLGAGQFGEVWMGYYNNS-TKVAVK--TLKPGTMSVQAFLEEANLMKTLQHDKLVRLYA 74
Query: 95  ICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHC 154
           + +  +        I+ E+M   +L  +L+   G    L + ++ +  ++  + Y     
Sbjct: 75  VVTKEEP-----IYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK- 128
Query: 155 QPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAP 214
             + +H DL+ +N+L+ + ++  + D GLA+ +   E  TA E A   I+      + AP
Sbjct: 129 --NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE-YTAREGAKFPIK------WTAP 179
Query: 215 EYGMGSKASVSGDVYNFGILLLEMFT 240
           E       ++  +V++FGILL E+ T
Sbjct: 180 EAINFGCFTIKSNVWSFGILLYEIVT 205

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 109/239 (45%), Gaps = 32/239 (13%)
Query: 62  VVNLKQKEASRSFAAECNALRNIRHRNLIKIIT----ICSSIDFEGF--------DFKAI 109
           VV  ++   SR +A +    R+I   N +  +T    + S +D   F        D + +
Sbjct: 48  VVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL 107
Query: 110 VF--EYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSN 167
            F   Y +N  L +++R+  G       R   A  VS A+EY H      I+H DLKP N
Sbjct: 108 YFGLSYAKNGCLLKYIRKI-GSFDETCTRFYTAEIVS-ALEYLHGK---GIIHRDLKPEN 162
Query: 168 ILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGD 227
           ILL++D+   + D G AK L    P +    A++ +   G   YV+PE      AS S D
Sbjct: 163 ILLNEDMHIQITDFGTAKVL---SPESKQARANSFV---GTAQYVSPELLTEKSASKSSD 216
Query: 228 VYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMA--LPDKVM----EIVDPSLLLEVT 280
           ++  G ++ ++     P  A  NE L   + +K+    P+K      ++V+  L+L+ T
Sbjct: 217 LWALGCIIYQLVAGLPPFRAG-NEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDAT 274

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 108/239 (45%), Gaps = 32/239 (13%)
Query: 62  VVNLKQKEASRSFAAECNALRNIRHRNLIKIIT----ICSSIDFEGF--------DFKAI 109
           VV  ++   SR +A +    R+I   N +  +T    + S +D   F        D + +
Sbjct: 45  VVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL 104
Query: 110 VF--EYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSN 167
            F   Y +N  L +++R+  G       R   A  VS A+EY H      I+H DLKP N
Sbjct: 105 YFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVS-ALEYLHGK---GIIHRDLKPEN 159
Query: 168 ILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGD 227
           ILL++D+   + D G AK L    P +    A++ +   G   YV+PE      A  S D
Sbjct: 160 ILLNEDMHIQITDFGTAKVL---SPESKQARANSFV---GTAQYVSPELLTEKSACKSSD 213
Query: 228 VYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMA--LPDKVM----EIVDPSLLLEVT 280
           ++  G ++ ++     P  A  NE L   + +K+    P+K      ++V+  L+L+ T
Sbjct: 214 LWALGCIIYQLVAGLPPFRAG-NEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDAT 271

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 102/229 (44%), Gaps = 32/229 (13%)
Query: 39  GQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITI--- 95
            +G    V+K  L      VAVK+  L+ K++ +S   E  +   ++H NL++ I     
Sbjct: 24  ARGRFGCVWKAQL--MNDFVAVKIFPLQDKQSWQS-EREIFSTPGMKHENLLQFIAAEKR 80
Query: 96  CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHC- 154
            S+++ E +    ++  +    +L  +L+   G +    +  ++A  +S  + Y H    
Sbjct: 81  GSNLEVELW----LITAFHDKGSLTDYLK---GNIITWNELCHVAETMSRGLSYLHEDVP 133
Query: 155 -------QPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKG 207
                  +PSI H D K  N+LL  D+ A + D GLA     +EPG         +   G
Sbjct: 134 WCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLA---VRFEPGKPPGDTHGQV---G 187
Query: 208 IVGYVAPEYGMGS-----KASVSGDVYNFGILLLEMFTRRRPTDAMFNE 251
              Y+APE   G+      A +  D+Y  G++L E+ +R +  D   +E
Sbjct: 188 TRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAADGPVDE 236

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 108/239 (45%), Gaps = 32/239 (13%)
Query: 62  VVNLKQKEASRSFAAECNALRNIRHRNLIKIIT----ICSSIDFEGF--------DFKAI 109
           VV  ++   SR +A +    R+I   N +  +T    + S +D   F        D + +
Sbjct: 49  VVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL 108
Query: 110 VF--EYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSN 167
            F   Y +N  L +++R+  G       R   A  VS A+EY H      I+H DLKP N
Sbjct: 109 YFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVS-ALEYLHGK---GIIHRDLKPEN 163
Query: 168 ILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGD 227
           ILL++D+   + D G AK L    P +    A++ +   G   YV+PE      A  S D
Sbjct: 164 ILLNEDMHIQITDFGTAKVL---SPESKQARANSFV---GTAQYVSPELLTEKSACKSSD 217
Query: 228 VYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMA--LPDKVM----EIVDPSLLLEVT 280
           ++  G ++ ++     P  A  NE L   + +K+    P+K      ++V+  L+L+ T
Sbjct: 218 LWALGCIIYQLVAGLPPFRAG-NEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDAT 275

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 93/231 (40%), Gaps = 21/231 (9%)
Query: 36  NKIGQGGVSIVYKGILD-ESRSIVAVKVVNLK-----QKEASRSFAAECNALRNIRHRNL 89
            K+G G   +V +G  D  S   V+V V  LK     Q EA   F  E NA+ ++ HRNL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 90  IKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEY 149
           I++  +  +   +      +V E     +L   LR+  G    L      A+ V+  + Y
Sbjct: 84  IRLYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHF-LLGTLSRYAVQVAEGMGY 136
Query: 150 FHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
                    +H DL   N+LL    +  +GD GL + L   +     +        K   
Sbjct: 137 LESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHR-----KVPF 188
Query: 210 GYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVK 260
            + APE       S + D + FG+ L EMFT  +      N    LH+  K
Sbjct: 189 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 239

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 87/211 (41%), Gaps = 21/211 (9%)
Query: 36  NKIGQGGVSIVYKGILD-ESRSIVAVKVVNLK-----QKEASRSFAAECNALRNIRHRNL 89
            K+G G   +V +G  D  S   V+V V  LK     Q EA   F  E NA+ ++ HRNL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 90  IKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEY 149
           I++  +  +   +      +V E     +L   LR+  G    L      A+ V+  + Y
Sbjct: 74  IRLYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHF-LLGTLSRYAVQVAEGMGY 126
Query: 150 FHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
                    +H DL   N+LL    +  +GD GL + L   +     +        K   
Sbjct: 127 LE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHR-----KVPF 178
Query: 210 GYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
            + APE       S + D + FG+ L EMFT
Sbjct: 179 AWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/245 (21%), Positives = 109/245 (44%), Gaps = 33/245 (13%)
Query: 24  ELSKATNNFSPANKIGQGGVSIVYKGIL-----DESRSIVAVKVVNLKQKEASR-SFAAE 77
           E   A    + + ++GQG   +VY+G+      DE  + VA+K VN       R  F  E
Sbjct: 13  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 72
Query: 78  CNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLR------ 131
            + ++     ++++++ + S           ++ E M   +L+ +LR    ++       
Sbjct: 73  ASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 127
Query: 132 --FLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG 189
              L++ + +A +++  + Y + +     VH DL   N ++ +D    +GD G+ + ++ 
Sbjct: 128 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY- 183
Query: 190 YEPGTAAETASNSIEIKGI--VGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTD 246
                  ET       KG+  V +++PE       +   DV++FG++L E+ T   +P  
Sbjct: 184 -------ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 236
Query: 247 AMFNE 251
            + NE
Sbjct: 237 GLSNE 241

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/245 (21%), Positives = 109/245 (44%), Gaps = 33/245 (13%)
Query: 24  ELSKATNNFSPANKIGQGGVSIVYKGIL-----DESRSIVAVKVVNLKQKEASR-SFAAE 77
           E   A    + + ++GQG   +VY+G+      DE  + VA+K VN       R  F  E
Sbjct: 6   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 65
Query: 78  CNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLR------ 131
            + ++     ++++++ + S           ++ E M   +L+ +LR    ++       
Sbjct: 66  ASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 120
Query: 132 --FLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG 189
              L++ + +A +++  + Y + +     VH DL   N ++ +D    +GD G+ + ++ 
Sbjct: 121 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY- 176
Query: 190 YEPGTAAETASNSIEIKGI--VGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTD 246
                  ET       KG+  V +++PE       +   DV++FG++L E+ T   +P  
Sbjct: 177 -------ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 229
Query: 247 AMFNE 251
            + NE
Sbjct: 230 GLSNE 234

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 107/239 (44%), Gaps = 32/239 (13%)
Query: 62  VVNLKQKEASRSFAAECNALRNIRHRNLIKIIT----ICSSIDFEGF--------DFKAI 109
           VV  ++   SR +A +    R+I   N +  +T    + S +D   F        D + +
Sbjct: 30  VVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL 89
Query: 110 VF--EYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSN 167
            F   Y +N  L +++R+  G       R   A  VS A+EY H      I+H DLKP N
Sbjct: 90  YFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVS-ALEYLHGK---GIIHRDLKPEN 144
Query: 168 ILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGD 227
           ILL++D+   + D G AK L    P +    A+  +   G   YV+PE      A  S D
Sbjct: 145 ILLNEDMHIQITDFGTAKVL---SPESKQARANXFV---GTAQYVSPELLTEKSACKSSD 198
Query: 228 VYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMA--LPDKVM----EIVDPSLLLEVT 280
           ++  G ++ ++     P  A  NE L   + +K+    P+K      ++V+  L+L+ T
Sbjct: 199 LWALGCIIYQLVAGLPPFRAG-NEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDAT 256

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 107/239 (44%), Gaps = 32/239 (13%)
Query: 62  VVNLKQKEASRSFAAECNALRNIRHRNLIKIIT----ICSSIDFEGF--------DFKAI 109
           VV  ++   SR +A +    R+I   N +  +T    + S +D   F        D + +
Sbjct: 24  VVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL 83
Query: 110 VF--EYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSN 167
            F   Y +N  L +++R+  G       R   A  VS A+EY H      I+H DLKP N
Sbjct: 84  YFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVS-ALEYLHGK---GIIHRDLKPEN 138
Query: 168 ILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGD 227
           ILL++D+   + D G AK L    P +    A+  +   G   YV+PE      A  S D
Sbjct: 139 ILLNEDMHIQITDFGTAKVL---SPESKQARANXFV---GTAQYVSPELLTEKSACKSSD 192
Query: 228 VYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMA--LPDKVM----EIVDPSLLLEVT 280
           ++  G ++ ++     P  A  NE L   + +K+    P+K      ++V+  L+L+ T
Sbjct: 193 LWALGCIIYQLVAGLPPFRAG-NEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDAT 250

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/245 (21%), Positives = 109/245 (44%), Gaps = 33/245 (13%)
Query: 24  ELSKATNNFSPANKIGQGGVSIVYKGIL-----DESRSIVAVKVVNLKQKEASR-SFAAE 77
           E   A    + + ++GQG   +VY+G+      DE  + VA+K VN       R  F  E
Sbjct: 10  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 69
Query: 78  CNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLR------ 131
            + ++     ++++++ + S           ++ E M   +L+ +LR    ++       
Sbjct: 70  ASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 124
Query: 132 --FLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG 189
              L++ + +A +++  + Y + +     VH DL   N ++ +D    +GD G+ + ++ 
Sbjct: 125 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY- 180
Query: 190 YEPGTAAETASNSIEIKGI--VGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTD 246
                  ET       KG+  V +++PE       +   DV++FG++L E+ T   +P  
Sbjct: 181 -------ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 233
Query: 247 AMFNE 251
            + NE
Sbjct: 234 GLSNE 238

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 107/239 (44%), Gaps = 32/239 (13%)
Query: 62  VVNLKQKEASRSFAAECNALRNIRHRNLIKIIT----ICSSIDFEGF--------DFKAI 109
           VV  ++   SR +A +    R+I   N +  +T    + S +D   F        D + +
Sbjct: 46  VVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL 105
Query: 110 VF--EYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSN 167
            F   Y +N  L +++R+  G       R   A  VS A+EY H      I+H DLKP N
Sbjct: 106 YFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVS-ALEYLHGK---GIIHRDLKPEN 160
Query: 168 ILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGD 227
           ILL++D+   + D G AK L    P +    A+  +   G   YV+PE      A  S D
Sbjct: 161 ILLNEDMHIQITDFGTAKVL---SPESKQARANXFV---GTAQYVSPELLTEKSACKSSD 214
Query: 228 VYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMA--LPDKVM----EIVDPSLLLEVT 280
           ++  G ++ ++     P  A  NE L   + +K+    P+K      ++V+  L+L+ T
Sbjct: 215 LWALGCIIYQLVAGLPPFRAG-NEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDAT 272

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 107/239 (44%), Gaps = 32/239 (13%)
Query: 62  VVNLKQKEASRSFAAECNALRNIRHRNLIKIIT----ICSSIDFEGF--------DFKAI 109
           VV  ++   SR +A +    R+I   N +  +T    + S +D   F        D + +
Sbjct: 25  VVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL 84
Query: 110 VF--EYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSN 167
            F   Y +N  L +++R+  G       R   A  VS A+EY H      I+H DLKP N
Sbjct: 85  YFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVS-ALEYLHGK---GIIHRDLKPEN 139
Query: 168 ILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGD 227
           ILL++D+   + D G AK L    P +    A+  +   G   YV+PE      A  S D
Sbjct: 140 ILLNEDMHIQITDFGTAKVL---SPESKQARANXFV---GTAQYVSPELLTEKSACKSSD 193
Query: 228 VYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMA--LPDKVM----EIVDPSLLLEVT 280
           ++  G ++ ++     P  A  NE L   + +K+    P+K      ++V+  L+L+ T
Sbjct: 194 LWALGCIIYQLVAGLPPFRAG-NEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDAT 251

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 93/231 (40%), Gaps = 21/231 (9%)
Query: 36  NKIGQGGVSIVYKGILD-ESRSIVAVKVVNLK-----QKEASRSFAAECNALRNIRHRNL 89
            K+G G   +V +G  D  S   V+V V  LK     Q EA   F  E NA+ ++ HRNL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 90  IKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEY 149
           I++  +  +   +      +V E     +L   LR+  G    L      A+ V+  + Y
Sbjct: 74  IRLYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHF-LLGTLSRYAVQVAEGMGY 126
Query: 150 FHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
                    +H DL   N+LL    +  +GD GL + L   +     +        K   
Sbjct: 127 LE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR-----KVPF 178
Query: 210 GYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVK 260
            + APE       S + D + FG+ L EMFT  +      N    LH+  K
Sbjct: 179 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 229

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/262 (24%), Positives = 120/262 (45%), Gaps = 43/262 (16%)
Query: 20  ISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAA--E 77
           +S A  + + + +    K+G+G    VYK I   +   VA+K + L+ +E      A  E
Sbjct: 24  VSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIRE 83
Query: 78  CNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWL-RQSNGQLR----F 132
            + L+ ++HRN+I++ ++             ++FEY +N +L++++ +  +  +R    F
Sbjct: 84  VSLLKELQHRNIIELKSV-----IHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSF 137
Query: 133 LTQRVNIAIDVSFAIEYFH-HHCQPSIVHGDLKPSNILL-----DQDIVAHVGDLGLAKF 186
           L Q +N        + + H   C    +H DLKP N+LL      +  V  +GD GLA+ 
Sbjct: 138 LYQLIN-------GVNFCHSRRC----LHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186
Query: 187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKA-SVSGDVYNFGILLLEMFTRRR-- 243
                 G      ++ I     + Y  PE  +GS+  S S D+++   +  EM  +    
Sbjct: 187 F-----GIPIRQFTHEI---ITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLF 238
Query: 244 PTDAMFNEGLTLHEFVKMALPD 265
           P D+  ++   + E   + LPD
Sbjct: 239 PGDSEIDQLFKIFEV--LGLPD 258

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 107/239 (44%), Gaps = 32/239 (13%)
Query: 62  VVNLKQKEASRSFAAECNALRNIRHRNLIKIIT----ICSSIDFEGF--------DFKAI 109
           VV  ++   SR +A +    R+I   N +  +T    + S +D   F        D + +
Sbjct: 23  VVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL 82
Query: 110 VF--EYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSN 167
            F   Y +N  L +++R+  G       R   A  VS A+EY H      I+H DLKP N
Sbjct: 83  YFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVS-ALEYLHGK---GIIHRDLKPEN 137
Query: 168 ILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGD 227
           ILL++D+   + D G AK L    P +    A+  +   G   YV+PE      A  S D
Sbjct: 138 ILLNEDMHIQITDFGTAKVL---SPESKQARANXFV---GTAQYVSPELLTEKSACKSSD 191
Query: 228 VYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMA--LPDKVM----EIVDPSLLLEVT 280
           ++  G ++ ++     P  A  NE L   + +K+    P+K      ++V+  L+L+ T
Sbjct: 192 LWALGCIIYQLVAGLPPFRAG-NEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDAT 249

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 107/239 (44%), Gaps = 32/239 (13%)
Query: 62  VVNLKQKEASRSFAAECNALRNIRHRNLIKIIT----ICSSIDFEGF--------DFKAI 109
           VV  ++   SR +A +    R+I   N +  +T    + S +D   F        D + +
Sbjct: 26  VVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL 85
Query: 110 VF--EYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSN 167
            F   Y +N  L +++R+  G       R   A  VS A+EY H      I+H DLKP N
Sbjct: 86  YFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVS-ALEYLHGK---GIIHRDLKPEN 140
Query: 168 ILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGD 227
           ILL++D+   + D G AK L    P +    A+  +   G   YV+PE      A  S D
Sbjct: 141 ILLNEDMHIQITDFGTAKVL---SPESKQARANXFV---GTAQYVSPELLTEKSACKSSD 194
Query: 228 VYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMA--LPDKVM----EIVDPSLLLEVT 280
           ++  G ++ ++     P  A  NE L   + +K+    P+K      ++V+  L+L+ T
Sbjct: 195 LWALGCIIYQLVAGLPPFRAG-NEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDAT 252

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 107/239 (44%), Gaps = 32/239 (13%)
Query: 62  VVNLKQKEASRSFAAECNALRNIRHRNLIKIIT----ICSSIDFEGF--------DFKAI 109
           VV  ++   SR +A +    R+I   N +  +T    + S +D   F        D + +
Sbjct: 48  VVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL 107
Query: 110 VF--EYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSN 167
            F   Y +N  L +++R+  G       R   A  VS A+EY H      I+H DLKP N
Sbjct: 108 YFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVS-ALEYLHGK---GIIHRDLKPEN 162
Query: 168 ILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGD 227
           ILL++D+   + D G AK L    P +    A+  +   G   YV+PE      A  S D
Sbjct: 163 ILLNEDMHIQITDFGTAKVL---SPESKQARANXFV---GTAQYVSPELLTEKSACKSSD 216
Query: 228 VYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMA--LPDKVM----EIVDPSLLLEVT 280
           ++  G ++ ++     P  A  NE L   + +K+    P+K      ++V+  L+L+ T
Sbjct: 217 LWALGCIIYQLVAGLPPFRAG-NEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDAT 274

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 109/254 (42%), Gaps = 40/254 (15%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRS----FAAECNALRNIRHRNLIKI 92
           +IG+G    VYKG+  ++ + V V    L+ ++ ++S    F  E   L+ ++H N+++ 
Sbjct: 33  EIGRGSFKTVYKGL--DTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRF 90
Query: 93  ITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNI----AIDVSFAIE 148
                S   +G     +V E   +  L+ +L+      RF   ++ +       +   ++
Sbjct: 91  YDSWEST-VKGKKCIVLVTELXTSGTLKTYLK------RFKVXKIKVLRSWCRQILKGLQ 143
Query: 149 YFHHHCQPSIVHGDLKPSNILLDQDIVA-HVGDLGLAKFLFGYEPGTAAETASNSIEIKG 207
           + H    P I+H DLK  NI +     +  +GDLGLA            + AS +  + G
Sbjct: 144 FLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----------KRASFAKAVIG 192
Query: 208 IVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFN---------EGLTLHEF 258
              + APE     K   S DVY FG   LE  T   P     N          G+    F
Sbjct: 193 TPEFXAPEX-YEEKYDESVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPASF 251
Query: 259 VKMALPDKVMEIVD 272
            K+A+P+ V EI++
Sbjct: 252 DKVAIPE-VKEIIE 264

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/245 (21%), Positives = 109/245 (44%), Gaps = 33/245 (13%)
Query: 24  ELSKATNNFSPANKIGQGGVSIVYKGIL-----DESRSIVAVKVVNLKQKEASR-SFAAE 77
           E   A    + + ++GQG   +VY+G+      DE  + VA+K VN       R  F  E
Sbjct: 12  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 71
Query: 78  CNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLR------ 131
            + ++     ++++++ + S           ++ E M   +L+ +LR    ++       
Sbjct: 72  ASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 126
Query: 132 --FLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG 189
              L++ + +A +++  + Y + +     VH DL   N ++ +D    +GD G+ + ++ 
Sbjct: 127 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY- 182
Query: 190 YEPGTAAETASNSIEIKGI--VGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTD 246
                  ET       KG+  V +++PE       +   DV++FG++L E+ T   +P  
Sbjct: 183 -------ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 235
Query: 247 AMFNE 251
            + NE
Sbjct: 236 GLSNE 240

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 107/239 (44%), Gaps = 32/239 (13%)
Query: 62  VVNLKQKEASRSFAAECNALRNIRHRNLIKIIT----ICSSIDFEGF--------DFKAI 109
           VV  ++   SR +A +    R+I   N +  +T    + S +D   F        D + +
Sbjct: 45  VVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL 104
Query: 110 VF--EYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSN 167
            F   Y +N  L +++R+  G       R   A  VS A+EY H      I+H DLKP N
Sbjct: 105 YFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVS-ALEYLHGK---GIIHRDLKPEN 159
Query: 168 ILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGD 227
           ILL++D+   + D G AK L    P +    A+  +   G   YV+PE      A  S D
Sbjct: 160 ILLNEDMHIQITDFGTAKVL---SPESKQARANXFV---GTAQYVSPELLTEKSACKSSD 213
Query: 228 VYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMA--LPDKVM----EIVDPSLLLEVT 280
           ++  G ++ ++     P  A  NE L   + +K+    P+K      ++V+  L+L+ T
Sbjct: 214 LWALGCIIYQLVAGLPPFRAG-NEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDAT 271

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/245 (21%), Positives = 109/245 (44%), Gaps = 33/245 (13%)
Query: 24  ELSKATNNFSPANKIGQGGVSIVYKGIL-----DESRSIVAVKVVNLKQKEASR-SFAAE 77
           E   A    + + ++GQG   +VY+G+      DE  + VA+K VN       R  F  E
Sbjct: 19  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 78
Query: 78  CNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLR------ 131
            + ++     ++++++ + S           ++ E M   +L+ +LR    ++       
Sbjct: 79  ASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 133
Query: 132 --FLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG 189
              L++ + +A +++  + Y + +     VH DL   N ++ +D    +GD G+ + ++ 
Sbjct: 134 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY- 189
Query: 190 YEPGTAAETASNSIEIKGI--VGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTD 246
                  ET       KG+  V +++PE       +   DV++FG++L E+ T   +P  
Sbjct: 190 -------ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 242
Query: 247 AMFNE 251
            + NE
Sbjct: 243 GLSNE 247

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/245 (21%), Positives = 109/245 (44%), Gaps = 33/245 (13%)
Query: 24  ELSKATNNFSPANKIGQGGVSIVYKGIL-----DESRSIVAVKVVNLKQKEASR-SFAAE 77
           E   A    + + ++GQG   +VY+G+      DE  + VA+K VN       R  F  E
Sbjct: 12  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 71
Query: 78  CNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLR------ 131
            + ++     ++++++ + S           ++ E M   +L+ +LR    ++       
Sbjct: 72  ASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 126
Query: 132 --FLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG 189
              L++ + +A +++  + Y + +     VH DL   N ++ +D    +GD G+ + ++ 
Sbjct: 127 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY- 182
Query: 190 YEPGTAAETASNSIEIKGI--VGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTD 246
                  ET       KG+  V +++PE       +   DV++FG++L E+ T   +P  
Sbjct: 183 -------ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 235
Query: 247 AMFNE 251
            + NE
Sbjct: 236 GLSNE 240

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 107/239 (44%), Gaps = 32/239 (13%)
Query: 62  VVNLKQKEASRSFAAECNALRNIRHRNLIKIIT----ICSSIDFEGF--------DFKAI 109
           VV  ++   SR +A +    R+I   N +  +T    + S +D   F        D + +
Sbjct: 48  VVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL 107
Query: 110 VF--EYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSN 167
            F   Y +N  L +++R+  G       R   A  VS A+EY H      I+H DLKP N
Sbjct: 108 YFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVS-ALEYLHGK---GIIHRDLKPEN 162
Query: 168 ILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGD 227
           ILL++D+   + D G AK L    P +    A+  +   G   YV+PE      A  S D
Sbjct: 163 ILLNEDMHIQITDFGTAKVL---SPESKQARANXFV---GTAQYVSPELLTEKSACKSSD 216
Query: 228 VYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMA--LPDKVM----EIVDPSLLLEVT 280
           ++  G ++ ++     P  A  NE L   + +K+    P+K      ++V+  L+L+ T
Sbjct: 217 LWALGCIIYQLVAGLPPFRAG-NEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDAT 274

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 107/239 (44%), Gaps = 32/239 (13%)
Query: 62  VVNLKQKEASRSFAAECNALRNIRHRNLIKIIT----ICSSIDFEGF--------DFKAI 109
           VV  ++   SR +A +    R+I   N +  +T    + S +D   F        D + +
Sbjct: 48  VVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL 107
Query: 110 VF--EYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSN 167
            F   Y +N  L +++R+  G       R   A  VS A+EY H      I+H DLKP N
Sbjct: 108 YFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVS-ALEYLHGK---GIIHRDLKPEN 162
Query: 168 ILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGD 227
           ILL++D+   + D G AK L    P +    A+  +   G   YV+PE      A  S D
Sbjct: 163 ILLNEDMHIQITDFGTAKVL---SPESKQARANXFV---GTAQYVSPELLTEKSACKSSD 216
Query: 228 VYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMA--LPDKVM----EIVDPSLLLEVT 280
           ++  G ++ ++     P  A  NE L   + +K+    P+K      ++V+  L+L+ T
Sbjct: 217 LWALGCIIYQLVAGLPPFRAG-NEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDAT 274

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 93/231 (40%), Gaps = 21/231 (9%)
Query: 36  NKIGQGGVSIVYKGILD-ESRSIVAVKVVNLK-----QKEASRSFAAECNALRNIRHRNL 89
            K+G G   +V +G  D  S   V+V V  LK     Q EA   F  E NA+ ++ HRNL
Sbjct: 18  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 90  IKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEY 149
           I++  +  +   +      +V E     +L   LR+  G    L      A+ V+  + Y
Sbjct: 78  IRLYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHF-LLGTLSRYAVQVAEGMGY 130
Query: 150 FHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
                    +H DL   N+LL    +  +GD GL + L   +     +        K   
Sbjct: 131 LE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR-----KVPF 182
Query: 210 GYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVK 260
            + APE       S + D + FG+ L EMFT  +      N    LH+  K
Sbjct: 183 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 233

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 106/239 (44%), Gaps = 32/239 (13%)
Query: 62  VVNLKQKEASRSFAAECNALRNIRHRNLIKIIT----ICSSIDFEGF--------DFKAI 109
           VV  ++   SR +A +    R+I   N +  +T    + S +D   F        D + +
Sbjct: 51  VVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL 110
Query: 110 VF--EYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSN 167
            F   Y +N  L +++R+  G       R   A  VS A+EY H      I+H DLKP N
Sbjct: 111 YFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVS-ALEYLHGK---GIIHRDLKPEN 165
Query: 168 ILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGD 227
           ILL++D+   + D G AK L    P +    A+  +   G   YV+PE      A  S D
Sbjct: 166 ILLNEDMHIQITDFGTAKVL---SPESKQARANXFV---GTAQYVSPELLTEKSACKSSD 219
Query: 228 VYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKM------ALPDKVMEIVDPSLLLEVT 280
           ++  G ++ ++     P  A  NE L   + +K+      A   K  ++V+  L+L+ T
Sbjct: 220 LWALGCIIYQLVAGLPPFRAG-NEYLIFQKIIKLEYDFPAAFFPKARDLVEKLLVLDAT 277

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 107/239 (44%), Gaps = 32/239 (13%)
Query: 62  VVNLKQKEASRSFAAECNALRNIRHRNLIKIIT----ICSSIDFEGF--------DFKAI 109
           VV  ++   SR +A +    R+I   N +  +T    + S +D   F        D + +
Sbjct: 46  VVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL 105
Query: 110 VF--EYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSN 167
            F   Y +N  L +++R+  G       R   A  VS A+EY H      I+H DLKP N
Sbjct: 106 YFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVS-ALEYLHGK---GIIHRDLKPEN 160
Query: 168 ILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGD 227
           ILL++D+   + D G AK L    P +    A+  +   G   YV+PE      A  S D
Sbjct: 161 ILLNEDMHIQITDFGTAKVL---SPESKQARANXFV---GTAQYVSPELLTEKSACKSSD 214
Query: 228 VYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMA--LPDKVM----EIVDPSLLLEVT 280
           ++  G ++ ++     P  A  NE L   + +K+    P+K      ++V+  L+L+ T
Sbjct: 215 LWALGCIIYQLVAGLPPFRAG-NEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDAT 272

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/275 (21%), Positives = 123/275 (44%), Gaps = 40/275 (14%)
Query: 24  ELSKATNNFSPANKIGQGGVSIVYKGIL-----DESRSIVAVKVVNLKQKEASR-SFAAE 77
           E   A    + + ++GQG   +VY+G+      DE  + VA+K VN       R  F  E
Sbjct: 4   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 63
Query: 78  CNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLR------ 131
            + ++     ++++++ + S           ++ E M   +L+ +LR    ++       
Sbjct: 64  ASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 118
Query: 132 --FLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG 189
              L++ + +A +++  + Y + +     VH DL   N ++ +D    +GD G+ + +  
Sbjct: 119 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-- 173
Query: 190 YEPGTAAETASNSIEIKGI--VGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTD 246
                  ET       KG+  V +++PE       +   DV++FG++L E+ T   +P  
Sbjct: 174 ------XETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY- 226
Query: 247 AMFNEGLTLHEFVKMALPDKVMEIVD--PSLLLEV 279
               +GL+  + ++  +   +++  D  P +LLE+
Sbjct: 227 ----QGLSNEQVLRFVMEGGLLDKPDNCPDMLLEL 257

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 107/239 (44%), Gaps = 32/239 (13%)
Query: 62  VVNLKQKEASRSFAAECNALRNIRHRNLIKIIT----ICSSIDFEGF--------DFKAI 109
           VV  ++   SR +A +    R+I   N +  +T    + S +D   F        D + +
Sbjct: 53  VVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFCFQDDEKL 112
Query: 110 VF--EYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSN 167
            F   Y +N  L +++R+  G       R   A  VS A+EY H      I+H DLKP N
Sbjct: 113 YFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVS-ALEYLHGK---GIIHRDLKPEN 167
Query: 168 ILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGD 227
           ILL++D+   + D G AK L    P +    A+  +   G   YV+PE      A  S D
Sbjct: 168 ILLNEDMHIQITDFGTAKVL---SPESKQARANXFV---GTAQYVSPELLTEKSACKSSD 221
Query: 228 VYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMA--LPDKVM----EIVDPSLLLEVT 280
           ++  G ++ ++     P  A  NE L   + +K+    P+K      ++V+  L+L+ T
Sbjct: 222 LWALGCIIYQLVAGLPPFRAG-NEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDAT 279

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 93/230 (40%), Gaps = 21/230 (9%)
Query: 37  KIGQGGVSIVYKGILD-ESRSIVAVKVVNLK-----QKEASRSFAAECNALRNIRHRNLI 90
           K+G G   +V +G  D  S   V+V V  LK     Q EA   F  E NA+ ++ HRNLI
Sbjct: 19  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 78
Query: 91  KIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYF 150
           ++  +  +   +      +V E     +L   LR+  G    L      A+ V+  + Y 
Sbjct: 79  RLYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHF-LLGTLSRYAVQVAEGMGYL 131
Query: 151 HHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG 210
                   +H DL   N+LL    +  +GD GL + L   +     +        K    
Sbjct: 132 ESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR-----KVPFA 183
Query: 211 YVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVK 260
           + APE       S + D + FG+ L EMFT  +      N    LH+  K
Sbjct: 184 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 233

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 107/239 (44%), Gaps = 32/239 (13%)
Query: 62  VVNLKQKEASRSFAAECNALRNIRHRNLIKIIT----ICSSIDFEGF--------DFKAI 109
           VV  ++   SR +A +    R+I   N +  +T    + S +D   F        D + +
Sbjct: 46  VVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL 105
Query: 110 VF--EYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSN 167
            F   Y +N  L +++R+  G       R   A  VS A+EY H      I+H DLKP N
Sbjct: 106 YFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVS-ALEYLHGK---GIIHRDLKPEN 160
Query: 168 ILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGD 227
           ILL++D+   + D G AK L    P +    A+  +   G   YV+PE      A  S D
Sbjct: 161 ILLNEDMHIQITDFGTAKVL---SPESKQARANAFV---GTAQYVSPELLTEKSACKSSD 214
Query: 228 VYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMA--LPDKVM----EIVDPSLLLEVT 280
           ++  G ++ ++     P  A  NE L   + +K+    P+K      ++V+  L+L+ T
Sbjct: 215 LWALGCIIYQLVAGLPPFRAG-NEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDAT 272

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 107/239 (44%), Gaps = 32/239 (13%)
Query: 62  VVNLKQKEASRSFAAECNALRNIRHRNLIKIIT----ICSSIDFEGF--------DFKAI 109
           VV  ++   SR +A +    R+I   N +  +T    + S +D   F        D + +
Sbjct: 49  VVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL 108
Query: 110 VF--EYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSN 167
            F   Y +N  L +++R+  G       R   A  VS A+EY H      I+H DLKP N
Sbjct: 109 YFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVS-ALEYLHGK---GIIHRDLKPEN 163
Query: 168 ILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGD 227
           ILL++D+   + D G AK L    P +    A+  +   G   YV+PE      A  S D
Sbjct: 164 ILLNEDMHIQITDFGTAKVL---SPESKQARANXFV---GTAQYVSPELLTEKSACKSSD 217
Query: 228 VYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMA--LPDKVM----EIVDPSLLLEVT 280
           ++  G ++ ++     P  A  NE L   + +K+    P+K      ++V+  L+L+ T
Sbjct: 218 LWALGCIIYQLVAGLPPFRAG-NEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDAT 275

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 98/220 (44%), Gaps = 33/220 (15%)
Query: 27  KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRH 86
           K   N  P     QG V   Y  IL+ + +I  +      Q  A R++  E   ++ + H
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNH 82
Query: 87  RNLIKIITI-CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQS--NGQLRFLTQRVNIAIDV 143
           +N+I ++ +       E F    IV E M + NL Q ++    + ++ +L  ++ + I  
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQMELDHERMSYLLYQMLVGIK- 140
Query: 144 SFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSI 203
                  H H    I+H DLKPSNI++  D    + D GLA+            TA  S 
Sbjct: 141 -------HLHSA-GIIHRDLKPSNIVVKSDATLKILDFGLAR------------TAGTSF 180
Query: 204 EIKGIV---GYVAPE--YGMGSKASVSGDVYNFGILLLEM 238
            +   V    Y APE   GMG K +V  D+++ G+++ EM
Sbjct: 181 MMTPYVVTRYYRAPEVILGMGYKENV--DIWSVGVIMGEM 218

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 93/231 (40%), Gaps = 21/231 (9%)
Query: 36  NKIGQGGVSIVYKGILD-ESRSIVAVKVVNLK-----QKEASRSFAAECNALRNIRHRNL 89
            K+G G   +V +G  D  S   V+V V  LK     Q EA   F  E NA+ ++ HRNL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 90  IKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEY 149
           I++  +  +   +      +V E     +L   LR+  G    L      A+ V+  + Y
Sbjct: 84  IRLYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHF-LLGTLSRYAVQVAEGMGY 136
Query: 150 FHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
                    +H DL   N+LL    +  +GD GL + L   +     +        K   
Sbjct: 137 LESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR-----KVPF 188
Query: 210 GYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVK 260
            + APE       S + D + FG+ L EMFT  +      N    LH+  K
Sbjct: 189 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 239

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 93/231 (40%), Gaps = 21/231 (9%)
Query: 36  NKIGQGGVSIVYKGILD-ESRSIVAVKVVNLK-----QKEASRSFAAECNALRNIRHRNL 89
            K+G G   +V +G  D  S   V+V V  LK     Q EA   F  E NA+ ++ HRNL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 90  IKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEY 149
           I++  +  +   +      +V E     +L   LR+  G    L      A+ V+  + Y
Sbjct: 74  IRLYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHF-LLGTLSRYAVQVAEGMGY 126
Query: 150 FHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
                    +H DL   N+LL    +  +GD GL + L   +     +        K   
Sbjct: 127 LE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR-----KVPF 178
Query: 210 GYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVK 260
            + APE       S + D + FG+ L EMFT  +      N    LH+  K
Sbjct: 179 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 229

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 98/220 (44%), Gaps = 33/220 (15%)
Query: 27  KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRH 86
           K   N  P     QG V   Y  IL+ + +I  +      Q  A R++  E   ++ + H
Sbjct: 24  KRYQNLKPIGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNH 82
Query: 87  RNLIKIITI-CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQS--NGQLRFLTQRVNIAIDV 143
           +N+I ++ +       E F    IV E M + NL Q ++    + ++ +L  ++ + I  
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQMELDHERMSYLLYQMLVGIK- 140
Query: 144 SFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSI 203
                  H H    I+H DLKPSNI++  D    + D GLA+            TA  S 
Sbjct: 141 -------HLHSA-GIIHRDLKPSNIVVKSDATLKILDFGLAR------------TAGTSF 180
Query: 204 EIKGIV---GYVAPE--YGMGSKASVSGDVYNFGILLLEM 238
            +   V    Y APE   GMG K +V  D+++ G+++ EM
Sbjct: 181 MMTPYVVTRYYRAPEVILGMGYKENV--DIWSVGVIMGEM 218

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 99/223 (44%), Gaps = 31/223 (13%)
Query: 27  KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRH 86
           K   N  P     QG V   Y  +LD + +I  +      Q  A R++  E   ++ + H
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNH 82
Query: 87  RNLIKIITICSSID-FEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-DVS 144
           +N+I ++ + +     E F    +V E M + NL Q +     Q+    +R++  +  + 
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVI-----QMELDHERMSYLLYQML 136
Query: 145 FAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIE 204
             I++ H      I+H DLKPSNI++  D    + D GLA+            TA  S  
Sbjct: 137 XGIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLAR------------TAGTSFM 181
Query: 205 IKGIV---GYVAPE--YGMGSKASVSGDVYNFGILLLEMFTRR 242
           +   V    Y APE   GMG K +V  D+++ G ++ EM   +
Sbjct: 182 MTPYVVTRYYRAPEVILGMGYKENV--DIWSVGCIMGEMVRHK 222

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/245 (21%), Positives = 108/245 (44%), Gaps = 33/245 (13%)
Query: 24  ELSKATNNFSPANKIGQGGVSIVYKGIL-----DESRSIVAVKVVNLKQKEASR-SFAAE 77
           E   A    + + ++GQG   +VY+G+      DE  + VA+K VN       R  F  E
Sbjct: 13  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 72
Query: 78  CNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLR------ 131
            + ++     ++++++ + S           ++ E M   +L+ +LR    ++       
Sbjct: 73  ASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 127
Query: 132 --FLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG 189
              L++ + +A +++  + Y + +     VH DL   N ++ +D    +GD G+ + +  
Sbjct: 128 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-- 182
Query: 190 YEPGTAAETASNSIEIKGI--VGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTD 246
                  ET       KG+  V +++PE       +   DV++FG++L E+ T   +P  
Sbjct: 183 ------XETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 236
Query: 247 AMFNE 251
            + NE
Sbjct: 237 GLSNE 241

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 31/210 (14%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVK--VVNLKQKEASRSFAAECNALRNIRHRNLIKIITI 95
           +G+G   +V K    ++  IVA+K  + +   K   +    E   L+ +RH NL+ ++ +
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 96  CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQ-----LRFLTQRVNIAIDVSFAIEYF 150
           C            +VFE++ +  L+      NG       ++L Q +N        I + 
Sbjct: 93  CKKKKRW-----YLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIIN-------GIGFC 140
Query: 151 HHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG 210
           H H   +I+H D+KP NIL+ Q  V  + D G A+ L         E   + +  +    
Sbjct: 141 HSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL-----AAPGEVYDDEVATR---W 189
Query: 211 YVAPEYGMGS-KASVSGDVYNFGILLLEMF 239
           Y APE  +G  K   + DV+  G L+ EMF
Sbjct: 190 YRAPELLVGDVKYGKAVDVWAIGCLVTEMF 219

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/245 (22%), Positives = 111/245 (45%), Gaps = 33/245 (13%)
Query: 24  ELSKATNNFSPANKIGQGGVSIVYKGIL-----DESRSIVAVKVVNLKQKEASR-SFAAE 77
           E   A    + + ++GQG   +VY+G+      DE  + VA+K VN       R  F  E
Sbjct: 41  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 100
Query: 78  CNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLR------ 131
            + ++     ++++++ + S    +G     ++ E M   +L+ +LR    ++       
Sbjct: 101 ASVMKEFNCHHVVRLLGVVS----QG-QPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 155
Query: 132 --FLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG 189
              L++ + +A +++  + Y + +     VH DL   N ++ +D    +GD G+ + ++ 
Sbjct: 156 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY- 211
Query: 190 YEPGTAAETASNSIEIKGI--VGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTD 246
                  ET       KG+  V +++PE       +   DV++FG++L E+ T   +P  
Sbjct: 212 -------ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 264
Query: 247 AMFNE 251
            + NE
Sbjct: 265 GLSNE 269

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 106/226 (46%), Gaps = 32/226 (14%)
Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNL 89
           ++F   +++G G   +V+K     S  ++A K+++L+ K A          +RN   R L
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA----------IRNQIIREL 58
Query: 90  IKIITICSS---IDFEGFDFK----AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAID 142
            +++  C+S   + F G  +     +I  E+M   +L+Q L+++      +  +V+IA+ 
Sbjct: 59  -QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI 117
Query: 143 VSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNS 202
                    H     I+H D+KPSNIL++      + D G++        G   +  +N 
Sbjct: 118 KGLTYLREKH----KIMHRDVKPSNILVNSRGEIKLCDFGVS--------GQLIDEMAN- 164
Query: 203 IEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAM 248
            E  G   Y++PE   G+  SV  D+++ G+ L+EM   R P   M
Sbjct: 165 -EFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPRPPM 209

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 99/223 (44%), Gaps = 31/223 (13%)
Query: 27  KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRH 86
           K   N  P     QG V   Y  +LD + +I  +      Q  A R++  E   ++ + H
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNH 82
Query: 87  RNLIKIITICSSID-FEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-DVS 144
           +N+I ++ + +     E F    +V E M + NL Q +     Q+    +R++  +  + 
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVI-----QMELDHERMSYLLYQML 136
Query: 145 FAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIE 204
             I++ H      I+H DLKPSNI++  D    + D GLA+            TA  S  
Sbjct: 137 CGIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLAR------------TAGTSFM 181
Query: 205 IKGIV---GYVAPE--YGMGSKASVSGDVYNFGILLLEMFTRR 242
           +   V    Y APE   GMG K +V  D+++ G ++ EM   +
Sbjct: 182 MTPYVVTRYYRAPEVILGMGYKENV--DIWSVGCIMGEMVRHK 222

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/275 (21%), Positives = 123/275 (44%), Gaps = 40/275 (14%)
Query: 24  ELSKATNNFSPANKIGQGGVSIVYKGIL-----DESRSIVAVKVVNLKQKEASR-SFAAE 77
           E   A    + + ++GQG   +VY+G+      DE  + VA+K VN       R  F  E
Sbjct: 6   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 65
Query: 78  CNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLR------ 131
            + ++     ++++++ + S           ++ E M   +L+ +LR    ++       
Sbjct: 66  ASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 120
Query: 132 --FLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG 189
              L++ + +A +++  + Y + +     VH DL   N  + +D    +GD G+ + ++ 
Sbjct: 121 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIY- 176
Query: 190 YEPGTAAETASNSIEIKGI--VGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTD 246
                  ET       KG+  V +++PE       +   DV++FG++L E+ T   +P  
Sbjct: 177 -------ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY- 228
Query: 247 AMFNEGLTLHEFVKMALPDKVMEIVD--PSLLLEV 279
               +GL+  + ++  +   +++  D  P +LLE+
Sbjct: 229 ----QGLSNEQVLRFVMEGGLLDKPDNCPDMLLEL 259

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 99/231 (42%), Gaps = 35/231 (15%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICS 97
           +G+G   IVY G    ++  +A+K +  +    S+    E    ++++H+N+++ +    
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLG--- 86
Query: 98  SIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-DVSFAIEYFHHHCQP 156
              F    F  I  E +   +L   LR   G L+   Q +      +   ++Y H +   
Sbjct: 87  --SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN--- 141
Query: 157 SIVHGDLKPSNILLDQ-DIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPE 215
            IVH D+K  N+L++    V  + D G +K L G  P T   T        G + Y+APE
Sbjct: 142 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT--------GTLQYMAPE 193
Query: 216 ------YGMGSKASVSGDVYNFGILLLEMFTRR-------RPTDAMFNEGL 253
                  G G  A    D+++ G  ++EM T +        P  AMF  G+
Sbjct: 194 IIDKGPRGYGKAA----DIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGM 240

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 99/223 (44%), Gaps = 31/223 (13%)
Query: 27  KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRH 86
           K   N  P     QG V   Y  +LD + +I  +      Q  A R++  E   ++ + H
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 75
Query: 87  RNLIKIITICSSID-FEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-DVS 144
           +N+I ++ + +     E F    +V E M + NL Q +     Q+    +R++  +  + 
Sbjct: 76  KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVI-----QMELDHERMSYLLYQML 129
Query: 145 FAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIE 204
             I++ H      I+H DLKPSNI++  D    + D GLA+            TA  S  
Sbjct: 130 XGIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLAR------------TAGTSFM 174
Query: 205 IKGIV---GYVAPE--YGMGSKASVSGDVYNFGILLLEMFTRR 242
           +   V    Y APE   GMG K +V  D+++ G ++ EM   +
Sbjct: 175 MTPYVVTRYYRAPEVILGMGYKENV--DIWSVGCIMGEMVRHK 215

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 99/223 (44%), Gaps = 31/223 (13%)
Query: 27  KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRH 86
           K   N  P     QG V   Y  +LD + +I  +      Q  A R++  E   ++ + H
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 82
Query: 87  RNLIKIITICSSID-FEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-DVS 144
           +N+I ++ + +     E F    +V E M + NL Q +     Q+    +R++  +  + 
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVI-----QMELDHERMSYLLYQML 136
Query: 145 FAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIE 204
             I++ H      I+H DLKPSNI++  D    + D GLA+            TA  S  
Sbjct: 137 XGIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLAR------------TAGTSFM 181
Query: 205 IKGIV---GYVAPE--YGMGSKASVSGDVYNFGILLLEMFTRR 242
           +   V    Y APE   GMG K +V  D+++ G ++ EM   +
Sbjct: 182 MTPYVVTRYYRAPEVILGMGYKENV--DIWSVGCIMGEMVRHK 222

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 102/226 (45%), Gaps = 20/226 (8%)
Query: 25  LSKATNNFSPANKIGQGGVSIVYKGI-LDESRSIVAVKVVNLKQKEASRSFAA--ECNAL 81
           L +A   +    +IG+G    V+K   L      VA+K V ++  E     +   E   L
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 82  RNIR---HRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVN 138
           R++    H N++++  +C+    +      +VFE++ +++L  +L +            +
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKD 124
Query: 139 IAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAET 198
           +   +   +++ H H    +VH DLKP NIL+       + D GLA+         + + 
Sbjct: 125 MMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY-------SFQM 174
Query: 199 ASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
           A  S+ +   + Y APE  + S  +   D+++ G +  EMF RR+P
Sbjct: 175 ALTSVVV--TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF-RRKP 217

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 102/226 (45%), Gaps = 20/226 (8%)
Query: 25  LSKATNNFSPANKIGQGGVSIVYKGI-LDESRSIVAVKVVNLKQKEASRSFAA--ECNAL 81
           L +A   +    +IG+G    V+K   L      VA+K V ++  E     +   E   L
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 82  RNIR---HRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVN 138
           R++    H N++++  +C+    +      +VFE++ +++L  +L +            +
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKD 124
Query: 139 IAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAET 198
           +   +   +++ H H    +VH DLKP NIL+       + D GLA+         + + 
Sbjct: 125 MMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY-------SFQM 174
Query: 199 ASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
           A  S+ +   + Y APE  + S  +   D+++ G +  EMF RR+P
Sbjct: 175 ALTSVVV--TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF-RRKP 217

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 115/254 (45%), Gaps = 40/254 (15%)
Query: 32  FSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKE-----ASRSFAAECNALRNIRH 86
           +S   +IG GG S V++ +L+E + I A+K VNL++ +     + R+  A  N L+  +H
Sbjct: 14  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ--QH 70
Query: 87  RNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFA 146
            +  KII +    D+E  D    +     N +L  WL++      +  +R +   ++  A
Sbjct: 71  SD--KIIRL---YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPW--ERKSYWKNMLEA 123
Query: 147 IEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIK 206
           +   H H    IVH DLKP+N L+  D +  + D G+A  +   +P T +    + +   
Sbjct: 124 VHTIHQH---GIVHSDLKPANFLI-VDGMLKLIDFGIANQM---QPDTTSVVKDSQV--- 173
Query: 207 GIVGYVAPEYGMGSKASVSG-----------DVYNFGILLLEMFTRRRPTDAMFNEGLTL 255
           G V Y+ PE      +S              DV++ G +L  M   + P   + N+   L
Sbjct: 174 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL 233
Query: 256 HEFV----KMALPD 265
           H  +    ++  PD
Sbjct: 234 HAIIDPNHEIEFPD 247

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/251 (25%), Positives = 112/251 (44%), Gaps = 34/251 (13%)
Query: 32  FSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASR--SFAAECNALRNIRHRNL 89
           +S   +IG GG S V++ +L+E + I A+K VNL++ +     S+  E   L  ++  + 
Sbjct: 30  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS- 87
Query: 90  IKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEY 149
            KII +    D+E  D    +     N +L  WL++      +  +R +   ++  A+  
Sbjct: 88  DKIIRL---YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPW--ERKSYWKNMLEAVHT 142
Query: 150 FHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
            H H    IVH DLKP+N L+  D +  + D G+A  +   +P T +    + +   G V
Sbjct: 143 IHQH---GIVHSDLKPANFLI-VDGMLKLIDFGIANQM---QPDTTSVVKDSQV---GTV 192
Query: 210 GYVAPEYGMGSKASVSG-----------DVYNFGILLLEMFTRRRPTDAMFNEGLTLHEF 258
            Y+ PE      +S              DV++ G +L  M   + P   + N+   LH  
Sbjct: 193 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 252
Query: 259 V----KMALPD 265
           +    ++  PD
Sbjct: 253 IDPNHEIEFPD 263

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 102/226 (45%), Gaps = 20/226 (8%)
Query: 25  LSKATNNFSPANKIGQGGVSIVYKGI-LDESRSIVAVKVVNLKQKEASRSFAA--ECNAL 81
           L +A   +    +IG+G    V+K   L      VA+K V ++  E     +   E   L
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 82  RNIR---HRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVN 138
           R++    H N++++  +C+    +      +VFE++ +++L  +L +            +
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKD 124
Query: 139 IAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAET 198
           +   +   +++ H H    +VH DLKP NIL+       + D GLA+         + + 
Sbjct: 125 MMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY-------SFQM 174
Query: 199 ASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
           A  S+ +   + Y APE  + S  +   D+++ G +  EMF RR+P
Sbjct: 175 ALTSVVV--TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF-RRKP 217

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 101/225 (44%), Gaps = 24/225 (10%)
Query: 36  NKIGQG--GVSIVYKGILDESRSIVA---VKVVNLKQKEASRSFAAECNALRNIRHRNLI 90
            KIG+G  G +I+ K   D  + ++    +  ++ K++E SR    E   L N++H N++
Sbjct: 30  QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRR---EVAVLANMKHPNIV 86
Query: 91  KIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYF 150
           +         FE      IV +Y +  +L + +    G L    Q ++  + +  A+++ 
Sbjct: 87  QYRE-----SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV 141
Query: 151 HHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG 210
           H      I+H D+K  NI L +D    +GD G+A+ L      +  E A   I   G   
Sbjct: 142 HDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVL-----NSTVELARACI---GTPY 190
Query: 211 YVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTL 255
           Y++PE       +   D++  G +L E+ T +   +A   + L L
Sbjct: 191 YLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVL 235

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/232 (23%), Positives = 104/232 (44%), Gaps = 33/232 (14%)
Query: 37  KIGQGGVSIVYKG-----ILDESRSIVAVKVVNLKQKEASR-SFAAECNALRNIRHRNLI 90
           ++GQG   +VY+G     I  E+ + VAVK VN       R  F  E + ++     +++
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 91  KIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLR--------FLTQRVNIAID 142
           +++ + S           +V E M + +L+ +LR    +           L + + +A +
Sbjct: 84  RLLGVVSK-----GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 143 VSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNS 202
           ++  + Y +       VH DL   N ++  D    +GD G+ + ++        ETA   
Sbjct: 139 IADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIY--------ETAYYR 187
Query: 203 IEIKGI--VGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNE 251
              KG+  V ++APE       + S D+++FG++L E+ +   +P   + NE
Sbjct: 188 KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE 239

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 103/231 (44%), Gaps = 32/231 (13%)
Query: 70  ASRSFAAECNALRNIRHRNLIKIIT----ICSSIDFEGF--------DFKAIVF--EYMQ 115
            SR +A +    R+I   N +  +T    + S +D   F        D + + F   Y +
Sbjct: 54  TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAK 113
Query: 116 NRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIV 175
           N  L +++R+  G       R   A  VS A+EY H      I+H DLKP NILL++D+ 
Sbjct: 114 NGELLKYIRKI-GSFDETCTRFYTAEIVS-ALEYLHGK---GIIHRDLKPENILLNEDMH 168
Query: 176 AHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILL 235
             + D G AK L    P +    A+  +   G   YV+PE      A  S D++  G ++
Sbjct: 169 IQITDFGTAKVL---SPESKQARANXFV---GTAQYVSPELLTEKSACKSSDLWALGCII 222
Query: 236 LEMFTRRRPTDAMFNEGLTLHEFVKMA--LPDKVM----EIVDPSLLLEVT 280
            ++     P  A  NE L   + +K+    P+K      ++V+  L+L+ T
Sbjct: 223 YQLVAGLPPFRAG-NEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDAT 272

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 115/254 (45%), Gaps = 40/254 (15%)
Query: 32  FSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKE-----ASRSFAAECNALRNIRH 86
           +S   +IG GG S V++ +L+E + I A+K VNL++ +     + R+  A  N L+  +H
Sbjct: 10  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ--QH 66
Query: 87  RNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFA 146
            +  KII +    D+E  D    +     N +L  WL++      +  +R +   ++  A
Sbjct: 67  SD--KIIRL---YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPW--ERKSYWKNMLEA 119
Query: 147 IEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIK 206
           +   H H    IVH DLKP+N L+   ++  + D G+A  +   +P T +    + +   
Sbjct: 120 VHTIHQH---GIVHSDLKPANFLIVDGMLKLI-DFGIANQM---QPDTTSVVKDSQV--- 169
Query: 207 GIVGYVAPEYGMGSKASVSG-----------DVYNFGILLLEMFTRRRPTDAMFNEGLTL 255
           G V Y+ PE      +S              DV++ G +L  M   + P   + N+   L
Sbjct: 170 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL 229
Query: 256 HEFV----KMALPD 265
           H  +    ++  PD
Sbjct: 230 HAIIDPNHEIEFPD 243

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 106/222 (47%), Gaps = 32/222 (14%)
Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNL 89
           ++F   +++G G   +V+K     S  ++A K+++L+ K A          +RN   R L
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA----------IRNQIIREL 55
Query: 90  IKIITICSS---IDFEGFDFK----AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAID 142
            +++  C+S   + F G  +     +I  E+M   +L+Q L+++      +  +V+IA+ 
Sbjct: 56  -QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI 114
Query: 143 VSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNS 202
                    H     I+H D+KPSNIL++      + D G++        G   ++ +NS
Sbjct: 115 KGLTYLREKH----KIMHRDVKPSNILVNSRGEIKLCDFGVS--------GQLIDSMANS 162
Query: 203 IEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
               G   Y++PE   G+  SV  D+++ G+ L+EM   R P
Sbjct: 163 F--VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 97/219 (44%), Gaps = 31/219 (14%)
Query: 27  KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRH 86
           K   N  P     QG V   Y  IL+ + +I  +      Q  A R++  E   ++ + H
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 82
Query: 87  RNLIKIITI-CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-DVS 144
           +N+I ++ +       E F    IV E M + NL Q +     Q+    +R++  +  + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVI-----QMELDHERMSYLLYQML 136
Query: 145 FAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIE 204
             I++ H      I+H DLKPSNI++  D    + D GLA+            TA  S  
Sbjct: 137 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR------------TAGTSFM 181
Query: 205 IKGIV---GYVAPE--YGMGSKASVSGDVYNFGILLLEM 238
           +   V    Y APE   GMG K +V  D+++ G ++ EM
Sbjct: 182 MTPYVVTRYYRAPEVILGMGYKENV--DIWSVGCIMGEM 218

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 106/222 (47%), Gaps = 32/222 (14%)
Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNL 89
           ++F   +++G G   +V+K     S  ++A K+++L+ K A          +RN   R L
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA----------IRNQIIREL 55
Query: 90  IKIITICSS---IDFEGFDFK----AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAID 142
            +++  C+S   + F G  +     +I  E+M   +L+Q L+++      +  +V+IA+ 
Sbjct: 56  -QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI 114
Query: 143 VSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNS 202
                    H     I+H D+KPSNIL++      + D G++        G   ++ +NS
Sbjct: 115 KGLTYLREKH----KIMHRDVKPSNILVNSRGEIKLCDFGVS--------GQLIDSMANS 162
Query: 203 IEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
               G   Y++PE   G+  SV  D+++ G+ L+EM   R P
Sbjct: 163 F--VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 63/251 (25%), Positives = 112/251 (44%), Gaps = 34/251 (13%)
Query: 32  FSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASR--SFAAECNALRNIRHRNL 89
           +S   +IG GG S V++ +L+E + I A+K VNL++ +     S+  E   L  ++  + 
Sbjct: 11  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS- 68
Query: 90  IKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEY 149
            KII +    D+E  D    +     N +L  WL++      +  +R +   ++  A+  
Sbjct: 69  DKIIRL---YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPW--ERKSYWKNMLEAVHT 123
Query: 150 FHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
            H H    IVH DLKP+N L+   ++  + D G+A  +   +P T +    + +   G V
Sbjct: 124 IHQH---GIVHSDLKPANFLIVDGMLKLI-DFGIANQM---QPDTTSVVKDSQV---GTV 173
Query: 210 GYVAPEYGMGSKASVSG-----------DVYNFGILLLEMFTRRRPTDAMFNEGLTLHEF 258
            Y+ PE      +S              DV++ G +L  M   + P   + N+   LH  
Sbjct: 174 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 233
Query: 259 V----KMALPD 265
           +    ++  PD
Sbjct: 234 IDPNHEIEFPD 244

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 99/223 (44%), Gaps = 31/223 (13%)
Query: 27  KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRH 86
           K   N  P     QG V   Y  +LD + +I  +      Q  A R++  E   ++ + H
Sbjct: 62  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 120
Query: 87  RNLIKIITICSSID-FEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-DVS 144
           +N+I ++ + +     E F    +V E M + NL Q +     Q+    +R++  +  + 
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI-----QMELDHERMSYLLYQML 174
Query: 145 FAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIE 204
             I++ H      I+H DLKPSNI++  D    + D GLA+            TA  S  
Sbjct: 175 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR------------TAGTSFM 219
Query: 205 IKGIV---GYVAPE--YGMGSKASVSGDVYNFGILLLEMFTRR 242
           +   V    Y APE   GMG K +V  D+++ G ++ EM   +
Sbjct: 220 MTPYVVTRYYRAPEVILGMGYKENV--DIWSVGCIMGEMVRHK 260

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 64/251 (25%), Positives = 112/251 (44%), Gaps = 34/251 (13%)
Query: 32  FSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASR--SFAAECNALRNIRHRNL 89
           +S   +IG GG S V++ +L+E + I A+K VNL++ +     S+  E   L  ++  + 
Sbjct: 58  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS- 115
Query: 90  IKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEY 149
            KII +    D+E  D    +     N +L  WL++      +  +R +   ++  A+  
Sbjct: 116 DKIIRL---YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPW--ERKSYWKNMLEAVHT 170
Query: 150 FHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
            H H    IVH DLKP+N L+  D +  + D G+A  +   +P T +    + +   G V
Sbjct: 171 IHQH---GIVHSDLKPANFLI-VDGMLKLIDFGIANQM---QPDTTSVVKDSQV---GTV 220
Query: 210 GYVAPEYGMGSKASVSG-----------DVYNFGILLLEMFTRRRPTDAMFNEGLTLHEF 258
            Y+ PE      +S              DV++ G +L  M   + P   + N+   LH  
Sbjct: 221 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 280
Query: 259 V----KMALPD 265
           +    ++  PD
Sbjct: 281 IDPNHEIEFPD 291

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 106/222 (47%), Gaps = 32/222 (14%)
Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNL 89
           ++F   +++G G   +V+K     S  ++A K+++L+ K A          +RN   R L
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA----------IRNQIIREL 82
Query: 90  IKIITICSS---IDFEGFDFK----AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAID 142
            +++  C+S   + F G  +     +I  E+M   +L+Q L+++      +  +V+IA+ 
Sbjct: 83  -QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI 141
Query: 143 VSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNS 202
                    H     I+H D+KPSNIL++      + D G++        G   ++ +NS
Sbjct: 142 KGLTYLREKH----KIMHRDVKPSNILVNSRGEIKLCDFGVS--------GQLIDSMANS 189
Query: 203 IEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
               G   Y++PE   G+  SV  D+++ G+ L+EM   R P
Sbjct: 190 F--VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 31/219 (14%)
Query: 27  KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRH 86
           K   N  P     QG V   Y  +LD + +I  +      Q  A R++  E   ++ + H
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNH 82
Query: 87  RNLIKIITICS-SIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-DVS 144
           +N+I ++ + +     E F    +V E M + NL Q +     Q+    +R++  +  + 
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI-----QMELDHERMSYLLYQML 136
Query: 145 FAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIE 204
             I++ H      I+H DLKPSNI++  D    + D GLA+            TA  S  
Sbjct: 137 CGIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLAR------------TAGTSFM 181
Query: 205 IKGIV---GYVAPE--YGMGSKASVSGDVYNFGILLLEM 238
           +   V    Y APE   GMG K +V  D+++ G ++ EM
Sbjct: 182 MTPYVVTRYYRAPEVILGMGYKENV--DIWSVGCIMGEM 218

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 106/222 (47%), Gaps = 32/222 (14%)
Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNL 89
           ++F   +++G G   +V+K     S  ++A K+++L+ K A          +RN   R L
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA----------IRNQIIREL 55
Query: 90  IKIITICSS---IDFEGFDFK----AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAID 142
            +++  C+S   + F G  +     +I  E+M   +L+Q L+++      +  +V+IA+ 
Sbjct: 56  -QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI 114
Query: 143 VSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNS 202
                    H     I+H D+KPSNIL++      + D G++        G   ++ +NS
Sbjct: 115 KGLTYLREKH----KIMHRDVKPSNILVNSRGEIKLCDFGVS--------GQLIDSMANS 162
Query: 203 IEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
               G   Y++PE   G+  SV  D+++ G+ L+EM   R P
Sbjct: 163 F--VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 99/223 (44%), Gaps = 31/223 (13%)
Query: 27  KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRH 86
           K   N  P     QG V   Y  +LD + +I  +      Q  A R++  E   ++ + H
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 75
Query: 87  RNLIKIITICSSID-FEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-DVS 144
           +N+I ++ + +     E F    +V E M + NL Q +     Q+    +R++  +  + 
Sbjct: 76  KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI-----QMELDHERMSYLLYQML 129
Query: 145 FAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIE 204
             I++ H      I+H DLKPSNI++  D    + D GLA+            TA  S  
Sbjct: 130 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR------------TAGTSFM 174
Query: 205 IKGIV---GYVAPE--YGMGSKASVSGDVYNFGILLLEMFTRR 242
           +   V    Y APE   GMG K +V  D+++ G ++ EM   +
Sbjct: 175 MTPYVVTRYYRAPEVILGMGYKENV--DIWSVGCIMGEMVRHK 215

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 99/223 (44%), Gaps = 31/223 (13%)
Query: 27  KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRH 86
           K   N  P     QG V   Y  +LD + +I  +      Q  A R++  E   ++ + H
Sbjct: 18  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 76
Query: 87  RNLIKIITICSSID-FEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-DVS 144
           +N+I ++ + +     E F    +V E M + NL Q +     Q+    +R++  +  + 
Sbjct: 77  KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI-----QMELDHERMSYLLYQML 130
Query: 145 FAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIE 204
             I++ H      I+H DLKPSNI++  D    + D GLA+            TA  S  
Sbjct: 131 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR------------TAGTSFM 175
Query: 205 IKGIV---GYVAPE--YGMGSKASVSGDVYNFGILLLEMFTRR 242
           +   V    Y APE   GMG K +V  D+++ G ++ EM   +
Sbjct: 176 MTPYVVTRYYRAPEVILGMGYKENV--DIWSVGCIMGEMVRHK 216

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 106/222 (47%), Gaps = 32/222 (14%)
Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNL 89
           ++F   +++G G   +V+K     S  ++A K+++L+ K A          +RN   R L
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA----------IRNQIIREL 55
Query: 90  IKIITICSS---IDFEGFDFK----AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAID 142
            +++  C+S   + F G  +     +I  E+M   +L+Q L+++      +  +V+IA+ 
Sbjct: 56  -QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI 114
Query: 143 VSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNS 202
                    H     I+H D+KPSNIL++      + D G++        G   ++ +NS
Sbjct: 115 KGLTYLREKH----KIMHRDVKPSNILVNSRGEIKLCDFGVS--------GQLIDSMANS 162
Query: 203 IEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
               G   Y++PE   G+  SV  D+++ G+ L+EM   R P
Sbjct: 163 F--VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 106/222 (47%), Gaps = 32/222 (14%)
Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNL 89
           ++F   +++G G   +V+K     S  ++A K+++L+ K A          +RN   R L
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA----------IRNQIIREL 55
Query: 90  IKIITICSS---IDFEGFDFK----AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAID 142
            +++  C+S   + F G  +     +I  E+M   +L+Q L+++      +  +V+IA+ 
Sbjct: 56  -QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI 114
Query: 143 VSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNS 202
                    H     I+H D+KPSNIL++      + D G++        G   ++ +NS
Sbjct: 115 KGLTYLREKH----KIMHRDVKPSNILVNSRGEIKLCDFGVS--------GQLIDSMANS 162
Query: 203 IEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
               G   Y++PE   G+  SV  D+++ G+ L+EM   R P
Sbjct: 163 F--VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 99/231 (42%), Gaps = 35/231 (15%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICS 97
           +G+G   IVY G    ++  +A+K +  +    S+    E    ++++H+N+++ +    
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLG--- 72
Query: 98  SIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-DVSFAIEYFHHHCQP 156
              F    F  I  E +   +L   LR   G L+   Q +      +   ++Y H +   
Sbjct: 73  --SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN--- 127
Query: 157 SIVHGDLKPSNILLDQ-DIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPE 215
            IVH D+K  N+L++    V  + D G +K L G  P T   T        G + Y+APE
Sbjct: 128 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT--------GTLQYMAPE 179
Query: 216 Y------GMGSKASVSGDVYNFGILLLEMFTRR-------RPTDAMFNEGL 253
                  G G  A    D+++ G  ++EM T +        P  AMF  G+
Sbjct: 180 IIDKGPRGYGKAA----DIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGM 226

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 97/219 (44%), Gaps = 31/219 (14%)
Query: 27  KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRH 86
           K   N  P     QG V   Y  IL+ + +I  +      Q  A R++  E   ++ + H
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNH 82
Query: 87  RNLIKIITI-CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-DVS 144
           +N+I ++ +       E F    IV E M + NL Q +     Q+    +R++  +  + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVI-----QMELDHERMSYLLYQML 136
Query: 145 FAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIE 204
             I++ H      I+H DLKPSNI++  D    + D GLA+            TA  S  
Sbjct: 137 VGIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLAR------------TAGTSFM 181
Query: 205 IKGIV---GYVAPE--YGMGSKASVSGDVYNFGILLLEM 238
           +   V    Y APE   GMG K +V  D+++ G ++ EM
Sbjct: 182 MTPYVVTRYYRAPEVILGMGYKENV--DIWSVGCIMGEM 218

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 99/223 (44%), Gaps = 31/223 (13%)
Query: 27  KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRH 86
           K   N  P     QG V   Y  +LD + +I  +      Q  A R++  E   ++ + H
Sbjct: 25  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 83
Query: 87  RNLIKIITICSSID-FEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-DVS 144
           +N+I ++ + +     E F    +V E M + NL Q +     Q+    +R++  +  + 
Sbjct: 84  KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI-----QMELDHERMSYLLYQML 137
Query: 145 FAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIE 204
             I++ H      I+H DLKPSNI++  D    + D GLA+            TA  S  
Sbjct: 138 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR------------TAGTSFM 182
Query: 205 IKGIV---GYVAPE--YGMGSKASVSGDVYNFGILLLEMFTRR 242
           +   V    Y APE   GMG K +V  D+++ G ++ EM   +
Sbjct: 183 MTPYVVTRYYRAPEVILGMGYKENV--DIWSVGCIMGEMVRHK 223

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 99/223 (44%), Gaps = 31/223 (13%)
Query: 27  KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRH 86
           K   N  P     QG V   Y  +LD + +I  +      Q  A R++  E   ++ + H
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 82
Query: 87  RNLIKIITICSSID-FEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-DVS 144
           +N+I ++ + +     E F    +V E M + NL Q +     Q+    +R++  +  + 
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI-----QMELDHERMSYLLYQML 136
Query: 145 FAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIE 204
             I++ H      I+H DLKPSNI++  D    + D GLA+            TA  S  
Sbjct: 137 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR------------TAGTSFM 181
Query: 205 IKGIV---GYVAPE--YGMGSKASVSGDVYNFGILLLEMFTRR 242
           +   V    Y APE   GMG K +V  D+++ G ++ EM   +
Sbjct: 182 MTPYVVTRYYRAPEVILGMGYKENV--DIWSVGCIMGEMVRHK 222

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 99/223 (44%), Gaps = 31/223 (13%)
Query: 27  KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRH 86
           K   N  P     QG V   Y  +LD + +I  +      Q  A R++  E   ++ + H
Sbjct: 23  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 81
Query: 87  RNLIKIITICSSID-FEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-DVS 144
           +N+I ++ + +     E F    +V E M + NL Q +     Q+    +R++  +  + 
Sbjct: 82  KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI-----QMELDHERMSYLLYQML 135
Query: 145 FAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIE 204
             I++ H      I+H DLKPSNI++  D    + D GLA+            TA  S  
Sbjct: 136 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR------------TAGTSFM 180
Query: 205 IKGIV---GYVAPE--YGMGSKASVSGDVYNFGILLLEMFTRR 242
           +   V    Y APE   GMG K +V  D+++ G ++ EM   +
Sbjct: 181 MTPYVVTRYYRAPEVILGMGYKENV--DIWSVGCIMGEMVRHK 221

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 99/223 (44%), Gaps = 31/223 (13%)
Query: 27  KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRH 86
           K   N  P     QG V   Y  +LD + +I  +      Q  A R++  E   ++ + H
Sbjct: 62  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 120
Query: 87  RNLIKIITICSSID-FEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-DVS 144
           +N+I ++ + +     E F    +V E M + NL Q +     Q+    +R++  +  + 
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI-----QMELDHERMSYLLYQML 174
Query: 145 FAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIE 204
             I++ H      I+H DLKPSNI++  D    + D GLA+            TA  S  
Sbjct: 175 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR------------TAGTSFM 219
Query: 205 IKGIV---GYVAPE--YGMGSKASVSGDVYNFGILLLEMFTRR 242
           +   V    Y APE   GMG K +V  D+++ G ++ EM   +
Sbjct: 220 MTPYVVTRYYRAPEVILGMGYKENV--DIWSVGCIMGEMVRHK 260

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 99/223 (44%), Gaps = 31/223 (13%)
Query: 27  KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRH 86
           K   N  P     QG V   Y  +LD + +I  +      Q  A R++  E   ++ + H
Sbjct: 18  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 76
Query: 87  RNLIKIITICSSID-FEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-DVS 144
           +N+I ++ + +     E F    +V E M + NL Q +     Q+    +R++  +  + 
Sbjct: 77  KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI-----QMELDHERMSYLLYQML 130
Query: 145 FAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIE 204
             I++ H      I+H DLKPSNI++  D    + D GLA+            TA  S  
Sbjct: 131 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR------------TAGTSFM 175
Query: 205 IKGIV---GYVAPE--YGMGSKASVSGDVYNFGILLLEMFTRR 242
           +   V    Y APE   GMG K +V  D+++ G ++ EM   +
Sbjct: 176 MTPYVVTRYYRAPEVILGMGYKENV--DIWSVGCIMGEMVRHK 216

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 97/219 (44%), Gaps = 31/219 (14%)
Query: 27  KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRH 86
           K   N  P     QG V   Y  IL+ + +I  +      Q  A R++  E   ++ + H
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 82
Query: 87  RNLIKIITI-CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-DVS 144
           +N+I ++ +       E F    IV E M + NL Q +     Q+    +R++  +  + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVI-----QMELDHERMSYLLYQML 136
Query: 145 FAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIE 204
             I++ H      I+H DLKPSNI++  D    + D GLA+            TA  S  
Sbjct: 137 CGIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLAR------------TAGTSFM 181
Query: 205 IKGIV---GYVAPE--YGMGSKASVSGDVYNFGILLLEM 238
           +   V    Y APE   GMG K +V  D+++ G ++ EM
Sbjct: 182 MTPYVVTRYYRAPEVILGMGYKENV--DIWSVGCIMGEM 218

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 99/223 (44%), Gaps = 31/223 (13%)
Query: 27  KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRH 86
           K   N  P     QG V   Y  +LD + +I  +      Q  A R++  E   ++ + H
Sbjct: 25  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 83
Query: 87  RNLIKIITICSSID-FEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-DVS 144
           +N+I ++ + +     E F    +V E M + NL Q +     Q+    +R++  +  + 
Sbjct: 84  KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI-----QMELDHERMSYLLYQML 137
Query: 145 FAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIE 204
             I++ H      I+H DLKPSNI++  D    + D GLA+            TA  S  
Sbjct: 138 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR------------TAGTSFM 182
Query: 205 IKGIV---GYVAPE--YGMGSKASVSGDVYNFGILLLEMFTRR 242
           +   V    Y APE   GMG K +V  D+++ G ++ EM   +
Sbjct: 183 MTPYVVTRYYRAPEVILGMGYKENV--DIWSVGCIMGEMVRHK 223

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 106/222 (47%), Gaps = 32/222 (14%)
Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNL 89
           ++F   +++G G   +V+K     S  ++A K+++L+ K A          +RN   R L
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA----------IRNQIIREL 117
Query: 90  IKIITICSSIDFEGF------DFK-AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAID 142
            +++  C+S    GF      D + +I  E+M   +L+Q L+++      +  +V+IA+ 
Sbjct: 118 -QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI 176
Query: 143 VSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNS 202
                    H     I+H D+KPSNIL++      + D G++        G   ++ +NS
Sbjct: 177 KGLTYLREKH----KIMHRDVKPSNILVNSRGEIKLCDFGVS--------GQLIDSMANS 224
Query: 203 IEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
               G   Y++PE   G+  SV  D+++ G+ L+EM   R P
Sbjct: 225 F--VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 264

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/245 (21%), Positives = 108/245 (44%), Gaps = 33/245 (13%)
Query: 24  ELSKATNNFSPANKIGQGGVSIVYKGIL-----DESRSIVAVKVVNLKQKEASR-SFAAE 77
           E   A    + + ++GQG   +VY+G+      DE  + VA+K VN       R  F  E
Sbjct: 19  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 78
Query: 78  CNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLR------ 131
            + ++     ++++++ + S           ++ E M   +L+ +LR     +       
Sbjct: 79  ASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 133
Query: 132 --FLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG 189
              L++ + +A +++  + Y + +     VH DL   N ++ +D    +GD G+ + ++ 
Sbjct: 134 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY- 189
Query: 190 YEPGTAAETASNSIEIKGI--VGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTD 246
                  ET       KG+  V +++PE       +   DV++FG++L E+ T   +P  
Sbjct: 190 -------ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 242
Query: 247 AMFNE 251
            + NE
Sbjct: 243 GLSNE 247

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 99/223 (44%), Gaps = 31/223 (13%)
Query: 27  KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRH 86
           K   N  P     QG V   Y  +LD + +I  +      Q  A R++  E   ++ + H
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 82
Query: 87  RNLIKIITICSSID-FEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-DVS 144
           +N+I ++ + +     E F    +V E M + NL Q +     Q+    +R++  +  + 
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI-----QMELDHERMSYLLYQML 136
Query: 145 FAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIE 204
             I++ H      I+H DLKPSNI++  D    + D GLA+            TA  S  
Sbjct: 137 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR------------TAGTSFM 181
Query: 205 IKGIV---GYVAPE--YGMGSKASVSGDVYNFGILLLEMFTRR 242
           +   V    Y APE   GMG K +V  D+++ G ++ EM   +
Sbjct: 182 MTPYVVTRYYRAPEVILGMGYKENV--DIWSVGCIMGEMVRHK 222

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/245 (21%), Positives = 108/245 (44%), Gaps = 33/245 (13%)
Query: 24  ELSKATNNFSPANKIGQGGVSIVYKGIL-----DESRSIVAVKVVNLKQKEASR-SFAAE 77
           E   A    + + ++GQG   +VY+G+      DE  + VA+K VN       R  F  E
Sbjct: 9   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 68
Query: 78  CNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLR------ 131
            + ++     ++++++ + S           ++ E M   +L+ +LR     +       
Sbjct: 69  ASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 123
Query: 132 --FLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG 189
              L++ + +A +++  + Y + +     VH DL   N ++ +D    +GD G+ + ++ 
Sbjct: 124 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY- 179
Query: 190 YEPGTAAETASNSIEIKGI--VGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTD 246
                  ET       KG+  V +++PE       +   DV++FG++L E+ T   +P  
Sbjct: 180 -------ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 232
Query: 247 AMFNE 251
            + NE
Sbjct: 233 GLSNE 237

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 98/215 (45%), Gaps = 32/215 (14%)
Query: 12  SMKQQFPMISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL------ 65
           SM  +  +  +A   +    + P + IG+G  S+V + +   +    AVK++ +      
Sbjct: 76  SMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLS 135
Query: 66  --KQKEASRSFAAECNALRNIR-HRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQW 122
             + +E   +   E + LR +  H ++I +I       +E   F  +VF+ M+   L  +
Sbjct: 136 PEQLEEVREATRRETHILRQVAGHPHIITLID-----SYESSSFMFLVFDLMRKGELFDY 190
Query: 123 LRQSNGQLRFLTQRVNIAIDVSF--AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGD 180
           L +       L+++   +I  S   A+ + H +   +IVH DLKP NILLD ++   + D
Sbjct: 191 LTEKVA----LSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSD 243
Query: 181 LGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPE 215
            G +  L   EPG          E+ G  GY+APE
Sbjct: 244 FGFSCHL---EPGEKLR------ELCGTPGYLAPE 269

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 107/222 (48%), Gaps = 32/222 (14%)
Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNL 89
           ++F   +++G G   +V K     S  I+A K+++L+ K A          +RN   R L
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPA----------IRNQIIREL 65
Query: 90  IKIITICSSIDFEGF------DFK-AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAID 142
            +++  C+S    GF      D + +I  E+M   +L+Q L+++      +  +V+IA+ 
Sbjct: 66  -QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVL 124
Query: 143 VSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNS 202
              A  Y     Q  I+H D+KPSNIL++      + D G++        G   ++ +NS
Sbjct: 125 RGLA--YLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVS--------GQLIDSMANS 172
Query: 203 IEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
               G   Y+APE   G+  SV  D+++ G+ L+E+   R P
Sbjct: 173 F--VGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYP 212

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 113/254 (44%), Gaps = 33/254 (12%)
Query: 32  FSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASR--SFAAECNALRNIRHRNL 89
           +S   +IG GG S V++ +L+E + I A+K VNL++ +     S+  E   L  ++  + 
Sbjct: 58  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS- 115
Query: 90  IKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEY 149
            KII +    D+E  D    +     N +L  WL++      +  +R +   ++  A+  
Sbjct: 116 DKIIRL---YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPW--ERKSYWKNMLEAVHT 170
Query: 150 FHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
            H H    IVH DLKP+N L+   ++  + D G+A  +   +P T +    + +   G V
Sbjct: 171 IHQH---GIVHSDLKPANFLIVDGMLKLI-DFGIANQM---QPDTTSVVKDSQV---GTV 220
Query: 210 GYVAPEYGMGSKASVSG-----------DVYNFGILLLEMFTRRRPTDAMFNEGLTLHEF 258
            Y+ PE      +S              DV++ G +L  M   + P   + N+   LH  
Sbjct: 221 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 280
Query: 259 VKMALPDKVMEIVD 272
           +    P+  +E  D
Sbjct: 281 ID---PNHEIEFPD 291

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 98/204 (48%), Gaps = 20/204 (9%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFA-AECNALRNIRHRNLIKIITI 95
           KIG+G   +VYK   +   +    K+   K+ E   S    E + L+ ++H N++K+  +
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 96  CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQ 155
             +          +VFE++ +++L++ L    G L  +T + +  + +   I Y H    
Sbjct: 69  IHTKKR-----LVLVFEHL-DQDLKKLLDVCEGGLESVTAK-SFLLQLLNGIAYCHDR-- 119
Query: 156 PSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPE 215
             ++H DLKP N+L++++    + D GLA+       G      ++ I     + Y AP+
Sbjct: 120 -RVLHRDLKPQNLLINREGELKIADFGLARAF-----GIPVRKYTHEIV---TLWYRAPD 170
Query: 216 YGMGSKA-SVSGDVYNFGILLLEM 238
             MGSK  S + D+++ G +  EM
Sbjct: 171 VLMGSKKYSTTIDIWSVGCIFAEM 194

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 97/219 (44%), Gaps = 31/219 (14%)
Query: 27  KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRH 86
           K   N  P     QG V   Y  IL+ + +I  +      Q  A R++  E   ++ + H
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNH 82
Query: 87  RNLIKIITI-CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-DVS 144
           +N+I ++ +       E F    IV E M + NL Q +     Q+    +R++  +  + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVI-----QMELDHERMSYLLYQML 136
Query: 145 FAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIE 204
             I++ H      I+H DLKPSNI++  D    + D GLA+            TA  S  
Sbjct: 137 CGIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLAR------------TAGTSFM 181
Query: 205 IKGIV---GYVAPE--YGMGSKASVSGDVYNFGILLLEM 238
           +   V    Y APE   GMG K +V  D+++ G ++ EM
Sbjct: 182 MTPYVVTRYYRAPEVILGMGYKENV--DIWSVGCIMGEM 218

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 97/219 (44%), Gaps = 31/219 (14%)
Query: 27  KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRH 86
           K   N  P     QG V   Y  IL+ + +I  +      Q  A R++  E   ++ + H
Sbjct: 25  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 83
Query: 87  RNLIKIITI-CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-DVS 144
           +N+I ++ +       E F    IV E M + NL Q +     Q+    +R++  +  + 
Sbjct: 84  KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVI-----QMELDHERMSYLLYQML 137
Query: 145 FAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIE 204
             I++ H      I+H DLKPSNI++  D    + D GLA+            TA  S  
Sbjct: 138 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR------------TAGTSFM 182
Query: 205 IKGIV---GYVAPE--YGMGSKASVSGDVYNFGILLLEM 238
           +   V    Y APE   GMG K +V  D+++ G ++ EM
Sbjct: 183 MTPYVVTRYYRAPEVILGMGYKENV--DIWSVGCIMGEM 219

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 96/227 (42%), Gaps = 37/227 (16%)
Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNL 89
           N+FS    IG+GG   VY     ++  + A+K ++ K+ +  +      N       R +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALN------ERIM 242
Query: 90  IKIIT-------ICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQ----SNGQLRFLTQRVN 138
           + +++       +C S  F   D  + + + M   +L   L Q    S   +RF      
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF------ 296
Query: 139 IAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAET 198
            A ++   +E+ H+     +V+ DLKP+NILLD+     + DLGLA      +P  +   
Sbjct: 297 YAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-- 351
Query: 199 ASNSIEIKGIVGYVAPE-YGMGSKASVSGDVYNFGILLLEMFTRRRP 244
                   G  GY+APE    G     S D ++ G +L ++     P
Sbjct: 352 --------GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 96/227 (42%), Gaps = 37/227 (16%)
Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNL 89
           N+FS    IG+GG   VY     ++  + A+K ++ K+ +  +      N       R +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALN------ERIM 242
Query: 90  IKIIT-------ICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQ----SNGQLRFLTQRVN 138
           + +++       +C S  F   D  + + + M   +L   L Q    S   +RF      
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF------ 296
Query: 139 IAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAET 198
            A ++   +E+ H+     +V+ DLKP+NILLD+     + DLGLA      +P  +   
Sbjct: 297 YAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-- 351
Query: 199 ASNSIEIKGIVGYVAPE-YGMGSKASVSGDVYNFGILLLEMFTRRRP 244
                   G  GY+APE    G     S D ++ G +L ++     P
Sbjct: 352 --------GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 101/218 (46%), Gaps = 35/218 (16%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAA--ECNALRNIRHRNLIKIIT 94
           KIG+G    V+K    E+  IVA+K V L   +     +A  E   L+ ++H+N++++  
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 95  ICSSIDFEGFDFK-AIVFEYMQNRNLEQWLRQSNGQL------RFLTQRVNIAIDVSFAI 147
           +  S      D K  +VFE+  +++L+++    NG L       FL Q +         +
Sbjct: 69  VLHS------DKKLTLVFEFC-DQDLKKYFDSCNGDLDPEIVKSFLFQLLK-------GL 114
Query: 148 EYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKG 207
            + H     +++H DLKP N+L++++    + D GLA+       G      S  +    
Sbjct: 115 GFCHSR---NVLHRDLKPQNLLINRNGELKLADFGLARAF-----GIPVRCYSAEVV--- 163
Query: 208 IVGYVAPEYGMGSKA-SVSGDVYNFGILLLEMFTRRRP 244
            + Y  P+   G+K  S S D+++ G +  E+    RP
Sbjct: 164 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAARP 201

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 99/223 (44%), Gaps = 31/223 (13%)
Query: 27  KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRH 86
           K   N  P     QG V   Y  IL+ + +I  +      Q  A R++  E   ++ + H
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 82
Query: 87  RNLIKIITI-CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-DVS 144
           +N+I ++ +       E F    IV E M + NL Q +     Q+    +R++  +  + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVI-----QMELDHERMSYLLYQML 136
Query: 145 FAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIE 204
             I++ H      I+H DLKPSNI++  D    + D GLA+            TA  S  
Sbjct: 137 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR------------TAGTSFM 181
Query: 205 IKGIV---GYVAPE--YGMGSKASVSGDVYNFGILLLEMFTRR 242
           ++  V    Y APE   GMG K +V  D+++ G ++ EM   +
Sbjct: 182 MEPEVVTRYYRAPEVILGMGYKENV--DIWSVGCIMGEMVCHK 222

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 97/219 (44%), Gaps = 31/219 (14%)
Query: 27  KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRH 86
           K   N  P     QG V   Y  IL+ + +I  +      Q  A R++  E   ++ + H
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 82
Query: 87  RNLIKIITI-CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-DVS 144
           +N+I ++ +       E F    IV E M + NL Q +     Q+    +R++  +  + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVI-----QMELDHERMSYLLYQML 136
Query: 145 FAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIE 204
             I++ H      I+H DLKPSNI++  D    + D GLA+            TA  S  
Sbjct: 137 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR------------TAGTSFM 181
Query: 205 IKGIV---GYVAPE--YGMGSKASVSGDVYNFGILLLEM 238
           +   V    Y APE   GMG K +V  D+++ G ++ EM
Sbjct: 182 MTPYVVTRYYRAPEVILGMGYKENV--DIWSVGCIMGEM 218

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 113/254 (44%), Gaps = 33/254 (12%)
Query: 32  FSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASR--SFAAECNALRNIRHRNL 89
           +S   +IG GG S V++ +L+E + I A+K VNL++ +     S+  E   L  ++  + 
Sbjct: 58  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS- 115
Query: 90  IKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEY 149
            KII +    D+E  D    +     N +L  WL++      +  +R +   ++  A+  
Sbjct: 116 DKIIRL---YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPW--ERKSYWKNMLEAVHT 170
Query: 150 FHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
            H H    IVH DLKP+N L+   ++  + D G+A  +   +P T +    + +   G V
Sbjct: 171 IHQH---GIVHSDLKPANFLIVDGMLKLI-DFGIANQM---QPDTTSVVKDSQV---GAV 220
Query: 210 GYVAPEYGMGSKASVSG-----------DVYNFGILLLEMFTRRRPTDAMFNEGLTLHEF 258
            Y+ PE      +S              DV++ G +L  M   + P   + N+   LH  
Sbjct: 221 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 280
Query: 259 VKMALPDKVMEIVD 272
           +    P+  +E  D
Sbjct: 281 ID---PNHEIEFPD 291

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 106/222 (47%), Gaps = 32/222 (14%)
Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNL 89
           ++F   +++G G   +V+K     S  ++A K+++L+ K A          +RN   R L
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA----------IRNQIIREL 74
Query: 90  IKIITICSS---IDFEGFDFK----AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAID 142
            +++  C+S   + F G  +     +I  E+M   +L+Q L+++      +  +V+IA+ 
Sbjct: 75  -QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI 133
Query: 143 VSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNS 202
                    H     I+H D+KPSNIL++      + D G++        G   ++ +NS
Sbjct: 134 KGLTYLREKH----KIMHRDVKPSNILVNSRGEIKLCDFGVS--------GQLIDSMANS 181
Query: 203 IEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
               G   Y++PE   G+  SV  D+++ G+ L+EM   R P
Sbjct: 182 F--VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 221

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 96/227 (42%), Gaps = 37/227 (16%)
Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNL 89
           N+FS    IG+GG   VY     ++  + A+K ++ K+ +  +      N       R +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALN------ERIM 242
Query: 90  IKIIT-------ICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQ----SNGQLRFLTQRVN 138
           + +++       +C S  F   D  + + + M   +L   L Q    S   +RF      
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF------ 296
Query: 139 IAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAET 198
            A ++   +E+ H+     +V+ DLKP+NILLD+     + DLGLA      +P  +   
Sbjct: 297 YAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-- 351
Query: 199 ASNSIEIKGIVGYVAPE-YGMGSKASVSGDVYNFGILLLEMFTRRRP 244
                   G  GY+APE    G     S D ++ G +L ++     P
Sbjct: 352 --------GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 96/227 (42%), Gaps = 37/227 (16%)
Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNL 89
           N+FS    IG+GG   VY     ++  + A+K ++ K+ +  +      N       R +
Sbjct: 188 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALN------ERIM 241
Query: 90  IKIIT-------ICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQ----SNGQLRFLTQRVN 138
           + +++       +C S  F   D  + + + M   +L   L Q    S   +RF      
Sbjct: 242 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF------ 295
Query: 139 IAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAET 198
            A ++   +E+ H+     +V+ DLKP+NILLD+     + DLGLA      +P  +   
Sbjct: 296 YAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-- 350
Query: 199 ASNSIEIKGIVGYVAPE-YGMGSKASVSGDVYNFGILLLEMFTRRRP 244
                   G  GY+APE    G     S D ++ G +L ++     P
Sbjct: 351 --------GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 389

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/225 (23%), Positives = 86/225 (38%), Gaps = 37/225 (16%)
Query: 31  NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLI 90
           +F     IG GG   V+K           +K V    ++A R    E  AL  + H N++
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDHVNIV 67
Query: 91  KIITICSSIDFEGFDFKA----------------IVFEYMQNRNLEQWLRQSNGQLRFLT 134
                C    ++GFD+                  I  E+     LEQW+ +  G+     
Sbjct: 68  HY-NGC----WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122
Query: 135 QRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGT 194
             + +   ++  ++Y H      +++ DLKPSNI L       +GD GL          T
Sbjct: 123 LALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLV---------T 170
Query: 195 AAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMF 239
           + +        KG + Y++PE           D+Y  G++L E+ 
Sbjct: 171 SLKNDGKRXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 99/223 (44%), Gaps = 31/223 (13%)
Query: 27  KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRH 86
           K   N  P     QG V   Y  IL+ + +I  +      Q  A R++  E   ++ + H
Sbjct: 18  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 76
Query: 87  RNLIKIITICS-SIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-DVS 144
           +N+I ++ + +     E F    IV E M + NL Q +     Q+    +R++  +  + 
Sbjct: 77  KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVI-----QMELDHERMSYLLYQML 130
Query: 145 FAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIE 204
             I++ H      I+H DLKPSNI++  D    + D GLA+            TA  S  
Sbjct: 131 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR------------TAGTSFM 175
Query: 205 IKGIV---GYVAPE--YGMGSKASVSGDVYNFGILLLEMFTRR 242
           +   V    Y APE   GMG K +V  D+++ G ++ EM   +
Sbjct: 176 MTPYVVTRYYRAPEVILGMGYKENV--DLWSVGCIMGEMVCHK 216

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 98/223 (43%), Gaps = 31/223 (13%)
Query: 27  KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRH 86
           K   N  P     QG V   Y  IL+ + +I  +      Q  A R++  E   ++ + H
Sbjct: 29  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 87
Query: 87  RNLIKIITI-CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-DVS 144
           +N+I ++ +       E F    IV E M + NL Q +     Q+    +R++  +  + 
Sbjct: 88  KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVI-----QMELDHERMSYLLYQML 141
Query: 145 FAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIE 204
             I++ H      I+H DLKPSNI++  D    + D GLA+            TA  S  
Sbjct: 142 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR------------TAGTSFM 186
Query: 205 IKGIV---GYVAPE--YGMGSKASVSGDVYNFGILLLEMFTRR 242
           +   V    Y APE   GMG K +V  D+++ G ++ EM   +
Sbjct: 187 MTPYVVTRYYRAPEVILGMGYKENV--DLWSVGCIMGEMVCHK 227

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 98/204 (48%), Gaps = 20/204 (9%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFA-AECNALRNIRHRNLIKIITI 95
           KIG+G   +VYK   +   +    K+   K+ E   S    E + L+ ++H N++K+  +
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 96  CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQ 155
             +          +VFE++ +++L++ L    G L  +T + +  + +   I Y H    
Sbjct: 69  IHTKKR-----LVLVFEHL-DQDLKKLLDVCEGGLESVTAK-SFLLQLLNGIAYCHDR-- 119
Query: 156 PSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPE 215
             ++H DLKP N+L++++    + D GLA+       G      ++ +     + Y AP+
Sbjct: 120 -RVLHRDLKPQNLLINREGELKIADFGLARAF-----GIPVRKYTHEVV---TLWYRAPD 170
Query: 216 YGMGSKA-SVSGDVYNFGILLLEM 238
             MGSK  S + D+++ G +  EM
Sbjct: 171 VLMGSKKYSTTIDIWSVGCIFAEM 194

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 98/216 (45%), Gaps = 25/216 (11%)
Query: 27  KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRH 86
           K   N  P     QG V   Y  IL+ + +I  +      Q  A R++  E   ++ + H
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 82
Query: 87  RNLIKIITI-CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-DVS 144
           +N+I ++ +       E F    IV E M + NL Q +     Q+    +R++  +  + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVI-----QMELDHERMSYLLYQML 136
Query: 145 FAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIE 204
             I++ H      I+H DLKPSNI++  D    + D GLA+        TA  +   + E
Sbjct: 137 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--------TAGTSFMMTPE 185
Query: 205 IKGIVGYVAPE--YGMGSKASVSGDVYNFGILLLEM 238
           +     Y APE   GMG K +V  D+++ G ++ EM
Sbjct: 186 VVTRY-YRAPEVILGMGYKENV--DIWSVGCIMGEM 218

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 98/219 (44%), Gaps = 31/219 (14%)
Query: 27  KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRH 86
           K   N  P     QG V   Y  IL+ + +I  +      Q  A R++  E   ++ + H
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 82
Query: 87  RNLIKIITICS-SIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-DVS 144
           +N+I ++ + +     E F    IV E M + NL Q +     Q+    +R++  +  + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVI-----QMELDHERMSYLLYQML 136
Query: 145 FAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIE 204
             I++ H      I+H DLKPSNI++  D    + D GLA+            TA  S  
Sbjct: 137 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR------------TAGTSFM 181
Query: 205 IKGIV---GYVAPE--YGMGSKASVSGDVYNFGILLLEM 238
           +   V    Y APE   GMG K +V  D+++ G ++ EM
Sbjct: 182 MTPYVVTRYYRAPEVILGMGYKENV--DIWSVGCIMGEM 218

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 97/219 (44%), Gaps = 31/219 (14%)
Query: 27  KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRH 86
           K   N  P     QG V   Y  IL+ + +I  +      Q  A R++  E   ++ + H
Sbjct: 26  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 84
Query: 87  RNLIKIITI-CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-DVS 144
           +N+I ++ +       E F    IV E M + NL Q +     Q+    +R++  +  + 
Sbjct: 85  KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVI-----QMELDHERMSYLLYQML 138
Query: 145 FAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIE 204
             I++ H      I+H DLKPSNI++  D    + D GLA+            TA  S  
Sbjct: 139 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR------------TAGTSFM 183
Query: 205 IKGIV---GYVAPE--YGMGSKASVSGDVYNFGILLLEM 238
           +   V    Y APE   GMG K +V  D+++ G ++ EM
Sbjct: 184 MVPFVVTRYYRAPEVILGMGYKENV--DIWSVGCIMGEM 220

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 98/204 (48%), Gaps = 20/204 (9%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFA-AECNALRNIRHRNLIKIITI 95
           KIG+G   +VYK   +   +    K+   K+ E   S    E + L+ ++H N++K+  +
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 96  CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQ 155
             +          +VFE++ +++L++ L    G L  +T + +  + +   I Y H    
Sbjct: 69  IHTKKR-----LVLVFEHL-DQDLKKLLDVCEGGLESVTAK-SFLLQLLNGIAYCHDR-- 119
Query: 156 PSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPE 215
             ++H DLKP N+L++++    + D GLA+       G      ++ +     + Y AP+
Sbjct: 120 -RVLHRDLKPQNLLINREGELKIADFGLARAF-----GIPVRKYTHEVV---TLWYRAPD 170
Query: 216 YGMGSKA-SVSGDVYNFGILLLEM 238
             MGSK  S + D+++ G +  EM
Sbjct: 171 VLMGSKKYSTTIDIWSVGCIFAEM 194

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 99/223 (44%), Gaps = 31/223 (13%)
Query: 27  KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRH 86
           K   N  P     QG V   Y  IL+ + +I  +      Q  A R++  E   ++ + H
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 82
Query: 87  RNLIKIITI-CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-DVS 144
           +N+I ++ +       E F    IV E M + NL Q +     Q+    +R++  +  + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVI-----QMELDHERMSYLLYQML 136
Query: 145 FAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIE 204
             I++ H      I+H DLKPSNI++  D    + D GLA+            TA  S  
Sbjct: 137 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR------------TAGTSFM 181
Query: 205 IKGIV---GYVAPE--YGMGSKASVSGDVYNFGILLLEMFTRR 242
           ++  V    Y APE   GMG K +V  D+++ G ++ EM   +
Sbjct: 182 MEPEVVTRYYRAPEVILGMGYKENV--DLWSVGCIMGEMVCHK 222

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 87/211 (41%), Gaps = 20/211 (9%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           K+ +     ++KG    +  +V V  V       SR F  EC  LR   H N++ ++  C
Sbjct: 17  KLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQP 156
            S          ++  +M   +L   L +    +   +Q V  A+D++  + +  H  +P
Sbjct: 77  QS---PPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFL-HTLEP 132
Query: 157 SIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEY 216
            I    L   ++++D+D+ A +  +   KF F   PG     A           +VAPE 
Sbjct: 133 LIPRHALNSRSVMIDEDMTARIS-MADVKFSF-QSPGRMYAPA-----------WVAPEA 179
Query: 217 GMGSKASV---SGDVYNFGILLLEMFTRRRP 244
                      S D+++F +LL E+ TR  P
Sbjct: 180 LQKKPEDTNRRSADMWSFAVLLWELVTREVP 210

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/247 (23%), Positives = 104/247 (42%), Gaps = 26/247 (10%)
Query: 28  ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVV---NLKQKEASRSFAAECNALRNI 84
           A  +F     +G+G    VY     +S+ I+A+KV+    L++         E     ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 85  RHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-DV 143
           RH N++++        +  F     V+  ++   L    R+     +F  QR    I ++
Sbjct: 66  RHPNILRL--------YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 117
Query: 144 SFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSI 203
           + A+ Y H      ++H D+KP N+LL        G+L +A F  G+   +    +S   
Sbjct: 118 ANALSYCH---SKRVIHRDIKPENLLL-----GSAGELKIADF--GW---SVHAPSSRRT 164
Query: 204 EIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDA-MFNEGLTLHEFVKMA 262
           E+ G + Y+ PE   G       D+++ G+L  E    + P +A  + E       V+  
Sbjct: 165 ELCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT 224
Query: 263 LPDKVME 269
            PD V E
Sbjct: 225 FPDFVTE 231

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 88/204 (43%), Gaps = 20/204 (9%)
Query: 41  GGVSI-VYKGILDESRSIVAVKVVNLKQKEASRS-FAAECNALRNIRHRNLIKIITICSS 98
           G VS+  Y    D +  +VAVK +        RS +  E   LR + H +++K    C  
Sbjct: 23  GKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCED 82
Query: 99  IDFEGFDFKAIVFEYMQNRNLEQWL-RQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPS 157
              +G     +V EY+   +L  +L R   G    L Q +  A  +   + Y H      
Sbjct: 83  ---QGEKSVQLVMEYVPLGSLRDYLPRHCVG----LAQLLLFAQQICEGMAYLHAQ---H 132
Query: 158 IVHGDLKPSNILLDQDIVAHVGDLGLAKFL-FGYEPGTAAETASNSIEIKGIVGYVAPEY 216
            +H  L   N+LLD D +  +GD GLAK +  G+E     E   +       V + APE 
Sbjct: 133 YIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP------VFWYAPEC 186
Query: 217 GMGSKASVSGDVYNFGILLLEMFT 240
               K   + DV++FG+ L E+ T
Sbjct: 187 LKECKFYYASDVWSFGVTLYELLT 210

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 101/218 (46%), Gaps = 35/218 (16%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAA--ECNALRNIRHRNLIKIIT 94
           KIG+G    V+K    E+  IVA+K V L   +     +A  E   L+ ++H+N++++  
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 95  ICSSIDFEGFDFK-AIVFEYMQNRNLEQWLRQSNGQL------RFLTQRVNIAIDVSFAI 147
           +  S      D K  +VFE+  +++L+++    NG L       FL Q +         +
Sbjct: 69  VLHS------DKKLTLVFEFC-DQDLKKYFDSCNGDLDPEIVKSFLFQLLK-------GL 114
Query: 148 EYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKG 207
            + H     +++H DLKP N+L++++     G+L LA F      G      S  +    
Sbjct: 115 GFCHSR---NVLHRDLKPQNLLINRN-----GELKLANFGLARAFGIPVRCYSAEVV--- 163
Query: 208 IVGYVAPEYGMGSKA-SVSGDVYNFGILLLEMFTRRRP 244
            + Y  P+   G+K  S S D+++ G +  E+    RP
Sbjct: 164 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 88/204 (43%), Gaps = 20/204 (9%)
Query: 41  GGVSI-VYKGILDESRSIVAVKVVNLKQKEASRS-FAAECNALRNIRHRNLIKIITICSS 98
           G VS+  Y    D +  +VAVK +        RS +  E   LR + H +++K    C  
Sbjct: 22  GKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCED 81
Query: 99  IDFEGFDFKAIVFEYMQNRNLEQWL-RQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPS 157
              +G     +V EY+   +L  +L R   G    L Q +  A  +   + Y H      
Sbjct: 82  ---QGEKSVQLVMEYVPLGSLRDYLPRHCVG----LAQLLLFAQQICEGMAYLHAQ---H 131
Query: 158 IVHGDLKPSNILLDQDIVAHVGDLGLAKFL-FGYEPGTAAETASNSIEIKGIVGYVAPEY 216
            +H  L   N+LLD D +  +GD GLAK +  G+E     E   +       V + APE 
Sbjct: 132 YIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP------VFWYAPEC 185
Query: 217 GMGSKASVSGDVYNFGILLLEMFT 240
               K   + DV++FG+ L E+ T
Sbjct: 186 LKECKFYYASDVWSFGVTLYELLT 209

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 104/232 (44%), Gaps = 33/232 (14%)
Query: 37  KIGQGGVSIVYKG-----ILDESRSIVAVKVVNLKQKEASR-SFAAECNALRNIRHRNLI 90
           ++GQG   +VY+G     I  E+ + VAVK VN       R  F  E + ++     +++
Sbjct: 23  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 82
Query: 91  KIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQ-----SNGQLR---FLTQRVNIAID 142
           +++ + S           +V E M + +L+ +LR       N   R    L + + +A +
Sbjct: 83  RLLGVVSK-----GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 137
Query: 143 VSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNS 202
           ++  + Y +       VH DL   N ++  D    +GD G+ + ++        ET    
Sbjct: 138 IADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIY--------ETDYYR 186
Query: 203 IEIKGI--VGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNE 251
              KG+  V ++APE       + S D+++FG++L E+ +   +P   + NE
Sbjct: 187 KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE 238

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/232 (22%), Positives = 103/232 (44%), Gaps = 33/232 (14%)
Query: 37  KIGQGGVSIVYKG-----ILDESRSIVAVKVVNLKQKEASR-SFAAECNALRNIRHRNLI 90
           ++GQG   +VY+G     I  E+ + VAVK VN       R  F  E + ++     +++
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 91  KIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLR--------FLTQRVNIAID 142
           +++ + S           +V E M + +L+ +LR    +           L + + +A +
Sbjct: 84  RLLGVVSK-----GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 143 VSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNS 202
           ++  + Y +       VH DL   N ++  D    +GD G+ + ++        ET    
Sbjct: 139 IADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIY--------ETDYYR 187
Query: 203 IEIKGI--VGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNE 251
              KG+  V ++APE       + S D+++FG++L E+ +   +P   + NE
Sbjct: 188 KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE 239

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 92/214 (42%), Gaps = 21/214 (9%)
Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVK-VVNLKQKEASRSFA-AECNALRNIRHR 87
             +    KIG+G   +V+K    ++  IVA+K  +  +     +  A  E   L+ ++H 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 88  NLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAI 147
           NL+ ++ +     F       +VFEY  +  L +  R   G    L +  +I      A+
Sbjct: 63  NLVNLLEV-----FRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVK--SITWQTLQAV 115
Query: 148 EYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKG 207
            + H H   + +H D+KP NIL+ +  V  + D G A+ L G       E A+       
Sbjct: 116 NFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR------ 166
Query: 208 IVGYVAPEYGMG-SKASVSGDVYNFGILLLEMFT 240
              Y +PE  +G ++     DV+  G +  E+ +
Sbjct: 167 --WYRSPELLVGDTQYGPPVDVWAIGCVFAELLS 198

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 103/232 (44%), Gaps = 33/232 (14%)
Query: 37  KIGQGGVSIVYKG-----ILDESRSIVAVKVVNLKQKEASR-SFAAECNALRNIRHRNLI 90
           ++GQG   +VY+G     I  E+ + VAVK VN       R  F  E + ++     +++
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 91  KIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQ-----SNGQLR---FLTQRVNIAID 142
           +++ + S           +V E M + +L+ +LR       N   R    L + + +A +
Sbjct: 84  RLLGVVSK-----GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 143 VSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNS 202
           ++  + Y +       VH DL   N ++  D    +GD G+ + +         ET    
Sbjct: 139 IADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDI--------XETDXXR 187
Query: 203 IEIKGI--VGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNE 251
              KG+  V ++APE       + S D+++FG++L E+ +   +P   + NE
Sbjct: 188 KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE 239

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/233 (21%), Positives = 84/233 (36%), Gaps = 40/233 (17%)
Query: 31  NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLI 90
           +F     IG GG   V+K           ++ V    ++A R    E  AL  + H N++
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAER----EVKALAKLDHVNIV 68
Query: 91  KIITICSSIDF---------EGFDFKA---------------IVFEYMQNRNLEQWLRQS 126
                    D+         E  D+                 I  E+     LEQW+ + 
Sbjct: 69  HYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR 128
Query: 127 NGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF 186
            G+       + +   ++  ++Y H      ++H DLKPSNI L       +GD GL   
Sbjct: 129 RGEKLDKVLALELFEQITKGVDYIH---SKKLIHRDLKPSNIFLVDTKQVKIGDFGLV-- 183
Query: 187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMF 239
                  T+ +        KG + Y++PE           D+Y  G++L E+ 
Sbjct: 184 -------TSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/232 (22%), Positives = 102/232 (43%), Gaps = 33/232 (14%)
Query: 37  KIGQGGVSIVYKG-----ILDESRSIVAVKVVNLKQKEASR-SFAAECNALRNIRHRNLI 90
           ++GQG   +VY+G     I  E+ + VAVK VN       R  F  E + ++     +++
Sbjct: 21  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 80
Query: 91  KIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLR--------FLTQRVNIAID 142
           +++ + S           +V E M + +L+ +LR    +           L + + +A +
Sbjct: 81  RLLGVVSK-----GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 135
Query: 143 VSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNS 202
           ++  + Y +       VH DL   N ++  D    +GD G+ + +         ET    
Sbjct: 136 IADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDI--------XETDXXR 184
Query: 203 IEIKGI--VGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNE 251
              KG+  V ++APE       + S D+++FG++L E+ +   +P   + NE
Sbjct: 185 KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE 236

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/232 (22%), Positives = 102/232 (43%), Gaps = 33/232 (14%)
Query: 37  KIGQGGVSIVYKG-----ILDESRSIVAVKVVNLKQKEASR-SFAAECNALRNIRHRNLI 90
           ++GQG   +VY+G     I  E+ + VAVK VN       R  F  E + ++     +++
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 91  KIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLR--------FLTQRVNIAID 142
           +++ + S           +V E M + +L+ +LR    +           L + + +A +
Sbjct: 84  RLLGVVSK-----GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 143 VSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNS 202
           ++  + Y +       VH DL   N ++  D    +GD G+ + +         ET    
Sbjct: 139 IADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDI--------XETDXXR 187
Query: 203 IEIKGI--VGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNE 251
              KG+  V ++APE       + S D+++FG++L E+ +   +P   + NE
Sbjct: 188 KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE 239

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/247 (23%), Positives = 104/247 (42%), Gaps = 26/247 (10%)
Query: 28  ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVV---NLKQKEASRSFAAECNALRNI 84
           A  +F     +G+G    VY     +S+ I+A+KV+    L++         E     ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 85  RHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-DV 143
           RH N++++        +  F     V+  ++   L    R+     +F  QR    I ++
Sbjct: 66  RHPNILRL--------YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 117
Query: 144 SFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSI 203
           + A+ Y H      ++H D+KP N+LL        G+L +A F  G+   +    +S   
Sbjct: 118 ANALSYCH---SKRVIHRDIKPENLLL-----GSAGELKIADF--GW---SVHAPSSRRT 164
Query: 204 EIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDA-MFNEGLTLHEFVKMA 262
           ++ G + Y+ PE   G       D+++ G+L  E    + P +A  + E       V+  
Sbjct: 165 DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT 224
Query: 263 LPDKVME 269
            PD V E
Sbjct: 225 FPDFVTE 231

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 50/99 (50%), Gaps = 11/99 (11%)
Query: 146 AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEI 205
            +E+ H   Q +I++ DLKP N+LLD D    + DLGLA  L       A +T +     
Sbjct: 301 GLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL------KAGQTKTKG--Y 349
Query: 206 KGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
            G  G++APE  +G +   S D +  G+ L EM   R P
Sbjct: 350 AGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/102 (35%), Positives = 51/102 (50%), Gaps = 11/102 (10%)
Query: 146 AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEI 205
            +E+ H   Q +I++ DLKP N+LLD D    + DLGLA  L       A +T +     
Sbjct: 301 GLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL------KAGQTKTKG--Y 349
Query: 206 KGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDA 247
            G  G++APE  +G +   S D +  G+ L EM   R P  A
Sbjct: 350 AGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRA 391

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/247 (23%), Positives = 104/247 (42%), Gaps = 26/247 (10%)
Query: 28  ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVV---NLKQKEASRSFAAECNALRNI 84
           A  +F     +G+G    VY     +S+ I+A+KV+    L++         E     ++
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 85  RHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-DV 143
           RH N++++        +  F     V+  ++   L    R+     +F  QR    I ++
Sbjct: 67  RHPNILRL--------YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 118
Query: 144 SFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSI 203
           + A+ Y H      ++H D+KP N+LL        G+L +A F  G+   +    +S   
Sbjct: 119 ANALSYCH---SKRVIHRDIKPENLLL-----GSAGELKIADF--GW---SVHAPSSRRT 165
Query: 204 EIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDA-MFNEGLTLHEFVKMA 262
           ++ G + Y+ PE   G       D+++ G+L  E    + P +A  + E       V+  
Sbjct: 166 DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT 225
Query: 263 LPDKVME 269
            PD V E
Sbjct: 226 FPDFVTE 232

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 63/271 (23%), Positives = 112/271 (41%), Gaps = 36/271 (13%)
Query: 4   AHKDSNMLSMKQQFPMISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVV 63
           A K  N  S K+Q+          A  +F     +G+G    VY     +S+ I+A+KV+
Sbjct: 18  ASKQKNEESKKRQW----------ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL 67
Query: 64  ---NLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLE 120
               L++         E     ++RH N++++        +  F     V+  ++   L 
Sbjct: 68  FKAQLEKAGVEHQLRREVEIQSHLRHPNILRL--------YGYFHDATRVYLILEYAPLG 119
Query: 121 QWLRQSNGQLRFLTQRVNIAI-DVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVG 179
              R+     +F  QR    I +++ A+ Y H      ++H D+KP N+LL        G
Sbjct: 120 TVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLL-----GSAG 171
Query: 180 DLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMF 239
           +L +A   FG+   +    +S   ++ G + Y+ PE   G       D+++ G+L  E  
Sbjct: 172 ELKIAD--FGW---SVHAPSSRRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL 226
Query: 240 TRRRPTDA-MFNEGLTLHEFVKMALPDKVME 269
             + P +A  + E       V+   PD V E
Sbjct: 227 VGKPPFEANTYQETYKRISRVEFTFPDFVTE 257

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/247 (23%), Positives = 104/247 (42%), Gaps = 26/247 (10%)
Query: 28  ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVV---NLKQKEASRSFAAECNALRNI 84
           A  +F     +G+G    VY     +S+ I+A+KV+    L++         E     ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 85  RHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-DV 143
           RH N++++        +  F     V+  ++   L    R+     +F  QR    I ++
Sbjct: 66  RHPNILRL--------YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 117
Query: 144 SFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSI 203
           + A+ Y H      ++H D+KP N+LL        G+L +A F  G+   +    +S   
Sbjct: 118 ANALSYCH---SKRVIHRDIKPENLLL-----GSAGELKIADF--GW---SVHAPSSRRT 164
Query: 204 EIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDA-MFNEGLTLHEFVKMA 262
           ++ G + Y+ PE   G       D+++ G+L  E    + P +A  + E       V+  
Sbjct: 165 DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT 224
Query: 263 LPDKVME 269
            PD V E
Sbjct: 225 FPDFVTE 231

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 36/102 (35%), Positives = 51/102 (50%), Gaps = 11/102 (10%)
Query: 146 AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEI 205
            +E+ H   Q +I++ DLKP N+LLD D    + DLGLA  L       A +T +     
Sbjct: 301 GLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL------KAGQTKTKG--Y 349
Query: 206 KGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDA 247
            G  G++APE  +G +   S D +  G+ L EM   R P  A
Sbjct: 350 AGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRA 391

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/271 (22%), Positives = 110/271 (40%), Gaps = 36/271 (13%)
Query: 4   AHKDSNMLSMKQQFPMISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVV 63
           A K  N  S K+Q+          A  +F     +G+G    VY     +S+ I+A+KV+
Sbjct: 9   ASKQKNEESKKRQW----------ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL 58
Query: 64  ---NLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLE 120
               L++         E     ++RH N++++        +  F     V+  ++   L 
Sbjct: 59  FKAQLEKAGVEHQLRREVEIQSHLRHPNILRL--------YGYFHDATRVYLILEYAPLG 110
Query: 121 QWLRQSNGQLRFLTQRVNIAI-DVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVG 179
              R+     +F  QR    I +++ A+ Y H      ++H D+KP N+LL        G
Sbjct: 111 TVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLL-----GSAG 162
Query: 180 DLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMF 239
           +L +A F +     ++  T      + G + Y+ PE   G       D+++ G+L  E  
Sbjct: 163 ELKIADFGWSVHAPSSRRTT-----LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL 217
Query: 240 TRRRPTDA-MFNEGLTLHEFVKMALPDKVME 269
             + P +A  + E       V+   PD V E
Sbjct: 218 VGKPPFEANTYQETYKRISRVEFTFPDFVTE 248

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 50/99 (50%), Gaps = 11/99 (11%)
Query: 146 AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEI 205
            +E+ H   Q +I++ DLKP N+LLD D    + DLGLA  L       A +T +     
Sbjct: 301 GLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL------KAGQTKTKG--Y 349
Query: 206 KGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
            G  G++APE  +G +   S D +  G+ L EM   R P
Sbjct: 350 AGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/275 (21%), Positives = 106/275 (38%), Gaps = 67/275 (24%)
Query: 26  SKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRS-FAAECNALRNI 84
           S+   +F P   +G+GG  +V++          A+K + L  +E +R     E  AL  +
Sbjct: 2   SRYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL 61
Query: 85  RHRNLIKI-----------------------------ITICSSIDFEGFDFKAI------ 109
            H  +++                              ++  S +D      + +      
Sbjct: 62  EHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTK 121
Query: 110 ------------VFEYMQ-----NRNLEQWL-RQSNGQLRFLTQRVNIAIDVSFAIEYFH 151
                       V+ Y+Q       NL+ W+ R+ + + R     ++I I ++ A+E+ H
Sbjct: 122 NTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH 181
Query: 152 HHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYE-------PGTAAETASNSIE 204
                 ++H DLKPSNI    D V  VGD GL   +   E       P  A  T    + 
Sbjct: 182 SK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQV- 237
Query: 205 IKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMF 239
             G   Y++PE   G+  S   D+++ G++L E+ 
Sbjct: 238 --GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/247 (23%), Positives = 104/247 (42%), Gaps = 26/247 (10%)
Query: 28  ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVV---NLKQKEASRSFAAECNALRNI 84
           A  +F     +G+G    VY     +S+ I+A+KV+    L++         E     ++
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 85  RHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-DV 143
           RH N++++        +  F     V+  ++   L    R+     +F  QR    I ++
Sbjct: 71  RHPNILRL--------YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 122
Query: 144 SFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSI 203
           + A+ Y H      ++H D+KP N+LL        G+L +A F  G+   +    +S   
Sbjct: 123 ANALSYCH---SKRVIHRDIKPENLLL-----GSAGELKIADF--GW---SVHAPSSRRT 169
Query: 204 EIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDA-MFNEGLTLHEFVKMA 262
           ++ G + Y+ PE   G       D+++ G+L  E    + P +A  + E       V+  
Sbjct: 170 DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT 229
Query: 263 LPDKVME 269
            PD V E
Sbjct: 230 FPDFVTE 236

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/247 (23%), Positives = 105/247 (42%), Gaps = 26/247 (10%)
Query: 28  ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVV---NLKQKEASRSFAAECNALRNI 84
           A  +F     +G+G    VY     +S+ I+A+KV+    L++         E     ++
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 85  RHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-DV 143
           RH N++++        F       ++ EY     + + L++ +   +F  QR    I ++
Sbjct: 71  RHPNILRLYGY-----FHDATRVYLILEYAPRGEVYKELQKLS---KFDEQRTATYITEL 122
Query: 144 SFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSI 203
           + A+ Y H      ++H D+KP N+LL        G+L +A   FG+   +    +S   
Sbjct: 123 ANALSYCH---SKRVIHRDIKPENLLL-----GSAGELKIAD--FGW---SVHAPSSRRX 169
Query: 204 EIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDA-MFNEGLTLHEFVKMA 262
            + G + Y+ PE   G       D+++ G+L  E    + P +A  + E       V+  
Sbjct: 170 XLXGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT 229
Query: 263 LPDKVME 269
            PD V E
Sbjct: 230 FPDFVTE 236

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 68/237 (28%), Positives = 100/237 (42%), Gaps = 27/237 (11%)
Query: 38  IGQGGVSIVYKG--ILDESRSIVAVKVVNLKQKE----ASRSFAAECNALRNIRHRNLIK 91
           IG GG   VY+   I DE    VAVK       E       +   E      ++H N+I 
Sbjct: 15  IGIGGFGKVYRAFWIGDE----VAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 92  IITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFH 151
           +  +C            +V E+ +   L + L         L   VN A+ ++  + Y H
Sbjct: 71  LRGVCLK-----EPNLCLVMEFARGGPLNRVLSGKRIPPDIL---VNWAVQIARGMNYLH 122
Query: 152 HHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAET-ASNSIEIKGIVG 210
                 I+H DLK SNIL+ Q +    GDL   K L   + G A E   +  +   G   
Sbjct: 123 DEAIVPIIHRDLKSSNILILQKV--ENGDLS-NKILKITDFGLAREWHRTTKMSAAGAYA 179
Query: 211 YVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFV---KMALP 264
           ++APE    S  S   DV+++G+LL E+ T   P   +  +GL +   V   K+ALP
Sbjct: 180 WMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI--DGLAVAYGVAMNKLALP 234

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 113/254 (44%), Gaps = 40/254 (15%)
Query: 32  FSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKE-----ASRSFAAECNALRNIRH 86
           +S   +IG GG S V++ +L+E + I A+K VNL++ +     + R+  A  N L+  +H
Sbjct: 30  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ--QH 86
Query: 87  RNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFA 146
            +  KII +    D+E  D    +     N +L  WL++      +  +R +   ++  A
Sbjct: 87  SD--KIIRL---YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPW--ERKSYWKNMLEA 139
Query: 147 IEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIK 206
           +   H H    IVH DLKP+N L+  D +  + D G+A  +   +P        + +   
Sbjct: 140 VHTIHQH---GIVHSDLKPANFLI-VDGMLKLIDFGIANQM---QPDXXXVVKDSQV--- 189
Query: 207 GIVGYVAPEYGMGSKASVSG-----------DVYNFGILLLEMFTRRRPTDAMFNEGLTL 255
           G V Y+ PE      +S              DV++ G +L  M   + P   + N+   L
Sbjct: 190 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL 249
Query: 256 HEFV----KMALPD 265
           H  +    ++  PD
Sbjct: 250 HAIIDPNHEIEFPD 263

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 63/271 (23%), Positives = 111/271 (40%), Gaps = 36/271 (13%)
Query: 4   AHKDSNMLSMKQQFPMISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVV 63
           A K  N  S K+Q+          A  +F     +G+G    VY     +S+ I+A+KV+
Sbjct: 18  ASKQKNEESKKRQW----------ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL 67
Query: 64  ---NLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLE 120
               L++         E     ++RH N++++        +  F     V+  ++   L 
Sbjct: 68  FKAQLEKAGVEHQLRREVEIQSHLRHPNILRL--------YGYFHDATRVYLILEYAPLG 119
Query: 121 QWLRQSNGQLRFLTQRVNIAI-DVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVG 179
              R+     +F  QR    I +++ A+ Y H      ++H D+KP N+LL        G
Sbjct: 120 TVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLL-----GSAG 171
Query: 180 DLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMF 239
           +L +A   FG+   +    +S    + G + Y+ PE   G       D+++ G+L  E  
Sbjct: 172 ELKIAD--FGW---SVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL 226
Query: 240 TRRRPTDA-MFNEGLTLHEFVKMALPDKVME 269
             + P +A  + E       V+   PD V E
Sbjct: 227 VGKPPFEANTYQETYKRISRVEFTFPDFVTE 257

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 88/198 (44%), Gaps = 33/198 (16%)
Query: 58  VAVKVVN---LKQKEASRSFAAECNALRNIRHRNLIKIITICSS-IDFEGFDFKAIVFEY 113
           VAVK++N   ++  +       E   L+  RH ++IK+  + S+  DF       +V EY
Sbjct: 39  VAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF------FMVMEY 92
Query: 114 MQNRNLEQWL----RQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNIL 169
           +    L  ++    R    + R L Q++  A+D      Y H H    +VH DLKP N+L
Sbjct: 93  VSGGELFDYICKHGRVEEMEARRLFQQILSAVD------YCHRHM---VVHRDLKPENVL 143
Query: 170 LDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGS-KASVSGDV 228
           LD  + A + D GL+  +      +  E   +S    G   Y APE   G   A    D+
Sbjct: 144 LDAHMNAKIADFGLSNMM------SDGEFLRDSC---GSPNYAAPEVISGRLYAGPEVDI 194
Query: 229 YNFGILLLEMFTRRRPTD 246
           ++ G++L  +     P D
Sbjct: 195 WSCGVILYALLCGTLPFD 212

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 87/198 (43%), Gaps = 33/198 (16%)
Query: 58  VAVKVVN---LKQKEASRSFAAECNALRNIRHRNLIKIITICSS-IDFEGFDFKAIVFEY 113
           VAVK++N   ++  +       E   L+  RH ++IK+  + S+  DF       +V EY
Sbjct: 39  VAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF------FMVMEY 92
Query: 114 MQNRNLEQWL----RQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNIL 169
           +    L  ++    R    + R L Q++  A+D      Y H H    +VH DLKP N+L
Sbjct: 93  VSGGELFDYICKHGRVEEMEARRLFQQILSAVD------YCHRHM---VVHRDLKPENVL 143
Query: 170 LDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGS-KASVSGDV 228
           LD  + A + D GL+  +     G    T+  S        Y APE   G   A    D+
Sbjct: 144 LDAHMNAKIADFGLSNMM---SDGEFLRTSCGS------PNYAAPEVISGRLYAGPEVDI 194
Query: 229 YNFGILLLEMFTRRRPTD 246
           ++ G++L  +     P D
Sbjct: 195 WSCGVILYALLCGTLPFD 212

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 100/211 (47%), Gaps = 15/211 (7%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAA--ECNALRNIRHRNLIKIIT 94
           KIGQG    V+K    ++   VA+K V ++ ++      A  E   L+ ++H N++ +I 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 95  ICSSIDFEGFDFKA---IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFH 151
           IC +        KA   +VF++ ++ +L   L  SN  ++F    +   + +     Y+ 
Sbjct: 85  ICRTKASPYNRCKASIYLVFDFCEH-DLAGLL--SNVLVKFTLSEIKRVMQMLLNGLYYI 141
Query: 152 HHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGY 211
           H  +  I+H D+K +N+L+ +D V  + D GLA+  F     +      N +     + Y
Sbjct: 142 HRNK--ILHRDMKAANVLITRDGVLKLADFGLAR-AFSLAKNSQPNRYXNRVV---TLWY 195
Query: 212 VAPEYGMGSKA-SVSGDVYNFGILLLEMFTR 241
             PE  +G +      D++  G ++ EM+TR
Sbjct: 196 RPPELLLGERDYGPPIDLWGAGCIMAEMWTR 226

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/247 (23%), Positives = 103/247 (41%), Gaps = 26/247 (10%)
Query: 28  ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVV---NLKQKEASRSFAAECNALRNI 84
           A  +F     +G+G    VY     +S+ I+A+KV+    L++         E     ++
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 85  RHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-DV 143
           RH N++++        +  F     V+  ++   L    R+     +F  QR    I ++
Sbjct: 67  RHPNILRL--------YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 118
Query: 144 SFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSI 203
           + A+ Y H      ++H D+KP N+LL        G+L +A F  G+   +    +S   
Sbjct: 119 ANALSYCH---SKRVIHRDIKPENLLL-----GSAGELKIADF--GW---SCHAPSSRRT 165
Query: 204 EIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDA-MFNEGLTLHEFVKMA 262
            + G + Y+ PE   G       D+++ G+L  E    + P +A  + E       V+  
Sbjct: 166 TLSGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT 225
Query: 263 LPDKVME 269
            PD V E
Sbjct: 226 FPDFVTE 232

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/247 (22%), Positives = 102/247 (41%), Gaps = 26/247 (10%)
Query: 28  ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVV---NLKQKEASRSFAAECNALRNI 84
           A  +F     +G+G    VY     +S+ I+A+KV+    L++         E     ++
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 85  RHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-DV 143
           RH N++++        +  F     V+  ++   L    R+     +F  QR    I ++
Sbjct: 71  RHPNILRL--------YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 122
Query: 144 SFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSI 203
           + A+ Y H      ++H D+KP N+LL        G+L +A F +     ++  T     
Sbjct: 123 ANALSYCH---SKRVIHRDIKPENLLL-----GSAGELKIADFGWSVHAPSSRRTT---- 170
Query: 204 EIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDA-MFNEGLTLHEFVKMA 262
            + G + Y+ PE   G       D+++ G+L  E    + P +A  + E       V+  
Sbjct: 171 -LCGTLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT 229
Query: 263 LPDKVME 269
            PD V E
Sbjct: 230 FPDFVTE 236

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 90/194 (46%), Gaps = 23/194 (11%)
Query: 76  AECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQ 135
           AE N ++ + +  ++++I IC +  +       +V E  +   L ++L+Q+    R +  
Sbjct: 61  AEANVMQQLDNPYIVRMIGICEAESW------MLVMEMAELGPLNKYLQQN----RHVKD 110
Query: 136 R--VNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPG 193
           +  + +   VS  ++Y     + + VH DL   N+LL     A + D GL+K L   E  
Sbjct: 111 KNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENX 167
Query: 194 TAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTR-RRPTDAMFNEG 252
             A+T       K  V + APE     K S   DV++FG+L+ E F+  ++P   M    
Sbjct: 168 YKAQTHG-----KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 222
Query: 253 LT--LHEFVKMALP 264
           +T  L +  +M  P
Sbjct: 223 VTAMLEKGERMGCP 236

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 86/201 (42%), Gaps = 23/201 (11%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASR-SFAAECNALRNIRHRNLIKIITIC 96
           +G G  S V       ++ +VA+K +  K  E    S   E   L  I+H N++ +  I 
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQP 156
            S        + +    + +R +E+         R + Q ++       A++Y H     
Sbjct: 86  ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLD-------AVKYLH---DL 135
Query: 157 SIVHGDLKPSNIL---LDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVA 213
            IVH DLKP N+L   LD+D    + D GL+K     +PG+   TA       G  GYVA
Sbjct: 136 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTAC------GTPGYVA 186
Query: 214 PEYGMGSKASVSGDVYNFGIL 234
           PE       S + D ++ G++
Sbjct: 187 PEVLAQKPYSKAVDCWSIGVI 207

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/247 (22%), Positives = 104/247 (42%), Gaps = 26/247 (10%)
Query: 28  ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVV---NLKQKEASRSFAAECNALRNI 84
           A  +F     +G+G    VY     +S+ I+A+KV+    L++         E     ++
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 85  RHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-DV 143
           RH N++++        F       ++ EY     + + L++ +   +F  QR    I ++
Sbjct: 71  RHPNILRLYGY-----FHDATRVYLILEYAPRGEVYKELQKLS---KFDEQRTATYITEL 122
Query: 144 SFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSI 203
           + A+ Y H      ++H D+KP N+LL        G+L +A F +     ++  T     
Sbjct: 123 ANALSYCH---SKRVIHRDIKPENLLL-----GSAGELKIADFGWSVHAPSSRRTT---- 170
Query: 204 EIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDA-MFNEGLTLHEFVKMA 262
            + G + Y+ PE   G       D+++ G+L  E    + P +A  + E       V+  
Sbjct: 171 -LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT 229
Query: 263 LPDKVME 269
            PD V E
Sbjct: 230 FPDFVTE 236

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/247 (23%), Positives = 104/247 (42%), Gaps = 26/247 (10%)
Query: 28  ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVV---NLKQKEASRSFAAECNALRNI 84
           A  +F     +G+G    VY     +S+ I+A+KV+    L++         E     ++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 85  RHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-DV 143
           RH N++++        +  F     V+  ++   L    R+     +F  QR    I ++
Sbjct: 69  RHPNILRL--------YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 120
Query: 144 SFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSI 203
           + A+ Y H      ++H D+KP N+LL        G+L +A   FG+   +    +S   
Sbjct: 121 ANALSYCH---SKRVIHRDIKPENLLL-----GSAGELKIAD--FGW---SVHAPSSRRD 167
Query: 204 EIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDA-MFNEGLTLHEFVKMA 262
           ++ G + Y+ PE   G       D+++ G+L  E    + P +A  + E       V+  
Sbjct: 168 DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT 227
Query: 263 LPDKVME 269
            PD V E
Sbjct: 228 FPDFVTE 234

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/247 (23%), Positives = 103/247 (41%), Gaps = 26/247 (10%)
Query: 28  ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVV---NLKQKEASRSFAAECNALRNI 84
           A  +F     +G+G    VY     +S+ I+A+KV+    L++         E     ++
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 85  RHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-DV 143
           RH N++++        +  F     V+  ++   L    R+     +F  QR    I ++
Sbjct: 65  RHPNILRL--------YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 116
Query: 144 SFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSI 203
           + A+ Y H      ++H D+KP N+LL        G+L +A   FG+   +    +S   
Sbjct: 117 ANALSYCH---SKRVIHRDIKPENLLL-----GSAGELKIAD--FGW---SVHAPSSRRT 163
Query: 204 EIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDA-MFNEGLTLHEFVKMA 262
            + G + Y+ PE   G       D+++ G+L  E    + P +A  + E       V+  
Sbjct: 164 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT 223
Query: 263 LPDKVME 269
            PD V E
Sbjct: 224 FPDFVTE 230

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 62/246 (25%), Positives = 102/246 (41%), Gaps = 50/246 (20%)
Query: 21  SYAELSKATNNFSPAN------KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSF 74
           S  +    T + +P +      ++G G    VYK    E+  + A KV++ K +E    +
Sbjct: 22  SMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDY 81
Query: 75  AAECNALRNIRHRNLIKII-------TICSSIDF-EGFDFKAIVFEYMQNRNLEQWLRQS 126
             E + L +  H N++K++        +   I+F  G    A++ E      LE+ L +S
Sbjct: 82  MVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE------LERPLTES 135
Query: 127 NGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF 186
             Q+    Q ++       A+ Y H +    I+H DLK  NIL   D     GD+ LA F
Sbjct: 136 QIQV-VCKQTLD-------ALNYLHDN---KIIHRDLKAGNILFTLD-----GDIKLADF 179
Query: 187 LFGYEPGTAAETASNSIEIKGIVG---YVAPEYGMGSKA-----SVSGDVYNFGILLLEM 238
                 G +A+           +G   ++APE  M   +         DV++ GI L+EM
Sbjct: 180 ------GVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233
Query: 239 FTRRRP 244
                P
Sbjct: 234 AEIEPP 239

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 35/112 (31%), Positives = 55/112 (49%), Gaps = 11/112 (9%)
Query: 133 LTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEP 192
           L++    A ++   +++ H      IV+ DLK  NILLD+D    + D G+ K       
Sbjct: 118 LSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCK------E 168
Query: 193 GTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
               +  +N  E  G   Y+APE  +G K + S D ++FG+LL EM   + P
Sbjct: 169 NMLGDAKTN--EFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 218

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 57/247 (23%), Positives = 103/247 (41%), Gaps = 26/247 (10%)
Query: 28  ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVV---NLKQKEASRSFAAECNALRNI 84
           A  +F     +G+G    VY     +S+ I+A+KV+    L++         E     ++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 85  RHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-DV 143
           RH N++++        +  F     V+  ++   L    R+     +F  QR    I ++
Sbjct: 69  RHPNILRL--------YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 120
Query: 144 SFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSI 203
           + A+ Y H      ++H D+KP N+LL        G+L +A   FG+   +    +S   
Sbjct: 121 ANALSYCH---SKRVIHRDIKPENLLL-----GSAGELKIAD--FGW---SVHAPSSRRT 167
Query: 204 EIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDA-MFNEGLTLHEFVKMA 262
            + G + Y+ PE   G       D+++ G+L  E    + P +A  + E       V+  
Sbjct: 168 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT 227
Query: 263 LPDKVME 269
            PD V E
Sbjct: 228 FPDFVTE 234

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 57/247 (23%), Positives = 103/247 (41%), Gaps = 26/247 (10%)
Query: 28  ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVV---NLKQKEASRSFAAECNALRNI 84
           A  +F     +G+G    VY     +S+ I+A+KV+    L++         E     ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 85  RHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-DV 143
           RH N++++        +  F     V+  ++   L    R+     +F  QR    I ++
Sbjct: 66  RHPNILRL--------YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 117
Query: 144 SFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSI 203
           + A+ Y H      ++H D+KP N+LL        G+L +A   FG+   +    +S   
Sbjct: 118 ANALSYCH---SKRVIHRDIKPENLLL-----GSAGELKIAD--FGW---SVHAPSSRRT 164
Query: 204 EIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDA-MFNEGLTLHEFVKMA 262
            + G + Y+ PE   G       D+++ G+L  E    + P +A  + E       V+  
Sbjct: 165 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT 224
Query: 263 LPDKVME 269
            PD V E
Sbjct: 225 FPDFVTE 231

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/247 (22%), Positives = 102/247 (41%), Gaps = 26/247 (10%)
Query: 28  ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVV---NLKQKEASRSFAAECNALRNI 84
           A  +F     +G+G    VY     +S+ I+A+KV+    L++         E     ++
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 85  RHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-DV 143
           RH N++++        +  F     V+  ++   L    R+     +F  QR    I ++
Sbjct: 71  RHPNILRL--------YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 122
Query: 144 SFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSI 203
           + A+ Y H      ++H D+KP N+LL        G+L +A F +     ++  T     
Sbjct: 123 ANALSYCH---SKRVIHRDIKPENLLL-----GSAGELKIADFGWSVHAPSSRRTT---- 170
Query: 204 EIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDA-MFNEGLTLHEFVKMA 262
            + G + Y+ PE   G       D+++ G+L  E    + P +A  + E       V+  
Sbjct: 171 -LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT 229
Query: 263 LPDKVME 269
            PD V E
Sbjct: 230 FPDFVTE 236

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/247 (23%), Positives = 103/247 (41%), Gaps = 26/247 (10%)
Query: 28  ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVV---NLKQKEASRSFAAECNALRNI 84
           A  +F     +G+G    VY     +S+ I+A+KV+    L++         E     ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 85  RHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-DV 143
           RH N++++        +  F     V+  ++   L    R+     +F  QR    I ++
Sbjct: 66  RHPNILRL--------YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 117
Query: 144 SFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSI 203
           + A+ Y H      ++H D+KP N+LL        G+L +A   FG+   +    +S   
Sbjct: 118 ANALSYCH---SKRVIHRDIKPENLLL-----GSAGELKIAD--FGW---SVHAPSSRRT 164
Query: 204 EIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDA-MFNEGLTLHEFVKMA 262
            + G + Y+ PE   G       D+++ G+L  E    + P +A  + E       V+  
Sbjct: 165 XLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT 224
Query: 263 LPDKVME 269
            PD V E
Sbjct: 225 FPDFVTE 231

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/248 (22%), Positives = 104/248 (41%), Gaps = 28/248 (11%)
Query: 28  ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVV---NLKQKEASRSFAAECNALRNI 84
           A  +F     +G+G    VY     +S+ I+A+KV+    L++         E     ++
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 85  RHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-DV 143
           RH N++++        +  F     V+  ++   L    R+     +F  QR    I ++
Sbjct: 67  RHPNILRL--------YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 118
Query: 144 SFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG-YEPGTAAETASNS 202
           + A+ Y H      ++H D+KP N+LL        G+L +A F +  + P +  +T    
Sbjct: 119 ANALSYCH---SKRVIHRDIKPENLLL-----GSAGELKIADFGWSVHAPSSRRDT---- 166
Query: 203 IEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDA-MFNEGLTLHEFVKM 261
             + G + Y+ PE   G       D+++ G+L  E    + P +A  + E       V+ 
Sbjct: 167 --LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF 224
Query: 262 ALPDKVME 269
             PD V E
Sbjct: 225 TFPDFVTE 232

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/247 (23%), Positives = 103/247 (41%), Gaps = 26/247 (10%)
Query: 28  ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVV---NLKQKEASRSFAAECNALRNI 84
           A  +F     +G+G    VY     +S+ I+A+KV+    L++         E     ++
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 85  RHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-DV 143
           RH N++++        +  F     V+  ++   L    R+     +F  QR    I ++
Sbjct: 70  RHPNILRL--------YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 121
Query: 144 SFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSI 203
           + A+ Y H      ++H D+KP N+LL        G+L +A   FG+   +    +S   
Sbjct: 122 ANALSYCH---SKRVIHRDIKPENLLL-----GSAGELKIAD--FGW---SVHAPSSRRT 168
Query: 204 EIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDA-MFNEGLTLHEFVKMA 262
            + G + Y+ PE   G       D+++ G+L  E    + P +A  + E       V+  
Sbjct: 169 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT 228
Query: 263 LPDKVME 269
            PD V E
Sbjct: 229 FPDFVTE 235

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/247 (23%), Positives = 103/247 (41%), Gaps = 26/247 (10%)
Query: 28  ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVV---NLKQKEASRSFAAECNALRNI 84
           A  +F     +G+G    VY     +S+ I+A+KV+    L++         E     ++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 85  RHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-DV 143
           RH N++++        +  F     V+  ++   L    R+     +F  QR    I ++
Sbjct: 69  RHPNILRL--------YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 120
Query: 144 SFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSI 203
           + A+ Y H      ++H D+KP N+LL        G+L +A F  G+   +    +S   
Sbjct: 121 ANALSYCH---SKRVIHRDIKPENLLL-----GSAGELKIANF--GW---SVHAPSSRRT 167
Query: 204 EIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDA-MFNEGLTLHEFVKMA 262
            + G + Y+ PE   G       D+++ G+L  E    + P +A  + E       V+  
Sbjct: 168 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT 227
Query: 263 LPDKVME 269
            PD V E
Sbjct: 228 FPDFVTE 234

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 63/137 (45%), Gaps = 18/137 (13%)
Query: 109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNI-AIDVSFAIEYFHHHCQPSIVHGDLKPSN 167
           ++ +Y++   L   LR+S    RF        A +V  A+EY H      I++ DLKP N
Sbjct: 83  MIMDYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPEN 136
Query: 168 ILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGD 227
           ILLD++    + D G AK++              +  + G   Y+APE       + S D
Sbjct: 137 ILLDKNGHIKITDFGFAKYV-----------PDVTYXLCGTPDYIAPEVVSTKPYNKSID 185
Query: 228 VYNFGILLLEMFTRRRP 244
            ++FGIL+ EM     P
Sbjct: 186 WWSFGILIYEMLAGYTP 202

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/247 (22%), Positives = 102/247 (41%), Gaps = 26/247 (10%)
Query: 28  ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVV---NLKQKEASRSFAAECNALRNI 84
           A  +F     +G+G    VY     +S+ I+A+KV+    L++         E     ++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 85  RHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-DV 143
           RH N++++        +  F     V+  ++   L    R+     +F  QR    I ++
Sbjct: 69  RHPNILRL--------YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 120
Query: 144 SFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSI 203
           + A+ Y H      ++H D+KP N+LL        G+L +A F +     ++  T     
Sbjct: 121 ANALSYCH---SKRVIHRDIKPENLLL-----GSAGELKIADFGWSVHAPSSRRTT---- 168
Query: 204 EIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDA-MFNEGLTLHEFVKMA 262
            + G + Y+ PE   G       D+++ G+L  E    + P +A  + E       V+  
Sbjct: 169 -LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT 227
Query: 263 LPDKVME 269
            PD V E
Sbjct: 228 FPDFVTE 234

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/247 (23%), Positives = 103/247 (41%), Gaps = 26/247 (10%)
Query: 28  ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVV---NLKQKEASRSFAAECNALRNI 84
           A  +F     +G+G    VY     +S+ I+A+KV+    L++         E     ++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 85  RHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-DV 143
           RH N++++        +  F     V+  ++   L    R+     +F  QR    I ++
Sbjct: 69  RHPNILRL--------YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 120
Query: 144 SFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSI 203
           + A+ Y H      ++H D+KP N+LL        G+L +A   FG+   +    +S   
Sbjct: 121 ANALSYCH---SKRVIHRDIKPENLLL-----GSAGELKIAD--FGW---SVHAPSSRRX 167
Query: 204 EIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDA-MFNEGLTLHEFVKMA 262
            + G + Y+ PE   G       D+++ G+L  E    + P +A  + E       V+  
Sbjct: 168 XLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT 227
Query: 263 LPDKVME 269
            PD V E
Sbjct: 228 FPDFVTE 234

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/247 (23%), Positives = 103/247 (41%), Gaps = 26/247 (10%)
Query: 28  ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVV---NLKQKEASRSFAAECNALRNI 84
           A  +F     +G+G    VY     +S+ I+A+KV+    L++         E     ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 85  RHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-DV 143
           RH N++++        +  F     V+  ++   L    R+     +F  QR    I ++
Sbjct: 66  RHPNILRL--------YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 117
Query: 144 SFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSI 203
           + A+ Y H      ++H D+KP N+LL        G+L +A   FG+   +    +S   
Sbjct: 118 ANALSYCH---SKRVIHRDIKPENLLL-----GSAGELKIAD--FGW---SVHAPSSRRX 164
Query: 204 EIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDA-MFNEGLTLHEFVKMA 262
            + G + Y+ PE   G       D+++ G+L  E    + P +A  + E       V+  
Sbjct: 165 XLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT 224
Query: 263 LPDKVME 269
            PD V E
Sbjct: 225 FPDFVTE 231

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/247 (22%), Positives = 102/247 (41%), Gaps = 26/247 (10%)
Query: 28  ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVV---NLKQKEASRSFAAECNALRNI 84
           A  +F     +G+G    VY     +S+ I+A+KV+    L++         E     ++
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 85  RHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-DV 143
           RH N++++        +  F     V+  ++   L    R+     +F  QR    I ++
Sbjct: 68  RHPNILRL--------YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 119
Query: 144 SFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSI 203
           + A+ Y H      ++H D+KP N+LL        G+L +A F +     ++  T     
Sbjct: 120 ANALSYCH---SKRVIHRDIKPENLLL-----GSAGELKIANFGWSVHAPSSRRTT---- 167
Query: 204 EIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDA-MFNEGLTLHEFVKMA 262
            + G + Y+ PE   G       D+++ G+L  E    + P +A  + E       V+  
Sbjct: 168 -LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT 226
Query: 263 LPDKVME 269
            PD V E
Sbjct: 227 FPDFVTE 233

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 90/194 (46%), Gaps = 23/194 (11%)
Query: 76  AECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQ 135
           AE N ++ + +  ++++I IC +  +       +V E  +   L ++L+Q+    R +  
Sbjct: 77  AEANVMQQLDNPYIVRMIGICEAESW------MLVMEMAELGPLNKYLQQN----RHVKD 126
Query: 136 R--VNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPG 193
           +  + +   VS  ++Y     + + VH DL   N+LL     A + D GL+K L   E  
Sbjct: 127 KNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 183
Query: 194 TAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTR-RRPTDAMFNEG 252
             A+T       K  V + APE     K S   DV++FG+L+ E F+  ++P   M    
Sbjct: 184 YKAQTHG-----KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 238
Query: 253 LT--LHEFVKMALP 264
           +T  L +  +M  P
Sbjct: 239 VTAMLEKGERMGCP 252

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 90/194 (46%), Gaps = 23/194 (11%)
Query: 76  AECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQ 135
           AE N ++ + +  ++++I IC +  +       +V E  +   L ++L+Q+    R +  
Sbjct: 77  AEANVMQQLDNPYIVRMIGICEAESW------MLVMEMAELGPLNKYLQQN----RHVKD 126
Query: 136 R--VNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPG 193
           +  + +   VS  ++Y     + + VH DL   N+LL     A + D GL+K L   E  
Sbjct: 127 KNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 183
Query: 194 TAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTR-RRPTDAMFNEG 252
             A+T       K  V + APE     K S   DV++FG+L+ E F+  ++P   M    
Sbjct: 184 YKAQTHG-----KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 238
Query: 253 LT--LHEFVKMALP 264
           +T  L +  +M  P
Sbjct: 239 VTAMLEKGERMGCP 252

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 90/194 (46%), Gaps = 23/194 (11%)
Query: 76  AECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQ 135
           AE N ++ + +  ++++I IC +  +       +V E  +   L ++L+Q+    R +  
Sbjct: 61  AEANVMQQLDNPYIVRMIGICEAESW------MLVMEMAELGPLNKYLQQN----RHVKD 110
Query: 136 R--VNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPG 193
           +  + +   VS  ++Y     + + VH DL   N+LL     A + D GL+K L   E  
Sbjct: 111 KNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 167
Query: 194 TAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTR-RRPTDAMFNEG 252
             A+T       K  V + APE     K S   DV++FG+L+ E F+  ++P   M    
Sbjct: 168 YKAQTHG-----KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 222
Query: 253 LT--LHEFVKMALP 264
           +T  L +  +M  P
Sbjct: 223 VTAMLEKGERMGCP 236

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/252 (23%), Positives = 105/252 (41%), Gaps = 26/252 (10%)
Query: 23  AELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVV---NLKQKEASRSFAAECN 79
           A+   A  +F     +G+G    VY     +S+ I+A+KV+    L++         E  
Sbjct: 1   AKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 60
Query: 80  ALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNI 139
              ++RH N++++        +  F     V+  ++   L    R+     +F  QR   
Sbjct: 61  IQSHLRHPNILRL--------YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT 112
Query: 140 AI-DVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAET 198
            I +++ A+ Y H      ++H D+KP N+LL        G+L +A   FG+   +    
Sbjct: 113 YITELANALSYCH---SKRVIHRDIKPENLLL-----GSAGELKIAD--FGW---SVHAP 159
Query: 199 ASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDA-MFNEGLTLHE 257
           +S    + G + Y+ PE   G       D+++ G+L  E    + P +A  + E      
Sbjct: 160 SSRRAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS 219
Query: 258 FVKMALPDKVME 269
            V+   PD V E
Sbjct: 220 RVEFTFPDFVTE 231

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 98/220 (44%), Gaps = 30/220 (13%)
Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNL 89
           +++    K+G+G  S V++ I   +   V VK++   +K   +    E   L N+R    
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKNKIKR---EIKILENLR--GG 91
Query: 90  IKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQ-SNGQLRFLTQRVNIAIDVSFAIE 148
             IIT+   +        A+VFE++ N + +Q  +  ++  +RF    +  A+D   ++ 
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSM- 150
Query: 149 YFHHHCQPSIVHGDLKPSNILLDQDIVA-HVGDLGLAKFLFGYEPGTAAETASNSIEIKG 207
                    I+H D+KP N+++D +     + D GLA+F   Y PG        S   KG
Sbjct: 151 --------GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF---YHPGQEYNVRVASRYFKG 199
Query: 208 ---IVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
              +V Y   +Y +        D+++ G +L  M  R+ P
Sbjct: 200 PELLVDYQMYDYSL--------DMWSLGCMLASMIFRKEP 231

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 52/232 (22%), Positives = 103/232 (44%), Gaps = 33/232 (14%)
Query: 37  KIGQGGVSIVYKG-----ILDESRSIVAVKVVNLKQKEASR-SFAAECNALRNIRHRNLI 90
           ++GQG   +VY+G     I  E+ + VAVK VN       R  F  E + ++     +++
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 91  KIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLR--------FLTQRVNIAID 142
           +++ + S           +V E M + +L+ +LR    +           L + + +A +
Sbjct: 84  RLLGVVSK-----GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 143 VSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNS 202
           ++  + Y +       VH +L   N ++  D    +GD G+ + ++        ET    
Sbjct: 139 IADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIY--------ETDYYR 187
Query: 203 IEIKGI--VGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNE 251
              KG+  V ++APE       + S D+++FG++L E+ +   +P   + NE
Sbjct: 188 KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE 239

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 62/246 (25%), Positives = 102/246 (41%), Gaps = 50/246 (20%)
Query: 21  SYAELSKATNNFSPAN------KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSF 74
           S  +    T + +P +      ++G G    VYK    E+  + A KV++ K +E    +
Sbjct: 22  SMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDY 81
Query: 75  AAECNALRNIRHRNLIKII-------TICSSIDF-EGFDFKAIVFEYMQNRNLEQWLRQS 126
             E + L +  H N++K++        +   I+F  G    A++ E      LE+ L +S
Sbjct: 82  MVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE------LERPLTES 135
Query: 127 NGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF 186
             Q+    Q ++       A+ Y H +    I+H DLK  NIL   D     GD+ LA F
Sbjct: 136 QIQV-VCKQTLD-------ALNYLHDN---KIIHRDLKAGNILFTLD-----GDIKLADF 179
Query: 187 LFGYEPGTAAETASNSIEIKGIVG---YVAPEYGMGSKA-----SVSGDVYNFGILLLEM 238
                 G +A+           +G   ++APE  M   +         DV++ GI L+EM
Sbjct: 180 ------GVSAKNTRXIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233
Query: 239 FTRRRP 244
                P
Sbjct: 234 AEIEPP 239

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 90/194 (46%), Gaps = 23/194 (11%)
Query: 76  AECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQ 135
           AE N ++ + +  ++++I IC +  +       +V E  +   L ++L+Q+    R +  
Sbjct: 57  AEANVMQQLDNPYIVRMIGICEAESW------MLVMEMAELGPLNKYLQQN----RHVKD 106
Query: 136 R--VNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPG 193
           +  + +   VS  ++Y     + + VH DL   N+LL     A + D GL+K L   E  
Sbjct: 107 KNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 163
Query: 194 TAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTR-RRPTDAMFNEG 252
             A+T       K  V + APE     K S   DV++FG+L+ E F+  ++P   M    
Sbjct: 164 YKAQTHG-----KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 218
Query: 253 LT--LHEFVKMALP 264
           +T  L +  +M  P
Sbjct: 219 VTAMLEKGERMGCP 232

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 90/194 (46%), Gaps = 23/194 (11%)
Query: 76  AECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQ 135
           AE N ++ + +  ++++I IC +  +       +V E  +   L ++L+Q+    R +  
Sbjct: 75  AEANVMQQLDNPYIVRMIGICEAESW------MLVMEMAELGPLNKYLQQN----RHVKD 124
Query: 136 R--VNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPG 193
           +  + +   VS  ++Y     + + VH DL   N+LL     A + D GL+K L   E  
Sbjct: 125 KNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 181
Query: 194 TAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTR-RRPTDAMFNEG 252
             A+T       K  V + APE     K S   DV++FG+L+ E F+  ++P   M    
Sbjct: 182 YKAQTHG-----KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 236
Query: 253 LT--LHEFVKMALP 264
           +T  L +  +M  P
Sbjct: 237 VTAMLEKGERMGCP 250

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 90/194 (46%), Gaps = 23/194 (11%)
Query: 76  AECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQ 135
           AE N ++ + +  ++++I IC +  +       +V E  +   L ++L+Q+    R +  
Sbjct: 55  AEANVMQQLDNPYIVRMIGICEAESW------MLVMEMAELGPLNKYLQQN----RHVKD 104
Query: 136 R--VNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPG 193
           +  + +   VS  ++Y     + + VH DL   N+LL     A + D GL+K L   E  
Sbjct: 105 KNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 161
Query: 194 TAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTR-RRPTDAMFNEG 252
             A+T       K  V + APE     K S   DV++FG+L+ E F+  ++P   M    
Sbjct: 162 YKAQTHG-----KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 216
Query: 253 LT--LHEFVKMALP 264
           +T  L +  +M  P
Sbjct: 217 VTAMLEKGERMGCP 230

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/232 (23%), Positives = 104/232 (44%), Gaps = 33/232 (14%)
Query: 37  KIGQGGVSIVYKG-----ILDESRSIVAVKVVNLKQKEASR-SFAAECNALRNIRHRNLI 90
           ++GQG   +VY+G     I  E+ + VAVK VN       R  F  E + ++     +++
Sbjct: 25  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 84
Query: 91  KIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQ-----SNGQLR---FLTQRVNIAID 142
           +++ + S           +V E M + +L+ +LR       N   R    L + + +A +
Sbjct: 85  RLLGVVSK-----GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 139
Query: 143 VSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNS 202
           ++  + Y +       VH +L   N ++  D    +GD G+ + ++        ET    
Sbjct: 140 IADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIY--------ETDYYR 188
Query: 203 IEIKGI--VGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNE 251
              KG+  V ++APE       + S D+++FG++L E+ +   +P   + NE
Sbjct: 189 KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE 240

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 90/194 (46%), Gaps = 23/194 (11%)
Query: 76  AECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQ 135
           AE N ++ + +  ++++I IC +  +       +V E  +   L ++L+Q+    R +  
Sbjct: 67  AEANVMQQLDNPYIVRMIGICEAESW------MLVMEMAELGPLNKYLQQN----RHVKD 116
Query: 136 R--VNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPG 193
           +  + +   VS  ++Y     + + VH DL   N+LL     A + D GL+K L   E  
Sbjct: 117 KNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 173
Query: 194 TAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTR-RRPTDAMFNEG 252
             A+T       K  V + APE     K S   DV++FG+L+ E F+  ++P   M    
Sbjct: 174 YKAQTHG-----KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 228
Query: 253 LT--LHEFVKMALP 264
           +T  L +  +M  P
Sbjct: 229 VTAMLEKGERMGCP 242

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/247 (23%), Positives = 103/247 (41%), Gaps = 26/247 (10%)
Query: 28  ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVV---NLKQKEASRSFAAECNALRNI 84
           A  +F     +G+G    VY     +S+ I+A+KV+    L++         E     ++
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 85  RHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-DV 143
           RH N++++        +  F     V+  ++   L    R+     +F  QR    I ++
Sbjct: 68  RHPNILRL--------YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 119
Query: 144 SFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSI 203
           + A+ Y H      ++H D+KP N+LL        G+L +A   FG+   +    +S   
Sbjct: 120 ANALSYCH---SKRVIHRDIKPENLLL-----GSAGELKIAD--FGW---SVHAPSSRRX 166
Query: 204 EIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDA-MFNEGLTLHEFVKMA 262
            + G + Y+ PE   G       D+++ G+L  E    + P +A  + E       V+  
Sbjct: 167 XLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT 226
Query: 263 LPDKVME 269
            PD V E
Sbjct: 227 FPDFVTE 233

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 101/229 (44%), Gaps = 35/229 (15%)
Query: 30  NNFSPANKIGQGGVSIVYKGIL--DESRSIVAVK-VVNLKQKEASRSFAAECNALRNI-R 85
           N+    + IG+G    V K  +  D  R   A+K +     K+  R FA E   L  +  
Sbjct: 15  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 74
Query: 86  HRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQS------------NGQLRFL 133
           H N+I ++  C   +  G+ + AI  EY  + NL  +LR+S            N     L
Sbjct: 75  HPNIINLLGAC---EHRGYLYLAI--EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 129
Query: 134 T--QRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYE 191
           +  Q ++ A DV+  ++Y     Q   +H DL   NIL+ ++ VA + D GL++    Y 
Sbjct: 130 SSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV 186
Query: 192 PGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
             T              V ++A E    S  + + DV+++G+LL E+ +
Sbjct: 187 KKTMGRLP---------VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/247 (22%), Positives = 102/247 (41%), Gaps = 26/247 (10%)
Query: 28  ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVV---NLKQKEASRSFAAECNALRNI 84
           A  +F     +G+G    VY     +S+ I+A+KV+    L++         E     ++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 85  RHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-DV 143
           RH N++++        +  F     V+  ++   L    R+     +F  QR    I ++
Sbjct: 69  RHPNILRL--------YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 120
Query: 144 SFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSI 203
           + A+ Y H      ++H D+KP N+LL        G+L +A F +     ++   A    
Sbjct: 121 ANALSYCH---SKRVIHRDIKPENLLL-----GSAGELKIADFGWSVHAPSSRRAA---- 168
Query: 204 EIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDA-MFNEGLTLHEFVKMA 262
            + G + Y+ PE   G       D+++ G+L  E    + P +A  + E       V+  
Sbjct: 169 -LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT 227
Query: 263 LPDKVME 269
            PD V E
Sbjct: 228 FPDFVTE 234

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 101/229 (44%), Gaps = 35/229 (15%)
Query: 30  NNFSPANKIGQGGVSIVYKGIL--DESRSIVAVK-VVNLKQKEASRSFAAECNALRNI-R 85
           N+    + IG+G    V K  +  D  R   A+K +     K+  R FA E   L  +  
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 86  HRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQS------------NGQLRFL 133
           H N+I ++  C   +  G+ + AI  EY  + NL  +LR+S            N     L
Sbjct: 85  HPNIINLLGAC---EHRGYLYLAI--EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 139
Query: 134 T--QRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYE 191
           +  Q ++ A DV+  ++Y     Q   +H DL   NIL+ ++ VA + D GL++    Y 
Sbjct: 140 SSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV 196
Query: 192 PGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
             T              V ++A E    S  + + DV+++G+LL E+ +
Sbjct: 197 KKTMGRLP---------VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 104/214 (48%), Gaps = 27/214 (12%)
Query: 38  IGQGG---VSIVYKGILDESRSIVAVKVVN---LKQKEASRSFAAECNALRNIRHRNLIK 91
           +GQG    V +V K    ++R + A+KV+    LK ++  R+   E + L  + H  ++K
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVEVNHPFIVK 90
Query: 92  IITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-DVSFAIEYF 150
           +     +   EG  +  ++ ++++  +L     + + ++ F  + V   + +++ A+++ 
Sbjct: 91  L---HYAFQTEGKLY--LILDFLRGGDL---FTRLSKEVMFTEEDVKFYLAELALALDHL 142
Query: 151 HHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG 210
           H      I++ DLKP NILLD++    + D GL+K    +E          +    G V 
Sbjct: 143 H---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--------KKAYSFCGTVE 191
Query: 211 YVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
           Y+APE       + S D ++FG+L+ EM T   P
Sbjct: 192 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/246 (25%), Positives = 102/246 (41%), Gaps = 50/246 (20%)
Query: 21  SYAELSKATNNFSPAN------KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSF 74
           S  +    T + +P +      ++G G    VYK    E+  + A KV++ K +E    +
Sbjct: 22  SMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDY 81
Query: 75  AAECNALRNIRHRNLIKII-------TICSSIDF-EGFDFKAIVFEYMQNRNLEQWLRQS 126
             E + L +  H N++K++        +   I+F  G    A++ E      LE+ L +S
Sbjct: 82  MVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE------LERPLTES 135
Query: 127 NGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF 186
             Q+    Q ++       A+ Y H +    I+H DLK  NIL   D     GD+ LA F
Sbjct: 136 QIQV-VCKQTLD-------ALNYLHDN---KIIHRDLKAGNILFTLD-----GDIKLADF 179
Query: 187 LFGYEPGTAAETASNSIEIKGIVG---YVAPEYGMGSKA-----SVSGDVYNFGILLLEM 238
                 G +A+           +G   ++APE  M   +         DV++ GI L+EM
Sbjct: 180 ------GVSAKNTRXIQRRDXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233
Query: 239 FTRRRP 244
                P
Sbjct: 234 AEIEPP 239

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 90/194 (46%), Gaps = 23/194 (11%)
Query: 76  AECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQ 135
           AE N ++ + +  ++++I IC +  +       +V E  +   L ++L+Q+    R +  
Sbjct: 419 AEANVMQQLDNPYIVRMIGICEAESW------MLVMEMAELGPLNKYLQQN----RHVKD 468
Query: 136 R--VNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPG 193
           +  + +   VS  ++Y     + + VH DL   N+LL     A + D GL+K L   E  
Sbjct: 469 KNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 525
Query: 194 TAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTR-RRPTDAMFNEG 252
             A+T       K  V + APE     K S   DV++FG+L+ E F+  ++P   M    
Sbjct: 526 YKAQTHG-----KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 580
Query: 253 LT--LHEFVKMALP 264
           +T  L +  +M  P
Sbjct: 581 VTAMLEKGERMGCP 594

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 114/243 (46%), Gaps = 28/243 (11%)
Query: 30  NNFSPANKIGQGG---VSIVYKGILDESRSIVAVKVV---NLKQKEASRSFAAECNALRN 83
           ++F     +GQG    V +V K    +S  + A+KV+    LK ++  R+   E + L +
Sbjct: 28  SHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRT-KMERDILAD 86
Query: 84  IRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-D 142
           + H  ++K+     +   EG  +  ++ ++++  +L     + + ++ F  + V   + +
Sbjct: 87  VNHPFVVKL---HYAFQTEGKLY--LILDFLRGGDL---FTRLSKEVMFTEEDVKFYLAE 138
Query: 143 VSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNS 202
           ++  +++ H      I++ DLKP NILLD++    + D GL+K         A +    +
Sbjct: 139 LALGLDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--------EAIDHEKKA 187
Query: 203 IEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAM-FNEGLTLHEFVKM 261
               G V Y+APE       S S D +++G+L+ EM T   P       E +TL    K+
Sbjct: 188 YSFCGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKL 247
Query: 262 ALP 264
            +P
Sbjct: 248 GMP 250

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 90/194 (46%), Gaps = 23/194 (11%)
Query: 76  AECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQ 135
           AE N ++ + +  ++++I IC +  +       +V E  +   L ++L+Q+    R +  
Sbjct: 420 AEANVMQQLDNPYIVRMIGICEAESW------MLVMEMAELGPLNKYLQQN----RHVKD 469
Query: 136 R--VNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPG 193
           +  + +   VS  ++Y     + + VH DL   N+LL     A + D GL+K L   E  
Sbjct: 470 KNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 526
Query: 194 TAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTR-RRPTDAMFNEG 252
             A+T       K  V + APE     K S   DV++FG+L+ E F+  ++P   M    
Sbjct: 527 YKAQTHG-----KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 581
Query: 253 LT--LHEFVKMALP 264
           +T  L +  +M  P
Sbjct: 582 VTAMLEKGERMGCP 595

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 99/211 (46%), Gaps = 15/211 (7%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAA--ECNALRNIRHRNLIKIIT 94
           KIGQG    V+K    ++   VA+K V ++ ++      A  E   L+ ++H N++ +I 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 95  ICSSIDFEGFDFKA---IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFH 151
           IC +        K    +VF++ ++ +L   L  SN  ++F    +   + +     Y+ 
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFCEH-DLAGLL--SNVLVKFTLSEIKRVMQMLLNGLYYI 141
Query: 152 HHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGY 211
           H  +  I+H D+K +N+L+ +D V  + D GLA+  F     +      N +     + Y
Sbjct: 142 HRNK--ILHRDMKAANVLITRDGVLKLADFGLAR-AFSLAKNSQPNRYXNRVV---TLWY 195
Query: 212 VAPEYGMGSKA-SVSGDVYNFGILLLEMFTR 241
             PE  +G +      D++  G ++ EM+TR
Sbjct: 196 RPPELLLGERDYGPPIDLWGAGCIMAEMWTR 226

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 106/222 (47%), Gaps = 27/222 (12%)
Query: 30  NNFSPANKIGQGG---VSIVYKGILDESRSIVAVKVVN---LKQKEASRSFAAECNALRN 83
           + F     +GQG    V +V K    ++R + A+KV+    LK ++  R+   E + L  
Sbjct: 25  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVE 83
Query: 84  IRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-D 142
           + H  ++K+     +   EG  +  ++ ++++  +L     + + ++ F  + V   + +
Sbjct: 84  VNHPFIVKL---HYAFQTEGKLY--LILDFLRGGDL---FTRLSKEVMFTEEDVKFYLAE 135
Query: 143 VSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNS 202
           ++ A+++ H      I++ DLKP NILLD++    + D GL+K         + +    +
Sbjct: 136 LALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--------ESIDHEKKA 184
Query: 203 IEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
               G V Y+APE       + S D ++FG+L+ EM T   P
Sbjct: 185 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 226

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 86/201 (42%), Gaps = 23/201 (11%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASR-SFAAECNALRNIRHRNLIKIITIC 96
           +G G  S V       ++ +VA+K +  +  E    S   E   L  I+H N++ +  I 
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQP 156
            S        + +    + +R +E+         R + Q ++       A++Y H     
Sbjct: 86  ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLD-------AVKYLH---DL 135
Query: 157 SIVHGDLKPSNIL---LDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVA 213
            IVH DLKP N+L   LD+D    + D GL+K     +PG+   TA       G  GYVA
Sbjct: 136 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTAC------GTPGYVA 186
Query: 214 PEYGMGSKASVSGDVYNFGIL 234
           PE       S + D ++ G++
Sbjct: 187 PEVLAQKPYSKAVDCWSIGVI 207

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 106/222 (47%), Gaps = 27/222 (12%)
Query: 30  NNFSPANKIGQGG---VSIVYKGILDESRSIVAVKVV---NLKQKEASRSFAAECNALRN 83
           + F     +GQG    V +V K    ++R + A+KV+    LK ++  R+   E + L  
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVE 82
Query: 84  IRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-D 142
           + H  ++K+     +   EG  +  ++ ++++  +L     + + ++ F  + V   + +
Sbjct: 83  VNHPFIVKL---HYAFQTEGKLY--LILDFLRGGDL---FTRLSKEVMFTEEDVKFYLAE 134
Query: 143 VSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNS 202
           ++ A+++ H      I++ DLKP NILLD++    + D GL+K         + +    +
Sbjct: 135 LALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--------ESIDHEKKA 183
Query: 203 IEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
               G V Y+APE       + S D ++FG+L+ EM T   P
Sbjct: 184 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 99/211 (46%), Gaps = 15/211 (7%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAA--ECNALRNIRHRNLIKIIT 94
           KIGQG    V+K    ++   VA+K V ++ ++      A  E   L+ ++H N++ +I 
Sbjct: 24  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 83
Query: 95  ICSSIDFEGFDFKA---IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFH 151
           IC +        K    +VF++ ++ +L   L  SN  ++F    +   + +     Y+ 
Sbjct: 84  ICRTKASPYNRCKGSIYLVFDFCEH-DLAGLL--SNVLVKFTLSEIKRVMQMLLNGLYYI 140
Query: 152 HHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGY 211
           H  +  I+H D+K +N+L+ +D V  + D GLA+  F     +      N +     + Y
Sbjct: 141 HRNK--ILHRDMKAANVLITRDGVLKLADFGLAR-AFSLAKNSQPNRYXNRV---VTLWY 194
Query: 212 VAPEYGMGSKA-SVSGDVYNFGILLLEMFTR 241
             PE  +G +      D++  G ++ EM+TR
Sbjct: 195 RPPELLLGERDYGPPIDLWGAGCIMAEMWTR 225

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 86/201 (42%), Gaps = 23/201 (11%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASR-SFAAECNALRNIRHRNLIKIITIC 96
           +G G  S V       ++ +VA+K +  +  E    S   E   L  I+H N++ +  I 
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQP 156
            S        + +    + +R +E+         R + Q ++       A++Y H     
Sbjct: 86  ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLD-------AVKYLH---DL 135
Query: 157 SIVHGDLKPSNIL---LDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVA 213
            IVH DLKP N+L   LD+D    + D GL+K     +PG+   TA       G  GYVA
Sbjct: 136 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTAC------GTPGYVA 186
Query: 214 PEYGMGSKASVSGDVYNFGIL 234
           PE       S + D ++ G++
Sbjct: 187 PEVLAQKPYSKAVDCWSIGVI 207

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 86/201 (42%), Gaps = 23/201 (11%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASR-SFAAECNALRNIRHRNLIKIITIC 96
           +G G  S V       ++ +VA+K +  +  E    S   E   L  I+H N++ +  I 
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQP 156
            S        + +    + +R +E+         R + Q ++       A++Y H     
Sbjct: 86  ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLD-------AVKYLH---DL 135
Query: 157 SIVHGDLKPSNIL---LDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVA 213
            IVH DLKP N+L   LD+D    + D GL+K     +PG+   TA       G  GYVA
Sbjct: 136 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTAC------GTPGYVA 186
Query: 214 PEYGMGSKASVSGDVYNFGIL 234
           PE       S + D ++ G++
Sbjct: 187 PEVLAQKPYSKAVDCWSIGVI 207

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/118 (33%), Positives = 53/118 (44%), Gaps = 13/118 (11%)
Query: 128 GQLRFLTQR-VNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF 186
           GQ  F   R V  A ++   +E  H      IV+ DLKP NILLD      + DLGLA  
Sbjct: 279 GQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVH 335
Query: 187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
           +         +T    +   G VGY+APE     + + S D +  G LL EM   + P
Sbjct: 336 V------PEGQTIKGRV---GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 99/211 (46%), Gaps = 15/211 (7%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAA--ECNALRNIRHRNLIKIIT 94
           KIGQG    V+K    ++   VA+K V ++ ++      A  E   L+ ++H N++ +I 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 95  ICSSIDFEGFDFKA---IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFH 151
           IC +        K    +VF++ ++ +L   L  SN  ++F    +   + +     Y+ 
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFCEH-DLAGLL--SNVLVKFTLSEIKRVMQMLLNGLYYI 141
Query: 152 HHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGY 211
           H  +  I+H D+K +N+L+ +D V  + D GLA+  F     +      N +     + Y
Sbjct: 142 HRNK--ILHRDMKAANVLITRDGVLKLADFGLAR-AFSLAKNSQPNRYXNRVV---TLWY 195
Query: 212 VAPEYGMGSKA-SVSGDVYNFGILLLEMFTR 241
             PE  +G +      D++  G ++ EM+TR
Sbjct: 196 RPPELLLGERDYGPPIDLWGAGCIMAEMWTR 226

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/118 (33%), Positives = 53/118 (44%), Gaps = 13/118 (11%)
Query: 128 GQLRFLTQR-VNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF 186
           GQ  F   R V  A ++   +E  H      IV+ DLKP NILLD      + DLGLA  
Sbjct: 279 GQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVH 335
Query: 187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
           +         +T    +   G VGY+APE     + + S D +  G LL EM   + P
Sbjct: 336 V------PEGQTIKGRV---GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 95/200 (47%), Gaps = 32/200 (16%)
Query: 58  VAVKVVNLKQKEASRS-FAAECNALRNI-RHRNLIKIITICSSIDFEGFDFKAIVFEYMQ 115
           VAVK++     E   S   +E   ++ I +H+N+I ++  C+    +G  +  ++ EY  
Sbjct: 63  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ---DGPLY--VIVEYAS 117
Query: 116 NRNLEQWL--RQSNGQLRF-----------LTQR--VNIAIDVSFAIEYFHHHCQPSIVH 160
             NL ++L  R+  G L F           L+ +  V+ A  V+  +EY         +H
Sbjct: 118 KGNLREYLQARRPPG-LEFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIH 173
Query: 161 GDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGS 220
            DL   N+L+ +D V  + D GLA+ +   +     +T +  + +K    ++APE     
Sbjct: 174 RDLAARNVLVTEDNVMKIADFGLARDIHHID--XXKKTTNGRLPVK----WMAPEALFDR 227
Query: 221 KASVSGDVYNFGILLLEMFT 240
             +   DV++FG+LL E+FT
Sbjct: 228 IYTHQSDVWSFGVLLWEIFT 247

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/245 (23%), Positives = 102/245 (41%), Gaps = 26/245 (10%)
Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVV---NLKQKEASRSFAAECNALRNIRH 86
            +F     +G+G    VY     +S+ I+A+KV+    L++         E     ++RH
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 87  RNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-DVSF 145
            N++++        +  F     V+  ++   L    R+     RF  QR    I +++ 
Sbjct: 72  PNILRL--------YGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELAN 123
Query: 146 AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEI 205
           A+ Y H      ++H D+KP N+LL  +     G+L +A   FG+   +    +S    +
Sbjct: 124 ALSYCH---SKRVIHRDIKPENLLLGSN-----GELKIAD--FGW---SVHAPSSRRTTL 170
Query: 206 KGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDA-MFNEGLTLHEFVKMALP 264
            G + Y+ PE   G       D+++ G+L  E      P +A  + E       V+   P
Sbjct: 171 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFP 230
Query: 265 DKVME 269
           D V E
Sbjct: 231 DFVTE 235

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 90/194 (46%), Gaps = 24/194 (12%)
Query: 58  VAVKVVNLKQKEAS--RSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQ 115
           VAVK+++  Q  +S  +    E   ++ + H N++K+  +   I+ E   +  +V EY  
Sbjct: 42  VAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV---IETEKTLY--LVMEYAS 96
Query: 116 NRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIV 175
              +  +L  ++G+++    R      VS A++Y H   Q  IVH DLK  N+LLD D+ 
Sbjct: 97  GGEVFDYL-VAHGRMKEKEARAKFRQIVS-AVQYCH---QKFIVHRDLKAENLLLDADMN 151
Query: 176 AHVGDLGLA-KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKAS-VSGDVYNFGI 233
             + D G + +F FG +  T            G   Y APE   G K      DV++ G+
Sbjct: 152 IKIADFGFSNEFTFGNKLDTFC----------GSPPYAAPELFQGKKYDGPEVDVWSLGV 201
Query: 234 LLLEMFTRRRPTDA 247
           +L  + +   P D 
Sbjct: 202 ILYTLVSGSLPFDG 215

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 90/194 (46%), Gaps = 24/194 (12%)
Query: 58  VAVKVVNLKQKEAS--RSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQ 115
           VAVK+++  Q  +S  +    E   ++ + H N++K+  +   I+ E   +  +V EY  
Sbjct: 42  VAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV---IETEKTLY--LVMEYAS 96
Query: 116 NRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIV 175
              +  +L  ++G+++    R      VS A++Y H   Q  IVH DLK  N+LLD D+ 
Sbjct: 97  GGEVFDYL-VAHGRMKEKEARAKFRQIVS-AVQYCH---QKFIVHRDLKAENLLLDADMN 151
Query: 176 AHVGDLGLA-KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKAS-VSGDVYNFGI 233
             + D G + +F FG +  T            G   Y APE   G K      DV++ G+
Sbjct: 152 IKIADFGFSNEFTFGNKLDTFC----------GSPPYAAPELFQGKKYDGPEVDVWSLGV 201
Query: 234 LLLEMFTRRRPTDA 247
           +L  + +   P D 
Sbjct: 202 ILYTLVSGSLPFDG 215

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 92/197 (46%), Gaps = 26/197 (13%)
Query: 58  VAVKVVNLKQKEASRS-FAAECNALRNI-RHRNLIKIITICSSIDFEG-------FDFKA 108
           VAVK++     E   S   +E   ++ I +H+N+I ++  C+    +G       +  K 
Sbjct: 48  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ---DGPLYVIVEYASKG 104
Query: 109 IVFEYMQNRN---LEQWLRQSNGQLRFLTQR--VNIAIDVSFAIEYFHHHCQPSIVHGDL 163
            + EY+Q R    LE     S+     L+ +  V+ A  V+  +EY         +H DL
Sbjct: 105 NLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDL 161
Query: 164 KPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKAS 223
              N+L+ +D V  + D GLA+ +   +     +T +  + +K    ++APE       +
Sbjct: 162 AARNVLVTEDNVMKIADFGLARDIHHID--YYKKTTNGRLPVK----WMAPEALFDRIYT 215
Query: 224 VSGDVYNFGILLLEMFT 240
              DV++FG+LL E+FT
Sbjct: 216 HQSDVWSFGVLLWEIFT 232

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/247 (22%), Positives = 102/247 (41%), Gaps = 26/247 (10%)
Query: 28  ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVV---NLKQKEASRSFAAECNALRNI 84
           A  +F     +G+G    VY     + + I+A+KV+    L++         E     ++
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 85  RHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-DV 143
           RH N++++        +  F     V+  ++   L    R+     +F  QR    I ++
Sbjct: 63  RHPNILRL--------YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 114
Query: 144 SFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSI 203
           + A+ Y H      ++H D+KP N+LL        G+L +A   FG+   +    +S   
Sbjct: 115 ANALSYCH---SKRVIHRDIKPENLLL-----GSAGELKIAD--FGW---SVHAPSSRRT 161
Query: 204 EIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDA-MFNEGLTLHEFVKMA 262
            + G + Y+ PE   G       D+++ G+L  E    + P +A  + E       V+  
Sbjct: 162 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT 221
Query: 263 LPDKVME 269
            PD V E
Sbjct: 222 FPDFVTE 228

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 92/197 (46%), Gaps = 26/197 (13%)
Query: 58  VAVKVVNLKQKEASRS-FAAECNALRNI-RHRNLIKIITICSSIDFEG-------FDFKA 108
           VAVK++     E   S   +E   ++ I +H+N+I ++  C+    +G       +  K 
Sbjct: 63  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ---DGPLYVIVEYASKG 119
Query: 109 IVFEYMQNRN---LEQWLRQSNGQLRFLTQR--VNIAIDVSFAIEYFHHHCQPSIVHGDL 163
            + EY+Q R    LE     S+     L+ +  V+ A  V+  +EY         +H DL
Sbjct: 120 NLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDL 176
Query: 164 KPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKAS 223
              N+L+ +D V  + D GLA+ +   +     +T +  + +K    ++APE       +
Sbjct: 177 AARNVLVTEDNVMKIADFGLARDIHHID--YYKKTTNGRLPVK----WMAPEALFDRIYT 230
Query: 224 VSGDVYNFGILLLEMFT 240
              DV++FG+LL E+FT
Sbjct: 231 HQSDVWSFGVLLWEIFT 247

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/246 (23%), Positives = 103/246 (41%), Gaps = 28/246 (11%)
Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVV---NLKQKEASRSFAAECNALRNIRH 86
            +F     +G+G    VY     +S+ I+A+KV+    L++         E     ++RH
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 87  RNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-DVSF 145
            N++++        +  F     V+  ++   L    R+     RF  QR    I +++ 
Sbjct: 72  PNILRL--------YGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELAN 123
Query: 146 AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG-YEPGTAAETASNSIE 204
           A+ Y H      ++H D+KP N+LL  +     G+L +A F +  + P +  +T      
Sbjct: 124 ALSYCH---SKRVIHRDIKPENLLLGSN-----GELKIADFGWSVHAPSSRRDT------ 169
Query: 205 IKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDA-MFNEGLTLHEFVKMAL 263
           + G + Y+ PE   G       D+++ G+L  E      P +A  + E       V+   
Sbjct: 170 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTF 229
Query: 264 PDKVME 269
           PD V E
Sbjct: 230 PDFVTE 235

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 48/107 (44%), Gaps = 11/107 (10%)
Query: 140 AIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETA 199
           + ++S A+ Y H      I++ DLK  N+LLD +    + D G+ K   G  PG    T 
Sbjct: 159 SAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE--GLRPGDTTSTF 213
Query: 200 SNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTD 246
                  G   Y+APE   G     S D +  G+L+ EM   R P D
Sbjct: 214 C------GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 254

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 92/197 (46%), Gaps = 26/197 (13%)
Query: 58  VAVKVVNLKQKEASRS-FAAECNALRNI-RHRNLIKIITICSSIDFEG-------FDFKA 108
           VAVK++     E   S   +E   ++ I +H+N+I ++  C+    +G       +  K 
Sbjct: 63  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ---DGPLYVIVEYASKG 119
Query: 109 IVFEYMQNRN---LEQWLRQSNGQLRFLTQR--VNIAIDVSFAIEYFHHHCQPSIVHGDL 163
            + EY+Q R    LE     S+     L+ +  V+ A  V+  +EY         +H DL
Sbjct: 120 NLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDL 176
Query: 164 KPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKAS 223
              N+L+ +D V  + D GLA+ +   +     +T +  + +K    ++APE       +
Sbjct: 177 AARNVLVTEDNVMKIADFGLARDIHHID--YYKKTTNGRLPVK----WMAPEALFDRIYT 230
Query: 224 VSGDVYNFGILLLEMFT 240
              DV++FG+LL E+FT
Sbjct: 231 HQSDVWSFGVLLWEIFT 247

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 92/197 (46%), Gaps = 26/197 (13%)
Query: 58  VAVKVVNLKQKEASRS-FAAECNALRNI-RHRNLIKIITICSSIDFEG-------FDFKA 108
           VAVK++     E   S   +E   ++ I +H+N+I ++  C+    +G       +  K 
Sbjct: 55  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ---DGPLYVIVEYASKG 111
Query: 109 IVFEYMQNRN---LEQWLRQSNGQLRFLTQR--VNIAIDVSFAIEYFHHHCQPSIVHGDL 163
            + EY+Q R    LE     S+     L+ +  V+ A  V+  +EY         +H DL
Sbjct: 112 NLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDL 168
Query: 164 KPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKAS 223
              N+L+ +D V  + D GLA+ +   +     +T +  + +K    ++APE       +
Sbjct: 169 AARNVLVTEDNVMKIADFGLARDIHHID--YYKKTTNGRLPVK----WMAPEALFDRIYT 222
Query: 224 VSGDVYNFGILLLEMFT 240
              DV++FG+LL E+FT
Sbjct: 223 HQSDVWSFGVLLWEIFT 239

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 92/197 (46%), Gaps = 26/197 (13%)
Query: 58  VAVKVVNLKQKEASRS-FAAECNALRNI-RHRNLIKIITICSSIDFEG-------FDFKA 108
           VAVK++     E   S   +E   ++ I +H+N+I ++  C+    +G       +  K 
Sbjct: 63  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ---DGPLYVIVEYASKG 119
Query: 109 IVFEYMQNRN---LEQWLRQSNGQLRFLTQR--VNIAIDVSFAIEYFHHHCQPSIVHGDL 163
            + EY+Q R    LE     S+     L+ +  V+ A  V+  +EY         +H DL
Sbjct: 120 NLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDL 176
Query: 164 KPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKAS 223
              N+L+ +D V  + D GLA+ +   +     +T +  + +K    ++APE       +
Sbjct: 177 AARNVLVTEDNVMKIADFGLARDIHHID--YYKKTTNGRLPVK----WMAPEALFDRIYT 230
Query: 224 VSGDVYNFGILLLEMFT 240
              DV++FG+LL E+FT
Sbjct: 231 HQSDVWSFGVLLWEIFT 247

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/112 (30%), Positives = 54/112 (48%), Gaps = 11/112 (9%)
Query: 133 LTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEP 192
           L++    A ++   +++ H      IV+ DLK  NILLD+D    + D G+ K       
Sbjct: 117 LSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCK------E 167
Query: 193 GTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
               +  +N     G   Y+APE  +G K + S D ++FG+LL EM   + P
Sbjct: 168 NMLGDAKTNXF--CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 92/197 (46%), Gaps = 26/197 (13%)
Query: 58  VAVKVVNLKQKEASRS-FAAECNALRNI-RHRNLIKIITICSSIDFEG-------FDFKA 108
           VAVK++     E   S   +E   ++ I +H+N+I ++  C+    +G       +  K 
Sbjct: 52  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ---DGPLYVIVEYASKG 108
Query: 109 IVFEYMQNRN---LEQWLRQSNGQLRFLTQR--VNIAIDVSFAIEYFHHHCQPSIVHGDL 163
            + EY+Q R    LE     S+     L+ +  V+ A  V+  +EY         +H DL
Sbjct: 109 NLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDL 165
Query: 164 KPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKAS 223
              N+L+ +D V  + D GLA+ +   +     +T +  + +K    ++APE       +
Sbjct: 166 AARNVLVTEDNVMKIADFGLARDIHHID--YYKKTTNGRLPVK----WMAPEALFDRIYT 219
Query: 224 VSGDVYNFGILLLEMFT 240
              DV++FG+LL E+FT
Sbjct: 220 HQSDVWSFGVLLWEIFT 236

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/228 (23%), Positives = 107/228 (46%), Gaps = 33/228 (14%)
Query: 40  QGGVSIVYKG-ILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITI--- 95
           +G    V+K  +L+E    VAVK+  ++ K++ ++   E  +L  ++H N+++ I     
Sbjct: 34  RGRFGCVWKAQLLNE---YVAVKIFPIQDKQSWQN-EYEVYSLPGMKHENILQFIGAEKR 89
Query: 96  CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHC- 154
            +S+D + +    ++  + +  +L  +L+     +    +  +IA  ++  + Y H    
Sbjct: 90  GTSVDVDLW----LITAFHEKGSLSDFLK---ANVVSWNELCHIAETMARGLAYLHEDIP 142
Query: 155 ------QPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGI 208
                 +P+I H D+K  N+LL  ++ A + D GLA     +E G +A      +   G 
Sbjct: 143 GLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA---LKFEAGKSAGDTHGQV---GT 196
Query: 209 VGYVAPEYGMGS-----KASVSGDVYNFGILLLEMFTRRRPTDAMFNE 251
             Y+APE   G+      A +  D+Y  G++L E+ +R    D   +E
Sbjct: 197 RRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/252 (22%), Positives = 104/252 (41%), Gaps = 26/252 (10%)
Query: 23  AELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVV---NLKQKEASRSFAAECN 79
           A+   A  +F     +G+G    VY      S+ I+A+KV+    L++         E  
Sbjct: 1   AKRQWALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVE 60
Query: 80  ALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNI 139
              ++RH N++++        +  F     V+  ++   L    R+     +F  QR   
Sbjct: 61  IQSHLRHPNILRL--------YGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTAT 112
Query: 140 AI-DVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAET 198
            I +++ A+ Y H      ++H D+KP N+LL        G+L +A   FG+   +    
Sbjct: 113 YITELANALSYCH---SKKVIHRDIKPENLLL-----GSAGELKIAD--FGW---SVHAP 159
Query: 199 ASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDA-MFNEGLTLHE 257
           +S    + G + Y+ PE   G       D+++ G+L  E    + P +A  + +      
Sbjct: 160 SSRRAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRIS 219
Query: 258 FVKMALPDKVME 269
            V+   PD V E
Sbjct: 220 RVEFTFPDFVTE 231

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 92/197 (46%), Gaps = 26/197 (13%)
Query: 58  VAVKVVNLKQKEASRS-FAAECNALRNI-RHRNLIKIITICSSIDFEG-------FDFKA 108
           VAVK++     E   S   +E   ++ I +H+N+I ++  C+    +G       +  K 
Sbjct: 56  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ---DGPLYVIVEYASKG 112
Query: 109 IVFEYMQNRN---LEQWLRQSNGQLRFLTQR--VNIAIDVSFAIEYFHHHCQPSIVHGDL 163
            + EY+Q R    LE     S+     L+ +  V+ A  V+  +EY         +H DL
Sbjct: 113 NLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDL 169
Query: 164 KPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKAS 223
              N+L+ +D V  + D GLA+ +   +     +T +  + +K    ++APE       +
Sbjct: 170 AARNVLVTEDNVMKIADFGLARDIHHID--YYKKTTNGRLPVK----WMAPEALFDRIYT 223
Query: 224 VSGDVYNFGILLLEMFT 240
              DV++FG+LL E+FT
Sbjct: 224 HQSDVWSFGVLLWEIFT 240

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/225 (23%), Positives = 97/225 (43%), Gaps = 25/225 (11%)
Query: 30  NNFSPANKIGQGGVSIVYKGIL-DESRSIVAVKVVNLKQKEASRS----FAAECNALRNI 84
             F+    +G+G    V +  L  E  S V V V  LK    + S    F  E   ++  
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 85  RHRNLIKIITICSSIDFEG-FDFKAIVFEYMQNRNLEQWLRQSN-GQLRF---LTQRVNI 139
            H ++ K++ +      +G      ++  +M++ +L  +L  S  G+  F   L   V  
Sbjct: 83  DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 140 AIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG---YEPGTAA 196
            +D++  +EY       + +H DL   N +L +D+   V D GL++ ++    Y  G A+
Sbjct: 143 MVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCAS 199
Query: 197 ETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTR 241
           +           V ++A E    +  +V  DV+ FG+ + E+ TR
Sbjct: 200 KLP---------VKWLALESLADNLYTVHSDVWAFGVTMWEIMTR 235

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 92/214 (42%), Gaps = 32/214 (14%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASR----SFAAECNALRNIRHRNLIKI 92
           K+G G    V+   L E RS    +V+    K+ S+       AE   L+++ H N+IKI
Sbjct: 29  KLGSGAFGDVH---LVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKI 85
Query: 93  ITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQR--VNIAIDVSFAIEYF 150
             +     FE +    IV E  +   L + +  +  + + L++     +   +  A+ YF
Sbjct: 86  FEV-----FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140
Query: 151 HHHCQPSIVHGDLKPSNILLDQDIVAH----VGDLGLAKFLFGYEPGTAAETASNSIEIK 206
           H      +VH DLKP NIL  QD   H    + D GLA+     E  T A          
Sbjct: 141 HSQ---HVVHKDLKPENILF-QDTSPHSPIKIIDFGLAELFKSDEHSTNA---------A 187
Query: 207 GIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
           G   Y+APE       +   D+++ G+++  + T
Sbjct: 188 GTALYMAPEV-FKRDVTFKCDIWSAGVVMYFLLT 220

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 52  DESRSIVAVKVVNLKQKEASRSFA---AECNALRNI-RHRNLIKIITICSSIDFEG---- 103
           D+   +  V V  LK     +  +   +E   ++ I +H+N+I ++  C+    +G    
Sbjct: 96  DKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ---DGPLYV 152
Query: 104 ---FDFKAIVFEYMQNR---NLEQWLRQSNGQLRFLTQR--VNIAIDVSFAIEYFHHHCQ 155
              +  K  + EY+Q R    LE     S+     L+ +  V+ A  V+  +EY      
Sbjct: 153 IVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---AS 209
Query: 156 PSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPE 215
              +H DL   N+L+ +D V  + D GLA+ +   +     +T +  + +K    ++APE
Sbjct: 210 KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID--YYKKTTNGRLPVK----WMAPE 263
Query: 216 YGMGSKASVSGDVYNFGILLLEMFT 240
                  +   DV++FG+LL E+FT
Sbjct: 264 ALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 98/221 (44%), Gaps = 24/221 (10%)
Query: 31  NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEAS--RSFAAECNALRNIRHRN 88
           N+     IG+G  + V       +   VAVK+++  Q  +S  +    E   ++ + H N
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 67
Query: 89  LIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIE 148
           ++K+  +   I+ E   +  +V EY     +  +L  ++G ++    R      VS A++
Sbjct: 68  IVKLFEV---IETEKTLY--LVMEYASGGEVFDYL-VAHGWMKEKEARAKFRQIVS-AVQ 120
Query: 149 YFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA-KFLFGYEPGTAAETASNSIEIKG 207
           Y H   Q  IVH DLK  N+LLD D+   + D G + +F FG +  T            G
Sbjct: 121 YCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC----------G 167
Query: 208 IVGYVAPEYGMGSKAS-VSGDVYNFGILLLEMFTRRRPTDA 247
              Y APE   G K      DV++ G++L  + +   P D 
Sbjct: 168 SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 208

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/238 (23%), Positives = 104/238 (43%), Gaps = 29/238 (12%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           KIG+G   IV       +   VAVK ++L++++       E   +R+  H N++ + +  
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYS-- 109
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQP 156
               +   D   +V E+++   L   +  +        Q   + + V  A+ Y H+    
Sbjct: 110 ---SYLVGDELWVVMEFLEGGALTDIVTHTRMNEE---QIATVCLSVLRALSYLHNQ--- 160
Query: 157 SIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG---YVA 213
            ++H D+K  +ILL  D     G + L+ F      G  A+ +    + K +VG   ++A
Sbjct: 161 GVIHRDIKSDSILLTSD-----GRIKLSDF------GFCAQVSKEVPKRKXLVGTPYWMA 209
Query: 214 PEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNE-GLTLHEFVKMALPDKVMEI 270
           PE           D+++ GI+++EM     P    FNE  L     ++ +LP +V ++
Sbjct: 210 PEVISRLPYGTEVDIWSLGIMVIEMIDGEPP---YFNEPPLQAMRRIRDSLPPRVKDL 264

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 34/136 (25%), Positives = 61/136 (44%), Gaps = 10/136 (7%)
Query: 109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNI 168
           IV EY+    L   +  + G +    + + +  D   A+ + H   Q  I+H D+KP+NI
Sbjct: 93  IVMEYVDGVTLRDIV-HTEGPM-TPKRAIEVIADACQALNFSH---QNGIIHRDVKPANI 147
Query: 169 LLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDV 228
           ++       V D G+A+ +       +  + + +  + G   Y++PE   G       DV
Sbjct: 148 MISATNAVKVMDFGIARAI-----ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDV 202
Query: 229 YNFGILLLEMFTRRRP 244
           Y+ G +L E+ T   P
Sbjct: 203 YSLGCVLYEVLTGEPP 218

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 40/173 (23%), Positives = 78/173 (45%), Gaps = 23/173 (13%)
Query: 74  FAAECNALRNIRHRNLIK----IITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQ 129
             +E N LR ++H N+++    II   ++  +       IV EY +  +L   + +   +
Sbjct: 52  LVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY-------IVMEYCEGGDLASVITKGTKE 104
Query: 130 LRFLTQR--VNIAIDVSFAIEYFHHHCQP--SIVHGDLKPSNILLDQDIVAHVGDLGLAK 185
            ++L +   + +   ++ A++  H       +++H DLKP+N+ LD      +GD GLA+
Sbjct: 105 RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164
Query: 186 FLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEM 238
            L              + E  G   Y++PE       +   D+++ G LL E+
Sbjct: 165 IL--------NHDEDFAKEFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 34/136 (25%), Positives = 61/136 (44%), Gaps = 10/136 (7%)
Query: 109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNI 168
           IV EY+    L   +  + G +    + + +  D   A+ + H   Q  I+H D+KP+NI
Sbjct: 93  IVMEYVDGVTLRDIV-HTEGPM-TPKRAIEVIADACQALNFSH---QNGIIHRDVKPANI 147
Query: 169 LLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDV 228
           ++       V D G+A+ +       +  + + +  + G   Y++PE   G       DV
Sbjct: 148 MISATNAVKVMDFGIARAI-----ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDV 202
Query: 229 YNFGILLLEMFTRRRP 244
           Y+ G +L E+ T   P
Sbjct: 203 YSLGCVLYEVLTGEPP 218

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 34/136 (25%), Positives = 61/136 (44%), Gaps = 10/136 (7%)
Query: 109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNI 168
           IV EY+    L   +  + G +    + + +  D   A+ + H   Q  I+H D+KP+NI
Sbjct: 93  IVMEYVDGVTLRDIV-HTEGPM-TPKRAIEVIADACQALNFSH---QNGIIHRDVKPANI 147
Query: 169 LLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDV 228
           ++       V D G+A+ +       +  + + +  + G   Y++PE   G       DV
Sbjct: 148 MISATNAVKVMDFGIARAI-----ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDV 202
Query: 229 YNFGILLLEMFTRRRP 244
           Y+ G +L E+ T   P
Sbjct: 203 YSLGCVLYEVLTGEPP 218

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 100/222 (45%), Gaps = 26/222 (11%)
Query: 31  NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEAS--RSFAAECNALRNIRHRN 88
           N+     IG+G  + V       +   VAVK+++  Q  +S  +    E   ++ + H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 89  LIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIE 148
           ++K+  +   I+ E   +  +V EY     +  +L  ++G+++    R      VS A++
Sbjct: 75  IVKLFEV---IETEKTLY--LVMEYASGGEVFDYL-VAHGRMKEKEARAKFRQIVS-AVQ 127
Query: 149 YFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA-KFLFGYEPGTAAETASNSIE-IK 206
           Y H   Q  IVH DLK  N+LLD D+   + D G + +F FG           N ++   
Sbjct: 128 YCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFG-----------NKLDAFC 173
Query: 207 GIVGYVAPEYGMGSKAS-VSGDVYNFGILLLEMFTRRRPTDA 247
           G   Y APE   G K      DV++ G++L  + +   P D 
Sbjct: 174 GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 215

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 35/136 (25%), Positives = 60/136 (44%), Gaps = 10/136 (7%)
Query: 109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNI 168
           IV EY+    L   +  + G +    + + +  D   A+ + H   Q  I+H D+KP+NI
Sbjct: 93  IVMEYVDGVTLRDIV-HTEGPM-TPKRAIEVIADACQALNFSH---QNGIIHRDVKPANI 147
Query: 169 LLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDV 228
           L+       V D G+A+ +       +  +   +  + G   Y++PE   G       DV
Sbjct: 148 LISATNAVKVVDFGIARAI-----ADSGNSVXQTAAVIGTAQYLSPEQARGDSVDARSDV 202
Query: 229 YNFGILLLEMFTRRRP 244
           Y+ G +L E+ T   P
Sbjct: 203 YSLGCVLYEVLTGEPP 218

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 34/136 (25%), Positives = 61/136 (44%), Gaps = 10/136 (7%)
Query: 109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNI 168
           IV EY+    L   +  + G +    + + +  D   A+ + H   Q  I+H D+KP+NI
Sbjct: 93  IVMEYVDGVTLRDIV-HTEGPM-TPKRAIEVIADACQALNFSH---QNGIIHRDVKPANI 147
Query: 169 LLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDV 228
           ++       V D G+A+ +       +  + + +  + G   Y++PE   G       DV
Sbjct: 148 MISATNAVKVMDFGIARAI-----ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDV 202
Query: 229 YNFGILLLEMFTRRRP 244
           Y+ G +L E+ T   P
Sbjct: 203 YSLGCVLYEVLTGEPP 218

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 90/194 (46%), Gaps = 24/194 (12%)
Query: 58  VAVKVVNLKQKEAS--RSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQ 115
           VAV++++  Q  +S  +    E   ++ + H N++K+  +   I+ E   +  +V EY  
Sbjct: 42  VAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV---IETEKTLY--LVMEYAS 96
Query: 116 NRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIV 175
              +  +L  ++G+++    R      VS A++Y H   Q  IVH DLK  N+LLD D+ 
Sbjct: 97  GGEVFDYL-VAHGRMKEKEARAKFRQIVS-AVQYCH---QKFIVHRDLKAENLLLDADMN 151
Query: 176 AHVGDLGLA-KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKAS-VSGDVYNFGI 233
             + D G + +F FG +  T            G   Y APE   G K      DV++ G+
Sbjct: 152 IKIADFGFSNEFTFGNKLDTFC----------GSPPYAAPELFQGKKYDGPEVDVWSLGV 201
Query: 234 LLLEMFTRRRPTDA 247
           +L  + +   P D 
Sbjct: 202 ILYTLVSGSLPFDG 215

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 101/229 (44%), Gaps = 35/229 (15%)
Query: 30  NNFSPANKIGQGGVSIVYKGIL--DESRSIVAVK-VVNLKQKEASRSFAAECNALRNI-R 85
           N+    + IG+G    V K  +  D  R   A+K +     K+  R FA E   L  +  
Sbjct: 22  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 81
Query: 86  HRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQS------------NGQLRFL 133
           H N+I ++  C   +  G+ + AI  EY  + NL  +LR+S            N     L
Sbjct: 82  HPNIINLLGAC---EHRGYLYLAI--EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 136
Query: 134 T--QRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYE 191
           +  Q ++ A DV+  ++Y     Q   +H +L   NIL+ ++ VA + D GL++    Y 
Sbjct: 137 SSQQLLHFAADVARGMDYLS---QKQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYV 193
Query: 192 PGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
             T              V ++A E    S  + + DV+++G+LL E+ +
Sbjct: 194 KKTMGRLP---------VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/217 (23%), Positives = 97/217 (44%), Gaps = 38/217 (17%)
Query: 32  FSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIK 91
           F+  ++IG+G    VYKGI + ++ +VA+K+++L++ E       +            I 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQE-----------IT 69
Query: 92  IITICSS---IDFEGFDFKA----IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVS 144
           +++ C S     + G   K+    I+ EY+   +    L+    +  ++     I  ++ 
Sbjct: 70  VLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYI---ATILREIL 126
Query: 145 FAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIE 204
             ++Y H   +   +H D+K +N+LL +      GD+ LA F      G A +     I+
Sbjct: 127 KGLDYLHSERK---IHRDIKAANVLLSEQ-----GDVKLADF------GVAGQLTDTQIK 172
Query: 205 IKGIVG---YVAPEYGMGSKASVSGDVYNFGILLLEM 238
               VG   ++APE    S      D+++ GI  +E+
Sbjct: 173 RNXFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIEL 209

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 34/136 (25%), Positives = 61/136 (44%), Gaps = 10/136 (7%)
Query: 109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNI 168
           IV EY+    L   +  + G +    + + +  D   A+ + H   Q  I+H D+KP+NI
Sbjct: 110 IVMEYVDGVTLRDIV-HTEGPM-TPKRAIEVIADACQALNFSH---QNGIIHRDVKPANI 164
Query: 169 LLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDV 228
           ++       V D G+A+ +       +  + + +  + G   Y++PE   G       DV
Sbjct: 165 MISATNAVKVMDFGIARAI-----ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDV 219
Query: 229 YNFGILLLEMFTRRRP 244
           Y+ G +L E+ T   P
Sbjct: 220 YSLGCVLYEVLTGEPP 235

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 90/194 (46%), Gaps = 24/194 (12%)
Query: 58  VAVKVVNLKQKEAS--RSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQ 115
           VAV++++  Q  +S  +    E   ++ + H N++K+  +   I+ E   +  +V EY  
Sbjct: 42  VAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV---IETEKTLY--LVMEYAS 96
Query: 116 NRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIV 175
              +  +L  ++G+++    R      VS A++Y H   Q  IVH DLK  N+LLD D+ 
Sbjct: 97  GGEVFDYL-VAHGRMKEKEARAKFRQIVS-AVQYCH---QKFIVHRDLKAENLLLDADMN 151
Query: 176 AHVGDLGLA-KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKAS-VSGDVYNFGI 233
             + D G + +F FG          +   E  G   Y APE   G K      DV++ G+
Sbjct: 152 IKIADFGFSNEFTFG----------NKLDEFCGSPPYAAPELFQGKKYDGPEVDVWSLGV 201
Query: 234 LLLEMFTRRRPTDA 247
           +L  + +   P D 
Sbjct: 202 ILYTLVSGSLPFDG 215

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/242 (22%), Positives = 108/242 (44%), Gaps = 48/242 (19%)
Query: 30  NNFSPANKIGQGGVSIVYK----GILD-ESRSIVAVKVVNLKQKEASRS----FAAECNA 80
           NN      IG+G    V++    G+L  E  ++VAVK++   ++EAS      F  E   
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML---KEEASADMQADFQREAAL 103
Query: 81  LRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQ--------------- 125
           +    + N++K++ +C+           ++FEYM   +L ++LR                
Sbjct: 104 MAEFDNPNIVKLLGVCAV-----GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 158
Query: 126 ------SNGQLRF-LTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHV 178
                 S G       +++ IA  V+  + Y         VH DL   N L+ +++V  +
Sbjct: 159 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKI 215
Query: 179 GDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEM 238
            D GL++ ++  +   A    +++I I+    ++ PE    ++ +   DV+ +G++L E+
Sbjct: 216 ADFGLSRNIYSADYYKA--DGNDAIPIR----WMPPESIFYNRYTTESDVWAYGVVLWEI 269
Query: 239 FT 240
           F+
Sbjct: 270 FS 271

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 89/197 (45%), Gaps = 31/197 (15%)
Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL---------KQKEASRSFAAECNA 80
            N+ P   +G+G  S+V + I   +    AVK++++         + +E   +   E + 
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 81  LRNIR-HRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNI 139
           LR +  H N+I++        +E   F  +VF+ M+   L  +L +        T+++  
Sbjct: 77  LRKVSGHPNIIQLKDT-----YETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMR 131
Query: 140 AI-DVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAET 198
           A+ +V  A+         +IVH DLKP NILLD D+   + D G +  L   +PG     
Sbjct: 132 ALLEVICALHKL------NIVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPGEKLR- 181
Query: 199 ASNSIEIKGIVGYVAPE 215
                E+ G   Y+APE
Sbjct: 182 -----EVCGTPSYLAPE 193

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/208 (22%), Positives = 92/208 (44%), Gaps = 34/208 (16%)
Query: 52  DESRSIVAVKVVNLKQKEASRSFA---AECNALRNI-RHRNLIKIITICSSIDFEGFDFK 107
           D+ +  V V V  LK     +  +   +E   ++ I +H+N+I ++  C+    +G  + 
Sbjct: 62  DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ---DGPLY- 117
Query: 108 AIVFEYMQNRNLEQWLRQ---------------SNGQLRFLTQRVNIAIDVSFAIEYFHH 152
            ++ EY    NL ++LR                   Q+ F    V+    ++  +EY   
Sbjct: 118 -VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF-KDLVSCTYQLARGMEYLAS 175
Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
                 +H DL   N+L+ ++ V  + D GLA+ +   +     +T +  + +K    ++
Sbjct: 176 Q---KCIHRDLAARNVLVTENNVMKIADFGLARDINNID--XXKKTTNGRLPVK----WM 226
Query: 213 APEYGMGSKASVSGDVYNFGILLLEMFT 240
           APE       +   DV++FG+L+ E+FT
Sbjct: 227 APEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/208 (22%), Positives = 92/208 (44%), Gaps = 34/208 (16%)
Query: 52  DESRSIVAVKVVNLKQKEASRSFA---AECNALRNI-RHRNLIKIITICSSIDFEGFDFK 107
           D+ +  V V V  LK     +  +   +E   ++ I +H+N+I ++  C+    +G  + 
Sbjct: 62  DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ---DGPLY- 117
Query: 108 AIVFEYMQNRNLEQWLRQ---------------SNGQLRFLTQRVNIAIDVSFAIEYFHH 152
            ++ EY    NL ++LR                   Q+ F    V+    ++  +EY   
Sbjct: 118 -VIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTF-KDLVSCTYQLARGMEYLAS 175
Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
                 +H DL   N+L+ ++ V  + D GLA+ +   +     +T +  + +K    ++
Sbjct: 176 Q---KCIHRDLAARNVLVTENNVMKIADFGLARDINNID--XXKKTTNGRLPVK----WM 226
Query: 213 APEYGMGSKASVSGDVYNFGILLLEMFT 240
           APE       +   DV++FG+L+ E+FT
Sbjct: 227 APEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 89/223 (39%), Gaps = 44/223 (19%)
Query: 36  NKIGQGGVSIV----YKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIK 91
           +++G+G    V    Y  + D + ++VAVK +     +  R F  E   L+ +    ++K
Sbjct: 16  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 75
Query: 92  IITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFH 151
              +       G     +V EY+            +G LR   QR    +D S  + Y  
Sbjct: 76  YRGVSYG---PGRQSLRLVMEYL-----------PSGCLRDFLQRHRARLDASRLLLYSS 121
Query: 152 HHCQ-------PSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL-------FGYEPGTAAE 197
             C+          VH DL   NIL++ +    + D GLAK L          EPG +  
Sbjct: 122 QICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP- 180
Query: 198 TASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
                      + + APE    +  S   DV++FG++L E+FT
Sbjct: 181 -----------IFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 89/223 (39%), Gaps = 44/223 (19%)
Query: 36  NKIGQGGVSIV----YKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIK 91
           +++G+G    V    Y  + D + ++VAVK +     +  R F  E   L+ +    ++K
Sbjct: 13  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 72
Query: 92  IITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFH 151
              +       G     +V EY+            +G LR   QR    +D S  + Y  
Sbjct: 73  YRGVSYG---PGRPELRLVMEYL-----------PSGCLRDFLQRHRARLDASRLLLYSS 118
Query: 152 HHCQ-------PSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL-------FGYEPGTAAE 197
             C+          VH DL   NIL++ +    + D GLAK L          EPG +  
Sbjct: 119 QICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSP- 177
Query: 198 TASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
                      + + APE    +  S   DV++FG++L E+FT
Sbjct: 178 -----------IFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/173 (23%), Positives = 78/173 (45%), Gaps = 23/173 (13%)
Query: 74  FAAECNALRNIRHRNLIK----IITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQ 129
             +E N LR ++H N+++    II   ++  +       IV EY +  +L   + +   +
Sbjct: 52  LVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY-------IVMEYCEGGDLASVITKGTKE 104
Query: 130 LRFLTQR--VNIAIDVSFAIEYFHHHCQP--SIVHGDLKPSNILLDQDIVAHVGDLGLAK 185
            ++L +   + +   ++ A++  H       +++H DLKP+N+ LD      +GD GLA+
Sbjct: 105 RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164
Query: 186 FLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEM 238
            L            S +    G   Y++PE       +   D+++ G LL E+
Sbjct: 165 IL--------NHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/243 (20%), Positives = 116/243 (47%), Gaps = 25/243 (10%)
Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNL 89
           ++  P  ++G+G       G++++ R + + +++ +K+  A+ +   +   L ++     
Sbjct: 51  DDLEPIMELGRGAY-----GVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDIS-- 103
Query: 90  IKIITICSSIDFEGFDFKA----IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSF 145
           ++ +    ++ F G  F+     I  E M + +L+++ +Q   + + + + +   I VS 
Sbjct: 104 MRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSI 162
Query: 146 AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEI 205
                H H + S++H D+KPSN+L++      + D G++ +L         ++ + +I+ 
Sbjct: 163 VKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL--------VDSVAKTID- 213
Query: 206 KGIVGYVAPEY---GMGSKA-SVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKM 261
            G   Y+APE     +  K  SV  D+++ GI ++E+   R P D+       L + V+ 
Sbjct: 214 AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEE 273
Query: 262 ALP 264
             P
Sbjct: 274 PSP 276

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 89/223 (39%), Gaps = 44/223 (19%)
Query: 36  NKIGQGGVSIV----YKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIK 91
           +++G+G    V    Y  + D + ++VAVK +     +  R F  E   L+ +    ++K
Sbjct: 17  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 76
Query: 92  IITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFH 151
              +       G     +V EY+            +G LR   QR    +D S  + Y  
Sbjct: 77  YRGVSYG---PGRQSLRLVMEYL-----------PSGCLRDFLQRHRARLDASRLLLYSS 122
Query: 152 HHCQ-------PSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL-------FGYEPGTAAE 197
             C+          VH DL   NIL++ +    + D GLAK L          EPG +  
Sbjct: 123 QICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP- 181
Query: 198 TASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
                      + + APE    +  S   DV++FG++L E+FT
Sbjct: 182 -----------IFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 89/223 (39%), Gaps = 44/223 (19%)
Query: 36  NKIGQGGVSIV----YKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIK 91
           +++G+G    V    Y  + D + ++VAVK +     +  R F  E   L+ +    ++K
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 92  IITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFH 151
              +       G     +V EY+            +G LR   QR    +D S  + Y  
Sbjct: 89  YRGVSYG---PGRQSLRLVMEYL-----------PSGCLRDFLQRHRARLDASRLLLYSS 134
Query: 152 HHCQ-------PSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL-------FGYEPGTAAE 197
             C+          VH DL   NIL++ +    + D GLAK L          EPG +  
Sbjct: 135 QICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP- 193
Query: 198 TASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
                      + + APE    +  S   DV++FG++L E+FT
Sbjct: 194 -----------IFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 40/173 (23%), Positives = 78/173 (45%), Gaps = 23/173 (13%)
Query: 74  FAAECNALRNIRHRNLIK----IITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQ 129
             +E N LR ++H N+++    II   ++  +       IV EY +  +L   + +   +
Sbjct: 52  LVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY-------IVMEYCEGGDLASVITKGTKE 104
Query: 130 LRFLTQR--VNIAIDVSFAIEYFHHHCQP--SIVHGDLKPSNILLDQDIVAHVGDLGLAK 185
            ++L +   + +   ++ A++  H       +++H DLKP+N+ LD      +GD GLA+
Sbjct: 105 RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164
Query: 186 FLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEM 238
            L            S +    G   Y++PE       +   D+++ G LL E+
Sbjct: 165 IL--------NHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 89/197 (45%), Gaps = 31/197 (15%)
Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL---------KQKEASRSFAAECNA 80
            N+ P   +G+G  S+V + I   +    AVK++++         + +E   +   E + 
Sbjct: 4   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 63
Query: 81  LRNIR-HRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNI 139
           LR +  H N+I++        +E   F  +VF+ M+   L  +L +        T+++  
Sbjct: 64  LRKVSGHPNIIQLKDT-----YETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMR 118
Query: 140 AI-DVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAET 198
           A+ +V  A+         +IVH DLKP NILLD D+   + D G +  L   +PG     
Sbjct: 119 ALLEVICALHKL------NIVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPGEKLR- 168
Query: 199 ASNSIEIKGIVGYVAPE 215
                E+ G   Y+APE
Sbjct: 169 -----EVCGTPSYLAPE 180

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 49/217 (22%), Positives = 96/217 (44%), Gaps = 28/217 (12%)
Query: 38  IGQGGVSIVYKGIL-----DESRSIVAVKVV-NLKQKEASRSFAAECNALRNIRHRNLIK 91
           +G G    VY+G +     D S   VAVK +  +  ++    F  E   +    H+N+++
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 92  IITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLR-----FLTQRVNIAIDVSFA 146
               C  +  +    + I+ E M   +L+ +LR++  +        +   +++A D++  
Sbjct: 116 ----CIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 170
Query: 147 IEYFHHHCQPSIVHGDLKPSNILLD---QDIVAHVGDLGLAKFLFGYEPGTAAETASNSI 203
            +Y   +     +H D+   N LL       VA +GD G+A+ +  Y  G   +     +
Sbjct: 171 CQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI--YRAGYYRKGGCAML 225
Query: 204 EIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
            +K    ++ PE  M    +   D ++FG+LL E+F+
Sbjct: 226 PVK----WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 107/245 (43%), Gaps = 31/245 (12%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           KIG+G   IV    +  S  +VAVK ++L++++       E   +R+ +H N++++    
Sbjct: 27  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN-- 84
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQP 156
               +   D   +V E+++   L   +  +        Q   + + V  A+   H     
Sbjct: 85  ---SYLVGDELWVVMEFLEGGALTDIVTHTRMNEE---QIAAVCLAVLQALSVLHAQ--- 135
Query: 157 SIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG---YVA 213
            ++H D+K  +ILL  D     G + L+ F      G  A+ +      K +VG   ++A
Sbjct: 136 GVIHRDIKSDSILLTHD-----GRVKLSDF------GFCAQVSKEVPRRKXLVGTPYWMA 184
Query: 214 PEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNE-GLTLHEFVKMALPDKVMEI-- 270
           PE           D+++ GI+++EM     P    FNE  L   + ++  LP ++  +  
Sbjct: 185 PELISRLPYGPEVDIWSLGIMVIEMVDGEPP---YFNEPPLKAMKMIRDNLPPRLKNLHK 241
Query: 271 VDPSL 275
           V PSL
Sbjct: 242 VSPSL 246

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 100/226 (44%), Gaps = 37/226 (16%)
Query: 29  TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRN 88
           T+ +     IG G  S+  + I   +    AVK+++  +++ +         LR  +H N
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEI---LLRYGQHPN 77
Query: 89  LIKIITICSSIDFEGFDFKAIVFEYMQNRNL-EQWLRQSNGQLRFLTQRVNIAI--DVSF 145
           +I +  +     ++   +  +V E M+   L ++ LRQ     +F ++R   A+   ++ 
Sbjct: 78  IITLKDV-----YDDGKYVYVVTELMKGGELLDKILRQ-----KFFSEREASAVLFTITK 127
Query: 146 AIEYFHHHCQPSIVHGDLKPSNIL-LDQD---IVAHVGDLGLAKFLFGYEPG---TAAET 198
            +EY H      +VH DLKPSNIL +D+        + D G AK L   E G   T   T
Sbjct: 128 TVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA-ENGLLMTPCYT 183
Query: 199 ASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
           A+          +VAPE         + D+++ G+LL  M T   P
Sbjct: 184 AN----------FVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 47/208 (22%), Positives = 90/208 (43%), Gaps = 34/208 (16%)
Query: 52  DESRSIVAVKVVNLKQKEASRSFA---AECNALRNI-RHRNLIKIITICSSIDFEGFDFK 107
           D+ +  V V V  LK     +  +   +E   ++ I +H+N+I ++  C+    +G  + 
Sbjct: 62  DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ---DGPLY- 117
Query: 108 AIVFEYMQNRNLEQWLRQ---------------SNGQLRFLTQRVNIAIDVSFAIEYFHH 152
            ++ EY    NL ++LR                   Q+ F    V+    ++  +EY   
Sbjct: 118 -VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF-KDLVSCTYQLARGMEYLAS 175
Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
                 +H DL   N+L+ ++ V  + D GLA+ +         +   N+   +  V ++
Sbjct: 176 Q---KCIHRDLAARNVLVTENNVMKIADFGLARDI------NNIDYYKNTTNGRLPVKWM 226
Query: 213 APEYGMGSKASVSGDVYNFGILLLEMFT 240
           APE       +   DV++FG+L+ E+FT
Sbjct: 227 APEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 107/245 (43%), Gaps = 31/245 (12%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           KIG+G   IV    +  S  +VAVK ++L++++       E   +R+ +H N++++    
Sbjct: 31  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN-- 88
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQP 156
               +   D   +V E+++   L   +  +        Q   + + V  A+   H     
Sbjct: 89  ---SYLVGDELWVVMEFLEGGALTDIVTHTRMNEE---QIAAVCLAVLQALSVLHAQ--- 139
Query: 157 SIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG---YVA 213
            ++H D+K  +ILL  D     G + L+ F      G  A+ +      K +VG   ++A
Sbjct: 140 GVIHRDIKSDSILLTHD-----GRVKLSDF------GFCAQVSKEVPRRKXLVGTPYWMA 188
Query: 214 PEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNE-GLTLHEFVKMALPDKVMEI-- 270
           PE           D+++ GI+++EM     P    FNE  L   + ++  LP ++  +  
Sbjct: 189 PELISRLPYGPEVDIWSLGIMVIEMVDGEPP---YFNEPPLKAMKMIRDNLPPRLKNLHK 245
Query: 271 VDPSL 275
           V PSL
Sbjct: 246 VSPSL 250

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/258 (20%), Positives = 112/258 (43%), Gaps = 39/258 (15%)
Query: 7   DSNMLSMKQQFPMISYAELSKATNNFSPANKIGQG--GVSIVYKGI---LDESRSIVAVK 61
           D+ ML+   ++ +    +     +  +    +G+G  G  ++ + +    D+ +  V V 
Sbjct: 58  DTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVA 117
Query: 62  VVNLKQKEASRSFA---AECNALRNI-RHRNLIKIITICSSIDFEGFDFKAIVFEYMQNR 117
           V  LK     +  +   +E   ++ I +H+N+I ++  C+    +G  +  ++ EY    
Sbjct: 118 VKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ---DGPLY--VIVEYASKG 172
Query: 118 NLEQWLRQSNG---------------QLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGD 162
           NL ++LR                   Q+ F    V+    ++  +EY         +H D
Sbjct: 173 NLREYLRARRPPGMEYSYDINRVPEEQMTF-KDLVSCTYQLARGMEYLASQ---KCIHRD 228
Query: 163 LKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKA 222
           L   N+L+ ++ V  + D GLA+ +   +     +T +  + +K    ++APE       
Sbjct: 229 LAARNVLVTENNVMKIADFGLARDINNID--YYKKTTNGRLPVK----WMAPEALFDRVY 282
Query: 223 SVSGDVYNFGILLLEMFT 240
           +   DV++FG+L+ E+FT
Sbjct: 283 THQSDVWSFGVLMWEIFT 300

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 49/217 (22%), Positives = 96/217 (44%), Gaps = 28/217 (12%)
Query: 38  IGQGGVSIVYKGIL-----DESRSIVAVKVV-NLKQKEASRSFAAECNALRNIRHRNLIK 91
           +G G    VY+G +     D S   VAVK +  +  ++    F  E   +    H+N+++
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 92  IITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLR-----FLTQRVNIAIDVSFA 146
               C  +  +    + I+ E M   +L+ +LR++  +        +   +++A D++  
Sbjct: 139 ----CIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193
Query: 147 IEYFHHHCQPSIVHGDLKPSNILLD---QDIVAHVGDLGLAKFLFGYEPGTAAETASNSI 203
            +Y   +     +H D+   N LL       VA +GD G+A+ +  Y  G   +     +
Sbjct: 194 CQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI--YRAGYYRKGGCAML 248
Query: 204 EIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
            +K    ++ PE  M    +   D ++FG+LL E+F+
Sbjct: 249 PVK----WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 49/211 (23%), Positives = 90/211 (42%), Gaps = 25/211 (11%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           KIGQG    VY  +   +   VA++ +NL+Q+        E   +R  ++ N++  +   
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD-- 84
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQS---NGQLRFLTQRVNIAIDVSFAIEYFHHH 153
               +   D   +V EY+   +L   + ++    GQ+  + +      +   A+E+ H +
Sbjct: 85  ---SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR------ECLQALEFLHSN 135
Query: 154 CQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVA 213
               ++H D+K  NILL  D    + D       FG+      E +  S E+ G   ++A
Sbjct: 136 ---QVIHRDIKSDNILLGMDGSVKLTD-------FGFCAQITPEQSKRS-EMVGTPYWMA 184
Query: 214 PEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
           PE           D+++ GI+ +EM     P
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 106/240 (44%), Gaps = 40/240 (16%)
Query: 56  SIVAVKVVNLKQKEAS-RSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYM 114
           + VAVK++      +  R   +E N L+ + H ++IK+   CS    +G     ++ EY 
Sbjct: 54  TTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ---DGPLL--LIVEYA 108
Query: 115 QNRNLEQWLRQSN----GQLRFLTQRVNIAID------------VSFAIEY---FHHHCQ 155
           +  +L  +LR+S     G L     R + ++D            +SFA +      +  +
Sbjct: 109 KYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE 168
Query: 156 PSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPE 215
            S+VH DL   NIL+ +     + D GL++ +  YE  +  + +   I +K    ++A E
Sbjct: 169 MSLVHRDLAARNILVAEGRKMKISDFGLSRDV--YEEDSXVKRSQGRIPVK----WMAIE 222
Query: 216 YGMGSKASVSGDVYNFGILLLEMFTRRR------PTDAMFNEGLTLHEFVKMALPDKVME 269
                  +   DV++FG+LL E+ T         P + +FN   T H   +M  PD   E
Sbjct: 223 SLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGH---RMERPDNCSE 279

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 107/245 (43%), Gaps = 31/245 (12%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           KIG+G   IV    +  S  +VAVK ++L++++       E   +R+ +H N++++    
Sbjct: 36  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN-- 93
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQP 156
               +   D   +V E+++   L   +  +        Q   + + V  A+   H     
Sbjct: 94  ---SYLVGDELWVVMEFLEGGALTDIVTHTRMNEE---QIAAVCLAVLQALSVLHAQ--- 144
Query: 157 SIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG---YVA 213
            ++H D+K  +ILL  D     G + L+ F      G  A+ +      K +VG   ++A
Sbjct: 145 GVIHRDIKSDSILLTHD-----GRVKLSDF------GFCAQVSKEVPRRKXLVGTPYWMA 193
Query: 214 PEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNE-GLTLHEFVKMALPDKVMEI-- 270
           PE           D+++ GI+++EM     P    FNE  L   + ++  LP ++  +  
Sbjct: 194 PELISRLPYGPEVDIWSLGIMVIEMVDGEPP---YFNEPPLKAMKMIRDNLPPRLKNLHK 250
Query: 271 VDPSL 275
           V PSL
Sbjct: 251 VSPSL 255

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 53/258 (20%), Positives = 112/258 (43%), Gaps = 39/258 (15%)
Query: 7   DSNMLSMKQQFPMISYAELSKATNNFSPANKIGQG--GVSIVYKGI---LDESRSIVAVK 61
           D+ ML+   ++ +    +     +  +    +G+G  G  ++ + +    D+ +  V V 
Sbjct: 4   DTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVA 63
Query: 62  VVNLKQKEASRSFA---AECNALRNI-RHRNLIKIITICSSIDFEGFDFKAIVFEYMQNR 117
           V  LK     +  +   +E   ++ I +H+N+I ++  C+    +G  +  ++ EY    
Sbjct: 64  VKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ---DGPLY--VIVEYASKG 118
Query: 118 NLEQWLRQ---------------SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGD 162
           NL ++LR                   Q+ F    V+    ++  +EY         +H D
Sbjct: 119 NLREYLRARRPPGMEYSYDINRVPEEQMTF-KDLVSCTYQLARGMEYLASQ---KCIHRD 174
Query: 163 LKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKA 222
           L   N+L+ ++ V  + D GLA+ +   +     +T +  + +K    ++APE       
Sbjct: 175 LAARNVLVTENNVMKIADFGLARDINNID--YYKKTTNGRLPVK----WMAPEALFDRVY 228
Query: 223 SVSGDVYNFGILLLEMFT 240
           +   DV++FG+L+ E+FT
Sbjct: 229 THQSDVWSFGVLMWEIFT 246

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 100/223 (44%), Gaps = 34/223 (15%)
Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITI 95
            +IG+G    V+ G     +  VAVKV     +EAS     E      +RH N++  I  
Sbjct: 43  KQIGKGRYGEVWMGKWRGEK--VAVKVF-FTTEEASWFRETEIYQTVLMRHENILGFI-- 97
Query: 96  CSSIDFEG---FDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAID--VSFAIEYF 150
             + D +G   +    ++ +Y +N +L  +L+ +    + + +    ++        E F
Sbjct: 98  --AADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIF 155
Query: 151 HHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA-KFLFGYEPGTAAETASNSIEIK--- 206
               +P+I H DLK  NIL+ ++    + DLGLA KF+          + +N ++I    
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFI----------SDTNEVDIPPNT 205
Query: 207 --GIVGYVAPEYGMGS------KASVSGDVYNFGILLLEMFTR 241
             G   Y+ PE    S      ++ +  D+Y+FG++L E+  R
Sbjct: 206 RVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR 248

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 47/208 (22%), Positives = 92/208 (44%), Gaps = 34/208 (16%)
Query: 52  DESRSIVAVKVVNLKQKEASRSFA---AECNALRNI-RHRNLIKIITICSSIDFEGFDFK 107
           D+ +  V V V  LK     +  +   +E   ++ I +H+N+I ++  C+    +G  + 
Sbjct: 62  DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ---DGPLY- 117
Query: 108 AIVFEYMQNRNLEQWLRQ---------------SNGQLRFLTQRVNIAIDVSFAIEYFHH 152
            ++ EY    NL ++LR                   Q+ F    V+    ++  +EY   
Sbjct: 118 -VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF-KDLVSCTYQLARGMEYLAS 175
Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
                 +H DL   N+L+ ++ V  + D GLA+ +   +     +T +  + +K    ++
Sbjct: 176 Q---KCIHRDLAARNVLVTENNVMRIADFGLARDINNID--YYKKTTNGRLPVK----WM 226
Query: 213 APEYGMGSKASVSGDVYNFGILLLEMFT 240
           APE       +   DV++FG+L+ E+FT
Sbjct: 227 APEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 107/245 (43%), Gaps = 31/245 (12%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           KIG+G   IV    +  S  +VAVK ++L++++       E   +R+ +H N++++    
Sbjct: 38  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN-- 95
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQP 156
               +   D   +V E+++   L   +  +        Q   + + V  A+   H     
Sbjct: 96  ---SYLVGDELWVVMEFLEGGALTDIVTHTRMNEE---QIAAVCLAVLQALSVLHAQ--- 146
Query: 157 SIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG---YVA 213
            ++H D+K  +ILL  D     G + L+ F      G  A+ +      K +VG   ++A
Sbjct: 147 GVIHRDIKSDSILLTHD-----GRVKLSDF------GFCAQVSKEVPRRKXLVGTPYWMA 195
Query: 214 PEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNE-GLTLHEFVKMALPDKVMEI-- 270
           PE           D+++ GI+++EM     P    FNE  L   + ++  LP ++  +  
Sbjct: 196 PELISRLPYGPEVDIWSLGIMVIEMVDGEPP---YFNEPPLKAMKMIRDNLPPRLKNLHK 252
Query: 271 VDPSL 275
           V PSL
Sbjct: 253 VSPSL 257

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 47/107 (43%), Gaps = 11/107 (10%)
Query: 140 AIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETA 199
           + ++S A+ Y H      I++ DLK  N+LLD +    + D G+ K   G  PG      
Sbjct: 127 SAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE--GLRPGDTTSXF 181
Query: 200 SNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTD 246
                  G   Y+APE   G     S D +  G+L+ EM   R P D
Sbjct: 182 C------GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 222

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/227 (23%), Positives = 96/227 (42%), Gaps = 41/227 (18%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIR----------H 86
           K+G+G   IV+K I   +  +VAVK +         +F    +A R  R          H
Sbjct: 16  KLGKGAYGIVWKSIDRRTGEVVAVKKI-------FDAFQNSTDAQRTFREIMILTELSGH 68
Query: 87  RNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFA 146
            N++ ++ +  + +        +VF+YM+  +L   +R     +     +  +   +   
Sbjct: 69  ENIVNLLNVLRADNDRDV---YLVFDYMET-DLHAVIR---ANILEPVHKQYVVYQLIKV 121
Query: 147 IEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYE------PGTAAETAS 200
           I+Y H      ++H D+KPSNILL+ +    V D GL++            P +  E   
Sbjct: 122 IKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTE 178
Query: 201 NSIEIKGIVG-------YVAPEYGMGSKASVSG-DVYNFGILLLEMF 239
           N  + + I+        Y APE  +GS     G D+++ G +L E+ 
Sbjct: 179 NFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEIL 225

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/208 (22%), Positives = 92/208 (44%), Gaps = 34/208 (16%)
Query: 52  DESRSIVAVKVVNLKQKEASRSFA---AECNALRNI-RHRNLIKIITICSSIDFEGFDFK 107
           D+ +  V V V  LK     +  +   +E   ++ I +H+N+I ++  C+    +G  + 
Sbjct: 49  DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ---DGPLY- 104
Query: 108 AIVFEYMQNRNLEQWLRQ---------------SNGQLRFLTQRVNIAIDVSFAIEYFHH 152
            ++ EY    NL ++LR                   Q+ F    V+    ++  +EY   
Sbjct: 105 -VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF-KDLVSCTYQLARGMEYLAS 162
Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
                 +H DL   N+L+ ++ V  + D GLA+ +   +     +T +  + +K    ++
Sbjct: 163 Q---KCIHRDLTARNVLVTENNVMKIADFGLARDINNID--YYKKTTNGRLPVK----WM 213
Query: 213 APEYGMGSKASVSGDVYNFGILLLEMFT 240
           APE       +   DV++FG+L+ E+FT
Sbjct: 214 APEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/208 (22%), Positives = 92/208 (44%), Gaps = 34/208 (16%)
Query: 52  DESRSIVAVKVVNLKQKEASRSFA---AECNALRNI-RHRNLIKIITICSSIDFEGFDFK 107
           D+ +  V V V  LK     +  +   +E   ++ I +H+N+I ++  C+    +G  + 
Sbjct: 51  DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ---DGPLY- 106
Query: 108 AIVFEYMQNRNLEQWLRQ---------------SNGQLRFLTQRVNIAIDVSFAIEYFHH 152
            ++ EY    NL ++LR                   Q+ F    V+    ++  +EY   
Sbjct: 107 -VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF-KDLVSCTYQLARGMEYLAS 164
Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
                 +H DL   N+L+ ++ V  + D GLA+ +   +     +T +  + +K    ++
Sbjct: 165 Q---KCIHRDLAARNVLVTENNVMKIADFGLARDINNID--YYKKTTNGRLPVK----WM 215
Query: 213 APEYGMGSKASVSGDVYNFGILLLEMFT 240
           APE       +   DV++FG+L+ E+FT
Sbjct: 216 APEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 98/222 (44%), Gaps = 35/222 (15%)
Query: 35  ANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAA----ECNALRNIRHRNLI 90
            + +G G    V  G  + +   VAVK++N +QK  S         E   L+  RH ++I
Sbjct: 21  GDTLGVGTFGKVKVGKHELTGHKVAVKILN-RQKIRSLDVVGKIRREIQNLKLFRHPHII 79
Query: 91  KIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQL-----RFLTQRVNIAIDVSF 145
           K+  + S+   + F    +V EY+    L  ++ + NG+L     R L Q++   +D   
Sbjct: 80  KLYQVISTPS-DIF----MVMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVD--- 130
Query: 146 AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEI 205
              Y H H    +VH DLKP N+LLD  + A + D GL+  +      +  E    S   
Sbjct: 131 ---YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM------SDGEFLRXSC-- 176
Query: 206 KGIVGYVAPEYGMGS-KASVSGDVYNFGILLLEMFTRRRPTD 246
            G   Y APE   G   A    D+++ G++L  +     P D
Sbjct: 177 -GSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFD 217

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/226 (21%), Positives = 92/226 (40%), Gaps = 32/226 (14%)
Query: 31  NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALR---NIRHR 87
           +F   N +G+G  + VY+     +   VA+K+++ K    +       N ++    ++H 
Sbjct: 12  DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHP 71
Query: 88  NLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQ------SNGQLRFLTQRVNIAI 141
           +++++        FE  ++  +V E   N  + ++L+        N    F+ Q +    
Sbjct: 72  SILELYNY-----FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIIT--- 123
Query: 142 DVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASN 201
                + Y H H    I+H DL  SN+LL +++   + D GLA  L              
Sbjct: 124 ----GMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQL--------KMPHEK 168
Query: 202 SIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDA 247
              + G   Y++PE    S   +  DV++ G +   +   R P D 
Sbjct: 169 HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDT 214

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/220 (22%), Positives = 96/220 (43%), Gaps = 34/220 (15%)
Query: 38  IGQGGVSIVYKGIL-----DESRSIVAVKVV-NLKQKEASRSFAAECNALRNIRHRNLIK 91
           +G G    VY+G +     D S   VAVK +  +  ++    F  E   +  + H+N+++
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 92  IITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLR-----FLTQRVNIAIDVSFA 146
               C  +  +    + I+ E M   +L+ +LR++  +        +   +++A D++  
Sbjct: 99  ----CIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 153
Query: 147 IEYFHHHCQPSIVHGDLKPSNILLD---QDIVAHVGDLGLAKFLFG---YEPGTAAETAS 200
            +Y   +     +H D+   N LL       VA +GD G+A+ ++    Y  G  A    
Sbjct: 154 CQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLP- 209
Query: 201 NSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
                   V ++ PE  M    +   D ++FG+LL E+F+
Sbjct: 210 --------VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/246 (23%), Positives = 109/246 (44%), Gaps = 31/246 (12%)
Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVV--NLKQKEASRSFAAECNALRNIRHR 87
           ++  P  ++G+G   +V K     S  I+AVK +   +  +E  R       ++R +   
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVD-- 64
Query: 88  NLIKIITICS-SIDFEGFDFKA----IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAID 142
                   C  ++ F G  F+     I  E M + +L+++ +Q   + + + + +   I 
Sbjct: 65  --------CPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIA 115
Query: 143 VSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNS 202
           VS      H H + S++H D+KPSN+L++      + D G++ +L         +  +  
Sbjct: 116 VSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL--------VDDVAKD 167
Query: 203 IEIKGIVGYVAPEY---GMGSKA-SVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEF 258
           I+  G   Y+APE     +  K  SV  D+++ GI ++E+   R P D+       L + 
Sbjct: 168 ID-AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV 226
Query: 259 VKMALP 264
           V+   P
Sbjct: 227 VEEPSP 232

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 22/211 (10%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVN-LKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           IG+G   +V     + ++  VA+K ++  + +   +    E   L   RH N+I I  I 
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 92
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQ---SNGQL-RFLTQRVNIAIDVSFAIEYFHH 152
            +   E      IV + M+  +L + L+    SN  +  FL Q       +   ++Y H 
Sbjct: 93  RAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQ-------ILRGLKYIH- 143
Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
               +++H DLKPSN+LL+      + D GLA+        T   T     E      Y 
Sbjct: 144 --SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT-----EYVATRWYR 196
Query: 213 APEYGMGSKA-SVSGDVYNFGILLLEMFTRR 242
           APE  + SK  + S D+++ G +L EM + R
Sbjct: 197 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/208 (22%), Positives = 92/208 (44%), Gaps = 34/208 (16%)
Query: 52  DESRSIVAVKVVNLKQKEASRSFA---AECNALRNI-RHRNLIKIITICSSIDFEGFDFK 107
           D+ +  V V V  LK     +  +   +E   ++ I +H+N+I ++  C+    +G  + 
Sbjct: 62  DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIITLLGACTQ---DGPLY- 117
Query: 108 AIVFEYMQNRNLEQWLRQ---------------SNGQLRFLTQRVNIAIDVSFAIEYFHH 152
            ++ EY    NL ++LR                   Q+ F    V+    ++  +EY   
Sbjct: 118 -VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF-KDLVSCTYQLARGMEYLAS 175
Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
                 +H DL   N+L+ ++ V  + D GLA+ +   +     +T +  + +K    ++
Sbjct: 176 Q---KCIHRDLAARNVLVTENNVMKIADFGLARDINNID--YYKKTTNGRLPVK----WM 226
Query: 213 APEYGMGSKASVSGDVYNFGILLLEMFT 240
           APE       +   DV++FG+L+ E+FT
Sbjct: 227 APEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 22/211 (10%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVN-LKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           IG+G   +V     + ++  VA+K ++  + +   +    E   L   RH N+I I  I 
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQ---SNGQL-RFLTQRVNIAIDVSFAIEYFHH 152
            +   E      IV + M+  +L + L+    SN  +  FL Q       +   ++Y H 
Sbjct: 91  RAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQ-------ILRGLKYIH- 141
Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
               +++H DLKPSN+LL+      + D GLA+        T   T     E      Y 
Sbjct: 142 --SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT-----EYVATRWYR 194
Query: 213 APEYGMGSKA-SVSGDVYNFGILLLEMFTRR 242
           APE  + SK  + S D+++ G +L EM + R
Sbjct: 195 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/210 (22%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 38  IGQGGVSIVYKGI-LDESRSI---VAVKVVN-LKQKEASRSFAAECNALRNIRHRNLIKI 92
           +G G    VYKGI + E  ++   VA+K++N     +A+  F  E   + ++ H +L+++
Sbjct: 46  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 105
Query: 93  ITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQL--RFLTQRVNIAIDVSFAIEYF 150
           + +C S   +      +V + M +  L +++ +    +  + L   +N  + ++  + Y 
Sbjct: 106 LGVCLSPTIQ------LVTQLMPHGCLLEYVHEHKDNIGSQLL---LNWCVQIAKGMMYL 156
Query: 151 HHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG 210
                  +VH DL   N+L+       + D GLA+ L G E    A+     I+      
Sbjct: 157 EER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK------ 207
Query: 211 YVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
           ++A E     K +   DV+++G+ + E+ T
Sbjct: 208 WMALECIHYRKFTHQSDVWSYGVTIWELMT 237

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/208 (22%), Positives = 92/208 (44%), Gaps = 34/208 (16%)
Query: 52  DESRSIVAVKVVNLKQKEASRSFA---AECNALRNI-RHRNLIKIITICSSIDFEGFDFK 107
           D+ +  V V V  LK     +  +   +E   ++ I +H+N+I ++  C+    +G  + 
Sbjct: 62  DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIHLLGACTQ---DGPLY- 117
Query: 108 AIVFEYMQNRNLEQWLRQ---------------SNGQLRFLTQRVNIAIDVSFAIEYFHH 152
            ++ EY    NL ++LR                   Q+ F    V+    ++  +EY   
Sbjct: 118 -VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF-KDLVSCTYQLARGMEYLAS 175
Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
                 +H DL   N+L+ ++ V  + D GLA+ +   +     +T +  + +K    ++
Sbjct: 176 Q---KCIHRDLAARNVLVTENNVMKIADFGLARDINNID--YYKKTTNGRLPVK----WM 226
Query: 213 APEYGMGSKASVSGDVYNFGILLLEMFT 240
           APE       +   DV++FG+L+ E+FT
Sbjct: 227 APEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 89/197 (45%), Gaps = 31/197 (15%)
Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL---------KQKEASRSFAAECNA 80
            N+ P   +G+G  S+V + I   +    AVK++++         + +E   +   E + 
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 81  LRNIR-HRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNI 139
           LR +  H N+I++        +E   F  +VF+ M+   L  +L +        T+++  
Sbjct: 77  LRKVSGHPNIIQLKDT-----YETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMR 131
Query: 140 AI-DVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAET 198
           A+ +V  A+         +IVH DLKP NILLD D+   + D G +  L   +PG    +
Sbjct: 132 ALLEVICALHKL------NIVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPGEKLRS 182
Query: 199 ASNSIEIKGIVGYVAPE 215
                 + G   Y+APE
Sbjct: 183 ------VCGTPSYLAPE 193

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 22/211 (10%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVN-LKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           IG+G   +V     + ++  VA+K ++  + +   +    E   L   RH N+I I  I 
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQ---SNGQL-RFLTQRVNIAIDVSFAIEYFHH 152
            +   E      IV + M+  +L + L+    SN  +  FL Q       +   ++Y H 
Sbjct: 89  RAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQ-------ILRGLKYIH- 139
Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
               +++H DLKPSN+LL+      + D GLA+        T   T     E      Y 
Sbjct: 140 --SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT-----EYVATRWYR 192
Query: 213 APEYGMGSKA-SVSGDVYNFGILLLEMFTRR 242
           APE  + SK  + S D+++ G +L EM + R
Sbjct: 193 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/215 (20%), Positives = 94/215 (43%), Gaps = 31/215 (14%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVN---LKQKEASRSFAAECNALRNIRHRNLIKIIT 94
           +G+GG +  ++    +++ + A K+V    L +       + E +  R++ H++++    
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 95  ICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQ----SNGQLRFLTQRVNIAIDVSFAIEYF 150
                 FE  DF  +V E  + R+L +  ++    +  + R+  +++ +        +Y 
Sbjct: 85  F-----FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC------QYL 133
Query: 151 HHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAE-TASNSIEIKGIV 209
           H +    ++H DLK  N+ L++D+   +GD GLA         T  E        + G  
Sbjct: 134 HRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLA---------TKVEYDGERKKTLCGTP 181
Query: 210 GYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
            Y+APE       S   DV++ G ++  +   + P
Sbjct: 182 NYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 216

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 22/211 (10%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVN-LKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           IG+G   +V     + ++  VA+K ++  + +   +    E   L   RH N+I I  I 
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQ---SNGQL-RFLTQRVNIAIDVSFAIEYFHH 152
            +   E      IV + M+  +L + L+    SN  +  FL Q       +   ++Y H 
Sbjct: 89  RAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQ-------ILRGLKYIH- 139
Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
               +++H DLKPSN+LL+      + D GLA+        T   T     E      Y 
Sbjct: 140 --SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT-----EYVATRWYR 192
Query: 213 APEYGMGSKA-SVSGDVYNFGILLLEMFTRR 242
           APE  + SK  + S D+++ G +L EM + R
Sbjct: 193 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/220 (22%), Positives = 96/220 (43%), Gaps = 34/220 (15%)
Query: 38  IGQGGVSIVYKGIL-----DESRSIVAVKVV-NLKQKEASRSFAAECNALRNIRHRNLIK 91
           +G G    VY+G +     D S   VAVK +  +  ++    F  E   +  + H+N+++
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 92  IITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLR-----FLTQRVNIAIDVSFA 146
               C  +  +    + I+ E M   +L+ +LR++  +        +   +++A D++  
Sbjct: 113 ----CIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 167
Query: 147 IEYFHHHCQPSIVHGDLKPSNILLD---QDIVAHVGDLGLAKFLFG---YEPGTAAETAS 200
            +Y   +     +H D+   N LL       VA +GD G+A+ ++    Y  G  A    
Sbjct: 168 CQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLP- 223
Query: 201 NSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
                   V ++ PE  M    +   D ++FG+LL E+F+
Sbjct: 224 --------VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 22/211 (10%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVN-LKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           IG+G   +V     + ++  VA+K ++  + +   +    E   L   RH N+I I  I 
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQ---SNGQL-RFLTQRVNIAIDVSFAIEYFHH 152
            +   E      IV + M+  +L + L+    SN  +  FL Q       +   ++Y H 
Sbjct: 111 RAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQ-------ILRGLKYIH- 161
Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
               +++H DLKPSN+LL+      + D GLA+        T   T     E      Y 
Sbjct: 162 --SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT-----EYVATRWYR 214
Query: 213 APEYGMGSKA-SVSGDVYNFGILLLEMFTRR 242
           APE  + SK  + S D+++ G +L EM + R
Sbjct: 215 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 47/107 (43%), Gaps = 11/107 (10%)
Query: 140 AIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETA 199
           + ++S A+ Y H      I++ DLK  N+LLD +    + D G+ K   G  PG      
Sbjct: 112 SAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE--GLRPGDTTSXF 166
Query: 200 SNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTD 246
                  G   Y+APE   G     S D +  G+L+ EM   R P D
Sbjct: 167 C------GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 207

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 22/211 (10%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVN-LKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           IG+G   +V     + ++  VA+K ++  + +   +    E   L   RH N+I I  I 
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQ---SNGQL-RFLTQRVNIAIDVSFAIEYFHH 152
            +   E      IV + M+  +L + L+    SN  +  FL Q       +   ++Y H 
Sbjct: 96  RAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQ-------ILRGLKYIH- 146
Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
               +++H DLKPSN+LL+      + D GLA+        T   T     E      Y 
Sbjct: 147 --SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT-----EYVATRWYR 199
Query: 213 APEYGMGSKA-SVSGDVYNFGILLLEMFTRR 242
           APE  + SK  + S D+++ G +L EM + R
Sbjct: 200 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/215 (20%), Positives = 94/215 (43%), Gaps = 31/215 (14%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVN---LKQKEASRSFAAECNALRNIRHRNLIKIIT 94
           +G+GG +  ++    +++ + A K+V    L +       + E +  R++ H++++    
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 95  ICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQ----SNGQLRFLTQRVNIAIDVSFAIEYF 150
                 FE  DF  +V E  + R+L +  ++    +  + R+  +++ +        +Y 
Sbjct: 85  F-----FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC------QYL 133
Query: 151 HHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAE-TASNSIEIKGIV 209
           H +    ++H DLK  N+ L++D+   +GD GLA         T  E        + G  
Sbjct: 134 HRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLA---------TKVEYDGERKKTLCGTP 181
Query: 210 GYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
            Y+APE       S   DV++ G ++  +   + P
Sbjct: 182 NYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 216

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 94/218 (43%), Gaps = 25/218 (11%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASR-SFAAECNALRNIRHRNLIKIITIC 96
           IG G  ++V        +  VA+K +NL++ + S      E  A+    H N++   T  
Sbjct: 18  IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYT-- 75
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQ--SNGQLR--FLTQRV--NIAIDVSFAIEYF 150
               F   D   +V + +   ++   ++   + G+ +   L +     I  +V   +EY 
Sbjct: 76  ---SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYL 132
Query: 151 HHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG 210
           H + Q   +H D+K  NILL +D    + D G++ FL      T  +   N +  K  VG
Sbjct: 133 HKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFL-----ATGGDITRNKVR-KTFVG 183
Query: 211 ---YVAPEYGMGSKA-SVSGDVYNFGILLLEMFTRRRP 244
              ++APE     +      D+++FGI  +E+ T   P
Sbjct: 184 TPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 221

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 22/211 (10%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVN-LKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           IG+G   +V     + ++  VA+K ++  + +   +    E   L   RH N+I I  I 
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 96
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQ---SNGQL-RFLTQRVNIAIDVSFAIEYFHH 152
            +   E      IV + M+  +L + L+    SN  +  FL Q       +   ++Y H 
Sbjct: 97  RAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQ-------ILRGLKYIH- 147
Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
               +++H DLKPSN+LL+      + D GLA+        T   T     E      Y 
Sbjct: 148 --SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT-----EYVATRWYR 200
Query: 213 APEYGMGSKA-SVSGDVYNFGILLLEMFTRR 242
           APE  + SK  + S D+++ G +L EM + R
Sbjct: 201 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 22/211 (10%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVN-LKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           IG+G   +V     + ++  VA+K ++  + +   +    E   L   RH N+I I  I 
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 87
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQ---SNGQL-RFLTQRVNIAIDVSFAIEYFHH 152
            +   E      IV + M+  +L + L+    SN  +  FL Q       +   ++Y H 
Sbjct: 88  RAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQ-------ILRGLKYIH- 138
Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
               +++H DLKPSN+LL+      + D GLA+        T   T     E      Y 
Sbjct: 139 --SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT-----EYVATRWYR 191
Query: 213 APEYGMGSKA-SVSGDVYNFGILLLEMFTRR 242
           APE  + SK  + S D+++ G +L EM + R
Sbjct: 192 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 22/211 (10%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVN-LKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           IG+G   +V     + ++  VA+K ++  + +   +    E   L   RH N+I I  I 
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQ---SNGQL-RFLTQRVNIAIDVSFAIEYFHH 152
            +   E      IV + M+  +L + L+    SN  +  FL Q       +   ++Y H 
Sbjct: 95  RAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQ-------ILRGLKYIH- 145
Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
               +++H DLKPSN+LL+      + D GLA+        T   T     E      Y 
Sbjct: 146 --SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT-----EYVATRWYR 198
Query: 213 APEYGMGSKA-SVSGDVYNFGILLLEMFTRR 242
           APE  + SK  + S D+++ G +L EM + R
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 22/211 (10%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVN-LKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           IG+G   +V     + ++  VA+K ++  + +   +    E   L   RH N+I I  I 
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQ---SNGQL-RFLTQRVNIAIDVSFAIEYFHH 152
            +   E      IV + M+  +L + L+    SN  +  FL Q       +   ++Y H 
Sbjct: 91  RAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQ-------ILRGLKYIH- 141
Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
               +++H DLKPSN+LL+      + D GLA+        T   T     E      Y 
Sbjct: 142 --SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLT-----EYVATRWYR 194
Query: 213 APEYGMGSKA-SVSGDVYNFGILLLEMFTRR 242
           APE  + SK  + S D+++ G +L EM + R
Sbjct: 195 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/254 (22%), Positives = 109/254 (42%), Gaps = 48/254 (18%)
Query: 8   SNMLSMKQQFPMISYAELSKAT-------NNFSPANKIGQGGVSIVYKGILDESRSIVAV 60
           S+ML M Q+ P     EL+K          N SP      G V   +     ++++ + V
Sbjct: 1   SHMLEMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAF-----DTKTGLRV 55
Query: 61  KVVNLKQK-----EASRSFAAECNALRNIRHRNLIKIITICSSI-DFEGFDFKAIVFEYM 114
            V  L +       A R++  E   L++++H N+I ++ + +     E F+   +V   M
Sbjct: 56  AVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM 114
Query: 115 --QNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQ 172
                N+ +  + ++  ++FL  ++         ++Y H      I+H DLKPSN+ +++
Sbjct: 115 GADLNNIVKCQKLTDDHVQFLIYQI------LRGLKYIH---SADIIHRDLKPSNLAVNE 165
Query: 173 DIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG---YVAPEYGMG-SKASVSGDV 228
           D    + D GLA+                  E+ G V    Y APE  +     + + D+
Sbjct: 166 DCELKILDFGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDI 211
Query: 229 YNFGILLLEMFTRR 242
           ++ G ++ E+ T R
Sbjct: 212 WSVGCIMAELLTGR 225

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 22/211 (10%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVN-LKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           IG+G   +V     + ++  VA+K ++  + +   +    E   L   RH N+I I  I 
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 98
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQ---SNGQL-RFLTQRVNIAIDVSFAIEYFHH 152
            +   E      IV + M+  +L + L+    SN  +  FL Q       +   ++Y H 
Sbjct: 99  RAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQ-------ILRGLKYIH- 149
Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
               +++H DLKPSN+LL+      + D GLA+        T   T     E      Y 
Sbjct: 150 --SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT-----EYVATRWYR 202
Query: 213 APEYGMGSKA-SVSGDVYNFGILLLEMFTRR 242
           APE  + SK  + S D+++ G +L EM + R
Sbjct: 203 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 22/211 (10%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVN-LKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           IG+G   +V     + ++  VA+K ++  + +   +    E   L   RH N+I I  I 
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQ---SNGQL-RFLTQRVNIAIDVSFAIEYFHH 152
            +   E      IV + M+  +L + L+    SN  +  FL Q       +   ++Y H 
Sbjct: 91  RAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQ-------ILRGLKYIH- 141
Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
               +++H DLKPSN+LL+      + D GLA+        T   T     E      Y 
Sbjct: 142 --SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT-----EYVATRWYR 194
Query: 213 APEYGMGSKA-SVSGDVYNFGILLLEMFTRR 242
           APE  + SK  + S D+++ G +L EM + R
Sbjct: 195 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 92/211 (43%), Gaps = 22/211 (10%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVN-LKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           IG+G   +V        ++ VA+K ++  + +   +    E   L   RH N+I I  I 
Sbjct: 51  IGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDIL 110
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQ---SNGQL-RFLTQRVNIAIDVSFAIEYFHH 152
            +   E      IV + M+  +L + L+    SN  +  FL Q       +   ++Y H 
Sbjct: 111 RASTLEAMRDVYIVQDLMET-DLYKLLKSQQLSNDHICYFLYQ-------ILRGLKYIH- 161
Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
               +++H DLKPSN+L++      + D GLA+        T   T     E      Y 
Sbjct: 162 --SANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLT-----EXVATRWYR 214
Query: 213 APEYGMGSKA-SVSGDVYNFGILLLEMFTRR 242
           APE  + SK  + S D+++ G +L EM + R
Sbjct: 215 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/215 (20%), Positives = 94/215 (43%), Gaps = 31/215 (14%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVN---LKQKEASRSFAAECNALRNIRHRNLIKIIT 94
           +G+GG +  ++    +++ + A K+V    L +       + E +  R++ H++++    
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 95  ICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQ----SNGQLRFLTQRVNIAIDVSFAIEYF 150
                 FE  DF  +V E  + R+L +  ++    +  + R+  +++ +        +Y 
Sbjct: 89  F-----FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC------QYL 137
Query: 151 HHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAE-TASNSIEIKGIV 209
           H +    ++H DLK  N+ L++D+   +GD GLA         T  E        + G  
Sbjct: 138 HRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLA---------TKVEYDGERKKTLCGTP 185
Query: 210 GYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
            Y+APE       S   DV++ G ++  +   + P
Sbjct: 186 NYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 220

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/208 (23%), Positives = 92/208 (44%), Gaps = 34/208 (16%)
Query: 52  DESRSIVAVKVVNLKQ---KEASRSFAAECNALRNI-RHRNLIKIITICSSIDFEGFDFK 107
           D+ +  V V V  LK    +E      +E   ++ I +H+N+I ++  C+    +G  + 
Sbjct: 62  DKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKNIINLLGACTQ---DGPLY- 117
Query: 108 AIVFEYMQNRNLEQWLRQ---------------SNGQLRFLTQRVNIAIDVSFAIEYFHH 152
            ++ EY    NL ++LR                   Q+ F    V+    ++  +EY   
Sbjct: 118 -VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF-KDLVSCTYQLARGMEYLAS 175
Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
                 +H DL   N+L+ ++ V  + D GLA+ +   +     +T +  + +K    ++
Sbjct: 176 Q---KCIHRDLAARNVLVTENNVMKIADFGLARDINNID--YYKKTTNGRLPVK----WM 226
Query: 213 APEYGMGSKASVSGDVYNFGILLLEMFT 240
           APE       +   DV++FG+L+ E+FT
Sbjct: 227 APEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 22/211 (10%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVN-LKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           IG+G   +V     + ++  VA+K ++  + +   +    E   L   RH N+I I  I 
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQ---SNGQL-RFLTQRVNIAIDVSFAIEYFHH 152
            +   E      IV + M+  +L + L+    SN  +  FL Q       +   ++Y H 
Sbjct: 91  RAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQ-------ILRGLKYIH- 141
Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
               +++H DLKPSN+LL+      + D GLA+        T   T     E      Y 
Sbjct: 142 --SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLT-----EYVATRWYR 194
Query: 213 APEYGMGSKA-SVSGDVYNFGILLLEMFTRR 242
           APE  + SK  + S D+++ G +L EM + R
Sbjct: 195 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/215 (20%), Positives = 95/215 (44%), Gaps = 31/215 (14%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVN---LKQKEASRSFAAECNALRNIRHRNLIKIIT 94
           +G+GG +  ++    +++ + A K+V    L +       + E +  R++ H++++    
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 95  ICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQ----SNGQLRFLTQRVNIAIDVSFAIEYF 150
                 FE  DF  +V E  + R+L +  ++    +  + R+  +++ +        +Y 
Sbjct: 109 F-----FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC------QYL 157
Query: 151 HHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIK-GIV 209
           H +    ++H DLK  N+ L++D+   +GD GLA         T  E      ++  G  
Sbjct: 158 HRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLA---------TKVEYDGERKKVLCGTP 205
Query: 210 GYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
            Y+APE       S   DV++ G ++  +   + P
Sbjct: 206 NYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 22/211 (10%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVN-LKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           IG+G   +V     + ++  VA+K ++  + +   +    E   L   RH N+I I  I 
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQ---SNGQL-RFLTQRVNIAIDVSFAIEYFHH 152
            +   E      IV + M+  +L + L+    SN  +  FL Q       +   ++Y H 
Sbjct: 91  RAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQ-------ILRGLKYIH- 141
Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
               +++H DLKPSN+LL+      + D GLA+        T   T     E      Y 
Sbjct: 142 --SANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLT-----EYVATRWYR 194
Query: 213 APEYGMGSKA-SVSGDVYNFGILLLEMFTRR 242
           APE  + SK  + S D+++ G +L EM + R
Sbjct: 195 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 94/218 (43%), Gaps = 25/218 (11%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASR-SFAAECNALRNIRHRNLIKIITIC 96
           IG G  ++V        +  VA+K +NL++ + S      E  A+    H N++   T  
Sbjct: 23  IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYT-- 80
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQ--SNGQLR--FLTQRV--NIAIDVSFAIEYF 150
               F   D   +V + +   ++   ++   + G+ +   L +     I  +V   +EY 
Sbjct: 81  ---SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYL 137
Query: 151 HHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG 210
           H + Q   +H D+K  NILL +D    + D G++ FL      T  +   N +  K  VG
Sbjct: 138 HKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFL-----ATGGDITRNKVR-KTFVG 188
Query: 211 ---YVAPEYGMGSKA-SVSGDVYNFGILLLEMFTRRRP 244
              ++APE     +      D+++FGI  +E+ T   P
Sbjct: 189 TPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/210 (22%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 38  IGQGGVSIVYKGI-LDESRSI---VAVKVVN-LKQKEASRSFAAECNALRNIRHRNLIKI 92
           +G G    VYKGI + E  ++   VA+K++N     +A+  F  E   + ++ H +L+++
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 82
Query: 93  ITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQL--RFLTQRVNIAIDVSFAIEYF 150
           + +C S   +      +V + M +  L +++ +    +  + L   +N  + ++  + Y 
Sbjct: 83  LGVCLSPTIQ------LVTQLMPHGCLLEYVHEHKDNIGSQLL---LNWCVQIAKGMMYL 133
Query: 151 HHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG 210
                  +VH DL   N+L+       + D GLA+ L G E    A+     I+      
Sbjct: 134 EER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK------ 184
Query: 211 YVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
           ++A E     K +   DV+++G+ + E+ T
Sbjct: 185 WMALECIHYRKFTHQSDVWSYGVTIWELMT 214

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 107/245 (43%), Gaps = 31/245 (12%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           KIG+G   IV    +  S  +VAVK ++L++++       E   +R+ +H N++++    
Sbjct: 81  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN-- 138
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQP 156
               +   D   +V E+++   L   +  +        Q   + + V  A+   H     
Sbjct: 139 ---SYLVGDELWVVMEFLEGGALTDIVTHTRMN---EEQIAAVCLAVLQALSVLHAQ--- 189
Query: 157 SIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG---YVA 213
            ++H D+K  +ILL  D     G + L+ F      G  A+ +      K +VG   ++A
Sbjct: 190 GVIHRDIKSDSILLTHD-----GRVKLSDF------GFCAQVSKEVPRRKXLVGTPYWMA 238
Query: 214 PEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNE-GLTLHEFVKMALPDKVMEI-- 270
           PE           D+++ GI+++EM     P    FNE  L   + ++  LP ++  +  
Sbjct: 239 PELISRLPYGPEVDIWSLGIMVIEMVDGEPP---YFNEPPLKAMKMIRDNLPPRLKNLHK 295
Query: 271 VDPSL 275
           V PSL
Sbjct: 296 VSPSL 300

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/215 (20%), Positives = 95/215 (44%), Gaps = 31/215 (14%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVN---LKQKEASRSFAAECNALRNIRHRNLIKIIT 94
           +G+GG +  ++    +++ + A K+V    L +       + E +  R++ H++++    
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 95  ICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQ----SNGQLRFLTQRVNIAIDVSFAIEYF 150
                 FE  DF  +V E  + R+L +  ++    +  + R+  +++ +        +Y 
Sbjct: 107 F-----FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC------QYL 155
Query: 151 HHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIK-GIV 209
           H +    ++H DLK  N+ L++D+   +GD GLA         T  E      ++  G  
Sbjct: 156 HRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLA---------TKVEYDGERKKVLCGTP 203
Query: 210 GYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
            Y+APE       S   DV++ G ++  +   + P
Sbjct: 204 NYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 238

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/256 (22%), Positives = 110/256 (42%), Gaps = 48/256 (18%)
Query: 6   KDSNMLSMKQQFPMISYAELSKAT-------NNFSPANKIGQGGVSIVYKGILDESRSIV 58
           + S+ML M Q+ P     EL+K          N SP      G V   +     ++++ +
Sbjct: 17  RGSHMLEMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAF-----DTKTGL 71
Query: 59  AVKVVNLKQK-----EASRSFAAECNALRNIRHRNLIKIITICSSI-DFEGFDFKAIVFE 112
            V V  L +       A R++  E   L++++H N+I ++ + +     E F+   +V  
Sbjct: 72  RVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTH 130
Query: 113 YM--QNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILL 170
            M     N+ +  + ++  ++FL  ++         ++Y H      I+H DLKPSN+ +
Sbjct: 131 LMGADLNNIVKCQKLTDDHVQFLIYQI------LRGLKYIH---SADIIHRDLKPSNLAV 181
Query: 171 DQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG---YVAPEYGMG-SKASVSG 226
           ++D    + D GLA+                  E+ G V    Y APE  +     + + 
Sbjct: 182 NEDCELKILDFGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTV 227
Query: 227 DVYNFGILLLEMFTRR 242
           D+++ G ++ E+ T R
Sbjct: 228 DIWSVGCIMAELLTGR 243

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/252 (23%), Positives = 110/252 (43%), Gaps = 44/252 (17%)
Query: 8   SNMLSMKQQFPMISYAELSKAT-------NNFSPANKIGQGGVSIVYKGILDESRSIVAV 60
           S+ML M Q+ P     EL+K          N SP   +G G    V      ++   VAV
Sbjct: 2   SHMLEMSQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAV 58
Query: 61  KVVNLKQK---EASRSFAAECNALRNIRHRNLIKIITICSSI-DFEGFDFKAIVFEYM-- 114
           K ++   +    A R++  E   L++++H N+I ++ + +     E F+   +V   M  
Sbjct: 59  KKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA 117
Query: 115 QNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDI 174
              N+ +  + ++  ++FL  ++         ++Y H      I+H DLKPSN+ +++D 
Sbjct: 118 DLNNIVKCQKLTDDHVQFLIYQI------LRGLKYIH---SADIIHRDLKPSNLAVNEDC 168
Query: 175 VAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG---YVAPEYGMG-SKASVSGDVYN 230
              + D GLA+                  E+ G V    Y APE  +     + + D+++
Sbjct: 169 ELKILDFGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWS 214
Query: 231 FGILLLEMFTRR 242
            G ++ E+ T R
Sbjct: 215 VGCIMAELLTGR 226

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 47/107 (43%), Gaps = 11/107 (10%)
Query: 140 AIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETA 199
           + ++S A+ Y H      I++ DLK  N+LLD +    + D G+ K   G  PG      
Sbjct: 116 SAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE--GLRPGDTTSXF 170
Query: 200 SNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTD 246
                  G   Y+APE   G     S D +  G+L+ EM   R P D
Sbjct: 171 C------GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 211

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 98/212 (46%), Gaps = 29/212 (13%)
Query: 38  IGQGGVSIVYKGI-LDESRSI---VAVKVVNLKQKEASRSFAAECN---ALRNIRHRNLI 90
           +G G    V+KG+ + E  SI   V +KV+  + K   +SF A  +   A+ ++ H +++
Sbjct: 39  LGSGVFGTVHKGVWIPEGESIKIPVCIKVI--EDKSGRQSFQAVTDHMLAIGSLDHAHIV 96
Query: 91  KIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQL--RFLTQRVNIAIDVSFAIE 148
           +++ +C     +      +V +Y+   +L   +RQ  G L  + L   +N  + ++  + 
Sbjct: 97  RLLGLCPGSSLQ------LVTQYLPLGSLLDHVRQHRGALGPQLL---LNWGVQIAKGMY 147
Query: 149 YFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGI 208
           Y   H    +VH +L   N+LL       V D G+A  L    P    +   +  E K  
Sbjct: 148 YLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLL----PPDDKQLLYS--EAKTP 198
Query: 209 VGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
           + ++A E     K +   DV+++G+ + E+ T
Sbjct: 199 IKWMALESIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 103/225 (45%), Gaps = 33/225 (14%)
Query: 30  NNFSPANKIGQGG---VSIVYKGILDESRSIVAVKVVNLK---QKEASRSFAAECNALRN 83
           ++F     IG+G    V IV K   ++++ + A+K +N +   ++   R+   E   ++ 
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQK---NDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQG 71
Query: 84  IRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-D 142
           + H  L+ +        F+  +   +V + +   +L   L+Q+   + F  + V + I +
Sbjct: 72  LEHPFLVNLW-----YSFQDEEDMFMVVDLLLGGDLRYHLQQN---VHFKEETVKLFICE 123
Query: 143 VSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNS 202
           +  A++Y  +     I+H D+KP NILLD+    H+ D  +A  L         ET   +
Sbjct: 124 LVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAML-------PRETQITT 173
Query: 203 IEIKGIVGYVAPEY---GMGSKASVSGDVYNFGILLLEMFTRRRP 244
             + G   Y+APE      G+  S + D ++ G+   E+   RRP
Sbjct: 174 --MAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/220 (22%), Positives = 95/220 (43%), Gaps = 34/220 (15%)
Query: 38  IGQGGVSIVYKGIL-----DESRSIVAVKVV-NLKQKEASRSFAAECNALRNIRHRNLIK 91
           +G G    VY+G +     D S   VAVK +  +  ++    F  E   +    H+N+++
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 92  IITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLR-----FLTQRVNIAIDVSFA 146
               C  +  +    + I+ E M   +L+ +LR++  +        +   +++A D++  
Sbjct: 115 ----CIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 169
Query: 147 IEYFHHHCQPSIVHGDLKPSNILLD---QDIVAHVGDLGLAKFLFG---YEPGTAAETAS 200
            +Y   +     +H D+   N LL       VA +GD G+A+ ++    Y  G  A    
Sbjct: 170 CQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLP- 225
Query: 201 NSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
                   V ++ PE  M    +   D ++FG+LL E+F+
Sbjct: 226 --------VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 22/211 (10%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVN-LKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           IG+G   +V     + ++  VA+K ++  + +   +    E   L   RH N+I I  I 
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQ---SNGQL-RFLTQRVNIAIDVSFAIEYFHH 152
            +   E      IV + M+  +L + L+    SN  +  FL Q       +   ++Y H 
Sbjct: 95  RAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQ-------ILRGLKYIH- 145
Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
               +++H DLKPSN+LL+      + D GLA+        T   T     E      Y 
Sbjct: 146 --SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLT-----EYVATRWYR 198
Query: 213 APEYGMGSKA-SVSGDVYNFGILLLEMFTRR 242
           APE  + SK  + S D+++ G +L EM + R
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/215 (20%), Positives = 95/215 (44%), Gaps = 31/215 (14%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVN---LKQKEASRSFAAECNALRNIRHRNLIKIIT 94
           +G+GG +  ++    +++ + A K+V    L +       + E +  R++ H++++    
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 95  ICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQ----SNGQLRFLTQRVNIAIDVSFAIEYF 150
                 FE  DF  +V E  + R+L +  ++    +  + R+  +++ +        +Y 
Sbjct: 83  F-----FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC------QYL 131
Query: 151 HHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIK-GIV 209
           H +    ++H DLK  N+ L++D+   +GD GLA         T  E      ++  G  
Sbjct: 132 HRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLA---------TKVEYDGERKKVLCGTP 179
Query: 210 GYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
            Y+APE       S   DV++ G ++  +   + P
Sbjct: 180 NYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 214

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 94/224 (41%), Gaps = 35/224 (15%)
Query: 23  AELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEAS--RSFAAECNA 80
           A  ++ T+++    ++G+G  S+V + +        A K++N K+  A   +    E   
Sbjct: 24  ATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARI 83
Query: 81  LRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQL--RFLTQRVN 138
            R ++H N++++     SI  EGF +  +VF+ +           + G+L    + +   
Sbjct: 84  CRLLKHPNIVRLH---DSISEEGFHY--LVFDLV-----------TGGELFEDIVAREYY 127
Query: 139 IAIDVSFAI----EYFHHHCQPSIVHGDLKPSNILLD---QDIVAHVGDLGLAKFLFGYE 191
              D S  I    E  +H  Q  IVH DLKP N+LL    +     + D GLA  + G +
Sbjct: 128 SEADASHCIHQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQ 187
Query: 192 PGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILL 235
                          G  GY++PE           D++  G++L
Sbjct: 188 QAWFG--------FAGTPGYLSPEVLRKDPYGKPVDIWACGVIL 223

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/220 (22%), Positives = 95/220 (43%), Gaps = 34/220 (15%)
Query: 38  IGQGGVSIVYKGIL-----DESRSIVAVKVV-NLKQKEASRSFAAECNALRNIRHRNLIK 91
           +G G    VY+G +     D S   VAVK +  +  ++    F  E   +    H+N+++
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 92  IITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLR-----FLTQRVNIAIDVSFA 146
               C  +  +    + I+ E M   +L+ +LR++  +        +   +++A D++  
Sbjct: 98  ----CIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152
Query: 147 IEYFHHHCQPSIVHGDLKPSNILLD---QDIVAHVGDLGLAKFLFG---YEPGTAAETAS 200
            +Y   +     +H D+   N LL       VA +GD G+A+ ++    Y  G  A    
Sbjct: 153 CQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLP- 208
Query: 201 NSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
                   V ++ PE  M    +   D ++FG+LL E+F+
Sbjct: 209 --------VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 22/211 (10%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVN-LKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           IG+G   +V     + ++  VA+K ++  + +   +    E   L   RH N+I I  I 
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQ---SNGQL-RFLTQRVNIAIDVSFAIEYFHH 152
            +   E      IV + M+  +L + L+    SN  +  FL Q       +   ++Y H 
Sbjct: 93  RAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQ-------ILRGLKYIH- 143
Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
               +++H DLKPSN+LL+      + D GLA+        T   T     E      Y 
Sbjct: 144 --SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT-----EYVATRWYR 196
Query: 213 APEYGMGSKA-SVSGDVYNFGILLLEMFTRR 242
           APE  + SK  + S D+++ G +L EM + R
Sbjct: 197 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/220 (22%), Positives = 95/220 (43%), Gaps = 34/220 (15%)
Query: 38  IGQGGVSIVYKGIL-----DESRSIVAVKVV-NLKQKEASRSFAAECNALRNIRHRNLIK 91
           +G G    VY+G +     D S   VAVK +  +  ++    F  E   +    H+N+++
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 92  IITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLR-----FLTQRVNIAIDVSFA 146
               C  +  +    + I+ E M   +L+ +LR++  +        +   +++A D++  
Sbjct: 105 ----CIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 159
Query: 147 IEYFHHHCQPSIVHGDLKPSNILLD---QDIVAHVGDLGLAKFLFG---YEPGTAAETAS 200
            +Y   +     +H D+   N LL       VA +GD G+A+ ++    Y  G  A    
Sbjct: 160 CQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLP- 215
Query: 201 NSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
                   V ++ PE  M    +   D ++FG+LL E+F+
Sbjct: 216 --------VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 93/221 (42%), Gaps = 40/221 (18%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVN----LKQKEASRSFAAECNALRNIRHRNLIKI 92
           K G G V  V K     +  I A+KV+     ++  + +    AE N L  ++H  ++ +
Sbjct: 27  KGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDL 86
Query: 93  ITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAID---------V 143
           I       F+      ++ EY+           S G+L    +R  I ++         +
Sbjct: 87  IYA-----FQTGGKLYLILEYL-----------SGGELFMQLEREGIFMEDTACFYLAEI 130
Query: 144 SFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSI 203
           S A+ + H   Q  I++ DLKP NI+L+      + D GL K       GT   T   +I
Sbjct: 131 SMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHTFCGTI 185
Query: 204 EIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
           E      Y+APE  M S  + + D ++ G L+ +M T   P
Sbjct: 186 E------YMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/220 (22%), Positives = 95/220 (43%), Gaps = 34/220 (15%)
Query: 38  IGQGGVSIVYKGIL-----DESRSIVAVKVV-NLKQKEASRSFAAECNALRNIRHRNLIK 91
           +G G    VY+G +     D S   VAVK +  +  ++    F  E   +    H+N+++
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 92  IITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLR-----FLTQRVNIAIDVSFA 146
               C  +  +    + I+ E M   +L+ +LR++  +        +   +++A D++  
Sbjct: 99  ----CIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 153
Query: 147 IEYFHHHCQPSIVHGDLKPSNILLD---QDIVAHVGDLGLAKFLFG---YEPGTAAETAS 200
            +Y   +     +H D+   N LL       VA +GD G+A+ ++    Y  G  A    
Sbjct: 154 CQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLP- 209
Query: 201 NSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
                   V ++ PE  M    +   D ++FG+LL E+F+
Sbjct: 210 --------VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 89/206 (43%), Gaps = 20/206 (9%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKI-ITIC 96
           IG G   +VY+  L +S  +VA+K V   ++  +R    E   +R + H N++++     
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVRLRYFFY 83
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSF-AIEYFHHHCQ 155
           SS + +   +  +V +Y+           S  +       V + +   F ++ Y H    
Sbjct: 84  SSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-- 141
Query: 156 PSIVHGDLKPSNILLDQDI-VAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAP 214
             I H D+KP N+LLD D  V  + D G AK L   EP  +   +           Y AP
Sbjct: 142 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY---------YRAP 191
Query: 215 EYGMGSKASVSG-DVYNFGILLLEMF 239
           E   G+    S  DV++ G +L E+ 
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 98/212 (46%), Gaps = 29/212 (13%)
Query: 38  IGQGGVSIVYKGI-LDESRSI---VAVKVVNLKQKEASRSFAAECN---ALRNIRHRNLI 90
           +G G    V+KG+ + E  SI   V +KV+  + K   +SF A  +   A+ ++ H +++
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVI--EDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 91  KIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQL--RFLTQRVNIAIDVSFAIE 148
           +++ +C     +      +V +Y+   +L   +RQ  G L  + L   +N  + ++  + 
Sbjct: 79  RLLGLCPGSSLQ------LVTQYLPLGSLLDHVRQHRGALGPQLL---LNWGVQIAKGMY 129
Query: 149 YFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGI 208
           Y   H    +VH +L   N+LL       V D G+A  L    P    +   +  E K  
Sbjct: 130 YLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLL----PPDDKQLLYS--EAKTP 180
Query: 209 VGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
           + ++A E     K +   DV+++G+ + E+ T
Sbjct: 181 IKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 22/211 (10%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVN-LKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           IG+G   +V     + ++  VA+K ++  + +   +    E   L   RH N+I I  I 
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLR---QSNGQL-RFLTQRVNIAIDVSFAIEYFHH 152
            +   E      IV + M+  +L + L+    SN  +  FL Q       +   ++Y H 
Sbjct: 95  RAPTIEQMKDVYIVQDLMET-DLYKLLKCQHLSNDHICYFLYQ-------ILRGLKYIH- 145
Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
               +++H DLKPSN+LL+      + D GLA+        T   T     E      Y 
Sbjct: 146 --SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT-----EYVATRWYR 198
Query: 213 APEYGMGSKA-SVSGDVYNFGILLLEMFTRR 242
           APE  + SK  + S D+++ G +L EM + R
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/220 (22%), Positives = 95/220 (43%), Gaps = 34/220 (15%)
Query: 38  IGQGGVSIVYKGIL-----DESRSIVAVKVV-NLKQKEASRSFAAECNALRNIRHRNLIK 91
           +G G    VY+G +     D S   VAVK +  +  ++    F  E   +    H+N+++
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 92  IITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLR-----FLTQRVNIAIDVSFA 146
               C  +  +    + I+ E M   +L+ +LR++  +        +   +++A D++  
Sbjct: 98  ----CIGVSLQSLP-RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152
Query: 147 IEYFHHHCQPSIVHGDLKPSNILLD---QDIVAHVGDLGLAKFLFG---YEPGTAAETAS 200
            +Y   +     +H D+   N LL       VA +GD G+A+ ++    Y  G  A    
Sbjct: 153 CQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLP- 208
Query: 201 NSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
                   V ++ PE  M    +   D ++FG+LL E+F+
Sbjct: 209 --------VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 22/211 (10%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVN-LKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           IG+G   +V     + ++  VA+K ++  + +   +    E   L   RH N+I I  I 
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDII 94
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQ---SNGQL-RFLTQRVNIAIDVSFAIEYFHH 152
            +   E      IV + M+  +L + L+    SN  +  FL Q       +   ++Y H 
Sbjct: 95  RAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQ-------ILRGLKYIH- 145
Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
               +++H DLKPSN+LL+      + D GLA+        T   T     E      Y 
Sbjct: 146 --SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLT-----EYVATRWYR 198
Query: 213 APEYGMGSKA-SVSGDVYNFGILLLEMFTRR 242
           APE  + SK  + S D+++ G +L EM + R
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/220 (22%), Positives = 95/220 (43%), Gaps = 34/220 (15%)
Query: 38  IGQGGVSIVYKGIL-----DESRSIVAVKVV-NLKQKEASRSFAAECNALRNIRHRNLIK 91
           +G G    VY+G +     D S   VAVK +  +  ++    F  E   +    H+N+++
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 92  IITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLR-----FLTQRVNIAIDVSFA 146
               C  +  +    + I+ E M   +L+ +LR++  +        +   +++A D++  
Sbjct: 90  ----CIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 144
Query: 147 IEYFHHHCQPSIVHGDLKPSNILLD---QDIVAHVGDLGLAKFLFG---YEPGTAAETAS 200
            +Y   +     +H D+   N LL       VA +GD G+A+ ++    Y  G  A    
Sbjct: 145 CQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLP- 200
Query: 201 NSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
                   V ++ PE  M    +   D ++FG+LL E+F+
Sbjct: 201 --------VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 92/211 (43%), Gaps = 22/211 (10%)
Query: 38  IGQGGVSIVYKGILDESRSIVAV-KVVNLKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           IG+G   +V     + ++  VA+ K+   + +   +    E   L   RH N+I I  I 
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQ---SNGQL-RFLTQRVNIAIDVSFAIEYFHH 152
            +   E      IV + M+  +L + L+    SN  +  FL Q       +   ++Y H 
Sbjct: 95  RAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQ-------ILRGLKYIH- 145
Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
               +++H DLKPSN+LL+      + D GLA+        T   T     E      Y 
Sbjct: 146 --SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT-----EYVATRWYR 198
Query: 213 APEYGMGSKA-SVSGDVYNFGILLLEMFTRR 242
           APE  + SK  + S D+++ G +L EM + R
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/220 (22%), Positives = 95/220 (43%), Gaps = 34/220 (15%)
Query: 38  IGQGGVSIVYKGIL-----DESRSIVAVKVV-NLKQKEASRSFAAECNALRNIRHRNLIK 91
           +G G    VY+G +     D S   VAVK +  +  ++    F  E   +    H+N+++
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 92  IITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLR-----FLTQRVNIAIDVSFA 146
               C  +  +    + I+ E M   +L+ +LR++  +        +   +++A D++  
Sbjct: 125 ----CIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 179
Query: 147 IEYFHHHCQPSIVHGDLKPSNILLD---QDIVAHVGDLGLAKFLFG---YEPGTAAETAS 200
            +Y   +     +H D+   N LL       VA +GD G+A+ ++    Y  G  A    
Sbjct: 180 CQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLP- 235
Query: 201 NSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
                   V ++ PE  M    +   D ++FG+LL E+F+
Sbjct: 236 --------VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/220 (22%), Positives = 95/220 (43%), Gaps = 34/220 (15%)
Query: 38  IGQGGVSIVYKGIL-----DESRSIVAVKVV-NLKQKEASRSFAAECNALRNIRHRNLIK 91
           +G G    VY+G +     D S   VAVK +  +  ++    F  E   +    H+N+++
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 92  IITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLR-----FLTQRVNIAIDVSFA 146
               C  +  +    + I+ E M   +L+ +LR++  +        +   +++A D++  
Sbjct: 113 ----CIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 167
Query: 147 IEYFHHHCQPSIVHGDLKPSNILLD---QDIVAHVGDLGLAKFLFG---YEPGTAAETAS 200
            +Y   +     +H D+   N LL       VA +GD G+A+ ++    Y  G  A    
Sbjct: 168 CQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLP- 223
Query: 201 NSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
                   V ++ PE  M    +   D ++FG+LL E+F+
Sbjct: 224 --------VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 107/245 (43%), Gaps = 31/245 (12%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           KIG+G   IV    +  S  +VAVK ++L++++       E   +R+ +H N++++    
Sbjct: 158 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN-- 215
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQP 156
               +   D   +V E+++   L   +  +        Q   + + V  A+   H     
Sbjct: 216 ---SYLVGDELWVVMEFLEGGALTDIVTHTRMN---EEQIAAVCLAVLQALSVLHAQ--- 266
Query: 157 SIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG---YVA 213
            ++H D+K  +ILL  D     G + L+ F      G  A+ +      K +VG   ++A
Sbjct: 267 GVIHRDIKSDSILLTHD-----GRVKLSDF------GFCAQVSKEVPRRKXLVGTPYWMA 315
Query: 214 PEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNE-GLTLHEFVKMALPDKVMEI-- 270
           PE           D+++ GI+++EM     P    FNE  L   + ++  LP ++  +  
Sbjct: 316 PELISRLPYGPEVDIWSLGIMVIEMVDGEPP---YFNEPPLKAMKMIRDNLPPRLKNLHK 372
Query: 271 VDPSL 275
           V PSL
Sbjct: 373 VSPSL 377

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/211 (22%), Positives = 88/211 (41%), Gaps = 25/211 (11%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           KIGQG    VY  +   +   VA++ +NL+Q+        E   +R  ++ N++  +   
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD-- 84
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQS---NGQLRFLTQRVNIAIDVSFAIEYFHHH 153
               +   D   +V EY+   +L   + ++    GQ+        +  +   A+E+ H +
Sbjct: 85  ---SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI------AAVCRECLQALEFLHSN 135
Query: 154 CQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVA 213
               ++H D+K  NILL  D    + D       FG+      E +  S  + G   ++A
Sbjct: 136 ---QVIHRDIKSDNILLGMDGSVKLTD-------FGFCAQITPEQSKRSTMV-GTPYWMA 184
Query: 214 PEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
           PE           D+++ GI+ +EM     P
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 98/212 (46%), Gaps = 27/212 (12%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           KIG+G   IV       S   VAVK+++L++++       E   +R+ +H N++++    
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYK-- 109
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSF-AIEYFHHHCQ 155
           S +  E      ++ E++Q   L   +     Q+R   +++    +    A+ Y H    
Sbjct: 110 SYLVGEEL---WVLMEFLQGGALTDIV----SQVRLNEEQIATVCEAVLQALAYLHAQ-- 160
Query: 156 PSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG---YV 212
             ++H D+K  +ILL  D     G + L+ F      G  A+ + +  + K +VG   ++
Sbjct: 161 -GVIHRDIKSDSILLTLD-----GRVKLSDF------GFCAQISKDVPKRKXLVGTPYWM 208
Query: 213 APEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
           APE    S  +   D+++ GI+++EM     P
Sbjct: 209 APEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/220 (22%), Positives = 95/220 (43%), Gaps = 34/220 (15%)
Query: 38  IGQGGVSIVYKGIL-----DESRSIVAVKVV-NLKQKEASRSFAAECNALRNIRHRNLIK 91
           +G G    VY+G +     D S   VAVK +  +  ++    F  E   +    H+N+++
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 92  IITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLR-----FLTQRVNIAIDVSFA 146
               C  +  +    + I+ E M   +L+ +LR++  +        +   +++A D++  
Sbjct: 99  ----CIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 153
Query: 147 IEYFHHHCQPSIVHGDLKPSNILLD---QDIVAHVGDLGLAKFLFG---YEPGTAAETAS 200
            +Y   +     +H D+   N LL       VA +GD G+A+ ++    Y  G  A    
Sbjct: 154 CQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLP- 209
Query: 201 NSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
                   V ++ PE  M    +   D ++FG+LL E+F+
Sbjct: 210 --------VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 60/240 (25%), Positives = 105/240 (43%), Gaps = 40/240 (16%)
Query: 56  SIVAVKVVNLKQKEAS-RSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYM 114
           + VAVK++      +  R   +E N L+ + H ++IK+   CS    +G     ++ EY 
Sbjct: 54  TTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ---DGPLL--LIVEYA 108
Query: 115 QNRNLEQWLRQSN----GQLRFLTQRVNIAID------------VSFAIEY---FHHHCQ 155
           +  +L  +LR+S     G L     R + ++D            +SFA +      +  +
Sbjct: 109 KYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE 168
Query: 156 PSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPE 215
             +VH DL   NIL+ +     + D GL++ +  YE  +  + +   I +K    ++A E
Sbjct: 169 MKLVHRDLAARNILVAEGRKMKISDFGLSRDV--YEEDSXVKRSQGRIPVK----WMAIE 222
Query: 216 YGMGSKASVSGDVYNFGILLLEMFTRRR------PTDAMFNEGLTLHEFVKMALPDKVME 269
                  +   DV++FG+LL E+ T         P + +FN   T H   +M  PD   E
Sbjct: 223 SLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGH---RMERPDNCSE 279

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 61/274 (22%), Positives = 114/274 (41%), Gaps = 56/274 (20%)
Query: 32  FSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIK 91
           F+   +IG+G    V+KGI + ++ +VA+K+++L++ E                 +  I 
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIE-----------DIQQEIT 73
Query: 92  IITICSS---IDFEGFDFKA----IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVS 144
           +++ C S     + G   K     I+ EY+   +    LR   G      Q   +  ++ 
Sbjct: 74  VLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRA--GPFDEF-QIATMLKEIL 130
Query: 145 FAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIE 204
             ++Y H   +   +H D+K +N+LL +      GD+ LA F      G A +     I+
Sbjct: 131 KGLDYLHSEKK---IHRDIKAANVLLSEQ-----GDVKLADF------GVAGQLTDTQIK 176
Query: 205 IKGIVG---YVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKM 261
               VG   ++APE    S      D+++ GI  +E+     P   M             
Sbjct: 177 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMH------------ 224
Query: 262 ALPDKVMEIV----DPSLLLEVTANNYSWIEDCL 291
             P +V+ ++     P+L+ + T +   +I+ CL
Sbjct: 225 --PMRVLFLIPKNNPPTLVGDFTKSFKEFIDACL 256

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 60/252 (23%), Positives = 110/252 (43%), Gaps = 44/252 (17%)
Query: 8   SNMLSMKQQFPMISYAELSKAT-------NNFSPANKIGQGGVSIVYKGILDESRSIVAV 60
           S+ML M Q+ P     EL+K          N SP   +G G    V      ++   VAV
Sbjct: 2   SHMLEMSQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAV 58
Query: 61  KVVNLKQK---EASRSFAAECNALRNIRHRNLIKIITICSSI-DFEGFDFKAIVFEYM-- 114
           K ++   +    A R++  E   L++++H N+I ++ + +     E F+   +V   M  
Sbjct: 59  KKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA 117
Query: 115 QNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDI 174
              N+ +  + ++  ++FL  ++         ++Y H      I+H DLKPSN+ +++D 
Sbjct: 118 DLNNIVKCQKLTDDHVQFLIYQI------LRGLKYIH---SADIIHRDLKPSNLAVNEDS 168
Query: 175 VAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG---YVAPEYGMG-SKASVSGDVYN 230
              + D GLA+                  E+ G V    Y APE  +     + + D+++
Sbjct: 169 ELKILDFGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWS 214
Query: 231 FGILLLEMFTRR 242
            G ++ E+ T R
Sbjct: 215 VGCIMAELLTGR 226

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/220 (22%), Positives = 95/220 (43%), Gaps = 34/220 (15%)
Query: 38  IGQGGVSIVYKGIL-----DESRSIVAVKVV-NLKQKEASRSFAAECNALRNIRHRNLIK 91
           +G G    VY+G +     D S   VAVK +  +  ++    F  E   +    H+N+++
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 92  IITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLR-----FLTQRVNIAIDVSFA 146
               C  +  +    + I+ E M   +L+ +LR++  +        +   +++A D++  
Sbjct: 113 ----CIGVSLQSLP-RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 167
Query: 147 IEYFHHHCQPSIVHGDLKPSNILLD---QDIVAHVGDLGLAKFLFG---YEPGTAAETAS 200
            +Y   +     +H D+   N LL       VA +GD G+A+ ++    Y  G  A    
Sbjct: 168 CQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLP- 223
Query: 201 NSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
                   V ++ PE  M    +   D ++FG+LL E+F+
Sbjct: 224 --------VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/211 (22%), Positives = 89/211 (42%), Gaps = 25/211 (11%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           KIGQG    VY  +   +   VA++ +NL+Q+        E   +R  ++ N++  +   
Sbjct: 28  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD-- 85
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQS---NGQLRFLTQRVNIAIDVSFAIEYFHHH 153
               +   D   +V EY+   +L   + ++    GQ+  + +      +   A+E+ H +
Sbjct: 86  ---SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR------ECLQALEFLHSN 136
Query: 154 CQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVA 213
               ++H D+K  NILL  D    + D       FG+      E +  S  + G   ++A
Sbjct: 137 ---QVIHRDIKSDNILLGMDGSVKLTD-------FGFCAQITPEQSKRSXMV-GTPYWMA 185
Query: 214 PEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
           PE           D+++ GI+ +EM     P
Sbjct: 186 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/211 (22%), Positives = 89/211 (42%), Gaps = 25/211 (11%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           KIGQG    VY  +   +   VA++ +NL+Q+        E   +R  ++ N++  +   
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD-- 84
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQS---NGQLRFLTQRVNIAIDVSFAIEYFHHH 153
               +   D   +V EY+   +L   + ++    GQ+  + +      +   A+E+ H +
Sbjct: 85  ---SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR------ECLQALEFLHSN 135
Query: 154 CQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVA 213
               ++H D+K  NILL  D    + D       FG+      E +  S  + G   ++A
Sbjct: 136 ---QVIHRDIKSDNILLGMDGSVKLTD-------FGFCAQITPEQSKRSXMV-GTPYWMA 184
Query: 214 PEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
           PE           D+++ GI+ +EM     P
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 95/213 (44%), Gaps = 33/213 (15%)
Query: 38  IGQGGVSIVYKGILDES---RSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIIT 94
           I  GG+  +Y   LD +   R +V   +V+    EA     AE   L  + H ++++I  
Sbjct: 88  IAHGGLGWIYLA-LDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 95  ICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHC 154
                D  G     IV EY+      Q L++S GQ   + + +   +++  A+ Y H   
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGG----QSLKRSKGQKLPVAEAIAYLLEILPALSYLHSI- 201
Query: 155 QPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL--FGYEPGTAAETASNSIEIKGIVGYV 212
              +V+ DLKP NI+L ++ +  + DLG    +  FGY              + G  G+ 
Sbjct: 202 --GLVYNDLKPENIMLTEEQLKLI-DLGAVSRINSFGY--------------LYGTPGFQ 244
Query: 213 APEYGMGSKASVSGDVYNFG----ILLLEMFTR 241
           APE  + +  +V+ D+Y  G     L L++ TR
Sbjct: 245 APEI-VRTGPTVATDIYTVGRTLAALTLDLPTR 276

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/211 (23%), Positives = 81/211 (38%), Gaps = 20/211 (9%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           K+ +     ++KG    +  +V V  V       SR F  EC  LR   H N++ ++  C
Sbjct: 17  KLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQP 156
            S          ++  +    +L   L +    +   +Q V  A+D +    +  H  +P
Sbjct: 77  QS---PPAPHPTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAFL-HTLEP 132
Query: 157 SIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEY 216
            I    L   ++ +D+D  A +    + KF F   PG     A           +VAPE 
Sbjct: 133 LIPRHALNSRSVXIDEDXTARISXADV-KFSF-QSPGRXYAPA-----------WVAPEA 179
Query: 217 GMGSKASV---SGDVYNFGILLLEMFTRRRP 244
                      S D ++F +LL E+ TR  P
Sbjct: 180 LQKKPEDTNRRSADXWSFAVLLWELVTREVP 210

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 89/206 (43%), Gaps = 20/206 (9%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKI-ITIC 96
           IG G   +VY+  L +S  +VA+K V   ++  +R    E   +R + H N++++     
Sbjct: 47  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVRLRYFFY 102
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSF-AIEYFHHHCQ 155
           SS + +   +  +V +Y+           S  +       V + +   F ++ Y H    
Sbjct: 103 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-- 160
Query: 156 PSIVHGDLKPSNILLDQDI-VAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAP 214
             I H D+KP N+LLD D  V  + D G AK L   EP  +   +           Y AP
Sbjct: 161 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY---------YRAP 210
Query: 215 EYGMGSKASVSG-DVYNFGILLLEMF 239
           E   G+    S  DV++ G +L E+ 
Sbjct: 211 ELIFGATDYTSSIDVWSAGCVLAELL 236

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 89/206 (43%), Gaps = 20/206 (9%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKI-ITIC 96
           IG G   +VY+  L +S  +VA+K V   ++  +R    E   +R + H N++++     
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVRLRYFFY 95
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSF-AIEYFHHHCQ 155
           SS + +   +  +V +Y+           S  +       V + +   F ++ Y H    
Sbjct: 96  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-- 153
Query: 156 PSIVHGDLKPSNILLDQDI-VAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAP 214
             I H D+KP N+LLD D  V  + D G AK L   EP  +   +           Y AP
Sbjct: 154 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY---------YRAP 203
Query: 215 EYGMGSKASVSG-DVYNFGILLLEMF 239
           E   G+    S  DV++ G +L E+ 
Sbjct: 204 ELIFGATDYTSSIDVWSAGCVLAELL 229

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 89/206 (43%), Gaps = 20/206 (9%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKI-ITIC 96
           IG G   +VY+  L +S  +VA+K V   ++  +R    E   +R + H N++++     
Sbjct: 29  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVRLRYFFY 84
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSF-AIEYFHHHCQ 155
           SS + +   +  +V +Y+           S  +       V + +   F ++ Y H    
Sbjct: 85  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-- 142
Query: 156 PSIVHGDLKPSNILLDQDI-VAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAP 214
             I H D+KP N+LLD D  V  + D G AK L   EP  +   +           Y AP
Sbjct: 143 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY---------YRAP 192
Query: 215 EYGMGSKASVSG-DVYNFGILLLEMF 239
           E   G+    S  DV++ G +L E+ 
Sbjct: 193 ELIFGATDYTSSIDVWSAGCVLAELL 218

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 89/206 (43%), Gaps = 20/206 (9%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKI-ITIC 96
           IG G   +VY+  L +S  +VA+K V   ++  +R    E   +R + H N++++     
Sbjct: 36  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVRLRYFFY 91
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSF-AIEYFHHHCQ 155
           SS + +   +  +V +Y+           S  +       V + +   F ++ Y H    
Sbjct: 92  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-- 149
Query: 156 PSIVHGDLKPSNILLDQDI-VAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAP 214
             I H D+KP N+LLD D  V  + D G AK L   EP  +   +           Y AP
Sbjct: 150 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY---------YRAP 199
Query: 215 EYGMGSKASVSG-DVYNFGILLLEMF 239
           E   G+    S  DV++ G +L E+ 
Sbjct: 200 ELIFGATDYTSSIDVWSAGCVLAELL 225

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 47/96 (48%), Gaps = 8/96 (8%)
Query: 149 YFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGI 208
           Y+ H  Q +IVH DLKP NILL    +  +GD+ +  F    + G A E      EI G 
Sbjct: 145 YYLH--QNNIVHLDLKPQNILLSS--IYPLGDIKIVDFGMSRKIGHACELR----EIMGT 196
Query: 209 VGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
             Y+APE       + + D++N GI+   + T   P
Sbjct: 197 PEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 89/206 (43%), Gaps = 20/206 (9%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKI-ITIC 96
           IG G   +VY+  L +S  +VA+K V   ++  +R    E   +R + H N++++     
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVRLRYFFY 83
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSF-AIEYFHHHCQ 155
           SS + +   +  +V +Y+           S  +       V + +   F ++ Y H    
Sbjct: 84  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-- 141
Query: 156 PSIVHGDLKPSNILLDQDI-VAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAP 214
             I H D+KP N+LLD D  V  + D G AK L   EP  +   +           Y AP
Sbjct: 142 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY---------YRAP 191
Query: 215 EYGMGSKASVSG-DVYNFGILLLEMF 239
           E   G+    S  DV++ G +L E+ 
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 89/206 (43%), Gaps = 20/206 (9%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKI-ITIC 96
           IG G   +VY+  L +S  +VA+K V   ++  +R    E   +R + H N++++     
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVRLRYFFY 95
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSF-AIEYFHHHCQ 155
           SS + +   +  +V +Y+           S  +       V + +   F ++ Y H    
Sbjct: 96  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-- 153
Query: 156 PSIVHGDLKPSNILLDQDI-VAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAP 214
             I H D+KP N+LLD D  V  + D G AK L   EP  +   +           Y AP
Sbjct: 154 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY---------YRAP 203
Query: 215 EYGMGSKASVSG-DVYNFGILLLEMF 239
           E   G+    S  DV++ G +L E+ 
Sbjct: 204 ELIFGATDYTSSIDVWSAGCVLAELL 229

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 89/206 (43%), Gaps = 20/206 (9%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKI-ITIC 96
           IG G   +VY+  L +S  +VA+K V   ++  +R    E   +R + H N++++     
Sbjct: 32  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVRLRYFFY 87
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSF-AIEYFHHHCQ 155
           SS + +   +  +V +Y+           S  +       V + +   F ++ Y H    
Sbjct: 88  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-- 145
Query: 156 PSIVHGDLKPSNILLDQDI-VAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAP 214
             I H D+KP N+LLD D  V  + D G AK L   EP  +   +           Y AP
Sbjct: 146 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY---------YRAP 195
Query: 215 EYGMGSKASVSG-DVYNFGILLLEMF 239
           E   G+    S  DV++ G +L E+ 
Sbjct: 196 ELIFGATDYTSSIDVWSAGCVLAELL 221

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 89/206 (43%), Gaps = 20/206 (9%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKI-ITIC 96
           IG G   +VY+  L +S  +VA+K V   ++  +R    E   +R + H N++++     
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVRLRYFFY 83
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSF-AIEYFHHHCQ 155
           SS + +   +  +V +Y+           S  +       V + +   F ++ Y H    
Sbjct: 84  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-- 141
Query: 156 PSIVHGDLKPSNILLDQDI-VAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAP 214
             I H D+KP N+LLD D  V  + D G AK L   EP  +   +           Y AP
Sbjct: 142 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY---------YRAP 191
Query: 215 EYGMGSKASVSG-DVYNFGILLLEMF 239
           E   G+    S  DV++ G +L E+ 
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 79/164 (48%), Gaps = 25/164 (15%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICS 97
           +G GG  +V+  + ++    VA+K + L   ++ +    E   +R + H N++K+  I  
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 98  SIDFEGFDFKA---------IVFEYMQN---RNLEQW-LRQSNGQLRFLTQRVNIAIDVS 144
               +  D            IV EYM+      LEQ  L + + +L F+ Q +       
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARL-FMYQLLR------ 131
Query: 145 FAIEYFHHHCQPSIVHGDLKPSNILLD-QDIVAHVGDLGLAKFL 187
             ++Y H     +++H DLKP+N+ ++ +D+V  +GD GLA+ +
Sbjct: 132 -GLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIM 171

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 60/240 (25%), Positives = 105/240 (43%), Gaps = 40/240 (16%)
Query: 56  SIVAVKVVNLKQKEAS-RSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYM 114
           + VAVK++      +  R   +E N L+ + H ++IK+   CS    +G     ++ EY 
Sbjct: 54  TTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ---DGPLL--LIVEYA 108
Query: 115 QNRNLEQWLRQSN----GQLRFLTQRVNIAID------------VSFAIEY---FHHHCQ 155
           +  +L  +LR+S     G L     R + ++D            +SFA +      +  +
Sbjct: 109 KYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE 168
Query: 156 PSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPE 215
             +VH DL   NIL+ +     + D GL++ +  YE  +  + +   I +K    ++A E
Sbjct: 169 MKLVHRDLAARNILVAEGRKMKISDFGLSRDV--YEEDSYVKRSQGRIPVK----WMAIE 222
Query: 216 YGMGSKASVSGDVYNFGILLLEMFTRRR------PTDAMFNEGLTLHEFVKMALPDKVME 269
                  +   DV++FG+LL E+ T         P + +FN   T H   +M  PD   E
Sbjct: 223 SLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGH---RMERPDNCSE 279

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 92/211 (43%), Gaps = 22/211 (10%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVN-LKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           IG+G   +V     + ++  VA+K ++  + +   +    E   L   RH N+I I  I 
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQ---SNGQL-RFLTQRVNIAIDVSFAIEYFHH 152
            +   E      IV + M+  +L + L+    SN  +  FL Q       +   ++Y H 
Sbjct: 95  RAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQ-------ILRGLKYIH- 145
Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
               +++H DLKPSN+LL+      + D GLA+           +      E      Y 
Sbjct: 146 --SANVLHRDLKPSNLLLNTTCDLKICDFGLARVA-----DPDHDHTGFLXEXVATRWYR 198
Query: 213 APEYGMGSKA-SVSGDVYNFGILLLEMFTRR 242
           APE  + SK  + S D+++ G +L EM + R
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 92/211 (43%), Gaps = 22/211 (10%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVN-LKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           IG+G   +V     + ++  VA+K ++  + +   +    E   L   RH N+I I  I 
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQ---SNGQL-RFLTQRVNIAIDVSFAIEYFHH 152
            +   E      IV + M+  +L + L+    SN  +  FL Q       +   ++Y H 
Sbjct: 96  RAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQ-------ILRGLKYIH- 146
Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
               +++H DLKPSN+LL+      + D GLA+           +      E      Y 
Sbjct: 147 --SANVLHRDLKPSNLLLNTTCDLKICDFGLARVA-----DPDHDHTGFLXEXVATRWYR 199
Query: 213 APEYGMGSKA-SVSGDVYNFGILLLEMFTRR 242
           APE  + SK  + S D+++ G +L EM + R
Sbjct: 200 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 22/211 (10%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVN-LKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           IG+G   +V     + ++  VA+K ++  + +   +    E   L   RH N+I I  I 
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQ---SNGQL-RFLTQRVNIAIDVSFAIEYFHH 152
            +   E      IV + M+  +L + L+    SN  +  FL Q       +   ++Y H 
Sbjct: 93  RAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQ-------ILRGLKYIH- 143
Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
               +++H DLKPSN+LL+      + D GLA+        T   T     E      Y 
Sbjct: 144 --SANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLT-----EYVATRWYR 196
Query: 213 APEYGMGSKA-SVSGDVYNFGILLLEMFTRR 242
           APE  + SK  + S D+++ G +L EM + R
Sbjct: 197 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 36/131 (27%), Positives = 60/131 (45%), Gaps = 18/131 (13%)
Query: 109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNI 168
           I+ E M+   L   +++   Q     +   I  D+  AI++ H H   +I H D+KP N+
Sbjct: 84  IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENL 140
Query: 169 LL---DQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG-YVAPEYGMGSKASV 224
           L    ++D V  + D G AK           ET  N+++       YVAPE     K   
Sbjct: 141 LYTSKEKDAVLKLTDFGFAK-----------ETTQNALQTPCYTPYYVAPEVLGPEKYDK 189
Query: 225 SGDVYNFGILL 235
           S D+++ G+++
Sbjct: 190 SCDMWSLGVIM 200

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 89/206 (43%), Gaps = 20/206 (9%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKI-ITIC 96
           IG G   +VY+  L +S  +VA+K V   ++  +R    E   +R + H N++++     
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVRLRYFFY 117
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSF-AIEYFHHHCQ 155
           SS + +   +  +V +Y+           S  +       V + +   F ++ Y H    
Sbjct: 118 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-- 175
Query: 156 PSIVHGDLKPSNILLDQDI-VAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAP 214
             I H D+KP N+LLD D  V  + D G AK L   EP  +   +           Y AP
Sbjct: 176 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY---------YRAP 225
Query: 215 EYGMGSKASVSG-DVYNFGILLLEMF 239
           E   G+    S  DV++ G +L E+ 
Sbjct: 226 ELIFGATDYTSSIDVWSAGCVLAELL 251

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 36/131 (27%), Positives = 60/131 (45%), Gaps = 18/131 (13%)
Query: 109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNI 168
           I+ E M+   L   +++   Q     +   I  D+  AI++ H H   +I H D+KP N+
Sbjct: 103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENL 159
Query: 169 LL---DQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG-YVAPEYGMGSKASV 224
           L    ++D V  + D G AK           ET  N+++       YVAPE     K   
Sbjct: 160 LYTSKEKDAVLKLTDFGFAK-----------ETTQNALQTPCYTPYYVAPEVLGPEKYDK 208
Query: 225 SGDVYNFGILL 235
           S D+++ G+++
Sbjct: 209 SCDMWSLGVIM 219

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 83/212 (39%), Gaps = 24/212 (11%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVN----LKQKEASRSFAAECNALRNIRHRNLIKII 93
           IG+G    V            AVKV+     LK+KE     +     L+N++H  L+ + 
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL- 104
Query: 94  TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNI-AIDVSFAIEYFHH 152
                  F+  D    V +Y+    L   L++      FL  R    A +++ A+ Y H 
Sbjct: 105 ----HFSFQTADKLYFVLDYINGGELFYHLQRERC---FLEPRARFYAAEIASALGYLH- 156
Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
               +IV+ DLKP NILLD      + D GL K           E  S +    G   Y+
Sbjct: 157 --SLNIVYRDLKPENILLDSQGHIVLTDFGLCK--------ENIEHNSTTSTFCGTPEYL 206
Query: 213 APEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
           APE         + D +  G +L EM     P
Sbjct: 207 APEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 101/250 (40%), Gaps = 34/250 (13%)
Query: 29  TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRN 88
           ++ F   +++G+G  SIVY+     ++   A+KV  LK+    +    E   L  + H N
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKV--LKKTVDKKIVRTEIGVLLRLSHPN 109
Query: 89  LIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQR--VNIAIDVSFA 146
           +IK+  I     FE     ++V E +    L   + +      + ++R   +    +  A
Sbjct: 110 IIKLKEI-----FETPTEISLVLELVTGGELFDRIVEKG----YYSERDAADAVKQILEA 160
Query: 147 IEYFHHHCQPSIVHGDLKPSNILLDQ---DIVAHVGDLGLAKFLFGYEPGTAAETASNSI 203
           + Y H +    IVH DLKP N+L      D    + D GL+K +   E     +T     
Sbjct: 161 VAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV---EHQVLMKT----- 209
Query: 204 EIKGIVGYVAPEYGMGSKASVSGDVYNFGILL------LEMFTRRRPTDAMFNEGLTLHE 257
            + G  GY APE   G       D+++ GI+        E F   R    MF   L    
Sbjct: 210 -VCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEY 268
Query: 258 FVKMALPDKV 267
           +      D+V
Sbjct: 269 YFISPWWDEV 278

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/206 (22%), Positives = 87/206 (42%), Gaps = 21/206 (10%)
Query: 38  IGQGGVSIVYKGIL---DESRSIVAVKVV-NLKQKEASRSFAAECNALRNIRHRNLIKII 93
           IG+G    V++GI    +     VA+K   N         F  E   +R   H +++K+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 94  TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHH 153
            + +       +   I+ E      L  +L+     L  L   +  A  +S A+ Y    
Sbjct: 78  GVITE------NPVWIIMELCTLGELRSFLQVRKFSLD-LASLILYAYQLSTALAYLESK 130
Query: 154 CQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVA 213
                VH D+   N+L+  +    +GD GL++++   E  T  + +   + IK    ++A
Sbjct: 131 ---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTXXKASKGKLPIK----WMA 180
Query: 214 PEYGMGSKASVSGDVYNFGILLLEMF 239
           PE     + + + DV+ FG+ + E+ 
Sbjct: 181 PESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/242 (22%), Positives = 103/242 (42%), Gaps = 34/242 (14%)
Query: 23  AELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALR 82
            E  K  N++     + QG  + +   + ++     A+K       E  R F    N   
Sbjct: 24  KEKDKYINDYRIIRTLNQGKFNKII--LCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKI 81
Query: 83  NIRHR-----NLIKIIT--------ICSSIDFEGFDFKAIVFEYMQNRNL----EQWLRQ 125
           +I+ +     N ++IIT         C  I    +D   I++EYM+N ++    E +   
Sbjct: 82  SIKSKYDDFKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVL 140
Query: 126 SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAK 185
                 F+  +V   I  S    + + H + +I H D+KPSNIL+D++    + D G ++
Sbjct: 141 DKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESE 200
Query: 186 FLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSG---DVYNFGILLLEMFTRR 242
           ++   +   +          +G   ++ PE+   +++S +G   D+++ GI L  MF   
Sbjct: 201 YMVDKKIKGS----------RGTYEFMPPEF-FSNESSYNGAKVDIWSLGICLYVMFYNV 249
Query: 243 RP 244
            P
Sbjct: 250 VP 251

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 89/206 (43%), Gaps = 20/206 (9%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKI-ITIC 96
           IG G   +VY+  L +S  +VA+K V   ++  +R    E   +R + H N++++     
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVRLRYFFY 83
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSF-AIEYFHHHCQ 155
           SS + +   +  +V +Y+           S  +       V + +   F ++ Y H    
Sbjct: 84  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-- 141
Query: 156 PSIVHGDLKPSNILLDQDI-VAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAP 214
             I H D+KP N+LLD D  V  + D G AK L   EP  +   +           Y AP
Sbjct: 142 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY---------YRAP 191
Query: 215 EYGMGSKASVSG-DVYNFGILLLEMF 239
           E   G+    S  DV++ G +L E+ 
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 89/206 (43%), Gaps = 20/206 (9%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKI-ITIC 96
           IG G   +VY+  L +S  +VA+K V   ++  +R    E   +R + H N++++     
Sbjct: 41  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVRLRYFFY 96
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSF-AIEYFHHHCQ 155
           SS + +   +  +V +Y+           S  +       V + +   F ++ Y H    
Sbjct: 97  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-- 154
Query: 156 PSIVHGDLKPSNILLDQDI-VAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAP 214
             I H D+KP N+LLD D  V  + D G AK L   EP  +   +           Y AP
Sbjct: 155 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY---------YRAP 204
Query: 215 EYGMGSKASVSG-DVYNFGILLLEMF 239
           E   G+    S  DV++ G +L E+ 
Sbjct: 205 ELIFGATDYTSSIDVWSAGCVLAELL 230

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 91/223 (40%), Gaps = 47/223 (21%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICS 97
           +G+GG +  Y+    +++ + A KVV             +   L+  +   +   I I  
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVV------------PKSMLLKPHQKEKMSTEIAIHK 97
Query: 98  SID------FEGF----DFKAIVFEYMQNRNLEQWLRQSNGQLR-----FLTQRVNIAID 142
           S+D      F GF    DF  +V E  + R+L +  ++           F+ Q +     
Sbjct: 98  SLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQ---- 153
Query: 143 VSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA-KFLFGYEPGTAAETASN 201
               ++Y H++    ++H DLK  N+ L+ D+   +GD GLA K  F  E          
Sbjct: 154 ---GVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGE---------R 198
Query: 202 SIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
             ++ G   Y+APE       S   D+++ G +L  +   + P
Sbjct: 199 KKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 82/174 (47%), Gaps = 22/174 (12%)
Query: 77  ECNALRNIRHRNLIKIITIC-SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNG----QLR 131
           E   L++ +H N+I I  I   ++ +  F    +V + M++ +L Q +  S       +R
Sbjct: 104 ELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVR 162
Query: 132 -FLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGY 190
            FL Q +         ++Y H      ++H DLKPSN+L++++    +GD G+A+ L   
Sbjct: 163 YFLYQLLR-------GLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLC-- 210
Query: 191 EPGTAAETASNSIEIKGIVGYVAPEYGMG-SKASVSGDVYNFGILLLEMFTRRR 243
              + AE      E      Y APE  +   + + + D+++ G +  EM  RR+
Sbjct: 211 --TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 82/174 (47%), Gaps = 22/174 (12%)
Query: 77  ECNALRNIRHRNLIKIITIC-SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNG----QLR 131
           E   L++ +H N+I I  I   ++ +  F    +V + M++ +L Q +  S       +R
Sbjct: 103 ELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVR 161
Query: 132 -FLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGY 190
            FL Q +         ++Y H      ++H DLKPSN+L++++    +GD G+A+ L   
Sbjct: 162 YFLYQLLR-------GLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLC-- 209
Query: 191 EPGTAAETASNSIEIKGIVGYVAPEYGMG-SKASVSGDVYNFGILLLEMFTRRR 243
              + AE      E      Y APE  +   + + + D+++ G +  EM  RR+
Sbjct: 210 --TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 89/206 (43%), Gaps = 20/206 (9%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKI-ITIC 96
           IG G   +VY+  L +S  +VA+K V   ++  +R    E   +R + H N++++     
Sbjct: 56  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVRLRYFFY 111
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSF-AIEYFHHHCQ 155
           SS + +   +  +V +Y+           S  +       V + +   F ++ Y H    
Sbjct: 112 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-- 169
Query: 156 PSIVHGDLKPSNILLDQDI-VAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAP 214
             I H D+KP N+LLD D  V  + D G AK L   EP  +   +           Y AP
Sbjct: 170 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY---------YRAP 219
Query: 215 EYGMGSKASVSG-DVYNFGILLLEMF 239
           E   G+    S  DV++ G +L E+ 
Sbjct: 220 ELIFGATDYTSSIDVWSAGCVLAELL 245

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 89/204 (43%), Gaps = 27/204 (13%)
Query: 51  LDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNI-RHRNLIKIITICSSIDFEGFDF 106
           +D++ +   V V  LK+       R+  +E   L +I  H N++ ++  C+     G   
Sbjct: 51  IDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK---PGGPL 107
Query: 107 KAIVFEYMQNRNLEQWLRQSNGQL--------RFLT--QRVNIAIDVSFAIEYFHHHCQP 156
             IV E+ +  NL  +LR    +          FLT    +  +  V+  +E+       
Sbjct: 108 MVIV-EFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVAKGMEFL---ASR 163
Query: 157 SIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEY 216
             +H DL   NILL +  V  + D GLA+ +  Y+           + +K    ++APE 
Sbjct: 164 KXIHRDLAARNILLSEKNVVKIXDFGLARDI--YKDPDYVRKGDARLPLK----WMAPET 217
Query: 217 GMGSKASVSGDVYNFGILLLEMFT 240
                 ++  DV++FG+LL E+F+
Sbjct: 218 IFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 89/206 (43%), Gaps = 20/206 (9%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKI-ITIC 96
           IG G   +VY+  L +S  +VA+K V   ++  +R    E   +R + H N++++     
Sbjct: 33  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVRLRYFFY 88
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSF-AIEYFHHHCQ 155
           SS + +   +  +V +Y+           S  +       V + +   F ++ Y H    
Sbjct: 89  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-- 146
Query: 156 PSIVHGDLKPSNILLDQDI-VAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAP 214
             I H D+KP N+LLD D  V  + D G AK L   EP  +   +           Y AP
Sbjct: 147 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY---------YRAP 196
Query: 215 EYGMGSKASVSG-DVYNFGILLLEMF 239
           E   G+    S  DV++ G +L E+ 
Sbjct: 197 ELIFGATDYTSSIDVWSAGCVLAELL 222

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 89/206 (43%), Gaps = 20/206 (9%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKI-ITIC 96
           IG G   +VY+  L +S  +VA+K V   ++  +R    E   +R + H N++++     
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVRLRYFFY 117
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSF-AIEYFHHHCQ 155
           SS + +   +  +V +Y+           S  +       V + +   F ++ Y H    
Sbjct: 118 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-- 175
Query: 156 PSIVHGDLKPSNILLDQDI-VAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAP 214
             I H D+KP N+LLD D  V  + D G AK L   EP  +   +           Y AP
Sbjct: 176 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY---------YRAP 225
Query: 215 EYGMGSKASVSG-DVYNFGILLLEMF 239
           E   G+    S  DV++ G +L E+ 
Sbjct: 226 ELIFGATDYTSSIDVWSAGCVLAELL 251

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/216 (21%), Positives = 91/216 (42%), Gaps = 33/216 (15%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVN---LKQKEASRSFAAECNALRNIRHRNLIKIIT 94
           +G+GG +  Y+    +++ + A KVV    L +       + E    +++ + +++    
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 93
Query: 95  ICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLR-----FLTQRVNIAIDVSFAIEY 149
                 FE  DF  +V E  + R+L +  ++           F+ Q +         ++Y
Sbjct: 94  F-----FEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQ-------GVQY 141
Query: 150 FHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA-KFLFGYEPGTAAETASNSIEIKGI 208
            H++    ++H DLK  N+ L+ D+   +GD GLA K  F  E            ++ G 
Sbjct: 142 LHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGE---------RKKDLCGT 189
Query: 209 VGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
             Y+APE       S   D+++ G +L  +   + P
Sbjct: 190 PNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPP 225

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 89/206 (43%), Gaps = 20/206 (9%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKI-ITIC 96
           IG G   +VY+  L +S  +VA+K V   ++  +R    E   +R + H N++++     
Sbjct: 64  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVRLRYFFY 119
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSF-AIEYFHHHCQ 155
           SS + +   +  +V +Y+           S  +       V + +   F ++ Y H    
Sbjct: 120 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-- 177
Query: 156 PSIVHGDLKPSNILLDQDI-VAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAP 214
             I H D+KP N+LLD D  V  + D G AK L   EP  +   +           Y AP
Sbjct: 178 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY---------YRAP 227
Query: 215 EYGMGSKASVSG-DVYNFGILLLEMF 239
           E   G+    S  DV++ G +L E+ 
Sbjct: 228 ELIFGATDYTSSIDVWSAGCVLAELL 253

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 96/223 (43%), Gaps = 38/223 (17%)
Query: 32  FSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIK 91
           F+   KIG+G    V+KGI + ++ +VA+K+++L++ E                 +  I 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDI-----------QQEIT 72
Query: 92  IITICSS---IDFEGFDFKA----IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVS 144
           +++ C S     + G   K     I+ EY+   +    L    G L   TQ   I  ++ 
Sbjct: 73  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP--GPLD-ETQIATILREIL 129
Query: 145 FAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIE 204
             ++Y H   +   +H D+K +N+LL +      G++ LA F      G A +     I+
Sbjct: 130 KGLDYLHSEKK---IHRDIKAANVLLSEH-----GEVKLADF------GVAGQLTDTQIK 175
Query: 205 IKGIVG---YVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
               VG   ++APE    S      D+++ GI  +E+     P
Sbjct: 176 RNXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 46/208 (22%), Positives = 91/208 (43%), Gaps = 34/208 (16%)
Query: 52  DESRSIVAVKVVNLKQKEASRSFA---AECNALRNI-RHRNLIKIITICSSIDFEGFDFK 107
           D+ +  V V V  LK     +  +   +E   ++ I +H+N+I ++  C+    +G  + 
Sbjct: 62  DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ---DGPLY- 117
Query: 108 AIVFEYMQNRNLEQWLRQ---------------SNGQLRFLTQRVNIAIDVSFAIEYFHH 152
            ++  Y    NL ++LR                   Q+ F    V+    ++  +EY   
Sbjct: 118 -VIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF-KDLVSCTYQLARGMEYLAS 175
Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
                 +H DL   N+L+ ++ V  + D GLA+ +   +     +T +  + +K    ++
Sbjct: 176 Q---KCIHRDLAARNVLVTENNVMKIADFGLARDINNID--YYKKTTNGRLPVK----WM 226
Query: 213 APEYGMGSKASVSGDVYNFGILLLEMFT 240
           APE       +   DV++FG+L+ E+FT
Sbjct: 227 APEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 88/194 (45%), Gaps = 24/194 (12%)
Query: 58  VAVKVVNLKQKEAS--RSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQ 115
           VAVK+++  Q   +  +    E   ++ + H N++K+  +   I+ E   +  +V EY  
Sbjct: 43  VAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV---IETEKTLY--LVMEYAS 97
Query: 116 NRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIV 175
              +  +L  ++G+++    R      VS A++Y H   Q  IVH DLK  N+LLD D+ 
Sbjct: 98  GGEVFDYL-VAHGRMKEKEARAKFRQIVS-AVQYCH---QKYIVHRDLKAENLLLDGDMN 152
Query: 176 AHVGDLGLA-KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKAS-VSGDVYNFGI 233
             + D G + +F  G +  T            G   Y APE   G K      DV++ G+
Sbjct: 153 IKIADFGFSNEFTVGNKLDTFC----------GSPPYAAPELFQGKKYDGPEVDVWSLGV 202
Query: 234 LLLEMFTRRRPTDA 247
           +L  + +   P D 
Sbjct: 203 ILYTLVSGSLPFDG 216

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 96/223 (43%), Gaps = 38/223 (17%)
Query: 32  FSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIK 91
           F+   KIG+G    V+KGI + ++ +VA+K+++L++ E                 +  I 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDI-----------QQEIT 77
Query: 92  IITICSS---IDFEGFDFKA----IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVS 144
           +++ C S     + G   K     I+ EY+   +    L    G L   TQ   I  ++ 
Sbjct: 78  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP--GPLD-ETQIATILREIL 134
Query: 145 FAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIE 204
             ++Y H   +   +H D+K +N+LL +      G++ LA F      G A +     I+
Sbjct: 135 KGLDYLHSEKK---IHRDIKAANVLLSEH-----GEVKLADF------GVAGQLTDTQIK 180
Query: 205 IKGIVG---YVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
               VG   ++APE    S      D+++ GI  +E+     P
Sbjct: 181 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 223

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 96/223 (43%), Gaps = 38/223 (17%)
Query: 32  FSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIK 91
           F+   KIG+G    V+KGI + ++ +VA+K+++L++ E                 +  I 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDI-----------QQEIT 57
Query: 92  IITICSS---IDFEGFDFK----AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVS 144
           +++ C S     + G   K     I+ EY+   +    L    G L   TQ   I  ++ 
Sbjct: 58  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP--GPLD-ETQIATILREIL 114
Query: 145 FAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIE 204
             ++Y H   +   +H D+K +N+LL +      G++ LA F      G A +     I+
Sbjct: 115 KGLDYLHSEKK---IHRDIKAANVLLSEH-----GEVKLADF------GVAGQLTDTQIK 160
Query: 205 IKGIVG---YVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
               VG   ++APE    S      D+++ GI  +E+     P
Sbjct: 161 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 203

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 96/223 (43%), Gaps = 38/223 (17%)
Query: 32  FSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIK 91
           F+   KIG+G    V+KGI + ++ +VA+K+++L++ E                 +  I 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDI-----------QQEIT 57
Query: 92  IITICSS---IDFEGFDFK----AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVS 144
           +++ C S     + G   K     I+ EY+   +    L    G L   TQ   I  ++ 
Sbjct: 58  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP--GPLD-ETQIATILREIL 114
Query: 145 FAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIE 204
             ++Y H   +   +H D+K +N+LL +      G++ LA F      G A +     I+
Sbjct: 115 KGLDYLHSEKK---IHRDIKAANVLLSEH-----GEVKLADF------GVAGQLTDTQIK 160
Query: 205 IKGIVG---YVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
               VG   ++APE    S      D+++ GI  +E+     P
Sbjct: 161 RNXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 203

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 89/206 (43%), Gaps = 20/206 (9%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKI-ITIC 96
           IG G   +VY+  L +S  +VA+K V   ++  +R    E   +R + H N++++     
Sbjct: 107 IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVRLRYFFY 162
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSF-AIEYFHHHCQ 155
           SS + +   +  +V +Y+           S  +       V + +   F ++ Y H    
Sbjct: 163 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-- 220
Query: 156 PSIVHGDLKPSNILLDQDI-VAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAP 214
             I H D+KP N+LLD D  V  + D G AK L   EP  +   +           Y AP
Sbjct: 221 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY---------YRAP 270
Query: 215 EYGMGSKASVSG-DVYNFGILLLEMF 239
           E   G+    S  DV++ G +L E+ 
Sbjct: 271 ELIFGATDYTSSIDVWSAGCVLAELL 296

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 53/226 (23%), Positives = 98/226 (43%), Gaps = 16/226 (7%)
Query: 36  NKIGQGGVSIV--YKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKII 93
            K+G+GG S V   +G+ D      A+K +   +++       E +  R   H N+++++
Sbjct: 35  QKLGEGGFSYVDLVEGLHDGH--FYALKRILCHEQQDREEAQREADMHRLFNHPNILRLV 92
Query: 94  TICSSIDFEGFDFKA-IVFEYMQNRNLEQWLRQSNGQLRFLT--QRVNIAIDVSFAIEYF 150
             C  +   G   +A ++  + +   L   + +   +  FLT  Q + + + +   +E  
Sbjct: 93  AYC--LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAI 150
Query: 151 HHHCQPSIVHGDLKPSNILLDQDIVAHVGDLG-LAKFLFGYEPGTAAETASNSIEIKGIV 209
           H        H DLKP+NILL  +    + DLG + +     E    A T  +    +  +
Sbjct: 151 H---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207
Query: 210 GYVAPE-YGMGSKASVS--GDVYNFGILLLEMFTRRRPTDAMFNEG 252
            Y APE + + S   +    DV++ G +L  M     P D +F +G
Sbjct: 208 SYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG 253

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 89/206 (43%), Gaps = 20/206 (9%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKI-ITIC 96
           IG G   +VY+  L +S  +VA+K V   ++  +R    E   +R + H N++++     
Sbjct: 66  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVRLRYFFY 121
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSF-AIEYFHHHCQ 155
           SS + +   +  +V +Y+           S  +       V + +   F ++ Y H    
Sbjct: 122 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-- 179
Query: 156 PSIVHGDLKPSNILLDQDI-VAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAP 214
             I H D+KP N+LLD D  V  + D G AK L   EP  +   +           Y AP
Sbjct: 180 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY---------YRAP 229
Query: 215 EYGMGSKASVSG-DVYNFGILLLEMF 239
           E   G+    S  DV++ G +L E+ 
Sbjct: 230 ELIFGATDYTSSIDVWSAGCVLAELL 255

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 68/143 (47%), Gaps = 27/143 (18%)
Query: 108 AIVFEYMQNRNLEQWLRQS--NGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKP 165
           A+VFE++ N + +Q LRQ+  +  +RF    +  A+D   ++          I+H D+KP
Sbjct: 110 ALVFEHVNNTDFKQ-LRQTLTDYDIRFYMYEILKALDYCHSM---------GIMHRDVKP 159
Query: 166 SNILLDQDIVA-HVGDLGLAKFLFGYEPGTAAETASNSIEIKG---IVGYVAPEYGMGSK 221
            N+++D +     + D GLA+F   Y PG        S   KG   +V Y   +Y +   
Sbjct: 160 HNVMIDHEHRKLRLIDWGLAEF---YHPGQEYNVRVASRYFKGPELLVDYQMYDYSL--- 213
Query: 222 ASVSGDVYNFGILLLEMFTRRRP 244
                D+++ G +L  M  R+ P
Sbjct: 214 -----DMWSLGCMLASMIFRKEP 231

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 47/206 (22%), Positives = 87/206 (42%), Gaps = 21/206 (10%)
Query: 38  IGQGGVSIVYKGIL---DESRSIVAVKVV-NLKQKEASRSFAAECNALRNIRHRNLIKII 93
           IG+G    V++GI    +     VA+K   N         F  E   +R   H +++K+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 94  TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHH 153
            + +       +   I+ E      L  +L+     L  L   +  A  +S A+ Y    
Sbjct: 78  GVITE------NPVWIIMELCTLGELRSFLQVRKYSLD-LASLILYAYQLSTALAYLESK 130
Query: 154 CQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVA 213
                VH D+   N+L+  +    +GD GL++++   E  T  + +   + IK    ++A
Sbjct: 131 ---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYKASKGKLPIK----WMA 180
Query: 214 PEYGMGSKASVSGDVYNFGILLLEMF 239
           PE     + + + DV+ FG+ + E+ 
Sbjct: 181 PESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 59/239 (24%), Positives = 95/239 (39%), Gaps = 34/239 (14%)
Query: 14  KQQFPMISYAELSKATNN-FSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASR 72
           ++Q   +    L+K     F    K+G+G    VYK I  E+  IVA+K V         
Sbjct: 12  RRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV--------- 62
Query: 73  SFAAECNALRNIRHRNLIKIITICSS---IDFEGFDFK----AIVFEYMQNRNLEQWLRQ 125
               E +    I+    I I+  C S   + + G  FK     IV EY    ++   +R 
Sbjct: 63  --PVESDLQEIIKE---ISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRL 117
Query: 126 SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAK 185
            N  L    +   I       +EY H   +   +H D+K  NILL+ +  A + D G+A 
Sbjct: 118 RNKTLT-EDEIATILQSTLKGLEYLHFMRK---IHRDIKAGNILLNTEGHAKLADFGVA- 172
Query: 186 FLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
                  G   +  +    + G   ++APE       +   D+++ GI  +EM   + P
Sbjct: 173 -------GQLTDXMAKRNXVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 88/196 (44%), Gaps = 26/196 (13%)
Query: 58  VAVKVVNLKQKEAS--RSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQ 115
           VAVK+++  Q  +S  +    E    + + H N++K+  +   I+ E   +  +V EY  
Sbjct: 42  VAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEV---IETEKTLY--LVXEYAS 96
Query: 116 NRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIV 175
              +  +L  ++G+ +    R      VS A++Y H   Q  IVH DLK  N+LLD D  
Sbjct: 97  GGEVFDYL-VAHGRXKEKEARAKFRQIVS-AVQYCH---QKFIVHRDLKAENLLLDADXN 151
Query: 176 AHVGDLGLA-KFLFGYEPGTAAETASNSIE-IKGIVGYVAPEYGMGSKAS-VSGDVYNFG 232
             + D G + +F FG           N ++   G   Y APE   G K      DV++ G
Sbjct: 152 IKIADFGFSNEFTFG-----------NKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLG 200
Query: 233 ILLLEMFTRRRPTDAM 248
           ++L  + +   P D  
Sbjct: 201 VILYTLVSGSLPFDGQ 216

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 46/208 (22%), Positives = 91/208 (43%), Gaps = 34/208 (16%)
Query: 52  DESRSIVAVKVVNLKQKEASRSFA---AECNALRNI-RHRNLIKIITICSSIDFEGFDFK 107
           D+ +  V V V  LK     +  +   +E   ++ I +H+N+I ++  C+    +G  + 
Sbjct: 62  DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ---DGPLY- 117
Query: 108 AIVFEYMQNRNLEQWLRQ---------------SNGQLRFLTQRVNIAIDVSFAIEYFHH 152
            ++  Y    NL ++LR                   Q+ F    V+    ++  +EY   
Sbjct: 118 -VIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF-KDLVSCTYQLARGMEYLAS 175
Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
                 +H DL   N+L+ ++ V  + D GLA+ +   +     +T +  + +K    ++
Sbjct: 176 Q---KCIHRDLAARNVLVTENNVMKIADFGLARDINNID--YYKKTTNGRLPVK----WM 226
Query: 213 APEYGMGSKASVSGDVYNFGILLLEMFT 240
           APE       +   DV++FG+L+ E+FT
Sbjct: 227 APEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 92/221 (41%), Gaps = 40/221 (18%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVN----LKQKEASRSFAAECNALRNIRHRNLIKI 92
           K G G V  V K     +  I A+KV+     ++  + +    AE N L  ++H  ++ +
Sbjct: 27  KGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDL 86
Query: 93  ITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAID---------V 143
           I       F+      ++ EY+           S G+L    +R  I ++         +
Sbjct: 87  IYA-----FQTGGKLYLILEYL-----------SGGELFMQLEREGIFMEDTACFYLAEI 130
Query: 144 SFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSI 203
           S A+ + H   Q  I++ DLKP NI+L+      + D GL K       GT       +I
Sbjct: 131 SMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHXFCGTI 185
Query: 204 EIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
           E      Y+APE  M S  + + D ++ G L+ +M T   P
Sbjct: 186 E------YMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 47/211 (22%), Positives = 89/211 (42%), Gaps = 25/211 (11%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           KIGQG    VY  +   +   VA++ +NL+Q+        E   +R  ++ N++  +   
Sbjct: 28  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD-- 85
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQS---NGQLRFLTQRVNIAIDVSFAIEYFHHH 153
               +   D   +V EY+   +L   + ++    GQ+  + +      +   A+E+ H +
Sbjct: 86  ---SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR------ECLQALEFLHSN 136
Query: 154 CQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVA 213
               ++H ++K  NILL  D    + D       FG+      E +  S  + G   ++A
Sbjct: 137 ---QVIHRNIKSDNILLGMDGSVKLTD-------FGFCAQITPEQSKRSTMV-GTPYWMA 185
Query: 214 PEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
           PE           D+++ GI+ +EM     P
Sbjct: 186 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 92/223 (41%), Gaps = 47/223 (21%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICS 97
           +G+GG +  Y+    +++ + A KVV             +   L+  +   +   I I  
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVV------------PKSMLLKPHQKEKMSTEIAIHK 97
Query: 98  SID------FEGF----DFKAIVFEYMQNRNLEQWLRQSNGQLR-----FLTQRVNIAID 142
           S+D      F GF    DF  +V E  + R+L +  ++           F+ Q +     
Sbjct: 98  SLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQ---- 153
Query: 143 VSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA-KFLFGYEPGTAAETASN 201
               ++Y H++    ++H DLK  N+ L+ D+   +GD GLA K  F    G   +T   
Sbjct: 154 ---GVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFD---GERKKT--- 201
Query: 202 SIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
              + G   Y+APE       S   D+++ G +L  +   + P
Sbjct: 202 ---LCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 89/204 (43%), Gaps = 27/204 (13%)
Query: 51  LDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNI-RHRNLIKIITICSSIDFEGFDF 106
           +D++ +   V V  LK+       R+  +E   L +I  H N++ ++  C+     G   
Sbjct: 51  IDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK---PGGPL 107
Query: 107 KAIVFEYMQNRNLEQWLRQSNGQL--------RFLT--QRVNIAIDVSFAIEYFHHHCQP 156
             IV E+ +  NL  +LR    +          FLT    +  +  V+  +E+       
Sbjct: 108 MVIV-EFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVAKGMEFL---ASR 163
Query: 157 SIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEY 216
             +H DL   NILL +  V  + D GLA+ +  Y+           + +K    ++APE 
Sbjct: 164 KXIHRDLAARNILLSEKNVVKICDFGLARDI--YKDPDYVRKGDARLPLK----WMAPET 217
Query: 217 GMGSKASVSGDVYNFGILLLEMFT 240
                 ++  DV++FG+LL E+F+
Sbjct: 218 IFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 90/223 (40%), Gaps = 47/223 (21%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICS 97
           +G+GG +  Y+    +++ + A KVV             +   L+  +   +   I I  
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVV------------PKSMLLKPHQKEKMSTEIAIHK 97
Query: 98  SID------FEGF----DFKAIVFEYMQNRNLEQWLRQSNGQLR-----FLTQRVNIAID 142
           S+D      F GF    DF  +V E  + R+L +  ++           F+ Q +     
Sbjct: 98  SLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQ---- 153
Query: 143 VSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA-KFLFGYEPGTAAETASN 201
               ++Y H++    ++H DLK  N+ L+ D+   +GD GLA K  F  E          
Sbjct: 154 ---GVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGE---------R 198
Query: 202 SIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
              + G   Y+APE       S   D+++ G +L  +   + P
Sbjct: 199 KKXLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/206 (22%), Positives = 87/206 (42%), Gaps = 21/206 (10%)
Query: 38  IGQGGVSIVYKGIL---DESRSIVAVKVV-NLKQKEASRSFAAECNALRNIRHRNLIKII 93
           IG+G    V++GI    +     VA+K   N         F  E   +R   H +++K+I
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 94  TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHH 153
            + +       +   I+ E      L  +L+     L  L   +  A  +S A+ Y    
Sbjct: 75  GVITE------NPVWIIMELCTLGELRSFLQVRKYSLD-LASLILYAYQLSTALAYLESK 127
Query: 154 CQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVA 213
                VH D+   N+L+  +    +GD GL++++   E  T  + +   + IK    ++A
Sbjct: 128 ---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYKASKGKLPIK----WMA 177
Query: 214 PEYGMGSKASVSGDVYNFGILLLEMF 239
           PE     + + + DV+ FG+ + E+ 
Sbjct: 178 PESINFRRFTSASDVWMFGVCMWEIL 203

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/206 (22%), Positives = 87/206 (42%), Gaps = 21/206 (10%)
Query: 38  IGQGGVSIVYKGIL---DESRSIVAVKVV-NLKQKEASRSFAAECNALRNIRHRNLIKII 93
           IG+G    V++GI    +     VA+K   N         F  E   +R   H +++K+I
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 94  TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHH 153
            + +       +   I+ E      L  +L+     L  L   +  A  +S A+ Y    
Sbjct: 106 GVITE------NPVWIIMELCTLGELRSFLQVRKYSLD-LASLILYAYQLSTALAYLESK 158
Query: 154 CQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVA 213
                VH D+   N+L+  +    +GD GL++++   E  T  + +   + IK    ++A
Sbjct: 159 ---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYKASKGKLPIK----WMA 208
Query: 214 PEYGMGSKASVSGDVYNFGILLLEMF 239
           PE     + + + DV+ FG+ + E+ 
Sbjct: 209 PESINFRRFTSASDVWMFGVCMWEIL 234

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 92/211 (43%), Gaps = 22/211 (10%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVN-LKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           IG+G   +V     + ++  VA+K ++  + +   +    E   L   RH N+I I  I 
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQ---SNGQL-RFLTQRVNIAIDVSFAIEYFHH 152
            +   E      +V  ++   +L + L+    SN  +  FL Q       +   ++Y H 
Sbjct: 111 RAPTIEQMKDVYLV-THLMGADLYKLLKTQHLSNDHICYFLYQ-------ILRGLKYIH- 161
Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
               +++H DLKPSN+LL+      + D GLA+        T   T     E      Y 
Sbjct: 162 --SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLT-----EYVATRWYR 214
Query: 213 APEYGMGSKA-SVSGDVYNFGILLLEMFTRR 242
           APE  + SK  + S D+++ G +L EM + R
Sbjct: 215 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/206 (22%), Positives = 87/206 (42%), Gaps = 21/206 (10%)
Query: 38  IGQGGVSIVYKGIL---DESRSIVAVKVV-NLKQKEASRSFAAECNALRNIRHRNLIKII 93
           IG+G    V++GI    +     VA+K   N         F  E   +R   H +++K+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 94  TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHH 153
            + +       +   I+ E      L  +L+     L  L   +  A  +S A+ Y    
Sbjct: 78  GVITE------NPVWIIMELCTLGELRSFLQVRKYSLD-LASLILYAYQLSTALAYLESK 130
Query: 154 CQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVA 213
                VH D+   N+L+  +    +GD GL++++   E  T  + +   + IK    ++A
Sbjct: 131 ---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYKASKGKLPIK----WMA 180
Query: 214 PEYGMGSKASVSGDVYNFGILLLEMF 239
           PE     + + + DV+ FG+ + E+ 
Sbjct: 181 PESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/206 (22%), Positives = 87/206 (42%), Gaps = 21/206 (10%)
Query: 38  IGQGGVSIVYKGIL---DESRSIVAVKVV-NLKQKEASRSFAAECNALRNIRHRNLIKII 93
           IG+G    V++GI    +     VA+K   N         F  E   +R   H +++K+I
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 94  TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHH 153
            + +       +   I+ E      L  +L+     L  L   +  A  +S A+ Y    
Sbjct: 83  GVITE------NPVWIIMELCTLGELRSFLQVRKYSLD-LASLILYAYQLSTALAYLESK 135
Query: 154 CQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVA 213
                VH D+   N+L+  +    +GD GL++++   E  T  + +   + IK    ++A
Sbjct: 136 ---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYKASKGKLPIK----WMA 185
Query: 214 PEYGMGSKASVSGDVYNFGILLLEMF 239
           PE     + + + DV+ FG+ + E+ 
Sbjct: 186 PESINFRRFTSASDVWMFGVCMWEIL 211

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/206 (22%), Positives = 87/206 (42%), Gaps = 21/206 (10%)
Query: 38  IGQGGVSIVYKGIL---DESRSIVAVKVV-NLKQKEASRSFAAECNALRNIRHRNLIKII 93
           IG+G    V++GI    +     VA+K   N         F  E   +R   H +++K+I
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 94  TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHH 153
            + +       +   I+ E      L  +L+     L  L   +  A  +S A+ Y    
Sbjct: 80  GVITE------NPVWIIMELCTLGELRSFLQVRKYSLD-LASLILYAYQLSTALAYLESK 132
Query: 154 CQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVA 213
                VH D+   N+L+  +    +GD GL++++   E  T  + +   + IK    ++A
Sbjct: 133 ---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYKASKGKLPIK----WMA 182
Query: 214 PEYGMGSKASVSGDVYNFGILLLEMF 239
           PE     + + + DV+ FG+ + E+ 
Sbjct: 183 PESINFRRFTSASDVWMFGVCMWEIL 208

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 88/194 (45%), Gaps = 24/194 (12%)
Query: 58  VAVKVVNLKQKEAS--RSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQ 115
           VA+K+++  Q   +  +    E   ++ + H N++K+  +   I+ E   +  ++ EY  
Sbjct: 40  VAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV---IETEKTLY--LIMEYAS 94
Query: 116 NRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIV 175
              +  +L  ++G+++    R      VS A++Y H   Q  IVH DLK  N+LLD D+ 
Sbjct: 95  GGEVFDYL-VAHGRMKEKEARSKFRQIVS-AVQYCH---QKRIVHRDLKAENLLLDADMN 149
Query: 176 AHVGDLGLA-KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSK-ASVSGDVYNFGI 233
             + D G + +F  G +  T            G   Y APE   G K      DV++ G+
Sbjct: 150 IKIADFGFSNEFTVGGKLDTFC----------GSPPYAAPELFQGKKYDGPEVDVWSLGV 199
Query: 234 LLLEMFTRRRPTDA 247
           +L  + +   P D 
Sbjct: 200 ILYTLVSGSLPFDG 213

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 89/208 (42%), Gaps = 31/208 (14%)
Query: 51  LDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNI-RHRNLIKIITICSSIDFEGFDF 106
           +D++ +   V V  LK+       R+  +E   L +I  H N++ ++  C+     G   
Sbjct: 51  IDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK---PGGPL 107
Query: 107 KAIVFEYMQNRNLEQWLRQSNGQL------------RFLT--QRVNIAIDVSFAIEYFHH 152
             IV E+ +  NL  +LR    +              FLT    +  +  V+  +E+   
Sbjct: 108 MVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS 166
Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
                 +H DL   NILL +  V  + D GLA+ +  Y+           + +K    ++
Sbjct: 167 R---KCIHRDLAARNILLSEKNVVKICDFGLARDI--YKDPDXVRKGDARLPLK----WM 217
Query: 213 APEYGMGSKASVSGDVYNFGILLLEMFT 240
           APE       ++  DV++FG+LL E+F+
Sbjct: 218 APETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/236 (25%), Positives = 99/236 (41%), Gaps = 33/236 (13%)
Query: 13  MKQQFPMISYAELS----KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK 68
           M  QF  +  A+ +    K      P     QG V   +  +L  + ++  +      Q 
Sbjct: 4   MDSQFYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQT 63
Query: 69  EASRSFAAECNALRNIRHRNLIKIITICSSID-FEGFDFKAIVFEYMQNRNLEQWLRQSN 127
            A R++  E   L+ + H+N+I ++ + +     E F    +V E M + NL Q +    
Sbjct: 64  HAKRAYR-ELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIHMEL 121
Query: 128 GQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL 187
              R       +   +   I++ H      I+H DLKPSNI++  D    + D GLA+  
Sbjct: 122 DHERM----SYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-- 172
Query: 188 FGYEPGTAAETASNSIEIKGIV---GYVAPE--YGMGSKASVSGDVYNFGILLLEM 238
                     TAS +  +   V    Y APE   GMG K +V  D+++ G ++ E+
Sbjct: 173 ----------TASTNFMMTPYVVTRYYRAPEVILGMGYKENV--DIWSVGCIMGEL 216

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/206 (22%), Positives = 87/206 (42%), Gaps = 21/206 (10%)
Query: 38  IGQGGVSIVYKGIL---DESRSIVAVKVV-NLKQKEASRSFAAECNALRNIRHRNLIKII 93
           IG+G    V++GI    +     VA+K   N         F  E   +R   H +++K+I
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 94  TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHH 153
            + +       +   I+ E      L  +L+     L  L   +  A  +S A+ Y    
Sbjct: 81  GVITE------NPVWIIMELCTLGELRSFLQVRKYSLD-LASLILYAYQLSTALAYLESK 133
Query: 154 CQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVA 213
                VH D+   N+L+  +    +GD GL++++   E  T  + +   + IK    ++A
Sbjct: 134 ---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYKASKGKLPIK----WMA 183
Query: 214 PEYGMGSKASVSGDVYNFGILLLEMF 239
           PE     + + + DV+ FG+ + E+ 
Sbjct: 184 PESINFRRFTSASDVWMFGVCMWEIL 209

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 88/206 (42%), Gaps = 20/206 (9%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKI-ITIC 96
           IG G   +VY+  L +S  +VA+K V   +   +R    E   +R + H N++++     
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR----ELQIMRKLDHCNIVRLRYFFY 83
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSF-AIEYFHHHCQ 155
           SS + +   +  +V +Y+           S  +       V + +   F ++ Y H    
Sbjct: 84  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-- 141
Query: 156 PSIVHGDLKPSNILLDQDI-VAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAP 214
             I H D+KP N+LLD D  V  + D G AK L   EP  +   +           Y AP
Sbjct: 142 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY---------YRAP 191
Query: 215 EYGMGSKASVSG-DVYNFGILLLEMF 239
           E   G+    S  DV++ G +L E+ 
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 88/206 (42%), Gaps = 20/206 (9%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKI-ITIC 96
           IG G   +VY+  L +S  +VA+K V   +   +R    E   +R + H N++++     
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR----ELQIMRKLDHCNIVRLRYFFY 83
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSF-AIEYFHHHCQ 155
           SS + +   +  +V +Y+           S  +       V + +   F ++ Y H    
Sbjct: 84  SSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-- 141
Query: 156 PSIVHGDLKPSNILLDQDI-VAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAP 214
             I H D+KP N+LLD D  V  + D G AK L   EP  +   +           Y AP
Sbjct: 142 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY---------YRAP 191
Query: 215 EYGMGSKASVSG-DVYNFGILLLEMF 239
           E   G+    S  DV++ G +L E+ 
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 88/206 (42%), Gaps = 20/206 (9%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKI-ITIC 96
           IG G   +VY+  L +S  +VA+K V   +   +R    E   +R + H N++++     
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR----ELQIMRKLDHCNIVRLRYFFY 83
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSF-AIEYFHHHCQ 155
           SS + +   +  +V +Y+           S  +       V + +   F ++ Y H    
Sbjct: 84  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-- 141
Query: 156 PSIVHGDLKPSNILLDQDI-VAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAP 214
             I H D+KP N+LLD D  V  + D G AK L   EP  +   +           Y AP
Sbjct: 142 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY---------YRAP 191
Query: 215 EYGMGSKASVSG-DVYNFGILLLEMF 239
           E   G+    S  DV++ G +L E+ 
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/206 (22%), Positives = 86/206 (41%), Gaps = 21/206 (10%)
Query: 38  IGQGGVSIVYKGIL---DESRSIVAVKVV-NLKQKEASRSFAAECNALRNIRHRNLIKII 93
           IG+G    V++GI    +     VA+K   N         F  E   +R   H +++K+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 94  TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHH 153
            + +       +   I+ E      L  +L+     L  L   +  A  +S A+ Y    
Sbjct: 78  GVITE------NPVWIIMELCTLGELRSFLQVRKFSLD-LASLILYAYQLSTALAYLESK 130
Query: 154 CQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVA 213
                VH D+   N+L+       +GD GL++++   E  T  + +   + IK    ++A
Sbjct: 131 ---RFVHRDIAARNVLVSATDCVKLGDFGLSRYM---EDSTYYKASKGKLPIK----WMA 180
Query: 214 PEYGMGSKASVSGDVYNFGILLLEMF 239
           PE     + + + DV+ FG+ + E+ 
Sbjct: 181 PESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/206 (22%), Positives = 87/206 (42%), Gaps = 21/206 (10%)
Query: 38  IGQGGVSIVYKGIL---DESRSIVAVKVV-NLKQKEASRSFAAECNALRNIRHRNLIKII 93
           IG+G    V++GI    +     VA+K   N         F  E   +R   H +++K+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 94  TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHH 153
            + +       +   I+ E      L  +L+     L  L   +  A  +S A+ Y    
Sbjct: 458 GVITE------NPVWIIMELCTLGELRSFLQVRKFSLD-LASLILYAYQLSTALAYLESK 510
Query: 154 CQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVA 213
                VH D+   N+L+  +    +GD GL++++   E  T  + +   + IK    ++A
Sbjct: 511 ---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYKASKGKLPIK----WMA 560
Query: 214 PEYGMGSKASVSGDVYNFGILLLEMF 239
           PE     + + + DV+ FG+ + E+ 
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/233 (22%), Positives = 99/233 (42%), Gaps = 30/233 (12%)
Query: 23  AELSK---ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVV---NLKQKEASRSFAA 76
           AE+ K     ++F     +G+G    VY     +++ I+A+KV+    L+++        
Sbjct: 5   AEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRR 64
Query: 77  ECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQR 136
           E     ++RH N++++        F       ++ E+     L + L Q +G  RF  QR
Sbjct: 65  EIEIQSHLRHPNILRMYNY-----FHDRKRIYLMLEFAPRGELYKEL-QKHG--RFDEQR 116
Query: 137 -VNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTA 195
                 +++ A+ Y H   +  ++H D+KP N+L+      + G+L +A F      G +
Sbjct: 117 SATFMEELADALHYCH---ERKVIHRDIKPENLLM-----GYKGELKIADF------GWS 162
Query: 196 AETAS-NSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDA 247
               S     + G + Y+ PE   G       D++  G+L  E      P D+
Sbjct: 163 VHAPSLRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS 215

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 74/165 (44%), Gaps = 26/165 (15%)
Query: 77  ECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQN---RNLEQWLRQSNGQLRFL 133
           E   L+ + H N++K++ +   +D    D   +VFE +       +      S  Q RF 
Sbjct: 86  EIAILKKLDHPNVVKLVEV---LDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFY 142
Query: 134 TQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPG 193
            Q      D+   IEY H+     I+H D+KPSN+L+ +D    + D G++    G    
Sbjct: 143 FQ------DLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG---- 189
Query: 194 TAAETASNSIEIKGIVGYVAPEYGMGSKASVSG---DVYNFGILL 235
            +    SN++   G   ++APE    ++   SG   DV+  G+ L
Sbjct: 190 -SDALLSNTV---GTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 89/208 (42%), Gaps = 31/208 (14%)
Query: 51  LDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNI-RHRNLIKIITICSSIDFEGFDF 106
           +D++ +   V V  LK+       R+  +E   L +I  H N++ ++  C+     G   
Sbjct: 51  IDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK---PGGPL 107
Query: 107 KAIVFEYMQNRNLEQWLRQSNGQL------------RFLT--QRVNIAIDVSFAIEYFHH 152
             IV E+ +  NL  +LR    +              FLT    +  +  V+  +E+   
Sbjct: 108 MVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS 166
Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
                 +H DL   NILL +  V  + D GLA+ +  Y+           + +K    ++
Sbjct: 167 R---KCIHRDLAARNILLSEKNVVKICDFGLARDI--YKDPDYVRKGDARLPLK----WM 217
Query: 213 APEYGMGSKASVSGDVYNFGILLLEMFT 240
           APE       ++  DV++FG+LL E+F+
Sbjct: 218 APETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 97/220 (44%), Gaps = 30/220 (13%)
Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNL 89
           +++    K+G+G  S V++ I   +   VAVK++   +K+  +        LR       
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVAVKILKPVKKKKIKREIKILENLRGG----- 91
Query: 90  IKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQ-SNGQLRFLTQRVNIAIDVSFAIE 148
             IIT+   +        A+VFE++ N + +Q  +  ++  +RF    +  A+D   ++ 
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSM- 150
Query: 149 YFHHHCQPSIVHGDLKPSNILLDQDIVA-HVGDLGLAKFLFGYEPGTAAETASNSIEIKG 207
                    I+H D+KP N+L+D +     + D GLA+F   Y PG        S   KG
Sbjct: 151 --------GIMHRDVKPHNVLIDHEHRKLRLIDWGLAEF---YHPGQEYNVRVASRYFKG 199
Query: 208 ---IVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
              +V Y   +Y +        D+++ G +L  M  R+ P
Sbjct: 200 PELLVDYQMYDYSL--------DMWSLGCMLASMIFRKEP 231

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/233 (22%), Positives = 99/233 (42%), Gaps = 30/233 (12%)
Query: 23  AELSK---ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVV---NLKQKEASRSFAA 76
           AE+ K     ++F     +G+G    VY     +++ I+A+KV+    L+++        
Sbjct: 4   AEMPKRKFTIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRR 63
Query: 77  ECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQR 136
           E     ++RH N++++        F       ++ E+     L + L Q +G  RF  QR
Sbjct: 64  EIEIQSHLRHPNILRMYNY-----FHDRKRIYLMLEFAPRGELYKEL-QKHG--RFDEQR 115
Query: 137 -VNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTA 195
                 +++ A+ Y H   +  ++H D+KP N+L+      + G+L +A F      G +
Sbjct: 116 SATFMEELADALHYCH---ERKVIHRDIKPENLLM-----GYKGELKIADF------GWS 161
Query: 196 AETAS-NSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDA 247
               S     + G + Y+ PE   G       D++  G+L  E      P D+
Sbjct: 162 VHAPSLRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS 214

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 89/208 (42%), Gaps = 31/208 (14%)
Query: 51  LDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNI-RHRNLIKIITICSSIDFEGFDF 106
           +D++ +   V V  LK+       R+  +E   L +I  H N++ ++  C+     G   
Sbjct: 88  IDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK---PGGPL 144
Query: 107 KAIVFEYMQNRNLEQWLRQSNGQL------------RFLT--QRVNIAIDVSFAIEYFHH 152
             IV E+ +  NL  +LR    +              FLT    +  +  V+  +E+   
Sbjct: 145 MVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS 203
Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
                 +H DL   NILL +  V  + D GLA+ +  Y+           + +K    ++
Sbjct: 204 R---KCIHRDLAARNILLSEKNVVKICDFGLARDI--YKDPDYVRKGDARLPLK----WM 254
Query: 213 APEYGMGSKASVSGDVYNFGILLLEMFT 240
           APE       ++  DV++FG+LL E+F+
Sbjct: 255 APETIFDRVYTIQSDVWSFGVLLWEIFS 282

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 91/206 (44%), Gaps = 19/206 (9%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICS 97
           IG+G    V K    +    VA+K+V   +K   R  A E   L ++R ++    + +  
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVR-NEKRFHRQAAEEIRILEHLRKQDKDNTMNVIH 163
Query: 98  SIDFEGFDFK---AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHC 154
            +  E F F+    + FE + + NL + ++++  Q   L      A  +   ++  H + 
Sbjct: 164 ML--ENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN- 219
Query: 155 QPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAP 214
              I+H DLKP NILL Q      G  G+    FG    +  E       I+    Y AP
Sbjct: 220 --RIIHCDLKPENILLKQQ-----GRSGIKVIDFG---SSCYEHQRVYTXIQSRF-YRAP 268
Query: 215 EYGMGSKASVSGDVYNFGILLLEMFT 240
           E  +G++  +  D+++ G +L E+ T
Sbjct: 269 EVILGARYGMPIDMWSLGCILAELLT 294

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 89/208 (42%), Gaps = 31/208 (14%)
Query: 51  LDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNI-RHRNLIKIITICSSIDFEGFDF 106
           +D++ +   V V  LK+       R+  +E   L +I  H N++ ++  C+     G   
Sbjct: 53  IDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK---PGGPL 109
Query: 107 KAIVFEYMQNRNLEQWLRQSNGQL------------RFLT--QRVNIAIDVSFAIEYFHH 152
             IV E+ +  NL  +LR    +              FLT    +  +  V+  +E+   
Sbjct: 110 MVIV-EFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS 168
Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
                 +H DL   NILL +  V  + D GLA+ +  Y+           + +K    ++
Sbjct: 169 R---KCIHRDLAARNILLSEKNVVKICDFGLARDI--YKDPDYVRKGDARLPLK----WM 219
Query: 213 APEYGMGSKASVSGDVYNFGILLLEMFT 240
           APE       ++  DV++FG+LL E+F+
Sbjct: 220 APETIFDRVYTIQSDVWSFGVLLWEIFS 247

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 91/206 (44%), Gaps = 19/206 (9%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICS 97
           IG+G    V K    +    VA+K+V   +K   R  A E   L ++R ++    + +  
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVR-NEKRFHRQAAEEIRILEHLRKQDKDNTMNVIH 163
Query: 98  SIDFEGFDFK---AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHC 154
            +  E F F+    + FE + + NL + ++++  Q   L      A  +   ++  H + 
Sbjct: 164 ML--ENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN- 219
Query: 155 QPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAP 214
              I+H DLKP NILL Q      G  G+    FG    +  E       I+    Y AP
Sbjct: 220 --RIIHCDLKPENILLKQQ-----GRSGIKVIDFG---SSCYEHQRVYTXIQSRF-YRAP 268
Query: 215 EYGMGSKASVSGDVYNFGILLLEMFT 240
           E  +G++  +  D+++ G +L E+ T
Sbjct: 269 EVILGARYGMPIDMWSLGCILAELLT 294

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 98/226 (43%), Gaps = 37/226 (16%)
Query: 29  TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRN 88
           T+ +     IG G  S+  + I   +    AVK+++  +++ +         LR  +H N
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTEEIEI---LLRYGQHPN 77
Query: 89  LIKIITICSSIDFEGFDFKAIVFEYMQNRNL-EQWLRQSNGQLRFLTQRVNIAI--DVSF 145
           +I +  +     ++   +  +V E  +   L ++ LRQ     +F ++R   A+   ++ 
Sbjct: 78  IITLKDV-----YDDGKYVYVVTELXKGGELLDKILRQ-----KFFSEREASAVLFTITK 127
Query: 146 AIEYFHHHCQPSIVHGDLKPSNIL-LDQD---IVAHVGDLGLAKFLFGYEPG---TAAET 198
            +EY H      +VH DLKPSNIL +D+        + D G AK L   E G   T   T
Sbjct: 128 TVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA-ENGLLXTPCYT 183
Query: 199 ASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
           A+          +VAPE         + D+++ G+LL    T   P
Sbjct: 184 AN----------FVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTP 219

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 107/243 (44%), Gaps = 25/243 (10%)
Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVV--NLKQKEASRSFAAECNALRNIRHR 87
           ++  P  ++G+G   +V K     S  I AVK +   +  +E  R       + R +   
Sbjct: 34  DDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTV--- 90
Query: 88  NLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRV--NIAIDVSF 145
           +    +T   ++  EG      +   + + +L+++ +Q   + + + + +   IA+ +  
Sbjct: 91  DCPFTVTFYGALFREG---DVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVK 147
Query: 146 AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEI 205
           A+E  H H + S++H D+KPSN+L++        D G++ +L         +  +  I+ 
Sbjct: 148 ALE--HLHSKLSVIHRDVKPSNVLINALGQVKXCDFGISGYL--------VDDVAKDID- 196
Query: 206 KGIVGYVAPEY---GMGSKA-SVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKM 261
            G   Y APE     +  K  SV  D+++ GI  +E+   R P D+       L + V+ 
Sbjct: 197 AGCKPYXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVVEE 256
Query: 262 ALP 264
             P
Sbjct: 257 PSP 259

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/250 (22%), Positives = 106/250 (42%), Gaps = 48/250 (19%)
Query: 12  SMKQQFPMISYAELSKAT-------NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVN 64
           SM Q+ P     EL+K          N SP      G V   +     ++++ + V V  
Sbjct: 12  SMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAF-----DTKTGLRVAVKK 66
Query: 65  LKQK-----EASRSFAAECNALRNIRHRNLIKIITICSSI-DFEGFDFKAIVFEYM--QN 116
           L +       A R++  E   L++++H N+I ++ + +     E F+   +V   M    
Sbjct: 67  LSKPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 125
Query: 117 RNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVA 176
            N+ +  + ++  ++FL  ++         ++Y H      I+H DLKPSN+ +++D   
Sbjct: 126 NNIVKCQKLTDDHVQFLIYQI------LRGLKYIH---SADIIHRDLKPSNLAVNEDCEL 176
Query: 177 HVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG---YVAPEYGMG-SKASVSGDVYNFG 232
            + D GLA+                  E+ G V    Y APE  +     + + D+++ G
Sbjct: 177 KILDFGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 222
Query: 233 ILLLEMFTRR 242
            ++ E+ T R
Sbjct: 223 CIMAELLTGR 232

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/258 (21%), Positives = 106/258 (41%), Gaps = 35/258 (13%)
Query: 5   HKDSNMLSMKQQFPMISY--AELSKATNNFSPANKIGQGGVSIVYKGI---LDESRSIVA 59
           H D + L + +    + Y  ++     +  +    +G+G    V +     +D++ +   
Sbjct: 1   HMDPDELPLDEHCERLPYDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATCRT 60
Query: 60  VKVVNLKQ---KEASRSFAAECNALRNI-RHRNLIKIITICSSIDFEGFDFKAIVFEYMQ 115
           V V  LK+       R+  +E   L +I  H N++ ++  C+     G     IV E+ +
Sbjct: 61  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK---PGGPLMVIV-EFCK 116
Query: 116 NRNLEQWLRQSNGQL-----------RFLT--QRVNIAIDVSFAIEYFHHHCQPSIVHGD 162
             NL  +LR    +             FLT    +  +  V+  +E+         +H D
Sbjct: 117 FGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 173
Query: 163 LKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKA 222
           L   NILL +  V  + D GLA+ +   +           + +K    ++APE       
Sbjct: 174 LAARNILLSEKNVVKICDFGLARDI--XKDPDXVRKGDARLPLK----WMAPETIFDRVY 227
Query: 223 SVSGDVYNFGILLLEMFT 240
           ++  DV++FG+LL E+F+
Sbjct: 228 TIQSDVWSFGVLLWEIFS 245

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/226 (21%), Positives = 97/226 (42%), Gaps = 36/226 (15%)
Query: 36  NKIGQGGVSIVYKGIL-----DESRSIVAVKVVNLKQKEASRS-FAAECNALRNIRHRNL 89
            ++G+     VYKG L      E    VA+K +  K +   R  F  E      ++H N+
Sbjct: 32  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 91
Query: 90  IKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWL---------------RQSNGQLRFLT 134
           + ++ + +          +++F Y  + +L ++L               R     L    
Sbjct: 92  VCLLGVVTKDQP-----LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALE-PP 145
Query: 135 QRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGT 194
             V++   ++  +EY   H    +VH DL   N+L+   +   + DLGL + ++      
Sbjct: 146 DFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYA---AD 199
Query: 195 AAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
             +   NS+     + ++APE  M  K S+  D++++G++L E+F+
Sbjct: 200 YYKLLGNSLLP---IRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 107/248 (43%), Gaps = 44/248 (17%)
Query: 12  SMKQQFPMISYAELSKAT-------NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVN 64
           SM Q+ P     EL+K          N SP   +G G    V      ++   VAVK ++
Sbjct: 2   SMSQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLS 58
Query: 65  LKQK---EASRSFAAECNALRNIRHRNLIKIITICSSI-DFEGFDFKAIVFEYM--QNRN 118
              +    A R++  E   L++++H N+I ++ + +     E F+   +V   M     N
Sbjct: 59  RPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN 117
Query: 119 LEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHV 178
           + +  + ++  ++FL  ++         ++Y H      I+H DLKPSN+ +++D    +
Sbjct: 118 IVKCQKLTDDHVQFLIYQI------LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 168
Query: 179 GDLGLAKFLFGYEPGTAAETASNSIEIKGIVG---YVAPEYGMG-SKASVSGDVYNFGIL 234
            D GLA+                  E+ G V    Y APE  +     + + D+++ G +
Sbjct: 169 LDFGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCI 214
Query: 235 LLEMFTRR 242
           + E+ T R
Sbjct: 215 MAELLTGR 222

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 73/162 (45%), Gaps = 10/162 (6%)
Query: 27  KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEA--SRSFAAECNALRNI 84
           K  +N+   + IG+G    VY      +   VA+K VN   ++    +    E   L  +
Sbjct: 25  KVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRL 84
Query: 85  RHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLT-QRVNIAIDV 143
           +   +I++  +    D   FD   IV E + + +L++  +       FLT Q V   +  
Sbjct: 85  KSDYIIRLHDLIIPEDLLKFDELYIVLE-IADSDLKKLFKTP----IFLTEQHVKTILYN 139
Query: 144 SFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAK 185
               E F H  +  I+H DLKP+N LL+QD    + D GLA+
Sbjct: 140 LLLGEKFIH--ESGIIHRDLKPANCLLNQDCSVKICDFGLAR 179

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 76/182 (41%), Gaps = 32/182 (17%)
Query: 61  KVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLE 120
           KVV LKQ E + +   E   L+ +    L+K+        F+      +V EYM   ++ 
Sbjct: 78  KVVKLKQIEHTLN---EKRILQAVNFPFLVKL-----EFSFKDNSNLYMVMEYMPGGDMF 129
Query: 121 QWLRQ----SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVA 176
             LR+    S    RF       A  +    EY H      +++ DLKP N+L+DQ    
Sbjct: 130 SHLRRIGRFSEPHARFY------AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYI 180
Query: 177 HVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLL 236
            V D G AK + G            +  + G   Y+APE  +    + + D +  G+L+ 
Sbjct: 181 KVADFGFAKRVKG-----------RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 229
Query: 237 EM 238
           EM
Sbjct: 230 EM 231

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/226 (21%), Positives = 97/226 (42%), Gaps = 36/226 (15%)
Query: 36  NKIGQGGVSIVYKGIL-----DESRSIVAVKVVNLKQKEASRS-FAAECNALRNIRHRNL 89
            ++G+     VYKG L      E    VA+K +  K +   R  F  E      ++H N+
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 90  IKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWL---------------RQSNGQLRFLT 134
           + ++ + +          +++F Y  + +L ++L               R     L    
Sbjct: 75  VCLLGVVTKDQP-----LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALE-PP 128
Query: 135 QRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGT 194
             V++   ++  +EY   H    +VH DL   N+L+   +   + DLGL + ++      
Sbjct: 129 DFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYA---AD 182
Query: 195 AAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
             +   NS+     + ++APE  M  K S+  D++++G++L E+F+
Sbjct: 183 YYKLLGNSLLP---IRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/250 (22%), Positives = 106/250 (42%), Gaps = 48/250 (19%)
Query: 12  SMKQQFPMISYAELSKAT-------NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVN 64
           SM Q+ P     EL+K          N SP      G V   +     ++++ + V V  
Sbjct: 12  SMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAF-----DTKTGLRVAVKK 66
Query: 65  LKQK-----EASRSFAAECNALRNIRHRNLIKIITICSSI-DFEGFDFKAIVFEYM--QN 116
           L +       A R++  E   L++++H N+I ++ + +     E F+   +V   M    
Sbjct: 67  LSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 125
Query: 117 RNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVA 176
            N+ +  + ++  ++FL  ++         ++Y H      I+H DLKPSN+ +++D   
Sbjct: 126 NNIVKCQKLTDDHVQFLIYQI------LRGLKYIH---SADIIHRDLKPSNLAVNEDCEL 176
Query: 177 HVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG---YVAPEYGMG-SKASVSGDVYNFG 232
            + D GLA+                  E+ G V    Y APE  +     + + D+++ G
Sbjct: 177 KILDFGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 222
Query: 233 ILLLEMFTRR 242
            ++ E+ T R
Sbjct: 223 CIMAELLTGR 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/250 (22%), Positives = 106/250 (42%), Gaps = 48/250 (19%)
Query: 12  SMKQQFPMISYAELSKAT-------NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVN 64
           SM Q+ P     EL+K          N SP      G V   +     ++++ + V V  
Sbjct: 12  SMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAF-----DTKTGLRVAVKK 66
Query: 65  LKQK-----EASRSFAAECNALRNIRHRNLIKIITICSSI-DFEGFDFKAIVFEYM--QN 116
           L +       A R++  E   L++++H N+I ++ + +     E F+   +V   M    
Sbjct: 67  LSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 125
Query: 117 RNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVA 176
            N+ +  + ++  ++FL  ++         ++Y H      I+H DLKPSN+ +++D   
Sbjct: 126 NNIVKCQKLTDDHVQFLIYQI------LRGLKYIH---SADIIHRDLKPSNLAVNEDCEL 176
Query: 177 HVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG---YVAPEYGMG-SKASVSGDVYNFG 232
            + D GLA+                  E+ G V    Y APE  +     + + D+++ G
Sbjct: 177 KILDFGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 222
Query: 233 ILLLEMFTRR 242
            ++ E+ T R
Sbjct: 223 CIMAELLTGR 232

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 76/182 (41%), Gaps = 32/182 (17%)
Query: 61  KVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLE 120
           KVV LKQ E + +   E   L+ +    L+K+        F+      +V EYM   ++ 
Sbjct: 78  KVVKLKQIEHTLN---EKRILQAVNFPFLVKL-----EFSFKDNSNLYMVMEYMPGGDMF 129
Query: 121 QWLRQ----SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVA 176
             LR+    S    RF       A  +    EY H      +++ DLKP N+L+DQ    
Sbjct: 130 SHLRRIGRFSEPHARFY------AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYI 180
Query: 177 HVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLL 236
            V D G AK + G            +  + G   Y+APE  +    + + D +  G+L+ 
Sbjct: 181 KVADFGFAKRVKG-----------RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 229
Query: 237 EM 238
           EM
Sbjct: 230 EM 231

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/144 (29%), Positives = 66/144 (45%), Gaps = 29/144 (20%)
Query: 108 AIVFEYMQNRNLEQWLRQ--SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPS-IVHGDLK 164
           A+VFEY+ N + +Q L Q  ++  +RF    +  A+D          +C    I+H D+K
Sbjct: 111 ALVFEYINNTDFKQ-LYQILTDFDIRFYMYELLKALD----------YCHSKGIMHRDVK 159
Query: 165 PSNILLD-QDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKG---IVGYVAPEYGMGS 220
           P N+++D Q     + D GLA+F   Y P         S   KG   +V Y   +Y +  
Sbjct: 160 PHNVMIDHQQKKLRLIDWGLAEF---YHPAQEYNVRVASRYFKGPELLVDYQMYDYSL-- 214
Query: 221 KASVSGDVYNFGILLLEMFTRRRP 244
                 D+++ G +L  M  RR P
Sbjct: 215 ------DMWSLGCMLASMIFRREP 232

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 87/194 (44%), Gaps = 24/194 (12%)
Query: 58  VAVKVVNLKQKEAS--RSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQ 115
           VA+K+++  Q   +  +    E   ++ + H N++K+  +   I+ E   +  ++ EY  
Sbjct: 43  VAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV---IETEKTLY--LIMEYAS 97
Query: 116 NRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIV 175
              +  +L  ++G+++    R      VS A++Y H   Q  IVH DLK  N+LLD D+ 
Sbjct: 98  GGEVFDYL-VAHGRMKEKEARSKFRQIVS-AVQYCH---QKRIVHRDLKAENLLLDADMN 152
Query: 176 AHVGDLGLA-KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKAS-VSGDVYNFGI 233
             + D G + +F  G +               G   Y APE   G K      DV++ G+
Sbjct: 153 IKIADFGFSNEFTVGGKLDAFC----------GAPPYAAPELFQGKKYDGPEVDVWSLGV 202
Query: 234 LLLEMFTRRRPTDA 247
           +L  + +   P D 
Sbjct: 203 ILYTLVSGSLPFDG 216

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 91/206 (44%), Gaps = 19/206 (9%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICS 97
           IG+G    V K    +    VA+K+V   +K   R  A E   L ++R ++    + +  
Sbjct: 105 IGKGXFGQVVKAYDHKVHQHVALKMVR-NEKRFHRQAAEEIRILEHLRKQDKDNTMNVIH 163
Query: 98  SIDFEGFDFK---AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHC 154
            +  E F F+    + FE + + NL + ++++  Q   L      A  +   ++  H + 
Sbjct: 164 ML--ENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN- 219
Query: 155 QPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAP 214
              I+H DLKP NILL Q      G  G+    FG    +  E       I+    Y AP
Sbjct: 220 --RIIHCDLKPENILLKQQ-----GRSGIKVIDFG---SSCYEHQRVYXXIQSRF-YRAP 268
Query: 215 EYGMGSKASVSGDVYNFGILLLEMFT 240
           E  +G++  +  D+++ G +L E+ T
Sbjct: 269 EVILGARYGMPIDMWSLGCILAELLT 294

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/142 (26%), Positives = 66/142 (46%), Gaps = 25/142 (17%)
Query: 108 AIVFEYMQNRNLEQWLRQ-SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPS 166
           A+VFE++ N + +Q  +  ++  +RF    +  A+D   ++          I+H D+KP 
Sbjct: 110 ALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSM---------GIMHRDVKPH 160
Query: 167 NILLDQDIVA-HVGDLGLAKFLFGYEPGTAAETASNSIEIKG---IVGYVAPEYGMGSKA 222
           N+++D +     + D GLA+F   Y PG        S   KG   +V Y   +Y +    
Sbjct: 161 NVMIDHEHRKLRLIDWGLAEF---YHPGQEYNVRVASRYFKGPELLVDYQMYDYSL---- 213
Query: 223 SVSGDVYNFGILLLEMFTRRRP 244
               D+++ G +L  M  R+ P
Sbjct: 214 ----DMWSLGCMLASMIFRKEP 231

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 37/142 (26%), Positives = 66/142 (46%), Gaps = 25/142 (17%)
Query: 108 AIVFEYMQNRNLEQWLRQ-SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPS 166
           A+VFE++ N + +Q  +  ++  +RF    +  A+D   ++          I+H D+KP 
Sbjct: 110 ALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSM---------GIMHRDVKPH 160
Query: 167 NILLDQDIVA-HVGDLGLAKFLFGYEPGTAAETASNSIEIKG---IVGYVAPEYGMGSKA 222
           N+++D +     + D GLA+F   Y PG        S   KG   +V Y   +Y +    
Sbjct: 161 NVMIDHEHRKLRLIDWGLAEF---YHPGQEYNVRVASRYFKGPELLVDYQMYDYSL---- 213
Query: 223 SVSGDVYNFGILLLEMFTRRRP 244
               D+++ G +L  M  R+ P
Sbjct: 214 ----DMWSLGCMLASMIFRKEP 231

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/210 (22%), Positives = 93/210 (44%), Gaps = 27/210 (12%)
Query: 38  IGQGGVSIVYKGILDESRSI---VAVKVV----NLKQKEASRSFAAECNALRNIRHRNLI 90
           +G+G    VY+G+    +     VAVK       L  KE    F +E   ++N+ H +++
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKE---KFMSEAVIMKNLDHPHIV 72
Query: 91  KIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYF 150
           K+I I         +   I+ E      L  +L ++   L+ LT  V  ++ +  A+ Y 
Sbjct: 73  KLIGIIEE------EPTWIIMELYPYGELGHYLERNKNSLKVLTL-VLYSLQICKAMAYL 125
Query: 151 HHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG 210
                 + VH D+   NIL+       +GD GL++++   E     + +   + IK    
Sbjct: 126 E---SINCVHRDIAVRNILVASPECVKLGDFGLSRYI---EDEDYYKASVTRLPIK---- 175
Query: 211 YVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
           +++PE     + + + DV+ F + + E+ +
Sbjct: 176 WMSPESINFRRFTTASDVWMFAVCMWEILS 205

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/211 (23%), Positives = 94/211 (44%), Gaps = 29/211 (13%)
Query: 38  IGQGGVSIVYKGILDESRSI---VAVKVV----NLKQKEASRSFAAECNALRNIRHRNLI 90
           +G+G    VY+G+    +     VAVK       L  KE    F +E   ++N+ H +++
Sbjct: 32  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKE---KFMSEAVIMKNLDHPHIV 88
Query: 91  KIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYF 150
           K+I I         +   I+ E      L  +L ++   L+ LT  V  ++ +  A+ Y 
Sbjct: 89  KLIGIIEE------EPTWIIMELYPYGELGHYLERNKNSLKVLTL-VLYSLQICKAMAYL 141
Query: 151 HH-HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
              +C    VH D+   NIL+       +GD GL++++   E     + +   + IK   
Sbjct: 142 ESINC----VHRDIAVRNILVASPECVKLGDFGLSRYI---EDEDYYKASVTRLPIK--- 191
Query: 210 GYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
            +++PE     + + + DV+ F + + E+ +
Sbjct: 192 -WMSPESINFRRFTTASDVWMFAVCMWEILS 221

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 37/142 (26%), Positives = 66/142 (46%), Gaps = 25/142 (17%)
Query: 108 AIVFEYMQNRNLEQWLRQ-SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPS 166
           A+VFE++ N + +Q  +  ++  +RF    +  A+D   ++          I+H D+KP 
Sbjct: 110 ALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSM---------GIMHRDVKPH 160
Query: 167 NILLDQDIVA-HVGDLGLAKFLFGYEPGTAAETASNSIEIKG---IVGYVAPEYGMGSKA 222
           N+++D +     + D GLA+F   Y PG        S   KG   +V Y   +Y +    
Sbjct: 161 NVMIDHEHRKLRLIDWGLAEF---YHPGQEYNVRVASRYFKGPELLVDYQMYDYSL---- 213
Query: 223 SVSGDVYNFGILLLEMFTRRRP 244
               D+++ G +L  M  R+ P
Sbjct: 214 ----DMWSLGCMLASMIFRKEP 231

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 90/218 (41%), Gaps = 35/218 (16%)
Query: 29  TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEAS--RSFAAECNALRNIRH 86
           T+ +     IG+G  S+V + +   +    A K++N K+  A   +    E    R ++H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 87  RNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQL--RFLTQRVNIAIDVS 144
            N++++     SI  EGF +  +VF+ +           + G+L    + +      D S
Sbjct: 63  SNIVRLH---DSISEEGFHY--LVFDLV-----------TGGELFEDIVAREYYSEADAS 106
Query: 145 FAIEYFHH---HC-QPSIVHGDLKPSNILLD---QDIVAHVGDLGLAKFLFGYEPGTAAE 197
             I+       HC Q  +VH DLKP N+LL    +     + D GLA  + G +      
Sbjct: 107 HCIQQILEAVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFG- 165
Query: 198 TASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILL 235
                    G  GY++PE           D++  G++L
Sbjct: 166 -------FAGTPGYLSPEVLRKEAYGKPVDIWACGVIL 196

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 37/142 (26%), Positives = 66/142 (46%), Gaps = 25/142 (17%)
Query: 108 AIVFEYMQNRNLEQWLRQ-SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPS 166
           A+VFE++ N + +Q  +  ++  +RF    +  A+D   ++          I+H D+KP 
Sbjct: 110 ALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSM---------GIMHRDVKPH 160
Query: 167 NILLDQDIVA-HVGDLGLAKFLFGYEPGTAAETASNSIEIKG---IVGYVAPEYGMGSKA 222
           N+++D +     + D GLA+F   Y PG        S   KG   +V Y   +Y +    
Sbjct: 161 NVMIDHEHRKLRLIDWGLAEF---YHPGQEYNVRVASRYFKGPELLVDYQMYDYSL---- 213
Query: 223 SVSGDVYNFGILLLEMFTRRRP 244
               D+++ G +L  M  R+ P
Sbjct: 214 ----DMWSLGCMLASMIFRKEP 231

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 37/142 (26%), Positives = 66/142 (46%), Gaps = 25/142 (17%)
Query: 108 AIVFEYMQNRNLEQWLRQ-SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPS 166
           A+VFE++ N + +Q  +  ++  +RF    +  A+D   ++          I+H D+KP 
Sbjct: 110 ALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSM---------GIMHRDVKPH 160
Query: 167 NILLDQDIVA-HVGDLGLAKFLFGYEPGTAAETASNSIEIKG---IVGYVAPEYGMGSKA 222
           N+++D +     + D GLA+F   Y PG        S   KG   +V Y   +Y +    
Sbjct: 161 NVMIDHEHRKLRLIDWGLAEF---YHPGQEYNVRVASRYFKGPELLVDYQMYDYSL---- 213
Query: 223 SVSGDVYNFGILLLEMFTRRRP 244
               D+++ G +L  M  R+ P
Sbjct: 214 ----DMWSLGCMLASMIFRKEP 231

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 37/142 (26%), Positives = 66/142 (46%), Gaps = 25/142 (17%)
Query: 108 AIVFEYMQNRNLEQWLRQ-SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPS 166
           A+VFE++ N + +Q  +  ++  +RF    +  A+D   ++          I+H D+KP 
Sbjct: 110 ALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSM---------GIMHRDVKPH 160
Query: 167 NILLDQDIVA-HVGDLGLAKFLFGYEPGTAAETASNSIEIKG---IVGYVAPEYGMGSKA 222
           N+++D +     + D GLA+F   Y PG        S   KG   +V Y   +Y +    
Sbjct: 161 NVMIDHEHRKLRLIDWGLAEF---YHPGQEYNVRVASRYFKGPELLVDYQMYDYSL---- 213
Query: 223 SVSGDVYNFGILLLEMFTRRRP 244
               D+++ G +L  M  R+ P
Sbjct: 214 ----DMWSLGCMLASMIFRKEP 231

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 42/144 (29%), Positives = 66/144 (45%), Gaps = 29/144 (20%)
Query: 108 AIVFEYMQNRNLEQWLRQ--SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPS-IVHGDLK 164
           A+VFEY+ N + +Q L Q  ++  +RF    +  A+D          +C    I+H D+K
Sbjct: 116 ALVFEYINNTDFKQ-LYQILTDFDIRFYMYELLKALD----------YCHSKGIMHRDVK 164
Query: 165 PSNILLD-QDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKG---IVGYVAPEYGMGS 220
           P N+++D Q     + D GLA+F   Y P         S   KG   +V Y   +Y +  
Sbjct: 165 PHNVMIDHQQKKLRLIDWGLAEF---YHPAQEYNVRVASRYFKGPELLVDYQMYDYSL-- 219
Query: 221 KASVSGDVYNFGILLLEMFTRRRP 244
                 D+++ G +L  M  RR P
Sbjct: 220 ------DMWSLGCMLASMIFRREP 237

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 37/142 (26%), Positives = 66/142 (46%), Gaps = 25/142 (17%)
Query: 108 AIVFEYMQNRNLEQWLRQ-SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPS 166
           A+VFE++ N + +Q  +  ++  +RF    +  A+D   ++          I+H D+KP 
Sbjct: 110 ALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSM---------GIMHRDVKPH 160
Query: 167 NILLDQDIVA-HVGDLGLAKFLFGYEPGTAAETASNSIEIKG---IVGYVAPEYGMGSKA 222
           N+++D +     + D GLA+F   Y PG        S   KG   +V Y   +Y +    
Sbjct: 161 NVMIDHEHRKLRLIDWGLAEF---YHPGQEYNVRVASRYFKGPELLVDYQMYDYSL---- 213
Query: 223 SVSGDVYNFGILLLEMFTRRRP 244
               D+++ G +L  M  R+ P
Sbjct: 214 ----DMWSLGCMLASMIFRKEP 231

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/206 (22%), Positives = 86/206 (41%), Gaps = 21/206 (10%)
Query: 38  IGQGGVSIVYKGIL---DESRSIVAVKVV-NLKQKEASRSFAAECNALRNIRHRNLIKII 93
           IG+G    V++GI    +     VA+K   N         F  E   +R   H +++K+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 94  TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHH 153
            + +       +   I+ E      L  +L+     L  L   +  A  +S A+ Y    
Sbjct: 458 GVITE------NPVWIIMELCTLGELRSFLQVRKFSLD-LASLILYAYQLSTALAYLESK 510
Query: 154 CQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVA 213
                VH D+   N+L+       +GD GL++++   E  T  + +   + IK    ++A
Sbjct: 511 ---RFVHRDIAARNVLVSATDCVKLGDFGLSRYM---EDSTYYKASKGKLPIK----WMA 560
Query: 214 PEYGMGSKASVSGDVYNFGILLLEMF 239
           PE     + + + DV+ FG+ + E+ 
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 37/142 (26%), Positives = 66/142 (46%), Gaps = 25/142 (17%)
Query: 108 AIVFEYMQNRNLEQWLRQ-SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPS 166
           A+VFE++ N + +Q  +  ++  +RF    +  A+D   ++          I+H D+KP 
Sbjct: 110 ALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSM---------GIMHRDVKPH 160
Query: 167 NILLDQDIVA-HVGDLGLAKFLFGYEPGTAAETASNSIEIKG---IVGYVAPEYGMGSKA 222
           N+++D +     + D GLA+F   Y PG        S   KG   +V Y   +Y +    
Sbjct: 161 NVMIDHEHRKLRLIDWGLAEF---YHPGQEYNVRVASRYFKGPELLVDYQMYDYSL---- 213
Query: 223 SVSGDVYNFGILLLEMFTRRRP 244
               D+++ G +L  M  R+ P
Sbjct: 214 ----DMWSLGCMLASMIFRKEP 231

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/210 (22%), Positives = 93/210 (44%), Gaps = 27/210 (12%)
Query: 38  IGQGGVSIVYKGILDESRSI---VAVKVV----NLKQKEASRSFAAECNALRNIRHRNLI 90
           +G+G    VY+G+    +     VAVK       L  KE    F +E   ++N+ H +++
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKE---KFMSEAVIMKNLDHPHIV 76
Query: 91  KIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYF 150
           K+I I         +   I+ E      L  +L ++   L+ LT  V  ++ +  A+ Y 
Sbjct: 77  KLIGIIEE------EPTWIIMELYPYGELGHYLERNKNSLKVLTL-VLYSLQICKAMAYL 129
Query: 151 HHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG 210
                 + VH D+   NIL+       +GD GL++++   E     + +   + IK    
Sbjct: 130 E---SINCVHRDIAVRNILVASPECVKLGDFGLSRYI---EDEDYYKASVTRLPIK---- 179
Query: 211 YVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
           +++PE     + + + DV+ F + + E+ +
Sbjct: 180 WMSPESINFRRFTTASDVWMFAVCMWEILS 209

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 37/142 (26%), Positives = 66/142 (46%), Gaps = 25/142 (17%)
Query: 108 AIVFEYMQNRNLEQWLRQ-SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPS 166
           A+VFE++ N + +Q  +  ++  +RF    +  A+D   ++          I+H D+KP 
Sbjct: 109 ALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSM---------GIMHRDVKPH 159
Query: 167 NILLDQDIVA-HVGDLGLAKFLFGYEPGTAAETASNSIEIKG---IVGYVAPEYGMGSKA 222
           N+++D +     + D GLA+F   Y PG        S   KG   +V Y   +Y +    
Sbjct: 160 NVMIDHEHRKLRLIDWGLAEF---YHPGQEYNVRVASRYFKGPELLVDYQMYDYSL---- 212
Query: 223 SVSGDVYNFGILLLEMFTRRRP 244
               D+++ G +L  M  R+ P
Sbjct: 213 ----DMWSLGCMLASMIFRKEP 230

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 37/142 (26%), Positives = 66/142 (46%), Gaps = 25/142 (17%)
Query: 108 AIVFEYMQNRNLEQWLRQ-SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPS 166
           A+VFE++ N + +Q  +  ++  +RF    +  A+D   ++          I+H D+KP 
Sbjct: 108 ALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSM---------GIMHRDVKPH 158
Query: 167 NILLDQDIVA-HVGDLGLAKFLFGYEPGTAAETASNSIEIKG---IVGYVAPEYGMGSKA 222
           N+++D +     + D GLA+F   Y PG        S   KG   +V Y   +Y +    
Sbjct: 159 NVMIDHEHRKLRLIDWGLAEF---YHPGQEYNVRVASRYFKGPELLVDYQMYDYSL---- 211
Query: 223 SVSGDVYNFGILLLEMFTRRRP 244
               D+++ G +L  M  R+ P
Sbjct: 212 ----DMWSLGCMLASMIFRKEP 229

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 37/142 (26%), Positives = 66/142 (46%), Gaps = 25/142 (17%)
Query: 108 AIVFEYMQNRNLEQWLRQ-SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPS 166
           A+VFE++ N + +Q  +  ++  +RF    +  A+D   ++          I+H D+KP 
Sbjct: 109 ALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSM---------GIMHRDVKPH 159
Query: 167 NILLDQDIVA-HVGDLGLAKFLFGYEPGTAAETASNSIEIKG---IVGYVAPEYGMGSKA 222
           N+++D +     + D GLA+F   Y PG        S   KG   +V Y   +Y +    
Sbjct: 160 NVMIDHEHRKLRLIDWGLAEF---YHPGQEYNVRVASRYFKGPELLVDYQMYDYSL---- 212
Query: 223 SVSGDVYNFGILLLEMFTRRRP 244
               D+++ G +L  M  R+ P
Sbjct: 213 ----DMWSLGCMLASMIFRKEP 230

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 57/247 (23%), Positives = 106/247 (42%), Gaps = 44/247 (17%)
Query: 13  MKQQFPMISYAELSKAT-------NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL 65
           M Q+ P     EL+K          N SP   +G G    V      ++   VAVK ++ 
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSR 57
Query: 66  KQK---EASRSFAAECNALRNIRHRNLIKIITICSSI-DFEGFDFKAIVFEYM--QNRNL 119
             +    A R++  E   L++++H N+I ++ + +     E F+   +V   M     N+
Sbjct: 58  PFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI 116
Query: 120 EQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVG 179
            +  + ++  ++FL  ++         ++Y H      I+H DLKPSN+ +++D    + 
Sbjct: 117 VKCQKLTDDHVQFLIYQI------LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 167
Query: 180 DLGLAKFLFGYEPGTAAETASNSIEIKGIVG---YVAPEYGMG-SKASVSGDVYNFGILL 235
           D GLA+                  E+ G V    Y APE  +     + + D+++ G ++
Sbjct: 168 DFGLAR--------------HTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 213
Query: 236 LEMFTRR 242
            E+ T R
Sbjct: 214 AELLTGR 220

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 57/247 (23%), Positives = 107/247 (43%), Gaps = 44/247 (17%)
Query: 13  MKQQFPMISYAELSKAT-------NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL 65
           M Q+ P     EL+K          N SP   +G G    V      ++   VAVK ++ 
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSR 57
Query: 66  KQK---EASRSFAAECNALRNIRHRNLIKIITICSSI-DFEGFDFKAIVFEYM--QNRNL 119
             +    A R++  E   L++++H N+I ++ + +     E F+   +V   M     N+
Sbjct: 58  PFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI 116
Query: 120 EQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVG 179
            +  + ++  ++FL  ++         ++Y H      I+H DLKPSN+ +++D    + 
Sbjct: 117 VKCQKLTDDHVQFLIYQI------LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 167
Query: 180 DLGLAKFLFGYEPGTAAETASNSIEIKGIVG---YVAPEYGMGS-KASVSGDVYNFGILL 235
           D GLA+                  E+ G V    Y APE  + +   + + D+++ G ++
Sbjct: 168 DFGLAR--------------HTDDEMTGYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIM 213
Query: 236 LEMFTRR 242
            E+ T R
Sbjct: 214 AELLTGR 220

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 57/247 (23%), Positives = 106/247 (42%), Gaps = 44/247 (17%)
Query: 13  MKQQFPMISYAELSKAT-------NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL 65
           M Q+ P     EL+K          N SP   +G G    V      ++   VAVK ++ 
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSR 57
Query: 66  KQK---EASRSFAAECNALRNIRHRNLIKIITICSSI-DFEGFDFKAIVFEYM--QNRNL 119
             +    A R++  E   L++++H N+I ++ + +     E F+   +V   M     N+
Sbjct: 58  PFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI 116
Query: 120 EQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVG 179
            +  + ++  ++FL  ++         ++Y H      I+H DLKPSN+ +++D    + 
Sbjct: 117 VKCQKLTDDHVQFLIYQI------LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 167
Query: 180 DLGLAKFLFGYEPGTAAETASNSIEIKGIVG---YVAPEYGMG-SKASVSGDVYNFGILL 235
           D GLA+                  E+ G V    Y APE  +     + + D+++ G ++
Sbjct: 168 DFGLAR--------------HTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 213
Query: 236 LEMFTRR 242
            E+ T R
Sbjct: 214 AELLTGR 220

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 59/143 (41%), Gaps = 23/143 (16%)
Query: 109 IVFEYMQNRNL------EQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGD 162
           I  EY +NR L      E   +Q +   R   Q +        A+ Y H      I+H D
Sbjct: 92  IQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQILE-------ALSYIHSQ---GIIHRD 141
Query: 163 LKPSNILLDQDIVAHVGDLGLAKF------LFGYEPGTAAETASNSIEIKGIVGYVAPEY 216
           LKP NI +D+     +GD GLAK       +   +      ++ N     G   YVA E 
Sbjct: 142 LKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEV 201
Query: 217 GMGS-KASVSGDVYNFGILLLEM 238
             G+   +   D+Y+ GI+  EM
Sbjct: 202 LDGTGHYNEKIDMYSLGIIFFEM 224

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 37/142 (26%), Positives = 66/142 (46%), Gaps = 25/142 (17%)
Query: 108 AIVFEYMQNRNLEQWLRQ-SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPS 166
           A+VFE++ N + +Q  +  ++  +RF    +  A+D   ++          I+H D+KP 
Sbjct: 115 ALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSM---------GIMHRDVKPH 165
Query: 167 NILLDQDIVA-HVGDLGLAKFLFGYEPGTAAETASNSIEIKG---IVGYVAPEYGMGSKA 222
           N+++D +     + D GLA+F   Y PG        S   KG   +V Y   +Y +    
Sbjct: 166 NVMIDHEHRKLRLIDWGLAEF---YHPGQEYNVRVASRYFKGPELLVDYQMYDYSL---- 218
Query: 223 SVSGDVYNFGILLLEMFTRRRP 244
               D+++ G +L  M  R+ P
Sbjct: 219 ----DMWSLGCMLASMIFRKEP 236

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 107/248 (43%), Gaps = 44/248 (17%)
Query: 12  SMKQQFPMISYAELSKAT-------NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVN 64
           SM Q+ P     EL+K          N SP   +G G    V      ++   VAVK ++
Sbjct: 2   SMSQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLS 58
Query: 65  LKQK---EASRSFAAECNALRNIRHRNLIKIITICSSI-DFEGFDFKAIVFEYM--QNRN 118
              +    A R++  E   L++++H N+I ++ + +     E F+   +V   M     N
Sbjct: 59  RPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN 117
Query: 119 LEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHV 178
           + +  + ++  ++FL  ++         ++Y H      I+H DLKPSN+ +++D    +
Sbjct: 118 IVKCQKLTDDHVQFLIYQI------LRGLKYIH---SADIIHRDLKPSNLAVNEDSELKI 168
Query: 179 GDLGLAKFLFGYEPGTAAETASNSIEIKGIVG---YVAPEYGMG-SKASVSGDVYNFGIL 234
            D GLA+                  E+ G V    Y APE  +     + + D+++ G +
Sbjct: 169 LDFGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCI 214
Query: 235 LLEMFTRR 242
           + E+ T R
Sbjct: 215 MAELLTGR 222

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 57/247 (23%), Positives = 106/247 (42%), Gaps = 44/247 (17%)
Query: 13  MKQQFPMISYAELSKAT-------NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL 65
           M Q+ P     EL+K          N SP   +G G    V      ++   VAVK ++ 
Sbjct: 21  MSQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSR 77
Query: 66  KQK---EASRSFAAECNALRNIRHRNLIKIITICSSI-DFEGFDFKAIVFEYM--QNRNL 119
             +    A R++  E   L++++H N+I ++ + +     E F+   +V   M     N+
Sbjct: 78  PFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI 136
Query: 120 EQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVG 179
            +  + ++  ++FL  ++         ++Y H      I+H DLKPSN+ +++D    + 
Sbjct: 137 VKCQKLTDDHVQFLIYQI------LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 187
Query: 180 DLGLAKFLFGYEPGTAAETASNSIEIKGIVG---YVAPEYGMG-SKASVSGDVYNFGILL 235
           D GLA+                  E+ G V    Y APE  +     + + D+++ G ++
Sbjct: 188 DFGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 233
Query: 236 LEMFTRR 242
            E+ T R
Sbjct: 234 AELLTGR 240

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 68/275 (24%), Positives = 115/275 (41%), Gaps = 40/275 (14%)
Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNL 89
           N F    K+G G    V      +++   AVKVV    K+ +RS   E + L+ I++ ++
Sbjct: 35  NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVR-NIKKYTRSAKIEADILKKIQNDDI 93
Query: 90  IKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQS-NGQLRFLTQRVNI-AIDVSFAI 147
                +     F  +D   ++FE +     E   R + NG   F  + + +  I++  A+
Sbjct: 94  NNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNG---FHIEDIKLYCIEILKAL 150
Query: 148 EYFHHHCQPSIVHGDLKPSNILLDQD-------IVAHVGD-----------LGLAKFLFG 189
            Y     + S+ H DLKP NILLD          V  V D            G+    F 
Sbjct: 151 NYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDF- 206
Query: 190 YEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMF 249
              G A   +     I     Y APE  +     VS D+++FG +L E++T       +F
Sbjct: 207 ---GCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT----GSLLF 259
Query: 250 NEGLTLHEFVK-MALPDKVMEIVDPSLLLEVTANN 283
                 HE ++ +A+ + +++ +  ++L E T  N
Sbjct: 260 RT----HEHMEHLAMMESIIQPIPKNMLYEATKTN 290

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 57/247 (23%), Positives = 106/247 (42%), Gaps = 44/247 (17%)
Query: 13  MKQQFPMISYAELSKAT-------NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL 65
           M Q+ P     EL+K          N SP   +G G    V      ++   VAVK ++ 
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSR 57
Query: 66  KQK---EASRSFAAECNALRNIRHRNLIKIITICSSI-DFEGFDFKAIVFEYM--QNRNL 119
             +    A R++  E   L++++H N+I ++ + +     E F+   +V   M     N+
Sbjct: 58  PFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI 116
Query: 120 EQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVG 179
            +  + ++  ++FL  ++         ++Y H      I+H DLKPSN+ +++D    + 
Sbjct: 117 VKCQKLTDDHVQFLIYQI------LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 167
Query: 180 DLGLAKFLFGYEPGTAAETASNSIEIKGIVG---YVAPEYGMG-SKASVSGDVYNFGILL 235
           D GLA+                  E+ G V    Y APE  +     + + D+++ G ++
Sbjct: 168 DFGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 213
Query: 236 LEMFTRR 242
            E+ T R
Sbjct: 214 AELLTGR 220

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 57/247 (23%), Positives = 106/247 (42%), Gaps = 44/247 (17%)
Query: 13  MKQQFPMISYAELSKAT-------NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL 65
           M Q+ P     EL+K          N SP   +G G    V      ++   VAVK ++ 
Sbjct: 20  MSQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSR 76
Query: 66  KQK---EASRSFAAECNALRNIRHRNLIKIITICSSI-DFEGFDFKAIVFEYM--QNRNL 119
             +    A R++  E   L++++H N+I ++ + +     E F+   +V   M     N+
Sbjct: 77  PFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI 135
Query: 120 EQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVG 179
            +  + ++  ++FL  ++         ++Y H      I+H DLKPSN+ +++D    + 
Sbjct: 136 VKCQKLTDDHVQFLIYQI------LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 186
Query: 180 DLGLAKFLFGYEPGTAAETASNSIEIKGIVG---YVAPEYGMG-SKASVSGDVYNFGILL 235
           D GLA+                  E+ G V    Y APE  +     + + D+++ G ++
Sbjct: 187 DFGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 232
Query: 236 LEMFTRR 242
            E+ T R
Sbjct: 233 AELLTGR 239

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 57/247 (23%), Positives = 106/247 (42%), Gaps = 44/247 (17%)
Query: 13  MKQQFPMISYAELSKAT-------NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL 65
           M Q+ P     EL+K          N SP   +G G    V      ++   VAVK ++ 
Sbjct: 21  MSQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSR 77
Query: 66  KQK---EASRSFAAECNALRNIRHRNLIKIITICSSI-DFEGFDFKAIVFEYM--QNRNL 119
             +    A R++  E   L++++H N+I ++ + +     E F+   +V   M     N+
Sbjct: 78  PFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI 136
Query: 120 EQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVG 179
            +  + ++  ++FL  ++         ++Y H      I+H DLKPSN+ +++D    + 
Sbjct: 137 VKCQKLTDDHVQFLIYQI------LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 187
Query: 180 DLGLAKFLFGYEPGTAAETASNSIEIKGIVG---YVAPEYGMG-SKASVSGDVYNFGILL 235
           D GLA+                  E+ G V    Y APE  +     + + D+++ G ++
Sbjct: 188 DFGLAR--------------HTDDEMXGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 233
Query: 236 LEMFTRR 242
            E+ T R
Sbjct: 234 AELLTGR 240

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 88/208 (42%), Gaps = 31/208 (14%)
Query: 51  LDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNI-RHRNLIKIITICSSIDFEGFDF 106
           +D++ +   V V  LK+       R+  +E   L +I  H N++ ++  C+     G   
Sbjct: 42  IDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK---PGGPL 98
Query: 107 KAIVFEYMQNRNLEQWLRQSNGQL------------RFLT--QRVNIAIDVSFAIEYFHH 152
             I  E+ +  NL  +LR    +              FLT    +  +  V+  +E+   
Sbjct: 99  MVIT-EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS 157
Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
                 +H DL   NILL +  V  + D GLA+ +  Y+           + +K    ++
Sbjct: 158 R---KCIHRDLAARNILLSEKNVVKICDFGLARDI--YKDPDYVRKGDARLPLK----WM 208
Query: 213 APEYGMGSKASVSGDVYNFGILLLEMFT 240
           APE       ++  DV++FG+LL E+F+
Sbjct: 209 APETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 88/208 (42%), Gaps = 31/208 (14%)
Query: 51  LDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNI-RHRNLIKIITICSSIDFEGFDF 106
           +D++ +   V V  LK+       R+  +E   L +I  H N++ ++  C+     G   
Sbjct: 42  IDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK---PGGPL 98
Query: 107 KAIVFEYMQNRNLEQWLRQSNGQL------------RFLT--QRVNIAIDVSFAIEYFHH 152
             I  E+ +  NL  +LR    +              FLT    +  +  V+  +E+   
Sbjct: 99  MVIT-EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS 157
Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
                 +H DL   NILL +  V  + D GLA+ +  Y+           + +K    ++
Sbjct: 158 R---KCIHRDLAARNILLSEKNVVKICDFGLARDI--YKDPDYVRKGDARLPLK----WM 208
Query: 213 APEYGMGSKASVSGDVYNFGILLLEMFT 240
           APE       ++  DV++FG+LL E+F+
Sbjct: 209 APETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 91/217 (41%), Gaps = 27/217 (12%)
Query: 27  KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRH 86
           K      P     QG V   +  +L  + ++  +      Q  A R++  E   L+ + H
Sbjct: 24  KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNH 82
Query: 87  RNLIKIITICSSID-FEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSF 145
           +N+I ++ + +     E F    +V E M + NL Q +       R       +   +  
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIHMELDHERM----SYLLYQMLC 137
Query: 146 AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEI 205
            I++ H      I+H DLKPSNI++  D    + D GLA+              +N +  
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-----------TACTNFMMT 183
Query: 206 KGIVG--YVAPE--YGMGSKASVSGDVYNFGILLLEM 238
             +V   Y APE   GMG  A+V  D+++ G ++ E+
Sbjct: 184 PYVVTRYYRAPEVILGMGYAANV--DIWSVGCIMGEL 218

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 96/213 (45%), Gaps = 26/213 (12%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAA-----ECNALRNIRHRNLIKI 92
           IG+G  S+V + I  E+    AVK+V++ +  +S   +      E +    ++H +++++
Sbjct: 32  IGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 93  ITICSSIDFEGFDFKAIVFEYMQNRNL--EQWLRQSNGQLRFLTQRVNIAIDVSFAIEYF 150
           +   SS   +G  +  +VFE+M   +L  E   R   G +       +    +  A+ Y 
Sbjct: 92  LETYSS---DGMLY--MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYC 146
Query: 151 HHHCQPSIVHGDLKPSNILL---DQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKG 207
           H +   +I+H D+KP N+LL   +      +GD G+A  L     G +   A   +   G
Sbjct: 147 HDN---NIIHRDVKPENVLLASKENSAPVKLGDFGVAIQL-----GESGLVAGGRV---G 195
Query: 208 IVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
              ++APE           DV+  G++L  + +
Sbjct: 196 TPHFMAPEVVKREPYGKPVDVWGCGVILFILLS 228

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 57/247 (23%), Positives = 106/247 (42%), Gaps = 44/247 (17%)
Query: 13  MKQQFPMISYAELSKAT-------NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL 65
           M Q+ P     EL+K          N SP   +G G    V      ++   VAVK ++ 
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSR 57
Query: 66  KQK---EASRSFAAECNALRNIRHRNLIKIITICSSI-DFEGFDFKAIVFEYM--QNRNL 119
             +    A R++  E   L++++H N+I ++ + +     E F+   +V   M     N+
Sbjct: 58  PFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI 116
Query: 120 EQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVG 179
            +  + ++  ++FL  ++         ++Y H      I+H DLKPSN+ +++D    + 
Sbjct: 117 VKCQKLTDDHVQFLIYQI------LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 167
Query: 180 DLGLAKFLFGYEPGTAAETASNSIEIKGIVG---YVAPEYGMG-SKASVSGDVYNFGILL 235
           D GLA+                  E+ G V    Y APE  +     + + D+++ G ++
Sbjct: 168 DFGLAR--------------HTDDEMTGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 213
Query: 236 LEMFTRR 242
            E+ T R
Sbjct: 214 AELLTGR 220

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 57/247 (23%), Positives = 106/247 (42%), Gaps = 44/247 (17%)
Query: 13  MKQQFPMISYAELSKAT-------NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL 65
           M Q+ P     EL+K          N SP   +G G    V      ++   VAVK ++ 
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSR 57
Query: 66  KQK---EASRSFAAECNALRNIRHRNLIKIITICSSI-DFEGFDFKAIVFEYM--QNRNL 119
             +    A R++  E   L++++H N+I ++ + +     E F+   +V   M     N+
Sbjct: 58  PFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI 116
Query: 120 EQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVG 179
            +  + ++  ++FL  ++         ++Y H      I+H DLKPSN+ +++D    + 
Sbjct: 117 VKCQKLTDDHVQFLIYQI------LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 167
Query: 180 DLGLAKFLFGYEPGTAAETASNSIEIKGIVG---YVAPEYGMG-SKASVSGDVYNFGILL 235
           D GLA+                  E+ G V    Y APE  +     + + D+++ G ++
Sbjct: 168 DFGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 213
Query: 236 LEMFTRR 242
            E+ T R
Sbjct: 214 AELLTGR 220

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 59/256 (23%), Positives = 105/256 (41%), Gaps = 54/256 (21%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKII--- 93
           ++G G    VYK    E+ ++ A KV+  K +E    +  E   L    H  ++K++   
Sbjct: 18  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 77
Query: 94  ----TICSSIDF-EGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIE 148
                +   I+F  G    AI+ E   +R L      +  Q++ + +++  A++      
Sbjct: 78  YHDGKLWIMIEFCPGGAVDAIMLEL--DRGL------TEPQIQVVCRQMLEALN------ 123
Query: 149 YFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGI 208
           + H      I+H DLK  N+L+  +     GD+ LA F      G +A+      +    
Sbjct: 124 FLHSK---RIIHRDLKAGNVLMTLE-----GDIRLADF------GVSAKNLKTLQKRDSF 169
Query: 209 VG---YVAPEYGM-----GSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVK 260
           +G   ++APE  M      +      D+++ GI L+EM     P           HE   
Sbjct: 170 IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPH----------HELNP 219
Query: 261 MALPDKVMEIVDPSLL 276
           M +  K+ +   P+LL
Sbjct: 220 MRVLLKIAKSDPPTLL 235

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 62/147 (42%), Gaps = 13/147 (8%)
Query: 101 FEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVH 160
           F+  D    V EY+   +L   ++Q  G+ +   Q V  A ++S  + + H      I++
Sbjct: 89  FQTVDRLYFVMEYVNGGDLMYHIQQV-GKFK-EPQAVFYAAEISIGLFFLHKR---GIIY 143
Query: 161 GDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGS 220
            DLK  N++LD +    + D G+ K                + E  G   Y+APE     
Sbjct: 144 RDLKLDNVMLDSEGHIKIADFGMCK--------EHMMDGVTTREFCGTPDYIAPEIIAYQ 195
Query: 221 KASVSGDVYNFGILLLEMFTRRRPTDA 247
               S D + +G+LL EM   + P D 
Sbjct: 196 PYGKSVDWWAYGVLLYEMLAGQPPFDG 222

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 81/197 (41%), Gaps = 40/197 (20%)
Query: 61  KVVNLKQKEASRSFA------AECNALRNIRH----RNLIKIITICSSIDFEGFDFK--- 107
           +V+ +K KE+   +A       +   L+ I H    + +++ +     +  E F FK   
Sbjct: 56  RVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE-FSFKDNS 114
Query: 108 --AIVFEYMQNRNLEQWLRQ----SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHG 161
              +V EY+    +   LR+    S    RF       A  +    EY H      +++ 
Sbjct: 115 NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY------AAQIVLTFEYLH---SLDLIYR 165
Query: 162 DLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSK 221
           DLKP N+L+DQ     V D G AK + G            +  + G   Y+APE  +   
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRVKG-----------RTWXLXGTPEYLAPEIILSKG 214
Query: 222 ASVSGDVYNFGILLLEM 238
            + + D +  G+L+ EM
Sbjct: 215 YNKAVDWWALGVLIYEM 231

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 57/247 (23%), Positives = 106/247 (42%), Gaps = 44/247 (17%)
Query: 13  MKQQFPMISYAELSKAT-------NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL 65
           M Q+ P     EL+K          N SP   +G G    V      ++   VAVK ++ 
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSR 57
Query: 66  KQK---EASRSFAAECNALRNIRHRNLIKIITICSSI-DFEGFDFKAIVFEYM--QNRNL 119
             +    A R++  E   L++++H N+I ++ + +     E F+   +V   M     N+
Sbjct: 58  PFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI 116
Query: 120 EQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVG 179
            +  + ++  ++FL  ++         ++Y H      I+H DLKPSN+ +++D    + 
Sbjct: 117 VKCQKLTDDHVQFLIYQI------LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 167
Query: 180 DLGLAKFLFGYEPGTAAETASNSIEIKGIVG---YVAPEYGMG-SKASVSGDVYNFGILL 235
           D GLA+                  E+ G V    Y APE  +     + + D+++ G ++
Sbjct: 168 DFGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 213
Query: 236 LEMFTRR 242
            E+ T R
Sbjct: 214 AELLTGR 220

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 81/197 (41%), Gaps = 40/197 (20%)
Query: 61  KVVNLKQKEASRSFA------AECNALRNIRH----RNLIKIITICSSIDFEGFDFK--- 107
           +V+ +K KE+   +A       +   L+ I H    + +++ +     +  E F FK   
Sbjct: 56  RVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE-FSFKDNS 114
Query: 108 --AIVFEYMQNRNLEQWLRQ----SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHG 161
              +V EY+    +   LR+    S    RF       A  +    EY H      +++ 
Sbjct: 115 NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY------AAQIVLTFEYLH---SLDLIYR 165
Query: 162 DLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSK 221
           DLKP N+L+DQ     V D G AK + G            +  + G   Y+APE  +   
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRVKG-----------RTWXLAGTPEYLAPEIILSKG 214
Query: 222 ASVSGDVYNFGILLLEM 238
            + + D +  G+L+ EM
Sbjct: 215 YNKAVDWWALGVLIYEM 231

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 57/247 (23%), Positives = 106/247 (42%), Gaps = 44/247 (17%)
Query: 13  MKQQFPMISYAELSKAT-------NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL 65
           M Q+ P     EL+K          N SP   +G G    V      ++   VAVK ++ 
Sbjct: 3   MSQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSR 59
Query: 66  KQK---EASRSFAAECNALRNIRHRNLIKIITICSSI-DFEGFDFKAIVFEYM--QNRNL 119
             +    A R++  E   L++++H N+I ++ + +     E F+   +V   M     N+
Sbjct: 60  PFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI 118
Query: 120 EQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVG 179
            +  + ++  ++FL  ++         ++Y H      I+H DLKPSN+ +++D    + 
Sbjct: 119 VKCQKLTDDHVQFLIYQI------LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 169
Query: 180 DLGLAKFLFGYEPGTAAETASNSIEIKGIVG---YVAPEYGMG-SKASVSGDVYNFGILL 235
           D GLA+                  E+ G V    Y APE  +     + + D+++ G ++
Sbjct: 170 DFGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 215
Query: 236 LEMFTRR 242
            E+ T R
Sbjct: 216 AELLTGR 222

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 57/247 (23%), Positives = 106/247 (42%), Gaps = 44/247 (17%)
Query: 13  MKQQFPMISYAELSKAT-------NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL 65
           M Q+ P     EL+K          N SP   +G G    V      ++   VAVK ++ 
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSR 57
Query: 66  KQK---EASRSFAAECNALRNIRHRNLIKIITICSSI-DFEGFDFKAIVFEYM--QNRNL 119
             +    A R++  E   L++++H N+I ++ + +     E F+   +V   M     N+
Sbjct: 58  PFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI 116
Query: 120 EQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVG 179
            +  + ++  ++FL  ++         ++Y H      I+H DLKPSN+ +++D    + 
Sbjct: 117 VKCQKLTDDHVQFLIYQI------LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 167
Query: 180 DLGLAKFLFGYEPGTAAETASNSIEIKGIVG---YVAPEYGMG-SKASVSGDVYNFGILL 235
           D GLA+                  E+ G V    Y APE  +     + + D+++ G ++
Sbjct: 168 DFGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 213
Query: 236 LEMFTRR 242
            E+ T R
Sbjct: 214 AELLTGR 220

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 57/247 (23%), Positives = 106/247 (42%), Gaps = 44/247 (17%)
Query: 13  MKQQFPMISYAELSKAT-------NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL 65
           M Q+ P     EL+K          N SP   +G G    V      ++   VAVK ++ 
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSR 57
Query: 66  KQK---EASRSFAAECNALRNIRHRNLIKIITICSSI-DFEGFDFKAIVFEYM--QNRNL 119
             +    A R++  E   L++++H N+I ++ + +     E F+   +V   M     N+
Sbjct: 58  PFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI 116
Query: 120 EQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVG 179
            +  + ++  ++FL  ++         ++Y H      I+H DLKPSN+ +++D    + 
Sbjct: 117 VKCQKLTDDHVQFLIYQI------LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 167
Query: 180 DLGLAKFLFGYEPGTAAETASNSIEIKGIVG---YVAPEYGMG-SKASVSGDVYNFGILL 235
           D GLA+                  E+ G V    Y APE  +     + + D+++ G ++
Sbjct: 168 DFGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 213
Query: 236 LEMFTRR 242
            E+ T R
Sbjct: 214 AELLTGR 220

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 55/249 (22%), Positives = 105/249 (42%), Gaps = 48/249 (19%)
Query: 13  MKQQFPMISYAELSKAT-------NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL 65
           M Q+ P     EL+K          N SP      G V   +     ++++ + V V  L
Sbjct: 12  MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAF-----DTKTGLRVAVKKL 66
Query: 66  KQK-----EASRSFAAECNALRNIRHRNLIKIITICSSI-DFEGFDFKAIVFEYM--QNR 117
            +       A R++  E   L++++H N+I ++ + +     E F+   +V   M     
Sbjct: 67  SRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN 125
Query: 118 NLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAH 177
           N+ +  + ++  ++FL  ++         ++Y H      I+H DLKPSN+ +++D    
Sbjct: 126 NIVKCQKLTDDHVQFLIYQI------LRGLKYIH---SADIIHRDLKPSNLAVNEDCELK 176
Query: 178 VGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG---YVAPEYGMG-SKASVSGDVYNFGI 233
           + D GLA+                  E+ G V    Y APE  +     + + D+++ G 
Sbjct: 177 ILDFGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGC 222
Query: 234 LLLEMFTRR 242
           ++ E+ T R
Sbjct: 223 IMAELLTGR 231

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 59/256 (23%), Positives = 105/256 (41%), Gaps = 54/256 (21%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKII--- 93
           ++G G    VYK    E+ ++ A KV+  K +E    +  E   L    H  ++K++   
Sbjct: 26  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85
Query: 94  ----TICSSIDF-EGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIE 148
                +   I+F  G    AI+ E   +R L      +  Q++ + +++  A++      
Sbjct: 86  YHDGKLWIMIEFCPGGAVDAIMLEL--DRGL------TEPQIQVVCRQMLEALN------ 131
Query: 149 YFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGI 208
           + H      I+H DLK  N+L+  +     GD+ LA F      G +A+      +    
Sbjct: 132 FLHSK---RIIHRDLKAGNVLMTLE-----GDIRLADF------GVSAKNLKTLQKRDSF 177
Query: 209 VG---YVAPEYGM-----GSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVK 260
           +G   ++APE  M      +      D+++ GI L+EM     P           HE   
Sbjct: 178 IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPH----------HELNP 227
Query: 261 MALPDKVMEIVDPSLL 276
           M +  K+ +   P+LL
Sbjct: 228 MRVLLKIAKSDPPTLL 243

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 55/249 (22%), Positives = 105/249 (42%), Gaps = 48/249 (19%)
Query: 13  MKQQFPMISYAELSKAT-------NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL 65
           M Q+ P     EL+K          N SP      G V   +     ++++ + V V  L
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAF-----DTKTGLRVAVKKL 55
Query: 66  KQK-----EASRSFAAECNALRNIRHRNLIKIITICSSI-DFEGFDFKAIVFEYM--QNR 117
            +       A R++  E   L++++H N+I ++ + +     E F+   +V   M     
Sbjct: 56  SRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN 114
Query: 118 NLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAH 177
           N+ +  + ++  ++FL  ++         ++Y H      I+H DLKPSN+ +++D    
Sbjct: 115 NIVKCQKLTDDHVQFLIYQI------LRGLKYIH---SADIIHRDLKPSNLAVNEDCELK 165
Query: 178 VGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG---YVAPEYGMG-SKASVSGDVYNFGI 233
           + D GLA+                  E+ G V    Y APE  +     + + D+++ G 
Sbjct: 166 ILDFGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGC 211
Query: 234 LLLEMFTRR 242
           ++ E+ T R
Sbjct: 212 IMAELLTGR 220

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 57/247 (23%), Positives = 106/247 (42%), Gaps = 44/247 (17%)
Query: 13  MKQQFPMISYAELSKAT-------NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL 65
           M Q+ P     EL+K          N SP   +G G    V      ++   VAVK ++ 
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSR 57
Query: 66  KQK---EASRSFAAECNALRNIRHRNLIKIITICSSI-DFEGFDFKAIVFEYM--QNRNL 119
             +    A R++  E   L++++H N+I ++ + +     E F+   +V   M     N+
Sbjct: 58  PFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI 116
Query: 120 EQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVG 179
            +  + ++  ++FL  ++         ++Y H      I+H DLKPSN+ +++D    + 
Sbjct: 117 VKCQKLTDDHVQFLIYQI------LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 167
Query: 180 DLGLAKFLFGYEPGTAAETASNSIEIKGIVG---YVAPEYGMG-SKASVSGDVYNFGILL 235
           D GLA+                  E+ G V    Y APE  +     + + D+++ G ++
Sbjct: 168 DFGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 213
Query: 236 LEMFTRR 242
            E+ T R
Sbjct: 214 AELLTGR 220

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 55/249 (22%), Positives = 105/249 (42%), Gaps = 48/249 (19%)
Query: 13  MKQQFPMISYAELSKAT-------NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL 65
           M Q+ P     EL+K          N SP      G V   +     ++++ + V V  L
Sbjct: 20  MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAF-----DTKTGLRVAVKKL 74
Query: 66  KQK-----EASRSFAAECNALRNIRHRNLIKIITICSSI-DFEGFDFKAIVFEYM--QNR 117
            +       A R++  E   L++++H N+I ++ + +     E F+   +V   M     
Sbjct: 75  SRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN 133
Query: 118 NLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAH 177
           N+ +  + ++  ++FL  ++         ++Y H      I+H DLKPSN+ +++D    
Sbjct: 134 NIVKCQKLTDDHVQFLIYQI------LRGLKYIH---SADIIHRDLKPSNLAVNEDCELK 184
Query: 178 VGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG---YVAPEYGMG-SKASVSGDVYNFGI 233
           + D GLA+                  E+ G V    Y APE  +     + + D+++ G 
Sbjct: 185 ILDFGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGC 230
Query: 234 LLLEMFTRR 242
           ++ E+ T R
Sbjct: 231 IMAELLTGR 239

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 91/218 (41%), Gaps = 35/218 (16%)
Query: 29  TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEAS--RSFAAECNALRNIRH 86
           T+ +    ++G+G  S+V + +   +    A K++N K+  A   +    E    R ++H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 87  RNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQL--RFLTQRVNIAIDVS 144
            N++++     SI  EGF +  +VF+ +           + G+L    + +      D S
Sbjct: 63  PNIVRLH---DSISEEGFHY--LVFDLV-----------TGGELFEDIVAREYYSEADAS 106
Query: 145 FAIEYFH---HHCQ-PSIVHGDLKPSNILL---DQDIVAHVGDLGLAKFLFGYEPGTAAE 197
             I+      +HC    IVH DLKP N+LL    +     + D GLA  + G +      
Sbjct: 107 HCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFG- 165
Query: 198 TASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILL 235
                    G  GY++PE           D++  G++L
Sbjct: 166 -------FAGTPGYLSPEVLRKDPYGKPVDMWACGVIL 196

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 57/247 (23%), Positives = 106/247 (42%), Gaps = 44/247 (17%)
Query: 13  MKQQFPMISYAELSKAT-------NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL 65
           M Q+ P     EL+K          N SP   +G G    V      ++   VAVK ++ 
Sbjct: 21  MSQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSR 77
Query: 66  KQK---EASRSFAAECNALRNIRHRNLIKIITICSSI-DFEGFDFKAIVFEYM--QNRNL 119
             +    A R++  E   L++++H N+I ++ + +     E F+   +V   M     N+
Sbjct: 78  PFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI 136
Query: 120 EQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVG 179
            +  + ++  ++FL  ++         ++Y H      I+H DLKPSN+ +++D    + 
Sbjct: 137 VKCQKLTDDHVQFLIYQI------LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 187
Query: 180 DLGLAKFLFGYEPGTAAETASNSIEIKGIVG---YVAPEYGMG-SKASVSGDVYNFGILL 235
           D GLA+                  E+ G V    Y APE  +     + + D+++ G ++
Sbjct: 188 DFGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 233
Query: 236 LEMFTRR 242
            E+ T R
Sbjct: 234 AELLTGR 240

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 91/218 (41%), Gaps = 35/218 (16%)
Query: 29  TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEAS--RSFAAECNALRNIRH 86
           T+ +    ++G+G  S+V + +   +    A K++N K+  A   +    E    R ++H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 87  RNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQL--RFLTQRVNIAIDVS 144
            N++++     SI  EGF +  +VF+ +           + G+L    + +      D S
Sbjct: 63  PNIVRLH---DSISEEGFHY--LVFDLV-----------TGGELFEDIVAREYYSEADAS 106
Query: 145 FAIEYFH---HHCQ-PSIVHGDLKPSNILL---DQDIVAHVGDLGLAKFLFGYEPGTAAE 197
             I+      +HC    IVH DLKP N+LL    +     + D GLA  + G +      
Sbjct: 107 HCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFG- 165
Query: 198 TASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILL 235
                    G  GY++PE           D++  G++L
Sbjct: 166 -------FAGTPGYLSPEVLRKDPYGKPVDMWACGVIL 196

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 45/86 (52%), Gaps = 14/86 (16%)
Query: 159 VHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKG----IVGYVAP 214
           +H D+   N+LL    VA +GD GLA+ +            SN I +KG     V ++AP
Sbjct: 186 IHRDVAARNVLLTNGHVAKIGDFGLARDIM---------NDSNYI-VKGNARLPVKWMAP 235
Query: 215 EYGMGSKASVSGDVYNFGILLLEMFT 240
           E       +V  DV+++GILL E+F+
Sbjct: 236 ESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 57/247 (23%), Positives = 106/247 (42%), Gaps = 44/247 (17%)
Query: 13  MKQQFPMISYAELSKAT-------NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL 65
           M Q+ P     EL+K          N SP   +G G    V      ++   VAVK ++ 
Sbjct: 12  MSQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSR 68
Query: 66  KQK---EASRSFAAECNALRNIRHRNLIKIITICSSI-DFEGFDFKAIVFEYM--QNRNL 119
             +    A R++  E   L++++H N+I ++ + +     E F+   +V   M     N+
Sbjct: 69  PFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI 127
Query: 120 EQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVG 179
            +  + ++  ++FL  ++         ++Y H      I+H DLKPSN+ +++D    + 
Sbjct: 128 VKCQKLTDDHVQFLIYQI------LRGLKYIH---SADIIHRDLKPSNLAVNEDXELKIL 178
Query: 180 DLGLAKFLFGYEPGTAAETASNSIEIKGIVG---YVAPEYGMG-SKASVSGDVYNFGILL 235
           D GLA+                  E+ G V    Y APE  +     + + D+++ G ++
Sbjct: 179 DFGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 224
Query: 236 LEMFTRR 242
            E+ T R
Sbjct: 225 AELLTGR 231

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 57/247 (23%), Positives = 106/247 (42%), Gaps = 44/247 (17%)
Query: 13  MKQQFPMISYAELSKAT-------NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL 65
           M Q+ P     EL+K          N SP   +G G    V      ++   VAVK ++ 
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSR 57
Query: 66  KQK---EASRSFAAECNALRNIRHRNLIKIITICSSI-DFEGFDFKAIVFEYM--QNRNL 119
             +    A R++  E   L++++H N+I ++ + +     E F+   +V   M     N+
Sbjct: 58  PFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI 116
Query: 120 EQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVG 179
            +  + ++  ++FL  ++         ++Y H      I+H DLKPSN+ +++D    + 
Sbjct: 117 VKXQKLTDDHVQFLIYQI------LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 167
Query: 180 DLGLAKFLFGYEPGTAAETASNSIEIKGIVG---YVAPEYGMG-SKASVSGDVYNFGILL 235
           D GLA+                  E+ G V    Y APE  +     + + D+++ G ++
Sbjct: 168 DFGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 213
Query: 236 LEMFTRR 242
            E+ T R
Sbjct: 214 AELLTGR 220

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/222 (22%), Positives = 100/222 (45%), Gaps = 36/222 (16%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNI--RHRNLIKIITI 95
           IG+G    V++G        VAVK+ + +++   RS+  E    + +  RH N++  I  
Sbjct: 50  IGKGRFGEVWRGKWRGEE--VAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIA- 103
Query: 96  CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHC- 154
             + D   +    +V +Y ++ +L  +L +    +  +   + +A+  +  + + H    
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM---IKLALSTASGLAHLHMEIV 160
Query: 155 ----QPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIK---- 206
               +P+I H DLK  NIL+ ++    + DLGLA            ++A+++I+I     
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA---------VRHDSATDTIDIAPNHR 211
Query: 207 -GIVGYVAPEYGMGS------KASVSGDVYNFGILLLEMFTR 241
            G   Y+APE    S      ++    D+Y  G++  E+  R
Sbjct: 212 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 88/206 (42%), Gaps = 29/206 (14%)
Query: 51  LDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNI-RHRNLIKIITICSSIDFEGFDF 106
           +D++ +   V V  LK+       R+  +E   L +I  H N++ ++  C+     G   
Sbjct: 53  IDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK---PGGPL 109
Query: 107 KAIVFEYMQNRNLEQWLRQSNGQL----------RFLT--QRVNIAIDVSFAIEYFHHHC 154
             IV E+ +  NL  +LR    +            FLT    +  +  V+  +E+     
Sbjct: 110 MVIV-EFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQVAKGMEFLASR- 167
Query: 155 QPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAP 214
               +H DL   NILL +  V  + D GLA+ +   +           + +K    ++AP
Sbjct: 168 --KXIHRDLAARNILLSEKNVVKICDFGLARDI--XKDPDXVRKGDARLPLK----WMAP 219
Query: 215 EYGMGSKASVSGDVYNFGILLLEMFT 240
           E       ++  DV++FG+LL E+F+
Sbjct: 220 ETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 46/88 (52%), Gaps = 14/88 (15%)
Query: 157 SIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKG----IVGYV 212
           + +H D+   N+LL    VA +GD GLA+ +            SN I +KG     V ++
Sbjct: 186 NCIHRDVAARNVLLTNGHVAKIGDFGLARDIM---------NDSNYI-VKGNARLPVKWM 235
Query: 213 APEYGMGSKASVSGDVYNFGILLLEMFT 240
           APE       +V  DV+++GILL E+F+
Sbjct: 236 APESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 57/247 (23%), Positives = 106/247 (42%), Gaps = 44/247 (17%)
Query: 13  MKQQFPMISYAELSKAT-------NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL 65
           M Q+ P     EL+K          N SP   +G G    V      ++   VAVK ++ 
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSR 57
Query: 66  KQK---EASRSFAAECNALRNIRHRNLIKIITICSSI-DFEGFDFKAIVFEYM--QNRNL 119
             +    A R++  E   L++++H N+I ++ + +     E F+   +V   M     N+
Sbjct: 58  PFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI 116
Query: 120 EQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVG 179
            +  + ++  ++FL  ++         ++Y H      I+H DLKPSN+ +++D    + 
Sbjct: 117 VKXQKLTDDHVQFLIYQI------LRGLKYIH---SADIIHRDLKPSNLAVNEDXELKIL 167
Query: 180 DLGLAKFLFGYEPGTAAETASNSIEIKGIVG---YVAPEYGMG-SKASVSGDVYNFGILL 235
           D GLA+                  E+ G V    Y APE  +     + + D+++ G ++
Sbjct: 168 DFGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 213
Query: 236 LEMFTRR 242
            E+ T R
Sbjct: 214 AELLTGR 220

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 45/86 (52%), Gaps = 14/86 (16%)
Query: 159 VHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKG----IVGYVAP 214
           +H D+   N+LL    VA +GD GLA+ +            SN I +KG     V ++AP
Sbjct: 186 IHRDVAARNVLLTNGHVAKIGDFGLARDIM---------NDSNYI-VKGNARLPVKWMAP 235
Query: 215 EYGMGSKASVSGDVYNFGILLLEMFT 240
           E       +V  DV+++GILL E+F+
Sbjct: 236 ESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/222 (22%), Positives = 100/222 (45%), Gaps = 36/222 (16%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNI--RHRNLIKIITI 95
           IG+G    V++G        VAVK+ + +++   RS+  E    + +  RH N++  I  
Sbjct: 12  IGKGRFGEVWRGKWRGEE--VAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIA- 65
Query: 96  CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHC- 154
             + D   +    +V +Y ++ +L  +L +    +  +   + +A+  +  + + H    
Sbjct: 66  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM---IKLALSTASGLAHLHMEIV 122
Query: 155 ----QPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIK---- 206
               +P+I H DLK  NIL+ ++    + DLGLA            ++A+++I+I     
Sbjct: 123 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA---------VRHDSATDTIDIAPNHR 173
Query: 207 -GIVGYVAPEYGMGS------KASVSGDVYNFGILLLEMFTR 241
            G   Y+APE    S      ++    D+Y  G++  E+  R
Sbjct: 174 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 215

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 73/159 (45%), Gaps = 10/159 (6%)
Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEA--SRSFAAECNALRNIRHR 87
           +N+   + IG+G    VY      +   VA+K VN   ++    +    E   L  ++  
Sbjct: 26  DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 85
Query: 88  NLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAI 147
            +I++  +    D   FD   IV E + + +L++  +       FLT+     I  +  +
Sbjct: 86  YIIRLYDLIIPDDLLKFDELYIVLE-IADSDLKKLFKTP----IFLTEEHIKTILYNLLL 140
Query: 148 -EYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAK 185
            E F H  +  I+H DLKP+N LL+QD    V D GLA+
Sbjct: 141 GENFIH--ESGIIHRDLKPANCLLNQDCSVKVCDFGLAR 177

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 46/88 (52%), Gaps = 14/88 (15%)
Query: 157 SIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKG----IVGYV 212
           + +H D+   N+LL    VA +GD GLA+ +            SN I +KG     V ++
Sbjct: 180 NCIHRDVAARNVLLTNGHVAKIGDFGLARDIM---------NDSNYI-VKGNARLPVKWM 229
Query: 213 APEYGMGSKASVSGDVYNFGILLLEMFT 240
           APE       +V  DV+++GILL E+F+
Sbjct: 230 APESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 71/173 (41%), Gaps = 25/173 (14%)
Query: 76  AECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQ----SNGQLR 131
            E   L+N RH  L  +        F+  D    V EY     L   L +    S  + R
Sbjct: 197 TENRVLQNSRHPFLTAL-----KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRAR 251
Query: 132 FLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYE 191
           F    +  A+D        + H + ++V+ DLK  N++LD+D    + D GL K   G +
Sbjct: 252 FYGAEIVSALD--------YLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIK 301
Query: 192 PGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
            G   +T   + E      Y+APE    +    + D +  G+++ EM   R P
Sbjct: 302 DGATMKTFCGTPE------YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 88/225 (39%), Gaps = 28/225 (12%)
Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVN---LKQKEASRSFAAECNALRNIRH 86
           +NF     +G+G    V    + E+  + AVKV+    + Q +       E   L   R+
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 87  RNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNI-AIDVSF 145
              +  +  C    F+  D    V E++   +L   +++S    RF   R    A ++  
Sbjct: 83  HPFLTQLFCC----FQTPDRLFFVMEFVNGGDLMFHIQKSR---RFDEARARFYAAEIIS 135
Query: 146 AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEI 205
           A+ + H      I++ DLK  N+LLD     H G   LA F      G   E   N +  
Sbjct: 136 ALMFLH---DKGIIYRDLKLDNVLLD-----HEGHCKLADF------GMCKEGICNGVTT 181
Query: 206 KGIVG---YVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDA 247
               G   Y+APE         + D +  G+LL EM     P +A
Sbjct: 182 ATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA 226

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/222 (22%), Positives = 100/222 (45%), Gaps = 36/222 (16%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNI--RHRNLIKIITI 95
           IG+G    V++G        VAVK+ + +++   RS+  E    + +  RH N++  I  
Sbjct: 37  IGKGRFGEVWRGKWRGEE--VAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIA- 90
Query: 96  CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHC- 154
             + D   +    +V +Y ++ +L  +L +    +  +   + +A+  +  + + H    
Sbjct: 91  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM---IKLALSTASGLAHLHMEIV 147
Query: 155 ----QPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIK---- 206
               +P+I H DLK  NIL+ ++    + DLGLA            ++A+++I+I     
Sbjct: 148 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA---------VRHDSATDTIDIAPNHR 198
Query: 207 -GIVGYVAPEYGMGS------KASVSGDVYNFGILLLEMFTR 241
            G   Y+APE    S      ++    D+Y  G++  E+  R
Sbjct: 199 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 240

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/222 (22%), Positives = 100/222 (45%), Gaps = 36/222 (16%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNI--RHRNLIKIITI 95
           IG+G    V++G        VAVK+ + +++   RS+  E    + +  RH N++  I  
Sbjct: 11  IGKGRFGEVWRGKWRGEE--VAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIA- 64
Query: 96  CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHC- 154
             + D   +    +V +Y ++ +L  +L +    +  +   + +A+  +  + + H    
Sbjct: 65  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM---IKLALSTASGLAHLHMEIV 121
Query: 155 ----QPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIK---- 206
               +P+I H DLK  NIL+ ++    + DLGLA            ++A+++I+I     
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA---------VRHDSATDTIDIAPNHR 172
Query: 207 -GIVGYVAPEYGMGS------KASVSGDVYNFGILLLEMFTR 241
            G   Y+APE    S      ++    D+Y  G++  E+  R
Sbjct: 173 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 214

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/222 (22%), Positives = 100/222 (45%), Gaps = 36/222 (16%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNI--RHRNLIKIITI 95
           IG+G    V++G        VAVK+ + +++   RS+  E    + +  RH N++  I  
Sbjct: 17  IGKGRFGEVWRGKWRGEE--VAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIA- 70
Query: 96  CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHC- 154
             + D   +    +V +Y ++ +L  +L +    +  +   + +A+  +  + + H    
Sbjct: 71  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM---IKLALSTASGLAHLHMEIV 127
Query: 155 ----QPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIK---- 206
               +P+I H DLK  NIL+ ++    + DLGLA            ++A+++I+I     
Sbjct: 128 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA---------VRHDSATDTIDIAPNHR 178
Query: 207 -GIVGYVAPEYGMGS------KASVSGDVYNFGILLLEMFTR 241
            G   Y+APE    S      ++    D+Y  G++  E+  R
Sbjct: 179 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 220

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/222 (22%), Positives = 100/222 (45%), Gaps = 36/222 (16%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNI--RHRNLIKIITI 95
           IG+G    V++G        VAVK+ + +++   RS+  E    + +  RH N++  I  
Sbjct: 14  IGKGRFGEVWRGKWRGEE--VAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIA- 67
Query: 96  CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHC- 154
             + D   +    +V +Y ++ +L  +L +    +  +   + +A+  +  + + H    
Sbjct: 68  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM---IKLALSTASGLAHLHMEIV 124
Query: 155 ----QPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIK---- 206
               +P+I H DLK  NIL+ ++    + DLGLA            ++A+++I+I     
Sbjct: 125 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA---------VRHDSATDTIDIAPNHR 175
Query: 207 -GIVGYVAPEYGMGS------KASVSGDVYNFGILLLEMFTR 241
            G   Y+APE    S      ++    D+Y  G++  E+  R
Sbjct: 176 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 217

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 46/88 (52%), Gaps = 14/88 (15%)
Query: 157 SIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKG----IVGYV 212
           + +H D+   N+LL    VA +GD GLA+ +            SN I +KG     V ++
Sbjct: 172 NCIHRDVAARNVLLTNGHVAKIGDFGLARDIM---------NDSNYI-VKGNARLPVKWM 221
Query: 213 APEYGMGSKASVSGDVYNFGILLLEMFT 240
           APE       +V  DV+++GILL E+F+
Sbjct: 222 APESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/139 (25%), Positives = 64/139 (46%), Gaps = 16/139 (11%)
Query: 109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI-DVSFAIEYFHHHCQPSIVHGDLKPSN 167
           ++ +Y+    L   L Q     RF    V I + ++  A+E+ H   +  I++ D+K  N
Sbjct: 136 LILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLEN 189
Query: 168 ILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPE--YGMGSKASVS 225
           ILLD +    + D GL+K          A+    + +  G + Y+AP+   G  S    +
Sbjct: 190 ILLDSNGHVVLTDFGLSKEF-------VADETERAYDFCGTIEYMAPDIVRGGDSGHDKA 242
Query: 226 GDVYNFGILLLEMFTRRRP 244
            D ++ G+L+ E+ T   P
Sbjct: 243 VDWWSLGVLMYELLTGASP 261

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 57/247 (23%), Positives = 106/247 (42%), Gaps = 44/247 (17%)
Query: 13  MKQQFPMISYAELSKAT-------NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL 65
           M Q+ P     EL+K          N SP   +G G    V      ++   VAVK ++ 
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSR 57
Query: 66  KQK---EASRSFAAECNALRNIRHRNLIKIITICSSI-DFEGFDFKAIVFEYM--QNRNL 119
             +    A R++  E   L++++H N+I ++ + +     E F+   +V   M     N+
Sbjct: 58  PFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI 116
Query: 120 EQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVG 179
            +  + ++  ++FL  ++         ++Y H      I+H DLKPSN+ +++D    + 
Sbjct: 117 VKCQKLTDDHVQFLIYQI------LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 167
Query: 180 DLGLAKFLFGYEPGTAAETASNSIEIKGIVG---YVAPEYGMG-SKASVSGDVYNFGILL 235
           D GLA+                  E+ G V    Y APE  +     + + D+++ G ++
Sbjct: 168 DYGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 213
Query: 236 LEMFTRR 242
            E+ T R
Sbjct: 214 AELLTGR 220

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 71/173 (41%), Gaps = 25/173 (14%)
Query: 76  AECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQ----SNGQLR 131
            E   L+N RH  L  +        F+  D    V EY     L   L +    S  + R
Sbjct: 200 TENRVLQNSRHPFLTAL-----KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRAR 254
Query: 132 FLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYE 191
           F    +  A+D        + H + ++V+ DLK  N++LD+D    + D GL K   G +
Sbjct: 255 FYGAEIVSALD--------YLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIK 304
Query: 192 PGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
            G   +T   + E      Y+APE    +    + D +  G+++ EM   R P
Sbjct: 305 DGATMKTFCGTPE------YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 351

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/229 (22%), Positives = 101/229 (44%), Gaps = 37/229 (16%)
Query: 24  ELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK---EASRSFAAECNA 80
           E+ +   N SP   +G G    V      ++   VAVK ++   +    A R++  E   
Sbjct: 15  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRL 70
Query: 81  LRNIRHRNLIKIITICSSI-DFEGFDFKAIVFEYM--QNRNLEQWLRQSNGQLRFLTQRV 137
           L++++H N+I ++ + +     E F+   +V   M     N+ +  + ++  ++FL  ++
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQI 130
Query: 138 NIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAE 197
                    ++Y H      I+H DLKPSN+ +++D    + D GLA+            
Sbjct: 131 ------LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR------------ 169
Query: 198 TASNSIEIKGIVG---YVAPEYGMG-SKASVSGDVYNFGILLLEMFTRR 242
                 E+ G V    Y APE  +     + + D+++ G ++ E+ T R
Sbjct: 170 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 74/163 (45%), Gaps = 14/163 (8%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEA---SRSFAAECNALRNIRHRNLIKIIT 94
           IG G    V +      + +VA+K + L+  E     +    E   L  + H +++K++ 
Sbjct: 61  IGTGSYGHVCEAYDKLEKRVVAIKKI-LRVFEDLIDCKRILREIAILNRLNHDHVVKVLD 119
Query: 95  ICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSN--GQLRFLTQRVNIAIDVSFAIEYFHH 152
           I    D E FD   +V E + + + ++  R      +L   T   N+ +     ++Y H 
Sbjct: 120 IVIPKDVEKFDELYVVLE-IADSDFKKLFRTPVYLTELHIKTLLYNLLV----GVKYVH- 173
Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTA 195
                I+H DLKP+N L++QD    V D GLA+ +   E G +
Sbjct: 174 --SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNS 214

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 85/209 (40%), Gaps = 27/209 (12%)
Query: 32  FSPANKIGQGGVSIVYKGILDESRSIVAVKVV---NLKQKEASRSFAAECNALRNIRHRN 88
           F     +G G  S V       +  + AVK +    LK KE+S     E   LR I+H N
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESS--IENEIAVLRKIKHEN 81
Query: 89  LIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIE 148
           ++ +  I  S +      + +    + +R +E+           + Q ++       A+ 
Sbjct: 82  IVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLD-------AVY 134
Query: 149 YFHHHCQPSIVHGDLKPSNILL---DQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEI 205
           Y H   +  IVH DLKP N+L    D++    + D GL+K       G    TA      
Sbjct: 135 YLH---RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKM---EGKGDVMSTAC----- 183
Query: 206 KGIVGYVAPEYGMGSKASVSGDVYNFGIL 234
            G  GYVAPE       S + D ++ G++
Sbjct: 184 -GTPGYVAPEVLAQKPYSKAVDCWSIGVI 211

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 86/215 (40%), Gaps = 30/215 (13%)
Query: 29  TNNFSPANKIGQGG---VSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIR 85
           ++ +    K+G G    V +    +    R+I  +K  ++     S +   E   L+ + 
Sbjct: 20  SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 79
Query: 86  HRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNL--EQWLRQSNGQLRFLTQRVNIAIDV 143
           H N++K+        FE      +V E  +   L  E  LRQ   ++        I   V
Sbjct: 80  HPNIMKLYEF-----FEDKRNYYLVMEVYRGGELFDEIILRQKFSEV----DAAVIMKQV 130
Query: 144 SFAIEYFHHHCQPSIVHGDLKPSNILLD---QDIVAHVGDLGLAKFLFGYEPGTAAETAS 200
                Y H H   +IVH DLKP N+LL+   +D +  + D GL+            E   
Sbjct: 131 LSGTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHF---------EVGG 178
Query: 201 NSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILL 235
              E  G   Y+APE  +  K     DV++ G++L
Sbjct: 179 KMKERLGTAYYIAPEV-LRKKYDEKCDVWSCGVIL 212

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 88/208 (42%), Gaps = 31/208 (14%)
Query: 51  LDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNI-RHRNLIKIITICSSIDFEGFDF 106
           +D++ +   V V  LK+       R+  +E   L +I  H N++ ++  C+     G   
Sbjct: 51  IDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK---PGGPL 107
Query: 107 KAIVFEYMQNRNLEQWLRQSNGQL------------RFLT--QRVNIAIDVSFAIEYFHH 152
             IV E+ +  NL  +LR    +              FLT    +  +  V+  +E+   
Sbjct: 108 MVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS 166
Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
                 +H DL   NILL +  V  + D GLA+ +   +           + +K    ++
Sbjct: 167 R---KCIHRDLAARNILLSEKNVVKICDFGLARDI--XKDPDXVRKGDARLPLK----WM 217
Query: 213 APEYGMGSKASVSGDVYNFGILLLEMFT 240
           APE       ++  DV++FG+LL E+F+
Sbjct: 218 APETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/229 (22%), Positives = 101/229 (44%), Gaps = 37/229 (16%)
Query: 24  ELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK---EASRSFAAECNA 80
           E+ +   N SP   +G G    V      ++   VAVK ++   +    A R++  E   
Sbjct: 15  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRL 70
Query: 81  LRNIRHRNLIKIITICSSI-DFEGFDFKAIVFEYM--QNRNLEQWLRQSNGQLRFLTQRV 137
           L++++H N+I ++ + +     E F+   +V   M     N+ +  + ++  ++FL  ++
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 130
Query: 138 NIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAE 197
                    ++Y H      I+H DLKPSN+ +++D    + D GLA+            
Sbjct: 131 ------LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR------------ 169
Query: 198 TASNSIEIKGIVG---YVAPEYGMG-SKASVSGDVYNFGILLLEMFTRR 242
                 E+ G V    Y APE  +     + + D+++ G ++ E+ T R
Sbjct: 170 --HTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 57/247 (23%), Positives = 106/247 (42%), Gaps = 44/247 (17%)
Query: 13  MKQQFPMISYAELSKAT-------NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL 65
           M Q+ P     EL+K          N SP   +G G    V      ++   VAVK ++ 
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSR 57
Query: 66  KQK---EASRSFAAECNALRNIRHRNLIKIITICSSI-DFEGFDFKAIVFEYM--QNRNL 119
             +    A R++  E   L++++H N+I ++ + +     E F+   +V   M     N+
Sbjct: 58  PFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI 116
Query: 120 EQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVG 179
            +  + ++  ++FL  ++         ++Y H      I+H DLKPSN+ +++D    + 
Sbjct: 117 VKCQKLTDDHVQFLIYQI------LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 167
Query: 180 DLGLAKFLFGYEPGTAAETASNSIEIKGIVG---YVAPEYGMG-SKASVSGDVYNFGILL 235
           D GLA+                  E+ G V    Y APE  +     + + D+++ G ++
Sbjct: 168 DAGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 213
Query: 236 LEMFTRR 242
            E+ T R
Sbjct: 214 AELLTGR 220

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 88/208 (42%), Gaps = 31/208 (14%)
Query: 51  LDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNI-RHRNLIKIITICSSIDFEGFDF 106
           +D++ +   V V  LK+       R+  +E   L +I  H N++ ++  C+     G   
Sbjct: 42  IDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK---PGGPL 98
Query: 107 KAIVFEYMQNRNLEQWLRQSNGQL------------RFLT--QRVNIAIDVSFAIEYFHH 152
             IV E+ +  NL  +LR    +              FLT    +  +  V+  +E+   
Sbjct: 99  MVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS 157
Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
                 +H DL   NILL +  V  + D GLA+ +   +           + +K    ++
Sbjct: 158 R---KCIHRDLAARNILLSEKNVVKICDFGLARDI--XKDPDXVRKGDARLPLK----WM 208
Query: 213 APEYGMGSKASVSGDVYNFGILLLEMFT 240
           APE       ++  DV++FG+LL E+F+
Sbjct: 209 APETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/229 (22%), Positives = 101/229 (44%), Gaps = 37/229 (16%)
Query: 24  ELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK---EASRSFAAECNA 80
           E+ +   N SP   +G G    V      ++   VAVK ++   +    A R++  E   
Sbjct: 25  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRL 80
Query: 81  LRNIRHRNLIKIITICSSI-DFEGFDFKAIVFEYM--QNRNLEQWLRQSNGQLRFLTQRV 137
           L++++H N+I ++ + +     E F+   +V   M     N+ +  + ++  ++FL  ++
Sbjct: 81  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 140
Query: 138 NIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAE 197
                    ++Y H      I+H DLKPSN+ +++D    + D GLA+            
Sbjct: 141 ------LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR------------ 179
Query: 198 TASNSIEIKGIVG---YVAPEYGMG-SKASVSGDVYNFGILLLEMFTRR 242
                 E+ G V    Y APE  +     + + D+++ G ++ E+ T R
Sbjct: 180 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 81/197 (41%), Gaps = 40/197 (20%)
Query: 61  KVVNLKQKEASRSFA------AECNALRNIRH----RNLIKIITICSSIDFEGFDFK--- 107
           +V+ +K KE+   +A       +   L+ I H    + +++ +     +  E F FK   
Sbjct: 56  RVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE-FSFKDNS 114
Query: 108 --AIVFEYMQNRNLEQWLRQ----SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHG 161
              +V EY+    +   LR+    S    RF       A  +    EY H      +++ 
Sbjct: 115 NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY------AAQIVLTFEYLH---SLDLIYR 165
Query: 162 DLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSK 221
           DLKP N+L+DQ     V D G AK + G            +  + G   Y+APE  +   
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRVKG-----------RTWXLCGTPEYLAPEIILSKG 214
Query: 222 ASVSGDVYNFGILLLEM 238
            + + D +  G+L+ EM
Sbjct: 215 YNKAVDWWALGVLIYEM 231

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 81/197 (41%), Gaps = 40/197 (20%)
Query: 61  KVVNLKQKEASRSFA------AECNALRNIRH----RNLIKIITICSSIDFEGFDFK--- 107
           +V+ +K KE+   +A       +   L+ I H    + +++ +     +  E F FK   
Sbjct: 57  RVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE-FSFKDNS 115
Query: 108 --AIVFEYMQNRNLEQWLRQ----SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHG 161
              +V EY+    +   LR+    S    RF       A  +    EY H      +++ 
Sbjct: 116 NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY------AAQIVLTFEYLH---SLDLIYR 166
Query: 162 DLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSK 221
           DLKP N+L+DQ     V D G AK + G            +  + G   Y+APE  +   
Sbjct: 167 DLKPENLLIDQQGYIQVTDFGFAKRVKG-----------RTWXLCGTPEYLAPEIILSKG 215
Query: 222 ASVSGDVYNFGILLLEM 238
            + + D +  G+L+ EM
Sbjct: 216 YNKAVDWWALGVLIYEM 232

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 46/88 (52%), Gaps = 14/88 (15%)
Query: 157 SIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKG----IVGYV 212
           + +H D+   N+LL    VA +GD GLA+ +            SN I +KG     V ++
Sbjct: 178 NCIHRDVAARNVLLTNGHVAKIGDFGLARDIM---------NDSNYI-VKGNARLPVKWM 227
Query: 213 APEYGMGSKASVSGDVYNFGILLLEMFT 240
           APE       +V  DV+++GILL E+F+
Sbjct: 228 APESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/99 (28%), Positives = 45/99 (45%), Gaps = 14/99 (14%)
Query: 140 AIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETA 199
           A  +    EY H      +++ DLKP N+++DQ     V D GLAK + G          
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKG---------- 193
Query: 200 SNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEM 238
             +  + G   Y+APE  +    + + D +  G+L+ EM
Sbjct: 194 -RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/229 (22%), Positives = 101/229 (44%), Gaps = 37/229 (16%)
Query: 24  ELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK---EASRSFAAECNA 80
           E+ +   N SP   +G G    V      ++   VAVK ++   +    A R++  E   
Sbjct: 15  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRL 70
Query: 81  LRNIRHRNLIKIITICSSI-DFEGFDFKAIVFEYM--QNRNLEQWLRQSNGQLRFLTQRV 137
           L++++H N+I ++ + +     E F+   +V   M     N+ +  + ++  ++FL  ++
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 130
Query: 138 NIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAE 197
                    ++Y H      I+H DLKPSN+ +++D    + D GLA+            
Sbjct: 131 ------LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR------------ 169
Query: 198 TASNSIEIKGIVG---YVAPEYGMG-SKASVSGDVYNFGILLLEMFTRR 242
                 E+ G V    Y APE  +     + + D+++ G ++ E+ T R
Sbjct: 170 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 93/215 (43%), Gaps = 31/215 (14%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVN---LKQKEASRSFAAECNALRNIRHRNLIKIIT 94
           +G+G    V K     ++   AVKV+N    K K+ S +   E   L+ + H N++K+  
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS-TILREVELLKKLDHPNIMKLFE 88
Query: 95  ICSSIDFEGFDFKAIVFE-YMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFA-IEYFHH 152
           I    D   F    IV E Y      ++ +++     RF        I   F+ I Y H 
Sbjct: 89  ILE--DSSSF---YIVGELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHK 139
Query: 153 HCQPSIVHGDLKPSNILL---DQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
           H   +IVH DLKP NILL   ++D    + D GL+         T  +  +   +  G  
Sbjct: 140 H---NIVHRDLKPENILLESKEKDCDIKIIDFGLS---------TCFQQNTKMKDRIGTA 187
Query: 210 GYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
            Y+APE   G+      DV++ G++L  + +   P
Sbjct: 188 YYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPP 221

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/247 (23%), Positives = 106/247 (42%), Gaps = 44/247 (17%)
Query: 13  MKQQFPMISYAELSKAT-------NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL 65
           M Q+ P     EL+K          N SP   +G G    V      ++   VAVK ++ 
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSR 57
Query: 66  KQK---EASRSFAAECNALRNIRHRNLIKIITICSSI-DFEGFDFKAIVFEYM--QNRNL 119
             +    A R++  E   L++++H N+I ++ + +     E F+   +V   M     N+
Sbjct: 58  PFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI 116
Query: 120 EQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVG 179
            +  + ++  ++FL  ++         ++Y H      I+H DLKPSN+ +++D    + 
Sbjct: 117 VKCQKLTDDHVQFLIYQI------LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 167
Query: 180 DLGLAKFLFGYEPGTAAETASNSIEIKGIVG---YVAPEYGMG-SKASVSGDVYNFGILL 235
           D GLA+                  E+ G V    Y APE  +     + + D+++ G ++
Sbjct: 168 DRGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 213
Query: 236 LEMFTRR 242
            E+ T R
Sbjct: 214 AELLTGR 220

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 81/197 (41%), Gaps = 40/197 (20%)
Query: 61  KVVNLKQKEASRSFA------AECNALRNIRH----RNLIKIITICSSIDFEGFDFK--- 107
           +V+ +K KE+   +A       +   L+ I H    + +++ +     +  E F FK   
Sbjct: 56  RVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE-FSFKDNS 114
Query: 108 --AIVFEYMQNRNLEQWLRQ----SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHG 161
              +V EY+    +   LR+    S    RF       A  +    EY H      +++ 
Sbjct: 115 NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY------AAQIVLTFEYLH---SLDLIYR 165
Query: 162 DLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSK 221
           DLKP N+L+DQ     V D G AK + G            +  + G   Y+APE  +   
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRVKG-----------RTWXLCGTPEYLAPEIILSKG 214
Query: 222 ASVSGDVYNFGILLLEM 238
            + + D +  G+L+ EM
Sbjct: 215 YNKAVDWWALGVLIYEM 231

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 81/197 (41%), Gaps = 40/197 (20%)
Query: 61  KVVNLKQKEASRSFA------AECNALRNIRH----RNLIKIITICSSIDFEGFDFK--- 107
           +V+ +K KE+   +A       +   L+ I H    + +++ +     +  E F FK   
Sbjct: 56  RVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE-FSFKDNS 114
Query: 108 --AIVFEYMQNRNLEQWLRQ----SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHG 161
              +V EY+    +   LR+    S    RF       A  +    EY H      +++ 
Sbjct: 115 NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY------AAQIVLTFEYLH---SLDLIYR 165
Query: 162 DLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSK 221
           DLKP N+L+DQ     V D G AK + G            +  + G   Y+APE  +   
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRVKG-----------RTWXLCGTPEYLAPEIILSKG 214
Query: 222 ASVSGDVYNFGILLLEM 238
            + + D +  G+L+ EM
Sbjct: 215 YNKAVDWWALGVLIYEM 231

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 42/224 (18%)
Query: 26  SKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAA---ECNALR 82
           +K ++N+    ++G+G  S+V + +   +    A K++N K K ++R F     E    R
Sbjct: 1   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTK-KLSARDFQKLEREARICR 59
Query: 83  NIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQL--RFLTQRVNIA 140
            ++H N++++     SI  E F +  +VF+ +           + G+L    + +     
Sbjct: 60  KLQHPNIVRLH---DSIQEESFHY--LVFDLV-----------TGGELFEDIVAREFYSE 103
Query: 141 IDVSFAIE-------YFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPG 193
            D S  I+       Y H +    IVH +LKP N+LL     A    + LA F      G
Sbjct: 104 ADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASK--AKGAAVKLADF------G 152
Query: 194 TAAETASNSIE--IKGIVGYVAPEYGMGSKASVSGDVYNFGILL 235
            A E   +       G  GY++PE       S   D++  G++L
Sbjct: 153 LAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 196

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 59/259 (22%), Positives = 106/259 (40%), Gaps = 30/259 (11%)
Query: 3   PAHKDSNMLSMKQQFPMISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKV 62
           P  +D+  + + ++   + Y E  +  +  +   ++G+G    V++    ++    AVK 
Sbjct: 48  PETEDNEGVLLTEKLKPVDY-EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKK 106
Query: 63  VNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQW 122
           V L+        A  C  L + R      I+ +  ++  EG  +  I  E ++  +L Q 
Sbjct: 107 VRLEVFRVEELVA--CAGLSSPR------IVPLYGAVR-EG-PWVNIFMELLEGGSLGQL 156
Query: 123 LRQ-----SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQD-IVA 176
           ++Q      +  L +L Q +         +EY H      I+HGD+K  N+LL  D   A
Sbjct: 157 IKQMGCLPEDRALYYLGQALE-------GLEYLHTR---RILHGDVKADNVLLSSDGSRA 206
Query: 177 HVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLL 236
            + D G A  L   +P    ++      I G   ++APE  MG       D+++   ++L
Sbjct: 207 ALCDFGHALCL---QPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMML 263
Query: 237 EMFTRRRPTDAMFNEGLTL 255
            M     P    F   L L
Sbjct: 264 HMLNGCHPWTQYFRGPLCL 282

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 81/197 (41%), Gaps = 40/197 (20%)
Query: 61  KVVNLKQKEASRSFA------AECNALRNIRH----RNLIKIITICSSIDFEGFDFK--- 107
           +V+ +K KE+   +A       +   L+ I H    + +++ +     +  E F FK   
Sbjct: 56  RVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE-FSFKDNS 114
Query: 108 --AIVFEYMQNRNLEQWLRQ----SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHG 161
              +V EY+    +   LR+    S    RF       A  +    EY H      +++ 
Sbjct: 115 NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY------AAQIVLTFEYLH---SLDLIYR 165
Query: 162 DLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSK 221
           DLKP N+L+DQ     V D G AK + G            +  + G   Y+APE  +   
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRVKG-----------RTWXLCGTPEYLAPEIILSKG 214
Query: 222 ASVSGDVYNFGILLLEM 238
            + + D +  G+L+ EM
Sbjct: 215 YNKAVDWWALGVLIYEM 231

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 82/197 (41%), Gaps = 40/197 (20%)
Query: 61  KVVNLKQKEASRSFA------AECNALRNIRH----RNLIKIITICSSIDFEGFDFK--- 107
           +V+ +K KE+   +A       +   L+ I H    + +++ +     +  E F FK   
Sbjct: 77  RVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE-FSFKDNS 135
Query: 108 --AIVFEYMQNRNLEQWLRQ----SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHG 161
              +V EY+    +   LR+    S    RF       A  +    EY H      +++ 
Sbjct: 136 NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY------AAQIVLTFEYLH---SLDLIYR 186
Query: 162 DLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSK 221
           DLKP N+L+DQ     V D G AK + G     A  T   + E      Y+APE  +   
Sbjct: 187 DLKPENLLIDQQGYIQVTDFGFAKRVKG-----ATWTLCGTPE------YLAPEIILSKG 235
Query: 222 ASVSGDVYNFGILLLEM 238
            + + D +  G+L+ EM
Sbjct: 236 YNKAVDWWALGVLIYEM 252

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 81/197 (41%), Gaps = 40/197 (20%)
Query: 61  KVVNLKQKEASRSFA------AECNALRNIRH----RNLIKIITICSSIDFEGFDFK--- 107
           +V+ +K KE+   +A       +   L+ I H    + +++ +     +  E F FK   
Sbjct: 56  RVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE-FSFKDNS 114
Query: 108 --AIVFEYMQNRNLEQWLRQ----SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHG 161
              +V EY+    +   LR+    S    RF       A  +    EY H      +++ 
Sbjct: 115 NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY------AAQIVLTFEYLH---SLDLIYR 165
Query: 162 DLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSK 221
           DLKP N+L+DQ     V D G AK + G            +  + G   Y+APE  +   
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRVKG-----------RTWXLCGTPEYLAPEIILSKG 214
Query: 222 ASVSGDVYNFGILLLEM 238
            + + D +  G+L+ EM
Sbjct: 215 YNKAVDWWALGVLIYEM 231

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 42/224 (18%)
Query: 26  SKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAA---ECNALR 82
           +K ++N+    ++G+G  S+V + +   +    A K++N K K ++R F     E    R
Sbjct: 2   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTK-KLSARDFQKLEREARICR 60
Query: 83  NIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQL--RFLTQRVNIA 140
            ++H N++++     SI  E F +  +VF+ +           + G+L    + +     
Sbjct: 61  KLQHPNIVRLH---DSIQEESFHY--LVFDLV-----------TGGELFEDIVAREFYSE 104
Query: 141 IDVSFAIE-------YFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPG 193
            D S  I+       Y H +    IVH +LKP N+LL     A    + LA F      G
Sbjct: 105 ADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASK--AKGAAVKLADF------G 153
Query: 194 TAAETASNSIE--IKGIVGYVAPEYGMGSKASVSGDVYNFGILL 235
            A E   +       G  GY++PE       S   D++  G++L
Sbjct: 154 LAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 197

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 93/215 (43%), Gaps = 31/215 (14%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVN---LKQKEASRSFAAECNALRNIRHRNLIKIIT 94
           +G+G    V K     ++   AVKV+N    K K+ S +   E   L+ + H N++K+  
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS-TILREVELLKKLDHPNIMKLFE 88
Query: 95  ICSSIDFEGFDFKAIVFE-YMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFA-IEYFHH 152
           I    D   F    IV E Y      ++ +++     RF        I   F+ I Y H 
Sbjct: 89  ILE--DSSSF---YIVGELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHK 139
Query: 153 HCQPSIVHGDLKPSNILL---DQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
           H   +IVH DLKP NILL   ++D    + D GL+         T  +  +   +  G  
Sbjct: 140 H---NIVHRDLKPENILLESKEKDCDIKIIDFGLS---------TCFQQNTKMKDRIGTA 187
Query: 210 GYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
            Y+APE   G+      DV++ G++L  + +   P
Sbjct: 188 YYIAPEVLRGTYDE-KCDVWSAGVILYILLSGTPP 221

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/229 (23%), Positives = 103/229 (44%), Gaps = 37/229 (16%)
Query: 24  ELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK---EASRSFAAECNA 80
           E+ +   N SP   +G G    V      ++   VAVK ++   +    A R++  E   
Sbjct: 26  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRL 81
Query: 81  LRNIRHRNLIKIITICSSI-DFEGFDFKAIVFEYM--QNRNLEQWLRQSNGQLRFLTQRV 137
           L++++H N+I ++ + +     E F+   +V   M     N+ +  + ++  ++FL  ++
Sbjct: 82  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 141
Query: 138 NIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAE 197
                    ++Y H      I+H DLKPSN+ +++D    + D GLA+            
Sbjct: 142 ------LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----------H 181
Query: 198 TASNSIEIKGIVG---YVAPEYGMG-SKASVSGDVYNFGILLLEMFTRR 242
           TA    E+ G V    Y APE  +     + + D+++ G ++ E+ T R
Sbjct: 182 TAD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 75/182 (41%), Gaps = 32/182 (17%)
Query: 61  KVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLE 120
           KVV LKQ E + +   E   L+ +    L+K+        F+      +V EY+    + 
Sbjct: 78  KVVKLKQIEHTLN---EKRILQAVNFPFLVKL-----EFSFKDNSNLYMVMEYVPGGEMF 129
Query: 121 QWLRQ----SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVA 176
             LR+    S    RF       A  +    EY H      +++ DLKP N+L+DQ    
Sbjct: 130 SHLRRIGRFSEPHARFY------AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYI 180
Query: 177 HVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLL 236
            V D G AK + G            +  + G   Y+APE  +    + + D +  G+L+ 
Sbjct: 181 KVADFGFAKRVKG-----------RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 229
Query: 237 EM 238
           EM
Sbjct: 230 EM 231

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/194 (24%), Positives = 80/194 (41%), Gaps = 34/194 (17%)
Query: 61  KVVNLKQKEASRSFA------AECNALRNIRH----RNLIKIITICSSIDFEGFDFK--- 107
           +V+ +K KE+   +A       +   L+ I H    + +++ +     +  E F FK   
Sbjct: 77  RVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE-FSFKDNS 135
Query: 108 --AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNI-AIDVSFAIEYFHHHCQPSIVHGDLK 164
              +V EY+    +   LR+     RF        A  +    EY H      +++ DLK
Sbjct: 136 NLYMVMEYVAGGEMFSHLRRIG---RFXEPHARFYAAQIVLTFEYLH---SLDLIYRDLK 189
Query: 165 PSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASV 224
           P N+L+DQ     V D G AK + G            +  + G   Y+APE  +    + 
Sbjct: 190 PENLLIDQQGYIQVTDFGFAKRVKG-----------RTWXLCGTPEYLAPEIILSKGYNK 238
Query: 225 SGDVYNFGILLLEM 238
           + D +  G+L+ EM
Sbjct: 239 AVDWWALGVLIYEM 252

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 75/182 (41%), Gaps = 32/182 (17%)
Query: 61  KVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLE 120
           KVV LKQ E + +   E   L+ +    L+K+        F+      +V EY+    + 
Sbjct: 71  KVVKLKQIEHTLN---EKRILQAVNFPFLVKL-----EFSFKDNSNLYMVMEYVPGGEMF 122
Query: 121 QWLRQ----SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVA 176
             LR+    S    RF       A  +    EY H      +++ DLKP N+L+DQ    
Sbjct: 123 SHLRRIGRFSEPHARFY------AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYI 173
Query: 177 HVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLL 236
            V D G AK + G            +  + G   Y+APE  +    + + D +  G+L+ 
Sbjct: 174 QVTDFGFAKRVKG-----------RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 222
Query: 237 EM 238
           EM
Sbjct: 223 EM 224

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 80/197 (40%), Gaps = 40/197 (20%)
Query: 61  KVVNLKQKEASRSFA------AECNALRNIRH----RNLIKIITICSSIDFEGFDFK--- 107
           +V+ +K KE    +A       +   L+ I H    + +++ +     +  E F FK   
Sbjct: 77  RVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE-FSFKDNS 135
Query: 108 --AIVFEYMQNRNLEQWLRQ----SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHG 161
              +V EY+    +   LR+    S    RF       A  +    EY H      +++ 
Sbjct: 136 NLYMVMEYVPGGEMFSHLRRIGRFSEPHARFY------AAQIVLTFEYLH---SLDLIYR 186
Query: 162 DLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSK 221
           DLKP N+L+DQ     V D G AK + G            +  + G   Y+APE  +   
Sbjct: 187 DLKPENLLIDQQGYIQVTDFGFAKRVKG-----------RTWXLCGTPEYLAPEIILSKG 235
Query: 222 ASVSGDVYNFGILLLEM 238
            + + D +  G+L+ EM
Sbjct: 236 YNKAVDWWALGVLIYEM 252

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/229 (23%), Positives = 103/229 (44%), Gaps = 37/229 (16%)
Query: 24  ELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK---EASRSFAAECNA 80
           E+ +   N SP   +G G    V      ++   VAVK ++   +    A R++  E   
Sbjct: 26  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRL 81
Query: 81  LRNIRHRNLIKIITICSSI-DFEGFDFKAIVFEYM--QNRNLEQWLRQSNGQLRFLTQRV 137
           L++++H N+I ++ + +     E F+   +V   M     N+ +  + ++  ++FL  ++
Sbjct: 82  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 141
Query: 138 NIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAE 197
                    ++Y H      I+H DLKPSN+ +++D    + D GLA+            
Sbjct: 142 ------LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----------H 181
Query: 198 TASNSIEIKGIVG---YVAPEYGMG-SKASVSGDVYNFGILLLEMFTRR 242
           TA    E+ G V    Y APE  +     + + D+++ G ++ E+ T R
Sbjct: 182 TAD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 45/100 (45%), Gaps = 10/100 (10%)
Query: 146 AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF------LFGYEPGTAAETA 199
           A+ Y H      I+H DLKP NI +D+     +GD GLAK       +   +      ++
Sbjct: 128 ALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 200 SNSIEIKGIVGYVAPEYGMGS-KASVSGDVYNFGILLLEM 238
            N     G   YVA E   G+   +   D+Y+ GI+  EM
Sbjct: 185 DNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM 224

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/229 (23%), Positives = 103/229 (44%), Gaps = 37/229 (16%)
Query: 24  ELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK---EASRSFAAECNA 80
           E+ +   N SP   +G G    V      ++   VAVK ++   +    A R++  E   
Sbjct: 26  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRL 81
Query: 81  LRNIRHRNLIKIITICSSI-DFEGFDFKAIVFEYM--QNRNLEQWLRQSNGQLRFLTQRV 137
           L++++H N+I ++ + +     E F+   +V   M     N+ +  + ++  ++FL  ++
Sbjct: 82  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 141
Query: 138 NIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAE 197
                    ++Y H      I+H DLKPSN+ +++D    + D GLA+            
Sbjct: 142 ------LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----------H 181
Query: 198 TASNSIEIKGIVG---YVAPEYGMG-SKASVSGDVYNFGILLLEMFTRR 242
           TA    E+ G V    Y APE  +     + + D+++ G ++ E+ T R
Sbjct: 182 TAD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/99 (28%), Positives = 44/99 (44%), Gaps = 14/99 (14%)
Query: 140 AIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETA 199
           A  +    EY H      +++ DLKP N+L+DQ     V D G AK + G          
Sbjct: 148 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG---------- 194
Query: 200 SNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEM 238
             +  + G   Y+APE  +    + + D +  G+L+ EM
Sbjct: 195 -RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 75/182 (41%), Gaps = 32/182 (17%)
Query: 61  KVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLE 120
           KVV LKQ E + +   E   L+ +    L+K+        F+      +V EY+    + 
Sbjct: 64  KVVKLKQIEHTLN---EKRILQAVNFPFLVKL-----EFSFKDNSNLYMVMEYVPGGEMF 115
Query: 121 QWLRQ----SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVA 176
             LR+    S    RF       A  +    EY H      +++ DLKP N+L+DQ    
Sbjct: 116 SHLRRIGRFSEPHARFY------AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYI 166
Query: 177 HVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLL 236
            V D G AK + G            +  + G   Y+APE  +    + + D +  G+L+ 
Sbjct: 167 QVTDFGFAKRVKG-----------RTWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 215
Query: 237 EM 238
           EM
Sbjct: 216 EM 217

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 80/197 (40%), Gaps = 40/197 (20%)
Query: 61  KVVNLKQKEASRSFA------AECNALRNIRH----RNLIKIITICSSIDFEGFDFK--- 107
           +V+ +K KE    +A       +   L+ I H    + +++ +     +  E F FK   
Sbjct: 57  RVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE-FSFKDNS 115
Query: 108 --AIVFEYMQNRNLEQWLRQ----SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHG 161
              +V EY+    +   LR+    S    RF       A  +    EY H      +++ 
Sbjct: 116 NLYMVMEYVPGGEMFSHLRRIGRFSEPHARFY------AAQIVLTFEYLH---SLDLIYR 166
Query: 162 DLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSK 221
           DLKP N+L+DQ     V D G AK + G            +  + G   Y+APE  +   
Sbjct: 167 DLKPENLLIDQQGYIQVTDFGFAKRVKG-----------RTWXLCGTPEYLAPEIILSKG 215
Query: 222 ASVSGDVYNFGILLLEM 238
            + + D +  G+L+ EM
Sbjct: 216 YNKAVDWWALGVLIYEM 232

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 80/197 (40%), Gaps = 40/197 (20%)
Query: 61  KVVNLKQKEASRSFA------AECNALRNIRH----RNLIKIITICSSIDFEGFDFK--- 107
           +V+ +K KE    +A       +   L+ I H    + +++ +     +  E F FK   
Sbjct: 57  RVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE-FSFKDNS 115
Query: 108 --AIVFEYMQNRNLEQWLRQ----SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHG 161
              +V EY+    +   LR+    S    RF       A  +    EY H      +++ 
Sbjct: 116 NLYMVMEYVPGGEMFSHLRRIGRFSEPHARFY------AAQIVLTFEYLH---SLDLIYR 166
Query: 162 DLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSK 221
           DLKP N+L+DQ     V D G AK + G            +  + G   Y+APE  +   
Sbjct: 167 DLKPENLLIDQQGYIQVTDFGFAKRVKG-----------RTWXLCGTPEYLAPEIILSKG 215
Query: 222 ASVSGDVYNFGILLLEM 238
            + + D +  G+L+ EM
Sbjct: 216 YNKAVDWWALGVLIYEM 232

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/248 (22%), Positives = 106/248 (42%), Gaps = 44/248 (17%)
Query: 12  SMKQQFPMISYAELSKAT-------NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVN 64
           S  Q+ P     EL+K          N SP   +G G    V      ++   VAVK ++
Sbjct: 2   SHSQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLS 58
Query: 65  LKQK---EASRSFAAECNALRNIRHRNLIKIITICSSI-DFEGFDFKAIVFEYM--QNRN 118
              +    A R++  E   L++++H N+I ++ + +     E F+   +V   M     N
Sbjct: 59  RPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN 117
Query: 119 LEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHV 178
           + +  + ++  ++FL  ++         ++Y H      I+H DLKPSN+ +++D    +
Sbjct: 118 IVKCQKLTDDHVQFLIYQI------LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 168
Query: 179 GDLGLAKFLFGYEPGTAAETASNSIEIKGIVG---YVAPEYGMG-SKASVSGDVYNFGIL 234
            D GLA+                  E+ G V    Y APE  +     + + D+++ G +
Sbjct: 169 LDFGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCI 214
Query: 235 LLEMFTRR 242
           + E+ T R
Sbjct: 215 MAELLTGR 222

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 80/197 (40%), Gaps = 40/197 (20%)
Query: 61  KVVNLKQKEASRSFA------AECNALRNIRH----RNLIKIITICSSIDFEGFDFK--- 107
           +V+ +K KE    FA       +   L+ I H    + +++ +     +  E + FK   
Sbjct: 56  RVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE-YSFKDNS 114
Query: 108 --AIVFEYMQNRNLEQWLRQ----SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHG 161
              +V EY+    +   LR+    S    RF       A  +    EY H      +++ 
Sbjct: 115 NLYMVMEYVPGGEMFSHLRRIGRFSEPHARFY------AAQIVLTFEYLH---SLDLIYR 165
Query: 162 DLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSK 221
           DLKP N+L+DQ     V D G AK + G            +  + G   Y+APE  +   
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRVKG-----------RTWXLCGTPEYLAPEIILSKG 214
Query: 222 ASVSGDVYNFGILLLEM 238
            + + D +  G+L+ EM
Sbjct: 215 YNKAVDWWALGVLIYEM 231

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/194 (24%), Positives = 80/194 (41%), Gaps = 34/194 (17%)
Query: 61  KVVNLKQKEASRSFA------AECNALRNIRH----RNLIKIITICSSIDFEGFDFK--- 107
           +V+ +K KE+   +A       +   L+ I H    + +++ +     +  E F FK   
Sbjct: 51  RVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE-FSFKDNS 109
Query: 108 --AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNI-AIDVSFAIEYFHHHCQPSIVHGDLK 164
              +V EY+    +   LR+     RF        A  +    EY H      +++ DLK
Sbjct: 110 NLYMVMEYVAGGEMFSHLRRIG---RFXEPHARFYAAQIVLTFEYLH---SLDLIYRDLK 163
Query: 165 PSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASV 224
           P N+L+DQ     V D G AK + G            +  + G   Y+APE  +    + 
Sbjct: 164 PENLLIDQQGYIQVTDFGFAKRVKG-----------RTWXLCGTPEYLAPEIILSKGYNK 212
Query: 225 SGDVYNFGILLLEM 238
           + D +  G+L+ EM
Sbjct: 213 AVDWWALGVLIYEM 226

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 70/170 (41%), Gaps = 20/170 (11%)
Query: 76  AECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQ 135
            E   L+N RH  L  +        F+  D    V EY     L  +   S  ++ F  +
Sbjct: 54  TESRVLQNTRHPFLTAL-----KYAFQTHDRLCFVMEYANGGEL--FFHLSRERV-FTEE 105
Query: 136 RVNI-AIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGT 194
           R      ++  A+EY H      +V+ D+K  N++LD+D    + D GL K   G   G 
Sbjct: 106 RARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGA 160
Query: 195 AAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
             +T   + E      Y+APE    +    + D +  G+++ EM   R P
Sbjct: 161 TMKTFCGTPE------YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/225 (23%), Positives = 95/225 (42%), Gaps = 44/225 (19%)
Query: 26  SKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAA---ECNALR 82
           +K ++N+    ++G+G  S+V + +   +    A K++N K K ++R F     E    R
Sbjct: 25  TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTK-KLSARDFQKLEREARICR 83
Query: 83  NIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQL--RFLTQRVNIA 140
            ++H N+++   +  SI  E F +  +VF+ +           + G+L    + +     
Sbjct: 84  KLQHPNIVR---LHDSIQEESFHY--LVFDLV-----------TGGELFEDIVAREFYSE 127
Query: 141 IDVSFAIE-------YFHHHCQPSIVHGDLKPSNILL---DQDIVAHVGDLGLAKFLFGY 190
            D S  I+       Y H +    IVH +LKP N+LL    +     + D GLA  +   
Sbjct: 128 ADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184
Query: 191 EPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILL 235
           E               G  GY++PE       S   D++  G++L
Sbjct: 185 EAWHG---------FAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/194 (24%), Positives = 80/194 (41%), Gaps = 34/194 (17%)
Query: 61  KVVNLKQKEASRSFA------AECNALRNIRH----RNLIKIITICSSIDFEGFDFK--- 107
           +V+ +K KE+   +A       +   L+ I H    + +++ +     +  E F FK   
Sbjct: 56  RVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE-FSFKDNS 114
Query: 108 --AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNI-AIDVSFAIEYFHHHCQPSIVHGDLK 164
              +V EY+    +   LR+     RF        A  +    EY H      +++ DLK
Sbjct: 115 NLYMVMEYVAGGEMFSHLRRIG---RFXEPHARFYAAQIVLTFEYLH---SLDLIYRDLK 168
Query: 165 PSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASV 224
           P N+L+DQ     V D G AK + G            +  + G   Y+APE  +    + 
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKG-----------RTWXLCGTPEYLAPEIILSKGYNK 217
Query: 225 SGDVYNFGILLLEM 238
           + D +  G+L+ EM
Sbjct: 218 AVDWWALGVLIYEM 231

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 98/233 (42%), Gaps = 42/233 (18%)
Query: 26  SKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAA---ECNALR 82
           +K ++N+    ++G+G  S+V + +   +    A K++N K K ++R F     E    R
Sbjct: 2   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTK-KLSARDFQKLEREARICR 60
Query: 83  NIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQL--RFLTQRVNIA 140
            ++H N++++     SI  E F +  +VF+ +           + G+L    + +     
Sbjct: 61  KLQHPNIVRLH---DSIQEESFHY--LVFDLV-----------TGGELFEDIVAREFYSE 104
Query: 141 IDVSFAIE-------YFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPG 193
            D S  I+       Y H +    IVH +LKP N+LL     A    + LA F      G
Sbjct: 105 ADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASK--AKGAAVKLADF------G 153
Query: 194 TAAETASNSIE--IKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
            A E   +       G  GY++PE       S   D++  G++L  +     P
Sbjct: 154 LAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 75/182 (41%), Gaps = 32/182 (17%)
Query: 61  KVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLE 120
           KVV LKQ E + +   E   L+ +    L+K+        F+      +V EY+    + 
Sbjct: 79  KVVKLKQIEHTLN---EKRILQAVNFPFLVKL-----EFSFKDNSNLYMVMEYVPGGEMF 130
Query: 121 QWLRQ----SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVA 176
             LR+    S    RF       A  +    EY H      +++ DLKP N+L+DQ    
Sbjct: 131 SHLRRIGRFSEPHARFY------AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYI 181
Query: 177 HVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLL 236
            V D G AK + G            +  + G   Y+APE  +    + + D +  G+L+ 
Sbjct: 182 QVTDFGFAKRVKG-----------RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 230
Query: 237 EM 238
           EM
Sbjct: 231 EM 232

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 86/215 (40%), Gaps = 30/215 (13%)
Query: 29  TNNFSPANKIGQGG---VSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIR 85
           ++ +    K+G G    V +    +    R+I  +K  ++     S +   E   L+ + 
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 62
Query: 86  HRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNL--EQWLRQSNGQLRFLTQRVNIAIDV 143
           H N++K+        FE      +V E  +   L  E  LRQ   ++        I   V
Sbjct: 63  HPNIMKLYEF-----FEDKRNYYLVMEVYRGGELFDEIILRQKFSEV----DAAVIMKQV 113
Query: 144 SFAIEYFHHHCQPSIVHGDLKPSNILLD---QDIVAHVGDLGLAKFLFGYEPGTAAETAS 200
                Y H H   +IVH DLKP N+LL+   +D +  + D GL+            E   
Sbjct: 114 LSGTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHF---------EVGG 161
Query: 201 NSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILL 235
              E  G   Y+APE  +  K     DV++ G++L
Sbjct: 162 KMKERLGTAYYIAPEV-LRKKYDEKCDVWSCGVIL 195

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 75/182 (41%), Gaps = 32/182 (17%)
Query: 61  KVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLE 120
           KVV LKQ E + +   E   L+ +    L+K+        F+      +V EY+    + 
Sbjct: 78  KVVKLKQIEHTLN---EKRILQAVNFPFLVKL-----EFSFKDNSNLYMVMEYVPGGEMF 129
Query: 121 QWLRQ----SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVA 176
             LR+    S    RF       A  +    EY H      +++ DLKP N+L+DQ    
Sbjct: 130 SHLRRIGRFSEPHARFY------AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYI 180
Query: 177 HVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLL 236
            V D G AK + G            +  + G   Y+APE  +    + + D +  G+L+ 
Sbjct: 181 QVTDFGFAKRVKG-----------RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 229
Query: 237 EM 238
           EM
Sbjct: 230 EM 231

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 80/197 (40%), Gaps = 40/197 (20%)
Query: 61  KVVNLKQKEASRSFA------AECNALRNIRH----RNLIKIITICSSIDFEGFDFK--- 107
           +V+ +K KE    FA       +   L+ I H    + +++ +     +  E + FK   
Sbjct: 56  RVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE-YSFKDNS 114
Query: 108 --AIVFEYMQNRNLEQWLRQ----SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHG 161
              +V EY+    +   LR+    S    RF       A  +    EY H      +++ 
Sbjct: 115 NLYMVMEYVPGGEMFSHLRRIGRFSEPHARFY------AAQIVLTFEYLH---SLDLIYR 165
Query: 162 DLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSK 221
           DLKP N+L+DQ     V D G AK + G            +  + G   Y+APE  +   
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRVKG-----------RTWXLCGTPEYLAPEIILSKG 214
Query: 222 ASVSGDVYNFGILLLEM 238
            + + D +  G+L+ EM
Sbjct: 215 YNKAVDWWALGVLIYEM 231

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 75/182 (41%), Gaps = 32/182 (17%)
Query: 61  KVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLE 120
           KVV LKQ E + +   E   L+ +    L+K+        F+      +V EY+    + 
Sbjct: 79  KVVKLKQIEHTLN---EKRILQAVNFPFLVKL-----EFSFKDNSNLYMVMEYVPGGEMF 130
Query: 121 QWLRQ----SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVA 176
             LR+    S    RF       A  +    EY H      +++ DLKP N+L+DQ    
Sbjct: 131 SHLRRIGRFSEPHARFY------AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYI 181
Query: 177 HVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLL 236
            V D G AK + G            +  + G   Y+APE  +    + + D +  G+L+ 
Sbjct: 182 QVTDFGFAKRVKG-----------RTWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 230
Query: 237 EM 238
           EM
Sbjct: 231 EM 232

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 80/197 (40%), Gaps = 40/197 (20%)
Query: 61  KVVNLKQKEASRSFA------AECNALRNIRH----RNLIKIITICSSIDFEGFDFK--- 107
           +V+ +K KE    +A       +   L+ I H    + +++ +     +  E F FK   
Sbjct: 57  RVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE-FSFKDNS 115
Query: 108 --AIVFEYMQNRNLEQWLRQ----SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHG 161
              +V EY+    +   LR+    S    RF       A  +    EY H      +++ 
Sbjct: 116 NLYMVMEYVPGGEMFSHLRRIGRFSEPHARFY------AAQIVLTFEYLH---SLDLIYR 166
Query: 162 DLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSK 221
           DLKP N+L+DQ     V D G AK + G            +  + G   Y+APE  +   
Sbjct: 167 DLKPENLLIDQQGYIQVTDFGFAKRVKG-----------RTWXLCGTPEYLAPEIILSKG 215
Query: 222 ASVSGDVYNFGILLLEM 238
            + + D +  G+L+ EM
Sbjct: 216 YNKAVDWWALGVLIYEM 232

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 80/197 (40%), Gaps = 40/197 (20%)
Query: 61  KVVNLKQKEASRSFA------AECNALRNIRH----RNLIKIITICSSIDFEGFDFK--- 107
           +V+ +K KE    FA       +   L+ I H    + +++ +     +  E + FK   
Sbjct: 56  RVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE-YSFKDNS 114
Query: 108 --AIVFEYMQNRNLEQWLRQ----SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHG 161
              +V EY+    +   LR+    S    RF       A  +    EY H      +++ 
Sbjct: 115 NLYMVMEYVPGGEMFSHLRRIGRFSEPHARFY------AAQIVLTFEYLH---SLDLIYR 165
Query: 162 DLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSK 221
           DLKP N+L+DQ     V D G AK + G            +  + G   Y+APE  +   
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRVKG-----------RTWXLCGTPEYLAPEIILSKG 214
Query: 222 ASVSGDVYNFGILLLEM 238
            + + D +  G+L+ EM
Sbjct: 215 YNKAVDWWALGVLIYEM 231

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 75/182 (41%), Gaps = 32/182 (17%)
Query: 61  KVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLE 120
           KVV LKQ E + +   E   L+ +    L+K+        F+      +V EY+    + 
Sbjct: 78  KVVKLKQIEHTLN---EKRILQAVNFPFLVKL-----EFSFKDNSNLYMVMEYVPGGEMF 129
Query: 121 QWLRQ----SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVA 176
             LR+    S    RF       A  +    EY H      +++ DLKP N+L+DQ    
Sbjct: 130 SHLRRIGRFSEPHARFY------AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYI 180
Query: 177 HVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLL 236
            V D G AK + G            +  + G   Y+APE  +    + + D +  G+L+ 
Sbjct: 181 QVTDFGFAKRVKG-----------RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 229
Query: 237 EM 238
           EM
Sbjct: 230 EM 231

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 59/259 (22%), Positives = 106/259 (40%), Gaps = 30/259 (11%)
Query: 3   PAHKDSNMLSMKQQFPMISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKV 62
           P  +D+  + + ++   + Y E  +  +  +   ++G+G    V++    ++    AVK 
Sbjct: 32  PETEDNEGVLLTEKLKPVDY-EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKK 90
Query: 63  VNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQW 122
           V L+        A  C  L + R      I+ +  ++  EG  +  I  E ++  +L Q 
Sbjct: 91  VRLEVFRVEELVA--CAGLSSPR------IVPLYGAVR-EG-PWVNIFMELLEGGSLGQL 140
Query: 123 LRQ-----SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQD-IVA 176
           ++Q      +  L +L Q +         +EY H      I+HGD+K  N+LL  D   A
Sbjct: 141 IKQMGCLPEDRALYYLGQALE-------GLEYLHTR---RILHGDVKADNVLLSSDGSRA 190
Query: 177 HVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLL 236
            + D G A  L   +P    ++      I G   ++APE  MG       D+++   ++L
Sbjct: 191 ALCDFGHALCL---QPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMML 247
Query: 237 EMFTRRRPTDAMFNEGLTL 255
            M     P    F   L L
Sbjct: 248 HMLNGCHPWTQYFRGPLCL 266

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/99 (28%), Positives = 44/99 (44%), Gaps = 14/99 (14%)
Query: 140 AIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETA 199
           A  +    EY H      +++ DLKP N+L+DQ     V D G AK + G          
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---------- 193
Query: 200 SNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEM 238
             +  + G   Y+APE  +    + + D +  G+L+ EM
Sbjct: 194 -RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 75/182 (41%), Gaps = 32/182 (17%)
Query: 61  KVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLE 120
           KVV LKQ E + +   E   L+ +    L+K+        F+      +V EY+    + 
Sbjct: 78  KVVKLKQIEHTLN---EKRILQAVNFPFLVKL-----EFSFKDNSNLYMVMEYVPGGEMF 129
Query: 121 QWLRQ----SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVA 176
             LR+    S    RF       A  +    EY H      +++ DLKP N+L+DQ    
Sbjct: 130 SHLRRIGRFSEPHARFY------AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYI 180
Query: 177 HVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLL 236
            V D G AK + G            +  + G   Y+APE  +    + + D +  G+L+ 
Sbjct: 181 QVTDFGFAKRVKG-----------RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 229
Query: 237 EM 238
           EM
Sbjct: 230 EM 231

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/99 (28%), Positives = 44/99 (44%), Gaps = 14/99 (14%)
Query: 140 AIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETA 199
           A  +    EY H      +++ DLKP N+L+DQ     V D G AK + G          
Sbjct: 140 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---------- 186
Query: 200 SNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEM 238
             +  + G   Y+APE  +    + + D +  G+L+ EM
Sbjct: 187 -RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 224

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/194 (24%), Positives = 80/194 (41%), Gaps = 34/194 (17%)
Query: 61  KVVNLKQKEASRSFA------AECNALRNIRH----RNLIKIITICSSIDFEGFDFK--- 107
           +V+ +K KE+   +A       +   L+ I H    + +++ +     +  E F FK   
Sbjct: 56  RVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE-FSFKDNS 114
Query: 108 --AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNI-AIDVSFAIEYFHHHCQPSIVHGDLK 164
              +V EY+    +   LR+     RF        A  +    EY H      +++ DLK
Sbjct: 115 NLYMVMEYVAGGEMFSHLRRIG---RFXEPHARFYAAQIVLTFEYLH---SLDLIYRDLK 168
Query: 165 PSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASV 224
           P N+L+DQ     V D G AK + G            +  + G   Y+APE  +    + 
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKG-----------RTWXLCGTPEYLAPEIILSKGYNK 217
Query: 225 SGDVYNFGILLLEM 238
           + D +  G+L+ EM
Sbjct: 218 AVDWWALGVLIYEM 231

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/99 (28%), Positives = 45/99 (45%), Gaps = 14/99 (14%)
Query: 140 AIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETA 199
           A  +    EY H      +++ DLKP N+++DQ     V D GLAK + G          
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKG---------- 193
Query: 200 SNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEM 238
             +  + G   Y+APE  +    + + D +  G+L+ EM
Sbjct: 194 -RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/194 (24%), Positives = 80/194 (41%), Gaps = 34/194 (17%)
Query: 61  KVVNLKQKEASRSFA------AECNALRNIRH----RNLIKIITICSSIDFEGFDFK--- 107
           +V+ +K KE+   +A       +   L+ I H    + +++ +     +  E F FK   
Sbjct: 56  RVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE-FSFKDNS 114
Query: 108 --AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNI-AIDVSFAIEYFHHHCQPSIVHGDLK 164
              +V EY+    +   LR+     RF        A  +    EY H      +++ DLK
Sbjct: 115 NLYMVMEYVAGGEMFSHLRRIG---RFXEPHARFYAAQIVLTFEYLH---SLDLIYRDLK 168
Query: 165 PSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASV 224
           P N+L+DQ     V D G AK + G            +  + G   Y+APE  +    + 
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKG-----------RTWXLCGTPEYLAPEIILSKGYNK 217
Query: 225 SGDVYNFGILLLEM 238
           + D +  G+L+ EM
Sbjct: 218 AVDWWALGVLIYEM 231

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 70/170 (41%), Gaps = 20/170 (11%)
Query: 76  AECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQ 135
            E   L+N RH  L  +        F+  D    V EY     L  +   S  ++ F  +
Sbjct: 57  TESRVLQNTRHPFLTAL-----KYAFQTHDRLCFVMEYANGGEL--FFHLSRERV-FTEE 108
Query: 136 RVNI-AIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGT 194
           R      ++  A+EY H      +V+ D+K  N++LD+D    + D GL K   G   G 
Sbjct: 109 RARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGA 163
Query: 195 AAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
             +T   + E      Y+APE    +    + D +  G+++ EM   R P
Sbjct: 164 TMKTFCGTPE------YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 207

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 70/170 (41%), Gaps = 20/170 (11%)
Query: 76  AECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQ 135
            E   L+N RH  L  +        F+  D    V EY     L  +   S  ++ F  +
Sbjct: 54  TESRVLQNTRHPFLTAL-----KYAFQTHDRLCFVMEYANGGEL--FFHLSRERV-FTEE 105
Query: 136 RVNI-AIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGT 194
           R      ++  A+EY H      +V+ D+K  N++LD+D    + D GL K   G   G 
Sbjct: 106 RARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGA 160
Query: 195 AAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
             +T   + E      Y+APE    +    + D +  G+++ EM   R P
Sbjct: 161 TMKTFCGTPE------YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/99 (28%), Positives = 44/99 (44%), Gaps = 14/99 (14%)
Query: 140 AIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETA 199
           A  +    EY H      +++ DLKP N+L+DQ     V D G AK + G          
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---------- 193
Query: 200 SNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEM 238
             +  + G   Y+APE  +    + + D +  G+L+ EM
Sbjct: 194 -RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 75/182 (41%), Gaps = 32/182 (17%)
Query: 61  KVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLE 120
           KVV LKQ E + +   E   L+ +    L+K+        F+      +V EY+    + 
Sbjct: 78  KVVKLKQIEHTLN---EKRILQAVNFPFLVKL-----EFSFKDNSNLYMVMEYVAGGEMF 129
Query: 121 QWLRQ----SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVA 176
             LR+    S    RF       A  +    EY H      +++ DLKP N+L+DQ    
Sbjct: 130 SHLRRIGRFSEPHARFY------AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYI 180
Query: 177 HVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLL 236
            V D G AK + G            +  + G   Y+APE  +    + + D +  G+L+ 
Sbjct: 181 QVTDFGFAKRVKG-----------RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 229
Query: 237 EM 238
           EM
Sbjct: 230 EM 231

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/229 (22%), Positives = 101/229 (44%), Gaps = 37/229 (16%)
Query: 24  ELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK---EASRSFAAECNA 80
           E+ +   N SP   +G G    V      ++   VAVK ++   +    A R++  E   
Sbjct: 25  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRL 80
Query: 81  LRNIRHRNLIKIITICSSI-DFEGFDFKAIVFEYM--QNRNLEQWLRQSNGQLRFLTQRV 137
           L++++H N+I ++ + +     E F+   +V   M     N+ +  + ++  ++FL  ++
Sbjct: 81  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 140
Query: 138 NIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAE 197
                    ++Y H      I+H DLKPSN+ +++D    + D GLA+            
Sbjct: 141 ------LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR------------ 179
Query: 198 TASNSIEIKGIVG---YVAPEYGMG-SKASVSGDVYNFGILLLEMFTRR 242
                 E+ G V    Y APE  +     + + D+++ G ++ E+ T R
Sbjct: 180 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/99 (28%), Positives = 44/99 (44%), Gaps = 14/99 (14%)
Query: 140 AIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETA 199
           A  +    EY H      +++ DLKP N+L+DQ     V D G AK + G          
Sbjct: 148 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---------- 194
Query: 200 SNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEM 238
             +  + G   Y+APE  +    + + D +  G+L+ EM
Sbjct: 195 -RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/99 (28%), Positives = 44/99 (44%), Gaps = 14/99 (14%)
Query: 140 AIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETA 199
           A  +    EY H      +++ DLKP N+L+DQ     V D G AK + G          
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---------- 193
Query: 200 SNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEM 238
             +  + G   Y+APE  +    + + D +  G+L+ EM
Sbjct: 194 -RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 93/215 (43%), Gaps = 31/215 (14%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVN---LKQKEASRSFAAECNALRNIRHRNLIKIIT 94
           +G+G    V K     ++   AVKV+N    K K+ S +   E   L+ + H N++K+  
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS-TILREVELLKKLDHPNIMKLFE 88
Query: 95  ICSSIDFEGFDFKAIVFE-YMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFA-IEYFHH 152
           I    D   F    IV E Y      ++ +++     RF        I   F+ I Y H 
Sbjct: 89  ILE--DSSSF---YIVGELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHK 139
Query: 153 HCQPSIVHGDLKPSNILL---DQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
           H   +IVH DLKP NILL   ++D    + D GL+         T  +  +   +  G  
Sbjct: 140 H---NIVHRDLKPENILLESKEKDCDIKIIDFGLS---------TCFQQNTKMKDRIGTA 187
Query: 210 GYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
            Y+APE   G+      DV++ G++L  + +   P
Sbjct: 188 YYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPP 221

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 89/218 (40%), Gaps = 32/218 (14%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQK-EASRSFAAECNALRNIRHRNLIKIITIC 96
           +G+G    V   +   +   VAVK+V++K+  +   +   E    + + H N++K     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFY--- 71
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQP 156
                EG + + +  EY            S G+L F     +I +    A  +FH     
Sbjct: 72  -GHRREG-NIQYLFLEYC-----------SGGEL-FDRIEPDIGMPEPDAQRFFHQLMAG 117
Query: 157 -------SIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
                   I H D+KP N+LLD+     + D GLA  +F Y      E   N  ++ G +
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLAT-VFRY---NNRERLLN--KMXGTL 171
Query: 210 GYVAPEYGMGSKASVSG-DVYNFGILLLEMFTRRRPTD 246
            YVAPE     +      DV++ GI+L  M     P D
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/229 (23%), Positives = 101/229 (44%), Gaps = 37/229 (16%)
Query: 24  ELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK---EASRSFAAECNA 80
           E+ +   N SP   IG G    V      ++   VAVK ++   +    A R++  E   
Sbjct: 24  EVPERYQNLSP---IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRL 79
Query: 81  LRNIRHRNLIKIITICSSI-DFEGFDFKAIVFEYM--QNRNLEQWLRQSNGQLRFLTQRV 137
           L++++H N+I ++ + +     E F+   +V   M     N+ +  + ++  ++FL  ++
Sbjct: 80  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 139
Query: 138 NIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAE 197
                    ++Y H      I+H DLKPSN+ +++D    + D GLA+            
Sbjct: 140 ------LRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLAR------------ 178
Query: 198 TASNSIEIKGIVG---YVAPEYGMG-SKASVSGDVYNFGILLLEMFTRR 242
                 E+ G V    Y APE  +     + + D+++ G ++ E+ T R
Sbjct: 179 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 52/229 (22%), Positives = 101/229 (44%), Gaps = 37/229 (16%)
Query: 24  ELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK---EASRSFAAECNA 80
           E+ +   N SP   +G G    V      ++   VAVK ++   +    A R++  E   
Sbjct: 16  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRL 71
Query: 81  LRNIRHRNLIKIITICSSI-DFEGFDFKAIVFEYM--QNRNLEQWLRQSNGQLRFLTQRV 137
           L++++H N+I ++ + +     E F+   +V   M     N+ +  + ++  ++FL  ++
Sbjct: 72  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 131
Query: 138 NIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAE 197
                    ++Y H      I+H DLKPSN+ +++D    + D GLA+            
Sbjct: 132 ------LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR------------ 170
Query: 198 TASNSIEIKGIVG---YVAPEYGMG-SKASVSGDVYNFGILLLEMFTRR 242
                 E+ G V    Y APE  +     + + D+++ G ++ E+ T R
Sbjct: 171 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 70/173 (40%), Gaps = 26/173 (15%)
Query: 76  AECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQ 135
            E   L+N RH  L  +        F+  D    V EY     L  +   S  ++ F  +
Sbjct: 54  TESRVLQNTRHPFLTAL-----KYAFQTHDRLCFVMEYANGGEL--FFHLSRERV-FTEE 105
Query: 136 RVNI-AIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGT 194
           R      ++  A+EY H      +V+ D+K  N++LD+D    + D GL K         
Sbjct: 106 RARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK--------- 153
Query: 195 AAETASNSIEIKGIVG---YVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
             E  S+   +K   G   Y+APE    +    + D +  G+++ EM   R P
Sbjct: 154 --EGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 52/229 (22%), Positives = 101/229 (44%), Gaps = 37/229 (16%)
Query: 24  ELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK---EASRSFAAECNA 80
           E+ +   N SP   +G G    V      ++   VAVK ++   +    A R++  E   
Sbjct: 15  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRL 70
Query: 81  LRNIRHRNLIKIITICSSI-DFEGFDFKAIVFEYM--QNRNLEQWLRQSNGQLRFLTQRV 137
           L++++H N+I ++ + +     E F+   +V   M     N+ +  + ++  ++FL  ++
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 130
Query: 138 NIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAE 197
                    ++Y H      I+H DLKPSN+ +++D    + D GLA+            
Sbjct: 131 ------LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR------------ 169
Query: 198 TASNSIEIKGIVG---YVAPEYGMG-SKASVSGDVYNFGILLLEMFTRR 242
                 E+ G V    Y APE  +     + + D+++ G ++ E+ T R
Sbjct: 170 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 57/247 (23%), Positives = 106/247 (42%), Gaps = 44/247 (17%)
Query: 13  MKQQFPMISYAELSKAT-------NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL 65
           M Q+ P     EL+K          N SP   +G G    V      ++   VAVK ++ 
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSR 57
Query: 66  KQK---EASRSFAAECNALRNIRHRNLIKIITICSSI-DFEGFDFKAIVFEYM--QNRNL 119
             +    A R++  E   L++++H N+I ++ + +     E F+   +V   M     N+
Sbjct: 58  PFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI 116
Query: 120 EQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVG 179
            +  + ++  ++FL  ++         ++Y H      I+H DLKPSN+ +++D    + 
Sbjct: 117 VKCQKLTDDHVQFLIYQI------LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 167
Query: 180 DLGLAKFLFGYEPGTAAETASNSIEIKGIVG---YVAPEYGMG-SKASVSGDVYNFGILL 235
           D GLA+                  E+ G V    Y APE  +     + + D+++ G ++
Sbjct: 168 DGGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 213
Query: 236 LEMFTRR 242
            E+ T R
Sbjct: 214 AELLTGR 220

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 70/173 (40%), Gaps = 26/173 (15%)
Query: 76  AECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQ 135
            E   L+N RH  L  +        F+  D    V EY     L  +   S  ++ F  +
Sbjct: 59  TESRVLQNTRHPFLTAL-----KYAFQTHDRLCFVMEYANGGEL--FFHLSRERV-FTEE 110
Query: 136 RVNI-AIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGT 194
           R      ++  A+EY H      +V+ D+K  N++LD+D    + D GL K         
Sbjct: 111 RARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK--------- 158
Query: 195 AAETASNSIEIKGIVG---YVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
             E  S+   +K   G   Y+APE    +    + D +  G+++ EM   R P
Sbjct: 159 --EGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 70/173 (40%), Gaps = 26/173 (15%)
Query: 76  AECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQ 135
            E   L+N RH  L  +        F+  D    V EY     L  +   S  ++ F  +
Sbjct: 54  TESRVLQNTRHPFLTAL-----KYAFQTHDRLCFVMEYANGGEL--FFHLSRERV-FTEE 105
Query: 136 RVNI-AIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGT 194
           R      ++  A+EY H      +V+ D+K  N++LD+D    + D GL K         
Sbjct: 106 RARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK--------- 153
Query: 195 AAETASNSIEIKGIVG---YVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
             E  S+   +K   G   Y+APE    +    + D +  G+++ EM   R P
Sbjct: 154 --EGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 52/229 (22%), Positives = 101/229 (44%), Gaps = 37/229 (16%)
Query: 24  ELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK---EASRSFAAECNA 80
           E+ +   N SP   +G G    V      ++   VAVK ++   +    A R++  E   
Sbjct: 16  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRL 71
Query: 81  LRNIRHRNLIKIITICSSI-DFEGFDFKAIVFEYM--QNRNLEQWLRQSNGQLRFLTQRV 137
           L++++H N+I ++ + +     E F+   +V   M     N+ +  + ++  ++FL  ++
Sbjct: 72  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 131
Query: 138 NIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAE 197
                    ++Y H      I+H DLKPSN+ +++D    + D GLA+            
Sbjct: 132 ------LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR------------ 170
Query: 198 TASNSIEIKGIVG---YVAPEYGMG-SKASVSGDVYNFGILLLEMFTRR 242
                 E+ G V    Y APE  +     + + D+++ G ++ E+ T R
Sbjct: 171 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 70/173 (40%), Gaps = 26/173 (15%)
Query: 76  AECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQ 135
            E   L+N RH  L  +        F+  D    V EY     L  +   S  ++ F  +
Sbjct: 54  TESRVLQNTRHPFLTAL-----KYAFQTHDRLCFVMEYANGGEL--FFHLSRERV-FTEE 105
Query: 136 RVNI-AIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGT 194
           R      ++  A+EY H      +V+ D+K  N++LD+D    + D GL K         
Sbjct: 106 RARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK--------- 153
Query: 195 AAETASNSIEIKGIVG---YVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
             E  S+   +K   G   Y+APE    +    + D +  G+++ EM   R P
Sbjct: 154 --EGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 87/193 (45%), Gaps = 29/193 (15%)
Query: 31  NFSPANKIGQGGV-SIVYKGILDESRSIVAVKVVNLKQKEASRSFA-AECNALR-NIRHR 87
           +F P + +G G   +IVY+G+ D +R +   +++         SFA  E   LR +  H 
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFD-NRDVAVKRIL-----PECFSFADREVQLLRESDEHP 78
Query: 88  NLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAI 147
           N+I+    C+  D +   F+ I  E +    L++++ Q +     L + + +    +  +
Sbjct: 79  NVIRYF--CTEKDRQ---FQYIAIE-LCAATLQEYVEQKDFAHLGL-EPITLLQQTTSGL 131
Query: 148 EYFHHHCQPSIVHGDLKPSNILLDQ-----DIVAHVGDLGLAKFLFGYEPGTAAETASNS 202
            + H     +IVH DLKP NIL+        I A + D GL K L          + S  
Sbjct: 132 AHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL-----AVGRHSFSRR 183
Query: 203 IEIKGIVGYVAPE 215
             + G  G++APE
Sbjct: 184 SGVPGTEGWIAPE 196

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 89/218 (40%), Gaps = 32/218 (14%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQK-EASRSFAAECNALRNIRHRNLIKIITIC 96
           +G+G    V   +   +   VAVK+V++K+  +   +   E    + + H N++K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFY--- 70
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQP 156
                EG + + +  EY            S G+L F     +I +    A  +FH     
Sbjct: 71  -GHRREG-NIQYLFLEYC-----------SGGEL-FDRIEPDIGMPEPDAQRFFHQLMAG 116
Query: 157 -------SIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
                   I H D+KP N+LLD+     + D GLA  +F Y      E   N  ++ G +
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLAT-VFRY---NNRERLLN--KMXGTL 170
Query: 210 GYVAPEYGMGSKASVSG-DVYNFGILLLEMFTRRRPTD 246
            YVAPE     +      DV++ GI+L  M     P D
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 25/82 (30%), Positives = 42/82 (51%), Gaps = 6/82 (7%)
Query: 159 VHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGM 218
           +H DL   NILL +  V  + D GLA+ +  Y+           + +K    ++APE   
Sbjct: 213 IHRDLAARNILLSEKNVVKICDFGLARDI--YKDPDYVRKGDARLPLK----WMAPETIF 266
Query: 219 GSKASVSGDVYNFGILLLEMFT 240
               ++  DV++FG+LL E+F+
Sbjct: 267 DRVYTIQSDVWSFGVLLWEIFS 288

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 25/82 (30%), Positives = 42/82 (51%), Gaps = 6/82 (7%)
Query: 159 VHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGM 218
           +H DL   NILL +  V  + D GLA+ +  Y+           + +K    ++APE   
Sbjct: 215 IHRDLAARNILLSEKNVVKICDFGLARDI--YKDPDYVRKGDARLPLK----WMAPETIF 268
Query: 219 GSKASVSGDVYNFGILLLEMFT 240
               ++  DV++FG+LL E+F+
Sbjct: 269 DRVYTIQSDVWSFGVLLWEIFS 290

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 52/229 (22%), Positives = 101/229 (44%), Gaps = 37/229 (16%)
Query: 24  ELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK---EASRSFAAECNA 80
           E+ +   N SP   +G G    V      ++   VAVK ++   +    A R++  E   
Sbjct: 17  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRL 72
Query: 81  LRNIRHRNLIKIITICSSI-DFEGFDFKAIVFEYM--QNRNLEQWLRQSNGQLRFLTQRV 137
           L++++H N+I ++ + +     E F+   +V   M     N+ +  + ++  ++FL  ++
Sbjct: 73  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 132
Query: 138 NIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAE 197
                    ++Y H      I+H DLKPSN+ +++D    + D GLA+            
Sbjct: 133 ------LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR------------ 171
Query: 198 TASNSIEIKGIVG---YVAPEYGMG-SKASVSGDVYNFGILLLEMFTRR 242
                 E+ G V    Y APE  +     + + D+++ G ++ E+ T R
Sbjct: 172 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 59/259 (22%), Positives = 106/259 (40%), Gaps = 30/259 (11%)
Query: 3   PAHKDSNMLSMKQQFPMISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKV 62
           P  +D+  + + ++   + Y E  +  +  +   ++G+G    V++    ++    AVK 
Sbjct: 46  PETEDNEGVLLTEKLKPVDY-EYREEVHWMTHQPRLGRGSFGEVHRMKDKQTGFQCAVKK 104
Query: 63  VNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQW 122
           V L+        A  C  L + R      I+ +  ++  EG  +  I  E ++  +L Q 
Sbjct: 105 VRLEVFRVEELVA--CAGLSSPR------IVPLYGAVR-EG-PWVNIFMELLEGGSLGQL 154
Query: 123 LRQ-----SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQD-IVA 176
           ++Q      +  L +L Q +         +EY H      I+HGD+K  N+LL  D   A
Sbjct: 155 IKQMGCLPEDRALYYLGQALE-------GLEYLHTR---RILHGDVKADNVLLSSDGSRA 204
Query: 177 HVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLL 236
            + D G A  L   +P    ++      I G   ++APE  MG       D+++   ++L
Sbjct: 205 ALCDFGHALCL---QPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMML 261
Query: 237 EMFTRRRPTDAMFNEGLTL 255
            M     P    F   L L
Sbjct: 262 HMLNGCHPWTQYFRGPLCL 280

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 52/229 (22%), Positives = 101/229 (44%), Gaps = 37/229 (16%)
Query: 24  ELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK---EASRSFAAECNA 80
           E+ +   N SP   +G G    V      ++   VAVK ++   +    A R++  E   
Sbjct: 26  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRL 81
Query: 81  LRNIRHRNLIKIITICSSI-DFEGFDFKAIVFEYM--QNRNLEQWLRQSNGQLRFLTQRV 137
           L++++H N+I ++ + +     E F+   +V   M     N+ +  + ++  ++FL  ++
Sbjct: 82  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 141
Query: 138 NIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAE 197
                    ++Y H      I+H DLKPSN+ +++D    + D GLA+            
Sbjct: 142 ------LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR------------ 180
Query: 198 TASNSIEIKGIVG---YVAPEYGMG-SKASVSGDVYNFGILLLEMFTRR 242
                 E+ G V    Y APE  +     + + D+++ G ++ E+ T R
Sbjct: 181 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 65/141 (46%), Gaps = 11/141 (7%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHR-----NLIK 91
           K+G G  S V+     + +  VA+KVV    +  + +   E   L+++R+      N   
Sbjct: 28  KLGWGHFSTVWLSWDIQGKKFVAMKVVK-SAEHYTETALDEIRLLKSVRNSDPNDPNREM 86
Query: 92  IITICSSIDFEGFDFKAI--VFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEY 149
           ++ +       G +   I  VFE +   +L +W+ +SN Q   L     I   V   ++Y
Sbjct: 87  VVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDY 145
Query: 150 FHHHCQPSIVHGDLKPSNILL 170
            H  C+  I+H D+KP NILL
Sbjct: 146 LHTKCR--IIHTDIKPENILL 164

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/218 (19%), Positives = 91/218 (41%), Gaps = 25/218 (11%)
Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEAS-----RSFAAECNALRNI 84
             F     +G G    VYKG+       V + V  ++ +EA+     +    E   + ++
Sbjct: 49  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASV 108
Query: 85  RHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQL--RFLTQRVNIAID 142
            + ++ +++ IC +   +      ++ + M    L  ++R+    +  ++L   +N  + 
Sbjct: 109 DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL---LNWCVQ 159
Query: 143 VSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNS 202
           ++  + Y        +VH DL   N+L+       + D GLAK L   E    AE     
Sbjct: 160 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 216
Query: 203 IEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
           I+      ++A E  +    +   DV+++G+ + E+ T
Sbjct: 217 IK------WMALESILHRIYTHQSDVWSYGVTVWELMT 248

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 98/225 (43%), Gaps = 50/225 (22%)
Query: 33  SPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNA---------LRN 83
           SP + +G G    V   I   S   VA+K       + SR F +E  A         L++
Sbjct: 28  SPTH-VGSGAYGSVCSAIDKRSGEKVAIK-------KLSRPFQSEIFAKRAYRELLLLKH 79
Query: 84  IRHRN---LIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVN-I 139
           ++H N   L+ + T  SS+    +DF  +V  +MQ       L++  G L+F  +++  +
Sbjct: 80  MQHENVIGLLDVFTPASSLR-NFYDF-YLVMPFMQTD-----LQKIMG-LKFSEEKIQYL 131
Query: 140 AIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETA 199
              +   ++Y H      +VH DLKP N+ +++D    + D GLA+              
Sbjct: 132 VYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR-------------- 174
Query: 200 SNSIEIKGIV---GYVAPEYGMG-SKASVSGDVYNFGILLLEMFT 240
               E+ G V    Y APE  +     + + D+++ G ++ EM T
Sbjct: 175 HADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLT 219

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 52/229 (22%), Positives = 101/229 (44%), Gaps = 37/229 (16%)
Query: 24  ELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK---EASRSFAAECNA 80
           E+ +   N SP   +G G    V      ++   VAVK ++   +    A R++  E   
Sbjct: 24  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRL 79
Query: 81  LRNIRHRNLIKIITICSSI-DFEGFDFKAIVFEYM--QNRNLEQWLRQSNGQLRFLTQRV 137
           L++++H N+I ++ + +     E F+   +V   M     N+ +  + ++  ++FL  ++
Sbjct: 80  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 139
Query: 138 NIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAE 197
                    ++Y H      I+H DLKPSN+ +++D    + D GLA+            
Sbjct: 140 ------LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR------------ 178
Query: 198 TASNSIEIKGIVG---YVAPEYGMG-SKASVSGDVYNFGILLLEMFTRR 242
                 E+ G V    Y APE  +     + + D+++ G ++ E+ T R
Sbjct: 179 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 52/229 (22%), Positives = 101/229 (44%), Gaps = 37/229 (16%)
Query: 24  ELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK---EASRSFAAECNA 80
           E+ +   N SP   +G G    V      ++   VAVK ++   +    A R++  E   
Sbjct: 18  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRL 73
Query: 81  LRNIRHRNLIKIITICSSI-DFEGFDFKAIVFEYM--QNRNLEQWLRQSNGQLRFLTQRV 137
           L++++H N+I ++ + +     E F+   +V   M     N+ +  + ++  ++FL  ++
Sbjct: 74  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 133
Query: 138 NIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAE 197
                    ++Y H      I+H DLKPSN+ +++D    + D GLA+            
Sbjct: 134 ------LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR------------ 172
Query: 198 TASNSIEIKGIVG---YVAPEYGMG-SKASVSGDVYNFGILLLEMFTRR 242
                 E+ G V    Y APE  +     + + D+++ G ++ E+ T R
Sbjct: 173 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 25/82 (30%), Positives = 42/82 (51%), Gaps = 6/82 (7%)
Query: 159 VHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGM 218
           +H DL   NILL +  V  + D GLA+ +  Y+           + +K    ++APE   
Sbjct: 220 IHRDLAARNILLSEKNVVKICDFGLARDI--YKDPDYVRKGDARLPLK----WMAPETIF 273
Query: 219 GSKASVSGDVYNFGILLLEMFT 240
               ++  DV++FG+LL E+F+
Sbjct: 274 DRVYTIQSDVWSFGVLLWEIFS 295

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 76/171 (44%), Gaps = 17/171 (9%)
Query: 77  ECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRF-LTQ 135
           E   LR +RH+N+I+++ +  + + +      +V EY      E  +  S  + RF + Q
Sbjct: 56  EIQLLRRLRHKNVIQLVDVLYNEEKQKM---YMVMEYCVCGMQE--MLDSVPEKRFPVCQ 110
Query: 136 RVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTA 195
                  +   +EY H      IVH D+KP N+LL       +  LG+A+ L    P  A
Sbjct: 111 AHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEAL---HPFAA 164
Query: 196 AETASNSIEIKGIVGYVAPEY--GMGSKASVSGDVYNFGILLLEMFTRRRP 244
            +T   S   +G   +  PE   G+ + +    D+++ G+ L  + T   P
Sbjct: 165 DDTCRTS---QGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 52/229 (22%), Positives = 101/229 (44%), Gaps = 37/229 (16%)
Query: 24  ELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK---EASRSFAAECNA 80
           E+ +   N SP   +G G    V      ++   VAVK ++   +    A R++  E   
Sbjct: 19  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRL 74
Query: 81  LRNIRHRNLIKIITICSSI-DFEGFDFKAIVFEYM--QNRNLEQWLRQSNGQLRFLTQRV 137
           L++++H N+I ++ + +     E F+   +V   M     N+ +  + ++  ++FL  ++
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 138 NIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAE 197
                    ++Y H      I+H DLKPSN+ +++D    + D GLA+            
Sbjct: 135 ------LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR------------ 173
Query: 198 TASNSIEIKGIVG---YVAPEYGMG-SKASVSGDVYNFGILLLEMFTRR 242
                 E+ G V    Y APE  +     + + D+++ G ++ E+ T R
Sbjct: 174 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 92/210 (43%), Gaps = 45/210 (21%)
Query: 58  VAVKVVNLKQKEASR-SFAAECNALRNI-RHRNLIKIITICSSIDFEGFDFKAIVFEYMQ 115
           VAVK++  K   + R +  +E   +  +  H N++ ++  C+     G  +  ++FEY  
Sbjct: 78  VAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT---LSGPIY--LIFEYCC 132
Query: 116 NRNLEQWLRQ-----SNGQLRFLTQR----------------VNIAIDVSFAIEYFHHHC 154
             +L  +LR      S  ++ +  Q+                +  A  V+  +E+     
Sbjct: 133 YGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK- 191
Query: 155 QPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKG----IVG 210
             S VH DL   N+L+    V  + D GLA+ +          + SN + ++G     V 
Sbjct: 192 --SCVHRDLAARNVLVTHGKVVKICDFGLARDIM---------SDSNYV-VRGNARLPVK 239
Query: 211 YVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
           ++APE       ++  DV+++GILL E+F+
Sbjct: 240 WMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 25/82 (30%), Positives = 42/82 (51%), Gaps = 6/82 (7%)
Query: 159 VHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGM 218
           +H DL   NILL +  V  + D GLA+ +  Y+           + +K    ++APE   
Sbjct: 222 IHRDLAARNILLSEKNVVKICDFGLARDI--YKDPDYVRKGDARLPLK----WMAPETIF 275
Query: 219 GSKASVSGDVYNFGILLLEMFT 240
               ++  DV++FG+LL E+F+
Sbjct: 276 DRVYTIQSDVWSFGVLLWEIFS 297

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 95/228 (41%), Gaps = 37/228 (16%)
Query: 32  FSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFA---AECNALRNIRHRN 88
           FS   +IG G    VY      +  +VA+K ++   K+++  +     E   L+ +RH N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 89  LIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIE 148
            I+    C   +   +    +V EY    +    L      L    Q V IA     A++
Sbjct: 116 TIQYRG-CYLREHTAW----LVMEYCLG-SASDLLEVHKKPL----QEVEIAAVTHGALQ 165
Query: 149 ---YFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEI 205
              Y H H   +++H D+K  NILL +  +  +GD G A  +            + +   
Sbjct: 166 GLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM------------APANXF 210
Query: 206 KGIVGYVAPEYGMG-SKASVSG--DVYNFGILLLEMFTRRRPTDAMFN 250
            G   ++APE  +   +    G  DV++ GI  +E+  R+ P   +FN
Sbjct: 211 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP---LFN 255

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 89/218 (40%), Gaps = 32/218 (14%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQK-EASRSFAAECNALRNIRHRNLIKIITIC 96
           +G+G    V   +   +   VAVK+V++K+  +   +   E    + + H N++K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY--- 70
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQP 156
                EG + + +  EY            S G+L F     +I +    A  +FH     
Sbjct: 71  -GHRREG-NIQYLFLEYC-----------SGGEL-FDRIEPDIGMPEPDAQRFFHQLMAG 116
Query: 157 -------SIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
                   I H D+KP N+LLD+     + D GLA  +F Y      E   N  ++ G +
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLAT-VFRY---NNRERLLN--KMXGTL 170
Query: 210 GYVAPEYGMGSKASVSG-DVYNFGILLLEMFTRRRPTD 246
            YVAPE     +      DV++ GI+L  M     P D
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 65/141 (46%), Gaps = 11/141 (7%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHR-----NLIK 91
           K+G G  S V+     + +  VA+KVV    +  + +   E   L+++R+      N   
Sbjct: 44  KLGWGHFSTVWLSWDIQGKKFVAMKVVK-SAEHYTETALDEIRLLKSVRNSDPNDPNREM 102
Query: 92  IITICSSIDFEGFDFKAI--VFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEY 149
           ++ +       G +   I  VFE +   +L +W+ +SN Q   L     I   V   ++Y
Sbjct: 103 VVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDY 161
Query: 150 FHHHCQPSIVHGDLKPSNILL 170
            H  C+  I+H D+KP NILL
Sbjct: 162 LHTKCR--IIHTDIKPENILL 180

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 52/229 (22%), Positives = 101/229 (44%), Gaps = 37/229 (16%)
Query: 24  ELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK---EASRSFAAECNA 80
           E+ +   N SP   +G G    V      ++   VAVK ++   +    A R++  E   
Sbjct: 42  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRL 97
Query: 81  LRNIRHRNLIKIITICSSI-DFEGFDFKAIVFEYM--QNRNLEQWLRQSNGQLRFLTQRV 137
           L++++H N+I ++ + +     E F+   +V   M     N+ +  + ++  ++FL  ++
Sbjct: 98  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 157
Query: 138 NIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAE 197
                    ++Y H      I+H DLKPSN+ +++D    + D GLA+            
Sbjct: 158 ------LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR------------ 196
Query: 198 TASNSIEIKGIVG---YVAPEYGMG-SKASVSGDVYNFGILLLEMFTRR 242
                 E+ G V    Y APE  +     + + D+++ G ++ E+ T R
Sbjct: 197 --HTDDEMXGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 52/229 (22%), Positives = 101/229 (44%), Gaps = 37/229 (16%)
Query: 24  ELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK---EASRSFAAECNA 80
           E+ +   N SP   +G G    V      ++   VAVK ++   +    A R++  E   
Sbjct: 24  EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRL 79
Query: 81  LRNIRHRNLIKIITICSSI-DFEGFDFKAIVFEYM--QNRNLEQWLRQSNGQLRFLTQRV 137
           L++++H N+I ++ + +     E F+   +V   M     N+ +  + ++  ++FL  ++
Sbjct: 80  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 139
Query: 138 NIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAE 197
                    ++Y H      I+H DLKPSN+ +++D    + D GLA+            
Sbjct: 140 ------LRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLAR------------ 178
Query: 198 TASNSIEIKGIVG---YVAPEYGMG-SKASVSGDVYNFGILLLEMFTRR 242
                 E+ G V    Y APE  +     + + D+++ G ++ E+ T R
Sbjct: 179 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 79/210 (37%), Gaps = 50/210 (23%)
Query: 61  KVVNLKQKEASRSFA-------------------AECNALRNIRHRNLIKIITICSSIDF 101
           KV+ +K+K   R +A                    E   L+N RH  L  +        F
Sbjct: 24  KVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL-----KYSF 78
Query: 102 EGFDFKAIVFEYMQNRNLEQWLRQ----SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPS 157
           +  D    V EY     L   L +    S  + RF    +  A+D        + H + +
Sbjct: 79  QTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALD--------YLHSEKN 130
Query: 158 IVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG---YVAP 214
           +V+ DLK  N++LD+D    + D GL K           E   +   +K   G   Y+AP
Sbjct: 131 VVYRDLKLENLMLDKDGHIKITDFGLCK-----------EGIKDGATMKXFCGTPEYLAP 179
Query: 215 EYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
           E    +    + D +  G+++ EM   R P
Sbjct: 180 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 83/209 (39%), Gaps = 41/209 (19%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICS 97
           +G G  S V+      +  + A+K +         S   E   L+ I+H N++ +  I  
Sbjct: 17  LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI-- 74
Query: 98  SIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQL--RFLTQRVNIAIDVSF-------AIE 148
              +E      +V + +           S G+L  R L + V    D S        A++
Sbjct: 75  ---YESTTHYYLVMQLV-----------SGGELFDRILERGVYTEKDASLVIQQVLSAVK 120
Query: 149 YFHHHCQPSIVHGDLKPSNILL---DQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEI 205
           Y H +    IVH DLKP N+L    +++    + D GL+K     E      TA      
Sbjct: 121 YLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKM----EQNGIMSTAC----- 168
Query: 206 KGIVGYVAPEYGMGSKASVSGDVYNFGIL 234
            G  GYVAPE       S + D ++ G++
Sbjct: 169 -GTPGYVAPEVLAQKPYSKAVDCWSIGVI 196

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 94/231 (40%), Gaps = 53/231 (22%)
Query: 26  SKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASR------SFAAECN 79
            K  + +    ++G G  +IV K     +    A K +  +Q  ASR          E +
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 80  ALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQL-RFLTQRVN 138
            LR + H N+I +  +     +E      ++ E +           S G+L  FL Q+ +
Sbjct: 68  ILRQVLHHNVITLHDV-----YENRTDVVLILELV-----------SGGELFDFLAQKES 111
Query: 139 IAID--VSF------AIEYFHHHCQPSIVHGDLKPSNI-LLDQDI-VAHVG--DLGLAKF 186
           ++ +   SF       + Y H      I H DLKP NI LLD++I + H+   D GL   
Sbjct: 112 LSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL--- 165
Query: 187 LFGYEPGTAAETASNSIEIKGIVG---YVAPEYGMGSKASVSGDVYNFGIL 234
                    A    + +E K I G   +VAPE        +  D+++ G++
Sbjct: 166 ---------AHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 79/210 (37%), Gaps = 50/210 (23%)
Query: 61  KVVNLKQKEASRSFA-------------------AECNALRNIRHRNLIKIITICSSIDF 101
           KV+ +K+K   R +A                    E   L+N RH  L  +        F
Sbjct: 25  KVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL-----KYSF 79
Query: 102 EGFDFKAIVFEYMQNRNLEQWLRQ----SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPS 157
           +  D    V EY     L   L +    S  + RF    +  A+D        + H + +
Sbjct: 80  QTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALD--------YLHSEKN 131
Query: 158 IVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG---YVAP 214
           +V+ DLK  N++LD+D    + D GL K           E   +   +K   G   Y+AP
Sbjct: 132 VVYRDLKLENLMLDKDGHIKITDFGLCK-----------EGIKDGATMKXFCGTPEYLAP 180
Query: 215 EYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
           E    +    + D +  G+++ EM   R P
Sbjct: 181 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 210

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 89/218 (40%), Gaps = 32/218 (14%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQK-EASRSFAAECNALRNIRHRNLIKIITIC 96
           +G+G    V   +   +   VAVK+V++K+  +   +   E    + + H N++K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY--- 70
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQP 156
                EG + + +  EY            S G+L F     +I +    A  +FH     
Sbjct: 71  -GHRREG-NIQYLFLEYC-----------SGGEL-FDRIEPDIGMPEPDAQRFFHQLMAG 116
Query: 157 -------SIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
                   I H D+KP N+LLD+     + D GLA  +F Y      E   N  ++ G +
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLAT-VFRY---NNRERLLN--KMXGTL 170
Query: 210 GYVAPEYGMGSKASVSG-DVYNFGILLLEMFTRRRPTD 246
            YVAPE     +      DV++ GI+L  M     P D
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 58/242 (23%), Positives = 97/242 (40%), Gaps = 38/242 (15%)
Query: 19  MISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVN----LKQKEASRSF 74
           ++   E+    ++F     IG+G  S V    + ++  + A+K++N    LK+ E S  F
Sbjct: 50  VVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVS-CF 108
Query: 75  AAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQL---- 130
             E + L N   R + ++        F+  ++  +V EY    +L   L +   ++    
Sbjct: 109 REERDVLVNGDRRWITQL-----HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEM 163
Query: 131 -RFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG 189
            RF    + +AID    + Y         VH D+KP NILLD+      G + LA   FG
Sbjct: 164 ARFYLAEIVMAIDSVHRLGY---------VHRDIKPDNILLDR-----CGHIRLAD--FG 207
Query: 190 YEPGTAAETASNSIEIKGIVGYVAPE-------YGMGSKASVSGDVYNFGILLLEMFTRR 242
                 A+    S+   G   Y++PE                  D +  G+   EMF  +
Sbjct: 208 SCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
Query: 243 RP 244
            P
Sbjct: 268 TP 269

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 57/230 (24%), Positives = 94/230 (40%), Gaps = 53/230 (23%)
Query: 27  KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASR------SFAAECNA 80
           K  + +    ++G G  +IV K     +    A K +  +Q  ASR          E + 
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68
Query: 81  LRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQL-RFLTQRVNI 139
           LR + H N+I +  +     +E      ++ E +           S G+L  FL Q+ ++
Sbjct: 69  LRQVLHHNVITLHDV-----YENRTDVVLILELV-----------SGGELFDFLAQKESL 112
Query: 140 AID--VSF------AIEYFHHHCQPSIVHGDLKPSNI-LLDQDI-VAHVG--DLGLAKFL 187
           + +   SF       + Y H      I H DLKP NI LLD++I + H+   D GL    
Sbjct: 113 SEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL---- 165
Query: 188 FGYEPGTAAETASNSIEIKGIVG---YVAPEYGMGSKASVSGDVYNFGIL 234
                   A    + +E K I G   +VAPE        +  D+++ G++
Sbjct: 166 --------AHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 80/207 (38%), Gaps = 44/207 (21%)
Query: 61  KVVNLKQKEASRSFA-------------------AECNALRNIRHRNLIKIITICSSIDF 101
           KV+ +K+K   R +A                    E   L+N RH  L  +        F
Sbjct: 23  KVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL-----KYSF 77
Query: 102 EGFDFKAIVFEYMQNRNLEQWLRQ----SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPS 157
           +  D    V EY     L   L +    S  + RF    +  A+D        + H + +
Sbjct: 78  QTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALD--------YLHSEKN 129
Query: 158 IVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYG 217
           +V+ DLK  N++LD+D    + D GL K   G + G   +    + E      Y+APE  
Sbjct: 130 VVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPE------YLAPEVL 181
Query: 218 MGSKASVSGDVYNFGILLLEMFTRRRP 244
             +    + D +  G+++ EM   R P
Sbjct: 182 EDNDYGRAVDWWGLGVVMYEMMCGRLP 208

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 55/260 (21%), Positives = 107/260 (41%), Gaps = 29/260 (11%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNIRHRNLIKII 93
           ++G G    V +G+    +  + V +  LKQ   K  +     E   +  + +  ++++I
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 94  TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHH 153
            +C +      +   +V E      L ++L     ++  ++    +   VS  ++Y    
Sbjct: 77  GVCQA------EALMLVMEMAGGGPLHKFLVGKREEIP-VSNVAELLHQVSMGMKYLE-- 127
Query: 154 CQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVA 213
            + + VH DL   N+LL     A + D GL+K L   +    A +A      K  + + A
Sbjct: 128 -EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG-----KWPLKWYA 181
Query: 214 PEYGMGSKASVSGDVYNFGILLLEMFTR-RRPTDAMFNEGLTLHEFVKMALPDKVMEIVD 272
           PE     K S   DV+++G+ + E  +  ++P   M  +G  +  F++     K ME   
Sbjct: 182 PECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM--KGPEVMAFIEQG---KRMECPP 236
Query: 273 PSLLLEVTANNYSWIEDCLV 292
                E     Y+ + DC +
Sbjct: 237 -----ECPPELYALMSDCWI 251

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 51/229 (22%), Positives = 101/229 (44%), Gaps = 37/229 (16%)
Query: 24  ELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK---EASRSFAAECNA 80
           E+ +   N +P   +G G    V      ++   VAVK ++   +    A R++  E   
Sbjct: 29  EVPERYQNLAP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRL 84
Query: 81  LRNIRHRNLIKIITICSSI-DFEGFDFKAIVFEYM--QNRNLEQWLRQSNGQLRFLTQRV 137
           L++++H N+I ++ + +     E F+   +V   M     N+ +  + ++  ++FL  ++
Sbjct: 85  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 144
Query: 138 NIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAE 197
                    ++Y H      I+H DLKPSN+ +++D    + D GLA+            
Sbjct: 145 ------LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR------------ 183
Query: 198 TASNSIEIKGIVG---YVAPEYGMG-SKASVSGDVYNFGILLLEMFTRR 242
                 E+ G V    Y APE  +     + + D+++ G ++ E+ T R
Sbjct: 184 --HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 27/104 (25%), Positives = 50/104 (48%), Gaps = 9/104 (8%)
Query: 137 VNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAA 196
           ++ +  V+  +E+         +H DL   NILL ++ V  + D GLA+ +  Y+     
Sbjct: 202 ISYSFQVARGMEFLSSR---KCIHRDLAARNILLSENNVVKICDFGLARDI--YKNPDYV 256
Query: 197 ETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
                 + +K    ++APE       S   DV+++G+LL E+F+
Sbjct: 257 RKGDTRLPLK----WMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 57/230 (24%), Positives = 95/230 (41%), Gaps = 53/230 (23%)
Query: 27  KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASR------SFAAECNA 80
           K  + +    ++G G  +IV K     +    A K +  +Q  ASR          E + 
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSI 68
Query: 81  LRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQL-RFLTQRVNI 139
           LR + H N+I +  +     +E      ++ E +           S G+L  FL Q+ ++
Sbjct: 69  LRQVLHPNIITLHDV-----YENRTDVVLILELV-----------SGGELFDFLAQKESL 112
Query: 140 AID--VSF------AIEYFHHHCQPSIVHGDLKPSNI-LLDQDI-VAHVG--DLGLAKFL 187
           + +   SF       + Y H      I H DLKP NI LLD++I + H+   D GLA  +
Sbjct: 113 SEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169
Query: 188 FGYEPGTAAETASNSIEIKGIVG---YVAPEYGMGSKASVSGDVYNFGIL 234
                        + +E K I G   +VAPE        +  D+++ G++
Sbjct: 170 ------------EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 47/197 (23%), Positives = 81/197 (41%), Gaps = 40/197 (20%)
Query: 61  KVVNLKQKEASRSFA------AECNALRNIRH----RNLIKIITICSSIDFEGFDFK--- 107
           +V+ +K KE+   +A       +   L+ I H    + +++ +     +  E F FK   
Sbjct: 56  RVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE-FSFKDNS 114
Query: 108 --AIVFEYMQNRNLEQWLRQ----SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHG 161
              +V EY+    +   LR+    S    RF       A  +    EY H      +++ 
Sbjct: 115 NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY------AAQIVLTFEYLH---SLDLIYR 165
Query: 162 DLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSK 221
           DLKP N+L+DQ     V D G AK + G            +  + G   Y+APE  +   
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRVKG-----------RTWXLCGTPEYLAPEIILSKG 214
Query: 222 ASVSGDVYNFGILLLEM 238
            + + D +  G+L+ +M
Sbjct: 215 YNKAVDWWALGVLIYQM 231

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 27/99 (27%), Positives = 44/99 (44%), Gaps = 14/99 (14%)
Query: 140 AIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETA 199
           A  +    EY H      +++ DLKP N+++DQ     V D G AK + G          
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKG---------- 193
Query: 200 SNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEM 238
             +  + G   Y+APE  +    + + D +  G+L+ EM
Sbjct: 194 -RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 51/222 (22%), Positives = 96/222 (43%), Gaps = 46/222 (20%)
Query: 35  ANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ------KEASRSF--AAECNALRNIRH 86
           +  +G G    V      ++   VA+K+++ ++      +EA  +     E   L+ + H
Sbjct: 21  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 80
Query: 87  RNLIKIITICSSIDFEGFDFKAIVFEYMQNRNL------EQWLRQSNGQLRFLTQRVNIA 140
             +IKI     + D+       IV E M+   L       + L+++  +L F        
Sbjct: 81  PCIIKIKNFFDAEDY------YIVLELMEGGELFDKVVGNKRLKEATCKLYFY------- 127
Query: 141 IDVSFAIEYFHHHCQPSIVHGDLKPSNILL---DQDIVAHVGDLGLAKFLFGYEPGTAAE 197
             +  A++Y H +    I+H DLKP N+LL   ++D +  + D G +K L         E
Sbjct: 128 -QMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--------GE 175
Query: 198 TASNSIEIKGIVGYVAPE--YGMGSKA-SVSGDVYNFGILLL 236
           T+     + G   Y+APE    +G+   + + D ++ G++L 
Sbjct: 176 TSLMRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF 216

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 51/222 (22%), Positives = 96/222 (43%), Gaps = 46/222 (20%)
Query: 35  ANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ------KEASRSF--AAECNALRNIRH 86
           +  +G G    V      ++   VA+K+++ ++      +EA  +     E   L+ + H
Sbjct: 15  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74
Query: 87  RNLIKIITICSSIDFEGFDFKAIVFEYMQNRNL------EQWLRQSNGQLRFLTQRVNIA 140
             +IKI     + D+       IV E M+   L       + L+++  +L F        
Sbjct: 75  PCIIKIKNFFDAEDY------YIVLELMEGGELFDKVVGNKRLKEATCKLYFY------- 121
Query: 141 IDVSFAIEYFHHHCQPSIVHGDLKPSNILL---DQDIVAHVGDLGLAKFLFGYEPGTAAE 197
             +  A++Y H +    I+H DLKP N+LL   ++D +  + D G +K L         E
Sbjct: 122 -QMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--------GE 169
Query: 198 TASNSIEIKGIVGYVAPE--YGMGSKA-SVSGDVYNFGILLL 236
           T+     + G   Y+APE    +G+   + + D ++ G++L 
Sbjct: 170 TSLMRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF 210

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 51/222 (22%), Positives = 96/222 (43%), Gaps = 46/222 (20%)
Query: 35  ANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ------KEASRSF--AAECNALRNIRH 86
           +  +G G    V      ++   VA+K+++ ++      +EA  +     E   L+ + H
Sbjct: 15  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74
Query: 87  RNLIKIITICSSIDFEGFDFKAIVFEYMQNRNL------EQWLRQSNGQLRFLTQRVNIA 140
             +IKI     + D+       IV E M+   L       + L+++  +L F        
Sbjct: 75  PCIIKIKNFFDAEDY------YIVLELMEGGELFDKVVGNKRLKEATCKLYFY------- 121
Query: 141 IDVSFAIEYFHHHCQPSIVHGDLKPSNILL---DQDIVAHVGDLGLAKFLFGYEPGTAAE 197
             +  A++Y H +    I+H DLKP N+LL   ++D +  + D G +K L         E
Sbjct: 122 -QMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--------GE 169
Query: 198 TASNSIEIKGIVGYVAPE--YGMGSKA-SVSGDVYNFGILLL 236
           T+     + G   Y+APE    +G+   + + D ++ G++L 
Sbjct: 170 TSLMRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF 210

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 47/197 (23%), Positives = 81/197 (41%), Gaps = 40/197 (20%)
Query: 61  KVVNLKQKEASRSFA------AECNALRNIRH----RNLIKIITICSSIDFEGFDFK--- 107
           +V+ +K KE+   +A       +   L+ I H    + +++ +     +  E F FK   
Sbjct: 43  RVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE-FSFKDNS 101
Query: 108 --AIVFEYMQNRNLEQWLRQ----SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHG 161
              +V EY+    +   LR+    S    RF       A  +    EY H      +++ 
Sbjct: 102 NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY------AAQIVLTFEYLH---SLDLIYR 152
Query: 162 DLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSK 221
           DLKP N+L+D+     V D G AK + G            +  + G   Y+APE  +   
Sbjct: 153 DLKPENLLIDEQGYIQVTDFGFAKRVKG-----------RTWXLCGTPEYLAPEIILSKG 201
Query: 222 ASVSGDVYNFGILLLEM 238
            + + D +  G+L+ EM
Sbjct: 202 YNKAVDWWALGVLIYEM 218

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 89/218 (40%), Gaps = 32/218 (14%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQK-EASRSFAAECNALRNIRHRNLIKIITIC 96
           +G+G    V   +   +   VAVK+V++K+  +   +   E    + + H N++K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY--- 70
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQP 156
                EG + + +  EY            S G+L F     +I +    A  +FH     
Sbjct: 71  -GHRREG-NIQYLFLEYC-----------SGGEL-FDRIEPDIGMPEPDAQRFFHQLMAG 116
Query: 157 -------SIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
                   I H D+KP N+LLD+     + D GLA  +F Y      E   N  ++ G +
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLAT-VFRY---NNRERLLN--KMXGTL 170
Query: 210 GYVAPEYGMGSKASVSG-DVYNFGILLLEMFTRRRPTD 246
            YVAPE     +      DV++ GI+L  M     P D
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 93/226 (41%), Gaps = 43/226 (19%)
Query: 38  IGQGGVSIVYKGILDESR--SIVAVKVVNL--KQKEASRSFAAECNALRNIRHRNLI-KI 92
           +G+G    V +  LD +R  S VA+K++    K +EA+R    E N L+ I+ ++   K 
Sbjct: 27  LGEGTFGKVVE-CLDHARGKSQVALKIIRNVGKYREAAR---LEINVLKKIKEKDKENKF 82
Query: 93  ITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHH 152
           + +  S  F       I FE +  +N  ++L+++N Q   L    ++A  +  A+ + H 
Sbjct: 83  LCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH- 140
Query: 153 HCQPSIVHGDLKPSNILL-------------------DQDIVAHVGDLGLAKFLFGYEPG 193
             +  + H DLKP NIL                     ++    V D G A F   +   
Sbjct: 141 --ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTT 198
Query: 194 TAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMF 239
             A       E+   +G+  P            DV++ G +L E +
Sbjct: 199 IVATRHYRPPEVILELGWAQP-----------CDVWSIGCILFEYY 233

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 48/208 (23%), Positives = 87/208 (41%), Gaps = 31/208 (14%)
Query: 51  LDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNI-RHRNLIKIITICSSIDFEGFDF 106
           +D++ +   V V  LK+       R+  +E   L +I  H N++ ++  C+     G   
Sbjct: 42  IDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK---PGGPL 98
Query: 107 KAIVFEYMQNRNLEQWLRQSNGQL------------RFLT--QRVNIAIDVSFAIEYFHH 152
             I  E+ +  NL  +LR    +              FLT    +  +  V+  +E+   
Sbjct: 99  MVIT-EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS 157
Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
                 +H DL   NILL +  V  + D GLA+ +   +           + +K    ++
Sbjct: 158 R---KCIHRDLAARNILLSEKNVVKICDFGLARDI--XKDPDXVRKGDARLPLK----WM 208
Query: 213 APEYGMGSKASVSGDVYNFGILLLEMFT 240
           APE       ++  DV++FG+LL E+F+
Sbjct: 209 APETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 93/226 (41%), Gaps = 43/226 (19%)
Query: 38  IGQGGVSIVYKGILDESR--SIVAVKVVNL--KQKEASRSFAAECNALRNIRHRNLI-KI 92
           +G+G    V +  LD +R  S VA+K++    K +EA+R    E N L+ I+ ++   K 
Sbjct: 36  LGEGTFGKVVE-CLDHARGKSQVALKIIRNVGKYREAAR---LEINVLKKIKEKDKENKF 91
Query: 93  ITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHH 152
           + +  S  F       I FE +  +N  ++L+++N Q   L    ++A  +  A+ + H 
Sbjct: 92  LCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH- 149
Query: 153 HCQPSIVHGDLKPSNILL-------------------DQDIVAHVGDLGLAKFLFGYEPG 193
             +  + H DLKP NIL                     ++    V D G A F   +   
Sbjct: 150 --ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTT 207
Query: 194 TAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMF 239
             A       E+   +G+  P            DV++ G +L E +
Sbjct: 208 IVATRHYRPPEVILELGWAQP-----------CDVWSIGCILFEYY 242

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 54/227 (23%), Positives = 89/227 (39%), Gaps = 45/227 (19%)
Query: 26  SKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASR------SFAAECN 79
            K  + +    ++G G  +IV K     +    A K +  +Q  ASR          E +
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 80  ALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNG-----QLRFLT 134
            LR + H N+I +  +     +E      ++ E +    L  +L Q           F+ 
Sbjct: 68  ILRQVLHHNVITLHDV-----YENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK 122
Query: 135 QRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNI-LLDQDI-VAHVG--DLGLAKFLFGY 190
           Q ++        + Y H      I H DLKP NI LLD++I + H+   D GL       
Sbjct: 123 QILD-------GVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL------- 165
Query: 191 EPGTAAETASNSIEIKGIVG---YVAPEYGMGSKASVSGDVYNFGIL 234
                A    + +E K I G   +VAPE        +  D+++ G++
Sbjct: 166 -----AHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 50/231 (21%), Positives = 99/231 (42%), Gaps = 41/231 (17%)
Query: 24  ELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK-----EASRSFAAEC 78
           E+ +     SP      G V   Y     + +S + + V  L +       A R++  E 
Sbjct: 48  EVPERYQTLSPVGSGAYGSVCSSY-----DVKSGLKIAVKKLSRPFQSIIHAKRTYR-EL 101
Query: 79  NALRNIRHRNLIKIITI-CSSIDFEGFDFKAIVFEYM--QNRNLEQWLRQSNGQLRFLTQ 135
             L++++H N+I ++ +   +   E F+   +V   M     N+ +  + ++  ++FL  
Sbjct: 102 RLLKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 161
Query: 136 RVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTA 195
           ++         ++Y H      I+H DLKPSN+ +++D    + D GLA+          
Sbjct: 162 QI------LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---------- 202
Query: 196 AETASNSIEIKGIVG---YVAPEYGMG-SKASVSGDVYNFGILLLEMFTRR 242
                   E+ G V    Y APE  +     +++ D+++ G ++ E+ T R
Sbjct: 203 ----HTDDEMTGYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 46/91 (50%), Gaps = 13/91 (14%)
Query: 158 IVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYG 217
           I+H D+KPSNILLD+     + D G++        G   ++ + + +  G   Y+APE  
Sbjct: 147 IIHRDIKPSNILLDRSGNIKLCDFGIS--------GQLVDSIAKTRD-AGCRPYMAPERI 197
Query: 218 MGSKA----SVSGDVYNFGILLLEMFTRRRP 244
             S +     V  DV++ GI L E+ T R P
Sbjct: 198 DPSASRQGYDVRSDVWSLGITLYELATGRFP 228

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 95/228 (41%), Gaps = 37/228 (16%)
Query: 32  FSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFA---AECNALRNIRHRN 88
           FS   +IG G    VY      +  +VA+K ++   K+++  +     E   L+ +RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 89  LIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIE 148
            I+    C   +   +    +V EY    +    L      L    Q V IA     A++
Sbjct: 77  TIQYRG-CYLREHTAW----LVMEYCLG-SASDLLEVHKKPL----QEVEIAAVTHGALQ 126
Query: 149 ---YFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEI 205
              Y H H   +++H D+K  NILL +  +  +GD G            +A   + +   
Sbjct: 127 GLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG------------SASIMAPANXF 171
Query: 206 KGIVGYVAPEYGMG-SKASVSG--DVYNFGILLLEMFTRRRPTDAMFN 250
            G   ++APE  +   +    G  DV++ GI  +E+  R+ P   +FN
Sbjct: 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP---LFN 216

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 51/222 (22%), Positives = 96/222 (43%), Gaps = 46/222 (20%)
Query: 35  ANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ------KEASRSF--AAECNALRNIRH 86
           +  +G G    V      ++   VA+K+++ ++      +EA  +     E   L+ + H
Sbjct: 14  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 73
Query: 87  RNLIKIITICSSIDFEGFDFKAIVFEYMQNRNL------EQWLRQSNGQLRFLTQRVNIA 140
             +IKI     + D+       IV E M+   L       + L+++  +L F        
Sbjct: 74  PCIIKIKNFFDAEDY------YIVLELMEGGELFDKVVGNKRLKEATCKLYFY------- 120
Query: 141 IDVSFAIEYFHHHCQPSIVHGDLKPSNILL---DQDIVAHVGDLGLAKFLFGYEPGTAAE 197
             +  A++Y H +    I+H DLKP N+LL   ++D +  + D G +K L         E
Sbjct: 121 -QMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--------GE 168
Query: 198 TASNSIEIKGIVGYVAPE--YGMGSKA-SVSGDVYNFGILLL 236
           T+     + G   Y+APE    +G+   + + D ++ G++L 
Sbjct: 169 TSLMRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF 209

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 47/197 (23%), Positives = 81/197 (41%), Gaps = 40/197 (20%)
Query: 61  KVVNLKQKEASRSFA------AECNALRNIRH----RNLIKIITICSSIDFEGFDFK--- 107
           +V+ +K KE+   +A       +   L+ I H    + +++ +     +  E F FK   
Sbjct: 56  RVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE-FSFKDNS 114
Query: 108 --AIVFEYMQNRNLEQWLRQ----SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHG 161
              +V EY+    +   LR+    S    RF       A  +    EY H      +++ 
Sbjct: 115 NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY------AAQIVLTFEYLH---SLDLIYR 165
Query: 162 DLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSK 221
           DLKP N+++DQ     V D G AK + G            +  + G   Y+APE  +   
Sbjct: 166 DLKPENLIIDQQGYIQVTDFGFAKRVKG-----------RTWXLCGTPEYLAPEIIISKG 214
Query: 222 ASVSGDVYNFGILLLEM 238
            + + D +  G+L+ EM
Sbjct: 215 YNKAVDWWALGVLIYEM 231

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 94/231 (40%), Gaps = 53/231 (22%)
Query: 26  SKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASR------SFAAECN 79
            K  + +    ++G G  +IV K     +    A K +  +Q  ASR          E +
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 80  ALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQL-RFLTQRVN 138
            LR + H N+I +  +     +E      ++ E +           S G+L  FL Q+ +
Sbjct: 68  ILRQVLHHNVITLHDV-----YENRTDVVLILELV-----------SGGELFDFLAQKES 111
Query: 139 IAID--VSF------AIEYFHHHCQPSIVHGDLKPSNI-LLDQDI-VAHVG--DLGLAKF 186
           ++ +   SF       + Y H      I H DLKP NI LLD++I + H+   D GL   
Sbjct: 112 LSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL--- 165
Query: 187 LFGYEPGTAAETASNSIEIKGIVG---YVAPEYGMGSKASVSGDVYNFGIL 234
                    A    + +E K I G   +VAPE        +  D+++ G++
Sbjct: 166 ---------AHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 57/230 (24%), Positives = 94/230 (40%), Gaps = 53/230 (23%)
Query: 27  KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASR------SFAAECNA 80
           K  + +    ++G G  +IV K     +    A K +  +Q  ASR          E + 
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68
Query: 81  LRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQL-RFLTQRVNI 139
           LR + H N+I +  +     +E      ++ E +           S G+L  FL Q+ ++
Sbjct: 69  LRQVLHHNVITLHDV-----YENRTDVVLILELV-----------SGGELFDFLAQKESL 112
Query: 140 AID--VSF------AIEYFHHHCQPSIVHGDLKPSNI-LLDQDI-VAHVG--DLGLAKFL 187
           + +   SF       + Y H      I H DLKP NI LLD++I + H+   D GL    
Sbjct: 113 SEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL---- 165
Query: 188 FGYEPGTAAETASNSIEIKGIVG---YVAPEYGMGSKASVSGDVYNFGIL 234
                   A    + +E K I G   +VAPE        +  D+++ G++
Sbjct: 166 --------AHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 89/218 (40%), Gaps = 32/218 (14%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQK-EASRSFAAECNALRNIRHRNLIKIITIC 96
           +G+G    V   +   +   VAVK+V++K+  +   +   E    + + H N++K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFY--- 70
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQP 156
                EG + + +  EY            S G+L F     +I +    A  +FH     
Sbjct: 71  -GHRREG-NIQYLFLEYC-----------SGGEL-FDRIEPDIGMPEPDAQRFFHQLMAG 116
Query: 157 -------SIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
                   I H D+KP N+LLD+     + D GLA  +F Y      E   N  ++ G +
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLAT-VFRY---NNRERLLN--KMCGTL 170
Query: 210 GYVAPEYGMGSKASVSG-DVYNFGILLLEMFTRRRPTD 246
            YVAPE     +      DV++ GI+L  M     P D
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 51/222 (22%), Positives = 96/222 (43%), Gaps = 46/222 (20%)
Query: 35  ANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ------KEASRSF--AAECNALRNIRH 86
           +  +G G    V      ++   VA+K+++ ++      +EA  +     E   L+ + H
Sbjct: 15  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74
Query: 87  RNLIKIITICSSIDFEGFDFKAIVFEYMQNRNL------EQWLRQSNGQLRFLTQRVNIA 140
             +IKI     + D+       IV E M+   L       + L+++  +L F        
Sbjct: 75  PCIIKIKNFFDAEDY------YIVLELMEGGELFDKVVGNKRLKEATCKLYFY------- 121
Query: 141 IDVSFAIEYFHHHCQPSIVHGDLKPSNILL---DQDIVAHVGDLGLAKFLFGYEPGTAAE 197
             +  A++Y H +    I+H DLKP N+LL   ++D +  + D G +K L         E
Sbjct: 122 -QMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--------GE 169
Query: 198 TASNSIEIKGIVGYVAPE--YGMGSKA-SVSGDVYNFGILLL 236
           T+     + G   Y+APE    +G+   + + D ++ G++L 
Sbjct: 170 TSLMRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF 210

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 78/184 (42%), Gaps = 28/184 (15%)
Query: 59  AVKVVN---LKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQ 115
           AVKV++   +KQK    S   E   L+ + H N++K+        +E F+ K   +   +
Sbjct: 61  AVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL--------YEFFEDKGYFYLVGE 112
Query: 116 NRNLEQWLRQSNGQLRFL-TQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLD--- 171
                +   +   + RF       I   V   I Y H +    IVH DLKP N+LL+   
Sbjct: 113 VYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKS 169
Query: 172 QDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNF 231
           +D    + D GL+         T  E +    +  G   Y+APE   G+      DV++ 
Sbjct: 170 KDANIRIIDFGLS---------THFEASKKMKDKIGTAYYIAPEVLHGT-YDEKCDVWST 219
Query: 232 GILL 235
           G++L
Sbjct: 220 GVIL 223

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 45/227 (19%), Positives = 98/227 (43%), Gaps = 26/227 (11%)
Query: 30  NNFSPANKIGQGGVSIVYKGI-LDESRSI-VAVKVVNLKQ---KEASRSFAAECNALRNI 84
             F     +G G    VYKG+ + E   + + V +  L++    +A++    E   + ++
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 85  RHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQL--RFLTQRVNIAID 142
            + ++ +++ IC +   +      ++ + M    L  ++R+    +  ++L   +N  + 
Sbjct: 76  DNPHVCRLLGICLTSTVQ------LIMQLMPFGXLLDYVREHKDNIGSQYL---LNWCVQ 126
Query: 143 VSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNS 202
           ++  + Y        +VH DL   N+L+       + D GLAK L   E    AE     
Sbjct: 127 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 183
Query: 203 IEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAM 248
           I+      ++A E  +    +   DV+++G+ + E+ T   +P D +
Sbjct: 184 IK------WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 224

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 91/217 (41%), Gaps = 37/217 (17%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICS 97
           IG G  S   + +   +    AVKV++  +++ S         LR  +H N+I +  +  
Sbjct: 35  IGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEI---LLRYGQHPNIITLKDV-- 89
Query: 98  SIDFEGFDFKAIVFEYMQNRNL-EQWLRQSNGQLRFLTQRVN--IAIDVSFAIEYFHHHC 154
              ++      +V E M+   L ++ LRQ     +F ++R    +   +   +EY H   
Sbjct: 90  ---YDDGKHVYLVTELMRGGELLDKILRQ-----KFFSEREASFVLHTIGKTVEYLHSQ- 140
Query: 155 QPSIVHGDLKPSNIL-LDQD---IVAHVGDLGLAKFLFGYEPG---TAAETASNSIEIKG 207
              +VH DLKPSNIL +D+        + D G AK L   E G   T   TA+       
Sbjct: 141 --GVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRA-ENGLLMTPCYTAN------- 190
Query: 208 IVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
              +VAPE           D+++ GILL  M     P
Sbjct: 191 ---FVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 27/99 (27%), Positives = 44/99 (44%), Gaps = 14/99 (14%)
Query: 140 AIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETA 199
           A  +    EY H      +++ DLKP N+++DQ     V D G AK + G          
Sbjct: 148 AAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG---------- 194
Query: 200 SNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEM 238
             +  + G   Y+APE  +    + + D +  G+L+ EM
Sbjct: 195 -RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 93/226 (41%), Gaps = 43/226 (19%)
Query: 38  IGQGGVSIVYKGILDESR--SIVAVKVVNL--KQKEASRSFAAECNALRNIRHRNLI-KI 92
           +G+G    V +  LD +R  S VA+K++    K +EA+R    E N L+ I+ ++   K 
Sbjct: 59  LGEGTFGKVVE-CLDHARGKSQVALKIIRNVGKYREAAR---LEINVLKKIKEKDKENKF 114
Query: 93  ITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHH 152
           + +  S  F       I FE +  +N  ++L+++N Q   L    ++A  +  A+ + H 
Sbjct: 115 LCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH- 172
Query: 153 HCQPSIVHGDLKPSNILL-------------------DQDIVAHVGDLGLAKFLFGYEPG 193
             +  + H DLKP NIL                     ++    V D G A F   +   
Sbjct: 173 --ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTT 230
Query: 194 TAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMF 239
             A       E+   +G+  P            DV++ G +L E +
Sbjct: 231 IVATRHYRPPEVILELGWAQP-----------CDVWSIGCILFEYY 265

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 27/99 (27%), Positives = 44/99 (44%), Gaps = 14/99 (14%)
Query: 140 AIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETA 199
           A  +    EY H      +++ DLKP N+++DQ     V D G AK + G          
Sbjct: 148 AAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG---------- 194
Query: 200 SNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEM 238
             +  + G   Y+APE  +    + + D +  G+L+ EM
Sbjct: 195 -RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 27/99 (27%), Positives = 44/99 (44%), Gaps = 14/99 (14%)
Query: 140 AIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETA 199
           A  +    EY H      +++ DLKP N+++DQ     V D G AK + G          
Sbjct: 148 AAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG---------- 194
Query: 200 SNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEM 238
             +  + G   Y+APE  +    + + D +  G+L+ EM
Sbjct: 195 -RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 89/218 (40%), Gaps = 32/218 (14%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQK-EASRSFAAECNALRNIRHRNLIKIITIC 96
           +G+G    V   +   +   VAVK+V++K+  +   +   E    + + H N++K     
Sbjct: 14  LGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY--- 70
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQP 156
                EG + + +  EY            S G+L F     +I +    A  +FH     
Sbjct: 71  -GHRREG-NIQYLFLEYC-----------SGGEL-FDRIEPDIGMPEPDAQRFFHQLMAG 116
Query: 157 -------SIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
                   I H D+KP N+LLD+     + D GLA  +F Y      E   N  ++ G +
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLAT-VFRY---NNRERLLN--KMCGTL 170
Query: 210 GYVAPEYGMGSKASVSG-DVYNFGILLLEMFTRRRPTD 246
            YVAPE     +      DV++ GI+L  M     P D
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 89/218 (40%), Gaps = 32/218 (14%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQK-EASRSFAAECNALRNIRHRNLIKIITIC 96
           +G+G    V   +   +   VAVK+V++K+  +   +   E    + + H N++K     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY--- 71
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQP 156
                EG + + +  EY            S G+L F     +I +    A  +FH     
Sbjct: 72  -GHRREG-NIQYLFLEYC-----------SGGEL-FDRIEPDIGMPEPDAQRFFHQLMAG 117
Query: 157 -------SIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
                   I H D+KP N+LLD+     + D GLA  +F Y      E   N  ++ G +
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLAT-VFRY---NNRERLLN--KMCGTL 171
Query: 210 GYVAPEYGMGSKASVSG-DVYNFGILLLEMFTRRRPTD 246
            YVAPE     +      DV++ GI+L  M     P D
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 27/99 (27%), Positives = 44/99 (44%), Gaps = 14/99 (14%)
Query: 140 AIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETA 199
           A  +    EY H      +++ DLKP N+++DQ     V D G AK + G          
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG---------- 193
Query: 200 SNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEM 238
             +  + G   Y+APE  +    + + D +  G+L+ EM
Sbjct: 194 -RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 27/99 (27%), Positives = 44/99 (44%), Gaps = 14/99 (14%)
Query: 140 AIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETA 199
           A  +    EY H      +++ DLKP N+++DQ     V D G AK + G          
Sbjct: 148 AAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG---------- 194
Query: 200 SNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEM 238
             +  + G   Y+APE  +    + + D +  G+L+ EM
Sbjct: 195 -RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 89/218 (40%), Gaps = 32/218 (14%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQK-EASRSFAAECNALRNIRHRNLIKIITIC 96
           +G+G    V   +   +   VAVK+V++K+  +   +   E    + + H N++K     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY--- 71
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQP 156
                EG + + +  EY            S G+L F     +I +    A  +FH     
Sbjct: 72  -GHRREG-NIQYLFLEYC-----------SGGEL-FDRIEPDIGMPEPDAQRFFHQLMAG 117
Query: 157 -------SIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
                   I H D+KP N+LLD+     + D GLA  +F Y      E   N  ++ G +
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLAT-VFRY---NNRERLLN--KMCGTL 171
Query: 210 GYVAPEYGMGSKASVSG-DVYNFGILLLEMFTRRRPTD 246
            YVAPE     +      DV++ GI+L  M     P D
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 89/218 (40%), Gaps = 32/218 (14%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQK-EASRSFAAECNALRNIRHRNLIKIITIC 96
           +G+G    V   +   +   VAVK+V++K+  +   +   E    + + H N++K     
Sbjct: 13  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY--- 69
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQP 156
                EG + + +  EY            S G+L F     +I +    A  +FH     
Sbjct: 70  -GHRREG-NIQYLFLEYC-----------SGGEL-FDRIEPDIGMPEPDAQRFFHQLMAG 115
Query: 157 -------SIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
                   I H D+KP N+LLD+     + D GLA  +F Y      E   N  ++ G +
Sbjct: 116 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLAT-VFRY---NNRERLLN--KMCGTL 169
Query: 210 GYVAPEYGMGSKASVSG-DVYNFGILLLEMFTRRRPTD 246
            YVAPE     +      DV++ GI+L  M     P D
Sbjct: 170 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 207

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 89/218 (40%), Gaps = 32/218 (14%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQK-EASRSFAAECNALRNIRHRNLIKIITIC 96
           +G+G    V   +   +   VAVK+V++K+  +   +   E    + + H N++K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY--- 70
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQP 156
                EG + + +  EY            S G+L F     +I +    A  +FH     
Sbjct: 71  -GHRREG-NIQYLFLEYC-----------SGGEL-FDRIEPDIGMPEPDAQRFFHQLMAG 116
Query: 157 -------SIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
                   I H D+KP N+LLD+     + D GLA  +F Y      E   N  ++ G +
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLAT-VFRY---NNRERLLN--KMCGTL 170
Query: 210 GYVAPEYGMGSKASVSG-DVYNFGILLLEMFTRRRPTD 246
            YVAPE     +      DV++ GI+L  M     P D
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 27/99 (27%), Positives = 44/99 (44%), Gaps = 14/99 (14%)
Query: 140 AIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETA 199
           A  +    EY H      +++ DLKP N+++DQ     V D G AK + G          
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG---------- 193
Query: 200 SNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEM 238
             +  + G   Y+APE  +    + + D +  G+L+ EM
Sbjct: 194 -RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 56/247 (22%), Positives = 105/247 (42%), Gaps = 44/247 (17%)
Query: 13  MKQQFPMISYAELSKAT-------NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL 65
           M Q+ P     EL+K          N SP   +G G    V      ++   VAVK ++ 
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSR 57
Query: 66  KQK---EASRSFAAECNALRNIRHRNLIKIITICSSI-DFEGFDFKAIVFEYM--QNRNL 119
             +    A R++  E   L++++H N+I ++ + +     E F+   +V   M     N+
Sbjct: 58  PFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI 116
Query: 120 EQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVG 179
            +  + ++  ++FL  ++         ++Y H      I+H DLKPSN+ +++D    + 
Sbjct: 117 VKCQKLTDDHVQFLIYQI------LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 167
Query: 180 DLGLAKFLFGYEPGTAAETASNSIEIKGIVG---YVAPEYGMG-SKASVSGDVYNFGILL 235
           D  LA+                  E+ G V    Y APE  +     + + D+++ G ++
Sbjct: 168 DFYLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 213
Query: 236 LEMFTRR 242
            E+ T R
Sbjct: 214 AELLTGR 220

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 89/218 (40%), Gaps = 32/218 (14%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQK-EASRSFAAECNALRNIRHRNLIKIITIC 96
           +G+G    V   +   +   VAVK+V++K+  +   +   E    + + H N++K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY--- 70
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQP 156
                EG + + +  EY            S G+L F     +I +    A  +FH     
Sbjct: 71  -GHRREG-NIQYLFLEYC-----------SGGEL-FDRIEPDIGMPEPDAQRFFHQLMAG 116
Query: 157 -------SIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
                   I H D+KP N+LLD+     + D GLA  +F Y      E   N  ++ G +
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLAT-VFRY---NNRERLLN--KMCGTL 170
Query: 210 GYVAPEYGMGSKASVSG-DVYNFGILLLEMFTRRRPTD 246
            YVAPE     +      DV++ GI+L  M     P D
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 45/227 (19%), Positives = 98/227 (43%), Gaps = 26/227 (11%)
Query: 30  NNFSPANKIGQGGVSIVYKGI-LDESRSI-VAVKVVNLKQ---KEASRSFAAECNALRNI 84
             F     +G G    VYKG+ + E   + + V +  L++    +A++    E   + ++
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 85  RHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQL--RFLTQRVNIAID 142
            + ++ +++ IC +   +      ++ + M    L  ++R+    +  ++L   +N  + 
Sbjct: 78  DNPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYL---LNWCVQ 128
Query: 143 VSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNS 202
           ++  + Y        +VH DL   N+L+       + D GLAK L   E    AE     
Sbjct: 129 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 185
Query: 203 IEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAM 248
           I+      ++A E  +    +   DV+++G+ + E+ T   +P D +
Sbjct: 186 IK------WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 226

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 89/218 (40%), Gaps = 32/218 (14%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQK-EASRSFAAECNALRNIRHRNLIKIITIC 96
           +G+G    V   +   +   VAVK+V++K+  +   +   E    + + H N++K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY--- 70
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQP 156
                EG + + +  EY            S G+L F     +I +    A  +FH     
Sbjct: 71  -GHRREG-NIQYLFLEYC-----------SGGEL-FDRIEPDIGMPEPDAQRFFHQLMAG 116
Query: 157 -------SIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
                   I H D+KP N+LLD+     + D GLA  +F Y      E   N  ++ G +
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLAT-VFRY---NNRERLLN--KMCGTL 170
Query: 210 GYVAPEYGMGSKASVSG-DVYNFGILLLEMFTRRRPTD 246
            YVAPE     +      DV++ GI+L  M     P D
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 45/227 (19%), Positives = 98/227 (43%), Gaps = 26/227 (11%)
Query: 30  NNFSPANKIGQGGVSIVYKGI-LDESRSI-VAVKVVNLKQ---KEASRSFAAECNALRNI 84
             F     +G G    VYKG+ + E   + + V +  L++    +A++    E   + ++
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 85  RHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQL--RFLTQRVNIAID 142
            + ++ +++ IC +   +      ++ + M    L  ++R+    +  ++L   +N  + 
Sbjct: 75  DNPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYL---LNWCVQ 125
Query: 143 VSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNS 202
           ++  + Y        +VH DL   N+L+       + D GLAK L   E    AE     
Sbjct: 126 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 203 IEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAM 248
           I+      ++A E  +    +   DV+++G+ + E+ T   +P D +
Sbjct: 183 IK------WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 89/218 (40%), Gaps = 32/218 (14%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQK-EASRSFAAECNALRNIRHRNLIKIITIC 96
           +G+G    V   +   +   VAVK+V++K+  +   +   E    + + H N++K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY--- 70
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQP 156
                EG + + +  EY            S G+L F     +I +    A  +FH     
Sbjct: 71  -GHRREG-NIQYLFLEYC-----------SGGEL-FDRIEPDIGMPEPDAQRFFHQLMAG 116
Query: 157 -------SIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
                   I H D+KP N+LLD+     + D GLA  +F Y      E   N  ++ G +
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLAT-VFRY---NNRERLLN--KMCGTL 170
Query: 210 GYVAPEYGMGSKASVSG-DVYNFGILLLEMFTRRRPTD 246
            YVAPE     +      DV++ GI+L  M     P D
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 45/227 (19%), Positives = 98/227 (43%), Gaps = 26/227 (11%)
Query: 30  NNFSPANKIGQGGVSIVYKGI-LDESRSI-VAVKVVNLKQ---KEASRSFAAECNALRNI 84
             F     +G G    VYKG+ + E   + + V +  L++    +A++    E   + ++
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 85  RHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQL--RFLTQRVNIAID 142
            + ++ +++ IC +   +      ++ + M    L  ++R+    +  ++L   +N  + 
Sbjct: 77  DNPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYL---LNWCVQ 127
Query: 143 VSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNS 202
           ++  + Y        +VH DL   N+L+       + D GLAK L   E    AE     
Sbjct: 128 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 184
Query: 203 IEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAM 248
           I+      ++A E  +    +   DV+++G+ + E+ T   +P D +
Sbjct: 185 IK------WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 225

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 88/219 (40%), Gaps = 29/219 (13%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQ--KEASRSFAAECNALRNIRHRNLIKIITI 95
           IG+G    VY G        VA++++++++  ++  ++F  E  A R  RH N++  +  
Sbjct: 41  IGKGRFGQVYHG---RWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97
Query: 96  CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQ 155
           C S         AI+    + R L   +R +   L     R  IA ++   + Y H    
Sbjct: 98  CMSP-----PHLAIITSLCKGRTLYSVVRDAKIVLDVNKTR-QIAQEIVKGMGYLH---A 148
Query: 156 PSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIK-GIVGYVAP 214
             I+H DLK  N+  D   V  + D G    LF       A    + + I+ G + ++AP
Sbjct: 149 KGILHKDLKSKNVFYDNGKVV-ITDFG----LFSISGVLQAGRREDKLRIQNGWLCHLAP 203
Query: 215 EYGMGSKA---------SVSGDVYNFGILLLEMFTRRRP 244
           E                S   DV+  G +  E+  R  P
Sbjct: 204 EIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 78/184 (42%), Gaps = 28/184 (15%)
Query: 59  AVKVVN---LKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQ 115
           AVKV++   +KQK    S   E   L+ + H N++K+        +E F+ K   +   +
Sbjct: 55  AVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL--------YEFFEDKGYFYLVGE 106
Query: 116 NRNLEQWLRQSNGQLRFL-TQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLD--- 171
                +   +   + RF       I   V   I Y H +    IVH DLKP N+LL+   
Sbjct: 107 VYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKS 163
Query: 172 QDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNF 231
           +D    + D GL+         T  E +    +  G   Y+APE   G+      DV++ 
Sbjct: 164 KDANIRIIDFGLS---------THFEASKKMKDKIGTAYYIAPEVLHGTYDE-KCDVWST 213
Query: 232 GILL 235
           G++L
Sbjct: 214 GVIL 217

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 45/227 (19%), Positives = 98/227 (43%), Gaps = 26/227 (11%)
Query: 30  NNFSPANKIGQGGVSIVYKGI-LDESRSI-VAVKVVNLKQ---KEASRSFAAECNALRNI 84
             F     +G G    VYKG+ + E   + + V +  L++    +A++    E   + ++
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 85  RHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQL--RFLTQRVNIAID 142
            + ++ +++ IC +   +      ++ + M    L  ++R+    +  ++L   +N  + 
Sbjct: 76  DNPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYL---LNWCVQ 126
Query: 143 VSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNS 202
           ++  + Y        +VH DL   N+L+       + D GLAK L   E    AE     
Sbjct: 127 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 183
Query: 203 IEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAM 248
           I+      ++A E  +    +   DV+++G+ + E+ T   +P D +
Sbjct: 184 IK------WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 224

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 61/262 (23%), Positives = 108/262 (41%), Gaps = 36/262 (13%)
Query: 3   PAHKDSNMLSMKQQFPMISYA---ELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVA 59
           P  +D+  + + ++   + Y    E+  AT+      ++G+G    V++    ++    A
Sbjct: 67  PKTEDNEGVLLTEKLKPVDYEYREEVHWATHQL----RLGRGSFGEVHRMEDKQTGFQCA 122
Query: 60  VKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNL 119
           VK V L+   A    A  C  L + R      I+ +  ++  EG  +  I  E ++  +L
Sbjct: 123 VKKVRLEVFRAEELMA--CAGLTSPR------IVPLYGAVR-EG-PWVNIFMELLEGGSL 172
Query: 120 EQWLRQS-----NGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDI 174
            Q +++      +  L +L Q +         +EY H      I+HGD+K  N+LL  D 
Sbjct: 173 GQLVKEQGCLPEDRALYYLGQALE-------GLEYLHSR---RILHGDVKADNVLLSSDG 222
Query: 175 V-AHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGI 233
             A + D G A  L   +P    ++      I G   ++APE  +G       DV++   
Sbjct: 223 SHAALCDFGHAVCL---QPDGLGKSLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCC 279
Query: 234 LLLEMFTRRRPTDAMFNEGLTL 255
           ++L M     P    F   L L
Sbjct: 280 MMLHMLNGCHPWTQFFRGPLCL 301

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 89/218 (40%), Gaps = 32/218 (14%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQK-EASRSFAAECNALRNIRHRNLIKIITIC 96
           +G+G    V   +   +   VAVK+V++K+  +   +   E    + + H N++K     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY--- 71
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQP 156
                EG + + +  EY            S G+L F     +I +    A  +FH     
Sbjct: 72  -GHRREG-NIQYLFLEYC-----------SGGEL-FDRIEPDIGMPEPDAQRFFHQLMAG 117
Query: 157 -------SIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
                   I H D+KP N+LLD+     + D GLA  +F Y      E   N  ++ G +
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLAT-VFRY---NNRERLLN--KMCGTL 171
Query: 210 GYVAPEYGMGSKASVSG-DVYNFGILLLEMFTRRRPTD 246
            YVAPE     +      DV++ GI+L  M     P D
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 89/218 (40%), Gaps = 32/218 (14%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQK-EASRSFAAECNALRNIRHRNLIKIITIC 96
           +G+G    V   +   +   VAVK+V++K+  +   +   E    + + H N++K     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY--- 71
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQP 156
                EG + + +  EY            S G+L F     +I +    A  +FH     
Sbjct: 72  -GHRREG-NIQYLFLEYC-----------SGGEL-FDRIEPDIGMPEPDAQRFFHQLMAG 117
Query: 157 -------SIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
                   I H D+KP N+LLD+     + D GLA  +F Y      E   N  ++ G +
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLAT-VFRY---NNRERLLN--KMCGTL 171
Query: 210 GYVAPEYGMGSKASVSG-DVYNFGILLLEMFTRRRPTD 246
            YVAPE     +      DV++ GI+L  M     P D
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 89/218 (40%), Gaps = 32/218 (14%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQK-EASRSFAAECNALRNIRHRNLIKIITIC 96
           +G+G    V   +   +   VAVK+V++K+  +   +   E    + + H N++K     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY--- 71
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQP 156
                EG + + +  EY            S G+L F     +I +    A  +FH     
Sbjct: 72  -GHRREG-NIQYLFLEYC-----------SGGEL-FDRIEPDIGMPEPDAQRFFHQLMAG 117
Query: 157 -------SIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
                   I H D+KP N+LLD+     + D GLA  +F Y      E   N  ++ G +
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLAT-VFRY---NNRERLLN--KMCGTL 171
Query: 210 GYVAPEYGMGSKASVSG-DVYNFGILLLEMFTRRRPTD 246
            YVAPE     +      DV++ GI+L  M     P D
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 89/218 (40%), Gaps = 32/218 (14%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQK-EASRSFAAECNALRNIRHRNLIKIITIC 96
           +G+G    V   +   +   VAVK+V++K+  +   +   E    + + H N++K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY--- 70
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQP 156
                EG + + +  EY            S G+L F     +I +    A  +FH     
Sbjct: 71  -GHRREG-NIQYLFLEYC-----------SGGEL-FDRIEPDIGMPEPDAQRFFHQLMAG 116
Query: 157 -------SIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
                   I H D+KP N+LLD+     + D GLA  +F Y      E   N  ++ G +
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLAT-VFRY---NNRERLLN--KMCGTL 170
Query: 210 GYVAPEYGMGSKASVSG-DVYNFGILLLEMFTRRRPTD 246
            YVAPE     +      DV++ GI+L  M     P D
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 45/227 (19%), Positives = 98/227 (43%), Gaps = 26/227 (11%)
Query: 30  NNFSPANKIGQGGVSIVYKGI-LDESRSI-VAVKVVNLKQ---KEASRSFAAECNALRNI 84
             F     +G G    VYKG+ + E   + + V +  L++    +A++    E   + ++
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 85  RHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQL--RFLTQRVNIAID 142
            + ++ +++ IC +   +      ++ + M    L  ++R+    +  ++L   +N  + 
Sbjct: 79  DNPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYL---LNWCVQ 129
Query: 143 VSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNS 202
           ++  + Y        +VH DL   N+L+       + D GLAK L   E    AE     
Sbjct: 130 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 186
Query: 203 IEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAM 248
           I+      ++A E  +    +   DV+++G+ + E+ T   +P D +
Sbjct: 187 IK------WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 227

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 91/217 (41%), Gaps = 37/217 (17%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICS 97
           IG G  S   + +   +    AVKV++  +++ S         LR  +H N+I +  +  
Sbjct: 35  IGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEI---LLRYGQHPNIITLKDV-- 89
Query: 98  SIDFEGFDFKAIVFEYMQNRNL-EQWLRQSNGQLRFLTQRVN--IAIDVSFAIEYFHHHC 154
              ++      +V E M+   L ++ LRQ     +F ++R    +   +   +EY H   
Sbjct: 90  ---YDDGKHVYLVTELMRGGELLDKILRQ-----KFFSEREASFVLHTIGKTVEYLHSQ- 140
Query: 155 QPSIVHGDLKPSNIL-LDQD---IVAHVGDLGLAKFLFGYEPG---TAAETASNSIEIKG 207
              +VH DLKPSNIL +D+        + D G AK L   E G   T   TA+       
Sbjct: 141 --GVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRA-ENGLLMTPCYTAN------- 190
Query: 208 IVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
              +VAPE           D+++ GILL  M     P
Sbjct: 191 ---FVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 89/218 (40%), Gaps = 32/218 (14%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQK-EASRSFAAECNALRNIRHRNLIKIITIC 96
           +G+G    V   +   +   VAVK+V++K+  +   +   E    + + H N++K     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY--- 71
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQP 156
                EG + + +  EY            S G+L F     +I +    A  +FH     
Sbjct: 72  -GHRREG-NIQYLFLEYC-----------SGGEL-FDRIEPDIGMPEPDAQRFFHQLMAG 117
Query: 157 -------SIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
                   I H D+KP N+LLD+     + D GLA  +F Y      E   N  ++ G +
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLAT-VFRY---NNRERLLN--KMCGTL 171
Query: 210 GYVAPEYGMGSKASVSG-DVYNFGILLLEMFTRRRPTD 246
            YVAPE     +      DV++ GI+L  M     P D
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 54/260 (20%), Positives = 107/260 (41%), Gaps = 29/260 (11%)
Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNIRHRNLIKII 93
           ++G G    V +G+    +  + V +  LKQ   K  +     E   +  + +  ++++I
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 94  TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHH 153
            +C +      +   +V E      L ++L     ++  ++    +   VS  ++Y    
Sbjct: 403 GVCQA------EALMLVMEMAGGGPLHKFLVGKREEIP-VSNVAELLHQVSMGMKYLE-- 453
Query: 154 CQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVA 213
            + + VH +L   N+LL     A + D GL+K L   +    A +A      K  + + A
Sbjct: 454 -EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG-----KWPLKWYA 507
Query: 214 PEYGMGSKASVSGDVYNFGILLLEMFTR-RRPTDAMFNEGLTLHEFVKMALPDKVMEIVD 272
           PE     K S   DV+++G+ + E  +  ++P   M  +G  +  F++     K ME   
Sbjct: 508 PECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM--KGPEVMAFIEQG---KRMECPP 562
Query: 273 PSLLLEVTANNYSWIEDCLV 292
                E     Y+ + DC +
Sbjct: 563 -----ECPPELYALMSDCWI 577

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 89/218 (40%), Gaps = 32/218 (14%)
Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQK-EASRSFAAECNALRNIRHRNLIKIITIC 96
           +G+G    V   +   +   VAVK+V++K+  +   +   E    + + H N++K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY--- 70
Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQP 156
                EG + + +  EY            S G+L F     +I +    A  +FH     
Sbjct: 71  -GHRREG-NIQYLFLEYC-----------SGGEL-FDRIEPDIGMPEPDAQRFFHQLMAG 116
Query: 157 -------SIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
                   I H D+KP N+LLD+     + D GLA  +F Y      E   N  ++ G +
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLAT-VFRY---NNRERLLN--KMCGTL 170
Query: 210 GYVAPEYGMGSKASVSG-DVYNFGILLLEMFTRRRPTD 246
            YVAPE     +      DV++ GI+L  M     P D
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 56/247 (22%), Positives = 105/247 (42%), Gaps = 44/247 (17%)
Query: 13  MKQQFPMISYAELSKAT-------NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL 65
           M Q+ P     EL+K          N SP   +G G    V      ++   VAVK ++ 
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSR 57
Query: 66  KQK---EASRSFAAECNALRNIRHRNLIKIITICSSI-DFEGFDFKAIVFEYM--QNRNL 119
             +    A R++  E   L++++H N+I ++ + +     E F+   +V   M     N+
Sbjct: 58  PFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI 116
Query: 120 EQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVG 179
            +  + ++  ++FL  ++         ++Y H      I+H DLKPSN+ +++D    + 
Sbjct: 117 VKCQKLTDDHVQFLIYQI------LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 167
Query: 180 DLGLAKFLFGYEPGTAAETASNSIEIKGIVG---YVAPEYGMG-SKASVSGDVYNFGILL 235
             GLA+                  E+ G V    Y APE  +     + + D+++ G ++
Sbjct: 168 GFGLAR--------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 213
Query: 236 LEMFTRR 242
            E+ T R
Sbjct: 214 AELLTGR 220

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 61/262 (23%), Positives = 107/262 (40%), Gaps = 36/262 (13%)
Query: 3   PAHKDSNMLSMKQQFPMISYA---ELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVA 59
           P  +D+  + + ++   + Y    E+  AT+      ++G+G    V++    ++    A
Sbjct: 48  PKTEDNEGVLLTEKLKPVDYEYREEVHWATHQL----RLGRGSFGEVHRMEDKQTGFQCA 103
Query: 60  VKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNL 119
           VK V L+   A    A  C  L + R      I+ +  ++  EG  +  I  E ++  +L
Sbjct: 104 VKKVRLEVFRAEELMA--CAGLTSPR------IVPLYGAVR-EG-PWVNIFMELLEGGSL 153
Query: 120 EQWLRQS-----NGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDI 174
            Q +++      +  L +L Q +         +EY H      I+HGD+K  N+LL  D 
Sbjct: 154 GQLVKEQGCLPEDRALYYLGQALE-------GLEYLHSR---RILHGDVKADNVLLSSDG 203
Query: 175 V-AHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGI 233
             A + D G A  L   +P    +       I G   ++APE  +G       DV++   
Sbjct: 204 SHAALCDFGHAVCL---QPDGLGKDLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCC 260
Query: 234 LLLEMFTRRRPTDAMFNEGLTL 255
           ++L M     P    F   L L
Sbjct: 261 MMLHMLNGCHPWTQFFRGPLCL 282

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 45/227 (19%), Positives = 98/227 (43%), Gaps = 26/227 (11%)
Query: 30  NNFSPANKIGQGGVSIVYKGI-LDESRSI-VAVKVVNLKQ---KEASRSFAAECNALRNI 84
             F     +G G    VYKG+ + E   + + V +  L++    +A++    E   + ++
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 85  RHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQL--RFLTQRVNIAID 142
            + ++ +++ IC +   +      ++ + M    L  ++R+    +  ++L   +N  + 
Sbjct: 75  DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL---LNWCVQ 125
Query: 143 VSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNS 202
           ++  + Y        +VH DL   N+L+       + D GLAK L   E    AE     
Sbjct: 126 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 203 IEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAM 248
           I+      ++A E  +    +   DV+++G+ + E+ T   +P D +
Sbjct: 183 IK------WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 43/94 (45%), Gaps = 16/94 (17%)
Query: 146 AIEYFHHHCQPSIVHGDLKPSNILL---DQDIVAHVGDLGLAKFLFGYEPGTAAETASNS 202
            + Y H H   +IVH DLKP N+LL   ++D +  + D GL+            E     
Sbjct: 148 GVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF---------ENQKKM 195
Query: 203 IEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLL 236
            E  G   Y+APE  +  K     DV++ G++L 
Sbjct: 196 KERLGTAYYIAPEV-LRKKYDEKCDVWSIGVILF 228

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 45/227 (19%), Positives = 97/227 (42%), Gaps = 26/227 (11%)
Query: 30  NNFSPANKIGQGGVSIVYKG--ILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNI 84
             F     +G G    VYKG  I +  +  + V +  L++    +A++    E   + ++
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 85  RHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQL--RFLTQRVNIAID 142
            + ++ +++ IC +   +      ++ + M    L  ++R+    +  ++L   +N  + 
Sbjct: 75  DNPHVCRLLGICLTSTVQ------LITQLMPFGXLLDYVREHKDNIGSQYL---LNWCVQ 125
Query: 143 VSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNS 202
           ++  + Y        +VH DL   N+L+       + D GLAK L   E    AE     
Sbjct: 126 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 203 IEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAM 248
           I+      ++A E  +    +   DV+++G+ + E+ T   +P D +
Sbjct: 183 IK------WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 78/184 (42%), Gaps = 28/184 (15%)
Query: 59  AVKVVN---LKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQ 115
           AVKV++   +KQK    S   E   L+ + H N++K+        +E F+ K   +   +
Sbjct: 79  AVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL--------YEFFEDKGYFYLVGE 130
Query: 116 NRNLEQWLRQSNGQLRFL-TQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLD--- 171
                +   +   + RF       I   V   I Y H +    IVH DLKP N+LL+   
Sbjct: 131 VYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKS 187
Query: 172 QDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNF 231
           +D    + D GL+         T  E +    +  G   Y+APE   G+      DV++ 
Sbjct: 188 KDANIRIIDFGLS---------THFEASKKMKDKIGTAYYIAPEVLHGTYDEKC-DVWST 237
Query: 232 GILL 235
           G++L
Sbjct: 238 GVIL 241

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	331
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	9e-82
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-72
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-66
3soc_A	322	Activin receptor type-2A; structural genomics cons	4e-51
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-47
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-44
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	3e-42
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-41
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-40
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-40
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-40
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-39
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	7e-39
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-37
3q4u_A	301	Activin receptor type-1; structural genomics conso	6e-34
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-33
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	9e-33
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-32
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-30
2a19_B	284	Interferon-induced, double-stranded RNA-activated	4e-28
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-27
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-26
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-26
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-26
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-26
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-26
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-26
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	3e-26
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	5e-26
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	7e-26
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	7e-26
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	8e-26
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	9e-26
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	3e-25
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-25
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-25
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	5e-25
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	8e-25
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-24
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-24
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-24
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-24
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-24
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-24
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	4e-24
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	4e-24
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	5e-24
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	5e-24
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	5e-24
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	5e-24
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	6e-24
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	6e-24
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-23
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-23
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-23
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	3e-23
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-23
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	3e-23
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	5e-23
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	6e-23
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	8e-23
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	9e-23
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	9e-23
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-22
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-22
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-22
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-22
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	4e-22
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	5e-22
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	9e-22
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-21
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-21
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-21
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-21
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	5e-21
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	7e-21
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	8e-21
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	9e-21
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-20
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	4e-20
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	9e-20
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-19
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-19
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-19
3o0g_A	292	Cell division protein kinase 5; kinase activator c	5e-19
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	5e-19
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	6e-19
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	7e-19
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-18
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-18
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-18
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	3e-18
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	4e-18
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	6e-18
4aoj_A	329	High affinity nerve growth factor receptor; transf	6e-18
3niz_A	311	Rhodanese family protein; structural genomics, str	7e-18
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	7e-18
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-17
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-17
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-17
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-17
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-17
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	3e-17
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	4e-17
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	4e-17
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	6e-17
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	8e-17
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	9e-17
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	9e-17
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-16
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-16
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-16
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-16
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-16
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	3e-16
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	4e-16
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	6e-16
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	6e-16
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	9e-16
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	9e-16
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	9e-16
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-15
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-15
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-15
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-15
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	3e-15
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-15
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-15
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	4e-15
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	5e-15
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	5e-15
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	6e-15
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	6e-15
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	9e-15
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-14
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-14
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-14
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-14
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-14
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-14
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-14
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-14
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-14
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-14
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-14
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-14
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-14
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-14
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-14
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-14
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-14
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	3e-14
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	3e-14
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	5e-14
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	5e-14
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	6e-14
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	8e-14
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-13
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-13
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-13
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-13
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-13
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-13
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-13
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-13
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-13
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-13
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	3e-13
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	3e-13
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	4e-13
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	4e-13
3an0_A	340	Dual specificity mitogen-activated protein kinase;	5e-13
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	6e-13
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	6e-13
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	7e-13
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-12
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-12
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-12
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-12
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-12
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-12
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-12
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-12
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-12
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-12
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	3e-12
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	4e-12
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	4e-12
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	4e-12
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	7e-12
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-11
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-11
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-11
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-11
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-11
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	3e-11
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	3e-11
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	5e-11
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	7e-11
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	9e-11
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-10
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-10
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-10
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-10
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-10
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	4e-10
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	4e-10
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	5e-10
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	5e-10
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	7e-10
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	7e-10
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	7e-10
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	8e-10
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	8e-10
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	8e-10
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-09
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-09
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-09
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-09
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-09
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-09
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	4e-09
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	5e-09
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	7e-09
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	9e-09
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-08
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-08
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-08
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-08
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-08
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-08
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	3e-08
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	3e-08
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	6e-08
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	7e-08
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-07
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	8e-04
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-07

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  250 bits (640), Expect = 9e-82
 Identities = 100/306 (32%), Positives = 159/306 (51%), Gaps = 27/306 (8%)

Query: 21  SYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEAS-RSFAAECN 79
           S  EL  A++NFS  N +G+GG   VYKG L +   +VAVK +  ++ +     F  E  
Sbjct: 21  SLRELQVASDNFSNKNILGRGGFGKVYKGRLADGT-LVAVKRLKEERTQGGELQFQTEVE 79

Query: 80  ALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLT--QRV 137
            +    HRNL+++   C          + +V+ YM N ++   LR+       L   +R 
Sbjct: 80  MISMAVHRNLLRLRGFCM----TP-TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQ 134

Query: 138 NIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAE 197
            IA+  +  + Y H HC P I+H D+K +NILLD++  A VGD GLAK +   +  T   
Sbjct: 135 RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD--THVT 192

Query: 198 TASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMF---NEGLT 254
           TA     ++G +G++APEY    K+S   DV+ +G++LLE+ T +R  D      ++ + 
Sbjct: 193 TA-----VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 247

Query: 255 LHEFVKMALPD-KVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMR 313
           L ++VK  L + K+  +VD  L       NY   ++ +  +I   + C+  SPMER +M 
Sbjct: 248 LLDWVKGLLKEKKLEALVDVDL-----QGNYK--DEEVEQLIQVALLCTQSSPMERPKMS 300

Query: 314 DVVAKL 319
           +VV  L
Sbjct: 301 EVVRML 306

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  226 bits (579), Expect = 1e-72
 Identities = 90/307 (29%), Positives = 147/307 (47%), Gaps = 26/307 (8%)

Query: 20  ISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECN 79
           +   +L +ATNNF     IG G    VYKG+L +    VA+K    +  +    F  E  
Sbjct: 29  VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGA-KVALKRRTPESSQGIEEFETEIE 87

Query: 80  ALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLT--QRV 137
            L   RH +L+ +I  C     E  +   ++++YM+N NL++ L  S+     ++  QR+
Sbjct: 88  TLSFCRHPHLVSLIGFCD----ER-NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRL 142

Query: 138 NIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAE 197
            I I  +  + Y H     +I+H D+K  NILLD++ V  + D G++K       GT  +
Sbjct: 143 EICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKK------GTELD 193

Query: 198 TASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEG-LTLH 256
               S  +KG +GY+ PEY +  + +   DVY+FG++L E+   R           + L 
Sbjct: 194 QTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLA 253

Query: 257 EFVKMALPD-KVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDV 315
           E+   +  + ++ +IVDP+L     A+      + L     T V C   S  +R  M DV
Sbjct: 254 EWAVESHNNGQLEQIVDPNL-----ADKIR--PESLRKFGDTAVKCLALSSEDRPSMGDV 306

Query: 316 VAKLRHA 322
           + KL +A
Sbjct: 307 LWKLEYA 313

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  210 bits (537), Expect = 2e-66
 Identities = 80/318 (25%), Positives = 136/318 (42%), Gaps = 41/318 (12%)

Query: 16  QFPMISYAELSKATNNFSP------ANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKE 69
           +F   S+ EL   TNNF         NK+G+GG  +VYKG ++ +   VAVK +      
Sbjct: 11  RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNT--TVAVKKLAAMVDI 68

Query: 70  AS----RSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQ 125
            +    + F  E   +   +H NL++++   S    +G D   +V+ YM N +L   L  
Sbjct: 69  TTEELKQQFDQEIKVMAKCQHENLVELLGFSS----DG-DDLCLVYVYMPNGSLLDRLSC 123

Query: 126 SNGQLRFL--TQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGL 183
            +G    L    R  IA   +  I + H +     +H D+K +NILLD+   A + D GL
Sbjct: 124 LDGTPP-LSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGL 179

Query: 184 AKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRR 243
           A+        T   +      I G   Y+APE  +  + +   D+Y+FG++LLE+ T   
Sbjct: 180 AR-ASEKFAQTVMTSR-----IVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLP 232

Query: 244 PTDAMFNEGLTLHEFVKMALPDK--VMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTC 301
             D        L +  +    ++  + + +D  +      N+       + A+      C
Sbjct: 233 AVDEHREPQ-LLLDIKEEIEDEEKTIEDYIDKKM------NDAD--STSVEAMYSVASQC 283

Query: 302 SMESPMERMEMRDVVAKL 319
             E   +R +++ V   L
Sbjct: 284 LHEKKNKRPDIKKVQQLL 301

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  171 bits (434), Expect = 4e-51
 Identities = 63/317 (19%), Positives = 120/317 (37%), Gaps = 34/317 (10%)

Query: 20  ISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECN 79
           +    L   +          +G    V+K  L      VAVK+    Q + S     E  
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEY--VAVKIFP-IQDKQSWQNEYEVY 70

Query: 80  ALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNI 139
           +L  ++H N+++ I           D   ++  + +  +L  +L+ +   + +  +  +I
Sbjct: 71  SLPGMKHENILQFIGAEKRGTSVDVDL-WLITAFHEKGSLSDFLKAN--VVSW-NELCHI 126

Query: 140 AIDVSFAIEYFHHH-------CQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEP 192
           A  ++  + Y H          +P+I H D+K  N+LL  ++ A + D GLA        
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKF----- 181

Query: 193 GTAAETASNSIEIKGIVG---YVAPEYGMGS-----KASVSGDVYNFGILLLEMFTRRRP 244
               E   ++ +  G VG   Y+APE   G+      A +  D+Y  G++L E+ +R   
Sbjct: 182 ----EAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTA 237

Query: 245 TDAMFNEGLTLHEFVKMALP--DKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCS 302
            D   +E +   E      P  + + E+V       V  + +      +  +  T   C 
Sbjct: 238 ADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQK-HAGMAMLCETIEECW 296

Query: 303 MESPMERMEMRDVVAKL 319
                 R+    V  ++
Sbjct: 297 DHDAEARLSAGCVGERI 313

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  162 bits (411), Expect = 2e-47
 Identities = 74/326 (22%), Positives = 122/326 (37%), Gaps = 41/326 (12%)

Query: 20  ISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECN 79
            + +E S   +N      IG+G    VYKG LDE    VAVKV +   +   ++F  E N
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDER--PVAVKVFSFANR---QNFINEKN 57

Query: 80  --ALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRV 137
              +  + H N+ + I     +  +G     +V EY  N +L ++L              
Sbjct: 58  IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWV---SSC 114

Query: 138 NIAIDVSFAIEYFH------HHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYE 191
            +A  V+  + Y H       H +P+I H DL   N+L+  D    + D GL+  L G  
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174

Query: 192 PGTAAETASNSIEIKGIVGYVAPEYGMGS-------KASVSGDVYNFGILLLEMFTRRRP 244
                E  + +I   G + Y+APE   G+        A    D+Y  G++  E+F R   
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC-- 232

Query: 245 TDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTA-----------NNYSWIEDCLVA 293
           TD    E        +MA   +V     P+                    +      + +
Sbjct: 233 TDLFPGES---VPEYQMAFQTEVGN--HPTFEDMQVLVSREKQRPKFPEAWKENSLAVRS 287

Query: 294 VIGTGVTCSMESPMERMEMRDVVAKL 319
           +  T   C  +    R+  +    ++
Sbjct: 288 LKETIEDCWDQDAEARLTAQXAEERM 313

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  152 bits (387), Expect = 3e-44
 Identities = 65/303 (21%), Positives = 115/303 (37%), Gaps = 57/303 (18%)

Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITI 95
             +G+G   +V K         VA+K   ++ +   ++F  E   L  + H N++K+   
Sbjct: 14  EVVGRGAFGVVCKAKWRAK--DVAIKQ--IESESERKAFIVELRQLSRVNHPNIVKLYGA 69

Query: 96  CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRF-LTQRVNIAIDVSFAIEYFHHHC 154
           C        +   +V EY +  +L   L  +     +     ++  +  S  + Y H   
Sbjct: 70  C-------LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122

Query: 155 QPSIVHGDLKPSNILLDQD-IVAHVGDLGLAKFLFGY---EPGTAAETASNSIEIKGIVG 210
             +++H DLKP N+LL     V  + D G A  +  +     G+AA              
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAA-------------- 168

Query: 211 YVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKM----ALPDK 266
           ++APE   GS  S   DV+++GI+L E+ TRR+P D +      +   V       L   
Sbjct: 169 WMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKN 228

Query: 267 VMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETF 326
           +     P  +  +       +  C             + P +R  M ++V  + H    F
Sbjct: 229 L-----PKPIESL-------MTRCW-----------SKDPSQRPSMEEIVKIMTHLMRYF 265

Query: 327 LGT 329
            G 
Sbjct: 266 PGA 268

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  147 bits (373), Expect = 3e-42
 Identities = 58/212 (27%), Positives = 101/212 (47%), Gaps = 19/212 (8%)

Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ--KEASRSFAAECNALRNIRHRNLIKII 93
            KIG G    V++     S   VAVK++  +    E    F  E   ++ +RH N++  +
Sbjct: 43  EKIGAGSFGTVHRAEWHGS--DVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100

Query: 94  TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRF-LTQRVNIAIDVSFAIEYFHH 152
              +          +IV EY+   +L + L +S  + +    +R+++A DV+  + Y H+
Sbjct: 101 GAVTQPPN-----LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN 155

Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
              P IVH +LK  N+L+D+     V D GL++          A T  +S    G   ++
Sbjct: 156 -RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK--------ASTFLSSKSAAGTPEWM 206

Query: 213 APEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
           APE      ++   DVY+FG++L E+ T ++P
Sbjct: 207 APEVLRDEPSNEKSDVYSFGVILWELATLQQP 238

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  144 bits (366), Expect = 2e-41
 Identities = 45/217 (20%), Positives = 88/217 (40%), Gaps = 30/217 (13%)

Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ--KEASRSFAAECNALRNIRHRNLIKII 93
            K+ +     ++KG    +   + VKV+ ++      SR F  EC  LR   H N++ ++
Sbjct: 16  TKLNENHSGELWKGRWQGN--DIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73

Query: 94  TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHH 153
             C S          ++  +M   +L   L +    +   +Q V  A+D++  + + H  
Sbjct: 74  GACQSPPAPHP---TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT- 129

Query: 154 CQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVA 213
            +P I    L   ++++D+D+ A +    +        PG                 +VA
Sbjct: 130 LEPLIPRHALNSRSVMIDEDMTARISMADVKFSF--QSPGRM-----------YAPAWVA 176

Query: 214 PE------YGMGSKASVSGDVYNFGILLLEMFTRRRP 244
           PE           +++   D+++F +LL E+ TR  P
Sbjct: 177 PEALQKKPEDTNRRSA---DMWSFAVLLWELVTREVP 210

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  143 bits (362), Expect = 1e-40
 Identities = 59/296 (19%), Positives = 105/296 (35%), Gaps = 42/296 (14%)

Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITI 95
             +G+G      K    E+  ++ +K +    +E  R+F  E   +R + H N++K I +
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75

Query: 96  CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQ 155
                         + EY++   L   ++  + Q    +QRV+ A D++  + Y H    
Sbjct: 76  LYKDKRL-----NFITEYIKGGTLRGIIKSMDSQYP-WSQRVSFAKDIASGMAYLHSM-- 127

Query: 156 PSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL------FGYEPGTAAETASNSIEIKGIV 209
            +I+H DL   N L+ ++    V D GLA+ +                       + G  
Sbjct: 128 -NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186

Query: 210 GYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTD--AMFNE--GLTLHEFVKMALPD 265
            ++APE   G       DV++FGI+L E+  R              GL +  F+    P 
Sbjct: 187 YWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPP 246

Query: 266 KVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRH 321
                  P     +          C          C ++ P +R     +   L  
Sbjct: 247 NC-----PPSFFPI-------TVRC----------CDLD-PEKRPSFVKLEHWLET 279

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  142 bits (360), Expect = 2e-40
 Identities = 52/223 (23%), Positives = 98/223 (43%), Gaps = 34/223 (15%)

Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEAS-------RSFAAECNALRNIRHRN 88
            +IG+GG  +V+KG L + +S+VA+K + L   E         + F  E   + N+ H N
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84

Query: 89  LIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIE 148
           ++K+  +  +          +V E++   +L   L      ++  + ++ + +D++  IE
Sbjct: 85  IVKLYGLMHNP-------PRMVMEFVPCGDLYHRLLDKAHPIK-WSVKLRLMLDIALGIE 136

Query: 149 YFHHHCQPSIVHGDLKPSNILLDQ-----DIVAHVGDLGLAKFLFGYEPGTAAETASNSI 203
           Y  +   P IVH DL+  NI L        + A V D GL++           ++  +  
Sbjct: 137 YMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----------QSVHSVS 184

Query: 204 EIKGIVGYVAPE--YGMGSKASVSGDVYNFGILLLEMFTRRRP 244
            + G   ++APE         +   D Y+F ++L  + T   P
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP 227

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  142 bits (359), Expect = 2e-40
 Identities = 67/294 (22%), Positives = 118/294 (40%), Gaps = 46/294 (15%)

Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ--KEASRSFAAECNALRNIRHRNLIKII 93
            +IG G    VYKG        VAVK++N+     +  ++F  E   LR  RH N++  +
Sbjct: 30  QRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86

Query: 94  TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHH 153
              ++         AIV ++ +  +L   L  S  +   + + ++IA   +  ++Y H  
Sbjct: 87  GYSTAPQL------AIVTQWCEGSSLYHHLHASETKFE-MKKLIDIARQTARGMDYLH-- 137

Query: 154 CQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVA 213
              SI+H DLK +NI L +D    +GD GLA     +      E         G + ++A
Sbjct: 138 -AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQL------SGSILWMA 190

Query: 214 PE---YGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEI 270
           PE       +  S   DVY FGI+L E+ T + P   + N    +    + +L   + ++
Sbjct: 191 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKV 250

Query: 271 ---VDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRH 321
                  +           + +CL            +   ER     ++A++  
Sbjct: 251 RSNCPKRM--------KRLMAECL-----------KKKRDERPSFPRILAEIEE 285

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  137 bits (348), Expect = 7e-39
 Identities = 54/221 (24%), Positives = 83/221 (37%), Gaps = 32/221 (14%)

Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLK----QKEASRSFAAECNALRNIRHRNLIK 91
             IG GG   VY+         VAVK           +   +   E      ++H N+I 
Sbjct: 13  EIIGIGGFGKVYRAFWIGD--EVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70

Query: 92  IITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFH 151
           +  +C            +V E+ +   L + L             VN A+ ++  + Y H
Sbjct: 71  LRGVCLKEPN-----LCLVMEFARGGPLNRVLSGKRIPPD---ILVNWAVQIARGMNYLH 122

Query: 152 HHCQPSIVHGDLKPSNILLDQDIVAH--------VGDLGLAKFLFGYEPGTAAETASNSI 203
                 I+H DLK SNIL+ Q +           + D GLA+        +AA       
Sbjct: 123 DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA------- 175

Query: 204 EIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
              G   ++APE    S  S   DV+++G+LL E+ T   P
Sbjct: 176 ---GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  135 bits (341), Expect = 2e-37
 Identities = 49/220 (22%), Positives = 85/220 (38%), Gaps = 27/220 (12%)

Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ--KEASRSFAAECNALRNIRHRNLIKII 93
             IG+G    VY G        VA++++++++  ++  ++F  E  A R  RH N++  +
Sbjct: 39  ELIGKGRFGQVYHGRW---HGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95

Query: 94  TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHH 153
             C S         AI+    + R L   +R +   L  + +   IA ++   + Y H  
Sbjct: 96  GACMS-----PPHLAIITSLCKGRTLYSVVRDAKIVLD-VNKTRQIAQEIVKGMGYLH-- 147

Query: 154 CQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVA 213
               I+H DLK  N+  D   V  + D GL       + G   +         G + ++A
Sbjct: 148 -AKGILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQN---GWLCHLA 202

Query: 214 PEYGMGSKASVSG---------DVYNFGILLLEMFTRRRP 244
           PE                    DV+  G +  E+  R  P
Sbjct: 203 PEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  125 bits (316), Expect = 6e-34
 Identities = 47/225 (20%), Positives = 86/225 (38%), Gaps = 28/225 (12%)

Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITI 95
             +G+G    V++G        VAVK+ +  + E S     E      +RH N++  I  
Sbjct: 14  ECVGKGRYGEVWRGSWQGEN--VAVKIFS-SRDEKSWFRETELYNTVMLRHENILGFIAS 70

Query: 96  CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFH---- 151
             +          ++  Y +  +L  +L+ +          + I + ++  + + H    
Sbjct: 71  DMTSRHSSTQL-WLITHYHEMGSLYDYLQLTTLDTV---SCLRIVLSIASGLAHLHIEIF 126

Query: 152 -HHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG 210
               +P+I H DLK  NIL+ ++    + DLGLA          +  T    +     VG
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMH-------SQSTNQLDVGNNPRVG 179

Query: 211 ---YVAPE------YGMGSKASVSGDVYNFGILLLEMFTRRRPTD 246
              Y+APE            +    D++ FG++L E+  R     
Sbjct: 180 TKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNG 224

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  125 bits (316), Expect = 1e-33
 Identities = 53/225 (23%), Positives = 87/225 (38%), Gaps = 28/225 (12%)

Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITI 95
            +IG+G    V+ G        VAVKV     +EAS     E      +RH N++  I  
Sbjct: 43  KQIGKGRYGEVWMGKWRGE--KVAVKVFF-TTEEASWFRETEIYQTVLMRHENILGFIAA 99

Query: 96  CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFH---- 151
                        ++ +Y +N +L  +L+ +    +     + +A      + + H    
Sbjct: 100 DIKGTGSWTQL-YLITDYHENGSLYDYLKSTTLDAK---SMLKLAYSSVSGLCHLHTEIF 155

Query: 152 -HHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG 210
               +P+I H DLK  NIL+ ++    + DLGLA           ++T    I     VG
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKF-------ISDTNEVDIPPNTRVG 208

Query: 211 ---YVAPEYGMGSKASVSG------DVYNFGILLLEMFTRRRPTD 246
              Y+ PE    S            D+Y+FG++L E+  R     
Sbjct: 209 TKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGG 253

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  122 bits (309), Expect = 1e-32
 Identities = 51/227 (22%), Positives = 90/227 (39%), Gaps = 28/227 (12%)

Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITI 95
             IG+G    V++G        VAVK+ +  ++E S    AE      +RH N++  I  
Sbjct: 48  ESIGKGRFGEVWRGKWRGEE--VAVKIFS-SREERSWFREAEIYQTVMLRHENILGFIAA 104

Query: 96  CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFH---- 151
            +  +        +V +Y ++ +L  +L +    +      + +A+  +  + + H    
Sbjct: 105 DNKDNGTWTQL-WLVSDYHEHGSLFDYLNRYTVTVE---GMIKLALSTASGLAHLHMEIV 160

Query: 152 -HHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG 210
               +P+I H DLK  NIL+ ++    + DLGLA           + T +  I     VG
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH-------DSATDTIDIAPNHRVG 213

Query: 211 ---YVAPEYGMGSKASVSG------DVYNFGILLLEMFTRRRPTDAM 248
              Y+APE    S            D+Y  G++  E+  R       
Sbjct: 214 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 260

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  115 bits (290), Expect = 3e-30
 Identities = 52/224 (23%), Positives = 89/224 (39%), Gaps = 16/224 (7%)

Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAA-ECNALRNIRHRN 88
            +F P   +G+GG  +V++          A+K + L  +E +R     E  AL  + H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 89  LIKIIT-------ICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRV-NIA 140
           +++                     +  I  +  +  NL+ W+               +I 
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124

Query: 141 IDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL-FGYEPGTAAETA 199
           + ++ A+E+ H      ++H DLKPSNI    D V  VGD GL   +    E  T     
Sbjct: 125 LQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181

Query: 200 SNSIEIKGIVG---YVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
                  G VG   Y++PE   G+  S   D+++ G++L E+  
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  109 bits (275), Expect = 4e-28
 Identities = 49/233 (21%), Positives = 81/233 (34%), Gaps = 33/233 (14%)

Query: 26  SKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIR 85
            +   +F     IG GG   V+K           +K V    ++A R    E  AL  + 
Sbjct: 7   KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLD 62

Query: 86  HRNLIKIITICSSIDFEGFDFKA-----------IVFEYMQNRNLEQWLRQSNGQLRFLT 134
           H N++         D++                 I  E+     LEQW+ +  G+     
Sbjct: 63  HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122

Query: 135 QRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGT 194
             + +   ++  ++Y H      +++ DLKPSNI L       +GD GL   L       
Sbjct: 123 LALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL------- 172

Query: 195 AAETASNSIEIKGIVG---YVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
                 N  +     G   Y++PE           D+Y  G++L E+      
Sbjct: 173 -----KNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  111 bits (279), Expect = 1e-27
 Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 23/220 (10%)

Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRS-FAAECNALRNIRHRNLIKIIT 94
           +K+G G    VY+G+  +    VAVK   LK+       F  E   ++ I+H NL++++ 
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 283

Query: 95  ICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHC 154
           +C+        F  I+ E+M   NL  +LR+ N Q       + +A  +S A+EY     
Sbjct: 284 VCT----REPPFY-IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK- 337

Query: 155 QPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG--YEPGTAAETASNSIEIKGIVGYV 212
             + +H +L   N L+ ++ +  V D GL++ + G  Y     A        IK    + 
Sbjct: 338 --NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA-----KFPIK----WT 386

Query: 213 APEYGMGSKASVSGDVYNFGILLLEMFTR-RRPTDAMFNE 251
           APE    +K S+  DV+ FG+LL E+ T    P   +   
Sbjct: 387 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 426

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  109 bits (274), Expect = 1e-26
 Identities = 47/214 (21%), Positives = 85/214 (39%), Gaps = 25/214 (11%)

Query: 37  KIGQGGVSIVYKGILDE--SRSIVAVKVVNLKQ-KEASRSFAAECNALRNIRHRNLIKII 93
            I  GG+  +Y   LD   +   V +K +      EA     AE   L  + H ++++I 
Sbjct: 87  CIAHGGLGWIYLA-LDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145

Query: 94  TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHH 153
                 D  G     IV EY+  ++L++       +L  + + +   +++  A+ Y H  
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG---QKLP-VAEAIAYLLEILPALSYLHSI 201

Query: 154 CQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVA 213
               +V+ DLKP NI+L ++ +  + DLG                +     + G  G+ A
Sbjct: 202 ---GLVYNDLKPENIMLTEEQLK-LIDLGAVS----------RINSFGY--LYGTPGFQA 245

Query: 214 PEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDA 247
           PE       +V+ D+Y  G  L  +       + 
Sbjct: 246 PEIVRT-GPTVATDIYTVGRTLAALTLDLPTRNG 278

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  105 bits (265), Expect = 1e-26
 Identities = 53/240 (22%), Positives = 85/240 (35%), Gaps = 44/240 (18%)

Query: 26  SKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIR 85
            +  ++F     +GQG    V K          A+K +   +++ S   + E   L ++ 
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILS-EVMLLASLN 60

Query: 86  HRNLIKIITICSSIDFEGFDFKA--------IVFEYMQNRNLEQWLRQSNGQL------R 131
           H+ +++                A        I  EY +N  L   +   N         R
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120

Query: 132 FLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL---F 188
              Q       +  A+ Y H      I+H DLKP NI +D+     +GD GLAK +    
Sbjct: 121 LFRQ-------ILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSL 170

Query: 189 GYEPGTAAETASNSIEIKGIVG---YVAPE-------YGMGSKASVSGDVYNFGILLLEM 238
                 +     +S  +   +G   YVA E       Y    K     D+Y+ GI+  EM
Sbjct: 171 DILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHY--NEKI----DMYSLGIIFFEM 224

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  105 bits (263), Expect = 2e-26
 Identities = 53/212 (25%), Positives = 89/212 (41%), Gaps = 20/212 (9%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQ--KEASRSFAAECNALRNIRHRNLIKIIT 94
           +IG+G    VYKG+  E+   VA   +  ++  K   + F  E   L+ ++H N+++   
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 95  ICSSIDFEGFDFKAIVF-EYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHH 153
             S           ++  E M +  L+    +    ++ +    +    +   +++ H  
Sbjct: 93  --SWESTVKGKKCIVLVTELMTSGTLKT-YLKRFKVMK-IKVLRSWCRQILKGLQFLHTR 148

Query: 154 CQPSIVHGDLKPSNILLD-QDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
             P I+H DLK  NI +        +GDLGLA              AS +  + G   ++
Sbjct: 149 -TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----------RASFAKAVIGTPEFM 197

Query: 213 APEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
           APE     K   S DVY FG+ +LEM T   P
Sbjct: 198 APEMYE-EKYDESVDVYAFGMCMLEMATSEYP 228

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  107 bits (269), Expect = 2e-26
 Identities = 61/220 (27%), Positives = 99/220 (45%), Gaps = 29/220 (13%)

Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITI 95
             IG+G    V  G    ++  VAVK   +K    +++F AE + +  +RH NL++++ +
Sbjct: 199 QTIGKGEFGDVMLGDYRGNK--VAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGV 254

Query: 96  CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQ 155
                 E      IV EYM   +L  +LR     +      +  ++DV  A+EY   +  
Sbjct: 255 IV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN-- 308

Query: 156 PSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPE 215
            + VH DL   N+L+ +D VA V D GL K           +     + +K    + APE
Sbjct: 309 -NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA--SSTQDTGK-----LPVK----WTAPE 356

Query: 216 ---YGMGSKASVSGDVYNFGILLLEMFTR-RRPTDAMFNE 251
                  S  S   DV++FGILL E+++  R P   +  +
Sbjct: 357 ALREKKFSTKS---DVWSFGILLWEIYSFGRVPYPRIPLK 393

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  104 bits (262), Expect = 3e-26
 Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 30/216 (13%)

Query: 37  KIGQGGVSIVYKG---ILDESRSIVAVKVVNLKQ-----KEASRSFAAECNALRNIRHRN 88
           K+G GG+S VY     IL+     VA+K   +       +E  + F  E +    + H+N
Sbjct: 18  KLGGGGMSTVYLAEDTILNI---KVAIKA--IFIPPREKEETLKRFEREVHNSSQLSHQN 72

Query: 89  LIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIE 148
           ++ +I +      +   +  +V EY++   L +++   +G L  +   +N    +   I+
Sbjct: 73  IVSMIDVDEE---DDCYY--LVMEYIEGPTLSEYIES-HGPLS-VDTAINFTNQILDGIK 125

Query: 149 YFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGI 208
           + H      IVH D+KP NIL+D +    + D G+AK L        + T +N +   G 
Sbjct: 126 HAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKAL-----SETSLTQTNHV--LGT 175

Query: 209 VGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
           V Y +PE   G       D+Y+ GI+L EM     P
Sbjct: 176 VQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  105 bits (265), Expect = 3e-26
 Identities = 52/251 (20%), Positives = 99/251 (39%), Gaps = 38/251 (15%)

Query: 3   PAHKDSNMLSMKQQFPMISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKV 62
             H  S+ + +  +          ++   +    KIG+G           E      +K 
Sbjct: 3   HHHHHSSGVDLGTE------NLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKE 56

Query: 63  VNL-----KQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNR 117
           +N+     K++E SR    E   L N++H N+++         FE      IV +Y +  
Sbjct: 57  INISRMSSKEREESRR---EVAVLANMKHPNIVQYRE-----SFEENGSLYIVMDYCEGG 108

Query: 118 NLEQWLRQSNGQLRFLTQRV-NIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVA 176
           +L + +    G L F   ++ +  + +  A+++ H      I+H D+K  NI L +D   
Sbjct: 109 DLFKRINAQKGVL-FQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTV 164

Query: 177 HVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG---YVAPEYGMGSKASVSGDVYNFGI 233
            +GD G+A+ L            S     +  +G   Y++PE       +   D++  G 
Sbjct: 165 QLGDFGIARVL-----------NSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGC 213

Query: 234 LLLEMFTRRRP 244
           +L E+ T +  
Sbjct: 214 VLYELCTLKHA 224

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  105 bits (263), Expect = 3e-26
 Identities = 45/232 (19%), Positives = 88/232 (37%), Gaps = 24/232 (10%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           K+G+GG S V            A+K +   +++       E +  R   H N+++++   
Sbjct: 36  KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVA-- 93

Query: 97  SSIDFEGFDFKA-IVFEYMQNRNLEQWLRQSNGQLRFLTQR--VNIAIDVSFAIEYFHHH 153
             +   G   +A ++  + +   L   + +   +  FLT+   + + + +   +E  H  
Sbjct: 94  YCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH-- 151

Query: 154 CQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG--- 210
                 H DLKP+NILL  +    + DLG            + +  +             
Sbjct: 152 -AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC-IHVEGSRQALTLQDWAA-QRCTIS 208

Query: 211 YVAPE-------YGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTL 255
           Y APE         +  +     DV++ G +L  M     P D +F +G ++
Sbjct: 209 YRAPELFSVQSHCVIDERT----DVWSLGCVLYAMMFGEGPYDMVFQKGDSV 256

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  107 bits (268), Expect = 5e-26
 Identities = 64/218 (29%), Positives = 104/218 (47%), Gaps = 21/218 (9%)

Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASR-SFAAECNALRNIRHRNLIKIIT 94
            K+GQG    V+ G  + +   VA+K   LK    S  +F  E   ++ +RH  L+++  
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTR-VAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 329

Query: 95  ICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHC 154
           + S    E      IV EYM   +L  +L+   G+   L Q V++A  ++  + Y     
Sbjct: 330 VVSE---EPI---YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM- 382

Query: 155 QPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAP 214
             + VH DL+ +NIL+ +++V  V D GLA+ +   E             IK    + AP
Sbjct: 383 --NYVHRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIK----WTAP 433

Query: 215 EYGMGSKASVSGDVYNFGILLLEMFTR-RRPTDAMFNE 251
           E  +  + ++  DV++FGILL E+ T+ R P   M N 
Sbjct: 434 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 471

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  106 bits (266), Expect = 7e-26
 Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 21/218 (9%)

Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASR-SFAAECNALRNIRHRNLIKIIT 94
            K+GQG    V+ G  + +   VA+K   LK    S  +F  E   ++ +RH  L+++  
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTR-VAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 246

Query: 95  ICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHC 154
           + S           IV EYM   +L  +L+   G+   L Q V++A  ++  + Y     
Sbjct: 247 VVSEEPI------YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM- 299

Query: 155 QPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAP 214
             + VH DL+ +NIL+ +++V  V D GLA+ +   E             IK    + AP
Sbjct: 300 --NYVHRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIK----WTAP 350

Query: 215 EYGMGSKASVSGDVYNFGILLLEMFTR-RRPTDAMFNE 251
           E  +  + ++  DV++FGILL E+ T+ R P   M N 
Sbjct: 351 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 388

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  103 bits (258), Expect = 7e-26
 Identities = 61/220 (27%), Positives = 99/220 (45%), Gaps = 29/220 (13%)

Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITI 95
             IG+G    V  G    ++  VAVK   +K    +++F AE + +  +RH NL++++ +
Sbjct: 27  QTIGKGEFGDVMLGDYRGNK--VAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGV 82

Query: 96  CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQ 155
                 E      IV EYM   +L  +LR     +      +  ++DV  A+EY   +  
Sbjct: 83  IV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN-- 136

Query: 156 PSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPE 215
            + VH DL   N+L+ +D VA V D GL K           +     + +K    + APE
Sbjct: 137 -NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA--SSTQDTGK-----LPVK----WTAPE 184

Query: 216 ---YGMGSKASVSGDVYNFGILLLEMFTR-RRPTDAMFNE 251
                  S  S   DV++FGILL E+++  R P   +  +
Sbjct: 185 ALREKKFSTKS---DVWSFGILLWEIYSFGRVPYPRIPLK 221

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  103 bits (258), Expect = 8e-26
 Identities = 51/230 (22%), Positives = 90/230 (39%), Gaps = 29/230 (12%)

Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL-----KQKEASRSFAAECNALRNI 84
            ++     IG G      K        I+  K ++       +K+   S   E N LR +
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVS---EVNLLREL 62

Query: 85  RHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRV--NIAID 142
           +H N   I+     I         IV EY +  +L   + +   + ++L +     +   
Sbjct: 63  KHPN---IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 119

Query: 143 VSFAIEYFH--HHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETAS 200
           ++ A++  H       +++H DLKP+N+ LD      +GD GLA+ L             
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-----------NH 168

Query: 201 NSIEIKGIVG---YVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDA 247
           ++   K  VG   Y++PE       +   D+++ G LL E+     P  A
Sbjct: 169 DTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA 218

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  105 bits (263), Expect = 9e-26
 Identities = 57/224 (25%), Positives = 98/224 (43%), Gaps = 31/224 (13%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNIRHRNLIKII 93
           +IG+G    V+ G L    ++VAVK    ++    +    F  E   L+   H N++++I
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKS--CRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178

Query: 94  TICSSID--FEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFH 151
            +C+     +       IV E +Q  +   +LR    +LR +   + +  D +  +EY  
Sbjct: 179 GVCTQKQPIY-------IVMELVQGGDFLTFLRTEGARLR-VKTLLQMVGDAAAGMEYLE 230

Query: 152 HHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGY 211
                  +H DL   N L+ +  V  + D G+++     +   AA      + +K    +
Sbjct: 231 SK---CCIHRDLAARNCLVTEKNVLKISDFGMSREE--ADGVYAASGGLRQVPVK----W 281

Query: 212 VAPE---YGMGSKASVSGDVYNFGILLLEMFTR-RRPTDAMFNE 251
            APE   YG  S  S   DV++FGILL E F+    P   + N+
Sbjct: 282 TAPEALNYGRYSSES---DVWSFGILLWETFSLGASPYPNLSNQ 322

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  101 bits (255), Expect = 3e-25
 Identities = 62/225 (27%), Positives = 101/225 (44%), Gaps = 33/225 (14%)

Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRS-FAAECNALRNIRHRNLIKIIT 94
           +K+G G    VY+G+  +    VAVK   LK+       F  E   ++ I+H NL++++ 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 76

Query: 95  ICSSID--FEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHH 152
           +C+     +       I+ E+M   NL  +LR+ N Q       + +A  +S A+EY   
Sbjct: 77  VCTREPPFY-------IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129

Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG--YEPGTAAETASNSIEIKGIVG 210
               + +H DL   N L+ ++ +  V D GL++ + G  Y     A+       IK    
Sbjct: 130 K---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK-----FPIK---- 177

Query: 211 YVAPE---YGMGSKASVSGDVYNFGILLLEMFTR-RRPTDAMFNE 251
           + APE   Y   S  S   DV+ FG+LL E+ T    P   +   
Sbjct: 178 WTAPESLAYNKFSIKS---DVWAFGVLLWEIATYGMSPYPGIDLS 219

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  104 bits (261), Expect = 3e-25
 Identities = 57/223 (25%), Positives = 102/223 (45%), Gaps = 31/223 (13%)

Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRS-FAAECNALRNIRHRNLIKIIT 94
            K+G G    V+    ++    VAVK   +K    S   F AE N ++ ++H  L+K+  
Sbjct: 194 KKLGAGQFGEVWMATYNKHTK-VAVKT--MKPGSMSVEAFLAEANVMKTLQHDKLVKLHA 250

Query: 95  ICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHC 154
           + +       +   I+ E+M   +L  +L+   G  + L + ++ +  ++  + +     
Sbjct: 251 VVTK------EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR- 303

Query: 155 QPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG--YEPGTAAETASNSIEIKGIVGYV 212
             + +H DL+ +NIL+   +V  + D GLA+ +    Y     A+       IK    + 
Sbjct: 304 --NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAK-----FPIK----WT 352

Query: 213 APE---YGMGSKASVSGDVYNFGILLLEMFTR-RRPTDAMFNE 251
           APE   +G  +  S   DV++FGILL+E+ T  R P   M N 
Sbjct: 353 APEAINFGSFTIKS---DVWSFGILLMEIVTYGRIPYPGMSNP 392

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  102 bits (256), Expect = 3e-25
 Identities = 49/216 (22%), Positives = 84/216 (38%), Gaps = 24/216 (11%)

Query: 37  KIGQGGVSIVYKG---ILDESRSIVAVKVVNLKQ-----KEASRSFAAECNALRNIRHRN 88
            +G GG+S V+             VAVKV  L+            F  E      + H  
Sbjct: 19  ILGFGGMSEVHLARDLRDHR---DVAVKV--LRADLARDPSFYLRFRREAQNAAALNHPA 73

Query: 89  LIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIE 148
           ++ +     +    G     IV EY+    L   +    G +    + + +  D   A+ 
Sbjct: 74  IVAVYDTGEAETPAG-PLPYIVMEYVDGVTLRDIVHT-EGPMT-PKRAIEVIADACQALN 130

Query: 149 YFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGI 208
           + H +    I+H D+KP+NI++       V D G+A+ +        + T + ++   G 
Sbjct: 131 FSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI---ADSGNSVTQTAAV--IGT 182

Query: 209 VGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
             Y++PE   G       DVY+ G +L E+ T   P
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  101 bits (254), Expect = 5e-25
 Identities = 56/226 (24%), Positives = 96/226 (42%), Gaps = 33/226 (14%)

Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL------KQKEASRSFAAECNALRN 83
            NF    KIG+G  S VY+         VA+K V +      K +        E + L+ 
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIK---EIDLLKQ 88

Query: 84  IRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRV--NIAI 141
           + H N   +I   +S  F   +   IV E     +L + ++    Q R + +R      +
Sbjct: 89  LNHPN---VIKYYAS--FIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFV 143

Query: 142 DVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASN 201
            +  A+E+ H      ++H D+KP+N+ +    V  +GDLGL +F            +S 
Sbjct: 144 QLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF-----------SSK 189

Query: 202 SIEIKGIVG---YVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
           +     +VG   Y++PE    +  +   D+++ G LL EM   + P
Sbjct: 190 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 235

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  100 bits (252), Expect = 8e-25
 Identities = 53/225 (23%), Positives = 92/225 (40%), Gaps = 25/225 (11%)

Query: 36  NKIGQGGVSIVYKGIL---DESRSIVAVKVVNLKQKEASRS-FAAECNALRNIRHRNLIK 91
             IG+G    VY G L   D  +   AVK +N        S F  E   +++  H N++ 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90

Query: 92  IITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFH 151
           ++ IC   +        +V  YM++ +L  ++R        +   +   + V+  ++Y  
Sbjct: 91  LLGICLRSEGSPL----VVLPYMKHGDLRNFIRNETHNPT-VKDLIGFGLQVAKGMKYLA 145

Query: 152 -HHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG 210
                   VH DL   N +LD+     V D GLA+ ++  E  +        + +K    
Sbjct: 146 SKKF----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK---- 197

Query: 211 YVAPE---YGMGSKASVSGDVYNFGILLLEMFTR-RRPTDAMFNE 251
           ++A E       +  S   DV++FG+LL E+ TR   P   +   
Sbjct: 198 WMALESLQTQKFTTKS---DVWSFGVLLWELMTRGAPPYPDVNTF 239

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  100 bits (251), Expect = 1e-24
 Identities = 53/225 (23%), Positives = 92/225 (40%), Gaps = 25/225 (11%)

Query: 36  NKIGQGGVSIVYKGIL---DESRSIVAVKVVNLKQKEASRS-FAAECNALRNIRHRNLIK 91
             IG+G   +VY G      ++R   A+K ++   +      F  E   +R + H N++ 
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86

Query: 92  IITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYF- 150
           +I I      EG     ++  YM + +L Q++R        +   ++  + V+  +EY  
Sbjct: 87  LIGIML--PPEGLPH--VLLPYMCHGDLLQFIRSPQRNPT-VKDLISFGLQVARGMEYLA 141

Query: 151 HHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG 210
                   VH DL   N +LD+     V D GLA+ +   E  +  +     + +K    
Sbjct: 142 EQKF----VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT-- 195

Query: 211 YVAPE---YGMGSKASVSGDVYNFGILLLEMFTR-RRPTDAMFNE 251
             A E       +  S   DV++FG+LL E+ TR   P   +   
Sbjct: 196 --ALESLQTYRFTTKS---DVWSFGVLLWELLTRGAPPYRHIDPF 235

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  100 bits (251), Expect = 1e-24
 Identities = 52/224 (23%), Positives = 101/224 (45%), Gaps = 36/224 (16%)

Query: 36  NKIGQGGVSIVYKGIL---DESRSIVAVKVVNLKQKEASRS----FAAECNALRNIRHRN 88
             +G+G    V +G L   D +   VAVK   +K   +S+     F +E   +++  H N
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKT--MKLDNSSQREIEEFLSEAACMKDFSHPN 97

Query: 89  LIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQS--NGQLRFLTQR--VNIAIDVS 144
           +I+++ +C  +  +G     ++  +M+  +L  +L  S      + +  +  +   +D++
Sbjct: 98  VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157

Query: 145 FAIEYF-HHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG---YEPGTAAETAS 200
             +EY  + +     +H DL   N +L  D+   V D GL+K ++    Y  G  A+   
Sbjct: 158 LGMEYLSNRNF----LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAK--- 210

Query: 201 NSIEIKGIVGYVAPE---YGMGSKASVSGDVYNFGILLLEMFTR 241
             + +K I    A E     + +  S   DV+ FG+ + E+ TR
Sbjct: 211 --MPVKWI----AIESLADRVYTSKS---DVWAFGVTMWEIATR 245

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 99.6 bits (249), Expect = 1e-24
 Identities = 61/223 (27%), Positives = 105/223 (47%), Gaps = 31/223 (13%)

Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRS-FAAECNALRNIRHRNLIKIIT 94
            ++G G    V+ G  +     VAVK   LKQ   S   F AE N ++ ++H+ L+++  
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTK-VAVKS--LKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75

Query: 95  ICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHC 154
           + +    E      I+ EYM+N +L  +L+  +G    + + +++A  ++  + +     
Sbjct: 76  VVTQ---EPI---YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER- 128

Query: 155 QPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG--YEPGTAAETASNSIEIKGIVGYV 212
             + +H DL+ +NIL+   +   + D GLA+ +    Y     A+       IK    + 
Sbjct: 129 --NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK-----FPIK----WT 177

Query: 213 APE---YGMGSKASVSGDVYNFGILLLEMFTR-RRPTDAMFNE 251
           APE   YG  +  S   DV++FGILL E+ T  R P   M N 
Sbjct: 178 APEAINYGTFTIKS---DVWSFGILLTEIVTHGRIPYPGMTNP 217

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  100 bits (250), Expect = 2e-24
 Identities = 58/224 (25%), Positives = 91/224 (40%), Gaps = 28/224 (12%)

Query: 37  KIGQGGVSIVYKGIL--DESRSI-VAVKVVN---LKQKEASRSFAAECNALRNIRHRNLI 90
           K+G G   +V +G       +++ VAVK +    L Q EA   F  E NA+ ++ HRNLI
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84

Query: 91  KIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYF 150
           ++  +  +          +V E     +L   LR+  G    L      A+ V+  + Y 
Sbjct: 85  RLYGVVLTPPM------KMVTELAPLGSLLDRLRKHQGHFL-LGTLSRYAVQVAEGMGYL 137

Query: 151 HHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG 210
                   +H DL   N+LL    +  +GD GL + L   +     +     +       
Sbjct: 138 ESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK-VPFA---- 189

Query: 211 YVAPE---YGMGSKASVSGDVYNFGILLLEMFTR-RRPTDAMFN 250
           + APE       S AS   D + FG+ L EMFT  + P   +  
Sbjct: 190 WCAPESLKTRTFSHAS---DTWMFGVTLWEMFTYGQEPWIGLNG 230

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  100 bits (250), Expect = 2e-24
 Identities = 44/229 (19%), Positives = 93/229 (40%), Gaps = 36/229 (15%)

Query: 36  NKIGQGGVSIVYKGIL----DESRSIVAVKVVNLK---QKEASRSFAAECNALRNIRHRN 88
             +G G    VYKG+     ++ +  VA+K   L+     +A++    E   + ++ + +
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE--LREATSPKANKEILDEAYVMASVDNPH 78

Query: 89  LIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIE 148
           + +++ IC +          ++ + M    L  ++R+    +      +N  + ++  + 
Sbjct: 79  VCRLLGICLT------STVQLITQLMPFGCLLDYVREHKDNIG-SQYLLNWCVQIAKGMN 131

Query: 149 YF-HHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNS-IEIK 206
           Y          VH DL   N+L+       + D GLAK L           A    + IK
Sbjct: 132 YLEDRRL----VHRDLAARNVLVKTPQHVKITDFGLAKLL---GAEEKEYHAEGGKVPIK 184

Query: 207 GIVGYVAPE---YGMGSKASVSGDVYNFGILLLEMFTR-RRPTDAMFNE 251
               ++A E   + + +  S   DV+++G+ + E+ T   +P D +   
Sbjct: 185 ----WMALESILHRIYTHQS---DVWSYGVTVWELMTFGSKPYDGIPAS 226

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  100 bits (251), Expect = 3e-24
 Identities = 52/225 (23%), Positives = 91/225 (40%), Gaps = 25/225 (11%)

Query: 36  NKIGQGGVSIVYKGIL---DESRSIVAVKVVNLKQKEASRS-FAAECNALRNIRHRNLIK 91
             IG+G    VY G L   D  +   AVK +N        S F  E   +++  H N++ 
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154

Query: 92  IITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYF- 150
           ++ IC   +        +V  YM++ +L  ++R        +   +   + V+  +++  
Sbjct: 155 LLGICLRSEGSPL----VVLPYMKHGDLRNFIRNETHNPT-VKDLIGFGLQVAKGMKFLA 209

Query: 151 HHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG 210
                   VH DL   N +LD+     V D GLA+ ++  E  +        + +K +  
Sbjct: 210 SKKF----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM-- 263

Query: 211 YVAPE---YGMGSKASVSGDVYNFGILLLEMFTR-RRPTDAMFNE 251
             A E       +  S   DV++FG+LL E+ TR   P   +   
Sbjct: 264 --ALESLQTQKFTTKS---DVWSFGVLLWELMTRGAPPYPDVNTF 303

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 99.3 bits (248), Expect = 4e-24
 Identities = 53/247 (21%), Positives = 103/247 (41%), Gaps = 27/247 (10%)

Query: 36  NKIGQGGVSIVYKGIL----DESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIK 91
           +++G+G    V         D + ++VAVK +     +  R F  E   L+ +    ++K
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88

Query: 92  IITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFH 151
              +      +      +V EY+ +  L  +L++   +L   ++ +  +  +   +EY  
Sbjct: 89  YRGVSYGPGRQSL---RLVMEYLPSGCLRDFLQRHRARLD-ASRLLLYSSQICKGMEYLG 144

Query: 152 -HHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG 210
              C    VH DL   NIL++ +    + D GLAK L   +             I     
Sbjct: 145 SRRC----VHRDLAARNILVESEAHVKIADFGLAKLL-PLDKDYYVVREPGQSPIF---- 195

Query: 211 YVAPE---YGMGSKASVSGDVYNFGILLLEMFTR-RRP-TDAMFNEGLTLHEFVKMALPD 265
           + APE     + S+ S   DV++FG++L E+FT   +  + +     +   E    AL  
Sbjct: 196 WYAPESLSDNIFSRQS---DVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR 252

Query: 266 KVMEIVD 272
            ++E+++
Sbjct: 253 -LLELLE 258

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 98.5 bits (246), Expect = 4e-24
 Identities = 48/224 (21%), Positives = 93/224 (41%), Gaps = 31/224 (13%)

Query: 37  KIGQGGVSIVYKGIL--DESRSIVAVKVVNLK---QKEASRSFAAECNALRNIRHRNLIK 91
           ++G G    V +G+    + +  VA+KV  LK   +K  +     E   +  + +  +++
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKV--LKQGTEKADTEEMMREAQIMHQLDNPYIVR 74

Query: 92  IITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYF- 150
           +I +C +          +V E      L ++L     ++  ++    +   VS  ++Y  
Sbjct: 75  LIGVCQAEAL------MLVMEMAGGGPLHKFLVGKREEIP-VSNVAELLHQVSMGMKYLE 127

Query: 151 HHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG 210
             +     VH DL   N+LL     A + D GL+K L   +    A +A     +K    
Sbjct: 128 EKNF----VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG-KWPLK---- 178

Query: 211 YVAPE---YGMGSKASVSGDVYNFGILLLEMFTR-RRPTDAMFN 250
           + APE   +   S  S   DV+++G+ + E  +  ++P   M  
Sbjct: 179 WYAPECINFRKFSSRS---DVWSYGVTMWEALSYGQKPYKKMKG 219

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 99.4 bits (248), Expect = 5e-24
 Identities = 51/213 (23%), Positives = 90/213 (42%), Gaps = 24/213 (11%)

Query: 36  NKIGQGGVSIVYKGIL----DESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIK 91
            ++G+G    V         D +  +VAVK +    +E  R F  E   L++++H N++K
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106

Query: 92  IITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFH 151
              +C S          ++ EY+   +L  +L++   ++    + +     +   +EY  
Sbjct: 107 YKGVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERID-HIKLLQYTSQICKGMEYLG 162

Query: 152 -HHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG 210
                   +H DL   NIL++ +    +GD GL K L   +             I     
Sbjct: 163 TKRY----IHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEYYKVKEPGESPIF---- 213

Query: 211 YVAPE---YGMGSKASVSGDVYNFGILLLEMFT 240
           + APE       S AS   DV++FG++L E+FT
Sbjct: 214 WYAPESLTESKFSVAS---DVWSFGVVLYELFT 243

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 98.5 bits (246), Expect = 5e-24
 Identities = 51/220 (23%), Positives = 90/220 (40%), Gaps = 37/220 (16%)

Query: 36  NKIGQGGVSIVYKGIL----DESRSIVAVKVVNLKQ---KEASRSFAAECNALRNIRHRN 88
             +G+G    V         D +   VAVK   LK             E   LRN+ H N
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKS--LKPESGGNHIADLKKEIEILRNLYHEN 84

Query: 89  LIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIE 148
           ++K   IC+     G     ++ E++ + +L+++L ++  ++  L Q++  A+ +   ++
Sbjct: 85  IVKYKGICTEDGGNGI---KLIMEFLPSGSLKEYLPKNKNKIN-LKQQLKYAVQICKGMD 140

Query: 149 YFH-HHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG----YEPGTAAETASNSI 203
           Y          VH DL   N+L++ +    +GD GL K +      Y      +      
Sbjct: 141 YLGSRQY----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRD-----S 191

Query: 204 EIKGIVGYVAPE---YGMGSKASVSGDVYNFGILLLEMFT 240
            +     + APE         AS   DV++FG+ L E+ T
Sbjct: 192 PVF----WYAPECLMQSKFYIAS---DVWSFGVTLHELLT 224

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 98.0 bits (245), Expect = 5e-24
 Identities = 50/226 (22%), Positives = 92/226 (40%), Gaps = 37/226 (16%)

Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRS-FAAECNALRNIRHRNLIKIIT 94
            +IG G   +V+ G        VA+K   +++   S   F  E   +  + H  L+++  
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDK-VAIKT--IREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 70

Query: 95  ICSSID--FEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYF-H 151
           +C              +V E+M++  L  +LR   G        + + +DV   + Y   
Sbjct: 71  VCLEQAPIC-------LVTEFMEHGCLSDYLRTQRGLFA-AETLLGMCLDVCEGMAYLEE 122

Query: 152 HHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG--YEPGTAAETASNSIEIKGIV 209
                  +H DL   N L+ ++ V  V D G+ +F+    Y   T  +       +K   
Sbjct: 123 ACV----IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK-----FPVK--- 170

Query: 210 GYVAPE---YGMGSKASVSGDVYNFGILLLEMFTR-RRPTDAMFNE 251
            + +PE   +   S  S   DV++FG+L+ E+F+  + P +   N 
Sbjct: 171 -WASPEVFSFSRYSSKS---DVWSFGVLMWEVFSEGKIPYENRSNS 212

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 98.1 bits (245), Expect = 5e-24
 Identities = 53/226 (23%), Positives = 96/226 (42%), Gaps = 37/226 (16%)

Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRS-FAAECNALRNIRHRNLIKIIT 94
            ++G G   +V  G        VA+K+  +K+   S   F  E   + N+ H  L+++  
Sbjct: 30  KELGTGQFGVVKYGKWRGQYD-VAIKM--IKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 86

Query: 95  ICSSID--FEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYF-H 151
           +C+     F       I+ EYM N  L  +LR+   + +   Q + +  DV  A+EY   
Sbjct: 87  VCTKQRPIF-------IITEYMANGCLLNYLREMRHRFQ-TQQLLEMCKDVCEAMEYLES 138

Query: 152 HHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG--YEPGTAAETASNSIEIKGIV 209
                  +H DL   N L++   V  V D GL++++    Y     ++       ++   
Sbjct: 139 KQF----LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK-----FPVR--- 186

Query: 210 GYVAPE---YGMGSKASVSGDVYNFGILLLEMFTR-RRPTDAMFNE 251
            +  PE   Y   S  S   D++ FG+L+ E+++  + P +   N 
Sbjct: 187 -WSPPEVLMYSKFSSKS---DIWAFGVLMWEIYSLGKMPYERFTNS 228

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 99.7 bits (249), Expect = 6e-24
 Identities = 62/226 (27%), Positives = 103/226 (45%), Gaps = 29/226 (12%)

Query: 36  NKIGQGGVSIVYKGIL---DESRSIVAVKVVNLKQ---KEASRSFAAECNALRNIRHRNL 89
             +G G    V  G L    +    VA+K   LK    ++  R F  E + +    H N+
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKT--LKVGYTEKQRRDFLGEASIMGQFDHPNI 108

Query: 90  IKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEY 149
           I++  + +           IV EYM+N +L+ +LR+ + Q   + Q V +   ++  ++Y
Sbjct: 109 IRLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKHDAQFT-VIQLVGMLRGIASGMKY 162

Query: 150 FHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
                    VH DL   NIL++ ++V  V D GL + L   +P  A  T    I I+   
Sbjct: 163 LSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLED-DPEAAYTTRGGKIPIR--- 215

Query: 210 GYVAPE---YGMGSKASVSGDVYNFGILLLEMFTR-RRPTDAMFNE 251
            + +PE   Y   + AS   DV+++GI+L E+ +   RP   M N+
Sbjct: 216 -WTSPEAIAYRKFTSAS---DVWSYGIVLWEVMSYGERPYWEMSNQ 257

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 98.5 bits (246), Expect = 6e-24
 Identities = 51/213 (23%), Positives = 90/213 (42%), Gaps = 24/213 (11%)

Query: 36  NKIGQGGVSIVYKGIL----DESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIK 91
            ++G+G    V         D +  +VAVK +    +E  R F  E   L++++H N++K
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75

Query: 92  IITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFH 151
              +C S          ++ EY+   +L  +L++   ++    + +     +   +EY  
Sbjct: 76  YKGVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERID-HIKLLQYTSQICKGMEYLG 131

Query: 152 -HHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG 210
                   +H DL   NIL++ +    +GD GL K L   +             I     
Sbjct: 132 TKRY----IHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEFFKVKEPGESPIF---- 182

Query: 211 YVAPE---YGMGSKASVSGDVYNFGILLLEMFT 240
           + APE       S AS   DV++FG++L E+FT
Sbjct: 183 WYAPESLTESKFSVAS---DVWSFGVVLYELFT 212

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 98.1 bits (245), Expect = 1e-23
 Identities = 65/230 (28%), Positives = 101/230 (43%), Gaps = 37/230 (16%)

Query: 36  NKIGQGGVSIVYKGIL---DESRSIVAVKVVNLKQ---KEASRSFAAECNALRNIRHRNL 89
             IG G    V  G L    +    VA+K   LK    +   R F +E + +    H N+
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKA--LKAGYTERQRRDFLSEASIMGQFDHPNI 112

Query: 90  IKIITICSSIDFEGFDFKA----IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSF 145
           I++  + +         +     IV EYM+N +L+ +LR  +GQ   + Q V +   V  
Sbjct: 113 IRLEGVVT---------RGRLAMIVTEYMENGSLDTFLRTHDGQFT-IMQLVGMLRGVGA 162

Query: 146 AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEI 205
            + Y         VH DL   N+L+D ++V  V D GL++ L   +P  A  T    I I
Sbjct: 163 GMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED-DPDAAYTTTGGKIPI 218

Query: 206 KGIVGYVAPE---YGMGSKASVSGDVYNFGILLLEMFTR-RRPTDAMFNE 251
           +    + APE   +   S AS   DV++FG+++ E+     RP   M N 
Sbjct: 219 R----WTAPEAIAFRTFSSAS---DVWSFGVVMWEVLAYGERPYWNMTNR 261

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 97.3 bits (243), Expect = 2e-23
 Identities = 50/214 (23%), Positives = 87/214 (40%), Gaps = 26/214 (12%)

Query: 37  KIGQGGVSIVYKG---ILDESRSIVAVKVV--NLKQKEASRS-FAAECNALRNIRHRNLI 90
            +G+GG+  VY+    + +  R IVA+K++   L      R+    E      ++  +  
Sbjct: 41  LVGRGGMGDVYEAEDTVRE--R-IVALKLMSETLSSDPVFRTRMQREARTAGRLQEPH-- 95

Query: 91  KIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYF 150
            ++ I    + +G  +  +    +   +L   LR+  G L    + V I   +  A++  
Sbjct: 96  -VVPIHDFGEIDGQLY--VDMRLINGVDLAAMLRR-QGPLA-PPRAVAIVRQIGSALDAA 150

Query: 151 HHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG 210
           H        H D+KP NIL+  D  A++ D G+A             T   +    G + 
Sbjct: 151 HAA---GATHRDVKPENILVSADDFAYLVDFGIASAT-----TDEKLTQLGN--TVGTLY 200

Query: 211 YVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
           Y+APE    S A+   D+Y    +L E  T   P
Sbjct: 201 YMAPERFSESHATYRADIYALTCVLYECLTGSPP 234

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 96.1 bits (240), Expect = 2e-23
 Identities = 59/224 (26%), Positives = 93/224 (41%), Gaps = 35/224 (15%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRS-FAAECNALRNIRHRNLIKIITI 95
           ++G G   +V  G        VAVK+  +K+   S   F  E   +  + H  L+K   +
Sbjct: 15  ELGSGQFGVVKLGKWKGQYD-VAVKM--IKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71

Query: 96  CSSID--FEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHH 153
           CS     +       IV EY+ N  L  +LR     L   +Q + +  DV   + +   H
Sbjct: 72  CSKEYPIY-------IVTEYISNGCLLNYLRSHGKGLE-PSQLLEMCYDVCEGMAFLESH 123

Query: 154 CQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG--YEPGTAAETASNSIEIKGIVGY 211
                +H DL   N L+D+D+   V D G+ +++    Y      +       +K    +
Sbjct: 124 ---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTK-----FPVK----W 171

Query: 212 VAPE---YGMGSKASVSGDVYNFGILLLEMFTR-RRPTDAMFNE 251
            APE   Y   S  S   DV+ FGIL+ E+F+  + P D   N 
Sbjct: 172 SAPEVFHYFKYSSKS---DVWAFGILMWEVFSLGKMPYDLYTNS 212

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 97.4 bits (243), Expect = 3e-23
 Identities = 65/230 (28%), Positives = 108/230 (46%), Gaps = 38/230 (16%)

Query: 37  KIGQGGVSIVYKGIL----DESRSIVAVKVVNLKQ---KEASRSFAAECNALRNIRHRNL 89
            IG G    VYKG+L     +    VA+K   LK    ++    F  E   +    H N+
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKT--LKAGYTEKQRVDFLGEAGIMGQFSHHNI 108

Query: 90  IKIITICSSIDFEGFDFKA----IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSF 145
           I++  + S         K     I+ EYM+N  L+++LR+ +G+   + Q V +   ++ 
Sbjct: 109 IRLEGVIS---------KYKPMMIITEYMENGALDKFLREKDGEFS-VLQLVGMLRGIAA 158

Query: 146 AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEI 205
            ++Y  +    + VH DL   NIL++ ++V  V D GL++ L   +P     T+   I I
Sbjct: 159 GMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED-DPEATYTTSGGKIPI 214

Query: 206 KGIVGYVAPE---YGMGSKASVSGDVYNFGILLLEMFTR-RRPTDAMFNE 251
           +    + APE   Y   + AS   DV++FGI++ E+ T   RP   + N 
Sbjct: 215 R----WTAPEAISYRKFTSAS---DVWSFGIVMWEVMTYGERPYWELSNH 257

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 99.3 bits (247), Expect = 3e-23
 Identities = 48/224 (21%), Positives = 94/224 (41%), Gaps = 31/224 (13%)

Query: 37  KIGQGGVSIVYKGIL-DESRSI-VAVKVVNLK---QKEASRSFAAECNALRNIRHRNLIK 91
           ++G G    V +G+     + I VA+KV  LK   +K  +     E   +  + +  +++
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKV--LKQGTEKADTEEMMREAQIMHQLDNPYIVR 400

Query: 92  IITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYF- 150
           +I +C +      +   +V E      L ++L     ++  ++    +   VS  ++Y  
Sbjct: 401 LIGVCQA------EALMLVMEMAGGGPLHKFLVGKREEIP-VSNVAELLHQVSMGMKYLE 453

Query: 151 HHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG 210
             +     VH +L   N+LL     A + D GL+K L   +    A +A     +K    
Sbjct: 454 EKNF----VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG-KWPLK---- 504

Query: 211 YVAPE---YGMGSKASVSGDVYNFGILLLEMFTR-RRPTDAMFN 250
           + APE   +   S  S   DV+++G+ + E  +  ++P   M  
Sbjct: 505 WYAPECINFRKFSSRS---DVWSYGVTMWEALSYGQKPYKKMKG 545

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 96.6 bits (241), Expect = 3e-23
 Identities = 58/254 (22%), Positives = 96/254 (37%), Gaps = 42/254 (16%)

Query: 36  NKIGQGGVSIVYKGIL----DESRSIVAVKVVNLK---QKEASRSFAAECNALRNIRHRN 88
             +G+G    V         D +  +VAVK   LK     +    +  E + LR + H +
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKA--LKADAGPQHRSGWKQEIDILRTLYHEH 94

Query: 89  LIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIE 148
           +IK    C            +V EY+   +L  +L + +  L  L   +  A  +   + 
Sbjct: 95  IIKYKGCCEDAGAASL---QLVMEYVPLGSLRDYLPRHSIGLAQL---LLFAQQICEGMA 148

Query: 149 YFH-HHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG----YEPGTAAETASNSI 203
           Y H  H     +H DL   N+LLD D +  +GD GLAK +      Y      +      
Sbjct: 149 YLHAQHY----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD-----S 199

Query: 204 EIKGIVGYVAPE---YGMGSKASVSGDVYNFGILLLEMFT--RRRPTDAMFNEGLTLHEF 258
            +     + APE         AS   DV++FG+ L E+ T      +       L     
Sbjct: 200 PVF----WYAPECLKEYKFYYAS---DVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ 252

Query: 259 VKMALPDKVMEIVD 272
            +M +   + E+++
Sbjct: 253 GQMTVLR-LTELLE 265

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 95.7 bits (239), Expect = 5e-23
 Identities = 48/226 (21%), Positives = 98/226 (43%), Gaps = 34/226 (15%)

Query: 37  KIGQGGVSIVYKGIL---DESRSIVAVKVVNLKQKEASRS-FAAECNALRNIRHRNLIKI 92
            +G+G    VY+G+       +  VAVK         ++  F +E   ++N+ H +++K+
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78

Query: 93  ITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYF-H 151
           I I         +   I+ E      L  +L ++   L+ +   V  ++ +  A+ Y   
Sbjct: 79  IGIIEE------EPTWIIMELYPYGELGHYLERNKNSLK-VLTLVLYSLQICKAMAYLES 131

Query: 152 HHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG--YEPGTAAETASNSIEIKGIV 209
            +C    VH D+   NIL+       +GD GL++++    Y   +        + IK   
Sbjct: 132 INC----VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTR-----LPIK--- 179

Query: 210 GYVAPE---YGMGSKASVSGDVYNFGILLLEMFTR-RRPTDAMFNE 251
            +++PE   +   + AS   DV+ F + + E+ +  ++P   + N+
Sbjct: 180 -WMSPESINFRRFTTAS---DVWMFAVCMWEILSFGKQPFFWLENK 221

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 96.2 bits (240), Expect = 6e-23
 Identities = 52/225 (23%), Positives = 96/225 (42%), Gaps = 37/225 (16%)

Query: 36  NKIGQGGVSIVYKGIL---DESRSIVAVKVVNLKQKEASRS----FAAECNALRNIRHRN 88
             +G+G    V +  L   D S   VAVK+  LK    + S    F  E   ++   H +
Sbjct: 29  RMLGKGEFGSVREAQLKQEDGSFVKVAVKM--LKADIIASSDIEEFLREAACMKEFDHPH 86

Query: 89  LIKIITICSSIDFEGFDFKA-IVFEYMQNRNLEQWLRQS----NGQLRFLTQRVNIAIDV 143
           + K++ +      +G      ++  +M++ +L  +L  S    N     L   V   +D+
Sbjct: 87  VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146

Query: 144 SFAIEYF-HHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG---YEPGTAAETA 199
           +  +EY    +     +H DL   N +L +D+   V D GL++ ++    Y  G A++  
Sbjct: 147 ACGMEYLSSRNF----IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASK-- 200

Query: 200 SNSIEIKGIVGYVAPE---YGMGSKASVSGDVYNFGILLLEMFTR 241
              + +K +    A E     + +  S   DV+ FG+ + E+ TR
Sbjct: 201 ---LPVKWL----ALESLADNLYTVHS---DVWAFGVTMWEIMTR 235

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 95.9 bits (239), Expect = 8e-23
 Identities = 46/227 (20%), Positives = 96/227 (42%), Gaps = 32/227 (14%)

Query: 36  NKIGQGGVSIVYKGIL----DESRSIVAVKVVNLK---QKEASRSFAAECNALRNIRHRN 88
             +G G    VYKG+     ++ +  VA+K   L+     +A++    E   + ++ + +
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE--LREATSPKANKEILDEAYVMASVDNPH 78

Query: 89  LIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIE 148
           + +++ IC +          ++ + M    L  ++R+    +      +N  + ++  + 
Sbjct: 79  VCRLLGICLT------STVQLITQLMPFGCLLDYVREHKDNIG-SQYLLNWCVQIAKGMN 131

Query: 149 YFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGI 208
           Y        +VH DL   N+L+       + D GLAK L   E    AE     + IK  
Sbjct: 132 YLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG--KVPIK-- 184

Query: 209 VGYVAPE---YGMGSKASVSGDVYNFGILLLEMFTR-RRPTDAMFNE 251
             ++A E   + + +  S   DV+++G+ + E+ T   +P D +   
Sbjct: 185 --WMALESILHRIYTHQS---DVWSYGVTVWELMTFGSKPYDGIPAS 226

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 98.2 bits (244), Expect = 9e-23
 Identities = 56/232 (24%), Positives = 96/232 (41%), Gaps = 20/232 (8%)

Query: 26  SKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASR-SFAAECNALRNI 84
           ++    +    ++G GG   V + I  ++   VA+K    +    +R  +  E   ++ +
Sbjct: 10  TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL 69

Query: 85  RHRNLIKII-TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRV--NIAI 141
            H N++               D   +  EY +  +L ++L Q       L +     +  
Sbjct: 70  NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQ-FENCCGLKEGPIRTLLS 128

Query: 142 DVSFAIEYFHHHCQPSIVHGDLKPSNILLD---QDIVAHVGDLGLAKFLFGYEPGTAAET 198
           D+S A+ Y H +    I+H DLKP NI+L    Q ++  + DLG AK L   + G     
Sbjct: 129 DISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL---DQGELCTE 182

Query: 199 ASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFN 250
                   G + Y+APE     K +V+ D ++FG L  E  T  RP    + 
Sbjct: 183 F------VGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ 228

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 95.0 bits (237), Expect = 9e-23
 Identities = 58/225 (25%), Positives = 98/225 (43%), Gaps = 33/225 (14%)

Query: 37  KIGQGGVSIVYKGILDESRSI--VAVKVVNLK----QKEASRSFAAECNALRNIRHRNLI 90
           ++G G    V KG     + +  VAVK+  LK             AE N ++ + +  ++
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKI--LKNEANDPALKDELLAEANVMQQLDNPYIV 81

Query: 91  KIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYF 150
           ++I IC +      +   +V E  +   L ++L+Q N  ++     + +   VS  ++Y 
Sbjct: 82  RMIGICEA------ESWMLVMEMAELGPLNKYLQQ-NRHVKDKNI-IELVHQVSMGMKYL 133

Query: 151 -HHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
              +     VH DL   N+LL     A + D GL+K L   E    A+T      +K   
Sbjct: 134 EESNF----VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK-WPVK--- 185

Query: 210 GYVAPE---YGMGSKASVSGDVYNFGILLLEMFTR-RRPTDAMFN 250
            + APE   Y   S  S   DV++FG+L+ E F+  ++P   M  
Sbjct: 186 -WYAPECINYYKFSSKS---DVWSFGVLMWEAFSYGQKPYRGMKG 226

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 95.9 bits (238), Expect = 1e-22
 Identities = 32/275 (11%), Positives = 69/275 (25%), Gaps = 46/275 (16%)

Query: 24  ELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEAS---RSFAAECNA 80
            LS+          +  G  S+V+     E     A+KV  +  + +            A
Sbjct: 56  LLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFA 115

Query: 81  LRNIRHRNLI---------------------KIITICSSIDFEGFDFKAIVFEYMQNRNL 119
              +   +                           +    D        ++       +L
Sbjct: 116 AARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDL 174

Query: 120 EQWLRQ-----SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDI 174
           E                 +     +   +              +VHG   P N+ +  D 
Sbjct: 175 ELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDG 231

Query: 175 VAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSG--DVYNFG 232
              +GD+         + GT    +S        V Y   E+   S A+ +   + +  G
Sbjct: 232 RLMLGDVSALW-----KVGTRGPASSVP------VTYAPREFLNASTATFTHALNAWQLG 280

Query: 233 ILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKV 267
           + +  ++    P   +        +   + +P   
Sbjct: 281 LSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTD 315

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 95.1 bits (237), Expect = 2e-22
 Identities = 48/228 (21%), Positives = 93/228 (40%), Gaps = 34/228 (14%)

Query: 36  NKIGQGGVSIVYKGIL----DESRSIVAVKVVNLKQKEASRS---FAAECNALRNIRHRN 88
             +G G    V+KG+     +  +  V +KV  ++ K   +S         A+ ++ H +
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKV--IEDKSGRQSFQAVTDHMLAIGSLDHAH 76

Query: 89  LIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIE 148
           +++++ +C            +V +Y+   +L   +RQ  G L      +N  + ++  + 
Sbjct: 77  IVRLLGLCPG------SSLQLVTQYLPLGSLLDHVRQHRGALG-PQLLLNWGVQIAKGMY 129

Query: 149 YFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNS-IEIKG 207
           Y   H    +VH +L   N+LL       V D G+A  L    P       S +   IK 
Sbjct: 130 YLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLL---PPDDKQLLYSEAKTPIK- 182

Query: 208 IVGYVAPE---YGMGSKASVSGDVYNFGILLLEMFTR-RRPTDAMFNE 251
              ++A E   +G  +  S   DV+++G+ + E+ T    P   +   
Sbjct: 183 ---WMALESIHFGKYTHQS---DVWSYGVTVWELMTFGAEPYAGLRLA 224

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 93.8 bits (234), Expect = 2e-22
 Identities = 50/227 (22%), Positives = 91/227 (40%), Gaps = 36/227 (15%)

Query: 37  KIGQGGVSIVYKGIL---DESRSIVAVKVVNLKQ---KEASRSFAAECNALRNIRHRNLI 90
            IG+G    V++GI    +     VA+K    K          F  E   +R   H +++
Sbjct: 22  CIGEGQFGDVHQGIYMSPENPALAVAIKT--CKNCTSDSVREKFLQEALTMRQFDHPHIV 79

Query: 91  KIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYF 150
           K+I + +       +   I+ E      L  +L+     L  L   +  A  +S A+ Y 
Sbjct: 80  KLIGVITE------NPVWIIMELCTLGELRSFLQVRKYSLD-LASLILYAYQLSTALAYL 132

Query: 151 HHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG--YEPGTAAETASNSIEIKGI 208
                   VH D+   N+L+  +    +GD GL++++    Y   +  +     + IK  
Sbjct: 133 ESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK-----LPIK-- 182

Query: 209 VGYVAPE---YGMGSKASVSGDVYNFGILLLEMFTR-RRPTDAMFNE 251
             ++APE   +   + AS   DV+ FG+ + E+     +P   + N 
Sbjct: 183 --WMAPESINFRRFTSAS---DVWMFGVCMWEILMHGVKPFQGVKNN 224

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 95.3 bits (237), Expect = 3e-22
 Identities = 61/260 (23%), Positives = 104/260 (40%), Gaps = 44/260 (16%)

Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ--KEASRSFAAECNALRNIRHRNLIKII 93
            +IG GG S V++  L+E + I A+K VNL++   +   S+  E   L  ++  +  KII
Sbjct: 62  KQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-DKII 119

Query: 94  TICSSID-FEGFDFKAIVFEYMQNRNLEQWLRQSNGQL------RFLTQRVNIAIDVSFA 146
            +    D      +  +V E   N +L  WL++    +       +    +        A
Sbjct: 120 RL---YDYEITDQYIYMVMEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLE-------A 167

Query: 147 IEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIK 206
           +   H H    IVH DLKP+N L+   ++  + D G+A  +         ++        
Sbjct: 168 VHTIHQH---GIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDS------QV 217

Query: 207 GIVGYVAPE-----------YGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTL 255
           G V Y+ PE               SK S   DV++ G +L  M   + P   + N+   L
Sbjct: 218 GAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL 277

Query: 256 HEFVKMALPDKVMEIVDPSL 275
           H  +      +  +I +  L
Sbjct: 278 HAIIDPNHEIEFPDIPEKDL 297

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 93.1 bits (232), Expect = 4e-22
 Identities = 50/221 (22%), Positives = 94/221 (42%), Gaps = 40/221 (18%)

Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICS 97
           +G+G   IVY G    ++  +A+K +  +    S+    E    ++++H+N+++      
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ------ 83

Query: 98  SIDFEGFDFKA----IVFEYMQNRNLEQWLRQSNGQLRFLTQRV-NIAIDVSFAIEYFHH 152
              + G   +     I  E +   +L   LR   G L+   Q +      +   ++Y H 
Sbjct: 84  ---YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD 140

Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG-- 210
           +    IVH D+K  N+L++     + G L ++ F      GT+   A  +   +   G  
Sbjct: 141 NQ---IVHRDIKGDNVLIN----TYSGVLKISDF------GTSKRLAGINPCTETFTGTL 187

Query: 211 -YVAPE------YGMGSKASVSGDVYNFGILLLEMFTRRRP 244
            Y+APE       G G  A    D+++ G  ++EM T + P
Sbjct: 188 QYMAPEIIDKGPRGYGKAA----DIWSLGCTIIEMATGKPP 224

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 93.7 bits (233), Expect = 5e-22
 Identities = 44/223 (19%), Positives = 83/223 (37%), Gaps = 31/223 (13%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQ-KEASRSFAAECNALRNIRHRNLIKIITI 95
            +GQG  + V++G   ++  + A+KV N             E   L+ + H+N++K+  I
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 96  CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRV--NIAIDVSFAIEYFHHH 153
               +      K ++ E+    +L   L +       L +     +  DV   + +   +
Sbjct: 76  ---EEETTTRHKVLIMEFCPCGSLYTVLEE-PSNAYGLPESEFLIVLRDVVGGMNHLREN 131

Query: 154 CQPSIVHGDLKPSNILL----DQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
               IVH ++KP NI+     D   V  + D G A+ L   E      +      + G  
Sbjct: 132 ---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL---EDDEQFVS------LYGTE 179

Query: 210 GYVAPE--------YGMGSKASVSGDVYNFGILLLEMFTRRRP 244
            Y+ P+             K   + D+++ G+      T   P
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 93.2 bits (232), Expect = 9e-22
 Identities = 61/260 (23%), Positives = 104/260 (40%), Gaps = 44/260 (16%)

Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ--KEASRSFAAECNALRNIRHRNLIKII 93
            +IG GG S V++  L+E + I A+K VNL++   +   S+  E   L  ++  +  KII
Sbjct: 15  KQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-DKII 72

Query: 94  TICSSID-FEGFDFKAIVFEYMQNRNLEQWLRQSNGQL------RFLTQRVNIAIDVSFA 146
            +    D      +  +V E   N +L  WL++    +       +    +        A
Sbjct: 73  RL---YDYEITDQYIYMVMEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLE-------A 120

Query: 147 IEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIK 206
           +   H H    IVH DLKP+N L+   ++  + D G+A  +         ++        
Sbjct: 121 VHTIHQH---GIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDS------QV 170

Query: 207 GIVGYVAPE-----------YGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTL 255
           G V Y+ PE               SK S   DV++ G +L  M   + P   + N+   L
Sbjct: 171 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL 230

Query: 256 HEFVKMALPDKVMEIVDPSL 275
           H  +      +  +I +  L
Sbjct: 231 HAIIDPNHEIEFPDIPEKDL 250

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 92.4 bits (230), Expect = 1e-21
 Identities = 61/260 (23%), Positives = 104/260 (40%), Gaps = 44/260 (16%)

Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ--KEASRSFAAECNALRNIRHRNLIKII 93
            +IG GG S V++  L+E + I A+K VNL++   +   S+  E   L  ++  +  KII
Sbjct: 34  KQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-DKII 91

Query: 94  TICSSID-FEGFDFKAIVFEYMQNRNLEQWLRQSNGQL------RFLTQRVNIAIDVSFA 146
            +    D      +  +V E   N +L  WL++    +       +    +        A
Sbjct: 92  RL---YDYEITDQYIYMVMECG-NIDLNSWLKK-KKSIDPWERKSYWKNMLE-------A 139

Query: 147 IEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIK 206
           +   H H    IVH DLKP+N L+   ++  + D G+A  +         ++        
Sbjct: 140 VHTIHQH---GIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDS------QV 189

Query: 207 GIVGYVAPE-----------YGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTL 255
           G V Y+ PE               SK S   DV++ G +L  M   + P   + N+   L
Sbjct: 190 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL 249

Query: 256 HEFVKMALPDKVMEIVDPSL 275
           H  +      +  +I +  L
Sbjct: 250 HAIIDPNHEIEFPDIPEKDL 269

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 92.5 bits (230), Expect = 1e-21
 Identities = 45/234 (19%), Positives = 92/234 (39%), Gaps = 24/234 (10%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIR-HRNLIKII-- 93
            + +GG + VY+     S    A+K +   ++E +R+   E   ++ +  H N+++    
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 94  TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRV-NIAIDVSFAIEYFHH 152
                 + +    + ++   +    L ++L++   +       V  I      A+++ H 
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154

Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIK----GI 208
             +P I+H DLK  N+LL       + D G A  +  Y   + +      +E +      
Sbjct: 155 Q-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213

Query: 209 VGYVAPE-------YGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTL 255
             Y  PE       + +G K     D++  G +L  +  R+ P    F +G  L
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQ----DIWALGCILYLLCFRQHP----FEDGAKL 259

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 91.9 bits (228), Expect = 2e-21
 Identities = 53/273 (19%), Positives = 89/273 (32%), Gaps = 61/273 (22%)

Query: 26  SKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK-QKEASRSFAAECNALRNI 84
           S+   +F P   +G+GG  +V++          A+K + L  ++ A      E  AL  +
Sbjct: 2   SRYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL 61

Query: 85  R----------------------------------------------------HRNLIKI 92
                                                                       
Sbjct: 62  EHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTK 121

Query: 93  ITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRV-NIAIDVSFAIEYFH 151
            T+          +  I  +  +  NL+ W+ +             +I I ++ A+E+ H
Sbjct: 122 NTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH 181

Query: 152 HHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL-FGYEPGTAAETASNSIEIKGIVG 210
                 ++H DLKPSNI    D V  VGD GL   +    E  T            G VG
Sbjct: 182 SK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG 238

Query: 211 ---YVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
              Y++PE   G+  S   D+++ G++L E+  
Sbjct: 239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY 271

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 92.2 bits (229), Expect = 3e-21
 Identities = 44/223 (19%), Positives = 83/223 (37%), Gaps = 31/223 (13%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVN-LKQKEASRSFAAECNALRNIRHRNLIKIITI 95
            +GQG  + V++G   ++  + A+KV N +           E   L+ + H+N++K+  I
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 96  CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRV--NIAIDVSFAIEYFHHH 153
               +      K ++ E+    +L   L +       L +     +  DV   + +   +
Sbjct: 76  ---EEETTTRHKVLIMEFCPCGSLYTVL-EEPSNAYGLPESEFLIVLRDVVGGMNHLREN 131

Query: 154 CQPSIVHGDLKPSNILL----DQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
               IVH ++KP NI+     D   V  + D G A+ L   E      +        G  
Sbjct: 132 ---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL---EDDEQFVSL------YGTE 179

Query: 210 GYVAPE--------YGMGSKASVSGDVYNFGILLLEMFTRRRP 244
            Y+ P+             K   + D+++ G+      T   P
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 90.0 bits (224), Expect = 5e-21
 Identities = 41/236 (17%), Positives = 99/236 (41%), Gaps = 46/236 (19%)

Query: 37  KIGQGGVSIVYKGIL-------DESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNL 89
            +GQG  + ++KG+            + V +KV++   +  S SF    + +  + H++L
Sbjct: 15  SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74

Query: 90  IKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEY 149
           +    +C        D   +V E+++  +L+ +L+++   +  +  ++ +A  ++ A+ +
Sbjct: 75  VLNYGVCVC-----GDENILVQEFVKFGSLDTYLKKNKNCIN-ILWKLEVAKQLAAAMHF 128

Query: 150 F-HHHCQPSIVHGDLKPSNILLDQDI--------VAHVGDLGLAKFLFGYEPGTAAETAS 200
              +      +HG++   NILL ++            + D G++  +   +         
Sbjct: 129 LEENTL----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQ------ 178

Query: 201 NSIEIKGIVGYVAPE----YGMGSKASVSGDVYNFGILLLEMFTR-RRPTDAMFNE 251
               I     +V PE        + A+   D ++FG  L E+ +   +P  A+ ++
Sbjct: 179 --ERIP----WVPPECIENPKNLNLAT---DKWSFGTTLWEICSGGDKPLSALDSQ 225

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 92.2 bits (229), Expect = 7e-21
 Identities = 50/228 (21%), Positives = 90/228 (39%), Gaps = 38/228 (16%)

Query: 37  KIGQGGVSIVYKGIL---DESRSIVAVKVVNLKQ---KEASRSFAAECNALRNIRHRNLI 90
            IG+G    V++GI    +     VA+K    K          F  E   +R   H +++
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKT--CKNCTSDSVREKFLQEALTMRQFDHPHIV 454

Query: 91  KIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYF 150
           K+I + +       +   I+ E      L  +L+     L  L   +  A  +S A+ Y 
Sbjct: 455 KLIGVITE------NPVWIIMELCTLGELRSFLQVRKFSLD-LASLILYAYQLSTALAYL 507

Query: 151 H-HHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG--YEPGTAAETASNSIEIKG 207
                    VH D+   N+L+  +    +GD GL++++    Y   +  +     + IK 
Sbjct: 508 ESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK-----LPIKW 558

Query: 208 IVGYVAPE---YGMGSKASVSGDVYNFGILLLEMFTR-RRPTDAMFNE 251
           +    APE   +   + AS   DV+ FG+ + E+     +P   + N 
Sbjct: 559 M----APESINFRRFTSAS---DVWMFGVCMWEILMHGVKPFQGVKNN 599

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 90.8 bits (226), Expect = 8e-21
 Identities = 57/244 (23%), Positives = 105/244 (43%), Gaps = 32/244 (13%)

Query: 13  MKQQFPMISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL-KQKEAS 71
           M +Q+  +      +  + +    KIGQG    V+K    ++   VA+K V +  +KE  
Sbjct: 1   MAKQYDSVECPFCDEV-SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGF 59

Query: 72  RSFAA-ECNALRNIRHRNLIKIITICSSIDFEGFDFKA---IVFEYMQNRNLEQWLRQSN 127
              A  E   L+ ++H N++ +I IC +        K    +VF++ ++ +L   L    
Sbjct: 60  PITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVL 118

Query: 128 GQL------RFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDL 181
            +       R +   +N        + Y H +    I+H D+K +N+L+ +D V  + D 
Sbjct: 119 VKFTLSEIKRVMQMLLN-------GLYYIHRN---KILHRDMKAANVLITRDGVLKLADF 168

Query: 182 GLAKFLFGYEPGTAAETASNSIEIKGIVG--YVAPEYGMGSKA-SVSGDVYNFGILLLEM 238
           GLA+  F     +     +N      +V   Y  PE  +G +      D++  G ++ EM
Sbjct: 169 GLARA-FSLAKNSQPNRYTNR-----VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 222

Query: 239 FTRR 242
           +TR 
Sbjct: 223 WTRS 226

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 91.4 bits (227), Expect = 9e-21
 Identities = 50/224 (22%), Positives = 92/224 (41%), Gaps = 30/224 (13%)

Query: 31  NFSPANKIGQGGV-SIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNI-RHRN 88
           +F P + +G G   +IVY+G+ D     VAVK +  +    +     E   LR    H N
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRD--VAVKRILPECFSFADR---EVQLLRESDEHPN 79

Query: 89  LIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIE 148
           +I+    C+    +   F+ I  E      L++++ +         + + +    +  + 
Sbjct: 80  VIRYF--CT---EKDRQFQYIAIELCAA-TLQEYV-EQKDFAHLGLEPITLLQQTTSGLA 132

Query: 149 YFHHHCQPSIVHGDLKPSNILL-----DQDIVAHVGDLGLAKFLFGYEPGTAAETASNSI 203
           + H     +IVH DLKP NIL+        I A + D GL K L     G  + +  +  
Sbjct: 133 HLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL---AVGRHSFSRRSG- 185

Query: 204 EIKGIVGYVAPEY---GMGSKASVSGDVYNFGILLLEMFTRRRP 244
            + G  G++APE          + + D+++ G +   + +    
Sbjct: 186 -VPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 90.1 bits (223), Expect = 2e-20
 Identities = 36/246 (14%), Positives = 69/246 (28%), Gaps = 54/246 (21%)

Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQK---EASRSFAAECNALRNIRH-------- 86
           +GQ       +    E+     V V    ++    A +    E   LR +R         
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 87  --------RNLIKIITICSSIDFEGFDFKAIVFEY-----MQNRNLEQWLRQSNGQLRF- 132
                    +L+K       I     +    V            NL+ +           
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205

Query: 133 ----LTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLF 188
                  R+ + + V   +   HH+    +VH  L+P +I+LDQ     +          
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV--- 259

Query: 189 GYEPGTAAETASNSIEIKGIVGYVAPEY----------GMGSKASVSGDVYNFGILLLEM 238
               G +A +           G+  PE              +  + + D +  G+ +  +
Sbjct: 260 --RDGASAVSPIGR-------GFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI 310

Query: 239 FTRRRP 244
           +    P
Sbjct: 311 WCADLP 316

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 87.8 bits (218), Expect = 4e-20
 Identities = 46/257 (17%), Positives = 88/257 (34%), Gaps = 33/257 (12%)

Query: 26  SKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAA--ECNALRN 83
           S+ T  F    KIG G    V+K +      I A+K        +     A  E  A   
Sbjct: 7   SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAV 66

Query: 84  I-RHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRV--NIA 140
           + +H ++++  +      +   D   I  EY    +L   + ++   + +  +    ++ 
Sbjct: 67  LGQHSHVVRYFSA-----WAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLL 121

Query: 141 IDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTA----- 195
           + V   + Y H     S+VH D+KPSNI + +  + +       +  +            
Sbjct: 122 LQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDL 178

Query: 196 --AETASNSIEIKGIVGYVAPE-----YGMGSKASVSGDVYNFGILLLEMFTRRRPTDAM 248
                 S+    +G   ++A E     Y    KA    D++   + ++            
Sbjct: 179 GHVTRISSPQVEEGDSRFLANEVLQENYTHLPKA----DIFALALTVVCAAGAEPL---- 230

Query: 249 FNEGLTLHEFVKMALPD 265
              G   HE  +  LP 
Sbjct: 231 PRNGDQWHEIRQGRLPR 247

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 87.3 bits (217), Expect = 9e-20
 Identities = 59/230 (25%), Positives = 102/230 (44%), Gaps = 50/230 (21%)

Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKE-----ASRSFAAECNALRNI 84
             +   +K+G+G  + VYKG    + ++VA+K + L+ +E     A R    E + L+++
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR----EVSLLKDL 57

Query: 85  RHRN---LIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQL------RFLTQ 135
           +H N   L  II    S+         +VFEY+ +++L+Q+L      +       FL Q
Sbjct: 58  KHANIVTLHDIIHTEKSL--------TLVFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQ 108

Query: 136 RVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTA 195
            +         + Y H      ++H DLKP N+L+++     + D GLA+          
Sbjct: 109 LLR-------GLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAK-----SIP 153

Query: 196 AETASNSIEIKGIVG--YVAPEYGMGSKA-SVSGDVYNFGILLLEMFTRR 242
            +T  N      +V   Y  P+  +GS   S   D++  G +  EM T R
Sbjct: 154 TKTYDNE-----VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 86.9 bits (216), Expect = 1e-19
 Identities = 54/236 (22%), Positives = 98/236 (41%), Gaps = 43/236 (18%)

Query: 26  SKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL-KQKEASRSFAAECNALRNI 84
           S AT+ + P  +IG G    VYK     S   VA+K V +              + +R +
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLP--ISTVREV 62

Query: 85  ---------RHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQL----- 130
                     H N+++++ +C++   +      +VFE++  ++L  +L ++         
Sbjct: 63  ALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAET 121

Query: 131 --RFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLF 188
               + Q +         +++ H +C   IVH DLKP NIL+       + D GLA+  +
Sbjct: 122 IKDLMRQFLR-------GLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI-Y 170

Query: 189 GYEPGTAAETASNSIEIKGIVG--YVAPEYGMGSKASVSGDVYNFGILLLEMFTRR 242
            Y+                +V   Y APE  + S  +   D+++ G +  EMF R+
Sbjct: 171 SYQMALTPV----------VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 87.1 bits (216), Expect = 1e-19
 Identities = 50/250 (20%), Positives = 92/250 (36%), Gaps = 30/250 (12%)

Query: 1   KKPAHKDSNMLSMKQQFPMISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAV 60
             P  +D+  + + ++   + Y E  +  +  +   ++G+G    V++    ++    AV
Sbjct: 30  LGPETEDNEGVLLTEKLKPVDY-EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAV 88

Query: 61  KVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA----IVFEYMQN 116
           K V L+          E  A   +    ++            G   +     I  E ++ 
Sbjct: 89  KKVRLEVFRVE-----ELVACAGLSSPRIVP---------LYGAVREGPWVNIFMELLEG 134

Query: 117 RNLEQWLRQSNGQLRFLTQRV-NIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQD-I 174
            +L Q ++Q          R           +EY H      I+HGD+K  N+LL  D  
Sbjct: 135 GSLGQLIKQMG---CLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGS 188

Query: 175 VAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGIL 234
            A + D G A  L   +P    ++      I G   ++APE  MG       D+++   +
Sbjct: 189 RAALCDFGHALCL---QPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCM 245

Query: 235 LLEMFTRRRP 244
           +L M     P
Sbjct: 246 MLHMLNGCHP 255

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 86.2 bits (214), Expect = 2e-19
 Identities = 52/250 (20%), Positives = 89/250 (35%), Gaps = 39/250 (15%)

Query: 26  SKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEAS--RSFAAECNALRN 83
           S    +F   +++G G    V+K    E   + AVK      +         AE  +   
Sbjct: 53  SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEK 112

Query: 84  I-RHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRV-NIAI 141
           + +H   +++     +  +E      +  E     +L+Q              +V     
Sbjct: 113 VGQHPCCVRLE---QA--WEEGGILYLQTELCG-PSLQQHCEAWGA--SLPEAQVWGYLR 164

Query: 142 DVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASN 201
           D   A+ + H      +VH D+KP+NI L       +GD GL   L          TA  
Sbjct: 165 DTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVEL---------GTAGA 212

Query: 202 SIEIKGIVGYVAPE-----YGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLH 256
               +G   Y+APE     Y  G+ A    DV++ G+ +LE+           + G    
Sbjct: 213 GEVQEGDPRYMAPELLQGSY--GTAA----DVFSLGLTILEVACNMEL----PHGGEGWQ 262

Query: 257 EFVKMALPDK 266
           +  +  LP +
Sbjct: 263 QLRQGYLPPE 272

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 84.9 bits (211), Expect = 5e-19
 Identities = 56/230 (24%), Positives = 101/230 (43%), Gaps = 45/230 (19%)

Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKE------ASRSFAAECNALRN 83
             +    KIG+G    V+K    E+  IVA+K V L   +      A R    E   L+ 
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR----EICLLKE 57

Query: 84  IRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQL------RFLTQRV 137
           ++H+N++++  +  S   +      +VFE+  +++L+++    NG L       FL Q +
Sbjct: 58  LKHKNIVRLHDVLHS---DKKLT--LVFEFC-DQDLKKYFDSCNGDLDPEIVKSFLFQLL 111

Query: 138 NIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAE 197
                    + + H      ++H DLKP N+L++++    + + GLA+  FG        
Sbjct: 112 K-------GLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARA-FGIPV----R 156

Query: 198 TASNSIEIKGIVG--YVAPEYGMGSKA-SVSGDVYNFGILLLEMFTRRRP 244
             S       +V   Y  P+   G+K  S S D+++ G +  E+    RP
Sbjct: 157 CYSAE-----VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 85.8 bits (212), Expect = 5e-19
 Identities = 38/282 (13%), Positives = 75/282 (26%), Gaps = 38/282 (13%)

Query: 1   KKPAHKDSNMLSMKQQFPMIS-YAELSKATNNFSPANKIGQGGVSIVYKGILDESRS--- 56
            KP     N    + + P I    E    +      + +G+G  + VY+    +      
Sbjct: 35  SKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKN 94

Query: 57  --IVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYM 114
                +KV                  L+       +K  +          +   +V E  
Sbjct: 95  KQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSA-----HLFQNGSVLVGELY 149

Query: 115 QNRNLEQWL---RQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLD 171
               L   +   + +  ++      ++ A+ + + IE  H      I+HGD+KP N +L 
Sbjct: 150 SYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILG 206

Query: 172 QDIVAHVG-----------DLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPE--YGM 218
              +               DLG +  +  +  GT               G+   E     
Sbjct: 207 NGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKC------ETSGFQCVEMLSNK 260

Query: 219 GSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVK 260
                +  D +     +  M                     +
Sbjct: 261 PWNYQI--DYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFR 300

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 85.1 bits (211), Expect = 6e-19
 Identities = 55/237 (23%), Positives = 99/237 (41%), Gaps = 41/237 (17%)

Query: 36  NKIGQGGVSIVYKGIL-----DESRSIVAVKVVNLKQKEASRS-FAAECNALRNIRHRNL 89
             +G G    VY+G +     D S   VAVK +     E     F  E   +    H+N+
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95

Query: 90  IKIITICSSID--FEGFDFKAIVFEYMQNRNLEQWLRQS---NGQLRFLTQR--VNIAID 142
           ++ I +       F       I+ E M   +L+ +LR++     Q   L     +++A D
Sbjct: 96  VRCIGVSLQSLPRF-------ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 148

Query: 143 VSFAIEYF-HHHCQPSIVHGDLKPSNILLD---QDIVAHVGDLGLAKFLFGYEPGTAAET 198
           ++   +Y   +H     +H D+   N LL       VA +GD G+A+ +  Y      + 
Sbjct: 149 IACGCQYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMARDI--YRASYYRKG 202

Query: 199 ASNSIEIKGIVGYVAPE---YGMGSKASVSGDVYNFGILLLEMFTR-RRPTDAMFNE 251
               + +K    ++ PE    G+ +  +   D ++FG+LL E+F+    P  +  N+
Sbjct: 203 GCAMLPVK----WMPPEAFMEGIFTSKT---DTWSFGVLLWEIFSLGYMPYPSKSNQ 252

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 85.9 bits (213), Expect = 7e-19
 Identities = 53/229 (23%), Positives = 96/229 (41%), Gaps = 42/229 (18%)

Query: 29  TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRN 88
             +++    IG G   +VY+  L +S  +VA+K V   ++  +R    E   +R + H N
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCN 108

Query: 89  LIKII-TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSF-- 145
           ++++     SS + +   +  +V +Y+    + +  R  +       Q + +     +  
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRA----KQTLPVIYVKLYMY 163

Query: 146 ----AIEYFHHHCQPSIVHGDLKPSNILLDQDI-VAHVGDLGLAKFLFGYEPGTAAETAS 200
               ++ Y H      I H D+KP N+LLD D  V  + D G AK L   EP  +     
Sbjct: 164 QLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS----- 215

Query: 201 NSIEIKGIVGYV------APEYGMGSKA-SVSGDVYNFGILLLEMFTRR 242
                     Y+      APE   G+   + S DV++ G +L E+   +
Sbjct: 216 ----------YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 84.7 bits (209), Expect = 1e-18
 Identities = 34/247 (13%), Positives = 72/247 (29%), Gaps = 55/247 (22%)

Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEAS----------------RSFAAECNAL 81
           +GQ       +    E+     V V    ++  S                R    +  A 
Sbjct: 81  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140

Query: 82  RNIRHRNLIKIITICSS-------IDFEGFDFKAIVFEYMQNR----NLEQWLRQSNGQL 130
            ++R      ++            +D       +  F Y + +       + L   +   
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200

Query: 131 RFLT--QRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLF 188
           + L    R+ + + V   +   HH+    +VH  L+P +I+LDQ     +          
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLV--- 254

Query: 189 GYEPGTAAETASNSIEIKGIVGYVAPEY-----------GMGSKASVSGDVYNFGILLLE 237
               G    ++          G+  PE               +  + S D +  G+++  
Sbjct: 255 --RDGARVVSS-------VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305

Query: 238 MFTRRRP 244
           ++    P
Sbjct: 306 IWCADLP 312

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 83.9 bits (208), Expect = 1e-18
 Identities = 49/232 (21%), Positives = 101/232 (43%), Gaps = 52/232 (22%)

Query: 36  NKIGQGGVSIVYKGIL-----DESRSIVAVKVVNLKQKEASRS----FAAECNALRNIRH 86
            ++GQG   +VY+G+      DE  + VA+K VN   + AS      F  E + ++    
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIEFLNEASVMKEFNC 87

Query: 87  RNLIKIITICSSID--FEGFDFKAIVFEYMQNRNLEQWLRQS------NGQLRFLTQR-- 136
            ++++++ + S             ++ E M   +L+ +LR        N  L   +    
Sbjct: 88  HHVVRLLGVVSQGQPTL-------VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 140

Query: 137 VNIAIDVSFAIEYFH-HHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG---YEP 192
           + +A +++  + Y + +      VH DL   N ++ +D    +GD G+ + ++    Y  
Sbjct: 141 IQMAGEIADGMAYLNANKF----VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 196

Query: 193 GTAAETASNSIEIKGIVGYVAPE---YGMGSKASVSGDVYNFGILLLEMFTR 241
           G         + ++ +    +PE    G+ +  S   DV++FG++L E+ T 
Sbjct: 197 GGKGL-----LPVRWM----SPESLKDGVFTTYS---DVWSFGVVLWEIATL 236

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 84.0 bits (208), Expect = 2e-18
 Identities = 57/240 (23%), Positives = 101/240 (42%), Gaps = 47/240 (19%)

Query: 36  NKIGQGGVSIVYKGIL-----DESRSIVAVKVVNLKQKEASRS-FAAECNALRNIRHRNL 89
             +G G    VY+G +     D S   VAVK +     E     F  E   +    H+N+
Sbjct: 77  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136

Query: 90  IKIITICSSID--FEGFDFKAIVFEYMQNRNLEQWLRQS---NGQLRFLTQR--VNIAID 142
           ++ I +       F       I+ E M   +L+ +LR++     Q   L     +++A D
Sbjct: 137 VRCIGVSLQSLPRF-------ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 189

Query: 143 VSFAIEYF-HHHCQPSIVHGDLKPSNILLD---QDIVAHVGDLGLAKFLFG---YEPGTA 195
           ++   +Y   +H     +H D+   N LL       VA +GD G+A+ ++    Y  G  
Sbjct: 190 IACGCQYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGC 245

Query: 196 AETASNSIEIKGIVGYVAPE---YGMGSKASVSGDVYNFGILLLEMFTR-RRPTDAMFNE 251
           A      + +K    ++ PE    G+ +  +   D ++FG+LL E+F+    P  +  N+
Sbjct: 246 AM-----LPVK----WMPPEAFMEGIFTSKT---DTWSFGVLLWEIFSLGYMPYPSKSNQ 293

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 82.6 bits (205), Expect = 3e-18
 Identities = 45/228 (19%), Positives = 84/228 (36%), Gaps = 45/228 (19%)

Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ-KEASRSFAA-ECNALRNIRHR 87
             +    KIG+G   +V+K    ++  IVA+K     +     +  A  E   L+ ++H 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62

Query: 88  NLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQL------RFLTQRVNIAI 141
           NL+ ++ +      +      +VFEY  +  +   L +    +          Q +    
Sbjct: 63  NLVNLLEVFRR---KRRLH--LVFEYC-DHTVLHELDRYQRGVPEHLVKSITWQTLQ--- 113

Query: 142 DVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASN 201
               A+ + H H   + +H D+KP NIL+ +  V  + D G A+ L              
Sbjct: 114 ----AVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLL-------------- 152

Query: 202 SIEIKGIVGYV------APEYGMGSKA-SVSGDVYNFGILLLEMFTRR 242
           +         V      +PE  +G        DV+  G +  E+ +  
Sbjct: 153 TGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 82.7 bits (205), Expect = 4e-18
 Identities = 47/234 (20%), Positives = 84/234 (35%), Gaps = 40/234 (17%)

Query: 26  SKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIR 85
            K  + F      GQG    V  G    +   VA+K V    +  +R        L  + 
Sbjct: 19  RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLAVLH 77

Query: 86  HRNLIKIITICSSIDFEGFD--FKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDV 143
           H N++++ +   ++        +  +V EY+ +  L +  R    +           I +
Sbjct: 78  HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPP-----PILI 131

Query: 144 SF-------AIEYFHHHCQPSIVHGDLKPSNILLD-QDIVAHVGDLGLAKFLFGYEPGTA 195
                    +I   H     ++ H D+KP N+L++  D    + D G AK L   EP  A
Sbjct: 132 KVFLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA 190

Query: 196 AETASNSIEIKGIVGYV------APEYGMGSKA-SVSGDVYNFGILLLEMFTRR 242
                          Y+      APE   G++  + + D+++ G +  EM    
Sbjct: 191 ---------------YICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 82.3 bits (204), Expect = 6e-18
 Identities = 56/224 (25%), Positives = 100/224 (44%), Gaps = 36/224 (16%)

Query: 29  TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL-KQKEASRSFAAECNALRNIR-H 86
            +++    K+G+G  S V++ I   +   V VK++   K+K+  R    E   L N+R  
Sbjct: 35  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR----EIKILENLRGG 90

Query: 87  RNLIKII-TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQ-SNGQLRFLTQRVNIAIDVS 144
            N+I +   +   +        A+VFE++ N + +Q  +  ++  +RF    +  A+D  
Sbjct: 91  PNIITLADIVKDPVSRT----PALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALD-- 144

Query: 145 FAIEYFHHHCQPSIVHGDLKPSNILLDQDIVA-HVGDLGLAKFLFGYEPGTA--AETASN 201
               Y H      I+H D+KP N+++D +     + D GLA+F   Y PG       AS 
Sbjct: 145 ----YCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF---YHPGQEYNVRVAS- 193

Query: 202 SIEIKGIVGYVAPEYGMGSKA-SVSGDVYNFGILLLEMFTRRRP 244
                    +  PE  +  +    S D+++ G +L  M  R+ P
Sbjct: 194 -------RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 82.0 bits (203), Expect = 6e-18
 Identities = 53/232 (22%), Positives = 102/232 (43%), Gaps = 50/232 (21%)

Query: 36  NKIGQGGVSIVYKGIL-----DESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLI 90
            ++G+G    V+         ++ + +VAVK +    + A + F  E   L  ++H++++
Sbjct: 47  WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106

Query: 91  KIITICSSID--FEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRF-------------LTQ 135
           +   +C+             +VFEYM++ +L ++LR      +              L Q
Sbjct: 107 RFFGVCTEGRPLL-------MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQ 159

Query: 136 RVNIAIDVSFAIEYF-HHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG---YE 191
            + +A  V+  + Y    H     VH DL   N L+ Q +V  +GD G+++ ++    Y 
Sbjct: 160 LLAVASQVAAGMVYLAGLHF----VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR 215

Query: 192 PGTAAETASNSIEIKGIVGYVAPE---YGMGSKASVSGDVYNFGILLLEMFT 240
            G         + I+    ++ PE   Y   +  S   DV++FG++L E+FT
Sbjct: 216 VGGRTM-----LPIR----WMPPESILYRKFTTES---DVWSFGVVLWEIFT 255

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 81.8 bits (203), Expect = 7e-18
 Identities = 62/228 (27%), Positives = 105/228 (46%), Gaps = 46/228 (20%)

Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKE------ASRSFAAECNALRN 83
             +    K+G+G   +VYK   D    IVA+K + L  ++      A R    E + L+ 
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAK-DSQGRIVALKRIRLDAEDEGIPSTAIR----EISLLKE 75

Query: 84  IRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQL------RFLTQRV 137
           + H N++ +I +  S   E      +VFE+M+  +L++ L ++   L       +L Q +
Sbjct: 76  LHHPNIVSLIDVIHS---ERCLT--LVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLL 129

Query: 138 NIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAE 197
                    + + H H    I+H DLKP N+L++ D    + D GLA+  FG        
Sbjct: 130 R-------GVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARA-FGIPV----R 174

Query: 198 TASNSIEIKGIVG--YVAPEYGMGSKA-SVSGDVYNFGILLLEMFTRR 242
           + ++      +V   Y AP+  MGSK  S S D+++ G +  EM T +
Sbjct: 175 SYTHE-----VVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 81.5 bits (202), Expect = 7e-18
 Identities = 53/237 (22%), Positives = 101/237 (42%), Gaps = 59/237 (24%)

Query: 36  NKIGQGGVSIVYKGIL-----DESRSIVAVKVVNLKQKEASRS----FAAECNALRNIRH 86
            ++G+G    V+          + + +VAVK +    K+ + +    F  E   L N++H
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL----KDPTLAARKDFQREAELLTNLQH 76

Query: 87  RNLIKIITICSSID--FEGFDFKAIVFEYMQNRNLEQWLRQS------------NGQLRF 132
            +++K   +C   D          +VFEYM++ +L ++LR                    
Sbjct: 77  EHIVKFYGVCGDGDPLI-------MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE 129

Query: 133 LTQR--VNIAIDVSFAIEYF-HHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG 189
           L     ++IA  ++  + Y    H     VH DL   N L+  +++  +GD G+++ ++ 
Sbjct: 130 LGLSQMLHIASQIASGMVYLASQHF----VHRDLATRNCLVGANLLVKIGDFGMSRDVYS 185

Query: 190 ---YEPGTAAETASNSIEIKGIVGYVAPE---YGMGSKASVSGDVYNFGILLLEMFT 240
              Y  G         + I+    ++ PE   Y   +  S   DV++FG++L E+FT
Sbjct: 186 TDYYRVGGHTM-----LPIR----WMPPESIMYRKFTTES---DVWSFGVILWEIFT 230

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 81.2 bits (201), Expect = 1e-17
 Identities = 53/236 (22%), Positives = 96/236 (40%), Gaps = 54/236 (22%)

Query: 36  NKIGQGGVSIVYKGIL-----DESRSIVAVKVVNLKQKEASRS----FAAECNALRNI-R 85
             +G+G    V +          +   VAVK++    + A+ S      +E   L +I  
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKILIHIGH 89

Query: 86  HRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQS------------NGQLRFL 133
           H N++ ++  C+           ++ E+ +  NL  +LR              +    FL
Sbjct: 90  HLNVVNLLGACTKPGGPLM----VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 145

Query: 134 TQR--VNIAIDVSFAIEYF-HHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG- 189
           T    +  +  V+  +E+     C    +H DL   NILL +  V  + D GLA+ ++  
Sbjct: 146 TLEHLICYSFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYKD 201

Query: 190 --YEPGTAAETASNSIEIKGIVGYVAPE---YGMGSKASVSGDVYNFGILLLEMFT 240
             Y     A      + +K    ++APE     + +  S   DV++FG+LL E+F+
Sbjct: 202 PDYVRKGDAR-----LPLK----WMAPETIFDRVYTIQS---DVWSFGVLLWEIFS 245

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 80.6 bits (200), Expect = 1e-17
 Identities = 58/230 (25%), Positives = 100/230 (43%), Gaps = 50/230 (21%)

Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKE------ASRSFAAECNALRN 83
             +    KIG+G   +VYK   +      A+K + L++++        R    E + L+ 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIR----EISILKE 56

Query: 84  IRHRNLIKIITICSSID--FEGFDFKAIVFEYMQNRNLEQWLRQSNGQL------RFLTQ 135
           ++H N++K+  +  +            +VFE++   +L++ L    G L       FL Q
Sbjct: 57  LKHSNIVKLYDVIHTKKRLV-------LVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQ 108

Query: 136 RVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTA 195
            +N        I Y H      ++H DLKP N+L++++    + D GLA+  FG      
Sbjct: 109 LLN-------GIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARA-FGIPVRK- 156

Query: 196 AETASNSIEIKGIVG--YVAPEYGMGSKA-SVSGDVYNFGILLLEMFTRR 242
                 + E   IV   Y AP+  MGSK  S + D+++ G +  EM    
Sbjct: 157 -----YTHE---IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 80.8 bits (200), Expect = 2e-17
 Identities = 58/234 (24%), Positives = 102/234 (43%), Gaps = 48/234 (20%)

Query: 36  NKIGQGGVSIVYKGIL--DESRSIVAVKVVNLKQ---KEASRSFAAECNALRNI-RHRNL 89
           + IG+G    V K  +  D  R   A+K   +K+   K+  R FA E   L  +  H N+
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKR--MKEYASKDDHRDFAGELEVLCKLGHHPNI 88

Query: 90  IKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQS------------NGQLRFLTQR- 136
           I ++  C      G+ +  +  EY  + NL  +LR+S            N     L+ + 
Sbjct: 89  INLLGACEH---RGYLY--LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 143

Query: 137 -VNIAIDVSFAIEYF-HHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGT 194
            ++ A DV+  ++Y          +H DL   NIL+ ++ VA + D GL++    Y   T
Sbjct: 144 LLHFAADVARGMDYLSQKQF----IHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT 199

Query: 195 AAETASNSIEIKGIVGYVAPE---YGMGSKASVSGDVYNFGILLLEMFTR-RRP 244
                   + ++    ++A E   Y + +  S   DV+++G+LL E+ +    P
Sbjct: 200 MGR-----LPVR----WMAIESLNYSVYTTNS---DVWSYGVLLWEIVSLGGTP 241

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 80.7 bits (200), Expect = 2e-17
 Identities = 59/229 (25%), Positives = 111/229 (48%), Gaps = 39/229 (17%)

Query: 28  ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKE-----ASRSFAAECNALR 82
           +++ F    K+G G  + VYKG+   +   VA+K V L  +E     A R    E + ++
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR----EISLMK 58

Query: 83  NIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAID 142
            ++H N++++  +  +   E      +VFE+M + +L++++      +    + + + + 
Sbjct: 59  ELKHENIVRLYDVIHT---ENKLT--LVFEFM-DNDLKKYMDSRT--VGNTPRGLELNLV 110

Query: 143 VSF------AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAA 196
             F       + + H +    I+H DLKP N+L+++     +GD GLA+  FG       
Sbjct: 111 KYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARA-FGIPVN--- 163

Query: 197 ETASNSIEIKGIVG--YVAPEYGMGSKA-SVSGDVYNFGILLLEMFTRR 242
            T S+      +V   Y AP+  MGS+  S S D+++ G +L EM T +
Sbjct: 164 -TFSSE-----VVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 80.7 bits (200), Expect = 2e-17
 Identities = 53/228 (23%), Positives = 90/228 (39%), Gaps = 45/228 (19%)

Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ-KEASRSFAA-ECNALRNIRHR 87
             +     +G+G   +V K    ++  IVA+K        +  +  A  E   L+ +RH 
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHE 84

Query: 88  NLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQL------RFLTQRVNIAI 141
           NL+ ++ +C     +   +  +VFE++    +   L      L      ++L Q +N   
Sbjct: 85  NLVNLLEVCKK---KKRWY--LVFEFVD-HTILDDLELFPNGLDYQVVQKYLFQIIN--- 135

Query: 142 DVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASN 201
                I + H H   +I+H D+KP NIL+ Q  V  + D G A+ L              
Sbjct: 136 ----GIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL-------------- 174

Query: 202 SIEIKGIVGYV------APEYGMGSKA-SVSGDVYNFGILLLEMFTRR 242
           +   +     V      APE  +G      + DV+  G L+ EMF   
Sbjct: 175 AAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 80.5 bits (199), Expect = 3e-17
 Identities = 55/224 (24%), Positives = 91/224 (40%), Gaps = 34/224 (15%)

Query: 29  TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVN---LKQKEASRSFAAECNALRNIR 85
              +     IG G   IV           VA+K ++     Q  A R++  E   ++ + 
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVN 82

Query: 86  HRNLIKIITI-CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQ--SNGQLRFLT-QRVNIAI 141
           H+N+I ++ +       E F    IV E M   NL Q ++    + ++ +L  Q +    
Sbjct: 83  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSYLLYQMLC--- 138

Query: 142 DVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASN 201
                I++ H      I+H DLKPSNI++  D    + D GLA+            TA  
Sbjct: 139 ----GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR------------TAGT 179

Query: 202 SIEIKGIVG---YVAPEYGMGSKASVSGDVYNFGILLLEMFTRR 242
           S  +   V    Y APE  +G     + D+++ G ++ EM    
Sbjct: 180 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 79.2 bits (196), Expect = 4e-17
 Identities = 44/222 (19%), Positives = 91/222 (40%), Gaps = 39/222 (17%)

Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVN---LKQKEASRSFAAECNALRNIRHRNLIKIIT 94
           +G+GG +  ++    +++ + A K+V    L +       + E +  R++ H++++    
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-- 80

Query: 95  ICSSIDFEGFDFKA---IVFEYMQNRNLEQWLRQSNGQL------RFLTQRVNIAIDVSF 145
                    F+      +V E  + R+L +  ++    L       +L Q V        
Sbjct: 81  ------HGFFEDNDFVFVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVL------- 126

Query: 146 AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEI 205
             +Y H +    ++H DLK  N+ L++D+   +GD GLA  +     G   +       +
Sbjct: 127 GCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKV------L 175

Query: 206 KGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDA 247
            G   Y+APE       S   DV++ G ++  +   + P + 
Sbjct: 176 CGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 217

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 80.5 bits (199), Expect = 4e-17
 Identities = 51/229 (22%), Positives = 93/229 (40%), Gaps = 43/229 (18%)

Query: 29  TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRN 88
              ++    IG G   +V++  L ES   VA+K V   ++  +R    E   +R ++H N
Sbjct: 39  EIAYTNCKVIGNGSFGVVFQAKLVESD-EVAIKKVLQDKRFKNR----ELQIMRIVKHPN 93

Query: 89  LIKII-TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSF-- 145
           ++ +     S+ D +   F  +V EY+    + +  R          Q + + +   +  
Sbjct: 94  VVDLKAFFYSNGDKKDEVFLNLVLEYVP-ETVYRASRHYAKL----KQTMPMLLIKLYMY 148

Query: 146 ----AIEYFHHHCQPSIVHGDLKPSNILLDQDI-VAHVGDLGLAKFLFGYEPGTAAETAS 200
               ++ Y H      I H D+KP N+LLD    V  + D G AK L   EP  +     
Sbjct: 149 QLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVS----- 200

Query: 201 NSIEIKGIVGYV------APEYGMGSKA-SVSGDVYNFGILLLEMFTRR 242
                     Y+      APE   G+   + + D+++ G ++ E+   +
Sbjct: 201 ----------YICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 78.8 bits (195), Expect = 6e-17
 Identities = 49/234 (20%), Positives = 96/234 (41%), Gaps = 52/234 (22%)

Query: 36  NKIGQGGVSIVYKGIL-----DESRSIVAVKVVNLKQKEASRS-FAAECNALRNIRHRNL 89
            ++G+     VYKG L      E    VA+K +  K +   R  F  E      ++H N+
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74

Query: 90  IKIITICSSID--FEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRF--------------L 133
           + ++ + +             ++F Y  + +L ++L   +                    
Sbjct: 75  VCLLGVVTKDQPLS-------MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEP 127

Query: 134 TQRVNIAIDVSFAIEYF-HHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG--- 189
              V++   ++  +EY   HH     VH DL   N+L+   +   + DLGL + ++    
Sbjct: 128 PDFVHLVAQIAAGMEYLSSHHV----VHKDLATRNVLVYDKLNVKISDLGLFREVYAADY 183

Query: 190 YEPGTAAETASNSIEIKGIVGYVAPE---YGMGSKASVSGDVYNFGILLLEMFT 240
           Y+    +      + I+    ++APE   YG  S  S   D++++G++L E+F+
Sbjct: 184 YKLLGNSL-----LPIR----WMAPEAIMYGKFSIDS---DIWSYGVVLWEVFS 225

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 78.9 bits (195), Expect = 9e-17
 Identities = 44/219 (20%), Positives = 90/219 (41%), Gaps = 39/219 (17%)

Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVN---LKQKEASRSFAAECNALRNIRHRNLIKIIT 94
           +G+GG +  ++    +++ + A K+V    L +       + E +  R++ H++++    
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-- 106

Query: 95  ICSSIDFEGFDFKA---IVFEYMQNRNLEQWLRQSNGQL------RFLTQRVNIAIDVSF 145
                    F+      +V E  + R+L +  ++    L       +L Q V        
Sbjct: 107 ------HGFFEDNDFVFVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVL------- 152

Query: 146 AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEI 205
             +Y H +    ++H DLK  N+ L++D+   +GD GLA  +     G   +       +
Sbjct: 153 GCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKV------L 201

Query: 206 KGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
            G   Y+APE       S   DV++ G ++  +   + P
Sbjct: 202 CGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 78.8 bits (195), Expect = 9e-17
 Identities = 58/240 (24%), Positives = 102/240 (42%), Gaps = 54/240 (22%)

Query: 24  ELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRS---FAA--EC 78
           ++      +   + +G+G  + VYK     +  IVA+K + L  +  ++      A  E 
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63

Query: 79  NALRNIRHRNLIK---IITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQL----- 130
             L+ + H N+I         S+I        ++VF++M   +LE  ++ ++  L     
Sbjct: 64  KLLQELSHPNIIGLLDAFGHKSNI--------SLVFDFM-ETDLEVIIKDNSLVLTPSHI 114

Query: 131 -RFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG 189
             ++   +         +EY H H    I+H DLKP+N+LLD++ V  + D GLAK  FG
Sbjct: 115 KAYMLMTLQ-------GLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKS-FG 163

Query: 190 YEPGTAAETASNSIEIKG----IVG--YVAPEYGMGSKA-SVSGDVYNFGILLLEMFTRR 242
                           +     +V   Y APE   G++   V  D++  G +L E+  R 
Sbjct: 164 -------------SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 78.0 bits (193), Expect = 2e-16
 Identities = 52/236 (22%), Positives = 97/236 (41%), Gaps = 45/236 (19%)

Query: 26  SKATNNFSPANKIGQGGVSIVYKGI-LDESRSIVAVKVVNLKQKE------ASRSFAAEC 78
            +A   +    +IG+G    V+K   L      VA+K V ++  E        R    E 
Sbjct: 7   CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR----EV 62

Query: 79  NALRNIR---HRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQL----- 130
             LR++    H N++++  +C+    +      +VFE++  ++L  +L +          
Sbjct: 63  AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTET 121

Query: 131 --RFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLF 188
               + Q +         +++ H H    +VH DLKP NIL+       + D GLA+  +
Sbjct: 122 IKDMMFQLLR-------GLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARI-Y 170

Query: 189 GYEPGTAAETASNSIEIKGIVG--YVAPEYGMGSKASVSGDVYNFGILLLEMFTRR 242
            ++    +           +V   Y APE  + S  +   D+++ G +  EMF R+
Sbjct: 171 SFQMALTSV----------VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 77.7 bits (192), Expect = 2e-16
 Identities = 55/245 (22%), Positives = 96/245 (39%), Gaps = 66/245 (26%)

Query: 36  NKIGQGGVSIVYKGIL-----DESRSIVAVKVVNLKQKEASRS----FAAECNALRNIRH 86
             +G+G    V K            + VAVK++    + AS S      +E N L+ + H
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK---ENASPSELRDLLSEFNVLKQVNH 85

Query: 87  RNLIKIITICSSID--FEGFDFKAIVFEYMQNRNLEQWLRQS------------------ 126
            ++IK+   CS             ++ EY +  +L  +LR+S                  
Sbjct: 86  PHVIKLYGACSQDGPLL-------LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138

Query: 127 --NGQLRFLTQR--VNIAIDVSFAIEYF-HHHCQPSIVHGDLKPSNILLDQDIVAHVGDL 181
             +   R LT    ++ A  +S  ++Y          VH DL   NIL+ +     + D 
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYLAEMKL----VHRDLAARNILVAEGRKMKISDF 194

Query: 182 GLAKFLFG---YEPGTAAETASNSIEIKGIVGYVAPE---YGMGSKASVSGDVYNFGILL 235
           GL++ ++    Y   +        I +K    ++A E     + +  S   DV++FG+LL
Sbjct: 195 GLSRDVYEEDSYVKRSQGR-----IPVK----WMAIESLFDHIYTTQS---DVWSFGVLL 242

Query: 236 LEMFT 240
            E+ T
Sbjct: 243 WEIVT 247

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 77.7 bits (192), Expect = 2e-16
 Identities = 55/233 (23%), Positives = 98/233 (42%), Gaps = 51/233 (21%)

Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKE------ASRSFAAECNALRN 83
           + +    K+G+G    VYK I   +   VA+K + L+ +E      A R    E + L+ 
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR----EVSLLKE 89

Query: 84  IRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQL------RFLTQRV 137
           ++HRN+I++ ++             ++FEY    +L++++   N  +       FL Q +
Sbjct: 90  LQHRNIIELKSVIHH---NHRLH--LIFEYA-ENDLKKYM-DKNPDVSMRVIKSFLYQLI 142

Query: 138 NIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVG-----DLGLAKFLFGYEP 192
           N        + + H       +H DLKP N+LL     +        D GLA+  FG   
Sbjct: 143 N-------GVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA-FGIPI 191

Query: 193 GTAAETASNSIEIKGIVG--YVAPEYGMGSKA-SVSGDVYNFGILLLEMFTRR 242
                  ++      I+   Y  PE  +GS+  S S D+++   +  EM  + 
Sbjct: 192 R----QFTHE-----IITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 78.2 bits (193), Expect = 2e-16
 Identities = 42/194 (21%), Positives = 76/194 (39%), Gaps = 39/194 (20%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVN--------LKQKEASRSFAAECNALRNIRHRN 88
            +G G    V      ++   VA+++++         ++ + + +   E   L+ + H  
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201

Query: 89  LIKIITICSSIDFEGFDFKA--IVFEYMQNRNLEQWLRQSNGQLRFLTQRV--NIAIDVS 144
           +IKI           FD +   IV E M+   L   +  +      L +         + 
Sbjct: 202 IIKI--------KNFFDAEDYYIVLELMEGGELFDKVVGNK----RLKEATCKLYFYQML 249

Query: 145 FAIEYFHHHCQPSIVHGDLKPSNILL---DQDIVAHVGDLGLAKFLFGYEPGTAAETASN 201
            A++Y H +    I+H DLKP N+LL   ++D +  + D G +K L      +   T   
Sbjct: 250 LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETSLMRTLC- 302

Query: 202 SIEIKGIVGYVAPE 215
                G   Y+APE
Sbjct: 303 -----GTPTYLAPE 311

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 78.3 bits (193), Expect = 3e-16
 Identities = 50/256 (19%), Positives = 91/256 (35%), Gaps = 42/256 (16%)

Query: 29  TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL---KQKEASRSFAAECNALRNIR 85
            + +   + IG G    V +      + +VA+K +        +  R    E   L  + 
Sbjct: 52  PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR-EIAILNRLN 110

Query: 86  HRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLR------FLTQRVNI 139
           H +++K++ I    D E FD   +V E     + ++  R +   L        L   +  
Sbjct: 111 HDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLFR-TPVYLTELHIKTLLYNLLV- 167

Query: 140 AIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA-------------KF 186
                  ++Y H      I+H DLKP+N L++QD    V D GLA               
Sbjct: 168 ------GVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPI 218

Query: 187 LFGYEPGTAAETASNSIEIKGIVGYV------APEYGMGSKA-SVSGDVYNFGILLLEMF 239
               +              + + G+V      APE  +  +  + + DV++ G +  E+ 
Sbjct: 219 SPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278

Query: 240 TRRRPTDAMFNEGLTL 255
              +   A   +   L
Sbjct: 279 NMIKENVAYHADRGPL 294

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 78.3 bits (193), Expect = 3e-16
 Identities = 54/224 (24%), Positives = 92/224 (41%), Gaps = 34/224 (15%)

Query: 29  TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVN---LKQKEASRSFAAECNALRNIR 85
              +     IG G   IV           VA+K ++     Q  A R++  E   ++ + 
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVN 119

Query: 86  HRNLIKIITI-CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQ--SNGQLRFLT-QRVNIAI 141
           H+N+I ++ +       E F    +V E M   NL Q ++    + ++ +L  Q +    
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHERMSYLLYQMLC--- 175

Query: 142 DVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASN 201
                I++ H      I+H DLKPSNI++  D    + D GLA+            TA  
Sbjct: 176 ----GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR------------TAGT 216

Query: 202 SIEIKGIVG---YVAPEYGMGSKASVSGDVYNFGILLLEMFTRR 242
           S  +   V    Y APE  +G     + D+++ G ++ EM   +
Sbjct: 217 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 76.5 bits (189), Expect = 4e-16
 Identities = 46/237 (19%), Positives = 87/237 (36%), Gaps = 55/237 (23%)

Query: 36  NKIGQGGVSIVYKGIL-----DESRSIVAVKVVNLKQKEASRS-FAAECNALRNI-RHRN 88
             +G G    V +         ++   VAVK++        R    +E   L  +  H N
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88

Query: 89  LIKIITICSSID--FEGFDFKAIVFEYMQNRNLEQWLRQS--------------NGQLRF 132
           ++ ++  C+             ++ EY    +L  +LR+                     
Sbjct: 89  IVNLLGACTIGGPTL-------VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141

Query: 133 LTQR--VNIAIDVSFAIEYFH-HHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG 189
           L     ++ +  V+  + +    +C    +H DL   NILL    +  + D GLA+ +  
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIKN 197

Query: 190 ---YEPGTAAETASNSIEIKGIVGYVAPE---YGMGSKASVSGDVYNFGILLLEMFT 240
              Y     A      + +K    ++APE     + +  S   DV+++GI L E+F+
Sbjct: 198 DSNYVVKGNAR-----LPVK----WMAPESIFNCVYTFES---DVWSYGIFLWELFS 242

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 76.6 bits (189), Expect = 6e-16
 Identities = 49/242 (20%), Positives = 96/242 (39%), Gaps = 60/242 (24%)

Query: 36  NKIGQGGVSIVYKGIL-----DESRSIVAVKVVNLKQKEASRS-FAAECNALRNIRHRNL 89
             IG+G    V++         E  ++VAVK++  +     ++ F  E   +    + N+
Sbjct: 53  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112

Query: 90  IKIITICSSID--FEGFDFKAIVFEYMQNRNLEQWLRQS--------------------N 127
           +K++ +C+             ++FEYM   +L ++LR                      +
Sbjct: 113 VKLLGVCAVGKPMC-------LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 165

Query: 128 GQLRFLTQR--VNIAIDVSFAIEYFH-HHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA 184
                L+    + IA  V+  + Y          VH DL   N L+ +++V  + D GL+
Sbjct: 166 PGPPPLSCAEQLCIARQVAAGMAYLSERKF----VHRDLATRNCLVGENMVVKIADFGLS 221

Query: 185 KFLFG---YEPGTAAETASNSIEIKGIVGYVAPE---YGMGSKASVSGDVYNFGILLLEM 238
           + ++    Y+           I I+ +     PE   Y   +  S   DV+ +G++L E+
Sbjct: 222 RNIYSADYYKADGNDA-----IPIRWM----PPESIFYNRYTTES---DVWAYGVVLWEI 269

Query: 239 FT 240
           F+
Sbjct: 270 FS 271

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 76.6 bits (189), Expect = 6e-16
 Identities = 51/237 (21%), Positives = 95/237 (40%), Gaps = 55/237 (23%)

Query: 36  NKIGQGGVSIVYKGIL-------DESRSIVAVKVVNLKQKEASRS-FAAECNALRNI-RH 86
             +G+G    V             +    VAVK++     E   S   +E   ++ I +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100

Query: 87  RNLIKIITICSSID--FEGFDFKAIVFEYMQNRNLEQWLRQS------------NGQLRF 132
           +N+I ++  C+     +       ++ EY    NL ++LR                    
Sbjct: 101 KNIINLLGACTQDGPLY-------VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153

Query: 133 LTQR--VNIAIDVSFAIEYF-HHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG 189
           +T +  V+    ++  +EY     C    +H DL   N+L+ ++ V  + D GLA+ +  
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINN 209

Query: 190 ---YEPGTAAETASNSIEIKGIVGYVAPE---YGMGSKASVSGDVYNFGILLLEMFT 240
              Y+  T        + +K +    APE     + +  S   DV++FG+L+ E+FT
Sbjct: 210 IDYYKKTTNGR-----LPVKWM----APEALFDRVYTHQS---DVWSFGVLMWEIFT 254

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 76.1 bits (188), Expect = 9e-16
 Identities = 60/227 (26%), Positives = 105/227 (46%), Gaps = 29/227 (12%)

Query: 29  TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL--KQKEASRSFAAECNALRNIRH 86
           +++F   + +G+G   +V       +  IVA+K +    K   A R+   E   L++ +H
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKH 68

Query: 87  RNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQ---SNGQLRFLT-QRVNIAID 142
            N+I I  I     FE F+   I+ E MQ  +L + +     S+  +++   Q +     
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVISTQMLSDDHIQYFIYQTLR---- 123

Query: 143 VSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNS 202
              A++  H     +++H DLKPSN+L++ +    V D GLA+ +       +  T   S
Sbjct: 124 ---AVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177

Query: 203 IEIKGIVGYV------APEYGMGSKA-SVSGDVYNFGILLLEMFTRR 242
                +V +V      APE  + S   S + DV++ G +L E+F RR
Sbjct: 178 G----MVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 75.3 bits (186), Expect = 9e-16
 Identities = 44/188 (23%), Positives = 73/188 (38%), Gaps = 29/188 (15%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVN-LKQKEASRSFAAECNALRNIRHRNLIKIITI 95
           K+G G    V+      S     +K +N  + +       AE   L+++ H N+IKI  +
Sbjct: 29  KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88

Query: 96  CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQR--VNIAIDVSFAIEYFHHH 153
                FE +    IV E  +   L + +  +  + + L++     +   +  A+ YFH  
Sbjct: 89  -----FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ 143

Query: 154 CQPSIVHGDLKPSNILL---DQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG 210
               +VH DLKP NIL           + D GLA+    ++                  G
Sbjct: 144 ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL---FKSDE---------HSTNAAG 188

Query: 211 ---YVAPE 215
              Y+APE
Sbjct: 189 TALYMAPE 196

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 75.8 bits (187), Expect = 9e-16
 Identities = 45/194 (23%), Positives = 72/194 (37%), Gaps = 39/194 (20%)

Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIR-HRNLIKIITIC 96
           +G+G  + V   I   +    AVK++  +          E   L   + HRN++++I   
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF- 79

Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQL-------RFLTQR--VNIAIDVSFAI 147
               FE  D   +VFE M             G +       R   +     +  DV+ A+
Sbjct: 80  ----FEEEDRFYLVFEKM-----------RGGSILSHIHKRRHFNELEASVVVQDVASAL 124

Query: 148 EYFHHHCQPSIVHGDLKPSNILL---DQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIE 204
           ++ H+     I H DLKP NIL    +Q     + D  L   +   +        S   E
Sbjct: 125 DFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI---KLNGDCSPISTP-E 177

Query: 205 IKGIVG---YVAPE 215
           +    G   Y+APE
Sbjct: 178 LLTPCGSAEYMAPE 191

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 76.4 bits (188), Expect = 1e-15
 Identities = 35/186 (18%), Positives = 68/186 (36%), Gaps = 30/186 (16%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           ++G G   +V++     + +  A K V    +    +   E   +  +RH  L+ +    
Sbjct: 164 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA- 222

Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQR--VNIAIDVSFAIEYFHHHC 154
               FE  +   +++E+M    L + +   +     +++   V     V   + + H + 
Sbjct: 223 ----FEDDNEMVMIYEFMSGGELFEKVADEHN---KMSEDEAVEYMRQVCKGLCHMHEN- 274

Query: 155 QPSIVHGDLKPSNILLDQDIVAHV--GDLGLAKFLFGYEPGTAAETASNSIEIKGIVG-- 210
             + VH DLKP NI+        +   D GL       +P            +K   G  
Sbjct: 275 --NYVHLDLKPENIMFTTKRSNELKLIDFGLTAH---LDPKQ---------SVKVTTGTA 320

Query: 211 -YVAPE 215
            + APE
Sbjct: 321 EFAAPE 326

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 75.4 bits (186), Expect = 1e-15
 Identities = 42/192 (21%), Positives = 82/192 (42%), Gaps = 32/192 (16%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAA-----ECNALRNIRHRNLIK 91
            IG+G  S+V + I  E+    AVK+V++ +  +S   +      E +    ++H ++++
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90

Query: 92  IITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRV--NIAIDVSFAIEY 149
           ++       +       +VFE+M   +L   + +        ++ V  +    +  A+ Y
Sbjct: 91  LLET-----YSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145

Query: 150 FHHHCQPSIVHGDLKPSNILL---DQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIK 206
            H +   +I+H D+KP  +LL   +      +G  G+A  L   E G             
Sbjct: 146 CHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG--ESGLV---------AG 191

Query: 207 GIVG---YVAPE 215
           G VG   ++APE
Sbjct: 192 GRVGTPHFMAPE 203

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 75.0 bits (185), Expect = 2e-15
 Identities = 47/238 (19%), Positives = 93/238 (39%), Gaps = 61/238 (25%)

Query: 36  NKIGQGGVSIVYKGIL-----DESRSIVAVKVVNLKQKEASRS----FAAECNALRNI-R 85
             +G G    V +        +++   VAVK++      A         +E   + ++ +
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK---STAHADEKEALMSELKIMSHLGQ 108

Query: 86  HRNLIKIITICSSIDFEGFDFKA----IVFEYMQNRNLEQWLR----------QSNGQLR 131
           H N++ ++  C+               ++ EY    +L  +LR                 
Sbjct: 109 HENIVNLLGACT---------HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANS 159

Query: 132 FLTQR--VNIAIDVSFAIEYF-HHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLF 188
             + R  ++ +  V+  + +    +C    +H D+   N+LL    VA +GD GLA+ + 
Sbjct: 160 TASTRDLLHFSSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIM 215

Query: 189 G---YEPGTAAETASNSIEIKGIVGYVAPE---YGMGSKASVSGDVYNFGILLLEMFT 240
               Y     A      + +K    ++APE     + +  S   DV+++GILL E+F+
Sbjct: 216 NDSNYIVKGNAR-----LPVK----WMAPESIFDCVYTVQS---DVWSYGILLWEIFS 261

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 74.5 bits (184), Expect = 2e-15
 Identities = 43/186 (23%), Positives = 73/186 (39%), Gaps = 31/186 (16%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
            +G G  S V+      +  + A+K +         S   E   L+ I+H N++ +  I 
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI- 74

Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQR--VNIAIDVSFAIEYFHHHC 154
               +E      +V + +    L   + +        T++    +   V  A++Y H + 
Sbjct: 75  ----YESTTHYYLVMQLVSGGELFDRILERG----VYTEKDASLVIQQVLSAVKYLHEN- 125

Query: 155 QPSIVHGDLKPSNILL-----DQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
              IVH DLKP N+L      +  I+  + D GL+K     + G  +          G  
Sbjct: 126 --GIVHRDLKPENLLYLTPEENSKIM--ITDFGLSKME---QNGIMSTAC-------GTP 171

Query: 210 GYVAPE 215
           GYVAPE
Sbjct: 172 GYVAPE 177

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 74.6 bits (184), Expect = 3e-15
 Identities = 57/229 (24%), Positives = 96/229 (41%), Gaps = 40/229 (17%)

Query: 29  TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKE--ASRSFAAECNALRNIRH 86
              ++  + IG+G   +V     + ++  VA+K ++  + +    R+   E   L   RH
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRH 84

Query: 87  RNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQ---SNGQLRFLT-Q--RVNIA 140
            N+I I  I  +   E      IV + M+  +L + L+    SN  + +   Q  R    
Sbjct: 85  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILR---- 139

Query: 141 IDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETAS 200
                 ++Y H     +++H DLKPSN+LL+      + D GLA+        T   T  
Sbjct: 140 -----GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT-- 189

Query: 201 NSIEIKGIVGYV------APEYGMGSKA-SVSGDVYNFGILLLEMFTRR 242
                     YV      APE  + SK  + S D+++ G +L EM + R
Sbjct: 190 ---------EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 74.7 bits (184), Expect = 3e-15
 Identities = 54/238 (22%), Positives = 101/238 (42%), Gaps = 57/238 (23%)

Query: 36  NKIGQGGVSIVYKGIL-------DESRSIVAVKVVNLKQKEASRS----FAAECNALRNI 84
             +G+G    V                + VAVK++     +A+        +E   ++ I
Sbjct: 75  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK---SDATEKDLSDLISEMEMMKMI 131

Query: 85  -RHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQS------------NGQLR 131
            +H+N+I ++  C+    +G  +  ++ EY    NL ++L+              +    
Sbjct: 132 GKHKNIINLLGACTQ---DGPLY--VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 186

Query: 132 FLTQR--VNIAIDVSFAIEYF-HHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLF 188
            L+ +  V+ A  V+  +EY     C    +H DL   N+L+ +D V  + D GLA+ + 
Sbjct: 187 QLSSKDLVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDIH 242

Query: 189 G---YEPGTAAETASNSIEIKGIVGYVAPE---YGMGSKASVSGDVYNFGILLLEMFT 240
               Y+  T        + +K    ++APE     + +  S   DV++FG+LL E+FT
Sbjct: 243 HIDYYKKTTNGR-----LPVK----WMAPEALFDRIYTHQS---DVWSFGVLLWEIFT 288

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 73.8 bits (182), Expect = 3e-15
 Identities = 54/210 (25%), Positives = 88/210 (41%), Gaps = 55/210 (26%)

Query: 29  TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---------KEASRSFAAECN 79
             N+ P   +G+G  S+V + I   +    AVK++++           +E   +   E +
Sbjct: 16  YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75

Query: 80  ALRNI-RHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRF--LTQR 136
            LR +  H N+I++        +E   F  +VF+ M             G+L F  LT++
Sbjct: 76  ILRKVSGHPNIIQLKDT-----YETNTFFFLVFDLM-----------KKGEL-FDYLTEK 118

Query: 137 V--------NIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLF 188
           V         I   +   I   H     +IVH DLKP NILLD D+   + D G +  L 
Sbjct: 119 VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQL- 174

Query: 189 GYEPGTAAETASNSIEIKGIVG---YVAPE 215
             +PG          +++ + G   Y+APE
Sbjct: 175 --DPGE---------KLREVCGTPSYLAPE 193

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 74.3 bits (183), Expect = 4e-15
 Identities = 50/240 (20%), Positives = 96/240 (40%), Gaps = 61/240 (25%)

Query: 36  NKIGQGGVSIVYKGIL-------DESRSIVAVKVVNLKQKEASRS----FAAECNALRNI 84
             +G+G    V             +    VAVK++     +A+        +E   ++ I
Sbjct: 87  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEMEMMKMI 143

Query: 85  -RHRNLIKIITICSSID--FEGFDFKAIVFEYMQNRNLEQWLRQS------------NGQ 129
            +H+N+I ++  C+     +       ++ EY    NL ++LR                 
Sbjct: 144 GKHKNIINLLGACTQDGPLY-------VIVEYASKGNLREYLRARRPPGMEYSYDINRVP 196

Query: 130 LRFLTQR--VNIAIDVSFAIEYF-HHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF 186
              +T +  V+    ++  +EY     C    +H DL   N+L+ ++ V  + D GLA+ 
Sbjct: 197 EEQMTFKDLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARD 252

Query: 187 LFG---YEPGTAAETASNSIEIKGIVGYVAPE---YGMGSKASVSGDVYNFGILLLEMFT 240
           +     Y+  T        + +K +    APE     + +  S   DV++FG+L+ E+FT
Sbjct: 253 INNIDYYKKTTNGR-----LPVKWM----APEALFDRVYTHQS---DVWSFGVLMWEIFT 300

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 74.0 bits (182), Expect = 5e-15
 Identities = 56/237 (23%), Positives = 100/237 (42%), Gaps = 54/237 (22%)

Query: 1   KKPAHKDSNMLSMKQQFPMISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAV 60
           +    ++    SM  +  +  +A   +    + P + IG+G  S+V + +   +    AV
Sbjct: 65  QPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAV 124

Query: 61  KVVNLKQKEASRSFAA--------ECNALRNIR-HRNLIKIITICSSIDFEGFDFKAIVF 111
           K++ +  +  S             E + LR +  H ++I +I       +E   F  +VF
Sbjct: 125 KIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS-----YESSSFMFLVF 179

Query: 112 EYMQNRNLEQWLRQSNGQLRF--LTQRV--------NIAIDVSFAIEYFHHHCQPSIVHG 161
           + M             G+L F  LT++V        +I   +  A+ + H +   +IVH 
Sbjct: 180 DLM-----------RKGEL-FDYLTEKVALSEKETRSIMRSLLEAVSFLHAN---NIVHR 224

Query: 162 DLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG---YVAPE 215
           DLKP NILLD ++   + D G +  L   EPG          +++ + G   Y+APE
Sbjct: 225 DLKPENILLDDNMQIRLSDFGFSCHL---EPGE---------KLRELCGTPGYLAPE 269

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 73.0 bits (180), Expect = 5e-15
 Identities = 43/210 (20%), Positives = 86/210 (40%), Gaps = 32/210 (15%)

Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVN---LKQKEASRSFAAECNALRNIRHRNLIKIIT 94
           +G+G  + VY+     +   VA+K+++   + +    +    E      ++H +++++  
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78

Query: 95  ICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQL------RFLTQRVNIAIDVSFAIE 148
                 FE  ++  +V E   N  + ++L+             F+ Q +         + 
Sbjct: 79  Y-----FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIIT-------GML 126

Query: 149 YFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGI 208
           Y H H    I+H DL  SN+LL +++   + D GLA  L    P     T      + G 
Sbjct: 127 YLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQL--KMPHEKHYT------LCGT 175

Query: 209 VGYVAPEYGMGSKASVSGDVYNFGILLLEM 238
             Y++PE    S   +  DV++ G +   +
Sbjct: 176 PNYISPEIATRSAHGLESDVWSLGCMFYTL 205

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 73.7 bits (181), Expect = 6e-15
 Identities = 60/258 (23%), Positives = 115/258 (44%), Gaps = 53/258 (20%)

Query: 1   KKPAHKDSNMLSMKQQFPMISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAV 60
           ++   +    L+ KQ+   +   +  K        +++G G   +V+K     S  ++A 
Sbjct: 11  EQQRKRLEAFLTQKQKVGELKDDDFEKI-------SELGAGNGGVVFKVSHKPSGLVMAR 63

Query: 61  KVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSS---IDFEGFDFKA----IVFEY 113
           K+++L+ K A R+        + IR    ++++  C+S   + F G  +      I  E+
Sbjct: 64  KLIHLEIKPAIRN--------QIIRE---LQVLHECNSPYIVGFYGAFYSDGEISICMEH 112

Query: 114 MQNRNLEQWLRQSNG----QLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNIL 169
           M   +L+Q L+++       L        ++I V   + Y     +  I+H D+KPSNIL
Sbjct: 113 MDGGSLDQVLKKAGRIPEQILGK------VSIAVIKGLTYLRE--KHKIMHRDVKPSNIL 164

Query: 170 LDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG---YVAPEYGMGSKASVSG 226
           ++       G++ L  F      G + +   +S+     VG   Y++PE   G+  SV  
Sbjct: 165 VN-----SRGEIKLCDF------GVSGQL-IDSMA-NSFVGTRSYMSPERLQGTHYSVQS 211

Query: 227 DVYNFGILLLEMFTRRRP 244
           D+++ G+ L+EM   R P
Sbjct: 212 DIWSMGLSLVEMAVGRYP 229

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 73.0 bits (180), Expect = 6e-15
 Identities = 50/187 (26%), Positives = 74/187 (39%), Gaps = 30/187 (16%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVN---LKQKEASRSFAAECNALRNIRHRNLIKII 93
            +G+G    V K     ++   AVKV+N    K K+ S     E   L+ + H N++K+ 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST-ILREVELLKKLDHPNIMKLF 87

Query: 94  TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQR--VNIAIDVSFAIEYFH 151
            I      E      IV E      L   + +        ++     I   V   I Y H
Sbjct: 88  EI-----LEDSSSFYIVGELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMH 138

Query: 152 HHCQPSIVHGDLKPSNILL---DQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGI 208
            H   +IVH DLKP NILL   ++D    + D GL+     ++  T  +         G 
Sbjct: 139 KH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC---FQQNTKMKDRI------GT 186

Query: 209 VGYVAPE 215
             Y+APE
Sbjct: 187 AYYIAPE 193

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 73.7 bits (181), Expect = 9e-15
 Identities = 48/222 (21%), Positives = 89/222 (40%), Gaps = 32/222 (14%)

Query: 37  KIGQGGVSIVYKGILDESRS--IVAVKVVNLKQKEASRSFAA--ECNALRNIRHRNLIKI 92
           K+G+G    VYK    + +     A+K    + +    S +A  E   LR ++H N+I +
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALK----QIEGTGISMSACREIALLRELKHPNVISL 83

Query: 93  ITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDV-SF------ 145
             +  S          ++F+Y ++ +L   ++                  V S       
Sbjct: 84  QKVFLSHADRKV---WLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139

Query: 146 AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAH----VGDLGLAKFLFGYEPGTAAETASN 201
            I Y H +    ++H DLKP+NIL+  +        + D+G A+ LF       A+    
Sbjct: 140 GIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR-LFNSPLKPLADLDPV 195

Query: 202 SIEIKGIVGYVAPEYGMGSKA-SVSGDVYNFGILLLEMFTRR 242
            +       Y APE  +G++  + + D++  G +  E+ T  
Sbjct: 196 VVTF----WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 73.6 bits (181), Expect = 1e-14
 Identities = 56/250 (22%), Positives = 89/250 (35%), Gaps = 44/250 (17%)

Query: 12  SMKQQFPMISYAELSKATNNFSPA----NKIGQGGVSIVYKGILDESRSIVAVKVVN--- 64
           SM           +  +T  FS        +G+G    V       +    AVKV++   
Sbjct: 4   SMMDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQ 63

Query: 65  LKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLR 124
           +KQK    S   E   L+ + H N++K+        FE   +  +V E      L   + 
Sbjct: 64  VKQKTDKESLLREVQLLKQLDHPNIMKLYEF-----FEDKGYFYLVGEVYTGGELFDEII 118

Query: 125 QSNGQLRFLTQR--VNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILL---DQDIVAHVG 179
                    ++     I   V   I Y H +    IVH DLKP N+LL    +D    + 
Sbjct: 119 SRK----RFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRII 171

Query: 180 DLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPE-----YGMGSKASVSGDVYNFGIL 234
           D GL+     +E     +    +        Y+APE     Y          DV++ G++
Sbjct: 172 DFGLSTH---FEASKKMKDKIGTA------YYIAPEVLHGTYDEKC------DVWSTGVI 216

Query: 235 LLEMFTRRRP 244
           L  + +   P
Sbjct: 217 LYILLSGCPP 226

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 72.3 bits (178), Expect = 1e-14
 Identities = 42/194 (21%), Positives = 75/194 (38%), Gaps = 39/194 (20%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVN--------LKQKEASRSFAAECNALRNIRHRN 88
            +G G    V      ++   VA+K+++         ++ + + +   E   L+ + H  
Sbjct: 17  TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76

Query: 89  LIKIITICSSIDFEGFDFKA--IVFEYMQNRNLEQWLRQSNGQLRFLTQRV--NIAIDVS 144
           +IKI           FD +   IV E M+   L   +  +      L +         + 
Sbjct: 77  IIKI--------KNFFDAEDYYIVLELMEGGELFDKVVGNK----RLKEATCKLYFYQML 124

Query: 145 FAIEYFHHHCQPSIVHGDLKPSNILL---DQDIVAHVGDLGLAKFLFGYEPGTAAETASN 201
            A++Y H +    I+H DLKP N+LL   ++D +  + D G +K        +   T   
Sbjct: 125 LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLC- 177

Query: 202 SIEIKGIVGYVAPE 215
                G   Y+APE
Sbjct: 178 -----GTPTYLAPE 186

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 71.9 bits (177), Expect = 1e-14
 Identities = 43/184 (23%), Positives = 66/184 (35%), Gaps = 26/184 (14%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
            IG+G    V   +   +R   A K +     E    F  E   ++++ H N+I++    
Sbjct: 16  TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET- 74

Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQR--VNIAIDVSFAIEYFHHHC 154
               FE      +V E      L + +           +     I  DV  A+ Y H   
Sbjct: 75  ----FEDNTDIYLVMELCTGGELFERVVHKR----VFRESDAARIMKDVLSAVAYCHKL- 125

Query: 155 QPSIVHGDLKPSNILL---DQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGY 211
             ++ H DLKP N L      D    + D GLA     ++PG    T        G   Y
Sbjct: 126 --NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR---FKPGKMMRT------KVGTPYY 174

Query: 212 VAPE 215
           V+P+
Sbjct: 175 VSPQ 178

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 71.7 bits (176), Expect = 2e-14
 Identities = 27/247 (10%), Positives = 63/247 (25%), Gaps = 63/247 (25%)

Query: 37  KIGQGGVSIVYKGILDES--RSIVAVKVVNLKQKEASRS---FAAECNALRNIRHRNLIK 91
             G       ++  LD +  R  VA+  V+ +            +    L  I    + +
Sbjct: 38  FHGGVPPLQFWQA-LDTALDR-QVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 92  IITICSSIDF-EGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQR-VNIAIDVSFAIEY 149
           ++      D         +V E+++  +L++                +     ++ A + 
Sbjct: 96  VL------DVVHTRAGGLVVAEWIRGGSLQEVADT-----SPSPVGAIRAMQSLAAAADA 144

Query: 150 FHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
            H      +      PS + +  D    +             P    +            
Sbjct: 145 AHRA---GVALSIDHPSRVRVSIDGDVVLAY-------PATMPDANPQD----------- 183

Query: 210 GYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVME 269
                            D+   G  L  +   R P          +   +  A  D   +
Sbjct: 184 -----------------DIRGIGASLYALLVNRWPLP-----EAGVRSGLAPAERDTAGQ 221

Query: 270 IVDPSLL 276
            ++P+ +
Sbjct: 222 PIEPADI 228

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 72.3 bits (178), Expect = 2e-14
 Identities = 53/245 (21%), Positives = 91/245 (37%), Gaps = 66/245 (26%)

Query: 36  NKIGQGGVSIVYKGIL-----DESRSIVAVKVVNLKQKEASRS----FAAECNALRNI-R 85
             +G G    V                VAVK++    ++A  S      +E   +  +  
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK---EKADSSEREALMSELKMMTQLGS 107

Query: 86  HRNLIKIITICSSID--FEGFDFKAIVFEYMQNRNLEQWLRQS----------------- 126
           H N++ ++  C+     +       ++FEY    +L  +LR                   
Sbjct: 108 HENIVNLLGACTLSGPIY-------LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 160

Query: 127 --NGQLRFLTQR--VNIAIDVSFAIEYF-HHHCQPSIVHGDLKPSNILLDQDIVAHVGDL 181
                L  LT    +  A  V+  +E+     C    VH DL   N+L+    V  + D 
Sbjct: 161 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSC----VHRDLAARNVLVTHGKVVKICDF 216

Query: 182 GLAKFLFG---YEPGTAAETASNSIEIKGIVGYVAPE---YGMGSKASVSGDVYNFGILL 235
           GLA+ +     Y     A      + +K    ++APE    G+ +  S   DV+++GILL
Sbjct: 217 GLARDIMSDSNYVVRGNAR-----LPVK----WMAPESLFEGIYTIKS---DVWSYGILL 264

Query: 236 LEMFT 240
            E+F+
Sbjct: 265 WEIFS 269

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 72.6 bits (178), Expect = 2e-14
 Identities = 41/252 (16%), Positives = 78/252 (30%), Gaps = 63/252 (25%)

Query: 12  SMKQQFPMISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---- 67
           S  ++        L +    +     IGQG   +V   I +++R+I A+K++N  +    
Sbjct: 8   SSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQI 67

Query: 68  -KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQ----------- 115
             +       E   ++ + H N+ ++  +     +E   +  +V E              
Sbjct: 68  NPKDVERIKTEVRLMKKLHHPNIARLYEV-----YEDEQYICLVMELCHGGHLLDKLNVF 122

Query: 116 -------------------------NRNLEQWLRQSNGQLRFLTQRV--NIAIDVSFAIE 148
                                                       +++  NI   +  A+ 
Sbjct: 123 IDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182

Query: 149 YFHHHCQPSIVHGDLKPSNILLDQDIVAHV--GDLGLAKFLFGYEPGTAAETASNSIEIK 206
           Y H+     I H D+KP N L   +    +   D GL+K  +    G           + 
Sbjct: 183 YLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNG-------EYYGMT 232

Query: 207 GIVG---YVAPE 215
              G   +VAPE
Sbjct: 233 TKAGTPYFVAPE 244

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 73.2 bits (180), Expect = 2e-14
 Identities = 46/221 (20%), Positives = 79/221 (35%), Gaps = 39/221 (17%)

Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ--KEASRSFAAECNALRNIRHRNLIKII 93
            K+G G    V       +    A+K++        ++     E   L+ + H N++K+ 
Sbjct: 43  KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY 102

Query: 94  TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQR--VNIAIDVSFAIEYFH 151
                  FE      +V E  +   L   +           +     I   V   + Y H
Sbjct: 103 DF-----FEDKRNYYLVMECYKGGELFDEIIHRM----KFNEVDAAVIIKQVLSGVTYLH 153

Query: 152 HHCQPSIVHGDLKPSNILL---DQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGI 208
            H   +IVH DLKP N+LL   ++D +  + D GL+     +E     +    +      
Sbjct: 154 KH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAV---FENQKKMKERLGTA----- 202

Query: 209 VGYVAPE-----YGMGSKASVSGDVYNFGILLLEMFTRRRP 244
             Y+APE     Y          DV++ G++L  +     P
Sbjct: 203 -YYIAPEVLRKKYDEKC------DVWSIGVILFILLAGYPP 236

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 72.0 bits (177), Expect = 2e-14
 Identities = 50/217 (23%), Positives = 87/217 (40%), Gaps = 33/217 (15%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRS-FAAECNALRNIRHRNLIKIITI 95
            IG G  ++V        +  VA+K +NL++ + S      E  A+    H N++     
Sbjct: 22  VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSY--Y 79

Query: 96  CSSIDFEGFDFKAIVFEYMQN---RNLEQWLRQSNGQLRFLTQRVNIAI---DVSFAIEY 149
            S   F   D   +V + +      ++ + +         +     IA    +V   +EY
Sbjct: 80  TS---FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 136

Query: 150 FHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
            H +     +H D+K  NILL +D    + D G++ FL            + +   K  V
Sbjct: 137 LHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFL------ATGGDITRNKVRKTFV 187

Query: 210 G---YVAPE-----YGMGSKASVSGDVYNFGILLLEM 238
           G   ++APE      G   KA    D+++FGI  +E+
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKA----DIWSFGITAIEL 220

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 71.9 bits (177), Expect = 2e-14
 Identities = 48/221 (21%), Positives = 86/221 (38%), Gaps = 31/221 (14%)

Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAA----ECNALRNIRHRNLIKII 93
           +G+G    V + +  E+    AVK++  K+     +  A    E   LR +RH+N+I+++
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 94  TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQL------RFLTQRVNIAIDVSFAI 147
            +   +  E      +V EY      E        +        +  Q ++        +
Sbjct: 73  DV---LYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLID-------GL 122

Query: 148 EYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKG 207
           EY H      IVH D+KP N+LL       +  LG+A+ L  +       T+       G
Sbjct: 123 EYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ------G 173

Query: 208 IVGYVAPEYGMGSK--ASVSGDVYNFGILLLEMFTRRRPTD 246
              +  PE   G    +    D+++ G+ L  + T   P +
Sbjct: 174 SPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 72.9 bits (179), Expect = 2e-14
 Identities = 43/240 (17%), Positives = 82/240 (34%), Gaps = 41/240 (17%)

Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALR-NIRHRN 88
           N       +G G    V      + R  VAVK + +   + +     E   L  +  H N
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSFQGRP-VAVKRMLIDFCDIALM---EIKLLTESDDHPN 70

Query: 89  LIKIITICSSIDFEGFDFKAIVFEYM----QNRNLEQWLRQSNGQLRFLTQRVNIAIDVS 144
           +I+              F  I  E      Q+    + +   N +L+     +++   ++
Sbjct: 71  VIRYYCS-----ETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 125

Query: 145 FAIEYFHHHCQPSIVHGDLKPSNILLD-------------QDIVAHVGDLGLAKFLFGYE 191
             + + H      I+H DLKP NIL+              +++   + D GL K L   +
Sbjct: 126 SGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182

Query: 192 PGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSG-------DVYNFGILLLEMFTRRRP 244
                   +      G  G+ APE    S    +        D+++ G +   + ++ + 
Sbjct: 183 SSFRTNLNN----PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 72.5 bits (178), Expect = 2e-14
 Identities = 49/262 (18%), Positives = 92/262 (35%), Gaps = 76/262 (29%)

Query: 29  TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRN 88
           +  +S    +G G   IV +    ES    A+K V    +  +R    E + ++ + H N
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR----ELDIMKVLDHVN 61

Query: 89  LIKIITI---------------------------------CSSIDFEGFDFKAIVFEYMQ 115
           +IK++                                      ++     +  ++ EY+ 
Sbjct: 62  IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121

Query: 116 NRNLEQWLRQSNGQLRFLTQRVNIAIDVSF-------AIEYFHHHCQPSIVHGDLKPSNI 168
           +  L + L+      R +         +S        A+ + H      I H D+KP N+
Sbjct: 122 D-TLHKVLKSFIRSGRSIPM-----NLISIYIYQLFRAVGFIHSL---GICHRDIKPQNL 172

Query: 169 LLD-QDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV------APEYGMGSK 221
           L++ +D    + D G AK L   EP  A               Y+      APE  +G+ 
Sbjct: 173 LVNSKDNTLKLCDFGSAKKLIPSEPSVA---------------YICSRFYRAPELMLGAT 217

Query: 222 A-SVSGDVYNFGILLLEMFTRR 242
             + S D+++ G +  E+   +
Sbjct: 218 EYTPSIDLWSIGCVFGELILGK 239

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 72.2 bits (177), Expect = 2e-14
 Identities = 41/219 (18%), Positives = 77/219 (35%), Gaps = 35/219 (15%)

Query: 36  NKIGQGGVSI--VYKGILDESRSIVAVKVVNLKQ--KEASRSFAAECNALRNIRHRNLIK 91
             IG+G   +  V       +   V V+ +NL+    E       E +  +   H N++ 
Sbjct: 31  TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVP 90

Query: 92  IITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI---DVSFAIE 148
                +   F   +   +V  +M   + +  +      +  + +   IA     V  A++
Sbjct: 91  Y--RAT---FIADNELWVVTSFMAYGSAKDLIC--THFMDGMNELA-IAYILQGVLKALD 142

Query: 149 YFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGI 208
           Y HH      VH  +K S+IL+  D   ++  L     +                  K  
Sbjct: 143 YIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMI----SHGQRQRVVHDFPKYS 195

Query: 209 VG---YVAPE------YGMGSKASVSGDVYNFGILLLEM 238
           V    +++PE       G  +K+    D+Y+ GI   E+
Sbjct: 196 VKVLPWLSPEVLQQNLQGYDAKS----DIYSVGITACEL 230

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 72.4 bits (178), Expect = 2e-14
 Identities = 44/198 (22%), Positives = 73/198 (36%), Gaps = 42/198 (21%)

Query: 31  NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLI 90
             S    +G G    V+K     +   +A K++  +  +       E + +  + H NLI
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149

Query: 91  KIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQL------RFLTQRVNIAIDVS 144
           ++        FE  +   +V EY+    L   +   +  L       F+ Q         
Sbjct: 150 QLYDA-----FESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICE------ 198

Query: 145 FAIEYFHHHCQPSIVHGDLKPSNILL----DQDIVAHVGDLGLAKFLFGYEPGTAAETAS 200
             I + H      I+H DLKP NIL      + I   + D GLA+    Y+P        
Sbjct: 199 -GIRHMHQM---YILHLDLKPENILCVNRDAKQIK--IIDFGLARR---YKPRE------ 243

Query: 201 NSIEIKGIVG---YVAPE 215
              ++K   G   ++APE
Sbjct: 244 ---KLKVNFGTPEFLAPE 258

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 72.0 bits (177), Expect = 2e-14
 Identities = 47/238 (19%), Positives = 79/238 (33%), Gaps = 51/238 (21%)

Query: 29  TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVN--LKQKEASRSFAAECNALRNIR- 85
            + ++    I  G    V  G+ D     VA+K V   +         +      R +R 
Sbjct: 21  QSPYTVQRFISSGSYGAVCAGV-DSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLRE 79

Query: 86  --------HRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLR------ 131
                   H N++ +  I    +        +V E M+  +L Q +      +       
Sbjct: 80  IRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQY 138

Query: 132 FLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYE 191
           F+   +         +   H   +  +VH DL P NILL  +    + D  LA+      
Sbjct: 139 FMYHILL-------GLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADA 188

Query: 192 PGTAAETASNSIEIKGIVGYV------APEYGMGSKA-SVSGDVYNFGILLLEMFTRR 242
             T                YV      APE  M  K  +   D+++ G ++ EMF R+
Sbjct: 189 NKT---------------HYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 71.7 bits (176), Expect = 3e-14
 Identities = 48/277 (17%), Positives = 95/277 (34%), Gaps = 50/277 (18%)

Query: 3   PAHKDSNMLSMKQQFPMISYAELSKAT--NNFSPANKIGQGGVSIVYKGILDESRSIVAV 60
           P     ++LS       ++     K    N++     + QG  + +      +     A+
Sbjct: 2   PLGSMKDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCE--KDNKFYAL 59

Query: 61  KVVNLKQKEASRSFAA-----------------ECNALRNIRHRNLIKIITICSSIDFEG 103
           K       E  R F                   E   + +I++   +    I        
Sbjct: 60  KKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGI-----IT- 113

Query: 104 FDFKAI--VFEYMQNRNLEQWLRQSNGQLRFLTQRV------NIAIDVSFAIEYFHHHCQ 155
            ++  +  ++EYM+N ++ ++        +  T  +       I   V  +  Y H+   
Sbjct: 114 -NYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK- 171

Query: 156 PSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPE 215
            +I H D+KPSNIL+D++    + D G ++    Y      + +  + E      ++ PE
Sbjct: 172 -NICHRDVKPSNILMDKNGRVKLSDFGESE----YMVDKKIKGSRGTYE------FMPPE 220

Query: 216 --YGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFN 250
                 S      D+++ GI L  MF    P     +
Sbjct: 221 FFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS 257

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 71.0 bits (175), Expect = 3e-14
 Identities = 41/204 (20%), Positives = 80/204 (39%), Gaps = 48/204 (23%)

Query: 29  TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ--KEASRSFAAECNALRNIRH 86
           ++N+    ++G+G  S+V + +   +    A K++N K+      +    E    R ++H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64

Query: 87  RNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQL-------RFLTQRV-- 137
            N++++         +   F  +VF+ +           + G+L        F ++    
Sbjct: 65  PNIVRLHDS-----IQEESFHYLVFDLV-----------TGGELFEDIVAREFYSEADAS 108

Query: 138 NIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILL---DQDIVAHVGDLGLAKFLFGYEPGT 194
           +    +  +I Y H +    IVH +LKP N+LL    +     + D GLA  +       
Sbjct: 109 HCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV---NDSE 162

Query: 195 AAETASNSIEIKGIVG---YVAPE 215
           A           G  G   Y++PE
Sbjct: 163 A---------WHGFAGTPGYLSPE 177

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 71.7 bits (176), Expect = 3e-14
 Identities = 48/223 (21%), Positives = 91/223 (40%), Gaps = 37/223 (16%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQK--EASRSFAAECNALRNIR--------H 86
           K+G G  S V+      + + VA+K+V   +   EA+     E   L+ +          
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED---EIKLLQRVNDADNTKEDS 82

Query: 87  RNLIKIITICSSIDFEGFDFK--AIVFEYMQNRNLEQWLRQSNGQLRFLTQRV-NIAIDV 143
                I+ +    + +G +     +VFE +   NL   +++   +       V  I+  +
Sbjct: 83  MGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHR-GIPLIYVKQISKQL 140

Query: 144 SFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAH------VGDLGLAKFLFGYEPGTAAE 197
              ++Y H  C   I+H D+KP N+L++            + DLG A +          E
Sbjct: 141 LLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW--------YDE 190

Query: 198 TASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
             +NSI+ +    Y +PE  +G+      D+++   L+ E+ T
Sbjct: 191 HYTNSIQTR---EYRSPEVLLGAPWGCGADIWSTACLIFELIT 230

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 72.1 bits (177), Expect = 3e-14
 Identities = 35/190 (18%), Positives = 68/190 (35%), Gaps = 38/190 (20%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           ++G G   +V++ +   +  +   K +N        +   E + +  + H  LI +    
Sbjct: 58  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA- 116

Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQL------RFLTQRVNIAIDVSFAIEYF 150
               FE      ++ E++    L   +   + ++       ++ Q           +++ 
Sbjct: 117 ----FEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACE-------GLKHM 165

Query: 151 HHHCQPSIVHGDLKPSNILLDQDIVAHV--GDLGLAKFLFGYEPGTAAETASNSIEIKGI 208
           H H   SIVH D+KP NI+ +    + V   D GLA       P            +K  
Sbjct: 166 HEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATK---LNPDE---------IVKVT 210

Query: 209 VG---YVAPE 215
                + APE
Sbjct: 211 TATAEFAAPE 220

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 71.6 bits (176), Expect = 3e-14
 Identities = 49/225 (21%), Positives = 96/225 (42%), Gaps = 37/225 (16%)

Query: 29  TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVN---LKQKEASRSFAAECNALRNIR 85
              +     +G G    V   I   S   VA+K ++     +  A R++  E   L++++
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR-ELLLLKHMQ 81

Query: 86  HRNLIKIITI-CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQ--SNGQLRFLT-QRVNIAI 141
           H N+I ++ +   +     F    +V  +MQ  +L++ +    S  ++++L  Q +    
Sbjct: 82  HENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQYLVYQMLK--- 137

Query: 142 DVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASN 201
                ++Y H      +VH DLKP N+ +++D    + D GLA+                
Sbjct: 138 ----GLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR--------------HA 176

Query: 202 SIEIKGIVG---YVAPEYGMGSKA-SVSGDVYNFGILLLEMFTRR 242
             E+ G V    Y APE  +     + + D+++ G ++ EM T +
Sbjct: 177 DAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 71.2 bits (175), Expect = 5e-14
 Identities = 43/230 (18%), Positives = 84/230 (36%), Gaps = 48/230 (20%)

Query: 3   PAHKDSNMLSMKQQFPMISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKV 62
           P            +         +K ++N+    ++G+G  S+V + +   +    A K+
Sbjct: 2   PHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKI 61

Query: 63  VNLKQ--KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLE 120
           +N K+      +    E    R ++H N++++         +   F  +VF+ +      
Sbjct: 62  INTKKLSARDFQKLEREARICRKLQHPNIVRLHDS-----IQEESFHYLVFDLV------ 110

Query: 121 QWLRQSNGQL-------RFLTQRV--NIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILL- 170
                + G+L        F ++    +    +  +I Y H +    IVH +LKP N+LL 
Sbjct: 111 -----TGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLA 162

Query: 171 --DQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG---YVAPE 215
              +     + D GLA  +       A           G  G   Y++PE
Sbjct: 163 SKAKGAAVKLADFGLAIEV---NDSEA---------WHGFAGTPGYLSPE 200

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 70.8 bits (174), Expect = 5e-14
 Identities = 49/196 (25%), Positives = 72/196 (36%), Gaps = 43/196 (21%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAA------ECNALRNIRHRNLI 90
           ++G G  +IV K     +    A K +  +Q  ASR          E + LR + H N+I
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78

Query: 91  KIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQR--VNIAIDVSFAIE 148
            +  +     +E      ++ E +    L  +L Q       L++    +    +   + 
Sbjct: 79  TLHDV-----YENRTDVVLILELVSGGELFDFLAQKE----SLSEEEATSFIKQILDGVN 129

Query: 149 YFHHHCQPSIVHGDLKPSNILL------DQDIVAHVGDLGLAKFLFGYEPGTAAETASNS 202
           Y H      I H DLKP NI+L         I     D GLA      E G         
Sbjct: 130 YLHTK---KIAHFDLKPENIMLLDKNIPIPHIKL--IDFGLAHE---IEDGV-------- 173

Query: 203 IEIKGIVG---YVAPE 215
            E K I G   +VAPE
Sbjct: 174 -EFKNIFGTPEFVAPE 188

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 70.8 bits (174), Expect = 6e-14
 Identities = 46/197 (23%), Positives = 78/197 (39%), Gaps = 51/197 (25%)

Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNAL-RNIRHRNLIKIIT 94
             IG G  S+  + I   +    AVK+++  +++ +     E   L R  +H N+I +  
Sbjct: 28  EDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE----EIEILLRYGQHPNIITLKD 83

Query: 95  ICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQL-------RFLTQR--VNIAIDVSF 145
           +     ++   +  +V E M             G+L       +F ++R    +   ++ 
Sbjct: 84  V-----YDDGKYVYVVTELM-----------KGGELLDKILRQKFFSEREASAVLFTITK 127

Query: 146 AIEYFHHHCQPSIVHGDLKPSNILL-----DQDIVAHVGDLGLAKFLFGYEPG--TAAET 198
            +EY H      +VH DLKPSNIL      + + +  + D G AK L        T   T
Sbjct: 128 TVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIR-ICDFGFAKQLRAENGLLMTPCYT 183

Query: 199 ASNSIEIKGIVGYVAPE 215
           A           +VAPE
Sbjct: 184 A----------NFVAPE 190

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 70.0 bits (172), Expect = 8e-14
 Identities = 39/195 (20%), Positives = 75/195 (38%), Gaps = 49/195 (25%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIR-HRNLIKIITI 95
            +G+G  SI  K +  +S    AVK+++ + +  ++    E  AL+    H N++K+  +
Sbjct: 18  PLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHEV 74

Query: 96  CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQL-------RFLTQR--VNIAIDVSFA 146
                F       +V E +           + G+L       +  ++     I   +  A
Sbjct: 75  -----FHDQLHTFLVMELL-----------NGGELFERIKKKKHFSETEASYIMRKLVSA 118

Query: 147 IEYFHHHCQPSIVHGDLKPSNILL---DQDIVAHVGDLGLAKFLFGYEPGTAAETASNSI 203
           + + H      +VH DLKP N+L    + ++   + D G A+               ++ 
Sbjct: 119 VSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP-----------DNQ 164

Query: 204 EIKGIVG---YVAPE 215
            +K       Y APE
Sbjct: 165 PLKTPCFTLHYAAPE 179

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 70.1 bits (172), Expect = 1e-13
 Identities = 39/165 (23%), Positives = 72/165 (43%), Gaps = 23/165 (13%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSF--------AAECNALRNIRHRN 88
           KIG GG  ++Y           A  VV ++ +E    F         A+ + ++    R 
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103

Query: 89  LIKIITI-----CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDV 143
            +  + I         +F+G  ++ +V E     +L++ +   NG  +  T  + + I +
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVME-RLGIDLQK-ISGQNGTFKKSTV-LQLGIRM 160

Query: 144 SFAIEYFHHHCQPSIVHGDLKPSNILL---DQDIVAHVGDLGLAK 185
              +EY H +     VHGD+K +N+LL   + D V ++ D GL+ 
Sbjct: 161 LDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQV-YLADYGLSY 201

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 69.6 bits (171), Expect = 1e-13
 Identities = 37/190 (19%), Positives = 74/190 (38%), Gaps = 39/190 (20%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
            +G+G   IV++ +   S+     K V   +         E + L   RHRN++ +    
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRNILHLHES- 69

Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQL------RFLTQRVNIAIDVSFAIEYF 150
               FE  +   ++FE++   ++ + +  S  +L       ++ Q          A+++ 
Sbjct: 70  ----FESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCE-------ALQFL 118

Query: 151 HHHCQPSIVHGDLKPSNILLDQDIVAHV--GDLGLAKFLFGYEPGTAAETASNSIEIKGI 208
           H H   +I H D++P NI+      + +   + G A+     +PG            + +
Sbjct: 119 HSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ---LKPGD---------NFRLL 163

Query: 209 VG---YVAPE 215
                Y APE
Sbjct: 164 FTAPEYYAPE 173

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 69.6 bits (171), Expect = 1e-13
 Identities = 49/228 (21%), Positives = 83/228 (36%), Gaps = 47/228 (20%)

Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKV------VNLKQKEASRSFAAECNALRN 83
            +F     +G+G  S V       +    A+K+      +   +         E + +  
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT---RERDVMSR 86

Query: 84  IRHRNLIKIITICSSIDFEGFDFKA-----IVFEYMQNRNLEQWLRQSNGQLRFLTQRVN 138
           + H   +K+           F F+          Y +N  L +++R+      F      
Sbjct: 87  LDHPFFVKLY----------FTFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTR 133

Query: 139 I-AIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHV--GDLGLAKFLFGYEPGTA 195
               ++  A+EY H      I+H DLKP NILL++D   H+   D G AK L        
Sbjct: 134 FYTAEIVSALEYLHGK---GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQAR 188

Query: 196 AETASNSIEIKGIVG---YVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
           A +          VG   YV+PE      A  S D++  G ++ ++  
Sbjct: 189 ANS---------FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 227

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 70.5 bits (173), Expect = 1e-13
 Identities = 46/187 (24%), Positives = 73/187 (39%), Gaps = 28/187 (14%)

Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ--KEASRSFAAECNALRNIRHRNLIKII 93
             +G+G    V K     ++   AVKV+N      + + +   E   L+ + H N++K+ 
Sbjct: 28  CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87

Query: 94  TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQR--VNIAIDVSFAIEYFH 151
            I      E      IV E      L   + +        ++     I   V   I Y H
Sbjct: 88  EI-----LEDSSSFYIVGELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMH 138

Query: 152 HHCQPSIVHGDLKPSNILL---DQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGI 208
            H   +IVH DLKP NILL   ++D    + D GL+     ++  T  +    +      
Sbjct: 139 KH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC---FQQNTKMKDRIGTA----- 187

Query: 209 VGYVAPE 215
             Y+APE
Sbjct: 188 -YYIAPE 193

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 70.2 bits (172), Expect = 2e-13
 Identities = 62/268 (23%), Positives = 104/268 (38%), Gaps = 29/268 (10%)

Query: 6   KDSNMLSMKQQFPMISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVN- 64
            DS   +   Q+  +    ++K  N F     +G+GG   V    +  +  + A K +  
Sbjct: 162 LDSIYFNRFLQWKWLERQPVTK--NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEK 219

Query: 65  --LKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQW 122
             +K+++       E   L  +  R    ++++  +  +E  D   +V   M   +L+  
Sbjct: 220 KRIKKRKGEAMALNEKQILEKVNSRF---VVSLAYA--YETKDALCLVLTLMNGGDLKFH 274

Query: 123 LRQSNGQLRFLTQRVNI-AIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHV--G 179
           +    GQ  F   R    A ++   +E  H      IV+ DLKP NILLD     H+   
Sbjct: 275 I-YHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDH--GHIRIS 328

Query: 180 DLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMF 239
           DLGLA  +     G   +         G VGY+APE     + + S D +  G LL EM 
Sbjct: 329 DLGLAVHV---PEGQTIKG------RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMI 379

Query: 240 TRRRPTDAMFNEGLTLHEFVKMALPDKV 267
             + P      + +   E  ++      
Sbjct: 380 AGQSPFQQ-RKKKIKREEVERLVKEVPE 406

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 69.2 bits (170), Expect = 2e-13
 Identities = 48/194 (24%), Positives = 73/194 (37%), Gaps = 39/194 (20%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAA------ECNALRNIRHRNLI 90
           ++G G  +IV K     +    A K +  +Q  ASR   +      E + LR + H N+I
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78

Query: 91  KIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQR--VNIAIDVSFAIE 148
            +  +     +E      ++ E +    L  +L Q       L++    +    +   + 
Sbjct: 79  TLHDV-----YENRTDVVLILELVSGGELFDFLAQKE----SLSEEEATSFIKQILDGVN 129

Query: 149 YFHHHCQPSIVHGDLKPSNILL----DQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIE 204
           Y H      I H DLKP NI+L           + D GLA      E G          E
Sbjct: 130 YLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE---IEDGV---------E 174

Query: 205 IKGIVG---YVAPE 215
            K I G   +VAPE
Sbjct: 175 FKNIFGTPEFVAPE 188

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 68.4 bits (168), Expect = 2e-13
 Identities = 43/216 (19%), Positives = 88/216 (40%), Gaps = 31/216 (14%)

Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVN---LKQKEASRSFAAECNALRNIRH 86
            +F     +G+G    VY     +S+ I+A+KV+    L++         E     ++RH
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68

Query: 87  RNLIKIITICSSIDFEGFDFKA---IVFEYMQNRNLEQWLRQSNGQLRFLTQRV-NIAID 142
            N++++        +  F       ++ EY     + + L++ +   +F  QR      +
Sbjct: 69  PNILRL--------YGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITE 117

Query: 143 VSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNS 202
           ++ A+ Y H      ++H D+KP N+LL       + D G +     + P +       +
Sbjct: 118 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTDLCGT 170

Query: 203 IEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEM 238
           ++      Y+ PE   G       D+++ G+L  E 
Sbjct: 171 LD------YLPPEMIEGRMHDEKVDLWSLGVLCYEF 200

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 68.9 bits (169), Expect = 2e-13
 Identities = 50/220 (22%), Positives = 90/220 (40%), Gaps = 36/220 (16%)

Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAA---ECNALRNIRHRNLIKIIT 94
           IG+G  + V       +   VA+K+++ K +    S      E   ++ + H N++K+  
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIID-KTQLNPTSLQKLFREVRIMKILNHPNIVKLFE 81

Query: 95  ICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQL------RFLTQRVNIAIDVSFAIE 148
           +   I+ E   +  ++ EY     +  +L   +G++          Q V+       A++
Sbjct: 82  V---IETEKTLY--LIMEYASGGEVFDYLVA-HGRMKEKEARSKFRQIVS-------AVQ 128

Query: 149 YFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGI 208
           Y H      IVH DLK  N+LLD D+   + D G +     +  G   +    +      
Sbjct: 129 YCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNE---FTVGGKLDAFCGAPP---- 178

Query: 209 VGYVAPEYGMGSK-ASVSGDVYNFGILLLEMFTRRRPTDA 247
             Y APE   G K      DV++ G++L  + +   P D 
Sbjct: 179 --YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 216

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 68.8 bits (169), Expect = 2e-13
 Identities = 45/236 (19%), Positives = 91/236 (38%), Gaps = 45/236 (19%)

Query: 29  TNNFSPANKIGQGGVSIVYKGILDESRSIVAVK-VVNLKQKEASRSFAAECNALRNIRHR 87
            + +     +G GG  +V+  + ++    VA+K +V    +    +   E   +R + H 
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR-EIKIIRRLDHD 68

Query: 88  NLIKIITI---------CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQ---SNGQLRFLT- 134
           N++K+  I                  +   IV EYM+  +L   L Q        R    
Sbjct: 69  NIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGPLLEEHARLFMY 127

Query: 135 QRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLD-QDIVAHVGDLGLAKFLFGYEPG 193
           Q +         ++Y H     +++H DLKP+N+ ++ +D+V  +GD GLA+ +  +   
Sbjct: 128 QLLR-------GLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSH 177

Query: 194 TAAETASNSIEIKGIVGYV------APEYGMGSKA-SVSGDVYNFGILLLEMFTRR 242
               +             +      +P   +     + + D++  G +  EM T +
Sbjct: 178 KGHLS-----------EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 68.4 bits (168), Expect = 2e-13
 Identities = 52/203 (25%), Positives = 74/203 (36%), Gaps = 57/203 (28%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAA------ECNALRNIRHRNLI 90
           ++G G  +IV K     +    A K +  ++  +SR   +      E N LR IRH N+I
Sbjct: 12  ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71

Query: 91  KIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQL-------RFLTQR--VNIAI 141
            +  I     FE      ++ E +           S G+L         LT+        
Sbjct: 72  TLHDI-----FENKTDVVLILELV-----------SGGELFDFLAEKESLTEDEATQFLK 115

Query: 142 DVSFAIEYFHHHCQPSIVHGDLKPSNILL------DQDIVAHVGDLGLAKFLFGYEPGTA 195
            +   + Y H      I H DLKP NI+L      +  I     D G+A      E G  
Sbjct: 116 QILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKL--IDFGIAHK---IEAGN- 166

Query: 196 AETASNSIEIKGIVG---YVAPE 215
                   E K I G   +VAPE
Sbjct: 167 --------EFKNIFGTPEFVAPE 181

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 69.0 bits (169), Expect = 3e-13
 Identities = 52/270 (19%), Positives = 91/270 (33%), Gaps = 54/270 (20%)

Query: 2   KPAHKDSNMLSMKQQFPMISYAELSKATNNFSPA----NKIGQGGVSIVYKGILDESRSI 57
              H         Q   +     + K       +     K+G G    V         S 
Sbjct: 4   HHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSE 63

Query: 58  VAVKVVNLKQ-------------KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGF 104
            A+KV+   Q             ++       E + L+++ H N+IK+  +     FE  
Sbjct: 64  KAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV-----FEDK 118

Query: 105 DFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQR--VNIAIDVSFAIEYFHHHCQPSIVHGD 162
            +  +V E+ +   L + +   +       +    NI   +   I Y H H   +IVH D
Sbjct: 119 KYFYLVTEFYEGGELFEQIINRH----KFDECDAANIMKQILSGICYLHKH---NIVHRD 171

Query: 163 LKPSNILL---DQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPE---- 215
           +KP NILL   +  +   + D GL+ F   +           +        Y+APE    
Sbjct: 172 IKPENILLENKNSLLNIKIVDFGLSSF---FSKDYKLRDRLGTA------YYIAPEVLKK 222

Query: 216 -YGMGSKASVSGDVYNFGILLLEMFTRRRP 244
            Y          DV++ G+++  +     P
Sbjct: 223 KYNEKC------DVWSCGVIMYILLCGYPP 246

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 69.0 bits (169), Expect = 3e-13
 Identities = 50/236 (21%), Positives = 87/236 (36%), Gaps = 37/236 (15%)

Query: 29  TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL---KQKEASRSFAAECNALRNIR 85
            +N+   + IG+G    VY      +   VA+K VN       +  R    E   L  ++
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR-EITILNRLK 83

Query: 86  HRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLR------FLTQRVNI 139
              +I++  +    D   FD   IV E     +L++  + +   L        L   +  
Sbjct: 84  SDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFK-TPIFLTEEHIKTILYNLLL- 140

Query: 140 AIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETA 199
                    + H   +  I+H DLKP+N LL+QD    V D GLA+ +   +        
Sbjct: 141 ------GENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDL 191

Query: 200 SNSIEIKGIV--------GYV------APEYGMGSKA-SVSGDVYNFGILLLEMFT 240
             + E              +V      APE  +  +  + S D+++ G +  E+  
Sbjct: 192 EENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLN 247

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 68.1 bits (167), Expect = 4e-13
 Identities = 43/190 (22%), Positives = 74/190 (38%), Gaps = 37/190 (19%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNAL-RNIRHRNLIKIITI 95
            +G G    V +     +    A+K++     +A +    E +   +     +++ I+ +
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLLY-DSPKARQ----EVDHHWQASGGPHIVCILDV 90

Query: 96  CSSIDFEGFDFKAIVFEYMQ-----NRNLEQWLRQSNGQLRFLTQR--VNIAIDVSFAIE 148
             ++         I+ E M+     +R  E+      G   F T+R    I  D+  AI+
Sbjct: 91  YENMHHGKRCL-LIIMECMEGGELFSRIQER------GDQAF-TEREAAEIMRDIGTAIQ 142

Query: 149 YFHHHCQPSIVHGDLKPSNILL---DQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEI 205
           + H H   +I H D+KP N+L    ++D V  + D G AK        T   T       
Sbjct: 143 FLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTP------ 193

Query: 206 KGIVGYVAPE 215
                YVAPE
Sbjct: 194 ----YYVAPE 199

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 68.0 bits (167), Expect = 4e-13
 Identities = 45/201 (22%), Positives = 78/201 (38%), Gaps = 53/201 (26%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAA------ECNALRNIRHRNLI 90
           ++G G  ++V K     +    A K +  ++ ++SR   +      E + L+ I+H N+I
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77

Query: 91  KIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQL-------RFLTQR--VNIAI 141
            +  +     +E      ++ E +           + G+L         LT+        
Sbjct: 78  TLHEV-----YENKTDVILILELV-----------AGGELFDFLAEKESLTEEEATEFLK 121

Query: 142 DVSFAIEYFHHHCQPSIVHGDLKPSNILL-DQDIVAH---VGDLGLAKFLFGYEPGTAAE 197
            +   + Y H      I H DLKP NI+L D+++      + D GLA      + G    
Sbjct: 122 QILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK---IDFGN--- 172

Query: 198 TASNSIEIKGIVG---YVAPE 215
                 E K I G   +VAPE
Sbjct: 173 ------EFKNIFGTPEFVAPE 187

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 68.1 bits (167), Expect = 6e-13
 Identities = 38/154 (24%), Positives = 60/154 (38%), Gaps = 30/154 (19%)

Query: 128 GQLRFLTQRVNI---------AIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHV 178
           G LR+  Q+              ++  A++Y  +     I+H D+KP NILLD+    H+
Sbjct: 100 GDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHI 156

Query: 179 GDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPE-----YGMGSKASVSGDVYNFGI 233
            D  +A  L      T   T + +        Y+APE      G G   +V  D ++ G+
Sbjct: 157 TDFNIAAML---PRETQITTMAGTKP------YMAPEMFSSRKGAGYSFAV--DWWSLGV 205

Query: 234 LLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKV 267
              E+   RRP     +   +  E V       V
Sbjct: 206 TAYELLRGRRPYHIRSST--SSKEIVHTFETTVV 237

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 67.3 bits (165), Expect = 6e-13
 Identities = 49/221 (22%), Positives = 89/221 (40%), Gaps = 47/221 (21%)

Query: 32  FSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIK 91
           ++   KIGQG    VY  +   +   VA++ +NL+Q+        E   +R  ++ N++ 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 92  IITICSSIDFEGFDFKA----IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI---DVS 144
                    +           +V EY+   +L   + +       + +   IA    +  
Sbjct: 82  ---------YLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEG-QIAAVCRECL 126

Query: 145 FAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIE 204
            A+E+ H +    ++H D+K  NILL  D     G + L  F      G  A+      +
Sbjct: 127 QALEFLHSN---QVIHRDIKSDNILLGMD-----GSVKLTDF------GFCAQITPEQSK 172

Query: 205 IKGIVG---YVAPE----YGMGSKASVSGDVYNFGILLLEM 238
              +VG   ++APE       G K     D+++ GI+ +EM
Sbjct: 173 RSTMVGTPYWMAPEVVTRKAYGPKV----DIWSLGIMAIEM 209

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 67.7 bits (166), Expect = 7e-13
 Identities = 49/226 (21%), Positives = 97/226 (42%), Gaps = 38/226 (16%)

Query: 29  TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL---KQKEASRSFAAECNALRNIR 85
              +   + +G G    V      ++   VAVK ++        A R++  E   L++++
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK 86

Query: 86  HRNLIKIITI-CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQ---SNGQLRFLT-QRVNIA 140
           H N+I ++ +   +   E F+   +V   M   +L   ++    ++  ++FL  Q +   
Sbjct: 87  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQILR-- 143

Query: 141 IDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETAS 200
                 ++Y H      I+H DLKPSN+ +++D    + D GLA+               
Sbjct: 144 -----GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--------------H 181

Query: 201 NSIEIKGIVG---YVAPEYGMGSKA-SVSGDVYNFGILLLEMFTRR 242
            + E+ G V    Y APE  +     + + D+++ G ++ E+ T R
Sbjct: 182 TADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 66.6 bits (163), Expect = 1e-12
 Identities = 47/222 (21%), Positives = 86/222 (38%), Gaps = 42/222 (18%)

Query: 32  FSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIK 91
           +    ++G G    VYK    E+ ++ A KV+  K +E    +  E   L    H  ++K
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 92  IITICSSIDFEGFDFKA----IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI---DVS 144
                      G  +      I+ E+     ++  + + +  L        I +    + 
Sbjct: 81  ---------LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGL----TEPQIQVVCRQML 127

Query: 145 FAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIE 204
            A+ + H      I+H DLK  N+L+  +     GD+ LA F      G +A+      +
Sbjct: 128 EALNFLHSK---RIIHRDLKAGNVLMTLE-----GDIRLADF------GVSAKNLKTLQK 173

Query: 205 IKGIVG---YVAPEYGMGSKASVSG-----DVYNFGILLLEM 238
               +G   ++APE  M      +      D+++ GI L+EM
Sbjct: 174 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 215

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 67.0 bits (164), Expect = 1e-12
 Identities = 47/186 (25%), Positives = 76/186 (40%), Gaps = 32/186 (17%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           ++G+G  SIVY+     ++   A+KV+     +       E   L  + H N+IK+  I 
Sbjct: 60  ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKI--VRTEIGVLLRLSHPNIIKLKEI- 116

Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQR--VNIAIDVSFAIEYFHHHC 154
               FE     ++V E +    L   + +      + ++R   +    +  A+ Y H + 
Sbjct: 117 ----FETPTEISLVLELVTGGELFDRIVEKG----YYSERDAADAVKQILEAVAYLHEN- 167

Query: 155 QPSIVHGDLKPSNILL-----DQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
              IVH DLKP N+L      D  +     D GL+K +   E     +T        G  
Sbjct: 168 --GIVHRDLKPENLLYATPAPDAPLKI--ADFGLSKIV---EHQVLMKTVC------GTP 214

Query: 210 GYVAPE 215
           GY APE
Sbjct: 215 GYCAPE 220

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 67.0 bits (164), Expect = 1e-12
 Identities = 54/244 (22%), Positives = 97/244 (39%), Gaps = 53/244 (21%)

Query: 29  TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIR--- 85
              +    K+G+G   IV+K I   +  +VAVK +         +F    +A R  R   
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKI-------FDAFQNSTDAQRTFREIM 60

Query: 86  -------HRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQ---SNGQLRFLT- 134
                  H N++ ++ +  + +        +VF+YM+  +L   +R         +++  
Sbjct: 61  ILTELSGHENIVNLLNVLRADNDRDV---YLVFDYMET-DLHAVIRANILEPVHKQYVVY 116

Query: 135 QRVNIAIDVSFAIEYFHHHCQPS--IVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEP 192
           Q +         I+Y H     S  ++H D+KPSNILL+ +    V D GL++       
Sbjct: 117 QLIK-------VIKYLH-----SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR 164

Query: 193 GTAAETASNSIEIKGIV-------GYV------APEYGMGSKA-SVSGDVYNFGILLLEM 238
            T     S +   +           YV      APE  +GS   +   D+++ G +L E+
Sbjct: 165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEI 224

Query: 239 FTRR 242
              +
Sbjct: 225 LCGK 228

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 66.2 bits (162), Expect = 1e-12
 Identities = 43/229 (18%), Positives = 84/229 (36%), Gaps = 39/229 (17%)

Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRS-FAAECNAL-RNIRHR 87
           N+     ++G G    V+K    ++  ++AVK +     +        + + + ++    
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84

Query: 88  NLIKIITICSSIDFEGFDFKA----IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDV 143
            +++           G         I  E M     E+  ++  G +        + + +
Sbjct: 85  YIVQ---------CFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIP-ERILGKMTVAI 133

Query: 144 SFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSI 203
             A+ Y     +  ++H D+KPSNILLD+      G + L  F      G +     +  
Sbjct: 134 VKALYYLKE--KHGVIHRDVKPSNILLDER-----GQIKLCDF------GISGRL-VDDK 179

Query: 204 EIKGIVG---YVAPE-----YGMGSKASVSGDVYNFGILLLEMFTRRRP 244
                 G   Y+APE             +  DV++ GI L+E+ T + P
Sbjct: 180 AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 66.6 bits (163), Expect = 1e-12
 Identities = 47/226 (20%), Positives = 93/226 (41%), Gaps = 38/226 (16%)

Query: 29  TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVN---LKQKEASRSFAAECNALRNIR 85
              +     +G G    V   +   + + VA+K +      +  A R++  E   L+++R
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMR 82

Query: 86  HRNLIKIITI-CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQ---SNGQLRFLT-QRVNIA 140
           H N+I ++ +       + F    +V  +M   +L + ++       +++FL  Q +   
Sbjct: 83  HENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRIQFLVYQMLK-- 139

Query: 141 IDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETAS 200
                 + Y H      I+H DLKP N+ +++D    + D GLA+               
Sbjct: 140 -----GLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR--------------Q 177

Query: 201 NSIEIKGIVG---YVAPEYGMGSKA-SVSGDVYNFGILLLEMFTRR 242
              E+ G V    Y APE  +     + + D+++ G ++ EM T +
Sbjct: 178 ADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 66.2 bits (162), Expect = 2e-12
 Identities = 55/224 (24%), Positives = 87/224 (38%), Gaps = 47/224 (20%)

Query: 29  TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRN 88
              F    K+G+G    VYK I  E+  IVA+K V ++     +    E + ++     +
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL--QEIIKEISIMQQCDSPH 85

Query: 89  LIKIITICSSIDFEGFDFKA----IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI--- 141
           ++K         + G  FK     IV EY    ++   +R  N  L        IA    
Sbjct: 86  VVK---------YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTL----TEDEIATILQ 132

Query: 142 DVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASN 201
                +EY H       +H D+K  NILL+ +     G   LA F      G A +    
Sbjct: 133 STLKGLEYLHFM---RKIHRDIKAGNILLNTE-----GHAKLADF------GVAGQLTDT 178

Query: 202 SIEIKGIVG---YVAPE----YGMGSKASVSGDVYNFGILLLEM 238
             +   ++G   ++APE     G    A    D+++ GI  +EM
Sbjct: 179 MAKRNTVIGTPFWMAPEVIQEIGYNCVA----DIWSLGITAIEM 218

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 66.2 bits (162), Expect = 2e-12
 Identities = 51/262 (19%), Positives = 103/262 (39%), Gaps = 57/262 (21%)

Query: 1   KKPAHKDSNMLSMKQQFPMISYAELSKA----------TNNFSPANKIGQGGVSIVYKGI 50
              +  D    ++  Q  ++++ +   A                  KIG+G   IV    
Sbjct: 6   HHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAR 65

Query: 51  LDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA-- 108
              S   VAVK+++L++++       E   +R+ +H N+++                   
Sbjct: 66  EKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE---------MYKSYLVGEE 116

Query: 109 --IVFEYMQNRNLEQWLRQ---SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDL 163
             ++ E++Q   L   + Q   +  Q+        +   V  A+ Y H      ++H D+
Sbjct: 117 LWVLMEFLQGGALTDIVSQVRLNEEQIAT------VCEAVLQALAYLHAQ---GVIHRDI 167

Query: 164 KPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG---YVAPE----Y 216
           K  +ILL  D     G + L+ F      G  A+ + +  + K +VG   ++APE     
Sbjct: 168 KSDSILLTLD-----GRVKLSDF------GFCAQISKDVPKRKSLVGTPYWMAPEVISRS 216

Query: 217 GMGSKASVSGDVYNFGILLLEM 238
              ++     D+++ GI+++EM
Sbjct: 217 LYATEV----DIWSLGIMVIEM 234

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 65.7 bits (161), Expect = 2e-12
 Identities = 42/208 (20%), Positives = 86/208 (41%), Gaps = 31/208 (14%)

Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVN---LKQKEASRSFAAECNALRNIRHRNLIKIIT 94
           +G+G    VY     +++ I+A+KV+    L+++        E     ++RH N++++  
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM-- 79

Query: 95  ICSSIDFEGFDFKA---IVFEYMQNRNLEQWLRQSNGQLRFLTQRV-NIAIDVSFAIEYF 150
                 +  F  +    ++ E+     L + L++     RF  QR      +++ A+ Y 
Sbjct: 80  ------YNYFHDRKRIYLMLEFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYC 130

Query: 151 HHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG 210
           H      ++H D+KP N+L+       + D G +     + P     T   +++      
Sbjct: 131 HER---KVIHRDIKPENLLMGYKGELKIADFGWSV----HAPSLRRRTMCGTLD------ 177

Query: 211 YVAPEYGMGSKASVSGDVYNFGILLLEM 238
           Y+ PE   G       D++  G+L  E 
Sbjct: 178 YLPPEMIEGKTHDEKVDLWCAGVLCYEF 205

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 66.6 bits (163), Expect = 2e-12
 Identities = 33/189 (17%), Positives = 71/189 (37%), Gaps = 33/189 (17%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEAS--RSFAAECNALRNIRHRNLIKIIT 94
           ++G+G  S+V + +   +    A  ++N K+  A   +    E    R ++H N++++  
Sbjct: 18  ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77

Query: 95  ICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQR--VNIAIDVSFAIEYFHH 152
                         ++F+ +    L + +        + ++    +    +  A+ + H 
Sbjct: 78  S-----ISEEGHHYLIFDLVTGGELFEDIVARE----YYSEADASHCIQQILEAVLHCHQ 128

Query: 153 HCQPSIVHGDLKPSNILL---DQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
                +VH +LKP N+LL    +     + D GLA  +                   G  
Sbjct: 129 M---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV-----------EGEQQAWFGFA 174

Query: 210 G---YVAPE 215
           G   Y++PE
Sbjct: 175 GTPGYLSPE 183

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 65.4 bits (160), Expect = 2e-12
 Identities = 46/223 (20%), Positives = 92/223 (41%), Gaps = 49/223 (21%)

Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITI 95
            ++G+G   +V K     S  I+AVK +        +              + L+  + I
Sbjct: 13  MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQ--------------KRLLMDLDI 58

Query: 96  ----CSS---IDFEGFDFK----AIVFEYMQNRNLEQWLRQSNGQLRFLTQRV--NIAID 142
                     + F G  F+     I  E M + +L+++ +Q   + + + + +   IA+ 
Sbjct: 59  SMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVS 117

Query: 143 VSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNS 202
           +  A+E+ H   + S++H D+KPSN+L++       G + +  F      G +     + 
Sbjct: 118 IVKALEHLHS--KLSVIHRDVKPSNVLINAL-----GQVKMCDF------GISGY-LVDD 163

Query: 203 IEIKGIVG---YVAPE----YGMGSKASVSGDVYNFGILLLEM 238
           +      G   Y+APE           SV  D+++ GI ++E+
Sbjct: 164 VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIEL 206

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 66.1 bits (161), Expect = 3e-12
 Identities = 52/266 (19%), Positives = 91/266 (34%), Gaps = 49/266 (18%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIR-----HRNLIK 91
           K+G G  S V+     + +  VA+KVV   +     +   E   L+++R       N   
Sbjct: 44  KLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-LDEIRLLKSVRNSDPNDPNREM 102

Query: 92  IITICSSIDFEGFDFK--AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEY 149
           ++ +       G +     +VFE +   +L +W+ +SN Q   L     I   V   ++Y
Sbjct: 103 VVQLLDDFKISGVNGTHICMVFEVLG-HHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDY 161

Query: 150 FHHHCQPSIVHGDLKPSNILL-------------------------DQDIVAHVGDLGLA 184
            H  C+  I+H D+KP NILL                             V+        
Sbjct: 162 LHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGN 219

Query: 185 KFLFGYEPGTAAETASNSIEIKGIV-------------GYVAPEYGMGSKASVSGDVYNF 231
             +   EP  A +      ++                  Y + E  +GS  +   D+++ 
Sbjct: 220 FLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWST 279

Query: 232 GILLLEMFTRRRPTDAMFNEGLTLHE 257
             +  E+ T     +    E  T  E
Sbjct: 280 ACMAFELATGDYLFEPHSGEEYTRDE 305

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 65.5 bits (160), Expect = 4e-12
 Identities = 40/195 (20%), Positives = 71/195 (36%), Gaps = 46/195 (23%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNI-RHRNLIKIITI 95
            +G G    V +     ++   A+K++     +A R    E        +  ++++I+ +
Sbjct: 69  VLGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARR----EVELHWRASQCPHIVRIVDV 123

Query: 96  CSSIDFEGFDFKAIVFEYMQ-----NRNLEQWLRQSNGQLRFLTQR--VNIAIDVSFAIE 148
             +  + G     IV E +      +R  ++      G   F T+R    I   +  AI+
Sbjct: 124 YEN-LYAGRKCLLIVMECLDGGELFSRIQDR------GDQAF-TEREASEIMKSIGEAIQ 175

Query: 149 YFHHHCQPSIVHGDLKPSNILL---DQDIVAHVGDLGLAKFLFGYEP-----GTAAETAS 200
           Y H     +I H D+KP N+L      + +  + D G AK    +        T      
Sbjct: 176 YLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTP----- 227

Query: 201 NSIEIKGIVGYVAPE 215
                     YVAPE
Sbjct: 228 ---------YYVAPE 233

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 65.5 bits (160), Expect = 4e-12
 Identities = 40/192 (20%), Positives = 69/192 (35%), Gaps = 46/192 (23%)

Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICS 97
           IG G   +        ++ +VAVK +  +      +   E    R++RH N+++   +  
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIE-RGAAIDENVQREIINHRSLRHPNIVRFKEVIL 86

Query: 98  S---IDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQL------RFLTQRVNIAIDVSFAIE 148
           +   +        AI+ EY     L + +  + G+        F  Q ++        + 
Sbjct: 87  TPTHL--------AIIMEYASGGELYERI-CNAGRFSEDEARFFFQQLLS-------GVS 130

Query: 149 YFHHHCQPSIVHGDLKPSNILLDQDIVAH--VGDLGLAKFLFGYEPGTAAETASNSIEIK 206
           Y H      I H DLK  N LLD        + D G +K        +  ++        
Sbjct: 131 YCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKS---SVLHSQPKST------- 177

Query: 207 GIVG---YVAPE 215
             VG   Y+APE
Sbjct: 178 --VGTPAYIAPE 187

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 64.6 bits (158), Expect = 4e-12
 Identities = 53/236 (22%), Positives = 90/236 (38%), Gaps = 64/236 (27%)

Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVN----LKQKEASRSFAA----------------- 76
           IG+G   +V     +   +  A+KV++    ++Q    R                     
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 77  -----ECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNL---EQWLRQSNG 128
                E   L+ + H N++K++ +   +D    D   +VFE +    +         S  
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEV---LDDPNEDHLYMVFELVNQGPVMEVPTLKPLSED 137

Query: 129 QLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLF 188
           Q RF  Q      D+   IEY H+     I+H D+KPSN+L+ +D    + D G++    
Sbjct: 138 QARFYFQ------DLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188

Query: 189 GYEP------GTAAETASNSIEIKGIVGYVAPEYGMGSKASVSG---DVYNFGILL 235
           G +       GT A              ++APE    ++   SG   DV+  G+ L
Sbjct: 189 GSDALLSNTVGTPA--------------FMAPESLSETRKIFSGKALDVWAMGVTL 230

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 64.3 bits (157), Expect = 7e-12
 Identities = 54/233 (23%), Positives = 92/233 (39%), Gaps = 58/233 (24%)

Query: 32  FSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRS-FAAECNALRNIRHRNLI 90
           F+   KIG+G    V+KGI + ++ +VA+K+++L++ E        E   L       + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 91  KIITICSSIDFEGFDFKA----IVFEYMQNRNLEQWLRQSNGQLRFLTQR-----VNIAI 141
           K         + G   K     I+ EY+             G    L +        IA 
Sbjct: 84  K---------YYGSYLKDTKLWIIMEYL-----------GGGSALDLLEPGPLDETQIAT 123

Query: 142 ---DVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAET 198
              ++   ++Y H       +H D+K +N+LL +      G++ LA F      G A + 
Sbjct: 124 ILREILKGLDYLHSE---KKIHRDIKAANVLLSEH-----GEVKLADF------GVAGQL 169

Query: 199 ASNSIEIKGIVG---YVAPE----YGMGSKASVSGDVYNFGILLLEMFTRRRP 244
               I+    VG   ++APE        SKA    D+++ GI  +E+     P
Sbjct: 170 TDTQIKRNTFVGTPFWMAPEVIKQSAYDSKA----DIWSLGITAIELARGEPP 218

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 64.4 bits (157), Expect = 1e-11
 Identities = 60/261 (22%), Positives = 101/261 (38%), Gaps = 27/261 (10%)

Query: 15  QQFPMISYAELSKAT-NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVN---LKQKEA 70
            +F    + E      + F     +G+GG   V+   +  +  + A K +N   LK+++ 
Sbjct: 169 LRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKG 228

Query: 71  SRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSN-GQ 129
            +    E   L  +  R ++ +    +   FE      +V   M   ++   +   +   
Sbjct: 229 YQGAMVEKKILAKVHSRFIVSLA--YA---FETKTDLCLVMTIMNGGDIRYHIYNVDEDN 283

Query: 130 LRFLTQRVNI-AIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHV--GDLGLAKF 186
             F   R       +   +E+ H     +I++ DLKP N+LLD D   +V   DLGLA  
Sbjct: 284 PGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDD--GNVRISDLGLAVE 338

Query: 187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTD 246
           L   +  T            G  G++APE  +G +   S D +  G+ L EM   R P  
Sbjct: 339 LKAGQTKTKG--------YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFR 390

Query: 247 AMFNEGLTLHEFVKMALPDKV 267
           A   E +   E  +  L   V
Sbjct: 391 A-RGEKVENKELKQRVLEQAV 410

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 64.5 bits (157), Expect = 1e-11
 Identities = 56/224 (25%), Positives = 95/224 (42%), Gaps = 31/224 (13%)

Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVN---LKQKEASRSFAAECNALRNIRH 86
           N+FS    IG+GG   VY     ++  + A+K ++   +K K+       E   L  +  
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248

Query: 87  RNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNI-AIDVSF 145
            +   I+ +  +  F   D  + + + M   +L   L Q      F    +   A ++  
Sbjct: 249 GDCPFIVCMSYA--FHTPDKLSFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIIL 303

Query: 146 AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHV--GDLGLAKFLFGYEPGTAAETASNSI 203
            +E+ H+     +V+ DLKP+NILLD+    HV   DLGLA      +P  +        
Sbjct: 304 GLEHMHNR---FVVYRDLKPANILLDEH--GHVRISDLGLACDFSKKKPHASV------- 351

Query: 204 EIKGIVGYVAPE---YGMGSKASVSGDVYNFGILLLEMFTRRRP 244
              G  GY+APE    G+   +S   D ++ G +L ++     P
Sbjct: 352 ---GTHGYMAPEVLQKGVAYDSSA--DWFSLGCMLFKLLRGHSP 390

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 63.5 bits (155), Expect = 2e-11
 Identities = 50/218 (22%), Positives = 88/218 (40%), Gaps = 40/218 (18%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRS-FAAECN-ALRNIRHRNLIKIIT 94
           +IG+G    V K +   S  I+AVK +     E  +     + +  +R+     +++   
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQ--- 85

Query: 95  ICSSIDFEGFDFKA----IVFEYMQNRNLEQWLRQSNGQL-RFLTQRV--NIAIDVSFAI 147
                 F G  F+     I  E M + + +++ +     L   + + +   I +    A+
Sbjct: 86  ------FYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKAL 138

Query: 148 EYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKG 207
            +        I+H D+KPSNILLD+      G++ L  F      G + +   +SI    
Sbjct: 139 NHLKE--NLKIIHRDIKPSNILLDRS-----GNIKLCDF------GISGQ-LVDSIAKTR 184

Query: 208 IVG---YVAPE----YGMGSKASVSGDVYNFGILLLEM 238
             G   Y+APE            V  DV++ GI L E+
Sbjct: 185 DAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYEL 222

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 63.2 bits (154), Expect = 2e-11
 Identities = 28/174 (16%), Positives = 62/174 (35%), Gaps = 24/174 (13%)

Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSI--------VAVKV--VNLKQKEASRSF--AAE 77
             +   +   +    I+Y+     + +          ++K+   + +       F  AA+
Sbjct: 42  RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101

Query: 78  CNALRNIRHRNLIKIITICSSIDF--EGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQ 135
              +   +      ++ I + + F      ++ +V      R+L+  L  S        +
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLP-SLGRSLQSALDVSPKH-VLSER 159

Query: 136 RV-NIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILL---DQDIVAHVGDLGLAK 185
            V  +A  +  A+E+ H +     VHG++   NI +   DQ  V  +   G A 
Sbjct: 160 SVLQVACRLLDALEFLHEN---EYVHGNVTAENIFVDPEDQSQV-TLAGYGFAF 209

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 62.2 bits (152), Expect = 2e-11
 Identities = 59/225 (26%), Positives = 95/225 (42%), Gaps = 47/225 (20%)

Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAA----ECNALRNIRHRNLIKII 93
           +G G    V  G    +   VAVK++N +QK  S         E   L+  RH ++IK+ 
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILN-RQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77

Query: 94  TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQL------RFLTQRVNIAIDVSFAI 147
            + S+   + F    +V EY+    L  ++   +G++      R   Q ++       A+
Sbjct: 78  QVIST-PTDFF----MVMEYVSGGELFDYI-CKHGRVEEMEARRLFQQILS-------AV 124

Query: 148 EYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKG 207
           +Y H H    +VH DLKP N+LLD  + A + D GL+        G    T+  S     
Sbjct: 125 DYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNM---MSDGEFLRTSCGS----- 173

Query: 208 IVGYVAPE------YGMGSKASVSGDVYNFGILLLEMFTRRRPTD 246
              Y APE      Y  G +     D+++ G++L  +     P D
Sbjct: 174 -PNYAAPEVISGRLYA-GPEV----DIWSCGVILYALLCGTLPFD 212

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 62.4 bits (152), Expect = 3e-11
 Identities = 48/230 (20%), Positives = 83/230 (36%), Gaps = 51/230 (22%)

Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAA-------ECNALRNIRHR--N 88
           +G GG   VY GI       VA+K V  K + +             E   L+ +      
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVE-KDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109

Query: 89  LIKIITICSSIDFEGFDFKA---IVFEYMQNR-NLEQWLRQSNGQL------RFLTQRVN 138
           +I++         + F+      ++ E  +   +L  ++ +  G L       F  Q + 
Sbjct: 110 VIRL--------LDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLE 160

Query: 139 IAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG-YEPGTAAE 197
                  A+ + H+     ++H D+K  NIL+D +     G+L L  F  G     T   
Sbjct: 161 -------AVRHCHNC---GVLHRDIKDENILIDLN----RGELKLIDFGSGALLKDTVYT 206

Query: 198 TASNSIEIKGIVGYVAPEYGMGSK-ASVSGDVYNFGILLLEMFTRRRPTD 246
               +        Y  PE+    +    S  V++ GILL +M     P +
Sbjct: 207 DFDGTRV------YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 250

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 62.4 bits (152), Expect = 3e-11
 Identities = 46/220 (20%), Positives = 89/220 (40%), Gaps = 31/220 (14%)

Query: 32  FSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNI-RHRNLI 90
           F     +G G    VYKG   ++  + A+KV+++   E       E N L+    HRN+ 
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEE-EIKQEINMLKKYSHHRNIA 84

Query: 91  KIITICSSIDFEGFDFKA-IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI---DVSFA 146
                    +  G D +  +V E+    ++   ++ + G    L +   IA    ++   
Sbjct: 85  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT--LKEEW-IAYICREILRG 141

Query: 147 IEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIK 206
           + + H H    ++H D+K  N+LL ++      ++ L  F      G +A+         
Sbjct: 142 LSHLHQH---KVIHRDIKGQNVLLTEN-----AEVKLVDF------GVSAQLDRTVGRRN 187

Query: 207 GIVG---YVAPEYGMGSKASVSG-----DVYNFGILLLEM 238
             +G   ++APE     +   +      D+++ GI  +EM
Sbjct: 188 TFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEM 227

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 61.9 bits (151), Expect = 5e-11
 Identities = 35/195 (17%), Positives = 74/195 (37%), Gaps = 43/195 (22%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQ--KEASRSFAAECNALRNIRHR-NLIKII 93
           ++G+G  ++V + I   +    A K +  ++  ++       E   L   +    +I + 
Sbjct: 36  ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95

Query: 94  TICSSIDFEGFDFKAIVFEYMQ-----NRNLEQWLRQSNGQLRFLTQR--VNIAIDVSFA 146
            +     +E      ++ EY       +  L +           +++   + +   +   
Sbjct: 96  EV-----YENTSEIILILEYAAGGEIFSLCLPE-------LAEMVSENDVIRLIKQILEG 143

Query: 147 IEYFHHHCQPSIVHGDLKPSNILL-DQDIVAHV--GDLGLAKFLFGYEPGTAAETASNSI 203
           + Y H +   +IVH DLKP NILL     +  +   D G+++                  
Sbjct: 144 VYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK---IGHAC--------- 188

Query: 204 EIKGIVG---YVAPE 215
           E++ I+G   Y+APE
Sbjct: 189 ELREIMGTPEYLAPE 203

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 61.6 bits (150), Expect = 7e-11
 Identities = 38/163 (23%), Positives = 62/163 (38%), Gaps = 20/163 (12%)

Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNL 89
            NF    KIG G    +  G    +   VA+K+  +K +                 ++ L
Sbjct: 9   PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRF-------YKQL 61

Query: 90  IKIITICSSIDF--EGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAI 147
                I     F   G  + A+V E +   +LE      +      T  + IAI +   +
Sbjct: 62  GSGDGIPQVYYFGPCG-KYNAMVLE-LLGPSLEDLFDLCDRTFSLKTV-LMIAIQLISRM 118

Query: 148 EYFHHHCQPSIVHGDLKPSNILLDQDI-----VAHVGDLGLAK 185
           EY H     ++++ D+KP N L+ +       V H+ D  LAK
Sbjct: 119 EYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 61.3 bits (149), Expect = 9e-11
 Identities = 49/224 (21%), Positives = 80/224 (35%), Gaps = 61/224 (27%)

Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAA---------ECNALRNIRHRN 88
           +G G    V+  +  E    V VK +  K+K     +           E   L  + H N
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIK-KEKVLEDCWIEDPKLGKVTLEIAILSRVEHAN 90

Query: 89  LIKIITICSSIDF---------EGFDFKAIVFEY-MQNRNL-EQWLRQSNGQLRFLTQRV 137
           +IK++ I  +  F          G D    +F +  ++  L E              Q V
Sbjct: 91  IIKVLDIFENQGFFQLVMEKHGSGLD----LFAFIDRHPRLDEPLAS------YIFRQLV 140

Query: 138 NIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAE 197
           +       A+ Y        I+H D+K  NI++ +D    + D G A +    E G    
Sbjct: 141 S-------AVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAY---LERGKLFY 187

Query: 198 TASNSIEIKGIVGYVAPE------YGMGSKASVSGDVYNFGILL 235
           T   +IE      Y APE      Y  G +     ++++ G+ L
Sbjct: 188 TFCGTIE------YCAPEVLMGNPYR-GPEL----EMWSLGVTL 220

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 60.6 bits (147), Expect = 2e-10
 Identities = 38/168 (22%), Positives = 68/168 (40%), Gaps = 26/168 (15%)

Query: 37  KIGQGGVSIVYKGILDESRSI-----VAVKVVNLKQKEASR-----SFAAECNALRNIRH 86
            IGQGG   +Y   ++ S S+       VKV                 AA+   ++    
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101

Query: 87  RNLIKIITICSSIDF-----EGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRV-NIA 140
              +K + +            G  ++ ++ +     +L++    +    RF  + V  ++
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMD-RFGSDLQKIYEANAK--RFSRKTVLQLS 158

Query: 141 IDVSFAIEYFHHHCQPSIVHGDLKPSNILL---DQDIVAHVGDLGLAK 185
           + +   +EY H H     VHGD+K SN+LL   + D V ++ D GLA 
Sbjct: 159 LRILDILEYIHEH---EYVHGDIKASNLLLNYKNPDQV-YLVDYGLAY 202

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 60.6 bits (147), Expect = 2e-10
 Identities = 53/188 (28%), Positives = 81/188 (43%), Gaps = 36/188 (19%)

Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAA----ECNALRNIRHRNLIKII 93
           +G G    V  G  + +   VAVK++N +QK  S         E   L+  RH ++IK+ 
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILN-RQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82

Query: 94  TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQL------RFLTQRVNIAIDVSFAI 147
            + S+   + F    +V EY+    L  ++   NG+L      R   Q ++        +
Sbjct: 83  QVIST-PSDIF----MVMEYVSGGELFDYI-CKNGRLDEKESRRLFQQILS-------GV 129

Query: 148 EYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKG 207
           +Y H H    +VH DLKP N+LLD  + A + D GL+        G    T+  S     
Sbjct: 130 DYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNM---MSDGEFLRTSCGS----- 178

Query: 208 IVGYVAPE 215
              Y APE
Sbjct: 179 -PNYAAPE 185

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 60.5 bits (147), Expect = 2e-10
 Identities = 48/228 (21%), Positives = 78/228 (34%), Gaps = 56/228 (24%)

Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVN---LKQKEASRSFAAECNALRNIRHRNLIKIIT 94
           IG+G  S V    + ++  + A+K++N   + ++     F  E + L N   R + ++  
Sbjct: 69  IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH- 127

Query: 95  ICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAID----------VS 144
             +   F+  ++  +V EY              G L  L  +    I           + 
Sbjct: 128 -FA---FQDENYLYLVMEYY-----------VGGDLLTLLSKFGERIPAEMARFYLAEIV 172

Query: 145 FAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHV--GDLGLAKFLFGYEPGTAAETASNS 202
            AI+  H       VH D+KP NILLD+    H+   D G        +        S  
Sbjct: 173 MAIDSVHRL---GYVHRDIKPDNILLDRC--GHIRLADFGSCL-----KLRADGTVRSLV 222

Query: 203 IEIKGIVG---YVAPEYGMGSKASVSGDVYN-------FGILLLEMFT 240
                 VG   Y++PE             Y         G+   EMF 
Sbjct: 223 -----AVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFY 265

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 59.5 bits (145), Expect = 2e-10
 Identities = 40/188 (21%), Positives = 67/188 (35%), Gaps = 35/188 (18%)

Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQK-EASRSFAAECNALRNIRHRNLIKIITIC 96
           +G+G    V   +   +   VAVK+V++K+  +   +   E    + + H N++K     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQL------RFLTQRVNIAIDVSFAIEYF 150
              + +      +  EY     L   + + +  +      RF  Q +         + Y 
Sbjct: 75  REGNIQ-----YLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMA-------GVVYL 121

Query: 151 HHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG 210
           H      I H D+KP N+LLD+     + D GLA                         G
Sbjct: 122 HGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM---------CG 169

Query: 211 ---YVAPE 215
              YVAPE
Sbjct: 170 TLPYVAPE 177

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 59.2 bits (144), Expect = 3e-10
 Identities = 59/235 (25%), Positives = 92/235 (39%), Gaps = 68/235 (28%)

Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAA----ECNALRNIRHRNLIKII 93
           +G+G    V      +++  VA+K ++ +Q             E + L+ +RH ++IK+ 
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFIS-RQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75

Query: 94  TICSSIDF----------EGFDFKAIVFEYMQNRNLEQWLRQSNGQL------RFLTQRV 137
            + ++             E FD+  IV                  ++      RF  Q +
Sbjct: 76  DVITTPTDIVMVIEYAGGELFDY--IV---------------EKKRMTEDEGRRFFQQII 118

Query: 138 NIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAE 197
                   AIEY H H    IVH DLKP N+LLD ++   + D GL+        G   +
Sbjct: 119 C-------AIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNI---MTDGNFLK 165

Query: 198 TASNSIEIKGIVGYVAPE------YGMGSKASVSGDVYNFGILLLEMFTRRRPTD 246
           T+  S        Y APE      Y  G +     DV++ GI+L  M   R P D
Sbjct: 166 TSCGSPN------YAAPEVINGKLYA-GPEV----DVWSCGIVLYVMLVGRLPFD 209

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 59.2 bits (144), Expect = 4e-10
 Identities = 40/188 (21%), Positives = 67/188 (35%), Gaps = 35/188 (18%)

Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQK-EASRSFAAECNALRNIRHRNLIKIITIC 96
           +G+G    V   +   +   VAVK+V++K+  +   +   E    + + H N++K     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQL------RFLTQRVNIAIDVSFAIEYF 150
              + +      +  EY     L   + + +  +      RF  Q +         + Y 
Sbjct: 75  REGNIQ-----YLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMA-------GVVYL 121

Query: 151 HHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG 210
           H      I H D+KP N+LLD+     + D GLA                         G
Sbjct: 122 HGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM---------CG 169

Query: 211 ---YVAPE 215
              YVAPE
Sbjct: 170 TLPYVAPE 177

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 58.9 bits (143), Expect = 4e-10
 Identities = 47/221 (21%), Positives = 80/221 (36%), Gaps = 53/221 (23%)

Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAA-------ECNALRNIR----H 86
           +G+GG   V+ G     R  VA+KV+  + +    S  +       E   L  +     H
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIP-RNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97

Query: 87  RNLIKIITICSSIDFEGFDFKA---IVFEYMQN-RNLEQWLRQSNGQL------RFLTQR 136
             +I++         + F+ +    +V E     ++L  ++ +  G L       F  Q 
Sbjct: 98  PGVIRL--------LDWFETQEGFMLVLERPLPAQDLFDYITE-KGPLGEGPSRCFFGQV 148

Query: 137 VNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG-YEPGTA 195
           V        AI++ H      +VH D+K  NIL+D       G   L  F  G       
Sbjct: 149 VA-------AIQHCHSR---GVVHRDIKDENILID----LRRGCAKLIDFGSGALLHDEP 194

Query: 196 AETASNSIEIKGIVGYVAPEYGMGSK-ASVSGDVYNFGILL 235
                 +        Y  PE+    +  ++   V++ GILL
Sbjct: 195 YTDFDGTRV------YSPPEWISRHQYHALPATVWSLGILL 229

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 59.0 bits (143), Expect = 5e-10
 Identities = 46/218 (21%), Positives = 82/218 (37%), Gaps = 38/218 (17%)

Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVN----LKQKEASRSFAAECNALRNIRHRNLIKII 93
           IG+G    V    L  +  + A+K++N    LK+ E +  F  E + L N   + +  + 
Sbjct: 82  IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETAC-FREERDVLVNGDSKWITTLH 140

Query: 94  TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNI-AIDVSFAIEYFHH 152
              +   F+  +   +V +Y    +L   L +     R   +       ++  AI+  H 
Sbjct: 141 --YA---FQDDNNLYLVMDYYVGGDLLTLLSKFED--RLPEEMARFYLAEMVIAIDSVHQ 193

Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHV--GDLGLAKFLFGYEPGTAAETASNSIEIKGIVG 210
                 VH D+KP NIL+D +   H+   D G        +        S+       VG
Sbjct: 194 L---HYVHRDIKPDNILMDMN--GHIRLADFGSCL-----KLMEDGTVQSSV-----AVG 238

Query: 211 ---YVAPEYGMGSKASVSG-----DVYNFGILLLEMFT 240
              Y++PE     +          D ++ G+ + EM  
Sbjct: 239 TPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLY 276

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 59.0 bits (143), Expect = 7e-10
 Identities = 52/219 (23%), Positives = 94/219 (42%), Gaps = 45/219 (20%)

Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFA-AECNALRNIRHR---NLIKII 93
           IG+G    V K    +    VA+K+V  + ++     A  E   L ++R +   N + +I
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMV--RNEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162

Query: 94  TICSSIDFEGFDFKA---IVFEYMQNRNLEQWLRQSNGQLRFLTQRV-NIAIDVSFAIEY 149
            +      E F F+    + FE + + NL + ++++  Q  F    V   A  +   ++ 
Sbjct: 163 HM-----LENFTFRNHICMTFELL-SMNLYELIKKNKFQ-GFSLPLVRKFAHSILQCLDA 215

Query: 150 FHHHCQPSIVHGDLKPSNILLDQDIVAH--VGDLGLAKFLFGYEPGTAAETASNSIEIKG 207
            H +    I+H DLKP NILL Q   +   V D G + +                 E + 
Sbjct: 216 LHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCY-----------------EHQR 255

Query: 208 IVGYV------APEYGMGSKASVSGDVYNFGILLLEMFT 240
           +  Y+      APE  +G++  +  D+++ G +L E+ T
Sbjct: 256 VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLT 294

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 58.6 bits (142), Expect = 7e-10
 Identities = 55/228 (24%), Positives = 88/228 (38%), Gaps = 58/228 (25%)

Query: 32  FSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFA---AECNALRNIRHRN 88
           FS   +IG G    VY      +  +VA+K ++   K+++  +     E   L+ +RH N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 89  LIKIITICSSIDFEGFDFKA----IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAI--- 141
            I+         + G   +     +V EY    +    L      L    Q V IA    
Sbjct: 116 TIQ---------YRGCYLREHTAWLVMEYCLG-SASDLLEVHKKPL----QEVEIAAVTH 161

Query: 142 DVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAE-TAS 200
                + Y H H   +++H D+K  NILL +      G + L  F      G+A+    +
Sbjct: 162 GALQGLAYLHSH---NMIHRDVKAGNILLSEP-----GLVKLGDF------GSASIMAPA 207

Query: 201 NSIEIKGIVG---YVAPE-------YGMGSKASVSGDVYNFGILLLEM 238
           NS      VG   ++APE            K     DV++ GI  +E+
Sbjct: 208 NS-----FVGTPYWMAPEVILAMDEGQYDGKV----DVWSLGITCIEL 246

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 58.5 bits (142), Expect = 7e-10
 Identities = 53/216 (24%), Positives = 83/216 (38%), Gaps = 36/216 (16%)

Query: 38  IGQGGVSIVYKGILDESRSIVAVK------VVNLKQKEASRSFAAECNALRNIRHRNLIK 91
           +G G    V      ES +  A+K      VV LKQ E + +   E   L+ +    L+K
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN---EKRILQAVNFPFLVK 105

Query: 92  IITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNI-AIDVSFAIEYF 150
           +    S   F+      +V EY+    +   LR+     RF        A  +    EY 
Sbjct: 106 LE--FS---FKDNSNLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYL 157

Query: 151 HHHCQPSIVHGDLKPSNILLDQDIVAHV--GDLGLAKFLFGYEPGTAAETASNSIEIKGI 208
           H      +++ DLKP N+L+DQ    ++   D G AK            T   + E    
Sbjct: 158 HSL---DLIYRDLKPENLLIDQQ--GYIQVTDFGFAK-----RVKGRTWTLCGTPE---- 203

Query: 209 VGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
              +APE  +    + + D +  G+L+ EM     P
Sbjct: 204 --ALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 58.2 bits (141), Expect = 8e-10
 Identities = 50/215 (23%), Positives = 84/215 (39%), Gaps = 31/215 (14%)

Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFA-AECNALRNIRHR---NLIK 91
           + IG+G    V K      +  VA+K++  K K+A  + A  E   L  +          
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKII--KNKKAFLNQAQIEVRLLELMNKHDTEMKYY 117

Query: 92  IITICSSIDFEGFDFKA---IVFEYMQNRNLEQWLRQSNGQLRFLTQRV-NIAIDVSFAI 147
           I+ +        F F+    +VFE + + NL   LR                A  +  A+
Sbjct: 118 IVHL-----KRHFMFRNHLCLVFEML-SYNLYDLLRN-TNFRGVSLNLTRKFAQQMCTAL 170

Query: 148 EYFHHHCQPSIVHGDLKPSNILLDQDIVAH--VGDLGLAKFLFGYEPGTAAETASNSIEI 205
            +     + SI+H DLKP NILL     +   + D G +    G       ++       
Sbjct: 171 LFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ-LGQRIYQYIQSRF----- 223

Query: 206 KGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
                Y +PE  +G    ++ D+++ G +L+EM T
Sbjct: 224 -----YRSPEVLLGMPYDLAIDMWSLGCILVEMHT 253

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 58.6 bits (142), Expect = 8e-10
 Identities = 41/217 (18%), Positives = 82/217 (37%), Gaps = 39/217 (17%)

Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVN----LKQKEASRSFAAECNALRNIRHRNLIKII 93
           IG+G    V       +R + A+K+++    +K+ +++  F  E + +       ++++ 
Sbjct: 77  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF-FWEERDIMAFANSPWVVQLF 135

Query: 94  TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNI-AIDVSFAIEYFHH 152
              +   F+   +  +V EYM   +L   +           +       +V  A++  H 
Sbjct: 136 --YA---FQDDRYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHS 186

Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHV--GDLGLAKFLFGYEPGTAAETASNSIEIKGIVG 210
                 +H D+KP N+LLD+    H+   D G        +         ++      VG
Sbjct: 187 M---GFIHRDVKPDNMLLDKS--GHLKLADFGTCM-----KMNKEGMVRCDT-----AVG 231

Query: 211 ---YVAPE----YGMGSKASVSGDVYNFGILLLEMFT 240
              Y++PE     G         D ++ G+ L EM  
Sbjct: 232 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 268

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 59.1 bits (142), Expect = 8e-10
 Identities = 49/329 (14%), Positives = 95/329 (28%), Gaps = 83/329 (25%)

Query: 22  YAELSKATNNFSPANKI---GQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFA--- 75
           Y +L +A     PA  +   G  G      G     ++ VA+ V    + +    F    
Sbjct: 137 YLKLRQALLELRPAKNVLIDGVLGS-----G-----KTWVALDVCLSYKVQCKMDFKIFW 186

Query: 76  ---AECNALRNIRHRNLIKII-TICSSIDFEGFDFKAIVFEYMQNRN-LEQWLRQSNGQL 130
                CN         +++++  +   ID                 + ++  LR      
Sbjct: 187 LNLKNCN-----SPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELR------ 235

Query: 131 RFLTQRVN-----IAIDV--SFAIEYFHHHCQPSIVHGDLKPSNILL---DQDIV----- 175
           R L  +       + ++V  + A   F+  C+            ILL    + +      
Sbjct: 236 RLLKSKPYENCLLVLLNVQNAKAWNAFNLSCK------------ILLTTRFKQVTDFLSA 283

Query: 176 AHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILL 235
           A    + L        P          ++ +     +  E    +               
Sbjct: 284 ATTTHISLDHHSMTLTPDEVKSLLLKYLDCR--PQDLPREVLTTNP------------RR 329

Query: 236 LEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLV--- 292
           L +            +GL   +  K    DK+  I++ SL +   A      +   V   
Sbjct: 330 LSIIA------ESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPP 383

Query: 293 -AVIGTGVTCSMESPMERMEMRDVVAKLR 320
            A I T +   +   + + ++  VV KL 
Sbjct: 384 SAHIPTILLSLIWFDVIKSDVMVVVNKLH 412

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 58.1 bits (141), Expect = 1e-09
 Identities = 52/233 (22%), Positives = 90/233 (38%), Gaps = 49/233 (21%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQK--EASRSFAAECNALRNIRHR-----NL 89
           K+G G    V      +++   AVKVV   +K   +++    E + L+ I++      N+
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKI---EADILKKIQNDDINNNNI 98

Query: 90  IKIITICSSIDFEGFDFKA---IVFEYMQNRNLEQWLRQSNGQLRFLTQRV-NIAIDVSF 145
           +K            F +     ++FE +   +L + + + N    F  + +    I++  
Sbjct: 99  VKY--------HGKFMYYDHMCLIFEPL-GPSLYEIITR-NNYNGFHIEDIKLYCIEILK 148

Query: 146 AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEI 205
           A+ Y       S+ H DLKP NILL         +  L       +        + S  I
Sbjct: 149 ALNYLRKM---SLTHTDLKPENILL----DDPYFEKSLITVRRVTDGKKIQIYRTKSTGI 201

Query: 206 KGI-VG-----------------YVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
           K I  G                 Y APE  +     VS D+++FG +L E++T
Sbjct: 202 KLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT 254

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 57.0 bits (138), Expect = 2e-09
 Identities = 31/163 (19%), Positives = 61/163 (37%), Gaps = 20/163 (12%)

Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNL 89
            ++    +IG+G   ++++G    +   VA+K    +    +     E         + L
Sbjct: 10  VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTY-----KLL 62

Query: 90  IKIITICSSIDF--EGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAI 147
                I +   F  EG     +V + +   +LE  L     +    T     A  +   +
Sbjct: 63  AGCTGIPNVYYFGQEG-LHNVLVID-LLGPSLEDLLDLCGRKFSVKTV-AMAAKQMLARV 119

Query: 148 EYFHHHCQPSIVHGDLKPSNILLDQDI-----VAHVGDLGLAK 185
           +  H     S+V+ D+KP N L+ +       + +V D G+ K
Sbjct: 120 QSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 56.8 bits (138), Expect = 2e-09
 Identities = 56/207 (27%), Positives = 85/207 (41%), Gaps = 48/207 (23%)

Query: 53  ESRSIVAVKV------VNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF 106
            +    A+KV      V LKQ E +     E   L  + H  +I++    +   F+    
Sbjct: 29  HNGRYYAMKVLKKEIVVRLKQVEHTN---DERLMLSIVTHPFIIRMW--GT---FQDAQQ 80

Query: 107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNI-AIDVSFAIEYFHHHCQPSIVHGDLKP 165
             ++ +Y++   L   LR+S    RF        A +V  A+EY H      I++ DLKP
Sbjct: 81  IFMIMDYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKP 134

Query: 166 SNILLDQDIVAHV--GDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPE------YG 217
            NILLD++   H+   D G AK            T   + +      Y+APE      Y 
Sbjct: 135 ENILLDKN--GHIKITDFGFAK-----YVPDVTYTLCGTPD------YIAPEVVSTKPYN 181

Query: 218 MGSKASVSGDVYNFGILLLEMFTRRRP 244
                S+  D ++FGIL+ EM     P
Sbjct: 182 K----SI--DWWSFGILIYEMLAGYTP 202

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 57.3 bits (138), Expect = 2e-09
 Identities = 32/128 (25%), Positives = 50/128 (39%), Gaps = 21/128 (16%)

Query: 131 RFLTQRVNI-AIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHV--GDLGLAKFL 187
           RF        A +++  + +        I++ DLK  N++LD +   H+   D G+ K  
Sbjct: 438 RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSE--GHIKIADFGMCK-- 490

Query: 188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP--- 244
                G   +T        G   Y+APE         S D + FG+LL EM   + P   
Sbjct: 491 ENIWDGVTTKT------FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 544

Query: 245 --TDAMFN 250
              D +F 
Sbjct: 545 EDEDELFQ 552

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 56.4 bits (135), Expect = 3e-09
 Identities = 33/200 (16%), Positives = 59/200 (29%), Gaps = 49/200 (24%)

Query: 28  ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVV--------NLKQKEASRSFAAECN 79
            T       KIG+G    V++ I D   + VA+K++        N   ++       E  
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTIAD--HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75

Query: 80  ALRNI---------RHRNLIKIITIC-------------------------SSIDFEGFD 105
             + +         R    I + ++                             DF   D
Sbjct: 76  ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135

Query: 106 FKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKP 165
              IV E+         L Q   +L  L    +I   ++ ++       +    H DL  
Sbjct: 136 QLFIVLEFEFGGID---LEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FEHRDLHW 190

Query: 166 SNILLDQDIVAHVGDLGLAK 185
            N+LL +  +  +      K
Sbjct: 191 GNVLLKKTSLKKLHYTLNGK 210

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 56.7 bits (137), Expect = 3e-09
 Identities = 55/232 (23%), Positives = 91/232 (39%), Gaps = 31/232 (13%)

Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVV---NLKQKEASRSFAAECNALRNIRH 86
           N F     +G+G    V       +    A+K++    +  K+       E   L+N RH
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207

Query: 87  RNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNI-AIDVSF 145
             L  +    S   F+  D    V EY     L   L +      F   R      ++  
Sbjct: 208 PFLTALK--YS---FQTHDRLCFVMEYANGGELFFHLSRER---VFSEDRARFYGAEIVS 259

Query: 146 AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHV--GDLGLAKFLFGYEPGTAAETASNSI 203
           A++Y H   + ++V+ DLK  N++LD+D   H+   D GL K   G + G   +T   + 
Sbjct: 260 ALDYLHS--EKNVVYRDLKLENLMLDKD--GHIKITDFGLCK--EGIKDGATMKTFCGTP 313

Query: 204 EIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP-----TDAMFN 250
           E      Y+APE    +    + D +  G+++ EM   R P      + +F 
Sbjct: 314 E------YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE 359

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 55.8 bits (135), Expect = 4e-09
 Identities = 34/160 (21%), Positives = 64/160 (40%), Gaps = 27/160 (16%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNI-RHRNLIKIITI 95
            +G G    V +     ++   A+K++     +A R    E        +  ++++I+ +
Sbjct: 25  VLGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARR----EVELHWRASQCPHIVRIVDV 79

Query: 96  CSSIDFEGFDFKAIVFEYMQ-----NRNLEQWLRQSNGQLRFLTQR--VNIAIDVSFAIE 148
             +  + G     IV E +      +R  ++      G   F T+R    I   +  AI+
Sbjct: 80  YEN-LYAGRKCLLIVMECLDGGELFSRIQDR------GDQAF-TEREASEIMKSIGEAIQ 131

Query: 149 YFHHHCQPSIVHGDLKPSNILL---DQDIVAHVGDLGLAK 185
           Y H     +I H D+KP N+L      + +  + D G AK
Sbjct: 132 YLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 55.8 bits (135), Expect = 5e-09
 Identities = 37/154 (24%), Positives = 63/154 (40%), Gaps = 18/154 (11%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           KIG G    +Y G    +   VA+K+  +K K        E    + ++       + I 
Sbjct: 16  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQ-----GGVGIP 68

Query: 97  SSIDF--EGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHC 154
           +      EG D+  +V E +   +LE      + +    T  + +A  +   IEY H   
Sbjct: 69  TIRWCGAEG-DYNVMVME-LLGPSLEDLFNFCSRKFSLKTV-LLLADQMISRIEYIHSK- 124

Query: 155 QPSIVHGDLKPSNILLDQDI---VAHVGDLGLAK 185
             + +H D+KP N L+       + ++ D GLAK
Sbjct: 125 --NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 55.2 bits (134), Expect = 7e-09
 Identities = 33/112 (29%), Positives = 48/112 (42%), Gaps = 20/112 (17%)

Query: 146 AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHV--GDLGLAKFLFGYEPGTAAETASNSI 203
           A+ + H      I++ DLKP NI+L+     HV   D GL K       GT   T   +I
Sbjct: 133 ALGHLHQK---GIIYRDLKPENIMLNHQ--GHVKLTDFGLCK--ESIHDGTVTHTFCGTI 185

Query: 204 EIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP-----TDAMFN 250
           E      Y+APE  M S  + + D ++ G L+ +M T   P          +
Sbjct: 186 E------YMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTID 231

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 55.3 bits (134), Expect = 9e-09
 Identities = 28/115 (24%), Positives = 47/115 (40%), Gaps = 20/115 (17%)

Query: 143 VSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHV--GDLGLAKFLFGYEPGTAAETAS 200
           ++  + +        I++ DLK  N++LD +   H+   D G+ K       G   +T  
Sbjct: 130 IAIGLFFLQSK---GIIYRDLKLDNVMLDSE--GHIKIADFGMCK--ENIWDGVTTKTFC 182

Query: 201 NSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP-----TDAMFN 250
            + +      Y+APE         S D + FG+LL EM   + P      D +F 
Sbjct: 183 GTPD------YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ 231

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 54.9 bits (133), Expect = 1e-08
 Identities = 34/115 (29%), Positives = 52/115 (45%), Gaps = 20/115 (17%)

Query: 143 VSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHV--GDLGLAKFLFGYEPGTAAETAS 200
           +   +++ H      IV+ DLK  NILLD+D   H+   D G+ K            T  
Sbjct: 127 IILGLQFLHSK---GIVYRDLKLDNILLDKD--GHIKIADFGMCK--ENMLGDAKTNT-- 177

Query: 201 NSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP-----TDAMFN 250
                 G   Y+APE  +G K + S D ++FG+LL EM   + P      + +F+
Sbjct: 178 ----FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH 228

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 55.0 bits (133), Expect = 1e-08
 Identities = 34/112 (30%), Positives = 46/112 (41%), Gaps = 20/112 (17%)

Query: 146 AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHV--GDLGLAKFLFGYEPGTAAETASNSI 203
           A+ Y H     +IV+ DLKP NILLD     H+   D GL K     E  +   T   + 
Sbjct: 151 ALGYLHSL---NIVYRDLKPENILLDSQ--GHIVLTDFGLCK--ENIEHNSTTSTFCGTP 203

Query: 204 EIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP-----TDAMFN 250
           E      Y+APE         + D +  G +L EM     P     T  M++
Sbjct: 204 E------YLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD 249

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 54.5 bits (132), Expect = 1e-08
 Identities = 33/104 (31%), Positives = 46/104 (44%), Gaps = 15/104 (14%)

Query: 143 VSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHV--GDLGLAKFLFGYEPGTAAETAS 200
           +S A+ Y H      I++ DLK  N+LLD +   H+   D G+ K   G  PG    T  
Sbjct: 119 ISLALNYLHER---GIIYRDLKLDNVLLDSE--GHIKLTDYGMCK--EGLRPGDTTSTFC 171

Query: 201 NSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
            +        Y+APE   G     S D +  G+L+ EM   R P
Sbjct: 172 GTPN------YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 54.5 bits (132), Expect = 1e-08
 Identities = 32/112 (28%), Positives = 51/112 (45%), Gaps = 20/112 (17%)

Query: 146 AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHV--GDLGLAKFLFGYEPGTAAETASNSI 203
           A+++ H      I++ DLKP NILLD++   H+   D GL+K     +    A +   ++
Sbjct: 138 ALDHLHSL---GIIYRDLKPENILLDEE--GHIKLTDFGLSK--ESIDHEKKAYSFCGTV 190

Query: 204 EIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP-----TDAMFN 250
           E      Y+APE       + S D ++FG+L+ EM T   P           
Sbjct: 191 E------YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMT 236

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 54.7 bits (132), Expect = 1e-08
 Identities = 33/104 (31%), Positives = 46/104 (44%), Gaps = 15/104 (14%)

Query: 143 VSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHV--GDLGLAKFLFGYEPGTAAETAS 200
           +S A+ Y H      I++ DLK  N+LLD +   H+   D G+ K   G  PG    T  
Sbjct: 162 ISLALNYLHER---GIIYRDLKLDNVLLDSE--GHIKLTDYGMCK--EGLRPGDTTSTFC 214

Query: 201 NSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
            +        Y+APE   G     S D +  G+L+ EM   R P
Sbjct: 215 GTPN------YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 53.8 bits (130), Expect = 2e-08
 Identities = 31/112 (27%), Positives = 50/112 (44%), Gaps = 20/112 (17%)

Query: 146 AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHV--GDLGLAKFLFGYEPGTAAETASNSI 203
           A+EY H      +V+ D+K  N++LD+D   H+   D GL K   G   G   +T   + 
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKD--GHIKITDFGLCK--EGISDGATMKTFCGTP 169

Query: 204 EIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP-----TDAMFN 250
           E      Y+APE    +    + D +  G+++ EM   R P      + +F 
Sbjct: 170 E------YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE 215

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 53.4 bits (129), Expect = 3e-08
 Identities = 35/128 (27%), Positives = 49/128 (38%), Gaps = 21/128 (16%)

Query: 131 RFLTQRVNI-AIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHV--GDLGLAKFL 187
           RF   R    A ++  A+ + H      I++ DLK  N+LLD +   H    D G+ K  
Sbjct: 120 RFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHE--GHCKLADFGMCK-- 172

Query: 188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP--- 244
            G   G    T        G   Y+APE         + D +  G+LL EM     P   
Sbjct: 173 EGICNGVTTAT------FCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA 226

Query: 245 --TDAMFN 250
              D +F 
Sbjct: 227 ENEDDLFE 234

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 53.5 bits (129), Expect = 3e-08
 Identities = 48/232 (20%), Positives = 88/232 (37%), Gaps = 51/232 (21%)

Query: 37  KIGQGGVSIVYKGI-LDESRSIVAVKVVNLKQK--EASRSFAAECNALRNIRHR---NLI 90
            +G+G    V + +     +S VA+K++    K  EA+R    E N L+ I+ +   N  
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARL---EINVLKKIKEKDKENKF 82

Query: 91  KIITICSSIDFEGFDFKA---IVFEYMQNRNLEQWLRQSNGQLRFLTQRV-NIAIDVSFA 146
             + +      + F+F     I FE +  +N  ++L++ N    +    V ++A  +  A
Sbjct: 83  LCVLM-----SDWFNFHGHMCIAFELL-GKNTFEFLKE-NNFQPYPLPHVRHMAYQLCHA 135

Query: 147 IEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIK 206
           + + H +    + H DLKP NIL                     E  +  E +  +  I+
Sbjct: 136 LRFLHEN---QLTHTDLKPENILFVNS----------EFETLYNEHKSCEEKSVKNTSIR 182

Query: 207 GI-VG-----------------YVAPEYGMGSKASVSGDVYNFGILLLEMFT 240
               G                 Y  PE  +    +   DV++ G +L E + 
Sbjct: 183 VADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYR 234

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 52.7 bits (127), Expect = 6e-08
 Identities = 31/103 (30%), Positives = 48/103 (46%), Gaps = 24/103 (23%)

Query: 146 AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHV--GDLGLAKFLFGYEPGTAAETASNSI 203
           A+E+ H      I++ D+K  NILLD +   HV   D GL+K  F  +    A     +I
Sbjct: 171 ALEHLHKL---GIIYRDIKLENILLDSN--GHVVLTDFGLSK-EFVADETERAYDFCGTI 224

Query: 204 EIKGIVGYVAPE------YGMGSKASVSGDVYNFGILLLEMFT 240
           E      Y+AP+       G     +V  D ++ G+L+ E+ T
Sbjct: 225 E------YMAPDIVRGGDSGHD--KAV--DWWSLGVLMYELLT 257

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 52.7 bits (126), Expect = 7e-08
 Identities = 41/154 (26%), Positives = 65/154 (42%), Gaps = 18/154 (11%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           KIG G    +Y G   ++   VA+K+ N+K K        E         R L     I 
Sbjct: 14  KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIY-----RILQGGTGIP 66

Query: 97  SSIDF--EGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHC 154
           +   F  EG D+  +V + +   +LE      + +L   T  + +A  +   +E+ H   
Sbjct: 67  NVRWFGVEG-DYNVLVMD-LLGPSLEDLFNFCSRKLSLKTV-LMLADQMINRVEFVHSK- 122

Query: 155 QPSIVHGDLKPSNILLDQDIVAH---VGDLGLAK 185
             S +H D+KP N L+     A+   + D GLAK
Sbjct: 123 --SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 51.1 bits (122), Expect = 2e-07
 Identities = 29/129 (22%), Positives = 54/129 (41%), Gaps = 9/129 (6%)

Query: 112 EYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLD 171
           + + +   E+           L   +  +  V+  +E+         +H DL   NILL 
Sbjct: 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLS 227

Query: 172 QDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNF 231
           +  V  + D GLA+ +  Y+           + +K +    APE       ++  DV++F
Sbjct: 228 EKNVVKICDFGLARDI--YKDPDYVRKGDARLPLKWM----APETIFDRVYTIQSDVWSF 281

Query: 232 GILLLEMFT 240
           G+LL E+F+
Sbjct: 282 GVLLWEIFS 290

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 39.9 bits (93), Expect = 8e-04
 Identities = 27/167 (16%), Positives = 54/167 (32%), Gaps = 26/167 (15%)

Query: 36  NKIGQGGVSIVYKGIL-----DESRSIVAVKVVNLKQKEASRS----FAAECNALRNI-R 85
             +G+G    V +          +   VAVK++    + A+ S      +E   L +I  
Sbjct: 28  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKILIHIGH 84

Query: 86  HRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSF 145
           H N++ ++  C+           ++ E+ +  NL  +LR         ++R       + 
Sbjct: 85  HLNVVNLLGACTKPGGPLM----VIVEFCKFGNLSTYLR---------SKRNEFVPYKTK 131

Query: 146 AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEP 192
              +         +  DLK     +     +        K L   E 
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 178

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 51.1 bits (123), Expect = 2e-07
 Identities = 49/232 (21%), Positives = 88/232 (37%), Gaps = 51/232 (21%)

Query: 37  KIGQGGVSIVYKGI-LDESRSIVAVKVVNLKQK--EASRSFAAECNALRNIRHR---NLI 90
            +G+G    V + I        VAVK+V    +  EA+RS   E   L ++      +  
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARS---EIQVLEHLNTTDPNSTF 77

Query: 91  KIITICSSIDFEGFDFKA---IVFEYMQNRNLEQWLRQSNGQLRFLTQRV-NIAIDVSFA 146
           + + +      E F+      IVFE +   +   ++++ NG L F    +  +A  +  +
Sbjct: 78  RCVQM-----LEWFEHHGHICIVFELL-GLSTYDFIKE-NGFLPFRLDHIRKMAYQICKS 130

Query: 147 IEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL------------FGYEPGT 194
           + + H +    + H DLKP NIL  Q       +  + +              FG     
Sbjct: 131 VNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG----- 182

Query: 195 AAETASNSIEIKGIVGYV------APEYGMGSKASVSGDVYNFGILLLEMFT 240
                S + + +     V      APE  +    S   DV++ G +L+E + 
Sbjct: 183 -----SATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYL 229

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	331
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.94
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.93
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.85
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.73
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.41
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.21
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.05
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.05
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.76
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.74
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.57
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.53
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.33
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.21
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.08
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.89
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.87
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.73
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.65
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.61
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.59
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.44
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.4
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.22
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.98
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.97
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.91
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.77
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.32
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	95.77
3mes_A	424	Choline kinase; malaria, structural genomics, stru	94.92
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.04
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	88.06
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	85.64
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	81.85

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=4.9e-59  Score=404.07  Aligned_cols=261  Identities=22%  Similarity=0.379  Sum_probs=212.1

Q ss_pred             cCCCcCceeeccCeeEEEEeeec-----CCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCc
Q 046639           30 NNFSPANKIGQGGVSIVYKGILD-----ESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGF  104 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  104 (331)
                      ++|.+.++||+|+||+||+|++.     .++..||||+++.......+.+.+|+.++++++|||||+++++|.     +.
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~-----~~   87 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV-----EG   87 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----SS
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEe-----eC
Confidence            47999999999999999999874     357889999998777777788999999999999999999999964     45


Q ss_pred             ceeeEEEeecCCCCHHHHHHhcc-----------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCC
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQSN-----------GQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQD  173 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~  173 (331)
                      +..++|||||++|+|.+++....           ...+++..+..++.|++.||.|||++   +|+||||||+|||++.+
T Consensus        88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~  164 (299)
T 4asz_A           88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGEN  164 (299)
T ss_dssp             SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCC
Confidence            67899999999999999997632           34688899999999999999999999   99999999999999999


Q ss_pred             CcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCc
Q 046639          174 IVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEG  252 (331)
Q Consensus       174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~  252 (331)
                      +.+||+|||+|+.....      ..........||+.|+|||++.+..|+.++|||||||++|||+| |..||.+.... 
T Consensus       165 ~~~Ki~DFGla~~~~~~------~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~-  237 (299)
T 4asz_A          165 LLVKIGDFGMSRDVYST------DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN-  237 (299)
T ss_dssp             GCEEECCCSCHHHHTGG------GCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-
T ss_pred             CcEEECCcccceecCCC------CceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-
Confidence            99999999999875211      11112223468999999999999999999999999999999998 99999764321 


Q ss_pred             chHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhh
Q 046639          253 LTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARET  325 (331)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~  325 (331)
                      ...........+                    ..+..|+..+.+|+.+||+.||++|||+.+|.+.|+.+.++
T Consensus       238 ~~~~~i~~~~~~--------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~  290 (299)
T 4asz_A          238 EVIECITQGRVL--------------------QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA  290 (299)
T ss_dssp             HHHHHHHHTCCC--------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHcCCCC--------------------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence            111111111110                    11234677899999999999999999999999999988764

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.8e-59  Score=411.35  Aligned_cols=251  Identities=20%  Similarity=0.276  Sum_probs=203.7

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc--chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCccee
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      ++|.+++.||+|+||+||+|++..+++.||||++...  .....+.+.+|+.++++++|||||++++++     .+.+.+
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~-----~~~~~~   98 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESF-----EENGSL   98 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEE-----EECCEE
Confidence            5899999999999999999999999999999999754  344457789999999999999999999995     456789


Q ss_pred             eEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccc
Q 046639          108 AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      |+|||||+||+|.+++....+..+++..++.++.|++.||.|||++   +|+||||||+|||++.+|.+||+|||+|+..
T Consensus        99 yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~  175 (350)
T 4b9d_A           99 YIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVL  175 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCC
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceee
Confidence            9999999999999999877666678889999999999999999999   9999999999999999999999999999865


Q ss_pred             ccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchh
Q 046639          188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKV  267 (331)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  267 (331)
                      ..        .........||+.|+|||++.+..|+.++|||||||++|||++|..||..... ...+........+   
T Consensus       176 ~~--------~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~-~~~~~~i~~~~~~---  243 (350)
T 4b9d_A          176 NS--------TVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM-KNLVLKIISGSFP---  243 (350)
T ss_dssp             CH--------HHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHTCCC---
T ss_pred             cC--------CcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-HHHHHHHHcCCCC---
Confidence            11        11122345799999999999999999999999999999999999999975321 1112222221111   


Q ss_pred             hhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          268 MEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                            .           ....++..+.+|+.+||+.||++|||+.|+++
T Consensus       244 ------~-----------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          244 ------P-----------VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             ------C-----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ------C-----------CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                  0           11234567899999999999999999999985

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1e-58  Score=407.14  Aligned_cols=250  Identities=20%  Similarity=0.300  Sum_probs=208.6

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeE
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAI  109 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~l  109 (331)
                      ..|.++++||+|+||+||+|+++.+++.||||++........+.+.+|+.+|+.++|||||++++++     .+.+.+|+
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~-----~~~~~~~i  148 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY-----LVGDELWV  148 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEE-----EETTEEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEEEE
Confidence            4699999999999999999999999999999999866655566788999999999999999999995     44578999


Q ss_pred             EEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccccc
Q 046639          110 VFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG  189 (331)
Q Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~  189 (331)
                      |||||++|+|.+++.+.   .+++..+..++.|++.||.|||++   +|+||||||+|||++.+|.+||+|||+|+.+..
T Consensus       149 vmEy~~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  222 (346)
T 4fih_A          149 VMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK  222 (346)
T ss_dssp             EECCCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCC
Confidence            99999999999999763   378899999999999999999999   999999999999999999999999999987521


Q ss_pred             CCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhh
Q 046639          190 YEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVME  269 (331)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  269 (331)
                              .........||+.|+|||++.+..|+.++|||||||++|||++|.+||.+...  ......+....+     
T Consensus       223 --------~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--~~~~~~i~~~~~-----  287 (346)
T 4fih_A          223 --------EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMIRDNLP-----  287 (346)
T ss_dssp             --------SSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHSSC-----
T ss_pred             --------CCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHHHHHHcCCC-----
Confidence                    11223456799999999999999999999999999999999999999975311  111111111111     


Q ss_pred             hcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          270 IVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                         +..         .....+++.+.+|+.+||+.||++|||+.|+++
T Consensus       288 ---~~~---------~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          288 ---PRL---------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             ---CCC---------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---CCC---------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence               110         112345678899999999999999999999975

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=4.6e-58  Score=403.23  Aligned_cols=261  Identities=23%  Similarity=0.384  Sum_probs=207.6

Q ss_pred             cCCCcCceeeccCeeEEEEeeec-----CCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCc
Q 046639           30 NNFSPANKIGQGGVSIVYKGILD-----ESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGF  104 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  104 (331)
                      ++|.+.++||+|+||+||+|++.     .+++.||||+++..+....+.+.+|+.++++++|||||+++++|.     ..
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~-----~~  115 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCT-----EG  115 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----SS
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----EC
Confidence            46888899999999999999864     367899999998777777788999999999999999999999964     45


Q ss_pred             ceeeEEEeecCCCCHHHHHHhcc-------------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEec
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQSN-------------GQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLD  171 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~  171 (331)
                      +..++|||||++|+|.+++....             ...+++..+..++.|++.||.|||++   +|+||||||+|||++
T Consensus       116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~  192 (329)
T 4aoj_A          116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVG  192 (329)
T ss_dssp             SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEEC
Confidence            67899999999999999997642             23578899999999999999999999   999999999999999


Q ss_pred             CCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccC
Q 046639          172 QDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFN  250 (331)
Q Consensus       172 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~  250 (331)
                      .++.+||+|||+|+.....      ..........||+.|+|||++.+..++.++|||||||++|||+| |..||.....
T Consensus       193 ~~~~~Ki~DFGla~~~~~~------~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~  266 (329)
T 4aoj_A          193 QGLVVKIGDFGMSRDIYST------DYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN  266 (329)
T ss_dssp             TTTEEEECCCC----------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH
T ss_pred             CCCcEEEcccccceeccCC------CcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH
Confidence            9999999999999865221      11122234568999999999999999999999999999999999 9999976422


Q ss_pred             CcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhh
Q 046639          251 EGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARET  325 (331)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~  325 (331)
                      .  .....+....        .+           ..+..|++.+.+|+.+||+.||++|||+.||++.|+.+.++
T Consensus       267 ~--~~~~~i~~g~--------~~-----------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          267 T--EAIDCITQGR--------EL-----------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             H--HHHHHHHHTC--------CC-----------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             H--HHHHHHHcCC--------CC-----------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence            1  1111111100        00           12234677899999999999999999999999999998765

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=3.8e-58  Score=398.63  Aligned_cols=263  Identities=25%  Similarity=0.394  Sum_probs=206.8

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc--chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCccee
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      +++.+.++||+|+||+||+|++..   .||||+++..  +....+.+.+|+.++++++|||||+++++|..      +.+
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~------~~~  106 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK------DNL  106 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS------SSC
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC------CeE
Confidence            578899999999999999998753   4899998643  34456789999999999999999999998632      357


Q ss_pred             eEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccc
Q 046639          108 AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      ++|||||++|+|.+++.... ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+|+..
T Consensus       107 ~iVmEy~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~  182 (307)
T 3omv_A          107 AIVTQWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVK  182 (307)
T ss_dssp             EEEEECCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC-
T ss_pred             EEEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceec
Confidence            99999999999999997643 3478899999999999999999999   9999999999999999999999999999865


Q ss_pred             ccCCCCCcccccCCceeecccccccCCcccCC---CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCc
Q 046639          188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMG---SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALP  264 (331)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  264 (331)
                      ....      .........||+.|+|||++.+   +.|+.++|||||||++|||++|..||.+..... .....+.....
T Consensus       183 ~~~~------~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~-~~~~~~~~~~~  255 (307)
T 3omv_A          183 SRWS------GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD-QIIFMVGRGYA  255 (307)
T ss_dssp             -----------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-HHHHHHHTTCC
T ss_pred             ccCC------cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH-HHHHHHhcCCC
Confidence            2211      1122334579999999999864   468999999999999999999999997643221 12222211111


Q ss_pred             chhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhhh
Q 046639          265 DKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETFL  327 (331)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~~  327 (331)
                             .|..        .....+|+..+.+|+.+||+.||++|||+.+|++.|+.++..+-
T Consensus       256 -------~p~~--------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp  303 (307)
T 3omv_A          256 -------SPDL--------SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP  303 (307)
T ss_dssp             -------CCCS--------TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred             -------CCCc--------ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence                   1110        12223567889999999999999999999999999999887763

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=2.6e-58  Score=403.47  Aligned_cols=264  Identities=20%  Similarity=0.214  Sum_probs=212.0

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCccee
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      ..+.|.+.++||+|+||+||+|++..+++.||||+++....     ..+|+.+++.++|||||++++++     .+.+.+
T Consensus        56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~-----~~~~~~  125 (336)
T 4g3f_A           56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAV-----REGPWV  125 (336)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEE-----EETTEE
T ss_pred             chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEE-----EECCEE
Confidence            34568888999999999999999999999999999975432     24699999999999999999995     445789


Q ss_pred             eEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCC-cEEEcccCcccc
Q 046639          108 AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDI-VAHVGDLGLAKF  186 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~-~~kl~Dfg~a~~  186 (331)
                      ++|||||+||+|.+++++.+  .+++..+..++.|++.||.|||++   +|+||||||+|||++.+| .+||+|||+|+.
T Consensus       126 ~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~  200 (336)
T 4g3f_A          126 NIFMELLEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALC  200 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEE
T ss_pred             EEEEeccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeE
Confidence            99999999999999997654  478899999999999999999999   999999999999999988 699999999987


Q ss_pred             cccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcch
Q 046639          187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDK  266 (331)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  266 (331)
                      +......   ..........||+.|+|||++.+..|+.++|||||||++|||++|.+||....... ....+.....+  
T Consensus       201 ~~~~~~~---~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~i~~~~~~--  274 (336)
T 4g3f_A          201 LQPDGLG---KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP-LCLKIASEPPP--  274 (336)
T ss_dssp             C---------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC-CHHHHHHSCCG--
T ss_pred             ccCCCcc---cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-HHHHHHcCCCC--
Confidence            6322111   11112234579999999999999999999999999999999999999998653332 22222221111  


Q ss_pred             hhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhhhc
Q 046639          267 VMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETFLG  328 (331)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~~~  328 (331)
                      ..                ..+..+++.+.+|+.+||+.||.+|||+.||++.|..+.+...+
T Consensus       275 ~~----------------~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~  320 (336)
T 4g3f_A          275 IR----------------EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGG  320 (336)
T ss_dssp             GG----------------GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTS
T ss_pred             ch----------------hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhh
Confidence            00                11234567889999999999999999999999999888776543

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.1e-57  Score=391.26  Aligned_cols=251  Identities=26%  Similarity=0.373  Sum_probs=201.2

Q ss_pred             CC-CcCceeeccCeeEEEEeeecCCCceEEEEEeecc--chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCccee
Q 046639           31 NF-SPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        31 ~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      +| ++.++||+|+||+||+|.+..++..||+|.+...  .....+.+.+|+.++++++|||||+++++|... ......+
T Consensus        26 r~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~-~~~~~~~  104 (290)
T 3fpq_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKCI  104 (290)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEE-ETTEEEE
T ss_pred             ceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeec-cCCCcEE
Confidence            44 6777899999999999999999999999998644  334456789999999999999999999997543 2335678


Q ss_pred             eEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCC--eeecCCCCCCEEec-CCCcEEEcccCcc
Q 046639          108 AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPS--IVHGDLKPSNILLD-QDIVAHVGDLGLA  184 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~--ivH~dik~~nilv~-~~~~~kl~Dfg~a  184 (331)
                      ++|||||++|+|.+++.+..  .+++..+..++.|++.||+|||++   +  |+||||||+|||++ .+|.+||+|||+|
T Consensus       105 ~lvmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla  179 (290)
T 3fpq_A          105 VLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA  179 (290)
T ss_dssp             EEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGG
T ss_pred             EEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCC
Confidence            99999999999999997644  477899999999999999999998   7  99999999999997 4799999999999


Q ss_pred             cccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCc
Q 046639          185 KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALP  264 (331)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  264 (331)
                      +...          ........||+.|+|||++.+ .|+.++|||||||++|||++|..||.+..............   
T Consensus       180 ~~~~----------~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~---  245 (290)
T 3fpq_A          180 TLKR----------ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG---  245 (290)
T ss_dssp             GGCC----------TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT---
T ss_pred             EeCC----------CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcC---
Confidence            7531          123345679999999999875 69999999999999999999999997532211111111100   


Q ss_pred             chhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          265 DKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                            ..+.          .+...+++.+.+|+.+||+.||++|||+.|+++
T Consensus       246 ------~~~~----------~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          246 ------VKPA----------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             ------CCCG----------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ------CCCC----------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                  0110          111234557889999999999999999999975

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.1e-58  Score=401.26  Aligned_cols=249  Identities=21%  Similarity=0.314  Sum_probs=207.1

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc---chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK---QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      ++|.+++.||+|+||+||+|++..+++.||||++...   +....+.+.+|+.+++.++||||++++++     +.+.+.
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~-----~~~~~~  106 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFT-----FQDDEK  106 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEE-----EECSSE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEE-----EEeCCE
Confidence            4699999999999999999999999999999999743   23345678999999999999999999999     455678


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      +|+|||||+||+|.+++.+.+  .+++..+..++.|++.||.|||++   +|+||||||+|||++.+|.+||+|||+|+.
T Consensus       107 ~yivmEy~~gG~L~~~i~~~~--~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~  181 (311)
T 4aw0_A          107 LYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKV  181 (311)
T ss_dssp             EEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCcee
Confidence            999999999999999997654  478899999999999999999999   999999999999999999999999999987


Q ss_pred             cccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcch
Q 046639          187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDK  266 (331)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  266 (331)
                      +...      .........+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.. ....+..+.....   
T Consensus       182 ~~~~------~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~-~~~~~~~i~~~~~---  251 (311)
T 4aw0_A          182 LSPE------SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN-EGLIFAKIIKLEY---  251 (311)
T ss_dssp             CCTT------TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHTCC---
T ss_pred             cCCC------CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHcCCC---
Confidence            6221      11223345679999999999999999999999999999999999999997531 1111222221111   


Q ss_pred             hhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHH
Q 046639          267 VMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVV  316 (331)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~  316 (331)
                                        .++..+++.+.+|+.+||+.||++|||+.|++
T Consensus       252 ------------------~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          252 ------------------DFPEKFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             ------------------CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             ------------------CCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence                              11223456788999999999999999999864

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.6e-57  Score=407.71  Aligned_cols=250  Identities=20%  Similarity=0.300  Sum_probs=208.5

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeE
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAI  109 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~l  109 (331)
                      +.|.++++||+|+||+||+|++..+++.||||++........+.+.+|+.+|+.++|||||++++++     ...+.+|+
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~-----~~~~~~~i  225 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY-----LVGDELWV  225 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEE-----EETTEEEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEE-----EECCEEEE
Confidence            5699999999999999999999999999999999876655566789999999999999999999995     44578999


Q ss_pred             EEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccccc
Q 046639          110 VFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG  189 (331)
Q Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~  189 (331)
                      |||||+||+|.+++...   .+++..+..++.|++.||.|||++   +|+||||||+|||++.+|.+||+|||+|+.+..
T Consensus       226 VmEy~~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~  299 (423)
T 4fie_A          226 VMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK  299 (423)
T ss_dssp             EEECCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCS
T ss_pred             EEeCCCCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCC
Confidence            99999999999999754   378899999999999999999999   999999999999999999999999999987522


Q ss_pred             CCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhh
Q 046639          190 YEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVME  269 (331)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  269 (331)
                              ........+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+..  .......+....+     
T Consensus       300 --------~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--~~~~~~~i~~~~~-----  364 (423)
T 4fie_A          300 --------EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP--PLKAMKMIRDNLP-----  364 (423)
T ss_dssp             --------SCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHHSCC-----
T ss_pred             --------CCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--HHHHHHHHHcCCC-----
Confidence                    1123345679999999999999999999999999999999999999997532  1111111111111     


Q ss_pred             hcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          270 IVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                         +.+         .....++..+.+|+.+||+.||++|||+.|+++
T Consensus       365 ---~~~---------~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          365 ---PRL---------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             ---CCC---------SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---CCC---------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence               111         111234567899999999999999999999976

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.2e-57  Score=389.49  Aligned_cols=246  Identities=24%  Similarity=0.371  Sum_probs=191.6

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc---chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK---QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      ++|.+++.||+|+||+||+|++..+++.||+|++...   .......+.+|+.+++.++||||++++++     +.+.+.
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~-----~~~~~~   87 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDV-----IKSKDE   87 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEE-----EECSSE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEE-----EEECCE
Confidence            5899999999999999999999999999999999644   23345678999999999999999999999     455678


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      +++||||+ +|+|.+++.+..  .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+|+.
T Consensus        88 ~~ivmEy~-~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~  161 (275)
T 3hyh_A           88 IIMVIEYA-GNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNI  161 (275)
T ss_dssp             EEEEEECC-CEEHHHHHHHSC--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC--
T ss_pred             EEEEEeCC-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCee
Confidence            99999999 789999997654  478899999999999999999999   999999999999999999999999999986


Q ss_pred             cccCCCCCcccccCCceeecccccccCCcccCCCCC-ccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcc
Q 046639          187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKA-SVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPD  265 (331)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  265 (331)
                      ...         ........||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+... ...+.......   
T Consensus       162 ~~~---------~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~-~~~~~~i~~~~---  228 (275)
T 3hyh_A          162 MTD---------GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI-PVLFKNISNGV---  228 (275)
T ss_dssp             ----------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHTC---
T ss_pred             cCC---------CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHHcCC---
Confidence            521         122334679999999999998886 6899999999999999999999975311 11111111111   


Q ss_pred             hhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          266 KVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                                        ..++..+++.+.+|+.+||+.||++|||+.|+++
T Consensus       229 ------------------~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          229 ------------------YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             ------------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ------------------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                              0111234567889999999999999999999986

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.9e-57  Score=394.58  Aligned_cols=257  Identities=23%  Similarity=0.355  Sum_probs=206.4

Q ss_pred             CCCcCceeeccCeeEEEEeeec-----CCCceEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCc
Q 046639           31 NFSPANKIGQGGVSIVYKGILD-----ESRSIVAVKVVNLKQ-KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGF  104 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  104 (331)
                      ++++.++||+|+||+||+|.+.     .+++.||||.++... ....+.+.+|+.++++++|||||+++++|.     ..
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-----~~  101 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVT-----KD  101 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SS
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEE-----EC
Confidence            5778899999999999999864     367889999996443 334567999999999999999999999964     34


Q ss_pred             ceeeEEEeecCCCCHHHHHHhcc--------------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEe
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQSN--------------GQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILL  170 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv  170 (331)
                      +..++|||||++|+|.+++....              ...+++..+..++.|++.||.|||++   +|+||||||+|||+
T Consensus       102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl  178 (308)
T 4gt4_A          102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLV  178 (308)
T ss_dssp             SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEE
Confidence            56899999999999999996532              23477889999999999999999999   99999999999999


Q ss_pred             cCCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCccc
Q 046639          171 DQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMF  249 (331)
Q Consensus       171 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~  249 (331)
                      +.++.+||+|||+|+.....      ..........||+.|+|||++.++.|+.++|||||||++|||+| |..||.+..
T Consensus       179 ~~~~~~Ki~DFGlar~~~~~------~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~  252 (308)
T 4gt4_A          179 YDKLNVKISDLGLFREVYAA------DYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS  252 (308)
T ss_dssp             CGGGCEEECCSCCBCGGGGG------GCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC
T ss_pred             CCCCCEEECCcccceeccCC------CceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC
Confidence            99999999999999875321      11122334568999999999999999999999999999999998 899997643


Q ss_pred             CCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHh
Q 046639          250 NEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHA  322 (331)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~  322 (331)
                      .  ......+...            ...       ..+.+|+..+.+|+.+||+.||++|||+.+|++.|+..
T Consensus       253 ~--~~~~~~i~~~------------~~~-------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          253 N--QDVVEMIRNR------------QVL-------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             H--HHHHHHHHTT------------CCC-------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             H--HHHHHHHHcC------------CCC-------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            2  1111111110            000       12235678899999999999999999999999999864

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.8e-56  Score=396.11  Aligned_cols=265  Identities=20%  Similarity=0.301  Sum_probs=213.2

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCC-----CceEEEEEeeccc-hhhHHHHHHHHHHHHcCCC-CCcceeeceeecccC
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDES-----RSIVAVKVVNLKQ-KEASRSFAAECNALRNIRH-RNLIKIITICSSIDF  101 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~  101 (331)
                      .++|.+++.||+|+||+||+|.+..+     ++.||||.+.... ....+.+.+|+.++++++| ||||+++++|.    
T Consensus        63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~----  138 (353)
T 4ase_A           63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT----  138 (353)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred             HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEE----
Confidence            46899999999999999999997643     4679999986543 3345679999999999975 89999999973    


Q ss_pred             CCcceeeEEEeecCCCCHHHHHHhcc--------------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCC
Q 046639          102 EGFDFKAIVFEYMQNRNLEQWLRQSN--------------GQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSN  167 (331)
Q Consensus       102 ~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~n  167 (331)
                      ...+.+++|||||++|+|.++++...              ...+++..+..++.|++.||.|||++   +|+||||||+|
T Consensus       139 ~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~N  215 (353)
T 4ase_A          139 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARN  215 (353)
T ss_dssp             CTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred             ecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccc
Confidence            33456899999999999999997632              23477889999999999999999999   99999999999


Q ss_pred             EEecCCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCC
Q 046639          168 ILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTD  246 (331)
Q Consensus       168 ilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~  246 (331)
                      ||++.++.+||+|||+|+......      .........||+.|+|||++.+..|+.++|||||||++|||+| |..||.
T Consensus       216 ILl~~~~~vKi~DFGlar~~~~~~------~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~  289 (353)
T 4ase_A          216 ILLSEKNVVKICDFGLARDIYKDP------DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP  289 (353)
T ss_dssp             EEECGGGCEEECCCGGGSCTTTCT------TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             eeeCCCCCEEECcchhhhhcccCC------CceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCC
Confidence            999999999999999998652211      1112234568999999999999999999999999999999998 999998


Q ss_pred             cccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhh
Q 046639          247 AMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETF  326 (331)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~  326 (331)
                      +..... .+...+.....        +           ..+..+++.+.+|+.+||+.||++|||+.+|++.|+.+.++-
T Consensus       290 ~~~~~~-~~~~~i~~g~~--------~-----------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~  349 (353)
T 4ase_A          290 GVKIDE-EFCRRLKEGTR--------M-----------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  349 (353)
T ss_dssp             TCCCSH-HHHHHHHHTCC--------C-----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             CCCHHH-HHHHHHHcCCC--------C-----------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence            653322 22222211110        0           112245678999999999999999999999999999987653

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=8.1e-56  Score=386.08  Aligned_cols=275  Identities=20%  Similarity=0.248  Sum_probs=204.0

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeE
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAI  109 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~l  109 (331)
                      ++|.+.++||+|+||+||+|++  +++.||||+++.... .......|+..+.+++||||++++++|...+ .....+++
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~-~~~~~~~l   78 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWL   78 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecC-CCceEEEE
Confidence            5688999999999999999998  478999999964432 2233445667777889999999999986532 22346799


Q ss_pred             EEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhc-----CCCCeeecCCCCCCEEecCCCcEEEcccCcc
Q 046639          110 VFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHH-----CQPSIVHGDLKPSNILLDQDIVAHVGDLGLA  184 (331)
Q Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-----~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a  184 (331)
                      ||||+++|+|.++++..   .+++..+..++.|++.||+|||++     ..++|+||||||+|||++.++.+||+|||+|
T Consensus        79 V~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla  155 (303)
T 3hmm_A           79 VSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             EEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence            99999999999999764   377889999999999999999975     2348999999999999999999999999999


Q ss_pred             cccccCCCCCcccccCCceeecccccccCCcccCCC------CCccchhhHhHHHHHHHHHhCCCCCCcccCCcc-----
Q 046639          185 KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGS------KASVSGDVYNFGILLLEMFTRRRPTDAMFNEGL-----  253 (331)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~------~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-----  253 (331)
                      +.......    ..........||+.|+|||++.+.      .++.++|||||||++|||++|.+||........     
T Consensus       156 ~~~~~~~~----~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~  231 (303)
T 3hmm_A          156 VRHDSATD----TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL  231 (303)
T ss_dssp             EEEETTTT----EESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTT
T ss_pred             ccccCCCC----ceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhc
Confidence            87632211    111222345799999999998764      467899999999999999999887754322111     


Q ss_pred             -----hHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhh
Q 046639          254 -----TLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARET  325 (331)
Q Consensus       254 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~  325 (331)
                           ..........        ...+...++..  ....++...+.+|+.+||+.||++|||+.+|++.|+++.+.
T Consensus       232 ~~~~~~~~~~~~~~~--------~~~~rp~~p~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          232 VPSDPSVEEMRKVVC--------EQKLRPNIPNR--WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             SCSSCCHHHHHHHHT--------TSCCCCCCCGG--GGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             ccccchHHHHHHHHh--------cccCCCCCCcc--ccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence                 1111111111        11111111110  11235778899999999999999999999999999998764

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=8e-57  Score=389.45  Aligned_cols=243  Identities=21%  Similarity=0.260  Sum_probs=192.6

Q ss_pred             cCCCcCceeeccCeeEEEEeeec---CCCceEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCc
Q 046639           30 NNFSPANKIGQGGVSIVYKGILD---ESRSIVAVKVVNLKQ--KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGF  104 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  104 (331)
                      ++|.+++.||+|+||+||+|++.   .+++.||+|+++...  ......+.+|+.++++++||||+++++++     .+.
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~   98 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAF-----QTE   98 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEE-----EET
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----EEC
Confidence            57999999999999999999874   467899999996432  22234577899999999999999999995     456


Q ss_pred             ceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcc
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA  184 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a  184 (331)
                      +.+++|||||+||+|.+++.+..  .+++..+..++.|++.||.|||++   +|+||||||+|||++.+|.+||+|||+|
T Consensus        99 ~~~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla  173 (304)
T 3ubd_A           99 GKLYLILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLS  173 (304)
T ss_dssp             TEEEEEECCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEE
T ss_pred             CEEEEEEEcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccc
Confidence            78999999999999999997654  478899999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCc
Q 046639          185 KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALP  264 (331)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  264 (331)
                      +....        .........||+.|+|||++.+..|+.++|||||||++|||++|..||.+... ...+..+..... 
T Consensus       174 ~~~~~--------~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~-~~~~~~i~~~~~-  243 (304)
T 3ubd_A          174 KESID--------HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR-KETMTMILKAKL-  243 (304)
T ss_dssp             EC-------------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHCCC-
T ss_pred             eeccC--------CCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH-HHHHHHHHcCCC-
Confidence            86421        11223346799999999999999999999999999999999999999975321 111112111110 


Q ss_pred             chhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcH
Q 046639          265 DKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEM  312 (331)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~  312 (331)
                                          .++..+++.+.+|+.+||+.||++|||+
T Consensus       244 --------------------~~p~~~s~~~~~li~~~L~~dP~~R~ta  271 (304)
T 3ubd_A          244 --------------------GMPQFLSPEAQSLLRMLFKRNPANRLGA  271 (304)
T ss_dssp             --------------------CCCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred             --------------------CCCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence                                1122345678999999999999999995

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=3.3e-55  Score=380.63  Aligned_cols=262  Identities=22%  Similarity=0.349  Sum_probs=192.0

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccch-hhHHHHHHHHHHHHcCCCCCcceeeceeecccC-------
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK-EASRSFAAECNALRNIRHRNLIKIITICSSIDF-------  101 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-------  101 (331)
                      ++|.+++.||+|+||+||+|+++.+++.||||++..... ...+.+.+|+.++++++|||||++++++...+.       
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            469999999999999999999999999999999975543 344678999999999999999999999764321       


Q ss_pred             CCcceeeEEEeecCCCCHHHHHHhccCC-ccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcc
Q 046639          102 EGFDFKAIVFEYMQNRNLEQWLRQSNGQ-LRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGD  180 (331)
Q Consensus       102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~D  180 (331)
                      .....+|+|||||++|+|.+++...... ..+...++.++.|++.||.|||++   +|+||||||+|||++.+|.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEcc
Confidence            2234579999999999999999864322 233456788999999999999999   999999999999999999999999


Q ss_pred             cCcccccccCCCCCcc----cccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHH
Q 046639          181 LGLAKFLFGYEPGTAA----ETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLH  256 (331)
Q Consensus       181 fg~a~~~~~~~~~~~~----~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~  256 (331)
                      ||+|+.+.........    ..........||+.|+|||++.+..|+.++|||||||++|||++   ||.....   .. 
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~---~~-  234 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME---RV-  234 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH---HH-
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH---HH-
Confidence            9999876432211110    11122334579999999999999999999999999999999995   7753211   11 


Q ss_pred             HHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          257 EFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ..+..     +.....|           ....+..+.+.+|+.+||+.||.+|||+.|+++
T Consensus       235 ~~~~~-----~~~~~~p-----------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          235 RTLTD-----VRNLKFP-----------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             HHHHH-----HHTTCCC-----------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHH-----HhcCCCC-----------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            11110     0000001           222345566788999999999999999999986

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.5e-53  Score=379.54  Aligned_cols=277  Identities=19%  Similarity=0.246  Sum_probs=207.1

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc--chhhHHHHHHHHHHHHcCCCCCcceeeceeecc-cCCCcce
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRNIRHRNLIKIITICSSI-DFEGFDF  106 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~~~  106 (331)
                      ++|.+++.||+|+||+||+|++..+++.||||+++..  .....+.+.+|+.+|+.++||||+++++++... .+...+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            5799999999999999999999999999999999643  234456788999999999999999999987543 2445678


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      +|+||||| +|+|.+++...  ..+++..+..++.|++.||.|||++   ||+||||||+|||++.+|.+||+|||+|+.
T Consensus       134 ~~ivmE~~-~g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~  207 (398)
T 4b99_A          134 VYVVLDLM-ESDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARG  207 (398)
T ss_dssp             EEEEEECC-SEEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred             EEEEEeCC-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeee
Confidence            99999999 57899999654  4588899999999999999999999   999999999999999999999999999986


Q ss_pred             cccCCCCCcccccCCceeecccccccCCcccCCC-CCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcc
Q 046639          187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGS-KASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPD  265 (331)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  265 (331)
                      +.....    ..........||+.|+|||++.+. .++.++||||+||++|||++|.+||.+.. ....+..+.......
T Consensus       208 ~~~~~~----~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~-~~~~l~~I~~~~g~p  282 (398)
T 4b99_A          208 LCTSPA----EHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN-YVHQLQLIMMVLGTP  282 (398)
T ss_dssp             C-----------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSS-HHHHHHHHHHHHCCC
T ss_pred             cccCcc----ccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCC-HHHHHHHHHHhcCCC
Confidence            532111    112233456799999999998875 46999999999999999999999997642 122222222221111


Q ss_pred             h--hhhhcCccc----ccccccCC----cchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          266 K--VMEIVDPSL----LLEVTANN----YSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       266 ~--~~~~~~~~~----~~~~~~~~----~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      .  .........    ...+....    ..........+.+|+.+||+.||.+|||+.|+++
T Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          283 SPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             CGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            1  000000000    00000000    0111234567889999999999999999999875

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.5e-51  Score=366.83  Aligned_cols=275  Identities=19%  Similarity=0.239  Sum_probs=199.2

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeec---CCCceEEEEEeeccchhhHHHHHHHHHHHHcC-CCCCcceeeceeecccCCC
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILD---ESRSIVAVKVVNLKQKEASRSFAAECNALRNI-RHRNLIKIITICSSIDFEG  103 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~  103 (331)
                      ..++|.+.++||+|+||+||+|+++   .+++.||+|.+....  ....+.+|+.+++.+ .||||+++++++     ..
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~-----~~   91 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCF-----RK   91 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEE-----EE
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEE-----EE
Confidence            4578999999999999999999874   467899999885443  234578899999998 699999999984     45


Q ss_pred             cceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCC-CcEEEcccC
Q 046639          104 FDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQD-IVAHVGDLG  182 (331)
Q Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~-~~~kl~Dfg  182 (331)
                      .+.+++||||+++++|.++++.     +++..+..++.|++.||.|||++   ||+||||||+|||++.+ +.+||+|||
T Consensus        92 ~~~~~lvmE~~~g~~L~~~~~~-----l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFG  163 (361)
T 4f9c_A           92 NDHVVIAMPYLEHESFLDILNS-----LSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFG  163 (361)
T ss_dssp             TTEEEEEEECCCCCCHHHHHTT-----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             CCEEEEEEeCCCcccHHHHHcC-----CCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCC
Confidence            6789999999999999999842     67889999999999999999999   99999999999999876 799999999


Q ss_pred             cccccccCCCCCc--------------------ccccCCceeecccccccCCcccCCC-CCccchhhHhHHHHHHHHHhC
Q 046639          183 LAKFLFGYEPGTA--------------------AETASNSIEIKGIVGYVAPEYGMGS-KASVSGDVYNFGILLLEMFTR  241 (331)
Q Consensus       183 ~a~~~~~~~~~~~--------------------~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g  241 (331)
                      +|+..........                    ...........||+.|+|||++.+. .|+.++||||+||++|||++|
T Consensus       164 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G  243 (361)
T 4f9c_A          164 LAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSG  243 (361)
T ss_dssp             TCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHT
T ss_pred             CCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHC
Confidence            9986532211000                    0011122345799999999999876 489999999999999999999


Q ss_pred             CCCCCcccCCcchHHHHHHhhCcchhh---hhc----------------------------Cccccccccc--CCcchHH
Q 046639          242 RRPTDAMFNEGLTLHEFVKMALPDKVM---EIV----------------------------DPSLLLEVTA--NNYSWIE  288 (331)
Q Consensus       242 ~~pf~~~~~~~~~~~~~~~~~~~~~~~---~~~----------------------------~~~~~~~~~~--~~~~~~~  288 (331)
                      ..||....++...+..+..........   ...                            .+........  .......
T Consensus       244 ~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~  323 (361)
T 4f9c_A          244 RYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWN  323 (361)
T ss_dssp             CSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CT
T ss_pred             CCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccc
Confidence            999965443333333332211100000   000                            0000000000  0001112


Q ss_pred             HHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          289 DCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       289 ~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ..++.+.+|+.+||+.||.+|||+.|+++
T Consensus       324 ~is~~a~DLl~~lL~~dP~~R~ta~eaL~  352 (361)
T 4f9c_A          324 EVPDEAYDLLDKLLDLNPASRITAEEALL  352 (361)
T ss_dssp             TCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             cCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            34567889999999999999999999874

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=5e-51  Score=384.14  Aligned_cols=253  Identities=18%  Similarity=0.246  Sum_probs=209.3

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      .++|.+++.||+|+||+||+|+++.+++.||+|++........+.+.+|+.+|+.++||||++++++     +.+...++
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~-----~~~~~~~~  230 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA-----FEDDNEMV  230 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEE-----EECSSEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEE-----EEECCEEE
Confidence            3689999999999999999999999999999999987766667788999999999999999999999     45567899


Q ss_pred             EEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCC--CcEEEcccCcccc
Q 046639          109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQD--IVAHVGDLGLAKF  186 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~--~~~kl~Dfg~a~~  186 (331)
                      +|||||+||+|.+++.... ..+++..+..++.||+.||.|||++   +|+||||||+|||++.+  +.+||+|||+|+.
T Consensus       231 iv~E~~~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~  306 (573)
T 3uto_A          231 MIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAH  306 (573)
T ss_dssp             EEEECCCCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEE
T ss_pred             EEEeecCCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeE
Confidence            9999999999999996533 3478899999999999999999999   99999999999999854  8999999999987


Q ss_pred             cccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcch
Q 046639          187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDK  266 (331)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  266 (331)
                      +.         .........||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+... ...+..+......  
T Consensus       307 ~~---------~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~-~~~~~~i~~~~~~--  374 (573)
T 3uto_A          307 LD---------PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-DETLRNVKSCDWN--  374 (573)
T ss_dssp             CC---------TTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-HHHHHHHHTTCCC--
T ss_pred             cc---------CCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-HHHHHHHHhCCCC--
Confidence            62         12233456799999999999999999999999999999999999999975421 1111111111100  


Q ss_pred             hhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          267 VMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                          ...           .....++..+.+|+.+||+.||.+|||+.|+++
T Consensus       375 ----~~~-----------~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          375 ----MDD-----------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             ----CCS-----------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ----CCc-----------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                000           111234567889999999999999999999986

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=5.6e-51  Score=382.55  Aligned_cols=249  Identities=22%  Similarity=0.254  Sum_probs=199.0

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhH---HHHHHHHHHHHcCCCCCcceeeceeecccCC
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEAS---RSFAAECNALRNIRHRNLIKIITICSSIDFE  102 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  102 (331)
                      .++|.+++.||+|+||+||+|++..+++.||||++....   ....   .....++.+++.++||||++++++     +.
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~-----f~  262 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYA-----FH  262 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEE-----EE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEE-----EE
Confidence            467999999999999999999999999999999996432   1111   223344667778899999999999     55


Q ss_pred             CcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccC
Q 046639          103 GFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLG  182 (331)
Q Consensus       103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg  182 (331)
                      +.+.+|+||||++||+|.+++.+.+  .+++..+..++.||+.||.|||++   ||+||||||+|||++.+|.+||+|||
T Consensus       263 ~~~~lylVmEy~~GGdL~~~l~~~~--~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFG  337 (689)
T 3v5w_A          263 TPDKLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLG  337 (689)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             ECCEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccc
Confidence            6678999999999999999997654  478899999999999999999999   99999999999999999999999999


Q ss_pred             cccccccCCCCCcccccCCceeecccccccCCcccCC-CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHh
Q 046639          183 LAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG-SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKM  261 (331)
Q Consensus       183 ~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  261 (331)
                      +|+.+..          ......+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+......  ......
T Consensus       338 lA~~~~~----------~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~--~~i~~~  405 (689)
T 3v5w_A          338 LACDFSK----------KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRM  405 (689)
T ss_dssp             TCEECSS----------CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH--HHHHHH
T ss_pred             eeeecCC----------CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHh
Confidence            9987521          12234579999999999975 5799999999999999999999999976433221  111111


Q ss_pred             hCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCc-----HHHHH
Q 046639          262 ALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERME-----MRDVV  316 (331)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps-----~~~i~  316 (331)
                      ....      .           ..++..+++.+.+|+.+||+.||.+|++     +.||+
T Consensus       406 i~~~------~-----------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~  448 (689)
T 3v5w_A          406 TLTM------A-----------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK  448 (689)
T ss_dssp             HHHC------C-----------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHT
T ss_pred             hcCC------C-----------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHh
Confidence            1000      0           0122234567899999999999999998     56664

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=4.8e-49  Score=345.66  Aligned_cols=268  Identities=21%  Similarity=0.334  Sum_probs=216.6

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      .++|.+.+.||+|+||+||+|.+..+++.||+|.+........+.+.+|+.+++.++||||+++++++.     ..+..+
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~~   83 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY-----KDKRLN   83 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEe-----cCCeeE
Confidence            357999999999999999999999999999999987666777788999999999999999999999964     356789


Q ss_pred             EEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccc
Q 046639          109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLF  188 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~  188 (331)
                      +|||++++++|.+++.... ..+++..+..++.|++.||+|||++   +++|+||||+||+++.++.+||+|||++....
T Consensus        84 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  159 (310)
T 3s95_A           84 FITEYIKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMV  159 (310)
T ss_dssp             EEEECCTTCBHHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC
T ss_pred             EEEEecCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecc
Confidence            9999999999999998643 3477889999999999999999999   99999999999999999999999999998763


Q ss_pred             cCCCCCc------ccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcch----HHHH
Q 046639          189 GYEPGTA------AETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLT----LHEF  258 (331)
Q Consensus       189 ~~~~~~~------~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~----~~~~  258 (331)
                      .......      ...........||+.|+|||++.+..++.++||||||+++|+|++|..||.........    ....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~  239 (310)
T 3s95_A          160 DEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGF  239 (310)
T ss_dssp             --------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHH
T ss_pred             cccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcc
Confidence            3221110      00111112456899999999999999999999999999999999999998754332211    1111


Q ss_pred             HHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhhhc
Q 046639          259 VKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETFLG  328 (331)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~~~  328 (331)
                      .....                       ...++..+.+++.+||+.||++|||+.++++.|+.+...+.+
T Consensus       240 ~~~~~-----------------------~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~  286 (310)
T 3s95_A          240 LDRYC-----------------------PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG  286 (310)
T ss_dssp             HHHTC-----------------------CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred             ccccC-----------------------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccC
Confidence            11110                       123445688999999999999999999999999999887654

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=8.7e-49  Score=341.90  Aligned_cols=252  Identities=20%  Similarity=0.252  Sum_probs=207.3

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCccee
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      ..++|.+.+.||+|+||+||+|.+..+++.||+|.+........+.+.+|+.+++.++||||+++++++.     ..+..
T Consensus        18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~   92 (297)
T 3fxz_A           18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDEL   92 (297)
T ss_dssp             GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEE
T ss_pred             hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEE-----ECCEE
Confidence            3568999999999999999999999999999999997666666677899999999999999999999854     35678


Q ss_pred             eEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccc
Q 046639          108 AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      ++||||+++++|.+++...   .++...+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++...
T Consensus        93 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~  166 (297)
T 3fxz_A           93 WVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI  166 (297)
T ss_dssp             EEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceec
Confidence            9999999999999999764   367788999999999999999999   9999999999999999999999999998765


Q ss_pred             ccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchh
Q 046639          188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKV  267 (331)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  267 (331)
                      ...        ........||+.|+|||++.+..++.++||||||+++|+|++|..||....... ..........+   
T Consensus       167 ~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~---  234 (297)
T 3fxz_A          167 TPE--------QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-ALYLIATNGTP---  234 (297)
T ss_dssp             CST--------TCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHHCSC---
T ss_pred             CCc--------ccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCC---
Confidence            211        122334568999999999999999999999999999999999999997532111 11111111100   


Q ss_pred             hhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          268 MEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                            ..         .....++..+.+|+.+||+.||++|||+.++++
T Consensus       235 ------~~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          235 ------EL---------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             ------CC---------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ------CC---------CCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence                  00         112235567899999999999999999999975

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=6.9e-49  Score=346.83  Aligned_cols=255  Identities=20%  Similarity=0.264  Sum_probs=205.7

Q ss_pred             HHHHHHHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc--chhhHHHHHHHHHHHHcCCCCCcceeeceeecc
Q 046639           22 YAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRNIRHRNLIKIITICSSI   99 (331)
Q Consensus        22 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   99 (331)
                      ..+.....++|.+.+.||+|+||+||+|.+..+++.||+|++...  +......+.+|+.+++.++||||+++++++   
T Consensus         7 ~~~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~---   83 (328)
T 3fe3_A            7 CADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI---   83 (328)
T ss_dssp             ----CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE---
T ss_pred             ccccCCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE---
Confidence            344445667899999999999999999999999999999999654  344556788999999999999999999995   


Q ss_pred             cCCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEc
Q 046639          100 DFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVG  179 (331)
Q Consensus       100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~  179 (331)
                        ...+..++|||++++++|.+++....  .++...+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+
T Consensus        84 --~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~  156 (328)
T 3fe3_A           84 --ETEKTLYLIMEYASGGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIA  156 (328)
T ss_dssp             --ECSSEEEEEECCCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEEC
T ss_pred             --EECCEEEEEEECCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEe
Confidence              44577899999999999999997654  377889999999999999999999   99999999999999999999999


Q ss_pred             ccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCC-ccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHH
Q 046639          180 DLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKA-SVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEF  258 (331)
Q Consensus       180 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  258 (331)
                      |||++.....         ........||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+...  ......
T Consensus       157 DFG~a~~~~~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~~  225 (328)
T 3fe3_A          157 DFGFSNEFTV---------GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL--KELRER  225 (328)
T ss_dssp             STTCCGGGSS---------SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHH
T ss_pred             eccCceecCC---------CCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH--HHHHHH
Confidence            9999976521         122334569999999999988876 4899999999999999999999975321  111111


Q ss_pred             HHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          259 VKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ....                    ....+..++..+.+|+.+||+.||.+|||+.++++
T Consensus       226 i~~~--------------------~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          226 VLRG--------------------KYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             HHHC--------------------CCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             HHhC--------------------CCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            1100                    00111124567889999999999999999999975

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=4.2e-48  Score=341.30  Aligned_cols=284  Identities=30%  Similarity=0.475  Sum_probs=225.7

Q ss_pred             ccHHHHHHHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecc
Q 046639           20 ISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSI   99 (331)
Q Consensus        20 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   99 (331)
                      ++..++....++|.+.+.||+|+||+||+|.+. +++.||+|.+........+.+.+|+.+++.++||||+++++++   
T Consensus        29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~---  104 (321)
T 2qkw_B           29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFC---  104 (321)
T ss_dssp             -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEEC---
T ss_pred             ecHHHHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEE---
Confidence            345566678899999999999999999999975 6889999998766666677899999999999999999999994   


Q ss_pred             cCCCcceeeEEEeecCCCCHHHHHHhcc--CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEE
Q 046639          100 DFEGFDFKAIVFEYMQNRNLEQWLRQSN--GQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAH  177 (331)
Q Consensus       100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~k  177 (331)
                        ...+..++|||++++++|.+++....  ...+++..++.++.|++.||.|||++   +++|+||||+||+++.++.+|
T Consensus       105 --~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~k  179 (321)
T 2qkw_B          105 --DERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPK  179 (321)
T ss_dssp             --CCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEE
T ss_pred             --cCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEE
Confidence              45667899999999999999986543  23477889999999999999999999   999999999999999999999


Q ss_pred             EcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcc-hHH
Q 046639          178 VGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGL-TLH  256 (331)
Q Consensus       178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~  256 (331)
                      |+|||++.......      .........||+.|+|||++.+..++.++||||||+++|+|++|..||........ ...
T Consensus       180 l~Dfg~~~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~  253 (321)
T 2qkw_B          180 ITDFGISKKGTELD------QTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLA  253 (321)
T ss_dssp             ECCCTTCEECSSSS------CCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHH
T ss_pred             Eeeccccccccccc------ccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHH
Confidence            99999997642111      11122334588999999999888999999999999999999999999976543322 122


Q ss_pred             HHH-HhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhh
Q 046639          257 EFV-KMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARET  325 (331)
Q Consensus       257 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~  325 (331)
                      .+. .......+....++....       ....+++..+.+++.+||+.||++|||+.+|++.|+.+.+.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~  316 (321)
T 2qkw_B          254 EWAVESHNNGQLEQIVDPNLAD-------KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL  316 (321)
T ss_dssp             HHTHHHHTTTCCCSSSSSSCTT-------CSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             HHhhhccccccHHHhcChhhcc-------ccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence            211 111112222222322221       23357888999999999999999999999999999988754

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=4.7e-48  Score=341.66  Aligned_cols=289  Identities=33%  Similarity=0.536  Sum_probs=227.6

Q ss_pred             hccCCcccHHHHHHHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchh-hHHHHHHHHHHHHcCCCCCccee
Q 046639           14 KQQFPMISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKE-ASRSFAAECNALRNIRHRNLIKI   92 (331)
Q Consensus        14 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~   92 (331)
                      ......++..++....++|.+.+.||+|+||+||+|.+. +++.||+|++...... ....+.+|+.+++.++||||+++
T Consensus        14 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~   92 (326)
T 3uim_A           14 LGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL   92 (326)
T ss_dssp             -CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCC
T ss_pred             cCccceecHHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccce
Confidence            445677899999999999999999999999999999865 6889999998654322 22358899999999999999999


Q ss_pred             eceeecccCCCcceeeEEEeecCCCCHHHHHHhcc--CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEe
Q 046639           93 ITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSN--GQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILL  170 (331)
Q Consensus        93 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv  170 (331)
                      ++++     ......++|||++++++|.+++....  ...+++..+..++.|++.||.|||+...++++|+||||+||++
T Consensus        93 ~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~  167 (326)
T 3uim_A           93 RGFC-----MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL  167 (326)
T ss_dssp             CEEE-----CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEE
T ss_pred             EEEE-----ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEE
Confidence            9995     44567799999999999999998743  3347888999999999999999999866689999999999999


Q ss_pred             cCCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcc--
Q 046639          171 DQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAM--  248 (331)
Q Consensus       171 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~--  248 (331)
                      +.++.+||+|||++......       .........||+.|+|||++.+..++.++||||||+++|+|++|..||...  
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~  240 (326)
T 3uim_A          168 DEEFEAVVGDFGLAKLMDYK-------DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL  240 (326)
T ss_dssp             CTTCCEEECCCSSCEECCSS-------SSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHH
T ss_pred             CCCCCEEeccCccccccCcc-------cccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccccccc
Confidence            99999999999999865211       112223345899999999998888999999999999999999999999632  


Q ss_pred             -cCCcchHHHHHHhhCc-chhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHh
Q 046639          249 -FNEGLTLHEFVKMALP-DKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHA  322 (331)
Q Consensus       249 -~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~  322 (331)
                       .........+...... .......+....       ..+..++...+.+++.+||+.||.+|||+.+|++.|+..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          241 ANDDDVMLLDWVKGLLKEKKLEALVDVDLQ-------GNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             TTTSCSBHHHHHTTTTSSCCSTTSSCTTCT-------TSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             ccccchhHHHHHHHHhhchhhhhhcChhhc-------cccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence             1222233333322221 122222222221       134467888999999999999999999999999999753

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2.8e-48  Score=338.37  Aligned_cols=279  Identities=22%  Similarity=0.344  Sum_probs=211.8

Q ss_pred             HhcCCCcCceeeccCeeEEEEee----ecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCC
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGI----LDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEG  103 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  103 (331)
                      ..++|++++.||+|+||+||+|+    +..+++.||+|++........+.+.+|+.+++.++||||+++++++...   +
T Consensus         8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~   84 (295)
T 3ugc_A            8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---G   84 (295)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH---H
T ss_pred             CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---C
Confidence            34689999999999999999998    5668899999999877777778899999999999999999999986432   2


Q ss_pred             cceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCc
Q 046639          104 FDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGL  183 (331)
Q Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~  183 (331)
                      ....++|||++++++|.+++..... .+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||+
T Consensus        85 ~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~  160 (295)
T 3ugc_A           85 RRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGL  160 (295)
T ss_dssp             HTSCEEEEECCTTCBHHHHHHHCGG-GCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred             CCceEEEEEeCCCCCHHHHHHhccc-ccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcc
Confidence            3457999999999999999976532 467888999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhC
Q 046639          184 AKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMAL  263 (331)
Q Consensus       184 a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  263 (331)
                      +.......     ..........++..|+|||++.+..++.++||||||+++|+|++|..||......   .........
T Consensus       161 ~~~~~~~~-----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~---~~~~~~~~~  232 (295)
T 3ugc_A          161 TKVLPQDK-----EFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE---FMRMIGNDK  232 (295)
T ss_dssp             CC------------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH---HHHHHCTTC
T ss_pred             cccccCCc-----ceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH---HHhhhcCcc
Confidence            98752211     1111222334677799999999999999999999999999999999998643111   111100000


Q ss_pred             cc-----hhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhhhc
Q 046639          264 PD-----KVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETFLG  328 (331)
Q Consensus       264 ~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~~~  328 (331)
                      ..     .+........       ....+..++..+.+++.+||+.||++|||+.+|++.|+.+.+.+.|
T Consensus       233 ~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l~g  295 (295)
T 3ugc_A          233 QGQMIVFHLIELLKNNG-------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG  295 (295)
T ss_dssp             CTHHHHHHHHHHHHTTC-------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC---
T ss_pred             ccchhHHHHHHHHhccC-------cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhccC
Confidence            00     0000000000       0112234667899999999999999999999999999999988754

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2.5e-47  Score=342.49  Aligned_cols=266  Identities=20%  Similarity=0.323  Sum_probs=211.6

Q ss_pred             hcCCCcCceeeccCeeEEEEeeec-------CCCceEEEEEeeccc-hhhHHHHHHHHHHHHcC-CCCCcceeeceeecc
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILD-------ESRSIVAVKVVNLKQ-KEASRSFAAECNALRNI-RHRNLIKIITICSSI   99 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~   99 (331)
                      .++|.+.+.||+|+||+||+|++.       .++..||+|+++... ......+.+|+.+++.+ +||||++++++|   
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~---  156 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC---  156 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE---
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE---
Confidence            467999999999999999999874       345679999996543 34456789999999999 899999999995   


Q ss_pred             cCCCcceeeEEEeecCCCCHHHHHHhccC--------------CccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCC
Q 046639          100 DFEGFDFKAIVFEYMQNRNLEQWLRQSNG--------------QLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKP  165 (331)
Q Consensus       100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~  165 (331)
                        ...+..++||||+++++|.+++.....              ..+++..++.++.|++.||.|||++   +|+||||||
T Consensus       157 --~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp  231 (370)
T 2psq_A          157 --TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAA  231 (370)
T ss_dssp             --CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCG
T ss_pred             --ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ceeccccch
Confidence              445678999999999999999986432              3467888999999999999999999   999999999


Q ss_pred             CCEEecCCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCC
Q 046639          166 SNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRP  244 (331)
Q Consensus       166 ~nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p  244 (331)
                      +||+++.++.+||+|||+++.......      ........+|+.|+|||++.+..++.++||||||+++|||++ |..|
T Consensus       232 ~NIll~~~~~~kl~DFG~a~~~~~~~~------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p  305 (370)
T 2psq_A          232 RNVLVTENNVMKIADFGLARDINNIDY------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP  305 (370)
T ss_dssp             GGEEECTTCCEEECCCSSCEETTCCCT------TCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             hhEEECCCCCEEEccccCCcccCcccc------eecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCC
Confidence            999999999999999999986522111      111222346788999999999999999999999999999999 9999


Q ss_pred             CCcccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhh
Q 046639          245 TDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARE  324 (331)
Q Consensus       245 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~  324 (331)
                      |......  .....+.....        +           ..+..++..+.+++.+||+.||.+|||+.+|++.|+.+..
T Consensus       306 ~~~~~~~--~~~~~~~~~~~--------~-----------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~  364 (370)
T 2psq_A          306 YPGIPVE--ELFKLLKEGHR--------M-----------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT  364 (370)
T ss_dssp             STTCCGG--GHHHHHHTTCC--------C-----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCHH--HHHHHHhcCCC--------C-----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            9764322  12111111100        0           1112456789999999999999999999999999999987


Q ss_pred             hhhcC
Q 046639          325 TFLGT  329 (331)
Q Consensus       325 ~~~~~  329 (331)
                      ...+.
T Consensus       365 ~~~~~  369 (370)
T 2psq_A          365 LTTNE  369 (370)
T ss_dssp             HHC--
T ss_pred             HhccC
Confidence            66543

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=9.2e-48  Score=337.21  Aligned_cols=263  Identities=24%  Similarity=0.329  Sum_probs=202.4

Q ss_pred             HHHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCC
Q 046639           26 SKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ--KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEG  103 (331)
Q Consensus        26 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  103 (331)
                      ....++|.+.+.||+|+||+||+|++  ++..||+|++....  ......+.+|+.++++++||||+++++++     ..
T Consensus        33 ~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~  105 (309)
T 3p86_A           33 DIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV-----TQ  105 (309)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CS
T ss_pred             cCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EE
Confidence            34456899999999999999999987  47789999986443  34456788999999999999999999995     44


Q ss_pred             cceeeEEEeecCCCCHHHHHHhccC-CccchHHHHHHHHHHHHHHHHHhhcCCCC--eeecCCCCCCEEecCCCcEEEcc
Q 046639          104 FDFKAIVFEYMQNRNLEQWLRQSNG-QLRFLTQRVNIAIDVSFAIEYFHHHCQPS--IVHGDLKPSNILLDQDIVAHVGD  180 (331)
Q Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~~~~--ivH~dik~~nilv~~~~~~kl~D  180 (331)
                      ....++|||++++++|.+++..... ..+++..++.++.|++.||+|||+.   +  ++|+||||+||+++.++.+||+|
T Consensus       106 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~D  182 (309)
T 3p86_A          106 PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCD  182 (309)
T ss_dssp             TTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECC
T ss_pred             CCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECC
Confidence            5678999999999999999976432 2377888999999999999999999   8  99999999999999999999999


Q ss_pred             cCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHH
Q 046639          181 LGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVK  260 (331)
Q Consensus       181 fg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  260 (331)
                      ||+++....        .........||+.|+|||++.+..++.++||||||+++|+|++|..||......  .......
T Consensus       183 fg~a~~~~~--------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~--~~~~~~~  252 (309)
T 3p86_A          183 FGLSRLKAS--------TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA--QVVAAVG  252 (309)
T ss_dssp             CC-------------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH--HHHHHHH
T ss_pred             CCCCccccc--------cccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHH
Confidence            999975411        112233456899999999999999999999999999999999999999754211  1111111


Q ss_pred             hhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhh
Q 046639          261 MALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETF  326 (331)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~  326 (331)
                      ....       .           ......++..+.+|+.+||+.||.+|||+.+|++.|+.+.+..
T Consensus       253 ~~~~-------~-----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~  300 (309)
T 3p86_A          253 FKCK-------R-----------LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA  300 (309)
T ss_dssp             HSCC-------C-----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred             hcCC-------C-----------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence            0000       0           0112235567899999999999999999999999999887654

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.8e-47  Score=337.75  Aligned_cols=265  Identities=24%  Similarity=0.316  Sum_probs=209.1

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCc---eEEEEEeecc-chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCc
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRS---IVAVKVVNLK-QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGF  104 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  104 (331)
                      .++|.+.+.||+|+||+||+|.+..++.   .||||++... .....+.+.+|+.+++.++||||+++++++     ...
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~  122 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVV-----TRG  122 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----CGG
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EeC
Confidence            3578899999999999999999975444   5999999754 344456789999999999999999999995     445


Q ss_pred             ceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcc
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA  184 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a  184 (331)
                      +..++|||++++++|.+++.... ..+++..++.++.|++.||.|||+.   +|+|+||||+||+++.++.++|+|||++
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  198 (325)
T 3kul_A          123 RLAMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLS  198 (325)
T ss_dssp             GCCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSC
T ss_pred             CccEEEeeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcc
Confidence            67899999999999999997543 3477889999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhC
Q 046639          185 KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMAL  263 (331)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~  263 (331)
                      ........     .........+|+.|+|||++.+..++.++||||||+++|+|++ |..||......  ..........
T Consensus       199 ~~~~~~~~-----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~~~~~~~~  271 (325)
T 3kul_A          199 RVLEDDPD-----AAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR--DVISSVEEGY  271 (325)
T ss_dssp             EECC---------CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--HHHHHHHTTC
T ss_pred             cccccCcc-----ceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH--HHHHHHHcCC
Confidence            87632111     1111222345778999999998899999999999999999999 99999754221  1111111110


Q ss_pred             cchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhhhc
Q 046639          264 PDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETFLG  328 (331)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~~~  328 (331)
                              ..           .....++..+.+|+.+||+.||.+|||+.+|++.|+.+.+....
T Consensus       272 --------~~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~  317 (325)
T 3kul_A          272 --------RL-----------PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES  317 (325)
T ss_dssp             --------CC-----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred             --------CC-----------CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence                    00           11123567899999999999999999999999999999876544

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.1e-47  Score=343.72  Aligned_cols=274  Identities=19%  Similarity=0.296  Sum_probs=216.9

Q ss_pred             ccHHHHHHHhcCCCcCceeeccCeeEEEEee-----ecCCCceEEEEEeeccc-hhhHHHHHHHHHHHHcC-CCCCccee
Q 046639           20 ISYAELSKATNNFSPANKIGQGGVSIVYKGI-----LDESRSIVAVKVVNLKQ-KEASRSFAAECNALRNI-RHRNLIKI   92 (331)
Q Consensus        20 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~   92 (331)
                      ++........++|.+.+.||+|+||.||+|.     ...+++.||||++.... ....+.+.+|+.+++.+ .||||+++
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~   91 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   91 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence            4455555667899999999999999999998     55677899999997543 33446789999999999 79999999


Q ss_pred             eceeecccCCCcceeeEEEeecCCCCHHHHHHhccCC-------------------------------------------
Q 046639           93 ITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQ-------------------------------------------  129 (331)
Q Consensus        93 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------------------------------------------  129 (331)
                      ++++.    ......++||||+++++|.+++......                                           
T Consensus        92 ~~~~~----~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (359)
T 3vhe_A           92 LGACT----KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGF  167 (359)
T ss_dssp             EEEEC----STTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------
T ss_pred             eeeee----cCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccc
Confidence            99974    3345589999999999999999865421                                           


Q ss_pred             ---------------------ccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccc
Q 046639          130 ---------------------LRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLF  188 (331)
Q Consensus       130 ---------------------~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~  188 (331)
                                           .+++..++.++.|++.||+|||++   +|+|+||||+||+++.++.+||+|||++....
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  244 (359)
T 3vhe_A          168 VEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIY  244 (359)
T ss_dssp             ----------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTT
T ss_pred             ccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeec
Confidence                                 277888999999999999999999   99999999999999999999999999998652


Q ss_pred             cCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhCcchh
Q 046639          189 GYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMALPDKV  267 (331)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  267 (331)
                      ...      .........+|+.|+|||++.+..++.++||||||+++|+|++ |..||............ .......  
T Consensus       245 ~~~------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~-~~~~~~~--  315 (359)
T 3vhe_A          245 KDP------DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR-LKEGTRM--  315 (359)
T ss_dssp             SCT------TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHH-HHHTCCC--
T ss_pred             ccc------cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHH-HHcCCCC--
Confidence            211      1122234557888999999998899999999999999999998 99999765333222211 1111100  


Q ss_pred             hhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhh
Q 046639          268 MEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETF  326 (331)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~  326 (331)
                                       ..+..++..+.+++.+||+.||.+|||+.+|++.|+.+.++-
T Consensus       316 -----------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  357 (359)
T 3vhe_A          316 -----------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  357 (359)
T ss_dssp             -----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             -----------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence                             011224567899999999999999999999999999988753

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=5.7e-47  Score=333.99  Aligned_cols=266  Identities=20%  Similarity=0.240  Sum_probs=213.1

Q ss_pred             hccCCcccHHHHHHHhcC----------CCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHc
Q 046639           14 KQQFPMISYAELSKATNN----------FSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRN   83 (331)
Q Consensus        14 ~~~~~~~~~~~~~~~~~~----------y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~   83 (331)
                      -.+.+.++..++..+.+.          |...+.||+|+||.||+|++..+++.||||++........+.+.+|+.+++.
T Consensus        19 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~   98 (321)
T 2c30_A           19 YFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRD   98 (321)
T ss_dssp             ------CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTT
T ss_pred             eecCCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHh
Confidence            334477888998888765          7788899999999999999998999999999976666566778999999999


Q ss_pred             CCCCCcceeeceeecccCCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCC
Q 046639           84 IRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDL  163 (331)
Q Consensus        84 l~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~di  163 (331)
                      ++||||+++++++.     ..+..++||||+++++|.+++...   .+++..+..++.|++.||.|||+.   +++|+||
T Consensus        99 l~h~niv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dl  167 (321)
T 2c30_A           99 YQHFNVVEMYKSYL-----VGEELWVLMEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDI  167 (321)
T ss_dssp             CCCTTBCCEEEEEE-----ETTEEEEEECCCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred             CCCCCcceEEEEEE-----ECCEEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCC
Confidence            99999999999964     346789999999999999998643   477899999999999999999999   9999999


Q ss_pred             CCCCEEecCCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCC
Q 046639          164 KPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRR  243 (331)
Q Consensus       164 k~~nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~  243 (331)
                      ||+||+++.++.+||+|||++......        ........||+.|+|||++.+..++.++||||||+++|+|++|..
T Consensus       168 kp~NIll~~~~~~kl~Dfg~~~~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~  239 (321)
T 2c30_A          168 KSDSILLTLDGRVKLSDFGFCAQISKD--------VPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEP  239 (321)
T ss_dssp             SGGGEEECTTCCEEECCCTTCEECCSS--------SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CHHHEEECCCCcEEEeeeeeeeecccC--------ccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence            999999999999999999998765211        112234568999999999999999999999999999999999999


Q ss_pred             CCCcccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          244 PTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       244 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ||.....  ..........        ..+..         .....++..+.+++.+||+.||++|||+.++++
T Consensus       240 pf~~~~~--~~~~~~~~~~--------~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          240 PYFSDSP--VQAMKRLRDS--------PPPKL---------KNSHKVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             TTTTSCH--HHHHHHHHHS--------SCCCC---------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCCCCCH--HHHHHHHhcC--------CCCCc---------CccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            9965321  1111111111        11111         111234567889999999999999999999986

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.2e-46  Score=328.91  Aligned_cols=269  Identities=20%  Similarity=0.297  Sum_probs=208.1

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHc--CCCCCcceeeceeecccCCCcc
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRN--IRHRNLIKIITICSSIDFEGFD  105 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~~~~~~~  105 (331)
                      ..++|.+.+.||+|+||+||+|.+  +++.||+|++....   ...+..|.+++..  ++||||+++++++... .....
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~-~~~~~   79 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTS-RHSST   79 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEE-ETTEE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccc-cCCCc
Confidence            356899999999999999999988  58899999986442   2344556666665  7899999999987543 24456


Q ss_pred             eeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHh--------hcCCCCeeecCCCCCCEEecCCCcEE
Q 046639          106 FKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFH--------HHCQPSIVHGDLKPSNILLDQDIVAH  177 (331)
Q Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH--------~~~~~~ivH~dik~~nilv~~~~~~k  177 (331)
                      ..++|||++++++|.++++..   .+++..++.++.|++.||.|||        +.   +++|+||||+||+++.++.+|
T Consensus        80 ~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~k  153 (301)
T 3q4u_A           80 QLWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCC  153 (301)
T ss_dssp             EEEEEECCCTTCBHHHHHTTC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEE
T ss_pred             eeEEehhhccCCCHHHHHhhc---ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEE
Confidence            789999999999999999543   4778899999999999999999        87   999999999999999999999


Q ss_pred             EcccCcccccccCCCCCcccccCCceeecccccccCCcccCCC------CCccchhhHhHHHHHHHHHhC----------
Q 046639          178 VGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGS------KASVSGDVYNFGILLLEMFTR----------  241 (331)
Q Consensus       178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~------~~~~~~DiwslG~il~el~~g----------  241 (331)
                      |+|||++........    ..........||+.|+|||++.+.      .++.++||||||+++|+|++|          
T Consensus       154 l~Dfg~a~~~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~  229 (301)
T 3q4u_A          154 IADLGLAVMHSQSTN----QLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDY  229 (301)
T ss_dssp             ECCCTTCEEEETTTT----EEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred             EeeCCCeeecccccc----cccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccc
Confidence            999999976532211    111112234689999999999876      556899999999999999999          


Q ss_pred             CCCCCcccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHH
Q 046639          242 RRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRH  321 (331)
Q Consensus       242 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~  321 (331)
                      ..||......................    .+..      ....+...++..+.+|+.+||+.||.+|||+.+|++.|++
T Consensus       230 ~~pf~~~~~~~~~~~~~~~~~~~~~~----~~~~------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~  299 (301)
T 3q4u_A          230 KPPFYDVVPNDPSFEDMRKVVCVDQQ----RPNI------PNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK  299 (301)
T ss_dssp             CCTTTTTSCSSCCHHHHHHHHTTSCC----CCCC------CGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred             cccccccCCCCcchhhhhHHHhccCC----CCCC------ChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence            88887655544444443332211110    1111      0112334678899999999999999999999999999987


Q ss_pred             h
Q 046639          322 A  322 (331)
Q Consensus       322 ~  322 (331)
                      +
T Consensus       300 i  300 (301)
T 3q4u_A          300 I  300 (301)
T ss_dssp             H
T ss_pred             c
Confidence            5

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=3.7e-46  Score=326.76  Aligned_cols=286  Identities=27%  Similarity=0.429  Sum_probs=224.6

Q ss_pred             hccCCcccHHHHHHHhcCCCcC------ceeeccCeeEEEEeeecCCCceEEEEEeecc----chhhHHHHHHHHHHHHc
Q 046639           14 KQQFPMISYAELSKATNNFSPA------NKIGQGGVSIVYKGILDESRSIVAVKVVNLK----QKEASRSFAAECNALRN   83 (331)
Q Consensus        14 ~~~~~~~~~~~~~~~~~~y~~~------~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~   83 (331)
                      .+.++.++..++...+++|...      +.||+|+||+||+|.+  +++.||+|.+...    .....+.+.+|+.+++.
T Consensus         9 ~~~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~   86 (307)
T 2nru_A            9 DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAK   86 (307)
T ss_dssp             --CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHH
T ss_pred             CCCCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHh
Confidence            4457889999999999998877      8999999999999987  4778999998643    23445778999999999


Q ss_pred             CCCCCcceeeceeecccCCCcceeeEEEeecCCCCHHHHHHhc-cCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecC
Q 046639           84 IRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQS-NGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGD  162 (331)
Q Consensus        84 l~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~d  162 (331)
                      ++||||+++++++     ...+..++|||++++++|.+++... ....+++..++.++.|++.||.+||+.   +++|+|
T Consensus        87 l~h~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~d  158 (307)
T 2nru_A           87 CQHENLVELLGFS-----SDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRD  158 (307)
T ss_dssp             CCCTTBCCEEEEE-----CSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred             cCCCCeEEEEEEE-----ecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCC
Confidence            9999999999995     4456789999999999999999753 334578889999999999999999999   999999


Q ss_pred             CCCCCEEecCCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCC
Q 046639          163 LKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRR  242 (331)
Q Consensus       163 ik~~nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~  242 (331)
                      |||+||+++.++.++|+|||++........      ........||+.|+|||++.+ .++.++||||||+++|+|++|.
T Consensus       159 lkp~Nili~~~~~~kl~Dfg~~~~~~~~~~------~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~  231 (307)
T 2nru_A          159 IKSANILLDEAFTAKISDFGLARASEKFAQ------TVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGL  231 (307)
T ss_dssp             CCGGGEEECTTCCEEECCCTTCEECCSCSS------CEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCC
T ss_pred             CCHHHEEEcCCCcEEEeecccccccccccc------cccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCC
Confidence            999999999999999999999976522111      111223458999999999875 5889999999999999999999


Q ss_pred             CCCCcccCCcchHHHHHH--hhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHH
Q 046639          243 RPTDAMFNEGLTLHEFVK--MALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLR  320 (331)
Q Consensus       243 ~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~  320 (331)
                      .||.......... .+..  ......+...+++..        ......++..+.+++.+||+.||.+|||+.+|++.|+
T Consensus       232 ~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~  302 (307)
T 2nru_A          232 PAVDEHREPQLLL-DIKEEIEDEEKTIEDYIDKKM--------NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ  302 (307)
T ss_dssp             CSBCTTBSSSBTT-HHHHHHHTTSCCHHHHSCSSC--------SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred             CCcccCcchHHHH-HHHHHhhhhhhhhhhhccccc--------cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence            9998654332221 1111  111112222222221        1234567889999999999999999999999999999


Q ss_pred             Hhhhh
Q 046639          321 HARET  325 (331)
Q Consensus       321 ~~~~~  325 (331)
                      .+.++
T Consensus       303 ~l~~s  307 (307)
T 2nru_A          303 EMTAS  307 (307)
T ss_dssp             HHC--
T ss_pred             HHhcC
Confidence            88653

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2.5e-47  Score=336.46  Aligned_cols=284  Identities=20%  Similarity=0.263  Sum_probs=211.0

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCccee
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      ..++|.+.+.||+|+||+||+|++.  ++.||||++.... ........|+.+++.++||||+++++++.... ......
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~~~~   97 (322)
T 3soc_A           22 QSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGT-SVDVDL   97 (322)
T ss_dssp             TTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEE
T ss_pred             chhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCC-CCCceE
Confidence            3468999999999999999999886  7899999996543 33445667999999999999999999976432 223457


Q ss_pred             eEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhc-------CCCCeeecCCCCCCEEecCCCcEEEcc
Q 046639          108 AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHH-------CQPSIVHGDLKPSNILLDQDIVAHVGD  180 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-------~~~~ivH~dik~~nilv~~~~~~kl~D  180 (331)
                      ++||||+++++|.+++....   +++..++.++.|++.||.|||+.       +..+|+|+||||+||+++.++.+||+|
T Consensus        98 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D  174 (322)
T 3soc_A           98 WLITAFHEKGSLSDFLKANV---VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD  174 (322)
T ss_dssp             EEEEECCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred             EEEEecCCCCCHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence            99999999999999997643   77899999999999999999975       123899999999999999999999999


Q ss_pred             cCcccccccCCCCCcccccCCceeecccccccCCcccCCC-----CCccchhhHhHHHHHHHHHhCCCCCCcccCCcch-
Q 046639          181 LGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGS-----KASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLT-  254 (331)
Q Consensus       181 fg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-  254 (331)
                      ||+++.......      ........||+.|+|||++.+.     .++.++||||||+++|+|++|..||......... 
T Consensus       175 Fg~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~  248 (322)
T 3soc_A          175 FGLALKFEAGKS------AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP  248 (322)
T ss_dssp             CTTCEEECTTSC------CCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCT
T ss_pred             CCcccccccccC------ccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccc
Confidence            999987632211      1122234689999999998873     5677899999999999999999999865432221 


Q ss_pred             HHHHHHhhCc-chhhhh-cCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhh
Q 046639          255 LHEFVKMALP-DKVMEI-VDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETF  326 (331)
Q Consensus       255 ~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~  326 (331)
                      +......... ..+... ..........  .......+...+.+|+.+||+.||++|||+.+|++.|+.+.+..
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~  320 (322)
T 3soc_A          249 FEEEIGQHPSLEDMQEVVVHKKKRPVLR--DYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT  320 (322)
T ss_dssp             THHHHCSSCCHHHHHHHHTTSCCCCCCC--GGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             hhhhhccCCchhhhhhhhhcccCCCCcc--ccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence            1111000000 000000 0000000000  00112356778999999999999999999999999999988653

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.5e-47  Score=337.86  Aligned_cols=249  Identities=20%  Similarity=0.244  Sum_probs=203.5

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc---chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcc
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK---QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFD  105 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~  105 (331)
                      .++|.+++.||+|+||+||+|++..+++.||+|++...   .......+.+|+.+++.++||||+++++++     ...+
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~-----~~~~   78 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHD   78 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECSS
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEE-----EeCC
Confidence            45799999999999999999999999999999999644   223446688999999999999999999985     4456


Q ss_pred             eeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccc
Q 046639          106 FKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAK  185 (331)
Q Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~  185 (331)
                      ..++||||+++++|.+++....  .+++..+..++.|++.||.|||++   +|+||||||+||+++.+|.+||+|||+++
T Consensus        79 ~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~  153 (337)
T 1o6l_A           79 RLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK  153 (337)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             EEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchh
Confidence            8899999999999999997643  467889999999999999999999   99999999999999999999999999997


Q ss_pred             ccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcc
Q 046639          186 FLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPD  265 (331)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  265 (331)
                      ....        .........||+.|+|||++.+..++.++||||||+++|+|++|..||..... ............  
T Consensus       154 ~~~~--------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-~~~~~~i~~~~~--  222 (337)
T 1o6l_A          154 EGIS--------DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILMEEI--  222 (337)
T ss_dssp             CSCC--------TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHCCC--
T ss_pred             hccc--------CCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH-HHHHHHHHcCCC--
Confidence            5311        11223446799999999999999999999999999999999999999975321 111111111100  


Q ss_pred             hhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCC-----cHHHHHH
Q 046639          266 KVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERM-----EMRDVVA  317 (331)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----s~~~i~~  317 (331)
                                         .++..++..+.+|+.+||+.||.+||     ++.+|++
T Consensus       223 -------------------~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          223 -------------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             -------------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             -------------------CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence                               11123456789999999999999999     8888864

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-46  Score=331.63  Aligned_cols=279  Identities=16%  Similarity=0.196  Sum_probs=214.2

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCccee
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ-KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      .++|.+.+.||+|+||+||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++..   ......
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~~~~   84 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE---TTTRHK   84 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC---TTTCCE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeec---CCCceE
Confidence            468999999999999999999999999999999996433 2334667899999999999999999998643   234477


Q ss_pred             eEEEeecCCCCHHHHHHhccC-CccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEe----cCCCcEEEcccC
Q 046639          108 AIVFEYMQNRNLEQWLRQSNG-QLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILL----DQDIVAHVGDLG  182 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv----~~~~~~kl~Dfg  182 (331)
                      ++|||++++++|.+++..... ..+++..++.++.|++.||.|||+.   +|+|+||||+||++    +.++.+||+|||
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg  161 (319)
T 4euu_A           85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFG  161 (319)
T ss_dssp             EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCT
T ss_pred             EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCC
Confidence            999999999999999987432 3378899999999999999999999   99999999999999    788899999999


Q ss_pred             cccccccCCCCCcccccCCceeecccccccCCcccC--------CCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcch
Q 046639          183 LAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGM--------GSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLT  254 (331)
Q Consensus       183 ~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~--------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~  254 (331)
                      ++.....         ........||+.|+|||++.        +..++.++||||||+++|+|++|..||.........
T Consensus       162 ~a~~~~~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~  232 (319)
T 4euu_A          162 AARELED---------DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN  232 (319)
T ss_dssp             TCEECCT---------TCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC
T ss_pred             CceecCC---------CCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh
Confidence            9987521         11223356899999999875        567899999999999999999999999754332222


Q ss_pred             ---HHHHHHhhCcchhhhhcCc----ccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHh
Q 046639          255 ---LHEFVKMALPDKVMEIVDP----SLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHA  322 (331)
Q Consensus       255 ---~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~  322 (331)
                         .........+..+......    .......+............+.+++.+||+.||++|||+.|+++.....
T Consensus       233 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~  307 (319)
T 4euu_A          233 KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (319)
T ss_dssp             HHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             HHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence               2222222221111110000    0000011112244567888999999999999999999999999877653

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.5e-47  Score=333.72  Aligned_cols=263  Identities=22%  Similarity=0.372  Sum_probs=207.2

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc---chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcc
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK---QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFD  105 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~  105 (331)
                      .++|.+.+.||+|+||+||+|++..+++.||+|.+...   .......+.+|+.+++.++||||+++++++     ...+
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~~~~   84 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD-----EEDD   84 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE-----ECSS
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee-----eeCC
Confidence            46899999999999999999999999999999998543   334457789999999999999999999994     4557


Q ss_pred             eeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccc
Q 046639          106 FKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAK  185 (331)
Q Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~  185 (331)
                      ..++|||++++++|.+++....  .+++..+..++.|++.||.+||+.   +++|+||||+||+++.++.+||+|||++.
T Consensus        85 ~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~  159 (294)
T 4eqm_A           85 CYYLVMEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAK  159 (294)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSST
T ss_pred             eEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcc
Confidence            7899999999999999997654  477889999999999999999999   99999999999999999999999999997


Q ss_pred             ccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcc
Q 046639          186 FLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPD  265 (331)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  265 (331)
                      .....       .........||+.|+|||++.+..++.++||||||+++|+|++|..||......... ........+.
T Consensus       160 ~~~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~-~~~~~~~~~~  231 (294)
T 4eqm_A          160 ALSET-------SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA-IKHIQDSVPN  231 (294)
T ss_dssp             TC--------------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH-HHHHSSCCCC
T ss_pred             ccccc-------cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHhhccCCC
Confidence            65211       112223456899999999999999999999999999999999999999753211110 0111000000


Q ss_pred             hhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCC-cHHHHHHHHHHhhhh
Q 046639          266 KVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERM-EMRDVVAKLRHARET  325 (331)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-s~~~i~~~L~~~~~~  325 (331)
                               ...       ....+++..+.+++.+||+.||.+|| +++++.+.|+.+...
T Consensus       232 ---------~~~-------~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~  276 (294)
T 4eqm_A          232 ---------VTT-------DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE  276 (294)
T ss_dssp             ---------HHH-------HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred             ---------cch-------hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence                     000       11123566789999999999999998 999999999887544

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.6e-47  Score=337.43  Aligned_cols=247  Identities=23%  Similarity=0.329  Sum_probs=202.5

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcc
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFD  105 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~  105 (331)
                      .++|.+.+.||+|+||+||+|.+..+++.||+|++....   ......+.+|+.+++.++||||+++++++     ....
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-----~~~~   82 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVI-----TTPT   82 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCC
Confidence            468999999999999999999999999999999986432   22235688999999999999999999995     4456


Q ss_pred             eeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccc
Q 046639          106 FKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAK  185 (331)
Q Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~  185 (331)
                      ..++||||+ +|+|.+++....  .+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.
T Consensus        83 ~~~lv~E~~-~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~  156 (336)
T 3h4j_B           83 DIVMVIEYA-GGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSN  156 (336)
T ss_dssp             EEEEEECCC-CEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTB
T ss_pred             EEEEEEECC-CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccce
Confidence            789999999 789999987644  477889999999999999999999   99999999999999999999999999997


Q ss_pred             ccccCCCCCcccccCCceeecccccccCCcccCCCCC-ccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCc
Q 046639          186 FLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKA-SVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALP  264 (331)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  264 (331)
                      ....         ........||+.|+|||++.+..+ +.++||||||+++|+|++|..||.......            
T Consensus       157 ~~~~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~------------  215 (336)
T 3h4j_B          157 IMTD---------GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN------------  215 (336)
T ss_dssp             TTTT---------SBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT------------
T ss_pred             eccC---------CcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH------------
Confidence            6521         122334568999999999998876 789999999999999999999997532211            


Q ss_pred             chhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          265 DKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                                +...+.......+..++..+.+|+.+||+.||.+|||+.++++
T Consensus       216 ----------~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          216 ----------LFKKVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             ----------CBCCCCSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             ----------HHHHHHcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence                      1111111111223345677899999999999999999999975

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=6.1e-47  Score=338.30  Aligned_cols=253  Identities=19%  Similarity=0.251  Sum_probs=205.2

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchh------hHHHHHHHHHHHHcCCCCCcceeeceeecccC
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKE------ASRSFAAECNALRNIRHRNLIKIITICSSIDF  101 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  101 (331)
                      ..++|.+++.||+|+||+||+|++..+++.||+|++......      ..+.+.+|+.+++.++||||+++++++     
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-----   84 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVY-----   84 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEE-----
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEE-----
Confidence            456899999999999999999999999999999999754322      246788999999999999999999995     


Q ss_pred             CCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCC----cEE
Q 046639          102 EGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDI----VAH  177 (331)
Q Consensus       102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~----~~k  177 (331)
                      ......++|||++++++|.+++...  ..+++..+..++.|++.||.|||++   ||+|+||||+||+++.++    .+|
T Consensus        85 ~~~~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vk  159 (361)
T 2yab_A           85 ENRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIK  159 (361)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEE
T ss_pred             EeCCEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEE
Confidence            4557889999999999999999653  3578899999999999999999999   999999999999998777    799


Q ss_pred             EcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHH
Q 046639          178 VGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHE  257 (331)
Q Consensus       178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~  257 (331)
                      |+|||++.....         ........||+.|+|||++.+..++.++||||||+++|+|++|..||.+.... ..+..
T Consensus       160 l~DFG~a~~~~~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~-~~~~~  229 (361)
T 2yab_A          160 LIDFGLAHEIED---------GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-ETLAN  229 (361)
T ss_dssp             ECCCSSCEECCT---------TCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHH
T ss_pred             EEecCCceEcCC---------CCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-HHHHH
Confidence            999999987521         12223456999999999999999999999999999999999999999753211 11111


Q ss_pred             HHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          258 FVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      +......      .+           ..+...++..+.+|+.+||..||.+|||+.++++
T Consensus       230 i~~~~~~------~~-----------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          230 ITAVSYD------FD-----------EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             HHTTCCC------CC-----------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHhcCCC------CC-----------chhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            1111000      00           0122335567899999999999999999999974

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.7e-47  Score=344.62  Aligned_cols=262  Identities=24%  Similarity=0.340  Sum_probs=210.0

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ-KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      ..++|.+.+.||+|+||+||+|.+..+++.||+|.+.... ......+.+|+.+++.++||||+++++++     ...+.
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~~  186 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC-----TQKQP  186 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEE-----CSSSS
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----ecCCC
Confidence            3457999999999999999999999899999999986442 33345688999999999999999999995     34567


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      .++|||++++++|.+++.... ..+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||+++.
T Consensus       187 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~  262 (377)
T 3cbl_A          187 IYIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSRE  262 (377)
T ss_dssp             CEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             cEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCcee
Confidence            899999999999999997643 3467888999999999999999999   999999999999999999999999999976


Q ss_pred             cccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhCcc
Q 046639          187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMALPD  265 (331)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~  265 (331)
                      ....      ..........+++.|+|||++.+..++.++||||||+++|||++ |..||.....  ......+..... 
T Consensus       263 ~~~~------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~--~~~~~~~~~~~~-  333 (377)
T 3cbl_A          263 EADG------VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN--QQTREFVEKGGR-  333 (377)
T ss_dssp             CTTS------EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH--HHHHHHHHTTCC-
T ss_pred             cCCC------ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCC-
Confidence            4110      01111112235677999999998899999999999999999998 9999976422  111121111100 


Q ss_pred             hhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhh
Q 046639          266 KVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARET  325 (331)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~  325 (331)
                                 .       ..+..++..+.+|+.+||+.||++|||+.+|++.|+.+.+.
T Consensus       334 -----------~-------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~  375 (377)
T 3cbl_A          334 -----------L-------PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR  375 (377)
T ss_dssp             -----------C-------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----------C-------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence                       0       11123567889999999999999999999999999998764

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-46  Score=331.40  Aligned_cols=252  Identities=19%  Similarity=0.259  Sum_probs=205.6

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      .++|.+.+.||+|+||+||+|.+..+++.+|+|.+.... .....+.+|+.+++.++||||+++++++     ...+..+
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~~~~~   77 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESF-----ESMEELV   77 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEE-----EETTEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEE-----ecCCEEE
Confidence            468999999999999999999999999999999987543 3446688999999999999999999995     4456789


Q ss_pred             EEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecC--CCcEEEcccCcccc
Q 046639          109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQ--DIVAHVGDLGLAKF  186 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~--~~~~kl~Dfg~a~~  186 (331)
                      +|||++++++|.+++.... ..+++..+..++.|++.||.|||++   +++|+||||+||+++.  ++.+||+|||++..
T Consensus        78 lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~  153 (321)
T 1tki_A           78 MIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ  153 (321)
T ss_dssp             EEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred             EEEEeCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeE
Confidence            9999999999999996533 3477889999999999999999999   9999999999999987  78999999999987


Q ss_pred             cccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcch
Q 046639          187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDK  266 (331)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  266 (331)
                      ..         .........+|+.|+|||++.+..++.++||||||+++|+|++|..||..... .............. 
T Consensus       154 ~~---------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~-  222 (321)
T 1tki_A          154 LK---------PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-QQIIENIMNAEYTF-  222 (321)
T ss_dssp             CC---------TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH-HHHHHHHHHTCCCC-
T ss_pred             CC---------CCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH-HHHHHHHHcCCCCC-
Confidence            52         11223456689999999999998899999999999999999999999975321 11111111111110 


Q ss_pred             hhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          267 VMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                           .           ......++..+.+|+.+||+.||.+|||+.++++
T Consensus       223 -----~-----------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          223 -----D-----------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             -----C-----------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -----C-----------hhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                 0           0111234667899999999999999999999986

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=3.2e-47  Score=335.83  Aligned_cols=254  Identities=20%  Similarity=0.246  Sum_probs=203.3

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccch-hhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCccee
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK-EASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      .++|.+.+.||+|+||+||+|++..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++     ...+..
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~~~~   80 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR-----REGNIQ   80 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEE-----ECSSEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEE-----ecCCeE
Confidence            4689999999999999999999999999999999865433 2235688999999999999999999985     445678


Q ss_pred             eEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccc
Q 046639          108 AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      ++|||++++++|.+++...  ..+++..+..++.|++.||.|||+.   +|+|+||||+||+++.++.+||+|||++..+
T Consensus        81 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  155 (323)
T 3tki_A           81 YLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVF  155 (323)
T ss_dssp             EEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeecccee
Confidence            9999999999999998543  3478899999999999999999999   9999999999999999999999999999765


Q ss_pred             ccCCCCCcccccCCceeecccccccCCcccCCCCC-ccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcch
Q 046639          188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKA-SVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDK  266 (331)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  266 (331)
                      ....      .........||+.|+|||++.+..+ +.++||||||+++|+|++|..||............+....... 
T Consensus       156 ~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-  228 (323)
T 3tki_A          156 RYNN------RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL-  228 (323)
T ss_dssp             EETT------EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTS-
T ss_pred             ccCC------cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccC-
Confidence            2111      1122234568999999999988775 8899999999999999999999986544333333222111100 


Q ss_pred             hhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          267 VMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                                        .....+...+.+|+.+||+.||.+|||+.|+++
T Consensus       229 ------------------~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~  261 (323)
T 3tki_A          229 ------------------NPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (323)
T ss_dssp             ------------------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ------------------CccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence                              001234567889999999999999999999975

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=5.5e-47  Score=332.20  Aligned_cols=276  Identities=20%  Similarity=0.247  Sum_probs=206.0

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccch-----hhHHHHHHHHHHHHcCC---CCCcceeeceeecc
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK-----EASRSFAAECNALRNIR---HRNLIKIITICSSI   99 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~   99 (331)
                      ..++|.+.+.||+|+||+||+|++..+++.||+|++.....     .......+|+.+++.++   ||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            45789999999999999999999999999999999864321     11245667777777664   99999999998765


Q ss_pred             cCCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEc
Q 046639          100 DFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVG  179 (331)
Q Consensus       100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~  179 (331)
                      ........++|||++ +++|.+++.......+++..+..++.|++.||+|||++   +++|+||||+||+++.++.+||+
T Consensus        87 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~  162 (308)
T 3g33_A           87 RTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLA  162 (308)
T ss_dssp             CSSSEEEEEEEEECC-CCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEEC
T ss_pred             CCCCceeEEEEehhh-hcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEEe
Confidence            444445689999999 56999999887666688999999999999999999999   99999999999999999999999


Q ss_pred             ccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHH
Q 046639          180 DLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFV  259 (331)
Q Consensus       180 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~  259 (331)
                      |||++....         .........+|+.|+|||++.+..++.++||||||+++|+|++|..||...... .......
T Consensus       163 Dfg~a~~~~---------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~i~  232 (308)
T 3g33_A          163 DFGLARIYS---------YQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-DQLGKIF  232 (308)
T ss_dssp             SCSCTTTST---------TCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH-HHHHHHH
T ss_pred             eCccccccC---------CCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHH
Confidence            999997652         112223456899999999999999999999999999999999999999764221 1222222


Q ss_pred             HhhCcchhhhhcCc------ccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          260 KMALPDKVMEIVDP------SLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       260 ~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ..............      ...............++...+.+|+.+||+.||++|||+.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          233 DLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             HHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            21111100000000      00000000001122245577899999999999999999999975

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.5e-46  Score=332.08  Aligned_cols=252  Identities=18%  Similarity=0.256  Sum_probs=204.2

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchh------hHHHHHHHHHHHHcCCCCCcceeeceeecccCC
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKE------ASRSFAAECNALRNIRHRNLIKIITICSSIDFE  102 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  102 (331)
                      .++|.+.+.||+|+||+||+|.+..+++.||+|++......      ....+.+|+.+++.++||||+++++++     .
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~   84 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY-----E   84 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----E
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----E
Confidence            35799999999999999999999999999999999754321      346788999999999999999999995     4


Q ss_pred             CcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCC----cEEE
Q 046639          103 GFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDI----VAHV  178 (331)
Q Consensus       103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~----~~kl  178 (331)
                      .....++|||++++++|.+++...  ..+++..+..++.|++.||.|||++   +++|+||||+||+++.++    .+||
T Consensus        85 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl  159 (326)
T 2y0a_A           85 NKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKI  159 (326)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEE
T ss_pred             eCCEEEEEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEE
Confidence            456789999999999999999653  3578899999999999999999999   999999999999999887    8999


Q ss_pred             cccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHH
Q 046639          179 GDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEF  258 (331)
Q Consensus       179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  258 (331)
                      +|||++.....         ........||+.|+|||++.+..++.++||||||+++|+|++|..||...... ......
T Consensus       160 ~Dfg~a~~~~~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~~  229 (326)
T 2y0a_A          160 IDFGLAHKIDF---------GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-ETLANV  229 (326)
T ss_dssp             CCCTTCEECCT---------TSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHHH
T ss_pred             EECCCCeECCC---------CCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH-HHHHHH
Confidence            99999987521         11223456899999999999999999999999999999999999999653211 111111


Q ss_pred             HHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          259 VKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ......          ..       ......++..+.+|+.+||+.||.+|||+.++++
T Consensus       230 ~~~~~~----------~~-------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          230 SAVNYE----------FE-------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             HHTCCC----------CC-------HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HhcCCC----------cC-------ccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            111000          00       0122234567889999999999999999999986

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-46  Score=334.36  Aligned_cols=269  Identities=22%  Similarity=0.371  Sum_probs=212.0

Q ss_pred             HHHHhcCCCcCceeeccCeeEEEEeeec-----CCCceEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCcceeeceeec
Q 046639           25 LSKATNNFSPANKIGQGGVSIVYKGILD-----ESRSIVAVKVVNLKQ-KEASRSFAAECNALRNIRHRNLIKIITICSS   98 (331)
Q Consensus        25 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   98 (331)
                      +....++|.+.+.||+|+||.||+|.+.     .+++.||+|++.... ......+.+|+.+++.++||||+++++++  
T Consensus        42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~--  119 (343)
T 1luf_A           42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC--  119 (343)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE--
T ss_pred             eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE--
Confidence            3445679999999999999999999986     345899999997543 34456789999999999999999999995  


Q ss_pred             ccCCCcceeeEEEeecCCCCHHHHHHhcc----------------------CCccchHHHHHHHHHHHHHHHHHhhcCCC
Q 046639           99 IDFEGFDFKAIVFEYMQNRNLEQWLRQSN----------------------GQLRFLTQRVNIAIDVSFAIEYFHHHCQP  156 (331)
Q Consensus        99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------------~~~~~~~~~~~~~~~i~~~l~~LH~~~~~  156 (331)
                         ......++||||+++++|.+++....                      ...+++..++.++.|++.||.|||++   
T Consensus       120 ---~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---  193 (343)
T 1luf_A          120 ---AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---  193 (343)
T ss_dssp             ---CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred             ---ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence               44567899999999999999998742                      14578889999999999999999999   


Q ss_pred             CeeecCCCCCCEEecCCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHH
Q 046639          157 SIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLL  236 (331)
Q Consensus       157 ~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~  236 (331)
                      +++|+||||+||+++.++.+||+|||++......      ..........+|+.|+|||++.+..++.++||||||+++|
T Consensus       194 ~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~  267 (343)
T 1luf_A          194 KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA------DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLW  267 (343)
T ss_dssp             TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGG------GCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred             CeecCCCCcceEEECCCCeEEEeecCCCcccccC------ccccccCCCcccceecChhhhccCCcCcccccHHHHHHHH
Confidence            9999999999999999999999999999865211      1112223345788899999998888999999999999999


Q ss_pred             HHHh-CCCCCCcccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHH
Q 046639          237 EMFT-RRRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDV  315 (331)
Q Consensus       237 el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i  315 (331)
                      +|++ |..||......  ..........   .     +           .....++..+.+|+.+||+.||.+|||+.+|
T Consensus       268 el~t~g~~p~~~~~~~--~~~~~~~~~~---~-----~-----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~  326 (343)
T 1luf_A          268 EIFSYGLQPYYGMAHE--EVIYYVRDGN---I-----L-----------ACPENCPLELYNLMRLCWSKLPADRPSFCSI  326 (343)
T ss_dssp             HHHTTTCCTTTTSCHH--HHHHHHHTTC---C-----C-----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHhcCCCcCCCCChH--HHHHHHhCCC---c-----C-----------CCCCCCCHHHHHHHHHHcccCcccCCCHHHH
Confidence            9999 99999754211  1111111100   0     0           1112355678999999999999999999999


Q ss_pred             HHHHHHhhhhhhc
Q 046639          316 VAKLRHARETFLG  328 (331)
Q Consensus       316 ~~~L~~~~~~~~~  328 (331)
                      ++.|+.+.+...+
T Consensus       327 ~~~L~~~~~~~~~  339 (343)
T 1luf_A          327 HRILQRMCERAEG  339 (343)
T ss_dssp             HHHHHHTTC----
T ss_pred             HHHHHHHHhhhhh
Confidence            9999999877654

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2.3e-46  Score=334.07  Aligned_cols=254  Identities=19%  Similarity=0.248  Sum_probs=202.6

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccch-----hhHHHHHHHHHHHHcCCCCCcceeeceeecccCCC
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK-----EASRSFAAECNALRNIRHRNLIKIITICSSIDFEG  103 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  103 (331)
                      .++|.+.+.||+|+||+||+|.+..+++.||+|++.....     ...+.+.+|+.+++.++||||+++++++     ..
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~   97 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETY-----SS   97 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEE-----Ee
Confidence            4579999999999999999999999999999999864321     1346788999999999999999999995     34


Q ss_pred             cceeeEEEeecCCCCHHHHHHhc--cCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCc---EEE
Q 046639          104 FDFKAIVFEYMQNRNLEQWLRQS--NGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIV---AHV  178 (331)
Q Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~---~kl  178 (331)
                      .+..++|||++++++|.+.+...  .+..+++..+..++.|++.||.|||++   +|+|+||||+||+++.++.   +||
T Consensus        98 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl  174 (351)
T 3c0i_A           98 DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKL  174 (351)
T ss_dssp             TTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEE
T ss_pred             CCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEE
Confidence            56789999999999999888653  233467888999999999999999999   9999999999999986654   999


Q ss_pred             cccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHH
Q 046639          179 GDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEF  258 (331)
Q Consensus       179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  258 (331)
                      +|||++......        ........||+.|+|||++.+..++.++||||||+++|+|++|..||....  .......
T Consensus       175 ~Dfg~a~~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~i  244 (351)
T 3c0i_A          175 GGFGVAIQLGES--------GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGI  244 (351)
T ss_dssp             CCCTTCEECCTT--------SCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH--HHHHHHH
T ss_pred             ecCcceeEecCC--------CeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH--HHHHHHH
Confidence            999999875211        112234568999999999999999999999999999999999999997531  1111111


Q ss_pred             HHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          259 VKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      .......      .+           .....++..+.+|+.+||+.||++|||+.++++
T Consensus       245 ~~~~~~~------~~-----------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          245 IKGKYKM------NP-----------RQWSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             HHTCCCC------CH-----------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HcCCCCC------Cc-----------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            1111100      00           111234567899999999999999999999985

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1e-46  Score=327.25  Aligned_cols=263  Identities=24%  Similarity=0.353  Sum_probs=216.4

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCccee
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      ..++|.+.+.||+|+||+||+|.+..++..||+|++... ....+.+.+|+.+++.++||||+++++++     ......
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~   84 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPPF   84 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCCCE
Confidence            456899999999999999999999989999999999744 33456788999999999999999999995     445678


Q ss_pred             eEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccc
Q 046639          108 AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      ++|||++++++|.+++.......+++..++.++.|++.||.+||+.   +++|+||||+||+++.++.++|+|||++...
T Consensus        85 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~  161 (288)
T 3kfa_A           85 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM  161 (288)
T ss_dssp             EEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred             EEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceec
Confidence            9999999999999999887767788899999999999999999999   9999999999999999999999999999865


Q ss_pred             ccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhCcch
Q 046639          188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMALPDK  266 (331)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~  266 (331)
                      ...       .........+++.|+|||++.+..++.++||||||+++|+|++ |..||.....  ............  
T Consensus       162 ~~~-------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~--~~~~~~~~~~~~--  230 (288)
T 3kfa_A          162 TGD-------TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQVYELLEKDYR--  230 (288)
T ss_dssp             CSS-------SSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG--GGHHHHHHTTCC--
T ss_pred             cCC-------ccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHhccCC--
Confidence            211       1112223446778999999998899999999999999999999 9999976422  122222211110  


Q ss_pred             hhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhhh
Q 046639          267 VMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETFL  327 (331)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~~  327 (331)
                            .           .....++..+.+|+.+||+.||.+|||+.++++.|+.+.+...
T Consensus       231 ------~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~  274 (288)
T 3kfa_A          231 ------M-----------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS  274 (288)
T ss_dssp             ------C-----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             ------C-----------CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhcc
Confidence                  0           1112345678999999999999999999999999999877643

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=3.5e-46  Score=341.73  Aligned_cols=255  Identities=16%  Similarity=0.199  Sum_probs=203.8

Q ss_pred             HHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCc
Q 046639           27 KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ--KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGF  104 (331)
Q Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  104 (331)
                      ...++|.+.+.||+|+||+||+|.+..+++.+|+|++....  ......+.+|+.+++.++||||+++++++     ...
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-----~~~   82 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI-----SEE   82 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEE-----ECS
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEE-----EEC
Confidence            34567999999999999999999999999999999997543  33446789999999999999999999994     456


Q ss_pred             ceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEec---CCCcEEEccc
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLD---QDIVAHVGDL  181 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~---~~~~~kl~Df  181 (331)
                      +..++|||++++++|.+.+....  .+++..+..++.|++.||.|||++   +|+||||||+||+++   .++.+||+||
T Consensus        83 ~~~~lv~E~~~gg~L~~~i~~~~--~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DF  157 (444)
T 3soa_A           83 GHHYLIFDLVTGGELFEDIVARE--YYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADF  157 (444)
T ss_dssp             SEEEEEECCCBCCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCC
T ss_pred             CEEEEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccC
Confidence            78899999999999999997654  477899999999999999999999   999999999999998   4678999999


Q ss_pred             CcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHh
Q 046639          182 GLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKM  261 (331)
Q Consensus       182 g~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  261 (331)
                      |++......        ........||+.|+|||++.+..++.++||||||+++|+|++|..||..... ..........
T Consensus       158 G~a~~~~~~--------~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~-~~~~~~i~~~  228 (444)
T 3soa_A          158 GLAIEVEGE--------QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ-HRLYQQIKAG  228 (444)
T ss_dssp             SSCBCCCTT--------CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHT
T ss_pred             ceeEEecCC--------CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH-HHHHHHHHhC
Confidence            999765211        1222345699999999999999999999999999999999999999965321 1111111111


Q ss_pred             hCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          262 ALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ....     ..            .....+++.+.+|+.+||+.||.+|||+.++++
T Consensus       229 ~~~~-----~~------------~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          229 AYDF-----PS------------PEWDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             CCCC-----CT------------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCCC-----Cc------------cccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            1100     00            011234567889999999999999999999986

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2.7e-46  Score=336.13  Aligned_cols=250  Identities=20%  Similarity=0.288  Sum_probs=201.8

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcc
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFD  105 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~  105 (331)
                      .++|.+++.||+|+||+||+|.+..+++.||+|++....   ......+.+|+.+++.++||||+++++++     ....
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~~   88 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSF-----QDEE   88 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSS
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EeCC
Confidence            457999999999999999999999999999999986432   23346788999999999999999999995     4456


Q ss_pred             eeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccc
Q 046639          106 FKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAK  185 (331)
Q Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~  185 (331)
                      ..++|||++.+++|.+++...  ..++...+..++.|++.||.|||++   ||+||||||+||+++.+|.+||+|||++.
T Consensus        89 ~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~  163 (384)
T 4fr4_A           89 DMFMVVDLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAA  163 (384)
T ss_dssp             EEEEEECCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceee
Confidence            789999999999999999764  3477889999999999999999999   99999999999999999999999999998


Q ss_pred             ccccCCCCCcccccCCceeecccccccCCcccCC---CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhh
Q 046639          186 FLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG---SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMA  262 (331)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  262 (331)
                      ...         .........||+.|+|||++.+   ..++.++||||||+++|+|++|..||.......  ........
T Consensus       164 ~~~---------~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~--~~~~~~~~  232 (384)
T 4fr4_A          164 MLP---------RETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS--SKEIVHTF  232 (384)
T ss_dssp             ECC---------TTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC--HHHHHHHH
T ss_pred             ecc---------CCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc--HHHHHHHH
Confidence            652         1122344669999999999874   458999999999999999999999997543222  11111110


Q ss_pred             CcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCc-HHHHH
Q 046639          263 LPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERME-MRDVV  316 (331)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps-~~~i~  316 (331)
                      ..                 ....++..++..+.+|+.+||+.||.+||+ +.+|+
T Consensus       233 ~~-----------------~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~  270 (384)
T 4fr4_A          233 ET-----------------TVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQ  270 (384)
T ss_dssp             HH-----------------CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHH
T ss_pred             hh-----------------cccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHH
Confidence            00                 000112234567899999999999999998 66654

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=3.2e-46  Score=343.65  Aligned_cols=254  Identities=27%  Similarity=0.346  Sum_probs=208.7

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      .++|.+.+.||+|+||+||+|.+.  ++.||||+++...  ..+.+.+|+.+++.++||||+++++++..    .....+
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~~  263 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGLY  263 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEEC----TTSCEE
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEc----CCCceE
Confidence            467999999999999999999986  6789999996443  45678999999999999999999999743    334689


Q ss_pred             EEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccc
Q 046639          109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLF  188 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~  188 (331)
                      +|||++++++|.+++.......++...++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||+++...
T Consensus       264 iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  340 (450)
T 1k9a_A          264 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  340 (450)
T ss_dssp             EEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence            999999999999999886665577888999999999999999999   99999999999999999999999999997541


Q ss_pred             cCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhCcchh
Q 046639          189 GYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMALPDKV  267 (331)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  267 (331)
                      .           ......++..|+|||++.+..++.++||||||+++|||++ |..||.......  ....+....    
T Consensus       341 ~-----------~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~~~i~~~~----  403 (450)
T 1k9a_A          341 S-----------TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRVEKGY----  403 (450)
T ss_dssp             -----------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT--HHHHHHTTC----
T ss_pred             c-----------cccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCC----
Confidence            1           1112246778999999999999999999999999999998 999998653322  111111110    


Q ss_pred             hhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhh
Q 046639          268 MEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARET  325 (331)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~  325 (331)
                          ..           ..+..|+..+.+|+.+||+.||.+|||+.+|++.|+.+...
T Consensus       404 ----~~-----------~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          404 ----KM-----------DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             ----CC-----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             ----CC-----------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence                00           11234677899999999999999999999999999998764

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.7e-47  Score=339.74  Aligned_cols=251  Identities=20%  Similarity=0.237  Sum_probs=198.8

Q ss_pred             HHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc---chhhHHHHHHHHHHHHcC-CCCCcceeeceeecccCC
Q 046639           27 KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK---QKEASRSFAAECNALRNI-RHRNLIKIITICSSIDFE  102 (331)
Q Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~  102 (331)
                      ...++|.+++.||+|+||+||+|++..+++.||+|++...   .......+..|..+++.+ +||||+++++++     .
T Consensus        20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~   94 (353)
T 3txo_A           20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCF-----Q   94 (353)
T ss_dssp             ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE-----E
T ss_pred             CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEE-----E
Confidence            3456899999999999999999999999999999999743   233446678899999988 699999999995     4


Q ss_pred             CcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccC
Q 046639          103 GFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLG  182 (331)
Q Consensus       103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg  182 (331)
                      ..+.+++||||+++++|.+++.+..  .+++..+..++.|++.||.|||++   +|+||||||+||+++.+|.+||+|||
T Consensus        95 ~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG  169 (353)
T 3txo_A           95 TPDRLFFVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFG  169 (353)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEcccc
Confidence            5567999999999999999997654  477889999999999999999999   99999999999999999999999999


Q ss_pred             cccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhh
Q 046639          183 LAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMA  262 (331)
Q Consensus       183 ~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  262 (331)
                      +++...        ..........||+.|+|||++.+..++.++||||||+++|+|++|..||..... ...+..+....
T Consensus       170 ~a~~~~--------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-~~~~~~i~~~~  240 (353)
T 3txo_A          170 MCKEGI--------CNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE-DDLFEAILNDE  240 (353)
T ss_dssp             TCBCSC--------C---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHCC
T ss_pred             ceeecc--------cCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH-HHHHHHHHcCC
Confidence            997531        112233445799999999999988899999999999999999999999975321 11111111111


Q ss_pred             CcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcH------HHHHH
Q 046639          263 LPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEM------RDVVA  317 (331)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~------~~i~~  317 (331)
                      .                     .++......+.+|+.+||+.||.+||++      .+|++
T Consensus       241 ~---------------------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          241 V---------------------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             C---------------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             C---------------------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence            0                     1112245678899999999999999998      66653

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=7e-47  Score=339.35  Aligned_cols=263  Identities=22%  Similarity=0.320  Sum_probs=207.7

Q ss_pred             hcCCCcCceeeccCeeEEEEeee-----cCCCceEEEEEeecc-chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCC
Q 046639           29 TNNFSPANKIGQGGVSIVYKGIL-----DESRSIVAVKVVNLK-QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFE  102 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  102 (331)
                      .++|.+.+.||+|+||+||+|.+     ..+++.||||++... .......+.+|+.+++.++||||+++++++     .
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~  144 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVS-----L  144 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----C
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEE-----e
Confidence            35799999999999999999994     456788999998643 344446688999999999999999999995     4


Q ss_pred             CcceeeEEEeecCCCCHHHHHHhccC-----CccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCC---
Q 046639          103 GFDFKAIVFEYMQNRNLEQWLRQSNG-----QLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDI---  174 (331)
Q Consensus       103 ~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~---  174 (331)
                      .....++|||++++++|.+++.....     ..+++..++.++.|++.||.|||++   +|+||||||+||+++.++   
T Consensus       145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~  221 (367)
T 3l9p_A          145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGR  221 (367)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTC
T ss_pred             cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCc
Confidence            45667999999999999999987432     3477888999999999999999999   999999999999999555   


Q ss_pred             cEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcc
Q 046639          175 VAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGL  253 (331)
Q Consensus       175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~  253 (331)
                      .+||+|||+++......      .........+|+.|+|||++.+..++.++||||||+++|+|++ |..||.....  .
T Consensus       222 ~~kL~DFG~a~~~~~~~------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~--~  293 (367)
T 3l9p_A          222 VAKIGDFGMARDIYRAG------YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--Q  293 (367)
T ss_dssp             CEEECCCHHHHHHHHHS------SCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--H
T ss_pred             eEEECCCcccccccccc------ccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--H
Confidence            59999999998652211      1122233457889999999998899999999999999999998 9999975421  1


Q ss_pred             hHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhh
Q 046639          254 TLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETF  326 (331)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~  326 (331)
                      ...........        .           .....++..+.+|+.+||+.||.+|||+.+|++.|+.+.+..
T Consensus       294 ~~~~~i~~~~~--------~-----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~  347 (367)
T 3l9p_A          294 EVLEFVTSGGR--------M-----------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  347 (367)
T ss_dssp             HHHHHHHTTCC--------C-----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             HHHHHHHcCCC--------C-----------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence            11111111100        0           111234567899999999999999999999999999987754

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=2.1e-46  Score=339.08  Aligned_cols=281  Identities=16%  Similarity=0.129  Sum_probs=209.2

Q ss_pred             HHhcCCCcCceeecc--CeeEEEEeeecCCCceEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCC
Q 046639           27 KATNNFSPANKIGQG--GVSIVYKGILDESRSIVAVKVVNLKQ--KEASRSFAAECNALRNIRHRNLIKIITICSSIDFE  102 (331)
Q Consensus        27 ~~~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  102 (331)
                      ...++|.+.+.||+|  +||+||+|++..+++.||+|++....  ......+.+|+.+++.++||||+++++++.     
T Consensus        22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----   96 (389)
T 3gni_B           22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFI-----   96 (389)
T ss_dssp             CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred             CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEE-----
Confidence            345689999999999  99999999999999999999997543  444567889999999999999999999954     


Q ss_pred             CcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccC
Q 046639          103 GFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLG  182 (331)
Q Consensus       103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg  182 (331)
                      ..+..++|||++++++|.+++.......+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg  173 (389)
T 3gni_B           97 ADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLR  173 (389)
T ss_dssp             ETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGG
T ss_pred             ECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccc
Confidence            456789999999999999999886556688899999999999999999999   99999999999999999999999999


Q ss_pred             cccccccCCCCCcccccCCceeecccccccCCcccCC--CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHH
Q 046639          183 LAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG--SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVK  260 (331)
Q Consensus       183 ~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  260 (331)
                      .+.......... ...........||+.|+|||++.+  ..++.++|||||||++|+|++|..||.......... ....
T Consensus       174 ~~~~~~~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~-~~~~  251 (389)
T 3gni_B          174 SNLSMISHGQRQ-RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL-EKLN  251 (389)
T ss_dssp             GCEECEETTEEC-SCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHH-HC--
T ss_pred             cceeeccccccc-cccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHH-HHhc
Confidence            887653222111 111122233468899999999987  578999999999999999999999997653332221 1111


Q ss_pred             hhCcchhhhhcCc---------------c----------cccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHH
Q 046639          261 MALPDKVMEIVDP---------------S----------LLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDV  315 (331)
Q Consensus       261 ~~~~~~~~~~~~~---------------~----------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i  315 (331)
                      ...+........+               .          ...........+...+...+.+|+.+||+.||.+|||+.++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~el  331 (389)
T 3gni_B          252 GTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTL  331 (389)
T ss_dssp             ------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHH
T ss_pred             CCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHH
Confidence            1111000000000               0          00000000112334566789999999999999999999999


Q ss_pred             HH
Q 046639          316 VA  317 (331)
Q Consensus       316 ~~  317 (331)
                      ++
T Consensus       332 l~  333 (389)
T 3gni_B          332 LN  333 (389)
T ss_dssp             TT
T ss_pred             hc
Confidence            74

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=8.8e-47  Score=340.38  Aligned_cols=250  Identities=22%  Similarity=0.275  Sum_probs=198.8

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHHcC-CCCCcceeeceeecccCCC
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNI-RHRNLIKIITICSSIDFEG  103 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~  103 (331)
                      ..++|.+++.||+|+||+||+|++..+++.||+|+++...   ......+..|..++..+ +||||+++++++     ..
T Consensus        50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~~  124 (396)
T 4dc2_A           50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QT  124 (396)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEE-----EC
T ss_pred             ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEE-----EE
Confidence            3468999999999999999999999999999999997542   22335578899999887 899999999985     45


Q ss_pred             cceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCc
Q 046639          104 FDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGL  183 (331)
Q Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~  183 (331)
                      ...+++||||+++++|.+++.+..  .+++..+..++.|++.||.|||++   +|+||||||+||+++.+|.+||+|||+
T Consensus       125 ~~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGl  199 (396)
T 4dc2_A          125 ESRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGM  199 (396)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             CCEEEEEEEcCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecce
Confidence            678999999999999999997654  477899999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcc----hHHHHH
Q 046639          184 AKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGL----TLHEFV  259 (331)
Q Consensus       184 a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~----~~~~~~  259 (331)
                      ++...        ..........||+.|+|||++.+..++.++||||||+++|+|++|..||........    ......
T Consensus       200 a~~~~--------~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~  271 (396)
T 4dc2_A          200 CKEGL--------RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF  271 (396)
T ss_dssp             CBCCC--------CTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHH
T ss_pred             eeecc--------cCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHH
Confidence            97531        112233456799999999999999999999999999999999999999964321111    001111


Q ss_pred             HhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcH
Q 046639          260 KMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEM  312 (331)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~  312 (331)
                      ....                 .....++..++..+.+|+.+||+.||.+||++
T Consensus       272 ~~i~-----------------~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          272 QVIL-----------------EKQIRIPRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             HHHH-----------------HCCCCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             HHHh-----------------ccccCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence            1000                 00011222345678899999999999999996

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.7e-46  Score=336.55  Aligned_cols=268  Identities=21%  Similarity=0.305  Sum_probs=213.6

Q ss_pred             HHhcCCCcCceeeccCeeEEEEeeecC-------CCceEEEEEeeccc-hhhHHHHHHHHHHHHcC-CCCCcceeeceee
Q 046639           27 KATNNFSPANKIGQGGVSIVYKGILDE-------SRSIVAVKVVNLKQ-KEASRSFAAECNALRNI-RHRNLIKIITICS   97 (331)
Q Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~   97 (331)
                      ...++|.+.+.||+|+||+||+|.+..       .+..||+|++.... ......+.+|+.+++.+ +||||+++++++ 
T Consensus        66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~-  144 (382)
T 3tt0_A           66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC-  144 (382)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-
T ss_pred             cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee-
Confidence            345689999999999999999999753       33579999996543 34457789999999999 899999999995 


Q ss_pred             cccCCCcceeeEEEeecCCCCHHHHHHhccC--------------CccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCC
Q 046639           98 SIDFEGFDFKAIVFEYMQNRNLEQWLRQSNG--------------QLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDL  163 (331)
Q Consensus        98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~di  163 (331)
                          ...+..++|||++++++|.+++.....              ..+++..++.++.|++.||.+||+.   +|+|+||
T Consensus       145 ----~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dl  217 (382)
T 3tt0_A          145 ----TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDL  217 (382)
T ss_dssp             ----CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred             ----ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCC
Confidence                445678999999999999999987542              3478899999999999999999999   9999999


Q ss_pred             CCCCEEecCCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CC
Q 046639          164 KPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RR  242 (331)
Q Consensus       164 k~~nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~  242 (331)
                      ||+||+++.++.+||+|||+++......      .........+|+.|+|||++.+..++.++||||||+++|+|++ |.
T Consensus       218 kp~NIll~~~~~~kL~DFG~a~~~~~~~------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~  291 (382)
T 3tt0_A          218 AARNVLVTEDNVMKIADFGLARDIHHID------YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG  291 (382)
T ss_dssp             CGGGEEECTTCCEEECSCSCCCCSSCCC------TTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             CcceEEEcCCCcEEEcccCccccccccc------ccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCC
Confidence            9999999999999999999998652211      1112223446788999999999999999999999999999999 99


Q ss_pred             CCCCcccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHh
Q 046639          243 RPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHA  322 (331)
Q Consensus       243 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~  322 (331)
                      .||.....  ......+....        ..           .....++..+.+|+.+||+.||++|||+.+|++.|+.+
T Consensus       292 ~p~~~~~~--~~~~~~~~~~~--------~~-----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  350 (382)
T 3tt0_A          292 SPYPGVPV--EELFKLLKEGH--------RM-----------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  350 (382)
T ss_dssp             CSSTTCCH--HHHHHHHHTTC--------CC-----------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCCH--HHHHHHHHcCC--------CC-----------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            99975421  11111111110        00           11123456789999999999999999999999999999


Q ss_pred             hhhhhcC
Q 046639          323 RETFLGT  329 (331)
Q Consensus       323 ~~~~~~~  329 (331)
                      .......
T Consensus       351 ~~~~~~~  357 (382)
T 3tt0_A          351 VALTSNQ  357 (382)
T ss_dssp             HHHSCSC
T ss_pred             HHHHhcC
Confidence            8776544

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.3e-46  Score=330.60  Aligned_cols=265  Identities=22%  Similarity=0.327  Sum_probs=212.3

Q ss_pred             HHHhcCCCcCceeeccCeeEEEEeeec-----CCCceEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCcceeeceeecc
Q 046639           26 SKATNNFSPANKIGQGGVSIVYKGILD-----ESRSIVAVKVVNLKQ-KEASRSFAAECNALRNIRHRNLIKIITICSSI   99 (331)
Q Consensus        26 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   99 (331)
                      ....++|.+.+.||+|+||.||+|.+.     .++..||+|++.... ....+.+.+|+.+++.++||||+++++++   
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~---   95 (314)
T 2ivs_A           19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC---   95 (314)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE---
T ss_pred             ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEE---
Confidence            344678999999999999999999873     455889999996543 34457789999999999999999999995   


Q ss_pred             cCCCcceeeEEEeecCCCCHHHHHHhccC----------------------CccchHHHHHHHHHHHHHHHHHhhcCCCC
Q 046639          100 DFEGFDFKAIVFEYMQNRNLEQWLRQSNG----------------------QLRFLTQRVNIAIDVSFAIEYFHHHCQPS  157 (331)
Q Consensus       100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----------------------~~~~~~~~~~~~~~i~~~l~~LH~~~~~~  157 (331)
                        ...+..++|||++++++|.+++.....                      ..+++..++.++.|++.||.|||++   +
T Consensus        96 --~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~  170 (314)
T 2ivs_A           96 --SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---K  170 (314)
T ss_dssp             --CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred             --ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---C
Confidence              445678999999999999999987432                      3477889999999999999999999   9


Q ss_pred             eeecCCCCCCEEecCCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHH
Q 046639          158 IVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLE  237 (331)
Q Consensus       158 ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~e  237 (331)
                      ++|+||||+||+++.++.++|+|||++.......      .........+++.|+|||++.+..++.++||||||+++|+
T Consensus       171 ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e  244 (314)
T 2ivs_A          171 LVHRDLAARNILVAEGRKMKISDFGLSRDVYEED------SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWE  244 (314)
T ss_dssp             EECCCCSGGGEEEETTTEEEECCCTTCEECTTTS------CEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHH
T ss_pred             CcccccchheEEEcCCCCEEEccccccccccccc------cceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHH
Confidence            9999999999999999999999999998652211      1111223446788999999988889999999999999999


Q ss_pred             HHh-CCCCCCcccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHH
Q 046639          238 MFT-RRRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVV  316 (331)
Q Consensus       238 l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~  316 (331)
                      |++ |..||......  ...........        .           .....++..+.+++.+||+.||++|||+.+|+
T Consensus       245 l~t~g~~p~~~~~~~--~~~~~~~~~~~--------~-----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~  303 (314)
T 2ivs_A          245 IVTLGGNPYPGIPPE--RLFNLLKTGHR--------M-----------ERPDNCSEEMYRLMLQCWKQEPDKRPVFADIS  303 (314)
T ss_dssp             HHTTSCCSSTTCCGG--GHHHHHHTTCC--------C-----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             HHhCCCCCCCCCCHH--HHHHHhhcCCc--------C-----------CCCccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            999 99999764322  22222211110        0           11123456789999999999999999999999


Q ss_pred             HHHHHhhhh
Q 046639          317 AKLRHARET  325 (331)
Q Consensus       317 ~~L~~~~~~  325 (331)
                      +.|+.+.+.
T Consensus       304 ~~l~~~~~~  312 (314)
T 2ivs_A          304 KDLEKMMVK  312 (314)
T ss_dssp             HHHHHHHHT
T ss_pred             HHHHHHHhh
Confidence            999988764

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=8.2e-46  Score=341.68  Aligned_cols=271  Identities=19%  Similarity=0.195  Sum_probs=202.3

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc--chhhHHHHHHHHHHHHcCCCCCcceeeceeeccc-CCCcc
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRNIRHRNLIKIITICSSID-FEGFD  105 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~~~  105 (331)
                      .++|.+++.||+|+||+||+|.+..+++.||||++...  .......+.+|+.+++.++||||+++++++.... .+...
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            46899999999999999999999999999999999644  3445577889999999999999999999975432 23446


Q ss_pred             eeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccc
Q 046639          106 FKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAK  185 (331)
Q Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~  185 (331)
                      ..++||||++ ++|.+.+..    .++...+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus       141 ~~~lv~E~~~-~~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~  212 (464)
T 3ttj_A          141 DVYLVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (464)
T ss_dssp             EEEEEEECCS-EEHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred             eEEEEEeCCC-CCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeee
Confidence            7899999994 567777743    267788999999999999999999   99999999999999999999999999998


Q ss_pred             ccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcc
Q 046639          186 FLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPD  265 (331)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  265 (331)
                      ...         .........||+.|+|||++.+..++.++|||||||++|+|++|..||.+... ...+..+.......
T Consensus       213 ~~~---------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~-~~~~~~i~~~lg~p  282 (464)
T 3ttj_A          213 TAG---------TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY-IDQWNKVIEQLGTP  282 (464)
T ss_dssp             -------------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCSC
T ss_pred             ecC---------CCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCC
Confidence            651         11223346789999999999999999999999999999999999999976421 11222222211110


Q ss_pred             --hhh--------hhcCc----------c-cccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          266 --KVM--------EIVDP----------S-LLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       266 --~~~--------~~~~~----------~-~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                        ...        .....          . ...................+.+|+.+||+.||++|||+.|+++
T Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          283 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             CHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence              000        00000          0 0000111112223344678999999999999999999999985

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=4.9e-46  Score=323.73  Aligned_cols=270  Identities=19%  Similarity=0.249  Sum_probs=202.8

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCccee
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ--KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      ++|.+.+.||+|+||+||+|.+..+++.||+|++....  ......+.+|+.+++.++||||+++++++     ...+..
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~   76 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKL   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEE-----EETTEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEE-----EeCCEE
Confidence            57999999999999999999999999999999996443  33446788999999999999999999995     345678


Q ss_pred             eEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccc
Q 046639          108 AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      ++|||+++ +++.+.+.... ..+++..+..++.|++.||.|||++   +|+|+||||+||+++.++.+||+|||++...
T Consensus        77 ~lv~e~~~-~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~  151 (292)
T 3o0g_A           77 TLVFEFCD-QDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF  151 (292)
T ss_dssp             EEEEECCS-EEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEecCC-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence            99999995 57777665533 3477899999999999999999999   9999999999999999999999999999865


Q ss_pred             ccCCCCCcccccCCceeecccccccCCcccCCCC-CccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcch
Q 046639          188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSK-ASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDK  266 (331)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  266 (331)
                      ..        .........+|+.|+|||++.+.. ++.++||||||+++|+|++|..||.....................
T Consensus       152 ~~--------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~  223 (292)
T 3o0g_A          152 GI--------PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPT  223 (292)
T ss_dssp             CS--------CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             CC--------ccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCC
Confidence            21        112223446789999999988766 799999999999999999988886433222222333322211110


Q ss_pred             hh------hhcCccccc--ccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          267 VM------EIVDPSLLL--EVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       267 ~~------~~~~~~~~~--~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ..      ...+.....  ............+...+.+|+.+||+.||++|||+.|+++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          224 EEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            00      000000000  0000111222345677889999999999999999999975

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=5.7e-46  Score=333.26  Aligned_cols=283  Identities=17%  Similarity=0.186  Sum_probs=212.8

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCC-----CceEEEEEeeccchhh-----------HHHHHHHHHHHHcCCCCCcce
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDES-----RSIVAVKVVNLKQKEA-----------SRSFAAECNALRNIRHRNLIK   91 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~~i~~   91 (331)
                      ..++|.+.+.||+|+||+||+|.+..+     ++.||+|++.......           ......|+..++.++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            345899999999999999999998654     5789999986543211           122445666777889999999


Q ss_pred             eeceeecccCCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEec
Q 046639           92 IITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLD  171 (331)
Q Consensus        92 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~  171 (331)
                      +++++... ..+....++|||++ +++|.+++... ...+++..++.++.|++.||.|||++   +|+||||||+||+++
T Consensus       113 ~~~~~~~~-~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~  186 (364)
T 3op5_A          113 YWGSGLHD-KNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLN  186 (364)
T ss_dssp             EEEEEEEE-ETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEE
T ss_pred             EEeeeeec-cCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEe
Confidence            99997653 23346689999999 99999999764 34578899999999999999999999   999999999999999


Q ss_pred             --CCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCccc
Q 046639          172 --QDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMF  249 (331)
Q Consensus       172 --~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  249 (331)
                        .++.+||+|||+++.+....... ...........||+.|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus       187 ~~~~~~~kl~DFG~a~~~~~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~  265 (364)
T 3op5_A          187 YKNPDQVYLVDYGLAYRYCPEGVHK-AYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL  265 (364)
T ss_dssp             SSCTTCEEECCCTTCEESSGGGCCC-CSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             cCCCCeEEEEECCcceecccCCccc-ccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence              88999999999998763221111 111112234559999999999999999999999999999999999999998643


Q ss_pred             CCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhhhc
Q 046639          250 NEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETFLG  328 (331)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~~~  328 (331)
                      .... ............+....++.+..          ..++..+.+++..||+.+|.+|||+.+|++.|+.+.+....
T Consensus       266 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~  333 (364)
T 3op5_A          266 KDPK-YVRDSKIRYRENIASLMDKCFPA----------ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGS  333 (364)
T ss_dssp             TCHH-HHHHHHHHHHHCHHHHHHHHSCT----------TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             cCHH-HHHHHHHHhhhhHHHHHHHhccc----------ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence            3322 22222221112222222211100          12367899999999999999999999999999999876643

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.5e-46  Score=321.72  Aligned_cols=258  Identities=22%  Similarity=0.369  Sum_probs=206.6

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      .++|.+.+.||+|+||+||+|.+. ++..||+|++..... ..+.+.+|+.++++++||||+++++++     ......+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~   81 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVC-----LEQAPIC   81 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSSSEE
T ss_pred             hhhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCCceE
Confidence            357999999999999999999987 566799999974432 335688999999999999999999995     4456789


Q ss_pred             EEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccc
Q 046639          109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLF  188 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~  188 (331)
                      +|||++++++|.+++.... ..+++..++.++.|++.||.+||+.   +++|+||||+||+++.++.++|+|||++....
T Consensus        82 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  157 (269)
T 4hcu_A           82 LVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVL  157 (269)
T ss_dssp             EEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBC
T ss_pred             EEEEeCCCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccc
Confidence            9999999999999997643 3467888999999999999999999   99999999999999999999999999998652


Q ss_pred             cCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhCcchh
Q 046639          189 GYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMALPDKV  267 (331)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  267 (331)
                      .       ..........+++.|+|||++.+..++.++||||||+++|+|++ |..||......  ..........    
T Consensus       158 ~-------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~--~~~~~~~~~~----  224 (269)
T 4hcu_A          158 D-------DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--EVVEDISTGF----  224 (269)
T ss_dssp             C-------HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTTC----
T ss_pred             c-------cccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH--HHHHHHhcCc----
Confidence            1       11112223446778999999998899999999999999999999 99999753211  1111111110    


Q ss_pred             hhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhh
Q 046639          268 MEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARET  325 (331)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~  325 (331)
                          ..           .....++..+.+++.+||+.||++|||+.++++.|+.+.++
T Consensus       225 ----~~-----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          225 ----RL-----------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             ----CC-----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             ----cC-----------CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence                00           00112356788999999999999999999999999998764

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=5.1e-46  Score=322.75  Aligned_cols=254  Identities=24%  Similarity=0.390  Sum_probs=203.8

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhh-------HHHHHHHHHHHHcCCCCCcceeeceeecccC
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEA-------SRSFAAECNALRNIRHRNLIKIITICSSIDF  101 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  101 (331)
                      .++|.+.+.||+|+||+||+|.+..+++.||+|++.......       .+.+.+|+.+++.++||||+++++++..   
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---   94 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN---   94 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT---
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC---
Confidence            358999999999999999999999999999999986432211       1678899999999999999999998632   


Q ss_pred             CCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCC--eeecCCCCCCEEecCCCc----
Q 046639          102 EGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPS--IVHGDLKPSNILLDQDIV----  175 (331)
Q Consensus       102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~--ivH~dik~~nilv~~~~~----  175 (331)
                        .  .++|||++++++|.+.+.... ..+++..++.++.|++.||.|||+.   +  ++|+||||+||+++.++.    
T Consensus        95 --~--~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~  166 (287)
T 4f0f_A           95 --P--PRMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPV  166 (287)
T ss_dssp             --T--TEEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSC
T ss_pred             --C--CeEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCce
Confidence              2  269999999999999886543 3577889999999999999999999   8  999999999999988776    


Q ss_pred             -EEEcccCcccccccCCCCCcccccCCceeecccccccCCcccC--CCCCccchhhHhHHHHHHHHHhCCCCCCcccCCc
Q 046639          176 -AHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGM--GSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEG  252 (331)
Q Consensus       176 -~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~  252 (331)
                       +||+|||++...           ........+|+.|+|||++.  ...++.++||||||+++|+|++|..||.......
T Consensus       167 ~~kl~Dfg~~~~~-----------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~  235 (287)
T 4f0f_A          167 CAKVADFGLSQQS-----------VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK  235 (287)
T ss_dssp             CEEECCCTTCBCC-----------SSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH
T ss_pred             eEEeCCCCccccc-----------cccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH
Confidence             999999998753           11233456899999999984  4567899999999999999999999997654333


Q ss_pred             chHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHh
Q 046639          253 LTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHA  322 (331)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~  322 (331)
                      ............       .+           .....++..+.+++.+||+.||.+|||+.+|++.|+++
T Consensus       236 ~~~~~~~~~~~~-------~~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          236 IKFINMIREEGL-------RP-----------TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             HHHHHHHHHSCC-------CC-----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             HHHHHHHhccCC-------CC-----------CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            222222211110       00           11224567899999999999999999999999999864

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.3e-46  Score=332.60  Aligned_cols=278  Identities=21%  Similarity=0.277  Sum_probs=212.7

Q ss_pred             hcCCCcCceeeccCeeEEEEee----ecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCc
Q 046639           29 TNNFSPANKIGQGGVSIVYKGI----LDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGF  104 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  104 (331)
                      .++|.+.+.||+|+||+||+|+    +..+++.||+|++........+.+.+|+.+++.++||||+++++++..   ...
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~   98 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYG---PGR   98 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC---SSS
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEec---CCC
Confidence            3589999999999999999998    567889999999987777777789999999999999999999998642   345


Q ss_pred             ceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcc
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA  184 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a  184 (331)
                      ...++|||++++++|.+++..... .+++..++.++.|++.||.+||+.   +++|+||||+||+++.++.++|+|||++
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~  174 (327)
T 3lxl_A           99 QSLRLVMEYLPSGCLRDFLQRHRA-RLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLA  174 (327)
T ss_dssp             CEEEEEEECCTTCBHHHHHHHHGG-GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGC
T ss_pred             ceEEEEEeecCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccc
Confidence            678999999999999999976432 477889999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHH--hh
Q 046639          185 KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVK--MA  262 (331)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~--~~  262 (331)
                      .......     ..........+|+.|+|||++.+..++.++||||||+++|+|++|..||......   ......  ..
T Consensus       175 ~~~~~~~-----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~---~~~~~~~~~~  246 (327)
T 3lxl_A          175 KLLPLDK-----DYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAE---FLRMMGCERD  246 (327)
T ss_dssp             EECCTTC-----SEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH---HHHHCC----
T ss_pred             eecccCC-----ccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccch---hhhhcccccc
Confidence            8752211     1111223345788899999999888999999999999999999999998643211   000000  00


Q ss_pred             Cc--chhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhhhc
Q 046639          263 LP--DKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETFLG  328 (331)
Q Consensus       263 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~~~  328 (331)
                      .+  ..+.........       ......++..+.+|+.+||+.||.+|||+.+|++.|+.+.....+
T Consensus       247 ~~~~~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~  307 (327)
T 3lxl_A          247 VPALSRLLELLEEGQR-------LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRG  307 (327)
T ss_dssp             CCHHHHHHHHHHTTCC-------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC------
T ss_pred             cccHHHHHHHhhcccC-------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcC
Confidence            00  000000000000       011234567899999999999999999999999999998876554

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=6.6e-46  Score=334.45  Aligned_cols=254  Identities=17%  Similarity=0.216  Sum_probs=206.6

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCccee
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      ..++|.+.+.||+|+||+||+|.+..+++.||+|++..........+.+|+.+++.++||||+++++++     ......
T Consensus        49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~~  123 (387)
T 1kob_A           49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF-----EDKYEM  123 (387)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEE-----ECSSEE
T ss_pred             cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEE-----EeCCEE
Confidence            346899999999999999999999999999999999866655566789999999999999999999995     445778


Q ss_pred             eEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecC--CCcEEEcccCccc
Q 046639          108 AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQ--DIVAHVGDLGLAK  185 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~--~~~~kl~Dfg~a~  185 (331)
                      ++|||++++++|.+++.... ..+++..+..++.|++.||.|||++   +|+|+||||+||+++.  ++.+||+|||++.
T Consensus       124 ~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~  199 (387)
T 1kob_A          124 VLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLAT  199 (387)
T ss_dssp             EEEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCE
T ss_pred             EEEEEcCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccce
Confidence            99999999999999986533 3477899999999999999999999   9999999999999974  5789999999998


Q ss_pred             ccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcc
Q 046639          186 FLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPD  265 (331)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  265 (331)
                      ...         .........||+.|+|||++.+..++.++||||||+++|+|++|..||..... ............. 
T Consensus       200 ~~~---------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-~~~~~~i~~~~~~-  268 (387)
T 1kob_A          200 KLN---------PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD-LETLQNVKRCDWE-  268 (387)
T ss_dssp             ECC---------TTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-HHHHHHHHHCCCC-
T ss_pred             ecC---------CCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCCC-
Confidence            752         11223345689999999999999999999999999999999999999975321 1111111111100 


Q ss_pred             hhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          266 KVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                           .++           .....++..+.+|+.+||+.||.+|||+.++++
T Consensus       269 -----~~~-----------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          269 -----FDE-----------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             -----CCS-----------STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             -----CCc-----------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence                 000           111234567899999999999999999999986

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=5.3e-46  Score=332.86  Aligned_cols=254  Identities=19%  Similarity=0.253  Sum_probs=204.0

Q ss_pred             HHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCc
Q 046639           27 KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ--KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGF  104 (331)
Q Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  104 (331)
                      ...++|.+.+.||+|+||.||+|.+..+++.||+|++....  ....+.+.+|+.+++.++||||+++++++     ...
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~  100 (362)
T 2bdw_A           26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEE  100 (362)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECS
T ss_pred             CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeC
Confidence            34567999999999999999999999999999999996542  34456788999999999999999999995     445


Q ss_pred             ceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCC---cEEEccc
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDI---VAHVGDL  181 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~---~~kl~Df  181 (331)
                      +..++|||++++++|.+.+...  ..+++..+..++.|++.||.|||++   +|+|+||||+||+++.++   .+||+||
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Df  175 (362)
T 2bdw_A          101 SFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADF  175 (362)
T ss_dssp             SEEEEEECCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCC
T ss_pred             CEEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeec
Confidence            6789999999999999999654  3477889999999999999999999   999999999999998654   5999999


Q ss_pred             CcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHh
Q 046639          182 GLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKM  261 (331)
Q Consensus       182 g~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  261 (331)
                      |++.....         ........||+.|+|||++.+..++.++||||||+++|+|++|..||..... ..........
T Consensus       176 G~a~~~~~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~-~~~~~~i~~~  245 (362)
T 2bdw_A          176 GLAIEVND---------SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-HRLYAQIKAG  245 (362)
T ss_dssp             TTCBCCTT---------CCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHT
T ss_pred             CcceEecC---------CcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHHhC
Confidence            99976521         1122345689999999999999999999999999999999999999975321 1111111111


Q ss_pred             hCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          262 ALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ....     ..            .....++..+.+|+.+||+.||++|||+.++++
T Consensus       246 ~~~~-----~~------------~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          246 AYDY-----PS------------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  284 (362)
T ss_dssp             CCCC-----CT------------TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             CCCC-----Cc------------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            1100     00            111234567899999999999999999999875

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=5.8e-46  Score=323.98  Aligned_cols=272  Identities=13%  Similarity=0.136  Sum_probs=214.9

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcC-CCCCcceeeceeecccCCCcce
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNI-RHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      ..++|.+.+.||+|+||+||+|.+..+++.||+|++....  ....+.+|+.+++.+ .|++++++++++     .....
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~   80 (298)
T 1csn_A            8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFG-----QEGLH   80 (298)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEE-----EETTE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeec-----CCCce
Confidence            3568999999999999999999998899999999986432  234577899999999 799999999985     44567


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCc-----EEEccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIV-----AHVGDL  181 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~-----~kl~Df  181 (331)
                      .++|||++ +++|.+++.... ..+++..+..++.|++.||.|||++   +++|+||||+||+++.++.     ++|+||
T Consensus        81 ~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Df  155 (298)
T 1csn_A           81 NVLVIDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDF  155 (298)
T ss_dssp             EEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred             eEEEEEec-CCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEEC
Confidence            89999999 999999998643 3477899999999999999999999   9999999999999987776     999999


Q ss_pred             CcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcch--HHHHH
Q 046639          182 GLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLT--LHEFV  259 (331)
Q Consensus       182 g~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~  259 (331)
                      |++........... ..........||+.|+|||++.+..++.++||||||+++|+|++|..||.........  .....
T Consensus       156 g~~~~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~  234 (298)
T 1csn_A          156 GMVKFYRDPVTKQH-IPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG  234 (298)
T ss_dssp             TTCEESBCTTTCCB-CCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH
T ss_pred             cccccccccccccc-ccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHH
Confidence            99987643222111 1112234566999999999999999999999999999999999999999865322211  11111


Q ss_pred             HhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhhhc
Q 046639          260 KMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETFLG  328 (331)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~~~  328 (331)
                      .........                .....++..+.+++.+||+.||++|||+.+|++.|+.+.+.+..
T Consensus       235 ~~~~~~~~~----------------~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~  287 (298)
T 1csn_A          235 EKKQSTPLR----------------ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT  287 (298)
T ss_dssp             HHHHHSCHH----------------HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             hhccCccHH----------------HHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCC
Confidence            111111000                11123567899999999999999999999999999999887654

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=5.1e-47  Score=336.73  Aligned_cols=253  Identities=21%  Similarity=0.295  Sum_probs=201.7

Q ss_pred             HHHHHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHHcC-CCCCcceeeceeecc
Q 046639           24 ELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNI-RHRNLIKIITICSSI   99 (331)
Q Consensus        24 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~   99 (331)
                      ......++|.+.+.||+|+||+||+|++..+++.||+|+++...   ......+..|..++..+ +||||+++++++   
T Consensus        11 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~---   87 (345)
T 1xjd_A           11 QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF---   87 (345)
T ss_dssp             -----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE---
T ss_pred             cCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEE---
Confidence            34456789999999999999999999999999999999997442   23345677899999876 899999999985   


Q ss_pred             cCCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEc
Q 046639          100 DFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVG  179 (331)
Q Consensus       100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~  179 (331)
                        ......++||||+++++|.+++....  .+++..+..++.|++.||.|||++   +|+||||||+||+++.+|.+||+
T Consensus        88 --~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~  160 (345)
T 1xjd_A           88 --QTKENLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIA  160 (345)
T ss_dssp             --ECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEEC
T ss_pred             --EeCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEe
Confidence              44567999999999999999997643  377889999999999999999999   99999999999999999999999


Q ss_pred             ccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHH
Q 046639          180 DLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFV  259 (331)
Q Consensus       180 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~  259 (331)
                      |||+++....        .........||+.|+|||++.+..++.++||||||+++|+|++|..||..... ...+....
T Consensus       161 DFG~a~~~~~--------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-~~~~~~i~  231 (345)
T 1xjd_A          161 DFGMCKENML--------GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-EELFHSIR  231 (345)
T ss_dssp             CCTTCBCCCC--------TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHH
T ss_pred             EChhhhhccc--------CCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH-HHHHHHHH
Confidence            9999975311        11223456799999999999999999999999999999999999999975321 11111111


Q ss_pred             HhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHH-HHH
Q 046639          260 KMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMR-DVV  316 (331)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~-~i~  316 (331)
                      ...          +           .++..++..+.+|+.+||+.||.+||++. +|+
T Consensus       232 ~~~----------~-----------~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          232 MDN----------P-----------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             HCC----------C-----------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             hCC----------C-----------CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence            100          0           11122456788999999999999999997 554

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=3.7e-46  Score=330.12  Aligned_cols=268  Identities=17%  Similarity=0.201  Sum_probs=211.9

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcC-CCCCcceeeceeecccCCCccee
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNI-RHRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      .++|.+.+.||+|+||+||+|.+..+++.||||++.....  ...+..|+.+++.+ .||||+++++++.     .....
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~-----~~~~~   80 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGP-----CGKYN   80 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEE-----ETTEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEe-----cCCcc
Confidence            4689999999999999999999999999999999864432  23578999999999 8999999999853     35678


Q ss_pred             eEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCc-----EEEcccC
Q 046639          108 AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIV-----AHVGDLG  182 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~-----~kl~Dfg  182 (331)
                      ++|||++ +++|.+++... ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.     +||+|||
T Consensus        81 ~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg  155 (330)
T 2izr_A           81 AMVLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFA  155 (330)
T ss_dssp             EEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCT
T ss_pred             EEEEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcc
Confidence            9999999 99999999864 34578899999999999999999999   9999999999999998887     9999999


Q ss_pred             cccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcch--HHHHHH
Q 046639          183 LAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLT--LHEFVK  260 (331)
Q Consensus       183 ~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~  260 (331)
                      ++..+........ ..........||+.|+|||++.+..++.++||||||+++|+|++|..||.........  +.....
T Consensus       156 ~a~~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~  234 (330)
T 2izr_A          156 LAKEYIDPETKKH-IPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGD  234 (330)
T ss_dssp             TCEESBCTTTCCB-CCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHH
T ss_pred             cceeeecCCCCcc-ccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHh
Confidence            9987633222111 1112234567999999999999999999999999999999999999999875332221  111111


Q ss_pred             hhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhh
Q 046639          261 MALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETF  326 (331)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~  326 (331)
                      ...+....                .....++ .+.+++..||+.||.+||++.+|.+.|+.+.+..
T Consensus       235 ~~~~~~~~----------------~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~  283 (330)
T 2izr_A          235 TKRATPIE----------------VLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK  283 (330)
T ss_dssp             HHHHSCHH----------------HHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             hhccCCHH----------------HHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence            11110000                0011234 8999999999999999999999999999887765

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=3.5e-46  Score=327.65  Aligned_cols=267  Identities=19%  Similarity=0.291  Sum_probs=213.5

Q ss_pred             HHhcCCCcCceeeccCeeEEEEeee-----cCCCceEEEEEeeccch-hhHHHHHHHHHHHHcC-CCCCcceeeceeecc
Q 046639           27 KATNNFSPANKIGQGGVSIVYKGIL-----DESRSIVAVKVVNLKQK-EASRSFAAECNALRNI-RHRNLIKIITICSSI   99 (331)
Q Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~   99 (331)
                      ...++|.+.+.||+|+||+||+|.+     ..+++.||+|++..... ...+.+.+|+.+++.+ +||||+++++++   
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~---   96 (313)
T 1t46_A           20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC---   96 (313)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE---
T ss_pred             cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEE---
Confidence            3456899999999999999999985     45778999999975432 3457789999999999 899999999995   


Q ss_pred             cCCCcceeeEEEeecCCCCHHHHHHhccCC----------------ccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCC
Q 046639          100 DFEGFDFKAIVFEYMQNRNLEQWLRQSNGQ----------------LRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDL  163 (331)
Q Consensus       100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~----------------~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~di  163 (331)
                        ...+..++|||++++++|.+++......                .+++..++.++.|++.||.+||++   +++|+||
T Consensus        97 --~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl  171 (313)
T 1t46_A           97 --TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDL  171 (313)
T ss_dssp             --CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred             --ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCC
Confidence              4456789999999999999999875432                478889999999999999999999   9999999


Q ss_pred             CCCCEEecCCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CC
Q 046639          164 KPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RR  242 (331)
Q Consensus       164 k~~nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~  242 (331)
                      ||+||+++.++.+||+|||++.......      .........+|+.|+|||++.+..++.++||||||+++|+|++ |.
T Consensus       172 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~  245 (313)
T 1t46_A          172 AARNILLTHGRITKICDFGLARDIKNDS------NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS  245 (313)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCTTSCT------TSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred             ccceEEEcCCCCEEEccccccccccccc------cceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCC
Confidence            9999999999999999999998652211      1111223446788999999988899999999999999999999 99


Q ss_pred             CCCCcccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHh
Q 046639          243 RPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHA  322 (331)
Q Consensus       243 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~  322 (331)
                      .||........ ...........        .           ....++..+.+++.+||+.||.+|||+.+|++.|+++
T Consensus       246 ~p~~~~~~~~~-~~~~~~~~~~~--------~-----------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  305 (313)
T 1t46_A          246 SPYPGMPVDSK-FYKMIKEGFRM--------L-----------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (313)
T ss_dssp             CSSTTCCSSHH-HHHHHHHTCCC--------C-----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCcccchhH-HHHHhccCCCC--------C-----------CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence            99976543222 22222211110        0           0112456789999999999999999999999999998


Q ss_pred             hhhhh
Q 046639          323 RETFL  327 (331)
Q Consensus       323 ~~~~~  327 (331)
                      .....
T Consensus       306 ~~~~~  310 (313)
T 1t46_A          306 ISEST  310 (313)
T ss_dssp             HHHTC
T ss_pred             HHHhh
Confidence            87654

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=3.6e-46  Score=335.28  Aligned_cols=263  Identities=25%  Similarity=0.348  Sum_probs=198.6

Q ss_pred             hcCCCcCceeeccCeeEEEEeeec---CCCceEEEEEeecc-chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCc
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILD---ESRSIVAVKVVNLK-QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGF  104 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  104 (331)
                      .++|.+.+.||+|+||+||+|++.   .++..||+|.++.. .....+.+.+|+.+++.++||||+++++++     ...
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~  118 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVV-----TKS  118 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----CSS
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----eeC
Confidence            347999999999999999999886   56778999999754 334456799999999999999999999995     445


Q ss_pred             ceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcc
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA  184 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a  184 (331)
                      ...++||||+++++|.+++.... ..+++..++.++.|++.||.|||++   +|+|+||||+||+++.++.+||+|||++
T Consensus       119 ~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  194 (373)
T 2qol_A          119 KPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLG  194 (373)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred             CceEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccc
Confidence            67899999999999999997643 3477888999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhC
Q 046639          185 KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMAL  263 (331)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~  263 (331)
                      +.......     .........+++.|+|||++.+..++.++||||||+++|||++ |..||.....  ......+... 
T Consensus       195 ~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~--~~~~~~i~~~-  266 (373)
T 2qol_A          195 RVLEDDPE-----AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN--QDVIKAVDEG-  266 (373)
T ss_dssp             ------------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH--HHHHHHHHTT-
T ss_pred             cccccCCc-----cceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcC-
Confidence            87522111     0111112235677999999998899999999999999999998 9999975421  1111111110 


Q ss_pred             cchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhh
Q 046639          264 PDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETF  326 (331)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~  326 (331)
                                 ...       .....++..+.+++.+||+.||.+|||+.+|++.|+.+.+..
T Consensus       267 -----------~~~-------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~  311 (373)
T 2qol_A          267 -----------YRL-------PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP  311 (373)
T ss_dssp             -----------EEC-------CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred             -----------CCC-------CCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence                       000       011235677999999999999999999999999999987653

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-46  Score=329.29  Aligned_cols=246  Identities=23%  Similarity=0.253  Sum_probs=202.2

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcc
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFD  105 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~  105 (331)
                      .++|.+.+.||+|+||+||+|++..+++.||+|++....   ....+.+.+|..+++.++||||+++++++     .+..
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~   79 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDAQ   79 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-----ECSS
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEE-----EeCC
Confidence            357999999999999999999999999999999996442   22346678899999999999999999995     4456


Q ss_pred             eeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccc
Q 046639          106 FKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAK  185 (331)
Q Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~  185 (331)
                      ..++||||+++++|.+++....  .++...+..++.|++.||.|||++   +|+||||||+||+++.+|.+||+|||++.
T Consensus        80 ~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~  154 (318)
T 1fot_A           80 QIFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAK  154 (318)
T ss_dssp             EEEEEECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred             EEEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcce
Confidence            7899999999999999997643  477888999999999999999999   99999999999999999999999999998


Q ss_pred             ccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcc
Q 046639          186 FLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPD  265 (331)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  265 (331)
                      ...           .......||+.|+|||++.+..++.++||||||+++|+|++|..||..... ...+........  
T Consensus       155 ~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~--  220 (318)
T 1fot_A          155 YVP-----------DVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-MKTYEKILNAEL--  220 (318)
T ss_dssp             ECS-----------SCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-HHHHHHHHHCCC--
T ss_pred             ecC-----------CccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCC--
Confidence            641           112345689999999999999999999999999999999999999975321 111111111110  


Q ss_pred             hhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCC-----cHHHHHH
Q 046639          266 KVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERM-----EMRDVVA  317 (331)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----s~~~i~~  317 (331)
                                         .++......+.+++.+||+.||.+||     ++.+|++
T Consensus       221 -------------------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          221 -------------------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             -------------------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             -------------------CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence                               11122456788999999999999999     8888863

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-46  Score=333.61  Aligned_cols=267  Identities=19%  Similarity=0.268  Sum_probs=207.6

Q ss_pred             HhcCCCcCceeeccCeeEEEEeee-----cCCCceEEEEEeeccc-hhhHHHHHHHHHHHHcC-CCCCcceeeceeeccc
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGIL-----DESRSIVAVKVVNLKQ-KEASRSFAAECNALRNI-RHRNLIKIITICSSID  100 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~  100 (331)
                      ..++|.+.+.||+|+||+||+|.+     ..++..||+|++.... ......+.+|+.+++.+ .||||+++++++    
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~----  118 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC----  118 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE----
Confidence            356899999999999999999997     3466789999996442 33446789999999999 899999999995    


Q ss_pred             CCCcceeeEEEeecCCCCHHHHHHhccC---------------------CccchHHHHHHHHHHHHHHHHHhhcCCCCee
Q 046639          101 FEGFDFKAIVFEYMQNRNLEQWLRQSNG---------------------QLRFLTQRVNIAIDVSFAIEYFHHHCQPSIV  159 (331)
Q Consensus       101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------------------~~~~~~~~~~~~~~i~~~l~~LH~~~~~~iv  159 (331)
                       ...+..++|||++++++|.+++.....                     ..+++..++.++.|++.||.|||+.   +|+
T Consensus       119 -~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iv  194 (344)
T 1rjb_A          119 -TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCV  194 (344)
T ss_dssp             -CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred             -eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence             445678999999999999999986442                     2367888999999999999999999   999


Q ss_pred             ecCCCCCCEEecCCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHH
Q 046639          160 HGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMF  239 (331)
Q Consensus       160 H~dik~~nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~  239 (331)
                      |+||||+||+++.++.++|+|||++.......      .........+|+.|+|||++.+..++.++||||||+++|+|+
T Consensus       195 H~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~  268 (344)
T 1rjb_A          195 HRDLAARNVLVTHGKVVKICDFGLARDIMSDS------NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF  268 (344)
T ss_dssp             ETTCSGGGEEEETTTEEEECCCGGGSCGGGCT------TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHT
T ss_pred             cCCCChhhEEEcCCCcEEeCCCccCcccccCc------cceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHH
Confidence            99999999999999999999999998652211      111122345678899999998889999999999999999999


Q ss_pred             h-CCCCCCcccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHH
Q 046639          240 T-RRRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAK  318 (331)
Q Consensus       240 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~  318 (331)
                      + |..||....... ...........        .           .....++..+.+|+.+||+.||.+|||+.+|++.
T Consensus       269 t~g~~p~~~~~~~~-~~~~~~~~~~~--------~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  328 (344)
T 1rjb_A          269 SLGVNPYPGIPVDA-NFYKLIQNGFK--------M-----------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  328 (344)
T ss_dssp             TTSCCSSTTCCCSH-HHHHHHHTTCC--------C-----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCCCCcccCCcHH-HHHHHHhcCCC--------C-----------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            8 999997653322 22222211110        0           0112245678999999999999999999999999


Q ss_pred             HHHhhhhhhc
Q 046639          319 LRHARETFLG  328 (331)
Q Consensus       319 L~~~~~~~~~  328 (331)
                      |+.+.+....
T Consensus       329 l~~~~~~~~~  338 (344)
T 1rjb_A          329 LGCQLADAEE  338 (344)
T ss_dssp             HHHHC-----
T ss_pred             HHHHHHHHHH
Confidence            9998876544

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=3.5e-46  Score=331.78  Aligned_cols=249  Identities=22%  Similarity=0.277  Sum_probs=199.4

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc---chhhHHHHHHHHHHHHcC-CCCCcceeeceeecccCCCc
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK---QKEASRSFAAECNALRNI-RHRNLIKIITICSSIDFEGF  104 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~  104 (331)
                      .++|.+++.||+|+||+||+|++..+++.||+|++...   .......+..|..+++.+ +||||+++++++     ...
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~~~   82 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QTE   82 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECS
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEE-----EeC
Confidence            35799999999999999999999999999999999754   234456688999999988 899999999995     445


Q ss_pred             ceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcc
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA  184 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a  184 (331)
                      ...++|||++++++|.+++....  .+++..+..++.|++.||.|||++   +|+||||||+||+++.+|.+||+|||++
T Consensus        83 ~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a  157 (345)
T 3a8x_A           83 SRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMC  157 (345)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGC
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEecccc
Confidence            78899999999999999997643  477889999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcc----hHHHHHH
Q 046639          185 KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGL----TLHEFVK  260 (331)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~----~~~~~~~  260 (331)
                      +....        .........||+.|+|||++.+..++.++||||||+++|+|++|..||........    .......
T Consensus       158 ~~~~~--------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  229 (345)
T 3a8x_A          158 KEGLR--------PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ  229 (345)
T ss_dssp             BCSCC--------TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHH
T ss_pred             ccccC--------CCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHH
Confidence            75311        11223345799999999999999999999999999999999999999965321110    0011110


Q ss_pred             hhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcH
Q 046639          261 MALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEM  312 (331)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~  312 (331)
                      ....                 ....++..++..+.+|+.+||+.||.+||++
T Consensus       230 ~i~~-----------------~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          230 VILE-----------------KQIRIPRSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             HHHH-----------------CCCCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             HHHc-----------------CCCCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence            0000                 0001122345678899999999999999996

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=4.1e-46  Score=328.80  Aligned_cols=270  Identities=19%  Similarity=0.317  Sum_probs=196.8

Q ss_pred             HHhcCCCcCceeeccCeeEEEEeeecCCCc---eEEEEEeecc--chhhHHHHHHHHHHHHcCCCCCcceeeceeecccC
Q 046639           27 KATNNFSPANKIGQGGVSIVYKGILDESRS---IVAVKVVNLK--QKEASRSFAAECNALRNIRHRNLIKIITICSSIDF  101 (331)
Q Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  101 (331)
                      ...++|.+.+.||+|+||+||+|.+..++.   .||+|++...  .....+.+.+|+.+++.++||||+++++++.....
T Consensus        20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   99 (323)
T 3qup_A           20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA   99 (323)
T ss_dssp             CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred             cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence            445689999999999999999999876664   8999998644  34455778999999999999999999999754321


Q ss_pred             C-CcceeeEEEeecCCCCHHHHHHhcc----CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcE
Q 046639          102 E-GFDFKAIVFEYMQNRNLEQWLRQSN----GQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVA  176 (331)
Q Consensus       102 ~-~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~  176 (331)
                      . .....++|||++++++|.+++....    ...+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+
T Consensus       100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~  176 (323)
T 3qup_A          100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTV  176 (323)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCE
T ss_pred             ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCE
Confidence            1 1123489999999999999997632    12477889999999999999999999   99999999999999999999


Q ss_pred             EEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchH
Q 046639          177 HVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTL  255 (331)
Q Consensus       177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~  255 (331)
                      ||+|||++.......      .........+++.|+|||.+.+..++.++||||||+++|+|++ |..||......  ..
T Consensus       177 kl~Dfg~a~~~~~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~  248 (323)
T 3qup_A          177 CVADFGLSRKIYSGD------YYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA--EI  248 (323)
T ss_dssp             EECCCCC-----------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GH
T ss_pred             EEeeccccccccccc------cccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH--HH
Confidence            999999998652211      1112223446778999999999999999999999999999999 99999764322  11


Q ss_pred             HHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhh
Q 046639          256 HEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETF  326 (331)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~  326 (331)
                      .........        .           .....++..+.+|+.+||+.||.+|||+.++++.|+.+....
T Consensus       249 ~~~~~~~~~--------~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~  300 (323)
T 3qup_A          249 YNYLIGGNR--------L-----------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL  300 (323)
T ss_dssp             HHHHHTTCC--------C-----------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             HHHHhcCCC--------C-----------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence            111111100        0           111234567899999999999999999999999999987654

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.4e-46  Score=349.90  Aligned_cols=260  Identities=24%  Similarity=0.370  Sum_probs=212.6

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      ..+|.+.+.||+|+||.||+|.+..++..||||++.... ...+.+.+|+.++++++||||++++++|     ......+
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~-----~~~~~~~  292 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPPFY  292 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSCE
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEE-----ecCCcEE
Confidence            457999999999999999999999889999999997443 3456789999999999999999999996     3446789


Q ss_pred             EEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccc
Q 046639          109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLF  188 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~  188 (331)
                      +|||++++++|.+++.......+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+|||+++...
T Consensus       293 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  369 (495)
T 1opk_A          293 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMT  369 (495)
T ss_dssp             EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred             EEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceecc
Confidence            999999999999999876666688889999999999999999999   99999999999999999999999999998752


Q ss_pred             cCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhCcchh
Q 046639          189 GYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMALPDKV  267 (331)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  267 (331)
                      ..       .........++..|+|||++.+..++.++||||||+++|||++ |..||......  .....+.....   
T Consensus       370 ~~-------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~~~---  437 (495)
T 1opk_A          370 GD-------TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYELLEKDYR---  437 (495)
T ss_dssp             TC-------CEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHHHHTTCC---
T ss_pred             CC-------ceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCC---
Confidence            11       1111122345678999999998899999999999999999999 99999765322  22222211110   


Q ss_pred             hhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhh
Q 046639          268 MEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARET  325 (331)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~  325 (331)
                               .       ..+..++..+.+|+.+||+.||++|||+.+|++.|+.+.+.
T Consensus       438 ---------~-------~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~  479 (495)
T 1opk_A          438 ---------M-------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  479 (495)
T ss_dssp             ---------C-------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred             ---------C-------CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence                     0       11124567899999999999999999999999999987543

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=7e-46  Score=329.04  Aligned_cols=294  Identities=20%  Similarity=0.255  Sum_probs=206.6

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCccee
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      ..++|.+.+.||+|+||+||+|++  +++.||+|++....... .....|+..+..++||||+++++.+...........
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~-~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           11 DLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQN-FINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHH-HHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             ChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhh-HHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            456899999999999999999987  58899999997443321 122334444555799999999987766556667778


Q ss_pred             eEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcC------CCCeeecCCCCCCEEecCCCcEEEccc
Q 046639          108 AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHC------QPSIVHGDLKPSNILLDQDIVAHVGDL  181 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~------~~~ivH~dik~~nilv~~~~~~kl~Df  181 (331)
                      ++||||+++++|.+++....   .++..+..++.|++.||.|||+..      .++|+||||||+||+++.++.+||+||
T Consensus        88 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DF  164 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDF  164 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCC
T ss_pred             EEEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeec
Confidence            99999999999999997644   367888899999999999999762      228999999999999999999999999


Q ss_pred             CcccccccCCCCCcccccCCceeecccccccCCcccCC-------CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcch
Q 046639          182 GLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG-------SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLT  254 (331)
Q Consensus       182 g~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~  254 (331)
                      |++..+...................||+.|+|||++.+       ..++.++||||||+++|+|++|..||.........
T Consensus       165 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~  244 (336)
T 3g2f_A          165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY  244 (336)
T ss_dssp             TTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCC
T ss_pred             cceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHH
Confidence            99987643222111122222334568999999999987       45678999999999999999997766432211110


Q ss_pred             ---HHHHHHhhCc-chhhhh-cCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhhhc
Q 046639          255 ---LHEFVKMALP-DKVMEI-VDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETFLG  328 (331)
Q Consensus       255 ---~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~~~  328 (331)
                         .......... ...... ........+ +........++..+.+|+.+||+.||++|||+.++++.|+.+......
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~  322 (336)
T 3g2f_A          245 QMAFQTEVGNHPTFEDMQVLVSREKQRPKF-PEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWER  322 (336)
T ss_dssp             CCTTHHHHCSSCCHHHHHHHHTTSCCCCCC-CTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC
T ss_pred             HHhhhcccCCCchHHHHHhhhcccccCCCC-CcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHh
Confidence               0000000000 000000 001111111 111112235778899999999999999999999999999999876543

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=3.4e-46  Score=328.19  Aligned_cols=275  Identities=19%  Similarity=0.294  Sum_probs=216.4

Q ss_pred             cHHHHHHHhcCCCcCceeeccCeeEEEEeee-----cCCCceEEEEEeeccc-hhhHHHHHHHHHHHHcC-CCCCcceee
Q 046639           21 SYAELSKATNNFSPANKIGQGGVSIVYKGIL-----DESRSIVAVKVVNLKQ-KEASRSFAAECNALRNI-RHRNLIKII   93 (331)
Q Consensus        21 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~   93 (331)
                      .........++|.+.+.||+|+||+||+|.+     ..+++.||+|++.... ......+.+|+.+++.+ .||||++++
T Consensus        18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~   97 (316)
T 2xir_A           18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   97 (316)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence            4445555678999999999999999999985     4577899999997543 33446789999999999 699999999


Q ss_pred             ceeecccCCCcceeeEEEeecCCCCHHHHHHhccCC--------------ccchHHHHHHHHHHHHHHHHHhhcCCCCee
Q 046639           94 TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQ--------------LRFLTQRVNIAIDVSFAIEYFHHHCQPSIV  159 (331)
Q Consensus        94 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--------------~~~~~~~~~~~~~i~~~l~~LH~~~~~~iv  159 (331)
                      +++.    ......++|||++++++|.+++......              .+++..++.++.|++.||.+||+.   +++
T Consensus        98 ~~~~----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~  170 (316)
T 2xir_A           98 GACT----KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCI  170 (316)
T ss_dssp             EEEC----CTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred             EEEe----cCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence            9973    3345689999999999999999875432              277889999999999999999999   999


Q ss_pred             ecCCCCCCEEecCCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHH
Q 046639          160 HGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMF  239 (331)
Q Consensus       160 H~dik~~nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~  239 (331)
                      |+||||+||+++.++.+||+|||++.......      .........+|+.|+|||++.+..++.++||||||+++|+|+
T Consensus       171 H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~  244 (316)
T 2xir_A          171 HRDLAARNILLSEKNVVKICDFGLARDIYKDP------DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF  244 (316)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCGGGSCTTTCT------TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred             cccCccceEEECCCCCEEECCCccccccccCc------cceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHH
Confidence            99999999999999999999999997652111      111222345788899999999889999999999999999999


Q ss_pred             h-CCCCCCcccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHH
Q 046639          240 T-RRRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAK  318 (331)
Q Consensus       240 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~  318 (331)
                      + |..||............ .......                   .....++..+.+++.+||+.||.+|||+.+|++.
T Consensus       245 t~g~~p~~~~~~~~~~~~~-~~~~~~~-------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          245 SLGASPYPGVKIDEEFCRR-LKEGTRM-------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             TTSCCSSTTCCCSHHHHHH-HHHTCCC-------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hCCCCCCcccchhHHHHHH-hccCccC-------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            8 99999764332222211 1111100                   0111245678899999999999999999999999


Q ss_pred             HHHhhhhhhc
Q 046639          319 LRHARETFLG  328 (331)
Q Consensus       319 L~~~~~~~~~  328 (331)
                      |+.+.+....
T Consensus       305 L~~~~~~~~~  314 (316)
T 2xir_A          305 LGNLLQANAQ  314 (316)
T ss_dssp             HHHHHHHHC-
T ss_pred             HHHHHhhhcc
Confidence            9999876543

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=6.4e-46  Score=332.45  Aligned_cols=281  Identities=23%  Similarity=0.236  Sum_probs=212.7

Q ss_pred             ccCCcccHHHHHHHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCC-----CCCc
Q 046639           15 QQFPMISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIR-----HRNL   89 (331)
Q Consensus        15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i   89 (331)
                      .....+++.+.....++|.+.+.||+|+||+||+|++..+++.||+|++... .........|+.+++.+.     ||||
T Consensus        20 ~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~i   98 (360)
T 3llt_A           20 DEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNI   98 (360)
T ss_dssp             CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGB
T ss_pred             ccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCe
Confidence            3444556677677788999999999999999999999999999999999633 344456778999999986     9999


Q ss_pred             ceeeceeecccCCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEE
Q 046639           90 IKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNIL  169 (331)
Q Consensus        90 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nil  169 (331)
                      +++++++.     ..+..++|||++ +++|.+++.......++...+..++.|++.||.|||+.   +|+||||||+||+
T Consensus        99 v~~~~~~~-----~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIl  169 (360)
T 3llt_A           99 VKYHGKFM-----YYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENIL  169 (360)
T ss_dssp             CCEEEEEE-----ETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred             ecccceee-----ECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEE
Confidence            99999854     346789999999 99999999887666688899999999999999999999   9999999999999


Q ss_pred             ecC-------------------------CCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCcc
Q 046639          170 LDQ-------------------------DIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASV  224 (331)
Q Consensus       170 v~~-------------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~  224 (331)
                      ++.                         ++.+||+|||++....           .......||+.|+|||++.+..++.
T Consensus       170 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~  238 (360)
T 3llt_A          170 LDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKS-----------DYHGSIINTRQYRAPEVILNLGWDV  238 (360)
T ss_dssp             ESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETT-----------SCCCSCCSCGGGCCHHHHTTCCCCT
T ss_pred             EccccccccccchhcccccccccccccCCCCEEEEeccCceecC-----------CCCcCccCcccccCcHHHcCCCCCC
Confidence            975                         7899999999997641           1122456899999999999999999


Q ss_pred             chhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhC--cchhh---------hhcCcccccccccCCcc--------
Q 046639          225 SGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMAL--PDKVM---------EIVDPSLLLEVTANNYS--------  285 (331)
Q Consensus       225 ~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~---------~~~~~~~~~~~~~~~~~--------  285 (331)
                      ++||||||+++|+|++|..||...... ...........  +....         ...+........+....        
T Consensus       239 ~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~  317 (360)
T 3llt_A          239 SSDMWSFGCVLAELYTGSLLFRTHEHM-EHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHV  317 (360)
T ss_dssp             THHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHH
T ss_pred             ccchHHHHHHHHHHHHCCCCCCCCcHH-HHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhh
Confidence            999999999999999999999753211 11111111111  10000         00000000000000000        


Q ss_pred             ------hHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          286 ------WIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       286 ------~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                            +.......+.+|+.+||+.||.+|||+.++++
T Consensus       318 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~  355 (360)
T 3llt_A          318 KKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLK  355 (360)
T ss_dssp             HTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             hhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence                  01111267889999999999999999999974

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=3.8e-46  Score=332.31  Aligned_cols=253  Identities=21%  Similarity=0.298  Sum_probs=190.6

Q ss_pred             HHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           27 KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      ...++|.+.+.||+|+||+||+|.+..+++.||+|++....  ..+.+.+|+.+++.++||||+++++++     .....
T Consensus        50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~  122 (349)
T 2w4o_A           50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIF-----ETPTE  122 (349)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred             cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeE-----ecCCe
Confidence            34567999999999999999999999999999999997442  335678899999999999999999995     44567


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecC---CCcEEEcccCc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQ---DIVAHVGDLGL  183 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~---~~~~kl~Dfg~  183 (331)
                      .++|||++++++|.+++...  ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.   ++.+||+|||+
T Consensus       123 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~  197 (349)
T 2w4o_A          123 ISLVLELVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGL  197 (349)
T ss_dssp             EEEEECCCCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC-
T ss_pred             EEEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCcc
Confidence            89999999999999999654  3477889999999999999999999   9999999999999975   88999999999


Q ss_pred             ccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhC
Q 046639          184 AKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMAL  263 (331)
Q Consensus       184 a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  263 (331)
                      +.....         ........||+.|+|||++.+..++.++||||||+++|+|++|..||.........+........
T Consensus       198 a~~~~~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~  268 (349)
T 2w4o_A          198 SKIVEH---------QVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEY  268 (349)
T ss_dssp             ------------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCC
T ss_pred             ccccCc---------ccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCC
Confidence            976521         11223456899999999999999999999999999999999999999754322212222211110


Q ss_pred             cchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          264 PDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ..     .            ..+...++..+.+|+.+||+.||++|||+.++++
T Consensus       269 ~~-----~------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          269 YF-----I------------SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             CC-----C------------TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             cc-----C------------CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00     0            0111234567899999999999999999999985

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.8e-46  Score=332.90  Aligned_cols=246  Identities=20%  Similarity=0.213  Sum_probs=202.8

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcc
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFD  105 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~  105 (331)
                      .++|.+++.||+|+||.||+|++..+++.||+|++....   ......+.+|+.+++.++||||+++++++     ....
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~  114 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDNS  114 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EcCC
Confidence            358999999999999999999999999999999996442   23346788999999999999999999985     4456


Q ss_pred             eeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccc
Q 046639          106 FKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAK  185 (331)
Q Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~  185 (331)
                      ..++||||+++++|.+++....  .++...+..++.|++.||.|||++   +|+||||||+||+++.+|.+||+|||+++
T Consensus       115 ~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~  189 (350)
T 1rdq_E          115 NLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK  189 (350)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccce
Confidence            8899999999999999997654  377889999999999999999999   99999999999999999999999999998


Q ss_pred             ccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcc
Q 046639          186 FLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPD  265 (331)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  265 (331)
                      ....           ......||+.|+|||++.+..++.++||||||+++|+|++|..||..... ...+..+.....  
T Consensus       190 ~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-~~~~~~i~~~~~--  255 (350)
T 1rdq_E          190 RVKG-----------RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-IQIYEKIVSGKV--  255 (350)
T ss_dssp             ECSS-----------CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHCCC--
T ss_pred             eccC-----------CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH-HHHHHHHHcCCC--
Confidence            6521           12345689999999999999999999999999999999999999975321 111111111110  


Q ss_pred             hhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCc-----HHHHHH
Q 046639          266 KVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERME-----MRDVVA  317 (331)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps-----~~~i~~  317 (331)
                                         .++..++..+.+|+.+||+.||.+||+     +.+|++
T Consensus       256 -------------------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          256 -------------------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             -------------------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             -------------------CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence                               111234567899999999999999998     777763

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=4.6e-46  Score=319.84  Aligned_cols=259  Identities=24%  Similarity=0.346  Sum_probs=205.9

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCccee
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      ..++|.+.+.||+|+||+||+|.+. ++..||+|++..... ....+.+|+.+++.++||||+++++++     ......
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~   78 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVC-----SKEYPI   78 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSE
T ss_pred             chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCCce
Confidence            3468999999999999999999886 566799999964432 345688999999999999999999995     455678


Q ss_pred             eEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccc
Q 046639          108 AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      ++|||++++++|.+++.... ..+++..++.++.|++.||++||+.   +++|+||||+||+++.++.++|+|||++...
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~  154 (268)
T 3sxs_A           79 YIVTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYV  154 (268)
T ss_dssp             EEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEEC
T ss_pred             EEEEEccCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceec
Confidence            99999999999999997643 3477889999999999999999999   9999999999999999999999999999865


Q ss_pred             ccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhCcch
Q 046639          188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMALPDK  266 (331)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~  266 (331)
                      ....       ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||......  ...........  
T Consensus       155 ~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~~~~--  223 (268)
T 3sxs_A          155 LDDQ-------YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS--EVVLKVSQGHR--  223 (268)
T ss_dssp             CTTC-------EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHHHHHHTTCC--
T ss_pred             chhh-------hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH--HHHHHHHcCCC--
Confidence            2111       111223345677999999998889999999999999999999 99999754221  11111110000  


Q ss_pred             hhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhh
Q 046639          267 VMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARET  325 (331)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~  325 (331)
                         ..              .+..++..+.+++.+||+.||.+|||+.++++.|+.+.+.
T Consensus       224 ---~~--------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          224 ---LY--------------RPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             ---CC--------------CCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             ---CC--------------CCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence               00              0112345788999999999999999999999999988754

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=3.3e-46  Score=330.98  Aligned_cols=268  Identities=20%  Similarity=0.314  Sum_probs=210.4

Q ss_pred             HHHhcCCCcCceeeccCeeEEEEeeec-------CCCceEEEEEeeccc-hhhHHHHHHHHHHHHcC-CCCCcceeecee
Q 046639           26 SKATNNFSPANKIGQGGVSIVYKGILD-------ESRSIVAVKVVNLKQ-KEASRSFAAECNALRNI-RHRNLIKIITIC   96 (331)
Q Consensus        26 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~   96 (331)
                      ....++|.+.+.||+|+||+||+|.+.       .++..||+|++.... ......+.+|+.+++.+ +||||+++++++
T Consensus        31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  110 (334)
T 2pvf_A           31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC  110 (334)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence            344578999999999999999999975       356789999997543 34456789999999999 899999999995


Q ss_pred             ecccCCCcceeeEEEeecCCCCHHHHHHhccC--------------CccchHHHHHHHHHHHHHHHHHhhcCCCCeeecC
Q 046639           97 SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNG--------------QLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGD  162 (331)
Q Consensus        97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~d  162 (331)
                           ...+..++|||++++++|.+++.....              ..+++..++.++.|++.||.+||+.   +++|+|
T Consensus       111 -----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~D  182 (334)
T 2pvf_A          111 -----TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRD  182 (334)
T ss_dssp             -----CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred             -----ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCC
Confidence                 445678999999999999999986432              2367888999999999999999999   999999


Q ss_pred             CCCCCEEecCCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-C
Q 046639          163 LKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-R  241 (331)
Q Consensus       163 ik~~nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g  241 (331)
                      |||+||+++.++.+||+|||++.......      .........+++.|+|||++.+..++.++||||||+++|+|++ |
T Consensus       183 lkp~NIll~~~~~~kL~Dfg~~~~~~~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g  256 (334)
T 2pvf_A          183 LAARNVLVTENNVMKIADFGLARDINNID------YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG  256 (334)
T ss_dssp             CSGGGEEECTTCCEEECCCTTCEECTTTS------SEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTS
T ss_pred             CccceEEEcCCCCEEEccccccccccccc------cccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCC
Confidence            99999999999999999999998652211      1111223346788999999988889999999999999999999 9


Q ss_pred             CCCCCcccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHH
Q 046639          242 RRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRH  321 (331)
Q Consensus       242 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~  321 (331)
                      ..||.....  ......+.....        .           .....++..+.+++.+||+.||.+|||+.+|++.|+.
T Consensus       257 ~~p~~~~~~--~~~~~~~~~~~~--------~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~  315 (334)
T 2pvf_A          257 GSPYPGIPV--EELFKLLKEGHR--------M-----------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR  315 (334)
T ss_dssp             CCSSTTCCH--HHHHHHHHHTCC--------C-----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCcCcCCH--HHHHHHHhcCCC--------C-----------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            999975421  111111111100        0           1112345678999999999999999999999999999


Q ss_pred             hhhhhhc
Q 046639          322 ARETFLG  328 (331)
Q Consensus       322 ~~~~~~~  328 (331)
                      +.....+
T Consensus       316 l~~~~~~  322 (334)
T 2pvf_A          316 ILTLTTN  322 (334)
T ss_dssp             HHHHHC-
T ss_pred             HHhcccc
Confidence            9876544

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.3e-45  Score=323.94  Aligned_cols=275  Identities=21%  Similarity=0.279  Sum_probs=203.5

Q ss_pred             HHHHHHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCcceeeceeeccc
Q 046639           23 AELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ--KEASRSFAAECNALRNIRHRNLIKIITICSSID  100 (331)
Q Consensus        23 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  100 (331)
                      ...+...++|.+++.||+|+||+||+|.+. +++.||+|++....  ......+.+|+.+++.++||||+++++++    
T Consensus        14 ~~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~----   88 (311)
T 3niz_A           14 LYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI----   88 (311)
T ss_dssp             -CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred             eeecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEE----
Confidence            334455679999999999999999999985 58899999986442  22346688999999999999999999994    


Q ss_pred             CCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcc
Q 046639          101 FEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGD  180 (331)
Q Consensus       101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~D  180 (331)
                       ......++|||+++ ++|.+++.... ..++...+..++.|++.||.|||++   +|+|+||||+||+++.++.+||+|
T Consensus        89 -~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~D  162 (311)
T 3niz_A           89 -HSERCLTLVFEFME-KDLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLAD  162 (311)
T ss_dssp             -CCSSCEEEEEECCS-EEHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECC
T ss_pred             -ccCCEEEEEEcCCC-CCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEcc
Confidence             45677899999995 58888887643 3477888999999999999999999   999999999999999999999999


Q ss_pred             cCcccccccCCCCCcccccCCceeecccccccCCcccCC-CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHH
Q 046639          181 LGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG-SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFV  259 (331)
Q Consensus       181 fg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~  259 (331)
                      ||++......        ........+|+.|+|||++.+ ..++.++||||||+++|+|++|..||....... ......
T Consensus       163 fg~a~~~~~~--------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~  233 (311)
T 3niz_A          163 FGLARAFGIP--------VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD-QLPKIF  233 (311)
T ss_dssp             CTTCEETTSC--------CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT-HHHHHH
T ss_pred             CcCceecCCC--------cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHH
Confidence            9999865211        122233457899999999876 568999999999999999999999998754333 222222


Q ss_pred             HhhCcc---hhhhhcCcc-----ccccccc-CCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          260 KMALPD---KVMEIVDPS-----LLLEVTA-NNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       260 ~~~~~~---~~~~~~~~~-----~~~~~~~-~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ......   .........     ....+.. ........+...+.+|+.+||+.||.+|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          234 SILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             HHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            211111   000000000     0000000 000112234567889999999999999999999985

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=4.4e-46  Score=325.45  Aligned_cols=270  Identities=22%  Similarity=0.344  Sum_probs=206.0

Q ss_pred             hcCCCcCceeeccCeeEEEEee----ecCCCceEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCC
Q 046639           29 TNNFSPANKIGQGGVSIVYKGI----LDESRSIVAVKVVNLKQ-KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEG  103 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  103 (331)
                      .++|.+.+.||+|+||.||+|+    +..+++.||+|++.... ......+.+|+.+++.++||||+++++++..   ..
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~   96 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE---DG   96 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEec---CC
Confidence            4569999999999999999998    56789999999986443 2334678899999999999999999999753   22


Q ss_pred             cceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCc
Q 046639          104 FDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGL  183 (331)
Q Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~  183 (331)
                      ....++|||++++++|.+++.... ..+++..++.++.|++.||.+||+.   +++|+||||+||+++.++.++|+|||+
T Consensus        97 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~  172 (302)
T 4e5w_A           97 GNGIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGL  172 (302)
T ss_dssp             -CCEEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred             CceEEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccc
Confidence            356799999999999999996543 3477889999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhC
Q 046639          184 AKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMAL  263 (331)
Q Consensus       184 a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  263 (331)
                      +.......     ..........+|..|+|||++.+..++.++||||||+++|+|++|..|+....      ........
T Consensus       173 ~~~~~~~~-----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~  241 (302)
T 4e5w_A          173 TKAIETDK-----EYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPM------ALFLKMIG  241 (302)
T ss_dssp             CEECCTTC-----CEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH------HHHHHHHC
T ss_pred             cccccCCC-----cceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchh------hHHhhccC
Confidence            98762211     11122233457788999999999899999999999999999999999875321      00100000


Q ss_pred             cc-------hhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhh
Q 046639          264 PD-------KVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHAR  323 (331)
Q Consensus       264 ~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~  323 (331)
                      +.       ..........       .......++..+.+|+.+||+.||.+|||+.++++.|+.+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          242 PTHGQMTVTRLVNTLKEGK-------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             SCCGGGHHHHHHHHHHTTC-------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CcccccCHHHHHHHHhccC-------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            00       0000000000       00112245678999999999999999999999999999875

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.4e-46  Score=330.14  Aligned_cols=266  Identities=19%  Similarity=0.281  Sum_probs=199.3

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc---chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCc
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK---QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGF  104 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  104 (331)
                      ..++|.+.+.||+|+||+||+|++..+++.||+|++...   .......+.+|+.+++.++||||+++++++.... ...
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~   88 (311)
T 3ork_A           10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAG   88 (311)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE-TTE
T ss_pred             ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC-CCC
Confidence            356899999999999999999999999999999999654   3344567889999999999999999999875432 223


Q ss_pred             ceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcc
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA  184 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a  184 (331)
                      ...++||||+++++|.+++....  .+++..++.++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++
T Consensus        89 ~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a  163 (311)
T 3ork_A           89 PLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA  163 (311)
T ss_dssp             EEEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred             cccEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence            34599999999999999997644  477889999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCc
Q 046639          185 KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALP  264 (331)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  264 (331)
                      .......     ..........||+.|+|||++.+..++.++||||||+++|+|++|..||........ ..........
T Consensus       164 ~~~~~~~-----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~-~~~~~~~~~~  237 (311)
T 3ork_A          164 RAIADSG-----NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV-AYQHVREDPI  237 (311)
T ss_dssp             -----------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHCCCC
T ss_pred             ccccccc-----cccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHhcCCCC
Confidence            8652211     111222345689999999999999999999999999999999999999975422111 1111111100


Q ss_pred             chhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHH-HHHHHh
Q 046639          265 DKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVV-AKLRHA  322 (331)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~-~~L~~~  322 (331)
                      ..                 ......++..+.+++.+||+.||.+||++.+++ ..+...
T Consensus       238 ~~-----------------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          238 PP-----------------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             CH-----------------HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             Cc-----------------ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence            00                 001123456789999999999999999666554 444433

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.6e-46  Score=336.87  Aligned_cols=283  Identities=16%  Similarity=0.190  Sum_probs=216.2

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ-KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      ..++|.+.+.||+|+||+||+|++..+++.||+|++.... ......+.+|+.+++.++||||+++++++..   .....
T Consensus         7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~---~~~~~   83 (396)
T 4eut_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE---TTTRH   83 (396)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC---TTTCC
T ss_pred             CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeecc---CCCCe
Confidence            3568999999999999999999999999999999996433 2334667899999999999999999998653   22346


Q ss_pred             eeEEEeecCCCCHHHHHHhcc-CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEe----cCCCcEEEccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSN-GQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILL----DQDIVAHVGDL  181 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv----~~~~~~kl~Df  181 (331)
                      .++||||+++++|.+++.... ...+++..++.++.|++.||.|||+.   +|+|+||||+||++    +.++.+||+||
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DF  160 (396)
T 4eut_A           84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDF  160 (396)
T ss_dssp             EEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCG
T ss_pred             eEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecC
Confidence            799999999999999997643 23378899999999999999999999   99999999999999    78888999999


Q ss_pred             CcccccccCCCCCcccccCCceeecccccccCCcccCC--------CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcc
Q 046639          182 GLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG--------SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGL  253 (331)
Q Consensus       182 g~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~  253 (331)
                      |+++....         ........||+.|+|||++.+        ..++.++||||||+++|+|++|..||........
T Consensus       161 G~a~~~~~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~  231 (396)
T 4eut_A          161 GAARELED---------DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR  231 (396)
T ss_dssp             GGCEECCC---------GGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTT
T ss_pred             CCceEccC---------CCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccc
Confidence            99987521         112223568999999998764        4678899999999999999999999976543322


Q ss_pred             hHH---HHHHhhCcchhhhhcC---cc-cccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhh
Q 046639          254 TLH---EFVKMALPDKVMEIVD---PS-LLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARET  325 (331)
Q Consensus       254 ~~~---~~~~~~~~~~~~~~~~---~~-~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~  325 (331)
                      ...   .......+..+.....   .. ......+....+...+...+.+++.+||+.||++|||+.++++.++.+.+.
T Consensus       232 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          232 NKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             CHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             hHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence            222   2222211111110000   00 000011112234467888999999999999999999999999999887653

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.4e-45  Score=324.00  Aligned_cols=275  Identities=21%  Similarity=0.364  Sum_probs=205.3

Q ss_pred             HHHHHhcCCCcCceeeccCeeEEEEeeecC---CCceEEEEEeecc--chhhHHHHHHHHHHHHcCCCCCcceeeceeec
Q 046639           24 ELSKATNNFSPANKIGQGGVSIVYKGILDE---SRSIVAVKVVNLK--QKEASRSFAAECNALRNIRHRNLIKIITICSS   98 (331)
Q Consensus        24 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   98 (331)
                      ++....++|.+.+.||+|+||+||+|.+..   ++..||+|++...  .......+.+|+.+++.++||||+++++++..
T Consensus        28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  107 (313)
T 3brb_A           28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE  107 (313)
T ss_dssp             TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred             hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence            344456789999999999999999998754   5668999998644  33445678999999999999999999999865


Q ss_pred             ccCCCcceeeEEEeecCCCCHHHHHHh----ccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCC
Q 046639           99 IDFEGFDFKAIVFEYMQNRNLEQWLRQ----SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDI  174 (331)
Q Consensus        99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~  174 (331)
                      .........++|||++++++|.+++..    .....+++..++.++.|++.||.|||++   +++|+||||+||+++.++
T Consensus       108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~  184 (313)
T 3brb_A          108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDM  184 (313)
T ss_dssp             -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTS
T ss_pred             ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCC
Confidence            433333456999999999999999854    2334578899999999999999999999   999999999999999999


Q ss_pred             cEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcc
Q 046639          175 VAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGL  253 (331)
Q Consensus       175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~  253 (331)
                      .+||+|||++.......      .........+++.|+|||.+.+..++.++||||||+++|+|++ |..||......  
T Consensus       185 ~~kl~Dfg~~~~~~~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--  256 (313)
T 3brb_A          185 TVCVADFGLSKKIYSGD------YYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH--  256 (313)
T ss_dssp             CEEECSCSCC----------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--
T ss_pred             cEEEeecCcceeccccc------ccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH--
Confidence            99999999997652211      1112223446778999999999999999999999999999999 89999764322  


Q ss_pred             hHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhhhc
Q 046639          254 TLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETFLG  328 (331)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~~~  328 (331)
                      ..........        .+           .....++..+.+++.+||+.||.+|||+.+|++.|+.+.+.+.+
T Consensus       257 ~~~~~~~~~~--------~~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp~  312 (313)
T 3brb_A          257 EMYDYLLHGH--------RL-----------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLPD  312 (313)
T ss_dssp             GHHHHHHTTC--------CC-----------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred             HHHHHHHcCC--------CC-----------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence            1111111110        00           11123456799999999999999999999999999999887653

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1e-45  Score=325.47  Aligned_cols=271  Identities=21%  Similarity=0.285  Sum_probs=189.5

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccch-hhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCccee
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK-EASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      .++|.+++.||+|+||+||+|.+..+++.||+|.+..... .....+.+|+.+++.++||||+++++++     ...+..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~   78 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI-----HTENKL   78 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEE-----CCTTEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEE-----EECCeE
Confidence            4689999999999999999999999999999999975432 2336688999999999999999999994     456788


Q ss_pred             eEEEeecCCCCHHHHHHhcc----CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCc
Q 046639          108 AIVFEYMQNRNLEQWLRQSN----GQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGL  183 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~  183 (331)
                      ++|||+++ ++|.+++....    ...+++..+..++.|++.||.|||++   +|+|+||||+||+++.++.+||+|||+
T Consensus        79 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  154 (317)
T 2pmi_A           79 TLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGL  154 (317)
T ss_dssp             EEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSS
T ss_pred             EEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCcc
Confidence            99999995 69999987632    23477888899999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCcccccCCceeecccccccCCcccCCC-CCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhh
Q 046639          184 AKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGS-KASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMA  262 (331)
Q Consensus       184 a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  262 (331)
                      +......        ........+|+.|+|||++.+. .++.++||||||+++|+|++|..||...... ..........
T Consensus       155 ~~~~~~~--------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~  225 (317)
T 2pmi_A          155 ARAFGIP--------VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE-EQLKLIFDIM  225 (317)
T ss_dssp             CEETTSC--------CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHH
T ss_pred             ceecCCC--------cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHh
Confidence            9865211        1122334689999999998764 6899999999999999999999999764221 1222222211


Q ss_pred             Cc--chhhhhc--CcccccccccCCc---------chHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          263 LP--DKVMEIV--DPSLLLEVTANNY---------SWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       263 ~~--~~~~~~~--~~~~~~~~~~~~~---------~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ..  .......  .+.....+.....         .....+...+.+|+.+||+.||++|||+.++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          226 GTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             CSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             CCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence            10  0000000  0000000000000         001124567899999999999999999999974

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.8e-45  Score=320.56  Aligned_cols=272  Identities=18%  Similarity=0.208  Sum_probs=211.1

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCccee
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      ..++|.+.+.||+|+||+||+|++..+++.||+|++.....  ...+..|+.+++.++|++++..+..+.    ......
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~----~~~~~~   80 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCG----AEGDYN   80 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEE----EETTEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeec----CCCCce
Confidence            45689999999999999999999999999999998754322  235778999999999998888887763    345678


Q ss_pred             eEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEe---cCCCcEEEcccCcc
Q 046639          108 AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILL---DQDIVAHVGDLGLA  184 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv---~~~~~~kl~Dfg~a  184 (331)
                      ++|||++ +++|.+++.... ..+++..+..++.|++.||.|||++   +++|+||||+||++   +.++.+||+|||++
T Consensus        81 ~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a  155 (296)
T 4hgt_A           81 VMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA  155 (296)
T ss_dssp             EEEEECC-CCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTC
T ss_pred             EEEEEcc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccc
Confidence            9999999 999999997543 3477899999999999999999999   99999999999999   78899999999999


Q ss_pred             cccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcc--hHHHHHHhh
Q 046639          185 KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGL--TLHEFVKMA  262 (331)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~  262 (331)
                      ........... ..........+|+.|+|||++.+..++.++||||||+++|+|++|..||........  .........
T Consensus       156 ~~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  234 (296)
T 4hgt_A          156 KKYRDARTHQH-IPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK  234 (296)
T ss_dssp             EECBCTTTCCB-CCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH
T ss_pred             eeccCcccCcc-CCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccc
Confidence            87643222111 111233456789999999999999999999999999999999999999986533221  122221111


Q ss_pred             CcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhhh
Q 046639          263 LPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETFL  327 (331)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~~  327 (331)
                      ......                .....++..+.+|+.+||+.||++|||+.+|++.|+.+.+...
T Consensus       235 ~~~~~~----------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~  283 (296)
T 4hgt_A          235 MSTPIE----------------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  283 (296)
T ss_dssp             HHSCHH----------------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred             ccchhh----------------hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence            111100                0112245679999999999999999999999999999988754

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=6.3e-46  Score=322.60  Aligned_cols=261  Identities=25%  Similarity=0.388  Sum_probs=197.1

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc--chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      .++|++.+.||+|+||+||+|.+..   .+|+|++...  .....+.+.+|+.+++.++||||+++++++.      ...
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~------~~~   93 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST------APQ   93 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC------SSS
T ss_pred             ccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc------CCc
Confidence            5689999999999999999998753   4999998644  3444577899999999999999999998742      345


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      .++|||++++++|.+++.... ..+++..++.++.|++.||.+||+.   +++|+||||+||+++.++.++|+|||++..
T Consensus        94 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~  169 (289)
T 3og7_A           94 LAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATE  169 (289)
T ss_dssp             CEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC----
T ss_pred             cEEEEEecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccc
Confidence            789999999999999996543 3477888999999999999999999   999999999999999999999999999976


Q ss_pred             cccCCCCCcccccCCceeecccccccCCcccC---CCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhC
Q 046639          187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGM---GSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMAL  263 (331)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  263 (331)
                      .....      .........||+.|+|||++.   +..++.++||||||+++|+|++|..||..................
T Consensus       170 ~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~  243 (289)
T 3og7_A          170 KSRWS------GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSL  243 (289)
T ss_dssp             --------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSC
T ss_pred             ccccc------ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhccccc
Confidence            52111      112223456899999999986   567889999999999999999999999764332221111111111


Q ss_pred             cchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhh
Q 046639          264 PDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARE  324 (331)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~  324 (331)
                      ....                ......++..+.+|+.+||+.||.+|||+.+|++.|+.+.+
T Consensus       244 ~~~~----------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          244 SPDL----------------SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             CCCT----------------TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             Ccch----------------hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence            1110                01122456789999999999999999999999999998764

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=3.4e-46  Score=332.49  Aligned_cols=250  Identities=18%  Similarity=0.239  Sum_probs=201.7

Q ss_pred             HHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHHcC-CCCCcceeeceeecccCC
Q 046639           27 KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNI-RHRNLIKIITICSSIDFE  102 (331)
Q Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~  102 (331)
                      ...++|.+++.||+|+||+||+|++..+++.||+|++....   ......+..|..++..+ .||+|+++++++     .
T Consensus        17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~   91 (353)
T 2i0e_A           17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----Q   91 (353)
T ss_dssp             --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE-----E
T ss_pred             CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE-----E
Confidence            34568999999999999999999999999999999997442   23346678899999988 799999999984     4


Q ss_pred             CcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccC
Q 046639          103 GFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLG  182 (331)
Q Consensus       103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg  182 (331)
                      ..+..++||||+++++|.+++....  .+++..++.++.|++.||.|||++   ||+||||||+||+++.+|.+||+|||
T Consensus        92 ~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG  166 (353)
T 2i0e_A           92 TMDRLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFG  166 (353)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCC
Confidence            5578999999999999999997644  377889999999999999999999   99999999999999999999999999


Q ss_pred             cccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhh
Q 046639          183 LAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMA  262 (331)
Q Consensus       183 ~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  262 (331)
                      ++.....        .........||+.|+|||++.+..++.++||||||+++|||++|..||..... ...+..+....
T Consensus       167 ~a~~~~~--------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-~~~~~~i~~~~  237 (353)
T 2i0e_A          167 MCKENIW--------DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQSIMEHN  237 (353)
T ss_dssp             TCBCCCC--------TTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHCC
T ss_pred             ccccccc--------CCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH-HHHHHHHHhCC
Confidence            9975311        11223345799999999999999999999999999999999999999975321 11111111111


Q ss_pred             CcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCc-----HHHHH
Q 046639          263 LPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERME-----MRDVV  316 (331)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps-----~~~i~  316 (331)
                      .                     .++..++..+.+|+.+||+.||.+||+     +.+|+
T Consensus       238 ~---------------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~  275 (353)
T 2i0e_A          238 V---------------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIK  275 (353)
T ss_dssp             C---------------------CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHH
T ss_pred             C---------------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence            0                     111234567899999999999999995     46654

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2.7e-46  Score=329.03  Aligned_cols=277  Identities=19%  Similarity=0.206  Sum_probs=213.3

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCccee
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      ..++|.+.+.||+|+||.||+|.+..+++.||+|++..........+.+|+.+++.++||||+++++++... .......
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~~~~  105 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRE-RGAKHEA  105 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEE-ETTEEEE
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEec-cCCCcee
Confidence            346899999999999999999999989999999999776666778899999999999999999999997532 1234578


Q ss_pred             eEEEeecCCCCHHHHHHhc--cCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccc
Q 046639          108 AIVFEYMQNRNLEQWLRQS--NGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAK  185 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~  185 (331)
                      ++|||++++++|.+++...  .+..+++..++.++.|++.||.+||+.   +++|+||||+||+++.++.++|+|||++.
T Consensus       106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~  182 (317)
T 2buj_A          106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMN  182 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred             EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence            9999999999999999763  345578899999999999999999999   99999999999999999999999999887


Q ss_pred             ccccCCCCCc-ccccCCceeecccccccCCcccCCCC---CccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHh
Q 046639          186 FLFGYEPGTA-AETASNSIEIKGIVGYVAPEYGMGSK---ASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKM  261 (331)
Q Consensus       186 ~~~~~~~~~~-~~~~~~~~~~~~t~~y~aPE~~~~~~---~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  261 (331)
                      .......... ...........||+.|+|||++.+..   ++.++||||||+++|+|++|..||................
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~  262 (317)
T 2buj_A          183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN  262 (317)
T ss_dssp             ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC
T ss_pred             hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc
Confidence            5411000000 00000112334688999999987654   6889999999999999999999996532222222221111


Q ss_pred             hCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhhh
Q 046639          262 ALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETFL  327 (331)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~~  327 (331)
                      ....                   .....++..+.+++.+||+.||.+|||+.+|++.|+.+....-
T Consensus       263 ~~~~-------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~  309 (317)
T 2buj_A          263 QLSI-------------------PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP  309 (317)
T ss_dssp             C--C-------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCC
T ss_pred             cCCC-------------------CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCC
Confidence            0000                   0011245678999999999999999999999999998865543

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=3.3e-46  Score=320.97  Aligned_cols=255  Identities=21%  Similarity=0.310  Sum_probs=205.0

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ--KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      .++|.+.+.||+|+||+||+|++.  +..||+|++....  ....+.+.+|+.+++.++||||+++++++...   ....
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~   83 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSP---PAPH   83 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTT---TSSS
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccC---CCCC
Confidence            347999999999999999999985  7889999997543  34456789999999999999999999996432   2367


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCC--eeecCCCCCCEEecCCCcEEEcccCcc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPS--IVHGDLKPSNILLDQDIVAHVGDLGLA  184 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~--ivH~dik~~nilv~~~~~~kl~Dfg~a  184 (331)
                      .++|||++++++|.+++.......+++..++.++.|++.||.|||+.   +  ++|+||||+||+++.++.++|+|||++
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~  160 (271)
T 3kmu_A           84 PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVK  160 (271)
T ss_dssp             CEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSC
T ss_pred             eEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccce
Confidence            89999999999999999876665688899999999999999999998   8  999999999999999999999988876


Q ss_pred             cccccCCCCCcccccCCceeecccccccCCcccCCCCCcc---chhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHh
Q 046639          185 KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASV---SGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKM  261 (331)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~---~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  261 (331)
                      ...             ......+|+.|+|||++.+..++.   ++||||||+++|+|++|..||........ .......
T Consensus       161 ~~~-------------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~~  226 (271)
T 3kmu_A          161 FSF-------------QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI-GMKVALE  226 (271)
T ss_dssp             CTT-------------SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH-HHHHHHS
T ss_pred             eee-------------cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH-HHHHHhc
Confidence            532             111235788999999998765544   79999999999999999999975422111 1111111


Q ss_pred             hCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhh
Q 046639          262 ALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARE  324 (331)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~  324 (331)
                      .        ..+           .....++..+.+++.+||+.||++|||+.++++.|+.+.+
T Consensus       227 ~--------~~~-----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          227 G--------LRP-----------TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             C--------CCC-----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             C--------CCC-----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            0        011           1112345678999999999999999999999999998864

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.8e-45  Score=322.50  Aligned_cols=258  Identities=24%  Similarity=0.389  Sum_probs=200.3

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeE
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAI  109 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~l  109 (331)
                      ++|.+.+.||+|+||+||+|.+.  ++.||+|.+...  ...+.+.+|+.++++++||||+++++++.       +..++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-------~~~~l   76 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL-------NPVCL   76 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT-------TTTEE
T ss_pred             hHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc-------CCcEE
Confidence            47999999999999999999985  678999998533  34567889999999999999999999853       23689


Q ss_pred             EEeecCCCCHHHHHHhccC-CccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCc-EEEcccCccccc
Q 046639          110 VFEYMQNRNLEQWLRQSNG-QLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIV-AHVGDLGLAKFL  187 (331)
Q Consensus       110 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~-~kl~Dfg~a~~~  187 (331)
                      ||||+++++|.+++..... ..++...++.++.|++.||.|||+....+++|+||||+||+++.++. +||+|||++...
T Consensus        77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~  156 (307)
T 2eva_A           77 VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI  156 (307)
T ss_dssp             EEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred             EEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccc
Confidence            9999999999999976432 23566788899999999999999931129999999999999998886 799999999754


Q ss_pred             ccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchh
Q 046639          188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKV  267 (331)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  267 (331)
                      ..           ......||+.|+|||++.+..++.++||||||+++|+|++|..||.................     
T Consensus       157 ~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-----  220 (307)
T 2eva_A          157 QT-----------HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNG-----  220 (307)
T ss_dssp             -------------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTT-----
T ss_pred             cc-----------ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcC-----
Confidence            11           11234589999999999999999999999999999999999999975433221111111110     


Q ss_pred             hhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhhhc
Q 046639          268 MEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETFLG  328 (331)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~~~  328 (331)
                         ..+           .....++..+.+++.+||+.||.+|||+.++++.|+.+.+.+.+
T Consensus       221 ---~~~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~  267 (307)
T 2eva_A          221 ---TRP-----------PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG  267 (307)
T ss_dssp             ---CCC-----------CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred             ---CCC-----------CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence               001           11123456788999999999999999999999999999877654

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=2.2e-45  Score=322.23  Aligned_cols=267  Identities=22%  Similarity=0.280  Sum_probs=202.5

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc---chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCc
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK---QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGF  104 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  104 (331)
                      ..++|.+.+.||+|+||.||+|.+..+++.||+|++...   .......+.+|+.+++.++||||+++++++.     ..
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~  104 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI-----ED  104 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ET
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----cC
Confidence            345799999999999999999999889999999998642   3445577899999999999999999999964     34


Q ss_pred             ceeeEEEeecCCCCHHHHHHh--ccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccC
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQ--SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLG  182 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg  182 (331)
                      +..++|||++++++|.+++..  .....++...++.++.|++.||.+||+.   +++|+||||+||+++.++.++|+|||
T Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg  181 (310)
T 2wqm_A          105 NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLG  181 (310)
T ss_dssp             TEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-
T ss_pred             CcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEecc
Confidence            678999999999999999975  2344577889999999999999999999   99999999999999999999999999


Q ss_pred             cccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhh
Q 046639          183 LAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMA  262 (331)
Q Consensus       183 ~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  262 (331)
                      ++......        ........+++.|+|||++.+..++.++||||||+++|+|++|..||.................
T Consensus       182 ~~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  253 (310)
T 2wqm_A          182 LGRFFSSK--------TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC  253 (310)
T ss_dssp             -------------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTT
T ss_pred             ceeeecCC--------CccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcc
Confidence            98765211        1122334688899999999999999999999999999999999999975322211111111110


Q ss_pred             CcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhhhc
Q 046639          263 LPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETFLG  328 (331)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~~~  328 (331)
                              ..+...          ...++..+.+|+.+||+.||.+|||+.+|++.|+++......
T Consensus       254 --------~~~~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~  301 (310)
T 2wqm_A          254 --------DYPPLP----------SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS  301 (310)
T ss_dssp             --------CSCCCC----------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred             --------cCCCCc----------ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence                    000000          013456789999999999999999999999999999876543

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=3.5e-45  Score=317.97  Aligned_cols=254  Identities=25%  Similarity=0.356  Sum_probs=203.4

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc--chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcc
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFD  105 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~  105 (331)
                      ..+.|.+.+.||+|+||+||+|.+..++..||+|.+...  .......+.+|+.+++.++||||+++++++... .....
T Consensus        24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~~  102 (290)
T 1t4h_A           24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKK  102 (290)
T ss_dssp             TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE-SSSCE
T ss_pred             CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccc-cCCCc
Confidence            345689999999999999999999999999999998644  344557789999999999999999999987543 34456


Q ss_pred             eeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCC--eeecCCCCCCEEec-CCCcEEEcccC
Q 046639          106 FKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPS--IVHGDLKPSNILLD-QDIVAHVGDLG  182 (331)
Q Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~--ivH~dik~~nilv~-~~~~~kl~Dfg  182 (331)
                      ..++|||++++++|.+++....  .+++..++.++.|++.||.|||+.   +  ++|+||||+||+++ .++.++|+|||
T Consensus       103 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg  177 (290)
T 1t4h_A          103 CIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLG  177 (290)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred             eEEEEEEecCCCCHHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCC
Confidence            7899999999999999997643  367788999999999999999999   8  99999999999997 78999999999


Q ss_pred             cccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhh
Q 046639          183 LAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMA  262 (331)
Q Consensus       183 ~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  262 (331)
                      ++...          .........+|+.|+|||++.+ .++.++||||||+++|+|++|..||.................
T Consensus       178 ~~~~~----------~~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  246 (290)
T 1t4h_A          178 LATLK----------RASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV  246 (290)
T ss_dssp             GGGGC----------CTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTC
T ss_pred             Ccccc----------cccccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccC
Confidence            99754          1122334568999999998875 589999999999999999999999975432211111111100


Q ss_pred             CcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          263 LPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                               .+.          .+...+++.+.+++.+||+.||.+|||+.++++
T Consensus       247 ---------~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          247 ---------KPA----------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             ---------CCG----------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ---------Ccc----------ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                     000          111223457899999999999999999999975

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=8.3e-46  Score=327.43  Aligned_cols=260  Identities=19%  Similarity=0.303  Sum_probs=200.6

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCce----EEEEEeecc-chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCC
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSI----VAVKVVNLK-QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEG  103 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  103 (331)
                      .++|.+.+.||+|+||+||+|++..+++.    ||+|.+... .......+.+|+.+++.++||||++++++|..     
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----   88 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-----   88 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEES-----
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----
Confidence            35799999999999999999998777665    477776433 23345678999999999999999999999753     


Q ss_pred             cceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCc
Q 046639          104 FDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGL  183 (331)
Q Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~  183 (331)
                       ...++|+|++.+++|.+++.... ..+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        89 -~~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~  163 (327)
T 3poz_A           89 -STVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGL  163 (327)
T ss_dssp             -SSEEEEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTH
T ss_pred             -CCeEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcc
Confidence             23679999999999999997644 3467888999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhh
Q 046639          184 AKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMA  262 (331)
Q Consensus       184 a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~  262 (331)
                      ++......      .........+|+.|+|||++.+..++.++||||||+++|+|++ |..||......  .........
T Consensus       164 a~~~~~~~------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~~~~~  235 (327)
T 3poz_A          164 AKLLGAEE------KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILEKG  235 (327)
T ss_dssp             HHHHTTTC------C-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHHTT
T ss_pred             eeEccCCc------ccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH--HHHHHHHcC
Confidence            98763211      1112223446778999999999999999999999999999999 99999764322  222222211


Q ss_pred             CcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhh
Q 046639          263 LPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARET  325 (331)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~  325 (331)
                      ...                   .....+...+.+++.+||+.||.+|||+.+|++.|+.+...
T Consensus       236 ~~~-------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~  279 (327)
T 3poz_A          236 ERL-------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             CCC-------------------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred             CCC-------------------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence            100                   01123456788999999999999999999999999988654

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=9.4e-46  Score=331.19  Aligned_cols=254  Identities=19%  Similarity=0.211  Sum_probs=193.5

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCccee
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      ..++|.+.+.||+|+||+||+|++..+++.||+|++.... .....+.+|+.+++.++||||+++++++     ......
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~~~   91 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVI-----LTPTHL   91 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEE-----eeCCEE
Confidence            4568999999999999999999999999999999996432 2335678999999999999999999995     445678


Q ss_pred             eEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCc--EEEcccCccc
Q 046639          108 AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIV--AHVGDLGLAK  185 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~--~kl~Dfg~a~  185 (331)
                      ++||||+++++|.+++....  .+++..+..++.|++.||.|||++   +|+||||||+||+++.++.  +||+|||+++
T Consensus        92 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~  166 (361)
T 3uc3_A           92 AIIMEYASGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSK  166 (361)
T ss_dssp             EEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC-
T ss_pred             EEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccc
Confidence            99999999999999997644  377899999999999999999999   9999999999999987765  9999999987


Q ss_pred             ccccCCCCCcccccCCceeecccccccCCcccCCCCCccc-hhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCc
Q 046639          186 FLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVS-GDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALP  264 (331)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  264 (331)
                      ...         .........||+.|+|||++.+..++.+ +||||||+++|+|++|..||........ +.........
T Consensus       167 ~~~---------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-~~~~~~~~~~  236 (361)
T 3uc3_A          167 SSV---------LHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD-YRKTIQRILS  236 (361)
T ss_dssp             -----------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC-HHHHHHHHHT
T ss_pred             ccc---------ccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH-HHHHHHHHhc
Confidence            431         1122334569999999999988877555 8999999999999999999986533222 2222221111


Q ss_pred             chhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          265 DKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ...      ...         ....++..+.+|+.+||+.||.+|||+.++++
T Consensus       237 ~~~------~~~---------~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  274 (361)
T 3uc3_A          237 VKY------SIP---------DDIRISPECCHLISRIFVADPATRISIPEIKT  274 (361)
T ss_dssp             TCC------CCC---------TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             CCC------CCC---------CcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence            000      000         00123467889999999999999999999985

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=3.9e-45  Score=331.41  Aligned_cols=254  Identities=17%  Similarity=0.197  Sum_probs=194.3

Q ss_pred             hcCCCcC-ceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHc-CCCCCcceeeceeecccCCCcce
Q 046639           29 TNNFSPA-NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRN-IRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        29 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      .++|.+. +.||+|+||+||+|.+..+++.||||++...     ..+.+|+.++.+ .+||||+++++++... +.+...
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~-~~~~~~  133 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENL-YAGRKC  133 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeec-ccCCcE
Confidence            3456666 6899999999999999999999999998632     245678887744 5899999999987542 234567


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecC---CCcEEEcccCc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQ---DIVAHVGDLGL  183 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~---~~~~kl~Dfg~  183 (331)
                      +++||||+++++|.+++.......+++..+..++.|++.||.|||+.   +|+||||||+||+++.   ++.+||+|||+
T Consensus       134 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~  210 (400)
T 1nxk_A          134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF  210 (400)
T ss_dssp             EEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEeccc
Confidence            89999999999999999876656688999999999999999999999   9999999999999997   78999999999


Q ss_pred             ccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcc---hHHHHHH
Q 046639          184 AKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGL---TLHEFVK  260 (331)
Q Consensus       184 a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~~~~~  260 (331)
                      ++....         ........||+.|+|||++.+..++.++||||||+++|+|++|..||........   .......
T Consensus       211 a~~~~~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~  281 (400)
T 1nxk_A          211 AKETTS---------HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM  281 (400)
T ss_dssp             CEECC--------------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHH
T ss_pred             ccccCC---------CCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHc
Confidence            986521         1122345689999999999999999999999999999999999999976433221   1111111


Q ss_pred             hhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          261 MALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      .....     ..            .....++..+.+|+.+||+.||++|||+.++++
T Consensus       282 ~~~~~-----~~------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  321 (400)
T 1nxk_A          282 GQYEF-----PN------------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  321 (400)
T ss_dssp             TCCCC-----CT------------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CcccC-----CC------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            11000     00            001234567899999999999999999999986

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.9e-46  Score=327.13  Aligned_cols=279  Identities=22%  Similarity=0.331  Sum_probs=214.1

Q ss_pred             HhcCCCcCceeeccCeeEEEEee----ecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCC
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGI----LDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEG  103 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  103 (331)
                      ..++|.+.+.||+|+||.||+|.    +..+++.||+|++........+.+.+|+.+++.++||||+++++++..   ..
T Consensus        39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~  115 (326)
T 2w1i_A           39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYS---AG  115 (326)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-----
T ss_pred             CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe---cC
Confidence            34579999999999999999998    456889999999987666677889999999999999999999998642   22


Q ss_pred             cceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCc
Q 046639          104 FDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGL  183 (331)
Q Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~  183 (331)
                      ....++|||++++++|.+++.... ..+++..++.++.|++.||.+||+.   +++|+||||+||+++.++.++|+|||+
T Consensus       116 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~  191 (326)
T 2w1i_A          116 RRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGL  191 (326)
T ss_dssp             --CCEEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred             CCceEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcc
Confidence            346799999999999999998653 3467888999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhC
Q 046639          184 AKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMAL  263 (331)
Q Consensus       184 a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  263 (331)
                      +........     .........++..|+|||++.+..++.++||||||+++|+|++|..||.....   .+........
T Consensus       192 ~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~---~~~~~~~~~~  263 (326)
T 2w1i_A          192 TKVLPQDKE-----YYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA---EFMRMIGNDK  263 (326)
T ss_dssp             CEECCSSCS-----EEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH---HHHHHHCTTC
T ss_pred             hhhcccccc-----ccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH---HHHHhhcccc
Confidence            987522111     11112233467779999999988899999999999999999999999864211   0111000000


Q ss_pred             c-----chhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhhhc
Q 046639          264 P-----DKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETFLG  328 (331)
Q Consensus       264 ~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~~~  328 (331)
                      .     ..+...+.....       ......++..+.+|+.+||+.||.+|||+.+|++.|+.+.+.+.|
T Consensus       264 ~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l~g  326 (326)
T 2w1i_A          264 QGQMIVFHLIELLKNNGR-------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMAG  326 (326)
T ss_dssp             CTHHHHHHHHHHHHTTCC-------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHHHC
T ss_pred             chhhhHHHHHHHhhcCCC-------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhcC
Confidence            0     000000000000       011234567899999999999999999999999999999988764

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.5e-45  Score=320.16  Aligned_cols=268  Identities=20%  Similarity=0.273  Sum_probs=198.5

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccch--hhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCccee
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK--EASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      ++|.+.+.||+|+||+||+|.+ .+++.||+|.+.....  .....+.+|+.+++.++||||+++++++     ...+..
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~   75 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI-----HTKKRL   75 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEE-----ECSSCE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEE-----ccCCeE
Confidence            5799999999999999999998 5788999999865432  2336688999999999999999999995     445678


Q ss_pred             eEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccc
Q 046639          108 AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      ++|||+++ ++|.+++.... ..++...+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++...
T Consensus        76 ~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  150 (288)
T 1ob3_A           76 VLVFEHLD-QDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF  150 (288)
T ss_dssp             EEEEECCS-EEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHH
T ss_pred             EEEEEecC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECcccccc
Confidence            99999995 59999987643 3467788999999999999999999   9999999999999999999999999999865


Q ss_pred             ccCCCCCcccccCCceeecccccccCCcccCCC-CCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcch
Q 046639          188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMGS-KASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDK  266 (331)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  266 (331)
                      ...        ........+|+.|+|||++.+. .++.++||||||+++|+|++|..||...... ..............
T Consensus       151 ~~~--------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~  221 (288)
T 1ob3_A          151 GIP--------VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA-DQLMRIFRILGTPN  221 (288)
T ss_dssp             CC-----------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCC
T ss_pred             Ccc--------ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHHCCCC
Confidence            211        1122334578999999998764 5899999999999999999999999764221 12222222111100


Q ss_pred             h------hh--hcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          267 V------ME--IVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       267 ~------~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      .      ..  ..++............+...+...+.+|+.+||+.||++|||+.++++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          222 SKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             TTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            0      00  000000000000011222345677899999999999999999999974

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=5.9e-45  Score=317.34  Aligned_cols=271  Identities=18%  Similarity=0.210  Sum_probs=213.6

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      .++|.+.+.||+|+||+||+|++..+++.||+|++.....  ...+.+|+.+++.+.|++++..+..+.    ......+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~----~~~~~~~   81 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCG----AEGDYNV   81 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEE----EETTEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCcccccc----CCCCceE
Confidence            5689999999999999999999999999999999864432  245789999999999988887777663    3356789


Q ss_pred             EEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEe---cCCCcEEEcccCccc
Q 046639          109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILL---DQDIVAHVGDLGLAK  185 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv---~~~~~~kl~Dfg~a~  185 (331)
                      +|||++ +++|.+++.... ..+++..++.++.|++.||.|||++   +++|+||||+||++   +.++.+||+|||++.
T Consensus        82 lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~  156 (296)
T 3uzp_A           82 MVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  156 (296)
T ss_dssp             EEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             EEEEec-CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcc
Confidence            999999 999999997533 3477899999999999999999999   99999999999999   488899999999998


Q ss_pred             ccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCc--chHHHHHHhhC
Q 046639          186 FLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEG--LTLHEFVKMAL  263 (331)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~  263 (331)
                      .......... ..........||+.|+|||++.+..++.++||||||+++|+|++|..||.......  ..+........
T Consensus       157 ~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  235 (296)
T 3uzp_A          157 KYRDARTHQH-IPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM  235 (296)
T ss_dssp             ECBCTTTCCB-CCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred             cccccccccc-cccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccccc
Confidence            7643222111 11122345668999999999999999999999999999999999999998643221  12222222111


Q ss_pred             cchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhhh
Q 046639          264 PDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETFL  327 (331)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~~  327 (331)
                      .....                .....++..+.+++.+||+.||++|||+.+|++.|+.+.+...
T Consensus       236 ~~~~~----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~  283 (296)
T 3uzp_A          236 STPIE----------------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  283 (296)
T ss_dssp             HSCHH----------------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             CCchH----------------HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcC
Confidence            11100                0112345679999999999999999999999999999987654

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=4.1e-46  Score=343.46  Aligned_cols=261  Identities=22%  Similarity=0.361  Sum_probs=209.5

Q ss_pred             HHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           27 KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      ...++|.+.+.||+|+||+||+|.+. ++..||||+++... ...+.+.+|+.+++.++||||+++++++.      ...
T Consensus       185 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~------~~~  256 (454)
T 1qcf_A          185 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT------KEP  256 (454)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC------SSS
T ss_pred             echHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe------CCc
Confidence            34568999999999999999999986 46779999997443 34577899999999999999999999863      345


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      .++|||++++++|.+++.......+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||+++.
T Consensus       257 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~  333 (454)
T 1qcf_A          257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARV  333 (454)
T ss_dssp             CEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGG
T ss_pred             cEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceE
Confidence            79999999999999999865444567788899999999999999999   999999999999999999999999999987


Q ss_pred             cccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhCcc
Q 046639          187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMALPD  265 (331)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~  265 (331)
                      ....       .........++..|+|||++.+..++.++||||||+++|||++ |..||......  .....+..... 
T Consensus       334 ~~~~-------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~--~~~~~i~~~~~-  403 (454)
T 1qcf_A          334 IEDN-------EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIRALERGYR-  403 (454)
T ss_dssp             BCCH-------HHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHHHHHHHTCC-
T ss_pred             cCCC-------ceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCC-
Confidence            5211       0111122345678999999998899999999999999999999 99999764221  11111111100 


Q ss_pred             hhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhh
Q 046639          266 KVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETF  326 (331)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~  326 (331)
                             .           ..+..++..+.+|+.+||+.||++|||+.+|++.|+.+....
T Consensus       404 -------~-----------~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~  446 (454)
T 1qcf_A          404 -------M-----------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT  446 (454)
T ss_dssp             -------C-----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred             -------C-----------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence                   0           011245678999999999999999999999999999886543

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=2.2e-45  Score=325.01  Aligned_cols=263  Identities=21%  Similarity=0.308  Sum_probs=200.0

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccch-hhHHHHHHHHHHHHcCCCCCcceeeceeecccC------
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK-EASRSFAAECNALRNIRHRNLIKIITICSSIDF------  101 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~------  101 (331)
                      .++|.+.+.||+|+||.||+|++..+++.||||++..... ...+.+.+|+.+++.++||||+++++++.....      
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            4579999999999999999999999999999999975443 345778999999999999999999998754321      


Q ss_pred             ----------------------------------------------CCcceeeEEEeecCCCCHHHHHHhccC-CccchH
Q 046639          102 ----------------------------------------------EGFDFKAIVFEYMQNRNLEQWLRQSNG-QLRFLT  134 (331)
Q Consensus       102 ----------------------------------------------~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~  134 (331)
                                                                    ......++|||++++++|.+++..... ......
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                          112347999999999999999987432 223344


Q ss_pred             HHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccccCCCCCcc----cccCCceeeccccc
Q 046639          135 QRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAA----ETASNSIEIKGIVG  210 (331)
Q Consensus       135 ~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~----~~~~~~~~~~~t~~  210 (331)
                      .++.++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++............    ..........||+.
T Consensus       165 ~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            5789999999999999999   9999999999999999999999999999876332211110    00122334568999


Q ss_pred             ccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHH
Q 046639          211 YVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDC  290 (331)
Q Consensus       211 y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (331)
                      |+|||++.+..++.++||||||+++|+|++|..|+...       .......     ....           ........
T Consensus       242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-------~~~~~~~-----~~~~-----------~~~~~~~~  298 (332)
T 3qd2_B          242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-------VRIITDV-----RNLK-----------FPLLFTQK  298 (332)
T ss_dssp             GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-------HHHHHHH-----HTTC-----------CCHHHHHH
T ss_pred             ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-------HHHHHHh-----hccC-----------CCcccccC
Confidence            99999999999999999999999999999987765321       0111000     0000           01223455


Q ss_pred             HHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          291 LVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       291 ~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      .+.+.+|+.+||+.||.+|||+.++++
T Consensus       299 ~~~~~~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          299 YPQEHMMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             CHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred             ChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence            667889999999999999999999985

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.3e-45  Score=319.48  Aligned_cols=259  Identities=23%  Similarity=0.351  Sum_probs=204.0

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCccee
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      ..++|.+.+.||+|+||+||+|.+. ++..||+|++..... ....+.+|+.+++.++||||+++++++     ......
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~   94 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVC-----TKQRPI   94 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSSSE
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEE-----ecCCCe
Confidence            3457999999999999999999887 667899999974432 335688999999999999999999995     455678


Q ss_pred             eEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccc
Q 046639          108 AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      ++|||++++++|.+++.... ..+++..++.++.|++.||.+||++   +++|+||||+||+++.++.++|+|||++...
T Consensus        95 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  170 (283)
T 3gen_A           95 FIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYV  170 (283)
T ss_dssp             EEEECCCTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGB
T ss_pred             EEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccc
Confidence            99999999999999997633 2477889999999999999999999   9999999999999999999999999999865


Q ss_pred             ccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhCcch
Q 046639          188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMALPDK  266 (331)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~  266 (331)
                      ...       .........+|+.|+|||++.+..++.++||||||+++|+|++ |..||......  ..........   
T Consensus       171 ~~~-------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~~~---  238 (283)
T 3gen_A          171 LDD-------EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--ETAEHIAQGL---  238 (283)
T ss_dssp             CCH-------HHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHHHHHHTTC---
T ss_pred             ccc-------ccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh--HHHHHHhccc---
Confidence            211       1112223346778999999998899999999999999999998 99999754221  1111111110   


Q ss_pred             hhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhh
Q 046639          267 VMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARET  325 (331)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~  325 (331)
                           ...           ....++..+.+++.+||+.||.+|||+.++++.|+.+.+.
T Consensus       239 -----~~~-----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          239 -----RLY-----------RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             -----CCC-----------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----CCC-----------CCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence                 000           0112345788999999999999999999999999988754

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.3e-45  Score=319.34  Aligned_cols=261  Identities=20%  Similarity=0.273  Sum_probs=199.2

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCC---CceEEEEEeecc-chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCC
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDES---RSIVAVKVVNLK-QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEG  103 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  103 (331)
                      ..++|.+.+.||+|+||+||+|.+..+   +..||+|.+... .....+.+.+|+.+++.++||||+++++++.      
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------   86 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT------   86 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC------
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc------
Confidence            356899999999999999999998643   456999988643 3344567899999999999999999999852      


Q ss_pred             cceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCc
Q 046639          104 FDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGL  183 (331)
Q Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~  183 (331)
                      .+..++|||++++++|.+++.... ..+++..++.++.|++.||.+||+.   +++|+||||+||+++.++.+||+|||+
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~  162 (281)
T 1mp8_A           87 ENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGL  162 (281)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC---
T ss_pred             cCccEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECcccc
Confidence            245789999999999999997643 3477888999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhh
Q 046639          184 AKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMA  262 (331)
Q Consensus       184 a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~  262 (331)
                      +.......       ........+++.|+|||++.+..++.++||||||+++|+|++ |..||.......  ....+...
T Consensus       163 ~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~--~~~~i~~~  233 (281)
T 1mp8_A          163 SRYMEDST-------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIGRIENG  233 (281)
T ss_dssp             -----------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHHHTT
T ss_pred             ccccCccc-------ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH--HHHHHHcC
Confidence            98752211       111223346778999999988899999999999999999996 999997643221  11111110


Q ss_pred             CcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhh
Q 046639          263 LPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETF  326 (331)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~  326 (331)
                      ..        .           .....++..+.+++.+||+.||++|||+.++++.|+.+.+.-
T Consensus       234 ~~--------~-----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  278 (281)
T 1mp8_A          234 ER--------L-----------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  278 (281)
T ss_dssp             CC--------C-----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CC--------C-----------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence            00        0           111235677899999999999999999999999999987653

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=6.1e-46  Score=342.39  Aligned_cols=248  Identities=21%  Similarity=0.299  Sum_probs=202.8

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcc
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFD  105 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~  105 (331)
                      .++|.+++.||+|+||+||+|++..+++.||+|++....   ......+.+|+.+++.++||||+++++++     ....
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~-----~~~~   89 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVI-----STPS   89 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECC
Confidence            458999999999999999999999999999999996442   22346788999999999999999999995     4456


Q ss_pred             eeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccc
Q 046639          106 FKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAK  185 (331)
Q Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~  185 (331)
                      ..++|||++++++|.+++...  ..+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++.
T Consensus        90 ~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~  164 (476)
T 2y94_A           90 DIFMVMEYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSN  164 (476)
T ss_dssp             EEEEEEECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred             EEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchh
Confidence            789999999999999999653  3478899999999999999999999   99999999999999999999999999998


Q ss_pred             ccccCCCCCcccccCCceeecccccccCCcccCCCCC-ccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCc
Q 046639          186 FLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKA-SVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALP  264 (331)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  264 (331)
                      ....         ........||+.|+|||++.+..+ +.++||||||+++|+|++|..||...... ..........  
T Consensus       165 ~~~~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~~--  232 (476)
T 2y94_A          165 MMSD---------GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP-TLFKKICDGI--  232 (476)
T ss_dssp             ECCT---------TCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH-HHHHHHHTTC--
T ss_pred             hccc---------cccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH-HHHHHHhcCC--
Confidence            7521         122234568999999999998776 78999999999999999999999753211 1111111100  


Q ss_pred             chhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          265 DKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                                         ...+..+...+.+|+.+||+.||.+|||+.++++
T Consensus       233 -------------------~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          233 -------------------FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             -------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -------------------cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence                               0111123457889999999999999999999986

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.2e-45  Score=320.50  Aligned_cols=252  Identities=21%  Similarity=0.271  Sum_probs=195.9

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccch--------------------------hhHHHHHHHHHHHH
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK--------------------------EASRSFAAECNALR   82 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~e~~~l~   82 (331)
                      .++|.+.+.||+|+||+||+|.+..+++.||+|++.....                          ...+.+.+|+.+++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            4689999999999999999999999999999999864421                          12345889999999


Q ss_pred             cCCCCCcceeeceeecccCCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecC
Q 046639           83 NIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGD  162 (331)
Q Consensus        83 ~l~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~d  162 (331)
                      .++||||+++++++..   ......++|||++++++|.+++..   ..+++..+..++.|++.||.|||++   +++|+|
T Consensus        92 ~l~h~~iv~~~~~~~~---~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~D  162 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDD---PNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRD  162 (298)
T ss_dssp             TCCCTTBCCEEEEEEC---SSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred             hCCCCCCCeEEEEEEc---CCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccC
Confidence            9999999999999753   235678999999999999886532   3578899999999999999999999   999999


Q ss_pred             CCCCCEEecCCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCC---CccchhhHhHHHHHHHHH
Q 046639          163 LKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSK---ASVSGDVYNFGILLLEMF  239 (331)
Q Consensus       163 ik~~nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~---~~~~~DiwslG~il~el~  239 (331)
                      |||+||+++.++.+||+|||++......        ........||+.|+|||++.+..   ++.++||||||+++|+|+
T Consensus       163 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~  234 (298)
T 2zv2_A          163 IKPSNLLVGEDGHIKIADFGVSNEFKGS--------DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFV  234 (298)
T ss_dssp             CCGGGEEECTTSCEEECCCTTCEECSSS--------SCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHH
T ss_pred             CCHHHEEECCCCCEEEecCCCccccccc--------cccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHH
Confidence            9999999999999999999999865211        11123356899999999988765   478899999999999999


Q ss_pred             hCCCCCCcccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          240 TRRRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       240 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      +|..||.....  .............    .  +            ....++..+.+|+.+||+.||++|||+.++++
T Consensus       235 ~g~~pf~~~~~--~~~~~~~~~~~~~----~--~------------~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          235 FGQCPFMDERI--MCLHSKIKSQALE----F--P------------DQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             HSSCSSCCSSH--HHHHHHHHHCCCC----C--C------------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HCCCCCCCccH--HHHHHHHhcccCC----C--C------------CccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            99999975311  1111111110000    0  0            00124567899999999999999999999874

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=7e-46  Score=328.68  Aligned_cols=268  Identities=19%  Similarity=0.288  Sum_probs=212.2

Q ss_pred             HHHhcCCCcCceeeccCeeEEEEeeecCCCc-----eEEEEEeeccc-hhhHHHHHHHHHHHHcC-CCCCcceeeceeec
Q 046639           26 SKATNNFSPANKIGQGGVSIVYKGILDESRS-----IVAVKVVNLKQ-KEASRSFAAECNALRNI-RHRNLIKIITICSS   98 (331)
Q Consensus        26 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~   98 (331)
                      ....++|.+.+.||+|+||+||+|.+..++.     .||+|.+.... ......+.+|+.+++.+ +||||+++++++  
T Consensus        42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~--  119 (333)
T 2i1m_A           42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC--  119 (333)
T ss_dssp             BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE--
T ss_pred             cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE--
Confidence            3456789999999999999999999876554     79999986543 33456789999999999 899999999995  


Q ss_pred             ccCCCcceeeEEEeecCCCCHHHHHHhcc------------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCC
Q 046639           99 IDFEGFDFKAIVFEYMQNRNLEQWLRQSN------------GQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPS  166 (331)
Q Consensus        99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~  166 (331)
                         ...+..++|||++++++|.+++....            ...+++..++.++.|++.||.|||+.   +++|+||||+
T Consensus       120 ---~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~  193 (333)
T 2i1m_A          120 ---THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAAR  193 (333)
T ss_dssp             ---CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGG
T ss_pred             ---ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccc
Confidence               44567899999999999999997642            33467888999999999999999999   9999999999


Q ss_pred             CEEecCCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCC
Q 046639          167 NILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPT  245 (331)
Q Consensus       167 nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf  245 (331)
                      ||+++.++.++|+|||++........      ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||
T Consensus       194 NIl~~~~~~~kl~Dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  267 (333)
T 2i1m_A          194 NVLLTNGHVAKIGDFGLARDIMNDSN------YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY  267 (333)
T ss_dssp             GCEEEGGGEEEBCCCGGGCCGGGCTT------SEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             eEEECCCCeEEECccccccccccccc------eeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCC
Confidence            99999999999999999986522111      111223446778999999988899999999999999999998 99999


Q ss_pred             CcccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhh
Q 046639          246 DAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARET  325 (331)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~  325 (331)
                      ....... ............        .           ....++..+.+|+.+||+.||.+|||+.+|++.|+.+...
T Consensus       268 ~~~~~~~-~~~~~~~~~~~~--------~-----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~  327 (333)
T 2i1m_A          268 PGILVNS-KFYKLVKDGYQM--------A-----------QPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE  327 (333)
T ss_dssp             TTCCSSH-HHHHHHHHTCCC--------C-----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cccchhH-HHHHHHhcCCCC--------C-----------CCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence            7643322 222222211110        0           0112346788999999999999999999999999998776


Q ss_pred             hh
Q 046639          326 FL  327 (331)
Q Consensus       326 ~~  327 (331)
                      ..
T Consensus       328 ~~  329 (333)
T 2i1m_A          328 DR  329 (333)
T ss_dssp             HH
T ss_pred             hh
Confidence            43

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=3.2e-45  Score=316.16  Aligned_cols=253  Identities=19%  Similarity=0.190  Sum_probs=204.8

Q ss_pred             HHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           27 KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      ...++|.+.+.||+|+||+||+|.+..++..+|+|.+........+.+.+|+.+++.++||||+++++++     .....
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~   80 (277)
T 3f3z_A            6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF-----EDNTD   80 (277)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSE
T ss_pred             hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCCe
Confidence            3456899999999999999999999999999999999766555667889999999999999999999995     44567


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEe---cCCCcEEEcccCc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILL---DQDIVAHVGDLGL  183 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv---~~~~~~kl~Dfg~  183 (331)
                      .++|||++++++|.+++....  .+++..+..++.|++.||.+||++   +++|+||||+||++   +.++.++|+|||+
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~  155 (277)
T 3f3z_A           81 IYLVMELCTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGL  155 (277)
T ss_dssp             EEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEEEeccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEeccc
Confidence            899999999999999987643  367889999999999999999999   99999999999999   7888999999999


Q ss_pred             ccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhC
Q 046639          184 AKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMAL  263 (331)
Q Consensus       184 a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  263 (331)
                      +.....         ........+|+.|+|||++.+. ++.++||||||+++|+|++|..||...... ...........
T Consensus       156 ~~~~~~---------~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~  224 (277)
T 3f3z_A          156 AARFKP---------GKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS-EVMLKIREGTF  224 (277)
T ss_dssp             CEECCT---------TSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCCC
T ss_pred             ceeccC---------ccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHhCCC
Confidence            976521         1222345689999999998764 899999999999999999999999753211 11111111111


Q ss_pred             cchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          264 PDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ...                 ......++..+.+++.+||+.||.+|||+.++++
T Consensus       225 ~~~-----------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          225 TFP-----------------EKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             CCC-----------------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CCC-----------------chhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            000                 0011134567899999999999999999999985

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.8e-45  Score=322.83  Aligned_cols=266  Identities=20%  Similarity=0.213  Sum_probs=200.7

Q ss_pred             HHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCC
Q 046639           27 KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEG  103 (331)
Q Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  103 (331)
                      ...++|.+.+.||+|+||.||+|.+..+++.||+|++....   ......+.+|+.+++.++||||+++++++.     .
T Consensus        31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~-----~  105 (309)
T 2h34_A           31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGE-----I  105 (309)
T ss_dssp             ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----E
T ss_pred             cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEe-----e
Confidence            44578999999999999999999999899999999986442   333477889999999999999999999954     3


Q ss_pred             cceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCc
Q 046639          104 FDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGL  183 (331)
Q Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~  183 (331)
                      .+..++|||++++++|.+++....  .+++..++.++.|++.||.+||+.   +++|+||||+||+++.++.++|+|||+
T Consensus       106 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~  180 (309)
T 2h34_A          106 DGQLYVDMRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGI  180 (309)
T ss_dssp             TTEEEEEEECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC
T ss_pred             CCeEEEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCcc
Confidence            567899999999999999997643  467889999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhC
Q 046639          184 AKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMAL  263 (331)
Q Consensus       184 a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  263 (331)
                      +......       .........+++.|+|||++.+..++.++||||||+++|+|++|..||......  ..........
T Consensus       181 ~~~~~~~-------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~  251 (309)
T 2h34_A          181 ASATTDE-------KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--VMGAHINQAI  251 (309)
T ss_dssp             -----------------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--HHHHHHHSCC
T ss_pred             Ccccccc-------ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--HHHHHhccCC
Confidence            8765211       111223456889999999999999999999999999999999999999753211  1111111111


Q ss_pred             cchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCC-cHHHHHHHHHHhhhhhhc
Q 046639          264 PDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERM-EMRDVVAKLRHARETFLG  328 (331)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-s~~~i~~~L~~~~~~~~~  328 (331)
                      +.       +          ......++..+.+++.+||+.||++|| |+.++++.|+.+......
T Consensus       252 ~~-------~----------~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~  300 (309)
T 2h34_A          252 PR-------P----------STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQ  300 (309)
T ss_dssp             CC-------G----------GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC----
T ss_pred             CC-------c----------cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcc
Confidence            00       0          011123456788999999999999999 999999999988765543

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.4e-45  Score=323.73  Aligned_cols=253  Identities=18%  Similarity=0.246  Sum_probs=204.1

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchh------hHHHHHHHHHHHHcCCCCCcceeeceeecccC
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKE------ASRSFAAECNALRNIRHRNLIKIITICSSIDF  101 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  101 (331)
                      ..++|.+.+.||+|+||.||+|.+..+++.||+|++......      ..+.+.+|+.+++.++||||+++++++     
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----   84 (321)
T 2a2a_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVY-----   84 (321)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred             hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEE-----
Confidence            345799999999999999999999999999999999654321      346788999999999999999999995     


Q ss_pred             CCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCC----cEE
Q 046639          102 EGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDI----VAH  177 (331)
Q Consensus       102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~----~~k  177 (331)
                      ......++|||++++++|.+++...  ..+++..++.++.|++.||.+||+.   +++|+||||+||+++.++    .++
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~k  159 (321)
T 2a2a_A           85 ENRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIK  159 (321)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEE
T ss_pred             ecCCEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEE
Confidence            4456789999999999999999753  3578899999999999999999999   999999999999999888    799


Q ss_pred             EcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHH
Q 046639          178 VGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHE  257 (331)
Q Consensus       178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~  257 (331)
                      |+|||++.....         ........||+.|+|||++.+..++.++||||||+++|+|++|..||...... .....
T Consensus       160 l~Dfg~~~~~~~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~  229 (321)
T 2a2a_A          160 LIDFGLAHEIED---------GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-ETLAN  229 (321)
T ss_dssp             ECCCTTCEECCT---------TCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHH
T ss_pred             EccCccceecCc---------cccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH-HHHHH
Confidence            999999986522         11223445899999999999999999999999999999999999999753211 11111


Q ss_pred             HHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          258 FVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ......          ...       ......++..+.+|+.+||+.||++|||+.++++
T Consensus       230 i~~~~~----------~~~-------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          230 ITSVSY----------DFD-------EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             HHTTCC----------CCC-------HHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             HHhccc----------ccC-------hhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            100000          000       0112234567899999999999999999999985

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.5e-45  Score=317.83  Aligned_cols=269  Identities=22%  Similarity=0.340  Sum_probs=209.0

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCc---eEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcc
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRS---IVAVKVVNLKQ-KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFD  105 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~  105 (331)
                      -.|.+.+.||+|+||+||+|.+..++.   .||+|.+.... ....+.+.+|+.+++.++||||+++++++.    ....
T Consensus        21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----~~~~   96 (298)
T 3pls_A           21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIML----PPEG   96 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEC----CSSS
T ss_pred             eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEe----cCCC
Confidence            357777999999999999999754443   79999986433 344577899999999999999999999963    2334


Q ss_pred             eeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccc
Q 046639          106 FKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAK  185 (331)
Q Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~  185 (331)
                      ..++|||++.+++|.+++... ...+++..++.++.|++.||.+||+.   +++|+||||+||+++.++.+||+|||++.
T Consensus        97 ~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~  172 (298)
T 3pls_A           97 LPHVLLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLAR  172 (298)
T ss_dssp             CCEEEECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSC
T ss_pred             CcEEEEecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcc
Confidence            458999999999999999763 34567888999999999999999999   99999999999999999999999999997


Q ss_pred             ccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcc
Q 046639          186 FLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPD  265 (331)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  265 (331)
                      ......    ...........+++.|+|||.+.+..++.++||||||+++|+|++|..|+..... ..............
T Consensus       173 ~~~~~~----~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~-~~~~~~~~~~~~~~  247 (298)
T 3pls_A          173 DILDRE----YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID-PFDLTHFLAQGRRL  247 (298)
T ss_dssp             TTTTGG----GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-GGGHHHHHHTTCCC
T ss_pred             cccCCc----ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC-HHHHHHHhhcCCCC
Confidence            652211    1112223344578889999999999999999999999999999995555432221 11222222111100


Q ss_pred             hhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhhhcCC
Q 046639          266 KVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETFLGTR  330 (331)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~~~~~  330 (331)
                                         .....++..+.+++.+||+.||.+|||+.++++.|+++.+.+.+..
T Consensus       248 -------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~~  293 (298)
T 3pls_A          248 -------------------PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDH  293 (298)
T ss_dssp             -------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSCC
T ss_pred             -------------------CCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhccc
Confidence                               0112245678999999999999999999999999999999987764

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=3.5e-45  Score=337.86  Aligned_cols=283  Identities=19%  Similarity=0.232  Sum_probs=193.4

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc--chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      .++|.+++.||+|+||+||+|++..+++.||||++...  .....+.+.+|+.+++.++||||+++++++..........
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            46899999999999999999999999999999998543  3444577899999999999999999999986655566678


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      +++|||++ +++|.+++...  ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~  205 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLART  205 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred             EEEEEecc-ccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchh
Confidence            99999998 78999999653  3478899999999999999999999   999999999999999999999999999987


Q ss_pred             cccCCCCCcc-------------------cccCCceeecccccccCCccc-CCCCCccchhhHhHHHHHHHHHh------
Q 046639          187 LFGYEPGTAA-------------------ETASNSIEIKGIVGYVAPEYG-MGSKASVSGDVYNFGILLLEMFT------  240 (331)
Q Consensus       187 ~~~~~~~~~~-------------------~~~~~~~~~~~t~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~------  240 (331)
                      ..........                   ..........||+.|+|||++ .+..++.++|||||||++|||++      
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~  285 (458)
T 3rp9_A          206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV  285 (458)
T ss_dssp             TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred             ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccc
Confidence            6322211100                   001223445689999999976 56679999999999999999998      


Q ss_pred             -----CCCCCCcccCCc-------------------chHHHHHHhhC--cchhhhhcCc--------ccccccccCCcch
Q 046639          241 -----RRRPTDAMFNEG-------------------LTLHEFVKMAL--PDKVMEIVDP--------SLLLEVTANNYSW  286 (331)
Q Consensus       241 -----g~~pf~~~~~~~-------------------~~~~~~~~~~~--~~~~~~~~~~--------~~~~~~~~~~~~~  286 (331)
                           |.++|++...-.                   ..+..+.....  +.........        .............
T Consensus       286 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  365 (458)
T 3rp9_A          286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAER  365 (458)
T ss_dssp             SSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGG
T ss_pred             cccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHH
Confidence                 666665432100                   00000000000  0000000000        0000000001111


Q ss_pred             HHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          287 IEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       287 ~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ...+...+.+|+.+||+.||.+|||+.|+++
T Consensus       366 ~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~  396 (458)
T 3rp9_A          366 FPASSADAIHLLKRMLVFNPNKRITINECLA  396 (458)
T ss_dssp             STTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence            2234677899999999999999999999986

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.9e-45  Score=331.40  Aligned_cols=280  Identities=20%  Similarity=0.302  Sum_probs=196.5

Q ss_pred             HHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc--chhhHHHHHHHHHHHHcCC-CCCcceeeceeecccCCC
Q 046639           27 KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRNIR-HRNLIKIITICSSIDFEG  103 (331)
Q Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~  103 (331)
                      ...++|.+++.||+|+||+||+|.+..+++.||+|++...  .......+.+|+.+++.+. ||||+++++++..   .+
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~---~~   82 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRA---DN   82 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC---TT
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEec---CC
Confidence            3457899999999999999999999999999999998532  3445567889999999997 9999999999753   33


Q ss_pred             cceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCc
Q 046639          104 FDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGL  183 (331)
Q Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~  183 (331)
                      ...+++|||+++ ++|.+++...   .++...+..++.|++.||.|||+.   ||+||||||+||+++.++.+||+|||+
T Consensus        83 ~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~  155 (388)
T 3oz6_A           83 DRDVYLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGL  155 (388)
T ss_dssp             SSCEEEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             CCEEEEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcc
Confidence            457899999995 6999999763   467788889999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCc-------------ccccCCceeecccccccCCcccCC-CCCccchhhHhHHHHHHHHHhCCCCCCccc
Q 046639          184 AKFLFGYEPGTA-------------AETASNSIEIKGIVGYVAPEYGMG-SKASVSGDVYNFGILLLEMFTRRRPTDAMF  249 (331)
Q Consensus       184 a~~~~~~~~~~~-------------~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~  249 (331)
                      ++.+........             ...........||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+..
T Consensus       156 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  235 (388)
T 3oz6_A          156 SRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS  235 (388)
T ss_dssp             CEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            987633211110             011122344679999999999887 678999999999999999999999997642


Q ss_pred             CCcchHHHHHHhhCcchhh--hhcCccccc--------cc---ccCCcchH-------------HHHHHHHHHhhccccC
Q 046639          250 NEGLTLHEFVKMALPDKVM--EIVDPSLLL--------EV---TANNYSWI-------------EDCLVAVIGTGVTCSM  303 (331)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~--------~~---~~~~~~~~-------------~~~~~~l~~l~~~cl~  303 (331)
                      . ...+..+..........  .........        ..   ........             ..+...+.+|+.+||+
T Consensus       236 ~-~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~  314 (388)
T 3oz6_A          236 T-MNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQ  314 (388)
T ss_dssp             H-HHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCC
T ss_pred             H-HHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhc
Confidence            2 11222222111110000  000000000        00   00000000             0345678999999999


Q ss_pred             CCCCCCCcHHHHHH
Q 046639          304 ESPMERMEMRDVVA  317 (331)
Q Consensus       304 ~~P~~Rps~~~i~~  317 (331)
                      .||++|||+.++++
T Consensus       315 ~dP~~R~t~~e~l~  328 (388)
T 3oz6_A          315 FNPNKRISANDALK  328 (388)
T ss_dssp             SSGGGSCCHHHHTT
T ss_pred             cCcccCCCHHHHhC
Confidence            99999999999975

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.2e-45  Score=328.70  Aligned_cols=269  Identities=19%  Similarity=0.240  Sum_probs=204.8

Q ss_pred             HHHHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc-----chhhHHHHHHHHHHHHcCCCCCcceeeceeecc
Q 046639           25 LSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK-----QKEASRSFAAECNALRNIRHRNLIKIITICSSI   99 (331)
Q Consensus        25 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   99 (331)
                      +....++|.+.+.||+|+||+||+|.+..+++.||+|++...     .......+.+|+.+++.++||||+++++++   
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~---   97 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVY---   97 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEE---
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhh---
Confidence            345667899999999999999999999999999999998643     234457789999999999999999999995   


Q ss_pred             cCCCcceeeEEEeecCCCCHHHHHHhc--------------------------------------cCCccchHHHHHHHH
Q 046639          100 DFEGFDFKAIVFEYMQNRNLEQWLRQS--------------------------------------NGQLRFLTQRVNIAI  141 (331)
Q Consensus       100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--------------------------------------~~~~~~~~~~~~~~~  141 (331)
                        ...+..++|||++++++|.+++...                                      ....+++..++.++.
T Consensus        98 --~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  175 (345)
T 3hko_A           98 --EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMR  175 (345)
T ss_dssp             --ECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHH
T ss_pred             --ccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHH
Confidence              4456789999999999999998521                                      012235677888999


Q ss_pred             HHHHHHHHHhhcCCCCeeecCCCCCCEEecCCC--cEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCC
Q 046639          142 DVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDI--VAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG  219 (331)
Q Consensus       142 ~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~  219 (331)
                      |++.||.|||++   +++|+||||+||+++.++  .+||+|||++..+......    .........||+.|+|||++.+
T Consensus       176 qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~  248 (345)
T 3hko_A          176 QIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNG----EYYGMTTKAGTPYFVAPEVLNT  248 (345)
T ss_dssp             HHHHHHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC------------CCCGGGCCHHHHTC
T ss_pred             HHHHHHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCcc----ccccccccCCCccccCchhhcc
Confidence            999999999999   999999999999998776  8999999999865322211    1112334568999999999875


Q ss_pred             --CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHh
Q 046639          220 --SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGT  297 (331)
Q Consensus       220 --~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  297 (331)
                        ..++.++||||||+++|+|++|..||...... .............     ..            .....++..+.+|
T Consensus       249 ~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~-----~~------------~~~~~~~~~~~~l  310 (345)
T 3hko_A          249 TNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDA-DTISQVLNKKLCF-----EN------------PNYNVLSPLARDL  310 (345)
T ss_dssp             SSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCCCCT-----TS------------GGGGGSCHHHHHH
T ss_pred             CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChH-HHHHHHHhccccc-----CC------------cccccCCHHHHHH
Confidence              67899999999999999999999999754221 1111111111100     00            1112345678999


Q ss_pred             hccccCCCCCCCCcHHHHHH--HHHHhh
Q 046639          298 GVTCSMESPMERMEMRDVVA--KLRHAR  323 (331)
Q Consensus       298 ~~~cl~~~P~~Rps~~~i~~--~L~~~~  323 (331)
                      +.+||+.||.+|||+.++++  +++...
T Consensus       311 i~~~l~~~p~~Rps~~~~l~hp~~~~~~  338 (345)
T 3hko_A          311 LSNLLNRNVDERFDAMRALQHPWISQFS  338 (345)
T ss_dssp             HHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred             HHHHcCCChhHCCCHHHHhcChhhccCh
Confidence            99999999999999999986  344443

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=3.1e-46  Score=324.35  Aligned_cols=254  Identities=19%  Similarity=0.308  Sum_probs=202.0

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCC-------ceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccC
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESR-------SIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDF  101 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  101 (331)
                      .++|.+.+.||+|+||+||+|.+..++       ..||+|++........+.+.+|+.+++.++||||+++++++     
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----   81 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVC-----   81 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEE-----
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEE-----
Confidence            457999999999999999999998666       47999999766666678899999999999999999999995     


Q ss_pred             CCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCc------
Q 046639          102 EGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIV------  175 (331)
Q Consensus       102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~------  175 (331)
                      ...+..++|||++++++|.+++.... ..+++..++.++.|++.||.|||++   +++|+||||+||+++.++.      
T Consensus        82 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~  157 (289)
T 4fvq_A           82 VCGDENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNP  157 (289)
T ss_dssp             CCTTCCEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBC
T ss_pred             EeCCCCEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCccccccc
Confidence            44567799999999999999997643 2367788999999999999999999   9999999999999998886      


Q ss_pred             --EEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCC-CCCccchhhHhHHHHHHHHHhCC-CCCCcccCC
Q 046639          176 --AHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG-SKASVSGDVYNFGILLLEMFTRR-RPTDAMFNE  251 (331)
Q Consensus       176 --~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~-~pf~~~~~~  251 (331)
                        ++|+|||++...            .......+|+.|+|||++.+ ..++.++||||||+++|+|++|. +||.... .
T Consensus       158 ~~~kl~Dfg~~~~~------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~-~  224 (289)
T 4fvq_A          158 PFIKLSDPGISITV------------LPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD-S  224 (289)
T ss_dssp             CEEEECCCCSCTTT------------SCHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-H
T ss_pred             ceeeeccCcccccc------------cCccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc-h
Confidence              999999998654            11223457888999999987 67899999999999999999955 4444321 1


Q ss_pred             cchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhh
Q 046639          252 GLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETF  326 (331)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~  326 (331)
                       ...........          ...           ..++..+.+|+.+||+.||.+|||+.++++.|+.+...-
T Consensus       225 -~~~~~~~~~~~----------~~~-----------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~  277 (289)
T 4fvq_A          225 -QRKLQFYEDRH----------QLP-----------APKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD  277 (289)
T ss_dssp             -HHHHHHHHTTC----------CCC-----------CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred             -HHHHHHhhccC----------CCC-----------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence             11111111100          000           011345788999999999999999999999999886643

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=2.5e-45  Score=320.07  Aligned_cols=272  Identities=22%  Similarity=0.346  Sum_probs=210.5

Q ss_pred             HHHhcCCCcCceeeccCeeEEEEeeecC---CCceEEEEEeecc-chhhHHHHHHHHHHHHcCCCCCcceeeceeecccC
Q 046639           26 SKATNNFSPANKIGQGGVSIVYKGILDE---SRSIVAVKVVNLK-QKEASRSFAAECNALRNIRHRNLIKIITICSSIDF  101 (331)
Q Consensus        26 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  101 (331)
                      .....+|.+.+.||+|+||+||+|.+..   +...+|+|.+... .......+.+|+.++++++||||++++++|    .
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~----~   96 (298)
T 3f66_A           21 GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC----L   96 (298)
T ss_dssp             CGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEE----C
T ss_pred             CccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEE----E
Confidence            3455679999999999999999999753   3346899988643 344557789999999999999999999987    3


Q ss_pred             CCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEccc
Q 046639          102 EGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDL  181 (331)
Q Consensus       102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Df  181 (331)
                      ...+..++|||++++++|.+++.... ..+++..++.++.|++.||.+||+.   +++|+||||+||+++.++.+||+||
T Consensus        97 ~~~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Df  172 (298)
T 3f66_A           97 RSEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADF  172 (298)
T ss_dssp             CSSSCCEEEEECCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSC
T ss_pred             cCCCceEEEEeCCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcc
Confidence            44567899999999999999997533 3467788999999999999999999   9999999999999999999999999


Q ss_pred             CcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHH
Q 046639          182 GLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVK  260 (331)
Q Consensus       182 g~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~  260 (331)
                      |++.......    ...........+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||.......  ......
T Consensus       173 g~a~~~~~~~----~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~--~~~~~~  246 (298)
T 3f66_A          173 GLARDMYDKE----YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITVYLL  246 (298)
T ss_dssp             GGGCCCSCGG----GCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT--HHHHHH
T ss_pred             cccccccccc----hhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH--HHHHHh
Confidence            9998652211    111122334457788999999998899999999999999999999 666675532221  111111


Q ss_pred             hhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhhhcCC
Q 046639          261 MALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETFLGTR  330 (331)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~~~~~  330 (331)
                      .....                   .....++..+.+++.+||+.||.+|||+.++++.|+.+...+.+..
T Consensus       247 ~~~~~-------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~~~  297 (298)
T 3f66_A          247 QGRRL-------------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH  297 (298)
T ss_dssp             TTCCC-------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCCSC
T ss_pred             cCCCC-------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccCC
Confidence            11000                   0011234678999999999999999999999999999999887653

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=6.5e-46  Score=322.81  Aligned_cols=270  Identities=22%  Similarity=0.302  Sum_probs=210.2

Q ss_pred             HHHHHHhcCCCcCc-eeeccCeeEEEEeee--cCCCceEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCcceeeceee
Q 046639           23 AELSKATNNFSPAN-KIGQGGVSIVYKGIL--DESRSIVAVKVVNLKQ--KEASRSFAAECNALRNIRHRNLIKIITICS   97 (331)
Q Consensus        23 ~~~~~~~~~y~~~~-~lg~G~~g~V~~~~~--~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   97 (331)
                      .++....++|.+.+ .||+|+||+||+|.+  ..+++.||+|++....  ....+.+.+|+.+++.++||||+++++++.
T Consensus         9 ~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   88 (291)
T 1xbb_A            9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE   88 (291)
T ss_dssp             --CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             ceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC
Confidence            44445567899988 999999999999954  5677899999986442  333567899999999999999999999862


Q ss_pred             cccCCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEE
Q 046639           98 SIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAH  177 (331)
Q Consensus        98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~k  177 (331)
                            .+..++|||++++++|.+++....  .++...++.++.|++.||.+||+.   +++|+||||+||+++.++.++
T Consensus        89 ------~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~k  157 (291)
T 1xbb_A           89 ------AESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAK  157 (291)
T ss_dssp             ------SSSEEEEEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEE
T ss_pred             ------CCCcEEEEEeCCCCCHHHHHHhCc--CCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEE
Confidence                  345789999999999999997643  477889999999999999999999   999999999999999999999


Q ss_pred             EcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHH
Q 046639          178 VGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLH  256 (331)
Q Consensus       178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~  256 (331)
                      |+|||++.......     ..........+++.|+|||++.+..++.++||||||+++|+|++ |..||.....  ....
T Consensus       158 l~Dfg~~~~~~~~~-----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~  230 (291)
T 1xbb_A          158 ISDFGLSKALRADE-----NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SEVT  230 (291)
T ss_dssp             ECCCTTCEECCTTC-----SEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHH
T ss_pred             EccCCcceeeccCC-----CcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH--HHHH
Confidence            99999998652211     11111222335678999999988889999999999999999999 9999975422  1111


Q ss_pred             HHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhhhcC
Q 046639          257 EFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETFLGT  329 (331)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~~~~  329 (331)
                      .......        .+           .....++..+.+++.+||+.||.+|||+.+|++.|+.+.....+.
T Consensus       231 ~~~~~~~--------~~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~  284 (291)
T 1xbb_A          231 AMLEKGE--------RM-----------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE  284 (291)
T ss_dssp             HHHHTTC--------CC-----------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHcCC--------CC-----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhhc
Confidence            1111110        00           111235667999999999999999999999999999998876653

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=6.1e-46  Score=319.54  Aligned_cols=251  Identities=24%  Similarity=0.352  Sum_probs=192.4

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccch----hhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCc
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK----EASRSFAAECNALRNIRHRNLIKIITICSSIDFEGF  104 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  104 (331)
                      .++|.+.+.||+|+||+||+|.+.  +..||+|++.....    ...+.+.+|+.+++.++||||+++++++     ...
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~   78 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVC-----LKE   78 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----CCC
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE-----ecC
Confidence            458999999999999999999985  78899999864432    2246788999999999999999999995     445


Q ss_pred             ceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCC---eeecCCCCCCEEecC--------C
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPS---IVHGDLKPSNILLDQ--------D  173 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~---ivH~dik~~nilv~~--------~  173 (331)
                      +..++|||++++++|.+++..   ..+++..++.++.|++.||.+||++   +   ++|+||||+||+++.        +
T Consensus        79 ~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~---~~~~i~H~dikp~Nil~~~~~~~~~~~~  152 (271)
T 3dtc_A           79 PNLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDE---AIVPIIHRDLKSSNILILQKVENGDLSN  152 (271)
T ss_dssp             --CEEEEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHS---SSSCCCCSCCSGGGEEESSCCSSSCCSS
T ss_pred             CceEEEEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CCCceeecCCchHHEEEecccccccccC
Confidence            678999999999999999853   3477889999999999999999999   7   999999999999986        7


Q ss_pred             CcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcc
Q 046639          174 IVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGL  253 (331)
Q Consensus       174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~  253 (331)
                      +.++|+|||++.....          .......+|+.|+|||++.+..++.++||||||+++|+|++|..||....... 
T Consensus       153 ~~~kl~Dfg~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-  221 (271)
T 3dtc_A          153 KILKITDFGLAREWHR----------TTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA-  221 (271)
T ss_dssp             CCEEECCCCC-----------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH-
T ss_pred             cceEEccCCccccccc----------ccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-
Confidence            7899999999976521          11223468899999999998899999999999999999999999997542111 


Q ss_pred             hHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHh
Q 046639          254 TLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHA  322 (331)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~  322 (331)
                       ........           ....       .....++..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus       222 -~~~~~~~~-----------~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          222 -VAYGVAMN-----------KLAL-------PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             -HHHHHHTS-----------CCCC-------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             -HHHhhhcC-----------CCCC-------CCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence             11100000           0000       11123456799999999999999999999999999764

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.9e-45  Score=343.95  Aligned_cols=255  Identities=24%  Similarity=0.286  Sum_probs=207.1

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCc
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGF  104 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  104 (331)
                      ..++|.+.+.||+|+||.||+|++..+++.||+|++....   ......+.+|+.+++.++||||+++++++     ...
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-----~~~  256 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ETK  256 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECS
T ss_pred             cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEE-----eeC
Confidence            3567999999999999999999999999999999996432   22345678999999999999999999985     445


Q ss_pred             ceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcc
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA  184 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a  184 (331)
                      +.+++||||+++++|.+++.......+++..+..++.|++.||.|||++   +|+||||||+||+++.+|.+||+|||++
T Consensus       257 ~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla  333 (576)
T 2acx_A          257 DALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLA  333 (576)
T ss_dssp             SEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccc
Confidence            6899999999999999999876655688899999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCc
Q 046639          185 KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALP  264 (331)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  264 (331)
                      .....         ........||+.|+|||++.+..++.++||||||+++|+|++|..||........ ..........
T Consensus       334 ~~~~~---------~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~-~~~i~~~i~~  403 (576)
T 2acx_A          334 VHVPE---------GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-REEVERLVKE  403 (576)
T ss_dssp             EECCT---------TCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC-HHHHHHHHHH
T ss_pred             eeccc---------CccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh-HHHHHHHhhc
Confidence            86521         1122345799999999999999999999999999999999999999976432211 1111111000


Q ss_pred             chhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCC-----cHHHHHH
Q 046639          265 DKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERM-----EMRDVVA  317 (331)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----s~~~i~~  317 (331)
                            ...           .+...++..+.+|+.+||+.||.+||     ++.+|++
T Consensus       404 ------~~~-----------~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          404 ------VPE-----------EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             ------CCC-----------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             ------ccc-----------cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence                  000           11123456789999999999999999     7788864

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=3.6e-45  Score=328.62  Aligned_cols=247  Identities=17%  Similarity=0.175  Sum_probs=195.7

Q ss_pred             CceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeEEEeec
Q 046639           35 ANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYM  114 (331)
Q Consensus        35 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~  114 (331)
                      .+.||+|+||.||+|.+..+++.||+|++........+.+.+|+.+++.++||||+++++++     ...+..++||||+
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~~~~~lv~E~~  168 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAF-----ESKNDIVLVMEYV  168 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSEEEEEEECC
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEEEEEEeCC
Confidence            56899999999999999999999999999876666667899999999999999999999995     4456789999999


Q ss_pred             CCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEe--cCCCcEEEcccCcccccccCCC
Q 046639          115 QNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILL--DQDIVAHVGDLGLAKFLFGYEP  192 (331)
Q Consensus       115 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv--~~~~~~kl~Dfg~a~~~~~~~~  192 (331)
                      ++++|.+++.... ..+++..+..++.|++.||.|||+.   +|+|+||||+||++  +.++.+||+|||++.....   
T Consensus       169 ~~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~---  241 (373)
T 2x4f_A          169 DGGELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP---  241 (373)
T ss_dssp             TTCEEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCT---
T ss_pred             CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCC---
Confidence            9999999887533 3467788899999999999999999   99999999999999  5678999999999987521   


Q ss_pred             CCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhhhcC
Q 046639          193 GTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEIVD  272 (331)
Q Consensus       193 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (331)
                            ........||+.|+|||++.+..++.++||||||+++|+|++|..||..... ...+..+.......      .
T Consensus       242 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-~~~~~~i~~~~~~~------~  308 (373)
T 2x4f_A          242 ------REKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND-AETLNNILACRWDL------E  308 (373)
T ss_dssp             ------TCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH-HHHHHHHHHTCCCS------C
T ss_pred             ------ccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhccCCC------C
Confidence                  1112234589999999999999999999999999999999999999975421 11122222211100      0


Q ss_pred             cccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          273 PSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      .           .....++..+.+|+.+||+.||.+|||+.++++
T Consensus       309 ~-----------~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          309 D-----------EEFQDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             S-----------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             h-----------hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0           111234567899999999999999999999987

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=8.9e-45  Score=314.41  Aligned_cols=253  Identities=19%  Similarity=0.261  Sum_probs=203.5

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcc
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ--KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFD  105 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~  105 (331)
                      ..++|.+.+.||+|+||+||+|.+..+++.||+|++....  ......+.+|+.+++.++||||+++++++     ...+
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~   78 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEES   78 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEE-----EcCC
Confidence            3578999999999999999999999999999999986443  33456788999999999999999999995     4456


Q ss_pred             eeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCc---EEEcccC
Q 046639          106 FKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIV---AHVGDLG  182 (331)
Q Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~---~kl~Dfg  182 (331)
                      ..++|||++++++|.+.+....  .++...+..++.|++.||.+||+.   +++|+||||+||+++.++.   ++|+|||
T Consensus        79 ~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg  153 (284)
T 3kk8_A           79 FHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFG  153 (284)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCT
T ss_pred             EEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeece
Confidence            7899999999999999887653  477889999999999999999999   9999999999999986655   9999999


Q ss_pred             cccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhh
Q 046639          183 LAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMA  262 (331)
Q Consensus       183 ~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  262 (331)
                      ++.....         ........+|+.|+|||++.+..++.++||||||+++|+|++|..||.....  ..........
T Consensus       154 ~~~~~~~---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~~~~~~~~~~  222 (284)
T 3kk8_A          154 LAIEVND---------SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--HRLYAQIKAG  222 (284)
T ss_dssp             TCEECCS---------SCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHT
T ss_pred             eeEEccc---------CccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch--hHHHHHHHhc
Confidence            9976521         1222335689999999999999999999999999999999999999965321  1111111111


Q ss_pred             CcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          263 LPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ....    ..            .....++..+.+++.+||+.||++|||+.++++
T Consensus       223 ~~~~----~~------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          223 AYDY----PS------------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             CCCC----CT------------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cccC----Cc------------hhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            1000    00            011234567889999999999999999999986

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.1e-45  Score=320.08  Aligned_cols=258  Identities=20%  Similarity=0.291  Sum_probs=208.5

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccC------
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDF------  101 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~------  101 (331)
                      ..++|.+.+.||+|+||.||+|.+..+++.||+|.+.....    .+.+|+.+++.++||||+++++++....+      
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE----KAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSG----GGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccH----HHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            45679999999999999999999998999999999975543    35689999999999999999998754221      


Q ss_pred             -----CCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcE
Q 046639          102 -----EGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVA  176 (331)
Q Consensus       102 -----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~  176 (331)
                           ......++|||++++++|.+++.......+++..++.++.|++.||.+||++   +++|+||||+||+++.++.+
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~  161 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQV  161 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEE
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCCE
Confidence                 2245689999999999999999876656688899999999999999999999   99999999999999999999


Q ss_pred             EEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHH
Q 046639          177 HVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLH  256 (331)
Q Consensus       177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~  256 (331)
                      +|+|||++......         .......+|+.|+|||++.+..++.++||||||+++|+|++|..||...       .
T Consensus       162 kl~Dfg~~~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-------~  225 (284)
T 2a19_B          162 KIGDFGLVTSLKND---------GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-------S  225 (284)
T ss_dssp             EECCCTTCEESSCC---------SCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-------H
T ss_pred             EECcchhheecccc---------ccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-------H
Confidence            99999999865221         1222345889999999999989999999999999999999999887431       0


Q ss_pred             HHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhhh
Q 046639          257 EFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETFL  327 (331)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~~  327 (331)
                      ......        ......           ..++..+.+++.+||+.||.+|||+.++++.|+.+.++..
T Consensus       226 ~~~~~~--------~~~~~~-----------~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~  277 (284)
T 2a19_B          226 KFFTDL--------RDGIIS-----------DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE  277 (284)
T ss_dssp             HHHHHH--------HTTCCC-----------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred             HHHHHh--------hccccc-----------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence            111100        000000           1134567899999999999999999999999999877654

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=8.2e-46  Score=327.22  Aligned_cols=260  Identities=18%  Similarity=0.277  Sum_probs=202.7

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCce----EEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCC
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSI----VAVKVVNLKQ-KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEG  103 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  103 (331)
                      .++|.+.+.||+|+||+||+|.+..++..    ||+|.+.... ......+.+|+.+++.++||||+++++++.      
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------   85 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP------   85 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC------
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc------
Confidence            35799999999999999999999877765    7777764332 222345678999999999999999999863      


Q ss_pred             cceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCc
Q 046639          104 FDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGL  183 (331)
Q Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~  183 (331)
                      ....++|||++.+++|.+++.... ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        86 ~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~  161 (325)
T 3kex_A           86 GSSLQLVTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGV  161 (325)
T ss_dssp             BSSEEEEEECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSG
T ss_pred             CCccEEEEEeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCc
Confidence            245789999999999999997642 3577888999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhh
Q 046639          184 AKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMA  262 (331)
Q Consensus       184 a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~  262 (331)
                      ++......      .........++..|+|||++.+..++.++||||||+++|+|++ |..||......  .........
T Consensus       162 a~~~~~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~  233 (325)
T 3kex_A          162 ADLLPPDD------KQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA--EVPDLLEKG  233 (325)
T ss_dssp             GGGSCCCT------TCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT--HHHHHHHTT
T ss_pred             ccccCccc------ccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH--HHHHHHHcC
Confidence            98762211      1122234457788999999998899999999999999999999 99999764322  222222111


Q ss_pred             CcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhh
Q 046639          263 LPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARET  325 (331)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~  325 (331)
                      ...                   .....++..+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus       234 ~~~-------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~  277 (325)
T 3kex_A          234 ERL-------------------AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD  277 (325)
T ss_dssp             CBC-------------------CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred             CCC-------------------CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            100                   00112344577899999999999999999999999988654

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=4.4e-45  Score=314.96  Aligned_cols=255  Identities=20%  Similarity=0.248  Sum_probs=205.3

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ-KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      ..++|.+.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++.     ..+.
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~   79 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNI   79 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEE-----cCCE
Confidence            4568999999999999999999999899999999996543 334567889999999999999999999853     4567


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      .++|||++++++|.+++...  ..++...+..++.|++.||.+||+.   +++|+||+|+||+++.++.++|+|||++..
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  154 (276)
T 2yex_A           80 QYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATV  154 (276)
T ss_dssp             EEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEEecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccc
Confidence            89999999999999998543  3577889999999999999999999   999999999999999999999999999976


Q ss_pred             cccCCCCCcccccCCceeecccccccCCcccCCCCC-ccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcc
Q 046639          187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKA-SVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPD  265 (331)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  265 (331)
                      .....      .........+++.|+|||++.+..+ +.++||||||+++|+|++|..||.........+..+...... 
T Consensus       155 ~~~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-  227 (276)
T 2yex_A          155 FRYNN------RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY-  227 (276)
T ss_dssp             CEETT------EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTT-
T ss_pred             cCCCc------chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccc-
Confidence            52111      1112234568899999999988775 789999999999999999999998654433333222111000 


Q ss_pred             hhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          266 KVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                           .             .....++..+.+|+.+||+.||.+|||+.++++
T Consensus       228 -----~-------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          228 -----L-------------NPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             -----S-------------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -----c-------------CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence                 0             001234567889999999999999999999975

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=3.1e-46  Score=335.01  Aligned_cols=250  Identities=22%  Similarity=0.247  Sum_probs=193.1

Q ss_pred             HHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHH-HHcCCCCCcceeeceeecccCC
Q 046639           27 KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNA-LRNIRHRNLIKIITICSSIDFE  102 (331)
Q Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~  102 (331)
                      ...++|.+++.||+|+||+||+|++..+++.||+|++....   ......+..|..+ ++.++||||+++++++     .
T Consensus        35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~-----~  109 (373)
T 2r5t_A           35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-----Q  109 (373)
T ss_dssp             CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEE-----E
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----E
Confidence            34568999999999999999999999999999999996543   2233456667776 5668999999999985     4


Q ss_pred             CcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccC
Q 046639          103 GFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLG  182 (331)
Q Consensus       103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg  182 (331)
                      ..+..++||||+++++|.+++.+..  .++...+..++.|++.||.|||++   +|+||||||+||+++.+|.+||+|||
T Consensus       110 ~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG  184 (373)
T 2r5t_A          110 TADKLYFVLDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFG  184 (373)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCc
Confidence            4568999999999999999997643  366788899999999999999999   99999999999999999999999999


Q ss_pred             cccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhh
Q 046639          183 LAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMA  262 (331)
Q Consensus       183 ~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  262 (331)
                      +++....        .........||+.|+|||++.+..++.++||||||+++|||++|..||..... ...+..+....
T Consensus       185 ~a~~~~~--------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-~~~~~~i~~~~  255 (373)
T 2r5t_A          185 LCKENIE--------HNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-AEMYDNILNKP  255 (373)
T ss_dssp             BCGGGBC--------CCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH-HHHHHHHHHSC
T ss_pred             ccccccc--------CCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHhcc
Confidence            9976421        11223456799999999999999999999999999999999999999975321 11111111110


Q ss_pred             CcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHH
Q 046639          263 LPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVV  316 (331)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~  316 (331)
                      .                     .+...+...+.+|+.+||+.||.+||++.+.+
T Consensus       256 ~---------------------~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~  288 (373)
T 2r5t_A          256 L---------------------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDF  288 (373)
T ss_dssp             C---------------------CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred             c---------------------CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence            0                     11112456788999999999999999986443

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.4e-45  Score=328.43  Aligned_cols=276  Identities=17%  Similarity=0.206  Sum_probs=206.5

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecC---CCceEEEEEeeccchh-----------hHHHHHHHHHHHHcCCCCCcceeec
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDE---SRSIVAVKVVNLKQKE-----------ASRSFAAECNALRNIRHRNLIKIIT   94 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~~i~~~~~   94 (331)
                      .++|.+.+.||+|+||+||+|.+..   ++..+|+|++......           ....+..|+..++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            4689999999999999999999986   7889999998754321           1133667888999999999999999


Q ss_pred             eeecccCCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCC
Q 046639           95 ICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDI  174 (331)
Q Consensus        95 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~  174 (331)
                      ++... +.+....++|||++ +++|.+++....  .+++..++.++.|++.||.|||+.   +|+|+||||+||+++.++
T Consensus       116 ~~~~~-~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~  188 (345)
T 2v62_A          116 SGLTE-FKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKN  188 (345)
T ss_dssp             EEEEE-SSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSS
T ss_pred             ccccc-cCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCC
Confidence            97653 24467889999999 999999997654  578899999999999999999999   999999999999998877


Q ss_pred             --cEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCc
Q 046639          175 --VAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEG  252 (331)
Q Consensus       175 --~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~  252 (331)
                        .+||+|||+++.+...... ............||+.|+|||++.+..++.++||||||+++|+|++|..||.......
T Consensus       189 ~~~~kL~Dfg~a~~~~~~~~~-~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~  267 (345)
T 2v62_A          189 PDQVYLADYGLSYRYCPNGNH-KQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP  267 (345)
T ss_dssp             TTSEEECCCTTCEESSGGGCC-CCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred             CCcEEEEeCCCceeccccccc-ccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence              9999999999876322111 0111112234568999999999999999999999999999999999999996543332


Q ss_pred             chHHHHHHh---hCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhh
Q 046639          253 LTLHEFVKM---ALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETF  326 (331)
Q Consensus       253 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~  326 (331)
                      .........   ..+..+.....              ...++..+.+++.+||+.||++|||+.+|++.|+.+...+
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~  330 (345)
T 2v62_A          268 VAVQTAKTNLLDELPQSVLKWAP--------------SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPL  330 (345)
T ss_dssp             HHHHHHHHHHHHTTTHHHHHHSC--------------TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCC
T ss_pred             HHHHHHHHhhcccccHHHHhhcc--------------ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCcc
Confidence            222221111   11111111000              0134568999999999999999999999999998865443

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.9e-45  Score=317.85  Aligned_cols=248  Identities=19%  Similarity=0.292  Sum_probs=200.0

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCc
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGF  104 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  104 (331)
                      ..++|.+.+.||+|+||+||+|.+..++..||+|++....   ......+.+|+.+++.++||||+++++++     ...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~   81 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF-----HDA   81 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECS
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheE-----ecC
Confidence            3467999999999999999999999999999999986432   22346688999999999999999999995     445


Q ss_pred             ceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcc
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA  184 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a  184 (331)
                      ...++|||++++++|.+++....  .++...+..++.|++.||.+||+.   +++|+||||+||+++.++.++|+|||++
T Consensus        82 ~~~~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~  156 (279)
T 3fdn_A           82 TRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS  156 (279)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEE
T ss_pred             CEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEecccc
Confidence            67899999999999999997654  367888999999999999999999   9999999999999999999999999988


Q ss_pred             cccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCc
Q 046639          185 KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALP  264 (331)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  264 (331)
                      ....          ........+++.|+|||++.+..++.++||||||+++|+|++|..||.....  ..........  
T Consensus       157 ~~~~----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~--  222 (279)
T 3fdn_A          157 VHAP----------SSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--QETYKRISRV--  222 (279)
T ss_dssp             SCC------------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHHHHHHT--
T ss_pred             ccCC----------cccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH--HHHHHHHHhC--
Confidence            6531          1122345688999999999999999999999999999999999999975321  1111111100  


Q ss_pred             chhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          265 DKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                             .           ..++..++..+.+|+.+||+.||.+|||+.++++
T Consensus       223 -------~-----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  257 (279)
T 3fdn_A          223 -------E-----------FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  257 (279)
T ss_dssp             -------C-----------CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             -------C-----------CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence                   0           0111224567889999999999999999999985

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.4e-45  Score=329.32  Aligned_cols=279  Identities=13%  Similarity=0.100  Sum_probs=210.0

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecC--------CCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeec--
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDE--------SRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSS--   98 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--   98 (331)
                      .++|.+.+.||+|+||+||+|++..        .++.||+|++...     ..+.+|+.+++.++||||+++++....  
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            4789999999999999999999987        3789999998644     347789999999999999884332111  


Q ss_pred             ---------ccCCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEE
Q 046639           99 ---------IDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNIL  169 (331)
Q Consensus        99 ---------~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nil  169 (331)
                               .........++|||++ +++|.+++.......+++..++.++.|++.||.|||++   +++|+||||+||+
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl  191 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIF  191 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEE
Confidence                     0012356789999999 99999999876455688999999999999999999999   9999999999999


Q ss_pred             ecCCC--cEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCc
Q 046639          170 LDQDI--VAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDA  247 (331)
Q Consensus       170 v~~~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  247 (331)
                      ++.++  .+||+|||++..+....... ...........||+.|+|||++.+..++.++||||||+++|+|++|..||..
T Consensus       192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  270 (352)
T 2jii_A          192 VDPEDQSQVTLAGYGFAFRYCPSGKHV-AYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN  270 (352)
T ss_dssp             EETTEEEEEEECCGGGCBCSSGGGCCC-CCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             EcCCCCceEEEecCcceeeccCCCccc-cccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            99998  99999999998763221110 0111122334689999999999999999999999999999999999999987


Q ss_pred             ccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhhh
Q 046639          248 MFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETFL  327 (331)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~~  327 (331)
                      ............... ............          ....++..+.+|+.+||+.||.+|||+.+|++.|+.+.+...
T Consensus       271 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~  339 (352)
T 2jii_A          271 CLPNTEDIMKQKQKF-VDKPGPFVGPCG----------HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR  339 (352)
T ss_dssp             GTTCHHHHHHHHHHH-HHSCCCEECTTS----------CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             CCcCHHHHHHHHHhc-cCChhhhhhhcc----------ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence            543322222222111 000000011000          001235679999999999999999999999999999987765


Q ss_pred             c
Q 046639          328 G  328 (331)
Q Consensus       328 ~  328 (331)
                      .
T Consensus       340 ~  340 (352)
T 2jii_A          340 V  340 (352)
T ss_dssp             C
T ss_pred             C
Confidence            3

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.5e-45  Score=318.45  Aligned_cols=254  Identities=27%  Similarity=0.343  Sum_probs=200.4

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      .++|.+.+.||+|+||+||+|.+.  ++.||+|++...  ...+.+.+|+.+++.++||||+++++++.    ...+..+
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----~~~~~~~   91 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLY   91 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEEC----CC--CCE
T ss_pred             hhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEE----cCCCceE
Confidence            457999999999999999999885  789999998643  24567889999999999999999999863    3345789


Q ss_pred             EEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccc
Q 046639          109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLF  188 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~  188 (331)
                      +|||++++++|.+++.......++...++.++.|++.||.+||++   +++|+||||+||+++.++.++|+|||++....
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~  168 (278)
T 1byg_A           92 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  168 (278)
T ss_dssp             EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred             EEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccc
Confidence            999999999999999876544467788999999999999999999   99999999999999999999999999987542


Q ss_pred             cCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhCcchh
Q 046639          189 GYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMALPDKV  267 (331)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  267 (331)
                      .           ......+++.|+|||++.+..++.++||||||+++|+|++ |..||......  .........     
T Consensus       169 ~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--~~~~~~~~~-----  230 (278)
T 1byg_A          169 S-----------TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRVEKG-----  230 (278)
T ss_dssp             ------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--GHHHHHTTT-----
T ss_pred             c-----------cccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHhcC-----
Confidence            1           1122346778999999988899999999999999999998 99999754221  111111100     


Q ss_pred             hhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhh
Q 046639          268 MEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARET  325 (331)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~  325 (331)
                         ...           .....++..+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus       231 ---~~~-----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~  274 (278)
T 1byg_A          231 ---YKM-----------DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  274 (278)
T ss_dssp             ---CCC-----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---CCC-----------CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence               000           11123567899999999999999999999999999998764

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=5.9e-46  Score=336.69  Aligned_cols=260  Identities=17%  Similarity=0.189  Sum_probs=204.5

Q ss_pred             HHHHHHHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCcceeeceeec
Q 046639           22 YAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNIRHRNLIKIITICSS   98 (331)
Q Consensus        22 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   98 (331)
                      ..++....++|.+++.||+|+||+||+|++..+++.||+|++....   ......+.+|..+++.++||||+++++++  
T Consensus        61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~--  138 (410)
T 3v8s_A           61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF--  138 (410)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEE--
T ss_pred             HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE--
Confidence            3455556789999999999999999999999999999999996432   11223477899999999999999999995  


Q ss_pred             ccCCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEE
Q 046639           99 IDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHV  178 (331)
Q Consensus        99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl  178 (331)
                         .+...+++||||+++|+|.+++...   .+++..+..++.|++.||.|||++   +|+||||||+||+++.+|.+||
T Consensus       139 ---~~~~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL  209 (410)
T 3v8s_A          139 ---QDDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKL  209 (410)
T ss_dssp             ---ECSSEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEE
T ss_pred             ---EECCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEE
Confidence               4567899999999999999999754   367888999999999999999999   9999999999999999999999


Q ss_pred             cccCcccccccCCCCCcccccCCceeecccccccCCcccCCCC----CccchhhHhHHHHHHHHHhCCCCCCcccCCcch
Q 046639          179 GDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSK----ASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLT  254 (331)
Q Consensus       179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~----~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~  254 (331)
                      +|||+++.....       .........||+.|+|||++.+..    ++.++||||||+++|+|++|..||..... ...
T Consensus       210 ~DFG~a~~~~~~-------~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-~~~  281 (410)
T 3v8s_A          210 ADFGTCMKMNKE-------GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-VGT  281 (410)
T ss_dssp             CCCTTCEECCTT-------SEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH-HHH
T ss_pred             eccceeEeeccC-------CcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh-hhH
Confidence            999999865211       111223456999999999987655    88999999999999999999999975321 111


Q ss_pred             HHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCC--CCcHHHHHH
Q 046639          255 LHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPME--RMEMRDVVA  317 (331)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--Rps~~~i~~  317 (331)
                      +..+.....     ....+.            ...++..+.+|+.+||+.+|.+  ||++.+|++
T Consensus       282 ~~~i~~~~~-----~~~~p~------------~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~  329 (410)
T 3v8s_A          282 YSKIMNHKN-----SLTFPD------------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKR  329 (410)
T ss_dssp             HHHHHTHHH-----HCCCCT------------TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred             HHHHHhccc-----cccCCC------------cccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence            222211100     000000            0123567889999999999988  999999974

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=4.2e-46  Score=342.79  Aligned_cols=250  Identities=20%  Similarity=0.241  Sum_probs=194.1

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc---chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCc
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK---QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGF  104 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  104 (331)
                      ..++|.+++.||+|+||.||+|.+..+++.||+|++...   .......+.+|+.+++.++||||+++++++.     ..
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~-----~~  220 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ-----TH  220 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEE-----ET
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEe-----eC
Confidence            346799999999999999999999999999999999643   2333456788999999999999999999954     45


Q ss_pred             ceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCCEEecCCCcEEEcccCc
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHH-HCQPSIVHGDLKPSNILLDQDIVAHVGDLGL  183 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~  183 (331)
                      +..++||||+++++|.+++....  .+++..+..++.|++.||.|||+ .   +|+||||||+||+++.++.+||+|||+
T Consensus       221 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~  295 (446)
T 4ejn_A          221 DRLCFVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGL  295 (446)
T ss_dssp             TEEEEEECCCSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCC
T ss_pred             CEEEEEEeeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCC
Confidence            67899999999999999997644  47788999999999999999998 7   999999999999999999999999999


Q ss_pred             ccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhC
Q 046639          184 AKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMAL  263 (331)
Q Consensus       184 a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  263 (331)
                      ++....        .........||+.|+|||++.+..++.++||||||+++|+|++|..||.....  ...........
T Consensus       296 a~~~~~--------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~~~i~~~~  365 (446)
T 4ejn_A          296 CKEGIK--------DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKLFELILMEE  365 (446)
T ss_dssp             CCTTCC-------------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCC
T ss_pred             ceeccC--------CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH--HHHHHHHHhCC
Confidence            975311        11223346699999999999999999999999999999999999999975321  11111111100


Q ss_pred             cchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCC-----cHHHHHH
Q 046639          264 PDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERM-----EMRDVVA  317 (331)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----s~~~i~~  317 (331)
                                          ..++..+++.+.+|+.+||+.||.+||     |+.++++
T Consensus       366 --------------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          366 --------------------IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             --------------------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             --------------------CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence                                011123456789999999999999999     9999875

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-45  Score=330.42  Aligned_cols=268  Identities=22%  Similarity=0.352  Sum_probs=201.8

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCC---CceEEEEEeecc-chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcc
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDES---RSIVAVKVVNLK-QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFD  105 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~  105 (331)
                      ..|.+.+.||+|+||+||+|.+..+   ...||+|.+... .......+.+|+.+++.++||||++++++|    ....+
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~----~~~~~  164 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC----LRSEG  164 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEE----CCCSS
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEE----EcCCC
Confidence            3577789999999999999987533   346899988643 344567789999999999999999999987    33446


Q ss_pred             eeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccc
Q 046639          106 FKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAK  185 (331)
Q Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~  185 (331)
                      ..++|||++++++|.+++.... ..+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+|||+++
T Consensus       165 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~  240 (373)
T 3c1x_A          165 SPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLAR  240 (373)
T ss_dssp             CCEEEEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred             CeEEEEECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccc
Confidence            7799999999999999997543 3467788899999999999999999   99999999999999999999999999998


Q ss_pred             ccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhCc
Q 046639          186 FLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMALP  264 (331)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~  264 (331)
                      .......    ..........+++.|+|||++.+..++.++||||||+++|+|++ |.+||.......  ..........
T Consensus       241 ~~~~~~~----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~--~~~~~~~~~~  314 (373)
T 3c1x_A          241 DMYDKEF----DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITVYLLQGRR  314 (373)
T ss_dssp             ---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC--HHHHHHTTCC
T ss_pred             ccccccc----ccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH--HHHHHHcCCC
Confidence            6522111    11112223456788999999999999999999999999999999 778887643222  1111111100


Q ss_pred             chhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhhhcCC
Q 046639          265 DKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETFLGTR  330 (331)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~~~~~  330 (331)
                              .           ..+..++..+.+++.+||+.||++|||+.++++.|+.+...+.+..
T Consensus       315 --------~-----------~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~~  361 (373)
T 3c1x_A          315 --------L-----------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH  361 (373)
T ss_dssp             --------C-----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCC
T ss_pred             --------C-----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccccc
Confidence                    0           0012345678999999999999999999999999999998887653

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.5e-44  Score=318.08  Aligned_cols=280  Identities=21%  Similarity=0.293  Sum_probs=208.2

Q ss_pred             HHHHHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcC--CCCCcceeeceeecccC
Q 046639           24 ELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNI--RHRNLIKIITICSSIDF  101 (331)
Q Consensus        24 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~~i~~~~~~~~~~~~  101 (331)
                      ......++|.+.+.||+|+||.||+|.+.  ++.||+|++.....   .....|.+++...  +||||+++++++... .
T Consensus        31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~-~  104 (337)
T 3mdy_A           31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFIAADIKG-T  104 (337)
T ss_dssp             HHTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEES-C
T ss_pred             cccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecccc---chhhhHHHHHHHHhhcCCCeeeEEEEEccC-C
Confidence            33455678999999999999999999985  88999999864322   2344555555554  899999999987543 1


Q ss_pred             CCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcC-----CCCeeecCCCCCCEEecCCCcE
Q 046639          102 EGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHC-----QPSIVHGDLKPSNILLDQDIVA  176 (331)
Q Consensus       102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~-----~~~ivH~dik~~nilv~~~~~~  176 (331)
                      ......++|||++++++|.++++..   .+++..++.++.|++.||.|||+..     ..+++|+||||+||+++.++.+
T Consensus       105 ~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~  181 (337)
T 3mdy_A          105 GSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTC  181 (337)
T ss_dssp             GGGCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred             CCCCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCE
Confidence            2225789999999999999999764   3778899999999999999999751     2389999999999999999999


Q ss_pred             EEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccc------hhhHhHHHHHHHHHhC---------
Q 046639          177 HVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVS------GDVYNFGILLLEMFTR---------  241 (331)
Q Consensus       177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~------~DiwslG~il~el~~g---------  241 (331)
                      ||+|||++.........    .........||+.|+|||++.+...+..      +||||||+++|+|++|         
T Consensus       182 kl~Dfg~a~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~  257 (337)
T 3mdy_A          182 CIADLGLAVKFISDTNE----VDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE  257 (337)
T ss_dssp             EECCCTTCEECC-------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred             EEEeCCCceeecccccc----ccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccc
Confidence            99999999765322111    1111224468999999999988766554      9999999999999999         


Q ss_pred             -CCCCCcccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHH
Q 046639          242 -RRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLR  320 (331)
Q Consensus       242 -~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~  320 (331)
                       ..||.....................    ..+.....      ....+++..+.+|+.+||+.||.+|||+.+|++.|+
T Consensus       258 ~~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~  327 (337)
T 3mdy_A          258 YQLPYHDLVPSDPSYEDMREIVCIKK----LRPSFPNR------WSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA  327 (337)
T ss_dssp             CCCTTTTTSCSSCCHHHHHHHHTTSC----CCCCCCGG------GGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             ccccHhhhcCCCCchhhhHHHHhhhc----cCcccccc------chhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHH
Confidence             6677655444444333322221111    11111110      112378899999999999999999999999999999


Q ss_pred             Hhhhhh
Q 046639          321 HARETF  326 (331)
Q Consensus       321 ~~~~~~  326 (331)
                      .+.++.
T Consensus       328 ~l~~~~  333 (337)
T 3mdy_A          328 KMSESQ  333 (337)
T ss_dssp             HHHHTT
T ss_pred             HHHhhc
Confidence            998765

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=6.6e-46  Score=338.83  Aligned_cols=264  Identities=18%  Similarity=0.176  Sum_probs=206.4

Q ss_pred             cHHHHHHHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccch---hhHHHHHHHHHHHHcCCCCCcceeeceee
Q 046639           21 SYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK---EASRSFAAECNALRNIRHRNLIKIITICS   97 (331)
Q Consensus        21 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   97 (331)
                      +..++....++|.+++.||+|+||+||+|++..+++.||+|++.....   .....+.+|..++..++||||++++++| 
T Consensus        65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~-  143 (437)
T 4aw2_A           65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF-  143 (437)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE-
T ss_pred             hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-
Confidence            445566667899999999999999999999999999999999964321   1223378899999999999999999995 


Q ss_pred             cccCCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEE
Q 046639           98 SIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAH  177 (331)
Q Consensus        98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~k  177 (331)
                          .+.+.+++||||+++|+|.+++.+.. ..+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+|
T Consensus       144 ----~~~~~~~lV~Ey~~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vk  215 (437)
T 4aw2_A          144 ----QDDNNLYLVMDYYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIR  215 (437)
T ss_dssp             ----ECSSEEEEEECCCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEE
T ss_pred             ----eeCCEEEEEEecCCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEE
Confidence                44577999999999999999997632 3477889999999999999999999   999999999999999999999


Q ss_pred             EcccCcccccccCCCCCcccccCCceeecccccccCCcccC-----CCCCccchhhHhHHHHHHHHHhCCCCCCcccCCc
Q 046639          178 VGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGM-----GSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEG  252 (331)
Q Consensus       178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~  252 (331)
                      |+|||+++......       ........||+.|+|||++.     ...++.++||||||+++|||++|..||..... .
T Consensus       216 L~DFGla~~~~~~~-------~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~-~  287 (437)
T 4aw2_A          216 LADFGSCLKLMEDG-------TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL-V  287 (437)
T ss_dssp             ECCCTTCEECCTTS-------CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH-H
T ss_pred             EcchhhhhhcccCC-------CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh-h
Confidence            99999997652111       11122356999999999986     56789999999999999999999999975321 1


Q ss_pred             chHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCC--CCcHHHHHH
Q 046639          253 LTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPME--RMEMRDVVA  317 (331)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--Rps~~~i~~  317 (331)
                      ..+..+....     .....+..           ...++..+.+|+.+||+.+|++  ||++.++++
T Consensus       288 ~~~~~i~~~~-----~~~~~p~~-----------~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          288 ETYGKIMNHK-----ERFQFPTQ-----------VTDVSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             HHHHHHHTHH-----HHCCCCSS-----------CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             HHHHhhhhcc-----ccccCCcc-----------cccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence            1122211100     00000110           1124567889999999998888  999999874

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=5.6e-45  Score=332.43  Aligned_cols=254  Identities=18%  Similarity=0.249  Sum_probs=194.6

Q ss_pred             HHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccch--------hhHHHHHHHHHHHHcCCCCCcceeeceeec
Q 046639           27 KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK--------EASRSFAAECNALRNIRHRNLIKIITICSS   98 (331)
Q Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   98 (331)
                      ...++|.+.+.||+|+||+||+|.+..+++.||+|++.....        .....+.+|+.++++++||||+++++++. 
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-  210 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-  210 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence            456789999999999999999999999999999999864321        11234789999999999999999999853 


Q ss_pred             ccCCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCC---c
Q 046639           99 IDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDI---V  175 (331)
Q Consensus        99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~---~  175 (331)
                           ....++|||++++++|.+++...  ..+++..+..++.|++.||.|||++   +|+||||||+||+++.++   .
T Consensus       211 -----~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~  280 (419)
T 3i6u_A          211 -----AEDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCL  280 (419)
T ss_dssp             -----SSEEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCC
T ss_pred             -----cCceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcce
Confidence                 23468999999999999988543  3578899999999999999999999   999999999999997544   5


Q ss_pred             EEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCC---CCCccchhhHhHHHHHHHHHhCCCCCCcccCCc
Q 046639          176 AHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG---SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEG  252 (331)
Q Consensus       176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~  252 (331)
                      +||+|||+++...         .........||+.|+|||++.+   ..++.++||||||+++|+|++|..||.......
T Consensus       281 ~kl~DFG~a~~~~---------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~  351 (419)
T 3i6u_A          281 IKITDFGHSKILG---------ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV  351 (419)
T ss_dssp             EEECCSSTTTSCC--------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC
T ss_pred             EEEeecccceecC---------CCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH
Confidence            9999999998652         1122234568999999999864   568899999999999999999999997643332


Q ss_pred             chHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          253 LTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      . .............                ......++..+.+|+.+||+.||.+|||+.++++
T Consensus       352 ~-~~~~i~~~~~~~~----------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          352 S-LKDQITSGKYNFI----------------PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             C-HHHHHHTTCCCCC----------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             H-HHHHHhcCCCCCC----------------chhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            2 2222211110000                0111234567899999999999999999999985

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=2.7e-45  Score=322.97  Aligned_cols=276  Identities=23%  Similarity=0.337  Sum_probs=209.5

Q ss_pred             cCC-CcCceeeccCeeEEEEee----ecCCCceEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCC
Q 046639           30 NNF-SPANKIGQGGVSIVYKGI----LDESRSIVAVKVVNLKQ-KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEG  103 (331)
Q Consensus        30 ~~y-~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  103 (331)
                      ++| ++++.||+|+||+||++.    +..+++.||+|++.... ......+.+|+.+++.++||||+++++++...   +
T Consensus        30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~  106 (318)
T 3lxp_A           30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA---G  106 (318)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET---T
T ss_pred             HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC---C
Confidence            345 999999999999997765    44578999999997543 34456789999999999999999999997532   2


Q ss_pred             cceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCc
Q 046639          104 FDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGL  183 (331)
Q Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~  183 (331)
                      ....++|||++++++|.+++....   +++..++.++.|++.||.+||+.   +++|+||||+||+++.++.++|+|||+
T Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~  180 (318)
T 3lxp_A          107 AASLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGL  180 (318)
T ss_dssp             TTEEEEEECCCTTCBHHHHGGGSC---CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGG
T ss_pred             CceEEEEEecccCCcHHHHHhhCC---CCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccc
Confidence            467899999999999999997643   77889999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhC
Q 046639          184 AKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMAL  263 (331)
Q Consensus       184 a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  263 (331)
                      +.......     ..........+|..|+|||++.+..++.++||||||+++|+|++|..||......   .........
T Consensus       181 a~~~~~~~-----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~---~~~~~~~~~  252 (318)
T 3lxp_A          181 AKAVPEGH-----EYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTK---FLELIGIAQ  252 (318)
T ss_dssp             CEECCTTC-----SEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH---HHHHHCSCC
T ss_pred             cccccccc-----cccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchh---hhhhhcccc
Confidence            98752211     1112223345778899999999889999999999999999999999998643111   000000000


Q ss_pred             ----cchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhhhcC
Q 046639          264 ----PDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETFLGT  329 (331)
Q Consensus       264 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~~~~  329 (331)
                          ...+..........       .....++..+.+|+.+||+.||.+|||+.++++.|+.+.+.+.+.
T Consensus       253 ~~~~~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~  315 (318)
T 3lxp_A          253 GQMTVLRLTELLERGERL-------PRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQ  315 (318)
T ss_dssp             HHHHHHHHHHHHHTTCCC-------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC-
T ss_pred             cchhHHHHHHHHhcccCC-------CCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccC
Confidence                00011111111100       112345678999999999999999999999999999999887653

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.7e-45  Score=325.29  Aligned_cols=249  Identities=21%  Similarity=0.276  Sum_probs=191.5

Q ss_pred             hcCCCcCceeeccCeeEEEEeeec---CCCceEEEEEeeccc----hhhHHHHHHHHHHHHcCCCCCcceeeceeecccC
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILD---ESRSIVAVKVVNLKQ----KEASRSFAAECNALRNIRHRNLIKIITICSSIDF  101 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  101 (331)
                      .++|.+.+.||+|+||+||+|++.   .+++.||+|++....    ......+.+|+.+++.++||||+++++++     
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----   90 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAF-----   90 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEE-----
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEE-----
Confidence            457999999999999999999985   688999999986442    22345578899999999999999999985     


Q ss_pred             CCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEccc
Q 046639          102 EGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDL  181 (331)
Q Consensus       102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Df  181 (331)
                      ...+..++|||++++++|.+++....  .++...+..++.|++.||.|||++   +|+||||||+||+++.++.+||+||
T Consensus        91 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Df  165 (327)
T 3a62_A           91 QTGGKLYLILEYLSGGELFMQLEREG--IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDF  165 (327)
T ss_dssp             ECSSCEEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCC
T ss_pred             EcCCEEEEEEeCCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeC
Confidence            44567899999999999999997643  366788899999999999999999   9999999999999999999999999


Q ss_pred             CcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHh
Q 046639          182 GLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKM  261 (331)
Q Consensus       182 g~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  261 (331)
                      |++.....        .........||+.|+|||++.+..++.++||||||+++|+|++|..||..... ..........
T Consensus       166 g~~~~~~~--------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~i~~~  236 (327)
T 3a62_A          166 GLCKESIH--------DGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR-KKTIDKILKC  236 (327)
T ss_dssp             SCC------------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHT
T ss_pred             Cccccccc--------CCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHhC
Confidence            99875411        11122334689999999999999999999999999999999999999975321 1111111111


Q ss_pred             hCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCC-----cHHHHHH
Q 046639          262 ALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERM-----EMRDVVA  317 (331)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----s~~~i~~  317 (331)
                      ..                     .++..+...+.+|+.+||+.||.+||     ++.++++
T Consensus       237 ~~---------------------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          237 KL---------------------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             CC---------------------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             CC---------------------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence            10                     11122456788999999999999999     6777754

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.1e-45  Score=315.59  Aligned_cols=251  Identities=20%  Similarity=0.321  Sum_probs=183.4

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccch---hhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCc
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK---EASRSFAAECNALRNIRHRNLIKIITICSSIDFEGF  104 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  104 (331)
                      ..++|.+.+.||+|+||.||+|.+..+++.||+|++.....   .....+.+|+.+++.++||||+++++++     ...
T Consensus         9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~   83 (278)
T 3cok_A            9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYF-----EDS   83 (278)
T ss_dssp             SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEE-----ECS
T ss_pred             ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEE-----ccC
Confidence            34689999999999999999999988999999999964322   2246788999999999999999999995     445


Q ss_pred             ceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcc
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA  184 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a  184 (331)
                      +..++|||++++++|.+++.... ..+++..++.++.|++.||.+||+.   +++|+||||+||+++.++.++|+|||++
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~  159 (278)
T 3cok_A           84 NYVYLVLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLA  159 (278)
T ss_dssp             SEEEEEEECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTC
T ss_pred             CeEEEEEecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecce
Confidence            67899999999999999997643 3577889999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCc
Q 046639          185 KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALP  264 (331)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  264 (331)
                      ......        ........+|+.|+|||++.+..++.++||||||+++|+|++|..||........     ....  
T Consensus       160 ~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~~--  224 (278)
T 3cok_A          160 TQLKMP--------HEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-----LNKV--  224 (278)
T ss_dssp             EECC------------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------C--
T ss_pred             eeccCC--------CCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-----HHHH--
Confidence            865211        1122235688999999999998999999999999999999999999975422110     0000  


Q ss_pred             chhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          265 DKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                            ...         ....+..++..+.+++.+||+.||.+|||+.++++
T Consensus       225 ------~~~---------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          225 ------VLA---------DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             ------CSS---------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ------hhc---------ccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence                  000         00111234567889999999999999999999975

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=7.4e-45  Score=326.02  Aligned_cols=277  Identities=20%  Similarity=0.229  Sum_probs=208.0

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ-KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      ..++|.+++.||+|+||+||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++..........
T Consensus        25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  104 (364)
T 3qyz_A           25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD  104 (364)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence            3568999999999999999999999999999999986433 334477889999999999999999999987655555567


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      .++|||++ +++|.+++...   .+++..+..++.|++.||.|||++   +|+|+||||+||+++.++.+||+|||++..
T Consensus       105 ~~iv~e~~-~~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~  177 (364)
T 3qyz_A          105 VYIVQDLM-ETDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARV  177 (364)
T ss_dssp             EEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEccc-CcCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEe
Confidence            89999999 46999999764   377889999999999999999999   999999999999999999999999999986


Q ss_pred             cccCCCCCcccccCCceeecccccccCCcccCC-CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcc
Q 046639          187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG-SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPD  265 (331)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  265 (331)
                      ....     ...........||+.|+|||++.+ ..++.++||||||+++|+|++|..||...... .............
T Consensus       178 ~~~~-----~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~  251 (364)
T 3qyz_A          178 ADPD-----HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL-DQLNHILGILGSP  251 (364)
T ss_dssp             CCGG-----GCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGG-GHHHHHHHHHCSC
T ss_pred             cCCC-----CCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChH-HHHHHHHHHhCCC
Confidence            5211     111122234578999999998654 45899999999999999999999999764322 2222222211111


Q ss_pred             hhh---hhcCc---ccccccc----cCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          266 KVM---EIVDP---SLLLEVT----ANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       266 ~~~---~~~~~---~~~~~~~----~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ...   ...+.   .......    .........+...+.+|+.+||+.||.+|||+.++++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          252 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             CHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            000   00000   0000000    0000111234567899999999999999999999985

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=4.6e-45  Score=313.31  Aligned_cols=258  Identities=22%  Similarity=0.354  Sum_probs=206.3

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      .++|.+.+.||+|+||.||+|.+. ++..||+|++..... ..+.+.+|+.+++.++||||+++++++     ...+..+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~   79 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVC-----LEQAPIC   79 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSSSCE
T ss_pred             hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCCCeE
Confidence            357999999999999999999986 567899999975432 336788999999999999999999995     4456789


Q ss_pred             EEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccc
Q 046639          109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLF  188 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~  188 (331)
                      +|||++++++|.+++.... ..+++..+..++.|++.||.+||++   +++|+||||+||+++.++.++|+|||++....
T Consensus        80 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~  155 (267)
T 3t9t_A           80 LVTEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVL  155 (267)
T ss_dssp             EEECCCTTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBC
T ss_pred             EEEeCCCCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccc
Confidence            9999999999999997643 3467888999999999999999999   99999999999999999999999999998652


Q ss_pred             cCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhCcchh
Q 046639          189 GYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMALPDKV  267 (331)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  267 (331)
                      .       ..........+++.|+|||++.+..++.++||||||+++|+|++ |..||.....  ...........    
T Consensus       156 ~-------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~i~~~~----  222 (267)
T 3t9t_A          156 D-------DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--SEVVEDISTGF----  222 (267)
T ss_dssp             C-------HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHHHTTC----
T ss_pred             c-------ccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH--HHHHHHHhcCC----
Confidence            1       11111223446778999999988889999999999999999999 8999975321  11111111110    


Q ss_pred             hhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhh
Q 046639          268 MEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARET  325 (331)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~  325 (331)
                          ..           .....++..+.+++.+||+.||++|||+.++++.|+.+.++
T Consensus       223 ----~~-----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (267)
T 3t9t_A          223 ----RL-----------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  265 (267)
T ss_dssp             ----CC-----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             ----cC-----------CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence                00           00112356788999999999999999999999999998764

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.6e-45  Score=317.01  Aligned_cols=261  Identities=22%  Similarity=0.370  Sum_probs=207.3

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      .++|.+.+.||+|+||+||+|.+. ++..||+|.+.... ...+.+.+|+.+++.++||||+++++++.      .+..+
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~   83 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT------QEPIY   83 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC------SSSCE
T ss_pred             HHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc------CCCcE
Confidence            468999999999999999999976 56689999986443 23467889999999999999999999853      23478


Q ss_pred             EEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccc
Q 046639          109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLF  188 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~  188 (331)
                      +|||++++++|.+++....+..+++..+..++.|++.||.+||++   +++|+||||+||+++.++.++|+|||++....
T Consensus        84 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  160 (279)
T 1qpc_A           84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIE  160 (279)
T ss_dssp             EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             EEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence            999999999999999765444577889999999999999999999   99999999999999999999999999998752


Q ss_pred             cCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhCcchh
Q 046639          189 GYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMALPDKV  267 (331)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  267 (331)
                      ...       ........++..|+|||++.+..++.++||||||+++|+|++ |..||......  .........     
T Consensus       161 ~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~~~~-----  226 (279)
T 1qpc_A          161 DNE-------YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--EVIQNLERG-----  226 (279)
T ss_dssp             SSC-------EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTT-----
T ss_pred             Ccc-------cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH--HHHHHHhcc-----
Confidence            211       111122346778999999988889999999999999999999 99999753211  111111110     


Q ss_pred             hhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhhhc
Q 046639          268 MEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETFLG  328 (331)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~~~  328 (331)
                         ...           .....++..+.+++.+||+.||++|||+.+|++.|+.+.....+
T Consensus       227 ---~~~-----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~  273 (279)
T 1qpc_A          227 ---YRM-----------VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEG  273 (279)
T ss_dssp             ---CCC-----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred             ---cCC-----------CCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccC
Confidence               000           01123456789999999999999999999999999998876554

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.4e-45  Score=326.78  Aligned_cols=243  Identities=20%  Similarity=0.282  Sum_probs=200.2

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccch--------hhHHHHHHHHHHHHcCCCCCcceeeceeecc
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK--------EASRSFAAECNALRNIRHRNLIKIITICSSI   99 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   99 (331)
                      ..++|.+.+.||+|+||+||+|++..+++.||+|++.....        .....+.+|+.+++.++||||+++++++   
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~---   98 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF---   98 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEE---
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE---
Confidence            45689999999999999999999999999999999975421        1233567899999999999999999995   


Q ss_pred             cCCCcceeeEEEeecCCC-CHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEE
Q 046639          100 DFEGFDFKAIVFEYMQNR-NLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHV  178 (331)
Q Consensus       100 ~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl  178 (331)
                        ...+..++|||++.++ +|.+++....  .+++..+..++.|++.||.|||++   +|+|+||||+||+++.++.+||
T Consensus        99 --~~~~~~~lv~e~~~~g~~l~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL  171 (335)
T 3dls_A           99 --ENQGFFQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKL  171 (335)
T ss_dssp             --ECSSEEEEEEECCTTSCBHHHHHHTCC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEE
T ss_pred             --eeCCEEEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEE
Confidence              4556789999998666 9999997643  477889999999999999999999   9999999999999999999999


Q ss_pred             cccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCC-ccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHH
Q 046639          179 GDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKA-SVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHE  257 (331)
Q Consensus       179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~  257 (331)
                      +|||++.....         ........||+.|+|||++.+..+ +.++||||||+++|+|++|..||......      
T Consensus       172 ~Dfg~a~~~~~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------  236 (335)
T 3dls_A          172 IDFGSAAYLER---------GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------  236 (335)
T ss_dssp             CCCTTCEECCT---------TCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------
T ss_pred             eecccceECCC---------CCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------
Confidence            99999986521         122334568999999999988876 88999999999999999999999642110      


Q ss_pred             HHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          258 FVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                                   .....         ..+..++..+.+|+.+||+.||++|||+.++++
T Consensus       237 -------------~~~~~---------~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  274 (335)
T 3dls_A          237 -------------VEAAI---------HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVT  274 (335)
T ss_dssp             -------------TTTCC---------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------------Hhhcc---------CCCcccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                         00000         000113567899999999999999999999986

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=3e-45  Score=317.74  Aligned_cols=252  Identities=22%  Similarity=0.285  Sum_probs=196.8

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCccee
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ-KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      .++|.+.+.||+|+||+||+|.+..++..+|+|++.... ......+.+|+.+++.++||||+++++++     ......
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~   95 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF-----EDYHNM   95 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSEE
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhe-----ecCCeE
Confidence            357999999999999999999999999999999987543 22346788999999999999999999995     445678


Q ss_pred             eEEEeecCCCCHHHHHHhc--cCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEe---cCCCcEEEcccC
Q 046639          108 AIVFEYMQNRNLEQWLRQS--NGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILL---DQDIVAHVGDLG  182 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv---~~~~~~kl~Dfg  182 (331)
                      ++|||++++++|.+++...  .+..+++..++.++.|++.||.+||+.   +++|+||||+||++   +.++.++|+|||
T Consensus        96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg  172 (285)
T 3is5_A           96 YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFG  172 (285)
T ss_dssp             EEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCC
T ss_pred             EEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeee
Confidence            9999999999999998653  335578889999999999999999999   99999999999999   456789999999


Q ss_pred             cccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhh
Q 046639          183 LAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMA  262 (331)
Q Consensus       183 ~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  262 (331)
                      ++.....         ........+|+.|+|||++. ..++.++||||||+++|+|++|..||......  .........
T Consensus       173 ~a~~~~~---------~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~--~~~~~~~~~  240 (285)
T 3is5_A          173 LAELFKS---------DEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE--EVQQKATYK  240 (285)
T ss_dssp             CCCC-------------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHC
T ss_pred             cceecCC---------cccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH--HHHhhhccC
Confidence            9976521         12223456899999999986 46899999999999999999999999754211  111111110


Q ss_pred             CcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          263 LPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      .         +.....        .....+.+.+|+.+||+.||.+|||+.++++
T Consensus       241 ~---------~~~~~~--------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          241 E---------PNYAVE--------CRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             C---------CCCCC----------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             C---------cccccc--------cCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0         000000        0113457889999999999999999999974

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=4e-44  Score=318.47  Aligned_cols=280  Identities=20%  Similarity=0.267  Sum_probs=213.8

Q ss_pred             cHHHHHHHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHc--CCCCCcceeeceeec
Q 046639           21 SYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRN--IRHRNLIKIITICSS   98 (331)
Q Consensus        21 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~   98 (331)
                      ++.......++|.+.+.||+|+||+||+|.+  +++.||+|++...   ....+..|.+++..  ++||||+++++++..
T Consensus        33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~  107 (342)
T 1b6c_B           33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNK  107 (342)
T ss_dssp             CHHHHHHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred             ceeecccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence            3444455667899999999999999999998  4889999998643   23456788888887  689999999999754


Q ss_pred             ccCCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHh--------hcCCCCeeecCCCCCCEEe
Q 046639           99 IDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFH--------HHCQPSIVHGDLKPSNILL  170 (331)
Q Consensus        99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH--------~~~~~~ivH~dik~~nilv  170 (331)
                      .. ......++|||++++++|.+++...   .+++..++.++.|++.||.+||        +.   +++|+||||+||++
T Consensus       108 ~~-~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll  180 (342)
T 1b6c_B          108 DN-GTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILV  180 (342)
T ss_dssp             CC-SSCCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEE
T ss_pred             cC-CccceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEE
Confidence            21 1123689999999999999999764   3778899999999999999999        77   99999999999999


Q ss_pred             cCCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCC------CCccchhhHhHHHHHHHHHhC---
Q 046639          171 DQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGS------KASVSGDVYNFGILLLEMFTR---  241 (331)
Q Consensus       171 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~------~~~~~~DiwslG~il~el~~g---  241 (331)
                      +.++.+||+|||++.........    .........||+.|+|||++.+.      .++.++||||||+++|+|++|   
T Consensus       181 ~~~~~~kL~Dfg~~~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~  256 (342)
T 1b6c_B          181 KKNGTCCIADLGLAVRHDSATDT----IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI  256 (342)
T ss_dssp             CTTSCEEECCCTTCEEEETTTTE----EEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCB
T ss_pred             CCCCCEEEEECCCceeccccccc----cccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCc
Confidence            99999999999999875322110    00122344689999999998875      344789999999999999999   


Q ss_pred             -------CCCCCcccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHH
Q 046639          242 -------RRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRD  314 (331)
Q Consensus       242 -------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~  314 (331)
                             ..||.....................    ..+.....      ....++...+.+|+.+||+.||++|||+.+
T Consensus       257 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~  326 (342)
T 1b6c_B          257 GGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQK----LRPNIPNR------WQSCEALRVMAKIMRECWYANGAARLTALR  326 (342)
T ss_dssp             TTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSC----CCCCCCGG------GGTSHHHHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred             CCcccccccCccccCcCcccHHHHHHHHHHHH----hCCCCccc------ccchhHHHHHHHHHHHHhccChhhCCCHHH
Confidence                   7788765444433433333221111    11111110      112367889999999999999999999999


Q ss_pred             HHHHHHHhhhhh
Q 046639          315 VVAKLRHARETF  326 (331)
Q Consensus       315 i~~~L~~~~~~~  326 (331)
                      |++.|+.+.+..
T Consensus       327 i~~~L~~i~~~~  338 (342)
T 1b6c_B          327 IKKTLSQLSQQE  338 (342)
T ss_dssp             HHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHh
Confidence            999999988753

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-44  Score=320.87  Aligned_cols=263  Identities=24%  Similarity=0.352  Sum_probs=201.3

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCC----ceEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCc
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESR----SIVAVKVVNLKQ-KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGF  104 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  104 (331)
                      ++|.+.+.||+|+||+||+|.+..++    ..||+|++.... ......+.+|+.+++.++||||+++++++     ...
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~  118 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI-----SKY  118 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSS
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----ecC
Confidence            46778899999999999999986543    469999986543 33456789999999999999999999995     445


Q ss_pred             ceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcc
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA  184 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a  184 (331)
                      +..++|||++++++|.+++.... ..+++..++.++.|++.||.+||++   +++|+||||+||+++.++.+||+|||++
T Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~  194 (333)
T 1mqb_A          119 KPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLS  194 (333)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred             CCcEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcc
Confidence            67899999999999999997643 3477889999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhC
Q 046639          185 KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMAL  263 (331)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~  263 (331)
                      ........     .........+|+.|+|||++.+..++.++||||||+++|+|++ |..||.....  ......+... 
T Consensus       195 ~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~--~~~~~~~~~~-  266 (333)
T 1mqb_A          195 RVLEDDPE-----ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HEVMKAINDG-  266 (333)
T ss_dssp             ---------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHHHTT-
T ss_pred             hhhccccc-----cccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHHCC-
Confidence            87522111     1111222345778999999998899999999999999999999 9999965321  1111111110 


Q ss_pred             cchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhhh
Q 046639          264 PDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETFL  327 (331)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~~  327 (331)
                             ...           .....++..+.+++.+||+.||.+|||+.+|++.|+.+.+...
T Consensus       267 -------~~~-----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~  312 (333)
T 1mqb_A          267 -------FRL-----------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD  312 (333)
T ss_dssp             -------CCC-----------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred             -------CcC-----------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence                   000           0112345678999999999999999999999999999877654

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2.6e-45  Score=324.29  Aligned_cols=271  Identities=24%  Similarity=0.327  Sum_probs=210.9

Q ss_pred             hhhhccCCcccHHHHHHHhcCCCcCceeeccCeeEEEEeeecCCCceE--EEEEeecc-chhhHHHHHHHHHHHHcC-CC
Q 046639           11 LSMKQQFPMISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIV--AVKVVNLK-QKEASRSFAAECNALRNI-RH   86 (331)
Q Consensus        11 ~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~v--avK~~~~~-~~~~~~~~~~e~~~l~~l-~h   86 (331)
                      .+....||.+++.       +|.+.+.||+|+||.||+|++..++..+  |+|.+... .....+.+.+|+.+++++ +|
T Consensus        13 ~~~~~~~p~~~~~-------~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h   85 (327)
T 1fvr_A           13 NPDPTIYPVLDWN-------DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH   85 (327)
T ss_dssp             ---CCCSSBCCGG-------GCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCC
T ss_pred             CCCCcccccccHH-------HccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCC
Confidence            4556677877775       6999999999999999999998888755  89988643 233446688999999999 89


Q ss_pred             CCcceeeceeecccCCCcceeeEEEeecCCCCHHHHHHhcc--------------CCccchHHHHHHHHHHHHHHHHHhh
Q 046639           87 RNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSN--------------GQLRFLTQRVNIAIDVSFAIEYFHH  152 (331)
Q Consensus        87 ~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~~~~i~~~l~~LH~  152 (331)
                      |||+++++++     ...+..++|||++++++|.+++....              ...+++..++.++.|++.||.+||+
T Consensus        86 p~iv~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~  160 (327)
T 1fvr_A           86 PNIINLLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ  160 (327)
T ss_dssp             TTBCCEEEEE-----EETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             Cchhhhceee-----eeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh
Confidence            9999999995     34567899999999999999997643              2457888999999999999999999


Q ss_pred             cCCCCeeecCCCCCCEEecCCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHH
Q 046639          153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFG  232 (331)
Q Consensus       153 ~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG  232 (331)
                      +   +++|+||||+||+++.++.+||+|||++....         .........+++.|+|||++.+..++.++||||||
T Consensus       161 ~---~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~---------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG  228 (327)
T 1fvr_A          161 K---QFIHRDLAARNILVGENYVAKIADFGLSRGQE---------VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYG  228 (327)
T ss_dssp             T---TEECSCCSGGGEEECGGGCEEECCTTCEESSC---------EECCC----CCTTTCCHHHHHHCEECHHHHHHHHH
T ss_pred             C---CccCCCCccceEEEcCCCeEEEcccCcCcccc---------ccccccCCCCCccccChhhhccccCCchhcchHHH
Confidence            9   99999999999999999999999999987431         11122233467789999999888899999999999


Q ss_pred             HHHHHHHh-CCCCCCcccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCc
Q 046639          233 ILLLEMFT-RRRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERME  311 (331)
Q Consensus       233 ~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps  311 (331)
                      +++|+|++ |..||.....     .........     ....           .....++..+.+|+.+||+.||.+|||
T Consensus       229 ~il~ellt~g~~pf~~~~~-----~~~~~~~~~-----~~~~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps  287 (327)
T 1fvr_A          229 VLLWEIVSLGGTPYCGMTC-----AELYEKLPQ-----GYRL-----------EKPLNCDDEVYDLMRQCWREKPYERPS  287 (327)
T ss_dssp             HHHHHHHTTSCCTTTTCCH-----HHHHHHGGG-----TCCC-----------CCCTTBCHHHHHHHHHHTCSSGGGSCC
T ss_pred             HHHHHHHcCCCCCCCCCcH-----HHHHHHhhc-----CCCC-----------CCCCCCCHHHHHHHHHHccCChhhCcC
Confidence            99999998 9999975421     111111100     0000           111234567899999999999999999


Q ss_pred             HHHHHHHHHHhhhhh
Q 046639          312 MRDVVAKLRHARETF  326 (331)
Q Consensus       312 ~~~i~~~L~~~~~~~  326 (331)
                      +.++++.|+.+.+..
T Consensus       288 ~~ell~~L~~~~~~~  302 (327)
T 1fvr_A          288 FAQILVSLNRMLEER  302 (327)
T ss_dssp             HHHHHHHHHHHHHSS
T ss_pred             HHHHHHHHHHHHHhh
Confidence            999999999887754

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=7e-45  Score=314.67  Aligned_cols=261  Identities=18%  Similarity=0.282  Sum_probs=205.6

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecC---CCceEEEEEeecc-chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCC
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDE---SRSIVAVKVVNLK-QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEG  103 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  103 (331)
                      ..++|.+.+.||+|+||+||+|.+..   ++..||+|.+... .....+.+.+|+.+++.++||||+++++++..     
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----   84 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-----   84 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-----
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-----
Confidence            34679999999999999999998653   4456999998754 33455778999999999999999999998532     


Q ss_pred             cceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCc
Q 046639          104 FDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGL  183 (331)
Q Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~  183 (331)
                       +..++|||++++++|.+++.... ..++...+..++.|++.||.+||++   +++|+||||+||+++.++.++|+|||+
T Consensus        85 -~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~  159 (281)
T 3cc6_A           85 -EPTWIIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGL  159 (281)
T ss_dssp             -SSCEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCG
T ss_pred             -CCCEEEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCC
Confidence             34689999999999999997643 3467788999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhh
Q 046639          184 AKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMA  262 (331)
Q Consensus       184 a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~  262 (331)
                      +......       .........+++.|+|||++.+..++.++||||||+++|+|++ |..||......  .........
T Consensus       160 ~~~~~~~-------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~--~~~~~~~~~  230 (281)
T 3cc6_A          160 SRYIEDE-------DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK--DVIGVLEKG  230 (281)
T ss_dssp             GGCC----------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG--GHHHHHHHT
T ss_pred             Ccccccc-------cccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH--HHHHHHhcC
Confidence            9865221       1111223446778999999988899999999999999999998 99999754322  122221111


Q ss_pred             CcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhh
Q 046639          263 LPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETF  326 (331)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~  326 (331)
                      ...                   .....++..+.+++.+||+.||++|||+.++++.|+.+.+.-
T Consensus       231 ~~~-------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~  275 (281)
T 3cc6_A          231 DRL-------------------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME  275 (281)
T ss_dssp             CCC-------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CCC-------------------CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence            100                   001124567899999999999999999999999999987653

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.5e-45  Score=322.68  Aligned_cols=260  Identities=18%  Similarity=0.295  Sum_probs=200.9

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceE----EEEEeecc-chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCC
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIV----AVKVVNLK-QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEG  103 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~v----avK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  103 (331)
                      .++|.+.+.||+|+||+||+|.+..+++.+    |+|.+... .......+.+|+.+++.++||||+++++++..     
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----   88 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-----   88 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES-----
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec-----
Confidence            458999999999999999999998777655    66665432 33445778999999999999999999999753     


Q ss_pred             cceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCc
Q 046639          104 FDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGL  183 (331)
Q Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~  183 (331)
                       ...++++|++.+++|.+++..... .++...++.++.|++.||.|||+.   +|+|+||||+||+++.++.+||+|||+
T Consensus        89 -~~~~~v~~~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~  163 (327)
T 3lzb_A           89 -STVQLITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGL  163 (327)
T ss_dssp             -SSEEEEECCCSSCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC
T ss_pred             -CCceEEEEecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcc
Confidence             236899999999999999986433 467888999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhh
Q 046639          184 AKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMA  262 (331)
Q Consensus       184 a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~  262 (331)
                      +.......      .........+|+.|+|||++.+..++.++||||||+++|+|++ |..||......  .........
T Consensus       164 a~~~~~~~------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~~~~~~~  235 (327)
T 3lzb_A          164 AKLLGAEE------KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILEKG  235 (327)
T ss_dssp             ----------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHHTT
T ss_pred             eeEccCcc------ccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH--HHHHHHHcC
Confidence            98752211      1112223446778999999999999999999999999999999 99999764322  222222111


Q ss_pred             CcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhh
Q 046639          263 LPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARET  325 (331)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~  325 (331)
                      ...                   .....++..+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus       236 ~~~-------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          236 ERL-------------------PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             CCC-------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             CCC-------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            100                   01122455788999999999999999999999999998754

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=6.2e-45  Score=319.60  Aligned_cols=245  Identities=20%  Similarity=0.193  Sum_probs=192.6

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc--chhhHHHHHHHHHHHHcC-CCCCcceeeceeecccCCCcce
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRNI-RHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      ++|.+.++||+|+||+||+|++..+++.||||++...  ..........|+..+..+ .||||++++++|.     ..+.
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~-----~~~~  131 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE-----EGGI  131 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE-----eCCE
Confidence            5799999999999999999999999999999988543  233334455566655555 8999999999953     4577


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      .++|||++ +++|.+++.... ..+++..++.++.|++.||.|||+.   +|+|+||||+||+++.++.+||+|||++..
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~  206 (311)
T 3p1a_A          132 LYLQTELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVE  206 (311)
T ss_dssp             EEEEEECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEE
T ss_pred             EEEEEecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeee
Confidence            89999999 789999987653 3578899999999999999999999   999999999999999999999999999876


Q ss_pred             cccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcch
Q 046639          187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDK  266 (331)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  266 (331)
                      ...         ........||+.|+|||++.+ .++.++||||||+++|+|++|..|+...    ..........    
T Consensus       207 ~~~---------~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~----~~~~~~~~~~----  268 (311)
T 3p1a_A          207 LGT---------AGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG----EGWQQLRQGY----  268 (311)
T ss_dssp             CC---------------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH----HHHHHHTTTC----
T ss_pred             ccc---------CCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc----cHHHHHhccC----
Confidence            521         112223458999999999876 7899999999999999999997665431    1111110000    


Q ss_pred             hhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          267 VMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                              ..       ..+...++..+.+++.+||+.||++|||+.++++
T Consensus       269 --------~~-------~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          269 --------LP-------PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             --------CC-------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             --------CC-------cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence                    00       0222345678999999999999999999999985

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.9e-45  Score=338.77  Aligned_cols=260  Identities=25%  Similarity=0.408  Sum_probs=204.6

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCccee
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      ..++|.+.+.||+|+||+||+|.+.. +..||||+++... ...+.+.+|+.+++.++||||+++++++..      +..
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~~~  253 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPI  253 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSC
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC------Cce
Confidence            45679999999999999999999974 4569999997443 234678999999999999999999998632      457


Q ss_pred             eEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccc
Q 046639          108 AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      ++|||++++++|.+++....+..+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||+++..
T Consensus       254 ~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  330 (452)
T 1fmk_A          254 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLI  330 (452)
T ss_dssp             EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred             EEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceec
Confidence            9999999999999999765445577889999999999999999999   9999999999999999999999999999865


Q ss_pred             ccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhCcch
Q 046639          188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMALPDK  266 (331)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~  266 (331)
                      ...       .........++..|+|||++.+..++.++||||||+++|||++ |..||......  .....+....   
T Consensus       331 ~~~-------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~--~~~~~i~~~~---  398 (452)
T 1fmk_A          331 EDN-------EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EVLDQVERGY---  398 (452)
T ss_dssp             -------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTTC---
T ss_pred             CCC-------ceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCC---
Confidence            211       1111223346778999999998899999999999999999999 99999764221  1111111110   


Q ss_pred             hhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhh
Q 046639          267 VMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETF  326 (331)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~  326 (331)
                           .    .       ..+..++..+.+|+.+||+.||++|||+.+|++.|+.+..+.
T Consensus       399 -----~----~-------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~  442 (452)
T 1fmk_A          399 -----R----M-------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  442 (452)
T ss_dssp             -----C----C-------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             -----C----C-------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence                 0    0       111245678999999999999999999999999999886554

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.1e-45  Score=320.68  Aligned_cols=270  Identities=20%  Similarity=0.274  Sum_probs=198.2

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ--KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      .++|.+++.||+|+||+||+|.+..+++.||+|++....  ....+.+.+|+.+++.++||||+++++++.     ..+.
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~   76 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFR-----RKRR   76 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheee-----cCCe
Confidence            368999999999999999999999999999999885443  333466889999999999999999999954     4567


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      .++|||++++++|.+++....  .++...+..++.|++.||.+||+.   +++|+||||+||+++.++.++|+|||++..
T Consensus        77 ~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~  151 (311)
T 4agu_A           77 LHLVFEYCDHTVLHELDRYQR--GVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARL  151 (311)
T ss_dssp             EEEEEECCSEEHHHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEEeCCCchHHHHHhhhc--CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchh
Confidence            899999999999998886543  477889999999999999999999   999999999999999999999999999987


Q ss_pred             cccCCCCCcccccCCceeecccccccCCcccCC-CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhh---
Q 046639          187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG-SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMA---  262 (331)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~---  262 (331)
                      ....        ........+|+.|+|||++.+ ..++.++||||||+++|+|++|..||........ ........   
T Consensus       152 ~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~  222 (311)
T 4agu_A          152 LTGP--------SDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQ-LYLIRKTLGDL  222 (311)
T ss_dssp             CC--------------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCSC
T ss_pred             ccCc--------ccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhccc
Confidence            5211        112234468899999999876 5689999999999999999999999976432211 11111110   


Q ss_pred             CcchhhhhcCccccccc--c--cC---CcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          263 LPDKVMEIVDPSLLLEV--T--AN---NYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       263 ~~~~~~~~~~~~~~~~~--~--~~---~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      .+...............  .  ..   ......+++..+.+|+.+||+.||.+|||+.++++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          223 IPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             CHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             ccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            00000000000000000  0  00   00011235667899999999999999999999974

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=2.7e-45  Score=323.79  Aligned_cols=252  Identities=19%  Similarity=0.230  Sum_probs=180.5

Q ss_pred             CCCc---CceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCC-CCCcceeeceeecccCCCcce
Q 046639           31 NFSP---ANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIR-HRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        31 ~y~~---~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      +|.+   .+.||+|+||+||+|.+..+++.||+|++...   ......+|+.+++.+. ||||+++++++     .+...
T Consensus         9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~-----~~~~~   80 (325)
T 3kn6_A            9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVF-----HDQLH   80 (325)
T ss_dssp             HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECSSE
T ss_pred             ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEE-----EcCCE
Confidence            4554   37899999999999999999999999999643   3356778999999997 99999999995     45567


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCC---cEEEcccCc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDI---VAHVGDLGL  183 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~---~~kl~Dfg~  183 (331)
                      .++|||++++++|.+++...  ..+++..+..++.|++.||.|||++   +|+|+||||+||+++.++   .+||+|||+
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~  155 (325)
T 3kn6_A           81 TFLVMELLNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGF  155 (325)
T ss_dssp             EEEEECCCCSCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTT
T ss_pred             EEEEEEccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEecccc
Confidence            89999999999999999764  3478899999999999999999999   999999999999998766   899999999


Q ss_pred             ccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCc--chHHHHHHh
Q 046639          184 AKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEG--LTLHEFVKM  261 (331)
Q Consensus       184 a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~  261 (331)
                      +.....        .........+|+.|+|||++.+..++.++||||||+++|+|++|..||.......  .........
T Consensus       156 a~~~~~--------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~  227 (325)
T 3kn6_A          156 ARLKPP--------DNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKK  227 (325)
T ss_dssp             CEECCC------------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHH
T ss_pred             ceecCC--------CCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHH
Confidence            976421        1122234457899999999999999999999999999999999999997643211  111111111


Q ss_pred             hCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHH
Q 046639          262 ALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVV  316 (331)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~  316 (331)
                      .....        .     .........++..+.+|+.+||+.||.+|||+.+++
T Consensus       228 i~~~~--------~-----~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell  269 (325)
T 3kn6_A          228 IKKGD--------F-----SFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLR  269 (325)
T ss_dssp             HTTTC--------C-----CCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTST
T ss_pred             HHcCC--------C-----CCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHh
Confidence            11100        0     000112234567899999999999999999999886

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=6.5e-45  Score=333.37  Aligned_cols=212  Identities=22%  Similarity=0.298  Sum_probs=171.4

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc--chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      .++|.+.+.||+|+||+||+|.+..+++.||||++...  .......+.+|+.+++.++||||+++++++..........
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            35899999999999999999999999999999999643  3344567899999999999999999999976554445577


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      .++|||++ +++|.+++...  ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus       105 ~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~  178 (432)
T 3n9x_A          105 LYIVLEIA-DSDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLART  178 (432)
T ss_dssp             EEEEEECC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEecC-CcCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence            89999999 57999999653  3478899999999999999999999   999999999999999999999999999987


Q ss_pred             cccCCCCCc--------------ccccCCceeecccccccCCccc-CCCCCccchhhHhHHHHHHHHHhCCCCCC
Q 046639          187 LFGYEPGTA--------------AETASNSIEIKGIVGYVAPEYG-MGSKASVSGDVYNFGILLLEMFTRRRPTD  246 (331)
Q Consensus       187 ~~~~~~~~~--------------~~~~~~~~~~~~t~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~g~~pf~  246 (331)
                      .........              ...........||+.|+|||++ .+..++.++|||||||++|||++|..||.
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            632211100              0001123456789999999985 55679999999999999999998655543

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-45  Score=335.15  Aligned_cols=263  Identities=21%  Similarity=0.207  Sum_probs=204.7

Q ss_pred             cHHHHHHHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCcceeeceee
Q 046639           21 SYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNIRHRNLIKIITICS   97 (331)
Q Consensus        21 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   97 (331)
                      .++++....++|.+++.||+|+||+||+|++..+++.||+|++....   ......+.+|..++..++||||+++++++ 
T Consensus        52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~-  130 (412)
T 2vd5_A           52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF-  130 (412)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE-
T ss_pred             hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE-
Confidence            34555666789999999999999999999999999999999996432   22234578899999999999999999985 


Q ss_pred             cccCCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEE
Q 046639           98 SIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAH  177 (331)
Q Consensus        98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~k  177 (331)
                          .+.+.+++||||+++++|.+++.+.. ..+++..+..++.|++.||.|||++   +|+||||||+||+++.+|.+|
T Consensus       131 ----~~~~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vk  202 (412)
T 2vd5_A          131 ----QDENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIR  202 (412)
T ss_dssp             ----ECSSEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEE
T ss_pred             ----eeCCEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEE
Confidence                44578999999999999999997643 3477888999999999999999999   999999999999999999999


Q ss_pred             EcccCcccccccCCCCCcccccCCceeecccccccCCcccC-------CCCCccchhhHhHHHHHHHHHhCCCCCCcccC
Q 046639          178 VGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGM-------GSKASVSGDVYNFGILLLEMFTRRRPTDAMFN  250 (331)
Q Consensus       178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~  250 (331)
                      |+|||++.......       ........||+.|+|||++.       +..++.++||||||+++|||++|..||.....
T Consensus       203 L~DFGla~~~~~~~-------~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~  275 (412)
T 2vd5_A          203 LADFGSCLKLRADG-------TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST  275 (412)
T ss_dssp             ECCCTTCEECCTTS-------CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred             EeechhheeccCCC-------ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH
Confidence            99999998652111       11122356999999999987       45689999999999999999999999975321


Q ss_pred             CcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCC---CcHHHHHH
Q 046639          251 EGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMER---MEMRDVVA  317 (331)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~R---ps~~~i~~  317 (331)
                       ...+..+.....     ....+           .....++..+.+|+.+||+ +|.+|   |++.+|++
T Consensus       276 -~~~~~~i~~~~~-----~~~~p-----------~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          276 -AETYGKIVHYKE-----HLSLP-----------LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             -HHHHHHHHTHHH-----HCCCC---------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             -HHHHHHHHhccc-----CcCCC-----------ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence             111122211000     00001           0112345678999999999 99998   58888863

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=7.5e-45  Score=319.71  Aligned_cols=270  Identities=18%  Similarity=0.187  Sum_probs=198.0

Q ss_pred             hcCCCcC-ceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcC-CCCCcceeeceeecccCCCcce
Q 046639           29 TNNFSPA-NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNI-RHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        29 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      .++|.+. +.||+|+||+||+|.+..+++.||+|++..........+.+|+.++.++ +||||+++++++.     ..+.
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~-----~~~~   85 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFE-----EEDR   85 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEe-----eCCE
Confidence            4578885 7899999999999999999999999999766555567789999999985 7999999999954     4567


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCc---EEEcccCc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIV---AHVGDLGL  183 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~---~kl~Dfg~  183 (331)
                      .++|||++++++|.+++....  .+++..+..++.|++.||.|||++   +++|+||||+||+++.++.   +||+|||+
T Consensus        86 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~  160 (316)
T 2ac3_A           86 FYLVFEKMRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDL  160 (316)
T ss_dssp             EEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTC
T ss_pred             EEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccC
Confidence            899999999999999997653  467888999999999999999999   9999999999999988775   99999999


Q ss_pred             ccccccCCCCCcccccCCceeecccccccCCcccCC-----CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHH
Q 046639          184 AKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG-----SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEF  258 (331)
Q Consensus       184 a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  258 (331)
                      +.......... ...........||+.|+|||++.+     ..++.++||||||+++|+|++|..||.........+...
T Consensus       161 ~~~~~~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~  239 (316)
T 2ac3_A          161 GSGIKLNGDCS-PISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRG  239 (316)
T ss_dssp             CC--------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC---
T ss_pred             ccccccCCccc-cccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccc
Confidence            87652211100 011112233458999999999865     457899999999999999999999997653322111000


Q ss_pred             H-----HhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          259 V-----KMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       259 ~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      .     .......+... .....       ......++..+.+|+.+||+.||.+|||+.++++
T Consensus       240 ~~~~~~~~~~~~~i~~~-~~~~~-------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          240 EACPACQNMLFESIQEG-KYEFP-------DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             -CCHHHHHHHHHHHHHC-CCCCC-------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ccchhHHHHHHHHHhcc-CcccC-------chhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            0     00000000000 00000       0011234567899999999999999999999986

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.1e-45  Score=314.95  Aligned_cols=264  Identities=20%  Similarity=0.305  Sum_probs=209.5

Q ss_pred             hcCCCcCc-eeeccCeeEEEEeeec--CCCceEEEEEeecc-chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCc
Q 046639           29 TNNFSPAN-KIGQGGVSIVYKGILD--ESRSIVAVKVVNLK-QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGF  104 (331)
Q Consensus        29 ~~~y~~~~-~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  104 (331)
                      .++|.+.+ .||+|+||+||+|.+.  .++..||+|++... .....+.+.+|+.+++.++||||+++++++.      .
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~   81 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ------A   81 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE------S
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec------C
Confidence            45677777 9999999999999864  46788999999754 3345577899999999999999999999862      2


Q ss_pred             ceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcc
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA  184 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a  184 (331)
                      +..++|||++++++|.+++... ...+++..++.++.|++.||.+||+.   +++|+||||+||+++.++.++|+|||++
T Consensus        82 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~  157 (287)
T 1u59_A           82 EALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLS  157 (287)
T ss_dssp             SSEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTC
T ss_pred             CCcEEEEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccce
Confidence            4579999999999999999653 33477899999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhC
Q 046639          185 KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMAL  263 (331)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~  263 (331)
                      .......     ..........+|+.|+|||++.+..++.++||||||+++|+|++ |..||.....  ......+....
T Consensus       158 ~~~~~~~-----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~~~~~i~~~~  230 (287)
T 1u59_A          158 KALGADD-----SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEVMAFIEQGK  230 (287)
T ss_dssp             EECTTCS-----CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--HHHHHHHHTTC
T ss_pred             eeeccCc-----ceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHhcCC
Confidence            8752211     11111223346788999999988889999999999999999998 9999976422  11111111110


Q ss_pred             cchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhhhc
Q 046639          264 PDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETFLG  328 (331)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~~~  328 (331)
                              .+           .....++..+.+++.+||+.||.+|||+.++++.|+.+..+..+
T Consensus       231 --------~~-----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~  276 (287)
T 1u59_A          231 --------RM-----------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS  276 (287)
T ss_dssp             --------CC-----------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred             --------cC-----------CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence                    00           11124567899999999999999999999999999999887654

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=4.3e-44  Score=321.78  Aligned_cols=271  Identities=18%  Similarity=0.185  Sum_probs=198.0

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc--chhhHHHHHHHHHHHHcCCCCCcceeeceeeccc-CCCcc
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRNIRHRNLIKIITICSSID-FEGFD  105 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~~~  105 (331)
                      .++|.+.+.||+|+||+||+|.+..+++.||+|++...  .......+.+|+.+++.++||||+++++++.... .....
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            46899999999999999999999999999999998643  3444567889999999999999999999975432 23344


Q ss_pred             eeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccc
Q 046639          106 FKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAK  185 (331)
Q Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~  185 (331)
                      ..++|||+++ ++|.+.+..    .++...+..++.|++.||.|||++   +|+|+||||+||+++.++.+||+|||++.
T Consensus       104 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~  175 (371)
T 2xrw_A          104 DVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR  175 (371)
T ss_dssp             EEEEEEECCS-EEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred             ceEEEEEcCC-CCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeeccc
Confidence            7899999995 689888853    367788899999999999999999   99999999999999999999999999997


Q ss_pred             ccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCc-
Q 046639          186 FLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALP-  264 (331)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-  264 (331)
                      ...         .........||+.|+|||++.+..++.++||||||+++|+|++|..||.+.... ..+......... 
T Consensus       176 ~~~---------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~~~~  245 (371)
T 2xrw_A          176 TAG---------TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI-DQWNKVIEQLGTP  245 (371)
T ss_dssp             -----------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHC-CCCC
T ss_pred             ccc---------cccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCC
Confidence            641         111223456899999999999999999999999999999999999999764211 111111111000 


Q ss_pred             -chhhhhcC----------ccc---------ccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          265 -DKVMEIVD----------PSL---------LLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       265 -~~~~~~~~----------~~~---------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                       ........          +..         .....+............+.+|+.+||+.||.+|||+.++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          246 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             CHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence             00000000          000         000011112233455788999999999999999999999986

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=4.8e-45  Score=319.27  Aligned_cols=252  Identities=19%  Similarity=0.252  Sum_probs=201.3

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCccee
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      ..++|.+.+.||+|+||+||+|.+..+++.||+|++..........+.+|+.+++.++||||+++++++     ......
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~   81 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY-----ESTTHY   81 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEE-----ECSSEE
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhc-----ccCCEE
Confidence            456899999999999999999999999999999999765544556788999999999999999999985     445678


Q ss_pred             eEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEe---cCCCcEEEcccCcc
Q 046639          108 AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILL---DQDIVAHVGDLGLA  184 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv---~~~~~~kl~Dfg~a  184 (331)
                      ++|||++++++|.+++....  .++...+..++.|++.||.+||+.   +++|+||||+||++   +.++.++|+|||++
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~  156 (304)
T 2jam_A           82 YLVMQLVSGGELFDRILERG--VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLS  156 (304)
T ss_dssp             EEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTT
T ss_pred             EEEEEcCCCccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcc
Confidence            99999999999999997644  367888999999999999999999   99999999999999   77889999999998


Q ss_pred             cccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCc
Q 046639          185 KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALP  264 (331)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  264 (331)
                      ....          ........+|+.|+|||++.+..++.++||||||+++|+|++|..||...... ............
T Consensus       157 ~~~~----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~~  225 (304)
T 2jam_A          157 KMEQ----------NGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES-KLFEKIKEGYYE  225 (304)
T ss_dssp             CCCC----------CBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHHHHHHCCCC
T ss_pred             eecC----------CCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHcCCCC
Confidence            6531          11223345899999999999999999999999999999999999999753211 111111111100


Q ss_pred             chhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          265 DKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                            ..           ......++..+.+++.+||+.||.+|||+.++++
T Consensus       226 ------~~-----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          226 ------FE-----------SPFWDDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             ------CC-----------TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             ------CC-----------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                  00           0112234567899999999999999999999985

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.5e-44  Score=318.85  Aligned_cols=276  Identities=17%  Similarity=0.186  Sum_probs=198.1

Q ss_pred             HHHHHHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCC-CCCcceeeceeeccc-
Q 046639           23 AELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIR-HRNLIKIITICSSID-  100 (331)
Q Consensus        23 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~-  100 (331)
                      ..+.....+|.+.+.||+|+||+||+|.+..+++.||+|++..........+.+|+.+++.+. ||||+++++++.... 
T Consensus        21 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~  100 (337)
T 3ll6_A           21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKE  100 (337)
T ss_dssp             CEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTT
T ss_pred             ceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccc
Confidence            344455668999999999999999999999999999999987666666778899999999996 999999999874221 


Q ss_pred             --CCCcceeeEEEeecCCCCHHHHHHh-ccCCccchHHHHHHHHHHHHHHHHHhhcCCCC--eeecCCCCCCEEecCCCc
Q 046639          101 --FEGFDFKAIVFEYMQNRNLEQWLRQ-SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPS--IVHGDLKPSNILLDQDIV  175 (331)
Q Consensus       101 --~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~--ivH~dik~~nilv~~~~~  175 (331)
                        .......+++||++ +++|.+++.. .....+++..++.++.|++.||.|||+.   +  ++|+||||+||+++.++.
T Consensus       101 ~~~~~~~~~~lv~e~~-~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~  176 (337)
T 3ll6_A          101 ESDTGQAEFLLLTELC-KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGT  176 (337)
T ss_dssp             TSTTSSEEEEEEEECC-SEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSC
T ss_pred             ccccCCceEEEEEEec-CCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCC
Confidence              24456689999999 5799999876 2334578899999999999999999999   8  999999999999999999


Q ss_pred             EEEcccCcccccccCCCCCc----ccccCCceeecccccccCCccc---CCCCCccchhhHhHHHHHHHHHhCCCCCCcc
Q 046639          176 AHVGDLGLAKFLFGYEPGTA----AETASNSIEIKGIVGYVAPEYG---MGSKASVSGDVYNFGILLLEMFTRRRPTDAM  248 (331)
Q Consensus       176 ~kl~Dfg~a~~~~~~~~~~~----~~~~~~~~~~~~t~~y~aPE~~---~~~~~~~~~DiwslG~il~el~~g~~pf~~~  248 (331)
                      +||+|||++...........    ...........+|+.|+|||++   .+..++.++||||||+++|+|++|..||...
T Consensus       177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~  256 (337)
T 3ll6_A          177 IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG  256 (337)
T ss_dssp             EEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred             EEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcch
Confidence            99999999987632211100    0001112244588999999998   5667899999999999999999999999653


Q ss_pred             cCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhh
Q 046639          249 FNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETF  326 (331)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~  326 (331)
                      ...     .........            .       ....+...+.+|+.+||+.||.+|||+.++++.|+.+....
T Consensus       257 ~~~-----~~~~~~~~~------------~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~  310 (337)
T 3ll6_A          257 AKL-----RIVNGKYSI------------P-------PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR  310 (337)
T ss_dssp             --------------CCC------------C-------TTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             hHH-----HhhcCcccC------------C-------cccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence            211     111110000            0       00112234778999999999999999999999999987754

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.4e-45  Score=325.75  Aligned_cols=270  Identities=17%  Similarity=0.235  Sum_probs=199.8

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc--chhhHHHHHHHHHHHHcCCCCCcceeeceeeccc-CCCcc
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRNIRHRNLIKIITICSSID-FEGFD  105 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~~~  105 (331)
                      .++|.+.+.||+|+||+||+|.+..+++.||+|++...  .......+.+|+.+++.++||||+++++++.... .....
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            56899999999999999999999999999999998533  3344567889999999999999999999975432 22235


Q ss_pred             eeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccc
Q 046639          106 FKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAK  185 (331)
Q Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~  185 (331)
                      ..++|||++ +++|.+++...   .++...+..++.|++.||.|||+.   ||+||||||+||+++.++.+||+|||+++
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  176 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR  176 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             eEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence            579999999 89999999763   367888999999999999999999   99999999999999999999999999998


Q ss_pred             ccccCCCCCcccccCCceeecccccccCCcccCC-CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhC-
Q 046639          186 FLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG-SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMAL-  263 (331)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~-  263 (331)
                      ....           ......+|+.|+|||++.+ ..++.++||||+||++|+|++|..||.+... ...+........ 
T Consensus       177 ~~~~-----------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~l~~i~~~~g~  244 (367)
T 1cm8_A          177 QADS-----------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH-LDQLKEIMKVTGT  244 (367)
T ss_dssp             ECCS-----------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCC
T ss_pred             cccc-----------ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCC
Confidence            6421           1223468999999999877 6789999999999999999999999975422 112222222111 


Q ss_pred             -cchhhhhcCcc--------cccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          264 -PDKVMEIVDPS--------LLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       264 -~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                       +......+...        +..............+...+.+|+.+||+.||.+|||+.++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          245 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             CCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence             11111101000        0000000111222345678999999999999999999999986

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.4e-45  Score=325.14  Aligned_cols=267  Identities=19%  Similarity=0.352  Sum_probs=210.1

Q ss_pred             HHHHHHhcCCCcCceeeccCeeEEEEeeec-----CCCceEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCcceeecee
Q 046639           23 AELSKATNNFSPANKIGQGGVSIVYKGILD-----ESRSIVAVKVVNLKQ-KEASRSFAAECNALRNIRHRNLIKIITIC   96 (331)
Q Consensus        23 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   96 (331)
                      .+.....++|.+.+.||+|+||+||+|.+.     .+++.||+|.+.... ......+.+|+.+++.++||||+++++++
T Consensus        18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   97 (322)
T 1p4o_A           18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV   97 (322)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred             hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence            344566788999999999999999999876     357889999986443 33446688999999999999999999995


Q ss_pred             ecccCCCcceeeEEEeecCCCCHHHHHHhcc--------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCE
Q 046639           97 SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSN--------GQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNI  168 (331)
Q Consensus        97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~ni  168 (331)
                           ......++|||++++++|.+++....        ...+++..++.++.|++.||.+||++   +++|+||||+||
T Consensus        98 -----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NI  169 (322)
T 1p4o_A           98 -----SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNC  169 (322)
T ss_dssp             -----CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGE
T ss_pred             -----ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceE
Confidence                 44567899999999999999997632        13457788999999999999999999   999999999999


Q ss_pred             EecCCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCc
Q 046639          169 LLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDA  247 (331)
Q Consensus       169 lv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~  247 (331)
                      +++.++.+||+|||++......      ..........+|+.|+|||++.+..++.++||||||+++|+|++ |..||..
T Consensus       170 li~~~~~~kl~Dfg~~~~~~~~------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~  243 (322)
T 1p4o_A          170 MVAEDFTVKIGDFGMTRDIYET------DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG  243 (322)
T ss_dssp             EECTTCCEEECCTTCCCGGGGG------GCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT
T ss_pred             EEcCCCeEEECcCccccccccc------cccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCcccc
Confidence            9999999999999999765211      11111223346788999999998899999999999999999999 8999975


Q ss_pred             ccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhh
Q 046639          248 MFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARE  324 (331)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~  324 (331)
                      ...  ..........   ..     .           .....++..+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus       244 ~~~--~~~~~~~~~~---~~-----~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          244 LSN--EQVLRFVMEG---GL-----L-----------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             SCH--HHHHHHHHTT---CC-----C-----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             CCH--HHHHHHHHcC---Cc-----C-----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence            321  1111111100   00     0           1112355678999999999999999999999999988754

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=8e-45  Score=332.25  Aligned_cols=200  Identities=24%  Similarity=0.289  Sum_probs=172.9

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcC------CCCCcceeeceeecccC
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNI------RHRNLIKIITICSSIDF  101 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~~  101 (331)
                      ...+|.+++.||+|+||+||+|.+..+++.||||++... ......+..|+.+++.+      +|+||+.+++++.    
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~----  169 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT----  169 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE----
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc----
Confidence            345799999999999999999999999999999999643 33445677888888776      5779999999853    


Q ss_pred             CCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCc--EEEc
Q 046639          102 EGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIV--AHVG  179 (331)
Q Consensus       102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~--~kl~  179 (331)
                       .....++|||++ +++|.+++.......+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.  +||+
T Consensus       170 -~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~  244 (429)
T 3kvw_A          170 -FRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVI  244 (429)
T ss_dssp             -ETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEEC
T ss_pred             -cCCeEEEEEecc-CCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEe
Confidence             356789999999 57999999887666688899999999999999999999   9999999999999999887  9999


Q ss_pred             ccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcc
Q 046639          180 DLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAM  248 (331)
Q Consensus       180 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  248 (331)
                      |||++....           .......+|+.|+|||++.+..++.++|||||||++|+|++|.+||...
T Consensus       245 DFG~a~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~  302 (429)
T 3kvw_A          245 DFGSSCYEH-----------QRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE  302 (429)
T ss_dssp             CCTTCEETT-----------CCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ecccceecC-----------CcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence            999997541           1222356899999999999999999999999999999999999999764

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2.3e-45  Score=324.61  Aligned_cols=261  Identities=18%  Similarity=0.231  Sum_probs=205.9

Q ss_pred             HHHHHHHhcCCCcC-ceeeccCeeEEEEeeecCCCceEEEEEeeccc--hhhHHHHHHHHHHHHcCC-CCCcceeeceee
Q 046639           22 YAELSKATNNFSPA-NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ--KEASRSFAAECNALRNIR-HRNLIKIITICS   97 (331)
Q Consensus        22 ~~~~~~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~   97 (331)
                      +.......++|.+. +.||+|+||+||+|.+..+++.||+|++....  ......+.+|+.+++.+. ||||+++++++ 
T Consensus        20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~-   98 (327)
T 3lm5_A           20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY-   98 (327)
T ss_dssp             SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE-
T ss_pred             HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE-
Confidence            34555667778888 89999999999999999999999999986543  233567889999999995 69999999995 


Q ss_pred             cccCCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecC---CC
Q 046639           98 SIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQ---DI  174 (331)
Q Consensus        98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~---~~  174 (331)
                          ......++|||++++++|.+++.......+++..++.++.|++.||.+||+.   +++|+||||+||+++.   ++
T Consensus        99 ----~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~  171 (327)
T 3lm5_A           99 ----ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLG  171 (327)
T ss_dssp             ----ECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBC
T ss_pred             ----EeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCC
Confidence                4456789999999999999998765556688899999999999999999999   9999999999999987   78


Q ss_pred             cEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcch
Q 046639          175 VAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLT  254 (331)
Q Consensus       175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~  254 (331)
                      .+||+|||++.....         ........||+.|+|||++.+..++.++||||||+++|+|++|..||....... .
T Consensus       172 ~~kL~Dfg~a~~~~~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~  241 (327)
T 3lm5_A          172 DIKIVDFGMSRKIGH---------ACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE-T  241 (327)
T ss_dssp             CEEECCGGGCEEC------------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-H
T ss_pred             cEEEeeCccccccCC---------ccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-H
Confidence            999999999987521         112234568999999999999999999999999999999999999997532111 1


Q ss_pred             HHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          255 LHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ...........      .           ......+...+.+++.+||+.||.+|||+.++++
T Consensus       242 ~~~i~~~~~~~------~-----------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          242 YLNISQVNVDY------S-----------EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             HHHHHHTCCCC------C-----------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             HHHHHhccccc------C-----------chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence            11111111000      0           0111235567889999999999999999999974

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=6e-45  Score=324.28  Aligned_cols=246  Identities=22%  Similarity=0.280  Sum_probs=197.6

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc---chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK---QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      ++|.+.+.||+|+||+||+|++..+++.||+|++...   .......+.+|+.+++.++||||+++++++.     ..+.
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~  128 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL-----REHT  128 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----ECCe
Confidence            4599999999999999999999989999999999643   2334467889999999999999999999964     3467


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      .++|||++. |+|.+++.... ..+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++..
T Consensus       129 ~~lv~e~~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~  203 (348)
T 1u5q_A          129 AWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASI  203 (348)
T ss_dssp             EEEEEECCS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBS
T ss_pred             EEEEEecCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCcee
Confidence            899999995 78988886533 3477888999999999999999999   999999999999999999999999999976


Q ss_pred             cccCCCCCcccccCCceeecccccccCCcccC---CCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhC
Q 046639          187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGM---GSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMAL  263 (331)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  263 (331)
                      ..            ......||+.|+|||++.   +..++.++||||||+++|+|++|..||....... ......... 
T Consensus       204 ~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-~~~~~~~~~-  269 (348)
T 1u5q_A          204 MA------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNE-  269 (348)
T ss_dssp             SS------------SBCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSC-
T ss_pred             cC------------CCCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhcC-
Confidence            41            112346899999999974   5678999999999999999999999996532111 111111111 


Q ss_pred             cchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          264 PDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                              .+...          ...++..+.+|+.+||+.||.+|||+.++++
T Consensus       270 --------~~~~~----------~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~  305 (348)
T 1u5q_A          270 --------SPALQ----------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  305 (348)
T ss_dssp             --------CCCCC----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             --------CCCCC----------CCCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence                    11110          0123457889999999999999999999875

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.2e-44  Score=337.62  Aligned_cols=250  Identities=21%  Similarity=0.285  Sum_probs=201.7

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcc
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFD  105 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~  105 (331)
                      .++|.+.+.||+|+||+||+|++..+++.||+|++....   ......+..|+.+++.++||||+++++++     ....
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-----~~~~  258 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF-----ETKT  258 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEE-----eeCC
Confidence            367999999999999999999999999999999996442   22346688999999999999999999984     4457


Q ss_pred             eeeEEEeecCCCCHHHHHHhcc--CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCc
Q 046639          106 FKAIVFEYMQNRNLEQWLRQSN--GQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGL  183 (331)
Q Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~  183 (331)
                      .+++||||+++++|.+++....  ...+++..+..++.|++.||.|||++   +|+||||||+||+++.+|.+||+|||+
T Consensus       259 ~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGl  335 (543)
T 3c4z_A          259 DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGL  335 (543)
T ss_dssp             EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecce
Confidence            7899999999999999997643  44578889999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhC
Q 046639          184 AKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMAL  263 (331)
Q Consensus       184 a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  263 (331)
                      +..+...        ........||+.|+|||++.+..++.++|||||||++|||++|..||....... ..........
T Consensus       336 a~~~~~~--------~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~-~~~~~~~~i~  406 (543)
T 3c4z_A          336 AVELKAG--------QTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELKQRVL  406 (543)
T ss_dssp             CEECCTT--------CCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC-CHHHHHHHHH
T ss_pred             eeeccCC--------CcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch-hHHHHHHHHh
Confidence            9875211        111233579999999999999999999999999999999999999997642211 1111111110


Q ss_pred             cchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcH
Q 046639          264 PDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEM  312 (331)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~  312 (331)
                      ..                 ...++..++..+.+|+.+||+.||.+||++
T Consensus       407 ~~-----------------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~  438 (543)
T 3c4z_A          407 EQ-----------------AVTYPDKFSPASKDFCEALLQKDPEKRLGF  438 (543)
T ss_dssp             HC-----------------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred             hc-----------------ccCCCcccCHHHHHHHHHhccCCHhHCCCC
Confidence            00                 001122345678899999999999999965

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=4.4e-45  Score=323.06  Aligned_cols=275  Identities=19%  Similarity=0.241  Sum_probs=195.3

Q ss_pred             HHHHHHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccch--hhHHHHHHHHHHHHcCCCCCcceeeceeeccc
Q 046639           23 AELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK--EASRSFAAECNALRNIRHRNLIKIITICSSID  100 (331)
Q Consensus        23 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  100 (331)
                      .......++|.+.+.||+|+||+||+|++..+++.||+|++.....  .....+.+|+.+++.++||||+++++++    
T Consensus        27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~----  102 (329)
T 3gbz_A           27 APSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVI----  102 (329)
T ss_dssp             -----CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEE----
T ss_pred             CCcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEE----
Confidence            3445566789999999999999999999999999999999965432  2245677999999999999999999995    


Q ss_pred             CCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEec-----CCCc
Q 046639          101 FEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLD-----QDIV  175 (331)
Q Consensus       101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~-----~~~~  175 (331)
                       ......++|||+++ ++|.+++....  .+++..+..++.|++.||.|||++   +|+|+||||+||+++     .++.
T Consensus       103 -~~~~~~~lv~e~~~-~~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~  175 (329)
T 3gbz_A          103 -HHNHRLHLIFEYAE-NDLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPV  175 (329)
T ss_dssp             -EETTEEEEEEECCS-EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCE
T ss_pred             -ecCCEEEEEEecCC-CCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccce
Confidence             44567899999995 69999997654  377889999999999999999999   999999999999994     4556


Q ss_pred             EEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCC-CCccchhhHhHHHHHHHHHhCCCCCCcccCCcch
Q 046639          176 AHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGS-KASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLT  254 (331)
Q Consensus       176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~  254 (331)
                      +||+|||++.....        .........+|+.|+|||++.+. .++.++||||||+++|+|++|..||....... .
T Consensus       176 ~kl~Dfg~a~~~~~--------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~  246 (329)
T 3gbz_A          176 LKIGDFGLARAFGI--------PIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID-Q  246 (329)
T ss_dssp             EEECCTTHHHHHC-------------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-H
T ss_pred             EEECcCCCccccCC--------cccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH-H
Confidence            99999999987521        11222334578999999998875 48999999999999999999999997642221 2


Q ss_pred             HHHHHHhhCcchhhhhc----CcccccccccCCc-----chHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          255 LHEFVKMALPDKVMEIV----DPSLLLEVTANNY-----SWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       255 ~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~-----~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      .................    .+...........     .....+...+.+|+.+||+.||.+|||+.++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          247 LFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             HHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            22222111100000000    0000000000000     011124567899999999999999999999975

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=7.1e-45  Score=316.69  Aligned_cols=250  Identities=18%  Similarity=0.279  Sum_probs=204.1

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc---chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCc
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK---QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGF  104 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  104 (331)
                      ..++|.+.+.||+|+||+||+|.+..+++.+|+|++...   .....+.+.+|+.+++.++||||+++++++     ...
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~   87 (294)
T 2rku_A           13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF-----EDN   87 (294)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECS
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeee-----ccC
Confidence            456899999999999999999999999999999998644   234556788999999999999999999995     445


Q ss_pred             ceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcc
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA  184 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a  184 (331)
                      +..++|||++++++|.+++....  .+++..+..++.|++.||.+||++   +++|+||||+||+++.++.++|+|||++
T Consensus        88 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~  162 (294)
T 2rku_A           88 DFVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLA  162 (294)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             CEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCc
Confidence            67899999999999999987643  467889999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCc
Q 046639          185 KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALP  264 (331)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  264 (331)
                      ......        ........+|+.|+|||++.+..++.++||||||+++|+|++|..||......     ........
T Consensus       163 ~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~  229 (294)
T 2rku_A          163 TKVEYD--------GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK-----ETYLRIKK  229 (294)
T ss_dssp             EECCST--------TCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHHHHT
T ss_pred             eecccC--------ccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHhh
Confidence            865211        11223356889999999999988999999999999999999999999753211     11110000


Q ss_pred             chhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          265 DKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      .      ..           .....+...+.+++.+||+.||++|||+.++++
T Consensus       230 ~------~~-----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  265 (294)
T 2rku_A          230 N------EY-----------SIPKHINPVAASLIQKMLQTDPTARPTINELLN  265 (294)
T ss_dssp             T------CC-----------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             c------cC-----------CCccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence            0      00           111223457889999999999999999999986

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.3e-44  Score=313.29  Aligned_cols=258  Identities=19%  Similarity=0.249  Sum_probs=203.5

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccch------hhHHHHHHHHHHHHcCCCCCcceeeceeecccCC
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK------EASRSFAAECNALRNIRHRNLIKIITICSSIDFE  102 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  102 (331)
                      .++|.+.+.||+|+||+||+|.+..+++.||+|++.....      ...+.+.+|+.+++.++||||+++++++     .
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~   78 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIF-----E   78 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----E
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhhee-----c
Confidence            3579999999999999999999999999999999865422      1356789999999999999999999995     3


Q ss_pred             CcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCC----cEEE
Q 046639          103 GFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDI----VAHV  178 (331)
Q Consensus       103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~----~~kl  178 (331)
                      .....++|||++++++|.+++....  .+++..+..++.|++.||.+||+.   +++|+||||+||+++.++    .++|
T Consensus        79 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl  153 (283)
T 3bhy_A           79 NKTDVVLILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKL  153 (283)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEE
T ss_pred             CCCeEEEEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEE
Confidence            4567899999999999999997643  477889999999999999999999   999999999999998877    8999


Q ss_pred             cccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHH
Q 046639          179 GDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEF  258 (331)
Q Consensus       179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  258 (331)
                      +|||++.....         ........+++.|+|||++.+..++.++||||||+++|+|++|..||......  .....
T Consensus       154 ~dfg~~~~~~~---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~  222 (283)
T 3bhy_A          154 IDFGIAHKIEA---------GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ--ETLTN  222 (283)
T ss_dssp             CCCTTCEECC-----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHH
T ss_pred             EecccceeccC---------CCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH--HHHHH
Confidence            99999986521         11223345889999999999999999999999999999999999999753211  11111


Q ss_pred             HHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH--HHHHhh
Q 046639          259 VKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA--KLRHAR  323 (331)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~--~L~~~~  323 (331)
                      .....         ....       ......++..+.+++.+||+.||.+|||+.++++  +++.+.
T Consensus       223 ~~~~~---------~~~~-------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  273 (283)
T 3bhy_A          223 ISAVN---------YDFD-------EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR  273 (283)
T ss_dssp             HHTTC---------CCCC-------HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred             hHhcc---------cCCc-------chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence            11000         0000       0112234567899999999999999999999987  454443

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=6.2e-45  Score=314.57  Aligned_cols=257  Identities=19%  Similarity=0.234  Sum_probs=204.8

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc--chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      .++|.+.+.||+|+||+||+|.+..+++.||+|.+...  .....+.+.+|+.+++.++||||+++++++..   .....
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~~   81 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID---RTNTT   81 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE---GGGTE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEec---CCCce
Confidence            46899999999999999999999999999999999754  34455678999999999999999999998642   23467


Q ss_pred             eeEEEeecCCCCHHHHHHhcc--CCccchHHHHHHHHHHHHHHHHHhhcCCCC-----eeecCCCCCCEEecCCCcEEEc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSN--GQLRFLTQRVNIAIDVSFAIEYFHHHCQPS-----IVHGDLKPSNILLDQDIVAHVG  179 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~-----ivH~dik~~nilv~~~~~~kl~  179 (331)
                      .++|||++++++|.+++....  ...+++..++.++.|++.||.+||+.   +     ++|+||||+||+++.++.+||+
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~  158 (279)
T 2w5a_A           82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLG  158 (279)
T ss_dssp             EEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEEC
T ss_pred             EEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEe
Confidence            899999999999999997632  34477889999999999999999999   8     9999999999999999999999


Q ss_pred             ccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHH
Q 046639          180 DLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFV  259 (331)
Q Consensus       180 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~  259 (331)
                      |||++.....        .........+++.|+|||++.+..++.++||||||+++|+|++|..||.....  ......+
T Consensus       159 dfg~~~~~~~--------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~i  228 (279)
T 2w5a_A          159 DFGLARILNH--------DTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--KELAGKI  228 (279)
T ss_dssp             CCCHHHHC-----------CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHH
T ss_pred             cCchheeecc--------ccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH--HHHHHHH
Confidence            9999986521        11112234588999999999998999999999999999999999999975421  1111111


Q ss_pred             HhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHH
Q 046639          260 KMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLR  320 (331)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~  320 (331)
                      ....        .+           .....++..+.+++.+||+.||.+|||+.+|++.+.
T Consensus       229 ~~~~--------~~-----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~  270 (279)
T 2w5a_A          229 REGK--------FR-----------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL  270 (279)
T ss_dssp             HHTC--------CC-----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred             hhcc--------cc-----------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence            1110        00           011234567899999999999999999999987543

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=7.6e-45  Score=314.93  Aligned_cols=247  Identities=18%  Similarity=0.260  Sum_probs=202.0

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcc
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFD  105 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~  105 (331)
                      .++|.+.+.||+|+||.||+|.+..+++.||+|++....   ......+.+|+.+++.++||||+++++++     ...+
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~   87 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYF-----HDRK   87 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSS
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEE-----EcCC
Confidence            457999999999999999999999999999999986432   22346788999999999999999999995     3456


Q ss_pred             eeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccc
Q 046639          106 FKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAK  185 (331)
Q Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~  185 (331)
                      ..++|||++++++|.+++....  .++...+..++.|++.||.+||+.   +++|+||||+||+++.++.++|+|||++.
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~  162 (284)
T 2vgo_A           88 RIYLMLEFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSV  162 (284)
T ss_dssp             EEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccc
Confidence            7899999999999999997654  367889999999999999999999   99999999999999999999999999987


Q ss_pred             ccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcc
Q 046639          186 FLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPD  265 (331)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  265 (331)
                      ....          .......+++.|+|||++.+..++.++||||||+++|+|++|..||......  ........    
T Consensus       163 ~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~----  226 (284)
T 2vgo_A          163 HAPS----------LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT--ETHRRIVN----  226 (284)
T ss_dssp             ECSS----------SCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHT----
T ss_pred             cCcc----------cccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh--HHHHHHhc----
Confidence            5421          1123356889999999999999999999999999999999999999753211  11110000    


Q ss_pred             hhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          266 KVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                           .+.           .++..++..+.+++.+||+.||.+|||+.++++
T Consensus       227 -----~~~-----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          227 -----VDL-----------KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             -----TCC-----------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -----ccc-----------CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence                 000           111224567889999999999999999999986

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.7e-44  Score=335.60  Aligned_cols=252  Identities=22%  Similarity=0.223  Sum_probs=201.0

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcc
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ--KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFD  105 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~  105 (331)
                      ..++|.+.+.||+|+||+||+|.+..+++.||+|++....  ......+.+|+.+++.++||||+++++++     ....
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~   94 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL-----EDSS   94 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEE-----EcCC
Confidence            4567999999999999999999999999999999986432  23346788999999999999999999995     4457


Q ss_pred             eeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEec---CCCcEEEcccC
Q 046639          106 FKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLD---QDIVAHVGDLG  182 (331)
Q Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~---~~~~~kl~Dfg  182 (331)
                      ..++|||++.+++|.+.+....  .+++..+..++.|++.||.|||++   +|+||||||+||+++   .++.+||+|||
T Consensus        95 ~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg  169 (486)
T 3mwu_A           95 SFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFG  169 (486)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCS
T ss_pred             EEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECC
Confidence            7899999999999999987653  477889999999999999999999   999999999999995   45679999999


Q ss_pred             cccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhh
Q 046639          183 LAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMA  262 (331)
Q Consensus       183 ~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  262 (331)
                      ++.....         ........||+.|+|||++.+ .++.++||||||+++|+|++|..||..... ...........
T Consensus       170 ~a~~~~~---------~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~  238 (486)
T 3mwu_A          170 LSTCFQQ---------NTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE-YDILKRVETGK  238 (486)
T ss_dssp             CTTTBCC---------C----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHTC
T ss_pred             cCeECCC---------CCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCC
Confidence            9976521         122234568999999999876 589999999999999999999999975321 11111111111


Q ss_pred             CcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          263 LPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ....                 ......++..+.+|+.+||+.||.+|||+.++++
T Consensus       239 ~~~~-----------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~  276 (486)
T 3mwu_A          239 YAFD-----------------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (486)
T ss_dssp             CCSC-----------------SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CCCC-----------------CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            1100                 0111235567899999999999999999999986

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.6e-45  Score=325.26  Aligned_cols=269  Identities=20%  Similarity=0.270  Sum_probs=195.2

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhh-HHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEA-SRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      ++|.+++.||+|+||+||+|.+..+++.||+|++....... ...+.+|+.+++.++||||+++++++     ...+..+
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~   76 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII-----HTEKSLT   76 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEE-----ECSSCEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEE-----eeCCEEE
Confidence            57999999999999999999999999999999986543222 12355799999999999999999995     4456789


Q ss_pred             EEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccc
Q 046639          109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLF  188 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~  188 (331)
                      +|||+++ ++|.+++.... ..+++..+..++.|++.||.|||+.   +|+|+||||+||+++.++.+||+|||++....
T Consensus        77 lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  151 (324)
T 3mtl_A           77 LVFEYLD-KDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKS  151 (324)
T ss_dssp             EEEECCS-EEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC-
T ss_pred             EEecccc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCccccccc
Confidence            9999995 69999987643 3577888999999999999999999   99999999999999999999999999997542


Q ss_pred             cCCCCCcccccCCceeecccccccCCcccCC-CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcc--
Q 046639          189 GYEPGTAAETASNSIEIKGIVGYVAPEYGMG-SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPD--  265 (331)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--  265 (331)
                      .        .........+|+.|+|||++.+ ..++.++||||||+++|+|++|..||...... .............  
T Consensus       152 ~--------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~~~  222 (324)
T 3mtl_A          152 I--------PTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE-EQLHFIFRILGTPTE  222 (324)
T ss_dssp             -------------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCT
T ss_pred             C--------CccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCh
Confidence            1        1122233457899999999877 56899999999999999999999999764221 1122222111110  


Q ss_pred             -hhhhhcCcccccc------cccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          266 -KVMEIVDPSLLLE------VTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       266 -~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                       .+...........      ...........+...+.+|+.+||+.||.+|||+.|+++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          223 ETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             TTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             HhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence             0000000000000      000000111234567889999999999999999999986

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.6e-44  Score=314.47  Aligned_cols=252  Identities=21%  Similarity=0.286  Sum_probs=197.3

Q ss_pred             CCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeEE
Q 046639           31 NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIV  110 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv  110 (331)
                      +|.....||+|+||+||+|.+..+++.||+|.+........+.+.+|+.+++.++||||+++++++.     ..+..++|
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv   97 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS-----ENGFIKIF   97 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEEEEE
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEE-----eCCcEEEE
Confidence            4455559999999999999999999999999998766666678999999999999999999999953     34678999


Q ss_pred             EeecCCCCHHHHHHhcc-CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecC-CCcEEEcccCcccccc
Q 046639          111 FEYMQNRNLEQWLRQSN-GQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQ-DIVAHVGDLGLAKFLF  188 (331)
Q Consensus       111 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~-~~~~kl~Dfg~a~~~~  188 (331)
                      ||++++++|.+++.... ....+...+..++.|++.||.+||+.   +++|+||||+||+++. ++.++|+|||++....
T Consensus        98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~  174 (295)
T 2clq_A           98 MEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA  174 (295)
T ss_dssp             EECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESC
T ss_pred             EEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccC
Confidence            99999999999998753 23455778888999999999999999   9999999999999987 8999999999998652


Q ss_pred             cCCCCCcccccCCceeecccccccCCcccCCCC--CccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcch
Q 046639          189 GYEPGTAAETASNSIEIKGIVGYVAPEYGMGSK--ASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDK  266 (331)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  266 (331)
                      ..        ........+++.|+|||++.+..  ++.++||||||+++|+|++|..||.................    
T Consensus       175 ~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~----  242 (295)
T 2clq_A          175 GI--------NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFK----  242 (295)
T ss_dssp             C-------------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHC----
T ss_pred             CC--------CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccc----
Confidence            11        11123345889999999987654  78999999999999999999999975422211111110000    


Q ss_pred             hhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          267 VMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                          ..+           .....++..+.+++.+||+.||++|||+.++++
T Consensus       243 ----~~~-----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          243 ----VHP-----------EIPESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             ----CCC-----------CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             ----ccc-----------cccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                011           111234567889999999999999999999974

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.3e-44  Score=312.09  Aligned_cols=249  Identities=22%  Similarity=0.298  Sum_probs=194.8

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCc
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGF  104 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  104 (331)
                      ..++|.+.+.||+|+||.||+|.+..+++.||+|++....   ......+.+|+.+++.++||||+++++++     ...
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~   83 (276)
T 2h6d_A            9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVI-----STP   83 (276)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECS
T ss_pred             eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEE-----ecC
Confidence            3468999999999999999999999899999999986442   22346788999999999999999999985     445


Q ss_pred             ceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcc
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA  184 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a  184 (331)
                      +..++|||++++++|.+++....  .++...+..++.|++.||.+||++   +++|+||+|+||+++.++.++|+|||++
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~  158 (276)
T 2h6d_A           84 TDFFMVMEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLS  158 (276)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGG
T ss_pred             CeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccc
Confidence            67899999999999999997653  367788999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCcccccCCceeecccccccCCcccCCCCC-ccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhC
Q 046639          185 KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKA-SVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMAL  263 (331)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  263 (331)
                      .....         ........+++.|+|||++.+..+ +.++||||||+++|+|++|..||.....  ...........
T Consensus       159 ~~~~~---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~  227 (276)
T 2h6d_A          159 NMMSD---------GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV--PTLFKKIRGGV  227 (276)
T ss_dssp             GCCCC----------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCC
T ss_pred             cccCC---------CcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH--HHHHHHhhcCc
Confidence            76521         112233458889999999988765 6899999999999999999999965321  11111111110


Q ss_pred             cchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          264 PDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      .                    ..+..+...+.+++.+||+.||.+|||+.++++
T Consensus       228 ~--------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          228 F--------------------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             C--------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             c--------------------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence            0                    011123457889999999999999999999986

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=5.7e-45  Score=323.14  Aligned_cols=250  Identities=18%  Similarity=0.282  Sum_probs=204.3

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc---chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCc
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK---QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGF  104 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  104 (331)
                      ..++|.+.+.||+|+||.||+|.+..+++.+|+|++...   .....+.+.+|+.+++.++||||+++++++     ...
T Consensus        39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~  113 (335)
T 2owb_A           39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF-----EDN  113 (335)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECS
T ss_pred             cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----ecC
Confidence            456899999999999999999999999999999998644   334557788999999999999999999995     445


Q ss_pred             ceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcc
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA  184 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a  184 (331)
                      +..++|||++++++|.+++....  .+++..++.++.|++.||.|||++   +++|+||||+||+++.++.++|+|||++
T Consensus       114 ~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~  188 (335)
T 2owb_A          114 DFVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLA  188 (335)
T ss_dssp             SEEEEEECCCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred             CeEEEEEecCCCCCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCc
Confidence            67899999999999999987643  477889999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCc
Q 046639          185 KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALP  264 (331)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  264 (331)
                      ......        ........+|+.|+|||++.+..++.++||||||+++|+|++|..||....... .........  
T Consensus       189 ~~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~--  257 (335)
T 2owb_A          189 TKVEYD--------GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-TYLRIKKNE--  257 (335)
T ss_dssp             EECCST--------TCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHTC--
T ss_pred             eecccC--------cccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH-HHHHHhcCC--
Confidence            865211        112234568899999999999899999999999999999999999997532111 111111100  


Q ss_pred             chhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          265 DKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                              .           .....+...+.+|+.+||+.||++|||+.++++
T Consensus       258 --------~-----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          258 --------Y-----------SIPKHINPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             --------C-----------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             --------C-----------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                    0           111223457889999999999999999999985

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=9e-45  Score=320.83  Aligned_cols=263  Identities=22%  Similarity=0.318  Sum_probs=202.3

Q ss_pred             hcCCCcCceeeccCeeEEEEee-----ecCCCceEEEEEeecc-chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCC
Q 046639           29 TNNFSPANKIGQGGVSIVYKGI-----LDESRSIVAVKVVNLK-QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFE  102 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  102 (331)
                      .++|.+.+.||+|+||+||+|.     +..+++.||+|.+... .......+.+|+.+++.++||||+++++++     .
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~  103 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVS-----L  103 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----C
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEE-----c
Confidence            3579999999999999999999     4457789999998643 334456788999999999999999999995     4


Q ss_pred             CcceeeEEEeecCCCCHHHHHHhccC-----CccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecC---CC
Q 046639          103 GFDFKAIVFEYMQNRNLEQWLRQSNG-----QLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQ---DI  174 (331)
Q Consensus       103 ~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~---~~  174 (331)
                      .....++|||++++++|.+++.....     ..+++..++.++.|++.||.+||+.   +++|+||||+||+++.   +.
T Consensus       104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~  180 (327)
T 2yfx_A          104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGR  180 (327)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTC
T ss_pred             CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcc
Confidence            45667999999999999999987532     3477788999999999999999999   9999999999999984   44


Q ss_pred             cEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcc
Q 046639          175 VAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGL  253 (331)
Q Consensus       175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~  253 (331)
                      .++|+|||++.......      .........+++.|+|||++.+..++.++||||||+++|+|++ |..||.....  .
T Consensus       181 ~~kl~Dfg~~~~~~~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~  252 (327)
T 2yfx_A          181 VAKIGDFGMARDIYRAS------YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--Q  252 (327)
T ss_dssp             CEEECCCHHHHHHHC------------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--H
T ss_pred             eEEECcccccccccccc------ccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH--H
Confidence            69999999997652211      1112223457888999999988899999999999999999998 9999975321  1


Q ss_pred             hHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhh
Q 046639          254 TLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETF  326 (331)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~  326 (331)
                      ...........        .           .....++..+.+++.+||+.||.+|||+.+|++.|+.+....
T Consensus       253 ~~~~~~~~~~~--------~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~  306 (327)
T 2yfx_A          253 EVLEFVTSGGR--------M-----------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  306 (327)
T ss_dssp             HHHHHHHTTCC--------C-----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             HHHHHHhcCCC--------C-----------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence            11111111100        0           011234567889999999999999999999999999887643

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.7e-45  Score=324.69  Aligned_cols=253  Identities=26%  Similarity=0.371  Sum_probs=193.5

Q ss_pred             HHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc--chhhHHHHHHHHHHHHcCCC--CCcceeeceeecccCC
Q 046639           27 KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRNIRH--RNLIKIITICSSIDFE  102 (331)
Q Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~  102 (331)
                      ...++|.+.+.||+|+||+||+|.+. +++.||+|++...  .......+.+|+.+++.+.|  +||+++++++     .
T Consensus         6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~-----~   79 (343)
T 3dbq_A            6 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE-----I   79 (343)
T ss_dssp             SSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----E
T ss_pred             eecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeE-----e
Confidence            34678999999999999999999885 6889999998644  33445678999999999986  9999999995     3


Q ss_pred             CcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccC
Q 046639          103 GFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLG  182 (331)
Q Consensus       103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg  182 (331)
                      .....++|||+ .+++|.+++....  .+++..+..++.|++.||.|||+.   +|+||||||+||+++ ++.+||+|||
T Consensus        80 ~~~~~~lv~e~-~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG  152 (343)
T 3dbq_A           80 TDQYIYMVMEC-GNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFG  152 (343)
T ss_dssp             CSSEEEEEECC-CSEEHHHHHHHSC--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCS
T ss_pred             eCCEEEEEEeC-CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecc
Confidence            45678999995 4889999997643  467888999999999999999999   999999999999997 6789999999


Q ss_pred             cccccccCCCCCcccccCCceeecccccccCCcccCC-----------CCCccchhhHhHHHHHHHHHhCCCCCCcccCC
Q 046639          183 LAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG-----------SKASVSGDVYNFGILLLEMFTRRRPTDAMFNE  251 (331)
Q Consensus       183 ~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~  251 (331)
                      ++......      ..........||+.|+|||++.+           ..++.++||||||+++|+|++|..||......
T Consensus       153 ~a~~~~~~------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~  226 (343)
T 3dbq_A          153 IANQMQPD------TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ  226 (343)
T ss_dssp             SSCCC------------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH
T ss_pred             cccccCcc------cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH
Confidence            99865211      11112234568999999999754           67899999999999999999999999754222


Q ss_pred             cchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          252 GLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      .......            .++.....       +...+...+.+|+.+||+.||.+|||+.++++
T Consensus       227 ~~~~~~~------------~~~~~~~~-------~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~  273 (343)
T 3dbq_A          227 ISKLHAI------------IDPNHEIE-------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  273 (343)
T ss_dssp             HHHHHHH------------HCTTSCCC-------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHH------------hcCCcccC-------CcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence            1111111            11111111       11123456889999999999999999999975

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.3e-44  Score=326.49  Aligned_cols=275  Identities=20%  Similarity=0.241  Sum_probs=199.8

Q ss_pred             HHHHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccC---
Q 046639           25 LSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDF---  101 (331)
Q Consensus        25 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---  101 (331)
                      +....++|.+.+.||+|+||+||+|.+..+++.||+|++......    ..+|+.+++.++||||+++++++.....   
T Consensus         2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~   77 (383)
T 3eb0_A            2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEP   77 (383)
T ss_dssp             ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred             CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence            345677999999999999999999999999999999998644222    2379999999999999999999754321   


Q ss_pred             ------------------------------CCcceeeEEEeecCCCCHHHHHHh--ccCCccchHHHHHHHHHHHHHHHH
Q 046639          102 ------------------------------EGFDFKAIVFEYMQNRNLEQWLRQ--SNGQLRFLTQRVNIAIDVSFAIEY  149 (331)
Q Consensus       102 ------------------------------~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~i~~~l~~  149 (331)
                                                    ......++|||+++ ++|.+.+..  ..+..+++..+..++.|++.||.|
T Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~  156 (383)
T 3eb0_A           78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF  156 (383)
T ss_dssp             --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence                                          33455889999995 688888765  344567889999999999999999


Q ss_pred             HhhcCCCCeeecCCCCCCEEec-CCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCC-Cccchh
Q 046639          150 FHHHCQPSIVHGDLKPSNILLD-QDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSK-ASVSGD  227 (331)
Q Consensus       150 LH~~~~~~ivH~dik~~nilv~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~D  227 (331)
                      ||+.   ||+||||||+||+++ .++.+||+|||+++....         ........+|+.|+|||++.+.. ++.++|
T Consensus       157 LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~---------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~D  224 (383)
T 3eb0_A          157 IHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIP---------SEPSVAYICSRFYRAPELMLGATEYTPSID  224 (383)
T ss_dssp             HHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCT---------TSCCCCCCCCSSCCCHHHHTTCSSCCTHHH
T ss_pred             HHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCC---------CCCCcCcccCCCccCHHHhcCCCCCCcchh
Confidence            9999   999999999999997 688999999999986521         12223456788999999988754 899999


Q ss_pred             hHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchh--hhhcCcccc----cccccCCc--chHHHHHHHHHHhhc
Q 046639          228 VYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKV--MEIVDPSLL----LEVTANNY--SWIEDCLVAVIGTGV  299 (331)
Q Consensus       228 iwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~----~~~~~~~~--~~~~~~~~~l~~l~~  299 (331)
                      |||+||++|+|++|..||...... ..+............  ....++...    .......+  .+...++..+.+|+.
T Consensus       225 iwslG~il~ell~g~~pf~~~~~~-~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  303 (383)
T 3eb0_A          225 LWSIGCVFGELILGKPLFSGETSI-DQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLE  303 (383)
T ss_dssp             HHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHH
T ss_pred             hhhHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHH
Confidence            999999999999999999764221 222222221111100  000000000    00000000  112235667999999


Q ss_pred             cccCCCCCCCCcHHHHHH
Q 046639          300 TCSMESPMERMEMRDVVA  317 (331)
Q Consensus       300 ~cl~~~P~~Rps~~~i~~  317 (331)
                      +||+.||.+|||+.|+++
T Consensus       304 ~~L~~dP~~R~t~~e~l~  321 (383)
T 3eb0_A          304 QILRYEPDLRINPYEAMA  321 (383)
T ss_dssp             HHCCSSGGGSCCHHHHHT
T ss_pred             HHccCChhhCCCHHHHhc
Confidence            999999999999999984

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2.1e-44  Score=315.28  Aligned_cols=255  Identities=21%  Similarity=0.303  Sum_probs=200.9

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc----hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCC
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ----KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEG  103 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  103 (331)
                      ..++|.+.+.||+|+||.||+|.+..+++.||+|++....    ......+.+|+.+++.++||||+++++++..   ..
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~   79 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYN---EE   79 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC---C-
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEc---CC
Confidence            3578999999999999999999999999999999996442    2345678999999999999999999998632   34


Q ss_pred             cceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCc
Q 046639          104 FDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGL  183 (331)
Q Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~  183 (331)
                      ....++|||++++ +|.+++.......+++..+..++.|++.||.+||++   +++|+||||+||+++.++.++|+|||+
T Consensus        80 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~  155 (305)
T 2wtk_C           80 KQKMYMVMEYCVC-GMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGV  155 (305)
T ss_dssp             --CEEEEEECCSE-EHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             CCeEEEEehhccC-CHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccc
Confidence            5678999999965 488888876666788899999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCcccccCCceeecccccccCCcccCCCC--CccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHh
Q 046639          184 AKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSK--ASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKM  261 (331)
Q Consensus       184 a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  261 (331)
                      +.......      .........+|+.|+|||++.+..  ++.++||||||+++|+|++|..||.....  ......+..
T Consensus       156 ~~~~~~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~i~~  227 (305)
T 2wtk_C          156 AEALHPFA------ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI--YKLFENIGK  227 (305)
T ss_dssp             CEECCTTC------SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHH
T ss_pred             ccccCccc------cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH--HHHHHHHhc
Confidence            98652111      111223345889999999988754  47899999999999999999999975311  111111111


Q ss_pred             hCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          262 ALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ..                    ..+...+...+.+++.+||+.||.+|||+.++++
T Consensus       228 ~~--------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  263 (305)
T 2wtk_C          228 GS--------------------YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ  263 (305)
T ss_dssp             CC--------------------CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CC--------------------CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            00                    0111234567889999999999999999999985

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2e-44  Score=323.00  Aligned_cols=281  Identities=19%  Similarity=0.183  Sum_probs=204.9

Q ss_pred             cHHHHHHHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc-----------hhhHHHHHHHHHHHHcCCCCCc
Q 046639           21 SYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ-----------KEASRSFAAECNALRNIRHRNL   89 (331)
Q Consensus        21 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~~~~~e~~~l~~l~h~~i   89 (331)
                      ..+++....++|.+.+.||+|+||.||+|.+.. ++.||+|++....           ....+.+.+|+.+++.++||||
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   91 (362)
T 3pg1_A           13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI   91 (362)
T ss_dssp             HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             HHHHHHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence            456788889999999999999999999999864 8899999985321           2234678999999999999999


Q ss_pred             ceeeceeecccCCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEE
Q 046639           90 IKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNIL  169 (331)
Q Consensus        90 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nil  169 (331)
                      +++++++...........++|||++. ++|.+.+... ...+++..+..++.|++.||.|||+.   +++|+||||+||+
T Consensus        92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl  166 (362)
T 3pg1_A           92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNIL  166 (362)
T ss_dssp             CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEE
T ss_pred             cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEE
Confidence            99999986544455567899999995 7998888753 33577889999999999999999999   9999999999999


Q ss_pred             ecCCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCC-CCCccchhhHhHHHHHHHHHhCCCCCCcc
Q 046639          170 LDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG-SKASVSGDVYNFGILLLEMFTRRRPTDAM  248 (331)
Q Consensus       170 v~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~  248 (331)
                      ++.++.+||+|||++....         .........+|+.|+|||++.+ ..++.++||||||+++|+|++|..||...
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~---------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  237 (362)
T 3pg1_A          167 LADNNDITICDFNLAREDT---------ADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGS  237 (362)
T ss_dssp             ECTTCCEEECCTTC------------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             EcCCCCEEEEecCcccccc---------cccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCC
Confidence            9999999999999997541         1122234568889999999877 67899999999999999999999999753


Q ss_pred             cCCcchHHHHHHhhCcchh-----------hhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          249 FNEGLTLHEFVKMALPDKV-----------MEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      .. ................           ......................+.+.+.+|+.+||+.||.+|||+.++++
T Consensus       238 ~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          238 TF-YNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             SH-HHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CH-HHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence            21 1112222111111100           00111110000000011122234567899999999999999999999985

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1e-44  Score=322.01  Aligned_cols=254  Identities=22%  Similarity=0.279  Sum_probs=198.8

Q ss_pred             HHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcC-CCCCcceeeceeecccCCCcc
Q 046639           27 KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNI-RHRNLIKIITICSSIDFEGFD  105 (331)
Q Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~  105 (331)
                      ...++|.+.+.||+|+||+||+|.+..+++.||+|++......    ..+|+.++.++ +||||+++++++     .+..
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~   89 (342)
T 2qr7_A           19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVY-----DDGK   89 (342)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEE-----ECSS
T ss_pred             CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEE-----EcCC
Confidence            3456799999999999999999999999999999999754332    34678888887 799999999995     4567


Q ss_pred             eeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCC----CcEEEccc
Q 046639          106 FKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQD----IVAHVGDL  181 (331)
Q Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~----~~~kl~Df  181 (331)
                      ..++|||++++++|.+++....  .+++..+..++.|++.||.|||++   ||+||||||+||++..+    +.+||+||
T Consensus        90 ~~~lv~E~~~gg~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Df  164 (342)
T 2qr7_A           90 YVYVVTELMKGGELLDKILRQK--FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDF  164 (342)
T ss_dssp             EEEEEECCCCSCBHHHHHHTCT--TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCC
T ss_pred             EEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEEC
Confidence            8899999999999999997643  477899999999999999999999   99999999999998533    35999999


Q ss_pred             CcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHh
Q 046639          182 GLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKM  261 (331)
Q Consensus       182 g~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  261 (331)
                      |++......        ........+|+.|+|||++.+..++.++||||||+++|+|++|..||......  ........
T Consensus       165 g~a~~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~~~~  234 (342)
T 2qr7_A          165 GFAKQLRAE--------NGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD--TPEEILAR  234 (342)
T ss_dssp             TTCEECBCT--------TCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS--CHHHHHHH
T ss_pred             CCcccCcCC--------CCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC--CHHHHHHH
Confidence            999865221        11223456899999999998888999999999999999999999999754222  11121111


Q ss_pred             hCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          262 ALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ......      ...       ......++..+.+|+.+||+.||++|||+.++++
T Consensus       235 i~~~~~------~~~-------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          235 IGSGKF------SLS-------GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             HHHCCC------CCC-------STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             HccCCc------ccC-------ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            100000      000       0111234567899999999999999999999875

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-44  Score=321.59  Aligned_cols=274  Identities=20%  Similarity=0.261  Sum_probs=197.6

Q ss_pred             HHHHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchh-----hHHHHHHHHHHHHcCCCCCcceeeceeecc
Q 046639           25 LSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKE-----ASRSFAAECNALRNIRHRNLIKIITICSSI   99 (331)
Q Consensus        25 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   99 (331)
                      +....++|.+.+.||+|+||+||+|.+..+++.||+|++......     ....+.+|+.+++.++||||+++++++   
T Consensus         5 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~---   81 (346)
T 1ua2_A            5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF---   81 (346)
T ss_dssp             --------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE---
T ss_pred             hHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEE---
Confidence            345567899999999999999999999999999999998643221     124678999999999999999999995   


Q ss_pred             cCCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEc
Q 046639          100 DFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVG  179 (331)
Q Consensus       100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~  179 (331)
                        ......++|||+++ ++|.+++.... ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+
T Consensus        82 --~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~  154 (346)
T 1ua2_A           82 --GHKSNISLVFDFME-TDLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLA  154 (346)
T ss_dssp             --CCTTCCEEEEECCS-EEHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred             --eeCCceEEEEEcCC-CCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEE
Confidence              45567899999995 58998886543 3467788999999999999999999   99999999999999999999999


Q ss_pred             ccCcccccccCCCCCcccccCCceeecccccccCCcccCCC-CCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHH
Q 046639          180 DLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGS-KASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEF  258 (331)
Q Consensus       180 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  258 (331)
                      |||++......        ........+|+.|+|||++.+. .++.++||||||+++|+|++|.+||..... ...+...
T Consensus       155 Dfg~a~~~~~~--------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~-~~~~~~i  225 (346)
T 1ua2_A          155 DFGLAKSFGSP--------NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD-LDQLTRI  225 (346)
T ss_dssp             CCGGGSTTTSC--------CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHH
T ss_pred             ecccceeccCC--------cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH-HHHHHHH
Confidence            99999865211        1222344689999999998764 589999999999999999999999976422 1222222


Q ss_pred             HHhhCcchhhh------hcCcccccccccC-CcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          259 VKMALPDKVME------IVDPSLLLEVTAN-NYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       259 ~~~~~~~~~~~------~~~~~~~~~~~~~-~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ...........      ..+.......... .......++..+.+|+.+||+.||.+|||+.|+++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  291 (346)
T 1ua2_A          226 FETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  291 (346)
T ss_dssp             HHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             HHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence            22211110000      0000000000000 00111344578999999999999999999999985

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.2e-44  Score=326.36  Aligned_cols=273  Identities=22%  Similarity=0.304  Sum_probs=208.3

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCC--------CCCcceeeceeeccc
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIR--------HRNLIKIITICSSID  100 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------h~~i~~~~~~~~~~~  100 (331)
                      .++|.+.+.||+|+||+||+|++..+++.||+|++... ......+.+|+.+++.++        |+||+++++++... 
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~-  113 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS-  113 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE-
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec-
Confidence            47899999999999999999999999999999999643 444567889999999985        78899999986532 


Q ss_pred             CCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCC------
Q 046639          101 FEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDI------  174 (331)
Q Consensus       101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~------  174 (331)
                      .......++|||++ +++|.+.+.......+++..+..++.|++.||.|||++.  +|+||||||+||+++.++      
T Consensus       114 ~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~  190 (397)
T 1wak_A          114 GVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRL  190 (397)
T ss_dssp             ETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHH
T ss_pred             CCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhh
Confidence            12456789999999 778888887766566888999999999999999999853  899999999999999776      


Q ss_pred             -------------------------------------------cEEEcccCcccccccCCCCCcccccCCceeecccccc
Q 046639          175 -------------------------------------------VAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGY  211 (331)
Q Consensus       175 -------------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y  211 (331)
                                                                 .+||+|||++....           .......||+.|
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~-----------~~~~~~~gt~~y  259 (397)
T 1wak_A          191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVH-----------KHFTEDIQTRQY  259 (397)
T ss_dssp             HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETT-----------BCSCSCCSCGGG
T ss_pred             hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccc-----------ccCccCCCCCcc
Confidence                                                       79999999998652           112234689999


Q ss_pred             cCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchH-----HHHHHh--hCcchhh-------hhcC-cccc
Q 046639          212 VAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTL-----HEFVKM--ALPDKVM-------EIVD-PSLL  276 (331)
Q Consensus       212 ~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~-----~~~~~~--~~~~~~~-------~~~~-~~~~  276 (331)
                      +|||++.+..++.++|||||||++|+|++|..||..........     ......  ..+....       .... ....
T Consensus       260 ~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~  339 (397)
T 1wak_A          260 RSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDL  339 (397)
T ss_dssp             CCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSB
T ss_pred             cCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccc
Confidence            99999999999999999999999999999999997654332211     111111  1110000       0000 0000


Q ss_pred             -----------cccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          277 -----------LEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       277 -----------~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                                 .........+.......+.+|+.+||+.||++|||+.++++
T Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          340 KHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             SSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             ccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence                       00011122345677889999999999999999999999974

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=2.5e-44  Score=314.54  Aligned_cols=250  Identities=20%  Similarity=0.281  Sum_probs=203.9

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCccee
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ-KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      .++|.+.+.||+|+||+||+|.+..+++.||+|++.... ....+.+.+|+.+++.+.||||+++++++.     .....
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~   95 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KDTKL   95 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEe-----cCCeE
Confidence            457999999999999999999999999999999997543 334577899999999999999999999864     34678


Q ss_pred             eEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccc
Q 046639          108 AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      ++|||++++++|.+++..   ..++...+..++.|++.||.+||+.   +++|+||+|+||+++.++.++|+|||++...
T Consensus        96 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~  169 (303)
T 3a7i_A           96 WIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQL  169 (303)
T ss_dssp             EEEEECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceec
Confidence            999999999999999864   3477889999999999999999999   9999999999999999999999999999765


Q ss_pred             ccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchh
Q 046639          188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKV  267 (331)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  267 (331)
                      ...        ........+|+.|+|||++.+..++.++||||||+++|+|++|..||.....  ...........    
T Consensus       170 ~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~----  235 (303)
T 3a7i_A          170 TDT--------QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP--MKVLFLIPKNN----  235 (303)
T ss_dssp             BTT--------BCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHSC----
T ss_pred             Ccc--------ccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH--HHHHHHhhcCC----
Confidence            211        1122345688999999999999999999999999999999999999975321  11111111110    


Q ss_pred             hhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHH
Q 046639          268 MEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAK  318 (331)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~  318 (331)
                          .+.           ....++..+.+|+.+||+.||.+|||+.++++.
T Consensus       236 ----~~~-----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          236 ----PPT-----------LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             ----CCC-----------CCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             ----CCC-----------CccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence                011           111245678999999999999999999999864

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=6.6e-44  Score=319.78  Aligned_cols=256  Identities=23%  Similarity=0.315  Sum_probs=202.6

Q ss_pred             HHHHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc--------hhhHHHHHHHHHHHHcC-CCCCcceeece
Q 046639           25 LSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ--------KEASRSFAAECNALRNI-RHRNLIKIITI   95 (331)
Q Consensus        25 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l-~h~~i~~~~~~   95 (331)
                      .....++|.+.+.||+|++|.||+|.+..+++.||||++....        ....+.+.+|+.+++.+ +||||++++++
T Consensus        89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  168 (365)
T 2y7j_A           89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS  168 (365)
T ss_dssp             HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence            3445678999999999999999999998899999999986442        12245678999999999 79999999998


Q ss_pred             eecccCCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCc
Q 046639           96 CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIV  175 (331)
Q Consensus        96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~  175 (331)
                      +     ......++|||++++++|.+++....  .+++..+..++.|++.||.|||+.   |++|+||||+||+++.++.
T Consensus       169 ~-----~~~~~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~  238 (365)
T 2y7j_A          169 Y-----ESSSFMFLVFDLMRKGELFDYLTEKV--ALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQ  238 (365)
T ss_dssp             E-----EBSSEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCC
T ss_pred             E-----eeCCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCC
Confidence            5     44567899999999999999997643  477889999999999999999999   9999999999999999999


Q ss_pred             EEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCC------CCCccchhhHhHHHHHHHHHhCCCCCCccc
Q 046639          176 AHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG------SKASVSGDVYNFGILLLEMFTRRRPTDAMF  249 (331)
Q Consensus       176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~DiwslG~il~el~~g~~pf~~~~  249 (331)
                      ++|+|||++.....         ........||+.|+|||++.+      ..++.++||||||+++|+|++|..||....
T Consensus       239 ikl~DfG~~~~~~~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~  309 (365)
T 2y7j_A          239 IRLSDFGFSCHLEP---------GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR  309 (365)
T ss_dssp             EEECCCTTCEECCT---------TCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             EEEEecCcccccCC---------CcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC
Confidence            99999999886521         112234568999999998753      358899999999999999999999996531


Q ss_pred             CCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          250 NEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      . ................                 .....++..+.+++.+||+.||++|||+.++++
T Consensus       310 ~-~~~~~~i~~~~~~~~~-----------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          310 Q-ILMLRMIMEGQYQFSS-----------------PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             H-HHHHHHHHHTCCCCCH-----------------HHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             H-HHHHHHHHhCCCCCCC-----------------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            1 1111111111110000                 001124567899999999999999999999985

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.1e-44  Score=336.82  Aligned_cols=252  Identities=22%  Similarity=0.249  Sum_probs=203.6

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCc
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGF  104 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  104 (331)
                      ..++|.+.+.||+|+||+||+|.+..+++.||+|++....   ......+.+|+.+++.++||||+++++++     ...
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~   98 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF-----EDK   98 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECS
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EeC
Confidence            3457999999999999999999999999999999986432   33456789999999999999999999995     445


Q ss_pred             ceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEe---cCCCcEEEccc
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILL---DQDIVAHVGDL  181 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv---~~~~~~kl~Df  181 (331)
                      +..++|||++.+++|.+.+....  .+++..+..++.|++.||.|||++   +|+||||||+||++   +.++.+||+||
T Consensus        99 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Df  173 (484)
T 3nyv_A           99 GYFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDF  173 (484)
T ss_dssp             SEEEEEECCCCSCBHHHHHHTCS--CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCT
T ss_pred             CEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEee
Confidence            78899999999999999996543  477899999999999999999999   99999999999999   56789999999


Q ss_pred             CcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHh
Q 046639          182 GLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKM  261 (331)
Q Consensus       182 g~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  261 (331)
                      |++.....         ........||+.|+|||++.+ .++.++||||||+++|+|++|.+||...... .........
T Consensus       174 g~a~~~~~---------~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~  242 (484)
T 3nyv_A          174 GLSTHFEA---------SKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY-DILKKVEKG  242 (484)
T ss_dssp             THHHHBCC---------CCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHC
T ss_pred             eeeEEccc---------ccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHcC
Confidence            99987521         122334569999999999876 6899999999999999999999999753211 111111111


Q ss_pred             hCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          262 ALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      .....                 ......++..+.+|+.+||+.||.+|||+.++++
T Consensus       243 ~~~~~-----------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          243 KYTFE-----------------LPQWKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             CCCCC-----------------SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCCC-----------------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence            11000                 0111235667899999999999999999999985

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=5.5e-44  Score=333.49  Aligned_cols=253  Identities=21%  Similarity=0.238  Sum_probs=200.7

Q ss_pred             HHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccch-------------hhHHHHHHHHHHHHcCCCCCcceee
Q 046639           27 KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK-------------EASRSFAAECNALRNIRHRNLIKII   93 (331)
Q Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i~~~~   93 (331)
                      ...++|.+++.||+|+||+||+|.+..+++.||+|++.....             ...+.+.+|+.+++.++||||++++
T Consensus        33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  112 (504)
T 3q5i_A           33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF  112 (504)
T ss_dssp             CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence            356789999999999999999999999999999999864421             2346788999999999999999999


Q ss_pred             ceeecccCCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCC
Q 046639           94 TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQD  173 (331)
Q Consensus        94 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~  173 (331)
                      +++     ......++|||++++++|.+.+....  .+++..+..++.|++.||.|||++   +|+||||||+||+++.+
T Consensus       113 ~~~-----~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~  182 (504)
T 3q5i_A          113 DVF-----EDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENK  182 (504)
T ss_dssp             EEE-----ECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESST
T ss_pred             EEE-----EcCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecC
Confidence            995     45678899999999999999997643  477899999999999999999999   99999999999999877


Q ss_pred             C---cEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccC
Q 046639          174 I---VAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFN  250 (331)
Q Consensus       174 ~---~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~  250 (331)
                      +   .+||+|||++.....         ........||+.|+|||++.+ .++.++||||+|+++|+|++|..||.....
T Consensus       183 ~~~~~~kl~Dfg~a~~~~~---------~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~  252 (504)
T 3q5i_A          183 NSLLNIKIVDFGLSSFFSK---------DYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQND  252 (504)
T ss_dssp             TCCSSEEECCCTTCEECCT---------TSCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             CCCccEEEEECCCCEEcCC---------CCccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            6   699999999987521         122334568999999999874 689999999999999999999999975321


Q ss_pred             CcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          251 EGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      . ..............                 ......++..+.+|+.+||+.||.+|||+.++++
T Consensus       253 ~-~~~~~i~~~~~~~~-----------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          253 Q-DIIKKVEKGKYYFD-----------------FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             H-HHHHHHHHCCCCCC-----------------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             H-HHHHHHHcCCCCCC-----------------ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            1 11111111111000                 0111234567899999999999999999999985

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.9e-44  Score=317.89  Aligned_cols=264  Identities=20%  Similarity=0.246  Sum_probs=201.7

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCC-CCCcceeeceeecccCCCccee
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIR-HRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      .++|.+.+.||+|+||+||+|++..+++.||+|++....   ...+.+|+.+++.++ ||||+++++++..   ......
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~---~~~~~~  108 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKD---PVSRTP  108 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEEC---TTTCCE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeecc---CCCCce
Confidence            357999999999999999999999999999999986433   356889999999997 9999999999753   224668


Q ss_pred             eEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCC-cEEEcccCcccc
Q 046639          108 AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDI-VAHVGDLGLAKF  186 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~-~~kl~Dfg~a~~  186 (331)
                      ++|||++++++|.+++..     ++...+..++.|++.||.|||++   +++|+||||+||+++.++ .+||+|||++..
T Consensus       109 ~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~  180 (330)
T 3nsz_A          109 ALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF  180 (330)
T ss_dssp             EEEEECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEEEeccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceE
Confidence            999999999999999853     66788899999999999999999   999999999999999776 899999999986


Q ss_pred             cccCCCCCcccccCCceeecccccccCCcccCC-CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcc
Q 046639          187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG-SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPD  265 (331)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  265 (331)
                      ...         ........+++.|+|||++.+ ..++.++||||||+++|+|++|..||....................
T Consensus       181 ~~~---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~  251 (330)
T 3nsz_A          181 YHP---------GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE  251 (330)
T ss_dssp             CCT---------TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHH
T ss_pred             cCC---------CCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCc
Confidence            521         112233468888999999877 6789999999999999999999999965433222222222211111


Q ss_pred             hhhhhcC-------cc-----------cccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          266 KVMEIVD-------PS-----------LLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       266 ~~~~~~~-------~~-----------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ......+       +.           ......  .......+...+.+|+.+||+.||.+|||+.++++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          252 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFV--HSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             HHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGC--CTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             hhhhHHHHhccccccchhhhhhhccccchhhhc--cccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            1111000       00           000000  00112235678999999999999999999999985

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.1e-44  Score=327.50  Aligned_cols=251  Identities=26%  Similarity=0.372  Sum_probs=192.7

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc--chhhHHHHHHHHHHHHcCC--CCCcceeeceeecccCCCc
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRNIR--HRNLIKIITICSSIDFEGF  104 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~~  104 (331)
                      .++|.+++.||+|+||+||+|.+.. ++.||||++...  .......+.+|+.+++.+.  ||||+++++++.     ..
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~-----~~  128 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----TD  128 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CS
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEe-----cC
Confidence            3569999999999999999999874 889999998654  3445577899999999996  599999999854     34


Q ss_pred             ceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcc
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA  184 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a  184 (331)
                      ...++||| +.+++|.+++....  .+++..+..++.|++.||.|||++   +|+||||||+||+++ ++.+||+|||++
T Consensus       129 ~~~~lv~E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a  201 (390)
T 2zmd_A          129 QYIYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIA  201 (390)
T ss_dssp             SEEEEEEE-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSS
T ss_pred             CEEEEEEe-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCcc
Confidence            56899999 55889999997654  466788899999999999999999   999999999999995 589999999999


Q ss_pred             cccccCCCCCcccccCCceeecccccccCCcccCC-----------CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcc
Q 046639          185 KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG-----------SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGL  253 (331)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~  253 (331)
                      ..+....      .........||+.|+|||++.+           ..++.++||||||+++|+|++|..||........
T Consensus       202 ~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~  275 (390)
T 2zmd_A          202 NQMQPDT------TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS  275 (390)
T ss_dssp             CCC---------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH
T ss_pred             ccccCCC------ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHH
Confidence            8652111      1112234569999999999865           4689999999999999999999999975322111


Q ss_pred             hHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          254 TLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      .+...            .++.....+       ...+...+.+|+.+||+.||.+|||+.++++
T Consensus       276 ~~~~~------------~~~~~~~~~-------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  320 (390)
T 2zmd_A          276 KLHAI------------IDPNHEIEF-------PDIPEKDLQDVLKCCLKRDPKQRISIPELLA  320 (390)
T ss_dssp             HHHHH------------HCTTSCCCC-------CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHH------------hCccccCCC-------CccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence            11111            111111111       1112456889999999999999999999985

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-44  Score=319.83  Aligned_cols=271  Identities=18%  Similarity=0.251  Sum_probs=203.9

Q ss_pred             ccCCcccHHHHHHHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcC-CCCCcceee
Q 046639           15 QQFPMISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNI-RHRNLIKII   93 (331)
Q Consensus        15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~   93 (331)
                      ...+.+++.++....++|.+.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.+ .||||++++
T Consensus         9 ~~~~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~   87 (326)
T 2x7f_A            9 RSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYY   87 (326)
T ss_dssp             -------CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEE
T ss_pred             CcchhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeee
Confidence            34455666677777889999999999999999999999899999999997543 2346688999999998 799999999


Q ss_pred             ceeecccC-CCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecC
Q 046639           94 TICSSIDF-EGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQ  172 (331)
Q Consensus        94 ~~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~  172 (331)
                      +++..... ......++|||++++++|.+++.......++...+..++.|++.||.+||+.   +++|+||||+||+++.
T Consensus        88 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~  164 (326)
T 2x7f_A           88 GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTE  164 (326)
T ss_dssp             EEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECT
T ss_pred             eEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcC
Confidence            99764321 1146789999999999999999876555678888999999999999999999   9999999999999999


Q ss_pred             CCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccC-----CCCCccchhhHhHHHHHHHHHhCCCCCCc
Q 046639          173 DIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGM-----GSKASVSGDVYNFGILLLEMFTRRRPTDA  247 (331)
Q Consensus       173 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~~g~~pf~~  247 (331)
                      ++.++|+|||++......        ........+|+.|+|||++.     +..++.++||||||+++|+|++|..||..
T Consensus       165 ~~~~kl~Dfg~~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  236 (326)
T 2x7f_A          165 NAEVKLVDFGVSAQLDRT--------VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD  236 (326)
T ss_dssp             TCCEEECCCTTTC---------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             CCCEEEeeCcCceecCcC--------ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence            999999999998765211        11223346899999999987     55689999999999999999999999965


Q ss_pred             ccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          248 MFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ....  .........        ..+...          ...++..+.+++.+||+.||.+|||+.++++
T Consensus       237 ~~~~--~~~~~~~~~--------~~~~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          237 MHPM--RALFLIPRN--------PAPRLK----------SKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             SCHH--HHHHHHHHS--------CCCCCS----------CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CcHH--HHHHHhhcC--------ccccCC----------ccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            3211  111111110        001100          0123467889999999999999999999986

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=3.9e-44  Score=333.71  Aligned_cols=252  Identities=19%  Similarity=0.235  Sum_probs=197.3

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcc
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ--KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFD  105 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~  105 (331)
                      ..++|.+++.||+|+||+||+|++..++..||+|++....  ......+.+|+.+++.++||||+++++++     ....
T Consensus        35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~  109 (494)
T 3lij_A           35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFF-----EDKR  109 (494)
T ss_dssp             HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred             hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCC
Confidence            4457999999999999999999999999999999986543  23346788999999999999999999995     4456


Q ss_pred             eeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCC---CcEEEcccC
Q 046639          106 FKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQD---IVAHVGDLG  182 (331)
Q Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~---~~~kl~Dfg  182 (331)
                      ..++||||+++++|.+.+....  .+++..+..++.|++.||.|||++   +|+||||||+||+++..   +.+||+|||
T Consensus       110 ~~~lv~e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG  184 (494)
T 3lij_A          110 NYYLVMECYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFG  184 (494)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             EEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECC
Confidence            7899999999999999887653  367788999999999999999999   99999999999999764   559999999


Q ss_pred             cccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhh
Q 046639          183 LAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMA  262 (331)
Q Consensus       183 ~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  262 (331)
                      ++.....         ........||+.|+|||++.+ .++.++||||||+++|+|++|..||...... ..........
T Consensus       185 ~a~~~~~---------~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~  253 (494)
T 3lij_A          185 LSAVFEN---------QKKMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQ-EILRKVEKGK  253 (494)
T ss_dssp             TCEECBT---------TBCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHTC
T ss_pred             CCeECCC---------CccccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCC
Confidence            9987521         122334569999999999864 6899999999999999999999999764221 1111111111


Q ss_pred             CcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          263 LPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ...      ..           .....++..+.+|+.+||+.||.+|||+.++++
T Consensus       254 ~~~------~~-----------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          254 YTF------DS-----------PEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             CCC------CS-----------GGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCC------Cc-----------hhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence            100      00           111234567889999999999999999999985

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.9e-44  Score=341.85  Aligned_cols=261  Identities=19%  Similarity=0.306  Sum_probs=203.5

Q ss_pred             CCcCc-eeeccCeeEEEEeeec--CCCceEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCccee
Q 046639           32 FSPAN-KIGQGGVSIVYKGILD--ESRSIVAVKVVNLKQ-KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        32 y~~~~-~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      +.+.+ .||+|+||+||+|.+.  .++..||||+++... ....+.+.+|+.+++.++||||++++++|..      +..
T Consensus       337 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~------~~~  410 (613)
T 2ozo_A          337 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------EAL  410 (613)
T ss_dssp             EEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES------SSE
T ss_pred             eeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc------CCe
Confidence            33344 7999999999999875  456779999997543 3345779999999999999999999999742      348


Q ss_pred             eEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccc
Q 046639          108 AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      ++|||++++++|.+++... ...+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||+++..
T Consensus       411 ~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~  486 (613)
T 2ozo_A          411 MLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKAL  486 (613)
T ss_dssp             EEEEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred             EEEEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence            9999999999999999654 34577899999999999999999999   9999999999999999999999999999865


Q ss_pred             ccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhCcch
Q 046639          188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMALPDK  266 (331)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~  266 (331)
                      ....     ..........+++.|+|||++.+..++.++||||||+++|||++ |..||......  .....+....   
T Consensus       487 ~~~~-----~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--~~~~~i~~~~---  556 (613)
T 2ozo_A          487 GADD-----SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAFIEQGK---  556 (613)
T ss_dssp             C-------------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH--HHHHHHHTTC---
T ss_pred             cCCC-----ceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH--HHHHHHHcCC---
Confidence            2111     11111122335678999999998899999999999999999998 99999865322  1211111110   


Q ss_pred             hhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhhhc
Q 046639          267 VMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETFLG  328 (331)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~~~  328 (331)
                               ..       ..+..++..+.+|+.+||+.||++|||+.+|++.|+.+..+...
T Consensus       557 ---------~~-------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~  602 (613)
T 2ozo_A          557 ---------RM-------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS  602 (613)
T ss_dssp             ---------CC-------CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSC
T ss_pred             ---------CC-------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence                     00       11234667899999999999999999999999999998877654

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.8e-44  Score=323.07  Aligned_cols=265  Identities=20%  Similarity=0.279  Sum_probs=202.4

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc-chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCccee
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK-QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      .++|.+.+.||+|+||+||+|.+..++..||+|++... .......+.+|+.+++.++||||+++++++.     ..+..
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~  106 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEI  106 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEE-----ETTEE
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEE-----ECCEE
Confidence            45799999999999999999999999999999999755 3444577899999999999999999999854     35678


Q ss_pred             eEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccc
Q 046639          108 AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      ++|||++++++|.+++....  .++...+..++.|++.||.|||+..  +++|+||||+||+++.++.++|+|||++...
T Consensus       107 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  182 (360)
T 3eqc_A          107 SICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  182 (360)
T ss_dssp             EEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred             EEEEECCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCccc
Confidence            99999999999999997654  3677889999999999999999842  8999999999999999999999999998765


Q ss_pred             ccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCc---
Q 046639          188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALP---  264 (331)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~---  264 (331)
                      ..          .......||+.|+|||++.+..++.++||||||+++|+|++|..||.......  ..........   
T Consensus       183 ~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~  250 (360)
T 3eqc_A          183 ID----------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE--LELMFGCQVEGDA  250 (360)
T ss_dssp             HH----------HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHH--HHHHHC-------
T ss_pred             cc----------ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHhcccccccC
Confidence            21          12234568999999999999999999999999999999999999997532211  1111000000   


Q ss_pred             ------------------------chhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          265 ------------------------DKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       265 ------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                                              .......+.......   .......++..+.+|+.+||+.||++|||+.++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          251 AETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPP---PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             -----------------------CCCHHHHHHHHHHSCC---CCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCC---CCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                                    000000000000000   00000124567899999999999999999999985

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=6.9e-45  Score=317.85  Aligned_cols=254  Identities=19%  Similarity=0.244  Sum_probs=199.0

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCccee
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      ..++|.+.+.||+|+||+||+|.+..+++.||+|++..........+.+|+.+++.++||||+++++++.     ..+..
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~   91 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY-----HDGKL   91 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CC-CE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeee-----eCCeE
Confidence            3468999999999999999999999999999999997666666678899999999999999999999954     35678


Q ss_pred             eEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccc
Q 046639          108 AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      ++|||++++++|.+++.... ..++...+..++.|++.||.+||+.   +++|+||||+||+++.++.++|+|||++...
T Consensus        92 ~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  167 (302)
T 2j7t_A           92 WIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKN  167 (302)
T ss_dssp             EEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHH
T ss_pred             EEEEEeCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccc
Confidence            99999999999999987633 3477889999999999999999999   9999999999999999999999999987643


Q ss_pred             ccCCCCCcccccCCceeecccccccCCccc-----CCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhh
Q 046639          188 FGYEPGTAAETASNSIEIKGIVGYVAPEYG-----MGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMA  262 (331)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~-----~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  262 (331)
                      ..        .........+|+.|+|||++     .+..++.++||||||+++|+|++|..||....... .........
T Consensus       168 ~~--------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~  238 (302)
T 2j7t_A          168 LK--------TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-VLLKIAKSD  238 (302)
T ss_dssp             HH--------HHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSC
T ss_pred             cc--------cccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH-HHHHHhccC
Confidence            11        11122334688999999997     46678999999999999999999999997542111 111111111


Q ss_pred             CcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          263 LPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      .         +..         .....++..+.+++.+||+.||.+|||+.++++
T Consensus       239 ~---------~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          239 P---------PTL---------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             C---------CCC---------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             C---------ccc---------CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            0         000         111234567899999999999999999999975

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=2.6e-44  Score=317.14  Aligned_cols=253  Identities=18%  Similarity=0.241  Sum_probs=197.2

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccch--------hhHHHHHHHHHHHHcCCCCCcceeeceeecc
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK--------EASRSFAAECNALRNIRHRNLIKIITICSSI   99 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   99 (331)
                      ..++|.+.+.||+|+||.||+|.+..+++.||||++.....        .....+.+|+.+++.++||||+++++++.. 
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-   86 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-   86 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES-
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC-
Confidence            44679999999999999999999999999999999864321        122457899999999999999999998632 


Q ss_pred             cCCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCc---E
Q 046639          100 DFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIV---A  176 (331)
Q Consensus       100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~---~  176 (331)
                           ...++|||++++++|.+++...  ..++...+..++.|++.||.|||++   +++|+||||+||+++.++.   +
T Consensus        87 -----~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~  156 (322)
T 2ycf_A           87 -----EDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLI  156 (322)
T ss_dssp             -----SSEEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCE
T ss_pred             -----CceEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeE
Confidence                 2379999999999999998643  3577889999999999999999999   9999999999999987664   9


Q ss_pred             EEcccCcccccccCCCCCcccccCCceeecccccccCCcccC---CCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcc
Q 046639          177 HVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGM---GSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGL  253 (331)
Q Consensus       177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~  253 (331)
                      ||+|||++....         .........||+.|+|||++.   ...++.++||||||+++|+|++|..||........
T Consensus       157 kl~Dfg~~~~~~---------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~  227 (322)
T 2ycf_A          157 KITDFGHSKILG---------ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS  227 (322)
T ss_dssp             EECCCTTCEECC---------CCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC
T ss_pred             EEccCccceecc---------cccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH
Confidence            999999997651         111122356899999999963   56789999999999999999999999976433322


Q ss_pred             hHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          254 TLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ............      .+           .....++..+.+|+.+||+.||++|||+.++++
T Consensus       228 ~~~~~~~~~~~~------~~-----------~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          228 LKDQITSGKYNF------IP-----------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             HHHHHHHTCCCC------CH-----------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHHhCcccc------Cc-----------hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            222221111100      00           111234567899999999999999999999984

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=3.2e-44  Score=311.19  Aligned_cols=246  Identities=19%  Similarity=0.207  Sum_probs=197.0

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc--chhhHHHHHHHHHHHHcC-CCCCcceeeceeecccCCCc
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRNI-RHRNLIKIITICSSIDFEGF  104 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~  104 (331)
                      ..++|.+.+.||+|+||+||+|.+..+++.||+|++...  .......+.+|+..+..+ +||||+++++++.     ..
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~-----~~   83 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWA-----ED   83 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEE-----ET
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeee-----cC
Confidence            346799999999999999999999999999999998753  233456788999999999 8999999999953     45


Q ss_pred             ceeeEEEeecCCCCHHHHHHhcc--CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCC---------
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQSN--GQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQD---------  173 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~---------  173 (331)
                      +..++|||++++++|.+++....  ...+++..++.++.|++.||.|||++   +++|+||||+||+++.+         
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~  160 (289)
T 1x8b_A           84 DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEE  160 (289)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----------
T ss_pred             CeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccc
Confidence            67899999999999999997642  24577899999999999999999999   99999999999999844         


Q ss_pred             ----------CcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCC-CCccchhhHhHHHHHHHHHhCC
Q 046639          174 ----------IVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGS-KASVSGDVYNFGILLLEMFTRR  242 (331)
Q Consensus       174 ----------~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~  242 (331)
                                ..++|+|||.+.....            .....+|+.|+|||++.+. .++.++||||||+++|+|++|.
T Consensus       161 ~~~~~~~~~~~~~kl~Dfg~~~~~~~------------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~  228 (289)
T 1x8b_A          161 GDEDDWASNKVMFKIGDLGHVTRISS------------PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE  228 (289)
T ss_dssp             ---------CCCEEECCCTTCEETTC------------SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCC
T ss_pred             cccccccCCceEEEEcccccccccCC------------ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCC
Confidence                      4799999999986521            1123488999999998876 5678999999999999999998


Q ss_pred             CCCCcccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          243 RPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       243 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      +|+...    ...........         +           .....++..+.+++.+||+.||++|||+.++++
T Consensus       229 ~~~~~~----~~~~~~~~~~~---------~-----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          229 PLPRNG----DQWHEIRQGRL---------P-----------RIPQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             CCCSSS----HHHHHHHTTCC---------C-----------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCcch----hHHHHHHcCCC---------C-----------CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence            876432    11111111110         1           111224567899999999999999999999974

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2.1e-44  Score=312.98  Aligned_cols=254  Identities=22%  Similarity=0.279  Sum_probs=188.1

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcc
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ--KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFD  105 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~  105 (331)
                      ..++|.+.+.||+|+||+||+|.+..+++.||+|++....  ......+..+...++.++||||+++++++.     ..+
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-----~~~   79 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALF-----REG   79 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeee-----ccC
Confidence            3468999999999999999999999999999999986442  222233445555678889999999999954     456


Q ss_pred             eeeEEEeecCCCCHHHHHHh--ccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCc
Q 046639          106 FKAIVFEYMQNRNLEQWLRQ--SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGL  183 (331)
Q Consensus       106 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~  183 (331)
                      ..++|||+++ ++|.+++..  .....+++..+..++.|++.||.|||++.  +++|+||||+||+++.++.+||+|||+
T Consensus        80 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T 3fme_A           80 DVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGI  156 (290)
T ss_dssp             SEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC--
T ss_pred             CEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCC
Confidence            7899999995 699888765  23456788999999999999999999853  899999999999999999999999999


Q ss_pred             ccccccCCCCCcccccCCceeecccccccCCccc----CCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHH
Q 046639          184 AKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYG----MGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFV  259 (331)
Q Consensus       184 a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~----~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~  259 (331)
                      +.....         ........+|+.|+|||++    .+..++.++||||||+++|+|++|..||..............
T Consensus       157 ~~~~~~---------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~  227 (290)
T 3fme_A          157 SGYLVD---------DVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVV  227 (290)
T ss_dssp             ----------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHH
T ss_pred             cccccc---------cccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHh
Confidence            976521         1122234588999999996    556789999999999999999999999975432222222222


Q ss_pred             HhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          260 KMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ....+.         .          ....++..+.+++.+||+.||++|||+.++++
T Consensus       228 ~~~~~~---------~----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          228 EEPSPQ---------L----------PADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             HSCCCC---------C----------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ccCCCC---------c----------ccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence            211111         0          00124567899999999999999999999987

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.1e-45  Score=333.02  Aligned_cols=255  Identities=15%  Similarity=0.137  Sum_probs=192.5

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeec---cchhhHHHHHHHHH---HHHcCCCCCcceeeceeeccc--
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNL---KQKEASRSFAAECN---ALRNIRHRNLIKIITICSSID--  100 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~e~~---~l~~l~h~~i~~~~~~~~~~~--  100 (331)
                      .++|.+.+.||+|+||+||+|++..+++.||||++..   ......+.+.+|+.   +++.++||||+++++.+....  
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            4679999999999999999999988999999999963   33445577889995   455557999999985432100  


Q ss_pred             CCCc------------c-----eeeEEEeecCCCCHHHHHHhcc-----CCccchHHHHHHHHHHHHHHHHHhhcCCCCe
Q 046639          101 FEGF------------D-----FKAIVFEYMQNRNLEQWLRQSN-----GQLRFLTQRVNIAIDVSFAIEYFHHHCQPSI  158 (331)
Q Consensus       101 ~~~~------------~-----~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i  158 (331)
                      +...            +     ..++|||++ +|+|.+++....     ...+++..++.++.|++.||+|||++   +|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence            1111            1     378999999 789999998632     12233577788999999999999999   99


Q ss_pred             eecCCCCCCEEecCCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCC-----------CCccchh
Q 046639          159 VHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGS-----------KASVSGD  227 (331)
Q Consensus       159 vH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-----------~~~~~~D  227 (331)
                      +||||||+||+++.++.+||+|||+++..           ........| +.|+|||++.+.           .++.++|
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~-----------~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~D  295 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRD-----------GARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFD  295 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEET-----------TCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheec-----------CCcccCCCC-cCccChhhhcccccccccccccccCChhhh
Confidence            99999999999999999999999999753           112233456 889999999887           8999999


Q ss_pred             hHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCC
Q 046639          228 VYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPM  307 (331)
Q Consensus       228 iwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~  307 (331)
                      |||||+++|+|++|..||........          ...+   ...             ...++..+.+|+.+||+.||+
T Consensus       296 vwSlG~il~elltg~~Pf~~~~~~~~----------~~~~---~~~-------------~~~~~~~~~~li~~~L~~dp~  349 (377)
T 3byv_A          296 AWALGLVIYWIWCADLPITKDAALGG----------SEWI---FRS-------------CKNIPQPVRALLEGFLRYPKE  349 (377)
T ss_dssp             HHHHHHHHHHHHHSSCCC------CC----------SGGG---GSS-------------CCCCCHHHHHHHHHHTCSSGG
T ss_pred             HHHHHHHHHHHHHCCCCCcccccccc----------hhhh---hhh-------------ccCCCHHHHHHHHHHcCCCch
Confidence            99999999999999999965322110          0000   000             012456788999999999999


Q ss_pred             CCCcHHHHHH--HHHHhhhh
Q 046639          308 ERMEMRDVVA--KLRHARET  325 (331)
Q Consensus       308 ~Rps~~~i~~--~L~~~~~~  325 (331)
                      +|||+.++++  +++.+.+.
T Consensus       350 ~Rpt~~e~l~hp~f~~~~~~  369 (377)
T 3byv_A          350 DRLLPLQAMETPEYEQLRTE  369 (377)
T ss_dssp             GCCCHHHHHTSHHHHHHHHH
T ss_pred             hCCCHHHHhhChHHHHHHHH
Confidence            9999999986  55555544

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=3.3e-44  Score=342.30  Aligned_cols=255  Identities=23%  Similarity=0.325  Sum_probs=200.8

Q ss_pred             ceeeccCeeEEEEeee--cCCCceEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeEEE
Q 046639           36 NKIGQGGVSIVYKGIL--DESRSIVAVKVVNLKQ--KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVF  111 (331)
Q Consensus        36 ~~lg~G~~g~V~~~~~--~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~  111 (331)
                      +.||+|+||+||+|.+  ..+++.||||+++...  ....+.+.+|+.+++.++||||++++++|..      ...++||
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------~~~~lv~  448 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ESWMLVM  448 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES------SSEEEEE
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------CCEEEEE
Confidence            3799999999999955  4567899999997542  3345779999999999999999999998632      3478999


Q ss_pred             eecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccccCC
Q 046639          112 EYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYE  191 (331)
Q Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~~  191 (331)
                      |++++++|.+++....  .+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||+++.+....
T Consensus       449 E~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~  523 (635)
T 4fl3_A          449 EMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE  523 (635)
T ss_dssp             ECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--
T ss_pred             EccCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCc
Confidence            9999999999997543  477889999999999999999999   99999999999999999999999999998762211


Q ss_pred             CCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhCcchhhhh
Q 046639          192 PGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMALPDKVMEI  270 (331)
Q Consensus       192 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  270 (331)
                           ..........+|+.|+|||++.+..++.++||||||+++|||++ |..||......  .....+.....      
T Consensus       524 -----~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--~~~~~i~~~~~------  590 (635)
T 4fl3_A          524 -----NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAMLEKGER------  590 (635)
T ss_dssp             ----------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTTCC------
T ss_pred             -----cccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCC------
Confidence                 11112223346778999999999899999999999999999998 99999764221  11111111100      


Q ss_pred             cCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhhh
Q 046639          271 VDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETFL  327 (331)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~~  327 (331)
                        .           ..+..++..+.+|+..||+.||++|||+.+|++.|+.+..++.
T Consensus       591 --~-----------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l~  634 (635)
T 4fl3_A          591 --M-----------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV  634 (635)
T ss_dssp             --C-----------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHC
T ss_pred             --C-----------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhc
Confidence              0           1122456789999999999999999999999999999887764

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=5e-44  Score=315.77  Aligned_cols=277  Identities=19%  Similarity=0.277  Sum_probs=206.8

Q ss_pred             HHhcCCCcCceeeccCeeEEEEeeec-CCCceEEEEEeeccch--hhHHHHHHHHHHHHcC---CCCCcceeeceeeccc
Q 046639           27 KATNNFSPANKIGQGGVSIVYKGILD-ESRSIVAVKVVNLKQK--EASRSFAAECNALRNI---RHRNLIKIITICSSID  100 (331)
Q Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~  100 (331)
                      ...++|.+.+.||+|+||+||+|.+. .+++.||+|++.....  .....+.+|+.+++.+   .||||+++++++....
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence            34578999999999999999999995 6788999999864432  1123455677777666   8999999999976433


Q ss_pred             CCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcc
Q 046639          101 FEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGD  180 (331)
Q Consensus       101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~D  180 (331)
                      .......++|||++. ++|.+++.......+++..+..++.|++.||.+||+.   |++|+||||+||+++.++.++|+|
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~D  163 (326)
T 1blx_A           88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD  163 (326)
T ss_dssp             CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred             cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEec
Confidence            345678899999995 6999999886666688899999999999999999999   999999999999999999999999


Q ss_pred             cCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHH
Q 046639          181 LGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVK  260 (331)
Q Consensus       181 fg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  260 (331)
                      ||++....         .........+|+.|+|||++.+..++.++||||||+++|+|++|..||...... ........
T Consensus       164 fg~~~~~~---------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~i~~  233 (326)
T 1blx_A          164 FGLARIYS---------FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILD  233 (326)
T ss_dssp             CCSCCCCC---------GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHH
T ss_pred             Cccccccc---------CCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHH
Confidence            99987641         111223456889999999999999999999999999999999999999764221 12222222


Q ss_pred             hhCcchhhhhcC----c--ccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          261 MALPDKVMEIVD----P--SLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       261 ~~~~~~~~~~~~----~--~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ............    +  ............+...++..+.+|+.+||+.||.+|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          234 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             HHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            111100000000    0  00000000111222345678899999999999999999999984

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=7.7e-45  Score=341.05  Aligned_cols=260  Identities=25%  Similarity=0.411  Sum_probs=207.8

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCccee
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      ..++|.+.+.||+|+||+||+|.+.. +..||||+++... ...+.+.+|+.+++.++|+||+++++++..      ...
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~~  336 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPI  336 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSC
T ss_pred             chhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee------ccc
Confidence            45679999999999999999999975 4569999997543 234678999999999999999999998632      457


Q ss_pred             eEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccc
Q 046639          108 AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      ++|||++++++|.+++....+..+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus       337 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  413 (535)
T 2h8h_A          337 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLI  413 (535)
T ss_dssp             EEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred             eEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence            9999999999999999765445577889999999999999999999   9999999999999999999999999999865


Q ss_pred             ccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhCcch
Q 046639          188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMALPDK  266 (331)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~  266 (331)
                      ..       ..........++..|+|||++.+..++.++||||||+++|||++ |..||......  .....+....   
T Consensus       414 ~~-------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~--~~~~~i~~~~---  481 (535)
T 2h8h_A          414 ED-------NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EVLDQVERGY---  481 (535)
T ss_dssp             CC-------HHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH--HHHHHHHTTC---
T ss_pred             CC-------CceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCC---
Confidence            21       01111122346678999999998899999999999999999999 99999764221  1111111110   


Q ss_pred             hhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhh
Q 046639          267 VMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETF  326 (331)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~  326 (331)
                           .    .       .....++..+.+|+.+||+.||++|||+.+|++.|+.+..+.
T Consensus       482 -----~----~-------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  525 (535)
T 2h8h_A          482 -----R----M-------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  525 (535)
T ss_dssp             -----C----C-------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred             -----C----C-------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence                 0    0       111245678899999999999999999999999999876544

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.4e-44  Score=345.40  Aligned_cols=245  Identities=19%  Similarity=0.250  Sum_probs=200.9

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc---chhhHHHHHHHHHHHHcC-CCCCcceeeceeecccCCC
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK---QKEASRSFAAECNALRNI-RHRNLIKIITICSSIDFEG  103 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~  103 (331)
                      ..++|.+++.||+|+||+||+|++..+++.||||++...   .......+..|..++..+ .||+|+.++++     +.+
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~-----~~~  413 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSC-----FQT  413 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEE-----CBC
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEE-----EEe
Confidence            456899999999999999999999999999999999743   233446678899999988 69999999998     566


Q ss_pred             cceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCc
Q 046639          104 FDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGL  183 (331)
Q Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~  183 (331)
                      .+.+++||||+++++|.+++....  .+++..+..++.|++.||.|||++   +|+||||||+|||++.+|.+||+|||+
T Consensus       414 ~~~~~lV~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGl  488 (674)
T 3pfq_A          414 MDRLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGM  488 (674)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTT
T ss_pred             CCEEEEEEeCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecce
Confidence            678999999999999999998654  477889999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhC
Q 046639          184 AKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMAL  263 (331)
Q Consensus       184 a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  263 (331)
                      ++....        .........||+.|+|||++.+..++.++||||||+++|||++|..||..... ...+..+...  
T Consensus       489 a~~~~~--------~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~-~~~~~~i~~~--  557 (674)
T 3pfq_A          489 CKENIW--------DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQSIMEH--  557 (674)
T ss_dssp             CEECCC--------TTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHSS--
T ss_pred             eecccc--------CCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH-HHHHHHHHhC--
Confidence            985311        11223456799999999999999999999999999999999999999975321 1111111110  


Q ss_pred             cchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcH
Q 046639          264 PDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEM  312 (331)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~  312 (331)
                                         ...++......+.+|+.+||+.||.+||++
T Consensus       558 -------------------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~  587 (674)
T 3pfq_A          558 -------------------NVAYPKSMSKEAVAICKGLMTKHPGKRLGC  587 (674)
T ss_dssp             -------------------CCCCCTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred             -------------------CCCCCccCCHHHHHHHHHHccCCHHHCCCC
Confidence                               011223356678999999999999999997

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.1e-44  Score=324.80  Aligned_cols=270  Identities=17%  Similarity=0.219  Sum_probs=188.4

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc--chhhHHHHHHHHHHHHcCCCCCcceeeceeecc-cCCCcc
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRNIRHRNLIKIITICSSI-DFEGFD  105 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~~  105 (331)
                      .++|.+++.||+|+||.||+|.+..+++.||+|++...  .......+.+|+.+++.++||||+++++++... ......
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            46899999999999999999999999999999998643  334456788999999999999999999997532 123345


Q ss_pred             eeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccc
Q 046639          106 FKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAK  185 (331)
Q Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~  185 (331)
                      ..++|+|++ +++|.+++..   ..++...+..++.|++.||.|||+.   ||+||||||+||+++.++.+||+|||+++
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~  180 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR  180 (367)
T ss_dssp             CCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred             eEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence            679999999 8899999865   3477889999999999999999999   99999999999999999999999999997


Q ss_pred             ccccCCCCCcccccCCceeecccccccCCcccCC-CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCc
Q 046639          186 FLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG-SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALP  264 (331)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  264 (331)
                      ...           .......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+... ...+..+......
T Consensus       181 ~~~-----------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~l~~i~~~~g~  248 (367)
T 2fst_X          181 HTA-----------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH-IDQLKLILRLVGT  248 (367)
T ss_dssp             ---------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCS
T ss_pred             ccc-----------ccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCC
Confidence            641           11234568999999999887 6789999999999999999999999976422 1122222221111


Q ss_pred             --chhhhhcCcccc----ccc---c-cCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          265 --DKVMEIVDPSLL----LEV---T-ANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       265 --~~~~~~~~~~~~----~~~---~-~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                        ......+.....    ...   . .........+.+.+.+|+.+||+.||.+|||+.++++
T Consensus       249 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          249 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             CCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence              000000000000    000   0 0000111234567899999999999999999999975

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.1e-43  Score=327.86  Aligned_cols=270  Identities=17%  Similarity=0.204  Sum_probs=210.0

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      .++|.+.+.||+|+||.||+|++..+++.||||++.....  ...+..|+.+++.+.|++.+..+.++    .......+
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~----~~~~~~~~   79 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWF----GVEGDYNV   79 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEE----EEETTEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEE----EeeCCEEE
Confidence            4689999999999999999999999999999998864432  23477899999999876555555544    23456789


Q ss_pred             EEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEe---cCCCcEEEcccCccc
Q 046639          109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILL---DQDIVAHVGDLGLAK  185 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv---~~~~~~kl~Dfg~a~  185 (331)
                      +|||++ +++|.+++.... ..+++..++.++.|++.||.|||++   +|+||||||+|||+   +.++.+||+|||+++
T Consensus        80 lvme~~-g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~  154 (483)
T 3sv0_A           80 LVMDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (483)
T ss_dssp             EEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             EEEECC-CCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcce
Confidence            999999 999999997543 3478899999999999999999999   99999999999999   588999999999998


Q ss_pred             ccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcch--HHHHHHhhC
Q 046639          186 FLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLT--LHEFVKMAL  263 (331)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~  263 (331)
                      .+........ ..........||+.|+|||++.+..++.++||||||+++|+|++|..||.........  +........
T Consensus       155 ~~~~~~~~~~-~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~  233 (483)
T 3sv0_A          155 KYRDTSTHQH-IPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV  233 (483)
T ss_dssp             ECBCTTTCCB-CCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHH
T ss_pred             eccCCccccc-cccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccc
Confidence            7643222111 1112233567999999999999999999999999999999999999999875432211  111111111


Q ss_pred             cchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhh
Q 046639          264 PDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETF  326 (331)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~  326 (331)
                      ...+.                .....++..+.+|+..||+.+|++||++.+|++.|+.+....
T Consensus       234 ~~~~~----------------~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~  280 (483)
T 3sv0_A          234 ATSIE----------------ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE  280 (483)
T ss_dssp             HSCHH----------------HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             cccHH----------------HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence            11110                111234678999999999999999999999999999987644

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=5.6e-44  Score=318.94  Aligned_cols=282  Identities=21%  Similarity=0.262  Sum_probs=205.8

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc-chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK-QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      ..++|.+.+.||+|+||+||+|.+..+++.||+|.+... .......+.+|+.+++.++||||+++++++....+.....
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   88 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE   88 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred             cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence            456899999999999999999999999999999998643 3344567889999999999999999999876555556678


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      .++|||++. ++|.+++...   .++...+..++.|++.||.+||++   +++|+||||+||+++.++.+||+|||++..
T Consensus        89 ~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (353)
T 2b9h_A           89 VYIIQELMQ-TDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARI  161 (353)
T ss_dssp             EEEEECCCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEeccC-ccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecccccc
Confidence            899999995 6999998763   477889999999999999999999   999999999999999999999999999987


Q ss_pred             cccCCCCCc--ccccCCceeecccccccCCcccCC-CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhC
Q 046639          187 LFGYEPGTA--AETASNSIEIKGIVGYVAPEYGMG-SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMAL  263 (331)
Q Consensus       187 ~~~~~~~~~--~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  263 (331)
                      .........  ...........||+.|+|||++.+ ..++.++||||||+++|+|++|..||....... ..........
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~  240 (353)
T 2b9h_A          162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH-QLLLIFGIIG  240 (353)
T ss_dssp             CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHC
T ss_pred             cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhC
Confidence            632211110  001112234568999999998654 678999999999999999999999997642211 1111111100


Q ss_pred             cch---hhhhcCc-c-------cccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          264 PDK---VMEIVDP-S-------LLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       264 ~~~---~~~~~~~-~-------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ...   ....... .       +..............++..+.+|+.+||+.||.+|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            000   0000000 0       0000000000111245678899999999999999999999986

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.4e-44  Score=320.16  Aligned_cols=268  Identities=22%  Similarity=0.253  Sum_probs=199.1

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ--KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      .++|.+.+.||+|+||+||+|++..+++.||+|++....  ......+.+|+.+++.++||||+++++++.     ....
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~   98 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCK-----KKKR   98 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEee-----cCCE
Confidence            357999999999999999999999999999999985443  333466789999999999999999999964     4567


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      .++|||++++++|.+++....  .+++..+..++.|++.||.+||+.   +++|+||||+||+++.++.++|+|||++..
T Consensus        99 ~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~  173 (331)
T 4aaa_A           99 WYLVFEFVDHTILDDLELFPN--GLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFART  173 (331)
T ss_dssp             EEEEEECCSEEHHHHHHHSTT--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred             EEEEEecCCcchHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCcee
Confidence            899999998888888765433  477899999999999999999999   999999999999999999999999999976


Q ss_pred             cccCCCCCcccccCCceeecccccccCCcccCCC-CCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhC--
Q 046639          187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGS-KASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMAL--  263 (331)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~--  263 (331)
                      ....        ........+|+.|+|||++.+. .++.++||||||+++|+|++|..||....... ..........  
T Consensus       174 ~~~~--------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~  244 (331)
T 4aaa_A          174 LAAP--------GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID-QLYHIMMCLGNL  244 (331)
T ss_dssp             ------------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCSC
T ss_pred             ecCC--------ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCC
Confidence            5211        1222334588999999998875 68999999999999999999999997643221 1111111100  


Q ss_pred             cchh----------hhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          264 PDKV----------MEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       264 ~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ....          .....+.....  .........++..+.+|+.+||+.||++|||+.++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          245 IPRHQELFNKNPVFAGVRLPEIKER--EPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             CHHHHHHHHHCGGGTTCCCCCCSSC--CCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ChhhhhHhhhccccccccCcccccc--chhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            0000          00000000000  0000111235678999999999999999999999875

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.6e-43  Score=315.81  Aligned_cols=279  Identities=20%  Similarity=0.259  Sum_probs=202.5

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccch--hhHHHHHHHHHHHHcCCCCCcceeeceeecccC---CC
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK--EASRSFAAECNALRNIRHRNLIKIITICSSIDF---EG  103 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---~~  103 (331)
                      .++|.+.+.||+|+||+||+|++..+++.||+|++.....  .....+.+|+.+++.++||||+++++++.....   ..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            4689999999999999999999999999999999854432  234567899999999999999999999765321   11


Q ss_pred             cceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCc
Q 046639          104 FDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGL  183 (331)
Q Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~  183 (331)
                      .+..++|||+++ ++|.+.+.... ..+++..+..++.|++.||.|||++   ||+|+||||+||+++.++.+||+|||+
T Consensus        96 ~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  170 (351)
T 3mi9_A           96 KGSIYLVFDFCE-HDLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGL  170 (351)
T ss_dssp             -CEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CceEEEEEeccC-CCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchh
Confidence            456899999995 58888876543 3477899999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCcccccCCceeecccccccCCcccCC-CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhh
Q 046639          184 AKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG-SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMA  262 (331)
Q Consensus       184 a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  262 (331)
                      +..+.....    ..........||+.|+|||++.+ ..++.++||||||+++|+|++|..||...... ..........
T Consensus       171 a~~~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~i~~~~  245 (351)
T 3mi9_A          171 ARAFSLAKN----SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ-HQLALISQLC  245 (351)
T ss_dssp             CEECCCCSS----SSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHH
T ss_pred             ccccccccc----ccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHh
Confidence            987632211    11122234568999999999876 45899999999999999999999999764221 1111211111


Q ss_pred             --Ccchhhhhc-Ccccccc---cccCCcchHHH-----HHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          263 --LPDKVMEIV-DPSLLLE---VTANNYSWIED-----CLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       263 --~~~~~~~~~-~~~~~~~---~~~~~~~~~~~-----~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                        .+....... .......   ...........     ..+.+.+|+.+||+.||.+|||+.|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          246 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             CCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence              111110000 0000000   00000111111     1356889999999999999999999985

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.2e-43  Score=309.31  Aligned_cols=254  Identities=23%  Similarity=0.283  Sum_probs=202.5

Q ss_pred             HHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc---------hhhHHHHHHHHHHHHcCC-CCCcceeecee
Q 046639           27 KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---------KEASRSFAAECNALRNIR-HRNLIKIITIC   96 (331)
Q Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~   96 (331)
                      ...++|.+.+.||+|+||.||+|.+..+++.||+|++....         ....+.+.+|+.+++++. ||||+++++++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   93 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence            45678999999999999999999999999999999996543         223466889999999995 99999999995


Q ss_pred             ecccCCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcE
Q 046639           97 SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVA  176 (331)
Q Consensus        97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~  176 (331)
                           ......++|||++++++|.+++....  .++...+..++.|++.||.+||++   +++|+||+|+||+++.++.+
T Consensus        94 -----~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~  163 (298)
T 1phk_A           94 -----ETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNI  163 (298)
T ss_dssp             -----ECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCE
T ss_pred             -----ccCCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcE
Confidence                 44577899999999999999997643  477889999999999999999999   99999999999999999999


Q ss_pred             EEcccCcccccccCCCCCcccccCCceeecccccccCCcccC------CCCCccchhhHhHHHHHHHHHhCCCCCCcccC
Q 046639          177 HVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGM------GSKASVSGDVYNFGILLLEMFTRRRPTDAMFN  250 (331)
Q Consensus       177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~  250 (331)
                      +|+|||++.....         ........+++.|+|||++.      ...++.++||||||+++|+|++|..||.....
T Consensus       164 kl~dfg~~~~~~~---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~  234 (298)
T 1phk_A          164 KLTDFGFSCQLDP---------GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ  234 (298)
T ss_dssp             EECCCTTCEECCT---------TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             EEecccchhhcCC---------CcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH
Confidence            9999999986521         11223356889999999874      45688999999999999999999999965321


Q ss_pred             CcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          251 EGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                       ..............     ..            .....++..+.+++.+||+.||.+|||+.++++
T Consensus       235 -~~~~~~~~~~~~~~-----~~------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          235 -MLMLRMIMSGNYQF-----GS------------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             -HHHHHHHHHTCCCC-----CT------------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             -HHHHHHHhcCCccc-----Cc------------ccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence             11111111111000     00            111235667899999999999999999999974

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=5.4e-44  Score=313.98  Aligned_cols=253  Identities=21%  Similarity=0.263  Sum_probs=198.0

Q ss_pred             HHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           27 KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      ...++|.+.+.||+|+||.||+|.+..+++.||+|.+....  ....+.+|+.+++.++||||+++++++.     ..+.
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~   98 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYF-----KNTD   98 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEE-----eCCE
Confidence            34568999999999999999999999999999999996543  3456889999999999999999999964     3467


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      .++|||++++++|.+++... ...++...+..++.|++.||.+||+.   +++|+||+|+||+++.++.++|+|||++..
T Consensus        99 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  174 (314)
T 3com_A           99 LWIVMEYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQ  174 (314)
T ss_dssp             EEEEEECCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEeecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchh
Confidence            89999999999999999743 23477889999999999999999999   999999999999999999999999999976


Q ss_pred             cccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcch
Q 046639          187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDK  266 (331)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  266 (331)
                      ....        ........+++.|+|||++.+..++.++||||||+++|+|++|..||......  ..........   
T Consensus       175 ~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~---  241 (314)
T 3com_A          175 LTDT--------MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM--RAIFMIPTNP---  241 (314)
T ss_dssp             CBTT--------BSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHSC---
T ss_pred             hhhh--------ccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHhcCC---
Confidence            5211        11223456889999999999989999999999999999999999999753211  1111111110   


Q ss_pred             hhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          267 VMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                           .+..         .....++..+.+|+.+||+.||.+|||+.++++
T Consensus       242 -----~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          242 -----PPTF---------RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             -----CCCC---------SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             -----Cccc---------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence                 0000         112234567899999999999999999999985

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.1e-44  Score=316.58  Aligned_cols=268  Identities=19%  Similarity=0.256  Sum_probs=185.2

Q ss_pred             HHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcc
Q 046639           27 KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ-KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFD  105 (331)
Q Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~  105 (331)
                      ...++|.+.+.||+|+||+||+|.+..+++.||+|.+.... ......+.+|+.+++.++||||+++++++.     ..+
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~   86 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFV-----VKD   86 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEE-----SSS
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEe-----ecC
Confidence            44678999999999999999999998889999999886443 233466889999999999999999999853     345


Q ss_pred             eeeEEEeecCCCCHHHHHHhc------cCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEc
Q 046639          106 FKAIVFEYMQNRNLEQWLRQS------NGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVG  179 (331)
Q Consensus       106 ~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~  179 (331)
                      ..++|||++++++|.+++...      ....+++..++.++.|++.||.+||+.   +++|+||||+||+++.++.++|+
T Consensus        87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~  163 (303)
T 2vwi_A           87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIA  163 (303)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEEC
T ss_pred             CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEE
Confidence            689999999999999999751      234577899999999999999999999   99999999999999999999999


Q ss_pred             ccCcccccccCCCCCcccccCCceeecccccccCCcccCC-CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHH
Q 046639          180 DLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG-SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEF  258 (331)
Q Consensus       180 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  258 (331)
                      |||++........   ...........+|+.|+|||++.+ ..++.++||||||+++|+|++|..||........ ....
T Consensus       164 dfg~~~~~~~~~~---~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~  239 (303)
T 2vwi_A          164 DFGVSAFLATGGD---ITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV-LMLT  239 (303)
T ss_dssp             CCHHHHHCC------------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH-HHHH
T ss_pred             eccchheeccCCC---ccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH-HHHH
Confidence            9999976522110   011122234568999999999876 5689999999999999999999999976432221 1111


Q ss_pred             HHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          259 VKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      .....+.......++           .....++..+.+++.+||+.||.+|||+.++++
T Consensus       240 ~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          240 LQNDPPSLETGVQDK-----------EMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             HTSSCCCTTC----------------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             hccCCCccccccccc-----------hhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            111111100000011           111234567889999999999999999999986

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=3.3e-44  Score=321.92  Aligned_cols=261  Identities=13%  Similarity=0.087  Sum_probs=204.3

Q ss_pred             HHHHHhcCCCcCceeeccCeeEEEEee-----ecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCC---CCCcceeece
Q 046639           24 ELSKATNNFSPANKIGQGGVSIVYKGI-----LDESRSIVAVKVVNLKQKEASRSFAAECNALRNIR---HRNLIKIITI   95 (331)
Q Consensus        24 ~~~~~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~   95 (331)
                      ++....++|.+.+.||+|+||+||+|.     +..+++.||+|++.....   ..+..|+.+++.+.   |+|++.++++
T Consensus        59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~l~~~~~~~iv~~~~~  135 (365)
T 3e7e_A           59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---WEFYIGTQLMERLKPSMQHMFMKFYSA  135 (365)
T ss_dssp             EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH---HHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred             eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh---hHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence            334456789999999999999999994     566889999999975433   35667777777775   9999999998


Q ss_pred             eecccCCCcceeeEEEeecCCCCHHHHHHhc---cCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecC
Q 046639           96 CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQS---NGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQ  172 (331)
Q Consensus        96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~  172 (331)
                      +.     ..+..++||||+++++|.+++...   ....+++..++.++.|++.||.|||+.   +|+||||||+||+++.
T Consensus       136 ~~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~  207 (365)
T 3e7e_A          136 HL-----FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGN  207 (365)
T ss_dssp             EE-----CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECG
T ss_pred             ee-----cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecc
Confidence            53     346789999999999999999752   345688899999999999999999999   9999999999999998


Q ss_pred             -----------CCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhC
Q 046639          173 -----------DIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTR  241 (331)
Q Consensus       173 -----------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g  241 (331)
                                 ++.+||+|||+++.+....      .........||+.|+|||++.+..++.++||||||+++|+|++|
T Consensus       208 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg  281 (365)
T 3e7e_A          208 GFLEQDDEDDLSAGLALIDLGQSIDMKLFP------KGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFG  281 (365)
T ss_dssp             GGTCC------CTTEEECCCTTCEEGGGSC------TTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHS
T ss_pred             cccCccccccccCCEEEeeCchhhhhhccC------CCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhC
Confidence                       8999999999997652211      11223345689999999999999999999999999999999999


Q ss_pred             CCCCCcccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCC-CcHHHHHHHHH
Q 046639          242 RRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMER-MEMRDVVAKLR  320 (331)
Q Consensus       242 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~R-ps~~~i~~~L~  320 (331)
                      ..||.........            +    .. .....         .....+.+++..||+.+|.+| |++.++.+.|+
T Consensus       282 ~~pf~~~~~~~~~------------~----~~-~~~~~---------~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~  335 (365)
T 3e7e_A          282 TYMKVKNEGGECK------------P----EG-LFRRL---------PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLK  335 (365)
T ss_dssp             SCCCEEEETTEEE------------E----CS-CCTTC---------SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHH
T ss_pred             CCccccCCCCcee------------e----ch-hcccc---------CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHH
Confidence            9999654221100            0    00 00000         124567788889999999999 78899998888


Q ss_pred             Hhhhhhh
Q 046639          321 HARETFL  327 (331)
Q Consensus       321 ~~~~~~~  327 (331)
                      ...+...
T Consensus       336 ~~l~~~~  342 (365)
T 3e7e_A          336 KVFQQHY  342 (365)
T ss_dssp             HHHHHHT
T ss_pred             HHHHHhh
Confidence            8776543

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.8e-43  Score=319.00  Aligned_cols=205  Identities=24%  Similarity=0.258  Sum_probs=171.6

Q ss_pred             HHHHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCC-CC-----Ccceeeceeec
Q 046639           25 LSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIR-HR-----NLIKIITICSS   98 (331)
Q Consensus        25 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----~i~~~~~~~~~   98 (331)
                      .....++|.+.+.||+|+||+||+|.+..+++.||||++... ......+..|+.+++.++ |+     +++.+++++  
T Consensus        49 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~--  125 (382)
T 2vx3_A           49 GEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF--  125 (382)
T ss_dssp             TCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEE--
T ss_pred             CCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeee--
Confidence            344567899999999999999999999999999999999743 334566778888888875 55     488888874  


Q ss_pred             ccCCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEec--CCCcE
Q 046639           99 IDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLD--QDIVA  176 (331)
Q Consensus        99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~--~~~~~  176 (331)
                         ...+..++|||++ +++|.+++.......+++..+..++.|++.||.|||+. ..+|+||||||+||+++  .++.+
T Consensus       126 ---~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~  200 (382)
T 2vx3_A          126 ---MFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAI  200 (382)
T ss_dssp             ---EETTEEEEEEECC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCE
T ss_pred             ---ccCCceEEEEecC-CCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcE
Confidence               3356889999999 56999999887656688899999999999999999952 11999999999999995  47789


Q ss_pred             EEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcc
Q 046639          177 HVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAM  248 (331)
Q Consensus       177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  248 (331)
                      ||+|||+++...           .......+|+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus       201 kL~DFG~a~~~~-----------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~  261 (382)
T 2vx3_A          201 KIVDFGSSCQLG-----------QRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA  261 (382)
T ss_dssp             EECCCTTCEETT-----------CCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             EEEeccCceecc-----------cccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            999999998651           1122456889999999999999999999999999999999999999864

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2.3e-44  Score=312.85  Aligned_cols=265  Identities=25%  Similarity=0.322  Sum_probs=196.0

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecC-CC--ceEEEEEeecc---chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCC
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDE-SR--SIVAVKVVNLK---QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFE  102 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~--~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  102 (331)
                      .++|.+.+.||+|+||+||+|.+.. ++  ..||+|++...   .....+.+.+|+.+++.++||||+++++++..    
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----   92 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT----   92 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc----
Confidence            4579999999999999999998643 33  36899988643   33455778999999999999999999998642    


Q ss_pred             CcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccC
Q 046639          103 GFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLG  182 (331)
Q Consensus       103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg  182 (331)
                       . ..++|+|++++++|.+++.... ..+++..+..++.|++.||.+||++   +++|+||||+||+++.++.++|+|||
T Consensus        93 -~-~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg  166 (291)
T 1u46_A           93 -P-PMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFG  166 (291)
T ss_dssp             -S-SCEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCT
T ss_pred             -C-CceeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccc
Confidence             2 3789999999999999997643 3467888999999999999999999   99999999999999999999999999


Q ss_pred             cccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHh
Q 046639          183 LAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKM  261 (331)
Q Consensus       183 ~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~  261 (331)
                      ++.......     ..........+|+.|+|||++.+..++.++||||||+++|+|++ |..||......  ........
T Consensus       167 ~~~~~~~~~-----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~  239 (291)
T 1u46_A          167 LMRALPQND-----DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS--QILHKIDK  239 (291)
T ss_dssp             TCEECCC-C-----CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHT
T ss_pred             ccccccccc-----cchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH--HHHHHHHc
Confidence            998752211     11112223456778999999988889999999999999999999 99999754211  11111110


Q ss_pred             hCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhhhc
Q 046639          262 ALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETFLG  328 (331)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~~~  328 (331)
                      ...       ..           .....++..+.+++.+||+.||.+|||+.++++.|+++...-..
T Consensus       240 ~~~-------~~-----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~  288 (291)
T 1u46_A          240 EGE-------RL-----------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDMR  288 (291)
T ss_dssp             SCC-------CC-----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-----
T ss_pred             cCC-------CC-----------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccchh
Confidence            000       00           01123556789999999999999999999999999988765443

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=4.8e-44  Score=321.53  Aligned_cols=260  Identities=10%  Similarity=0.014  Sum_probs=181.9

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHHcC--CCCCcceeecee-------
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNI--RHRNLIKIITIC-------   96 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l--~h~~i~~~~~~~-------   96 (331)
                      ..+|.+.+.||+|+||+||+|.+..+++.||+|++....   ......+.+|+.+++.+  +||||++++..+       
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            346999999999999999999999999999999997643   23345677775444444  699988855332       


Q ss_pred             ecccC------------CCcceeeEEEeecCCCCHHHHHHhccCCccchHHH------HHHHHHHHHHHHHHhhcCCCCe
Q 046639           97 SSIDF------------EGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQR------VNIAIDVSFAIEYFHHHCQPSI  158 (331)
Q Consensus        97 ~~~~~------------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~------~~~~~~i~~~l~~LH~~~~~~i  158 (331)
                      .....            ......++||||++ ++|.+++...... +.....      ..++.|++.||+|||++   +|
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~-~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~i  215 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFV-YVFRGDEGILALHILTAQLIRLAANLQSK---GL  215 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccc-cchhhhhhhhhHHHHHHHHHHHHHHHHHC---CC
Confidence            11100            01145899999997 8999999874322 233444      57779999999999999   99


Q ss_pred             eecCCCCCCEEecCCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCC--CCCccchhhHhHHHHHH
Q 046639          159 VHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG--SKASVSGDVYNFGILLL  236 (331)
Q Consensus       159 vH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~  236 (331)
                      +||||||+||+++.++.+||+|||+++...           .......+|+.|+|||++.+  ..++.++||||||+++|
T Consensus       216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~-----------~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~  284 (371)
T 3q60_A          216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVG-----------TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIY  284 (371)
T ss_dssp             EETTCSGGGEEECTTSCEEECCGGGEEETT-----------CEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHH
T ss_pred             ccCcCCHHHEEECCCCCEEEEecceeeecC-----------CCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHH
Confidence            999999999999999999999999998641           11113456789999999987  67999999999999999


Q ss_pred             HHHhCCCCCCcccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHH
Q 046639          237 EMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVV  316 (331)
Q Consensus       237 el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~  316 (331)
                      +|++|..||............      .............       ......++..+.+|+.+||+.||++|||+.+++
T Consensus       285 elltg~~Pf~~~~~~~~~~~~------~~~~~~~~~~~~~-------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l  351 (371)
T 3q60_A          285 RVWCLFLPFGLVTPGIKGSWK------RPSLRVPGTDSLA-------FGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAM  351 (371)
T ss_dssp             HHHHSSCSTTBCCTTCTTCCC------BCCTTSCCCCSCC-------CTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHT
T ss_pred             HHHhCCCCCCCcCcccccchh------hhhhhhccccccc-------hhhccCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence            999999999865332110000      0000000000000       011124567899999999999999999999997


Q ss_pred             H
Q 046639          317 A  317 (331)
Q Consensus       317 ~  317 (331)
                      +
T Consensus       352 ~  352 (371)
T 3q60_A          352 E  352 (371)
T ss_dssp             T
T ss_pred             c
Confidence            4

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=4.6e-43  Score=313.85  Aligned_cols=282  Identities=19%  Similarity=0.204  Sum_probs=195.2

Q ss_pred             cHHHHHHHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeeccc
Q 046639           21 SYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSID  100 (331)
Q Consensus        21 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  100 (331)
                      +........++|.+.+.||+|+||+||+|.+..+++.||||++... .........++..++.++||||+++++++....
T Consensus        14 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~   92 (360)
T 3e3p_A           14 ADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLG   92 (360)
T ss_dssp             SSHHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEEC
T ss_pred             hhhhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhccc
Confidence            3455667788999999999999999999999999999999988543 233345667888888899999999999986543


Q ss_pred             C--CCcceeeEEEeecCCCCHHHHHHh--ccCCccchHHHHHHHHHHHHHHHHHh--hcCCCCeeecCCCCCCEEecC-C
Q 046639          101 F--EGFDFKAIVFEYMQNRNLEQWLRQ--SNGQLRFLTQRVNIAIDVSFAIEYFH--HHCQPSIVHGDLKPSNILLDQ-D  173 (331)
Q Consensus       101 ~--~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~i~~~l~~LH--~~~~~~ivH~dik~~nilv~~-~  173 (331)
                      .  ......++|||++++ +|.+.+..  .....++...+..++.|++.||.+||  +.   +|+|+||||+||+++. +
T Consensus        93 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~  168 (360)
T 3e3p_A           93 ERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEAD  168 (360)
T ss_dssp             SSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTT
T ss_pred             cccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCC
Confidence            2  223347899999954 66655543  33445777888999999999999999  88   9999999999999996 8


Q ss_pred             CcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCC-CccchhhHhHHHHHHHHHhCCCCCCcccCCc
Q 046639          174 IVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSK-ASVSGDVYNFGILLLEMFTRRRPTDAMFNEG  252 (331)
Q Consensus       174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~  252 (331)
                      +.+||+|||++.....         ........||+.|+|||++.+.. ++.++||||||+++|+|++|..||..... .
T Consensus       169 ~~~kl~Dfg~a~~~~~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~-~  238 (360)
T 3e3p_A          169 GTLKLCDFGSAKKLSP---------SEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS-A  238 (360)
T ss_dssp             TEEEECCCTTCBCCCT---------TSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-H
T ss_pred             CcEEEeeCCCceecCC---------CCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCCh-H
Confidence            9999999999986521         11222345789999999987654 89999999999999999999999976422 1


Q ss_pred             chHHHHHHhhC--cchhhhhcCcccc-cccc-cCC-------cchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          253 LTLHEFVKMAL--PDKVMEIVDPSLL-LEVT-ANN-------YSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       253 ~~~~~~~~~~~--~~~~~~~~~~~~~-~~~~-~~~-------~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ...........  +.......++... .... ...       ......+...+.+|+.+||+.||.+|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          239 GQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             HHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence            22222222111  1111111111000 0000 000       0111125678999999999999999999999985

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.2e-43  Score=323.81  Aligned_cols=270  Identities=21%  Similarity=0.271  Sum_probs=198.2

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccC-CCcceee
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDF-EGFDFKA  108 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~~~~~~  108 (331)
                      .+|.+.+.||+|+||+||+|++..+++.||||++.....    ...+|+.+++.++||||+++++++..... .+...++
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            369999999999999999999999999999999864322    23469999999999999999998754321 2344578


Q ss_pred             EEEeecCCCCHHHHHHh--ccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCC-CcEEEcccCccc
Q 046639          109 IVFEYMQNRNLEQWLRQ--SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQD-IVAHVGDLGLAK  185 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~-~~~kl~Dfg~a~  185 (331)
                      +||||++ ++|.+.+..  .....+++..+..++.|++.||.|||++   +|+||||||+||+++.+ +.+||+|||+++
T Consensus       130 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          130 LVLDYVP-ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEECCC-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eehhccc-ccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            9999995 577777654  3345678888999999999999999999   99999999999999965 578999999998


Q ss_pred             ccccCCCCCcccccCCceeecccccccCCcccCCC-CCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCc
Q 046639          186 FLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGS-KASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALP  264 (331)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  264 (331)
                      ....         ........+|+.|+|||++.+. .++.++|||||||++|||++|..||.+... ...+..+......
T Consensus       206 ~~~~---------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~-~~~l~~i~~~lg~  275 (420)
T 1j1b_A          206 QLVR---------GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG-VDQLVEIIKVLGT  275 (420)
T ss_dssp             ECCT---------TCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCS
T ss_pred             hccc---------CCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCC
Confidence            6521         1122345689999999998765 689999999999999999999999976422 1222232221111


Q ss_pred             ch--hhhhcCcccc----cccccCCc--chHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          265 DK--VMEIVDPSLL----LEVTANNY--SWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       265 ~~--~~~~~~~~~~----~~~~~~~~--~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ..  .....++...    ..+....+  .+....+..+.+|+.+||+.||.+|||+.++++
T Consensus       276 p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          276 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             CCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence            00  0000111100    00000000  011234578999999999999999999999974

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=6.3e-44  Score=316.48  Aligned_cols=259  Identities=18%  Similarity=0.213  Sum_probs=178.4

Q ss_pred             HHhcCCCcCc-eeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcc
Q 046639           27 KATNNFSPAN-KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFD  105 (331)
Q Consensus        27 ~~~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~  105 (331)
                      ...++|.+.+ .||+|+||+||+|.+..+++.||+|++.... ...   ......++.+.||||+++++++... .....
T Consensus        25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~---~e~~~~~~~~~h~~i~~~~~~~~~~-~~~~~   99 (336)
T 3fhr_A           25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-KAR---QEVDHHWQASGGPHIVCILDVYENM-HHGKR   99 (336)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-HHH---HHHHHHHHHTTSTTBCCEEEEEEEE-ETTEE
T ss_pred             cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-HHH---HHHHHHHHhcCCCChHHHHHHHhhc-cCCCc
Confidence            4556899965 6999999999999999999999999986432 211   2223345667899999999997543 23355


Q ss_pred             eeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecC---CCcEEEcccC
Q 046639          106 FKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQ---DIVAHVGDLG  182 (331)
Q Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~---~~~~kl~Dfg  182 (331)
                      ..++|||++++++|.+++.......+++..++.++.|++.||.|||++   +++|+||||+||+++.   ++.+||+|||
T Consensus       100 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg  176 (336)
T 3fhr_A          100 CLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFG  176 (336)
T ss_dssp             EEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccc
Confidence            689999999999999999887666788999999999999999999999   9999999999999976   4569999999


Q ss_pred             cccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhh
Q 046639          183 LAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMA  262 (331)
Q Consensus       183 ~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  262 (331)
                      ++....          ........+|+.|+|||++.+..++.++||||||+++|+|++|..||...........  ....
T Consensus       177 ~~~~~~----------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--~~~~  244 (336)
T 3fhr_A          177 FAKETT----------QNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG--MKRR  244 (336)
T ss_dssp             TCEEC--------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------
T ss_pred             cceecc----------ccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh--HHHh
Confidence            997642          1122344578999999999888999999999999999999999999975432211100  0000


Q ss_pred             CcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          263 LPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ..........            .....++..+.+|+.+||+.||.+|||+.++++
T Consensus       245 ~~~~~~~~~~------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          245 IRLGQYGFPN------------PEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             ------CCCT------------TTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hhccccccCc------------hhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            0000000000            011234567899999999999999999999987

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=3.8e-44  Score=319.37  Aligned_cols=267  Identities=18%  Similarity=0.231  Sum_probs=202.5

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhh-----------------HHHHHHHHHHHHcCCCCCcce
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEA-----------------SRSFAAECNALRNIRHRNLIK   91 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~e~~~l~~l~h~~i~~   91 (331)
                      .++|.+.+.||+|+||.||+|.+  +++.||+|.+.......                 ...+.+|+.+++.++||||++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~  107 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT  107 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence            46899999999999999999999  79999999986442211                 167899999999999999999


Q ss_pred             eeceeecccCCCcceeeEEEeecCCCCHHHH------HHhccCCccchHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCC
Q 046639           92 IITICSSIDFEGFDFKAIVFEYMQNRNLEQW------LRQSNGQLRFLTQRVNIAIDVSFAIEYFHH-HCQPSIVHGDLK  164 (331)
Q Consensus        92 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~------l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~~~~ivH~dik  164 (331)
                      +++++.     ..+..++|||++++++|.++      +.......+++..++.++.|++.||.+||+ .   +++|+||+
T Consensus       108 ~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~  179 (348)
T 2pml_X          108 CEGIIT-----NYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVK  179 (348)
T ss_dssp             CSEEEE-----SSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCC
T ss_pred             EEEEEe-----eCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCC
Confidence            999953     45678999999999999998      655445678889999999999999999999 8   99999999


Q ss_pred             CCCEEecCCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCC-CCcc-chhhHhHHHHHHHHHhCC
Q 046639          165 PSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGS-KASV-SGDVYNFGILLLEMFTRR  242 (331)
Q Consensus       165 ~~nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~-~~DiwslG~il~el~~g~  242 (331)
                      |+||+++.++.++|+|||++.....          .......+++.|+|||++.+. .++. ++||||||+++|+|++|.
T Consensus       180 p~Nil~~~~~~~kl~dfg~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~  249 (348)
T 2pml_X          180 PSNILMDKNGRVKLSDFGESEYMVD----------KKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV  249 (348)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECBT----------TEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSS
T ss_pred             hHhEEEcCCCcEEEecccccccccc----------ccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCC
Confidence            9999999999999999999986521          122345688999999999887 6666 999999999999999999


Q ss_pred             CCCCcccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          243 RPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       243 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      .||......................  ....................++..+.+|+.+||+.||.+|||+.++++
T Consensus       250 ~pf~~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          250 VPFSLKISLVELFNNIRTKNIEYPL--DRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             CSSCCSSCSHHHHHHHTSCCCCCCC--SSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CCCCCCCcHHHHHHHHhccCcCCcc--chhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            9997643322212111111110000  000000000000001111345678899999999999999999999986

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=2.4e-43  Score=312.75  Aligned_cols=267  Identities=18%  Similarity=0.221  Sum_probs=202.4

Q ss_pred             hcCCCcCceeeccCeeEEEEeee-cCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCC------CcceeeceeecccC
Q 046639           29 TNNFSPANKIGQGGVSIVYKGIL-DESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHR------NLIKIITICSSIDF  101 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~  101 (331)
                      .++|.+.+.||+|+||+||+|.+ ..+++.||+|++... ......+.+|+.+++.++|+      +++++++++     
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~-----   86 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF-----   86 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE-----
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc-----
Confidence            46899999999999999999998 567899999999643 34456788899999988655      488888885     


Q ss_pred             CCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecC---------
Q 046639          102 EGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQ---------  172 (331)
Q Consensus       102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~---------  172 (331)
                      ...+..++|||++ +++|.+++.......+++..+..++.|++.||.|||++   +++|+||||+||+++.         
T Consensus        87 ~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~  162 (339)
T 1z57_A           87 EHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNP  162 (339)
T ss_dssp             EETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC-
T ss_pred             ccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCC
Confidence            4456889999999 99999999887666678899999999999999999999   9999999999999987         


Q ss_pred             ----------CCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCC
Q 046639          173 ----------DIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRR  242 (331)
Q Consensus       173 ----------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~  242 (331)
                                ++.+||+|||++....           .......||+.|+|||++.+..++.++||||||+++|+|++|.
T Consensus       163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~  231 (339)
T 1z57_A          163 KIKRDERTLINPDIKVVDFGSATYDD-----------EHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGF  231 (339)
T ss_dssp             ---CEEEEESCCCEEECCCSSCEETT-----------SCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             ccccccccccCCCceEeeCcccccCc-----------cccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCC
Confidence                      6689999999997641           1122346899999999999999999999999999999999999


Q ss_pred             CCCCcccCCcchHHHHHH--hhCcchhhhhcCcccc--------c-------------ccccCCcchHHHHHHHHHHhhc
Q 046639          243 RPTDAMFNEGLTLHEFVK--MALPDKVMEIVDPSLL--------L-------------EVTANNYSWIEDCLVAVIGTGV  299 (331)
Q Consensus       243 ~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~--------~-------------~~~~~~~~~~~~~~~~l~~l~~  299 (331)
                      .||....... .......  ...+............        .             ............+...+.+|+.
T Consensus       232 ~pf~~~~~~~-~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  310 (339)
T 1z57_A          232 TVFPTHDSKE-HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQ  310 (339)
T ss_dssp             CSCCCSCHHH-HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHH
T ss_pred             CCCCCCChHH-HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHH
Confidence            9997542211 1111111  1111111000000000        0             0000000112356788999999


Q ss_pred             cccCCCCCCCCcHHHHHH
Q 046639          300 TCSMESPMERMEMRDVVA  317 (331)
Q Consensus       300 ~cl~~~P~~Rps~~~i~~  317 (331)
                      +||+.||.+|||+.|+++
T Consensus       311 ~~L~~dP~~Rpt~~ell~  328 (339)
T 1z57_A          311 KMLEYDPAKRITLREALK  328 (339)
T ss_dssp             HHTCSSTTTSCCHHHHTT
T ss_pred             HHhCcCcccccCHHHHhc
Confidence            999999999999999984

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.3e-43  Score=310.50  Aligned_cols=276  Identities=18%  Similarity=0.287  Sum_probs=199.1

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeeccc--------
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSID--------  100 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--------  100 (331)
                      .++|.+.+.||+|+||.||+|.+..+++.||+|.+...+....+.+.+|+.+++.++||||+++++++....        
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            468999999999999999999999999999999998777777788999999999999999999999864321        


Q ss_pred             -CCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEec-CCCcEEE
Q 046639          101 -FEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLD-QDIVAHV  178 (331)
Q Consensus       101 -~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~-~~~~~kl  178 (331)
                       +......++|||+++ ++|.+++...   .++...++.++.|++.||.+||++   +++|+||||+||+++ .++.+||
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl  162 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQG---PLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKI  162 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEE
T ss_pred             cccccCceeEEeeccC-CCHHHHhhcC---CccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEE
Confidence             234567899999995 6999998642   467788999999999999999999   999999999999997 5679999


Q ss_pred             cccCcccccccCCCCCcccccCCceeecccccccCCcccCC-CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHH
Q 046639          179 GDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG-SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHE  257 (331)
Q Consensus       179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~  257 (331)
                      +|||++.......     ..........+|+.|+|||++.+ ..++.++||||||+++|+|++|..||...... .....
T Consensus       163 ~Dfg~~~~~~~~~-----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-~~~~~  236 (320)
T 2i6l_A          163 GDFGLARIMDPHY-----SHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL-EQMQL  236 (320)
T ss_dssp             CCCTTCBCC-------------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHH
T ss_pred             ccCccccccCCCc-----ccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH-HHHHH
Confidence            9999998652111     11112233457888999998765 67899999999999999999999999764221 11111


Q ss_pred             HHHhhCcch------hhhhcCcccccccc---cCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          258 FVKMALPDK------VMEIVDPSLLLEVT---ANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       258 ~~~~~~~~~------~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      .........      ..............   .........++..+.+++.+||+.||++|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          237 ILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             HHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            111110000      00000000000000   0000112235678999999999999999999999975

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=9.9e-44  Score=319.44  Aligned_cols=270  Identities=16%  Similarity=0.193  Sum_probs=199.0

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc--chhhHHHHHHHHHHHHcCCCCCcceeeceeecccC-CCc
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRNIRHRNLIKIITICSSIDF-EGF  104 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~~  104 (331)
                      ..++|.+.+.||+|+||+||+|.+..+++.||+|++...  .......+.+|+.+++.++||||+++++++...+. ...
T Consensus        40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  119 (371)
T 4exu_A           40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  119 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred             ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence            346899999999999999999999999999999999643  33445778899999999999999999999754321 112


Q ss_pred             ceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcc
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA  184 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a  184 (331)
                      ...++|||++ .++|.+++..    .+++..+..++.|++.||.|||+.   +|+|+||||+||+++.++.+||+|||++
T Consensus       120 ~~~~lv~e~~-~~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a  191 (371)
T 4exu_A          120 YDFYLVMPFM-QTDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLA  191 (371)
T ss_dssp             CCCEEEEECC-CEEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred             eeEEEEEccc-cccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCcc
Confidence            2348999999 4788888732    377889999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCcccccCCceeecccccccCCcccCC-CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhC
Q 046639          185 KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG-SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMAL  263 (331)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  263 (331)
                      ....           .......+|+.|+|||++.+ ..++.++||||||+++|+|++|..||...... ...........
T Consensus       192 ~~~~-----------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~~  259 (371)
T 4exu_A          192 RHAD-----------AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-DQLTQILKVTG  259 (371)
T ss_dssp             -------------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHC
T ss_pred             cccc-----------cCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhC
Confidence            7641           11223457899999999887 67899999999999999999999999754211 11222211111


Q ss_pred             c--chhhhhcCcc--------cccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          264 P--DKVMEIVDPS--------LLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       264 ~--~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      .  ..........        ...............+...+.+|+.+||+.||++|||+.++++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          260 VPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             CCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             CCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence            0  0000000000        0000000001112234678999999999999999999999975

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.9e-44  Score=318.99  Aligned_cols=255  Identities=19%  Similarity=0.272  Sum_probs=198.5

Q ss_pred             hcCCCcCceeeccCeeEEEEeeec---CCCceEEEEEeeccc----hhhHHHHHHHHHHHHcC-CCCCcceeeceeeccc
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILD---ESRSIVAVKVVNLKQ----KEASRSFAAECNALRNI-RHRNLIKIITICSSID  100 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~  100 (331)
                      .++|.+.+.||+|+||+||+|++.   .+++.||||+++...    ......+.+|+.+++.+ .||||+++++++    
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~----  128 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF----  128 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE----
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEE----
Confidence            358999999999999999999984   478999999986432    22334567899999999 699999999985    


Q ss_pred             CCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcc
Q 046639          101 FEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGD  180 (331)
Q Consensus       101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~D  180 (331)
                       ......++||||+++++|.+++....  .++...+..++.|++.||.|||++   +|+|+||||+||+++.++.+||+|
T Consensus       129 -~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~D  202 (355)
T 1vzo_A          129 -QTETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTD  202 (355)
T ss_dssp             -EETTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESC
T ss_pred             -eeCceEEEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEee
Confidence             34567899999999999999997644  477888999999999999999999   999999999999999999999999


Q ss_pred             cCcccccccCCCCCcccccCCceeecccccccCCcccCCC--CCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHH
Q 046639          181 LGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGS--KASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEF  258 (331)
Q Consensus       181 fg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  258 (331)
                      ||+++....       ..........||+.|+|||++.+.  .++.++||||||+++|+|++|..||........ ....
T Consensus       203 fG~a~~~~~-------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~~  274 (355)
T 1vzo_A          203 FGLSKEFVA-------DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-QAEI  274 (355)
T ss_dssp             SSEEEECCG-------GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-HHHH
T ss_pred             CCCCeeccc-------CCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch-HHHH
Confidence            999986521       111223345689999999999863  478999999999999999999999975432221 1121


Q ss_pred             HHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCC-----cHHHHHHH
Q 046639          259 VKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERM-----EMRDVVAK  318 (331)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----s~~~i~~~  318 (331)
                      ......      ..+           .+...+...+.+|+.+||+.||.+||     |+.++++.
T Consensus       275 ~~~~~~------~~~-----------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h  322 (355)
T 1vzo_A          275 SRRILK------SEP-----------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  322 (355)
T ss_dssp             HHHHHH------CCC-----------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             HHHHhc------cCC-----------CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence            111100      000           11123456788999999999999999     89998753

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=3.3e-43  Score=307.04  Aligned_cols=265  Identities=21%  Similarity=0.246  Sum_probs=195.2

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeeccc-------
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSID-------  100 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-------  100 (331)
                      ..++|.+.+.||+|+||+||+|++..+++.||+|++... ......+.+|+.+++.++||||+++++++....       
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            345799999999999999999999989999999999643 445577899999999999999999999875421       


Q ss_pred             -CCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEc
Q 046639          101 -FEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVG  179 (331)
Q Consensus       101 -~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~  179 (331)
                       .......++|||++++++|.+++.... ..++...++.++.|++.||.+||++   +++|+||||+||+++.++.++|+
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~  158 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIG  158 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEEC
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEe
Confidence             133567899999999999999997643 3456788889999999999999999   99999999999999999999999


Q ss_pred             ccCcccccccCCCCC------cccccCCceeecccccccCCcccCCC-CCccchhhHhHHHHHHHHHhCCCCCCcccCCc
Q 046639          180 DLGLAKFLFGYEPGT------AAETASNSIEIKGIVGYVAPEYGMGS-KASVSGDVYNFGILLLEMFTRRRPTDAMFNEG  252 (331)
Q Consensus       180 Dfg~a~~~~~~~~~~------~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~  252 (331)
                      |||++..........      ............+|+.|+|||++.+. .++.++||||||+++|+|++   ||.....  
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~--  233 (303)
T 1zy4_A          159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME--  233 (303)
T ss_dssp             CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH--
T ss_pred             eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh--
Confidence            999997653211000      00011223345688999999998865 68999999999999999998   5542111  


Q ss_pred             chHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          253 LTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                        ..........      .......       .+...++..+.+++.+||+.||.+|||+.++++
T Consensus       234 --~~~~~~~~~~------~~~~~~~-------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          234 --RVNILKKLRS------VSIEFPP-------DFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             --HHHHHHHHHS------TTCCCCT-------TCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --HHHHHHhccc------cccccCc-------cccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence              1111111000      0000000       122344567889999999999999999999985

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.9e-43  Score=317.76  Aligned_cols=273  Identities=19%  Similarity=0.294  Sum_probs=204.4

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCC-----------CCCcceeeceee
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIR-----------HRNLIKIITICS   97 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~~~~~~~   97 (331)
                      .++|.+.+.||+|+||+||+|.+..+++.||+|++... ......+.+|+.+++.+.           |+||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            46899999999999999999999999999999999643 334566788999998876           889999999875


Q ss_pred             cccCCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEec------
Q 046639           98 SIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLD------  171 (331)
Q Consensus        98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~------  171 (331)
                      ... ......++|||++ +++|.+++.......+++..+..++.|++.||.|||++.  +|+|+||||+||+++      
T Consensus        97 ~~~-~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~  172 (373)
T 1q8y_A           97 HKG-PNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPE  172 (373)
T ss_dssp             EEE-TTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTT
T ss_pred             ccC-CCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCc
Confidence            432 2334789999999 999999998866666888999999999999999999943  899999999999994      


Q ss_pred             CCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCC
Q 046639          172 QDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNE  251 (331)
Q Consensus       172 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~  251 (331)
                      ..+.+||+|||++.....           ......+|+.|+|||++.+..++.++||||||+++|+|++|..||......
T Consensus       173 ~~~~~kl~Dfg~a~~~~~-----------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  241 (373)
T 1q8y_A          173 NLIQIKIADLGNACWYDE-----------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGH  241 (373)
T ss_dssp             TEEEEEECCCTTCEETTB-----------CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC------
T ss_pred             CcceEEEcccccccccCC-----------CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCccc
Confidence            444899999999976521           122345899999999999999999999999999999999999999764322


Q ss_pred             cc-----hHHHHHHhh--Ccchhhh-------hcC-cccc-----------cccccCCcchHHHHHHHHHHhhccccCCC
Q 046639          252 GL-----TLHEFVKMA--LPDKVME-------IVD-PSLL-----------LEVTANNYSWIEDCLVAVIGTGVTCSMES  305 (331)
Q Consensus       252 ~~-----~~~~~~~~~--~~~~~~~-------~~~-~~~~-----------~~~~~~~~~~~~~~~~~l~~l~~~cl~~~  305 (331)
                      ..     .........  .+.....       ..+ ....           .........+...+...+.+|+.+||+.|
T Consensus       242 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  321 (373)
T 1q8y_A          242 SYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLD  321 (373)
T ss_dssp             ---CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSS
T ss_pred             ccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccC
Confidence            11     111111110  1110000       000 0000           01111122344678889999999999999


Q ss_pred             CCCCCcHHHHHH
Q 046639          306 PMERMEMRDVVA  317 (331)
Q Consensus       306 P~~Rps~~~i~~  317 (331)
                      |++|||+.++++
T Consensus       322 P~~Rpt~~ell~  333 (373)
T 1q8y_A          322 PRKRADAGGLVN  333 (373)
T ss_dssp             TTTCBCHHHHHT
T ss_pred             ccccCCHHHHhh
Confidence            999999999985

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=5.2e-43  Score=317.03  Aligned_cols=270  Identities=20%  Similarity=0.251  Sum_probs=195.4

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccC-CCccee
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDF-EGFDFK  107 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~~~~~  107 (331)
                      ..+|.+.+.||+|+||+||+|++..++. +|+|.+......    ..+|+.+++.++||||+++++++..... ......
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~  113 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL  113 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence            4579999999999999999999987766 888877533221    2369999999999999999999765432 344557


Q ss_pred             eEEEeecCCCCHHHHHHh--ccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEec-CCCcEEEcccCcc
Q 046639          108 AIVFEYMQNRNLEQWLRQ--SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLD-QDIVAHVGDLGLA  184 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~-~~~~~kl~Dfg~a  184 (331)
                      ++||||+++ ++.+.+..  .....+++..+..++.|++.||.|||++   +|+||||||+||+++ .++.+||+|||++
T Consensus       114 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a  189 (394)
T 4e7w_A          114 NLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSA  189 (394)
T ss_dssp             EEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             EEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence            899999965 55544432  2344577889999999999999999999   999999999999999 7999999999999


Q ss_pred             cccccCCCCCcccccCCceeecccccccCCcccCCC-CCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhC
Q 046639          185 KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGS-KASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMAL  263 (331)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  263 (331)
                      +....         ........+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.... ..+........
T Consensus       190 ~~~~~---------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~l~~i~~~~g  259 (394)
T 4e7w_A          190 KILIA---------GEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI-DQLVEIIKVLG  259 (394)
T ss_dssp             EECCT---------TCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHC
T ss_pred             ccccC---------CCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhC
Confidence            87521         1222345689999999998765 5899999999999999999999999764221 12222222111


Q ss_pred             cc--hhhhhcCcccc----cccccCC--cchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          264 PD--KVMEIVDPSLL----LEVTANN--YSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       264 ~~--~~~~~~~~~~~----~~~~~~~--~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ..  ......++...    .......  ..+...+++.+.+|+.+||+.||.+|||+.++++
T Consensus       260 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (394)
T 4e7w_A          260 TPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC  321 (394)
T ss_dssp             CCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence            10  00000011000    0000000  0111235678999999999999999999999985

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=8.3e-44  Score=323.64  Aligned_cols=205  Identities=21%  Similarity=0.285  Sum_probs=156.2

Q ss_pred             cCCCc-CceeeccCeeEEEEeeec--CCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           30 NNFSP-ANKIGQGGVSIVYKGILD--ESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        30 ~~y~~-~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      +.|.+ +++||+|+||+||+|++.  .+++.||+|++....  ....+.+|+.+++.++||||+++++++..   .....
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~---~~~~~   94 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLS---HADRK   94 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEE---TTTTE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEec---CCCCe
Confidence            34666 568999999999999965  578899999986432  23467899999999999999999999643   34567


Q ss_pred             eeEEEeecCCCCHHHHHHhcc-------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEe----cCCCc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSN-------GQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILL----DQDIV  175 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv----~~~~~  175 (331)
                      .++||||+ +++|.+++....       ...+++..++.++.|++.||.|||+.   +|+||||||+||++    +.++.
T Consensus        95 ~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~  170 (405)
T 3rgf_A           95 VWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGR  170 (405)
T ss_dssp             EEEEEECC-SEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTC
T ss_pred             EEEEEeCC-CCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCc
Confidence            89999999 568988886421       22377888999999999999999999   99999999999999    67789


Q ss_pred             EEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCC-CCccchhhHhHHHHHHHHHhCCCCCCcc
Q 046639          176 AHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGS-KASVSGDVYNFGILLLEMFTRRRPTDAM  248 (331)
Q Consensus       176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~  248 (331)
                      +||+|||+++......     ..........||+.|+|||++.+. .++.++|||||||++|+|++|..||...
T Consensus       171 ~kl~Dfg~a~~~~~~~-----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  239 (405)
T 3rgf_A          171 VKIADMGFARLFNSPL-----KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  239 (405)
T ss_dssp             EEECCTTCCC---------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred             EEEEECCCceecCCCC-----cccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence            9999999998752211     111223346689999999998874 5899999999999999999999999754

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=8.4e-43  Score=302.57  Aligned_cols=253  Identities=22%  Similarity=0.232  Sum_probs=201.1

Q ss_pred             HHHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCC
Q 046639           26 SKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ--KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEG  103 (331)
Q Consensus        26 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  103 (331)
                      ....++|.+.+.||+|+||+||+|.+..+++.||+|++....  ......+.+|+.++++++||||+++++++     ..
T Consensus        18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~   92 (287)
T 2wei_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL-----ED   92 (287)
T ss_dssp             HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----EC
T ss_pred             HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEE-----eC
Confidence            445668999999999999999999999899999999986442  23456788999999999999999999995     34


Q ss_pred             cceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCC---CcEEEcc
Q 046639          104 FDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQD---IVAHVGD  180 (331)
Q Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~---~~~kl~D  180 (331)
                      ....++|||++++++|.+++....  .++...++.++.|++.||.+||++   +++|+||+|+||+++.+   +.+||+|
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~D  167 (287)
T 2wei_A           93 SSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIID  167 (287)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECS
T ss_pred             CCeEEEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEec
Confidence            567899999999999999987643  477889999999999999999999   99999999999999754   4799999


Q ss_pred             cCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHH-
Q 046639          181 LGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFV-  259 (331)
Q Consensus       181 fg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~-  259 (331)
                      ||++.....         ........+++.|+|||++.+ .++.++||||||+++|+|++|..||.....  ......+ 
T Consensus       168 fg~~~~~~~---------~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~  235 (287)
T 2wei_A          168 FGLSTCFQQ---------NTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE--YDILKRVE  235 (287)
T ss_dssp             TTGGGTBCC---------CSSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHH
T ss_pred             cCcceeecC---------CCccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH--HHHHHHHH
Confidence            999976521         112223458889999999876 489999999999999999999999975321  1111111 


Q ss_pred             HhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          260 KMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ......      +           ......++..+.+++.+||+.||++|||+.++++
T Consensus       236 ~~~~~~------~-----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          236 TGKYAF------D-----------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             HCCCCC------C-----------SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCCCCC------C-----------chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence            111000      0           0011234567899999999999999999999987

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2.3e-42  Score=308.46  Aligned_cols=268  Identities=19%  Similarity=0.256  Sum_probs=200.2

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCC-ceEEEEEeeccchhhHHHHHHHHHHHHcCCCCC------cceeeceeeccc
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESR-SIVAVKVVNLKQKEASRSFAAECNALRNIRHRN------LIKIITICSSID  100 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~------i~~~~~~~~~~~  100 (331)
                      ..++|.+.+.||+|+||+||+|.+..++ +.||+|++... ......+..|+.+++.+.|++      ++.+.+++    
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~----   91 (355)
T 2eu9_A           17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWF----   91 (355)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE----
T ss_pred             ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee----
Confidence            3568999999999999999999997766 78999999643 344567888999999987655      77777774    


Q ss_pred             CCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEe----------
Q 046639          101 FEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILL----------  170 (331)
Q Consensus       101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv----------  170 (331)
                       ...+..++|||++ +++|.+.+.......+++..+..++.|++.||.|||++   +|+|+||||+||++          
T Consensus        92 -~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~  166 (355)
T 2eu9_A           92 -NFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYN  166 (355)
T ss_dssp             -EETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEEC
T ss_pred             -eeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccc
Confidence             4456789999999 78888888776656688899999999999999999999   99999999999999          


Q ss_pred             ---------cCCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhC
Q 046639          171 ---------DQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTR  241 (331)
Q Consensus       171 ---------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g  241 (331)
                               +.++.+||+|||++....           .......||+.|+|||++.+..++.++||||||+++|+|++|
T Consensus       167 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g  235 (355)
T 2eu9_A          167 EHKSCEEKSVKNTSIRVADFGSATFDH-----------EHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG  235 (355)
T ss_dssp             CC-CCCEEEESCCCEEECCCTTCEETT-----------SCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred             ccccccccccCCCcEEEeecCcccccc-----------ccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhC
Confidence                     567899999999997641           112234689999999999999999999999999999999999


Q ss_pred             CCCCCcccCCcchHHHHHHh--hCcchhhhhcCcc-cc-------cc-------------cccCCcchHHHHHHHHHHhh
Q 046639          242 RRPTDAMFNEGLTLHEFVKM--ALPDKVMEIVDPS-LL-------LE-------------VTANNYSWIEDCLVAVIGTG  298 (331)
Q Consensus       242 ~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~-~~-------~~-------------~~~~~~~~~~~~~~~l~~l~  298 (331)
                      ..||....... ........  ..+.......... ..       ..             ...............+.+|+
T Consensus       236 ~~pf~~~~~~~-~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  314 (355)
T 2eu9_A          236 FTLFQTHENRE-HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLM  314 (355)
T ss_dssp             SCSCCCSSHHH-HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHH
T ss_pred             CCCCCCCCHHH-HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHH
Confidence            99997542211 11111111  1111111000000 00       00             00000011123466899999


Q ss_pred             ccccCCCCCCCCcHHHHHH
Q 046639          299 VTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       299 ~~cl~~~P~~Rps~~~i~~  317 (331)
                      .+||+.||++|||+.++++
T Consensus       315 ~~~L~~dP~~Rpt~~e~l~  333 (355)
T 2eu9_A          315 RRMLEFDPAQRITLAEALL  333 (355)
T ss_dssp             HHHTCSSTTTSCCHHHHTT
T ss_pred             HHHhcCChhhCcCHHHHhc
Confidence            9999999999999999974

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=6.9e-43  Score=311.96  Aligned_cols=269  Identities=17%  Similarity=0.199  Sum_probs=199.1

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc--chhhHHHHHHHHHHHHcCCCCCcceeeceeecccC-CCcc
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRNIRHRNLIKIITICSSIDF-EGFD  105 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~~~  105 (331)
                      .++|.+.+.||+|+||.||+|.+..+++.||+|++...  .......+.+|+.+++.++||||+++++++..... ....
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            46899999999999999999999999999999998643  33345678899999999999999999999753211 1123


Q ss_pred             eeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccc
Q 046639          106 FKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAK  185 (331)
Q Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~  185 (331)
                      ..++|||++. ++|.+++..    .+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++.
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  174 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLAR  174 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred             eEEEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccccc
Confidence            4589999995 688887742    377889999999999999999999   99999999999999999999999999987


Q ss_pred             ccccCCCCCcccccCCceeecccccccCCcccCC-CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhC-
Q 046639          186 FLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG-SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMAL-  263 (331)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~-  263 (331)
                      ...           .......+|+.|+|||++.+ ..++.++||||||+++|+|++|..||...... ..+........ 
T Consensus       175 ~~~-----------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-~~~~~i~~~~~~  242 (353)
T 3coi_A          175 HAD-----------AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-DQLTQILKVTGV  242 (353)
T ss_dssp             C-------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH-HHHHHHHHHHCB
T ss_pred             CCC-----------CCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCC
Confidence            541           11223467899999999887 67899999999999999999999999764221 11222211110 


Q ss_pred             -cchhhhhcCcc--------cccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          264 -PDKVMEIVDPS--------LLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       264 -~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                       +..........        +..............++..+.+|+.+||+.||++|||+.++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          243 PGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             CCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             CCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence             00000000000        0000001111222345678999999999999999999999974

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=6.5e-43  Score=334.57  Aligned_cols=264  Identities=19%  Similarity=0.276  Sum_probs=206.2

Q ss_pred             HHHHHhcCCCcCceeeccCeeEEEEeeecCC---CceEEEEEeecc-chhhHHHHHHHHHHHHcCCCCCcceeeceeecc
Q 046639           24 ELSKATNNFSPANKIGQGGVSIVYKGILDES---RSIVAVKVVNLK-QKEASRSFAAECNALRNIRHRNLIKIITICSSI   99 (331)
Q Consensus        24 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   99 (331)
                      +.....++|.+.+.||+|+||+||+|.+..+   +..||+|.+... .....+.+.+|+.+++.++||||+++++++.  
T Consensus       384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~--  461 (656)
T 2j0j_A          384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT--  461 (656)
T ss_dssp             GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred             ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe--
Confidence            3334456899999999999999999998643   457999988643 3344577899999999999999999999863  


Q ss_pred             cCCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEc
Q 046639          100 DFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVG  179 (331)
Q Consensus       100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~  179 (331)
                          .+..++|||++++++|.+++.... ..+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+
T Consensus       462 ----~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~  533 (656)
T 2j0j_A          462 ----ENPVWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLG  533 (656)
T ss_dssp             ----SSSCEEEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEEC
T ss_pred             ----cCceEEEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEE
Confidence                245799999999999999997643 3467888999999999999999999   99999999999999999999999


Q ss_pred             ccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHH
Q 046639          180 DLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEF  258 (331)
Q Consensus       180 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~  258 (331)
                      |||++.......       ........+++.|+|||++.+..++.++||||||+++|||++ |..||......  .....
T Consensus       534 DFG~a~~~~~~~-------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~--~~~~~  604 (656)
T 2j0j_A          534 DFGLSRYMEDST-------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGR  604 (656)
T ss_dssp             CCCCCCSCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHH
T ss_pred             ecCCCeecCCCc-------ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH--HHHHH
Confidence            999998652111       111223346778999999988899999999999999999997 99999754221  11111


Q ss_pred             HHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhh
Q 046639          259 VKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARET  325 (331)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~  325 (331)
                      +....        ..           ..+..++..+.+|+.+||+.||.+|||+.+|++.|+.+.+.
T Consensus       605 i~~~~--------~~-----------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~  652 (656)
T 2j0j_A          605 IENGE--------RL-----------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  652 (656)
T ss_dssp             HHHTC--------CC-----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHcCC--------CC-----------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence            11100        00           11123567889999999999999999999999999998764

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.1e-42  Score=307.51  Aligned_cols=257  Identities=20%  Similarity=0.230  Sum_probs=178.7

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc-hhhHHHHHHHHH-HHHcCCCCCcceeeceeecccCCCcc
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ-KEASRSFAAECN-ALRNIRHRNLIKIITICSSIDFEGFD  105 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~~~  105 (331)
                      ..++|.+.+.||+|+||.||+|.+..+++.||+|++.... ......+..|+. +++.++||||+++++++.     ..+
T Consensus        20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~-----~~~   94 (327)
T 3aln_A           20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALF-----REG   94 (327)
T ss_dssp             CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEE-----CSS
T ss_pred             CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEE-----eCC
Confidence            3468999999999999999999999999999999997543 233345556666 677789999999999954     346


Q ss_pred             eeeEEEeecCCCCHHHHHHh---ccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccC
Q 046639          106 FKAIVFEYMQNRNLEQWLRQ---SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLG  182 (331)
Q Consensus       106 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg  182 (331)
                      ..++|||+++ ++|.+++..   .....++...+..++.|++.||.+||+..  +++|+||||+||+++.++.+||+|||
T Consensus        95 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg  171 (327)
T 3aln_A           95 DCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFG  171 (327)
T ss_dssp             EEEEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCS
T ss_pred             ceEEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCC
Confidence            7899999995 588888764   22455778889999999999999999853  89999999999999999999999999


Q ss_pred             cccccccCCCCCcccccCCceeecccccccCCccc----CCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHH
Q 046639          183 LAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYG----MGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEF  258 (331)
Q Consensus       183 ~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~----~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  258 (331)
                      ++.....         ........||+.|+|||++    .+..++.++||||||+++|+|++|..||........    .
T Consensus       172 ~~~~~~~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~  238 (327)
T 3aln_A          172 ISGQLVD---------SIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD----Q  238 (327)
T ss_dssp             SSCC---------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC----------
T ss_pred             Cceeccc---------ccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH----H
Confidence            9976521         1112233588999999998    456789999999999999999999999975321100    0


Q ss_pred             HHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          259 VKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ..     .......+.+..       .....++..+.+|+.+||+.||++|||+.+|++
T Consensus       239 ~~-----~~~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          239 LT-----QVVKGDPPQLSN-------SEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             -C-----CCCCSCCCCCCC-------CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HH-----HHhcCCCCCCCC-------cccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            00     000000001100       011234567999999999999999999999976

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2.2e-43  Score=310.03  Aligned_cols=259  Identities=25%  Similarity=0.372  Sum_probs=195.5

Q ss_pred             cHHHHHHHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc--chhhHHHHHHHHHHHHcCC--CCCcceeecee
Q 046639           21 SYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRNIR--HRNLIKIITIC   96 (331)
Q Consensus        21 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~   96 (331)
                      ++..+....++|.+.+.||+|+||.||+|.+. +++.||+|++...  .......+.+|+.+++.++  |+||+++++++
T Consensus        19 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~   97 (313)
T 3cek_A           19 YFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE   97 (313)
T ss_dssp             -CCEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred             CeeeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence            33444456778999999999999999999986 5888999998644  3445577899999999997  59999999985


Q ss_pred             ecccCCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcE
Q 046639           97 SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVA  176 (331)
Q Consensus        97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~  176 (331)
                      .     .....++||| +.+++|.+++....  .+++..+..++.|++.||.+||++   +++|+||||+||+++ ++.+
T Consensus        98 ~-----~~~~~~lv~e-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~-~~~~  165 (313)
T 3cek_A           98 I-----TDQYIYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGML  165 (313)
T ss_dssp             E-----CSSEEEEEEC-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEE
T ss_pred             e-----cCCEEEEEEe-cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEE-CCeE
Confidence            3     4567899999 45899999997643  467788999999999999999999   999999999999996 4899


Q ss_pred             EEcccCcccccccCCCCCcccccCCceeecccccccCCcccCC-----------CCCccchhhHhHHHHHHHHHhCCCCC
Q 046639          177 HVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG-----------SKASVSGDVYNFGILLLEMFTRRRPT  245 (331)
Q Consensus       177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----------~~~~~~~DiwslG~il~el~~g~~pf  245 (331)
                      ||+|||++.......      .........||+.|+|||++.+           ..++.++||||||+++|+|++|..||
T Consensus       166 kL~Dfg~~~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf  239 (313)
T 3cek_A          166 KLIDFGIANQMQPDT------TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF  239 (313)
T ss_dssp             EECCCSSSCC--------------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             EEeeccccccccCcc------ccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCch
Confidence            999999997652111      1112234468999999999875           46888999999999999999999999


Q ss_pred             CcccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          246 DAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      .............            .++.....       +...+...+.+++.+||+.||.+|||+.++++
T Consensus       240 ~~~~~~~~~~~~~------------~~~~~~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          240 QQIINQISKLHAI------------IDPNHEIE-------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             TTCCSHHHHHHHH------------HCTTSCCC-------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhHHHHHHHHHHH------------HhcccccC-------CcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence            7543221111111            11111111       11123457889999999999999999999985

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.7e-42  Score=304.80  Aligned_cols=253  Identities=19%  Similarity=0.221  Sum_probs=181.0

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccch-hh-HHHHHHHHHHHHcCCCCCcceeeceeecccCCCcc
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK-EA-SRSFAAECNALRNIRHRNLIKIITICSSIDFEGFD  105 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~  105 (331)
                      ..++|.+.+.||+|+||.||+|.+..+++.||+|++..... .. .+.+..+..+++.++||||+++++++.     ..+
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~-----~~~   97 (318)
T 2dyl_A           23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFI-----TNT   97 (318)
T ss_dssp             CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSS
T ss_pred             hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEe-----cCC
Confidence            34679999999999999999999998999999999975432 22 233445556788889999999999954     456


Q ss_pred             eeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCCEEecCCCcEEEcccCcc
Q 046639          106 FKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHH-HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA  184 (331)
Q Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a  184 (331)
                      ..++|||++ ++.+..+.... ...+++..+..++.|++.||.|||+ .   +++|+||||+||+++.++.+||+|||++
T Consensus        98 ~~~lv~e~~-~~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~  172 (318)
T 2dyl_A           98 DVFIAMELM-GTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGIS  172 (318)
T ss_dssp             EEEEEECCC-SEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             cEEEEEecc-CCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCc
Confidence            789999999 66666665432 3457788999999999999999998 6   8999999999999999999999999998


Q ss_pred             cccccCCCCCcccccCCceeecccccccCCcccC-----CCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHH
Q 046639          185 KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGM-----GSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFV  259 (331)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~  259 (331)
                      .....         ........+|+.|+|||++.     +..++.++||||||+++|+|++|..||..............
T Consensus       173 ~~~~~---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  243 (318)
T 2dyl_A          173 GRLVD---------DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVL  243 (318)
T ss_dssp             -----------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH
T ss_pred             hhccC---------CccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHh
Confidence            76521         11223345889999999984     45688999999999999999999999975432222222222


Q ss_pred             HhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          260 KMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ....+         ....         ...++..+.+++.+||+.||.+|||+.++++
T Consensus       244 ~~~~~---------~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          244 QEEPP---------LLPG---------HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             HSCCC---------CCCS---------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ccCCC---------CCCc---------cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            11110         0000         0124567889999999999999999999986

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.3e-43  Score=307.40  Aligned_cols=247  Identities=21%  Similarity=0.290  Sum_probs=190.6

Q ss_pred             HHHHHHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccch------hhHHHHHHHHHHHHcC----CCCCccee
Q 046639           23 AELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK------EASRSFAAECNALRNI----RHRNLIKI   92 (331)
Q Consensus        23 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l----~h~~i~~~   92 (331)
                      .+.....++|.+.+.||+|+||.||+|.+..+++.||+|++.....      .....+.+|+.+++++    +|+||+++
T Consensus        24 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~  103 (312)
T 2iwi_A           24 KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL  103 (312)
T ss_dssp             ---------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCE
T ss_pred             cchhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeE
Confidence            3445667799999999999999999999998999999999964432      1223356788988888    89999999


Q ss_pred             eceeecccCCCcceeeEEEee-cCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEec
Q 046639           93 ITICSSIDFEGFDFKAIVFEY-MQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLD  171 (331)
Q Consensus        93 ~~~~~~~~~~~~~~~~lv~e~-~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~  171 (331)
                      ++++     ...+..++|+|+ +.+++|.+++....  .+++..++.++.|++.||.+||+.   +++|+||||+||+++
T Consensus       104 ~~~~-----~~~~~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~  173 (312)
T 2iwi_A          104 LDWF-----ETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILID  173 (312)
T ss_dssp             EEEC----------CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEE
T ss_pred             EEEE-----ecCCeEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEe
Confidence            9984     445678999999 78899999997644  377889999999999999999999   999999999999999


Q ss_pred             -CCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCC-ccchhhHhHHHHHHHHHhCCCCCCccc
Q 046639          172 -QDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKA-SVSGDVYNFGILLLEMFTRRRPTDAMF  249 (331)
Q Consensus       172 -~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~  249 (331)
                       .++.++|+|||++.....          .......+++.|+|||++.+..+ +.++||||||+++|+|++|..||....
T Consensus       174 ~~~~~~kl~dfg~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  243 (312)
T 2iwi_A          174 LRRGCAKLIDFGSGALLHD----------EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ  243 (312)
T ss_dssp             TTTTEEEECCCSSCEECCS----------SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH
T ss_pred             CCCCeEEEEEcchhhhccc----------CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH
Confidence             889999999999987521          11234458899999999877665 568999999999999999999996421


Q ss_pred             CCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          250 NEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                             .......                     .+...+...+.+++.+||+.||++|||+.++++
T Consensus       244 -------~~~~~~~---------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          244 -------EILEAEL---------------------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             -------HHHHTCC---------------------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -------HHhhhcc---------------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                   1111000                     111234567889999999999999999999986

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=2.9e-43  Score=310.16  Aligned_cols=248  Identities=19%  Similarity=0.246  Sum_probs=197.4

Q ss_pred             HHHHHHHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchh------hHHHHHHHHHHHHcCC--CCCcceee
Q 046639           22 YAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKE------ASRSFAAECNALRNIR--HRNLIKII   93 (331)
Q Consensus        22 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--h~~i~~~~   93 (331)
                      ........++|.+.+.||+|+||+||+|.+..+++.||+|++......      ....+..|+.+++.+.  |+||++++
T Consensus        35 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~  114 (320)
T 3a99_A           35 GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL  114 (320)
T ss_dssp             -----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEE
T ss_pred             ccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEE
Confidence            344456677999999999999999999999999999999999654221      2234667899999996  59999999


Q ss_pred             ceeecccCCCcceeeEEEeecCC-CCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEec-
Q 046639           94 TICSSIDFEGFDFKAIVFEYMQN-RNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLD-  171 (331)
Q Consensus        94 ~~~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~-  171 (331)
                      +++     ...+..++|+|++.+ ++|.+++....  .++...++.++.|++.||.|||+.   +++|+||||+||+++ 
T Consensus       115 ~~~-----~~~~~~~lv~e~~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~  184 (320)
T 3a99_A          115 DWF-----ERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDL  184 (320)
T ss_dssp             EEE-----ECSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEET
T ss_pred             EEE-----ecCCcEEEEEEcCCCCccHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeC
Confidence            995     445678999999965 89999997643  467888999999999999999999   999999999999999 


Q ss_pred             CCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCC-ccchhhHhHHHHHHHHHhCCCCCCcccC
Q 046639          172 QDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKA-SVSGDVYNFGILLLEMFTRRRPTDAMFN  250 (331)
Q Consensus       172 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~  250 (331)
                      .++.+||+|||++.....          .......||+.|+|||++.+..+ +.++||||||+++|+|++|..||.... 
T Consensus       185 ~~~~~kL~Dfg~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-  253 (320)
T 3a99_A          185 NRGELKLIDFGSGALLKD----------TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-  253 (320)
T ss_dssp             TTTEEEECCCTTCEECCS----------SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-
T ss_pred             CCCCEEEeeCcccccccc----------ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-
Confidence            789999999999987521          12223458999999999877665 788999999999999999999996421 


Q ss_pred             CcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          251 EGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                            .......                     .+...++..+.+|+.+||+.||++|||+.+|++
T Consensus       254 ------~~~~~~~---------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          254 ------EIIRGQV---------------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             ------HHHHCCC---------------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ------hhhcccc---------------------cccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                  1111100                     011123567889999999999999999999985

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.9e-42  Score=326.89  Aligned_cols=280  Identities=21%  Similarity=0.241  Sum_probs=204.6

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc-chhhHHHHHHHHHHHHcCCCCCcceeeceeeccc-CCCcc
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK-QKEASRSFAAECNALRNIRHRNLIKIITICSSID-FEGFD  105 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~~~  105 (331)
                      ..++|.+.+.||+|+||+||+|.+..+++.||+|++... .......+.+|+.+++.++||||+++++++.... +...+
T Consensus        12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~   91 (676)
T 3qa8_A           12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND   91 (676)
T ss_dssp             -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred             CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence            347899999999999999999999999999999998644 3445577899999999999999999999865422 23366


Q ss_pred             eeeEEEeecCCCCHHHHHHhcc-CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCc---EEEccc
Q 046639          106 FKAIVFEYMQNRNLEQWLRQSN-GQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIV---AHVGDL  181 (331)
Q Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~---~kl~Df  181 (331)
                      ..++||||+++++|.+++.... ...+++..++.++.|++.||+|||+.   |++|+||||+||+++.++.   ++|+||
T Consensus        92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DF  168 (676)
T 3qa8_A           92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDL  168 (676)
T ss_dssp             SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred             eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccc
Confidence            7899999999999999998743 33577889999999999999999999   9999999999999997664   999999


Q ss_pred             CcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHh
Q 046639          182 GLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKM  261 (331)
Q Consensus       182 g~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  261 (331)
                      |++.....         ........||+.|+|||++.+..++.++||||||+++|+|++|..||.....    ...+...
T Consensus       169 G~a~~~~~---------~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~----~~~~~~~  235 (676)
T 3qa8_A          169 GYAKELDQ---------GELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ----PVQWHGK  235 (676)
T ss_dssp             CCCCBTTS---------CCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH----HHHSSTT
T ss_pred             cccccccc---------ccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc----hhhhhhh
Confidence            99986521         1122345689999999999999999999999999999999999999965311    0010000


Q ss_pred             hCc---c--hhhhhcCc-ccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHH-----HHHHHHHhh
Q 046639          262 ALP---D--KVMEIVDP-SLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRD-----VVAKLRHAR  323 (331)
Q Consensus       262 ~~~---~--~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~-----i~~~L~~~~  323 (331)
                      ...   .  ........ .......+.........+..+.+|+.+||+.||++|||+.+     +.+.++.+.
T Consensus       236 i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL  308 (676)
T 3qa8_A          236 VREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSIL  308 (676)
T ss_dssp             CC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHH
T ss_pred             hhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHH
Confidence            000   0  00000000 00011111122334457788999999999999999999988     444444443

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=4.6e-43  Score=308.62  Aligned_cols=265  Identities=20%  Similarity=0.274  Sum_probs=197.0

Q ss_pred             HHHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCC
Q 046639           26 SKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ--KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEG  103 (331)
Q Consensus        26 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  103 (331)
                      ....++|.+.+.||+|+||.||+|.+..   .+|+|++....  ....+.+.+|+.+++.++||||+++++++.     .
T Consensus        29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~  100 (319)
T 2y4i_B           29 DIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACM-----S  100 (319)
T ss_dssp             SSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEE-----C
T ss_pred             cCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEe-----c
Confidence            3446789999999999999999999863   48999986442  223345778999999999999999999964     3


Q ss_pred             cceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCc
Q 046639          104 FDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGL  183 (331)
Q Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~  183 (331)
                      ....++|||++++++|.+++.... ..+++..++.++.|++.||.+||+.   +++|+||||+||+++ ++.++|+|||+
T Consensus       101 ~~~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~  175 (319)
T 2y4i_B          101 PPHLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGL  175 (319)
T ss_dssp             SSCEEEECBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSC
T ss_pred             CCceEEEeecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCC
Confidence            456899999999999999997543 3577889999999999999999999   999999999999998 68999999999


Q ss_pred             ccccccCCCCCcccccCCceeecccccccCCcccCC---------CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcch
Q 046639          184 AKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG---------SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLT  254 (331)
Q Consensus       184 a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~---------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~  254 (331)
                      +........   ...........|++.|+|||++.+         ..++.++||||||+++|+|++|..||......  .
T Consensus       176 ~~~~~~~~~---~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~  250 (319)
T 2y4i_B          176 FSISGVLQA---GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE--A  250 (319)
T ss_dssp             CC-------------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH--H
T ss_pred             ccccccccc---cccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--H
Confidence            876421111   111122233458899999999864         45789999999999999999999999754221  1


Q ss_pred             HHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhh
Q 046639          255 LHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETF  326 (331)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~  326 (331)
                      ........        ..+....          ..++..+.+++.+||+.||.+|||+.+|++.|+.+.+..
T Consensus       251 ~~~~~~~~--------~~~~~~~----------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~  304 (319)
T 2y4i_B          251 IIWQMGTG--------MKPNLSQ----------IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN  304 (319)
T ss_dssp             HHHHHHTT--------CCCCCCC----------SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred             HHHHhccC--------CCCCCCc----------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence            11111111        1111100          013446889999999999999999999999999887654

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=3e-41  Score=292.45  Aligned_cols=236  Identities=10%  Similarity=0.043  Sum_probs=184.9

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcc
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFD  105 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~  105 (331)
                      .++|.+.+.||+|+||.||+|.+..+++.||+|++....   ......+.+|+.++..++||||+++++++.     ..+
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~-----~~~  104 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVH-----TRA  104 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETT
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEE-----ECC
Confidence            368999999999999999999999999999999996442   344577899999999999999999999953     456


Q ss_pred             eeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccc
Q 046639          106 FKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAK  185 (331)
Q Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~  185 (331)
                      ..++||||+++++|.++++..    .....+..++.|++.||.|||++   ||+|+||||+||+++.+|.++|++++   
T Consensus       105 ~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~---  174 (286)
T 3uqc_A          105 GGLVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA---  174 (286)
T ss_dssp             EEEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC---
T ss_pred             cEEEEEEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc---
Confidence            789999999999999999542    23456788999999999999999   99999999999999999999997443   


Q ss_pred             ccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcc
Q 046639          186 FLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPD  265 (331)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  265 (331)
                                               |++       +++.++||||||+++|+|++|..||..........          
T Consensus       175 -------------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~----------  212 (286)
T 3uqc_A          175 -------------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA----------  212 (286)
T ss_dssp             -------------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE----------
T ss_pred             -------------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH----------
Confidence                                     222       36889999999999999999999998643221000          


Q ss_pred             hhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhhh
Q 046639          266 KVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETFL  327 (331)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~~  327 (331)
                      .........     .........+++..+.+++.+||+.||.+| |+.++++.|+.+.....
T Consensus       213 ~~~~~~~~~-----~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~  268 (286)
T 3uqc_A          213 PAERDTAGQ-----PIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD  268 (286)
T ss_dssp             ECCBCTTSC-----BCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred             HHHHHhccC-----CCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence            000000000     000001222456779999999999999999 99999999999876544

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.2e-40  Score=290.70  Aligned_cols=237  Identities=17%  Similarity=0.234  Sum_probs=183.9

Q ss_pred             HhcCCCcC-ceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHH-HcCCCCCcceeeceeecccCCCcc
Q 046639           28 ATNNFSPA-NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNAL-RNIRHRNLIKIITICSSIDFEGFD  105 (331)
Q Consensus        28 ~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~~~~~~~~  105 (331)
                      ..++|.+. +.||+|+||.||+|.+..+++.||+|++...     ....+|+.++ +...||||+++++++... .....
T Consensus        15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~-~~~~~   88 (299)
T 3m2w_A           15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENL-YAGRK   88 (299)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEE
T ss_pred             cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhh-cCCCc
Confidence            34568777 7899999999999999999999999998632     3456788887 556899999999987542 23466


Q ss_pred             eeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecC---CCcEEEcccC
Q 046639          106 FKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQ---DIVAHVGDLG  182 (331)
Q Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~---~~~~kl~Dfg  182 (331)
                      ..++|||++++++|.+++.......+++..++.++.|++.||.|||+.   +++|+||||+||+++.   ++.++|+|||
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg  165 (299)
T 3m2w_A           89 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG  165 (299)
T ss_dssp             EEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred             eEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence            789999999999999999887666788999999999999999999999   9999999999999998   7899999999


Q ss_pred             cccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhh
Q 046639          183 LAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMA  262 (331)
Q Consensus       183 ~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  262 (331)
                      ++...                              .+..++.++||||||+++|+|++|..||........      .  
T Consensus       166 ~a~~~------------------------------~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~------~--  207 (299)
T 3m2w_A          166 FAKET------------------------------TGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI------S--  207 (299)
T ss_dssp             TCEEC------------------------------TTCGGGGHHHHHHHHHHHHHHHHSSCSCCC---------------
T ss_pred             ccccc------------------------------ccccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh------h--
Confidence            98653                              123567899999999999999999999965321100      0  


Q ss_pred             CcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          263 LPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                        .........    ............++..+.+++.+||+.||.+|||+.++++
T Consensus       208 --~~~~~~~~~----~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          208 --PGMKTRIRM----GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             --CCSCCSSCT----TCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             --HHHHHHHhh----ccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence              000000000    0000000111345678999999999999999999999986

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=4.5e-41  Score=307.96  Aligned_cols=254  Identities=19%  Similarity=0.213  Sum_probs=183.3

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcC-CCCCcceeeceeecccCCCcceee
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNI-RHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      +.|.+.+.||+|+||+||.+. ..+++.||||.+....   ...+.+|+.+++.+ +||||+++++++     ......+
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~-----~~~~~~~   85 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSE-----TTDRFLY   85 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEE-----ECSSEEE
T ss_pred             heeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCeEE
Confidence            455667889999999998653 3478999999986432   34567899999876 899999999884     4457789


Q ss_pred             EEEeecCCCCHHHHHHhccCCcc-----chHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCC----------
Q 046639          109 IVFEYMQNRNLEQWLRQSNGQLR-----FLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQD----------  173 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~-----~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~----------  173 (331)
                      +|||++ +++|.+++........     ....++.++.|++.||.|||++   +|+||||||+||+++.+          
T Consensus        86 lv~E~~-~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~  161 (434)
T 2rio_A           86 IALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTG  161 (434)
T ss_dssp             EEECCC-SEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTC
T ss_pred             EEEecC-CCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccC
Confidence            999999 5699999986432211     2234567999999999999999   99999999999999754          


Q ss_pred             ---CcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCC-------CCCccchhhHhHHHHHHHHHh-CC
Q 046639          174 ---IVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG-------SKASVSGDVYNFGILLLEMFT-RR  242 (331)
Q Consensus       174 ---~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~~-g~  242 (331)
                         +.+||+|||++........    ..........||+.|+|||++.+       ..++.++|||||||++|+|++ |.
T Consensus       162 ~~~~~~kL~DFG~a~~~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~  237 (434)
T 2rio_A          162 AENLRILISDFGLCKKLDSGQS----SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK  237 (434)
T ss_dssp             CCSCEEEECCCTTCEECCC------------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSC
T ss_pred             CCceEEEEcccccceecCCCCc----cceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCC
Confidence               4899999999987632111    01111234569999999999876       568999999999999999999 99


Q ss_pred             CCCCcccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          243 RPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       243 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      .||......   ............       ..       .......++..+.+|+.+||+.||.+|||+.+|++
T Consensus       238 ~Pf~~~~~~---~~~i~~~~~~~~-------~~-------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          238 HPFGDKYSR---ESNIIRGIFSLD-------EM-------KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             CTTCSTTTH---HHHHHHTCCCCC-------CC-------TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCCCchhh---HHHHhcCCCCcc-------cc-------cccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            999653221   112221111100       00       00112356788999999999999999999999985

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.8e-40  Score=303.27  Aligned_cols=252  Identities=20%  Similarity=0.235  Sum_probs=183.0

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcC-CCCCcceeeceeecccCCCcce
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNI-RHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      ...+|.+.+.||+|+||+|+. ....+++.||||++.....   ....+|+.+++.+ +||||+++++++     .....
T Consensus        22 ~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~-----~~~~~   92 (432)
T 3p23_A           22 GKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTE-----KDRQF   92 (432)
T ss_dssp             TTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEE-----EETTE
T ss_pred             ccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCE
Confidence            345799999999999999654 3334788999999864322   2245799999999 799999999985     44567


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecC-----CCcEEEccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQ-----DIVAHVGDL  181 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~-----~~~~kl~Df  181 (331)
                      .++|||++ +++|.+++...... .....+..++.|++.||.|||++   +|+||||||+||+++.     ...++|+||
T Consensus        93 ~~lv~E~~-~g~L~~~l~~~~~~-~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DF  167 (432)
T 3p23_A           93 QYIAIELC-AATLQEYVEQKDFA-HLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDF  167 (432)
T ss_dssp             EEEEEECC-SEEHHHHHHSSSCC-CCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCT
T ss_pred             EEEEEECC-CCCHHHHHHhcCCC-ccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecc
Confidence            89999999 56999999865432 33345678999999999999999   9999999999999953     235889999


Q ss_pred             CcccccccCCCCCcccccCCceeecccccccCCcccCC---CCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHH
Q 046639          182 GLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG---SKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHE  257 (331)
Q Consensus       182 g~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~  257 (331)
                      |++.......     ..........||+.|+|||++.+   ..++.++|||||||++|+|++ |..||.....   ....
T Consensus       168 G~a~~~~~~~-----~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~---~~~~  239 (432)
T 3p23_A          168 GLCKKLAVGR-----HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ---RQAN  239 (432)
T ss_dssp             TEEECC-----------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT---HHHH
T ss_pred             cceeeccCCC-----cceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH---HHHH
Confidence            9998752211     11122234569999999999874   567889999999999999999 9999964321   1111


Q ss_pred             HHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          258 FVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ........   ...             .........+.+|+.+||+.||.+|||+.+|++
T Consensus       240 ~~~~~~~~---~~~-------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          240 ILLGACSL---DCL-------------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             HHTTCCCC---TTS-------------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHhccCCc---ccc-------------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            11000000   000             111234566889999999999999999999983

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=2.8e-41  Score=307.41  Aligned_cols=247  Identities=15%  Similarity=0.131  Sum_probs=182.7

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccch---hhHHHHHHHHHHHHcCCC-CCcceeece---------
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK---EASRSFAAECNALRNIRH-RNLIKIITI---------   95 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h-~~i~~~~~~---------   95 (331)
                      .++|...+.||+|+||+||+|.+..+++.||||++.....   ...+.+.+|+.+++.+.| +|...+..+         
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            4468888999999999999999999999999999873322   224678899999999977 322111111         


Q ss_pred             ee------------cccCCCcceeeEEEeecCCCCHHHHHHh-----ccCCccchHHHHHHHHHHHHHHHHHhhcCCCCe
Q 046639           96 CS------------SIDFEGFDFKAIVFEYMQNRNLEQWLRQ-----SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSI  158 (331)
Q Consensus        96 ~~------------~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i  158 (331)
                      +.            ..........+++|+.+ +++|.++++.     .....+++..++.++.|++.||.|||++   +|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i  232 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL  232 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence            00            00000122356777776 7899999862     2344577778889999999999999999   99


Q ss_pred             eecCCCCCCEEecCCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCccc----------CCCCCccchhh
Q 046639          159 VHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYG----------MGSKASVSGDV  228 (331)
Q Consensus       159 vH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~----------~~~~~~~~~Di  228 (331)
                      +||||||+||+++.++.+||+|||+++....           ......| +.|+|||++          .+..++.++||
T Consensus       233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~-----------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~Dv  300 (413)
T 3dzo_A          233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----------SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDT  300 (413)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTE-----------EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHH
T ss_pred             ccCCcccceEEEecCCeEEEEeccceeecCC-----------ccccCCC-CceeCchhhhccccccccccCcCCCchhhH
Confidence            9999999999999999999999999876411           1223456 889999998          66668899999


Q ss_pred             HhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCC
Q 046639          229 YNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPME  308 (331)
Q Consensus       229 wslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~  308 (331)
                      ||||+++|+|++|..||........             ......         ..    ..++..+.+|+.+||+.||++
T Consensus       301 wSlGvil~elltg~~Pf~~~~~~~~-------------~~~~~~---------~~----~~~~~~~~~li~~~l~~dP~~  354 (413)
T 3dzo_A          301 WTLGLAIYWIWCADLPNTDDAALGG-------------SEWIFR---------SC----KNIPQPVRALLEGFLRYPKED  354 (413)
T ss_dssp             HHHHHHHHHHHHSSCCCCTTGGGSC-------------SGGGGS---------SC----CCCCHHHHHHHHHHTCSSGGG
T ss_pred             HHHHHHHHHHHHCCCCCCCcchhhh-------------HHHHHh---------hc----ccCCHHHHHHHHHHccCChhh
Confidence            9999999999999999975422110             000000         00    023467899999999999999


Q ss_pred             CCcHHHHHH
Q 046639          309 RMEMRDVVA  317 (331)
Q Consensus       309 Rps~~~i~~  317 (331)
                      |||+.++++
T Consensus       355 Rpt~~~~l~  363 (413)
T 3dzo_A          355 RLLPLQAME  363 (413)
T ss_dssp             SCCHHHHTT
T ss_pred             CcCHHHHHh
Confidence            999877754

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.2e-40  Score=319.55  Aligned_cols=247  Identities=21%  Similarity=0.269  Sum_probs=196.4

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecC-CCceEEEEEeecc-chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDE-SRSIVAVKVVNLK-QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      .++|.+.+.||+|+||+||+|.+.. +++.||||++... .......+..|+.+++.++||||+++++++...+......
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            4789999999999999999999975 7899999988643 3344567889999999999999999999986544333334


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      .++||||+++++|.+++..    .+++..++.++.|++.||.|||++   +|+||||||+||+++.+ .+||+|||++..
T Consensus       159 ~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~  230 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSR  230 (681)
T ss_dssp             EEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred             eEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchh
Confidence            6999999999999988754    478899999999999999999999   99999999999999975 899999999986


Q ss_pred             cccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcch
Q 046639          187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDK  266 (331)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  266 (331)
                      ...            .....||+.|+|||++.+.. +.++||||||+++|+|++|..||........             
T Consensus       231 ~~~------------~~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~-------------  284 (681)
T 2pzi_A          231 INS------------FGYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL-------------  284 (681)
T ss_dssp             TTC------------CSCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC-------------
T ss_pred             ccc------------CCccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc-------------
Confidence            521            13356899999999987654 8899999999999999999988864321110             


Q ss_pred             hhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCC-cHHHHHHHHHHhhh
Q 046639          267 VMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERM-EMRDVVAKLRHARE  324 (331)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-s~~~i~~~L~~~~~  324 (331)
                          .           ...........+.+|+.+||+.||.+|| ++.++...|..+..
T Consensus       285 ----~-----------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  328 (681)
T 2pzi_A          285 ----P-----------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR  328 (681)
T ss_dssp             ----C-----------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred             ----c-----------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence                0           0011123456789999999999999999 56667777766543

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.5e-39  Score=288.44  Aligned_cols=247  Identities=17%  Similarity=0.157  Sum_probs=184.0

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc--------hhhHHHHHHHHHHHHcCC---------CCCcce
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ--------KEASRSFAAECNALRNIR---------HRNLIK   91 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---------h~~i~~   91 (331)
                      .++|.+.+.||+|+||+||+|++  +++.||||++....        ....+.+.+|+.+++.++         |||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            46799999999999999999998  57999999997542        222366888999888875         666666


Q ss_pred             eeceee-----------------cc--------cCCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHH
Q 046639           92 IITICS-----------------SI--------DFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFA  146 (331)
Q Consensus        92 ~~~~~~-----------------~~--------~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~  146 (331)
                      +.+++.                 ..        ++......++||||+++|++.+.+.+   ..+++..+..++.|++.|
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHH
Confidence            655432                 10        01235788999999999977666643   346789999999999999


Q ss_pred             HHHHh-hcCCCCeeecCCCCCCEEecCCC--------------------cEEEcccCcccccccCCCCCcccccCCceee
Q 046639          147 IEYFH-HHCQPSIVHGDLKPSNILLDQDI--------------------VAHVGDLGLAKFLFGYEPGTAAETASNSIEI  205 (331)
Q Consensus       147 l~~LH-~~~~~~ivH~dik~~nilv~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~  205 (331)
                      |.||| ++   +|+||||||+|||++.++                    .+||+|||+|+....             ...
T Consensus       174 L~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------------~~~  237 (336)
T 2vuw_A          174 LAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------------GIV  237 (336)
T ss_dssp             HHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------------TEE
T ss_pred             HHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------------CcE
Confidence            99999 89   999999999999999887                    899999999987521             134


Q ss_pred             cccccccCCcccCCCCCccchhhHhHHHH-HHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhhhcCcccccccccCCc
Q 046639          206 KGIVGYVAPEYGMGSKASVSGDVYNFGIL-LLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNY  284 (331)
Q Consensus       206 ~~t~~y~aPE~~~~~~~~~~~DiwslG~i-l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (331)
                      .||+.|+|||++.+.. +.++||||++++ .+++++|..||...     .......    ..+.......     .....
T Consensus       238 ~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~-----~~~~~~~----~~~~~~~~~~-----~~~~~  302 (336)
T 2vuw_A          238 VFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV-----LWLHYLT----DKMLKQMTFK-----TKCNT  302 (336)
T ss_dssp             ECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH-----HHHHHHH----HHHHHTCCCS-----SCCCS
T ss_pred             EEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch-----hhhhHHH----HhhhhhhccC-----cccch
Confidence            6999999999998876 899999998777 78888999998531     0000000    0000000000     00111


Q ss_pred             chHHHHHHHHHHhhccccCCCCCCCCcHHHHH
Q 046639          285 SWIEDCLVAVIGTGVTCSMESPMERMEMRDVV  316 (331)
Q Consensus       285 ~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~  316 (331)
                      .....+++.+.+|+.+||+.|     |+.|++
T Consensus       303 ~~~~~~s~~~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          303 PAMKQIKRKIQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred             hhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence            344578899999999999977     888887

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=2.4e-32  Score=257.08  Aligned_cols=186  Identities=12%  Similarity=-0.013  Sum_probs=129.8

Q ss_pred             eeeccCeeEEEEeeecCCCceEEEEEeecc----------chhhHHHHHHHHHHHHcC-CCCCcceeeceeecccCCCcc
Q 046639           37 KIGQGGVSIVYKGILDESRSIVAVKVVNLK----------QKEASRSFAAECNALRNI-RHRNLIKIITICSSIDFEGFD  105 (331)
Q Consensus        37 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~  105 (331)
                      ..+.|++|.+..++....++.+++|.+...          .....+.+.+|+++|+++ .|+||++++++     +++++
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~-----~ed~~  315 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAH-----GENAQ  315 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEE-----EECSS
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEE-----EEECC
Confidence            355677777777777667889999998643          123346699999999999 69999999999     56778


Q ss_pred             eeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccc
Q 046639          106 FKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAK  185 (331)
Q Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~  185 (331)
                      ..||||||++|++|.+++....  .++.   ..++.||+.||.|+|++   ||+||||||+|||++.+|.+||+|||+|+
T Consensus       316 ~~yLVMEyv~G~~L~d~i~~~~--~l~~---~~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr  387 (569)
T 4azs_A          316 SGWLVMEKLPGRLLSDMLAAGE--EIDR---EKILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIV  387 (569)
T ss_dssp             EEEEEEECCCSEEHHHHHHTTC--CCCH---HHHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEE
T ss_pred             EEEEEEecCCCCcHHHHHHhCC--CCCH---HHHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCe
Confidence            8999999999999999997643  3433   35889999999999999   99999999999999999999999999998


Q ss_pred             ccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCC
Q 046639          186 FLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP  244 (331)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p  244 (331)
                      ....        .........||+.|+|||++.+ .+..++|+||+|++++++.++..+
T Consensus       388 ~~~~--------~~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          388 TTPQ--------DCSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             SCC-----------CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             eCCC--------CCccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            6521        1223345679999999999876 456789999999998877665444

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.94  E-value=8e-28  Score=225.12  Aligned_cols=192  Identities=18%  Similarity=0.150  Sum_probs=140.4

Q ss_pred             CCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc--------hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCC
Q 046639           32 FSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ--------KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEG  103 (331)
Q Consensus        32 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  103 (331)
                      +...+.||+|+||+||+|..  .++.+++|......        ....+.+.+|+.++++++||||+++..++.     .
T Consensus       338 ~~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~-----~  410 (540)
T 3en9_A          338 KIPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDV-----D  410 (540)
T ss_dssp             ----------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEE-----E
T ss_pred             CCCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEE-----e
Confidence            34567999999999999955  46788999864321        112345799999999999999995544432     2


Q ss_pred             cceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCc
Q 046639          104 FDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGL  183 (331)
Q Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~  183 (331)
                      .+..++||||+++++|.+++..          +..++.|++.||.|||++   +|+||||||+||+++.  .+||+|||+
T Consensus       411 ~~~~~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGl  475 (540)
T 3en9_A          411 LDNKRIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGL  475 (540)
T ss_dssp             TTTTEEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTT
T ss_pred             CCccEEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECcc
Confidence            3456999999999999999864          456899999999999999   9999999999999998  999999999


Q ss_pred             ccccccCCCCCcccccCCceeecccccccCCcccCC--CCCccchhhHhHHHHHHHHHhCCCCCC
Q 046639          184 AKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG--SKASVSGDVYNFGILLLEMFTRRRPTD  246 (331)
Q Consensus       184 a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~  246 (331)
                      ++....... .............||+.|+|||++..  ..|+..+|+||..+-..+-+.++.+|.
T Consensus       476 a~~~~~~~~-~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          476 GKISNLDED-KAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             CEECCCHHH-HHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             CEECCCccc-cccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            987521000 00000001235679999999999887  568888999999999888888777763

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.93  E-value=8.3e-26  Score=194.67  Aligned_cols=143  Identities=21%  Similarity=0.268  Sum_probs=115.3

Q ss_pred             cHHHHHHHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccch------------------hhHHHHHHHHHHHH
Q 046639           21 SYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK------------------EASRSFAAECNALR   82 (331)
Q Consensus        21 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~   82 (331)
                      +...+......|.+++.||+|+||.||+|.+ .+++.||+|+++....                  .....+.+|+.+++
T Consensus        81 ~l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~  159 (282)
T 1zar_A           81 SLHRLVRSGKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQ  159 (282)
T ss_dssp             HHHHHHHTTSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHhCCeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHH
Confidence            3445555666777789999999999999999 7899999999864321                  13456889999999


Q ss_pred             cCCCCCcceeeceeecccCCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecC
Q 046639           83 NIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGD  162 (331)
Q Consensus        83 ~l~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~d  162 (331)
                      .++  | +++++++.      .+..++|||++++++|.+ +..        .....++.|++.||.+||+.   ||+|+|
T Consensus       160 ~l~--~-~~v~~~~~------~~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~---giiHrD  218 (282)
T 1zar_A          160 KLQ--G-LAVPKVYA------WEGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHR---GIVHGD  218 (282)
T ss_dssp             HTT--T-SSSCCEEE------EETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred             hcc--C-CCcCeEEe------ccceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHC---CCEeCC
Confidence            998  4 66666532      145699999999999998 421        23446999999999999999   999999


Q ss_pred             CCCCCEEecCCCcEEEcccCcccc
Q 046639          163 LKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       163 ik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      |||+||+++ ++.++|+|||+++.
T Consensus       219 lkp~NILl~-~~~vkl~DFG~a~~  241 (282)
T 1zar_A          219 LSQYNVLVS-EEGIWIIDFPQSVE  241 (282)
T ss_dssp             CSTTSEEEE-TTEEEECCCTTCEE
T ss_pred             CCHHHEEEE-CCcEEEEECCCCeE
Confidence            999999999 99999999999864

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.85  E-value=4.1e-21  Score=163.33  Aligned_cols=146  Identities=19%  Similarity=0.120  Sum_probs=110.2

Q ss_pred             HHHHHHhcCCCcCceeeccCeeEEEEeeecCCCce--EEEEEeeccchh------------------------hHHHHHH
Q 046639           23 AELSKATNNFSPANKIGQGGVSIVYKGILDESRSI--VAVKVVNLKQKE------------------------ASRSFAA   76 (331)
Q Consensus        23 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vavK~~~~~~~~------------------------~~~~~~~   76 (331)
                      ..+.....-|.+.+.||+|+||.||+|.+..+++.  ||||+++.....                        ....+..
T Consensus        40 ~~~~~~~~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  119 (258)
T 1zth_A           40 YKLSAKGYITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEK  119 (258)
T ss_dssp             HHHHHTTSEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHH
T ss_pred             HHHHhCCCchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHH
Confidence            33333344477889999999999999999667888  999987533111                        1135788


Q ss_pred             HHHHHHcCCCCCc--ceeeceeecccCCCcceeeEEEeecCC-C----CHHHHHHhccCCccchHHHHHHHHHHHHHHHH
Q 046639           77 ECNALRNIRHRNL--IKIITICSSIDFEGFDFKAIVFEYMQN-R----NLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEY  149 (331)
Q Consensus        77 e~~~l~~l~h~~i--~~~~~~~~~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~  149 (331)
                      |+.+++.+.|+++  +.++..         ...++||||+.+ |    +|.++...     .+...+..++.|++.+|.+
T Consensus       120 E~~~l~~l~~~~i~~p~~~~~---------~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~  185 (258)
T 1zth_A          120 EFRNLERAKEAGVSVPQPYTY---------MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKR  185 (258)
T ss_dssp             HHHHHHHHHHTTCCCCCEEEE---------ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCeEEEc---------CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHH
Confidence            9999999987754  333322         346899999932 3    77766532     2245677899999999999


Q ss_pred             Hh-hcCCCCeeecCCCCCCEEecCCCcEEEcccCccccc
Q 046639          150 FH-HHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       150 LH-~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      || +.   ||+|+||||+|||++.  .++|+|||+|...
T Consensus       186 lH~~~---givHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          186 LYQEA---ELVHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             HHHTS---CEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             HHHHC---CEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence            99 88   9999999999999998  8999999999753

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.73  E-value=3.4e-18  Score=151.32  Aligned_cols=145  Identities=14%  Similarity=0.177  Sum_probs=103.8

Q ss_pred             cHHHHHHHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccch--------------hhHH--------HHHHHH
Q 046639           21 SYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK--------------EASR--------SFAAEC   78 (331)
Q Consensus        21 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------------~~~~--------~~~~e~   78 (331)
                      ++..+.....-|.++.+||+|++|.||+|.+. +|+.||||+++....              ....        ....|.
T Consensus        86 AL~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~  164 (397)
T 4gyi_A           86 ALHTHAARKDVYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEF  164 (397)
T ss_dssp             HHHHHHHTTSCSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHCCCEEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHH
Confidence            45566666666999999999999999999985 688999998753210              0001        123455


Q ss_pred             HHHHcCCCCCcc--eeeceeecccCCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCC
Q 046639           79 NALRNIRHRNLI--KIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQP  156 (331)
Q Consensus        79 ~~l~~l~h~~i~--~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~  156 (331)
                      ..|.++.+.++.  ..++.         ...++||||++|++|.++..        ......++.|++.++.+||..   
T Consensus       165 ~nL~rL~~~gv~vp~p~~~---------~~~~LVME~i~G~~L~~l~~--------~~~~~~l~~qll~~l~~lH~~---  224 (397)
T 4gyi_A          165 AFMKALYEEGFPVPEPIAQ---------SRHTIVMSLVDALPMRQVSS--------VPDPASLYADLIALILRLAKH---  224 (397)
T ss_dssp             HHHHHHHHTTCSCCCEEEE---------ETTEEEEECCSCEEGGGCCC--------CSCHHHHHHHHHHHHHHHHHT---
T ss_pred             HHHHHHHhcCCCCCeeeec---------cCceEEEEecCCccHhhhcc--------cHHHHHHHHHHHHHHHHHHHC---
Confidence            666665433321  11221         23479999999888876532        123456889999999999999   


Q ss_pred             CeeecCCCCCCEEecCCC----------cEEEcccCcccc
Q 046639          157 SIVHGDLKPSNILLDQDI----------VAHVGDLGLAKF  186 (331)
Q Consensus       157 ~ivH~dik~~nilv~~~~----------~~kl~Dfg~a~~  186 (331)
                      |||||||||.|||++++|          .+.|+||+-+..
T Consensus       225 gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          225 GLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             TEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred             CCcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence            999999999999998776          389999997654

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.41  E-value=9e-13  Score=111.94  Aligned_cols=150  Identities=17%  Similarity=0.147  Sum_probs=111.7

Q ss_pred             HHHHHHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCC-CCCcceeeceeecccC
Q 046639           23 AELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIR-HRNLIKIITICSSIDF  101 (331)
Q Consensus        23 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~  101 (331)
                      ..+......|.+...++.|+.+.||++...  +..+++|+...........+..|+.+++.+. +..+.++++++.    
T Consensus         7 ~~l~~~l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~----   80 (263)
T 3tm0_A            7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER----   80 (263)
T ss_dssp             HHHHHHHTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE----
T ss_pred             HHHHHHhccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEe----
Confidence            344556667998899998999999998754  5789999886422122345788999999884 667777887743    


Q ss_pred             CCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcC---------------------------
Q 046639          102 EGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHC---------------------------  154 (331)
Q Consensus       102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---------------------------  154 (331)
                       ..+..++|||+++|.+|.+.+..       ......++.++..+++.||+..                           
T Consensus        81 -~~~~~~lv~e~i~G~~l~~~~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (263)
T 3tm0_A           81 -HDGWSNLLMSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLAD  152 (263)
T ss_dssp             -ETTEEEEEEECCSSEEHHHHCCT-------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSC
T ss_pred             -cCCceEEEEEecCCeehhhccCC-------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccc
Confidence             34678999999999999876311       1223467789999999999810                           


Q ss_pred             -----------------------------CCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          155 -----------------------------QPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       155 -----------------------------~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                                                   ...++|+|+++.||++++++.+.|+||+.+..
T Consensus       153 ~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          153 VDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             CSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                                         02699999999999998766677999998753

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.21  E-value=1.4e-11  Score=104.26  Aligned_cols=144  Identities=13%  Similarity=0.084  Sum_probs=97.1

Q ss_pred             HHHHHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCC--cceeeceeecccC
Q 046639           24 ELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRN--LIKIITICSSIDF  101 (331)
Q Consensus        24 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~  101 (331)
                      .+......|.+....+.|..+.||++.. .++..+++|+....   ....+..|+.+++.+.+.+  +.+++.+.     
T Consensus        14 ~l~~~~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~-----   84 (264)
T 1nd4_A           14 AWVERLFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVV-----   84 (264)
T ss_dssp             GGTTTTTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEE-----
T ss_pred             HHHHhcCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEec-----
Confidence            3444445566544444566699999865 35667999987533   2234678899888885434  44566653     


Q ss_pred             CCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcC---------------------------
Q 046639          102 EGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHC---------------------------  154 (331)
Q Consensus       102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---------------------------  154 (331)
                      ...+..++|||+++|.+|.  ..  .   .   ....++.+++..++.||+..                           
T Consensus        85 ~~~~~~~~v~e~i~G~~l~--~~--~---~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (264)
T 1nd4_A           85 TEAGRDWLLLGEVPGQDLL--SS--H---L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVD  154 (264)
T ss_dssp             ECSSCEEEEEECCSSEETT--TS--C---C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCC
T ss_pred             cCCCCCEEEEEecCCcccC--cC--c---C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCcc
Confidence            2335579999999998884  21  1   1   11245667777788887642                           


Q ss_pred             ----------------------------CCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          155 ----------------------------QPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       155 ----------------------------~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                                                  ...++|+|++|.||++++++.+.|+||+.+..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          155 QDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             TTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             chhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                                        01399999999999998777777999998754

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.05  E-value=8.3e-10  Score=98.00  Aligned_cols=146  Identities=15%  Similarity=0.170  Sum_probs=102.0

Q ss_pred             CcCceeeccCeeEEEEeeecCCCceEEEEEee--ccc-hhhHHHHHHHHHHHHcCC--CCCcceeeceeecccCCCccee
Q 046639           33 SPANKIGQGGVSIVYKGILDESRSIVAVKVVN--LKQ-KEASRSFAAECNALRNIR--HRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        33 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      ...+.|+.|.++.||++...  +..+++|+..  ... ......+.+|+.+++.+.  +..+++++.++...  ...+..
T Consensus        41 ~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~--~~~g~~  116 (359)
T 3dxp_A           41 LSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDE--SVIGRA  116 (359)
T ss_dssp             CEEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCT--TTTSSC
T ss_pred             ceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC--CccCCe
Confidence            34678999999999998764  4578888764  221 112346788999999986  45577777775432  112457


Q ss_pred             eEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcC---------------------------------
Q 046639          108 AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHC---------------------------------  154 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---------------------------------  154 (331)
                      ++|||+++|..+.+..    ...++......++.+++.+|+.||+..                                 
T Consensus       117 ~~vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (359)
T 3dxp_A          117 FYIMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE  192 (359)
T ss_dssp             EEEEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred             EEEEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence            8999999887775411    112445667778899999999999731                                 


Q ss_pred             ----------------------CCCeeecCCCCCCEEecCCCc--EEEcccCcccc
Q 046639          155 ----------------------QPSIVHGDLKPSNILLDQDIV--AHVGDLGLAKF  186 (331)
Q Consensus       155 ----------------------~~~ivH~dik~~nilv~~~~~--~kl~Dfg~a~~  186 (331)
                                            ...++|+|+++.||+++.++.  +.|+||+.+..
T Consensus       193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                  137999999999999997753  68999998865

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.05  E-value=5.6e-10  Score=96.77  Aligned_cols=196  Identities=15%  Similarity=0.112  Sum_probs=116.3

Q ss_pred             CceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCC-CCC--cceeeceeecccCCCcceeeEEE
Q 046639           35 ANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIR-HRN--LIKIITICSSIDFEGFDFKAIVF  111 (331)
Q Consensus        35 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~--i~~~~~~~~~~~~~~~~~~~lv~  111 (331)
                      .+.++.|....||++.     ..+++|+...  ......+..|+.+++.+. +..  +..++.....  .......++||
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~--~~~~~~~~~vm   95 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMP--SETYQMSFAGF   95 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCC--CSSCSCSCEEE
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCC--CCCCCcceEEE
Confidence            4678999999999874     3588897642  234567889999998874 322  2333333211  11112457899


Q ss_pred             eecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcC-------------------------------------
Q 046639          112 EYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHC-------------------------------------  154 (331)
Q Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~-------------------------------------  154 (331)
                      ++++|.+|.+....    .++......++.+++..++.||+..                                     
T Consensus        96 ~~i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (304)
T 3sg8_A           96 TKIKGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK  171 (304)
T ss_dssp             ECCCCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred             cccCCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence            99999888653321    1334555667777777777777511                                     


Q ss_pred             ------------------CCCeeecCCCCCCEEecC--CCcEEEcccCcccccccCCCCCcccccC----Cc---eeecc
Q 046639          155 ------------------QPSIVHGDLKPSNILLDQ--DIVAHVGDLGLAKFLFGYEPGTAAETAS----NS---IEIKG  207 (331)
Q Consensus       155 ------------------~~~ivH~dik~~nilv~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~~~----~~---~~~~~  207 (331)
                                        .+.++|+|+++.||+++.  ++.+.|+||+.+....... ........    ..   .....
T Consensus       172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~-Dl~~~~~~~~~~~~~~~~~~l~  250 (304)
T 3sg8_A          172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN-DFISLMEDDEEYGMEFVSKILN  250 (304)
T ss_dssp             HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH-HHHTTCCTTTSCCHHHHHHHHH
T ss_pred             HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH-HHHHHHhhccccCHHHHHHHHH
Confidence                              136899999999999998  5667899999886531000 00000000    00   00000


Q ss_pred             cccccC-CcccCCCCCccchhhHhHHHHHHHHHhCCCCCC
Q 046639          208 IVGYVA-PEYGMGSKASVSGDVYNFGILLLEMFTRRRPTD  246 (331)
Q Consensus       208 t~~y~a-PE~~~~~~~~~~~DiwslG~il~el~~g~~pf~  246 (331)
                      ...... |+....  .....+.|+++.++|.+.+|..+|-
T Consensus       251 ~Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          251 HYKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             HHTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             HcCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHHH
Confidence            000111 111110  1223689999999999999988763

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.74  E-value=1.4e-07  Score=79.99  Aligned_cols=136  Identities=15%  Similarity=0.119  Sum_probs=97.5

Q ss_pred             eeeccCee-EEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCC-CCCcceeeceeecccCCCcceeeEEEeec
Q 046639           37 KIGQGGVS-IVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIR-HRNLIKIITICSSIDFEGFDFKAIVFEYM  114 (331)
Q Consensus        37 ~lg~G~~g-~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~lv~e~~  114 (331)
                      .+..|..+ .||+......+..+++|+-..   .....+..|...|+.+. +--+.+++.++.     ..+..++|||++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~-----~~~~~~lvme~l  102 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIR-----TPDDAWLLTTAI  102 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEE-----ETTEEEEEEECC
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEE-----ECCeEEEEEEee
Confidence            45556555 689877766677788997652   23456788999988874 333556666643     235679999999


Q ss_pred             CCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCC---------------------------------------
Q 046639          115 QNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQ---------------------------------------  155 (331)
Q Consensus       115 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---------------------------------------  155 (331)
                      +|.++.+......      .....++.++...|+.||+...                                       
T Consensus       103 ~G~~~~~~~~~~~------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (272)
T 4gkh_A          103 PGKTAFQVLEEYP------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV  176 (272)
T ss_dssp             CSEEHHHHHHHCG------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred             CCccccccccCCH------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence            9988887764321      2334566778888888886531                                       


Q ss_pred             ----------------CCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          156 ----------------PSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       156 ----------------~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                                      +.++|+|+.+.||++++++.+-|+||+.+..
T Consensus       177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                            2489999999999999887778999998754

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.53  E-value=1.2e-06  Score=75.64  Aligned_cols=137  Identities=15%  Similarity=0.150  Sum_probs=86.8

Q ss_pred             CceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCC---CcceeeceeecccCCCcceeeEEE
Q 046639           35 ANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHR---NLIKIITICSSIDFEGFDFKAIVF  111 (331)
Q Consensus        35 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~~~~~~~~~~~~lv~  111 (331)
                      .+.++.|....||..     +..+++|+.  ........+..|+.+++.+.+.   .+..++.++.    ...+..++||
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~--~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~----~~~g~~~~v~   92 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFP--KSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK----RSDGNPFVGY   92 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEE--SSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE----CTTSCEEEEE
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEec--CCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc----cCCCceEEEE
Confidence            457888888899987     355788875  2334456788999999998642   2444444432    2234568999


Q ss_pred             eecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhc--------------------------------------
Q 046639          112 EYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHH--------------------------------------  153 (331)
Q Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--------------------------------------  153 (331)
                      |+++|.++.+..-..    ++......++.++...|+.||+.                                      
T Consensus        93 e~i~G~~l~~~~~~~----l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~  168 (306)
T 3tdw_A           93 RKVQGQILGEDGMAV----LPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESL  168 (306)
T ss_dssp             ECCCSEECHHHHHTT----SCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHH
T ss_pred             eccCCeECchhhhhh----CCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhh
Confidence            999998876531100    11122222333333333333321                                      


Q ss_pred             -------------------CCCCeeecCCCCCCEEecC---CCc-EEEcccCcccc
Q 046639          154 -------------------CQPSIVHGDLKPSNILLDQ---DIV-AHVGDLGLAKF  186 (331)
Q Consensus       154 -------------------~~~~ivH~dik~~nilv~~---~~~-~kl~Dfg~a~~  186 (331)
                                         ..+.++|+|+.+.||+++.   ++. +.|+||+.+..
T Consensus       169 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          169 RDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                               2236799999999999987   355 47999998764

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.21  E-value=8.4e-06  Score=73.08  Aligned_cols=76  Identities=16%  Similarity=0.154  Sum_probs=46.3

Q ss_pred             CceeeccCeeEEEEeeecCCCceEEEEEeeccch-------hhHHHHHHHHHHHHcCCC--CC-cceeeceeecccCCCc
Q 046639           35 ANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK-------EASRSFAAECNALRNIRH--RN-LIKIITICSSIDFEGF  104 (331)
Q Consensus        35 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h--~~-i~~~~~~~~~~~~~~~  104 (331)
                      .+.||.|..+.||++....+++.+++|.......       .....+..|.++++.+..  +. +..++.+.       .
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d-------~  107 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD-------T  107 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE-------T
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc-------C
Confidence            5689999999999997765667899997642111       112345678888887632  33 33444331       1


Q ss_pred             ceeeEEEeecCCC
Q 046639          105 DFKAIVFEYMQNR  117 (331)
Q Consensus       105 ~~~~lv~e~~~~~  117 (331)
                      ...++|||++++.
T Consensus       108 ~~~~lvmE~l~g~  120 (397)
T 2olc_A          108 EMAVTVMEDLSHL  120 (397)
T ss_dssp             TTTEEEECCCTTS
T ss_pred             CccEEEEEeCCCc
Confidence            2357999999763

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.08  E-value=8.1e-06  Score=72.02  Aligned_cols=84  Identities=8%  Similarity=0.058  Sum_probs=51.8

Q ss_pred             Ccee-eccCeeEEEEeeec--C----CCceEEEEEeeccch--h-hHHHHHHHHHHHHcCC-C--CCcceeeceeecccC
Q 046639           35 ANKI-GQGGVSIVYKGILD--E----SRSIVAVKVVNLKQK--E-ASRSFAAECNALRNIR-H--RNLIKIITICSSIDF  101 (331)
Q Consensus        35 ~~~l-g~G~~g~V~~~~~~--~----~~~~vavK~~~~~~~--~-~~~~~~~e~~~l~~l~-h--~~i~~~~~~~~~~~~  101 (331)
                      .+.| +.|....+|+....  .    +++.+++|+......  . ....+..|+.+++.+. +  -.+.+++.++.... 
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~-  103 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD-  103 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST-
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC-
Confidence            4567 88889999987653  0    156788887643220  0 1245678888888874 2  34666666643211 


Q ss_pred             CCcceeeEEEeecCCCCHH
Q 046639          102 EGFDFKAIVFEYMQNRNLE  120 (331)
Q Consensus       102 ~~~~~~~lv~e~~~~~~L~  120 (331)
                       ..+..++|||+++|.++.
T Consensus       104 -~~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          104 -VLGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             -TTSSCEEEEECCCCBCCC
T ss_pred             -ccCCceEEEEecCCCChh
Confidence             113467999999876543

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.89  E-value=9.3e-05  Score=64.56  Aligned_cols=31  Identities=32%  Similarity=0.468  Sum_probs=27.7

Q ss_pred             CCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          156 PSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       156 ~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      ..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            3899999999999998888999999997753

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.87  E-value=7.9e-05  Score=63.59  Aligned_cols=80  Identities=15%  Similarity=0.171  Sum_probs=54.7

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCC---CCcceeeceeecccCCCcce
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRH---RNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h---~~i~~~~~~~~~~~~~~~~~  106 (331)
                      ....-.+.+|.|..+.||+.... +|+.+++|+...........+..|+..|+.+..   -.+.+++.+         +.
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~---------~~   84 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW---------DD   84 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE---------ET
T ss_pred             CCeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec---------cC
Confidence            35566788999999999998764 678899998754433333457789998888742   223444443         22


Q ss_pred             eeEEEeecCCCCH
Q 046639          107 KAIVFEYMQNRNL  119 (331)
Q Consensus       107 ~~lv~e~~~~~~L  119 (331)
                      .++|||+++++..
T Consensus        85 ~~lv~e~l~~~~~   97 (288)
T 3f7w_A           85 RTLAMEWVDERPP   97 (288)
T ss_dssp             TEEEEECCCCCCC
T ss_pred             ceEEEEeecccCC
Confidence            4789999876543

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.73  E-value=0.00038  Score=60.01  Aligned_cols=76  Identities=16%  Similarity=0.124  Sum_probs=54.8

Q ss_pred             cCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCC---CCCcceeeceeecccCCCcceeeEE
Q 046639           34 PANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIR---HRNLIKIITICSSIDFEGFDFKAIV  110 (331)
Q Consensus        34 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~~~~~~lv  110 (331)
                      -.+.|+.|....+|+...  ++..+++|+....   ....+..|+..|+.+.   ...+++++.++.     ..+..++|
T Consensus        40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~-----~~g~~~lv  109 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGN-----SQGHSFLL  109 (312)
T ss_dssp             EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEE-----CSSEEEEE
T ss_pred             eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEee-----cCCceEEE
Confidence            346789999999999875  3567889987532   2456788888888873   355667776643     23567999


Q ss_pred             EeecCCCCH
Q 046639          111 FEYMQNRNL  119 (331)
Q Consensus       111 ~e~~~~~~L  119 (331)
                      ||++++..+
T Consensus       110 me~l~G~~~  118 (312)
T 3jr1_A          110 LEALNKSKN  118 (312)
T ss_dssp             EECCCCCCC
T ss_pred             EEeccCCCC
Confidence            999988654

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.65  E-value=0.00037  Score=55.97  Aligned_cols=103  Identities=16%  Similarity=0.075  Sum_probs=67.2

Q ss_pred             CCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccccCCCCCcc
Q 046639          117 RNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAA  196 (331)
Q Consensus       117 ~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~  196 (331)
                      .+|.++++.. +.++++.++|.++.|.+.+|.-.-...  .-..+=+.|..|++..+|.|.+.+ +.+.           
T Consensus        33 vSL~eIL~~~-~~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------   97 (229)
T 2yle_A           33 LSLEEILRLY-NQPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------   97 (229)
T ss_dssp             EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred             ccHHHHHHHc-CCCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc-----------
Confidence            4799999864 456889999999999999988762211  111223357999999999998753 2110           


Q ss_pred             cccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCC
Q 046639          197 ETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP  244 (331)
Q Consensus       197 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p  244 (331)
                               .....+.|||... ...+.+.=|||||+++|..+-=..|
T Consensus        98 ---------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 ---------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             ------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             ---------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence                     1122367888864 3557888999999999999974443

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.61  E-value=0.00031  Score=63.30  Aligned_cols=30  Identities=27%  Similarity=0.516  Sum_probs=27.0

Q ss_pred             CeeecCCCCCCEEecCCCcEEEcccCccccc
Q 046639          157 SIVHGDLKPSNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       157 ~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      .++|+|+.+.||+++.++ +.++||+.+...
T Consensus       233 ~liHGDl~~~Nil~~~~~-~~lID~e~a~~G  262 (420)
T 2pyw_A          233 ALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG  262 (420)
T ss_dssp             EEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred             eEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence            899999999999999877 999999988753

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.59  E-value=0.0014  Score=56.61  Aligned_cols=167  Identities=11%  Similarity=0.086  Sum_probs=88.6

Q ss_pred             cCCcccHHHHHHHhcCCCcC-----ceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCC--
Q 046639           16 QFPMISYAELSKATNNFSPA-----NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRN--   88 (331)
Q Consensus        16 ~~~~~~~~~~~~~~~~y~~~-----~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~--   88 (331)
                      .|+.++..++.....+|.+.     +.|+.|....+|+.... ++ .+++|+....  .....+..|+.+++.+....  
T Consensus         3 v~~~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~   78 (322)
T 2ppq_A            3 VYTDITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLS   78 (322)
T ss_dssp             --CCCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEES-SC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCC
T ss_pred             ccccCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCC
Confidence            46678888888888888763     34556777889988754 23 5888988642  11233556777777663212  


Q ss_pred             cceeeceeec-ccCCCcceeeEEEeecCCCCHH-----------HHH---Hhc--c--CC-----c-cchHHHHH-----
Q 046639           89 LIKIITICSS-IDFEGFDFKAIVFEYMQNRNLE-----------QWL---RQS--N--GQ-----L-RFLTQRVN-----  138 (331)
Q Consensus        89 i~~~~~~~~~-~~~~~~~~~~lv~e~~~~~~L~-----------~~l---~~~--~--~~-----~-~~~~~~~~-----  138 (331)
                      +.+++..... .-....+..++++++++|..+.           +.+   ...  .  ..     . ..+.....     
T Consensus        79 vP~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~  158 (322)
T 2ppq_A           79 CPLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEER  158 (322)
T ss_dssp             CCCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGG
T ss_pred             CCcccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHH
Confidence            2333321000 0001124568999999875431           111   110  0  00     0 00111000     


Q ss_pred             -------HHHHHHHHHHHHhhc----CCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          139 -------IAIDVSFAIEYFHHH----CQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       139 -------~~~~i~~~l~~LH~~----~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                             +...+...+..+...    ...+++|+|+.+.||++++++.+.++||+.+..
T Consensus       159 ~~~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          159 ADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             GGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHhhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence                   000133344444421    123799999999999999877668999997753

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.44  E-value=0.00045  Score=59.20  Aligned_cols=71  Identities=11%  Similarity=0.163  Sum_probs=42.7

Q ss_pred             CceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCc-ceeeceeecccCCCcceeeEEEee
Q 046639           35 ANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNL-IKIITICSSIDFEGFDFKAIVFEY  113 (331)
Q Consensus        35 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~~~~~~lv~e~  113 (331)
                      .+.|+.|....+|++      ..+++|+...... .......|+.+++.+....+ .+++..+     .  ..-++++|+
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~-~~~~r~~E~~~l~~l~~~g~~P~~~~~~-----~--~~~~~v~e~   88 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTE-EYINRANEAVAAREAAKAGVSPEVLHVD-----P--ATGVMVTRY   88 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC-----T--TTCCEEEEC
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCcc-ceeCHHHHHHHHHHHHHcCCCCceEEEE-----C--CCCEEEEee
Confidence            678999999999998      3578898753321 11223467777776642222 3444432     1  223689999


Q ss_pred             c-CCCCH
Q 046639          114 M-QNRNL  119 (331)
Q Consensus       114 ~-~~~~L  119 (331)
                      + ++.++
T Consensus        89 i~~g~~l   95 (301)
T 3dxq_A           89 IAGAQTM   95 (301)
T ss_dssp             CTTCEEC
T ss_pred             cCCCccC
Confidence            9 66544

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.40  E-value=0.0026  Score=55.02  Aligned_cols=102  Identities=12%  Similarity=0.064  Sum_probs=60.0

Q ss_pred             hccCCcccHHHHHHHhcCCCc-----CceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCC
Q 046639           14 KQQFPMISYAELSKATNNFSP-----ANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRN   88 (331)
Q Consensus        14 ~~~~~~~~~~~~~~~~~~y~~-----~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~   88 (331)
                      ...++.++...+......|.+     ...++ |....||++... +++.+++|...... .....+..|..+++.+....
T Consensus         5 ~~~~~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g   81 (328)
T 1zyl_A            5 AFTFQTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDE-DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDE   81 (328)
T ss_dssp             CCCCCCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCT-TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTT
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcC-CCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcC
Confidence            356788888888888777754     23466 777889987653 45568899885221 12245666777777764212


Q ss_pred             --cceeeceeecccCCCcceeeEEEeecCCCC
Q 046639           89 --LIKIITICSSIDFEGFDFKAIVFEYMQNRN  118 (331)
Q Consensus        89 --i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~  118 (331)
                        ++.++..-...-....+..++++++++|..
T Consensus        82 ~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G~~  113 (328)
T 1zyl_A           82 VPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ  113 (328)
T ss_dssp             CSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred             CeecceeecCCcEEEEECCEEEEEEEecCCCC
Confidence              333333200000111345678999997744

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.22  E-value=0.00092  Score=59.22  Aligned_cols=142  Identities=11%  Similarity=0.143  Sum_probs=79.2

Q ss_pred             CceeeccCeeEEEEeeecC-------CCceEEEEEeeccchhhHHHHHHHHHHHHcCC-CCCcceeeceeecccCCCcce
Q 046639           35 ANKIGQGGVSIVYKGILDE-------SRSIVAVKVVNLKQKEASRSFAAECNALRNIR-HRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        35 ~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      .+.|..|-...+|++....       +++.+++|+... .......+.+|..+++.+. +.-..++++.+     .+   
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~-----~~---  125 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVF-----PE---  125 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEE-----TT---
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEc-----CC---
Confidence            4577778888899987632       346788998632 2223455668999988874 32235555553     22   


Q ss_pred             eeEEEeecCCCCHH--------------HHHHh---cc---CCcc--chHHHHHHHHHHHH-------------------
Q 046639          107 KAIVFEYMQNRNLE--------------QWLRQ---SN---GQLR--FLTQRVNIAIDVSF-------------------  145 (331)
Q Consensus       107 ~~lv~e~~~~~~L~--------------~~l~~---~~---~~~~--~~~~~~~~~~~i~~-------------------  145 (331)
                       .+|+||++|.+|.              +.+.+   ..   +...  -+..+..+..++..                   
T Consensus       126 -g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~  204 (379)
T 3feg_A          126 -GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKD  204 (379)
T ss_dssp             -EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHH
T ss_pred             -ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHH
Confidence             2899999875442              11111   00   1111  12334444433321                   


Q ss_pred             HHHH----Hhhc-CCCCeeecCCCCCCEEecCC----CcEEEcccCcccc
Q 046639          146 AIEY----FHHH-CQPSIVHGDLKPSNILLDQD----IVAHVGDLGLAKF  186 (331)
Q Consensus       146 ~l~~----LH~~-~~~~ivH~dik~~nilv~~~----~~~kl~Dfg~a~~  186 (331)
                      .+..    |... ....++|+|+.+.||+++.+    +.+.++||..+..
T Consensus       205 ~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          205 EMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            1222    2211 12379999999999999876    6899999998754

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.98  E-value=0.0079  Score=52.11  Aligned_cols=31  Identities=29%  Similarity=0.284  Sum_probs=27.2

Q ss_pred             CCeeecCCCCCCEEecCC----CcEEEcccCcccc
Q 046639          156 PSIVHGDLKPSNILLDQD----IVAHVGDLGLAKF  186 (331)
Q Consensus       156 ~~ivH~dik~~nilv~~~----~~~kl~Dfg~a~~  186 (331)
                      ..++|+|+.+.||+++.+    +.+.|+||+.+..
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            389999999999999874    6789999998865

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.97  E-value=0.0017  Score=58.57  Aligned_cols=73  Identities=22%  Similarity=0.292  Sum_probs=46.2

Q ss_pred             CceeeccCeeEEEEeeecC-------CCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCc-ceeeceeecccCCCcce
Q 046639           35 ANKIGQGGVSIVYKGILDE-------SRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNL-IKIITICSSIDFEGFDF  106 (331)
Q Consensus        35 ~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~~~~  106 (331)
                      .+.|+.|....+|++....       .+..+++|+......  ...+..|..+++.+...++ .++++.+     .+   
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~-----~~---  147 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIF-----SG---  147 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT---
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEe-----CC---
Confidence            4577888889999987642       246788998843211  1345578888888753333 4555542     21   


Q ss_pred             eeEEEeecCCCC
Q 046639          107 KAIVFEYMQNRN  118 (331)
Q Consensus       107 ~~lv~e~~~~~~  118 (331)
                       .+|+||++|.+
T Consensus       148 -g~v~e~l~G~~  158 (429)
T 1nw1_A          148 -GRLEEYIPSRP  158 (429)
T ss_dssp             -EEEECCCCEEE
T ss_pred             -CEEEEEeCCcc
Confidence             38899997633

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.91  E-value=0.0034  Score=57.07  Aligned_cols=75  Identities=17%  Similarity=0.115  Sum_probs=45.5

Q ss_pred             CceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCc-ceeeceeecccCCCcceeeEEEee
Q 046639           35 ANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNL-IKIITICSSIDFEGFDFKAIVFEY  113 (331)
Q Consensus        35 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~~~~~~lv~e~  113 (331)
                      .+.|+.|-...+|++.....+..+++|+....... .-....|..+++.+...++ .++++.+     .+    ..|+||
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~-----~~----G~v~e~  182 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFF-----TN----GRIEEF  182 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEE-----TT----EEEEEC
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEe-----CC----eEEEEe
Confidence            45788888899999887543477889987432211 1112578888888864444 4555543     11    259999


Q ss_pred             cCCCCH
Q 046639          114 MQNRNL  119 (331)
Q Consensus       114 ~~~~~L  119 (331)
                      ++|.+|
T Consensus       183 I~G~~l  188 (458)
T 2qg7_A          183 MDGYAL  188 (458)
T ss_dssp             CCSEEC
T ss_pred             eCCccC
Confidence            987443

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.77  E-value=0.0021  Score=56.67  Aligned_cols=74  Identities=11%  Similarity=0.138  Sum_probs=41.8

Q ss_pred             CceeeccCeeEEEEeeecC--------CCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCC-cceeeceeecccCCCcc
Q 046639           35 ANKIGQGGVSIVYKGILDE--------SRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRN-LIKIITICSSIDFEGFD  105 (331)
Q Consensus        35 ~~~lg~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~~~  105 (331)
                      .+.|+.|....+|++....        .++.+++|+...... .......|..+++.+...+ ..++++..     .   
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~-----~---  108 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF-----N---  108 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE-----T---
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec-----C---
Confidence            4577788888999987642        125788888753222 1122457778777774223 34555431     1   


Q ss_pred             eeeEEEeecCCCC
Q 046639          106 FKAIVFEYMQNRN  118 (331)
Q Consensus       106 ~~~lv~e~~~~~~  118 (331)
                       -++|+|+++|.+
T Consensus       109 -~~~v~e~i~G~~  120 (369)
T 3c5i_A          109 -GGRIEEWLYGDP  120 (369)
T ss_dssp             -TEEEEECCCSEE
T ss_pred             -CcEEEEEecCCc
Confidence             268999998754

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=95.77  E-value=0.062  Score=46.63  Aligned_cols=31  Identities=16%  Similarity=0.262  Sum_probs=27.6

Q ss_pred             CCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          156 PSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       156 ~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      ..++|+|+.+.||+++.++.+.++||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            3799999999999999888899999987754

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=94.92  E-value=0.12  Score=46.29  Aligned_cols=75  Identities=11%  Similarity=0.093  Sum_probs=45.9

Q ss_pred             CceeeccCeeEEEEeeecCC-------CceEEEEEeeccchhhHHHHHHHHHHHHcCC-CCCcceeeceeecccCCCcce
Q 046639           35 ANKIGQGGVSIVYKGILDES-------RSIVAVKVVNLKQKEASRSFAAECNALRNIR-HRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        35 ~~~lg~G~~g~V~~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      .+.+..|-...+|++.....       +..+++++.... ........+|..+++.+. +.-..++++.+     .    
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~-t~~~idR~~E~~~l~~L~~~gi~P~l~~~~-----~----  144 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKH-VGKFYDSKVELDVFRYLSNINIAPNIIADF-----P----  144 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCC-C-CCCCHHHHHHHHHHHHHTTSSCCEEEEE-----T----
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCC-cchhcCHHHHHHHHHHHHhcCCCCCEEEEc-----C----
Confidence            45677788888999876421       467888986432 222223457888887774 22234444432     1    


Q ss_pred             eeEEEeecCCCCH
Q 046639          107 KAIVFEYMQNRNL  119 (331)
Q Consensus       107 ~~lv~e~~~~~~L  119 (331)
                      -+.|+||++|.+|
T Consensus       145 ~~~I~efI~G~~l  157 (424)
T 3mes_A          145 EGRIEEFIDGEPL  157 (424)
T ss_dssp             TEEEEECCCSEEC
T ss_pred             CCEEEEEeCCccC
Confidence            2689999988553

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=94.04  E-value=0.032  Score=49.78  Aligned_cols=30  Identities=23%  Similarity=0.367  Sum_probs=25.2

Q ss_pred             CeeecCCCCCCEEe------cCCCcEEEcccCcccc
Q 046639          157 SIVHGDLKPSNILL------DQDIVAHVGDLGLAKF  186 (331)
Q Consensus       157 ~ivH~dik~~nilv------~~~~~~kl~Dfg~a~~  186 (331)
                      .++|+|+.+.||++      +.++.+.++||.+|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            46799999999999      4456799999998764

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=88.06  E-value=1.5  Score=34.95  Aligned_cols=116  Identities=15%  Similarity=0.187  Sum_probs=73.0

Q ss_pred             CCCCcceeeceeecccCCCcceeeEEEeecC-CCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCC
Q 046639           85 RHRNLIKIITICSSIDFEGFDFKAIVFEYMQ-NRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDL  163 (331)
Q Consensus        85 ~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~di  163 (331)
                      .||+.+.. .+     -..++.+.+.++.-+ +.++.. ++.     .+....+.++.+++....+++     .-+|.-+
T Consensus        43 ~~~~Fl~~-~I-----~e~eD~v~~~y~~~~~~~~f~~-ik~-----~~~~eKlr~l~ni~~l~~~~~-----~r~tf~L  105 (215)
T 4ann_A           43 HSPYFIDA-EL-----TELRDSFQIHYDINDNHTPFDN-IKS-----FTKNEKLRYLLNIKNLEEVNR-----TRYTFVL  105 (215)
T ss_dssp             CCTTBCCE-EE-----EECSSEEEEEECCCTTSEEGGG-GGG-----SCHHHHHHHHHHGGGGGGGGG-----SSEECCC
T ss_pred             cCCcccce-EE-----EEcccEEEEEEEcCcccCCHHH-HHh-----cCHHHHHHHHHHHHHHHHHhc-----CceEEEE
Confidence            57877754 22     122344444444432 333433 322     445778888888888775555     4478999


Q ss_pred             CCCCEEecCCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCC
Q 046639          164 KPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRR  243 (331)
Q Consensus       164 k~~nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~  243 (331)
                      .|+|++++.++.+++.-.|+-..                         ++|.     ..++..=.-.+=+++..+++++.
T Consensus       106 ~P~NL~f~~~~~p~i~~RGik~~-------------------------l~P~-----~~~ee~fL~qyKAliiall~~K~  155 (215)
T 4ann_A          106 APDELFFTRDGLPIAKTRGLQNV-------------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQ  155 (215)
T ss_dssp             SGGGEEECTTSCEEESCCEETTT-------------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTC
T ss_pred             ecceEEEcCCCCEEEEEccCccC-------------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCC
Confidence            99999999999999987775432                         2222     12222233456778889999988


Q ss_pred             CCCc
Q 046639          244 PTDA  247 (331)
Q Consensus       244 pf~~  247 (331)
                      .|..
T Consensus       156 ~Fe~  159 (215)
T 4ann_A          156 SFDA  159 (215)
T ss_dssp             CHHH
T ss_pred             CHHH
Confidence            8864

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=85.64  E-value=0.09  Score=47.78  Aligned_cols=61  Identities=10%  Similarity=0.017  Sum_probs=17.7

Q ss_pred             CcCceeeccCeeEEEEeeecCCCceEEE------EEeecc--chhhHHHHHHHHHHHHcCCCCCcceeecee
Q 046639           33 SPANKIGQGGVSIVYKGILDESRSIVAV------KVVNLK--QKEASRSFAAECNALRNIRHRNLIKIITIC   96 (331)
Q Consensus        33 ~~~~~lg~G~~g~V~~~~~~~~~~~vav------K~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   96 (331)
                      .+.+.||   ||.||+|.+..+..+||+      |.....  ..+....+.+|..+++.++|||+++.+++.
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~  213 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFK  213 (463)
T ss_dssp             CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEE
T ss_pred             cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceE
Confidence            4567776   999999999765568888      655321  122334577888999989999999887664

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=81.85  E-value=2.6  Score=33.75  Aligned_cols=103  Identities=13%  Similarity=0.106  Sum_probs=65.0

Q ss_pred             cceeeEEEeecC-CCCHHHHHHhccCCccchHHHHHHHHHHHHHHH-HHhhcCCCCeeecCCCCCCEEecCCCcEEEccc
Q 046639          104 FDFKAIVFEYMQ-NRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIE-YFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDL  181 (331)
Q Consensus       104 ~~~~~lv~e~~~-~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~-~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Df  181 (331)
                      ++.+.+.++.-+ +.++.. ++.     .+....+.++.+++.... +++     .-+|.-+.|+|++++.++.+++.-.
T Consensus        60 eD~~~i~y~~~~~~~~f~~-i~~-----~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~NL~f~~~~~p~i~hR  128 (219)
T 4ano_A           60 EDEVKVVIKPPSSFLTFAA-IRK-----TTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPENLMFNRALEPFFLHV  128 (219)
T ss_dssp             SSEEEEEEECCTTCEEHHH-HHT-----SCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGGGEEECTTCCEEESCC
T ss_pred             CCEEEEEEEcCcccCcHHH-HHh-----cCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCceEEEeCCCcEEEEEc
Confidence            344455555432 334443 332     445777778877777655 444     5688999999999999999999888


Q ss_pred             CcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCc
Q 046639          182 GLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDA  247 (331)
Q Consensus       182 g~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  247 (331)
                      |+-..                         ++|.-     .++.-=.-.+=|++..++.++..|..
T Consensus       129 Gi~~~-------------------------lpP~e-----~~ee~fl~qyKali~all~~K~~Fe~  164 (219)
T 4ano_A          129 GVKES-------------------------LPPDE-----WDDERLLREVKATVLALTEGEYRFDE  164 (219)
T ss_dssp             EETTT-------------------------BSSCS-----CCHHHHHHHHHHHHHHHTTCSSCHHH
T ss_pred             CCccc-------------------------CCCCC-----CCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence            76432                         23322     12222233567788888888877753

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	331
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	5e-53
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	9e-48
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	9e-48
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-47
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	9e-47
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	5e-46
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	6e-46
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	9e-46
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-45
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	6e-45
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-44
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	5e-44
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-43
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-43
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	5e-43
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	6e-42
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-41
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	8e-41
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-40
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	4e-40
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	7e-40
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-39
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-39
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	4e-39
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-38
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-38
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	7e-38
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	9e-38
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-37
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-35
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-35
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-35
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	4e-35
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	6e-34
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-33
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-33
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	8e-33
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	9e-33
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-31
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-31
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	7e-31
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	8e-31
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	9e-31
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-30
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-30
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	3e-30
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	6e-30
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	7e-30
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-29
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-29
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	8e-29
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-28
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	3e-28
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-27
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	8e-27
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	4e-26
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-25
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	3e-25
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-24
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-24
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-23
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	4e-23
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-13

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (440), Expect = 5e-53
 Identities = 65/301 (21%), Positives = 116/301 (38%), Gaps = 40/301 (13%)

Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ--KEASRSFAAECNALRNIRHR 87
              +   +IG G    VYKG        VAVK++N+     +  ++F  E   LR  RH 
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64

Query: 88  NLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAI 147
           N++  +   ++         AIV ++ +  +L   L     +   + + ++IA   +  +
Sbjct: 65  NILLFMGYSTA------PQLAIVTQWCEGSSLYHHLHIIETKFE-MIKLIDIARQTAQGM 117

Query: 148 EYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKG 207
           +Y H      I+H DLK +NI L +D+   +GD GLA     +      E       + G
Sbjct: 118 DYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ------LSG 168

Query: 208 IVGYVAPEYGMGSKA---SVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALP 264
            + ++APE          S   DVY FGI+L E+ T + P   + N    +    +  L 
Sbjct: 169 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLS 228

Query: 265 DKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARE 324
             + ++                + +CL            +   ER     ++A +     
Sbjct: 229 PDLSKVRS-----NCPKAMKRLMAECLK-----------KKRDERPLFPQILASIELLAR 272

Query: 325 T 325
           +
Sbjct: 273 S 273

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 9e-48
 Identities = 65/292 (22%), Positives = 117/292 (40%), Gaps = 38/292 (13%)

Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNL 89
            +     K+GQG    V+ G  + +   VA+K +      +  +F  E   ++ +RH  L
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKL 74

Query: 90  IKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEY 149
           +++  + S       +   IV EYM   +L  +L+   G+   L Q V++A  ++  + Y
Sbjct: 75  VQLYAVVS------EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 128

Query: 150 FHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
                    VH DL+ +NIL+ +++V  V D GLA+ +   E        +     K  +
Sbjct: 129 VERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE-------YTARQGAKFPI 178

Query: 210 GYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVME 269
            + APE  +  + ++  DV++FGILL E+ T+ R                   + D+V  
Sbjct: 179 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQVER 229

Query: 270 IVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRH 321
                   E   + +  +  C             + P ER     + A L  
Sbjct: 230 GYRMPCPPECPESLHDLMCQCWR-----------KEPEERPTFEYLQAFLED 270

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  160 bits (406), Expect = 9e-48
 Identities = 67/313 (21%), Positives = 128/313 (40%), Gaps = 45/313 (14%)

Query: 21  SYAELSKATNNFSPA---------NKIGQGGVSIVYKGIL---DESRSIVAVKVVNLKQK 68
           ++ + ++A   F+             IG G    V  G L    +    VA+K +     
Sbjct: 8   TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67

Query: 69  E-ASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSN 127
           E   R F +E + +    H N+I +  + +           I+ E+M+N +L+ +LRQ++
Sbjct: 68  EKQRRDFLSEASIMGQFDHPNVIHLEGVVTK-----STPVMIITEFMENGSLDSFLRQND 122

Query: 128 GQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL 187
           GQ   + Q V +   ++  ++Y         VH DL   NIL++ ++V  V D GL++FL
Sbjct: 123 GQFTVI-QLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFL 178

Query: 188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDA 247
              E  T+  T ++++  K  + + APE     K + + DV+++GI++ E+ +       
Sbjct: 179 ---EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER--- 232

Query: 248 MFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPM 307
                +T  + +     D  +                    DC  A+    + C  +   
Sbjct: 233 -PYWDMTNQDVINAIEQDYRLPP----------------PMDCPSALHQLMLDCWQKDRN 275

Query: 308 ERMEMRDVVAKLR 320
            R +   +V  L 
Sbjct: 276 HRPKFGQIVNTLD 288

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (407), Expect = 1e-47
 Identities = 52/232 (22%), Positives = 97/232 (41%), Gaps = 20/232 (8%)

Query: 25  LSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRS-FAAECNALRN 83
           +    ++F   +++G G   +V+K     S  ++A K+++L+ K A R+    E   L  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60

Query: 84  IRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDV 143
                ++                 +I  E+M   +L+Q L++  G++        ++I V
Sbjct: 61  CNSPYIVGFYGAF-----YSDGEISICMEHMDGGSLDQVLKK-AGRIP-EQILGKVSIAV 113

Query: 144 SFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSI 203
              + Y        I+H D+KPSNIL++      + D G++  L      +         
Sbjct: 114 IKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------- 164

Query: 204 EIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTL 255
              G   Y++PE   G+  SV  D+++ G+ L+EM   R P      + L L
Sbjct: 165 ---GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 213

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 9e-47
 Identities = 58/302 (19%), Positives = 114/302 (37%), Gaps = 39/302 (12%)

Query: 24  ELSKATNNFSPAN-KIGQGGVSIVYKGILDESRS--IVAVKVVNLK-QKEASRSFAAECN 79
           +L    +N   A+ ++G G    V +G+    +    VA+KV+    +K  +     E  
Sbjct: 2   KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61

Query: 80  ALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNI 139
            +  + +  ++++I +C +          +V E      L ++L     ++  ++    +
Sbjct: 62  IMHQLDNPYIVRLIGVCQAEAL------MLVMEMAGGGPLHKFLVGKREEIP-VSNVAEL 114

Query: 140 AIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETA 199
              VS  ++Y       + VH DL   N+LL     A + D GL+K L   +    A +A
Sbjct: 115 LHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 171

Query: 200 SNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFV 259
                 K  + + APE     K S   DV+++G+ + E  +  +       + +   E +
Sbjct: 172 -----GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK----PYKKMKGPEVM 222

Query: 260 KMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKL 319
                 K ME        E     Y+ + DC +               +R +   V  ++
Sbjct: 223 AFIEQGKRMECPP-----ECPPELYALMSDCWI-----------YKWEDRPDFLTVEQRM 266

Query: 320 RH 321
           R 
Sbjct: 267 RA 268

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 5e-46
 Identities = 62/302 (20%), Positives = 115/302 (38%), Gaps = 38/302 (12%)

Query: 31  NFSPANKIGQGGVSIVYKGILDESRS---IVAVKVVN-LKQKEASRSFAAECNALRNIRH 86
           +F+    IG+G    VY G L ++       AVK +N +        F  E   +++  H
Sbjct: 30  HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87

Query: 87  RNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFA 146
            N++ ++ IC   +        +V  YM++ +L  ++R        +   +   + V+  
Sbjct: 88  PNVLSLLGICLRSEGSPL----VVLPYMKHGDLRNFIRNETHNPT-VKDLIGFGLQVAKG 142

Query: 147 IEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIK 206
           +           VH DL   N +LD+     V D GLA+ +         ++  N    K
Sbjct: 143 M---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM----YDKEFDSVHNKTGAK 195

Query: 207 GIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDK 266
             V ++A E     K +   DV++FG+LL E+ TR  P        +   +     L  +
Sbjct: 196 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP----PYPDVNTFDITVYLLQGR 251

Query: 267 VMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETF 326
            +   +             +  D L  V+   + C       R    ++V+++     TF
Sbjct: 252 RLLQPE-------------YCPDPLYEVM---LKCWHPKAEMRPSFSELVSRISAIFSTF 295

Query: 327 LG 328
           +G
Sbjct: 296 IG 297

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (392), Expect = 6e-46
 Identities = 67/289 (23%), Positives = 114/289 (39%), Gaps = 40/289 (13%)

Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ--KEASRSFAAECNALRNIRHRNLIKII 93
            +IG+G    VYKG+  E+   VA   +  ++  K   + F  E   L+ ++H N+++  
Sbjct: 15  IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74

Query: 94  TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHH 153
               S   +G     +V E M +  L+ +L++    ++ +    +    +   +++ H  
Sbjct: 75  DSWES-TVKGKKCIVLVTELMTSGTLKTYLKR-FKVMK-IKVLRSWCRQILKGLQFLHTR 131

Query: 154 CQPSIVHGDLKPSNILL-DQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
             P I+H DLK  NI +        +GDLGLA              AS +  + G   ++
Sbjct: 132 TPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLK----------RASFAKAVIGTPEFM 180

Query: 213 APEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEIVD 272
           APE     K   S DVY FG+ +LEM T   P     N             P    ++  
Sbjct: 181 APEM-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 239

Query: 273 PSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRH 321
           P +           IE C+            ++  ER  ++D+   L H
Sbjct: 240 PEV--------KEIIEGCIR-----------QNKDERYSIKDL---LNH 266

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (391), Expect = 9e-46
 Identities = 59/292 (20%), Positives = 115/292 (39%), Gaps = 38/292 (13%)

Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNL 89
                  ++G G    V+ G  +     VAVK +  +   +  +F AE N ++ ++H+ L
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHT-KVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRL 70

Query: 90  IKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEY 149
           +++  + +       +   I+ EYM+N +L  +L+  +G    + + +++A  ++  + +
Sbjct: 71  VRLYAVVTQ------EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124

Query: 150 FHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
                    +H DL+ +NIL+   +   + D GLA+ +   E              K  +
Sbjct: 125 IEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA-------REGAKFPI 174

Query: 210 GYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVME 269
            + APE       ++  DV++FGILL E+ T  R        G+T  E ++       M 
Sbjct: 175 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRI----PYPGMTNPEVIQNLERGYRMV 230

Query: 270 IVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRH 321
             D           Y  +  C             E P +R     + + L  
Sbjct: 231 RPD-----NCPEELYQLMRLCWK-----------ERPEDRPTFDYLRSVLED 266

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (386), Expect = 3e-45
 Identities = 71/294 (24%), Positives = 113/294 (38%), Gaps = 42/294 (14%)

Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNL 89
                   IG+G    V  G    ++  VAVK   +K    +++F AE + +  +RH NL
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDYRGNK--VAVKC--IKNDATAQAFLAEASVMTQLRHSNL 62

Query: 90  IKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEY 149
           ++++ +      E      IV EYM   +L  +LR     +      +  ++DV  A+EY
Sbjct: 63  VQLLGVI----VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 118

Query: 150 FHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
              +     VH DL   N+L+ +D VA V D GL K             +S     K  V
Sbjct: 119 LEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEA-----------SSTQDTGKLPV 164

Query: 210 GYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVME 269
            + APE     K S   DV++FGILL E+++  R         + L + V        M+
Sbjct: 165 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV----PYPRIPLKDVVPRVEKGYKMD 220

Query: 270 IVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHAR 323
             D           Y  +++C                  R     +  +L H +
Sbjct: 221 APD-----GCPPAVYEVMKNCWH-----------LDAAMRPSFLQLREQLEHIK 258

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 6e-45
 Identities = 59/299 (19%), Positives = 108/299 (36%), Gaps = 22/299 (7%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
            IG+G    V++G        VAVK+ +  ++E S    AE      +RH N++  I   
Sbjct: 10  SIGKGRFGEVWRGKWRGE--EVAVKIFS-SREERSWFREAEIYQTVMLRHENILGFIAAD 66

Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHC-- 154
           +  D   +    +V +Y ++ +L  +L +       +   + +A+  +  + + H     
Sbjct: 67  NK-DNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVG 122

Query: 155 ---QPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGY 211
              +P+I H DLK  NIL+ ++    + DLGLA                      G   Y
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH----RVGTKRY 178

Query: 212 VAPEYGMGS------KASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPD 265
           +APE    S      ++    D+Y  G++  E+  R        +  L  ++ V      
Sbjct: 179 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238

Query: 266 KVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARE 324
           + M  V     L     N     + L  +      C   +   R+    +   L    +
Sbjct: 239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (381), Expect = 2e-44
 Identities = 55/302 (18%), Positives = 104/302 (34%), Gaps = 42/302 (13%)

Query: 26  SKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRN 83
           S+A  ++     IG G      K        I+  K ++     +   +   +E N LR 
Sbjct: 1   SRA-EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE 59

Query: 84  IRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLT--QRVNIAI 141
           ++H N+++                 IV EY +  +L   + +   + ++L     + +  
Sbjct: 60  LKHPNIVRYYDRIID---RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 116

Query: 142 DVSFAIEYFHHH--CQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETA 199
            ++ A++  H       +++H DLKP+N+ LD      +GD GLA+ L            
Sbjct: 117 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--------NHDT 168

Query: 200 SNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFV 259
           S +    G   Y++PE       +   D+++ G LL E+     P  A            
Sbjct: 169 SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--------- 219

Query: 260 KMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKL 319
              L  K+ E     +    +      I   L                 R  + ++   L
Sbjct: 220 -KELAGKIREGKFRRIPYRYSDELNEIITRMLN-----------LKDYHRPSVEEI---L 264

Query: 320 RH 321
            +
Sbjct: 265 EN 266

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  150 bits (380), Expect = 5e-44
 Identities = 66/301 (21%), Positives = 120/301 (39%), Gaps = 36/301 (11%)

Query: 21  SYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNA 80
           +Y +      + +  +K+G G    VY+G+  +    VAVK +  +       F  E   
Sbjct: 8   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 66

Query: 81  LRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIA 140
           ++ I+H NL++++ +C            I+ E+M   NL  +LR+ N Q       + +A
Sbjct: 67  MKEIKHPNLVQLLGVC-----TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 121

Query: 141 IDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETAS 200
             +S A+EY         +H DL   N L+ ++ +  V D GL++ + G       +T +
Sbjct: 122 TQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTG-------DTYT 171

Query: 201 NSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVK 260
                K  + + APE    +K S+  DV+ FG+LL E+ T         +          
Sbjct: 172 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID---------- 221

Query: 261 MALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLR 320
                +V E+++    +E         E C   V      C   +P +R    ++     
Sbjct: 222 ---LSQVYELLEKDYRME-------RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 271

Query: 321 H 321
            
Sbjct: 272 T 272

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (375), Expect = 2e-43
 Identities = 69/300 (23%), Positives = 119/300 (39%), Gaps = 39/300 (13%)

Query: 30  NNFSPANKIGQGGVSIVYKGILDESRS----IVAVKVVNLKQKEASR-SFAAECNALRNI 84
           +  +    IG G    VYKG+L  S       VA+K +     E  R  F  E   +   
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 85  RHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVS 144
            H N+I++  + S      +    I+ EYM+N  L+++LR+ +G+   L Q V +   + 
Sbjct: 67  SHHNIIRLEGVISK-----YKPMMIITEYMENGALDKFLREKDGEFSVL-QLVGMLRGI- 119

Query: 145 FAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIE 204
                  +    + VH DL   NIL++ ++V  V D GL++ L         E    +  
Sbjct: 120 --AAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL-----EDDPEATYTTSG 172

Query: 205 IKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALP 264
            K  + + APE     K + + DV++FGI++ E+ T         +              
Sbjct: 173 GKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-------------N 219

Query: 265 DKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARE 324
            +VM+ ++    L           DC  A+    + C  +    R +  D+V+ L     
Sbjct: 220 HEVMKAINDGFRLP-------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 2e-43
 Identities = 57/296 (19%), Positives = 117/296 (39%), Gaps = 38/296 (12%)

Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNL 89
           +  +   +IG G   +V+ G        VA+K +  +   +   F  E   +  + H  L
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKD-KVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKL 62

Query: 90  IKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEY 149
           +++  +C            +VFE+M++  L  +  ++   L      + + +DV   +  
Sbjct: 63  VQLYGVC-----LEQAPICLVFEFMEHGCLSDY-LRTQRGLFAAETLLGMCLDVCEGM-- 114

Query: 150 FHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
             +  +  ++H DL   N L+ ++ V  V D G+ +F+         +  ++S   K  V
Sbjct: 115 -AYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-------DQYTSSTGTKFPV 166

Query: 210 GYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVME 269
            + +PE    S+ S   DV++FG+L+ E+F+  +       E  +  E V+         
Sbjct: 167 KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI----PYENRSNSEVVEDIS--TGFR 220

Query: 270 IVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARET 325
           +  P L    + + Y  +  C             E P +R     ++ +L    E+
Sbjct: 221 LYKPRL---ASTHVYQIMNHCWK-----------ERPEDRPAFSRLLRQLAEIAES 262

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 5e-43
 Identities = 64/290 (22%), Positives = 106/290 (36%), Gaps = 40/290 (13%)

Query: 36  NKIGQGGVSIVYKGILDESRS--IVAVKVVNLK--QKEASRSFAAECNALRNIRHRNLIK 91
            ++G G    V KG     +    VAVK++  +           AE N ++ + +  +++
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72

Query: 92  IITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFH 151
           +I IC        +   +V E  +   L ++L+Q N  ++     + +   VS  ++Y  
Sbjct: 73  MIGICE------AESWMLVMEMAELGPLNKYLQQ-NRHVK-DKNIIELVHQVSMGMKYLE 124

Query: 152 HHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGY 211
                  VH DL   N+LL     A + D GL+K L   E    A+T       K  V +
Sbjct: 125 ESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH-----GKWPVKW 176

Query: 212 VAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEIV 271
            APE     K S   DV++FG+L+ E F+  +        G+   E   M    + M   
Sbjct: 177 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK----PYRGMKGSEVTAMLEKGERMGCP 232

Query: 272 DPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRH 321
                       Y  +  C                  R     V  +LR+
Sbjct: 233 A-----GCPREMYDLMNLCWT-----------YDVENRPGFAAVELRLRN 266

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 6e-42
 Identities = 59/291 (20%), Positives = 114/291 (39%), Gaps = 38/291 (13%)

Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNL 89
            + +   ++G G   +V  G        VA+K++  +   +   F  E   + N+ H  L
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQY-DVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKL 61

Query: 90  IKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEY 149
           +++  +C+           I+ EYM N  L  +LR+   + +   Q + +  DV  A+EY
Sbjct: 62  VQLYGVCTK-----QRPIFIITEYMANGCLLNYLREMRHRFQ-TQQLLEMCKDVCEAMEY 115

Query: 150 FHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIV 209
                    +H DL   N L++   V  V D GL++++         +  ++S+  K  V
Sbjct: 116 LESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-------DEYTSSVGSKFPV 165

Query: 210 GYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVME 269
            +  PE  M SK S   D++ FG+L+ E+++  +     F       E +   L      
Sbjct: 166 RWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-ETAEHIAQGLRLYRPH 224

Query: 270 IVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLR 320
           +    +        Y+ +  C             E   ER   + +++ + 
Sbjct: 225 LASEKV--------YTIMYSCWH-----------EKADERPTFKILLSNIL 256

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (363), Expect = 2e-41
 Identities = 57/291 (19%), Positives = 105/291 (36%), Gaps = 44/291 (15%)

Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITI 95
            ++G G    VYK    E+  + A KV++ K +E    +  E + L +  H N++K++  
Sbjct: 18  GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77

Query: 96  CSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQ 155
                    +   I+ E+     ++  + +    L   +Q   +      A+ Y H +  
Sbjct: 78  F-----YYENNLWILIEFCAGGAVDAVMLELERPLT-ESQIQVVCKQTLDALNYLHDN-- 129

Query: 156 PSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPE 215
             I+H DLK  NIL   D    + D G++             T        G   ++APE
Sbjct: 130 -KIIHRDLKAGNILFTLDGDIKLADFGVSAKN--------TRTIQRRDSFIGTPYWMAPE 180

Query: 216 YGMGSKA-----SVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEI 270
             M   +         DV++ GI L+EM     P     +  L     +      +   +
Sbjct: 181 VVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP-----HHELNPMRVLLKIAKSEPPTL 235

Query: 271 VDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRH 321
             PS     ++N   +++ CL            ++   R     +   L+H
Sbjct: 236 AQPS---RWSSNFKDFLKKCLE-----------KNVDARWTTSQL---LQH 269

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  142 bits (359), Expect = 8e-41
 Identities = 58/332 (17%), Positives = 121/332 (36%), Gaps = 62/332 (18%)

Query: 21  SYAELSKATNNFSPANKIGQGGVSIVYKGIL-----DESRSIVAVKVVNLK-QKEASRSF 74
               L    NN      IG+G    V++         E  ++VAVK++  +   +    F
Sbjct: 4   KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63

Query: 75  AAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLT 134
             E   +    + N++K++ +C            ++FEYM   +L ++LR  +       
Sbjct: 64  QREAALMAEFDNPNIVKLLGVC-----AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSL 118

Query: 135 ----------------------QRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQ 172
                                 +++ IA  V+  + Y         VH DL   N L+ +
Sbjct: 119 SHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGE 175

Query: 173 DIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFG 232
           ++V  + D GL++ ++  +   A             + ++ PE    ++ +   DV+ +G
Sbjct: 176 NMVVKIADFGLSRNIYSADYYKADGN------DAIPIRWMPPESIFYNRYTTESDVWAYG 229

Query: 233 ILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLV 292
           ++L E+F+                 +  MA  + +  + D ++L        +  E+C +
Sbjct: 230 VVLWEIFSYGLQP------------YYGMAHEEVIYYVRDGNIL--------ACPENCPL 269

Query: 293 AVIGTGVTCSMESPMERMEMRDVVAKLRHARE 324
            +      C  + P +R     +   L+   E
Sbjct: 270 ELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 2e-40
 Identities = 68/300 (22%), Positives = 106/300 (35%), Gaps = 40/300 (13%)

Query: 30  NNFSPANKIGQGGVSIVYKGILDESRS---IVAVKVVN---LKQKEASRSFAAECNALRN 83
            +     K+G G   +V +G  D        VAVK +    L Q EA   F  E NA+ +
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 84  IRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDV 143
           + HRNLI++  +  +   +      +V E     +L   LR+  G    L      A+ V
Sbjct: 68  LDHRNLIRLYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFL-LGTLSRYAVQV 120

Query: 144 SFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSI 203
           +  + Y         +H DL   N+LL    +  +GD GL + L   +     +      
Sbjct: 121 AEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH---- 173

Query: 204 EIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMAL 263
             K    + APE       S + D + FG+ L EMFT  +      N    LH+  K   
Sbjct: 174 -RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE 232

Query: 264 PDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHAR 323
                E     +        Y+ +  C               P +R     +   L  A+
Sbjct: 233 RLPRPEDCPQDI--------YNVMVQCWA-----------HKPEDRPTFVALRDFLLEAQ 273

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (352), Expect = 4e-40
 Identities = 55/294 (18%), Positives = 103/294 (35%), Gaps = 40/294 (13%)

Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ-KEASRSFAAECNALRNIRHRN 88
            ++     +G+G    V   +   +   VAVK+V++K+  +   +   E    + + H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 89  LIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIE 148
           ++K             + + +  EY     L   +    G      QR      +   + 
Sbjct: 65  VVKFYGHR-----REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMAGVV 117

Query: 149 YFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGI 208
           Y H      I H D+KP N+LLD+     + D GLA                   ++ G 
Sbjct: 118 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVF------RYNNRERLLNKMCGT 168

Query: 209 VGYVAPEYGMGSK-ASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKV 267
           + YVAPE     +  +   DV++ GI+L  M     P D   +      ++ +       
Sbjct: 169 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP 228

Query: 268 MEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRH 321
            + +D +          + +   LV           E+P  R+ + D+    + 
Sbjct: 229 WKKIDSAP--------LALLHKILV-----------ENPSARITIPDI---KKD 260

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 7e-40
 Identities = 67/326 (20%), Positives = 120/326 (36%), Gaps = 62/326 (19%)

Query: 17  FPMISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRS 73
           +P++ +       N+    + IG+G    V K  + +    +   +  +K+   K+  R 
Sbjct: 4   YPVLDW-------NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD 56

Query: 74  FAAECNALRNI-RHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRF 132
           FA E   L  +  H N+I ++  C     E   +  +  EY  + NL  +LR+S      
Sbjct: 57  FAGELEVLCKLGHHPNIINLLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETD 111

Query: 133 LT--------------QRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHV 178
                           Q ++ A DV+  +    +  Q   +H DL   NIL+ ++ VA +
Sbjct: 112 PAFAIANSTASTLSSQQLLHFAADVARGM---DYLSQKQFIHRDLAARNILVGENYVAKI 168

Query: 179 GDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEM 238
            D GL++    Y   T           +  V ++A E    S  + + DV+++G+LL E+
Sbjct: 169 ADFGLSRGQEVYVKKTM---------GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 219

Query: 239 FTRRRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTG 298
            +           G+T  E  +     K+ +       L      Y  +  C        
Sbjct: 220 VSLGGT----PYCGMTCAELYE-----KLPQGYRLEKPLNCDDEVYDLMRQCWR------ 264

Query: 299 VTCSMESPMERMEMRDVVAKLRHARE 324
                E P ER     ++  L    E
Sbjct: 265 -----EKPYERPSFAQILVSLNRMLE 285

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (351), Expect = 1e-39
 Identities = 48/237 (20%), Positives = 90/237 (37%), Gaps = 20/237 (8%)

Query: 29  TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRN 88
              ++   KIGQG    VY  +   +   VA++ +NL+Q+        E   +R  ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 89  LIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIE 148
           ++  +           D   +V EY+   +L   + ++        Q   +  +   A+E
Sbjct: 79  IVNYLDSY-----LVGDELWVVMEYLAGGSLTDVVTETCMDEG---QIAAVCRECLQALE 130

Query: 149 YFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGI 208
           + H +    ++H D+K  NILL  D    + D G    +   +        S    + G 
Sbjct: 131 FLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--------SKRSTMVGT 179

Query: 209 VGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPD 265
             ++APE           D+++ GI+ +EM     P     N    L+       P+
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE-NPLRALYLIATNGTPE 235

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  140 bits (353), Expect = 2e-39
 Identities = 52/294 (17%), Positives = 102/294 (34%), Gaps = 41/294 (13%)

Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNL 89
           +++    ++G G   +V++     + +  A K V    +    +   E   +  +RH  L
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85

Query: 90  IKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEY 149
           + +        FE  +   +++E+M    L + +   + ++    + V     V   + +
Sbjct: 86  VNLHDA-----FEDDNEMVMIYEFMSGGELFEKVADEHNKMS-EDEAVEYMRQVCKGLCH 139

Query: 150 FHHHCQPSIVHGDLKPSNILL--DQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKG 207
            H +     VH DLKP NI+    +     + D GL   L         +   +     G
Sbjct: 140 MHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---------DPKQSVKVTTG 187

Query: 208 IVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKV 267
              + APE   G       D+++ G+L   + +   P     N+  TL            
Sbjct: 188 TAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE-NDDETLRNVKSCDWN--- 243

Query: 268 MEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRH 321
              +D S    ++ +   +I   L+A            P  RM +      L H
Sbjct: 244 ---MDDSAFSGISEDGKDFIRKLLLA-----------DPNTRMTIHQA---LEH 280

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  138 bits (348), Expect = 4e-39
 Identities = 56/296 (18%), Positives = 102/296 (34%), Gaps = 51/296 (17%)

Query: 32  FSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK---EASRSFAAECNALRNIRHRN 88
           FS   +IG G    VY      +  +VA+K ++   K   E  +    E   L+ +RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 89  LIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIE 148
            I+                 +V EY      +         L+ + +   +       + 
Sbjct: 77  TIQYRGCY-----LREHTAWLVMEYCLGSASDLLEVH-KKPLQEV-EIAAVTHGALQGLA 129

Query: 149 YFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGI 208
           Y H H   +++H D+K  NILL +  +  +GD G A  +            + +    G 
Sbjct: 130 YLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM------------APANSFVGT 174

Query: 209 VGYVAPEYGMGS---KASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPD 265
             ++APE  +     +     DV++ GI  +E+  R+ P   M      L+   +   P 
Sbjct: 175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQNESPA 233

Query: 266 KVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRH 321
                              ++++ CL            + P +R     +   L+H
Sbjct: 234 LQSGHWSEYF--------RNFVDSCLQ-----------KIPQDRPTSEVL---LKH 267

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 2e-38
 Identities = 47/242 (19%), Positives = 93/242 (38%), Gaps = 24/242 (9%)

Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVN---LKQKEASRSFAAECNALRNIRH 86
            +F     +G+G    VY     +S+ I+A+KV+    L++         E     ++RH
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 87  RNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFA 146
            N++++                ++ EY     + + L++ +       +      +++ A
Sbjct: 66  PNILRLYGYF-----HDATRVYLILEYAPLGTVYRELQKLSKFD--EQRTATYITELANA 118

Query: 147 IEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIK 206
           + Y H      ++H D+KP N+LL       + D G +              +S    + 
Sbjct: 119 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA----------PSSRRTTLC 165

Query: 207 GIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAM-FNEGLTLHEFVKMALPD 265
           G + Y+ PE   G       D+++ G+L  E    + P +A  + E       V+   PD
Sbjct: 166 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD 225

Query: 266 KV 267
            V
Sbjct: 226 FV 227

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 3e-38
 Identities = 51/318 (16%), Positives = 98/318 (30%), Gaps = 61/318 (19%)

Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSI-----VAVKVVNLKQKEASR-SFAAECNALRN 83
            N      +G G    V                VAVK++  K   + R +  +E   +  
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 84  I-RHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRF---------- 132
           +  H N++ ++  C            ++FEY    +L  +LR    +             
Sbjct: 97  LGSHENIVNLLGAC-----TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKR 151

Query: 133 -----------LTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDL 181
                          +  A  V+  +E+       S VH DL   N+L+    V  + D 
Sbjct: 152 LEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDF 208

Query: 182 GLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTR 241
           GLA+ +                  +  V ++APE       ++  DV+++GILL E+F+ 
Sbjct: 209 GLARDIMSDSNYVVRGN------ARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL 262

Query: 242 RRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTC 301
                         ++ ++              +        Y  ++ C           
Sbjct: 263 GVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEI--------YIIMQSCWA--------- 305

Query: 302 SMESPMERMEMRDVVAKL 319
                 +R    ++ + L
Sbjct: 306 --FDSRKRPSFPNLTSFL 321

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 7e-38
 Identities = 48/293 (16%), Positives = 107/293 (36%), Gaps = 41/293 (13%)

Query: 32  FSPANKIGQGGVSIVYKGILDESRSIVAVKVV-----NLKQKEASRSFAAECNALRNIRH 86
           F     +G G    VYKG+       V + V           +A++    E   + ++ +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 87  RNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFA 146
            ++ +++ IC +   +      ++ + M    L  ++R+           +N  + ++  
Sbjct: 71  PHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQIAKG 123

Query: 147 IEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIK 206
           + Y        +VH DL   N+L+       + D GLAK L       A E   ++   K
Sbjct: 124 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL------GAEEKEYHAEGGK 174

Query: 207 GIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDK 266
             + ++A E  +    +   DV+++G+ + E+ T          +G+   E   +    +
Sbjct: 175 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK----PYDGIPASEISSILEKGE 230

Query: 267 VMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKL 319
            +    P   ++V    Y  +  C +                R + R+++ + 
Sbjct: 231 RLPQ-PPICTIDV----YMIMVKCWM-----------IDADSRPKFRELIIEF 267

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 9e-38
 Identities = 50/241 (20%), Positives = 91/241 (37%), Gaps = 20/241 (8%)

Query: 27  KATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVN---LKQKEASRSFAAECNALRN 83
           K   +F     +G+G  S V       +    A+K++    + ++        E + +  
Sbjct: 5   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64

Query: 84  IRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDV 143
           + H   +K+        F+  +       Y +N  L +++R+        T+     I  
Sbjct: 65  LDHPFFVKLYFT-----FQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI-- 117

Query: 144 SFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSI 203
              +    +     I+H DLKP NILL++D+   + D G AK L        A +     
Sbjct: 118 ---VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS----- 169

Query: 204 EIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMAL 263
              G   YV+PE      A  S D++  G ++ ++     P  A  NE L   + +K+  
Sbjct: 170 -FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG-NEYLIFQKIIKLEY 227

Query: 264 P 264
            
Sbjct: 228 D 228

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (337), Expect = 2e-37
 Identities = 51/313 (16%), Positives = 101/313 (32%), Gaps = 56/313 (17%)

Query: 30  NNFSPANKIGQGGVSIVYKGIL-----DESRSIVAVKVVNLKQKEASR-SFAAECNALRN 83
           N  S    +G G    V +         ++   VAVK++        R +  +E   L  
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 84  I-RHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRF---------- 132
           +  H N++ ++  C+           ++ EY    +L  +LR+                 
Sbjct: 83  LGNHMNIVNLLGACTI-----GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137

Query: 133 ------LTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF 186
                 L   ++ +  V+  + +         +H DL   NILL    +  + D GLA+ 
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARD 194

Query: 187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTD 246
           +                  +  V ++APE       +   DV+++GI L E+F+      
Sbjct: 195 I------KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 248

Query: 247 AMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESP 306
                    ++ +K        E     +        Y  ++ C               P
Sbjct: 249 PGMPVDSKFYKMIKEGFRMLSPEHAPAEM--------YDIMKTCWD-----------ADP 289

Query: 307 MERMEMRDVVAKL 319
           ++R   + +V  +
Sbjct: 290 LKRPTFKQIVQLI 302

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (324), Expect = 1e-35
 Identities = 53/314 (16%), Positives = 125/314 (39%), Gaps = 52/314 (16%)

Query: 30  NNFSPANKIGQGGVSIVYKGIL-----DESRSIVAVKVVNLKQKEASR-SFAAECNALRN 83
              + + ++GQG   +VY+G+      DE  + VA+K VN       R  F  E + ++ 
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 84  IRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRF--------LTQ 135
               ++++++ +             ++ E M   +L+ +LR     +          L++
Sbjct: 80  FNCHHVVRLLGVV-----SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 134

Query: 136 RVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTA 195
            + +A +++  + Y + +     VH DL   N ++ +D    +GD G+ + +        
Sbjct: 135 MIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDI------YE 185

Query: 196 AETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTL 255
            +      +    V +++PE       +   DV++FG++L E+ T          +GL+ 
Sbjct: 186 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ----PYQGLSN 241

Query: 256 HEFVKMALPDKVMEIVD--PSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMR 313
            + ++  +   +++  D  P +L E+       +  C              +P  R    
Sbjct: 242 EQVLRFVMEGGLLDKPDNCPDMLFEL-------MRMCWQ-----------YNPKMRPSFL 283

Query: 314 DVVAKLRHARETFL 327
           ++++ ++   E   
Sbjct: 284 EIISSIKEEMEPGF 297

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  129 bits (325), Expect = 2e-35
 Identities = 38/210 (18%), Positives = 75/210 (35%), Gaps = 20/210 (9%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           ++G G   +V++ +   +  +   K +N        +   E + +  + H  LI +    
Sbjct: 36  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA- 94

Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQP 156
               FE      ++ E++    L   +   + ++    + +N        +++ H H   
Sbjct: 95  ----FEDKYEMVLILEFLSGGELFDRIAAEDYKMS-EAEVINYMRQACEGLKHMHEH--- 146

Query: 157 SIVHGDLKPSNILLDQDIVAHV--GDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAP 214
           SIVH D+KP NI+ +    + V   D GLA  L                       + AP
Sbjct: 147 SIVHLDIKPENIMCETKKASSVKIIDFGLATKL---------NPDEIVKVTTATAEFAAP 197

Query: 215 EYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
           E           D++  G+L   + +   P
Sbjct: 198 EIVDREPVGFYTDMWAIGVLGYVLLSGLSP 227

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 3e-35
 Identities = 53/292 (18%), Positives = 103/292 (35%), Gaps = 41/292 (14%)

Query: 37  KIGQGGVSIVYKGIL---DESRSIVAVKVVNLKQKEASRS-FAAECNALRNIRHRNLIKI 92
            IG+G    V++GI    +     VA+K       ++ R  F  E   +R   H +++K+
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73

Query: 93  ITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHH 152
           I + +       +   I+ E      L  +L+     L  L   +  A  +S A+ Y   
Sbjct: 74  IGVITE------NPVWIIMELCTLGELRSFLQVRKYSLD-LASLILYAYQLSTALAYLES 126

Query: 153 HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYV 212
                 VH D+   N+L+  +    +GD GL++++          T   + + K  + ++
Sbjct: 127 KR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-------STYYKASKGKLPIKWM 176

Query: 213 APEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEIVD 272
           APE     + + + DV+ FG+ + E+                        +  ++     
Sbjct: 177 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---------NDVIGRIENGER 227

Query: 273 PSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARE 324
             +        YS +  C               P  R    ++ A+L    E
Sbjct: 228 LPMPPNCPPTLYSLMTKCWA-----------YDPSRRPRFTELKAQLSTILE 268

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  127 bits (319), Expect = 4e-35
 Identities = 46/222 (20%), Positives = 84/222 (37%), Gaps = 14/222 (6%)

Query: 26  SKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVN---LKQKEASRSFAAECNALR 82
           S  ++ +     +G GG+S V+          VAVKV+     +       F  E     
Sbjct: 3   SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAA 62

Query: 83  NIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAID 142
            + H  ++ +     +    G     IV EY+    L   +           + + +  D
Sbjct: 63  ALNHPAIVAVYDTGEAETPAG-PLPYIVMEYVDGVTLRDIVHTEGPMT--PKRAIEVIAD 119

Query: 143 VSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNS 202
                +  +   Q  I+H D+KP+NI++       V D G+A+ +       +  + + +
Sbjct: 120 A---CQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI-----ADSGNSVTQT 171

Query: 203 IEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
             + G   Y++PE   G       DVY+ G +L E+ T   P
Sbjct: 172 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 213

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  124 bits (313), Expect = 6e-34
 Identities = 44/218 (20%), Positives = 82/218 (37%), Gaps = 24/218 (11%)

Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVN---LKQKEASRSFAAECNALRNIRH 86
            +F     +G G    V+      +    A+KV+    + + +       E   L  + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 87  RNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFA 146
             +I++         +      ++ +Y++   L   LR+S      + +     +     
Sbjct: 64  PFIIRMWGTF-----QDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV----- 113

Query: 147 IEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIK 206
                +     I++ DLKP NILLD++    + D G AK++              +  + 
Sbjct: 114 CLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV-----------PDVTYTLC 162

Query: 207 GIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
           G   Y+APE       + S D ++FGIL+ EM     P
Sbjct: 163 GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 200

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 2e-33
 Identities = 46/219 (21%), Positives = 91/219 (41%), Gaps = 21/219 (9%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
            +G+G   IV++ +   S+     K V +K  +       E + L   RHRN++ +    
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL-VKKEISILNIARHRNILHLHES- 69

Query: 97  SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQP 156
               FE  +   ++FE++   ++ + +  S  +L    + V+    V  A+++ H H   
Sbjct: 70  ----FESMEELVMIFEFISGLDIFERINTSAFELN-EREIVSYVHQVCEALQFLHSHN-- 122

Query: 157 SIVHGDLKPSNILLDQDIVAHV--GDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAP 214
            I H D++P NI+      + +   + G A+ L         +   N   +     Y AP
Sbjct: 123 -IGHFDIRPENIIYQTRRSSTIKIIEFGQARQL---------KPGDNFRLLFTAPEYYAP 172

Query: 215 EYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGL 253
           E       S + D+++ G L+  + +   P  A  N+ +
Sbjct: 173 EVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI 211

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  124 bits (311), Expect = 2e-33
 Identities = 53/270 (19%), Positives = 100/270 (37%), Gaps = 35/270 (12%)

Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK------QKEASRSFAAECNALRN 83
           N+FS    IG+GG   VY     ++  + A+K ++ K       +  + +     + +  
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 84  IRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDV 143
                ++ +        F   D  + + + M   +L   L Q    +         A ++
Sbjct: 64  GDCPFIVCMSYA-----FHTPDKLSFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEI 116

Query: 144 SFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSI 203
              +E+ H+     +V+ DLKP+NILLD+     + DLGLA             +     
Sbjct: 117 ILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF----------SKKKPH 163

Query: 204 EIKGIVGYVAPEYGMGSKA-SVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMA 262
              G  GY+APE      A   S D ++ G +L ++     P      +     + + + 
Sbjct: 164 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT 223

Query: 263 LPDKVMEIVDPSLLLEVTANNYSWIEDCLV 292
           +  ++ +   P L         S +E  L 
Sbjct: 224 MAVELPDSFSPEL--------RSLLEGLLQ 245

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (304), Expect = 8e-33
 Identities = 58/308 (18%), Positives = 110/308 (35%), Gaps = 27/308 (8%)

Query: 25  LSKATNNFSPANKIGQGGVSIVYKGI-LDESRSIVAVKVVNLK-----QKEASRSFAAEC 78
           L +A   +    +IG+G    V+K   L      VA+K V ++        ++    A  
Sbjct: 2   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61

Query: 79  NALRNIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVN 138
             L    H N++++  +C+    +      +VFE++         +     +       +
Sbjct: 62  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGV-PTETIKD 120

Query: 139 IAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAET 198
           +   +   +++ H H    +VH DLKP NIL+       + D GLA+        T    
Sbjct: 121 MMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT---- 173

Query: 199 ASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEF 258
                 +   + Y APE  + S  +   D+++ G +  EMF R+       +        
Sbjct: 174 -----SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL 228

Query: 259 VKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVT-----CSMESPMERMEMR 313
             + LP +     D +L  +   +  +   +  V  I          C   +P +R+   
Sbjct: 229 DVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAY 288

Query: 314 DVVAKLRH 321
                L H
Sbjct: 289 SA---LSH 293

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (307), Expect = 9e-33
 Identities = 51/218 (23%), Positives = 91/218 (41%), Gaps = 20/218 (9%)

Query: 31  NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLI 90
           +++    IG G   +VY+  L +S  +VA+K V   ++  +R    E   +R + H N++
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 76

Query: 91  KIITIC-SSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRF-LTQRVNIAIDVSFAIE 148
           ++     SS + +   +  +V +Y+           S  +    +         +  ++ 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136

Query: 149 YFHHHCQPSIVHGDLKPSNILLDQDIVAH-VGDLGLAKFLFGYEPGTAAETASNSIEIKG 207
           Y H      I H D+KP N+LLD D     + D G AK L   EP         ++    
Sbjct: 137 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---------NVSYIC 184

Query: 208 IVGYVAPEYGMGS-KASVSGDVYNFGILLLEMFTRRRP 244
              Y APE   G+   + S DV++ G +L E+   +  
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 222

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (293), Expect = 2e-31
 Identities = 52/315 (16%), Positives = 102/315 (32%), Gaps = 51/315 (16%)

Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ------KEASRSFAAECNALRN 83
           +       +G+G    V +            + V +K           R+  +E   L +
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 84  IRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQL------------R 131
           I H   +  +        +      ++ E+ +  NL  +LR    +              
Sbjct: 73  IGHHLNVVNLLGAC---TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129

Query: 132 FLT--QRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG 189
           FLT    +  +  V+  +E+         +H DL   NILL +  V  + D GLA+ ++ 
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYK 186

Query: 190 YEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMF 249
                           +  + ++APE       ++  DV++FG+LL E+F+         
Sbjct: 187 DPDYVRKGD------ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240

Query: 250 NEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMER 309
                    +K     +  +   P +        Y  + DC               P +R
Sbjct: 241 KIDEEFCRRLKEGTRMRAPDYTTPEM--------YQTMLDCWH-----------GEPSQR 281

Query: 310 MEMRDVVAKLRHARE 324
               ++V  L +  +
Sbjct: 282 PTFSELVEHLGNLLQ 296

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  116 bits (292), Expect = 4e-31
 Identities = 50/296 (16%), Positives = 97/296 (32%), Gaps = 29/296 (9%)

Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNL 89
           N +    KIG G    +Y G    +   VA+K+  +K K        E    + ++    
Sbjct: 7   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 64

Query: 90  IKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEY 149
           I  I  C        D+  +V E +     + +      +   L   + +A  +   IEY
Sbjct: 65  IPTIRWC----GAEGDYNVMVMELLGPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEY 118

Query: 150 FHHHCQPSIVHGDLKPSNIL---LDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIK 206
            H     + +H D+KP N L     +  + ++ D GLAK  +             +  + 
Sbjct: 119 IHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK-YRDARTHQHIPYRENKNLT 174

Query: 207 GIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDK 266
           G   Y +    +G + S   D+ + G +L+       P   +     T  +  +     K
Sbjct: 175 GTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA--TKRQKYERISEKK 232

Query: 267 VMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHA 322
            M      L     +   +++  C                 ++ +   +    R+ 
Sbjct: 233 -MSTPIEVLCKGYPSEFATYLNFCR-----------SLRFDDKPDYSYLRQLFRNL 276

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (290), Expect = 7e-31
 Identities = 51/215 (23%), Positives = 88/215 (40%), Gaps = 24/215 (11%)

Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEAS-----RSFAAECNALRNIRHRNLI 90
           + +G+G  + VYK     +  IVA+K + L  +  +     R+   E   L+ + H N+I
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 91  KIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYF 150
            ++              ++VF++M+         + N  +   +      +     +EY 
Sbjct: 64  GLLDAF-----GHKSNISLVFDFMETDLEVII--KDNSLVLTPSHIKAYMLMTLQGLEYL 116

Query: 151 HHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVG 210
           H H    I+H DLKP+N+LLD++ V  + D GLAK                         
Sbjct: 117 HQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSF--------GSPNRAYTHQVVTRW 165

Query: 211 YVAPEYGMGSKA-SVSGDVYNFGILLLEMFTRRRP 244
           Y APE   G++   V  D++  G +L E+  R   
Sbjct: 166 YRAPELLFGARMYGVGVDMWAVGCILAELLLRVPF 200

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (291), Expect = 8e-31
 Identities = 45/221 (20%), Positives = 92/221 (41%), Gaps = 15/221 (6%)

Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRNIRHR 87
           + +    KIGQG    V+K    ++   VA+K V ++  ++    +   E   L+ ++H 
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69

Query: 88  NLIKIITICSSIDFEGFDFKA---IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVS 144
           N++ +I IC +        K    +VF++ ++                  +RV   +   
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML--- 126

Query: 145 FAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIE 204
             +   ++  +  I+H D+K +N+L+ +D V  + D GLA+     +        +    
Sbjct: 127 --LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN---- 180

Query: 205 IKGIVGYVAPEYGMGSKA-SVSGDVYNFGILLLEMFTRRRP 244
               + Y  PE  +G +      D++  G ++ EM+TR   
Sbjct: 181 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI 221

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (292), Expect = 9e-31
 Identities = 51/218 (23%), Positives = 87/218 (39%), Gaps = 14/218 (6%)

Query: 29  TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASR-SFAAECNALRNIRHR 87
              ++  + IG+G   +V     + ++  VA+K ++  + +        E   L   RH 
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 88  NLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAI 147
           N+I I  I  +   E      +V   M   +L + L+  +               +   +
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLM-GADLYKLLKTQHLSND---HICYFLYQILRGL 122

Query: 148 EYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKG 207
           +Y H      ++H DLKPSN+LL+      + D GLA+        T   T     E   
Sbjct: 123 KYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT-----EYVA 174

Query: 208 IVGYVAPEYGMGSKA-SVSGDVYNFGILLLEMFTRRRP 244
              Y APE  + SK  + S D+++ G +L EM + R  
Sbjct: 175 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 212

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (289), Expect = 2e-30
 Identities = 46/219 (21%), Positives = 85/219 (38%), Gaps = 22/219 (10%)

Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVN----LKQKEASRSFAAECNALRNIR 85
            +F     +G+G    V+     ++    A+K +     L   +   +   +        
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 86  HRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSF 145
           H  L  +         +  +    V EY+   +L   ++  +     L++    A ++  
Sbjct: 62  HPFLTHMFCTF-----QTKENLFFVMEYLNGGDLMYHIQSCHKFD--LSRATFYAAEIIL 114

Query: 146 AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEI 205
            +++ H      IV+ DLK  NILLD+D    + D G+ K              + +   
Sbjct: 115 GLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENM--------LGDAKTNTF 163

Query: 206 KGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
            G   Y+APE  +G K + S D ++FG+LL EM   + P
Sbjct: 164 CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 202

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  114 bits (286), Expect = 2e-30
 Identities = 49/224 (21%), Positives = 86/224 (38%), Gaps = 23/224 (10%)

Query: 31  NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---------KEASRSFAAECNAL 81
           N+ P   +G+G  S+V + I   +    AVK++++           +E   +   E + L
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 82  RNIR-HRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIA 140
           R +  H N+I++        +E   F  +VF+ M+   L  +L +    L    +   I 
Sbjct: 64  RKVSGHPNIIQLKD-----TYETNTFFFLVFDLMKKGELFDYLTE-KVTLS-EKETRKIM 116

Query: 141 IDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETAS 200
             +   I   H      IVH DLKP NILLD D+   + D G +  L   +PG       
Sbjct: 117 RALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPGEKLREVC 170

Query: 201 NSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
            +                        D+++ G+++  +     P
Sbjct: 171 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 214

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (286), Expect = 3e-30
 Identities = 59/315 (18%), Positives = 109/315 (34%), Gaps = 57/315 (18%)

Query: 30  NNFSPANKIGQGGVSIVYKGIL-------DESRSIVAVKVVNLKQKEASRS-FAAECNAL 81
           +       +G+G    V                + VAVK++     E   S   +E   +
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 82  RNI-RHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLT------ 134
           + I +H+N+I ++  C+           ++ EY    NL ++L+         +      
Sbjct: 73  KMIGKHKNIINLLGACTQ-----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 127

Query: 135 --------QRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF 186
                     V+ A  V+  +    +      +H DL   N+L+ +D V  + D GLA+ 
Sbjct: 128 PEEQLSSKDLVSCAYQVARGM---EYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 184

Query: 187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTD 246
           +         +    +   +  V ++APE       +   DV++FG+LL E+FT      
Sbjct: 185 I------HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS-- 236

Query: 247 AMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESP 306
                G+ + E  K+      M+          T   Y  + DC               P
Sbjct: 237 --PYPGVPVEELFKLLKEGHRMDKPS-----NCTNELYMMMRDCWH-----------AVP 278

Query: 307 MERMEMRDVVAKLRH 321
            +R   + +V  L  
Sbjct: 279 SQRPTFKQLVEDLDR 293

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (284), Expect = 6e-30
 Identities = 47/217 (21%), Positives = 92/217 (42%), Gaps = 20/217 (9%)

Query: 31  NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ--KEASRSFAAECNALRNIRHRN 88
           NF    KIG+G   +VYK     +  +VA+K + L    +    +   E + L+ + H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 89  LIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIE 148
           ++K++ +         +   +VFE++ +++L++++  S      L    +    +   ++
Sbjct: 63  IVKLLDVI-----HTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL---LQ 113

Query: 149 YFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGI 208
                    ++H DLKP N+L++ +    + D GLA+                       
Sbjct: 114 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--------GVPVRTYTHEVVT 165

Query: 209 VGYVAPE-YGMGSKASVSGDVYNFGILLLEMFTRRRP 244
           + Y APE        S + D+++ G +  EM TRR  
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRAL 202

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (285), Expect = 7e-30
 Identities = 50/287 (17%), Positives = 103/287 (35%), Gaps = 37/287 (12%)

Query: 38  IGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICS 97
           +G G    V +     ++   A+K++     +A R         R  +  ++++I+ +  
Sbjct: 20  LGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARREVELH---WRASQCPHIVRIVDVYE 75

Query: 98  SIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPS 157
           ++ + G     IV E +    L   ++    Q     +   I   +  AI+Y H     +
Sbjct: 76  NL-YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---N 131

Query: 158 IVHGDLKPSNILLD---QDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAP 214
           I H D+KP N+L      + +  + D G AK            + ++         YVAP
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKET---------TSHNSLTTPCYTPYYVAP 182

Query: 215 EYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPS 274
           E     K   S D+++ G+++  +     P  +     ++     ++ +        + S
Sbjct: 183 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 242

Query: 275 LLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRH 321
              EV+      I + L              P +RM + +    + H
Sbjct: 243 ---EVSEEVKMLIRNLLK-----------TEPTQRMTITEF---MNH 272

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  113 bits (283), Expect = 1e-29
 Identities = 45/226 (19%), Positives = 80/226 (35%), Gaps = 17/226 (7%)

Query: 29  TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASR-SFAAECNALRNIRHR 87
            + +   + +G G  S V       ++ +VA+K +  K  E    S   E   L  I+H 
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67

Query: 88  NLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAI 147
           N++ +  I     +E      ++ + +    L   + +  G          +   V  A+
Sbjct: 68  NIVALDDI-----YESGGHLYLIMQLVSGGELFDRIVE-KGFYT-ERDASRLIFQVLDAV 120

Query: 148 EYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKG 207
           +Y H                  LD+D    + D GL+K     +PG+   T        G
Sbjct: 121 KYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME---DPGSVLST------ACG 171

Query: 208 IVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGL 253
             GYVAPE       S + D ++ G++   +     P     +  L
Sbjct: 172 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL 217

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  112 bits (281), Expect = 1e-29
 Identities = 36/300 (12%), Positives = 88/300 (29%), Gaps = 31/300 (10%)

Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNL 89
            ++    +IG+G   ++++G    +   VA+K     ++  +     E    + +     
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF--EPRRSDAPQLRDEYRTYKLLAGCTG 62

Query: 90  IKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEY 149
           I  +        +      +V + +      + L    G+   +      A  +   ++ 
Sbjct: 63  IPNVYYF----GQEGLHNVLVIDLLGP--SLEDLLDLCGRKFSVKTVAMAAKQMLARVQS 116

Query: 150 FHHHCQPSIVHGDLKPSNILLDQDIVAHVG-----DLGLAKFLFGYEPGTAAETASNSIE 204
            H      +V+ D+KP N L+ +    +       D G+ KF +                
Sbjct: 117 IHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF-YRDPVTKQHIPYREKKN 172

Query: 205 IKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALP 264
           + G   Y++    +G + S   D+   G + +       P   +                
Sbjct: 173 LSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN-------KQKY 225

Query: 265 DKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARE 324
           +++ E    + L E+ A         +             +     +   +        E
Sbjct: 226 ERIGEKKQSTPLRELCAGFPEEFYKYMHY-------ARNLAFDATPDYDYLQGLFSKVLE 278

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (276), Expect = 8e-29
 Identities = 54/296 (18%), Positives = 100/296 (33%), Gaps = 52/296 (17%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRS------FAAECNALRNIRHRNLI 90
           ++G G  ++V K     +    A K +  ++ ++SR          E + L+ I+H N+I
Sbjct: 17  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76

Query: 91  KIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYF 150
            +  +     +E      ++ E +    L  +L +               I     +   
Sbjct: 77  TLHEV-----YENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI-----LNGV 126

Query: 151 HHHCQPSIVHGDLKPSNILLDQD----IVAHVGDLGLAKFLFGYEPGTAAETASNSIEIK 206
           ++     I H DLKP NI+L           + D GLA  +         +  +    I 
Sbjct: 127 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---------DFGNEFKNIF 177

Query: 207 GIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFN-EGLTLHEFVKMALPD 265
           G   +VAPE        +  D+++ G++   + +   P       E L     V     D
Sbjct: 178 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED 237

Query: 266 KVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRH 321
           +                   +I   LV           + P +RM ++D    L+H
Sbjct: 238 EYFSNTSALA--------KDFIRRLLV-----------KDPKKRMTIQDS---LQH 271

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (273), Expect = 1e-28
 Identities = 41/234 (17%), Positives = 87/234 (37%), Gaps = 19/234 (8%)

Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ--KEASRSFAAECNALRNIRHR 87
             +    KIG+G    V+K    E+  IVA+K V L    +    S   E   L+ ++H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 88  NLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAI 147
           N++++  +             +VFE+      + +   +      + +     +     +
Sbjct: 62  NIVRLHDV-----LHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQL-----L 111

Query: 148 EYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKG 207
           +        +++H DLKP N+L++++    + + GLA+                S E+  
Sbjct: 112 KGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAF-------GIPVRCYSAEVVT 164

Query: 208 IVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKM 261
           +              S S D+++ G +  E+    RP     +    L    ++
Sbjct: 165 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRL 218

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (274), Expect = 3e-28
 Identities = 42/218 (19%), Positives = 75/218 (34%), Gaps = 21/218 (9%)

Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVN---LKQKEASRSFAAECNALRNIRH 86
           N+F     +G+G    V       +    A+K++    +  K+       E   L+N RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 87  RNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFA 146
             L  +         +  D    V EY     L   L +         +      ++   
Sbjct: 65  PFLTALKYAF-----QTHDRLCFVMEYANGGELFFHLSRERVFTE--ERARFYGAEI--- 114

Query: 147 IEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIK 206
           +    +     +V+ D+K  N++LD+D    + D GL K              +      
Sbjct: 115 VSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI--------SDGATMKTFC 166

Query: 207 GIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
           G   Y+APE    +    + D +  G+++ EM   R P
Sbjct: 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  107 bits (268), Expect = 3e-27
 Identities = 47/222 (21%), Positives = 82/222 (36%), Gaps = 24/222 (10%)

Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVN---LKQKEASRSFAAECNALRNIRH 86
           + F     +G G    V      ES +  A+K+++   + + +       E   L+ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 87  RNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFA 146
             L+K+                +V EY+    +   LR+  G+          A  +   
Sbjct: 101 PFLVKLEFSFKD-----NSNLYMVMEYVAGGEMFSHLRR-IGRFS-EPHARFYAAQIVLT 153

Query: 147 IEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIK 206
            EY H      +++ DLKP N+L+DQ     V D G AK + G            +  + 
Sbjct: 154 FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----------RTWTLC 199

Query: 207 GIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAM 248
           G    +APE  +    + + D +  G+L+ EM     P  A 
Sbjct: 200 GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD 241

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  104 bits (261), Expect = 8e-27
 Identities = 46/218 (21%), Positives = 92/218 (42%), Gaps = 22/218 (10%)

Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ--KEASRSFAAECNALRNIRHR 87
             +    KIG+G   +VYK   +      A+K + L++  +    +   E + L+ ++H 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGE-TFALKKIRLEKEDEGIPSTTIREISILKELKHS 60

Query: 88  NLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAI 147
           N++K+  +  +          +VFE++   +L++ L    G L  +T +  +       +
Sbjct: 61  NIVKLYDVIHT-----KKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQ----LL 110

Query: 148 EYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKG 207
               +     ++H DLKP N+L++++    + D GLA+                      
Sbjct: 111 NGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAF--------GIPVRKYTHEIV 162

Query: 208 IVGYVAPEYGMGSKA-SVSGDVYNFGILLLEMFTRRRP 244
            + Y AP+  MGSK  S + D+++ G +  EM      
Sbjct: 163 TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPL 200

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (256), Expect = 4e-26
 Identities = 45/246 (18%), Positives = 82/246 (33%), Gaps = 30/246 (12%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLK------QKEASRSFAAECNALRNIR--HRN 88
            +G GG   VY GI       VA+K V         +         E   L+ +      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 89  LIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIE 148
           +I+++           D   ++ E  +            G L+      +    V  A+ 
Sbjct: 71  VIRLLDWFER-----PDSFVLILERPEPVQDLFDFITERGALQ-EELARSFFWQVLEAVR 124

Query: 149 YFHHHCQPSIVHGDLKPSNILLDQD-IVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKG 207
           + H+     ++H D+K  NIL+D +     + D G    L            +   +  G
Sbjct: 125 HCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALL----------KDTVYTDFDG 171

Query: 208 IVGYVAPEYGMGSKA-SVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDK 266
              Y  PE+    +    S  V++ GILL +M     P +    E +    F +  +  +
Sbjct: 172 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD-EEIIRGQVFFRQRVSSE 230

Query: 267 VMEIVD 272
              ++ 
Sbjct: 231 CQHLIR 236

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  102 bits (255), Expect = 2e-25
 Identities = 41/219 (18%), Positives = 83/219 (37%), Gaps = 21/219 (9%)

Query: 37  KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITIC 96
           K+G G  S V+      + + VA+K+V    K  + +   E   L+ +   +  K  ++ 
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78

Query: 97  S----------SIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFA 146
           +          +          +VFE +    L    +  +  +  L     I+  +   
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIP-LIYVKQISKQLLLG 137

Query: 147 IEYFHHHCQPSIVHGDLKPSNILLDQ-DIVAHVGDLGLAKFLFGYEPGTAAETASNSIEI 205
           ++Y H  C   I+H D+KP N+L++  D   ++  + +A        G A     +    
Sbjct: 138 LDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADL------GNACWYDEHYTNS 189

Query: 206 KGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
                Y +PE  +G+      D+++   L+ E+ T    
Sbjct: 190 IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL 228

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  101 bits (252), Expect = 3e-25
 Identities = 55/272 (20%), Positives = 111/272 (40%), Gaps = 28/272 (10%)

Query: 5   HKDSNMLSMKQQFPMISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVN 64
           + D N    ++ +   S+       +++    K+G+G  S V++ I   +   V VK++ 
Sbjct: 10  YTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK 69

Query: 65  LKQKEASRSFAAECNALRNIR-HRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWL 123
             +K+       E   L N+R   N+I +  I            A+VFE++ N + +Q  
Sbjct: 70  PVKKK---KIKREIKILENLRGGPNIITLADIVKDPVSRTP---ALVFEHVNNTDFKQLY 123

Query: 124 RQ-SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDI-VAHVGDL 181
           +  ++  +RF         ++  A++Y H      I+H D+KP N+++D +     + D 
Sbjct: 124 QTLTDYDIRF------YMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDW 174

Query: 182 GLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKA-SVSGDVYNFGILLLEMFT 240
           GLA+F    +                   +  PE  +  +    S D+++ G +L  M  
Sbjct: 175 GLAEFYHPGQEYN---------VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 225

Query: 241 RRRPTDAMFNEGLTLHEFVKMALPDKVMEIVD 272
           R+ P     +    L    K+   + + + +D
Sbjct: 226 RKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 257

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.5 bits (247), Expect = 1e-24
 Identities = 45/224 (20%), Positives = 85/224 (37%), Gaps = 25/224 (11%)

Query: 30  NNFSPANKIGQGGVSIVYKG---ILDESRSIVAVKVVN----LKQKEASRSFAAECNALR 82
            NF     +G G    V+        ++  + A+KV+     +++ + +     E   L 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 83  NIRHRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAID 142
           +IR    +  +       F+      ++ +Y+    L   L Q     R       + I 
Sbjct: 84  HIRQSPFLVTLHYA----FQTETKLHLILDYINGGELFTHLSQ-----RERFTEHEVQIY 134

Query: 143 VSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNS 202
           V   +    H  +  I++ D+K  NILLD +    + D GL+K     E          +
Sbjct: 135 VGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET-------ERA 187

Query: 203 IEIKGIVGYVAPEYGMGSKASVSG--DVYNFGILLLEMFTRRRP 244
            +  G + Y+AP+   G  +      D ++ G+L+ E+ T   P
Sbjct: 188 YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.1 bits (246), Expect = 3e-24
 Identities = 41/229 (17%), Positives = 89/229 (38%), Gaps = 26/229 (11%)

Query: 24  ELSKAT----NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVN--LKQKEASRSFAAE 77
           E++K        +     +G G    V   +   + + VA+K +    + +  ++    E
Sbjct: 8   EVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRE 67

Query: 78  CNALRNIRHRNLIKIITICSSID-FEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQR 136
              L+++RH N+I ++ + +  +  + F    +V  +M     +    +  G+     + 
Sbjct: 68  LRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGE----DRI 123

Query: 137 VNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAA 196
             +   +   + Y H        H DLKP N+ +++D    + D GLA+           
Sbjct: 124 QFLVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQA--------- 171

Query: 197 ETASNSIEIKGIVGYVAPEYGMGS-KASVSGDVYNFGILLLEMFTRRRP 244
              S          Y APE  +   + + + D+++ G ++ EM T +  
Sbjct: 172 --DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL 218

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.2 bits (238), Expect = 3e-23
 Identities = 42/218 (19%), Positives = 81/218 (37%), Gaps = 20/218 (9%)

Query: 30  NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVN--LKQKEASRSFAAECNALRNIRHR 87
             +     IG G   IV           VA+K ++   + +  ++    E   ++ + H+
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 88  NLIKIITICSSID-FEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFA 146
           N+I ++ + +     E F    +V E M     +    + +       +   +   +   
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-----HERMSYLLYQMLCG 131

Query: 147 IEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIK 206
           I++ H       +H DLKPSNI++  D    + D GLA+        T            
Sbjct: 132 IKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT---------PYV 179

Query: 207 GIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRP 244
               Y APE  +G     + D+++ G ++ EM   +  
Sbjct: 180 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKIL 217

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.7 bits (237), Expect = 4e-23
 Identities = 39/219 (17%), Positives = 83/219 (37%), Gaps = 20/219 (9%)

Query: 29  TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVN--LKQKEASRSFAAECNALRNIRH 86
              +   + +G G    V      ++   VAVK ++   +    ++    E   L++++H
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76

Query: 87  RNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFA 146
            N+I ++ + +            +  ++   +L   ++    Q         +   +   
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRG 133

Query: 147 IEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIK 206
           ++Y H        H DLKPSN+ +++D    + D GLA+     E      T        
Sbjct: 134 LKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARH-TDDEMTGYVATR------- 182

Query: 207 GIVGYVAPEYGMGSK-ASVSGDVYNFGILLLEMFTRRRP 244
               Y APE  +     + + D+++ G ++ E+ T R  
Sbjct: 183 ---WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 66.3 bits (161), Expect = 1e-13
 Identities = 25/162 (15%), Positives = 51/162 (31%), Gaps = 25/162 (15%)

Query: 36  NKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKE----------ASRSFAAECNALRNIR 85
             +G+G  S V+     E      VK   +                  F+          
Sbjct: 6   KLMGEGKESAVFNCY-SEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 86  HRNLIKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSF 145
            R L K+  +     +  ++  A++ E +  + L +           +     +   +  
Sbjct: 65  FRALQKLQGLAVPKVYA-WEGNAVLMELIDAKELYRV---------RVENPDEVLDMILE 114

Query: 146 AIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL 187
            +  F+H     IVHGDL   N+L+  +    + D   +  +
Sbjct: 115 EVAKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEV 152

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	331
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.91
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.78
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.97
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.75
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.1
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.1
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.6

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-57  Score=390.44  Aligned_cols=250  Identities=20%  Similarity=0.254  Sum_probs=207.8

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeE
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAI  109 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~l  109 (331)
                      ++|.+++.||+|+||+||+|++..+++.||||++........+.+.+|+.+++.++||||+++++++     ...+..++
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~~~i   94 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY-----LVGDELWV   94 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEE-----EECCEEEE
Confidence            4799999999999999999999999999999999866655667899999999999999999999995     44567899


Q ss_pred             EEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccccc
Q 046639          110 VFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG  189 (331)
Q Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~  189 (331)
                      ||||+++|+|.+++.+.   .+++..+..++.|++.||.|||++   ||+||||||+|||++.+|.+||+|||+|+.+..
T Consensus        95 vmEy~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~  168 (293)
T d1yhwa1          95 VMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (293)
T ss_dssp             EEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EEEecCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecc
Confidence            99999999999988653   377899999999999999999999   999999999999999999999999999987521


Q ss_pred             CCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhh
Q 046639          190 YEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVME  269 (331)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  269 (331)
                              .........||+.|+|||++.+..++.++|||||||++|+|++|..||.+..... ..........+     
T Consensus       169 --------~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~~~~~~~~-----  234 (293)
T d1yhwa1         169 --------EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-ALYLIATNGTP-----  234 (293)
T ss_dssp             --------TTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHHCSC-----
T ss_pred             --------ccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH-HHHHHHhCCCC-----
Confidence                    1122334569999999999999999999999999999999999999997532111 11111111110     


Q ss_pred             hcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          270 IVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                          ..         .....++..+.+|+.+||+.||++|||+.|+++
T Consensus       235 ----~~---------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         235 ----EL---------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             ----CC---------SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             ----CC---------CCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                00         112335667899999999999999999999975

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-57  Score=387.14  Aligned_cols=254  Identities=20%  Similarity=0.246  Sum_probs=204.1

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccch-hhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCccee
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK-EASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      .++|.+++.||+|+||+||+|+++.+++.||||++..... ...+.+.+|+.++++++||||+++++++     .+++..
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~-----~~~~~~   78 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR-----REGNIQ   78 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEE-----EETTEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeee-----ccCcee
Confidence            4579999999999999999999999999999999975532 2345688999999999999999999995     445788


Q ss_pred             eEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccc
Q 046639          108 AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      ++||||+++|+|.+++..  ...+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+|+..
T Consensus        79 ~ivmEy~~gg~L~~~l~~--~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~  153 (271)
T d1nvra_          79 YLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVF  153 (271)
T ss_dssp             EEEEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEeccCCCcHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheee
Confidence            999999999999999954  34588899999999999999999999   9999999999999999999999999999875


Q ss_pred             ccCCCCCcccccCCceeecccccccCCcccCCCCC-ccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcch
Q 046639          188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKA-SVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDK  266 (331)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  266 (331)
                      ....      .........||+.|+|||++.+..+ +.++|||||||++|+|++|..||.........+.......... 
T Consensus       154 ~~~~------~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~-  226 (271)
T d1nvra_         154 RYNN------RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL-  226 (271)
T ss_dssp             EETT------EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTS-
T ss_pred             ccCC------ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-
Confidence            2211      1122334679999999999988776 6889999999999999999999976543333332221111100 


Q ss_pred             hhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          267 VMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                                        .....++..+.+|+.+||+.||++|||+.|+++
T Consensus       227 ------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         227 ------------------NPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             ------------------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ------------------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                              011234567889999999999999999999864

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-56  Score=384.25  Aligned_cols=263  Identities=25%  Similarity=0.386  Sum_probs=206.1

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc--chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      .++|.+++.||+|+||+||+|++.   ..||||+++..  +....+.+.+|+.++++++||||+++++++..      +.
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~------~~   77 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA------PQ   77 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS------SS
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec------cE
Confidence            468999999999999999999874   25999998643  34456789999999999999999999998632      35


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      .++||||+++|+|.+++..... .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+|+.
T Consensus        78 ~~lv~Ey~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~  153 (276)
T d1uwha_          78 LAIVTQWCEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATV  153 (276)
T ss_dssp             CEEEEECCCEEEHHHHHHTSCC-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC
T ss_pred             EEEEEecCCCCCHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceee
Confidence            7999999999999999975433 477889999999999999999999   999999999999999999999999999976


Q ss_pred             cccCCCCCcccccCCceeecccccccCCcccCC---CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhC
Q 046639          187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG---SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMAL  263 (331)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  263 (331)
                      .....      .........||+.|+|||++.+   ..++.++||||||+++|||++|..||.+................
T Consensus       154 ~~~~~------~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~  227 (276)
T d1uwha_         154 KSRWS------GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYL  227 (276)
T ss_dssp             ------------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSC
T ss_pred             ccccC------CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCC
Confidence            52211      1122334568999999999864   35799999999999999999999999764332221111111111


Q ss_pred             cchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhh
Q 046639          264 PDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETF  326 (331)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~  326 (331)
                      +..+                .....++++.+.+|+.+||+.||++|||+.+|++.|+.+.+++
T Consensus       228 ~p~~----------------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~  274 (276)
T d1uwha_         228 SPDL----------------SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL  274 (276)
T ss_dssp             CCCG----------------GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             CCcc----------------hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence            1111                0122346678999999999999999999999999999998764

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-57  Score=384.11  Aligned_cols=246  Identities=19%  Similarity=0.288  Sum_probs=205.1

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc---chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK---QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      ++|.+++.||+|+||+||+|++..+++.||+|++...   .......+.+|+.+++.++||||+++++++     .+++.
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~   80 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF-----HDATR   80 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEE-----EECCE
Confidence            4699999999999999999999999999999998643   233456788999999999999999999995     45678


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      .++||||+++|+|.+++.+..  .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+|..
T Consensus        81 ~~ivmEy~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~  155 (263)
T d2j4za1          81 VYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVH  155 (263)
T ss_dssp             EEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSC
T ss_pred             EEEEEeecCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeee
Confidence            999999999999999997644  477899999999999999999999   999999999999999999999999999976


Q ss_pred             cccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcch
Q 046639          187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDK  266 (331)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  266 (331)
                      ..          ........||+.|+|||++.+..++.++|||||||++|+|++|..||.....     .......... 
T Consensus       156 ~~----------~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-----~~~~~~i~~~-  219 (263)
T d2j4za1         156 AP----------SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-----QETYKRISRV-  219 (263)
T ss_dssp             CC----------CCCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHHHTT-
T ss_pred             cC----------CCcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH-----HHHHHHHHcC-
Confidence            42          1223456799999999999999999999999999999999999999975321     1111111000 


Q ss_pred             hhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          267 VMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                                      ...++..+++.+.+|+.+||+.||++|||+.|+++
T Consensus       220 ----------------~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         220 ----------------EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             ----------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----------------CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence                            00112234567899999999999999999999986

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-55  Score=376.02  Aligned_cols=250  Identities=26%  Similarity=0.371  Sum_probs=201.1

Q ss_pred             CCcCceeeccCeeEEEEeeecCCCceEEEEEeecc--chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeE
Q 046639           32 FSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAI  109 (331)
Q Consensus        32 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~l  109 (331)
                      |++.++||+|+||+||+|++..++..||+|.+...  .....+.+.+|++++++++||||+++++++... ..+...+++
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~~~~~~i   89 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKCIVL   89 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE-SSSCEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeec-cccCCEEEE
Confidence            36677899999999999999999999999998644  334456789999999999999999999997543 244567899


Q ss_pred             EEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCC--eeecCCCCCCEEec-CCCcEEEcccCcccc
Q 046639          110 VFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPS--IVHGDLKPSNILLD-QDIVAHVGDLGLAKF  186 (331)
Q Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~--ivH~dik~~nilv~-~~~~~kl~Dfg~a~~  186 (331)
                      ||||+++++|.+++.+..  .+++..+..++.|++.||.|||++   +  |+||||||+|||++ .++.+||+|||+|+.
T Consensus        90 vmE~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~  164 (270)
T d1t4ha_          90 VTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  164 (270)
T ss_dssp             EEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EEeCCCCCcHHHHHhccc--cccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence            999999999999997654  477888999999999999999998   7  99999999999996 578999999999976


Q ss_pred             cccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcch
Q 046639          187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDK  266 (331)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  266 (331)
                      .          .........||+.|+|||++.+ .++.++|||||||++|+|++|..||....+...........     
T Consensus       165 ~----------~~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~-----  228 (270)
T d1t4ha_         165 K----------RASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG-----  228 (270)
T ss_dssp             C----------CTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT-----
T ss_pred             c----------cCCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcC-----
Confidence            4          1122345679999999999876 59999999999999999999999997543222111111110     


Q ss_pred             hhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          267 VMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                          ..+.          .+...+++.+.+|+.+||+.||++|||+.|+++
T Consensus       229 ----~~~~----------~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         229 ----VKPA----------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             ----CCCG----------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ----CCCc----------ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence                0110          112234567889999999999999999999975

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-56  Score=380.55  Aligned_cols=256  Identities=18%  Similarity=0.235  Sum_probs=195.6

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc--chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCccee
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      ++|.+++.||+|+||+||+|++..+++.||+|.+...  +....+.+.+|+.++++++||||+++++++.+   ...+.+
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~---~~~~~~   80 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID---RTNTTL   80 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------CE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEe---CCCCEE
Confidence            5799999999999999999999999999999998654  33445678999999999999999999998642   234568


Q ss_pred             eEEEeecCCCCHHHHHHhc--cCCccchHHHHHHHHHHHHHHHHHhhcC--CCCeeecCCCCCCEEecCCCcEEEcccCc
Q 046639          108 AIVFEYMQNRNLEQWLRQS--NGQLRFLTQRVNIAIDVSFAIEYFHHHC--QPSIVHGDLKPSNILLDQDIVAHVGDLGL  183 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~~~ivH~dik~~nilv~~~~~~kl~Dfg~  183 (331)
                      ++||||+++|+|.+++.+.  ....+++..++.++.|++.||.|||++.  ..+|+||||||+|||++.++.+||+|||+
T Consensus        81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~  160 (269)
T d2java1          81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL  160 (269)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHH
T ss_pred             EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccc
Confidence            9999999999999999752  3456888999999999999999999971  01399999999999999999999999999


Q ss_pred             ccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhC
Q 046639          184 AKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMAL  263 (331)
Q Consensus       184 a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  263 (331)
                      |+....        .........||+.|+|||++.+..++.++|||||||++|||++|..||...... ...........
T Consensus       161 a~~~~~--------~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~-~~~~~i~~~~~  231 (269)
T d2java1         161 ARILNH--------DTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK-ELAGKIREGKF  231 (269)
T ss_dssp             HHHC-------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHTCC
T ss_pred             eeeccc--------CCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH-HHHHHHHcCCC
Confidence            987621        112233467899999999999999999999999999999999999999753211 11111111110


Q ss_pred             cchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          264 PDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                               +.           .+..+++.+.+|+.+||+.||.+|||+.|+++
T Consensus       232 ---------~~-----------~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         232 ---------RR-----------IPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             ---------CC-----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---------CC-----------CCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence                     00           11234567899999999999999999999974

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.4e-56  Score=385.93  Aligned_cols=261  Identities=24%  Similarity=0.358  Sum_probs=212.4

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      .++|.+.+.||+|+||+||+|++..+++.||||+++.. ....+.+.+|+.++++++||||++++++|     ...+..+
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~~~   89 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPPFY   89 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSCE
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccE-----eeCCeeE
Confidence            35799999999999999999999999999999998644 33456789999999999999999999995     4456789


Q ss_pred             EEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccc
Q 046639          109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLF  188 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~  188 (331)
                      +||||+++|+|.+++.......+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+|+...
T Consensus        90 iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~  166 (287)
T d1opja_          90 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT  166 (287)
T ss_dssp             EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred             EEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecC
Confidence            999999999999999887777788899999999999999999999   99999999999999999999999999998752


Q ss_pred             cCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhh
Q 046639          189 GYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVM  268 (331)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  268 (331)
                      ..       .........|++.|+|||++.++.++.++||||||+++|||++|..||...... ......+....     
T Consensus       167 ~~-------~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~-~~~~~~i~~~~-----  233 (287)
T d1opja_         167 GD-------TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLEKDY-----  233 (287)
T ss_dssp             SS-------SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH-HHHHHHHHTTC-----
T ss_pred             CC-------CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH-HHHHHHHhcCC-----
Confidence            21       111122345788899999999999999999999999999999977665432211 11112211111     


Q ss_pred             hhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhh
Q 046639          269 EIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARET  325 (331)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~  325 (331)
                             ..       ..+..++..+.+|+.+||+.||++|||+.+|++.|+.+.+.
T Consensus       234 -------~~-------~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~  276 (287)
T d1opja_         234 -------RM-------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  276 (287)
T ss_dssp             -------CC-------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred             -------CC-------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence                   00       11223567899999999999999999999999999887543

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-56  Score=383.63  Aligned_cols=251  Identities=21%  Similarity=0.264  Sum_probs=206.5

Q ss_pred             CCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeEE
Q 046639           31 NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIV  110 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv  110 (331)
                      .|.+++.||+|+||+||+|++..+++.||+|++........+.+.+|+.+++.++||||+++++++.     +.+..++|
T Consensus        13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-----~~~~~~lv   87 (288)
T d2jfla1          13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY-----YENNLWIL   87 (288)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEE-----ETTEEEEE
T ss_pred             CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----eCCeEEEE
Confidence            6999999999999999999999999999999998776666778899999999999999999999954     45678999


Q ss_pred             EeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccccC
Q 046639          111 FEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGY  190 (331)
Q Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~  190 (331)
                      |||+++|+|.+++.+.. ..+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+|..... 
T Consensus        88 mEy~~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~-  162 (288)
T d2jfla1          88 IEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR-  162 (288)
T ss_dssp             EECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHH-
T ss_pred             EecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCC-
Confidence            99999999999986543 3478899999999999999999999   999999999999999999999999999976411 


Q ss_pred             CCCCcccccCCceeecccccccCCcccC-----CCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcc
Q 046639          191 EPGTAAETASNSIEIKGIVGYVAPEYGM-----GSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPD  265 (331)
Q Consensus       191 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  265 (331)
                             .........||+.|+|||++.     +..|+.++|||||||++|+|++|..||.+.... ..+........+ 
T Consensus       163 -------~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~-~~~~~i~~~~~~-  233 (288)
T d2jfla1         163 -------TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM-RVLLKIAKSEPP-  233 (288)
T ss_dssp             -------HHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG-GHHHHHHHSCCC-
T ss_pred             -------CcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH-HHHHHHHcCCCC-
Confidence                   111223456999999999974     456899999999999999999999999764322 222222221111 


Q ss_pred             hhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          266 KVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                              ..         ..+..++..+.+|+.+||+.||.+|||+.|+++
T Consensus       234 --------~~---------~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         234 --------TL---------AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             --------CC---------SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --------CC---------CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                    00         112345678899999999999999999999976

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-55  Score=373.77  Aligned_cols=257  Identities=22%  Similarity=0.365  Sum_probs=198.3

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeE
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAI  109 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~l  109 (331)
                      ++|.+++.||+|+||+||+|++. ++..||||+++.. ....+.+.+|+.++++++||||++++++|.     ..+..++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-----~~~~~~l   77 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCL-----EQAPICL   77 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSCEE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceec-----cCCceEE
Confidence            57999999999999999999986 5678999998643 333467899999999999999999999964     3457899


Q ss_pred             EEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccccc
Q 046639          110 VFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG  189 (331)
Q Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~  189 (331)
                      ||||+++|+|.+++.... ..+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus        78 v~E~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~  153 (263)
T d1sm2a_          78 VFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  153 (263)
T ss_dssp             EEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC-------
T ss_pred             EEEecCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccC
Confidence            999999999999987543 3467888999999999999999999   999999999999999999999999999987622


Q ss_pred             CCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhC-CCCCCcccCCcchHHHHHHhhCcchhh
Q 046639          190 YEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTR-RRPTDAMFNEGLTLHEFVKMALPDKVM  268 (331)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~  268 (331)
                      ..       ........||+.|+|||++.+..++.++||||||+++|||+++ .+||... .. ......+.....    
T Consensus       154 ~~-------~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~-~~-~~~~~~i~~~~~----  220 (263)
T d1sm2a_         154 DQ-------YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-SN-SEVVEDISTGFR----  220 (263)
T ss_dssp             ------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC-CH-HHHHHHHHHTCC----
T ss_pred             CC-------ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC-CH-HHHHHHHHhcCC----
Confidence            11       1122335688999999999999999999999999999999995 5555432 11 111111111100    


Q ss_pred             hhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhh
Q 046639          269 EIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARET  325 (331)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~  325 (331)
                          +           ..+..++..+.+|+.+||+.||++|||+.+|++.|+++.++
T Consensus       221 ----~-----------~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es  262 (263)
T d1sm2a_         221 ----L-----------YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES  262 (263)
T ss_dssp             ----C-----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----C-----------CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence                0           11123456789999999999999999999999999999875

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-56  Score=382.05  Aligned_cols=250  Identities=20%  Similarity=0.298  Sum_probs=202.8

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      ++|.+++.||+|+||+||+|++..+++.||||++....   ....+.+.+|+.++++++||||+++++++     .+.+.
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~~   82 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDDEK   82 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEE-----ECSSE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEE-----EECCE
Confidence            46999999999999999999999999999999996432   33446789999999999999999999994     45678


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      +++||||+++|+|.+++...+  .+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||+|+.
T Consensus        83 ~~ivmEy~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~  157 (288)
T d1uu3a_          83 LYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKV  157 (288)
T ss_dssp             EEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEEccCCCCHHHhhhccC--CCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEeccccccee
Confidence            899999999999999987654  477899999999999999999999   999999999999999999999999999987


Q ss_pred             cccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcch
Q 046639          187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDK  266 (331)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  266 (331)
                      +...      ..........||+.|+|||++.+..++.++|||||||++|+|++|..||..... ...+.......    
T Consensus       158 ~~~~------~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-~~~~~~i~~~~----  226 (288)
T d1uu3a_         158 LSPE------SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-YLIFQKIIKLE----  226 (288)
T ss_dssp             CC----------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHTTC----
T ss_pred             cccC------CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH-HHHHHHHHcCC----
Confidence            6211      111223345699999999999999999999999999999999999999975311 11111111100    


Q ss_pred             hhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          267 VMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                                       ..++..+++.+.+|+.+||+.||++|||+.|+++
T Consensus       227 -----------------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         227 -----------------YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             -----------------CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             -----------------CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence                             0112234567899999999999999999999754

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.5e-55  Score=378.07  Aligned_cols=264  Identities=24%  Similarity=0.346  Sum_probs=198.7

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCc---eEEEEEeecc-chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcc
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRS---IVAVKVVNLK-QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFD  105 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~  105 (331)
                      ++|++.+.||+|+||+||+|.++.+++   .||||.+... .....+.+.+|+.++++++||||++++++|     ...+
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~-----~~~~  100 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVV-----TKST  100 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----CSSS
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEE-----eeCC
Confidence            467788999999999999999876554   5889987543 344456799999999999999999999996     3456


Q ss_pred             eeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccc
Q 046639          106 FKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAK  185 (331)
Q Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~  185 (331)
                      ..++||||+++|+|.+++.... ..+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++
T Consensus       101 ~~~iv~Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~  176 (299)
T d1jpaa_         101 PVMIITEFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSR  176 (299)
T ss_dssp             SCEEEEECCTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred             EEEEEEEecCCCcceeeecccc-CCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccce
Confidence            7899999999999999887643 3477889999999999999999999   99999999999999999999999999998


Q ss_pred             ccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhCc
Q 046639          186 FLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMALP  264 (331)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~  264 (331)
                      .......   ...........+|+.|+|||++.++.++.++|||||||++|||++ |..||.+....  .....+.... 
T Consensus       177 ~~~~~~~---~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~--~~~~~i~~~~-  250 (299)
T d1jpaa_         177 FLEDDTS---DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ--DVINAIEQDY-  250 (299)
T ss_dssp             ----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTTC-
T ss_pred             EccCCCC---cceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCC-
Confidence            7632211   111122223457889999999999999999999999999999998 89999764221  1111111110 


Q ss_pred             chhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhh
Q 046639          265 DKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETF  326 (331)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~  326 (331)
                             .    .       ..+.+++..+.+|+.+||+.||++|||+.+|++.|+++.++-
T Consensus       251 -------~----~-------~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p  294 (299)
T d1jpaa_         251 -------R----L-------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP  294 (299)
T ss_dssp             -------C----C-------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             -------C----C-------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcCh
Confidence                   0    0       111245678999999999999999999999999999987654

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-55  Score=386.81  Aligned_cols=273  Identities=21%  Similarity=0.284  Sum_probs=205.8

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCccee
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ-KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      .++|.+++.||+|+||+||+|++..+++.||+|+++... ......+.+|+.+++.++||||++++++|     .+.+.+
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-----~~~~~~   79 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF-----YSDGEI   79 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEE-----ECSSEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEE
Confidence            468999999999999999999999999999999997543 34456789999999999999999999995     445679


Q ss_pred             eEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          108 AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHH-HCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      ++||||+++|+|.+++.+..  .+++..+..++.|++.||.|||+ +   +|+||||||+|||++.+|.+||+|||+|+.
T Consensus        80 ~iVmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~  154 (322)
T d1s9ja_          80 SICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQ  154 (322)
T ss_dssp             EEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred             EEEEEcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccc
Confidence            99999999999999997654  37789999999999999999997 5   899999999999999999999999999987


Q ss_pred             cccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHH--HhhCc
Q 046639          187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFV--KMALP  264 (331)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~--~~~~~  264 (331)
                      ...          .......||+.|+|||++.+..|+.++||||+||++|||++|+.||..............  .....
T Consensus       155 ~~~----------~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~  224 (322)
T d1s9ja_         155 LID----------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAA  224 (322)
T ss_dssp             HHH----------HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------
T ss_pred             cCC----------CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcc
Confidence            521          122345799999999999999999999999999999999999999976432211110000  00000


Q ss_pred             chhh--hh---------cCc----c---cccccccCC-cch-HHHHHHHHHHhhccccCCCCCCCCcHHHHHH--HHHH
Q 046639          265 DKVM--EI---------VDP----S---LLLEVTANN-YSW-IEDCLVAVIGTGVTCSMESPMERMEMRDVVA--KLRH  321 (331)
Q Consensus       265 ~~~~--~~---------~~~----~---~~~~~~~~~-~~~-~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~--~L~~  321 (331)
                      ....  ..         .+.    .   ......... ... ....+..+.+|+.+||+.||.+|||+.|+++  ++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~  303 (322)
T d1s9ja_         225 ETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR  303 (322)
T ss_dssp             ---------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred             cCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence            0000  00         000    0   000000000 000 0113467889999999999999999999987  4544

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-55  Score=374.96  Aligned_cols=257  Identities=21%  Similarity=0.354  Sum_probs=205.0

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeE
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAI  109 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~l  109 (331)
                      ++|.+.+.||+|+||+||+|+++ ++..||||+++... ...+.+.+|+.++++++||||+++++++..      +..++
T Consensus        13 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~------~~~~i   84 (272)
T d1qpca_          13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ------EPIYI   84 (272)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCEE
T ss_pred             HHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc------CCeEE
Confidence            57999999999999999999986 56789999996443 334678999999999999999999998632      34689


Q ss_pred             EEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccccc
Q 046639          110 VFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG  189 (331)
Q Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~  189 (331)
                      ||||+++|+|.+++.......+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||+|+....
T Consensus        85 v~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~  161 (272)
T d1qpca_          85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIED  161 (272)
T ss_dssp             EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccC
Confidence            99999999999988765555678899999999999999999999   999999999999999999999999999987632


Q ss_pred             CCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhh
Q 046639          190 YEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVME  269 (331)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  269 (331)
                      ..       ........||+.|+|||++.++.++.++||||||+++|||++|..|+........ ....+...       
T Consensus       162 ~~-------~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~-~~~~i~~~-------  226 (272)
T d1qpca_         162 NE-------YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLERG-------  226 (272)
T ss_dssp             SC-------EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-HHHHHHTT-------
T ss_pred             Cc-------cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHH-HHHHHHhc-------
Confidence            11       1122234588899999999988999999999999999999996555433222111 11111110       


Q ss_pred             hcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhh
Q 046639          270 IVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARE  324 (331)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~  324 (331)
                       ..+           ..+..++..+.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus       227 -~~~-----------~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         227 -YRM-----------VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             -CCC-----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -CCC-----------CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence             000           1112356678999999999999999999999999987654

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.5e-54  Score=382.48  Aligned_cols=254  Identities=18%  Similarity=0.237  Sum_probs=209.4

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCccee
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      ..++|.+++.||+|+||+||+|++..+++.||||++........+.+.+|+.++++++||||+++++++     .+.+..
T Consensus        24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~~   98 (350)
T d1koaa2          24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNEM   98 (350)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE-----EETTEE
T ss_pred             CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEE
Confidence            346899999999999999999999999999999999776666667889999999999999999999995     446789


Q ss_pred             eEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEec--CCCcEEEcccCccc
Q 046639          108 AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLD--QDIVAHVGDLGLAK  185 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~--~~~~~kl~Dfg~a~  185 (331)
                      ++||||+++|+|.+++.... ..+++..+..++.||+.||.|||++   ||+||||||+|||++  .++.+||+|||+++
T Consensus        99 ~ivmE~~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~  174 (350)
T d1koaa2          99 VMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTA  174 (350)
T ss_dssp             EEEECCCCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCE
T ss_pred             EEEEEcCCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchhe
Confidence            99999999999999986533 3478899999999999999999999   999999999999996  46789999999998


Q ss_pred             ccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcc
Q 046639          186 FLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPD  265 (331)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  265 (331)
                      .+.         .........||+.|+|||++.+..++.++|||||||++|+|++|..||.+... ...+......... 
T Consensus       175 ~~~---------~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-~~~~~~i~~~~~~-  243 (350)
T d1koaa2         175 HLD---------PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-DETLRNVKSCDWN-  243 (350)
T ss_dssp             ECC---------TTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHTCCC-
T ss_pred             ecc---------cccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCCC-
Confidence            752         22334456799999999999999999999999999999999999999975321 1112222111110 


Q ss_pred             hhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          266 KVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                           ...           .....++..+.+|+.+||+.||++|||+.|+++
T Consensus       244 -----~~~-----------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         244 -----MDD-----------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             -----SCC-----------GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             -----CCc-----------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 000           111234567899999999999999999999976

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.7e-55  Score=379.41  Aligned_cols=253  Identities=21%  Similarity=0.257  Sum_probs=191.2

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccch-hhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK-EASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      ..+.|.+.+.||+|+||+||+|+++.+++.||||++..... .....+.+|+.+++.++||||+++++++     .+++.
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-----~~~~~   81 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY-----ESGGH   81 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEE-----ECSSE
T ss_pred             CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCE
Confidence            34679999999999999999999999999999999975432 2335678999999999999999999994     55678


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEec---CCCcEEEcccCc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLD---QDIVAHVGDLGL  183 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~---~~~~~kl~Dfg~  183 (331)
                      +++||||+++++|.+++...  ..+++..+..++.|++.||.|||++   +|+||||||+||++.   .++.+||+|||+
T Consensus        82 ~~lvmE~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~  156 (307)
T d1a06a_          82 LYLIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGL  156 (307)
T ss_dssp             EEEEECCCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC--
T ss_pred             EEEEEeccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccce
Confidence            99999999999999999764  3578899999999999999999999   999999999999995   578999999999


Q ss_pred             ccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhC
Q 046639          184 AKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMAL  263 (331)
Q Consensus       184 a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  263 (331)
                      ++...         .........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.... ...........
T Consensus       157 a~~~~---------~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-~~~~~i~~~~~  226 (307)
T d1a06a_         157 SKMED---------PGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA-KLFEQILKAEY  226 (307)
T ss_dssp             -------------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHTTCC
T ss_pred             eEEcc---------CCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH-HHHHHHhccCC
Confidence            98652         112233456999999999999999999999999999999999999999753211 11111111111


Q ss_pred             cchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          264 PDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ..      .           .....++++.+.+|+.+||+.||++|||+.|+++
T Consensus       227 ~~------~-----------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         227 EF------D-----------SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             CC------C-----------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CC------C-----------CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            00      0           0112235567899999999999999999999986

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-54  Score=371.67  Aligned_cols=264  Identities=20%  Similarity=0.309  Sum_probs=210.0

Q ss_pred             hcCCCcCc-eeeccCeeEEEEeeecC--CCceEEEEEeecc-chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCc
Q 046639           29 TNNFSPAN-KIGQGGVSIVYKGILDE--SRSIVAVKVVNLK-QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGF  104 (331)
Q Consensus        29 ~~~y~~~~-~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  104 (331)
                      .++|.+.+ +||+|+||+||+|.++.  ++..||||+++.. .....+.+.+|+.++++++||||++++++|..      
T Consensus         7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~------   80 (285)
T d1u59a_           7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------   80 (285)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES------
T ss_pred             ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc------
Confidence            35677777 49999999999998753  4568999998644 34455779999999999999999999998742      


Q ss_pred             ceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcc
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA  184 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a  184 (331)
                      +..++||||+++|+|.+++.... ..+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++
T Consensus        81 ~~~~lvmE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla  156 (285)
T d1u59a_          81 EALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLS  156 (285)
T ss_dssp             SSEEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTC
T ss_pred             CeEEEEEEeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhh
Confidence            34789999999999999985433 3577899999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhC
Q 046639          185 KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMAL  263 (331)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~  263 (331)
                      +.+....     ..........||+.|+|||++.++.++.++||||||+++|||++ |..||......  .....+....
T Consensus       157 ~~~~~~~-----~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~--~~~~~i~~~~  229 (285)
T d1u59a_         157 KALGADD-----SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAFIEQGK  229 (285)
T ss_dssp             EECTTCS-----CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHHHHHHTTC
T ss_pred             hcccccc-----cccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCC
Confidence            8763211     11222233458899999999998999999999999999999998 99999864321  1211111100


Q ss_pred             cchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhhhc
Q 046639          264 PDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETFLG  328 (331)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~~~  328 (331)
                              .+           ..+..+++.+.+|+.+||+.||++|||+.+|++.|+....++..
T Consensus       230 --------~~-----------~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~  275 (285)
T d1u59a_         230 --------RM-----------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS  275 (285)
T ss_dssp             --------CC-----------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred             --------CC-----------CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhh
Confidence                    00           11234667899999999999999999999999999988776543

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=4.3e-54  Score=379.84  Aligned_cols=253  Identities=17%  Similarity=0.218  Sum_probs=208.7

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      .++|.+++.||+|+||+||+|++..+++.||||++..........+.+|+.++++++||||+++++++     .+++.++
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~~~  102 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF-----EDKYEMV  102 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEE-----ECSSEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEEE
Confidence            35799999999999999999999999999999999876666667788999999999999999999994     5567899


Q ss_pred             EEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEec--CCCcEEEcccCcccc
Q 046639          109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLD--QDIVAHVGDLGLAKF  186 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~--~~~~~kl~Dfg~a~~  186 (331)
                      +|||||++|+|.+++... +..+++..++.++.|++.||.|||++   ||+||||||+|||++  .++.+||+|||+|..
T Consensus       103 ivmE~~~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~  178 (352)
T d1koba_         103 LILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATK  178 (352)
T ss_dssp             EEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred             EEEEcCCCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeeccccee
Confidence            999999999999987643 33578899999999999999999999   999999999999997  678999999999987


Q ss_pred             cccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcch
Q 046639          187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDK  266 (331)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  266 (331)
                      ..         .........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.... ..+.........  
T Consensus       179 ~~---------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-~~~~~i~~~~~~--  246 (352)
T d1koba_         179 LN---------PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-ETLQNVKRCDWE--  246 (352)
T ss_dssp             CC---------TTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHHHHHCCCC--
T ss_pred             cC---------CCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCCC--
Confidence            52         223344567999999999999999999999999999999999999999753211 111111111110  


Q ss_pred             hhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          267 VMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                          ...           .....+++.+.+|+.+||+.||.+|||+.|+++
T Consensus       247 ----~~~-----------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         247 ----FDE-----------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             ----CCS-----------STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             ----CCc-----------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                000           111234567899999999999999999999975

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-54  Score=370.03  Aligned_cols=252  Identities=18%  Similarity=0.254  Sum_probs=205.2

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc------hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCC
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ------KEASRSFAAECNALRNIRHRNLIKIITICSSIDFE  102 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  102 (331)
                      .++|.+++.||+|+||+||+|+++.+++.||||++....      ....+.+.+|+.++++++||||+++++++     .
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~   83 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY-----E   83 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----E
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----E
Confidence            357999999999999999999999999999999986432      12356789999999999999999999994     5


Q ss_pred             CcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCC----cEEE
Q 046639          103 GFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDI----VAHV  178 (331)
Q Consensus       103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~----~~kl  178 (331)
                      +.+..++||||+++|+|.+++.+..  .+++..++.++.|++.||.|||++   +|+||||||+||+++.++    .+|+
T Consensus        84 ~~~~~~iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl  158 (293)
T d1jksa_          84 NKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKI  158 (293)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEE
T ss_pred             ECCEEEEEEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEe
Confidence            5678999999999999999997654  478899999999999999999999   999999999999998776    5999


Q ss_pred             cccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHH
Q 046639          179 GDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEF  258 (331)
Q Consensus       179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  258 (331)
                      +|||++.....         ........+|+.|+|||++.+..++.++|||||||++|+|++|..||.+.... ..+...
T Consensus       159 ~DfG~a~~~~~---------~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-~~~~~i  228 (293)
T d1jksa_         159 IDFGLAHKIDF---------GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-ETLANV  228 (293)
T ss_dssp             CCCTTCEECTT---------SCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHH
T ss_pred             cchhhhhhcCC---------CccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH-HHHHHH
Confidence            99999987521         12223456899999999999999999999999999999999999999753211 111111


Q ss_pred             HHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          259 VKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ......          .       ......+++..+.+|+.+||+.||++|||+.|+++
T Consensus       229 ~~~~~~----------~-------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         229 SAVNYE----------F-------EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             HTTCCC----------C-------CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HhcCCC----------C-------CchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            111100          0       00122345667899999999999999999999975

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.1e-54  Score=375.48  Aligned_cols=245  Identities=21%  Similarity=0.263  Sum_probs=199.5

Q ss_pred             CCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCccee
Q 046639           31 NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      .|++++.||+|+||+||+|++..+++.||||++....   ....+.+.+|+.++++++||||+++++++.     +.+..
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~~~   90 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL-----REHTA   90 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEE-----ECCEE
Confidence            5999999999999999999999999999999986543   344567899999999999999999999954     45678


Q ss_pred             eEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccc
Q 046639          108 AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      ++|||||.+++|..++...  ..+++..+..++.|++.||.|||++   ||+||||||+|||++.++.+||+|||+|...
T Consensus        91 ~iv~E~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~  165 (309)
T d1u5ra_          91 WLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM  165 (309)
T ss_dssp             EEEEECCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSS
T ss_pred             EEEEEecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeeccccccc
Confidence            9999999998887766543  3578899999999999999999999   9999999999999999999999999999764


Q ss_pred             ccCCCCCcccccCCceeecccccccCCcccCC---CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCc
Q 046639          188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMG---SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALP  264 (331)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  264 (331)
                      .            ......||+.|+|||++.+   +.|+.++|||||||++|||++|..||.+.... ..+........+
T Consensus       166 ~------------~~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~-~~~~~i~~~~~~  232 (309)
T d1u5ra_         166 A------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQNESP  232 (309)
T ss_dssp             S------------SBCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHHHHHHSCCC
T ss_pred             C------------CCCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHhCCCC
Confidence            1            1223569999999999864   45899999999999999999999999753211 111111111111


Q ss_pred             chhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          265 DKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                               ...          ...+++.+.+|+.+||+.||.+|||+.++++
T Consensus       233 ---------~~~----------~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         233 ---------ALQ----------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             ---------CCS----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ---------CCC----------CCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence                     000          0124567899999999999999999999975

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-54  Score=378.03  Aligned_cols=257  Identities=19%  Similarity=0.290  Sum_probs=204.1

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCc-----eEEEEEeecc-chhhHHHHHHHHHHHHcC-CCCCcceeeceeecccCC
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRS-----IVAVKVVNLK-QKEASRSFAAECNALRNI-RHRNLIKIITICSSIDFE  102 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~  102 (331)
                      ++|.+++.||+|+||+||+|++..+++     .||+|.+... .......+.+|+.+++++ +||||++++++|     .
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~-----~  111 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC-----T  111 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----C
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEE-----e
Confidence            579999999999999999999865443     6999988543 333446788999999998 899999999995     4


Q ss_pred             CcceeeEEEeecCCCCHHHHHHhccC---------------------CccchHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 046639          103 GFDFKAIVFEYMQNRNLEQWLRQSNG---------------------QLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHG  161 (331)
Q Consensus       103 ~~~~~~lv~e~~~~~~L~~~l~~~~~---------------------~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~  161 (331)
                      ..+..++||||+++|+|.+++.....                     ..+++..++.++.|++.||+|||++   +|+||
T Consensus       112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHR  188 (325)
T d1rjba_         112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHR  188 (325)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred             eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeec
Confidence            45678999999999999999976432                     3477888999999999999999999   99999


Q ss_pred             CCCCCCEEecCCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-
Q 046639          162 DLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-  240 (331)
Q Consensus       162 dik~~nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-  240 (331)
                      ||||+||+++.++.+||+|||+|+......      .........||+.|+|||++.++.++.++|||||||++|||++ 
T Consensus       189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~  262 (325)
T d1rjba_         189 DLAARNVLVTHGKVVKICDFGLARDIMSDS------NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL  262 (325)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCT------TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTT
T ss_pred             cCchhccccccCCeEEEeeccccccccCCC------ceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhC
Confidence            999999999999999999999998752211      1111223457899999999999999999999999999999998 


Q ss_pred             CCCCCCcccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHH
Q 046639          241 RRRPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLR  320 (331)
Q Consensus       241 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~  320 (331)
                      |..||.+..... .+...+.....        +           ..+..+++.+.+|+.+||+.||++|||+.||++.|.
T Consensus       263 g~~Pf~~~~~~~-~~~~~~~~~~~--------~-----------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         263 GVNPYPGIPVDA-NFYKLIQNGFK--------M-----------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             SCCSSTTCCCSH-HHHHHHHTTCC--------C-----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCCCCCCHHH-HHHHHHhcCCC--------C-----------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            899997653322 22222222111        0           112245678999999999999999999999999885

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-54  Score=367.30  Aligned_cols=254  Identities=23%  Similarity=0.328  Sum_probs=200.7

Q ss_pred             ceeeccCeeEEEEeeec--CCCceEEEEEeecc--chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeEEE
Q 046639           36 NKIGQGGVSIVYKGILD--ESRSIVAVKVVNLK--QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIVF  111 (331)
Q Consensus        36 ~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv~  111 (331)
                      ++||+|+||+||+|.++  .+++.||||+++..  +....+.+.+|+.++++++||||++++++|..      +..++||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~------~~~~lvm   86 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ESWMLVM   86 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES------SSEEEEE
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc------CCEEEEE
Confidence            47999999999999864  45678999998643  33445679999999999999999999999742      2468999


Q ss_pred             eecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccccCC
Q 046639          112 EYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYE  191 (331)
Q Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~~  191 (331)
                      ||+++|+|.+++....  .+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||+++......
T Consensus        87 E~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~  161 (277)
T d1xbba_          87 EMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE  161 (277)
T ss_dssp             ECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred             EcCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhccccc
Confidence            9999999999997643  477899999999999999999999   99999999999999999999999999998752211


Q ss_pred             CCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhCcchhhhh
Q 046639          192 PGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMALPDKVMEI  270 (331)
Q Consensus       192 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  270 (331)
                           ..........||+.|+|||++.+..++.++||||||+++|||++ |..||.+...  ......+....       
T Consensus       162 -----~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~--~~~~~~i~~~~-------  227 (277)
T d1xbba_         162 -----NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SEVTAMLEKGE-------  227 (277)
T ss_dssp             -----SEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHHTTC-------
T ss_pred             -----cccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH--HHHHHHHHcCC-------
Confidence                 11122234568899999999999999999999999999999998 8999976422  11111111110       


Q ss_pred             cCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhh
Q 046639          271 VDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETF  326 (331)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~  326 (331)
                           ..       ..+..++..+.+|+.+||+.||++|||+.+|++.|+....+.
T Consensus       228 -----~~-------~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~  271 (277)
T d1xbba_         228 -----RM-------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV  271 (277)
T ss_dssp             -----CC-------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             -----CC-------CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhc
Confidence                 00       112345678999999999999999999999999998876544

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-54  Score=367.80  Aligned_cols=263  Identities=23%  Similarity=0.334  Sum_probs=199.9

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCC----ceEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCc
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESR----SIVAVKVVNLKQ-KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGF  104 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  104 (331)
                      ++|++.+.||+|+||+||+|.++.++    ..||||.+.... ......+.+|+.++++++||||++++++|     ...
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~-----~~~   81 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI-----SKY   81 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSS
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEE-----ecC
Confidence            46899999999999999999987544    479999986443 33445688999999999999999999996     344


Q ss_pred             ceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcc
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA  184 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a  184 (331)
                      +..++|||++.++++.+++.... ..+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++
T Consensus        82 ~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla  157 (283)
T d1mqba_          82 KPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLS  157 (283)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred             CceEEEEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchh
Confidence            67899999999999999887543 3477888999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCc
Q 046639          185 KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALP  264 (331)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  264 (331)
                      +.......     .........||+.|+|||++.++.++.++||||||+++|||++|..|+........ ....+...  
T Consensus       158 ~~~~~~~~-----~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~-~~~~i~~~--  229 (283)
T d1mqba_         158 RVLEDDPE-----ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-VMKAINDG--  229 (283)
T ss_dssp             ---------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HHHHHHTT--
T ss_pred             hcccCCCc-----cceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH-HHHHHhcc--
Confidence            87632211     11122334588999999999999999999999999999999996665543222111 11111110  


Q ss_pred             chhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhh
Q 046639          265 DKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETF  326 (331)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~  326 (331)
                            ..+           ..+.+++..+.+|+.+||+.||++|||+.+|++.|+++.++-
T Consensus       230 ------~~~-----------~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p  274 (283)
T d1mqba_         230 ------FRL-----------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP  274 (283)
T ss_dssp             ------CCC-----------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             ------CCC-----------CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence                  000           111235678999999999999999999999999999887643

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-53  Score=374.96  Aligned_cols=249  Identities=20%  Similarity=0.251  Sum_probs=205.3

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc---chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcc
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK---QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFD  105 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~  105 (331)
                      .++|.+++.||+|+||+||+|++..+++.||+|+++..   .......+.+|+.+++.++||||++++++     +.+.+
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~-----~~~~~   78 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYA-----FQTHD   78 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEE-----EECSS
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEee-----ecccc
Confidence            35799999999999999999999999999999999743   23345678899999999999999999999     45567


Q ss_pred             eeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccc
Q 046639          106 FKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAK  185 (331)
Q Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~  185 (331)
                      .+++||||+++|+|.+++.+..  .+++..++.++.|++.||.|||++   +|+||||||+|||++.+|.+||+|||+|+
T Consensus        79 ~~~iv~ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~  153 (337)
T d1o6la_          79 RLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK  153 (337)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             ccccceeccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeeccccc
Confidence            8999999999999999997754  367788999999999999999999   99999999999999999999999999998


Q ss_pred             ccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcc
Q 046639          186 FLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPD  265 (331)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  265 (331)
                      ....        .........||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.... ..........   
T Consensus       154 ~~~~--------~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~-~~~~~i~~~~---  221 (337)
T d1o6la_         154 EGIS--------DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-RLFELILMEE---  221 (337)
T ss_dssp             CSCC--------TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCC---
T ss_pred             cccc--------CCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH-HHHHHHhcCC---
Confidence            6521        122334567999999999999999999999999999999999999999763211 1111111110   


Q ss_pred             hhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCc-----HHHHHH
Q 046639          266 KVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERME-----MRDVVA  317 (331)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps-----~~~i~~  317 (331)
                                        ..++..+++.+.+|+.+||+.||.+||+     +.++++
T Consensus       222 ------------------~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         222 ------------------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             ------------------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ------------------CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence                              0122234567889999999999999995     777764

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.1e-53  Score=366.70  Aligned_cols=267  Identities=19%  Similarity=0.289  Sum_probs=206.6

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc---chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcc
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK---QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFD  105 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~  105 (331)
                      .++|.+.+.||+|+||+||+|++..+++.||||+++..   +......+.+|+.+++.++||||+++++++...+ ....
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~~~   84 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP   84 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SSSE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-CCCc
Confidence            46899999999999999999999999999999999643   3444567899999999999999999999976532 2334


Q ss_pred             eeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccc
Q 046639          106 FKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAK  185 (331)
Q Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~  185 (331)
                      .+++||||+++++|.+++....  .+++..+..++.|++.||.|||++   ||+||||||+||+++.++.++++|||.+.
T Consensus        85 ~~~lvmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          85 LPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR  159 (277)
T ss_dssp             EEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred             eEEEEEECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhh
Confidence            5799999999999999987654  477899999999999999999999   99999999999999999999999999887


Q ss_pred             ccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcc
Q 046639          186 FLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPD  265 (331)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  265 (331)
                      ......     ..........||+.|+|||++.+..++.++|||||||++|+|++|.+||....... ............
T Consensus       160 ~~~~~~-----~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~~~~~~~~~~~~  233 (277)
T d1o6ya_         160 AIADSG-----NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS-VAYQHVREDPIP  233 (277)
T ss_dssp             ECC---------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHCCCCC
T ss_pred             hhcccc-----ccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH-HHHHHHhcCCCC
Confidence            652211     12223345679999999999999999999999999999999999999997532111 111111111000


Q ss_pred             hhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCC-cHHHHHHHHHHhhh
Q 046639          266 KVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERM-EMRDVVAKLRHARE  324 (331)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-s~~~i~~~L~~~~~  324 (331)
                             +          .....+++..+.+++.+||+.||.+|| |+.++++.|.++.+
T Consensus       234 -------~----------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n  276 (277)
T d1o6ya_         234 -------P----------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  276 (277)
T ss_dssp             -------G----------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred             -------C----------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence                   0          011123456789999999999999999 89999999888753

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-53  Score=360.74  Aligned_cols=254  Identities=24%  Similarity=0.361  Sum_probs=206.0

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      .++|++.++||+|+||+||+|+++ +++.||||+++.... ..+.+.+|+.++++++||||++++++|.     ..+.++
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~-----~~~~~~   75 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCT-----KQRPIF   75 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEEC-----CSSSEE
T ss_pred             hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEe-----eCCceE
Confidence            368999999999999999999985 778899999975433 3467899999999999999999999964     456789


Q ss_pred             EEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccc
Q 046639          109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLF  188 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~  188 (331)
                      +||||+++|+|.+++..... .+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++...
T Consensus        76 iv~Ey~~~g~l~~~~~~~~~-~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~  151 (258)
T d1k2pa_          76 IITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL  151 (258)
T ss_dssp             EEEECCTTEEHHHHHHSGGG-CCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCS
T ss_pred             EEEEccCCCcHHHhhhcccc-CCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheecc
Confidence            99999999999999765433 456788899999999999999999   99999999999999999999999999998752


Q ss_pred             cCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhCcchh
Q 046639          189 GYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMALPDKV  267 (331)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  267 (331)
                      ...       ........+|+.|+|||++.+..++.++||||||+++|||++ |..||......  .....+....    
T Consensus       152 ~~~-------~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~--~~~~~i~~~~----  218 (258)
T d1k2pa_         152 DDE-------YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--ETAEHIAQGL----  218 (258)
T ss_dssp             SSS-------CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--HHHHHHHTTC----
T ss_pred             CCC-------ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH--HHHHHHHhCC----
Confidence            211       112223458899999999999999999999999999999998 89999765322  1111111110    


Q ss_pred             hhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHH
Q 046639          268 MEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRH  321 (331)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~  321 (331)
                          ..           ..+..+++.+.+|+.+||+.||++|||+.+|++.|..
T Consensus       219 ----~~-----------~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         219 ----RL-----------YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             ----CC-----------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             ----CC-----------CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence                00           1112345689999999999999999999999998754

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-53  Score=361.27  Aligned_cols=252  Identities=28%  Similarity=0.354  Sum_probs=200.6

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeE
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAI  109 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~l  109 (331)
                      ++|.+++.||+|+||.||+|+++  +..||||+++..  ...+.+.+|+.++++++||||++++++|.    +..+.+++
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~----~~~~~~~l   78 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLYI   78 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEEC----CC--CCEE
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEE----ecCCcEEE
Confidence            46899999999999999999985  678999998643  34467899999999999999999999873    44466799


Q ss_pred             EEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccccc
Q 046639          110 VFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG  189 (331)
Q Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~  189 (331)
                      ||||+++|+|.+++.+.....+++..++.++.|++.||.|||++   +++||||||+||+++.++.+|++|||+++... 
T Consensus        79 v~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~-  154 (262)
T d1byga_          79 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-  154 (262)
T ss_dssp             EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred             EEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecC-
Confidence            99999999999999876555678899999999999999999999   99999999999999999999999999998642 


Q ss_pred             CCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhCcchhh
Q 046639          190 YEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMALPDKVM  268 (331)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  268 (331)
                                .......++..|+|||++.++.++.++||||||+++|||++ |.+||......  .....+..       
T Consensus       155 ----------~~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~--~~~~~i~~-------  215 (262)
T d1byga_         155 ----------STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRVEK-------  215 (262)
T ss_dssp             -----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--GHHHHHTT-------
T ss_pred             ----------CCCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH--HHHHHHHc-------
Confidence                      11223357888999999999999999999999999999998 78888754222  22221111       


Q ss_pred             hhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhh
Q 046639          269 EIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARE  324 (331)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~  324 (331)
                           ....       +++..+++.+.+|+.+||+.||.+|||+.+|++.|++++.
T Consensus       216 -----~~~~-------~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         216 -----GYKM-------DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             -----TCCC-------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----CCCC-------CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence                 0001       1223455788999999999999999999999999998864

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4e-53  Score=368.69  Aligned_cols=245  Identities=23%  Similarity=0.261  Sum_probs=202.5

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc---chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK---QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      ++|.+++.||+|+||+||+|+++.+++.||||+++..   .....+.+.+|+.+++.++||||+++++++     .+.+.
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~   78 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDAQQ   78 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-----ECSSE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeE-----eeCCe
Confidence            4699999999999999999999999999999999643   233456788999999999999999999994     45678


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      +++||||++|++|.+++....  .++...+..++.|++.||.|||++   +|+||||||+|||++.+|.+||+|||+|+.
T Consensus        79 ~~ivmE~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~  153 (316)
T d1fota_          79 IFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKY  153 (316)
T ss_dssp             EEEEECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             eeeEeeecCCccccccccccc--cccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceE
Confidence            999999999999999997654  356778888999999999999999   999999999999999999999999999987


Q ss_pred             cccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcch
Q 046639          187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDK  266 (331)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  266 (331)
                      ..           .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+... ............   
T Consensus       154 ~~-----------~~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~-~~~~~~i~~~~~---  218 (316)
T d1fota_         154 VP-----------DVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-MKTYEKILNAEL---  218 (316)
T ss_dssp             CS-----------SCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-HHHHHHHHHCCC---
T ss_pred             ec-----------cccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH-HHHHHHHHcCCC---
Confidence            52           122345799999999999999999999999999999999999999975321 111111111110   


Q ss_pred             hhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCC-----cHHHHHH
Q 046639          267 VMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERM-----EMRDVVA  317 (331)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----s~~~i~~  317 (331)
                                        .++..+++.+.+++.+||+.||.+|+     |+.++++
T Consensus       219 ------------------~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         219 ------------------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             ------------------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             ------------------CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence                              11122456788999999999999996     8999875

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-52  Score=367.51  Aligned_cols=257  Identities=17%  Similarity=0.200  Sum_probs=202.6

Q ss_pred             hcCCCcCc-eeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcC-CCCCcceeeceeecccCCCcce
Q 046639           29 TNNFSPAN-KIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNI-RHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        29 ~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      .++|.+.. .||+|+||+||+|++..+++.||||+++..     ..+.+|+.++.++ +||||+++++++.+. ......
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~-~~~~~~   83 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENL-YAGRKC   83 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeec-ccCCCE
Confidence            45798875 599999999999999999999999998632     3466889886654 799999999987542 234567


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecC---CCcEEEcccCc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQ---DIVAHVGDLGL  183 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~---~~~~kl~Dfg~  183 (331)
                      +++|||||+||+|.+++.+.+...+++..+..++.|++.||+|||++   +|+||||||+||+++.   ++.+||+|||+
T Consensus        84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~  160 (335)
T d2ozaa1          84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF  160 (335)
T ss_dssp             EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccce
Confidence            89999999999999999877667799999999999999999999999   9999999999999975   56799999999


Q ss_pred             ccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhC
Q 046639          184 AKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMAL  263 (331)
Q Consensus       184 a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  263 (331)
                      |+....         ........||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+...... .... ...+
T Consensus       161 a~~~~~---------~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~-~~~~-~~~i  229 (335)
T d2ozaa1         161 AKETTS---------HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-SPGM-KTRI  229 (335)
T ss_dssp             CEECCC---------CCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------CC
T ss_pred             eeeccC---------CCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH-HHHH-HHHH
Confidence            987521         1222345699999999999999999999999999999999999999976422111 1111 1000


Q ss_pred             cchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          264 PDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ..           ... .-.......+++.+.+|+.+||+.||++|||+.|+++
T Consensus       230 ~~-----------~~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         230 RM-----------GQY-EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             CS-----------CSS-SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hc-----------CCC-CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            00           000 0001122356778999999999999999999999976

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-52  Score=362.87  Aligned_cols=264  Identities=20%  Similarity=0.303  Sum_probs=200.3

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecC-----CCceEEEEEeeccc-hhhHHHHHHHHHHHHcC-CCCCcceeeceeecccC
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDE-----SRSIVAVKVVNLKQ-KEASRSFAAECNALRNI-RHRNLIKIITICSSIDF  101 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~  101 (331)
                      .++|.+++.||+|+||+||+|.+..     +++.||||.++... ....+.+..|..++.++ .|+||+.+++++    .
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~----~   87 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC----T   87 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE----C
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeee----c
Confidence            3689999999999999999999753     45789999986432 33446677888888777 589999999886    3


Q ss_pred             CCcceeeEEEeecCCCCHHHHHHhcc--------------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCC
Q 046639          102 EGFDFKAIVFEYMQNRNLEQWLRQSN--------------GQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSN  167 (331)
Q Consensus       102 ~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~n  167 (331)
                      .....+++||||+++|+|.+++....              ...+++..+..++.|++.||.|||++   +|+||||||+|
T Consensus        88 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~N  164 (299)
T d1ywna1          88 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARN  164 (299)
T ss_dssp             STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGG
T ss_pred             cCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccc
Confidence            44567899999999999999997642              23477889999999999999999999   99999999999


Q ss_pred             EEecCCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhC-CCCCC
Q 046639          168 ILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTR-RRPTD  246 (331)
Q Consensus       168 ilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g-~~pf~  246 (331)
                      ||++.++.+||+|||+|+......      .........||+.|+|||++.++.++.++|||||||++|||++| .+||.
T Consensus       165 ILl~~~~~~Kl~DFGla~~~~~~~------~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~  238 (299)
T d1ywna1         165 ILLSEKNVVKICDFGLARDIYKDP------DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP  238 (299)
T ss_dssp             EEECGGGCEEECC------CCSCT------TSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             eeECCCCcEEEccCcchhhccccc------cccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCC
Confidence            999999999999999998652211      11223345689999999999999999999999999999999986 56786


Q ss_pred             cccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhh
Q 046639          247 AMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARET  325 (331)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~  325 (331)
                      ..... ..+...+.....        +           ..+..+++.+.+|+.+||+.||++|||+.+|++.|+++.++
T Consensus       239 ~~~~~-~~~~~~~~~~~~--------~-----------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~  297 (299)
T d1ywna1         239 GVKID-EEFCRRLKEGTR--------M-----------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  297 (299)
T ss_dssp             TCCCS-HHHHHHHHHTCC--------C-----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCHH-HHHHHHHhcCCC--------C-----------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            54322 222222221111        1           11123456789999999999999999999999999988654

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-53  Score=363.99  Aligned_cols=258  Identities=25%  Similarity=0.389  Sum_probs=201.8

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeE
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAI  109 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~l  109 (331)
                      ++|++++.||+|+||+||+|++..+ ..||||+++... ...+.+.+|+.++++++||||++++++|.+      +..++
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~------~~~~l   88 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIYI   88 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCEE
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec------CCeEE
Confidence            5799999999999999999999755 569999996443 334678999999999999999999998632      34689


Q ss_pred             EEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccccc
Q 046639          110 VFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFG  189 (331)
Q Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~  189 (331)
                      ||||+++|+|..++.......+++..++.++.|++.||+|||++   +|+||||||+||+++.++++||+|||+++....
T Consensus        89 v~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~  165 (285)
T d1fmka3          89 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED  165 (285)
T ss_dssp             EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred             EEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccC
Confidence            99999999999998775555688999999999999999999999   999999999999999999999999999986521


Q ss_pred             CCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhh
Q 046639          190 YEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVME  269 (331)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  269 (331)
                      .       .........||+.|+|||++..+.++.++||||||+++|||++|..||.........+ ..+....      
T Consensus       166 ~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~-~~i~~~~------  231 (285)
T d1fmka3         166 N-------EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL-DQVERGY------  231 (285)
T ss_dssp             -----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-HHHHTTC------
T ss_pred             C-------CceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHH-HHHHhcC------
Confidence            1       1122233558999999999999999999999999999999999766654322211111 1111110      


Q ss_pred             hcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhh
Q 046639          270 IVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARET  325 (331)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~  325 (331)
                        .+           .....++..+.+|+.+||+.||++|||+.+|++.|+....+
T Consensus       232 --~~-----------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~  274 (285)
T d1fmka3         232 --RM-----------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  274 (285)
T ss_dssp             --CC-----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             --CC-----------CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence              00           11124567899999999999999999999999988876543

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-52  Score=358.08  Aligned_cols=259  Identities=20%  Similarity=0.286  Sum_probs=199.0

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCC---CceEEEEEeecc-chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCc
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDES---RSIVAVKVVNLK-QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGF  104 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  104 (331)
                      .++|.+++.||+|+||+||+|++..+   +..||||.++.. .....+.+.+|+.++++++||||+++++++.      .
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~------~   79 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT------E   79 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC------S
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe------c
Confidence            35799999999999999999998644   356889988543 3444567899999999999999999999863      2


Q ss_pred             ceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcc
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA  184 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a  184 (331)
                      +..++|||++++|+|.+++.... ..+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||+|
T Consensus        80 ~~~~iv~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a  155 (273)
T d1mp8a_          80 NPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLS  155 (273)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC----
T ss_pred             CeEEEEEEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhh
Confidence            46799999999999999876543 3467889999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhC
Q 046639          185 KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMAL  263 (331)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~  263 (331)
                      +.....       .........||+.|+|||++.+..++.++||||||+++|||++ |.+||....... ..........
T Consensus       156 ~~~~~~-------~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~-~~~~i~~~~~  227 (273)
T d1mp8a_         156 RYMEDS-------TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-VIGRIENGER  227 (273)
T ss_dssp             ----------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-HHHHHHTTCC
T ss_pred             eeccCC-------cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH-HHHHHHcCCC
Confidence            875211       1122234457899999999999999999999999999999998 899997643221 1111111100


Q ss_pred             cchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhh
Q 046639          264 PDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARET  325 (331)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~  325 (331)
                               +           ..+.+++..+.+|+.+||+.||++|||+.+|++.|+.+.+.
T Consensus       228 ---------~-----------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  269 (273)
T d1mp8a_         228 ---------L-----------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  269 (273)
T ss_dssp             ---------C-----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---------C-----------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence                     0           11224567899999999999999999999999999988765

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=4.7e-52  Score=355.30  Aligned_cols=252  Identities=23%  Similarity=0.293  Sum_probs=203.6

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc---------hhhHHHHHHHHHHHHcCC-CCCcceeeceeec
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---------KEASRSFAAECNALRNIR-HRNLIKIITICSS   98 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~   98 (331)
                      .++|.+.+.||+|+||+||+|++..+++.||||++....         ....+.+.+|+.++++++ ||||+++++++  
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~--   79 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY--   79 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE--
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeec--
Confidence            368999999999999999999999999999999986542         123356889999999997 99999999994  


Q ss_pred             ccCCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEE
Q 046639           99 IDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHV  178 (331)
Q Consensus        99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl  178 (331)
                         .+.+..++||||+++++|.+++....  .+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||
T Consensus        80 ---~~~~~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl  151 (277)
T d1phka_          80 ---ETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKL  151 (277)
T ss_dssp             ---ECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEE
T ss_pred             ---ccCcceEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEE
Confidence               55678999999999999999997654  478899999999999999999999   9999999999999999999999


Q ss_pred             cccCcccccccCCCCCcccccCCceeecccccccCCcccCC------CCCccchhhHhHHHHHHHHHhCCCCCCcccCCc
Q 046639          179 GDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG------SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEG  252 (331)
Q Consensus       179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~  252 (331)
                      +|||+++....         ........||+.|+|||++.+      ..++.++||||+||++|+|++|+.||.+... .
T Consensus       152 ~DFG~a~~~~~---------~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~-~  221 (277)
T d1phka_         152 TDFGFSCQLDP---------GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ-M  221 (277)
T ss_dssp             CCCTTCEECCT---------TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-H
T ss_pred             ccchheeEccC---------CCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH-H
Confidence            99999987521         122234568999999998753      3578899999999999999999999976421 1


Q ss_pred             chHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          253 LTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      .............      ..           .....+++.+.+|+.+||+.||++|||+.||++
T Consensus       222 ~~~~~i~~~~~~~------~~-----------~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         222 LMLRMIMSGNYQF------GS-----------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             HHHHHHHHTCCCC------CT-----------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHhCCCCC------CC-----------cccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            1111222211110      00           111245678999999999999999999999864

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=3.5e-52  Score=369.45  Aligned_cols=250  Identities=21%  Similarity=0.244  Sum_probs=198.3

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHH---HHHHHHHHcCCCCCcceeeceeecccCC
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSF---AAECNALRNIRHRNLIKIITICSSIDFE  102 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~---~~e~~~l~~l~h~~i~~~~~~~~~~~~~  102 (331)
                      .++|.+++.||+|+||+||+|++..+++.||||++....   ......+   ..++.+++.++||||+++++++     .
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~-----~   77 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----H   77 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE-----E
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEE-----E
Confidence            357999999999999999999999999999999986332   1111223   3457777788899999999994     4


Q ss_pred             CcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccC
Q 046639          103 GFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLG  182 (331)
Q Consensus       103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg  182 (331)
                      ..+.+++||||+++|+|.+++.+..  .+++..+..++.|++.||.|||++   +|+||||||+|||++.+|.+||+|||
T Consensus        78 ~~~~~~ivmE~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFG  152 (364)
T d1omwa3          78 TPDKLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLG  152 (364)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCT
T ss_pred             ECCEEEEEEEecCCCcHHHHHHhcc--cccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeec
Confidence            5678999999999999999997654  366788999999999999999999   99999999999999999999999999


Q ss_pred             cccccccCCCCCcccccCCceeecccccccCCcccCC-CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHh
Q 046639          183 LAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG-SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKM  261 (331)
Q Consensus       183 ~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  261 (331)
                      +|+.+..          .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.......  .......
T Consensus       153 la~~~~~----------~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~~~~~~~  220 (364)
T d1omwa3         153 LACDFSK----------KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEIDRM  220 (364)
T ss_dssp             TCEECSS----------SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC--HHHHHHH
T ss_pred             eeeecCC----------CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHh
Confidence            9987521          12234569999999999875 568999999999999999999999997643222  2222221


Q ss_pred             hCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCc-----HHHHHH
Q 046639          262 ALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERME-----MRDVVA  317 (331)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps-----~~~i~~  317 (331)
                      .....                 ..++..+++.+.+|+.+||+.||.+|||     +.++++
T Consensus       221 ~~~~~-----------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         221 TLTMA-----------------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             SSSCC-----------------CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             cccCC-----------------CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence            11110                 0111234567899999999999999999     677764

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-52  Score=363.64  Aligned_cols=259  Identities=19%  Similarity=0.304  Sum_probs=202.6

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCc----eEEEEEeecc-chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCc
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRS----IVAVKVVNLK-QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGF  104 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~  104 (331)
                      .+|++++.||+|+||+||+|.+..+++    +||+|.+... .....+.+.+|+.++++++||||++++++|..      
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~------   82 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT------   82 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES------
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------
Confidence            369999999999999999999987765    5888887533 33445779999999999999999999999753      


Q ss_pred             ceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcc
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA  184 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a  184 (331)
                      +..++++|++.+++|.+.+... ...+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++
T Consensus        83 ~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla  158 (317)
T d1xkka_          83 STVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA  158 (317)
T ss_dssp             SSEEEEEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHH
T ss_pred             CCeeEEEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccc
Confidence            2467889999999999988764 34577888999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhhC
Q 046639          185 KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMAL  263 (331)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~  263 (331)
                      +......      .........||+.|+|||++.++.++.++||||||+++|||++ |.+||......  .....+....
T Consensus       159 ~~~~~~~------~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~--~~~~~i~~~~  230 (317)
T d1xkka_         159 KLLGAEE------KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILEKGE  230 (317)
T ss_dssp             HHTTTTC------C--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG--GHHHHHHHTC
T ss_pred             eeccccc------ccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH--HHHHHHHcCC
Confidence            8763211      1122233458999999999999999999999999999999998 89999764322  2222222111


Q ss_pred             cchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhh
Q 046639          264 PDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARET  325 (331)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~  325 (331)
                      .        +           ..+..++..+.+|+.+||+.||++|||+.+|++.|..+...
T Consensus       231 ~--------~-----------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~  273 (317)
T d1xkka_         231 R--------L-----------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  273 (317)
T ss_dssp             C--------C-----------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             C--------C-----------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence            0        0           11123567789999999999999999999999999887643

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.4e-52  Score=370.18  Aligned_cols=245  Identities=20%  Similarity=0.208  Sum_probs=203.7

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      ++|.+++.||+|+||+||+|+++.+++.||||++....   ....+.+.+|+.+++.++||||+++++++     .....
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~  115 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDNSN  115 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccc-----ccccc
Confidence            47999999999999999999999999999999986432   23346788999999999999999999994     45677


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      .++|||++.+|+|.+++.+..  .+++..+..++.|++.||.|||++   +|+||||||+|||++.+|.+||+|||+|+.
T Consensus       116 ~~~v~e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~  190 (350)
T d1rdqe_         116 LYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKR  190 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             cccccccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeee
Confidence            899999999999999997654  477899999999999999999999   999999999999999999999999999987


Q ss_pred             cccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcch
Q 046639          187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDK  266 (331)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  266 (331)
                      ..           .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. ....+........   
T Consensus       191 ~~-----------~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~-~~~~~~~i~~~~~---  255 (350)
T d1rdqe_         191 VK-----------GRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKIVSGKV---  255 (350)
T ss_dssp             CS-----------SCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHCCC---
T ss_pred             cc-----------cccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC-HHHHHHHHhcCCC---
Confidence            52           12234569999999999999999999999999999999999999997531 1111111111110   


Q ss_pred             hhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCC-----cHHHHHH
Q 046639          267 VMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERM-----EMRDVVA  317 (331)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----s~~~i~~  317 (331)
                                        ..+..+++.+.+|+.+||+.||.+|+     |+.++++
T Consensus       256 ------------------~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         256 ------------------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             ------------------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ------------------CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence                              11123456789999999999999994     8999875

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-52  Score=361.81  Aligned_cols=252  Identities=19%  Similarity=0.259  Sum_probs=205.4

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      .++|.+++.||+|+||+||+|.+..+++.||+|+++.... ....+.+|+.+|+.++||||+++++++     .+.+.++
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~~~   77 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESF-----ESMEELV   77 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEE-----EETTEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEEE
Confidence            4689999999999999999999999999999999976543 335578999999999999999999994     5567899


Q ss_pred             EEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCC--CcEEEcccCcccc
Q 046639          109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQD--IVAHVGDLGLAKF  186 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~--~~~kl~Dfg~a~~  186 (331)
                      +|||||++++|.+++.... ..+++..+..++.|++.||.|||++   ||+||||||+||+++.+  +.+||+|||++..
T Consensus        78 lvmE~~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~  153 (321)
T d1tkia_          78 MIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ  153 (321)
T ss_dssp             EEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred             EEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhc
Confidence            9999999999999997543 3478899999999999999999999   99999999999999854  4899999999986


Q ss_pred             cccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcch
Q 046639          187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDK  266 (331)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  266 (331)
                      ..         .........+|+.|+|||...+..++.++|||||||++|+|++|..||..... ...+.......... 
T Consensus       154 ~~---------~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~-~~~~~~i~~~~~~~-  222 (321)
T d1tkia_         154 LK---------PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-QQIIENIMNAEYTF-  222 (321)
T ss_dssp             CC---------TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH-HHHHHHHHHTCCCC-
T ss_pred             cc---------cCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCCCC-
Confidence            51         12233456789999999999999999999999999999999999999975321 11122222111110 


Q ss_pred             hhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          267 VMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                           +           ......++..+.+|+.+||..||.+|||+.|+++
T Consensus       223 -----~-----------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         223 -----D-----------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             -----C-----------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -----C-----------hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 0           0111234567899999999999999999999986

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.7e-52  Score=362.11  Aligned_cols=261  Identities=21%  Similarity=0.372  Sum_probs=206.7

Q ss_pred             hcCCCcCceeeccCeeEEEEeeec-----CCCceEEEEEeeccch-hhHHHHHHHHHHHHcCCCCCcceeeceeecccCC
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILD-----ESRSIVAVKVVNLKQK-EASRSFAAECNALRNIRHRNLIKIITICSSIDFE  102 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  102 (331)
                      .++|.+++.||+|+||+||+|++.     .+++.||||+++.... .....+.+|+.+++.++||||++++++|.     
T Consensus        12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~-----   86 (301)
T d1lufa_          12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA-----   86 (301)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-----
T ss_pred             HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec-----
Confidence            568999999999999999999875     3567899999975433 34567999999999999999999999963     


Q ss_pred             CcceeeEEEeecCCCCHHHHHHhcc----------------------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 046639          103 GFDFKAIVFEYMQNRNLEQWLRQSN----------------------GQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVH  160 (331)
Q Consensus       103 ~~~~~~lv~e~~~~~~L~~~l~~~~----------------------~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH  160 (331)
                      ..+..+++||++++++|.+++....                      ...+++..+..++.|++.||+|||++   +++|
T Consensus        87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivH  163 (301)
T d1lufa_          87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVH  163 (301)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEe
Confidence            3567899999999999999996532                      22367788999999999999999999   9999


Q ss_pred             cCCCCCCEEecCCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh
Q 046639          161 GDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT  240 (331)
Q Consensus       161 ~dik~~nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~  240 (331)
                      |||||+||+++.++.+||+|||+++.+.+.      ..........+|+.|+|||.+.+..++.++||||||+++|||++
T Consensus       164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~------~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~  237 (301)
T d1lufa_         164 RDLATRNCLVGENMVVKIADFGLSRNIYSA------DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS  237 (301)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGG------GCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             eEEcccceEECCCCcEEEccchhheeccCC------ccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHc
Confidence            999999999999999999999999865221      11122234568889999999999999999999999999999999


Q ss_pred             CC-CCCCcccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHH
Q 046639          241 RR-RPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKL  319 (331)
Q Consensus       241 g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L  319 (331)
                      |. +||......  .....+...        ..+           ..+..+++.+.+|+.+||+.+|++|||+.+|++.|
T Consensus       238 ~~~~p~~~~~~~--e~~~~v~~~--------~~~-----------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L  296 (301)
T d1lufa_         238 YGLQPYYGMAHE--EVIYYVRDG--------NIL-----------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL  296 (301)
T ss_dssp             TTCCTTTTSCHH--HHHHHHHTT--------CCC-----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             cCCCCCCCCCHH--HHHHHHHcC--------CCC-----------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence            85 567653211  111111110        000           11234556789999999999999999999999999


Q ss_pred             HHhhh
Q 046639          320 RHARE  324 (331)
Q Consensus       320 ~~~~~  324 (331)
                      +++.+
T Consensus       297 ~~i~~  301 (301)
T d1lufa_         297 QRMCE  301 (301)
T ss_dssp             HHTTC
T ss_pred             HHhcC
Confidence            98753

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-52  Score=365.96  Aligned_cols=267  Identities=24%  Similarity=0.337  Sum_probs=210.1

Q ss_pred             hccCCcccHHHHHHHhcCCCcCceeeccCeeEEEEeeecCCCc--eEEEEEeecc-chhhHHHHHHHHHHHHcC-CCCCc
Q 046639           14 KQQFPMISYAELSKATNNFSPANKIGQGGVSIVYKGILDESRS--IVAVKVVNLK-QKEASRSFAAECNALRNI-RHRNL   89 (331)
Q Consensus        14 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i   89 (331)
                      ++.||.+++.       +|++.++||+|+||+||+|.+..++.  .||||.+... .....+.+.+|+.+++++ +||||
T Consensus         1 ~~~~~~i~~~-------~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnI   73 (309)
T d1fvra_           1 PTIYPVLDWN-------DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI   73 (309)
T ss_dssp             CCCSSBCCGG-------GCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTB
T ss_pred             CCCCCccCHH-------HcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCE
Confidence            3578888885       69999999999999999999987776  4677777533 333456789999999998 69999


Q ss_pred             ceeeceeecccCCCcceeeEEEeecCCCCHHHHHHhc--------------cCCccchHHHHHHHHHHHHHHHHHhhcCC
Q 046639           90 IKIITICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQS--------------NGQLRFLTQRVNIAIDVSFAIEYFHHHCQ  155 (331)
Q Consensus        90 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--------------~~~~~~~~~~~~~~~~i~~~l~~LH~~~~  155 (331)
                      ++++++|.     .++..++||||+++|+|.+++...              ....+++..+..++.|++.||.|||++  
T Consensus        74 v~~~~~~~-----~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~--  146 (309)
T d1fvra_          74 INLLGACE-----HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK--  146 (309)
T ss_dssp             CCEEEEEE-----ETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred             eeEEEEEe-----cCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC--
Confidence            99999964     356789999999999999999753              245678899999999999999999999  


Q ss_pred             CCeeecCCCCCCEEecCCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHH
Q 046639          156 PSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILL  235 (331)
Q Consensus       156 ~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il  235 (331)
                       +++||||||+|||++.++.+||+|||+++...         .........+|..|+|||.+.++.++.++||||||+++
T Consensus       147 -~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~---------~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil  216 (309)
T d1fvra_         147 -QFIHRDLAARNILVGENYVAKIADFGLSRGQE---------VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL  216 (309)
T ss_dssp             -TEECSCCSGGGEEECGGGCEEECCTTCEESSC---------EECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHH
T ss_pred             -CccccccccceEEEcCCCceEEcccccccccc---------ccccccceecCCcccchHHhccCCCCccceeehhHHHH
Confidence             99999999999999999999999999997641         11222344588899999999999999999999999999


Q ss_pred             HHHHhCC-CCCCcccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHH
Q 046639          236 LEMFTRR-RPTDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRD  314 (331)
Q Consensus       236 ~el~~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~  314 (331)
                      |||++|. +||....     .........     ....+           +.+..+++.+.+|+.+||+.||++|||+.+
T Consensus       217 ~ell~~~~~p~~~~~-----~~~~~~~i~-----~~~~~-----------~~~~~~~~~~~~li~~cl~~dP~~RPs~~e  275 (309)
T d1fvra_         217 WEIVSLGGTPYCGMT-----CAELYEKLP-----QGYRL-----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQ  275 (309)
T ss_dssp             HHHHTTSCCTTTTCC-----HHHHHHHGG-----GTCCC-----------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHHHhcCCCCCCCCC-----HHHHHHHHH-----hcCCC-----------CCCccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence            9999965 5675431     111111110     00011           122345678999999999999999999999


Q ss_pred             HHHHHHHhhhh
Q 046639          315 VVAKLRHARET  325 (331)
Q Consensus       315 i~~~L~~~~~~  325 (331)
                      |++.|+++.+.
T Consensus       276 il~~L~~i~~~  286 (309)
T d1fvra_         276 ILVSLNRMLEE  286 (309)
T ss_dssp             HHHHHHHHHHS
T ss_pred             HHHHHHHHHhc
Confidence            99999998754

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-52  Score=366.58  Aligned_cols=247  Identities=22%  Similarity=0.312  Sum_probs=200.2

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc---hhhHHHHHHHHHHHH-cCCCCCcceeeceeecccCCCcc
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ---KEASRSFAAECNALR-NIRHRNLIKIITICSSIDFEGFD  105 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~~~  105 (331)
                      ++|.+++.||+|+||+||+|++..+++.||||+++...   ......+..|..++. .++||||+++++++     ...+
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~-----~~~~   76 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-----QTKE   76 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----ECSS
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEE-----ccCC
Confidence            57999999999999999999999999999999996432   233455667777665 68999999999994     5567


Q ss_pred             eeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccc
Q 046639          106 FKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAK  185 (331)
Q Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~  185 (331)
                      ..++||||+++|+|.+++....  .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++
T Consensus        77 ~~yivmEy~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~  151 (320)
T d1xjda_          77 NLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCK  151 (320)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             ceeEEEeecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhh
Confidence            8999999999999999997654  367789999999999999999999   99999999999999999999999999998


Q ss_pred             ccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcc
Q 046639          186 FLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPD  265 (331)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  265 (331)
                      ....        .........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.... .........    
T Consensus       152 ~~~~--------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~-~~~~~i~~~----  218 (320)
T d1xjda_         152 ENML--------GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-ELFHSIRMD----  218 (320)
T ss_dssp             CCCC--------TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHC----
T ss_pred             hccc--------ccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH-HHHHHHHcC----
Confidence            6421        122333456999999999999999999999999999999999999999753211 111111110    


Q ss_pred             hhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHH-HHH
Q 046639          266 KVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMR-DVV  316 (331)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~-~i~  316 (331)
                            .+           .++..+++.+.+|+.+||+.||++|||+. +++
T Consensus       219 ------~~-----------~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~  253 (320)
T d1xjda_         219 ------NP-----------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  253 (320)
T ss_dssp             ------CC-----------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             ------CC-----------CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence                  01           11223466789999999999999999995 675

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-51  Score=358.30  Aligned_cols=284  Identities=19%  Similarity=0.223  Sum_probs=204.6

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      .++|.+.+.||+|+||+||+|++  +++.||||+++.... .......|+..+..++||||++++++|...+ .....++
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~~~~   77 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLW   77 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-CcceEEE
Confidence            35789999999999999999997  478999999864422 2222345566666789999999999987542 3334689


Q ss_pred             EEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhc-----CCCCeeecCCCCCCEEecCCCcEEEcccCc
Q 046639          109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHH-----CQPSIVHGDLKPSNILLDQDIVAHVGDLGL  183 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-----~~~~ivH~dik~~nilv~~~~~~kl~Dfg~  183 (331)
                      +||||+++|+|.+++++.   .+++...+.++.|++.||+|+|+.     +..+|+||||||+|||++.++.+||+|||+
T Consensus        78 lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl  154 (303)
T d1vjya_          78 LVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  154 (303)
T ss_dssp             EEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence            999999999999999764   377889999999999999999962     112999999999999999999999999999


Q ss_pred             ccccccCCCCCcccccCCceeecccccccCCcccCCCC------CccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHH
Q 046639          184 AKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSK------ASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHE  257 (331)
Q Consensus       184 a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~------~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~  257 (331)
                      ++.......    ..........||+.|+|||++.+..      ++.++|||||||++|||++|..||............
T Consensus       155 ~~~~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~  230 (303)
T d1vjya_         155 AVRHDSATD----TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD  230 (303)
T ss_dssp             CEEEETTTT----EECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT
T ss_pred             cccccCCCc----ceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhh
Confidence            987633221    1112233466999999999987643      677999999999999999999887543222111111


Q ss_pred             HHHhhCc--chhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhh
Q 046639          258 FVKMALP--DKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARET  325 (331)
Q Consensus       258 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~  325 (331)
                      .......  .......+......++.  .....++...+.+|+.+||+.||.+|||+.||++.|+++.+.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~p~~~~--~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  298 (303)
T d1vjya_         231 LVPSDPSVEEMRKVVCEQKLRPNIPN--RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             TSCSSCCHHHHHHHHTTSCCCCCCCG--GGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cccccchHHHHHHHHhccccCCCCCc--ccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence            0000000  00000111111111111  112235777899999999999999999999999999988754

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-51  Score=357.69  Aligned_cols=264  Identities=23%  Similarity=0.355  Sum_probs=207.5

Q ss_pred             CceeeccCeeEEEEeeecCC---CceEEEEEeec-cchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceeeEE
Q 046639           35 ANKIGQGGVSIVYKGILDES---RSIVAVKVVNL-KQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKAIV  110 (331)
Q Consensus        35 ~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~lv  110 (331)
                      .++||+|+||+||+|.+..+   ...||||.++. .+......+.+|+.++++++||||++++++|..    .++..++|
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~----~~~~~~lv  107 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR----SEGSPLVV  107 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEE----TTTEEEEE
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEe----cCCceEEE
Confidence            46899999999999998643   34699999864 345556789999999999999999999999743    34578999


Q ss_pred             EeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccccC
Q 046639          111 FEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLFGY  190 (331)
Q Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~~~  190 (331)
                      |||+++++|.+++..... ..++..+..++.|++.||.|||+.   +|+||||||+|||+++++.+||+|||+++.....
T Consensus       108 ~E~~~~g~l~~~~~~~~~-~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~  183 (311)
T d1r0pa_         108 LPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  183 (311)
T ss_dssp             EECCTTCBHHHHHHCTTC-CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred             EEEeecCchhhhhccccc-cchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence            999999999999875433 456678889999999999999999   9999999999999999999999999999876322


Q ss_pred             CCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchhhhh
Q 046639          191 EPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKVMEI  270 (331)
Q Consensus       191 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  270 (331)
                      ..    ..........||+.|+|||.+.+..++.++||||||+++|||++|..||..................+      
T Consensus       184 ~~----~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~------  253 (311)
T d1r0pa_         184 EF----DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL------  253 (311)
T ss_dssp             TC----CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCC------
T ss_pred             cc----ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC------
Confidence            21    11222233468999999999999999999999999999999999888876533222222221111110      


Q ss_pred             cCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhhhcCC
Q 046639          271 VDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETFLGTR  330 (331)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~~~~~  330 (331)
                                    ..+..+++.+.+|+.+||+.||++|||+.||++.|+.+.+.+.+.+
T Consensus       254 --------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~~  299 (311)
T d1r0pa_         254 --------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH  299 (311)
T ss_dssp             --------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCC
T ss_pred             --------------CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhhh
Confidence                          0112355678999999999999999999999999999998876654

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-52  Score=359.25  Aligned_cols=270  Identities=22%  Similarity=0.295  Sum_probs=204.1

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccch--hhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCccee
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK--EASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      ++|.+++.||+|+||+||+|++..+++.||||+++....  .....+.+|+.++++++||||+++++++     .+.+..
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~-----~~~~~~   76 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKL   76 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEE-----EETTEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccc-----ccccce
Confidence            579999999999999999999999999999999964432  2346788999999999999999999995     446789


Q ss_pred             eEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccc
Q 046639          108 AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      ++|||++ ++++.+++.......+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||+|+..
T Consensus        77 ~iv~e~~-~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~  152 (298)
T d1gz8a_          77 YLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF  152 (298)
T ss_dssp             EEEEECC-SEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHH
T ss_pred             eEEEeec-CCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceec
Confidence            9999999 56777777666666789999999999999999999999   9999999999999999999999999999875


Q ss_pred             ccCCCCCcccccCCceeecccccccCCcccCCCC-CccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhC-cc
Q 046639          188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSK-ASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMAL-PD  265 (331)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~-~~  265 (331)
                      ..        .........||+.|+|||++.... ++.++||||+|+++|+|++|+.||...... ..+........ +.
T Consensus       153 ~~--------~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~-~~~~~i~~~~~~~~  223 (298)
T d1gz8a_         153 GV--------PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI-DQLFRIFRTLGTPD  223 (298)
T ss_dssp             CC--------CSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCC
T ss_pred             cC--------CcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHH-HHHHHHHHhcCCCc
Confidence            21        122333456899999999877766 588999999999999999999999754222 12222222111 10


Q ss_pred             h-hhh--hcCcccccccccCC----cchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          266 K-VME--IVDPSLLLEVTANN----YSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       266 ~-~~~--~~~~~~~~~~~~~~----~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      . ...  ...+..........    ......+...+.+|+.+||+.||.+|||+.|+++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~  282 (298)
T d1gz8a_         224 EVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA  282 (298)
T ss_dssp             TTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            0 000  00000101100000    0111234567899999999999999999999986

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-52  Score=356.61  Aligned_cols=258  Identities=27%  Similarity=0.363  Sum_probs=195.7

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCC---CceEEEEEeecc---chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCC
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDES---RSIVAVKVVNLK---QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEG  103 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  103 (331)
                      ++|++++.||+|+||+||+|++...   ...||||++...   .....+.+.+|+.++++++||||++++++|.+     
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-----   82 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-----   82 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----
Confidence            5799999999999999999987432   347899988643   33445678999999999999999999999742     


Q ss_pred             cceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCc
Q 046639          104 FDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGL  183 (331)
Q Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~  183 (331)
                       ...++||||++++++.+.+....+ .+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||+
T Consensus        83 -~~~~lv~e~~~~~~l~~~~~~~~~-~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl  157 (273)
T d1u46a_          83 -PPMKMVTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGL  157 (273)
T ss_dssp             -SSCEEEEECCTTCBHHHHHHHHGG-GSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred             -cchheeeeeecCcchhhhhhcccC-CCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchh
Confidence             346899999999999998876443 477899999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCCCcccCCcchHHHHHHhh
Q 046639          184 AKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPTDAMFNEGLTLHEFVKMA  262 (331)
Q Consensus       184 a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~  262 (331)
                      ++......     ..........++..|+|||++.+..++.++||||||+++|||++ |..||.+..... ........ 
T Consensus       158 ~~~~~~~~-----~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~-~~~~i~~~-  230 (273)
T d1u46a_         158 MRALPQND-----DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ-ILHKIDKE-  230 (273)
T ss_dssp             CEECCC-C-----CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HHHHHHTS-
T ss_pred             hhhcccCC-----CcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH-HHHHHHhC-
Confidence            98762221     11122233457788999999999999999999999999999998 899997542211 11111110 


Q ss_pred             CcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHh
Q 046639          263 LPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHA  322 (331)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~  322 (331)
                                 ....       +.+..++..+.+|+.+||+.||++|||+.+|.+.|.++
T Consensus       231 -----------~~~~-------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         231 -----------GERL-------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             -----------CCCC-------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----------CCCC-------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                       0000       11123556789999999999999999999999998876

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-51  Score=358.32  Aligned_cols=275  Identities=19%  Similarity=0.255  Sum_probs=204.7

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCC-CceEEEEEeeccc--hhhHHHHHHHHHHHHcC---CCCCcceeeceeecccCC
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDES-RSIVAVKVVNLKQ--KEASRSFAAECNALRNI---RHRNLIKIITICSSIDFE  102 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~~  102 (331)
                      .++|.+++.||+|+||+||+|++..+ ++.||||+++...  ......+.+|+.+++.+   +||||++++++|......
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            46899999999999999999999655 6789999986442  22223456777777665   799999999998765566


Q ss_pred             CcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccC
Q 046639          103 GFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLG  182 (331)
Q Consensus       103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg  182 (331)
                      .....+++||++.++++ .+........+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||
T Consensus        86 ~~~~~~~~~e~~~~~~~-~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg  161 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLT-TYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG  161 (305)
T ss_dssp             SEEEEEEEEECCSCBHH-HHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred             cCceEEEEEEeccCCch-hhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchh
Confidence            67789999999966544 444445555678889999999999999999999   99999999999999999999999999


Q ss_pred             cccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhh
Q 046639          183 LAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMA  262 (331)
Q Consensus       183 ~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  262 (331)
                      ++...         ..........||+.|+|||++.+..|+.++||||+||++|||++|.+||..... ...+.......
T Consensus       162 ~~~~~---------~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~~~~i~~~~  231 (305)
T d1blxa_         162 LARIY---------SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD-VDQLGKILDVI  231 (305)
T ss_dssp             SCCCC---------CGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHH
T ss_pred             hhhhh---------cccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCH-HHHHHHHHHhh
Confidence            98754         122333456799999999999999999999999999999999999999975422 22222222221


Q ss_pred             CcchhhhhcC------cccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          263 LPDKVMEIVD------PSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       263 ~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ..........      .............+.......+.+|+.+||+.||++|||+.|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         232 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             CCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            1111000000      000001111111233345667889999999999999999999975

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-51  Score=356.29  Aligned_cols=265  Identities=21%  Similarity=0.224  Sum_probs=194.4

Q ss_pred             cCceeeccCeeEEEEeeecCCCceEEEEEeeccchh-----hHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           34 PANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKE-----ASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        34 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      .++.||+|+||+||+|++..+++.||||+++.....     ....+.+|+.+++.++||||+++++++     ..++..+
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~-----~~~~~~~   76 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF-----GHKSNIS   76 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE-----CCTTCCE
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeee-----ccCCcee
Confidence            367999999999999999999999999998644221     234688999999999999999999994     5567799


Q ss_pred             EEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccccc
Q 046639          109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFLF  188 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~~  188 (331)
                      +||||+.++++..+..  ....+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||+++...
T Consensus        77 ivmE~~~~~~~~~~~~--~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~  151 (299)
T d1ua2a_          77 LVFDFMETDLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFG  151 (299)
T ss_dssp             EEEECCSEEHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred             ehhhhhcchHHhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccC
Confidence            9999997776666553  334577889999999999999999999   99999999999999999999999999997652


Q ss_pred             cCCCCCcccccCCceeecccccccCCcccCCC-CCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcchh
Q 046639          189 GYEPGTAAETASNSIEIKGIVGYVAPEYGMGS-KASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDKV  267 (331)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  267 (331)
                      ..        ........||+.|+|||++.+. .++.++|||||||++|||++|.+||..... ...+..+.........
T Consensus       152 ~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~-~~~l~~i~~~~~~~~~  222 (299)
T d1ua2a_         152 SP--------NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD-LDQLTRIFETLGTPTE  222 (299)
T ss_dssp             SC--------CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCT
T ss_pred             CC--------cccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCH-HHHHHHHHHhcCCCCh
Confidence            21        1222345689999999998754 579999999999999999999999975422 1122222221111100


Q ss_pred             hhhcC------cccccccccC-CcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          268 MEIVD------PSLLLEVTAN-NYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       268 ~~~~~------~~~~~~~~~~-~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ....+      .......... ...........+.+|+.+||+.||++|||+.|+++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         223 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             TTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence            00000      0000000000 00111234567899999999999999999999975

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-51  Score=353.89  Aligned_cols=261  Identities=22%  Similarity=0.333  Sum_probs=203.8

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCC-------ceEEEEEeeccc-hhhHHHHHHHHHHHHcC-CCCCcceeeceeecc
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESR-------SIVAVKVVNLKQ-KEASRSFAAECNALRNI-RHRNLIKIITICSSI   99 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~   99 (331)
                      .++|.+++.||+|+||.||+|++..++       ..||||+++... ......+.+|...+.++ +||||++++++|.  
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~--   89 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT--   89 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc--
Confidence            347999999999999999999976543       479999986543 33456788899988888 7999999999964  


Q ss_pred             cCCCcceeeEEEeecCCCCHHHHHHhcc--------------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCC
Q 046639          100 DFEGFDFKAIVFEYMQNRNLEQWLRQSN--------------GQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKP  165 (331)
Q Consensus       100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~  165 (331)
                         .++..++||||+++|+|.+++....              ...+++..++.++.|++.||.|||++   +|+||||||
T Consensus        90 ---~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp  163 (299)
T d1fgka_          90 ---QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAA  163 (299)
T ss_dssp             ---SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred             ---cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecc
Confidence               3567899999999999999997643              23578899999999999999999999   999999999


Q ss_pred             CCEEecCCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCC
Q 046639          166 SNILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRP  244 (331)
Q Consensus       166 ~nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~p  244 (331)
                      +|||++.++.+||+|||+++......      .........+|+.|+|||.+.++.++.++||||||+++|||++ |.+|
T Consensus       164 ~NiLl~~~~~~kl~dfg~~~~~~~~~------~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p  237 (299)
T d1fgka_         164 RNVLVTEDNVMKIADFGLARDIHHID------YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP  237 (299)
T ss_dssp             GGEEECTTCCEEECSTTCCCCGGGCC------TTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             cceeecCCCCeEeccchhhccccccc------cccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCC
Confidence            99999999999999999998763322      1122334568889999999999999999999999999999998 7888


Q ss_pred             CCcccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhh
Q 046639          245 TDAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARE  324 (331)
Q Consensus       245 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~  324 (331)
                      |......  .....+....        .+           ..+..++..+.+|+.+||+.||.+|||+.||++.|+++.+
T Consensus       238 ~~~~~~~--~~~~~i~~~~--------~~-----------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         238 YPGVPVE--ELFKLLKEGH--------RM-----------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             STTCCHH--HHHHHHHTTC--------CC-----------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCHH--HHHHHHHcCC--------CC-----------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence            8653221  1111111110        11           1112345678999999999999999999999999998865

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-50  Score=352.42  Aligned_cols=262  Identities=20%  Similarity=0.296  Sum_probs=208.7

Q ss_pred             cCCCcCceeeccCeeEEEEeeec-----CCCceEEEEEeeccc-hhhHHHHHHHHHHHHcC-CCCCcceeeceeecccCC
Q 046639           30 NNFSPANKIGQGGVSIVYKGILD-----ESRSIVAVKVVNLKQ-KEASRSFAAECNALRNI-RHRNLIKIITICSSIDFE  102 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~  102 (331)
                      ++|.+++.||+|+||.||+|++.     .+++.||||+++... ......+.+|+.+++.+ +||||++++++|     .
T Consensus        23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~-----~   97 (311)
T d1t46a_          23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC-----T   97 (311)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----C
T ss_pred             HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE-----e
Confidence            57999999999999999999863     467799999997543 33446688999999999 699999999996     3


Q ss_pred             CcceeeEEEeecCCCCHHHHHHhcc----------------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCC
Q 046639          103 GFDFKAIVFEYMQNRNLEQWLRQSN----------------GQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPS  166 (331)
Q Consensus       103 ~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~  166 (331)
                      .....++||||+++++|.+++....                ...+++..+..++.|++.|++|||++   +++||||||+
T Consensus        98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~  174 (311)
T d1t46a_          98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAAR  174 (311)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred             eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccc
Confidence            4566899999999999999997642                22477888999999999999999999   9999999999


Q ss_pred             CEEecCCCcEEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHh-CCCCC
Q 046639          167 NILLDQDIVAHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFT-RRRPT  245 (331)
Q Consensus       167 nilv~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf  245 (331)
                      ||+++.++.++++|||+++......      .........||+.|+|||++.++.++.++||||||+++|||++ |.+||
T Consensus       175 NIl~~~~~~~ki~DfG~~~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~  248 (311)
T d1t46a_         175 NILLTHGRITKICDFGLARDIKNDS------NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY  248 (311)
T ss_dssp             GEEEETTTEEEECCCGGGSCTTSCT------TSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred             cccccccCcccccccchheeccCCC------cceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCC
Confidence            9999999999999999998752211      1122234568999999999999999999999999999999999 55555


Q ss_pred             CcccCCcchHHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhh
Q 046639          246 DAMFNEGLTLHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARET  325 (331)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~  325 (331)
                      ... .....+...+.......                   .+..++..+.+|+.+||+.||++|||+.+|++.|++...+
T Consensus       249 ~~~-~~~~~~~~~i~~~~~~~-------------------~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~  308 (311)
T d1t46a_         249 PGM-PVDSKFYKMIKEGFRML-------------------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (311)
T ss_dssp             TTC-CSSHHHHHHHHHTCCCC-------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCC-CHHHHHHHHHhcCCCCC-------------------CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence            443 33333333333221110                   0112456789999999999999999999999999877654

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-51  Score=352.92  Aligned_cols=241  Identities=20%  Similarity=0.262  Sum_probs=195.1

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccch------hhHHHHHHHHHHHHcCC--CCCcceeeceeeccc
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQK------EASRSFAAECNALRNIR--HRNLIKIITICSSID  100 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~  100 (331)
                      .++|.+++.||+|+||+||+|++..+++.||||++.....      .....+.+|+.++++++  ||||+++++++    
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~----   78 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF----   78 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE----
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEE----
Confidence            4689999999999999999999999999999999864321      11233568999999986  89999999994    


Q ss_pred             CCCcceeeEEEeecCC-CCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecC-CCcEEE
Q 046639          101 FEGFDFKAIVFEYMQN-RNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQ-DIVAHV  178 (331)
Q Consensus       101 ~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~-~~~~kl  178 (331)
                       ...+..++|||++.+ +++.+++....  .+++..++.++.|++.||.|||++   +|+||||||+||+++. ++.+||
T Consensus        79 -~~~~~~~lv~e~~~~~~~l~~~~~~~~--~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl  152 (273)
T d1xwsa_          79 -ERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKL  152 (273)
T ss_dssp             -ECSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEE
T ss_pred             -eeCCeEEEEEEeccCcchHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEE
Confidence             556788999999975 67888886643  477899999999999999999999   9999999999999985 479999


Q ss_pred             cccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCC-ccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHH
Q 046639          179 GDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKA-SVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHE  257 (331)
Q Consensus       179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~  257 (331)
                      +|||+|+....          .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||...       ..
T Consensus       153 ~DFG~a~~~~~----------~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~-------~~  215 (273)
T d1xwsa_         153 IDFGSGALLKD----------TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD-------EE  215 (273)
T ss_dssp             CCCTTCEECCS----------SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-------HH
T ss_pred             Cccccceeccc----------ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc-------hH
Confidence            99999976421          22234569999999999887665 67899999999999999999999642       11


Q ss_pred             HHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          258 FVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ......                     .+...++..+.+|+.+||+.||++|||+.|+++
T Consensus       216 i~~~~~---------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         216 IIRGQV---------------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             HHHCCC---------------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             Hhhccc---------------------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            111110                     111124567889999999999999999999976

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-50  Score=352.72  Aligned_cols=277  Identities=19%  Similarity=0.195  Sum_probs=201.9

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc-hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCccee
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ-KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      +.+|.+++.||+|+||+||+|++..+++.||||++.... ....+.+.+|+.+|+.++||||+++++++....+......
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            457999999999999999999999999999999996443 3445678999999999999999999999876555455556


Q ss_pred             eEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccc
Q 046639          108 AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      +++++ +.+++|.+++...   .+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++...
T Consensus        87 ~l~~~-~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~  159 (345)
T d1pmea_          87 YLVTH-LMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVA  159 (345)
T ss_dssp             EEEEE-CCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEe-ecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence            66655 5599999999754   378899999999999999999999   9999999999999999999999999999875


Q ss_pred             ccCCCCCcccccCCceeecccccccCCcccCC-CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcch
Q 046639          188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMG-SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDK  266 (331)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  266 (331)
                      ....     ..........||+.|+|||++.. ..++.++||||+||++|+|++|..||..................+..
T Consensus       160 ~~~~-----~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~  234 (345)
T d1pmea_         160 DPDH-----DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ  234 (345)
T ss_dssp             CGGG-----CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH
T ss_pred             cCCC-----ccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCCh
Confidence            2211     12223345668999999999855 46789999999999999999999999754321111111111111100


Q ss_pred             hhhhcC--cc-------cccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          267 VMEIVD--PS-------LLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       267 ~~~~~~--~~-------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      ......  ..       ...................+.+|+.+||+.||.+|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~  294 (345)
T d1pmea_         235 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  294 (345)
T ss_dssp             HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000000  00       0000000000111133457889999999999999999999985

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=5.2e-50  Score=345.55  Aligned_cols=268  Identities=19%  Similarity=0.239  Sum_probs=198.7

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCccee
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ--KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      ++|.++++||+|+||+||+|++. +++.||||++....  ......+.+|+.++++++||||+++++++     ...+..
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~~   75 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI-----HTKKRL   75 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEE-----ECSSCE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeec-----ccCCce
Confidence            58999999999999999999986 78899999996543  23357789999999999999999999995     456778


Q ss_pred             eEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccc
Q 046639          108 AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      ++++|++.++.+..+...  ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+|++|||.+...
T Consensus        76 ~i~~e~~~~~~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~  150 (286)
T d1ob3a_          76 VLVFEHLDQDLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF  150 (286)
T ss_dssp             EEEEECCSEEHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHH
T ss_pred             eEEEEeehhhhHHHHHhh--cCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceec
Confidence            999999966555555432  34578899999999999999999999   9999999999999999999999999999876


Q ss_pred             ccCCCCCcccccCCceeecccccccCCcccCCC-CCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcch
Q 046639          188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMGS-KASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDK  266 (331)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  266 (331)
                      ..        .........+++.|+|||.+.+. .++.++||||||+++|||++|+.||.+.... ..............
T Consensus       151 ~~--------~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~-~~~~~i~~~~~~~~  221 (286)
T d1ob3a_         151 GI--------PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA-DQLMRIFRILGTPN  221 (286)
T ss_dssp             CC-----------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCC
T ss_pred             cc--------CccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHH-HHHHHHHHhhCCCC
Confidence            21        11223344588899999998764 5699999999999999999999999764322 12222222111110


Q ss_pred             hhhhc--------CcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          267 VMEIV--------DPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       267 ~~~~~--------~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      .....        ..............+.......+.+|+.+||+.||++|||+.|+++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         222 SKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             TTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00000        0000000111112333345667899999999999999999999974

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-50  Score=348.11  Aligned_cols=260  Identities=20%  Similarity=0.359  Sum_probs=205.5

Q ss_pred             cCCCcCceeeccCeeEEEEeeecC-----CCceEEEEEeecc-chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCC
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDE-----SRSIVAVKVVNLK-QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEG  103 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  103 (331)
                      ++|.+++.||+|+||+||+|.+..     ++..||||+++.. .......+.+|+.++++++||||++++++|     ..
T Consensus        20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~-----~~   94 (308)
T d1p4oa_          20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV-----SQ   94 (308)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE-----CS
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEE-----ec
Confidence            579999999999999999998853     3568999999644 333445689999999999999999999996     34


Q ss_pred             cceeeEEEeecCCCCHHHHHHhcc--------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCc
Q 046639          104 FDFKAIVFEYMQNRNLEQWLRQSN--------GQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIV  175 (331)
Q Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~  175 (331)
                      .+..++|||++++|+|.+++....        ...+++..+..++.|++.||.|||++   +|+||||||+|||++.+++
T Consensus        95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~  171 (308)
T d1p4oa_          95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFT  171 (308)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCC
T ss_pred             CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCce
Confidence            567899999999999999986521        12356778889999999999999999   9999999999999999999


Q ss_pred             EEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhC-CCCCCcccCCcch
Q 046639          176 AHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTR-RRPTDAMFNEGLT  254 (331)
Q Consensus       176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g-~~pf~~~~~~~~~  254 (331)
                      +||+|||+++......      .........+|+.|+|||.+.+..++.++||||||+++|||++| .+||...... ..
T Consensus       172 ~Kl~DFGla~~~~~~~------~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~-~~  244 (308)
T d1p4oa_         172 VKIGDFGMTRDIYETD------YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-QV  244 (308)
T ss_dssp             EEECCTTCCCGGGGGG------CEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH-HH
T ss_pred             EEEeecccceeccCCc------ceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH-HH
Confidence            9999999998752211      11222334578999999999999999999999999999999998 4777543211 11


Q ss_pred             HHHHHHhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhh
Q 046639          255 LHEFVKMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARE  324 (331)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~  324 (331)
                      +........             .       ..+..++..+.+|+.+||+.||++|||+.+|++.|++..+
T Consensus       245 ~~~i~~~~~-------------~-------~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         245 LRFVMEGGL-------------L-------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             HHHHHTTCC-------------C-------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHHHHhCCC-------------C-------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            111111000             0       1112356789999999999999999999999999988754

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-49  Score=349.80  Aligned_cols=271  Identities=17%  Similarity=0.225  Sum_probs=199.8

Q ss_pred             HhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc--chhhHHHHHHHHHHHHcCCCCCcceeeceeeccc-CCCc
Q 046639           28 ATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRNIRHRNLIKIITICSSID-FEGF  104 (331)
Q Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~~  104 (331)
                      ..++|.++++||+|+||+||+|.+..+++.||||+++..  +....+.+.+|+.+|+.++||||++++++|...+ ....
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~   95 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF   95 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence            356899999999999999999999999999999999643  3444567899999999999999999999976433 2344


Q ss_pred             ceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcc
Q 046639          105 DFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLA  184 (331)
Q Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a  184 (331)
                      ..+++|||++ +.+|..+++..   .+++..+..++.|++.||.|||++   ||+||||||+|||++.++.+|++|||+|
T Consensus        96 ~~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a  168 (346)
T d1cm8a_          96 TDFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA  168 (346)
T ss_dssp             CCCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             ceEEEEEecc-cccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccce
Confidence            5679999999 77888887653   378899999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCcccccCCceeecccccccCCcccCCC-CCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhC
Q 046639          185 KFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGS-KASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMAL  263 (331)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  263 (331)
                      +...           .......+|+.|+|||++.+. .++.++||||+||++|+|++|.+||..... ...+........
T Consensus       169 ~~~~-----------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~-~~~~~~~~~~~~  236 (346)
T d1cm8a_         169 RQAD-----------SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH-LDQLKEIMKVTG  236 (346)
T ss_dssp             EECC-----------SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHC
T ss_pred             eccC-----------CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCCh-HHHHHHHHhccC
Confidence            8652           122345689999999998764 568999999999999999999999976421 111111111111


Q ss_pred             c--chhhhhcCc--------ccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          264 P--DKVMEIVDP--------SLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       264 ~--~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      .  .........        .+................+.+.+|+.+||+.||.+|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~  300 (346)
T d1cm8a_         237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  300 (346)
T ss_dssp             CCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            1  100000000        00000000111222344567889999999999999999999986

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.4e-49  Score=340.85  Aligned_cols=269  Identities=18%  Similarity=0.209  Sum_probs=206.2

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcceee
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      .++|.+++.||+|+||+||+|++..+++.||||++.....  ...+..|+++++.++|++++..+..+.    ...+..+
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~----~~~~~~~   79 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCG----AEGDYNV   79 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEE----EETTEEE
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEE----ecCCEEE
Confidence            3579999999999999999999999999999999865432  234778999999999888777766653    3456789


Q ss_pred             EEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecC---CCcEEEcccCccc
Q 046639          109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQ---DIVAHVGDLGLAK  185 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~---~~~~kl~Dfg~a~  185 (331)
                      +|||++ +++|.+.+.... ..+++..+..++.|++.||.|||++   +|+||||||+||+++.   +..++|+|||+|+
T Consensus        80 ivme~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~  154 (299)
T d1ckia_          80 MVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  154 (299)
T ss_dssp             EEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCE
T ss_pred             EEEEEc-CCchhhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcce
Confidence            999999 778877766533 3578899999999999999999999   9999999999999864   4579999999999


Q ss_pred             ccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHH--HHHhhC
Q 046639          186 FLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHE--FVKMAL  263 (331)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~--~~~~~~  263 (331)
                      .+....... ...........||+.|+|||++.+..++.++|||||||++|||++|..||............  ......
T Consensus       155 ~~~~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~  233 (299)
T d1ckia_         155 KYRDARTHQ-HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM  233 (299)
T ss_dssp             ECBCTTTCC-BCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHH
T ss_pred             ecccccccc-ceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccC
Confidence            874433221 11222334567999999999999999999999999999999999999999865433222111  111111


Q ss_pred             cchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhh
Q 046639          264 PDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARET  325 (331)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~  325 (331)
                      .....                .....+++.+.+++..||+.+|++||++.++.+.|+.+...
T Consensus       234 ~~~~~----------------~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~  279 (299)
T d1ckia_         234 STPIE----------------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  279 (299)
T ss_dssp             HSCHH----------------HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             CCChh----------------HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence            00000                11124567899999999999999999999999999887543

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-48  Score=339.82  Aligned_cols=279  Identities=19%  Similarity=0.219  Sum_probs=197.3

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc--chhhHHHHHHHHHHHHcCCCCCcceeeceeeccc---CCC
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRNIRHRNLIKIITICSSID---FEG  103 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---~~~  103 (331)
                      .++|.++++||+|+||+||+|++..+++.||||++...  .......+.+|+.+++.++|||++++++++....   ...
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            46899999999999999999999999999999998544  2334467889999999999999999999875432   123


Q ss_pred             cceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCc
Q 046639          104 FDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGL  183 (331)
Q Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~  183 (331)
                      .+..++|||++.++.+....  .....++...++.++.|++.||.|||++   +|+||||||+||+++.++.+||+|||+
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~--~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~  163 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLS--NVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGL  163 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHT--CTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             CceEEEEEeccCCCccchhh--hcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecce
Confidence            45689999999665555443  3334577788999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCcccccCCceeecccccccCCcccCCC-CCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhh
Q 046639          184 AKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGS-KASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMA  262 (331)
Q Consensus       184 a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  262 (331)
                      +........    ..........||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+... ...........
T Consensus       164 ~~~~~~~~~----~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~-~~~~~~i~~~~  238 (318)
T d3blha1         164 ARAFSLAKN----SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE-QHQLALISQLC  238 (318)
T ss_dssp             CEECCC---------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHH
T ss_pred             eeecccccc----cccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCH-HHHHHHHHHhc
Confidence            976532111    111223345699999999998765 689999999999999999999999975321 11111111111


Q ss_pred             C--cchhhhhcC-ccccc---ccccCCcchHH-----HHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          263 L--PDKVMEIVD-PSLLL---EVTANNYSWIE-----DCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       263 ~--~~~~~~~~~-~~~~~---~~~~~~~~~~~-----~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                      .  ......... .....   ...........     ...+.+.+|+.+||+.||++|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             CCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence            1  111111100 00000   00000111111     12446788999999999999999999974

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.8e-48  Score=335.29  Aligned_cols=269  Identities=13%  Similarity=0.145  Sum_probs=211.1

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCC-CCcceeeceeecccCCCccee
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRH-RNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      .++|.+++.||+|+||+||+|++..+++.||||++.....  ...+.+|++.++.+.| +|++.+++++     ......
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~~   76 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFG-----QEGLHN   76 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEE-----EETTEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEe-----ecCCcc
Confidence            4689999999999999999999999999999998864432  2346788999999975 8998888884     445678


Q ss_pred             eEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecC-----CCcEEEcccC
Q 046639          108 AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQ-----DIVAHVGDLG  182 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~-----~~~~kl~Dfg  182 (331)
                      ++|||++ +++|.+++.... ..++...+..++.|++.||.+||++   ||+||||||+||+++.     ++.++|+|||
T Consensus        77 ~~vme~~-~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG  151 (293)
T d1csna_          77 VLVIDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFG  151 (293)
T ss_dssp             EEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred             EEEEEec-CCCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccc
Confidence            9999999 889999987644 3577889999999999999999999   9999999999999964     5789999999


Q ss_pred             cccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHH--HHHH
Q 046639          183 LAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLH--EFVK  260 (331)
Q Consensus       183 ~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~--~~~~  260 (331)
                      +|+.......... ..........||+.|+|||++.+..++.++||||||+++|||++|..||...........  ....
T Consensus       152 ~a~~~~~~~~~~~-~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~  230 (293)
T d1csna_         152 MVKFYRDPVTKQH-IPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE  230 (293)
T ss_dssp             TCEESBCTTTCCB-CCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHH
T ss_pred             eeEEcccCccccc-eeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHh
Confidence            9998644332221 122233456799999999999999999999999999999999999999986543332211  1111


Q ss_pred             hhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHHHHHHhhhhh
Q 046639          261 MALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVAKLRHARETF  326 (331)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~~L~~~~~~~  326 (331)
                      ........                ....++++++.+++..|+..+|++||+++.+.+.|+++.+..
T Consensus       231 ~~~~~~~~----------------~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~  280 (293)
T d1csna_         231 KKQSTPLR----------------ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL  280 (293)
T ss_dssp             HHHHSCHH----------------HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             ccCCCChH----------------HhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence            11111110                111235567899999999999999999999999998887654

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-47  Score=340.50  Aligned_cols=270  Identities=19%  Similarity=0.200  Sum_probs=197.8

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc--chhhHHHHHHHHHHHHcCCCCCcceeeceeeccc-CCCcce
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRNIRHRNLIKIITICSSID-FEGFDF  106 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~~~~  106 (331)
                      ++|+++++||+|+||+||+|++..+++.||||++...  +......+.+|+.+++.++||||+++++++.... .+....
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            5799999999999999999999999999999999644  3444567889999999999999999999976432 245678


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      +|+||||+. +++.+.+.    ..+++..++.++.|++.||.|||++   ||+||||||+||+++.++.++++|||+++.
T Consensus        97 ~~iv~Ey~~-~~l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~  168 (355)
T d2b1pa1          97 VYLVMELMD-ANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART  168 (355)
T ss_dssp             EEEEEECCS-EEHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             eEEEEeccc-hHHHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhc
Confidence            999999995 55555553    2367889999999999999999999   999999999999999999999999999876


Q ss_pred             cccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcc-
Q 046639          187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPD-  265 (331)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-  265 (331)
                      ..         .........+|+.|+|||++.+..++.++||||+||++++|++|.+||.+... .............. 
T Consensus       169 ~~---------~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~-~~~~~~i~~~~~~~~  238 (355)
T d2b1pa1         169 AG---------TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY-IDQWNKVIEQLGTPC  238 (355)
T ss_dssp             ---------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCC
T ss_pred             cc---------cccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCH-HHHHHHHHHhccCCC
Confidence            41         22333455689999999999999999999999999999999999999975321 11111111111100 


Q ss_pred             ---------hhhhhcC----------c-ccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          266 ---------KVMEIVD----------P-SLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       266 ---------~~~~~~~----------~-~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                               .......          + ....................+.+|+.+||+.||++||||.||++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             HHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                     0000000          0 00011122233445567888999999999999999999999974

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-48  Score=335.04  Aligned_cols=270  Identities=18%  Similarity=0.220  Sum_probs=204.7

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc--hhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCccee
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ--KEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDFK  107 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~  107 (331)
                      ++|+++++||+|+||+||+|++..+++.||||+++...  ......+.+|+.+++.++||||+++++++     ......
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~-----~~~~~~   76 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKL   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccc-----ccccce
Confidence            58999999999999999999999999999999986443  34457789999999999999999999995     445678


Q ss_pred             eEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCccccc
Q 046639          108 AIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKFL  187 (331)
Q Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~~  187 (331)
                      +++++++.+++|..++...  ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||.++..
T Consensus        77 ~iv~~~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~  151 (292)
T d1unla_          77 TLVFEFCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF  151 (292)
T ss_dssp             EEEEECCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             eEEeeeccccccccccccc--cccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcc
Confidence            9999999888888877544  3467788999999999999999999   9999999999999999999999999999875


Q ss_pred             ccCCCCCcccccCCceeecccccccCCcccCCCC-CccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcch
Q 046639          188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSK-ASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPDK  266 (331)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  266 (331)
                      ...        ........+++.|+|||++.+.. ++.++||||+||++|||++|..||....+................
T Consensus       152 ~~~--------~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  223 (292)
T d1unla_         152 GIP--------VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPT  223 (292)
T ss_dssp             CSC--------CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             cCC--------CccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCC
Confidence            211        12222344677899999987765 699999999999999999999997543322222322222211110


Q ss_pred             ------hhhhcCcccc--cccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          267 ------VMEIVDPSLL--LEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       267 ------~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                            .....+....  .................+.+|+.+||+.||.+||||.|+++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         224 EEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                  0000000000  00111122233345567889999999999999999999975

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-48  Score=345.27  Aligned_cols=269  Identities=22%  Similarity=0.277  Sum_probs=196.5

Q ss_pred             CCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCCcceeeceeeccc-CCCcceeeE
Q 046639           31 NFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRNLIKIITICSSID-FEGFDFKAI  109 (331)
Q Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~~~~~~l  109 (331)
                      +|+.+++||+|+||+||+|++..+++.||||++......    ..+|+.+++.++||||+++++++.... ..+..++++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            699999999999999999999999999999999654322    347999999999999999999976542 234556789


Q ss_pred             EEeecCCCCHHHHHHh--ccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCC-cEEEcccCcccc
Q 046639          110 VFEYMQNRNLEQWLRQ--SNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDI-VAHVGDLGLAKF  186 (331)
Q Consensus       110 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~-~~kl~Dfg~a~~  186 (331)
                      ||||+++ ++.+.+..  .....+++..+..++.|++.||.|||++   ||+||||||+|||++.++ .+||+|||++..
T Consensus        97 v~Ey~~~-~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~  172 (350)
T d1q5ka_          97 VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ  172 (350)
T ss_dssp             EEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred             EEeccCC-ccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhh
Confidence            9999965 45444432  3445688899999999999999999999   999999999999999775 899999999986


Q ss_pred             cccCCCCCcccccCCceeecccccccCCcccCC-CCCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCc-
Q 046639          187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMG-SKASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALP-  264 (331)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-  264 (331)
                      ...         ........||+.|+|||.+.+ ..++.++||||+||++|||++|..||...... ..+......... 
T Consensus       173 ~~~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~-~~l~~i~~~~g~~  242 (350)
T d1q5ka_         173 LVR---------GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLGTP  242 (350)
T ss_dssp             CCT---------TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-HHHHHHHHHHCCC
T ss_pred             ccC---------CcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHH-HHHHHHHHHhCCC
Confidence            521         122334568999999998765 46899999999999999999999999754221 112222111110 


Q ss_pred             -chhhhhcCccc----ccccccC--CcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          265 -DKVMEIVDPSL----LLEVTAN--NYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       265 -~~~~~~~~~~~----~~~~~~~--~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                       ........+..    .......  .........+.+.+|+.+||+.||++|||+.|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         243 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             CHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             00000000000    0000000  00111234567899999999999999999999985

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=3.6e-48  Score=340.45  Aligned_cols=265  Identities=19%  Similarity=0.216  Sum_probs=199.0

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCC-CCCcceeeceeecccCCCcceee
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIR-HRNLIKIITICSSIDFEGFDFKA  108 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~  108 (331)
                      ++|.++++||+|+||+||+|++..+++.||||+++...   .+.+.+|+.+|+.++ ||||+++++++..   ......+
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~---~~~~~~~  108 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKD---PVSRTPA  108 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEEC---TTTCSEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEe---cCCCcee
Confidence            57999999999999999999999999999999986443   356789999999995 9999999998652   3346789


Q ss_pred             EEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCC-cEEEcccCccccc
Q 046639          109 IVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDI-VAHVGDLGLAKFL  187 (331)
Q Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~-~~kl~Dfg~a~~~  187 (331)
                      +|||++.+++|..+.+     .+++..+..++.|++.||.|||++   ||+||||||+|||++.++ .++|+|||+|...
T Consensus       109 ~v~e~~~~~~L~~~~~-----~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~  180 (328)
T d3bqca1         109 LVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY  180 (328)
T ss_dssp             EEEECCCSCBGGGTTT-----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred             EEEeecCCCcHHHHhc-----CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceec
Confidence            9999999999987642     377889999999999999999999   999999999999998655 6899999999875


Q ss_pred             ccCCCCCcccccCCceeecccccccCCcccCCC-CCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCcc-
Q 046639          188 FGYEPGTAAETASNSIEIKGIVGYVAPEYGMGS-KASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALPD-  265 (331)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-  265 (331)
                      ..         ........+|+.|+|||.+.+. .++.++||||+||++++|++|..||.................... 
T Consensus       181 ~~---------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~  251 (328)
T d3bqca1         181 HP---------GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED  251 (328)
T ss_dssp             CT---------TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHH
T ss_pred             cC---------CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCch
Confidence            21         1223345689999999998775 479999999999999999999999975433222221111110000 


Q ss_pred             --------------hhhhhcCccccccc-ccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          266 --------------KVMEIVDPSLLLEV-TANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       266 --------------~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                                    .............. ..........+.+++.+|+.+||+.||.+|||+.|+++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         252 LYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             HHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                          00000000000000 00001122345667899999999999999999999975

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-48  Score=337.85  Aligned_cols=253  Identities=19%  Similarity=0.285  Sum_probs=199.5

Q ss_pred             cCCCcCceeeccCeeEEEEeee---cCCCceEEEEEeecc----chhhHHHHHHHHHHHHcCCC-CCcceeeceeecccC
Q 046639           30 NNFSPANKIGQGGVSIVYKGIL---DESRSIVAVKVVNLK----QKEASRSFAAECNALRNIRH-RNLIKIITICSSIDF  101 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~---~~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~  101 (331)
                      ++|.+++.||+|+||+||+|++   ..+++.||||+++..    +....+.+.+|+.++++++| |||+++++++     
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~-----   98 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-----   98 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE-----
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeee-----
Confidence            5699999999999999999987   447889999998533    22334567899999999976 8999999984     


Q ss_pred             CCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEccc
Q 046639          102 EGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDL  181 (331)
Q Consensus       102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Df  181 (331)
                      ......+++||++.+++|.+++.....  .+...+..++.|++.||.|+|++   +|+||||||+||+++.+|.+||+||
T Consensus        99 ~~~~~~~~v~e~~~~~~L~~~i~~~~~--~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DF  173 (322)
T d1vzoa_          99 QTETKLHLILDYINGGELFTHLSQRER--FTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDF  173 (322)
T ss_dssp             EETTEEEEEECCCCSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCS
T ss_pred             ccCCceeeeeecccccHHHHHHHhccc--ccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeec
Confidence            455689999999999999999976553  55688889999999999999999   9999999999999999999999999


Q ss_pred             CcccccccCCCCCcccccCCceeecccccccCCcccCCC--CCccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHH
Q 046639          182 GLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGS--KASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFV  259 (331)
Q Consensus       182 g~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~  259 (331)
                      |++..+..       ..........|++.|+|||.+.+.  .++.++|||||||+||+|++|..||........ .....
T Consensus       174 G~a~~~~~-------~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~-~~~i~  245 (322)
T d1vzoa_         174 GLSKEFVA-------DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-QAEIS  245 (322)
T ss_dssp             SEEEECCG-------GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-HHHHH
T ss_pred             cchhhhcc-------cccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHH
Confidence            99986522       122223445689999999998765  468899999999999999999999987543332 22222


Q ss_pred             HhhCcchhhhhcCcccccccccCCcchHHHHHHHHHHhhccccCCCCCCCCc-----HHHHHH
Q 046639          260 KMALPDKVMEIVDPSLLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERME-----MRDVVA  317 (331)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps-----~~~i~~  317 (331)
                      .......      +           ..+..++..+.+|+.+||+.||++|||     +.|+++
T Consensus       246 ~~~~~~~------~-----------~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         246 RRILKSE------P-----------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             HHHHHCC------C-----------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             HhcccCC------C-----------CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence            2111110      0           112245678999999999999999994     788864

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-48  Score=341.43  Aligned_cols=271  Identities=15%  Similarity=0.176  Sum_probs=198.8

Q ss_pred             hcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeecc--chhhHHHHHHHHHHHHcCCCCCcceeeceeecccCCCcce
Q 046639           29 TNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLK--QKEASRSFAAECNALRNIRHRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      .++|.++++||+|+||+||+|++..+++.||||++...  +....+.+.+|+.+++.++|||++++++++..........
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            46899999999999999999999999999999999644  3344567889999999999999999999876543323334


Q ss_pred             eeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          107 KAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                      .+++++++.+++|.+++...   .+++..+..++.|++.||.|||++   ||+||||||+||+++.+|.+|++|||++..
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~  170 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARH  170 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred             eEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcc
Confidence            45566677799999998543   478899999999999999999999   999999999999999999999999999875


Q ss_pred             cccCCCCCcccccCCceeecccccccCCcccCCCC-CccchhhHhHHHHHHHHHhCCCCCCcccCCcchHHHHHHhhCc-
Q 046639          187 LFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSK-ASVSGDVYNFGILLLEMFTRRRPTDAMFNEGLTLHEFVKMALP-  264 (331)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-  264 (331)
                      .           ........||+.|+|||...+.. ++.++|||||||++|+|++|.+||.+.... ............ 
T Consensus       171 ~-----------~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~-~~~~~i~~~~~~~  238 (348)
T d2gfsa1         171 T-----------DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTP  238 (348)
T ss_dssp             C-----------TGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCC
T ss_pred             c-----------CcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCC
Confidence            4           12233456889999999877654 689999999999999999999999754211 111222111111 


Q ss_pred             -chhhhhcCcc--------cccccccCCcchHHHHHHHHHHhhccccCCCCCCCCcHHHHHH
Q 046639          265 -DKVMEIVDPS--------LLLEVTANNYSWIEDCLVAVIGTGVTCSMESPMERMEMRDVVA  317 (331)
Q Consensus       265 -~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~i~~  317 (331)
                       ..........        ...............+...+.+|+.+||+.||.+|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         239 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             CHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence             0000000000        0000000000111234567889999999999999999999986

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=8.6e-43  Score=310.24  Aligned_cols=270  Identities=19%  Similarity=0.271  Sum_probs=192.6

Q ss_pred             cCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCC-----------CCCcceeeceeec
Q 046639           30 NNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIR-----------HRNLIKIITICSS   98 (331)
Q Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~~~~~~~~   98 (331)
                      ++|+++++||+|+||+||+|++..+++.||||+++.. ....+...+|+.+++.+.           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            4699999999999999999999999999999999744 333456788888888775           5788888888643


Q ss_pred             ccCCCcceeeEEEeecCC-CCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCCEEecCCCc-
Q 046639           99 IDFEGFDFKAIVFEYMQN-RNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHH-HCQPSIVHGDLKPSNILLDQDIV-  175 (331)
Q Consensus        99 ~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~~~~ivH~dik~~nilv~~~~~-  175 (331)
                         ......+++++++.. ++............+++..+..++.|++.||.|||+ .   ||+||||||+|||++.++. 
T Consensus        92 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~  165 (362)
T d1q8ya_          92 ---KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSP  165 (362)
T ss_dssp             ---EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETT
T ss_pred             ---ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCcc
Confidence               223344555555533 344555555566667888999999999999999998 6   9999999999999986653 


Q ss_pred             -----EEEcccCcccccccCCCCCcccccCCceeecccccccCCcccCCCCCccchhhHhHHHHHHHHHhCCCCCCcccC
Q 046639          176 -----AHVGDLGLAKFLFGYEPGTAAETASNSIEIKGIVGYVAPEYGMGSKASVSGDVYNFGILLLEMFTRRRPTDAMFN  250 (331)
Q Consensus       176 -----~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~  250 (331)
                           ++++|||.+....           .......||+.|+|||++.+..++.++||||+||++++|++|+.||.....
T Consensus       166 ~~~~~~kl~dfg~s~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~  234 (362)
T d1q8ya_         166 ENLIQIKIADLGNACWYD-----------EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEG  234 (362)
T ss_dssp             TTEEEEEECCCTTCEETT-----------BCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred             cccceeeEeecccccccc-----------cccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCcc
Confidence                 9999999987541           222345699999999999999999999999999999999999999975422


Q ss_pred             Ccch-----HHHHHHh--hCcchhh-------hhcC-cccc-----------cccccCCcchHHHHHHHHHHhhccccCC
Q 046639          251 EGLT-----LHEFVKM--ALPDKVM-------EIVD-PSLL-----------LEVTANNYSWIEDCLVAVIGTGVTCSME  304 (331)
Q Consensus       251 ~~~~-----~~~~~~~--~~~~~~~-------~~~~-~~~~-----------~~~~~~~~~~~~~~~~~l~~l~~~cl~~  304 (331)
                      ....     .......  ..+....       ...+ ....           .........+.....+.+.+|+.+||..
T Consensus       235 ~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~  314 (362)
T d1q8ya_         235 HSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL  314 (362)
T ss_dssp             ----CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCS
T ss_pred             ccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCC
Confidence            1110     1111110  0010000       0000 0000           0001112234456788999999999999


Q ss_pred             CCCCCCcHHHHHH
Q 046639          305 SPMERMEMRDVVA  317 (331)
Q Consensus       305 ~P~~Rps~~~i~~  317 (331)
                      ||.+|||+.|+++
T Consensus       315 dP~~Rpta~e~L~  327 (362)
T d1q8ya_         315 DPRKRADAGGLVN  327 (362)
T ss_dssp             STTTCBCHHHHHT
T ss_pred             ChhHCcCHHHHhc
Confidence            9999999999975

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.91  E-value=6.4e-25  Score=176.43  Aligned_cols=133  Identities=20%  Similarity=0.216  Sum_probs=104.7

Q ss_pred             CCcCceeeccCeeEEEEeeecCCCceEEEEEeeccc------------------hhhHHHHHHHHHHHHcCCCCCcceee
Q 046639           32 FSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQ------------------KEASRSFAAECNALRNIRHRNLIKII   93 (331)
Q Consensus        32 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------------------~~~~~~~~~e~~~l~~l~h~~i~~~~   93 (331)
                      +.++++||+|+||+||+|++. +++.||||+++...                  .........|...+.++.|.+++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            457899999999999999985 68899999875221                  11123356688899999999998877


Q ss_pred             ceeecccCCCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEecCC
Q 046639           94 TICSSIDFEGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQPSIVHGDLKPSNILLDQD  173 (331)
Q Consensus        94 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ivH~dik~~nilv~~~  173 (331)
                      ++.         ..+++||++++..+.+         ++......++.|++.++.+||++   ||+|+||||+|||++++
T Consensus        81 ~~~---------~~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~  139 (191)
T d1zara2          81 AWE---------GNAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE  139 (191)
T ss_dssp             EEE---------TTEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT
T ss_pred             Eec---------CCEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC
Confidence            652         2379999997765543         23345567899999999999999   99999999999999976


Q ss_pred             CcEEEcccCccccc
Q 046639          174 IVAHVGDLGLAKFL  187 (331)
Q Consensus       174 ~~~kl~Dfg~a~~~  187 (331)
                      + ++|+|||.|...
T Consensus       140 ~-~~liDFG~a~~~  152 (191)
T d1zara2         140 G-IWIIDFPQSVEV  152 (191)
T ss_dssp             E-EEECCCTTCEET
T ss_pred             C-EEEEECCCcccC
Confidence            5 889999998764

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.78  E-value=1.5e-08  Score=83.60  Aligned_cols=150  Identities=17%  Similarity=0.141  Sum_probs=101.9

Q ss_pred             HHHHHHhcCCCcCceeeccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCC-CCCcceeeceeecccC
Q 046639           23 AELSKATNNFSPANKIGQGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIR-HRNLIKIITICSSIDF  101 (331)
Q Consensus        23 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~  101 (331)
                      .++......|.+.+..+.++.+.||+...  ++..+++|+...........+..|...++.+. +-.+.+++.++     
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~-----   79 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE-----   79 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE-----
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEE-----
Confidence            56777778888777766666678998754  45567788875444333445677888877663 33345555552     


Q ss_pred             CCcceeeEEEeecCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcCC--------------------------
Q 046639          102 EGFDFKAIVFEYMQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHCQ--------------------------  155 (331)
Q Consensus       102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--------------------------  155 (331)
                      ..++..++||++++|.++.+.....       .....++.++...++.||+...                          
T Consensus        80 ~~~~~~~lv~~~l~G~~~~~~~~~~-------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (263)
T d1j7la_          80 RHDGWSNLLMSEADGVLCSEEYEDE-------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLAD  152 (263)
T ss_dssp             EETTEEEEEEECCSSEEHHHHTTTC-------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSC
T ss_pred             ecCCceEEEEEeccccccccccccc-------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhh
Confidence            3346778999999998887654221       1123355666777777775431                          


Q ss_pred             ------------------------------CCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          156 ------------------------------PSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       156 ------------------------------~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                                                    ..++|+|+.|.||++++++.+-|+||+.+..
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         153 VDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             CCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             hhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                          2489999999999999877777999998764

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.97  E-value=8.7e-06  Score=66.07  Aligned_cols=131  Identities=13%  Similarity=0.087  Sum_probs=79.9

Q ss_pred             eeeccCe-eEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCC--CCcceeeceeecccCCCcceeeEEEee
Q 046639           37 KIGQGGV-SIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRH--RNLIKIITICSSIDFEGFDFKAIVFEY  113 (331)
Q Consensus        37 ~lg~G~~-g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~~~~~~lv~e~  113 (331)
                      .+..|.. +.||+.... ++..+++|......   ...+..|...++.+..  -.+.+++.++     .+.+..++||++
T Consensus        17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~-----~~~~~~~~v~~~   87 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVV-----TEAGRDWLLLGE   87 (255)
T ss_dssp             ECSCTTSSCEEEEEECT-TSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEE-----ECSSCEEEEEEC
T ss_pred             EcCCcccCCeEEEEEeC-CCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeec-----ccccceEEEEEe
Confidence            4444443 678987664 45567888764332   2345677777776642  2345555553     234567899999


Q ss_pred             cCCCCHHHHHHhccCCccchHHHHHHHHHHHHHHHHHhhcC---------------------------------------
Q 046639          114 MQNRNLEQWLRQSNGQLRFLTQRVNIAIDVSFAIEYFHHHC---------------------------------------  154 (331)
Q Consensus       114 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---------------------------------------  154 (331)
                      ++|.++.+..       ..   ....+.++...++.||+..                                       
T Consensus        88 i~G~~~~~~~-------~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (255)
T d1nd4a_          88 VPGQDLLSSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA  157 (255)
T ss_dssp             CSSEETTTSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred             eecccccccc-------cc---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhH
Confidence            9886653310       00   0112234444445555321                                       


Q ss_pred             ----------------CCCeeecCCCCCCEEecCCCcEEEcccCcccc
Q 046639          155 ----------------QPSIVHGDLKPSNILLDQDIVAHVGDLGLAKF  186 (331)
Q Consensus       155 ----------------~~~ivH~dik~~nilv~~~~~~kl~Dfg~a~~  186 (331)
                                      ...++|+|+.|.||+++++..+-|+||+.+..
T Consensus       158 ~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         158 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence                            02489999999999999877778999998753

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.75  E-value=6.4e-05  Score=65.05  Aligned_cols=77  Identities=16%  Similarity=0.141  Sum_probs=46.2

Q ss_pred             CceeeccCeeEEEEeeecCCCceEEEEEeecc-------chhhHHHHHHHHHHHHcCC-C--CCcceeeceeecccCCCc
Q 046639           35 ANKIGQGGVSIVYKGILDESRSIVAVKVVNLK-------QKEASRSFAAECNALRNIR-H--RNLIKIITICSSIDFEGF  104 (331)
Q Consensus        35 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~e~~~l~~l~-h--~~i~~~~~~~~~~~~~~~  104 (331)
                      .+.||.|....||++....+++.+++|.....       .+....+...|+..++.+. +  ..+++++.+.       .
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d-------~  103 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD-------T  103 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE-------T
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc-------C
Confidence            45789999999999988777888999864311       1112233556777777663 2  3345555442       2


Q ss_pred             ceeeEEEeecCCCC
Q 046639          105 DFKAIVFEYMQNRN  118 (331)
Q Consensus       105 ~~~~lv~e~~~~~~  118 (331)
                      ...++|||++.+..
T Consensus       104 ~~~~lvmE~L~~~~  117 (392)
T d2pula1         104 EMAVTVMEDLSHLK  117 (392)
T ss_dssp             TTTEEEECCCTTSE
T ss_pred             CCCEEEEeccCCcc
Confidence            23478999997644

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.10  E-value=0.0081  Score=49.52  Aligned_cols=62  Identities=6%  Similarity=0.053  Sum_probs=37.9

Q ss_pred             ccHHHHHHHhcCCCcCceee-----ccCeeEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCC
Q 046639           20 ISYAELSKATNNFSPANKIG-----QGGVSIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIR   85 (331)
Q Consensus        20 ~~~~~~~~~~~~y~~~~~lg-----~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~   85 (331)
                      ++..++.....+|.+++...     .|---+.|..... ++ .+++|++....  ....+..|+.++..+.
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~-~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~   69 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV--EKNDLPFFLGLMQHLA   69 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEES-SC-CEEEEEECC-----CCHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEEC-CC-cEEEEEcCCCC--CHHHHHHHHHHHHhhh
Confidence            46788889999999876554     4555778887664 33 58899885321  2233455666666653

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.10  E-value=0.0026  Score=53.02  Aligned_cols=71  Identities=13%  Similarity=0.084  Sum_probs=41.5

Q ss_pred             eEEEEeeecCCCceEEEEEeeccchhhHHHHHHHHHHHHcCCCCC--cceeeceeecccCCCcceeeEEEeecCC
Q 046639           44 SIVYKGILDESRSIVAVKVVNLKQKEASRSFAAECNALRNIRHRN--LIKIITICSSIDFEGFDFKAIVFEYMQN  116 (331)
Q Consensus        44 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~~~~~~lv~e~~~~  116 (331)
                      -.||++... +|..+++|+.... ....+.+..|...+..|....  ++..+...........+..+.++++++|
T Consensus        36 N~vy~v~~~-dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G  108 (325)
T d1zyla1          36 NRVYQFQDE-DRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG  108 (325)
T ss_dssp             SEEEEECCT-TCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred             ceeEEEEcC-CCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence            579998764 6778999987532 223455777888887774221  1212211111112335567888998865

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.60  E-value=0.0031  Score=54.10  Aligned_cols=74  Identities=22%  Similarity=0.217  Sum_probs=48.0

Q ss_pred             CceeeccCeeEEEEeeecC-------CCceEEEEEeeccchhhHHHHHHHHHHHHcCC-CCCcceeeceeecccCCCcce
Q 046639           35 ANKIGQGGVSIVYKGILDE-------SRSIVAVKVVNLKQKEASRSFAAECNALRNIR-HRNLIKIITICSSIDFEGFDF  106 (331)
Q Consensus        35 ~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~  106 (331)
                      ++.|+.|-.-.+|++....       ..+.|.+++....  .......+|..+++.+. +.-..++++++.         
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~---------  115 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS---------  115 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET---------
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcC---------
Confidence            4678888888999987642       3456777776522  22335668888888885 433456666631         


Q ss_pred             eeEEEeecCCCCH
Q 046639          107 KAIVFEYMQNRNL  119 (331)
Q Consensus       107 ~~lv~e~~~~~~L  119 (331)
                      -..|+||++|.++
T Consensus       116 ~g~I~efi~g~~l  128 (395)
T d1nw1a_         116 GGRLEEYIPSRPL  128 (395)
T ss_dssp             TEEEECCCCEEEC
T ss_pred             CceEEEEeccccC
Confidence            1578999976444